<SEC-DOCUMENT>0000927653-21-000013.txt : 20210202
<SEC-HEADER>0000927653-21-000013.hdr.sgml : 20210202
<ACCEPTANCE-DATETIME>20210202160449
ACCESSION NUMBER:		0000927653-21-000013
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		77
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210202
DATE AS OF CHANGE:		20210202

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MCKESSON CORP
		CENTRAL INDEX KEY:			0000927653
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				943207296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13252
		FILM NUMBER:		21581398

	BUSINESS ADDRESS:	
		STREET 1:		6555 STATE HIGHWAY 161
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039
		BUSINESS PHONE:		972-446-4800

	MAIL ADDRESS:	
		STREET 1:		6555 STATE HIGHWAY 161
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON HBOC INC
		DATE OF NAME CHANGE:	19990115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON CORP
		DATE OF NAME CHANGE:	19950209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SP VENTURES INC
		DATE OF NAME CHANGE:	19940728
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>mck-20201231.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:734100a7-c7c1-4795-ad72-160dc37ce333,g:f6cbe616-07cc-4518-be11-bf83875971ba,d:b9c6f28fe5144278bb122fe3b38cf454--><html xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:mck="http://mckesson123.com/20201231" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mck-20201231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80L2ZyYWc6MTU5OTdmZWM3NzNjNDY0ZmFlMTZiYTc2Nzk0YTA0NmQvdGFibGU6MTk1YzI1NGYyZWIxNDU0MjlkNTc4YmNiNzhkMDFhMmUvdGFibGVyYW5nZToxOTVjMjU0ZjJlYjE0NTQyOWQ1NzhiY2I3OGQwMWEyZV8zLTItMS0xLTA_576b9a88-aeff-4b10-8f96-0f6f5d9c9287">0000927653</ix:nonNumeric><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80L2ZyYWc6MTU5OTdmZWM3NzNjNDY0ZmFlMTZiYTc2Nzk0YTA0NmQvdGFibGU6MTk1YzI1NGYyZWIxNDU0MjlkNTc4YmNiNzhkMDFhMmUvdGFibGVyYW5nZToxOTVjMjU0ZjJlYjE0NTQyOWQ1NzhiY2I3OGQwMWEyZV80LTQtMS0xLTA_95fba560-ace9-45ee-a330-846e28a79ab8">03/31</ix:nonNumeric><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80L2ZyYWc6MTU5OTdmZWM3NzNjNDY0ZmFlMTZiYTc2Nzk0YTA0NmQvdGFibGU6MTk1YzI1NGYyZWIxNDU0MjlkNTc4YmNiNzhkMDFhMmUvdGFibGVyYW5nZToxOTVjMjU0ZjJlYjE0NTQyOWQ1NzhiY2I3OGQwMWEyZV8xMS0yLTEtMS0w_55c28bf5-46f5-4e46-9b50-21544f2b5d7d">2021</ix:nonNumeric><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80L2ZyYWc6MTU5OTdmZWM3NzNjNDY0ZmFlMTZiYTc2Nzk0YTA0NmQvdGFibGU6MTk1YzI1NGYyZWIxNDU0MjlkNTc4YmNiNzhkMDFhMmUvdGFibGVyYW5nZToxOTVjMjU0ZjJlYjE0NTQyOWQ1NzhiY2I3OGQwMWEyZV8xMi0yLTEtMS0w_54133081-b974-4cf1-b7de-c4076a82813d">Q3</ix:nonNumeric><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80L2ZyYWc6MTU5OTdmZWM3NzNjNDY0ZmFlMTZiYTc2Nzk0YTA0NmQvdGFibGU6MTk1YzI1NGYyZWIxNDU0MjlkNTc4YmNiNzhkMDFhMmUvdGFibGVyYW5nZToxOTVjMjU0ZjJlYjE0NTQyOWQ1NzhiY2I3OGQwMWEyZV8xMy0yLTEtMS0w_9675a51a-b29e-4bf5-be60-136b19c26ab6">false</ix:nonNumeric><ix:nonNumeric contextRef="id344251a53d94ccf87e27d63b0bfe5c9_D20190401-20200331" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNC0wLTEtMS0w_e059b575-1bdb-42b0-8a48-ed92a77e999c">us-gaap:AccountingStandardsUpdate201613Member</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mck-20201231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe90ddd61815466e8647519b72b5ccc1_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id264d9c87dcc405e945fdd97ce807af7_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A0625NotesDue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if58e825fe2a34bef8acbd60f66bf6ca3_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1500NotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0dab164e3ea46fe8045e94da8af3a96_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1625NotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18b68afdbd2149a79f7d4fbccb76c182_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A3125NotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i7a0bf71acb034de79df20792261b0fe2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f75dc9fda5c41feb4e0a7addec435d0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i046c55cb833a40dea20cd595ea58722c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9738445b8a5e41869bba0cf8d810974d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79239b1b57fc45128439b982e6e306d9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if702f6988b73408fb0203fbcf4cfff59_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22f4cb39451147ea9fe68b8f991a70ff_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib03cda0901f74396a9d42a5e93e5f9eb_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icda41b88f4cc470eb74edf0bae68f725_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76dbf276f41c433aa3233de59bace255_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37974d926d4e49eeae69ab2a0f22c9e5_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i454504e100134adfada4c6b22b8a933a_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f6abb61154c4e5580b369029cca081f_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7eb9f1e25c3d41efb703c958f350bf20_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3e05b2e0a9d44ed8dea34e18361b913_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36774e6a606943108bbf2290e991ad35_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67e7913b409c4c2188c465886e28af95_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7265c70a233467086b5103a31edaceb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6641e8af9e64c7aae662865d224c625_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4ddbb098af84acd823dab9a811ce25e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i436786cf3fa44a21863b50c1e252c871_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ab271cbf75f4a6992e0fb34901ba49d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4bf4310d43a446aa281ebdc500f1c56_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa5fbe0fd0874aebab734ed30f8b57f0_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a1d4b79fc7b43f7afae361190241425_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0374ed6096c4fc79915873d9944afab_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70252b6394004f7b954609f75985fb93_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6cbf15310ca46869b7c2a9274df3ebf_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id344251a53d94ccf87e27d63b0bfe5c9_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i639bd12a270543c8ad6932bf9f601e45_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i846abdfeaa6544789a5e524558b9443a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if69ab677c8f149499b3a80ccbdfc1050_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93b2ebdda56e4926b226f0d3df3470ab_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4b3986493e54543ab88e63dc656f1a2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb7456909d2b497aa24862ae836a1a66_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5636635f7cb74ec7bf4beff8d593f7f3_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i935b818ca9a54205944e103ce26b3be1_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16fd29d7481e4494b840a459e3299e08_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28e45f80bb9349f5a5ec660f5376691c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8106bbb2dc0a4f59acc6299d4f71a45a_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2011d00a9d33400ab4105b02fddf648e_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2895dc4463844ffe85d8bea8b2472d44_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6429e408d6643fe8ed7a32451d1973a_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbfbb7ecfac64c7d996917034b9d6fbe_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55fa8262a4e440d49790e9cf14b51dbd_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bbd5766e5e1426fa1e48b9db23fb33a_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f3407c46f4b4be98e132df1cb8b89d7_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45ef706885764ecd9440a440f9bd9396_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id768d1b9bff84003a458da02ab6054de_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e571302aec24a36936d3e24fb499981_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa37fcbfd262489885d497fe4920cf55_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fe05a45bd0447499ad4274ebee0e5de_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2706f6905b14cc3a97aaf70ac667df6_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87686bf1372a401ab1608bbccf25c908_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d696af4cf5445b28748e6c09ac7c601_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i308d835dd02042a8b515529815bd98ec_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7de52a5965ed47d1812e75a3c210ca1d_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i476906634a324f9287de597fd0120a9c_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03968c2d88954a3f8b182452bc2bbaa5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a823c07346941aca960d012bef9774a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34964563458343118c3362841fc34697_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1510b0bae31c44278e232e7cafd63a4d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd724fc113f1423fab76a0b7d9141942_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id25a265859cb4a5fab9c40c7cdf40f44_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9025fe41f3c4206832a02f6067cccc8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia65b1cdade72453c9c9547d6ed17b3e9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53dbe944eae1492aa687e479fc7a11b9_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0ed625dd55947b98750c596c6405402_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48dad6b27bfc4bb98f4e86f70d71263b_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e42b52ae7334bbc8d4c95f67d0beb34_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id686b4181792461ea0b02a307e3b6b16_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81babc7a70954522b7b22ac34fdd8414_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dcbc3a9c5dd4e11aa4f98339c48f19c_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic798201eb4fa4f7a804f2e801548f37c_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d03dd7c905342d1a2937caa74731528_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46e5c95277ec49cb8ca34ae6e95c7f38_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0170e2288b194e75bbcd4d3065c84185_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d01fe2b386243908ec14fc43582d826_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic38570a58197439eb0c8a6f1f9b9fd62_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f0d013d62e64c1a9ff51d7df3d8f8fc_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58124d80a4e44920b8506455c425e375_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6558f17c2334aff80dd0d663259b6c9_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8eca560196144a6ae00495db6084899_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8f0d7cc99df4d939573a16bbc9b0efb_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36d180f203204936b0e8fc121ab9b7de_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i457a8c3bc27049ef85e109fd88303f2c_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d7db3179e2e47f293b957b1ef8858cd_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01c4d416ec1c40a593cf210126c97ef4_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic26a952d776148b6b791451cbf1e0f2c_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i956f7e118d784444a97416bdea861a56_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>mck:segment</xbrli:measure></xbrli:unit><xbrli:context id="i8fda1e3442374708947bef1923d2f19e_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b34b0a4a2344072ae6737a15d1ec38a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bf1ccbd66194ee193c7054b7fb9cad3_I20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2ee20a5c84e431a9dbe88126ea7debb_D20190701-20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24bafc5133144c1f9d0575855df32cdd_D20190701-20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i651e12a9a9314eaead5f5def7b8cb902_I20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i6b3a22eac44c42f8966d20ec62021a93_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bb3d5efc8c84f3896fe23c52b92310e_I20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieba62539ca00495ba37020bffe3d644f_I20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b86094c4db947ae9f4ef0d8fd8d773a_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72904c34cf28486695441a05e83b4257_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0946d2a17db14d63b64a7a7251e88c34_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f856c9a81854c4287e9fd8fc2f4afdc_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TransitionServicesAgreementsTSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaaf01c3e7a448f788de27496483bc0d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i715e9debe5f0419fa1ede68430828e3c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54af79268ad141df9f90e22d7b9b6595_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0ee8653fb6141acba5c088e3b9425bc_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:WalgreensBootsAllianceJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb1ee1c3366844f7af5c1f57a7d2a100_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06bcacee536741a5b8412ad11e052a04_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i938f21cb5003435093dd61e42f1e4b04_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1089a6502fe643b2af007927de94cff7_D20200401-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd175625828b47dcab648e0b14392f10_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0736a2a757fc454b88a193a6988112ef_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0497adf27fa406783b9193a572e5457_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f9649ec563d482b84c3260463f09372_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6d5fffd99d0450f8f071044f671a597_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91c13ec8524c453f9fbf254e519c6157_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i616db767164b421690d7840423dc72a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd12a38f8159497f9b8bc50d69f1a89a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20a65cc8e8234e5eb9b8668ac6d80e35_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5777604ac50d42d29d8f706480015dbc_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39bbef1ec8fc483a88d5b2eb2083b4a9_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaba638f6e46a48be9bcfd94e751a80d0_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7e8ac65eea64557801e653b724c7e05_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40a1d1ff2c634d9f894ff1faed74cab9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd41af04654b404a9739658b0498956b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dcd5be0a9224164b3b9c477afe71a48_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5111ebf6d6d4aa8b255575260d32886_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia582bee9ce874e8bb235617714cf6227_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd022885b12e488c84b28eedee6a78ba_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e8de5e2935b4c3496531d27f8e5fb9d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60745e30425f4f529e698ec37e36d916_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cf4b0b9a9c540999eb1517cab23e300_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2223aea755c43138b22205b7dce1033_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if54fe59c7ab4486da50c3e383e0514cb_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc7a74b6b95d4a9e9c701380f77e3b51_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id80f00bff7b5467b812041c7200a62b2_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee23f0fe86e64c7bae441a8ea5cc1c91_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i499179d5d599419b93690bc3104dd04a_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia996899a77814c11b1495ca0445af186_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic713f1d7bbaa46368d505facade21e5e_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib36209733adf465ab9a09ed10cfc40ba_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief6c871b558e47b38754e0ea56f455a3_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f91b4dd9d724e81a9d50e837b7e65d6_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib74da540dfec4334b95c1028aad4aabb_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia76b1ab18790411e9e7fdeb98f2f4606_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55e8174fad24466896ea35fa3e18419c_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifafa9479474c4281a1fb299fa0ed48b3_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33926b73aa0043d2989ae3b788c16046_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib06a1c55db15496e8c44849e29aea6c6_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23356c66de0b48bfa4370bb815d51010_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib632ae517264462ea49f0e14b37abe4d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic60a002dcc044ef2a73c71e490891614_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifce4292925d84d7bb62d6111b21c8e27_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i877beefd260c4117b551163018536ff7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifad220b5d8ba4d42a4c7b10bf33c3d2c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65219f93663148a283a10dfe499597e9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3beceef97ffc465bb547b319a855c1fd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bb04a8ba65947f39b3457cfdc48939a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f647fda026d4fd8ab82de9ade2df506_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i001894ef5d384e6194e9a49a8e30453a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1d41963e1e64af4a2db91749e48ba60_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ae50b9f9854471da2e71204c4eedcb1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ab08a4977fc44d4908e07229d064f40_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e166dc2bc4e4407ac307367798e7a56_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f352c2923e048e7bcd08e46042cbead_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08ed9c0c5f6d4a748a507235f5b297eb_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ac4183cf22d4c829d4a7bc371cc268c_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30c6a601291c426daef2c98a6924abf6_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2503fe9d11b43b3b558877f874ef3c7_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea7615b447b24e05ba7119aa98301bad_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="county"><xbrli:measure>mck:county</xbrli:measure></xbrli:unit><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i2c1af7ae051f4acd85bdcfaf6f8522c4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i626c1e0e782e474b92df366e001d6dd2_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a434cdc734d4abf996142dfdc8544ec_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5b1c59088c8425e8c672396cbc8f14f_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7442088aa6c644dab9cdca71fad61eba_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96e8498baa5c4166b0360154493d4319_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia893650b8c174d97a0fff05ba6bde046_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0a2cb17de16467787ff8f495afca17a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10ab863a7218445ca985683b1005b32b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f97e844a5a143218fd2d44d5b013a4e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e8778eb76054f0395746e9375d66efe_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if22a8f70dcc24adc95cac8f86540d584_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i849ff8d4511349eb9c3153967d1f7f12_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a05c352bec44a6fae02dc63bfae55f7_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31fd56c5e498439cbb9f159e3e0e2e0d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied0e473ba615450b86643eccb05bd229_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3a8cac6d54b4c2ca9b7378d13ef870b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4af1d24608d74947ab7497e23209ad59_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c62b22aacf74756b7dfff6157966085_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie37cc4ec5c0e44558b2a32aba2c5fc0e_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11866fb0993444bd8e695ef414d06b6a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1e09321f5344cef88ba1a2c8931ec04_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ed9ea6e51234863bd501477e55a7136_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85b5d437b88a43c3b57c3014d5ae8bf1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4fae59f18a14a25b3bca73a248e3bc3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dbd3be0a56f450cba497eb475a1c80b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie24dd23acc4f44e2a91794113bb10c51_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02543cc7d8874da9b9dd772a66bad70c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0fa20a992b84dd9a41f9cbb8b17ee14_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i566978f4e878431094db0c99aa04c1ac_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i502121074c55491db6f36aeb28a2d5f2_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i900790fc3b604ed6aeaa993f4b448b36_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic38f289eb4674ef2811a0175289d6579_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb9d72428fbd4515ba2df2bc472b2522_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9435ea6faaa49bfa7de0a9fd3ee3563_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9099621a5b034f1783335526d709c949_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i378dda10c10e4abda769223163b7e4e7_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cd1df3bc0b547ba9f623f4ef73d5370_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i511bb16900684b6ea922b921c9d4dee0_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cfa3015624b4bc5b6b7f68095b82e08_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6773d34279984d34b8e2570dbfeac99d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i658902b07b2b449f913e2bd8456c8fa2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i523fcde586d342cc8bd48e9569ed97f0_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18fb0f7e2d57454c8ab3f9bf8d8d22cd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b800361d6a84fc7b5a2446b3d1e7341_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i963a00ca4138498ca7ab4ca57f1a7f37_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i725fcea7818746d1a1609a91129d7859_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id285ee1563e043a08cf17e27f0adff21_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc05b27d7e0a4e78a4db26cb12058f85_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5769cd643a314785bc6bb343b9674112_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieafb5736403f465eb913bf612cdc985a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i659552bb536e4d988f20153df0383f90_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a9556d9999d4dad8956e6c895b8d4ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f42cc658d804c91ab0038c670ab193b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e3d82d95ff34d09ad54cbb7a9568eeb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A365NotesDueNovember302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib62e3807a7114d0899925f4b51210868_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A365NotesDueNovember302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61243968789b45e78979a62d792f3bf2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMarch12021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic23cdb3eba794da3ab936c09bb3753eb_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMarch12021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic49f2f1769cd420c9df5352e8067b68d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff33e00fbaee41eea7defea825d96e6c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f896c781b42418fab54308abf10a3ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2024e246ff5243e1a182377483b428d9_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83ba1dcc0fa0463e870a0c6af64a8894_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3929998884064e1fb42a501356c5aa3b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45681222eb314cadaa16245b1eda2bb3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida48ca8acd984f98badfab324817c495_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13860847712f4090af128c3ef55aac24_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccb710e426964f068ee01c91061447f5_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i722ba8780dd64ef3998e85ae30f7b8e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c3b5bf1138e4193b4ed05d0221ddb16_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee65e5a7c91d480fa442a25bf99a4310_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa304a69e98947ed8c2ebd69d84693fe_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i543d6ee25e6648e9bfddfd675bdc4e0f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icac37f0bb50c47a88452230ae579cc0e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59f7fd483700447b913388bbe402cb2a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice7a4f35e6e047a59039a07c27481e3c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if338ee6ce8f3482a80ee390eacdd1b93_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf0ef65f413640089349522b6d1f61fb_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9e2e544a5d24e309b0b1d476df167c4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5859abcac6664cec9fd998af2d0f2d14_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57d99627daf846ff9841f02dd67e8763_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if427cce4e6654f628a7f645a93e796d1_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54d06a347a4e4e5e91c4f62ec54e8cc2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06786762035a45b180efa3c21821bf20_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b3e1030e25049dcab5e8f463f79cc7e_I20201203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a3ede9e6e5140df88d6504a6002bf36_D20201203-20201203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-03</xbrli:startDate><xbrli:endDate>2020-12-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dcb7ea25a61456ea8011e544254a46e_I20201201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMarch12021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8b3fd2d698249cdb62866fb761a1437_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbedee4fddac4d1e918ff2e43b85f5b3_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide009e05a6744804a59fcd84efd0b7a3_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b8012a1221f40588f7488916fd1b3b0_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia75a14b05a5c4c2ba266322f4ed4794b_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d587484c8314278aa228f8a047c449e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3673260c4a0e4c6789566685bcdc80f9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia561add5441945f9b6e6f005c32de046_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3df3eaf8483344e189aadb44a6e73dfc_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cf6891e4f624ba4b2c8f2b8b8ad994a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc76a63f576047c49638f41ac0d91ae3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if13ed91051e047c597b44d113a7413be_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i451d84e1d8a944789fa6835d4573fb2a_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c39c0200ce7449fb14e39cf375472fa_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9572515afb1f475086d3833719ce1ee7_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89e2b4abb66f4b8490bd136400166514_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia909bddd810745a78d740e262952804d_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5720a12c6a9847d3959ececda0b47b78_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie862f63e9e384a2384d0f8f2895b4fef_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:ExecutiveBenefitRetirementPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a58762e511c405da243fad3b79d9702_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:ExecutiveBenefitRetirementPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9ce75f89ad84830aa465d0823e6683b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87abebafd2444aea947519a813b73651_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="participant"><xbrli:measure>mck:participant</xbrli:measure></xbrli:unit><xbrli:context id="ie662489344214deea919f1b5ac9b8617_D20190601-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27e1b65706fe43c8b7b96d04e78a9a4b_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if044bd6776b7450a96d800457d558593_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77fd18e4162c441aa58436014d857d12_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i0d9cf49bcf574771b799ca4645191cd5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a0ca354dcd646dbb94a5e6bc0adc910_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide3c05407d4f405faeeb775e3cadb1ad_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3392a15e42349f38396d43edec58984_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieae8ce38c55c4a8183867cb63bfddafb_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ac357c6d2694d3e854ab420c7c33a3e_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d10966d07b64ebba1b226a32e8e56fa_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:context id="iae697c5a606444c8a0bf468944693083_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c3d87e0bc6d4b3788054a9adf38efdf_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib05778dd9f2047e7ab989296e4f1f027_I20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="i4ffae78da5324045885fd5c5f9e72fe7_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a1e7fab3c5a46bc80683fd7a9936356_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36b3bcf8d524467bacd1c159707af361_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09c294f2acd74c33bb8e9ada8e29bfef_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if86aed3e96a64acfb7d6c3d4ba3f32e0_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51b2cfed82a94bea9d5b40efccf351cc_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i132f49f70d8e4b459e1dfdc3b23932f9_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bed0108d30a4edbadaa59d784d7e6f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6fd83f4ec5346a89c43a4d4970b587b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e172a5b89714b5f980c0d1515d155bb_I20200427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idae826ee5fc34b5a8ac7443ee5012249_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4108ab99008d4e68a3dd3eae636c4e61_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacfcda1e22f341b0934dd329fa019e54_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2a0e643e93146bc9920807b4ff5583b_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i906ea84070b64689a6d04852f20df452_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35d99ea68d0b48eab76bb746417d8dd8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0eeec9e2862e4c51b6d12a38ac428a0e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic99175677b954f009bf7dd3ff1f205b9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie84b0678aefd46f39446455df3d55df3_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ba05cbb6a39421ca690fc9912bd454c_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57bde6e22b1b418fb5cb8d67718f73cc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b4553eec3884a74b9c29ba57c8f46fc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i041bb96bdf7c4fd18af85821acc08bdb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8c751112cf84239a9ea0b86ba0c4dce_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70cef476be954ba5826ef9cb90ed5bb0_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i941389e63f2541a1a376a9b746120d0e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ec64489b9604c8d8f972120fbda6056_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbfc5ce51aac4403bc97157e950c8b20_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i149087f716324b259895a04a05c5bb9c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b7780a8f9e948f093b5fd1cce4b2871_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89165375051c4a2399f00117e4669f3f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85e18c845f544dc5b2de3609dccc18d1_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e01229209e24fcbbaac835c6868ce3e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46eff3e723494b9b8db10c46e8d5141e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1a73cb404974bc2b79ec51446e9c1ae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9417de73a5c549f0be8c082c4db84e40_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69cadcfb856d4a7a9004d7cc9933b9d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb9595c53e61414fa6ad030992206402_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20f0b972582444239e16f4edffd19f90_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d9d75c3418b485e94de80a639f2a0fa_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib047b820d28e468fb76500c99500cb2c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaf792582ac14ec9877670dd6af11a65_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7840da1cacf0419993b0a527d8920e10_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c9db4a4610b4829b8b00be2a529a9cc_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i701d2f10e13b41148f385570a86bf3b1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadffe49dd7104768a9a656790d004b41_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="company"><xbrli:measure>mck:company</xbrli:measure></xbrli:unit><xbrli:unit id="investmentsecurity"><xbrli:measure>mck:investmentSecurity</xbrli:measure></xbrli:unit><xbrli:context id="ia32a43bf4c32481bb6ea7a38d845082c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f2700a332404782bc605abd43a2168b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="case"><xbrli:measure>mck:case</xbrli:measure></xbrli:unit><xbrli:context id="i9a5ab16c64ae4891a9ee3b4e317ce1eb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11feebab2b6a424dbf4daff39a96c1b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb5a21abc8d848b6956e3feaf80201be_I20200114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1814ff2457bd41d6804ef58f25e4d38e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>mck:state</xbrli:measure></xbrli:unit><xbrli:context id="icbc6c502b0884c4985e06716f2758c89_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="stateattorney"><xbrli:measure>mck:stateAttorney</xbrli:measure></xbrli:unit><xbrli:context id="if621de71312448b2a9e258676fa2ca7f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i466b8e02cb9445f399b466a5da7612c9_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i296306fefeb14dec9e27a205cd23548a_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i810be42fbf2d4974a731649985916aec_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b59d9c3f0e146b8a720c89acae06997_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f96022346a941118bddf4181736007f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i307db805735d4eed947d313935f69a7c_D20130517-20130517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-05-17</xbrli:startDate><xbrli:endDate>2013-05-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70c71945e9ab4abc8b1e9671bc5cf37f_D20130517-20130517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-05-17</xbrli:startDate><xbrli:endDate>2013-05-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="fax_number"><xbrli:measure>mck:fax_number</xbrli:measure></xbrli:unit><xbrli:context id="iea73c883add347f580abc569d92611ad_I20190813"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="fax"><xbrli:measure>mck:fax</xbrli:measure></xbrli:unit><xbrli:unit id="investmentfund"><xbrli:measure>mck:investmentFund</xbrli:measure></xbrli:unit><xbrli:context id="i4f79315064404a0d802db3a9c2d14fe6_I20171229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c90799af4454695aebcf7f2731092cd_I20171230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5f178fedc5b4cf6bdb61d18797a2680_I20180430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>mck:vote</xbrli:measure></xbrli:unit><xbrli:context id="i2b9d2822c0fe41fc86291a1793d818ec_D20200728-20200728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-28</xbrli:startDate><xbrli:endDate>2020-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee7001dbe701429a8640019b5e925c83_D20200729-20200729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-29</xbrli:startDate><xbrli:endDate>2020-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5c361bf141b4eb9891a9ae3f5e870b1_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia83332fa877f4f95a2db6855471cfa83_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85bcde357ef24cd5a6fe11d759211780_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42de281c12634e1094f4341b8340f8c9_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i245807132e61488c94b12390e4121f99_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30850816b81c420cb3a11454129cb099_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4565d58c6438432884a322271cdcb467_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60ebfe67a3044298876108334986e57c_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b20d10786654fff938ed21b46d91890_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b48d9346ede475eaa9d050fcd5e2432_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f8cdf78c925481bb9fb846b51a37d4c_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i171a7450485e4fa19bb98c562f3f0835_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad19a75609034338a9616075a375513e_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e441b29128c48aea910381165c7b723_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ad855b967ce4ddd8019fe6ca830c068_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4b2c4b06218485da8544d4e41e7e4cc_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i266fe3f418d84aa7b7249926cfc9d280_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida514f8038f5465c9dc701830da2f003_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39719f584adb44c1b39699ef890bfe15_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58b08f5f1f644db4945b8ba02324d11d_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaec3dac337e46b3b24229e240ac2c53_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3048995a4a7944508cb95b392a4d29cd_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4603c284d62e4e5c9442bdc1f75663f1_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67aca6db78904dec90dc3b22e3800fd5_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id38d110d6f9c4cf097c87208b255cff1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaff277eea93447ab86287935d95d1f47_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dd77d36d7ae4ca38af80569eac5764d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ab154724e0a4ea78f86170c48cb3e03_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7016c62d475b44cf8995815c2ee6e6c2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic53b88b03d43406caa082e97b8198de2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i287fd1b1acc740579e26c343e6d1186f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bafc11b2f6c48fe8846c0cbf49f1ca8_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8151b587ea184a12a863eb648c1d73b6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee018ab4a90c436e82e2d025bc7c4033_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1029504ec8324cdc9d1a8a6f2a854090_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28bde64152834b87bded353fb0352d95_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71a3e94889974300a0f149383fe25f18_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06a62989bb2744f8a8d872418308d4ba_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i513c2028d38b4884ac53975bfab5f078_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12907ec702d147a3bd56ff8747ef063f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a4dbe3271764ed783e43c160f22a5f7_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ea78334a4a544dcba38daccc7916a10_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a906828b06245e58bece79897fe99fc_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icafc8c81f18e4ee2a2a6e3b81ae88a12_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9c3b3edd0774f9db0813da0a381c7a0_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7ba00100ab34faa9bf1d5f5d42af04c_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27e40da0240940a7926bf05b6174ccd4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3663290a78c548f4aa7609a2c7554daf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib213387c8afd446b96bae95715bec72d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51ffaad82dab42a0ab9c8e587557236c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iade9d1af10904ff7acc439b8834a8395_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab70a6f91f224f69a6be90a2c01a8355_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa5330bd233547c98905a08caa8ca3a3_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib822aec9103b458dbc079db87594cd6e_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3caf5544ee374eb3a48285ec3fd9279a_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="country"><xbrli:measure>mck:country</xbrli:measure></xbrli:unit><xbrli:context id="id58d170d297c43bcace9dc7b5f556347_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="business_operation"><xbrli:measure>mck:business_operation</xbrli:measure></xbrli:unit><xbrli:unit id="numberofproducts"><xbrli:measure>mck:numberOfProducts</xbrli:measure></xbrli:unit><xbrli:context id="ic371359df42d46fc9cdaa20754eb2857_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45c05b8f83b741d992b83ccc3df6b908_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i294c2f089e43428d9f211ab6d5436a55_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4632c5240b01414e9082101b8768cac1_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifedf75934b37431f868f060ab5f6013a_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f550bcedc934c8b80cc03ee44b800ab_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08b6999463f4433f9cc082295167d9ae_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03a67644704d4440bb71e3a2701c416c_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52f55c7a43814e4181d18751f2048f0a_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ae066f96784452da1de68ea4e97704b_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79d5ebe53b9a4ebca65716989b93c5f8_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida0b040eb5e94d34b4dbc2a627b7da27_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if94267ba6de9458db3df283198381edf_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e8e81ee2fb849c29d5ea7c25273ee5e_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1de8191ab06245abb971e2b0ffe26491_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i115a3e3004e949119c249e28526ae1d6_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d023e4934d548c9bc3bd440f7da7aa3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1ab6dd9883343f8a42baa07fb972b7a_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9ff51a496f742c5a3c83d3b38d4dbb1_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i568b05318ce7413fa9252c00b9a77597_D20200401-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69eab42c07a44d5aabd460e6391ea635_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i797e794c99c4456e98cc170a98d8a85b_D20190401-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6909fe531ae47989d16e4519df3b5f9_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i422fe30a34754885aa9558599f8972f8_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;           &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTUz_69faf067-f085-4548-8861-c83b0157bdf8">10-Q</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MWVjYzczNjcwNzNiNGFkODg1YWNlYjI5MjFhNzY1YjEvdGFibGVyYW5nZToxZWNjNzM2NzA3M2I0YWQ4ODVhY2ViMjkyMWE3NjViMV8wLTAtMS0xLTA_6418e029-c3a6-4adf-95a3-61420a31f265">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8xMjQ_646c2896-ca6a-4056-b87f-78a0ba3c0688">December 31, 2020</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6ZGYzOWQzYzFhNDNiNDEzMDk4ZDMxODc5YWY2NzZlNDkvdGFibGVyYW5nZTpkZjM5ZDNjMWE0M2I0MTMwOThkMzE4NzlhZjY3NmU0OV8wLTAtMS0xLTA_59551cc1-9211-4675-b5c4-a4771f6841ae">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTQ2_238a4f3f-27e2-4afe-bb9e-4bf0e1c0f675">1-13252</ix:nonNumeric> </span></div><div style="text-align:center"><img src="mck-20201231_g1.jpg" alt="mck-20201231_g1.jpg" style="height:29px;margin-bottom:5pt;vertical-align:text-bottom;width:196px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTU0_1dc22c18-ee5e-41ec-b879-ee06a927c6b0">McKESSON CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6ZDIxMWQzNjBmNjRiNDIyM2EzZGJiY2NhNWJkZDU4ZjIvdGFibGVyYW5nZTpkMjExZDM2MGY2NGI0MjIzYTNkYmJjY2E1YmRkNThmMl8wLTAtMS0xLTA_ba384fbe-3564-48b5-bbe6-662e329f35bd">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6ZDIxMWQzNjBmNjRiNDIyM2EzZGJiY2NhNWJkZDU4ZjIvdGFibGVyYW5nZTpkMjExZDM2MGY2NGI0MjIzYTNkYmJjY2E1YmRkNThmMl8wLTItMS0xLTA_cca22bfb-1f8d-4caf-8990-a32d8be3817a">94-3207296</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction<br/>of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTQ4_c173ba11-3877-45ec-a8c7-c89ce16f6a51">6555 State Hwy 161</ix:nonNumeric>, </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTU3_1006e0b0-1e67-4cfd-bfbb-6ccbbcdc9337">Irving</ix:nonNumeric>, <ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTU1_2b70c50a-4491-4d4a-b18f-cdae349fd683">TX</ix:nonNumeric> <ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTQ5_7aa2a0ec-2bb4-474e-ade9-db5345e26b8a">75039</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTUw_80c302e6-0db2-464f-a116-25a9e7689661">972</ix:nonNumeric>) <ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTU4_8e8419f4-158f-4eab-8949-1143ae830069">446-4800</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Title of each class)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Trading Symbol)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Name of each exchange on which registered)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibe90ddd61815466e8647519b72b5ccc1_D20200401-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl8xLTAtMS0xLTA_61ac50c0-6315-4505-b4df-b6fedbd7a13d">Common stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibe90ddd61815466e8647519b72b5ccc1_D20200401-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl8xLTEtMS0xLTA_a06509ff-937d-4f17-a68d-cd29c097f5be">MCK</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibe90ddd61815466e8647519b72b5ccc1_D20200401-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl8xLTItMS0xLTA_4a4e960d-13d7-4a70-b0b1-b41141a012f9">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id264d9c87dcc405e945fdd97ce807af7_D20200401-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl8yLTAtMS0xLTA_d7c5d5c9-dbf9-4e5a-af28-9b4a42d8af8e">0.625% Notes due 2021</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id264d9c87dcc405e945fdd97ce807af7_D20200401-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl8yLTEtMS0xLTA_15c53130-e3a6-469e-bd6c-4fab2dfc4f3c">MCK21A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id264d9c87dcc405e945fdd97ce807af7_D20200401-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl8yLTItMS0xLTA_8c859c90-756c-45a4-bba5-5bc6888f2d9f">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if58e825fe2a34bef8acbd60f66bf6ca3_D20200401-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl8zLTAtMS0xLTA_0679891a-fcff-4da8-a0ad-f27da2cdad08">1.500% Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if58e825fe2a34bef8acbd60f66bf6ca3_D20200401-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl8zLTEtMS0xLTA_9dea067d-55ee-4eba-9b4d-1f80e8d018ff">MCK25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if58e825fe2a34bef8acbd60f66bf6ca3_D20200401-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl8zLTItMS0xLTA_6bae8fb3-fb02-43af-8ee7-ef5032cd0833">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia0dab164e3ea46fe8045e94da8af3a96_D20200401-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl80LTAtMS0xLTA_b5190e81-07bc-4095-a6dc-97186deb6e21">1.625% Notes due 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia0dab164e3ea46fe8045e94da8af3a96_D20200401-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl80LTEtMS0xLTA_e745d746-2d3d-4723-9381-86d19af0ca3a">MCK26</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia0dab164e3ea46fe8045e94da8af3a96_D20200401-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl80LTItMS0xLTA_f7e4545f-d7cc-4944-9e67-186fe77e0ea2">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i18b68afdbd2149a79f7d4fbccb76c182_D20200401-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl81LTAtMS0xLTA_3e6de1a3-5066-41b6-b46b-7200c8151afb">3.125% Notes due 2029</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i18b68afdbd2149a79f7d4fbccb76c182_D20200401-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl81LTEtMS0xLTA_1cbfcaec-a913-437b-806c-8377347e3022">MCK29</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i18b68afdbd2149a79f7d4fbccb76c182_D20200401-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl81LTItMS0xLTA_954e424c-7be6-41df-9f99-2fd6c6288080">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;<ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTQ3_cecacc0a-bbf4-4fdd-8401-60dae61d223e">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTUx_db19779f-dba6-4f21-aa45-07b0aa03e44f">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:28.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.727%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.745%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.749%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6YTgxZDA0ZTY3NTYwNDMwNWIxODM3MGRmZTFhNmJjY2YvdGFibGVyYW5nZTphODFkMDRlNjc1NjA0MzA1YjE4MzcwZGZlMWE2YmNjZl8wLTAtMS0xLTA_24396a5a-de37-4380-a59a-e51847c01294">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6YTgxZDA0ZTY3NTYwNDMwNWIxODM3MGRmZTFhNmJjY2YvdGFibGVyYW5nZTphODFkMDRlNjc1NjA0MzA1YjE4MzcwZGZlMWE2YmNjZl8xLTYtMS0xLTA_0b73d386-92ff-4df1-8b06-8eb2c5b279de">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6YTgxZDA0ZTY3NTYwNDMwNWIxODM3MGRmZTFhNmJjY2YvdGFibGVyYW5nZTphODFkMDRlNjc1NjA0MzA1YjE4MzcwZGZlMWE2YmNjZl8yLTYtMS0xLTA_7ab563de-0adf-4397-b160-33a1ef431307">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">f</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160; Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTUy_efbf747d-4216-4e05-bf03-2ed3089e1eb7">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date. <ix:nonFraction unitRef="shares" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMDc5_d0a944c8-f25e-4fa2-9c74-de3f25694fcd">159,167,434</ix:nonFraction> shares of the issuer&#8217;s common stock were outstanding as of December&#160;31, 2020.</span></div><div style="margin-bottom:5pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_10">PART I&#8212;FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_10">Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_13">Condensed Consolidated Statements of Operations for the three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_13">nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_13"> months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2020</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_13"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2019</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_13">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_16">Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2020</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_16"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2019</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_16">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_19">Condensed Consolidated Balance Sheets as of </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2020</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_19"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">March 31, 2020</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_19">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_22">Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) for the three and nine months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2020</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_22"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2019</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_22">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_25">Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_25">nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_25"> months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2020</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_25"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2019</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_25">8</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_28">Financial Notes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_28">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_31">Note 1 - Significant Accounting Policies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_31">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_34">Note 2 - Investment in Change Healthcare Joint Venture</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_34">11</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_43">Note 3 - Held for Sale</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_43">12</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_49">Note 4 - Restructuring, Impairment, and Related Charges</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_49">14</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_52">Note 5 - Income Taxes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_52">17</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_58">Note 6 - Redeemable Noncontrolling Interests and Noncontrolling Interests</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_58">18</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_64">Note 7 - Earnings</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_64"> (Loss) </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_64">per Common Share</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_64">20</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_67">Note 8 - Goodwill and Intangible Assets, Net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_67">21</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_70">Note 9 - Debt and Financing Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_70">23</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_76">Note 10 - Pension Benefits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_76">25</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_79">Note 11 - Hedging Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_79">25</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_85">Note 12 - Fair Value Measurements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_85">28</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_88">Note 13 - Commitments and Contingent Liabilities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_88">30</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_94">Note 14 - Stockholders&#8217; Equity (Deficit)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_94">34</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_97">Note 15 - Segments of Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_97">38</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_106">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_106">41</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_130">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_130">63</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_133">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_133">63</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_136">PART II&#8212;OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_139">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_139">64</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_142">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_142">64</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_145">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_145">64</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_151">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_151">64</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_154">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_154">65</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_157">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_157">65</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_160">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_160">66</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_163">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_163">67</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#8212;FINANCIAL INFORMATION</span></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Financial Statements.</span></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_13"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMi0xLTEtMS0w_9cfd0c92-26aa-4ca2-a492-76d59a5bc9b4">62,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMi0zLTEtMS0w_04e0e2be-ab98-4c5a-8d00-db0e9042b8aa">59,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMi01LTEtMS0w_4a58c509-2704-4330-8db0-5b8959329e40">179,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMi03LTEtMS0w_720ea66a-89ba-46b0-9c98-c2b5dc637d9a">172,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMy0xLTEtMS0w_97c59048-6fac-4327-a5a6-b712eed73e99">59,448</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMy0zLTEtMS0w_08b141f7-03c8-4195-912f-00f8309651f4">56,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMy01LTEtMS0w_b3930a6b-9777-4967-b9ac-4f0455756cb1">170,235</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMy03LTEtMS0w_32bfb0a0-24f2-43b2-a877-92f9ccd8869c">163,829</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNC0xLTEtMS0w_7148c174-f1de-482d-a4a5-c59145d7aad0">3,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNC0zLTEtMS0w_4b69d88b-9fbc-4926-bdef-bbfbabd178b9">3,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNC01LTEtMS0w_4ac6d36b-2445-4489-9869-7ba99dacd0bc">8,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNC03LTEtMS0w_427619ba-a04c-4019-831a-fc9ef1ffc3b7">8,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNS0xLTEtMS0w_a412aeae-f5bc-4bc3-a16c-309c8d4acdb9">2,291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNS0zLTEtMS0w_0a861e3d-d18e-4eeb-aeef-b71d20f76dda">2,535</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNS01LTEtMS0w_e5c696dd-c246-4827-976d-f36175cc6755">6,625</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNS03LTEtMS0w_60a37aaf-df8d-4164-9c1f-52eb50ee5d62">6,779</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims and litigation charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LegalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNi0xLTEtMS05MTEw_6fb61f4c-6697-499c-a65c-14a48ed33076">8,067</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LegalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNi0zLTEtMS05MTE1_2571c192-e5ef-4048-9398-cf0c27d3c3da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LegalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNi01LTEtMS05MTE5_d33bc0c4-50df-45e4-90a9-23c2b860d2b4">7,936</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:LegalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNi03LTEtMS05MTIz_8d6abc16-5819-4969-b900-576fdac2061d">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNi0xLTEtMS0w_94a6f080-9fb9-4e17-bfaf-d6caf638d6ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNi0zLTEtMS0w_f5d23a7a-df84-4c25-8d2a-b778efdcb5ce">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNi01LTEtMS0w_19b3b7e3-b01a-4ee5-ba62-911dc87ba09d">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNi03LTEtMS0w_d463aba3-fe27-4cd7-b51f-4e31436d341c">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNy0xLTEtMS0w_1ccd0277-913e-4d76-b87e-1c3aa3fa31f2">155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNy0zLTEtMS0w_8c53aa32-8142-4a80-a55e-1373e9659d16">136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNy01LTEtMS0w_768bc297-e084-4f69-b09e-713022ede34d">271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNy03LTEtMS0w_3861f252-beb0-4681-beb8-0ec39fcfc17b">204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfOS0xLTEtMS0w_04540a09-d6fb-4739-bd2d-3dba144b9e9c">10,513</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfOS0zLTEtMS0w_782e86c7-f930-4b20-8d50-4c6bd6959749">2,673</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfOS01LTEtMS0w_9290b6f8-e653-454c-91ba-7906bd1f456b">14,901</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfOS03LTEtMS0w_36d5107d-cbf5-461b-8a1f-84c1b4da84c5">7,067</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTAtMS0xLTEtMA_ea87d2c4-2a3d-4794-90ed-895f46f7bbba">7,362</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTAtMy0xLTEtMA_645babee-da86-4218-b93e-614ec6fa766f">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTAtNS0xLTEtMA_a5b198e7-af93-45ae-b664-c90dbca70d94">6,050</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTAtNy0xLTEtMA_bd483183-71e3-4f80-aa03-8741a31f9372">1,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTEtMS0xLTEtMA_7a7b8fa6-e615-4c7b-a1c0-192ed6abb94f">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTEtMy0xLTEtMA_78a8202d-ad38-4f74-9b8e-e1de36aacb27">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTEtNS0xLTEtMA_34ae9270-0b47-41d8-aa36-7ab1b8a57c11">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTEtNy0xLTEtMA_579dd05f-1e8c-4881-a3af-e4d1d96d1a58">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity earnings and charges from investment in Change Healthcare Joint Venture</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTItMS0xLTEtMA_afcfa422-ae95-4011-a951-ab177c621e65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTItMy0xLTEtMA_feb0b3be-d9df-4daf-bee8-dcfd07bcb532">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTItNS0xLTEtMA_3ff0cea5-a177-40dc-9e2a-1db5d4bceb27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTItNy0xLTEtMA_c8eadb3b-b9e0-490f-8dc7-bc74e2cfd301">1,478</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTMtMS0xLTEtMA_9d962c3b-2f1f-4a42-a178-d9cf326c34e4">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTMtMy0xLTEtMA_18936180-0a64-4abd-bdfe-a104de2f044e">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTMtNS0xLTEtMA_b6ee5fa2-3f9b-49f8-9224-ee6583c90156">165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTMtNy0xLTEtMA_89b3b0d3-9f08-4113-b417-bdd50425cc65">184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTQtMS0xLTEtMA_025cd720-b901-4dd5-bb0b-e52be64515f4">7,363</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTQtMy0xLTEtMA_ed9c1ed0-c115-4acb-9068-ff14aaa30fb8">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTQtNS0xLTEtMA_10884d1c-ecad-4b67-b796-d466cb2d6e1d">6,063</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTQtNy0xLTEtMA_d857a982-7afd-4980-b425-d2df3a8375d2">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTUtMS0xLTEtMA_7bfe2f06-43e2-4102-8eb0-2792fcd28a33">1,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTUtMy0xLTEtMA_627ff4ae-19f5-4cd9-ab0d-ec9241415758">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTUtNS0xLTEtMA_6736f3ab-0929-4f56-a676-d2fd67a44d57">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTUtNy0xLTEtMA_5e5d1c20-42c4-45d4-bf90-1cb24a4ba0ea">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTYtMS0xLTEtMA_d557c4c4-786d-4e45-8bc6-0470da424b70">6,174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTYtMy0xLTEtMA_e9f5dad7-6a53-4fed-a5d5-d0672fe4a590">247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTYtNS0xLTEtMA_7223f6e3-5761-4722-83d9-c134d250c489">5,052</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTYtNy0xLTEtMA_5de437a6-43ba-4cb0-ac5c-de857ae55039">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTctMS0xLTEtMA_e79a75e4-1484-43b7-8e69-6a652ee7c1e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTctMy0xLTEtMA_7aef10ce-20d9-4635-a645-f886085daaf4">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTctNS0xLTEtMA_c8e427bb-e670-42a8-8c7a-1a5b3c4d52a3">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTctNy0xLTEtMA_13abd7d6-bbb5-4998-8425-896c5a604fcb">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTgtMS0xLTEtMA_bbaca1a9-f543-4578-8483-144d55e82a05">6,174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTgtMy0xLTEtMA_6f5a221b-09c8-460b-9443-ddd1a670e5cf">242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTgtNS0xLTEtMA_bc338b22-34c8-4c98-b338-9e3e5d8db7b3">5,053</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTgtNy0xLTEtMA_4c5ec2a4-f8a4-4579-9695-4069349473bb">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTktMS0xLTEtMA_c4750c3f-6138-4933-996a-10e9f32b18a6">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTktMy0xLTEtMA_23b88cd6-58b3-43ec-a246-ef482c9f8469">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTktNS0xLTEtMA_a9465ed1-4769-40f1-ba61-df29f3e2ff55">152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTktNy0xLTEtMA_8d239508-a043-41ab-acf9-f92fae0c01ed">163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjAtMS0xLTEtMA_90be2734-1597-48a4-8831-e6dacfa8f058">6,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjAtMy0xLTEtMA_64a6d9f2-237b-4650-b67d-e1f789f97dd6">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjAtNS0xLTEtMA_669f2bd7-392a-4353-be7a-7a8218c52618">5,205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjAtNy0xLTEtMA_11c42248-cf4f-4e73-b2c4-176be3f7e9ae">121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjQtMS0xLTEtMA_c1d499f7-d489-483f-8417-07efbe9447d3">39.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjQtMy0xLTEtMA_5624a897-033e-475e-aa0b-5c384de6cdaf">1.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjQtNS0xLTEtMA_d20782f2-c749-4f82-94f0-839356704341">32.28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjQtNy0xLTEtMA_3d8620a1-a630-4072-bbbf-dcac28113986">0.60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjUtMS0xLTEtMA_7811f332-03b3-4776-9b95-3bfe59a32a77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjUtMy0xLTEtMA_691e7955-1b15-49eb-8db5-7f7e9104dcb6">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjUtNS0xLTEtMA_cee9a770-0880-4cf3-bc50-e71b01509e3e">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjUtNy0xLTEtMA_c0da256f-20c2-42d8-a3d9-7b1ff63442ff">0.06</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjYtMS0xLTEtMA_863b8a47-7d29-4a23-9cd0-72baa2d301a4">39.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjYtMy0xLTEtMA_7695407c-5618-468c-a651-e008430d5655">1.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjYtNS0xLTEtMA_0a170516-09e4-460b-8577-62315c60a495">32.29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjYtNy0xLTEtMA_202b57d9-f5c1-45a6-a14f-2735b5247818">0.66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjgtMS0xLTEtMA_8a2adeb0-15a7-4726-9c17-95e0d4db63c5">39.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjgtMy0xLTEtMA_125c5ec6-5691-41a2-9aad-d4bf813f5062">1.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjgtNS0xLTEtMA_6c2f9bd5-78a6-405d-bd1b-508061f88a2c">32.28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjgtNy0xLTEtMA_aaa3f2c2-e1c6-489f-8abe-9929edcf99f0">0.60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjktMS0xLTEtMA_d0e4166b-34c3-416f-aac4-fe9adc1168eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjktMy0xLTEtMA_4a8dd4f3-e7a0-4e7b-b71d-5c65480bf42e">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjktNS0xLTEtMA_7674386c-8208-4d9d-b45f-df20979d455d">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjktNy0xLTEtMA_b4ba164d-b49e-4755-ab49-d19b3e7dc16c">0.06</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzAtMS0xLTEtMA_1b8037ad-9c24-4800-936a-345cd9386aaf">39.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzAtMy0xLTEtMA_0a6eef13-0991-4c4e-8161-a58104161924">1.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzAtNS0xLTEtMA_f8f48523-c256-41c1-b2e2-36a61be13839">32.29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzAtNy0xLTEtMA_183bb1fd-8efe-4c6b-b2c0-38697d666cc2">0.66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzMtMS0xLTEtMA_7bd76a5b-08e4-4542-a811-336989bd3eb8">159.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzMtMy0xLTEtMA_e15a305f-1a4c-46df-be36-859ddf8eefa2">179.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzMtNS0xLTEtMA_c9f217a6-11be-4fe4-a93d-19d9aa000d3d">161.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzMtNy0xLTEtMA_8539dc93-b672-4f4d-92db-eaacece505fd">183.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzQtMS0xLTEtMA_5ec88204-e80f-4be7-8aa5-4ab92a0f341d">159.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzQtMy0xLTEtMA_f5e38d10-6ee8-477d-8bc4-fe8fe3995667">178.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzQtNS0xLTEtMA_c3be9645-e9fd-43e8-8318-61330e00d3fa">161.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzQtNy0xLTEtMA_c8dd6b6a-0f71-43ba-af1b-a79bbfcd366d">183.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMi0xLTEtMS0w_f36efcc3-dfe8-479c-bfca-b3aef005d93d">6,174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMi0zLTEtMS0w_98ce5f8b-db22-49c4-840c-69ce1935aadc">242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMi01LTEtMS0w_c9a0922a-d28d-42ed-a43b-77423b9376e3">5,053</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMi03LTEtMS0w_2a5fd172-fb86-42ba-9375-0dae5b0a0c1d">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNS0xLTEtMS0w_36147f49-79da-4639-9aa1-9ed2caf81841">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNS0zLTEtMS0w_eebdbebc-98be-4a67-8477-790ed96dde7e">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNS01LTEtMS0w_4846c016-0869-4809-b56f-5e3fe0ba5124">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNS03LTEtMS0w_1c1afd5d-c173-4935-b2a1-bff6b68697f8">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNi0xLTEtMS0w_8587366c-40da-44ae-a75a-aaf4aa598360">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNi0zLTEtMS0w_f3f8a8c3-25c8-434e-8a25-fd261c0c989e">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNi01LTEtMS0w_a536251d-5e55-4a1e-b52c-2c8ad0d73260">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNi03LTEtMS0w_fa12ce50-1e79-4c47-b44f-2b6693c3d87f">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNy0xLTEtMS0w_f912cc71-b51d-4202-ab18-512ac74b806b">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNy0zLTEtMS0w_d8b64dc4-1613-4baf-991b-8b5314165587">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNy01LTEtMS0w_27ec72c5-43da-489d-be03-f3e3f97d7e31">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNy03LTEtMS0w_051e4e87-bb0f-4b6b-90ae-abc2856c7d65">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfOC0xLTEtMS0w_2fe515ab-e180-41d5-a8e2-54887c2284d3">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfOC0zLTEtMS0w_9205f941-b4c4-4509-a932-3de717e5e69c">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfOC01LTEtMS0w_8bfbfd51-3dca-44bc-8560-9ed6e3dfb018">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfOC03LTEtMS0w_b12776be-0017-4656-920d-ee14195ab95a">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTAtMS0xLTEtMA_3d1a3490-abc2-4a44-b5e4-357493757ba4">6,055</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTAtMy0xLTEtMA_2f904aae-a067-47fb-b774-8b5d72d34223">293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTAtNS0xLTEtMA_2c00ad67-e5ad-4400-85cf-59700ab32d49">4,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTAtNy0xLTEtMA_caf88b90-6ccb-4009-9c41-e5c8dbd4a3d2">226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTEtMS0xLTEtMA_e5654083-23db-40ae-a1cc-67ae49015e4d">77</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTEtMy0xLTEtMA_2ba0514a-9be1-44aa-b979-b543acee6ebe">66</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTEtNS0xLTEtMA_d8471ad3-9e48-41cc-a8af-ab0dfda687ea">113</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTEtNy0xLTEtMA_a6bacac7-4c3a-4cdb-af4f-32c25a6f3294">161</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTItMS0xLTEtMA_2d2e8af5-4c3e-4e38-8042-d0695032a0ac">6,132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTItMy0xLTEtMA_cb0d9080-32e7-43f3-a268-17cfbb06385b">227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTItNS0xLTEtMA_4d564aed-e1af-4bbf-8cd0-07a259990838">5,005</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTItNy0xLTEtMA_c7de2cf6-2259-4597-bd10-51c59dca1921">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMy0xLTEtMS0w_01330c39-4e99-41cb-98b6-5c365309c216">3,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMy0zLTEtMS0w_83123532-c282-436a-9ac2-d90d09e6aedf">4,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNC0xLTEtMS0w_6e10c948-5267-40d7-a782-3edc25c56262">18,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNC0zLTEtMS0w_def8965c-f989-4143-9eab-cc29f6b3be6a">19,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNS0xLTEtMS0w_19c9a059-8ace-4084-bcbb-09489e1b64ef">19,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNS0zLTEtMS0w_efe1d79e-7983-4f8b-bf14-e442d0d16214">16,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNi0xLTEtMS0w_c89d11cf-6d0b-4300-b3ab-fda2f57ce921">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNi0zLTEtMS0w_071bf1ea-d871-4020-9aa2-1eb0b2d41e75">906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNy0xLTEtMS0w_401e68a2-188a-4e76-9bb3-306b4d40d831">688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNy0zLTEtMS0w_4aab5848-2c4e-45ca-a670-3470c762423a">617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfOC0xLTEtMS0w_6933e80a-67c7-4921-9984-4913eca5b23c">42,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfOC0zLTEtMS0w_9fe5ebc2-684e-447b-aff6-c434f5719378">42,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfOS0xLTEtMS0w_e7389535-57be-48b2-a5cc-a951a21a19cd">2,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfOS0zLTEtMS0w_9412a11f-48c5-4e95-b310-28ee6cbd8725">2,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTAtMS0xLTEtMA_6169cf53-c72e-4101-b336-f5c19064d3e6">1,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTAtMy0xLTEtMA_acb6f8f8-293f-422a-92de-3f0705231041">1,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTEtMS0xLTEtMA_d50ca2a5-4acf-4973-bb4a-a7a8e7654778">9,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTEtMy0xLTEtMA_5e330ce2-c570-47e2-95d3-43d276f344f0">9,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTItMS0xLTEtMA_c7679771-250e-4bfb-83e1-06e367dba6df">2,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTItMy0xLTEtMA_8eabd7d4-deda-46d7-8659-e9a98201f471">3,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTQtMS0xLTEtMA_7058ed73-cdfc-4794-bbab-2a6e158e5fb9">2,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTQtMy0xLTEtMA_9912a4e9-2000-489a-bd2a-eb6b1ebe0cc0">2,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTUtMS0xLTEtMA_b2c7f03a-0c6f-4ca6-acde-673d8dbb9896">61,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTUtMy0xLTEtMA_a6ea614c-d644-46a9-ae51-a4d8449125de">61,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND EQUITY (DEFICIT)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTktMS0xLTEtMA_bf250d77-f546-423d-a460-5c3df4acb599">36,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTktMy0xLTEtMA_38244ec6-448f-4a51-aff8-795ae0a94775">37,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjAtMS0xLTEtMA_d222728c-444b-457a-aedc-a5f50e7bf787">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjAtMy0xLTEtMA_74280825-1da1-40bc-81b7-182e2ec63de6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjEtMS0xLTEtMA_5093443d-cf97-4ade-8d98-26f0f1e39199">777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjEtMy0xLTEtMA_2e6b51c7-4e3a-4c8e-b10e-4972ca3bc7cd">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjItMS0xLTEtMA_9afb4d56-80d9-44e0-ac56-448dc559089c">384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjItMy0xLTEtMA_df2483aa-20c2-472f-800e-cd713a7b92fd">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjMtMS0xLTEtMA_ed04638f-32a4-47c4-b25e-1710b6782462">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjMtMy0xLTEtMA_2ddac7a0-db6e-4707-9edc-64addb8ada67">683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjQtMS0xLTEtMA_4347b0db-5f6e-4ea2-b02b-9858d602d4ac">4,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjQtMy0xLTEtMA_d45998d4-7b55-40b0-9688-ea198a6d6b8b">3,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjUtMS0xLTEtMA_1546eb8d-2cb4-4cde-9498-d613f3059be6">41,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjUtMy0xLTEtMA_8f4e625e-6cfe-4f82-b7ad-251958f6762e">42,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjYtMS0xLTEtMA_7f87af7c-ec20-4713-b600-ae3daa3b9c5c">6,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjYtMy0xLTEtMA_c94b99b1-2b93-4198-b7fc-6fbbf633b80b">6,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjctMS0xLTEtMA_5295c878-8c9a-4624-acf5-2a4e4be08868">773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjctMy0xLTEtMA_00e6adfc-f857-4e64-bad0-f7653c54176e">2,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjgtMS0xLTEtMA_1d8cf1d4-f219-4ef9-aea9-2b08ab24d34e">1,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjgtMy0xLTEtMA_a8dd5c2e-cc18-4d01-8d8a-344a0d86afe8">1,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjktMS0xLTEtOTEzNw_53a07912-e8a0-455b-99fc-5afc70045045">8,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjktMy0xLTEtOTE0MQ_d55c320b-2230-492c-9cb0-08f9361c9d2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjktMS0xLTEtMA_10a233b5-9626-4840-b71f-4e15388aae04">1,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjktMy0xLTEtMA_d2bdfa68-d892-4c79-b9f5-283746539820">1,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzAtMS0xLTEtMA_b060a2b2-ca8b-4219-9a9d-6305999d7a7d">1,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzAtMy0xLTEtMA_3ca2a79b-1081-4d5f-adcd-75c01db69567">1,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation stockholders&#8217; equity (deficit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmE0ZmFlZDcxYjhmNTQwOThiZWIzNGNmZDM4OWFjODY1XzIx_3fe9e2be-26de-4056-b017-795573aec4cc"><ix:nonFraction unitRef="usdPerShare" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmE0ZmFlZDcxYjhmNTQwOThiZWIzNGNmZDM4OWFjODY1XzIx_6f467565-6738-438d-b4f5-5d464a812492">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmE0ZmFlZDcxYjhmNTQwOThiZWIzNGNmZDM4OWFjODY1XzM1_86b3902c-67e9-42f7-a39f-02e954f8de3e"><ix:nonFraction unitRef="shares" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmE0ZmFlZDcxYjhmNTQwOThiZWIzNGNmZDM4OWFjODY1XzM1_a875dc21-f80d-463f-8ea0-111b63a41f87">100</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmE0ZmFlZDcxYjhmNTQwOThiZWIzNGNmZDM4OWFjODY1XzU3_4ac1a8c6-3df0-49a2-898a-f6b730b3e3d2"><ix:nonFraction unitRef="shares" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmE0ZmFlZDcxYjhmNTQwOThiZWIzNGNmZDM4OWFjODY1XzU3_b021712f-d960-4e73-89af-8c0fb66e7640"><ix:nonFraction unitRef="shares" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmE0ZmFlZDcxYjhmNTQwOThiZWIzNGNmZDM4OWFjODY1XzU3_b17732ee-c5d6-4dd2-b57f-3872ad73b79e"><ix:nonFraction unitRef="shares" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmE0ZmFlZDcxYjhmNTQwOThiZWIzNGNmZDM4OWFjODY1XzU3_d752486e-9981-4894-86c2-075e213c26a9">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMS0xLTEtMA_83645076-2e04-4456-bd59-72efcf8b03b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMy0xLTEtMA_1dfefa8b-f593-4b91-94e7-0f07f2059452">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmFjY2NmZWZhMTFjMDQxNGM4YTY3NzMzZDY2NGJhMDRhXzE4_227ed880-b9bb-442f-b86d-f66189914553"><ix:nonFraction unitRef="usdPerShare" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmFjY2NmZWZhMTFjMDQxNGM4YTY3NzMzZDY2NGJhMDRhXzE4_afff7ec1-fda5-49f8-bbff-c50a5fd16f6a">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmFjY2NmZWZhMTFjMDQxNGM4YTY3NzMzZDY2NGJhMDRhXzMy_0d7951a7-3c2d-43ad-af48-759b6df3ecf4"><ix:nonFraction unitRef="shares" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmFjY2NmZWZhMTFjMDQxNGM4YTY3NzMzZDY2NGJhMDRhXzMy_b414934d-366f-42de-80cb-91eb6ac5615b">800</ix:nonFraction></ix:nonFraction> shares authorized and <ix:nonFraction unitRef="shares" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmFjY2NmZWZhMTFjMDQxNGM4YTY3NzMzZDY2NGJhMDRhXzU3_80aa1230-9d97-4ab3-8199-bc9566793aed">273</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmFjY2NmZWZhMTFjMDQxNGM4YTY3NzMzZDY2NGJhMDRhXzY0_f0f6b23e-f9ca-4d2e-9e81-45a6fc06214c">272</ix:nonFraction> shares issued at December 31, 2020 and March 31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzMtMS0xLTEtMA_77d114e3-8336-403c-8376-f72bbe0a60bb">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzMtMy0xLTEtMA_9c4d7451-c0ee-4c05-8341-c1802eace13e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzQtMS0xLTEtMA_b50c46e8-02a9-4cd7-90c1-6e36a2141563">6,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzQtMy0xLTEtMA_a70c4d91-6147-4dab-9415-2922a24aff0d">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzUtMS0xLTEtMA_9bc2b261-1810-4e9e-b991-fc58ced0f09a">7,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzUtMy0xLTEtMA_7bf012d3-b6e5-4a15-89dd-ffc9f404d07f">13,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzYtMS0xLTEtMA_f8c59633-226b-495f-b795-247f5a4d6251">1,503</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzYtMy0xLTEtMA_99c474e8-e7da-42d7-be40-f54bb7ef965d">1,703</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury shares, at cost, <ix:nonFraction unitRef="shares" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjhmZmFiMTA1OTgyMzRjZWQ4ZjU2MjIwYjg2MjQyZmY4XzMw_e8244370-e136-454e-aa6d-073f39480b3c">114</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjhmZmFiMTA1OTgyMzRjZWQ4ZjU2MjIwYjg2MjQyZmY4XzM3_06dcda9c-79c9-4b94-8ab1-12ec831aaeeb">110</ix:nonFraction> shares at December 31, 2020 and March 31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzgtMS0xLTEtMA_18330d79-c361-4abb-9108-262668f46695">13,418</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzgtMy0xLTEtMA_5f3db5e7-f5c4-4180-99ed-c980f25d18f5">12,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total McKesson Corporation stockholders&#8217; equity (deficit)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzktMS0xLTEtMA_c469b38c-91ab-49fe-ae10-fc31b876df53">477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzktMy0xLTEtMA_88c125f5-f5e0-4607-a2bc-8a84330d4846">5,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNDAtMS0xLTEtMA_803854ba-1536-4fbc-8009-74280b8c751e">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNDAtMy0xLTEtMA_40917d5b-c401-4ce1-bc45-41574c3cf4c3">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity (deficit)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNDEtMS0xLTEtMA_f099bbba-29d4-4fb9-a58e-0f662f79eff0">277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNDEtMy0xLTEtMA_a959a278-d153-466c-ad50-935bf6fdd473">5,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, redeemable noncontrolling interests, and equity (deficit)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNDItMS0xLTEtMA_73d863f7-eb8b-4c0d-8341-ddca010998db">61,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNDItMy0xLTEtMA_190d1595-9223-4025-8265-34f0ee18a3a2">61,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:20.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.194%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.377%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity (Deficit)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8f75dc9fda5c41feb4e0a7addec435d0_I20200930" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy0xLTEtMS0w_6345d238-d026-43a2-8cec-25924159d19e">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f75dc9fda5c41feb4e0a7addec435d0_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy0zLTEtMS0w_ff0d76c5-b225-4f58-b093-f5b9c5f9975d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i046c55cb833a40dea20cd595ea58722c_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy01LTEtMS0w_1b070b21-2c29-4a9c-89fc-bfdde8109f5a">6,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9738445b8a5e41869bba0cf8d810974d_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy03LTEtMS0w_54afc0a7-b3c3-45bc-9554-24699623fa0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79239b1b57fc45128439b982e6e306d9_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy05LTEtMS0w_51dbc168-6f55-4c32-bcf5-159d55aac455">13,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if702f6988b73408fb0203fbcf4cfff59_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy0xMS0xLTEtMA_285dce36-044a-4e54-b56b-f18658865278">1,597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i22f4cb39451147ea9fe68b8f991a70ff_I20200930" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy0xMy0xLTEtMA_cb455fec-98c0-49f1-8bbc-5c7d9b6d6481">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22f4cb39451147ea9fe68b8f991a70ff_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy0xNS0xLTEtMA_1bbd6441-44ed-4216-94bb-08da1b393407">13,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib03cda0901f74396a9d42a5e93e5f9eb_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy0xNy0xLTEtMA_8643847d-558c-4ed5-932b-ac8aaa4e920a">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icda41b88f4cc470eb74edf0bae68f725_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy0xOS0xLTEtMA_1fa02627-4c73-4453-8809-2ecb51a20ec3">6,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of shares under employee plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76dbf276f41c433aa3233de59bace255_D20201001-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfNC01LTEtMS0w_afc5b65d-b543-4342-adf1-1f0185eaddf7">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37974d926d4e49eeae69ab2a0f22c9e5_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfNC0xNS0xLTEtMA_1e255789-bce0-4607-9da7-7ec99922538a">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfNC0xOS0xLTEtMA_11bf9911-f195-4141-9034-b250d2d08600">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76dbf276f41c433aa3233de59bace255_D20201001-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfNS01LTEtMS0w_73420101-43b5-4d4a-a492-af19df4f4e9f">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfNS0xOS0xLTEtMA_07042638-64fb-43d8-b1e2-cccc5366c284">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i454504e100134adfada4c6b22b8a933a_D20201001-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfNi0xNy0xLTEtMA_a567cfc7-bdc8-4f1f-bd50-cf78eb16a052">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfNi0xOS0xLTEtMA_232cc3cd-3313-42b2-afed-d4d5daf6bed2">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f6abb61154c4e5580b369029cca081f_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfNy0xMS0xLTEtMA_8b9f8900-6d69-4578-b6ca-d1fd1a8ed371">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfNy0xOS0xLTEtMA_4eeb4d18-c286-409b-8b99-49d612cfaa14">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7eb9f1e25c3d41efb703c958f350bf20_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfOC05LTEtMS0w_18074c1b-6eca-49f3-86ee-665961fddfa3">6,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i454504e100134adfada4c6b22b8a933a_D20201001-20201231" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfOC0xNy0xLTEtMA_95c3abc5-85b2-4e1e-9925-cec3ab21b282">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfOC0xOS0xLTEtMA_c24bcdd6-beb4-4e3f-b92f-69baa840f309">6,185</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i37974d926d4e49eeae69ab2a0f22c9e5_D20201001-20201231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfOS0xMy0xLTEtMA_eadc64ca-c5a6-4bce-a0b4-5affeeda7eda">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37974d926d4e49eeae69ab2a0f22c9e5_D20201001-20201231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfOS0xNS0xLTEtMA_87007e1d-8ab7-4cd8-9892-05c0e28affd8">231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfOS0xOS0xLTEtMA_e124d0f3-fb2f-47dc-9130-8abc8d142ff0">231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjllMmQ5NDk2N2M4ZjRkMzE5MTFiY2RhYjczMmMwNTIyXzI5_6e5a7202-0483-4f7b-b7de-0c05ac392a27">0.42</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7eb9f1e25c3d41efb703c958f350bf20_D20201001-20201231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTEtOS0xLTEtMA_74447c45-3df5-4781-9b0c-e9dfa4430e02">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTEtMTktMS0xLTA_ac312f48-c6bb-4e6e-86c6-fee2fb40f007">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7eb9f1e25c3d41efb703c958f350bf20_D20201001-20201231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTItOS0xLTEtMA_e068d79f-bf51-486e-8850-23407b940c79">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTItMTktMS0xLTA_41160d5a-4b28-4132-b355-cca663f461f7">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia3e05b2e0a9d44ed8dea34e18361b913_I20201231" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtMS0xLTEtMA_09bcc949-1636-4dc4-a1df-7c2830209068">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3e05b2e0a9d44ed8dea34e18361b913_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtMy0xLTEtMA_9784ad11-a502-4258-95fd-51bf45e3f48f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36774e6a606943108bbf2290e991ad35_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtNS0xLTEtMA_f772c1b5-8f2d-4f21-9a75-f5f51e2bd73b">6,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67e7913b409c4c2188c465886e28af95_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtNy0xLTEtMA_9315e81e-d499-4bbb-b560-62bffb350567">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7265c70a233467086b5103a31edaceb_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtOS0xLTEtMA_eb483862-e126-4331-a8b9-923106ebb6e2">7,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6641e8af9e64c7aae662865d224c625_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtMTEtMS0xLTA_e56ea226-de44-43cd-b355-fa44947ac085">1,503</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia4ddbb098af84acd823dab9a811ce25e_I20201231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtMTMtMS0xLTA_7cb0ae83-2ab4-4e38-8f47-0cc09140c2f9">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4ddbb098af84acd823dab9a811ce25e_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtMTUtMS0xLTA_2a9b3d26-1392-47be-bdb9-5f829e53ecc8">13,418</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i436786cf3fa44a21863b50c1e252c871_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtMTctMS0xLTA_5cc8a09c-cdcc-4b79-be63-d25a85fcb0f2">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtMTktMS0xLTA_ad61256f-60b6-4750-9e7b-57a62e46fb9d">277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:20.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.194%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.377%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive<br/>Loss</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity (Deficit)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ab271cbf75f4a6992e0fb34901ba49d_I20200331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy0xLTEtMS0w_bc52030a-34a8-4823-ba0b-e80af923b63e">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ab271cbf75f4a6992e0fb34901ba49d_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy0zLTEtMS0w_66b06f44-e347-422e-9125-b93175efab31">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4bf4310d43a446aa281ebdc500f1c56_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy01LTEtMS0w_a9a1083e-a59b-4054-82a3-2a33cd6ae40a">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa5fbe0fd0874aebab734ed30f8b57f0_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy03LTEtMS0w_df84968d-7fde-4315-9fdb-7cbba3f828ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a1d4b79fc7b43f7afae361190241425_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy05LTEtMS0w_5b4084f0-7395-4aeb-81e3-17047cdb11cf">13,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0374ed6096c4fc79915873d9944afab_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy0xMS0xLTEtMA_77b068fb-579b-426c-90c5-939cc64c6e82">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i70252b6394004f7b954609f75985fb93_I20200331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy0xMy0xLTEtMA_7a2f002e-eac1-443b-9e04-eb6c2506406f">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70252b6394004f7b954609f75985fb93_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy0xNS0xLTEtMA_1fe8ebf8-23de-4f81-ac22-1f777a918cae">12,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cbf15310ca46869b7c2a9274df3ebf_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy0xNy0xLTEtMA_680e6789-0bd4-422f-903e-3c0803c6e908">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy0xOS0xLTEtMA_91a25646-e879-43f2-a445-154ce97a26d5">5,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNC0wLTEtMS0w_e059b575-1bdb-42b0-8a48-ed92a77e999c">Opening retained earnings adjustment: adoption of new accounting standard</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i639bd12a270543c8ad6932bf9f601e45_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNC05LTEtMS0w_9af07a0b-826a-4e32-9bdd-da9b36bf81b6">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i846abdfeaa6544789a5e524558b9443a_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNC0xOS0xLTEtMA_a9c13e6c-7637-4d18-b6f0-dfdb244d597c">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, April 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if69ab677c8f149499b3a80ccbdfc1050_I20200331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS0xLTEtMS0w_73fd2a71-eb29-4a46-8325-1ed8391b9dc1">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if69ab677c8f149499b3a80ccbdfc1050_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS0zLTEtMS0w_f4d86166-3d4f-4e86-9945-65547d3302f3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93b2ebdda56e4926b226f0d3df3470ab_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS01LTEtMS0w_950ef0d1-9db0-4ac1-8310-b4c9102afec0">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4b3986493e54543ab88e63dc656f1a2_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS03LTEtMS0w_14012112-dd4b-47b2-8302-9411430fb828">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb7456909d2b497aa24862ae836a1a66_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS05LTEtMS0w_06d46c25-fb3f-4bf6-ba34-e9daf351ec97">13,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5636635f7cb74ec7bf4beff8d593f7f3_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS0xMS0xLTEtMA_8d3d09b2-269a-4fa2-87c6-04744a4a7d98">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i935b818ca9a54205944e103ce26b3be1_I20200331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS0xMy0xLTEtMA_bda781aa-aa46-41a6-9a9f-01f6b79e7e97">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i935b818ca9a54205944e103ce26b3be1_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS0xNS0xLTEtMA_d3760df4-2277-488b-a2b1-35f5d9234179">12,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16fd29d7481e4494b840a459e3299e08_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS0xNy0xLTEtMA_90db6ef3-9d22-4d7a-8b77-d18553dd7a32">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28e45f80bb9349f5a5ec660f5376691c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS0xOS0xLTEtMA_a12a9d48-f5ca-470c-8e1e-0df6911d5170">5,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of shares under employee plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8106bbb2dc0a4f59acc6299d4f71a45a_D20200401-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNi0xLTEtMS0w_e552c61a-9f4e-48b7-965a-6b616fb2c32c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2011d00a9d33400ab4105b02fddf648e_D20200401-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNi01LTEtMS0w_8ad5699e-6c4b-4652-9aea-acf69565d91e">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2895dc4463844ffe85d8bea8b2472d44_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNi0xNS0xLTEtMA_08fee3e7-b7ba-4343-8d32-06830c843285">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNi0xOS0xLTEtMA_39bba303-060b-46aa-b1d2-1f4dcd0eefa8">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2011d00a9d33400ab4105b02fddf648e_D20200401-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNy01LTEtMS0w_c66de18c-22e4-4cd3-b89a-1ec0898cc7c0">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNy0xOS0xLTEtMA_4005afb2-fb74-416a-a2d6-e0bd17af7be7">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6429e408d6643fe8ed7a32451d1973a_D20200401-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfOC0xNy0xLTEtMA_01e2ef85-e1a1-4755-a4c5-404430383156">134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfOC0xOS0xLTEtMA_05d0270d-3e0c-4924-811b-b225a1f06e98">134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbfbb7ecfac64c7d996917034b9d6fbe_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfOS0xMS0xLTEtMA_8368b42a-6497-400f-9081-e2c7633dc93f">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfOS0xOS0xLTEtMA_f9b2f044-34e2-45f2-8493-9b79e546e94f">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55fa8262a4e440d49790e9cf14b51dbd_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTAtOS0xLTEtMA_1e2a1f67-9454-482c-8fbd-1fd598a4ade9">5,205</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6429e408d6643fe8ed7a32451d1973a_D20200401-20201231" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTAtMTctMS0xLTA_2e4c1bac-178b-4d41-a07a-3dacb4b2705d">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTAtMTktMS0xLTA_53b516bb-59b8-4aaa-8ddf-7073b5d69b24">5,085</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2011d00a9d33400ab4105b02fddf648e_D20200401-20201231" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTEtNS0xLTEtMA_df1ab7d3-d8e9-4449-a4fa-825f49428494">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTEtMTktMS0xLTA_a629d382-56f8-43b9-9497-3c78635a2ebe">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2895dc4463844ffe85d8bea8b2472d44_D20200401-20201231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTItMTMtMS0xLTA_fdc286b2-fccf-4db7-98bb-73cd4f84d33e">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2895dc4463844ffe85d8bea8b2472d44_D20200401-20201231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTItMTUtMS0xLTA_df6ad40c-46cb-4742-a49a-236adca24f71">500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTItMTktMS0xLTA_158c37b8-689e-493f-9267-3c5e28546d52">500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjNiNDAwOTE1N2U5YTQxNDA5OTQxYjViMjI0MjcyOThkXzI5_53c44595-d486-4960-9557-f1d6fbff076d">1.25</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55fa8262a4e440d49790e9cf14b51dbd_D20200401-20201231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTMtOS0xLTEtMA_2d66b728-ed40-4447-ab64-2a740db01460">203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTMtMTktMS0xLTA_259d8b3e-f87d-431f-9fd1-9d5ac531c854">203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2011d00a9d33400ab4105b02fddf648e_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTQtNS0xLTEtMA_aeb57684-097b-49e6-895e-6e7ddaa5de3e">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55fa8262a4e440d49790e9cf14b51dbd_D20200401-20201231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTQtOS0xLTEtMA_211369b4-1dcc-4cfb-b2b0-74de89569af0">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6429e408d6643fe8ed7a32451d1973a_D20200401-20201231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTQtMTctMS0xLTA_f7f680ba-faf5-483d-a017-dd8e30ab75c9">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTQtMTktMS0xLTA_bd8c98b3-6015-4753-a843-7896d05ce9c8">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia3e05b2e0a9d44ed8dea34e18361b913_I20201231" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtMS0xLTEtMA_ca9f7f5a-2b96-407b-bf4b-436330669a4d">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3e05b2e0a9d44ed8dea34e18361b913_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtMy0xLTEtMA_9b9330a8-36e9-4ed4-baf5-075bb565f061">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36774e6a606943108bbf2290e991ad35_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtNS0xLTEtMA_a054dc5f-fa2f-46dd-8024-05d6c75ff9de">6,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67e7913b409c4c2188c465886e28af95_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtNy0xLTEtMA_ddf221b2-5e12-436c-8e7f-c95413bf7042">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7265c70a233467086b5103a31edaceb_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtOS0xLTEtMA_4837afb0-4dd8-4031-9d61-8d7079c070b0">7,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6641e8af9e64c7aae662865d224c625_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtMTEtMS0xLTA_5f36c289-9765-43ff-8be4-085ad5a16ea8">1,503</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia4ddbb098af84acd823dab9a811ce25e_I20201231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtMTMtMS0xLTA_0f15c38e-be5c-4a9b-81b2-538a94e5d447">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4ddbb098af84acd823dab9a811ce25e_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtMTUtMS0xLTA_232392fc-54eb-4ae3-9cf9-fe82b3d64433">13,418</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i436786cf3fa44a21863b50c1e252c871_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtMTctMS0xLTA_5304d2ca-79ba-44dd-9c75-7f26df8bc65e">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtMTktMS0xLTA_b007e6ad-c61e-4d59-ad54-73a47793e7e3">277</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:21.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.365%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.660%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.387%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.546%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.956%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.092%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.227%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, September 30, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3bbd5766e5e1426fa1e48b9db23fb33a_I20190930" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy0xLTEtMS0w_234d7993-be89-4c89-a351-839ee7ed9350">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bbd5766e5e1426fa1e48b9db23fb33a_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy0zLTEtMS0w_5801b2c9-db7e-49e3-801e-d659f639b1dc">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f3407c46f4b4be98e132df1cb8b89d7_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy01LTEtMS0w_eb8ef151-9118-43be-bae7-0b92758d36df">6,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45ef706885764ecd9440a440f9bd9396_I20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy03LTEtMS0w_bc987ca2-101c-4581-9c69-85d3d0ba3946">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id768d1b9bff84003a458da02ab6054de_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy05LTEtMS0w_9b7f7b26-7508-43f6-b8d4-59df2bf432af">11,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e571302aec24a36936d3e24fb499981_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy0xMS0xLTEtMA_7e815890-f460-44f8-adf0-5120614b68a2">1,704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iaa37fcbfd262489885d497fe4920cf55_I20190930" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy0xMy0xLTEtMA_eb1f2b2e-b102-4844-b36f-a8e99bfe9fab">92</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa37fcbfd262489885d497fe4920cf55_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy0xNS0xLTEtMA_9cacca82-84a2-42c8-92da-7dd115a22901">10,353</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fe05a45bd0447499ad4274ebee0e5de_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy0xNy0xLTEtMA_2da0f569-8110-4483-ad32-2659413d9ca9">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2706f6905b14cc3a97aaf70ac667df6_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy0xOS0xLTEtMA_9dd5cfaa-f6f3-4f28-bcba-221ed4fa1810">6,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of shares under employee plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87686bf1372a401ab1608bbccf25c908_D20191001-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfNC01LTEtMS0w_9628d7c1-ba1b-4333-932a-a13147d3498f">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfNC0xOS0xLTEtMA_05469a60-50b9-4a5b-b763-5338ad1064fb">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87686bf1372a401ab1608bbccf25c908_D20191001-20191231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfNS01LTEtMS0w_bcb538b8-29ef-47fc-bdd8-77d4e0ad9b76">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfNS0xOS0xLTEtMA_4888f223-478c-4a06-83d7-9dc117149ecb">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d696af4cf5445b28748e6c09ac7c601_D20191001-20191231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfNi0xNy0xLTEtMA_9ee0b5a8-0872-47f3-bbad-e95b78252e16">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfNi0xOS0xLTEtMA_3e91e13e-f650-4350-bbf5-3d36e5c4f73c">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i308d835dd02042a8b515529815bd98ec_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfNy0xMS0xLTEtMA_c24705a3-4e66-4409-b9d4-8a17637dfd1c">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfNy0xOS0xLTEtMA_2e01db98-0ea2-4df4-bafa-d7d2ac7150df">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de52a5965ed47d1812e75a3c210ca1d_D20191001-20191231" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfOC05LTEtMS0w_26c4c2be-28f3-40b2-8b6a-37068973cc3f">186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d696af4cf5445b28748e6c09ac7c601_D20191001-20191231" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfOC0xNy0xLTEtMA_96255b74-9645-478c-b46f-87cb845c36df">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfOC0xOS0xLTEtMA_2b70629a-153b-48f3-bfde-781190f0b8d3">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i476906634a324f9287de597fd0120a9c_D20191001-20191231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfOS0xMy0xLTEtMA_1beedf6b-8b9f-4712-8fcb-bf97c9f756b0">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i476906634a324f9287de597fd0120a9c_D20191001-20191231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfOS0xNS0xLTEtMA_d6c39f69-fdbe-4a00-be8a-d466badb7731">500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfOS0xOS0xLTEtMA_0b710c3e-376c-4c32-bb1f-59c89702c039">500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjhhYTQyMDNhYmYwZDRlMWQ5ZWU1ZmNjODYwMWY4OTQzXzI5_80c6f8f9-a71b-41e4-ad80-5392995cef5d">0.41</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7de52a5965ed47d1812e75a3c210ca1d_D20191001-20191231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTEtOS0xLTEtMA_d7593f67-8290-4838-bacb-b305744f7ece">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTEtMTktMS0xLTA_d4902c31-0acd-4b72-ac5c-0e65b9cc3396">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7de52a5965ed47d1812e75a3c210ca1d_D20191001-20191231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTItOS0xLTEtMA_360e3655-5fa0-41d4-9e54-83c83e491d0f">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d696af4cf5445b28748e6c09ac7c601_D20191001-20191231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTItMTctMS0xLTA_0cc96a20-08d0-4e48-a4c3-e9153e4b808e">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTItMTktMS0xLTA_29aac2dd-e118-4c8d-880f-5d05f991b0a2">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, December 31, 2019</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03968c2d88954a3f8b182452bc2bbaa5_I20191231" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtMS0xLTEtMA_0952d5f5-82f5-4453-b7f6-4057a1fbdcbf">272</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03968c2d88954a3f8b182452bc2bbaa5_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtMy0xLTEtMA_f500d4f3-52bc-4fec-a4ee-3e92b9efa0df">3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a823c07346941aca960d012bef9774a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtNS0xLTEtMA_1e66d456-b345-4523-a528-dddfbc7bcf73">6,614</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34964563458343118c3362841fc34697_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtNy0xLTEtMA_48fc012e-126e-480e-bf9b-589f3db53375">2</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1510b0bae31c44278e232e7cafd63a4d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtOS0xLTEtMA_c1953dc4-c992-4bee-80d8-059ca691eaf0">12,075</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd724fc113f1423fab76a0b7d9141942_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtMTEtMS0xLTA_f789c116-8cc0-427a-98a9-bbee1328b551">1,663</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id25a265859cb4a5fab9c40c7cdf40f44_I20191231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtMTMtMS0xLTA_56dcd076-fc63-4f21-b841-9fb3c8832fb2">95</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id25a265859cb4a5fab9c40c7cdf40f44_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtMTUtMS0xLTA_c73b4105-23ca-4a9d-a16d-d0bb4f610eca">10,853</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9025fe41f3c4206832a02f6067cccc8_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtMTctMS0xLTA_e72d1843-14f6-40c0-942f-d0a81e507fc8">211</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia65b1cdade72453c9c9547d6ed17b3e9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtMTktMS0xLTA_af716d83-6494-4521-8f79-61a55f4d40e6">6,385</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:21.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.365%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.660%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.387%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.546%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.956%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.092%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.227%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, March 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53dbe944eae1492aa687e479fc7a11b9_I20190331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy0xLTEtMS0w_fd8693ba-7df1-41fb-b2fb-db4b40c27128">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53dbe944eae1492aa687e479fc7a11b9_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy0zLTEtMS0w_27956f88-5690-454c-a10d-de1d0ab09409">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ed625dd55947b98750c596c6405402_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy01LTEtMS0w_a067cd2b-a897-4e8e-9e4d-b6f25b06a57b">6,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48dad6b27bfc4bb98f4e86f70d71263b_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy03LTEtMS0w_cdbf7d95-2de8-42c5-96ec-c1f1e24c2d0c">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e42b52ae7334bbc8d4c95f67d0beb34_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy05LTEtMS0w_09bebc05-9127-4a6e-a4cf-6f68402fdf5a">12,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id686b4181792461ea0b02a307e3b6b16_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy0xMS0xLTEtMA_69decfb6-19b7-46b2-bdc6-8ab8142dd1a4">1,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i81babc7a70954522b7b22ac34fdd8414_I20190331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy0xMy0xLTEtMA_080b7a4c-3df5-4535-b599-1ccd0612f242">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81babc7a70954522b7b22ac34fdd8414_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy0xNS0xLTEtMA_35879ad5-7ece-4a58-9c1e-8af6d73ebcb0">8,902</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbc3a9c5dd4e11aa4f98339c48f19c_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy0xNy0xLTEtMA_6f6f3cf1-8bdd-4392-9995-c80d2824fdec">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic798201eb4fa4f7a804f2e801548f37c_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy0xOS0xLTEtMA_67a55ebe-7a3d-4060-b250-097bab860225">8,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opening retained earnings adjustments: adoption of new accounting standards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d03dd7c905342d1a2937caa74731528_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNC05LTEtMS0w_0751bbf9-8bf5-46a6-aaf4-3e4ac4801973">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e5c95277ec49cb8ca34ae6e95c7f38_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNC0xOS0xLTEtMA_51be2d57-b30e-44a6-9bf4-048de5dc07ba">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, April 1, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0170e2288b194e75bbcd4d3065c84185_I20190331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS0xLTEtMS0w_9f3520d0-23e6-4c5f-b415-29a5c889b65c">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0170e2288b194e75bbcd4d3065c84185_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS0zLTEtMS0w_d34687d9-756b-4571-8b29-246406a02893">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d01fe2b386243908ec14fc43582d826_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS01LTEtMS0w_a4619b00-9903-4173-a104-0d5f3a9c371b">6,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic38570a58197439eb0c8a6f1f9b9fd62_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS03LTEtMS0w_074f6c53-c7c1-4cf2-95df-5cfa59159eb7">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f0d013d62e64c1a9ff51d7df3d8f8fc_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS05LTEtMS0w_a32510e1-900c-454d-82b4-a129023e85b3">12,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58124d80a4e44920b8506455c425e375_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS0xMS0xLTEtMA_9352c3ef-4dfa-407a-8795-058ad7a190d3">1,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id6558f17c2334aff80dd0d663259b6c9_I20190331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS0xMy0xLTEtMA_a53f19f6-9804-4744-a4d7-27275e32a952">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6558f17c2334aff80dd0d663259b6c9_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS0xNS0xLTEtMA_4e689e17-722f-4d99-b4c5-d8097017f9d3">8,902</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8eca560196144a6ae00495db6084899_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS0xNy0xLTEtMA_551a0fcd-7afd-4a56-9ee8-a2ce16db93c5">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8f0d7cc99df4d939573a16bbc9b0efb_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS0xOS0xLTEtMA_202be8a3-d8f2-4ffa-a2b1-fd5f17b1f604">8,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of shares under employee plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i36d180f203204936b0e8fc121ab9b7de_D20190401-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNi0xLTEtMS0w_bddd1bc4-4b4d-4d17-8c7a-fd65dc16dabf">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i457a8c3bc27049ef85e109fd88303f2c_D20190401-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNi01LTEtMS0w_7d9077bc-6030-4e0d-8e5b-c0ce13efb918">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d7db3179e2e47f293b957b1ef8858cd_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNi0xNS0xLTEtMA_ad853ecd-1973-47c1-9a96-4ecf5b0ad2cb">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNi0xOS0xLTEtMA_f7736bf1-b4e0-40fd-b6dd-227686a3e610">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i457a8c3bc27049ef85e109fd88303f2c_D20190401-20191231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNy01LTEtMS0w_1a4e6fb3-43bb-45fd-8040-5082d0752f06">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNy0xOS0xLTEtMA_a4273781-5e79-46f5-aceb-bb24050c5184">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01c4d416ec1c40a593cf210126c97ef4_D20190401-20191231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfOC0xNy0xLTEtMA_42aee07c-a9da-4459-847a-3140afa7fba7">115</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfOC0xOS0xLTEtMA_3245b18d-2b69-41b3-b899-ae65187d22ef">115</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26a952d776148b6b791451cbf1e0f2c_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfOS0xMS0xLTEtMA_aa7e5523-d01e-4e01-aade-1fd4cec565ee">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfOS0xOS0xLTEtMA_628368fd-5adf-4761-9b92-217f05db66e6">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i956f7e118d784444a97416bdea861a56_D20190401-20191231" decimals="-6" sign="-" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTAtOS0xLTEtMA_017557f7-9cab-4499-9900-a60bb2d3abb1">121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01c4d416ec1c40a593cf210126c97ef4_D20190401-20191231" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTAtMTctMS0xLTA_87987629-f0a8-4242-a76e-dc7052363fd0">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTAtMTktMS0xLTA_665fe426-db92-45b1-bae2-a95eb895dc4a">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9d7db3179e2e47f293b957b1ef8858cd_D20190401-20191231" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTEtMTMtMS0xLTA_ba615539-f158-42fb-a388-48f85bcaf26d">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d7db3179e2e47f293b957b1ef8858cd_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTEtMTUtMS0xLTA_bcfd79b8-d19f-43ef-8f6a-623bb2ae0813">1,934</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTEtMTktMS0xLTA_3516f936-5834-42af-a821-7244a1fa1cd4">1,934</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOmVjMzM3NDdhMjUyMDRkMjk4NmE1ODY0MGZkNmIwMjU4XzI5_2eef1799-3121-48ee-a062-4fc972653a58">1.21</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i956f7e118d784444a97416bdea861a56_D20190401-20191231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTMtOS0xLTEtMA_d8d493e2-9740-4b81-8117-49347807c37a">221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTMtMTktMS0xLTA_c595e89b-2dc3-436c-9772-cb3ab05a7c0e">221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i956f7e118d784444a97416bdea861a56_D20190401-20191231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTQtOS0xLTEtMA_27ee8667-f88a-4f83-916b-b8b521c7bb43">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01c4d416ec1c40a593cf210126c97ef4_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTQtMTctMS0xLTA_031446d2-211c-4e95-9b83-2e21871321df">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTQtMTktMS0xLTA_6f8baf1f-51aa-4d9e-b64c-ad8d7c819e10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances, December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03968c2d88954a3f8b182452bc2bbaa5_I20191231" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtMS0xLTEtMA_3e93348f-8de4-43af-9f48-9ad65a7d3ed7">272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03968c2d88954a3f8b182452bc2bbaa5_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtMy0xLTEtMA_f6e32402-cccf-45ed-81c2-433278e3d66a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a823c07346941aca960d012bef9774a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtNS0xLTEtMA_5f7ed4be-bf9c-40be-9ab3-500d5d780630">6,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34964563458343118c3362841fc34697_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtNy0xLTEtMA_74937f04-2899-4f82-8500-4c4a8dba9136">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1510b0bae31c44278e232e7cafd63a4d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtOS0xLTEtMA_c92ef7ea-4da3-4cd4-b219-7e2118d10b23">12,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd724fc113f1423fab76a0b7d9141942_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtMTEtMS0xLTA_e9951693-d610-4129-b43f-711257ff6d38">1,663</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id25a265859cb4a5fab9c40c7cdf40f44_I20191231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtMTMtMS0xLTA_b3be4bf3-7912-4b61-bda7-d7c58e74d746">95</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id25a265859cb4a5fab9c40c7cdf40f44_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtMTUtMS0xLTA_ea025fea-9db6-4f66-9317-66998a553849">10,853</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9025fe41f3c4206832a02f6067cccc8_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtMTctMS0xLTA_f4f7b707-f0da-4eaa-ad1b-8b52eaf732df">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia65b1cdade72453c9c9547d6ed17b3e9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtMTktMS0xLTA_c709b98c-f242-43eb-94e0-35ea29fa4c12">6,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMy0xLTEtMS0w_bfe94764-7a6c-4801-b48c-5bdc5a696013">5,053</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMy0zLTEtMS0w_46158649-55e0-43b8-8c0f-687c22e119cc">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNS0xLTEtMS0w_06b12535-f2cd-4636-8377-46b693abc9c8">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNS0zLTEtMS0w_096f952c-cf2d-4ad1-b95a-f87a0b9dd6a3">239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNi0xLTEtMS0w_a800f90e-151a-472d-ad37-3c017ab0d66a">429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNi0zLTEtMS0w_3fc6e6f6-30b2-4d53-b6b4-6fbe2d697a98">452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and other asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNy0xLTEtMS0w_9331ab45-d684-4b4c-b34b-979d050b327f">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNy0zLTEtMS0w_ba441c0b-70f5-464e-a6a2-5ce69b101a27">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity earnings and charges from investment in Change Healthcare Joint Venture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfOC0xLTEtMS0w_d7b4d545-0db5-456f-96ba-aa2e89dca5e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfOC0zLTEtMS0w_12316356-b05c-44d4-b0b6-ece80f1f6054">1,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfOS0xLTEtMS0w_680f0915-34c7-4a63-9aab-547e9ee8d9b5">1,520</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfOS0zLTEtMS0w_2a4d20e0-f4dd-4c3f-aaea-6484707b1ff5">387</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credits associated with last-in, first-out inventory method</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTAtMS0xLTEtMA_5e2d58cc-c8a3-440e-a0c9-686c1d76c2ee">115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTAtMy0xLTEtMA_fa42d7ef-54ea-485a-8675-12baf8571e31">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash operating lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTEtMS0xLTEtMA_a94ef5fa-88f1-4dc2-8241-1780d7401f13">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTEtMy0xLTEtMA_2b6a94d4-da31-4f09-af93-93f601ca3638">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from sales of businesses and investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTItMS0xLTEtMA_002cfacd-3fdf-4eef-a535-be45c22893f8">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTItMy0xLTEtMA_dc310a4c-fff2-4bed-adc8-a60993489e6c">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTMtMS0xLTEtMA_b209b2f6-212f-446b-b47d-475284d335ad">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTMtMy0xLTEtMA_dcfe5aa7-4e15-4752-96d9-27a17c947886">534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in assets and liabilities, net of acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTUtMS0xLTEtMA_c4d5d0ae-7478-48da-b019-c4ae98619cbe">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTUtMy0xLTEtMA_465e98d2-3031-4ec9-a9c2-5180a4d1363d">1,044</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTYtMS0xLTEtMA_103b7866-6361-43f7-9c96-b0e02a70bfe8">2,046</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTYtMy0xLTEtMA_e3f66c92-837e-457d-965d-5ba84d313ac6">689</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTctMS0xLTEtMA_f568f4cf-e790-47ec-93ae-37f8539e13f3">1,240</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTctMy0xLTEtMA_a142db73-0756-4805-895b-8ed8d612a8d6">929</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" name="mck:IncreaseDecreaseinOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTgtMS0xLTEtMA_c456394d-63e4-45c9-a671-85c665266378">291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="mck:IncreaseDecreaseinOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTgtMy0xLTEtMA_a0d10a9c-771c-42a7-9777-63b98650c55a">287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTktMS0xLTEtMA_a3ca3d6d-77dd-4c71-8cf1-33ffbce40d7a">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTktMy0xLTEtMA_5815376c-e611-4bb3-b0d5-bb849f6d2877">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="mck:IncreaseDecreaseInLitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjAtMS0xLTEtOTE0OQ_b6c8c5f8-56be-4da0-8a76-714b61dd122f">8,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="mck:IncreaseDecreaseInLitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjAtMy0xLTEtOTE1Mw_87dc55fd-6609-4807-b06a-31b557e3f007">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjAtMS0xLTEtMA_509d8d9f-16db-4b38-98f0-becbeb08fa77">403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjAtMy0xLTEtMA_cf5aa750-ffdf-44ca-b61f-5bc4a9edf9cf">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjEtMS0xLTEtMA_da6ef98e-480f-4f66-8b33-5783391d4551">1,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjEtMy0xLTEtMA_25e04b02-3771-4353-a941-faa86769ddc2">280</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for property, plant, and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjQtMS0xLTEtMA_99dd2f97-a7c7-4d6b-a9b8-d68da14d4bf3">293</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjQtMy0xLTEtMA_0a2adb30-d38b-47b4-a2d3-4640abb07942">242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized software expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjUtMS0xLTEtMA_93433fa6-3241-4cf4-ba4f-5e7d74ac9205">134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjUtMy0xLTEtMA_bb12c521-f30f-47d2-9baf-bb3438de5a3a">96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjYtMS0xLTEtMA_5049ba3a-d183-4d79-8155-744d9343d8f5">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjYtMy0xLTEtMA_b8e30ea1-b083-4a8a-ab50-af9213af0ada">97</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of businesses and investments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjctMS0xLTEtMA_8424b149-cb09-4f82-ad44-6c040c6e94e7">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjctMy0xLTEtMA_f7c4c1f5-694c-4e8a-baa9-5f2dcc3fa0f9">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjgtMS0xLTEtMA_e4b70f5a-d609-4358-b107-29a6e6785ea6">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjgtMy0xLTEtMA_a6ac0e31-00d8-4033-84ae-71e117db0349">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjktMS0xLTEtMA_4c8bbf11-f123-44db-b45a-58d359eecdb7">210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjktMy0xLTEtMA_9ecc116c-4bdf-48e4-8957-542d867feac4">409</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzItMS0xLTEtMA_1b38bd52-e33b-4114-b72e-75bcdced3d1a">5,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzItMy0xLTEtMA_91d45bea-3c7b-4947-bac7-168fac641e89">15,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzMtMS0xLTEtMA_e9c4ae41-9a19-4c1a-b3ab-dfa16330d419">5,303</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzMtMy0xLTEtMA_05b0a0f5-2777-4857-b6b7-7d1cb9c7c075">13,743</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuances of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzQtMS0xLTEtMA_6329f7eb-9234-46c0-be96-71f309468443">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzQtMy0xLTEtMA_da176e79-1e86-493c-b914-cb25a03908cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzUtMS0xLTEtMA_466df291-6d7a-48b4-82f3-f7761ea675c7">1,030</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzUtMy0xLTEtMA_d1da35c2-8d65-4b6c-81f2-0f3db2c82682">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock transactions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzctMS0xLTEtMA_62162324-1463-4b93-9893-2bbba8f9ea53">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzctMy0xLTEtMA_a5a1c04c-be7f-431c-8dde-6dca5f9f635c">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share repurchases, including shares surrendered for tax withholding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzgtMS0xLTEtMA_68967c61-8c3f-4b60-a67b-e20e280df5c7">526</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzgtMy0xLTEtMA_cf0200f0-4085-4b7c-a86a-e7df984d36bc">1,951</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzktMS0xLTEtMA_cc1b772b-47e9-4c71-8861-9775a04cfdc2">209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzktMy0xLTEtMA_002845b2-3de6-4c75-a467-cbc45f147269">222</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDAtMS0xLTEtMA_d53595c5-dd6c-42c1-bc38-1376371a2eeb">118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDAtMy0xLTEtMA_aa8f92d5-127e-41a8-ba4e-07530fbc195f">271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDEtMS0xLTEtMA_9160e7ac-dc47-4cba-b3fc-453df41fa607">1,176</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDEtMy0xLTEtMA_31b8548a-4406-44b1-8151-2f254af3d783">254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDItMS0xLTEtMA_fead058d-81f8-4a23-97d1-2d6bc970a45d">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDItMy0xLTEtMA_1e5c20e0-5cdb-4a63-9dc6-883a63f41187">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDMtMS0xLTEtMA_f6d48e75-076d-42cd-9fd4-26cf45c85366">291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDMtMy0xLTEtMA_c767f1bf-bf46-4fd3-9a88-6b4d3ea8b48a">916</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDQtMS0xLTEtMA_e70afbcd-b1df-4051-bd5d-843d837e2e03">4,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic798201eb4fa4f7a804f2e801548f37c_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDQtMy0xLTEtMA_d801ccf5-b767-48f0-894f-63efb4bd5423">2,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDUtMS0xLTEtMA_488baa5d-9d83-4477-81a7-e37d1242164d">3,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia65b1cdade72453c9c9547d6ed17b3e9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDUtMy0xLTEtMA_72df9064-e4b2-4b53-a362-a2b1b2013b7e">2,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Restricted cash at end of period included in Prepaid expenses and other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDYtMS0xLTEtMA_1debfa1e-08d2-4437-81a0-32d8de058338">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia65b1cdade72453c9c9547d6ed17b3e9_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDYtMy0xLTEtMA_f213dd9d-de34-44dd-b499-d9935c5a907c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDgtMS0xLTEtMA_1393b58c-9507-4320-91ba-23ffc6cab701">3,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia65b1cdade72453c9c9547d6ed17b3e9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDgtMy0xLTEtMA_c634a34d-6557-4d99-9b75-1a19e43b8eea">2,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_31"></div><div style="margin-bottom:12pt;margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zMS9mcmFnOjdkZTVmMDI0N2U0ZjRhYWZiNjFjNGFmNmNjOGQyNjcwL3RleHRyZWdpb246N2RlNWYwMjQ3ZTRmNGFhZmI2MWM0YWY2Y2M4ZDI2NzBfMTA2ODE_0dea23ac-fc7f-4700-814d-b37e0bca4b3f" continuedAt="i27bb4675232a441cafbdf5e7a5eed3d2" escape="true">Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i27bb4675232a441cafbdf5e7a5eed3d2" continuedAt="i088c99cf0e42433db8bced1ebee9a8f4"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: McKesson Corporation (&#8220;McKesson,&#8221; or the &#8220;Company,&#8221;) is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. Commencing with the second quarter of 2021, the Company reports its financial results in <ix:nonFraction unitRef="segment" contextRef="i8fda1e3442374708947bef1923d2f19e_D20200701-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zMS9mcmFnOjdkZTVmMDI0N2U0ZjRhYWZiNjFjNGFmNmNjOGQyNjcwL3RleHRyZWdpb246N2RlNWYwMjQ3ZTRmNGFhZmI2MWM0YWY2Y2M4ZDI2NzBfNjIw_4fdce319-6d18-4e0c-8a31-f6cc08f903d8">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (&#8220;RxTS&#8221;). The Company&#8217;s equity method investment in Change Healthcare LLC (&#8220;Change Healthcare JV&#8221;), which was split-off from McKesson in the fourth quarter of 2020, has been included in Other for retrospective periods presented. All prior segment information has been recast to reflect the Company&#8217;s new segment structure and current period presentation. Refer to Financial Note 15, &#8220;Segments of Business,&#8221; for more information.</span></div><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zMS9mcmFnOjdkZTVmMDI0N2U0ZjRhYWZiNjFjNGFmNmNjOGQyNjcwL3RleHRyZWdpb246N2RlNWYwMjQ3ZTRmNGFhZmI2MWM0YWY2Y2M4ZDI2NzBfMTA3MDc_b5948665-274f-4d7b-8c68-475d596ed0e0" continuedAt="i28cfce0d8f0c4ca383173696f00e0133" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers itself to control an entity if it has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S.&#8221;) of America (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The severity, magnitude, and duration, as well as the economic consequences of the coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic, are uncertain, rapidly changing and difficult to predict. Therefore, the Company&#8217;s accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i28cfce0d8f0c4ca383173696f00e0133">The Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) was enacted on March 27, 2020 in the U.S., and includes several provisions related to employment and income taxes, including provisions for the deferral of the employer portion of social security taxes through December 31, 2020. On December 27, 2020, the U.S. government enacted the Consolidated Appropriations Act, 2021, which enhances and expands certain provisions of the CARES Act. These legislative acts are not expected to have a material impact on the Company&#8217;s consolidated financial results.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zMS9mcmFnOjdkZTVmMDI0N2U0ZjRhYWZiNjFjNGFmNmNjOGQyNjcwL3RleHRyZWdpb246N2RlNWYwMjQ3ZTRmNGFhZmI2MWM0YWY2Y2M4ZDI2NzBfMTA2NzA_73211cd9-ea06-4501-893a-d09d186f97f2" escape="true">The results of operations for the three and nine months ended December 31, 2020 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2020 previously filed with the SEC on May 22, 2020 (&#8220;2020 Annual Report&#8221;).</ix:nonNumeric> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:FiscalPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zMS9mcmFnOjdkZTVmMDI0N2U0ZjRhYWZiNjFjNGFmNmNjOGQyNjcwL3RleHRyZWdpb246N2RlNWYwMjQ3ZTRmNGFhZmI2MWM0YWY2Y2M4ZDI2NzBfMTA2NzI_779d8fd1-894a-476c-adcd-78c41908e4e6" escape="true">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i088c99cf0e42433db8bced1ebee9a8f4" continuedAt="i3fcd247d92b04bf48e8ad3c036e89e25"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zMS9mcmFnOjdkZTVmMDI0N2U0ZjRhYWZiNjFjNGFmNmNjOGQyNjcwL3RleHRyZWdpb246N2RlNWYwMjQ3ZTRmNGFhZmI2MWM0YWY2Y2M4ZDI2NzBfMTA3MDk_3a6d610a-5f1f-42b5-8b6c-ca1c1da7443a" escape="true">Certain prior year amounts have been reclassified to conform to the current year presentation.</ix:nonNumeric></span></div><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zMS9mcmFnOjdkZTVmMDI0N2U0ZjRhYWZiNjFjNGFmNmNjOGQyNjcwL3RleHRyZWdpb246N2RlNWYwMjQ3ZTRmNGFhZmI2MWM0YWY2Y2M4ZDI2NzBfMTA2OTE_47c07d96-a9ef-484c-8d61-491651fec44c" continuedAt="i272edbbcd1604fd9a7c3f15f0559c189" escape="true"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company prospectively adopted Accounting Standards Update (&#8220;ASU&#8221;) 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs in a cloud computing arrangement that has a software license. As a result, the Company began capitalizing eligible implementation costs for such contracts and recognizing the expense over the service period. The adoption of this amended guidance did not have a material impact on the Company&#8217;s condensed consolidated financial statements or disclosures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company retrospectively adopted ASU 2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Retirement Benefits - Defined Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires the Company to disclose the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates, and an explanation of reasons for significant gains and losses related to changes in the benefit obligation for the period. The amended guidance also requires the Company to remove disclosures on the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit costs over the next fiscal year. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#8217;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company adopted ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to remove, modify and add disclosure requirements on fair value measurements. Certain requirements were applied prospectively while other changes were applied retrospectively on the effective date. The amended guidance removes disclosure requirements for transfers between Level 1 and Level 2 measurements and valuation processes for Level 3 measurements, but adds new disclosure requirements including changes in unrealized gains or losses in other comprehensive income related to recurring Level 3 measurements and requirements to disclose the range, and weighted-average used to develop significant unobservable inputs for Level 3 fair value measurements. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#8217;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company adopted ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2016-13&#8221;), which changed the impairment model for most financial assets from one based on current losses to a forward-looking model based on expected losses. The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses. The amended guidance requires financial assets that are measured at amortized cost be presented at the net amount expected to be collected. An allowance for credit losses is established as a valuation account that is deducted from the amortized cost basis of financial assets. The guidance also requires enhanced disclosures. This guidance was adopted on a modified retrospective basis and did not have a material impact on the Company&#8217;s condensed consolidated financial statements or disclosures. Upon adoption of the amended guidance in the first quarter of 2021, the Company recorded a cumulative-effect adjustment of $<ix:nonFraction unitRef="usd" contextRef="i1b34b0a4a2344072ae6737a15d1ec38a_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zMS9mcmFnOjdkZTVmMDI0N2U0ZjRhYWZiNjFjNGFmNmNjOGQyNjcwL3RleHRyZWdpb246N2RlNWYwMjQ3ZTRmNGFhZmI2MWM0YWY2Y2M4ZDI2NzBfODg3NA_d76e450d-de57-4828-97bd-79dae34483d8">13</ix:nonFraction> million to the opening balance of retained earnings, primarily as a result of adjustments to allowances for trade accounts receivable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for Credit Losses: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the adoption of ASU 2016-13 in the first quarter of 2021, the Company began using the Current Expected Credit Losses ("CECL") methodology to determine an allowance for credit losses related to financial assets measured at amortized cost. The Company considers historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop its allowance for credit losses. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zMS9mcmFnOjdkZTVmMDI0N2U0ZjRhYWZiNjFjNGFmNmNjOGQyNjcwL3RleHRyZWdpb246N2RlNWYwMjQ3ZTRmNGFhZmI2MWM0YWY2Y2M4ZDI2NzBfOTcxMw_63ccdfe3-7a49-45c7-8b54-71c9ae55e1a8">221</ix:nonFraction> million was included in Receivables, net on the Condensed Consolidated Balance Sheet as of December 31, 2020. Changes in the allowance were not material for the three and nine months ended December 31, 2020.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i3fcd247d92b04bf48e8ad3c036e89e25"><ix:continuation id="i272edbbcd1604fd9a7c3f15f0559c189"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In December 2019, ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was issued with the intent to simplify various aspects related to accounting for income taxes.&#160;The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The guidance is effective for the Company in the first quarter of 2022 and&#160;early adoption is permitted.&#160;The Company is currently evaluating the impact of this amended guidance on its condensed consolidated financial statements.</span></div></ix:continuation></ix:continuation><div id="ib9c6f28fe5144278bb122fe3b38cf454_34"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfNTkwNQ_aeee6395-5de6-48e6-821c-952b3509b363" continuedAt="i2a8e2fdbad8a43c6bacfbb2ad78a5044" escape="true">Investment in Change Healthcare Joint Venture</ix:nonNumeric></span></div><ix:continuation id="i2a8e2fdbad8a43c6bacfbb2ad78a5044" continuedAt="ibaa5a429e19745849438ebd53f3b1ed6"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the separation of its interest in the Change Healthcare JV on March 10, 2020, the Company accounted for its interest in the joint venture using the equity method of accounting with a one-month reporting lag, with disclosure made for any intervening events of the joint venture in the lag period that could materially affect its condensed consolidated financial statements. Effective April 1, 2019, the Change Healthcare JV adopted the amended revenue recognition guidance. In the first quarter of 2020, the Company recorded its proportionate share of the joint venture&#8217;s adoption impact of the amended revenue recognition guidance of approximately $<ix:nonFraction unitRef="usd" contextRef="i2bf1ccbd66194ee193c7054b7fb9cad3_I20190401" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfNjY3_3e280b1c-66a7-4d54-8dfe-3f5239038f08">80</ix:nonFraction> million, net of tax, to the Company&#8217;s opening retained earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2019, common stock and certain other securities of Change Healthcare Inc. (&#8220;Change&#8221;) began trading on the NASDAQ (&#8220;IPO&#8221;). Change was a holding company and did not own any material assets or have any operations other than its interest in the Change Healthcare JV. On July 1, 2019, upon the completion of its IPO, Change received net cash proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="ia2ee20a5c84e431a9dbe88126ea7debb_D20190701-20190701" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMTEwMg_f12e98b5-8bac-4eee-8d35-021d0fe7e8d8">888</ix:nonFraction> million. Change contributed the proceeds of $<ix:nonFraction unitRef="usd" contextRef="i24bafc5133144c1f9d0575855df32cdd_D20190701-20190701" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInterestInJointVenture" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMTE0MQ_8c81baa0-6d28-422a-98ef-be94a5ef408c">609</ix:nonFraction> million from its offering of common stock to the Change Healthcare&#160;JV in exchange for additional membership interests of the Change Healthcare JV (&#8220;LLC Units&#8221;) at the equivalent of its offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i651e12a9a9314eaead5f5def7b8cb902_I20190701" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMTMzOQ_6cde08a5-6e61-4cc1-ae57-f2bf9e229680">13</ix:nonFraction> per share. The proceeds of $<ix:nonFraction unitRef="usd" contextRef="ia2ee20a5c84e431a9dbe88126ea7debb_D20190701-20190701" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromOtherEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMTM2OQ_ea3be112-7cb1-498c-93fb-9b7c566daab1">279</ix:nonFraction> million from the concurrent offering of other securities were used by Change to acquire certain securities of the Change Healthcare JV that substantially mirrored the terms of other securities included in the offering by Change. As a result, McKesson&#8217;s equity interest in the Change Healthcare JV was diluted from approximately <ix:nonFraction unitRef="number" contextRef="i6b3a22eac44c42f8966d20ec62021a93_I20190630" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMTY5Mg_a48a2ef8-74a1-4194-9e46-c40d153be751">70</ix:nonFraction>% to approximately <ix:nonFraction unitRef="number" contextRef="i9bb3d5efc8c84f3896fe23c52b92310e_I20190701" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMTcxMg_100f0637-f1dc-42c4-9186-72ad879ce1f8">58.5</ix:nonFraction>% while Change owned approximately <ix:nonFraction unitRef="number" contextRef="ieba62539ca00495ba37020bffe3d644f_I20190701" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMTc0OA_9b5c766d-035f-4efb-917a-d124ff3a4d48">41.5</ix:nonFraction>% of the outstanding LLC Units. Accordingly, in the second quarter of 2020, the Company recognized a pre-tax dilution loss of $<ix:nonFraction unitRef="usd" contextRef="i5b86094c4db947ae9f4ef0d8fd8d773a_D20190401-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMTg3NQ_2c450e52-ab9e-4c0d-816d-a6961db02af2"><ix:nonFraction unitRef="usd" contextRef="i72904c34cf28486695441a05e83b4257_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMTg3NQ_f5906b50-0800-4327-9cc9-d5a1f8ba6891">246</ix:nonFraction></ix:nonFraction> million primarily representing the difference between its proportionate share of the IPO proceeds and the dilution effect on the investment&#8217;s carrying value. These items were included in Equity earnings and charges from investment in Change Healthcare Joint Venture in the Company&#8217;s Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2019. The Company&#8217;s proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, the Company recorded a pre-tax other-than-temporary&#160;impairment (&#8220;OTTI&#8221;) charge of $<ix:nonFraction unitRef="usd" contextRef="i72904c34cf28486695441a05e83b4257_D20190701-20190930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMjQyNQ_3daeff53-6ccf-4d7f-beff-2bf2e918d6d8"><ix:nonFraction unitRef="usd" contextRef="i5b86094c4db947ae9f4ef0d8fd8d773a_D20190401-20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMjQyNQ_67077b77-7a3f-4458-89c4-9c928d588708">1.2</ix:nonFraction></ix:nonFraction> billion to its investment in the Change Healthcare JV, representing the difference between the carrying value of the Company&#8217;s investment and the fair value derived from the corresponding closing price of Change&#8217;s common stock at September 30, 2019. This charge was included in Equity earnings and charges from investment in Change Healthcare Joint Venture in the Company&#8217;s Condensed Consolidated Statements of Operations for the nine months ended December 31, 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded its proportionate share of loss from its investment in Change Healthcare JV of $<ix:nonFraction unitRef="usd" contextRef="i0946d2a17db14d63b64a7a7251e88c34_D20191001-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:ProportionateGainLossOnEquityMethodInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMjg3OA_48078183-4582-42c2-8f3e-fff280b1665b">28</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5b86094c4db947ae9f4ef0d8fd8d773a_D20190401-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:ProportionateGainLossOnEquityMethodInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMjg4NQ_2f77dafd-4f88-4d35-8550-f7fd68ffe028">75</ix:nonFraction> million, respectively, for the three and nine months ended December 31, 2019. The Company&#8217;s proportionate share of income or loss from this investment included integration expenses incurred by Change Healthcare JV and basis differences between the joint venture and McKesson, including amortization of fair value adjustments primarily representing incremental intangible assets. These amounts were included within Equity earnings and charges from investment in Change Healthcare Joint Venture in the Company&#8217;s Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2020, the Company completed the previously announced separation of its interest in the Change Healthcare JV which eliminated the Company&#8217;s investment in the joint venture. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ibaa5a429e19745849438ebd53f3b1ed6"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While a party to the joint venture, the Company had various ancillary agreements related to the Change Healthcare JV, including transition services agreements (&#8220;TSA&#8221;), a transaction and advisory fee agreement (&#8220;Advisory Agreement&#8221;), a tax receivable agreement (&#8220;TRA&#8221;), and certain other agreements. Revenues recognized and expenses incurred under these agreements with the Change Healthcare JV were not material during the three and nine months ended December 31, 2020 and the three months ended December 31, 2019. Fees earned from the TSA were $<ix:nonFraction unitRef="usd" contextRef="i9f856c9a81854c4287e9fd8fc2f4afdc_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMzg0ODI5MDcwMzMzMA_99b7cc4f-9e41-45ac-bd36-a90c99a9fa04">18</ix:nonFraction> million for the nine months ended December 31, 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the agreement executed in 2019 between the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson. McKesson exercised its right under the agreement and allocated certain depreciation and amortization deductions to Change for the tax years ended March 31, 2019 and 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After McKesson&#8217;s separation of its interest in the Change Healthcare JV, the aforementioned TRA agreement requires the Change Healthcare JV to pay McKesson <ix:nonFraction unitRef="number" contextRef="idaaf01c3e7a448f788de27496483bc0d_I20201231" decimals="INF" name="mck:TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfNDg5OQ_1d51ed06-5f25-4f56-9818-6f6053a9b169">85</ix:nonFraction>% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the depreciation or amortization allocated to Change by McKesson. The receipt of any payments from the Change Healthcare JV under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings. This creates uncertainty over the amount, timing, and probability of the gain recognized. As such, the Company accounts for the TRA as a gain contingency, with <ix:nonFraction unitRef="usd" contextRef="idaaf01c3e7a448f788de27496483bc0d_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DueFromRelatedParties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfNTM5NA_e9fa13e4-12ab-445a-8b06-776eae11234d">no</ix:nonFraction> receivable recognized as of December 31, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020 in conjunction with the separation transaction, the Company recorded a reversal of the deferred tax liability related to its investment. Under the agreement with the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, there may be changes in future periods to the amount reversed as the relevant periods are audited by tax authorities. Any such change is not expected to have a material impact on the Company&#8217;s condensed consolidated financial statements.</span></div></ix:continuation><div id="ib9c6f28fe5144278bb122fe3b38cf454_43"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.&#160;&#160;&#160;&#160;</span><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMzM2OQ_1fc6fe4b-ca4e-44a7-accb-c87a8ff72236" continuedAt="i15946673328b462baba8b876610b21db" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></ix:nonNumeric></div><ix:continuation id="i15946673328b462baba8b876610b21db" continuedAt="ic6b52c23a56841bf89bc8cd2e966a23b"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are reclassified into &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The reclassification occurs when the disposal group is available for immediate sale and the sale is highly probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell and are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less cost to sell is reported as an adjustment to the carrying value of the disposal group. Assets and liabilities that have met the classification of held for sale were $<ix:nonFraction unitRef="usd" contextRef="i715e9debe5f0419fa1ede68430828e3c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI2MTE0Ng_72389648-3b27-4c36-9f5f-60cead645247">15</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i715e9debe5f0419fa1ede68430828e3c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI2MTE1Ng_c8446eff-017f-450b-b22c-62f60d33374d">14</ix:nonFraction> million, respectively, at December 31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i54af79268ad141df9f90e22d7b9b6595_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMzg0ODI5MDcyODU0Mg_902d5f9c-7f6d-4077-a32c-804876b3ad0c">906</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i54af79268ad141df9f90e22d7b9b6595_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMzg0ODI5MDcyODU0NQ_06868b5a-e8f2-4ca9-9ddd-e01db858bb71">683</ix:nonFraction>&#160;million, respectively, at March 31, 2020. These amounts at March 31, 2020 primarily consisted of the majority of the Company&#8217;s German pharmaceutical wholesale business described below. This disposal group had been recorded as assets and liabilities held for sale since the third quarter of 2020 through its contribution to a joint venture in the third quarter of 2021. Based on its analysis, the Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations and are not considered to be significant disposals based on its quantitative and qualitative evaluation. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">German Pharmaceutical Wholesale Joint Venture</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2020, the Company completed its previously announced transaction with Walgreens Boots Alliance (&#8220;WBA&#8221;) whereby the majority of its German pharmaceutical wholesale business was contributed to a newly formed joint venture in which McKesson has a <ix:nonFraction unitRef="number" contextRef="ic0ee8653fb6141acba5c088e3b9425bc_I20201101" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfOTM0NTg0ODg2Mzc5MQ_c855f2d2-0a60-4e2d-9452-d46f031d2966">30</ix:nonFraction>% noncontrolling interest. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration received included a receivable amount of $<ix:nonFraction unitRef="usd" contextRef="icb1ee1c3366844f7af5c1f57a7d2a100_I20201101" decimals="-6" format="ixt:numdotdecimal" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI4MzQ0Mg_c5f99519-278d-4cb6-96cf-40e52b9097ba">43</ix:nonFraction>&#160;million, primarily related to working capital and net debt adjustments from WBA, and the <ix:nonFraction unitRef="number" contextRef="ic0ee8653fb6141acba5c088e3b9425bc_I20201101" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfOTM0NTg0ODg2NzQxOA_c855f2d2-0a60-4e2d-9452-d46f031d2966">30</ix:nonFraction>% interest in the newly formed joint venture. At the transaction date, the carrying value of the equity investment in the joint venture was recorded at its fair value, which was measured using inputs that fell within Level 3 of the fair value hierarchy. The carrying value of the investment in the joint venture was <ix:nonFraction unitRef="usd" contextRef="i06bcacee536741a5b8412ad11e052a04_I20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI5MjM2Mg_08252936-efd5-4176-af94-f2ceefb8c668">nil</ix:nonFraction> as of December 31, 2020. The joint venture also assumed a note payable to the Company in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="i938f21cb5003435093dd61e42f1e4b04_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjc0ODc3OTA5Nzg5MA_8f1fddd0-01a4-4557-a5f6-e2c7938bf145">291</ix:nonFraction>&#160;million as of the transaction date, which was paid to the Company in the third quarter of 2021. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ic6b52c23a56841bf89bc8cd2e966a23b"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the contribution, the Company recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="i938f21cb5003435093dd61e42f1e4b04_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI3NDEzMA_606ed94e-b402-4a9f-8db5-9297a0ec658a"><ix:nonFraction unitRef="usd" contextRef="i938f21cb5003435093dd61e42f1e4b04_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:GainLossOnSaleOfBusinessNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI3NDEzMA_dea21788-bca2-4401-9c70-831cbd82826e">47</ix:nonFraction></ix:nonFraction>&#160;million (pre-tax and after-tax) in operating expenses in the three months ended December 31, 2020. In addition to this amount, the Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i1089a6502fe643b2af007927de94cff7_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI5MDI1Mg_1da3716d-1156-476a-afc9-d5015faef904"><ix:nonFraction unitRef="usd" contextRef="i1089a6502fe643b2af007927de94cff7_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI5MDI1Mg_2335f551-1510-4f6e-bfd6-8a78a78479ca"><ix:nonFraction unitRef="usd" contextRef="i1089a6502fe643b2af007927de94cff7_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI5MDI1Mg_44964288-5537-466f-9181-d994d2abee99"><ix:nonFraction unitRef="usd" contextRef="i1089a6502fe643b2af007927de94cff7_D20200401-20200930" decimals="-6" format="ixt:numdotdecimal" name="mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI5MDI1Mg_5dc00723-21ed-499d-80a8-32d231b446d0">10</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;million (pre-tax and after-tax) in the three and six months ended September 30, 2020 and $<ix:nonFraction unitRef="usd" contextRef="icd175625828b47dcab648e0b14392f10_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI5MDMzNw_62e2f44f-777c-488e-a9a2-e92a8e45659e"><ix:nonFraction unitRef="usd" contextRef="icd175625828b47dcab648e0b14392f10_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI5MDMzNw_6ae7b6a1-2644-4a56-8cab-1f1b116f0e73"><ix:nonFraction unitRef="usd" contextRef="i0736a2a757fc454b88a193a6988112ef_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI5MDMzNw_ca0bf28a-df2a-433b-b254-ca718669ab16"><ix:nonFraction unitRef="usd" contextRef="i0736a2a757fc454b88a193a6988112ef_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI5MDMzNw_dad717c7-9297-43f1-8161-63a54c923693">282</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;million (pre-tax and after-tax) in the three and nine months ended December 31, 2019 to remeasure the assets and liabilities held for sale to fair value less costs to sell. These charges were included within operating expenses in the condensed consolidated statements of operations. The Company&#8217;s measurement of the fair value of the disposal group was based on estimates of total consideration to be received by the Company as outlined in the contribution agreement between the Company and WBA. As a result of finalization of working capital amounts contributed and other adjustments, the Company may record additional gains or losses in future periods; however, these adjustments are not expected to have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its interest in the joint venture as an equity method investment within the International segment. The Company does not provide for losses on the investment as the Company has no guaranteed obligations for the joint venture to fund losses and is not otherwise committed to providing further financial support for the investee. If the joint venture subsequently generates income, the Company will only recognize its share of such income to the extent it exceeds its share of the previously unrecognized losses. As such, the Company has not recognized its proportionate share of earnings for the intervening period from the transaction date to December 31, 2020.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the completion of the transaction on November 1, 2020, there were <ix:nonFraction unitRef="usd" contextRef="ia0497adf27fa406783b9193a572e5457_I20201101" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfOTM0NTg0ODg2Mzc5OA_94889de2-c246-4661-9c16-962863c8385c"><ix:nonFraction unitRef="usd" contextRef="ia0497adf27fa406783b9193a572e5457_I20201101" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfOTM0NTg0ODg2Mzc5OA_a613b756-53c3-460b-b53c-5453c131dd7f">no</ix:nonFraction></ix:nonFraction> assets or liabilities of the German pharmaceutical wholesale joint venture classified as held for sale on the Company&#8217;s consolidated balance sheet. <ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMzM2Ng_4d55e88b-a388-4eb8-acf7-4d1b97ccf63a" continuedAt="ie753410e1b974d02b54184021084ecfa" escape="true">Total assets and liabilities of the German pharmaceutical wholesale joint venture that were classified as held for sale on the Company&#8217;s consolidated balance sheet as of March 31, 2020, were as follows:</ix:nonNumeric></span></div><ix:continuation id="ie753410e1b974d02b54184021084ecfa"><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9649ec563d482b84c3260463f09372_I20200331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RhYmxlOmI4OGVkNDIyMTYyYjRjZDJiMzlkMmMyZTgwMTAxZjFmL3RhYmxlcmFuZ2U6Yjg4ZWQ0MjIxNjJiNGNkMmIzOWQyYzJlODAxMDFmMWZfMy0zLTEtMS0w_869fd75c-208e-46dd-ab6a-c0f80e40dbfe">548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9649ec563d482b84c3260463f09372_I20200331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RhYmxlOmI4OGVkNDIyMTYyYjRjZDJiMzlkMmMyZTgwMTAxZjFmL3RhYmxlcmFuZ2U6Yjg4ZWQ0MjIxNjJiNGNkMmIzOWQyYzJlODAxMDFmMWZfNC0zLTEtMS0w_5b0aaa30-dd95-4860-9a23-def2ff6687ef">478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9649ec563d482b84c3260463f09372_I20200331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RhYmxlOmI4OGVkNDIyMTYyYjRjZDJiMzlkMmMyZTgwMTAxZjFmL3RhYmxlcmFuZ2U6Yjg4ZWQ0MjIxNjJiNGNkMmIzOWQyYzJlODAxMDFmMWZfNi0zLTEtMS0w_ff5faa33-2b66-4f7b-a3b8-5d6b30356fd4">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of business held for sale to fair value less costs to sell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f9649ec563d482b84c3260463f09372_I20200331" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RhYmxlOmI4OGVkNDIyMTYyYjRjZDJiMzlkMmMyZTgwMTAxZjFmL3RhYmxlcmFuZ2U6Yjg4ZWQ0MjIxNjJiNGNkMmIzOWQyYzJlODAxMDFmMWZfNy0zLTEtMS0w_18c12685-1fb0-416a-a7c5-f42c626aaff8">272</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9649ec563d482b84c3260463f09372_I20200331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RhYmxlOmI4OGVkNDIyMTYyYjRjZDJiMzlkMmMyZTgwMTAxZjFmL3RhYmxlcmFuZ2U6Yjg4ZWQ0MjIxNjJiNGNkMmIzOWQyYzJlODAxMDFmMWZfOC0zLTEtMS0w_48c5c6a6-e3a7-45f8-9f2b-4eccb456cdde">842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9649ec563d482b84c3260463f09372_I20200331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RhYmxlOmI4OGVkNDIyMTYyYjRjZDJiMzlkMmMyZTgwMTAxZjFmL3RhYmxlcmFuZ2U6Yjg4ZWQ0MjIxNjJiNGNkMmIzOWQyYzJlODAxMDFmMWZfMTItMy0xLTEtMA_5579c5b7-9d6d-4bd9-a042-7c66487b3196">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9649ec563d482b84c3260463f09372_I20200331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RhYmxlOmI4OGVkNDIyMTYyYjRjZDJiMzlkMmMyZTgwMTAxZjFmL3RhYmxlcmFuZ2U6Yjg4ZWQ0MjIxNjJiNGNkMmIzOWQyYzJlODAxMDFmMWZfMTMtMy0xLTEtMA_22416a31-0241-45dc-b913-36373a64ebde">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9649ec563d482b84c3260463f09372_I20200331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RhYmxlOmI4OGVkNDIyMTYyYjRjZDJiMzlkMmMyZTgwMTAxZjFmL3RhYmxlcmFuZ2U6Yjg4ZWQ0MjIxNjJiNGNkMmIzOWQyYzJlODAxMDFmMWZfMTQtMy0xLTEtMA_1c1d4d53-4e91-436b-be98-a78284603f92">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9649ec563d482b84c3260463f09372_I20200331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RhYmxlOmI4OGVkNDIyMTYyYjRjZDJiMzlkMmMyZTgwMTAxZjFmL3RhYmxlcmFuZ2U6Yjg4ZWQ0MjIxNjJiNGNkMmIzOWQyYzJlODAxMDFmMWZfMTUtMy0xLTEtMA_28afb2dd-bc90-4201-8088-4f0229903985">656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes the effect of approximately $<ix:nonFraction unitRef="usd" contextRef="id6d5fffd99d0450f8f071044f671a597_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI2NDk3MQ_668f2109-cb43-4744-ad5e-0caa5f89aab7">3</ix:nonFraction> million of favorable cumulative foreign currency translation adjustment as of March 31, 2020.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_49"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfNTg1Mw_6f5a7297-e56a-4862-8d6b-0f5009d87006" continuedAt="if2313606d75548c9884e43a57c8b0e2d" escape="true">Restructuring, Impairment, and Related Charges</ix:nonNumeric></span></div><ix:continuation id="if2313606d75548c9884e43a57c8b0e2d" continuedAt="id6d0ead1bd93401cabb56775dbbb4f4a"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded restructuring, impairment, and related charges of $<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfODM_2ae30b5a-3fea-431f-8e1a-3149191e6301">155</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfOTA_9bfb9ce0-59d0-4e46-b050-531f31f70db1">271</ix:nonFraction> million during the three and nine months ended December 31, 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMTI2_3721e1e1-ae3d-4828-bc16-1e43c87a66e3">136</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMTMz_cd079e56-d37b-405e-9637-95fa6a27e73a">204</ix:nonFraction> million during the three and nine months ended December 31, 2019, respectively. These charges are included under the caption, &#8220;Restructuring, impairment, and related charges&#8221; in Operating expenses in the Condensed Consolidated Statements of Operations. In addition, charges related to restructuring initiatives are included under the caption &#8220;Cost of sales&#8221; in its Condensed Consolidated Statements of Operations and were not material for the three and nine months ended December 31, 2020 and 2019.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously announced on November 30, 2018, the Company relocated its corporate headquarters, effective April 1, 2019, from San Francisco, California to Irving, Texas to improve efficiency, collaboration, and cost competitiveness. The Company expects to record total charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i91c13ec8524c453f9fbf254e519c6157_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfODMx_86555117-cf72-40ce-9787-4239d0a88718">105</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i616db767164b421690d7840423dc72a9_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfODM3_e8285521-5ddd-469c-903f-f9844b57f7f7">125</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="icd12a38f8159497f9b8bc50d69f1a89a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfODUw_e622af82-aed7-48ee-ab37-23e9e476bc55">104</ix:nonFraction> million of charges were recorded to date. The Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i20a65cc8e8234e5eb9b8668ac6d80e35_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDcyMzgzMQ_9de31508-f725-46f4-8500-4e3bec6e8a15">14</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5777604ac50d42d29d8f706480015dbc_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDcyNDA2OA_7b0f7c33-6665-461b-aff6-ce2a5e73439a">27</ix:nonFraction>&#160;million, respectively, during the three and nine months ended December 31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i39bbef1ec8fc483a88d5b2eb2083b4a9_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDczMTk1OA_f3ac1787-d353-4d59-9d16-6e6901c79d30">14</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iaba638f6e46a48be9bcfd94e751a80d0_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDczMTk2Nw_9d3da84d-93f1-491f-b793-26e2af7cb4d1">34</ix:nonFraction> million, respectively, during the three and nine months ended December 31, 2019, consisting primarily of employee retention expenses, severance, accelerated depreciation, and long-lived asset impairments. The relocation was substantially complete in January 2021 and the estimated remaining charges primarily relate to lease costs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, the Company committed to certain programs to continue its operating model and cost optimization efforts. The Company continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency. The programs also include reorganization and consolidation of business operations, related headcount reductions, the further closures of retail pharmacy stores in Europe, and closures of other facilities. The Company expects to incur total charges of approximately $<ix:nonFraction unitRef="usd" contextRef="if7e8ac65eea64557801e653b724c7e05_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDcwMzEwMQ_73d58968-64a6-4269-8ff7-f6c4bf7c36fd">310</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i40a1d1ff2c634d9f894ff1faed74cab9_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDcwMzEwNQ_58b146ca-375f-46f6-bd02-65492693f785">320</ix:nonFraction> million for these programs, of which $<ix:nonFraction unitRef="usd" contextRef="ibd41af04654b404a9739658b0498956b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDcwMzEwOQ_ae5a0318-faf0-4025-b0fc-3f7aebaf7786">288</ix:nonFraction> million of charges were recorded to date. The Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i7dcd5be0a9224164b3b9c477afe71a48_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDcyNDIxNQ_b26dbe73-b89e-46d6-b419-3d131aa402c0">17</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if5111ebf6d6d4aa8b255575260d32886_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDcyNDIyNA_d48122df-6e4a-4628-b2c3-3b1461d83582">53</ix:nonFraction> million, respectively, during the three and nine months ended December 31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="ia582bee9ce874e8bb235617714cf6227_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDczMjIzOQ_9b4edd3f-cf4f-4e06-9e76-783fb96f9d87">20</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="icd022885b12e488c84b28eedee6a78ba_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDczMjI0OA_36991e99-0df9-4fc3-93fe-82e63f161406">59</ix:nonFraction> million, respectively, during the three and nine months ended December 31, 2019, consisting primarily of employee severance, accelerated depreciation expense, and project consulting fees. The Company anticipates these additional programs will be substantially completed in 2022. The estimated remaining charges primarily consist of facility and other exit costs and employee-related costs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the first quarter of 2021, the Company committed to an initiative within the United Kingdom (&#8220;U.K.&#8221;), which is included in the Company&#8217;s International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings. The initiative includes reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. The Company expects to incur total charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i4e8de5e2935b4c3496531d27f8e5fb9d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDcwMzIwMQ_2716b3ae-ace3-4803-acbe-6f438f659f26">100</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i60745e30425f4f529e698ec37e36d916_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDcwMzIwNQ_60ddbef6-84de-4465-bbcc-4ba9eb0b9d3c">120</ix:nonFraction> million. The Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i0cf4b0b9a9c540999eb1517cab23e300_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMjc2MQ_caf62305-de50-4b57-ad20-fb37bdc409af">9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic2223aea755c43138b22205b7dce1033_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMjc2OA_135aa197-7f45-4472-9350-ab471659089a">50</ix:nonFraction> million, respectively, in the three and nine months ended December 31, 2020, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. The initiative is expected to be substantially complete by the end of 2021 and estimated remaining charges primarily consist of accelerated amortization of long-lived assets, facility and other exit costs, and employee-related costs.</span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="id6d0ead1bd93401cabb56775dbbb4f4a" continuedAt="i29103ec9ab27431c8fa5d3db26488bf5"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfNTgzNw_d99e6391-26f6-4d13-9ac5-3e256d909ca0" continuedAt="i7c5572b4e6064d6d927b8888533707fc" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three and nine months ended December 31, 2020 consisted of the following: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if54fe59c7ab4486da50c3e383e0514cb_D20201001-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMi0xLTEtMS0w_d6954091-fb6a-47f3-b770-81986645096d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7a74b6b95d4a9e9c701380f77e3b51_D20201001-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMi0zLTEtMS0w_2aaa0cf1-1287-4f2b-9f7e-e35637944abf">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id80f00bff7b5467b812041c7200a62b2_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMi01LTEtMS0w_fa7579f9-8d30-4525-aa57-e8db6d7e50f3">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee23f0fe86e64c7bae441a8ea5cc1c91_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMi03LTEtMS0w_e32212c7-57a7-440c-a2cb-8ee7d2ea8584">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499179d5d599419b93690bc3104dd04a_D20201001-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMi05LTEtMS0w_7f03d915-97b7-43b3-aa44-c6007f89b84e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMi0xMS0xLTEtMA_6284ecf9-1805-4f8d-9ea0-f62be0af43ca">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if54fe59c7ab4486da50c3e383e0514cb_D20201001-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMy0xLTEtMS0w_76e9bc8b-cb9c-45a7-9ba8-fb132245c6a4">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7a74b6b95d4a9e9c701380f77e3b51_D20201001-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMy0zLTEtMS0w_402d5a34-53e4-4423-924b-b1f83ed27fb6">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id80f00bff7b5467b812041c7200a62b2_D20201001-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMy01LTEtMS0w_c2869d61-b0ff-413b-b1fb-069aa21a8be1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee23f0fe86e64c7bae441a8ea5cc1c91_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMy03LTEtMS0w_fd204cb9-8bb9-45cc-b58d-d6cf10e05bb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499179d5d599419b93690bc3104dd04a_D20201001-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMy05LTEtMS0w_9c168fba-1b0e-40a9-84b0-d3bc4c0be43f">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMy0xMS0xLTEtMA_5de76d56-5e28-45df-931e-8abefda0f38d">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if54fe59c7ab4486da50c3e383e0514cb_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNC0xLTEtMS0w_fb53b5e5-7c9c-4abc-abe5-2b038fd9a18c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7a74b6b95d4a9e9c701380f77e3b51_D20201001-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNC0zLTEtMS0w_677989f5-2983-4a3d-8b00-c92ae48f2dc8">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id80f00bff7b5467b812041c7200a62b2_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNC01LTEtMS0w_b9f7a427-80da-4dda-88d4-589fe018b8e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee23f0fe86e64c7bae441a8ea5cc1c91_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNC03LTEtMS0w_cd1924e9-4914-43e5-adec-0347f493fdf5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499179d5d599419b93690bc3104dd04a_D20201001-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNC05LTEtMS0w_fce9b152-8fee-4062-a7a6-18d4ed675a4f">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNC0xMS0xLTEtMA_a07e077b-52ef-43c5-abd7-f08b54c60f4a">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if54fe59c7ab4486da50c3e383e0514cb_D20201001-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNS0xLTEtMS0w_d41ab884-f810-4bce-b1d4-f3d45e3021f4">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7a74b6b95d4a9e9c701380f77e3b51_D20201001-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNS0zLTEtMS0w_805f2239-8c33-4a10-978c-2a23ad8633f7">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id80f00bff7b5467b812041c7200a62b2_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNS01LTEtMS0w_09da208c-6869-419c-acfc-4bb22db8bb99">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee23f0fe86e64c7bae441a8ea5cc1c91_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNS03LTEtMS0w_670db83f-071f-4965-b235-f12f8a0f1dc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499179d5d599419b93690bc3104dd04a_D20201001-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNS05LTEtMS0w_94069cd3-676d-4131-bf17-ee907e791e59">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNS0xMS0xLTEtMA_4b18eeb9-8a76-4dcf-b342-282125f418e8">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of project consulting fees.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMi0xLTEtMS0w_a240db9a-1c99-4815-b45f-73164ebffe3f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMi0zLTEtMS0w_d722d895-ad99-449e-b96a-c17fe6a8dd49">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMi01LTEtMS0w_4004b8ba-ad65-479e-ac36-1a6f2d24bd6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMi03LTEtMS0w_f3b1e3a6-0954-4997-9298-cc9166445abc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMi05LTEtMS0w_3e7bc6f6-5c85-42fc-921a-9e930451d1ab">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMi0xMS0xLTEtMA_53edab48-9f87-4c88-86ff-9ce4c267804a">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMy0xLTEtMS0w_b1a3e6d0-5806-4185-8201-77d2f95e7027">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMy0zLTEtMS0w_ba52ad24-ecfa-4a57-a73b-df84d9766f7a">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMy01LTEtMS0w_35e23a73-4b23-4ab6-8d3c-27220c20d5d7">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMy03LTEtMS0w_b4290713-6ed0-41f0-8c42-15b18dc68f05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMy05LTEtMS0w_2e95b740-d7c1-47ed-b31d-cc8959354b43">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMy0xMS0xLTEtMA_27150825-1407-4a0d-bb50-cd59605be990">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNC0xLTEtMS0w_45cd54f0-08a6-43f8-ba41-178ab24b8d36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNC0zLTEtMS0w_a088d70a-5bcf-4fc8-8ba0-528f76dd279d">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNC01LTEtMS0w_b7e58ce2-1cf8-48fb-95e8-c2589a25f9f7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNC03LTEtMS0w_a0aa29da-1cce-40d8-a2d4-d5f91444310d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNC05LTEtMS0w_5800ed4d-f31c-4e5d-931f-0e7c9379ff17">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNC0xMS0xLTEtMA_331ce0ab-b3a3-470d-a635-00af20d6a478">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNS0xLTEtMS0w_9b81aae9-d2f4-4281-a094-87d8f8ea1999">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNS0zLTEtMS0w_de52ded8-f968-4dc5-a1cf-230d53aa8e06">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNS01LTEtMS0w_11f195e9-d86f-42e5-b5cd-78b27cee20ef">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNS03LTEtMS0w_9eaabd19-bc46-4c0d-ae1f-c989f0dced56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNS05LTEtMS0w_44893fd6-cdcb-4d14-9ec5-17d4b9bd6bb5">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNS0xMS0xLTEtMA_1df32a61-dab9-4b83-ac20-5a0c4af777aa">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of project consulting fees.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i29103ec9ab27431c8fa5d3db26488bf5" continuedAt="idb2afddddec249e8a17c8d6df6c0c09e"><ix:continuation id="i7c5572b4e6064d6d927b8888533707fc"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three and nine months ended December 31, 2019 consisted of the following: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.193%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic713f1d7bbaa46368d505facade21e5e_D20191001-20191231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMi0xLTEtMS0w_9fb31436-7b2f-4e03-884d-c6b5ff66c7a3">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib36209733adf465ab9a09ed10cfc40ba_D20191001-20191231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMi0zLTEtMS0w_58f92d6a-f562-4cce-9663-9f092a4c7565">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief6c871b558e47b38754e0ea56f455a3_D20191001-20191231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMi01LTEtMS0w_ab86178c-0bb7-47e2-be0c-16046b381014">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f91b4dd9d724e81a9d50e837b7e65d6_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMi03LTEtMS0w_ea1b94ab-38c3-4944-ab2a-2bace3c25f94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib74da540dfec4334b95c1028aad4aabb_D20191001-20191231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMi05LTEtMS0w_105dd2e6-c283-4cfb-b86b-0ff5cf373289">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMi0xMS0xLTEtMA_2f8abc9c-64c6-4a2a-bcdf-35fbe39af20e">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic713f1d7bbaa46368d505facade21e5e_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMy0xLTEtMS0w_d1da2860-e2d8-496a-8a0e-b60f9c636dc9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib36209733adf465ab9a09ed10cfc40ba_D20191001-20191231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMy0zLTEtMS0w_d5667697-3e84-4a05-8768-084dca68570f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief6c871b558e47b38754e0ea56f455a3_D20191001-20191231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMy01LTEtMS0w_6a828c06-d4ac-4117-84da-2c4d3ce47bff">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f91b4dd9d724e81a9d50e837b7e65d6_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMy03LTEtMS0w_1467e9be-799b-4b93-8d4c-2ad8643093ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib74da540dfec4334b95c1028aad4aabb_D20191001-20191231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMy05LTEtMS0w_39e75418-6c8e-4aaf-8a3c-a5e5f9710c3b">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMy0xMS0xLTEtMA_fdc1ba42-d600-402d-b5c7-c90ea8ba0a18">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic713f1d7bbaa46368d505facade21e5e_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNC0xLTEtMS0w_b9d07a90-be1d-45cf-9c66-935c935f8e91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib36209733adf465ab9a09ed10cfc40ba_D20191001-20191231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNC0zLTEtMS0w_e045ade9-2137-4f44-bcce-129b7714b889">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief6c871b558e47b38754e0ea56f455a3_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNC01LTEtMS0w_4ea5979e-3548-4c44-a343-41df26068489">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f91b4dd9d724e81a9d50e837b7e65d6_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNC03LTEtMS0w_e1acf4ba-f7ea-4592-9314-68cda5ae1b38">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib74da540dfec4334b95c1028aad4aabb_D20191001-20191231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNC05LTEtMS0w_c2a4c5c6-842e-4178-9a0d-da914665bf0d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNC0xMS0xLTEtMA_5750a0a1-a146-4d62-a660-0ab8a20ed6c3">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic713f1d7bbaa46368d505facade21e5e_D20191001-20191231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNS0xLTEtMS0w_b4d3e7d7-cfaa-4f73-a3a8-cdbb5487d0ec">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib36209733adf465ab9a09ed10cfc40ba_D20191001-20191231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNS0zLTEtMS0w_27140b1c-e2e1-4203-a4b9-351414c5d2e8">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief6c871b558e47b38754e0ea56f455a3_D20191001-20191231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNS01LTEtMS0w_5c0b57b7-b89f-47b1-8213-4baf3dc9caf2">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f91b4dd9d724e81a9d50e837b7e65d6_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNS03LTEtMS0w_83880986-f407-424e-80b6-50f3238a6b6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib74da540dfec4334b95c1028aad4aabb_D20191001-20191231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNS05LTEtMS0w_05b5bf81-79f4-40c7-8cce-48d92e73c312">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNS0xMS0xLTEtMA_7854908a-d95b-416b-80a9-4537d648f03d">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents exit costs associated with a disposition and costs related to the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts described above. Additionally, includes costs associated with a growth initiative, substantially completed in the year ended March 31, 2020, which included a reduction in workforce and facility consolidation.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.193%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia76b1ab18790411e9e7fdeb98f2f4606_D20190401-20191231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMi0xLTEtMS0w_34f7c404-94e2-4746-bd8a-d55f19c358fb">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55e8174fad24466896ea35fa3e18419c_D20190401-20191231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMi0zLTEtMS0w_ee4988da-6e36-45ae-97b5-59aa6710a3b5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifafa9479474c4281a1fb299fa0ed48b3_D20190401-20191231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMi01LTEtMS0w_f6bba208-1b7b-49fd-9048-2ec8140faa9d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33926b73aa0043d2989ae3b788c16046_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMi03LTEtMS0w_3cad037a-6697-4e09-a04a-8bc0c5e325df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib06a1c55db15496e8c44849e29aea6c6_D20190401-20191231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMi05LTEtMS0w_83d2ed0f-f2f7-4469-a464-d5c0b65fe6db">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMi0xMS0xLTEtMA_4f40f04c-5a4e-41b0-93fd-49179e81787e">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia76b1ab18790411e9e7fdeb98f2f4606_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMy0xLTEtMS0w_d61f3cfa-ffc6-4f21-96af-2bf749553b60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55e8174fad24466896ea35fa3e18419c_D20190401-20191231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMy0zLTEtMS0w_5659f28e-a876-4b87-974b-26d3dbc9c88d">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifafa9479474c4281a1fb299fa0ed48b3_D20190401-20191231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMy01LTEtMS0w_1d54d8ea-67d5-41c7-8ed1-bf8e6464577d">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33926b73aa0043d2989ae3b788c16046_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMy03LTEtMS0w_131a31ca-8134-4cea-9e0e-9839d061dc20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib06a1c55db15496e8c44849e29aea6c6_D20190401-20191231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMy05LTEtMS0w_159f118a-e0f5-4c62-8476-d34ebe8f5459">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMy0xMS0xLTEtMA_f4e7ee60-caf3-4b58-b708-11ee1baa803f">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia76b1ab18790411e9e7fdeb98f2f4606_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNC0xLTEtMS0w_0d3d482f-50e7-414e-abfc-3f607819f8d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55e8174fad24466896ea35fa3e18419c_D20190401-20191231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNC0zLTEtMS0w_217b9c48-3856-46a1-ad22-d5be2caa8cd2">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifafa9479474c4281a1fb299fa0ed48b3_D20190401-20191231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNC01LTEtMS0w_ac291fd1-8040-4988-b9e9-9fd763d4bc30">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33926b73aa0043d2989ae3b788c16046_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNC03LTEtMS0w_eafafca9-0a46-4fcd-aabe-e398793555b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib06a1c55db15496e8c44849e29aea6c6_D20190401-20191231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNC05LTEtMS0w_551dc3b7-f4ae-4bf2-84b4-17378c9d08ad">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNC0xMS0xLTEtMA_899212b8-416f-4ad9-be28-679fb5297510">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia76b1ab18790411e9e7fdeb98f2f4606_D20190401-20191231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNS0xLTEtMS0w_bc854a4e-052b-4483-a7a0-2ed05c8467c1">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55e8174fad24466896ea35fa3e18419c_D20190401-20191231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNS0zLTEtMS0w_60886531-404c-4e7b-a8c8-c48521eabd8b">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifafa9479474c4281a1fb299fa0ed48b3_D20190401-20191231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNS01LTEtMS0w_89c09da3-3806-4912-8b33-c754b42ae02b">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33926b73aa0043d2989ae3b788c16046_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNS03LTEtMS0w_d4e0cd29-d779-4504-818e-239e51a25865">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib06a1c55db15496e8c44849e29aea6c6_D20190401-20191231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNS05LTEtMS0w_1a8fce6a-cd31-4095-9a7a-ab9225a97f49">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNS0xMS0xLTEtMA_6e545b20-9fac-401c-8b01-66f3ac656fea">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents exit costs associated with a disposition and costs related to the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above. Additionally, includes costs associated with a growth initiative, substantially completed in the year ended March 31, 2020, which included a reduction in workforce and facility consolidation.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="idb2afddddec249e8a17c8d6df6c0c09e"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfNTg0Ng_5556c572-3904-4512-8216-44b39b3343b5" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the nine months ended December 31, 2020: </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23356c66de0b48bfa4370bb815d51010_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMS0xLTEtMS0w_03ee3093-b359-4a0f-989c-4b8a7024ec63">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib632ae517264462ea49f0e14b37abe4d_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMS0zLTEtMS0w_f7c739e2-3dab-4961-9c62-746d3b67ebc4">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic60a002dcc044ef2a73c71e490891614_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMS01LTEtMS0w_0a2f7ac7-208c-450b-a8ac-c154520c3c42">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifce4292925d84d7bb62d6111b21c8e27_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMS03LTEtMS0w_702ffca0-4a87-4ad2-9684-f6952e22e399">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i877beefd260c4117b551163018536ff7_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMS05LTEtMS0w_55676d78-a804-427e-98e7-74a0c039ebcb">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMS0xMS0xLTEtMA_5a3574ba-98cf-4823-a178-10e96bb4a4ea">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMi0xLTEtMS0w_9dc6ab05-7d19-4aaf-ae93-c5b0fb896e29">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMi0zLTEtMS0w_f75e94e5-1747-45ac-9ffb-6f45ad4a55c9">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMi01LTEtMS0w_7aa764ca-ccfe-4e74-afe2-1d381c4dc98b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMi03LTEtMS0w_0dc6cce0-be12-47cd-8719-232ae2c39108">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMi05LTEtMS0w_60188f71-906a-4a5c-9303-84182a882179">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMi0xMS0xLTEtMA_b3bb591d-78cb-4f89-84a5-03da7fbd2fe4">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMy0xLTEtMS0w_36629507-9fe6-499d-97ea-3f4d70e3ccd7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMy0zLTEtMS0w_a3f3ab21-1f2c-4e5b-89c7-3c68aa9b504f">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMy01LTEtMS0w_94a4991d-b210-49c2-8c84-ea5f636d8c72">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMy03LTEtMS0w_2597b158-17b9-463c-87c8-21de16de5160">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMy05LTEtMS0w_9e3816bb-5d97-4f82-9291-c06f9f627a8e">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMy0xMS0xLTEtMA_e715f54f-9837-448f-b565-e7bf0fb8f4df">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNC0xLTEtMS0w_ec587641-0ce9-46e4-b03f-b4ea42902bbe">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNC0zLTEtMS0w_0466ee6e-991c-4721-9e02-a2101e717bc2">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNC01LTEtMS0w_43975ec9-3852-49f3-9f71-e6b7e1e1ee25">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNC03LTEtMS0w_d37ebcc7-090e-4f8b-afd3-98d7796004c3">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNC05LTEtMS0w_2d9ad094-07db-4a1c-af4b-613ebdf9d05a">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNC0xMS0xLTEtMA_82db6cf7-d6ac-4a0e-bbe2-4b06cbb73fda">132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNS0xLTEtMS0w_52cce12d-3ad7-40bf-8df8-f9d061ac7a70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNS0zLTEtMS0w_92c276fa-12d2-417c-8b1b-82a2e6d25f4c">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNS01LTEtMS0w_874a6509-2605-47d1-ab97-d21078a38682">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNS03LTEtMS0w_db58a4ed-80a2-4ef3-bbdc-ddece297c6b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNS05LTEtMS0w_acb67465-bdef-4200-ab95-312f2b94e6a5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNS0xMS0xLTEtMA_527d97b0-085b-457b-b0f6-90f179f457af">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifad220b5d8ba4d42a4c7b10bf33c3d2c_I20201231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNi0xLTEtMS0w_dad90133-fdd4-4376-b5f4-2b9ac7790851">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65219f93663148a283a10dfe499597e9_I20201231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNi0zLTEtMS0w_fab0552b-ef87-4613-a83a-4271f344748e">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3beceef97ffc465bb547b319a855c1fd_I20201231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNi01LTEtMS0w_1c1c2d43-e7f0-41a5-a6dc-6ace2bf26ecb">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb04a8ba65947f39b3457cfdc48939a_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNi03LTEtMS0w_9d493835-aee0-47ec-8c46-3a8c0964979f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f647fda026d4fd8ab82de9ade2df506_I20201231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNi05LTEtMS0w_50ed2902-a430-4b65-9e54-ba3853d38011">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNi0xMS0xLTEtMA_289881b8-d612-421c-8033-94fa0a9ce3e5">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March 31, 2020, the total reserve balance was $<ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfNTY1OA_297654f8-95b8-4380-9e8d-bb3cc74591c3">157</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i001894ef5d384e6194e9a49a8e30453a_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfNTY3MQ_b1349ff3-8b47-4a37-80ff-8b45e3b19eae">118</ix:nonFraction> million was recorded in Other accrued liabilities and $<ix:nonFraction unitRef="usd" contextRef="ie1d41963e1e64af4a2db91749e48ba60_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfNTY5Nw_e36dccfc-ffdf-4ed6-9fc1-4d076160851a">39</ix:nonFraction> million was recorded in Other non-current liabilities. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of December 31, 2020, the total reserve balance was $<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfNTc3Nw_6b7277a6-8f4e-43ce-ab4d-acecfe34fe40">132</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i9ae50b9f9854471da2e71204c4eedcb1_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfNTc5MA_f2cfd90d-c49e-4509-aa3d-9f24e9a747ee">101</ix:nonFraction> million was recorded in Other accrued liabilities and $<ix:nonFraction unitRef="usd" contextRef="i4ab08a4977fc44d4908e07229d064f40_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfNTgxNg_25871e6e-dfcb-451f-9c2d-3900c615df6c">31</ix:nonFraction> million was recorded in Other non-current liabilities.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Long-Lived Asset Impairments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company recognized charges of $<ix:nonFraction unitRef="usd" contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMjE5OTAyMzI4MTkzNg_2eac6b27-072f-4a3e-9c14-3eca0f3ea5fc"><ix:nonFraction unitRef="usd" contextRef="i4e166dc2bc4e4407ac307367798e7a56_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMjE5OTAyMzI4MTkzNg_81885a80-fb34-4c78-81cf-5e38bec59f5c">115</ix:nonFraction></ix:nonFraction> million to impair certain long-lived assets within the Company&#8217;s International segment. These charges primarily related to long-lived assets associated with the Company&#8217;s retail pharmacy businesses in Canada and Europe and were due to declines in estimated future cash flows partially driven by a revised outlook regarding the impacts of COVID-19. The Company used both an income approach (a discounted cash flow (&#8220;DCF&#8221;) method) and a market approach to estimate the fair value of the long-lived assets. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2020, the Company recognized charges of $<ix:nonFraction unitRef="usd" contextRef="i8f352c2923e048e7bcd08e46042cbead_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMjc0ODc3OTA5ODA3Mw_5520f915-90ad-4a67-b0df-27d95f906a74"><ix:nonFraction unitRef="usd" contextRef="i08ed9c0c5f6d4a748a507235f5b297eb_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMjc0ODc3OTA5ODA3Mw_5720ffe0-1c23-487e-9b37-3b789233a625">94</ix:nonFraction></ix:nonFraction> million to impair certain long-lived assets within the Company&#8217;s International segment. These charges primarily related to long-lived assets associated with the Company&#8217;s retail pharmacy businesses in the U.K. and Canada due to declines in estimated future cash flows driven by government reimbursement reductions and lower than expected growth in both prescription volume and sales of non-prescription goods, respectively. The Company used both income (DCF) and market approaches to estimate the fair value of the long-lived assets. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the long-lived assets is considered a Level 3 fair value measurement due to the significance of unobservable inputs developed using company specific information. Refer to Financial Note 12, &#8220;Fair Value Measurements,&#8221; for more information on nonrecurring fair value measurements.</span></div></ix:continuation><div id="ib9c6f28fe5144278bb122fe3b38cf454_52"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjczMA_855fb525-86b5-42d5-972d-0f4366ae8798" continuedAt="i1317d15c325f4ab0a6e1050442f97113" escape="true">Income Taxes </ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1317d15c325f4ab0a6e1050442f97113" continuedAt="i366c2bbf923c4490abc6f5bd14583bc6">During the three months ended December 31, 2020 and 2019, the Company recorded an income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-8" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfOTc_c20c1adb-1946-4208-b89b-7f067683d096">1.2</ix:nonFraction> billion and income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMTI5_87222a8b-5b50-4d08-b616-1795909b2350">47</ix:nonFraction> million, respectively. During the nine months ended December 31, 2020 and 2019, the Company recorded an income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-8" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjYy_f443e21c-9b06-4f19-ac07-d09ce3adc437">1.0</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjk0_ab73f726-bd87-418c-b73f-7ba312d42726">111</ix:nonFraction> million, respectively. The Company reported an income tax benefit rate of <ix:nonFraction unitRef="number" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfNDAy_4b03b6c3-1595-400b-845b-fb626ea1981b">16.1</ix:nonFraction>% and an income tax expense rate of <ix:nonFraction unitRef="number" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfNDIw_82d212de-b23d-4fa0-afc7-2f6aab19b93f">16.0</ix:nonFraction>% for the three months ended December 31, 2020 and 2019, respectively, and income tax benefit rates of <ix:nonFraction unitRef="number" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfNDg5_156586ea-c08f-42ed-b151-dd198b46b4e4">16.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfNTA3_0bad5666-a576-4339-8b1a-d3a25f567a0b">194.7</ix:nonFraction>% for the nine months ended December 31, 2020 and 2019, respectively. Fluctuations in the Company&#8217;s reported income tax rates are primarily due to changes within the mix of earnings between various taxing jurisdictions, discrete items recognized in the quarters, including the impact of an intercompany sale of intellectual property during the nine months ended December 31, 2020, and impairment to the Company&#8217;s investment in the Change Healthcare JV, decreasing pre-tax income, for the nine months ended December 31, 2019. The charge for opioid-related claims of $<ix:nonFraction unitRef="usd" contextRef="i7ac4183cf22d4c829d4a7bc371cc268c_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfODI0NjMzNzIxODE3Mw_dcac3458-4279-4dfe-9a7f-1fca14a1a501"><ix:nonFraction unitRef="usd" contextRef="i30c6a601291c426daef2c98a6924abf6_D20200401-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfODI0NjMzNzIxODE3Mw_e9adc7c3-ed49-4c00-92cc-42ef2aa25053">8.1</ix:nonFraction></ix:nonFraction> billion ($<ix:nonFraction unitRef="usd" contextRef="i7ac4183cf22d4c829d4a7bc371cc268c_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="mck:LossContingencyAccrualProvisionNetOfTax" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfODI0NjMzNzIxODE3OA_05bac1f2-f26a-4d94-bd1f-00678e229869"><ix:nonFraction unitRef="usd" contextRef="i30c6a601291c426daef2c98a6924abf6_D20200401-20201231" decimals="-5" format="ixt:numdotdecimal" name="mck:LossContingencyAccrualProvisionNetOfTax" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfODI0NjMzNzIxODE3OA_4a2bd069-22f8-476e-96ad-73aeb42bae7e">6.7</ix:nonFraction></ix:nonFraction> billion after-tax), as described further in Financial Note 13, &#8220;Commitments and Contingent Liabilities,&#8221; unfavorably impacted the Company&#8217;s reported income tax benefit rates for the three and nine months ended December 31, 2020. Income tax benefit (expense) for the three and nine months ended December 31, 2019 included a discrete tax benefit of $<ix:nonFraction unitRef="usd" contextRef="id2503fe9d11b43b3b558877f874ef3c7_D20190401-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:IncomeTaxExpenseBenefitDiscreteItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjE5OTAyMzI2MDAyNA_971470c0-70cd-4992-9bfd-8e7b1fc6c593"><ix:nonFraction unitRef="usd" contextRef="iea7615b447b24e05ba7119aa98301bad_D20191001-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:IncomeTaxExpenseBenefitDiscreteItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjE5OTAyMzI2MDAyNA_d02a0a9f-61ba-46db-88aa-962e02399e8c">24</ix:nonFraction></ix:nonFraction> million recognized in connection with a planned divestiture in the Medical-Surgical Solutions segment and $<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:IncomeTaxExpenseBenefitDiscreteItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjE5OTAyMzI2MDA0Nw_08b06498-c31b-480e-a754-3d59e32f7e52"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:IncomeTaxExpenseBenefitDiscreteItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjE5OTAyMzI2MDA0Nw_4ec1fb6d-f118-426b-bf9e-9150193325d0">21</ix:nonFraction></ix:nonFraction> million recognized in connection with an agreement executed in December 2019 to settle all opioid-related claims filed by <ix:nonFraction unitRef="county" contextRef="ia65b1cdade72453c9c9547d6ed17b3e9_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencyNumberofCounties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfOTM0NTg0ODg0MDYwMQ_0f1fe092-4718-4c21-bfe4-d919228495a4">two</ix:nonFraction> Ohio counties.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i366c2bbf923c4490abc6f5bd14583bc6"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company sold intellectual property between wholly-owned legal entities within McKesson that are based in different tax jurisdictions. The transferor entity recognized a gain on the sale of assets which was not subject to income tax in its local jurisdiction; such gain was eliminated upon consolidation. The acquiring entity of the intellectual property is entitled to amortize the purchase price of the assets for tax purposes. In accordance with ASU 2016-16, &#8220;Intra-Entity Transfers of Assets Other Than Inventory,&#8221; a discrete tax benefit of $<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:IncomeTaxExpenseBenefitDiscreteItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMTQ0OQ_7d6d29df-ceb2-42fc-9ca2-9393dc4bf7ba"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="mck:IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMTQ0OQ_b2315211-d338-4834-8f5b-6edf818472e9">105</ix:nonFraction></ix:nonFraction> million was recognized for the nine months ended December 31, 2020 with a corresponding increase to a deferred tax asset for the temporary difference arising from the buyer&#8217;s excess tax basis. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended December 31, 2019, <ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="INF" format="ixt-sec:numwordsen" name="mck:IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfOTM0NTg0ODgzOTYwNA_51071a41-95ed-40fb-a57d-5cdd62c146f5"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="INF" format="ixt-sec:numwordsen" name="mck:IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfOTM0NTg0ODgzOTYwNA_686e33ef-3098-4603-9e69-119c9cfd1fc0">no</ix:nonFraction></ix:nonFraction> tax benefit was recognized for the pre-tax impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ImpairmentChargeOnReclassifiedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMzg0ODI5MDcwMDIyOQ_2933554b-8702-49c7-a9a3-033ce9e3d122"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ImpairmentChargeOnReclassifiedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMzg0ODI5MDcwMDIyOQ_a528c512-4b2c-4d14-8df9-de891cbedace">282</ix:nonFraction></ix:nonFraction> million for the remeasurement of assets and liabilities held for sale to fair value related to the formation of a new German pharmaceutical wholesale joint venture within the Company&#8217;s International segment. Refer to Financial Note 3, &#8220;Held for Sale,&#8221; for more information on this transaction which closed on November 1, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjc0ODc3OTA3NzYzMw_8a905995-6055-4a9f-b535-f2ab2203b468">1.5</ix:nonFraction> billion of unrecognized tax benefits, of which $<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjc0ODc3OTA3NzY1MQ_8bcb306c-5c05-42fc-9dfc-b705c43329d7">1.4</ix:nonFraction> billion would reduce income tax expense and the effective tax rate if recognized. The increase of $<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjc0ODc3OTA3NzY1OQ_50955440-4ec1-43d3-87ef-c94df2f871f8">497</ix:nonFraction> million during the three months ended December 31, 2020 in unrecognized tax benefit is mainly due to uncertainty in connection with the deductibility of Opioid related litigation and claims. Because many of the uncertainties associated with any potential settlement arrangements or other resolution of opioid claims, including provisions related to deductibility, have not been finalized, the actual amount of the tax benefit related to uncertain tax positions may differ from these estimates. Refer to Financial Note 13, &#8220;Commitments and Contingent Liabilities,&#8221; for more information. During the next twelve months, it is reasonably possible that the Company&#8217;s unrecognized tax benefits may decrease by as much as $<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjc0ODc3OTA3NzczOQ_a23489f5-80ca-4031-a2cc-bde8a0dde33b">93</ix:nonFraction> million due to settlements of tax examinations and statute of limitations expirations in the U.S. federal and state jurisdictions and in foreign jurisdictions. However, this amount may change as the Company continues to have ongoing negotiations with various taxing authorities throughout the year. The unrecognized tax benefit may also increase or decrease due to future developments in the Opioid related litigation and claims.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#8220;IRS&#8221;) is currently examining the Company&#8217;s U.S. corporation income tax returns for 2016 through 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2013 through the current fiscal year.</span></div></ix:continuation><div id="ib9c6f28fe5144278bb122fe3b38cf454_58"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:MinorityInterestDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMzM3Ng_f89fb045-6a07-4f57-b4e6-c2c3c7e90fe4" continuedAt="ief70fbb1195e46f0a1a193f274f8084b" escape="true"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:MinorityInterestDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMzM4Mw_5ddcd829-16ff-4d3c-9936-aeb6d62c536a" continuedAt="i825e22a488f342879390d67164f6da19" escape="true">Redeemable Noncontrolling Interests and Noncontrolling Interests</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="ief70fbb1195e46f0a1a193f274f8084b" continuedAt="if628de6c878048ab8a671377726d7d45"><ix:continuation id="i825e22a488f342879390d67164f6da19" continuedAt="i4430154fdd444f39a157d7cf52a20a10"><div style="margin-bottom:6pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s redeemable noncontrolling interests primarily relate to its consolidated subsidiary, McKesson Europe AG (&#8220;McKesson Europe&#8221;). Under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i2c1af7ae051f4acd85bdcfaf6f8522c4_I20201231" decimals="INF" name="mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfNDEw_e2a57c79-8ce3-4c38-a3d2-cbef92e29472">0.83</ix:nonFraction> per share. As a result, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $<ix:nonFraction unitRef="usd" contextRef="i626c1e0e782e474b92df366e001d6dd2_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfNTQ5_7471724f-0e86-4aa9-af30-4e2ed51c52e8">11</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9a434cdc734d4abf996142dfdc8544ec_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfNTU2_6a1a5dfc-7d8f-404f-bf6c-3c61afd5e4ce">32</ix:nonFraction> million during the three and nine months ended December 31, 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ib5b1c59088c8425e8c672396cbc8f14f_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfNTky_29b694bd-f50c-45c8-abd3-fa786ef668f3">11</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7442088aa6c644dab9cdca71fad61eba_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfNTk5_b5c1c592-1241-45c4-ba02-c57af4a2aca5">33</ix:nonFraction> million during the three and nine months ended December 31, 2019, respectively. All amounts were recorded in Net income attributable to noncontrolling interests in the Company&#8217;s Condensed Consolidated Statements of Operations and the corresponding liability balance was recorded in Other accrued liabilities in the Company&#8217;s Condensed Consolidated Balance Sheets.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="if628de6c878048ab8a671377726d7d45" continuedAt="i28017c8d16ab4483aa2e9b7b96eba050"><ix:continuation id="i4430154fdd444f39a157d7cf52a20a10" continuedAt="i97c695bc50ef43b7a01c779a4dc34db5"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe have a right to put (&#8220;Put Right&#8221;) their noncontrolling shares at &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfOTkx_3c191e21-caa5-4f30-859d-3d82ccba1607">22.99</ix:nonFraction> per share, increased annually for interest in the amount of <ix:nonFraction unitRef="number" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="mck:PutRightValueInterestRateSpread" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMTA1NA_6d8d64db-d1cc-4692-bf90-d8864cb304a2">five</ix:nonFraction> percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#8220;Put Amount&#8221;). The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests. During the nine months ended December 31, 2020, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i9a434cdc734d4abf996142dfdc8544ec_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMTQxOQ_34504549-d512-4b6a-8210-d48460bea525">49</ix:nonFraction> million to purchase <ix:nonFraction unitRef="shares" contextRef="i9a434cdc734d4abf996142dfdc8544ec_D20200401-20201231" decimals="-5" format="ixt:numdotdecimal" name="mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMTQzNA_a9ad44f8-69ff-4b31-b381-c1386e5a2d4e">1.8</ix:nonFraction>&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $<ix:nonFraction unitRef="usd" contextRef="i96e8498baa5c4166b0360154493d4319_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMTYwMw_fef3b712-4f81-489f-8486-8b44ea287f5c">49</ix:nonFraction> million, and the associated effect of the increase in the Company&#8217;s ownership interest on its equity of $<ix:nonFraction unitRef="usd" contextRef="i2011d00a9d33400ab4105b02fddf648e_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMTcwMg_df1ab7d3-d8e9-4449-a4fa-825f49428494">3</ix:nonFraction> million was recorded as a net increase to McKesson&#8217;s stockholders paid-in capital during 2021. During the three months ended December 31, 2020, and the three and nine months ended December 31, 2019, there were no material exercises of the Put Right. The balance of the associated liability for Redeemable noncontrolling interests is reported as the greater of its carrying value or its maximum redemption value at each reporting date. The redemption value is the Put Amount adjusted for exchange rate fluctuations each period. The Redeemable noncontrolling interest is also adjusted each period for the proportion of other comprehensive income, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders. At December 31, 2020, the carrying value of redeemable noncontrolling interests of $<ix:nonFraction unitRef="usd" contextRef="ia893650b8c174d97a0fff05ba6bde046_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMjE5OTAyMzI1OTIzMw_a18d3925-9dfe-4fe4-b748-e0f5b17e74e1">1.3</ix:nonFraction>&#160;billion approximated the maximum redemption value of $<ix:nonFraction unitRef="usd" contextRef="ia893650b8c174d97a0fff05ba6bde046_I20201231" decimals="INF" format="ixt:numdotdecimal" name="mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMjE5OTAyMzI1OTM3Mg_d8f8450b-2f06-421d-9ba0-64f1b58fbd47">1.3</ix:nonFraction> billion, and at March 31, 2020, the carrying value of $<ix:nonFraction unitRef="usd" contextRef="ib0a2cb17de16467787ff8f495afca17a_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMjQ2OQ_084bf1bf-3daa-42d0-b74e-7005137c5dbc">1.4</ix:nonFraction>&#160;billion exceeded the maximum redemption value of $<ix:nonFraction unitRef="usd" contextRef="ib0a2cb17de16467787ff8f495afca17a_I20200331" decimals="INF" format="ixt:numdotdecimal" name="mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMjE5OTAyMzI1OTM2Ng_66f19403-ba61-4dd5-ab76-7345df64db60">1.2</ix:nonFraction> billion. At December 31, 2020 and March 31, 2020, the Company owned approximately <ix:nonFraction unitRef="number" contextRef="ia893650b8c174d97a0fff05ba6bde046_I20201231" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMjU3OA_a2a84dd7-500b-42c5-86a1-4854407d56c5">78</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ib0a2cb17de16467787ff8f495afca17a_I20200331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMjU4NQ_9e4db841-1dc2-40d2-a48f-aa1225d3d172">77</ix:nonFraction>%, respectively, of McKesson Europe&#8217;s outstanding common shares.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity interests in the Company&#8217;s consolidated entities primarily related to ClarusONE Sourcing Services LLP, Vantage Oncology Holdings, LLC, and McKesson Europe, which were $<ix:nonFraction unitRef="usd" contextRef="i10ab863a7218445ca985683b1005b32b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMjg5Nw_a7c8d33d-641d-4d93-8c31-7d865200cbc7">200</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4f97e844a5a143218fd2d44d5b013a4e_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMjkwNA_4b249df4-35f6-4a51-a48c-f667484cd013">217</ix:nonFraction> million at December 31, 2020 and March 31, 2020, respectively, in the Company&#8217;s Condensed Consolidated Balance Sheets. The Company allocated a total of $<ix:nonFraction unitRef="usd" contextRef="i0e8778eb76054f0395746e9375d66efe_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMzAyNA_145d3335-5bcb-48ac-bbfc-9d6e42c204d8">41</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if22a8f70dcc24adc95cac8f86540d584_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMzAzMQ_0dbf4b62-f1f1-4316-aa40-aec0e6f3773f">120</ix:nonFraction> million of net income to noncontrolling interests during the three and nine months ended December 31, 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i849ff8d4511349eb9c3153967d1f7f12_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMzEwOQ_b91624e7-7b0b-4fb9-9493-08c177afed03">45</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5a05c352bec44a6fae02dc63bfae55f7_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMzExNg_d263924a-f4fd-41c8-9aa8-ee9351bd7652">130</ix:nonFraction> million during the three and nine months ended December 31, 2019, respectively.</span></div><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMzM3OA_ee2bc009-80db-4470-a9a9-2b16cf46ce4c" continuedAt="i5edafbda38e34cd29f4004e84e2db330" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2020 were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2020</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib03cda0901f74396a9d42a5e93e5f9eb_I20200930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfMS0yLTEtMS0w_1d825a28-4f89-40ab-bcff-d695f19d9931">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31fd56c5e498439cbb9f159e3e0e2e0d_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfMS00LTEtMS0w_20b631ae-1d3a-47f3-b8bb-868003b1e61c">1,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i454504e100134adfada4c6b22b8a933a_D20201001-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfMi0yLTEtMS0w_d47f881f-c624-4797-8d76-a08c1af52ef7">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied0e473ba615450b86643eccb05bd229_D20201001-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfMi00LTEtMS0w_9cd23287-0e2c-4589-a87d-5aa6acafa057">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i454504e100134adfada4c6b22b8a933a_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfMy0yLTEtMS0w_af96aa51-1a3e-453a-a6e1-476e32e47f1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied0e473ba615450b86643eccb05bd229_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfMy00LTEtMS0w_e3f427c1-76e0-4f23-a003-2d5332d12e2f">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied0e473ba615450b86643eccb05bd229_D20201001-20201231" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfNC00LTEtMS0w_d1266f8a-d7d2-4c22-9d37-126bf36769e6">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i454504e100134adfada4c6b22b8a933a_D20201001-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfNS0yLTEtMS0w_a3b6e3b2-097c-4e7a-b47b-53b1db85f824">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied0e473ba615450b86643eccb05bd229_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfNS00LTEtMS0w_4c15b3a4-1916-4f01-a0f9-81a8cd5d6f32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i454504e100134adfada4c6b22b8a933a_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfNy0yLTEtMS0w_ddf44a6c-9a17-48d4-8e61-a863c8ea5784">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied0e473ba615450b86643eccb05bd229_D20201001-20201231" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfNy00LTEtMS0w_7f8a2334-ef29-4d0d-ab68-34d4a3fe1cb3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i436786cf3fa44a21863b50c1e252c871_I20201231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfOC0yLTEtMS0w_ce10be1b-773a-4e9c-8e35-a82cff97b357">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3a8cac6d54b4c2ca9b7378d13ef870b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfOC00LTEtMS0w_5971cb7d-029e-423d-afe9-00a5a3925a03">1,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cbf15310ca46869b7c2a9274df3ebf_I20200331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfMS0yLTEtMS0w_ce914db1-ba89-4bf9-838d-e202344251cf">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4af1d24608d74947ab7497e23209ad59_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfMS00LTEtMS0w_f54d0e8a-7c99-45fd-addc-7c77e2f8cb7c">1,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6429e408d6643fe8ed7a32451d1973a_D20200401-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfMi0yLTEtMS0w_295a768b-8241-4f91-b700-ddadaa79173c">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96e8498baa5c4166b0360154493d4319_D20200401-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfMi00LTEtMS0w_296e23af-13f0-4659-9a3f-0623ac326ac7">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6429e408d6643fe8ed7a32451d1973a_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfMy0yLTEtMS0w_09b8a6f2-6939-4d88-a18a-9ef4483433f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96e8498baa5c4166b0360154493d4319_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfMy00LTEtMS0w_efe7f365-b216-4980-a3fc-5b5093239eab">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96e8498baa5c4166b0360154493d4319_D20200401-20201231" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfNC00LTEtMS0w_682b074a-1f14-4c2e-a2bd-beb687e5a501">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6429e408d6643fe8ed7a32451d1973a_D20200401-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfNS0yLTEtMS0w_1a792eb8-929a-4520-a193-4eea41278427">134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96e8498baa5c4166b0360154493d4319_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfNS00LTEtMS0w_087e8df4-9c8f-437d-b69b-8c6f92af8317">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96e8498baa5c4166b0360154493d4319_D20200401-20201231" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfNi00LTEtMS0w_fef3b712-4f81-489f-8486-8b44ea287f5c">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6429e408d6643fe8ed7a32451d1973a_D20200401-20201231" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfNy0yLTEtMS0w_e92ada89-8e79-44a7-88d9-92270b5ab827">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96e8498baa5c4166b0360154493d4319_D20200401-20201231" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfNy00LTEtMS0w_d863b56c-38d2-447d-bc59-5bc8827fe2be">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i436786cf3fa44a21863b50c1e252c871_I20201231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfOC0yLTEtMS0w_1561544f-9a3d-4537-8b1b-23e0ee43ebdd">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3a8cac6d54b4c2ca9b7378d13ef870b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfOC00LTEtMS0w_9704bae5-ccea-45c5-92db-70c168689490">1,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i28017c8d16ab4483aa2e9b7b96eba050"><ix:continuation id="i97c695bc50ef43b7a01c779a4dc34db5"><ix:continuation id="i5edafbda38e34cd29f4004e84e2db330"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2019 were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2019</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fe05a45bd0447499ad4274ebee0e5de_I20190930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfMS0yLTEtMS0w_47217942-340b-4d83-b133-9f0655ee7751">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c62b22aacf74756b7dfff6157966085_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfMS00LTEtMS0w_d0e78aed-c1e3-4086-a7bf-0bad22fb94bf">1,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d696af4cf5445b28748e6c09ac7c601_D20191001-20191231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfMi0yLTEtMS0w_a44e837c-e346-46ab-a6eb-8db125428a94">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie37cc4ec5c0e44558b2a32aba2c5fc0e_D20191001-20191231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfMi00LTEtMS0w_eee1fee2-930e-4096-a0f3-981a49313010">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d696af4cf5445b28748e6c09ac7c601_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfMy0yLTEtMS0w_21f1e207-f100-4bc7-ab62-d7d8b9cb3e0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie37cc4ec5c0e44558b2a32aba2c5fc0e_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfMy00LTEtMS0w_2e82be07-72b1-42bd-af0b-d9b0812a74bd">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie37cc4ec5c0e44558b2a32aba2c5fc0e_D20191001-20191231" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfNC00LTEtMS0w_976820dc-9221-4567-83a3-7e819e8a8606">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d696af4cf5445b28748e6c09ac7c601_D20191001-20191231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfNS0yLTEtMS0w_2c06013f-5abe-4bae-b336-4f5202018ea7">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie37cc4ec5c0e44558b2a32aba2c5fc0e_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfNS00LTEtMS0w_d5387634-46df-4d13-aad3-1a7c3bbde508">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d696af4cf5445b28748e6c09ac7c601_D20191001-20191231" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfNi0yLTEtMS0w_d2b50cfc-2318-49e0-b809-e031f08f5c8b">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie37cc4ec5c0e44558b2a32aba2c5fc0e_D20191001-20191231" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfNi00LTEtMS0w_546d2a77-db2c-413f-ba3c-70db6aa4dda8">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9025fe41f3c4206832a02f6067cccc8_I20191231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfNy0yLTEtMS0w_baf9a8a4-dd7a-486d-83ef-afd1c37d6672">211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11866fb0993444bd8e695ef414d06b6a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfNy00LTEtMS0w_9979300e-5fe4-4905-9f18-a81406e87b01">1,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:69.031%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcbc3a9c5dd4e11aa4f98339c48f19c_I20190331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfMS0yLTEtMS0w_38de8691-83e2-4bd6-aa9a-411d05978a74">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1e09321f5344cef88ba1a2c8931ec04_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfMS00LTEtMS0w_65b0f103-f379-40cd-8b35-2f6d8020c9a2">1,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01c4d416ec1c40a593cf210126c97ef4_D20190401-20191231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfMi0yLTEtMS0w_93fc0124-f5ce-4479-83ba-803614c2aee1">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed9ea6e51234863bd501477e55a7136_D20190401-20191231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfMi00LTEtMS0w_86be89c4-1162-4e88-9fc1-2b0722d9eb7e">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01c4d416ec1c40a593cf210126c97ef4_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfMy0yLTEtMS0w_513596f4-903e-4e80-aa74-82596420e84d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ed9ea6e51234863bd501477e55a7136_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfMy00LTEtMS0w_24252f57-c600-4223-9fa6-180a2dfface0">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ed9ea6e51234863bd501477e55a7136_D20190401-20191231" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfNC00LTEtMS0w_6621bbf9-30e0-46dc-8c74-4b448a564ced">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01c4d416ec1c40a593cf210126c97ef4_D20190401-20191231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfNS0yLTEtMS0w_31655cac-adc5-4b8e-85ba-01546e16083f">115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed9ea6e51234863bd501477e55a7136_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfNS00LTEtMS0w_e3abef4d-edbd-48b3-a089-885b2dd0dfcd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01c4d416ec1c40a593cf210126c97ef4_D20190401-20191231" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfNi0yLTEtMS0w_bec2f353-10a9-4081-9309-644ab4e728e1">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed9ea6e51234863bd501477e55a7136_D20190401-20191231" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfNi00LTEtMS0w_96e1e1dc-67cc-49ae-a6fe-66a8d28f7d93">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9025fe41f3c4206832a02f6067cccc8_I20191231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfNy0yLTEtMS0w_ba233d64-bba0-4db5-95e6-3a14eaa391a6">211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11866fb0993444bd8e695ef414d06b6a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfNy00LTEtMS0w_017f8471-f8ea-42c7-97cb-0359062aa065">1,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_64"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RleHRyZWdpb246OTJmMDY3YzBmNTA0NGQwOTliYWQ2MjUwYzBlMjE4MWZfMTEzOA_d7700a09-65ec-4b01-a812-f043a41a03fd" continuedAt="ic72b0c02ebf74b24a288b07361f817ef" escape="true">Earnings (Loss) Per Common Share</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic72b0c02ebf74b24a288b07361f817ef" continuedAt="i67c1e57fcd7a44cf8e5da3a6991c12b3">Basic earnings (loss) per common share are computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings (loss) per common share is similar to that of basic earnings (loss) per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Diluted loss per common share for the three and nine months ended December 31, 2020, and nine months ended December 31, 2019 was calculated by excluding potentially dilutive securities from the denominator of the share computation due to their anti-dilutive effects.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i67c1e57fcd7a44cf8e5da3a6991c12b3" continuedAt="i9a03ed3ad26e4ad88fc7ed6e765af6f9"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RleHRyZWdpb246OTJmMDY3YzBmNTA0NGQwOTliYWQ2MjUwYzBlMjE4MWZfMTE0NQ_df65d3a2-574e-421a-8486-32dca09e9125" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:52.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.967%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMi0xLTEtMS0w_8fe5a1ac-55d1-48f9-8dbd-273ce8352ce7">6,174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMi0zLTEtMS0w_54f20ed4-3382-4098-841d-5b747f26d83a">247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMi01LTEtMS0w_51b74202-d553-4aab-a843-14e36b8e3be7">5,052</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMi03LTEtMS0w_428c5dba-3d24-462b-9f6a-bd6f375f9c06">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMy0xLTEtMS0w_c4750c3f-6138-4933-996a-10e9f32b18a6">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMy0zLTEtMS0w_23b88cd6-58b3-43ec-a246-ef482c9f8469">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMy01LTEtMS0w_a9465ed1-4769-40f1-ba61-df29f3e2ff55">152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMy03LTEtMS0w_8d239508-a043-41ab-acf9-f92fae0c01ed">163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNC0xLTEtMS0w_6d6df432-723f-41ad-aa84-ec26d05de516">6,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNC0zLTEtMS0w_30fdd225-4e95-44b4-9691-9ffe04887884">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNC01LTEtMS0w_84c2630c-8914-45b1-b572-4375cb8c2fc3">5,204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNC03LTEtMS0w_f3280f94-09e2-4ad0-a640-e6fae09d81dc">109</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNS0xLTEtMS0w_11e5afbd-fbe3-4713-9fdd-469c738cf88b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNS0zLTEtMS0w_5869a3c8-e355-46e7-9a31-e0d7f4247f05">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNS01LTEtMS0w_613a1ce9-873b-431c-ad3b-137780d2c43e">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNS03LTEtMS0w_73630e47-2e5c-4bf7-abef-934781d225fc">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNi0xLTEtMS0w_a2d16288-ee24-417c-89af-0a60c06c1a87">6,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNi0zLTEtMS0w_ac3692c4-a0eb-48ed-b565-d03e95cdf48b">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNi01LTEtMS0w_31119bd6-9a93-42a8-8f54-a91fdaf2e336">5,205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNi03LTEtMS0w_ec34254e-a6ae-46a5-b4ba-8195e65d11d8">121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfOS0xLTEtMS0w_5ec88204-e80f-4be7-8aa5-4ab92a0f341d">159.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfOS0zLTEtMS0w_f5e38d10-6ee8-477d-8bc4-fe8fe3995667">178.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfOS01LTEtMS0w_c3be9645-e9fd-43e8-8318-61330e00d3fa">161.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfOS03LTEtMS0w_c8dd6b6a-0f71-43ba-af1b-a79bbfcd366d">183.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTEtMS0xLTEtMA_82e0fe20-287a-472b-8617-126331d27469">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTEtMy0xLTEtMA_f80ebe62-5e36-4759-bb70-7bbab1076f02">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTEtNS0xLTEtMA_526b1e6a-99cd-4a1d-ab1d-e6e108b44359">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTEtNy0xLTEtMA_ae7457e4-8c28-4fee-92d4-c4ed76fdd7b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTItMS0xLTEtMA_9b34f811-f2f9-40c3-bd26-3055ea47ead1">159.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTItMy0xLTEtMA_9c99725f-2504-4874-8921-6c862a38f323">179.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTItNS0xLTEtMA_2e042990-042d-40f7-87cb-1e6fd3a25c57">161.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTItNy0xLTEtMA_a1b1fa1f-ffb9-476d-a5d6-ef252e11bed2">183.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTYtMS0xLTEtMA_c1d499f7-d489-483f-8417-07efbe9447d3">39.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTYtMy0xLTEtMA_5624a897-033e-475e-aa0b-5c384de6cdaf">1.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTYtNS0xLTEtMA_d20782f2-c749-4f82-94f0-839356704341">32.28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTYtNy0xLTEtMA_3d8620a1-a630-4072-bbbf-dcac28113986">0.60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTctMS0xLTEtMA_7811f332-03b3-4776-9b95-3bfe59a32a77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTctMy0xLTEtMA_691e7955-1b15-49eb-8db5-7f7e9104dcb6">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTctNS0xLTEtMA_cee9a770-0880-4cf3-bc50-e71b01509e3e">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTctNy0xLTEtMA_c0da256f-20c2-42d8-a3d9-7b1ff63442ff">0.06</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTgtMS0xLTEtMA_b5228bb6-3252-4351-bf4e-58998af8f656">39.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTgtMy0xLTEtMA_2f7c4981-5d40-48d8-bde4-401a69cbbadf">1.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTgtNS0xLTEtMA_43d949a6-e37b-4a67-a275-cd2505fd1284">32.29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTgtNy0xLTEtMA_8f1ddd0a-424b-4358-b030-a20b17d0d75a">0.66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjAtMS0xLTEtMA_8a2adeb0-15a7-4726-9c17-95e0d4db63c5">39.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjAtMy0xLTEtMA_125c5ec6-5691-41a2-9aad-d4bf813f5062">1.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjAtNS0xLTEtMA_6c2f9bd5-78a6-405d-bd1b-508061f88a2c">32.28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjAtNy0xLTEtMA_aaa3f2c2-e1c6-489f-8abe-9929edcf99f0">0.60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjEtMS0xLTEtMA_d0e4166b-34c3-416f-aac4-fe9adc1168eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjEtMy0xLTEtMA_4a8dd4f3-e7a0-4e7b-b71d-5c65480bf42e">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjEtNS0xLTEtMA_7674386c-8208-4d9d-b45f-df20979d455d">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjEtNy0xLTEtMA_b4ba164d-b49e-4755-ab49-d19b3e7dc16c">0.06</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjItMS0xLTEtMA_322211a7-165c-4c9e-9f8e-e49ca7154d1a">39.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjItMy0xLTEtMA_13ce185f-5c2f-493f-8ebb-19f4b78764cd">1.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjItNS0xLTEtMA_a893edcc-26f9-4819-b823-3ebb9ae9f073">32.29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjItNy0xLTEtMA_142ae44b-cd0a-4ce2-8012-8f09fbd80e7b">0.66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"> Certain computations may reflect rounding adjustments.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9a03ed3ad26e4ad88fc7ed6e765af6f9">Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Approximately <ix:nonFraction unitRef="shares" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RleHRyZWdpb246OTJmMDY3YzBmNTA0NGQwOTliYWQ2MjUwYzBlMjE4MWZfOTM0NTg0ODgzODgzNw_fa5d130a-02b6-4f14-9872-59deeefdd29b">2</ix:nonFraction>&#160;million of potentially dilutive securities for the three months ended December 31, 2019 were excluded from the computation of diluted net earnings per common share as they were anti-dilutive.</ix:continuation> </span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_67"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTgxNA_3c6b37df-af1f-4989-9fce-224d8d1c2f83" continuedAt="ie3c7fbcaee554568a2519206e707f209" escape="true">Goodwill and Intangible Assets, Net </ix:nonNumeric></span></div><ix:continuation id="ie3c7fbcaee554568a2519206e707f209" continuedAt="idbcdaa37ff2247d7977c5d4f6e779742"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in <ix:nonFraction unitRef="segment" contextRef="i85b5d437b88a43c3b57c3014d5ae8bf1_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTIw_a079cb11-ec42-4973-92f6-9097fc5925c9">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. These reportable segments encompass all operating segments of the Company. This segment change prompted changes in multiple reporting units across the Company. As a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach and assessed for impairment both before and after the reallocation. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfNjEy_1799222b-3c6d-4ea4-a0db-0d1fcb46757b"><ix:nonFraction unitRef="usd" contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfNjEy_ddf155c1-4a61-4282-8503-f91b9e9814c1">69</ix:nonFraction></ix:nonFraction> million (pre-tax and after-tax) in the nine months ended December 31, 2020 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment. This impairment charge is included under the caption, &#8220;Goodwill impairment charges&#8221; in the Condensed Consolidated Statements of Operations. At December 31, 2020, the balance of goodwill for the reporting units in Europe was approximately <ix:nonFraction unitRef="usd" contextRef="ic4fae59f18a14a25b3bca73a248e3bc3_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:Goodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTEyMg_5e1e910d-a2e9-4fac-ac11-e710ce3bc1af">nil</ix:nonFraction> and the remaining balance of goodwill in the International segment primarily relates to one of its reporting units in Canada. </span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="idbcdaa37ff2247d7977c5d4f6e779742" continuedAt="i3f785fd6bbfa40f382b69f87c0d75a41"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist. The annual impairment testing performed for 2021 did not indicate any impairment of goodwill. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 12, &#8220;Fair Value Measurements,&#8221; for more information.</span></div><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTgyNQ_4cbf3242-b956-4d79-ae6d-23a93135fe88" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.942%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March&#160;31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dbd3be0a56f450cba497eb475a1c80b_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMS0xLTEtMS0w_c909658b-0dbb-4f9f-a4f8-fb00ba20ba8f">3,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie24dd23acc4f44e2a91794113bb10c51_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMS0zLTEtMS0w_eab34dfb-e5d6-4cb8-a826-980eca7eeb97">1,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02543cc7d8874da9b9dd772a66bad70c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMS01LTEtMS0w_202e8c2a-3c7b-4570-9be7-a264e97618e5">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0fa20a992b84dd9a41f9cbb8b17ee14_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMS03LTEtMS0w_e9867538-8f6a-4807-8e29-ad4ba61e4397">1,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMS05LTEtMS0w_372cb643-4c02-44bf-b016-5188a40c20a8">9,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566978f4e878431094db0c99aa04c1ac_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMi0xLTEtMS0w_f9816502-bb3b-4189-8888-e2b71013809d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMi0zLTEtMS0w_f00692c2-5873-47cc-99db-21fe2d8cfaa0">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i502121074c55491db6f36aeb28a2d5f2_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMi01LTEtMS0w_c0365e6a-86a3-4bb8-9399-f72bf0597865">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900790fc3b604ed6aeaa993f4b448b36_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMi03LTEtMS0w_eaecf279-0979-4500-b0a5-bfc7d3749750">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMi05LTEtMS0w_1cbb7073-475a-45d8-ac0f-c4fed356884d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting, transfers and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566978f4e878431094db0c99aa04c1ac_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNC0xLTEtMS0w_715373fd-d5d5-4d94-ac93-f0c4f4d5f6bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNC0zLTEtMS0w_7ce56f16-27d7-4fc1-b0c2-1fc600b81f34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i502121074c55491db6f36aeb28a2d5f2_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNC01LTEtMS0w_bf4be2f7-be45-4b5b-9a41-c88362048fe9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900790fc3b604ed6aeaa993f4b448b36_D20200401-20201231" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNC03LTEtMS0w_74464673-7171-404d-9ee3-9ed1e7cbf615">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNC05LTEtMS0w_db4f3466-9b83-4bba-ad28-da2a9d19dd84">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i566978f4e878431094db0c99aa04c1ac_D20200401-20201231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNS0xLTEtMS0w_e7ce519b-24fd-4d36-8d25-3c623e135f65">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNS0zLTEtMS0w_e64431fb-708d-4010-830b-f97e19a16308">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i502121074c55491db6f36aeb28a2d5f2_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNS01LTEtMS0w_d53ce7c0-918c-49bd-8c4a-3c37527f69e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900790fc3b604ed6aeaa993f4b448b36_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNS03LTEtMS0w_e4628454-828a-4c8f-ab9b-0c0ecd19c056">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNS05LTEtMS0w_bbf680c5-99da-49d1-8bd3-b9a4958c8a7b">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566978f4e878431094db0c99aa04c1ac_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNi0xLTEtMS0w_34b07aa7-9739-44ba-98d6-5d75d4fb64e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNi0zLTEtMS0w_1799222b-3c6d-4ea4-a0db-0d1fcb46757b"><ix:nonFraction unitRef="usd" contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNi0zLTEtMS0w_ddf155c1-4a61-4282-8503-f91b9e9814c1">69</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i502121074c55491db6f36aeb28a2d5f2_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNi01LTEtMS0w_acdae681-43a3-47eb-81ee-13fde1a58223">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900790fc3b604ed6aeaa993f4b448b36_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNi03LTEtMS0w_c61479f1-5cde-4fce-89fd-760723c88e12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNi05LTEtMS0w_6b3438ab-0f8b-40bb-821b-a0621acc1897">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566978f4e878431094db0c99aa04c1ac_D20200401-20201231" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNy0xLTEtMS0w_469342f3-d38a-4dbc-8d7f-23eaf1048ed8">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNy0zLTEtMS0w_74c27ff0-11c2-4096-9fc7-25bb060644d8">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i502121074c55491db6f36aeb28a2d5f2_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNy01LTEtMS0w_79cd9f25-1b6c-429e-b7bd-60f9f25a3eed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900790fc3b604ed6aeaa993f4b448b36_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNy03LTEtMS0w_fd7c53c8-5446-4408-83b4-9f0af065665f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNy05LTEtMS0w_ff9c8547-c4fd-41b7-9952-9e49aad40e05">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic38f289eb4674ef2811a0175289d6579_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfOC0xLTEtMS0w_fe86e305-6ffa-43d7-a316-3114d0feb0a5">3,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb9d72428fbd4515ba2df2bc472b2522_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfOC0zLTEtMS0w_8982b889-ef62-410b-8671-c954aac92cba">1,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9435ea6faaa49bfa7de0a9fd3ee3563_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfOC01LTEtMS0w_a0a051f1-8e67-4411-8cf9-4142c973bcc1">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9099621a5b034f1783335526d709c949_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfOC03LTEtMS0w_0bf4ff4b-9fd3-47ab-ac90-b7863b154e3d">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfOC05LTEtMS0w_e980d20b-d269-47a5-a3f2-f92f6b803209">9,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTgxOQ_8fd3e2f0-5ae5-45c1-94ed-36b7ac47c0e9" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i378dda10c10e4abda769223163b7e4e7_D20200401-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMi0xLTEtMS0w_8665a917-7b7f-4093-9540-b9eb2cc30edb">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cd1df3bc0b547ba9f623f4ef73d5370_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMi0zLTEtMS0w_a3a1d710-8f35-4036-bdb3-54cd607b721b">3,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cd1df3bc0b547ba9f623f4ef73d5370_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMi01LTEtMS0w_e16cf310-1e4e-4636-8ecc-849e82132abd">2,318</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cd1df3bc0b547ba9f623f4ef73d5370_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMi03LTEtMS0w_eb03e5bd-3e1d-4f46-91ee-06976cb4e5f4">1,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511bb16900684b6ea922b921c9d4dee0_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMi05LTEtMS0w_8884c9fd-db1c-41c1-bd85-329e884e20fe">3,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i511bb16900684b6ea922b921c9d4dee0_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMi0xMS0xLTEtMA_84bd4b53-7cef-4104-9f45-e2d2795fbe69">1,950</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511bb16900684b6ea922b921c9d4dee0_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMi0xMy0xLTEtMA_8f6bd5ce-3bda-4ecc-b41d-7815862f33b2">1,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5cfa3015624b4bc5b6b7f68095b82e08_D20200401-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMy0xLTEtMS0w_1eb28007-2748-4bec-a126-88c2bb6969b0">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773d34279984d34b8e2570dbfeac99d_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMy0zLTEtMS0w_fdc85ec7-310d-4d72-b4c1-e8877306b33d">859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6773d34279984d34b8e2570dbfeac99d_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMy01LTEtMS0w_a54989ab-a482-46ff-b7d4-43b2962e488c">402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773d34279984d34b8e2570dbfeac99d_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMy03LTEtMS0w_2f19b141-0505-4e6d-8494-45c2ce26487f">457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658902b07b2b449f913e2bd8456c8fa2_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMy05LTEtMS0w_e7cf506f-4210-4ad3-9291-44c9460f97dd">994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i658902b07b2b449f913e2bd8456c8fa2_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMy0xMS0xLTEtMA_25da2455-8656-45cf-b3df-711b6e3226e5">480</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658902b07b2b449f913e2bd8456c8fa2_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMy0xMy0xLTEtMA_a578154f-aa82-477c-8720-4a7a0cdb4265">514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i523fcde586d342cc8bd48e9569ed97f0_D20200401-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNC0xLTEtMS0w_3b520e7d-0310-4638-9fb1-688ada8526ad">26</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18fb0f7e2d57454c8ab3f9bf8d8d22cd_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNC0zLTEtMS0w_c60ac607-d125-4849-aad8-2736ab59ed7a">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18fb0f7e2d57454c8ab3f9bf8d8d22cd_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNC01LTEtMS0w_f9b5f2f8-5fd3-4111-b1ee-fed45344e1e4">240</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18fb0f7e2d57454c8ab3f9bf8d8d22cd_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNC03LTEtMS0w_cc28112e-e947-499e-918a-7bb842d42063">263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b800361d6a84fc7b5a2446b3d1e7341_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNC05LTEtMS0w_3f0682de-13e5-483c-ac3d-a9bd178ee494">492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b800361d6a84fc7b5a2446b3d1e7341_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNC0xMS0xLTEtMA_b68b42d7-244f-46ec-91ef-3282fab5a698">232</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b800361d6a84fc7b5a2446b3d1e7341_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNC0xMy0xLTEtMA_b07481ac-d095-4518-9e60-b6cf675c3970">260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i963a00ca4138498ca7ab4ca57f1a7f37_D20200401-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNS0xLTEtMS0w_f8d9a4d1-b97c-4fe4-9a35-9c46279465ad">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i725fcea7818746d1a1609a91129d7859_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNS0zLTEtMS0w_9ab62bea-a408-4ef8-9777-1c212d4699bc">922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i725fcea7818746d1a1609a91129d7859_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNS01LTEtMS0w_25f3bc9e-9b03-44a3-b8d1-d8e562eca255">379</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i725fcea7818746d1a1609a91129d7859_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNS03LTEtMS0w_ddcda345-ab96-42b6-845f-d3cef84cafae">543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id285ee1563e043a08cf17e27f0adff21_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNS05LTEtMS0w_32d4a428-c5fd-4849-8ed2-3b002270fe75">808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id285ee1563e043a08cf17e27f0adff21_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNS0xMS0xLTEtMA_89e51750-aaa4-4c24-bb51-a668905e1e3b">242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id285ee1563e043a08cf17e27f0adff21_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNS0xMy0xLTEtMA_4558b8d2-463e-4f6e-9f46-4f2a9151c3f3">566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibc05b27d7e0a4e78a4db26cb12058f85_D20200401-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNi0xLTEtMS0w_4f71b347-e166-4ec1-8e8c-96ef559c371f">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5769cd643a314785bc6bb343b9674112_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNi0zLTEtMS0w_09e0dffc-d663-4a50-bb01-3c7bfe7bb4d0">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5769cd643a314785bc6bb343b9674112_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNi01LTEtMS0w_04817886-79cd-4c0f-9337-37d1d2d0dbea">118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5769cd643a314785bc6bb343b9674112_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNi03LTEtMS0w_432daa6e-ae13-4c20-a394-b515271517c9">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieafb5736403f465eb913bf612cdc985a_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNi05LTEtMS0w_1533ec40-98df-45d1-9425-cbb1f3489c51">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieafb5736403f465eb913bf612cdc985a_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNi0xMS0xLTEtMA_ad814117-2ccd-40f8-81e9-f511b10632ca">111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieafb5736403f465eb913bf612cdc985a_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNi0xMy0xLTEtMA_de8b27be-26f2-4b43-8c2f-8a3b3e126e3c">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i659552bb536e4d988f20153df0383f90_D20200401-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNy0xLTEtMS0w_4fd8e46b-4c0e-4980-a61c-84ba61c6281e">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a9556d9999d4dad8956e6c895b8d4ab_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNy0zLTEtMS0w_11c3d281-635e-4609-8437-e46ca101095b">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a9556d9999d4dad8956e6c895b8d4ab_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNy01LTEtMS0w_ec39ddfd-4523-41c8-9574-d33c30683ffa">223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a9556d9999d4dad8956e6c895b8d4ab_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNy03LTEtMS0w_a78435fd-1c0d-49e9-8b37-33294eaae10f">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f42cc658d804c91ab0038c670ab193b_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNy05LTEtMS0w_7cb58aa1-3f43-43f5-8dde-b76fb87d8efd">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f42cc658d804c91ab0038c670ab193b_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNy0xMS0xLTEtMA_d382154a-aafc-4045-ab74-55fd3658270a">221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f42cc658d804c91ab0038c670ab193b_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNy0xMy0xLTEtMA_87ce633e-c29b-4e41-b842-7b28789da4ab">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfOC0zLTEtMS0w_906e4a09-2345-40f5-a8d7-12c046c8e7cc">6,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfOC01LTEtMS0w_c27b0146-ea9b-4c53-979f-f252a2d9dfe0">3,680</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfOC03LTEtMS0w_ce3c9d2b-de52-4ba2-b777-21837cba5943">2,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfOC05LTEtMS0w_8ef33103-8810-494f-8fd1-e6dde14609cf">6,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfOC0xMS0xLTEtMA_a7f1cfcf-8e56-4659-9649-4991eae13809">3,236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfOC0xMy0xLTEtMA_3ac6b007-a843-4f4b-8fd3-bbd65571e1e8">3,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3f785fd6bbfa40f382b69f87c0d75a41">Amortization expense of intangible assets was $<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTQ5MA_8f3b0dc9-b133-457b-8ee0-43a03ab01549">108</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTQ5Nw_a8b3d5a3-2f67-4251-8544-d5464b01ea17">320</ix:nonFraction> million during the three and nine months ended December 31, 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTUzMw_2a7cf7a9-1404-48b4-9e2a-c26197c87523">113</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTU0MA_0ef74c10-632f-4e06-948c-5b9ce89d13de">343</ix:nonFraction> million during the three and nine months ended December 31, 2019, respectively. Estimated amortization expense of these assets is as follows: $<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTYzNA_3e3657d5-e882-4086-9c1c-cc6dcbeb0351">96</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTYzOA_2b2a0e4c-278c-49e9-bf89-88c60f5b62c4">371</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTY0Mg_58b3e439-64d1-4527-87b6-f5c1bfb66e2f">272</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTY0Ng_bf10959a-9224-427f-848b-d2d5ebd683ad">254</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTY1NA_d1943b31-2d25-4644-b298-f66144f8f23d">251</ix:nonFraction> million for the remainder of 2021 and each of the succeeding years through 2025 and $<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-8" format="ixt:numdotdecimal" name="mck:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTcyOQ_1a4c5d9e-0c82-4e4c-a0bb-9e69dae5e2c8">1.7</ix:nonFraction> billion thereafter. All intangible assets were subject to amortization as of December 31, 2020 and March 31, 2020.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_70"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjg1Nw_efd9fc75-4a98-4489-8e86-39e234c8415b" continuedAt="i66a5d5227fdc4462a6ee57bb6d8b0f44" escape="true">Debt and Financing Activities</ix:nonNumeric></span></div><ix:continuation id="i66a5d5227fdc4462a6ee57bb6d8b0f44" continuedAt="i3aafa75d0115405e99e2048cc2daf4a6"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjg2Ng_02b20c29-578f-4608-a94a-b7e85c1ef2ae" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0e3d82d95ff34d09ad54cbb7a9568eeb_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMi0wLTEtMS0wL3RleHRyZWdpb246YzZmOGQ3YTI1Zjg4NDBiZTlkNmNjOWE5MzNiMzlmYTFfNA_c0083833-55ef-4826-a7e8-f652dc59d4d5">3.65</ix:nonFraction>% Notes due November 30, 2020</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3d82d95ff34d09ad54cbb7a9568eeb_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMi0xLTEtMS0w_1436ab57-9578-4153-b7c4-77b39186ffdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib62e3807a7114d0899925f4b51210868_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMi0zLTEtMS0w_e898cc15-e7f7-4850-b39e-4cd5c9f2002d">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61243968789b45e78979a62d792f3bf2_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMy0wLTEtMS0wL3RleHRyZWdpb246NDI5OTRjMzM5Y2NhNGVhNTg5ZWMzNDE5NzA5NjFmZWZfNA_ab24e655-d00d-4b56-9e78-afabf9f90176">4.75</ix:nonFraction>% Notes due March 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61243968789b45e78979a62d792f3bf2_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMy0xLTEtMS0w_001f08d6-9db6-4b7f-a52c-e92a347a1c53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic23cdb3eba794da3ab936c09bb3753eb_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMy0zLTEtMS0w_5f0c3936-019a-43fe-b713-3ce033b35da0">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic49f2f1769cd420c9df5352e8067b68d_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNC0wLTEtMS0wL3RleHRyZWdpb246YTc0N2Y1NzkxZmIyNDY4YWJmMTI5YWM3ZjY3ZTdhMmNfNA_8778e7e8-be87-4f05-a6c6-54467057fff5">2.70</ix:nonFraction>% Notes due December 15, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic49f2f1769cd420c9df5352e8067b68d_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNC0xLTEtMS0w_b84fae37-c1c8-4ad1-97e0-cc27a6b24606">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff33e00fbaee41eea7defea825d96e6c_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNC0zLTEtMS0w_3def5078-2888-4ea2-84ee-c3bebb724ea0">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5f896c781b42418fab54308abf10a3ab_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNS0wLTEtMS0wL3RleHRyZWdpb246MmZhMDFlYWM0MmIzNGNjYjk5ODljOGFlODg0YTA5Y2NfNA_f5108284-b30c-4cab-b53a-9da0f6050973">2.85</ix:nonFraction>% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f896c781b42418fab54308abf10a3ab_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNS0xLTEtMS0w_aa6090e8-5447-452c-99ae-86aeaed79ba1">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2024e246ff5243e1a182377483b428d9_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNS0zLTEtMS0w_bc048ab1-9b87-48f3-a9e5-a947d34a4c77">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i83ba1dcc0fa0463e870a0c6af64a8894_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNi0wLTEtMS0wL3RleHRyZWdpb246MmQxNDc2OTIxZDBkNGE5OTk4MTJlYzg4Y2NjYjM4YWFfNA_0ed52caa-1c85-46c6-bd6a-f668f810ec36">3.80</ix:nonFraction>% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ba1dcc0fa0463e870a0c6af64a8894_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNi0xLTEtMS0w_bb110fc4-7902-4d90-a667-21c47c20b89d">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3929998884064e1fb42a501356c5aa3b_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNi0zLTEtMS0w_82c44b42-fb1e-439b-94d9-042a4bbe024e">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i45681222eb314cadaa16245b1eda2bb3_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNy0wLTEtMS0yMTc4L3RleHRyZWdpb246YWM3MTkzZmYxZDkwNDdhNjkwODA4Yzk5MmIyMTNiNzlfMTA5OTUxMTYyNzgxNw_76190811-12c2-42ff-a82c-6a97d617f5f2">0.90</ix:nonFraction>% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45681222eb314cadaa16245b1eda2bb3_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNy0xLTEtMS0yMTgx_12d53baa-4a10-4f15-b1da-000a928667f8">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida48ca8acd984f98badfab324817c495_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNy0zLTEtMS0yMTgx_a4030ee5-51b7-4e40-87a0-9162ffc9e79c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i13860847712f4090af128c3ef55aac24_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNy0wLTEtMS0wL3RleHRyZWdpb246MWZmZTU2MTlhODZhNDg2ZmJjZTkwNmMwM2RlMWY4NGVfNA_59314a12-3435-4307-8d7e-c5efac78b2c7">7.65</ix:nonFraction>% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13860847712f4090af128c3ef55aac24_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNy0xLTEtMS0w_b032a572-0180-476f-8857-f2ff0bf42e72">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccb710e426964f068ee01c91061447f5_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNy0zLTEtMS0w_e8c90e52-3b30-4626-b0fa-10d204ced3f1">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i722ba8780dd64ef3998e85ae30f7b8e5_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfOC0wLTEtMS0wL3RleHRyZWdpb246ZTFjZWRlZDg1MjBkNGJlZTlhMjJmNTcxNzU0MzA0ZDZfNA_06b2d41f-d41f-4e9f-b8a8-01cfd4514402">3.95</ix:nonFraction>% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722ba8780dd64ef3998e85ae30f7b8e5_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfOC0xLTEtMS0w_7f7a822c-7b10-484f-b15d-82d04dd79682">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c3b5bf1138e4193b4ed05d0221ddb16_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfOC0zLTEtMS0w_d72f1290-8752-4cd5-bbb7-72426a1d0089">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iee65e5a7c91d480fa442a25bf99a4310_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfOS0wLTEtMS0wL3RleHRyZWdpb246OTY3YWI1ODM4ZGJlNGMzY2JiZTIxY2YzMmRjYTQ0NjZfNA_7f64990c-c3a5-417d-9365-1e533ad57f9c">4.75</ix:nonFraction>% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee65e5a7c91d480fa442a25bf99a4310_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfOS0xLTEtMS0w_f7f944c3-6179-4535-925b-19f5de6dda64">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa304a69e98947ed8c2ebd69d84693fe_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfOS0zLTEtMS0w_ca2f5c72-8357-4f86-9408-18c94f715ce3">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i543d6ee25e6648e9bfddfd675bdc4e0f_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjFmN2Q1NGEwNTY3NzQ5N2FiMmU1NzIyMjVlOGZlYjYzXzQ_d8eca8b1-1bc2-4a36-afe6-7ce3ceda0726">6.00</ix:nonFraction>% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i543d6ee25e6648e9bfddfd675bdc4e0f_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTAtMS0xLTEtMA_4e30b8da-c44d-44ed-8e30-6410e1564cab">282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icac37f0bb50c47a88452230ae579cc0e_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTAtMy0xLTEtMA_9febebee-2948-436b-97ab-1db5307fe6bb">282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i59f7fd483700447b913388bbe402cb2a_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjNkYzEwZTUzYjY0MzQ2OTViNzA0MzE3YWE4Mzg2NmU3XzQ_312a246c-15a7-4345-a37a-948b5363cb6b">4.88</ix:nonFraction>% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59f7fd483700447b913388bbe402cb2a_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTEtMS0xLTEtMA_3837f395-4944-4fc1-8fba-6f05594d4fb3">411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice7a4f35e6e047a59039a07c27481e3c_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTEtMy0xLTEtMA_70f72eb3-b529-4d40-b372-67be69544d1e">411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if338ee6ce8f3482a80ee390eacdd1b93_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjlkYjdkMDg5YjY5NTQwNmU5MjgzNDBmYjhlZGZiZDk5XzQ_23edd7b0-e461-48d5-ab63-77d4c852c549">0.63</ix:nonFraction>% Euro Notes due August 17, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if338ee6ce8f3482a80ee390eacdd1b93_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTMtMS0xLTEtMA_29557055-383b-4c80-99dd-bfc62264fc28">733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0ef65f413640089349522b6d1f61fb_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTMtMy0xLTEtMA_e09a5e9a-a3a6-47eb-83d9-5756054ce014">662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if9e2e544a5d24e309b0b1d476df167c4_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOmYzZWZmM2EzYjQ2ZDQ0MmJiNDE1YWJiMTljZDgyZjA2XzQ_dc57e325-2eea-481d-85e4-769c6d8b9aae">1.50</ix:nonFraction>% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e2e544a5d24e309b0b1d476df167c4_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTQtMS0xLTEtMA_c9dbe91b-4192-42b2-a72b-34952951a9ba">729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5859abcac6664cec9fd998af2d0f2d14_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTQtMy0xLTEtMA_f8f699f6-e505-4ce2-804f-7eb8983cdcdb">659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i57d99627daf846ff9841f02dd67e8763_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjBkNDViMzBjMjdlNzQxM2Y5NDIxYzMxMzZlZGZhOGQ5XzQ_2e68b1e3-abf1-4fd6-913b-99436b1c8bf1">1.63</ix:nonFraction>% Euro Notes due October 30, 2026 </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57d99627daf846ff9841f02dd67e8763_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTUtMS0xLTEtMA_4310cc24-bf51-4d37-aad4-07862aad6f39">611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if427cce4e6654f628a7f645a93e796d1_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTUtMy0xLTEtMA_9c470eb3-7175-461b-8257-f0c271254cd4">552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i54d06a347a4e4e5e91c4f62ec54e8cc2_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjE1Y2Q0NThmNDhlNDQxYmI5YjFmNmQ5OTgwZWQ2ZTE3XzQ_2f7566b5-75f9-4053-9f3c-65ab5ffc0936">3.13</ix:nonFraction>% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54d06a347a4e4e5e91c4f62ec54e8cc2_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTYtMS0xLTEtMA_5bce1ad5-d79c-4301-8bd3-ebf300fadcd0">639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06786762035a45b180efa3c21821bf20_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTYtMy0xLTEtMA_7fbd6715-a742-4a92-84dd-5f816ae5ca0a">557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTgtMS0xLTEtMA_1136daed-120e-4d65-899f-17b0d10eda99">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTgtMy0xLTEtMA_7f39cbad-942a-436a-8ad7-a2b710e17ac3">174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTktMS0xLTEtMA_02519961-2e5d-4ba9-9d18-19a9bca09ab8">7,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTktMy0xLTEtMA_c0f7b402-127a-47f7-b7ed-0e257825703d">7,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMjAtMS0xLTEtMA_7378860e-75fe-4ca4-bbab-67dd05b82f8a">777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMjAtMy0xLTEtMA_64948903-13bf-42ab-9c2c-0f41a884b186">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMjEtMS0xLTEtMA_bf802b38-e05b-4c90-8abb-8b21fa42ac6b">6,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMjEtMy0xLTEtMA_cf229cea-9815-488d-b4a6-313ad2afacdf">6,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. Debt outstanding totaled $<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMzg0_3f28a9cb-a33f-4609-830c-002aea138994">7.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMzkx_e6cec240-c399-4936-8896-f9f31dc13114">7.4</ix:nonFraction> billion at December 31, 2020 and March 31, 2020, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfNDMx_bf51c6d2-8f89-491d-9a6c-c5b4738612fa">777</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfNDM4_d6774732-7bb2-4de7-875f-c13dab3701d6">1.1</ix:nonFraction> billion, respectively, was included under the caption &#8220;Current portion of long-term debt&#8221; within the Company&#8217;s Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 3, 2020, the Company completed a public offering of <ix:nonFraction unitRef="number" contextRef="i1b3e1030e25049dcab5e8f463f79cc7e_I20201203" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMTA5OTUxMTY0NzIwOQ_fd625e7f-36f6-4824-92bf-f8301e5aefa7">0.90</ix:nonFraction>% Notes due December 3, 2025 (the &#8220;2025 Notes&#8221;) in a principal amount of $<ix:nonFraction unitRef="usd" contextRef="i1b3e1030e25049dcab5e8f463f79cc7e_I20201203" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMTA5OTUxMTY0NzI1NQ_05fbcd20-1fca-450d-a5a5-909013b67805">500</ix:nonFraction>&#160;million. Interest on the 2025 Notes is payable semi-annually on June 3rd and December 3rd of each year, commencing on June 3, 2021. Proceeds received from this note issuance, net of discounts and offering expenses, were $<ix:nonFraction unitRef="usd" contextRef="i5a3ede9e6e5140df88d6504a6002bf36_D20201203-20201203" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjE5OTAyMzI3NTIxNg_65399be8-6a72-4904-834f-43e154b76b65">496</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i3aafa75d0115405e99e2048cc2daf4a6"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 Notes, which constitutes a &#8220;Series,&#8221; are an unsecured and unsubordinated obligation of the Company and rank equally with all of the Company&#8217;s existing, and from time-to-time, future unsecured and unsubordinated indebtedness outstanding. The 2025 Notes are governed&#160;by materially similar indentures and officers&#8217; certificates as those of other Series issued by the Company. Upon required notice to holders of notes with fixed interest rates, the Company may redeem those notes at any time prior to maturity, in whole or in part, for cash at redemption prices. In the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of a Series below an investment grade rating by each of Fitch Inc., Moody&#8217;s Investors Service, Inc. and Standard &amp; Poor&#8217;s Ratings Services within a specified period, an offer must be made to purchase the 2025 Notes from the holders at a price equal to&#160;<ix:nonFraction unitRef="number" contextRef="i5a3ede9e6e5140df88d6504a6002bf36_D20201203-20201203" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfOTM0NTg0ODg1NTcxOA_a05135f2-056b-4a8c-9aa4-0e8be247f22c">101</ix:nonFraction>%&#160;of the then outstanding principal amount of the 2025 Notes, plus accrued and unpaid interest to, but not including, the date of repurchase. The indenture and the related officers&#8217; certificate for the 2025 Note, subject to the exceptions and in compliance with the conditions as applicable, specify that the Company may not consolidate, merge or sell all or substantially all of its assets, incur liens, or enter into sale-leaseback transactions exceeding specific terms, without lenders&#8217; consent. The indentures also contain customary events of default provisions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended December 31, 2020, the Company retired its $<ix:nonFraction unitRef="usd" contextRef="i0e3d82d95ff34d09ad54cbb7a9568eeb_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMTA5OTUxMTY0NzE1Nw_46f52404-b079-4eb4-b82e-1cc7744af7d9">700</ix:nonFraction>&#160;million total principal amount of notes due on November 30, 2020 at a fixed interest rate of <ix:nonFraction unitRef="number" contextRef="i0e3d82d95ff34d09ad54cbb7a9568eeb_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMTA5OTUxMTY0NzE2OA_e1f40325-8ca0-4b4f-a5da-f2d04bb0a7ce">3.65</ix:nonFraction>% upon maturity. On December 1, 2020, the Company redeemed its <ix:nonFraction unitRef="number" contextRef="i6dcb7ea25a61456ea8011e544254a46e_I20201201" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMTA5OTUxMTY0NzE3Ng_2ac92dd0-848c-43f1-b30f-f50207db4982">4.75</ix:nonFraction>% $<ix:nonFraction unitRef="usd" contextRef="i6dcb7ea25a61456ea8011e544254a46e_I20201201" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMTA5OTUxMTY0NzE5MQ_8f8475a1-04e6-4f53-9a12-04d3a9af79c6">323</ix:nonFraction>&#160;million total principal of notes due on March 1, 2021 prior to maturity. These notes were redeemed using cash on hand and the proceeds of the notes offering discussed above.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson maintains a syndicated $<ix:nonFraction unitRef="usd" contextRef="ie8b3fd2d698249cdb62866fb761a1437_I20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfNjUw_0e6fd3cb-19b8-44ec-a6ad-55c06bd04942">4</ix:nonFraction> billion <ix:nonNumeric contextRef="icbedee4fddac4d1e918ff2e43b85f5b3_D20190701-20190930" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjg2OA_a494cca0-7d8f-4082-b779-f9111cdfeddb">five-year</ix:nonNumeric> senior unsecured credit facility, dated as of September 25, 2019, as amended (the &#8220;2020 Credit Facility&#8221;), which has a $<ix:nonFraction unitRef="usd" contextRef="ide009e05a6744804a59fcd84efd0b7a3_I20190930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfNzM2_ab43fde8-080c-43a9-a950-59be6d8c7ec8">3.6</ix:nonFraction> billion aggregate sublimit of availability in Canadian dollars, British pound sterling and Euro. The 2020 Credit Facility matures in September 2024 and had <ix:nonFraction unitRef="usd" contextRef="i5b8012a1221f40588f7488916fd1b3b0_D20200401-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ProceedsFromLinesOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfODg3_00d51bc5-fe85-421f-b0bf-acd1e234cf1f"><ix:nonFraction unitRef="usd" contextRef="ia75a14b05a5c4c2ba266322f4ed4794b_D20201001-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ProceedsFromLinesOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfODg3_ce47ccaa-ea11-4c0a-940c-e87781c91a84">no</ix:nonFraction></ix:nonFraction>&#160;borrowings during the three and nine months ended December 31, 2020 and <ix:nonFraction unitRef="usd" contextRef="i9d587484c8314278aa228f8a047c449e_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfOTQ1_6986e7a3-1c9b-4b9d-9560-a4adf3153364"><ix:nonFraction unitRef="usd" contextRef="i3673260c4a0e4c6789566685bcdc80f9_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfOTQ1_a4b75796-c12f-45d3-bd4a-0af4e818e043">no</ix:nonFraction></ix:nonFraction> amounts outstanding as of December 31, 2020 and March 31, 2020. The remaining terms and conditions of the 2020 Credit Facility are substantially similar to those previously in place under the&#160;$<ix:nonFraction unitRef="usd" contextRef="ia561add5441945f9b6e6f005c32de046_I20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMTExMw_ae2279d3-4179-4d5a-9a5d-b7dc1553fa8d">3.5</ix:nonFraction> billion <ix:nonNumeric contextRef="i3df3eaf8483344e189aadb44a6e73dfc_D20190901-20190930" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjg3MA_e45033ec-cc9f-4d86-a892-6da86b4b9441">five-year</ix:nonNumeric> senior unsecured revolving credit facility (the &#8220;Global Facility&#8221;), which was scheduled to mature in October 2020. The Global Facility was terminated in connection with the execution of the 2020 Credit Facility in September 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#8220;LIBOR&#8221;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility contains financial covenants which obligate the Company to maintain a maximum debt to capital ratio, as defined in the 2020 Credit Facility, along with other customary investment grade covenants. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. As of December 31, 2020, the Company was in compliance with all covenants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains bilateral credit facilities primarily denominated in Euro with a committed amount of $<ix:nonFraction unitRef="usd" contextRef="i5cf6891e4f624ba4b2c8f2b8b8ad994a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjE5Mw_7db7af00-43a6-46be-9063-95b10cbbbc95">8</ix:nonFraction> million and an uncommitted amount of $<ix:nonFraction unitRef="usd" contextRef="i5cf6891e4f624ba4b2c8f2b8b8ad994a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjIyNQ_15bc9105-18c7-401d-b82f-202691b8adf5">183</ix:nonFraction> million as of December 31, 2020. Borrowings and repayments were not material during the three and nine months ended December 31, 2020 and 2019, and amounts outstanding under these credit lines were not material as of December 31, 2020 and March 31, 2020. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $<ix:nonFraction unitRef="usd" contextRef="ifc76a63f576047c49638f41ac0d91ae3_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjYxNA_4edc2938-88fb-40da-a190-4b81e3649a07">4.0</ix:nonFraction> billion in outstanding commercial paper notes. During the nine months ended December 31, 2020 and 2019, the Company borrowed $<ix:nonFraction unitRef="usd" contextRef="if13ed91051e047c597b44d113a7413be_D20200401-20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjcxNQ_ffe7db09-9692-4037-8407-25681ea1f589">5.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i451d84e1d8a944789fa6835d4573fb2a_D20190401-20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjcyMg_6edc5439-1623-4265-9db8-8ec3ea4fea37">15.9</ix:nonFraction> billion, respectively, and repaid $<ix:nonFraction unitRef="usd" contextRef="if13ed91051e047c597b44d113a7413be_D20200401-20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfCommercialPaper" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjc1MQ_f711933f-544c-431c-93fa-83f739181ff8">5.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i451d84e1d8a944789fa6835d4573fb2a_D20190401-20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfCommercialPaper" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjc1OA_241b646e-da7f-41b8-b943-69b7abcd8855">13.7</ix:nonFraction> billion, respectively, under the program. At December 31, 2020 there were $<ix:nonFraction unitRef="usd" contextRef="ifc76a63f576047c49638f41ac0d91ae3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermCommercialPaperCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMTA5OTUxMTY0ODQ1Mg_a54c0c7a-63c8-4813-965f-861b5f94bf91">152</ix:nonFraction> million of commercial paper notes outstanding with a weighted average interest rate of <ix:nonFraction unitRef="number" contextRef="ifc76a63f576047c49638f41ac0d91ae3_I20201231" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMTA5OTUxMTY0ODU2Ng_a7c70888-aab5-4539-893a-da8259726de4">0.21</ix:nonFraction>%. At March 31, 2020, there were <ix:nonFraction unitRef="usd" contextRef="i1c39c0200ce7449fb14e39cf375472fa_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LongTermCommercialPaperCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjgyMA_c6f9c4e0-2d9d-45fd-8d4d-69a392f870a8">no</ix:nonFraction> commercial paper notes outstanding.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_76"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMjAyMA_c12e5b9f-da22-4e02-b18f-3749b7606da1" continuedAt="i9dfd48b87437444788f4c4ab83180a81" escape="true">Pension Benefits</ix:nonNumeric></span></div><ix:continuation id="i9dfd48b87437444788f4c4ab83180a81"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic expense for defined benefit pension plans was $<ix:nonFraction unitRef="usd" contextRef="i9572515afb1f475086d3833719ce1ee7_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfNzU_672c13cb-698d-43b8-812e-238225b3f5cb">4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i89e2b4abb66f4b8490bd136400166514_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfODI_59d95cfe-3051-4a22-9d3d-ec429b475c88">17</ix:nonFraction> million for the three and nine months ended December 31, 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ia909bddd810745a78d740e262952804d_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMTE1_f5529e79-b266-4865-9d1c-ecd5fde93238">16</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5720a12c6a9847d3959ececda0b47b78_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMTIy_ba196d31-1169-4239-a5f3-4244436c2b9e">151</ix:nonFraction> million for the three and nine months ended December 31, 2019, respectively. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash contributions to these plans were $<ix:nonFraction unitRef="usd" contextRef="i9572515afb1f475086d3833719ce1ee7_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMTkw_6a220ae3-4c7b-4635-aff1-df93f4a2c15d">8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i89e2b4abb66f4b8490bd136400166514_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMTk3_a3d6e2cb-59ca-400b-8872-feb6addece80">19</ix:nonFraction> million for the three and nine months ended December 31, 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ia909bddd810745a78d740e262952804d_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMjMw_c310b72b-634a-4f79-8c1a-9a971eb17543">120</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5720a12c6a9847d3959ececda0b47b78_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMjM3_d63185d0-7223-4582-8cba-b791413d59ab">132</ix:nonFraction> million for the three and nine months ended December 31, 2019, respectively. The three and nine months ended December 31, 2019 included a cash payment of $<ix:nonFraction unitRef="usd" contextRef="ie862f63e9e384a2384d0f8f2895b4fef_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMjE5OTAyMzI1OTM3Ng_21911d0c-1b42-462c-bbe7-432ba5dab447"><ix:nonFraction unitRef="usd" contextRef="i5a58762e511c405da243fad3b79d9702_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMjE5OTAyMzI1OTM3Ng_b28dc718-68af-432b-8040-21ba2471300f">114</ix:nonFraction></ix:nonFraction>&#160;million from the executive benefit retirement plan. The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding <ix:nonFraction unitRef="number" contextRef="ib9ce75f89ad84830aa465d0823e6683b_I20201231" decimals="INF" name="us-gaap:DefinedBenefitPlanFundedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfNDQ5_02ed5624-0054-4280-a2ee-db54a08475a4">10</ix:nonFraction>% of the greater of the projected benefit obligation or the market value of assets are amortized on a straight-line basis over the average remaining future service periods and expected life expectancy.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2020, the Company derecognized $<ix:nonFraction unitRef="usd" contextRef="i938f21cb5003435093dd61e42f1e4b04_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="mck:DefinedBenefitPensionPlanLiabilitiesDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMjE5OTAyMzI2MzIyMg_1aeb2f84-4970-4bc9-98af-2754a64031d5">187</ix:nonFraction>&#160;million of pension liabilities included in liabilities held for sale and $<ix:nonFraction unitRef="usd" contextRef="i87abebafd2444aea947519a813b73651_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMjE5OTAyMzI2NTMzOA_c21c1207-7351-44d2-8060-3a59245577e8">24</ix:nonFraction>&#160;million of accumulated other comprehensive loss, net of tax, related to its German pharmaceutical wholesale business contributed to a joint venture, as discussed in more detail in Financial Note 3, &#8220;Held for Sale.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 23, 2018, the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) approved the termination of its frozen U.S. defined benefit pension plan (&#8220;Plan&#8221;). During the first quarter of 2020, the Company offered the option of receiving a lump sum payment to certain participants with vested qualified Plan benefits in lieu of receiving monthly annuity payments. Approximately <ix:nonFraction unitRef="participant" contextRef="ie662489344214deea919f1b5ac9b8617_D20190601-20190630" decimals="-2" format="ixt:numdotdecimal" name="mck:DefinedBenefitPlanSettlementPlanParticipants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMTAwMw_275b31fa-52b2-41f7-8ece-b93c8ad40502">1,300</ix:nonFraction> participants elected to receive the settlement, and lump sum payments of approximately $<ix:nonFraction unitRef="usd" contextRef="ie662489344214deea919f1b5ac9b8617_D20190601-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMTA5Mw_df66aa0c-e124-4259-86ef-583f2a5e8b28">49</ix:nonFraction> million were made from Plan assets to these participants in June 2019. The benefit obligation settled approximated payments to Plan participants and a pre-tax settlement charge of $<ix:nonFraction unitRef="usd" contextRef="i27e1b65706fe43c8b7b96d04e78a9a4b_D20190401-20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMTI2OA_662cde7f-0da0-4bd0-a836-22f55b18c847">17</ix:nonFraction> million was recorded during the first quarter of 2020. During the second quarter of 2020, the Company transferred the remainder of the Plan&#8217;s pension obligation to a third-party insurance provider by purchasing annuity contracts for approximately $<ix:nonFraction unitRef="usd" contextRef="if044bd6776b7450a96d800457d558593_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="mck:DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMTUxMA_3257658e-7342-4d53-b2d1-c5330dc8ba43">280</ix:nonFraction> million which was fully funded directly by Plan assets. The third-party insurance provider assumed the obligation to pay future benefits and provide administrative services on November 1, 2019 and a pre-tax settlement charge of $<ix:nonFraction unitRef="usd" contextRef="i77fd18e4162c441aa58436014d857d12_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMjc0ODc3OTA3ODY5OA_6eab9474-e521-4068-a2b6-d6145713e674">105</ix:nonFraction>&#160;million was recorded during the second quarter of 2020. Settlement charges were included within Other income (expense), net in the condensed consolidated statement of operations for the nine months ended December 31, 2019 as a result of the termination of the Plan.</span></div></ix:continuation><div id="ib9c6f28fe5144278bb122fe3b38cf454_79"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMTAyODY_2c972310-5da0-4620-abf0-751a5dfe77af" continuedAt="i1c7d80d133684aa191d79c7117fd15ec" escape="true">Hedging Activities </ix:nonNumeric></span></div><ix:continuation id="i1c7d80d133684aa191d79c7117fd15ec" continuedAt="ica57aa390d2c450ab1476935a14f3f0f"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives such as cross-currency swaps, foreign currency forward contracts, and interest rate swaps. In accordance with the Company&#8217;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. </span></div><div style="margin-bottom:6pt;padding-left:2.25pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#8217;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ica57aa390d2c450ab1476935a14f3f0f" continuedAt="id6f6b54437424fc58aa9b8ab1ddc1285"><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Derivative Instruments Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020 and March 31, 2020, the Company had &#8364;<ix:nonFraction unitRef="eur" contextRef="i0d9cf49bcf574771b799ca4645191cd5_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMTUwMg_021d3b9c-6ae6-4e7f-80ba-ca0c2683cdb9"><ix:nonFraction unitRef="eur" contextRef="i2a0ca354dcd646dbb94a5e6bc0adc910_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMTUwMg_36908ddb-0cde-4520-aa90-93836d21920d">1.7</ix:nonFraction></ix:nonFraction> billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#8217;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded in foreign currency translation adjustments within Accumulated other comprehensive loss in the Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments.&#160;To the extent foreign currency denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. In December 2019, the Company prospectively de-designated from net investment hedges &#8364;<ix:nonFraction unitRef="eur" contextRef="ide3c05407d4f405faeeb775e3cadb1ad_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMzg0ODI5MDcwNzYxMw_1eb2fa98-4cbe-459e-90d1-b726bc467efc">250</ix:nonFraction> million of its Euro-denominated notes which matured in February 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from net investment hedges recorded within Other comprehensive income were losses of $<ix:nonFraction unitRef="usd" contextRef="ic3392a15e42349f38396d43edec58984_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMjU1MQ_c5ba9968-07fa-4dfd-bde2-42bb1d6d4a83">84</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ieae8ce38c55c4a8183867cb63bfddafb_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMjU1OA_74906e52-dbd8-4083-83c8-12d8716e7648">201</ix:nonFraction> million during the three and nine months ended December 31, 2020, respectively, and losses of $<ix:nonFraction unitRef="usd" contextRef="i8ac357c6d2694d3e854ab420c7c33a3e_D20191001-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMjYwMw_0cf9bcaf-0217-4097-bdd6-8758c178ce93">59</ix:nonFraction> million and gains of $<ix:nonFraction unitRef="usd" contextRef="i6d10966d07b64ebba1b226a32e8e56fa_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMjYxMA_32364e8c-5518-494b-9bcf-03f7968c19c2">8</ix:nonFraction> million during the three and nine months ended December 31, 2019, respectively. There was no ineffectiveness in non-derivative net investment hedges during the three and nine months ended December 31, 2020. Ineffectiveness on the Company&#8217;s non-derivative net investment hedges during the three and nine months ended December 31, 2019 resulted in losses of $<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMjgzMQ_c105f2c6-ef97-47a5-8818-94c59cb3c378">3</ix:nonFraction> million and gains of $<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMjgzOA_04a399ef-c153-436f-a65a-0b3ca99d7ffa">26</ix:nonFraction>&#160;million, respectively, which were recorded in earnings in Other income (expense), net in the Condensed Consolidated Statements of Operations. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020 and March 31, 2020, the Company had cross-currency swaps designated as net investment hedges with a total gross notional amount of $<ix:nonFraction unitRef="cad" contextRef="iae697c5a606444c8a0bf468944693083_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMzEzNA_2928e209-b2ec-4922-b1c9-56cb1e1cee31">999</ix:nonFraction> million and $<ix:nonFraction unitRef="cad" contextRef="i4c3d87e0bc6d4b3788054a9adf38efdf_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMzg0ODI5MDcwNzc3MA_2da95d14-eac2-4187-bad9-124376739a71">1.5</ix:nonFraction> billion Canadian dollars, respectively. Under the terms of the cross-currency swap contracts, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These swaps are utilized to hedge portions of the Company&#8217;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in Accumulated other comprehensive loss in the Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in the Company&#8217;s net investment hedges for the three and nine months ended December 31, 2020 and 2019. In November 2020, cross currency swaps with an aggregate gross notional amount of $<ix:nonFraction unitRef="cad" contextRef="ib05778dd9f2047e7ab989296e4f1f027_I20201130" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfOTM0NTg0ODg1MDk1Nw_dff3c3c7-bf2b-4629-be56-c9ee9bb88756">500</ix:nonFraction>&#160;million Canadian dollars matured and the remaining cross-currency swaps will mature between March 2021 and November 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2020, the Company terminated cross-currency swaps with a total gross notional amount of &#163;<ix:nonFraction unitRef="gbp" contextRef="i4ffae78da5324045885fd5c5f9e72fe7_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNDUxNg_54e795c7-8566-4fa2-8e39-be606831e5ee">932</ix:nonFraction> million British pound sterling due to ineffectiveness in its British pound sterling hedging program that arose due to 2019 impairments of goodwill and certain long-lived assets in the U.K. businesses. Proceeds from the termination of these swaps totaled $<ix:nonFraction unitRef="usd" contextRef="i3a1e7fab3c5a46bc80683fd7a9936356_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNDc2NQ_9b6eb1e0-0c39-40da-83bd-86249ca91b09">84</ix:nonFraction> million and resulted in a settlement gain of $<ix:nonFraction unitRef="usd" contextRef="i3a1e7fab3c5a46bc80683fd7a9936356_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNDgwNQ_e082606d-4848-4e0b-a187-257097b48fa5">34</ix:nonFraction> million for the nine months ended December 31, 2019. This gain was recorded in earnings in Other income (expense), net, net in the Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from the Company&#8217;s cross-currency swaps designated as net investment hedges recorded in Other comprehensive income were losses of $<ix:nonFraction unitRef="usd" contextRef="i36b3bcf8d524467bacd1c159707af361_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNTA4NA_c265c6c4-fd5c-467c-b20d-8276484e503a">45</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i09c294f2acd74c33bb8e9ada8e29bfef_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNTA5MQ_5a406b85-3edc-4fb4-9e38-8d9812c503b6">108</ix:nonFraction> million during the three and nine months ended December 31, 2020, respectively, and losses of $<ix:nonFraction unitRef="usd" contextRef="if86aed3e96a64acfb7d6c3d4ba3f32e0_D20191001-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNTEzNg_2bb5a721-22b1-40b1-97ee-0fe83616eacf">20</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i51b2cfed82a94bea9d5b40efccf351cc_D20190401-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNTE0Mw_45bdb20e-77da-42e6-8dfa-c53808430199">11</ix:nonFraction> million during the three and nine months ended December 31, 2019, respectively. There was no ineffectiveness in the Company&#8217;s cross-currency swap hedges for the three and nine months ended December 31, 2020 and 2019. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="id6f6b54437424fc58aa9b8ab1ddc1285" continuedAt="i19ef7924bc7445e2823551e535dd1487"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2019, the Company entered into a number of cross-currency swaps designated as fair value hedges with total notional amounts of &#163;<ix:nonFraction unitRef="gbp" contextRef="i132f49f70d8e4b459e1dfdc3b23932f9_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNTUxNw_f843b2be-4d8f-481d-8510-602cba550667">450</ix:nonFraction> million British pound sterling. Under the terms of the cross-currency swap contracts, the Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. These swaps are utilized to hedge the changes in the fair value of the underlying &#163;<ix:nonFraction unitRef="gbp" contextRef="i132f49f70d8e4b459e1dfdc3b23932f9_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNTg2OQ_f843b2be-4d8f-481d-8510-602cba550667">450</ix:nonFraction> million British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives, which are designated as fair value hedges, and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from these fair value hedges recorded in earnings for the three and nine months December 31, 2020 and 2019 were largely offset by the losses recorded in earnings related to these notes. The swaps will mature in February 2023.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company also enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies. For cross-currency swap transactions, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These cross-currency swaps are designed to reduce the income statement effects arising from fluctuations in foreign exchange rates and have been designated as cash flow hedges. At December 31, 2020 and March 31, 2020, the Company had cross-currency swaps with total gross notional amounts of approximately $<ix:nonFraction unitRef="usd" contextRef="i5bed0108d30a4edbadaa59d784d7e6f2_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNzEzMQ_cfc6d829-ed8e-49ae-b1ec-e66b006e318d">2.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ia6fd83f4ec5346a89c43a4d4970b587b_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNzEzOA_0344d20b-d9ad-40f5-93aa-08564f3198e7">2.9</ix:nonFraction> billion, respectively, which are designated as cash flow hedges. These swaps will mature between February 2021 and January 2024. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For forward contracts and cross-currency swaps that are designated as cash flow hedges, the effective portion of changes in the fair value&#160;of the hedges is recorded in Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 27, 2020, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with combined notional amounts of $<ix:nonFraction unitRef="usd" contextRef="i7e172a5b89714b5f980c0d1515d155bb_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMzg0ODI5MDcwODI1MA_4902c8bd-6378-46b3-843c-fbdfcde1d946">500</ix:nonFraction> million and &#8364;<ix:nonFraction unitRef="eur" contextRef="i7e172a5b89714b5f980c0d1515d155bb_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMzg0ODI5MDcwODMwNw_12a3dcbf-6234-453f-85dd-3f2065ee9284">600</ix:nonFraction> million, to hedge the variability of future benchmark interest rates on planned bond issuances. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $<ix:nonFraction unitRef="usd" contextRef="i7e172a5b89714b5f980c0d1515d155bb_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMzg0ODI5MDcwODI3OQ_4902c8bd-6378-46b3-843c-fbdfcde1d946">500</ix:nonFraction> million swaps for floating interest payments in U.S. dollars based on three-month LIBOR and to pay fixed interest payments for floating interest payments in Euros based on six-month Euro Interbank Offered Rate (&#8220;EURIBOR&#8221;) for the &#8364;<ix:nonFraction unitRef="eur" contextRef="i7e172a5b89714b5f980c0d1515d155bb_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMzg0ODI5MDcwODMzNg_12a3dcbf-6234-453f-85dd-3f2065ee9284">600</ix:nonFraction> million swaps. The $<ix:nonFraction unitRef="usd" contextRef="i7e172a5b89714b5f980c0d1515d155bb_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMzg0ODI5MDcwODc3OQ_4902c8bd-6378-46b3-843c-fbdfcde1d946">500</ix:nonFraction> million swaps were terminated upon the issuance of the 2025 Notes in November 2020. The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the <ix:nonNumeric contextRef="idae826ee5fc34b5a8ac7443ee5012249_D20200401-20201231" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfOTM0NTg0ODg1MTA0MA_fab6e01f-bd20-46ce-8d2c-b34ac8e99ea4">five-year</ix:nonNumeric> life of the 2025 Notes. Refer to Financial Note 9, &#8220;Debt and Financing Activities,&#8221; for more information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Gains or losses from cash flow hedges recorded in Other comprehensive income were losses of $<ix:nonFraction unitRef="usd" contextRef="i4108ab99008d4e68a3dd3eae636c4e61_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfODM0MQ_fd734b77-9f1e-4fa5-906d-e51dab07060f">14</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iacfcda1e22f341b0934dd329fa019e54_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfODM0OA_7e7f07da-99be-4721-a213-d4a47c70b034">42</ix:nonFraction> million during the three and nine months ended December 31, 2020, respectively, and were gains of $<ix:nonFraction unitRef="usd" contextRef="if2a0e643e93146bc9920807b4ff5583b_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfODM5OA_0dd4c7b5-e3cb-4c9f-90e5-e4a7f53ee311">5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i906ea84070b64689a6d04852f20df452_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfODQwNQ_0e11c3f7-8a69-4530-934c-a5fcd3a6546a">40</ix:nonFraction> million during the three and nine months ended December 31, 2019, respectively. Gains or losses reclassified from Accumulated other comprehensive income and recorded in Operating expenses in the Condensed Consolidated Statements of Operations were not material in the three and nine months ended December 31, 2020 and 2019. There was no ineffectiveness in the Company&#8217;s cash flow hedges for the three and nine months ended December 31, 2020 and 2019.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in fair value included in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a number of forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. At December 31, 2020 and March 31, 2020, the total gross notional amounts of these contracts were $<ix:nonFraction unitRef="usd" contextRef="i35d99ea68d0b48eab76bb746417d8dd8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfOTEwNg_65c1f275-f38e-482f-93d6-2d754556e0fe">13</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0eeec9e2862e4c51b6d12a38ac428a0e_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfOTExMw_d76ab664-6490-4a0c-81af-143ea3a07d29">29</ix:nonFraction> million, respectively. These contracts will predominantly mature between January 2021 and October 2021 and none of these contracts were designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in Operating expenses. Changes in the fair values were not material in the three and nine months ended December 31, 2020 and 2019. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i19ef7924bc7445e2823551e535dd1487" continuedAt="ic5e2631436954daaab82e8a0c26dafad"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended December 31, 2019, the Company also entered into a number of forward contracts and swaps to offset a portion of the earnings impacts from the ineffectiveness of the net investment hedges discussed above. These contracts matured through January 2020 and none of these contracts were designated for hedge accounting. In December 2019, the Company entered into a series of forward contracts with a total notional amount of &#8364;<ix:nonFraction unitRef="usd" contextRef="ic99175677b954f009bf7dd3ff1f205b9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMzg0ODI5MDcwODUzOQ_831ffe8a-94af-4df8-8279-3244528d28d9">250</ix:nonFraction> million to offset the earnings impact from its Euro-denominated notes. These contracts and the notes against which they offset matured in February 2020 and were not designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly in earnings. During the three and nine months ended December 31, 2019, gains of $<ix:nonFraction unitRef="usd" contextRef="ie84b0678aefd46f39446455df3d55df3_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfOTk3NQ_04a2bb21-9b44-40b8-bb99-146cae670408">3</ix:nonFraction> million and losses of $<ix:nonFraction unitRef="usd" contextRef="i3ba05cbb6a39421ca690fc9912bd454c_D20190401-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfOTk4Mg_03dba129-017e-441c-a19a-09a8aa7b72cd">36</ix:nonFraction> million, respectively, were recorded in earnings within Other income (expense), net in the Condensed Consolidated Statements of Operations.</span></div><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMTAyODg_f37cf93f-ac34-4feb-9b50-08b675518475" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.481%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.672%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.206%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57bde6e22b1b418fb5cb8d67718f73cc_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNS0yLTEtMS0w_b98d4ba0-1b52-4d8b-a257-eab5f24f0f31">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b4553eec3884a74b9c29ba57c8f46fc_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNS00LTEtMS0w_07443f66-289e-425d-994f-776d19358a15">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i041bb96bdf7c4fd18af85821acc08bdb_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNS01LTEtMS0w_ae47ffb4-58fd-4663-9b8a-5059e50917c6">1,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8c751112cf84239a9ea0b86ba0c4dce_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNS03LTEtMS0w_c910e85e-a2ae-488a-bed7-31a99ce36e68">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70cef476be954ba5826ef9cb90ed5bb0_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNS05LTEtMS0w_67908c75-395f-40cd-b5c9-2e1298d4e78d">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i941389e63f2541a1a376a9b746120d0e_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNS0xMC0xLTEtMA_1e644a77-1d85-4fe8-9874-542317463696">1,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec64489b9604c8d8f972120fbda6056_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNi0yLTEtMS0w_aedb25b3-5b2e-462a-ab7f-33a36fadc49d">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbfc5ce51aac4403bc97157e950c8b20_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNi00LTEtMS0w_b2fe77a7-c8e0-4dbc-9a95-2debceedeb4d">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149087f716324b259895a04a05c5bb9c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNi01LTEtMS0w_6f95755f-b017-450f-a6eb-1f9aba36ce34">2,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b7780a8f9e948f093b5fd1cce4b2871_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNi03LTEtMS0w_508e9a4c-8f1e-442f-9703-ffb7eaa7b789">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89165375051c4a2399f00117e4669f3f_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNi05LTEtMS0w_770134a3-447a-4552-9acc-b3985f3336ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85e18c845f544dc5b2de3609dccc18d1_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNi0xMC0xLTEtMA_dffc2093-3654-4241-aafb-ffdf2984d16c">3,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e01229209e24fcbbaac835c6868ce3e_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNy0yLTEtMS0w_9493cc9b-8b8e-4e69-b2a7-a92d5f4b05a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e01229209e24fcbbaac835c6868ce3e_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNy00LTEtMS0w_a7657ba4-973a-49ee-b459-cca944192073">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e01229209e24fcbbaac835c6868ce3e_I20201231" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNy01LTEtMS0w_e85ba2db-513d-4f16-8360-bca7ff88a70c">733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46eff3e723494b9b8db10c46e8d5141e_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNy03LTEtMS0w_fea3ee2e-6801-467c-b480-d06875662bd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46eff3e723494b9b8db10c46e8d5141e_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNy05LTEtMS0w_bb8b7710-5ad5-4725-8359-1cde833337e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46eff3e723494b9b8db10c46e8d5141e_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNy0xMC0xLTEtMA_b3faf721-4ad6-4d02-aa8a-a1f4bab5304c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a73cb404974bc2b79ec51446e9c1ae_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfOS0yLTEtMS0w_c7c401b8-9651-44dc-8536-e3864e75dbb6">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a73cb404974bc2b79ec51446e9c1ae_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfOS00LTEtMS0w_cbb0a159-a18f-44cb-bb8c-86216339213d">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9417de73a5c549f0be8c082c4db84e40_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfOS03LTEtMS0w_23808b49-a335-496f-8289-36b70cf6b83b">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9417de73a5c549f0be8c082c4db84e40_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfOS05LTEtMS0w_65bf58fe-3a69-4928-946d-0ddc8a60276c">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated for hedge accounting</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69cadcfb856d4a7a9004d7cc9933b9d9_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTEtMi0xLTEtMA_daf80920-94a4-4a12-889e-1d61146a17ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69cadcfb856d4a7a9004d7cc9933b9d9_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTEtNC0xLTEtMA_aad864fb-f6fa-4028-9e7e-d124a0561f66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69cadcfb856d4a7a9004d7cc9933b9d9_I20201231" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTEtNS0xLTEtMA_99df6695-ec63-4bf4-a621-0a1e6a3cc05c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb9595c53e61414fa6ad030992206402_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTEtNy0xLTEtMA_428336ed-da2a-477d-baca-bb50bed1fecc">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb9595c53e61414fa6ad030992206402_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTEtOS0xLTEtMA_ebddd893-8ab3-40ad-85fe-102b6c8f88aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb9595c53e61414fa6ad030992206402_I20200331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTEtMTAtMS0xLTA_ead9f842-50b9-472b-98a4-65e531cbd98d">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f0b972582444239e16f4edffd19f90_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTItMi0xLTEtMA_05bc247a-65df-41b8-92b7-4a62dc74d5ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f0b972582444239e16f4edffd19f90_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTItNC0xLTEtMA_105f808b-88ae-4399-918a-e05642371996">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f0b972582444239e16f4edffd19f90_I20201231" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTItNS0xLTEtMA_82467b9e-83c4-4f43-b883-1c7bb710a9a3">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9d75c3418b485e94de80a639f2a0fa_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTItNy0xLTEtMA_cc1c9cac-77a7-455a-9dea-5d8fc40810da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9d75c3418b485e94de80a639f2a0fa_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTItOS0xLTEtMA_dfeaeead-dbe7-49ec-938c-8ec815a3db96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9d75c3418b485e94de80a639f2a0fa_I20200331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTItMTAtMS0xLTA_019e059e-760a-499f-869e-00cd76834150">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib047b820d28e468fb76500c99500cb2c_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTMtMi0xLTEtMA_ea1d70d1-c86d-417a-86bc-5009b55dc079">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib047b820d28e468fb76500c99500cb2c_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTMtNC0xLTEtMA_c6ed28dd-abe4-47db-aa45-362f4273c7ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaf792582ac14ec9877670dd6af11a65_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTMtNy0xLTEtMA_81595513-7ba5-4fd0-b4ed-26796e69681d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaf792582ac14ec9877670dd6af11a65_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTMtOS0xLTEtMA_356e74c7-6278-46e3-a39c-230a475ee6b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic5e2631436954daaab82e8a0c26dafad">Refer to Financial Note 12, "Fair Value Measurements," for more information on these recurring fair value measurements.</ix:continuation> </span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_85"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfNjcwOA_528000a3-a4e4-4df8-abef-1f1b4c92043f" continuedAt="ibc63909a585e456286f4e0b6de453dd6" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="ibc63909a585e456286f4e0b6de453dd6" continuedAt="i2da5247755144944bc8faaa6cfa13e34"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020 and March 31, 2020, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is carried at amortized cost. The carrying amounts and estimated fair values of these liabilities were $<ix:nonFraction unitRef="usd" contextRef="i7840da1cacf0419993b0a527d8920e10_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfNjE0_a8b04a56-b991-4dfb-8735-d8f1bbd098fc">7.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i7840da1cacf0419993b0a527d8920e10_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfNjIx_e2747597-5017-4424-b689-650ceec6d59a">8.0</ix:nonFraction> billion at December 31, 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i4c9db4a4610b4829b8b00be2a529a9cc_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfNjQ5_f1e7fd6e-6188-48cb-8088-5780766b55db">7.4</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i4c9db4a4610b4829b8b00be2a529a9cc_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfNjU2_9129330d-7584-4c9a-b131-31ab64e9d2b1">7.8</ix:nonFraction> billion at March 31, 2020, respectively. The estimated fair value of the Company&#8217;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i2da5247755144944bc8faaa6cfa13e34" continuedAt="i96331c8911574c3bae2e4d47cea370cc"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at December 31, 2020 and March 31, 2020 included investments in money market funds of $<ix:nonFraction unitRef="usd" contextRef="i701d2f10e13b41148f385570a86bf3b1_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfMTE3OA_397d9093-ae2b-43ed-a86d-de89210b0164">123</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iadffe49dd7104768a9a656790d004b41_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfMTE4NQ_b1fa2561-86d1-416f-83c9-6af2ce40eef5">2.0</ix:nonFraction> billion, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level&#160;1 inputs. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of the Company&#8217;s foreign currency forward contracts were determined using observable inputs from available market information. Fair values of the Company&#8217;s cross-currency swaps were determined using quoted foreign currency exchange rates and other observable inputs from available market information. Fair values of the Company&#8217;s interest rate swaps were determined using observable inputs from available market information. These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 11, &#8220;Hedging Activities,&#8221; for fair value and other information on the Company&#8217;s foreign currency derivatives including forward foreign currency contracts and cross-currency swaps.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry and which have carrying values of $<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfNjA0NzMxMzk2MDk1Mg_7fed0def-9a4a-4f4e-a06f-ecf66c76d33b">267</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfNjA0NzMxMzk2MDk2MA_2f896b8a-5043-40d8-b258-0899798e1cb2">170</ix:nonFraction> million at December 31, 2020 and March 31, 2020, respectively. These investments primarily consist of equity securities without readily determinable fair values and are included within Other non-current assets in the Condensed Consolidated Balance Sheets. In the second quarter of 2021, <ix:nonFraction unitRef="company" contextRef="i85b5d437b88a43c3b57c3014d5ae8bf1_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="mck:EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfMjg0Mg_b814b168-f0b7-4bb6-8268-a6a551b123c1">three</ix:nonFraction> of the companies in which McKesson holds investments in equity securities were converted into shares of public common stock through initial public offerings and an acquisition and are adjusted to fair value at each reporting period. In the third quarter of 2021, <ix:nonFraction unitRef="investmentsecurity" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="INF" format="ixt-sec:numwordsen" name="mck:EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfOTM0NTg0ODg0NDQ3MQ_ee92e97d-5ed6-4a76-bcf0-80321d26b345">two</ix:nonFraction> of the Company&#8217;s investments in equity securities without readily determinable fair values experienced transactions which resulted in changes in the observable price of those securities. As a result, net gains related to the Company&#8217;s investments in equity securities, primarily representing unrealized gains on the securities discussed above, were $<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfMjE5OTAyMzI2Mzk1Nw_e4e06af2-c971-4ea9-a1f9-649cadffe2ec">28</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfMjE5OTAyMzI2Mzk2NA_19cff5a0-cd58-4533-a4ef-20275f8c7101">87</ix:nonFraction> million for the three and nine months ended December 31, 2020, respectively. These gains were recorded under the caption, &#8220;Other income (expense), net,&#8221; in the Condensed Consolidated Income Statements. There were no other material changes in the carrying value of these investments during the three and nine months ended December 31, 2020. The carrying value of publicly traded investments was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets measured at fair value on a nonrecurring basis as of December 31, 2020 included long-lived assets in the Company&#8217;s International segment and goodwill of the Company&#8217;s Europe Retail Pharmacy reporting unit within the International segment. At March 31, 2020, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#8217;s European and Rexall Health businesses within the International segment. Refer to Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; and Financial Note 8, &#8220;Goodwill and Intangible Assets, Net,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aforementioned investments in equity securities includes the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="ia32a43bf4c32481bb6ea7a38d845082c_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfNDc3NA_ba217e50-dc8a-4b7b-8e8a-5790b6dc1b73"><ix:nonFraction unitRef="usd" contextRef="i0f2700a332404782bc605abd43a2168b_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfNDc3NA_e693014f-15d7-4608-b95b-255b2e10f776">no</ix:nonFraction></ix:nonFraction> liabilities measured at fair value on a nonrecurring basis at December 31, 2020 and March 31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash, included within Prepaid expenses and other on the Company&#8217;s Condensed Consolidated Balance Sheet as of December 31, 2020, primarily consists of funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. The amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds have been recorded by the Company within Other accrued liabilities on the Company&#8217;s Condensed Consolidated Balance Sheet as of December 31, 2020.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i96331c8911574c3bae2e4d47cea370cc" continuedAt="i4a4474a515834094ac7446ac32e00232"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of its reporting units. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.</span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4a4474a515834094ac7446ac32e00232">The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.</ix:continuation> </span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_88"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMTgxNTY_19fcbe3b-8a18-4277-9355-9802d1727ea1" continuedAt="i43d1aab33e764b048e8bed20b242e257" escape="true">Commitments and Contingent Liabilities</ix:nonNumeric></span></div><ix:continuation id="i43d1aab33e764b048e8bed20b242e257" continuedAt="i63c82619d023496b80cd824a84b50648"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMTgxNjg_c3135543-6ccc-4ba1-b6a6-b8493fc739b2" continuedAt="i853ec68491c64b218795542aa7921cc6" escape="true"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765320000033/mck10k3312020.htm#sFDC7F65C03045D74BF3631026AD9426B">Financial Note 21 to the Company&#8217;s 2020 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112">Financial Note 13 to the Company&#8217;s 10-Q filing for the quarterly period ended June 30, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88">Financial Note 13 to the Company</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88">&#8217;</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88">s 10-Q fil</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88">ing for the quarterly period ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88">September 30, 2020</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88">,</a></span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i853ec68491c64b218795542aa7921cc6">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, it is not reasonably possible for the Company to determine that a loss is probable for a claim, or to reasonably estimate the amount of loss or a range of loss, because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to be resolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the loss probability has changed and whether it can make a reasonable estimate of the possible loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability in the amount of its estimate for the ultimate loss. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.</ix:continuation> </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">I. Litigation and Claims Involving Distribution of Controlled Substances</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates are defendants in many cases asserting claims related to distribution of controlled substances. They are named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions include state attorneys general, county and municipal governments, hospitals, Indian tribes, pension funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico, and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), state and federal controlled substances laws, and other statutes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since December 5, 2017, nearly all such cases pending in federal district courts have been transferred for consolidated pre-trial proceedings to a multi-district litigation (&#8220;MDL&#8221;) in the United States District Court for the Northern District of Ohio captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: National Prescription Opiate Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 17-md-2804. At present, there are approximately <ix:nonFraction unitRef="case" contextRef="i9a5ab16c64ae4891a9ee3b4e317ce1eb_I20201231" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMzcxMg_d7d2a64d-95f2-4fec-b779-d45cd49777d0">2,900</ix:nonFraction> cases under the jurisdiction of the MDL court. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-indent:18pt"><span><br/></span></div><ix:continuation id="i63c82619d023496b80cd824a84b50648" continuedAt="i0a048983e5bc4f24bb9002ba38e7c610"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="case" contextRef="i11feebab2b6a424dbf4daff39a96c1b9_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNDM5OA_5a076b3f-a12e-4644-abb0-8326224cacda">Three</ix:nonFraction> cases involving McKesson that were previously part of the federal MDL have been remanded to other federal courts for discovery and trial. On January 14, 2020, the Judicial Panel on Multidistrict Litigation finalized its Conditional Remand Order, ordering that the cases against the <ix:nonFraction unitRef="company" contextRef="ieb5a21abc8d848b6956e3feaf80201be_I20200114" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNDY4Mw_3845396f-aabf-48de-8de4-6ff650a89600">three</ix:nonFraction> largest distributors brought by Cabell County, West Virginia and the City of Huntington, West Virginia be remanded to the U.S. District Court for the Southern District of West Virginia. Trial in that case is scheduled to begin on May 3, 2021. On February 5, 2020, the case brought by the City and County of San Francisco was remanded to the U.S. District Court for the Northern District of California; trial has been set for December 6, 2021. Also on February 5, 2020, the case brought by the Cherokee Nation was remanded by the MDL court to the U.S. District Court for the Eastern District of Oklahoma.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also named in approximately <ix:nonFraction unitRef="case" contextRef="i1814ff2457bd41d6804ef58f25e4d38e_I20201231" decimals="-2" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNTMwNA_944420a9-e589-4fdf-8309-489494aeae69">400</ix:nonFraction> similar state court cases pending in <ix:nonFraction unitRef="state" contextRef="i1814ff2457bd41d6804ef58f25e4d38e_I20201231" decimals="INF" name="mck:LossContingencyNumberofStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNTM0NA_35bd083a-920d-43c0-98f7-156f917c9238">38</ix:nonFraction> states plus Puerto Rico, along with <ix:nonFraction unitRef="case" contextRef="icbc6c502b0884c4985e06716f2758c89_I20201231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNTM4Mw_ff22acd3-2157-407e-ac19-d617dc92d644">3</ix:nonFraction> cases in Canada. These include actions filed by <ix:nonFraction unitRef="stateattorney" contextRef="i1814ff2457bd41d6804ef58f25e4d38e_I20201231" decimals="INF" name="mck:LossContingencyNumberofStateAttorneyGenerals" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNTQzNA_0f79ef79-e244-44a3-a765-ac3279ce49ca">26</ix:nonFraction> state attorneys general, and some by or on behalf of individuals, including wrongful death lawsuits, and putative class action lawsuits brought on behalf of children with neonatal abstinence syndrome due to alleged exposure to opioids in utero. Trial dates have been set in several of these state court cases. For example, trial was previously set to begin in March 2020 in the Supreme Court of New York, Suffolk County for a case brought by the New York attorney general and <ix:nonFraction unitRef="county" contextRef="if621de71312448b2a9e258676fa2ca7f_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="mck:NumberOfCountyGovernments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNTkwNw_3c22623e-5b4b-4766-a213-760b2bfffb1c">two</ix:nonFraction> New York county governments, but the trial was postponed in light of the COVID-19 pandemic. The case brought by the Alabama attorney general is scheduled to go to trial in May 2021, as is the case brought by the Washington attorney general.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to be involved in discussions with the objective of achieving broad resolution of opioid-related claims of states, their political subdivisions, and other government entities (&#8220;governmental entities&#8221;). The Company is in ongoing, advanced discussions with state attorneys general and plaintiffs&#8217; representatives regarding a framework under which the <ix:nonFraction unitRef="company" contextRef="i466b8e02cb9445f399b466a5da7612c9_I20201031" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNjQ5OQ_20f3e42a-554e-4fdb-9aef-873391c547c5">three</ix:nonFraction> largest U.S. pharmaceutical distributors would pay up to approximately $<ix:nonFraction unitRef="usd" contextRef="i296306fefeb14dec9e27a205cd23548a_D20201001-20201031" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNjU5Nw_71e80eef-41e5-4dc7-b14a-b73416f8aba0">21.0</ix:nonFraction> billion over a period of <ix:nonNumeric contextRef="i296306fefeb14dec9e27a205cd23548a_D20201001-20201031" format="ixt-sec:duryear" name="mck:LossContingencySettlementAgreementAwardPaymentPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNjYwNQ_e1aeed9e-5ed5-4daf-a514-3a7d43076e78">18</ix:nonNumeric> years, with up to approximately $<ix:nonFraction unitRef="usd" contextRef="i810be42fbf2d4974a731649985916aec_D20201001-20201031" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNjYzNA_e6508f07-ae97-4e3a-8e07-5c90bca3ec1d">8.0</ix:nonFraction> billion to be paid by the Company to resolve claims of governmental entities, with more than <ix:nonFraction unitRef="number" contextRef="i9b59d9c3f0e146b8a720c89acae06997_I20201031" decimals="2" name="mck:LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMjE5OTAyMzMyNzQ3Mg_7521db71-5c06-43b6-ae9a-6faf14ae2459">90</ix:nonFraction>% of the total amount anticipated to be used to remediate the opioids crisis. Most of the remaining amount relates to plaintiffs&#8217; attorneys fees and costs, and would be payable over a shorter time period. In addition, the proposed framework would require the three distributors, including the Company, to adopt changes to anti-diversion programs. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the framework, before the distributors determine whether to enter into any final settlement, they would assess the sufficiency of the scope of settlement, based in part on the number and identities of the governmental entities that would participate in any such settlement. The framework contemplates that if certain governmental entities did not agree to a settlement under the framework, but the distributors nonetheless concluded that there was sufficient participation to warrant going forward with the settlement, there would be a corresponding reduction in the amount due from the Company to account for the governmental entities that did not agree. Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has concluded that discussions under that framework have reached a stage at which a broad settlement of opioid claims by governmental entities is probable, and the loss related thereto can be reasonably estimated as of December 31, 2020. As a result of that conclusion, and its assessment of certain other opioid-related claims, the Company has recorded a charge of $<ix:nonFraction unitRef="usd" contextRef="i7ac4183cf22d4c829d4a7bc371cc268c_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMjE5OTAyMzI5MzA3MQ_dcac3458-4279-4dfe-9a7f-1fca14a1a501"><ix:nonFraction unitRef="usd" contextRef="i30c6a601291c426daef2c98a6924abf6_D20200401-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMjE5OTAyMzI5MzA3MQ_e9adc7c3-ed49-4c00-92cc-42ef2aa25053">8.1</ix:nonFraction></ix:nonFraction> billion ($<ix:nonFraction unitRef="usd" contextRef="i7ac4183cf22d4c829d4a7bc371cc268c_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="mck:LossContingencyAccrualProvisionNetOfTax" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMjE5OTAyMzI5MzA4OQ_05bac1f2-f26a-4d94-bd1f-00678e229869"><ix:nonFraction unitRef="usd" contextRef="i30c6a601291c426daef2c98a6924abf6_D20200401-20201231" decimals="-5" format="ixt:numdotdecimal" name="mck:LossContingencyAccrualProvisionNetOfTax" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMjE5OTAyMzI5MzA4OQ_4a2bd069-22f8-476e-96ad-73aeb42bae7e">6.7</ix:nonFraction></ix:nonFraction> billion after-tax) within Claims and litigation charges, net in the Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2020, related to its share of the settlement framework described above, as well as those certain other opioid-related claims. In light of the uncertainty, as described below, of the timing of amounts that would be paid with respect to the charge, the charge was recorded in Long-term litigation liabilities in the Company&#8217;s Condensed Consolidated Balance Sheet as of December 31, 2020. Moreover, in light of the uncertainties described below, the amount of loss that the Company ultimately might incur may differ materially from the amount accrued.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discussions with attorneys general and other parties continue. If the negotiating parties agree on terms under the framework for a broad resolution of claims of governmental entities, then those potential terms would need to be agreed to by numerous other state and local governments before an agreement could be accepted by the Company and finalized. In some cases, discovery has been paused during the parties&#8217; discussions. While the Company continues to be involved in discussions regarding a potential broad settlement framework, the Company also continues to prepare for trial in these pending matters. The Company believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i0a048983e5bc4f24bb9002ba38e7c610" continuedAt="ic58b8ff6b5e04f72aed68ef7f2a106a5"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the vast majority of opioid claims have been brought by U.S. governmental entities, the Company is also a defendant in cases brought by private plaintiffs, such as hospitals, pension funds, third-party payors, and individuals, as well as <ix:nonFraction unitRef="case" contextRef="i0f96022346a941118bddf4181736007f_I20201231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMjE5OTAyMzMyNzc2Mw_dd589bf4-e774-44b3-8a2a-ade814a09670">3</ix:nonFraction> cases in which the Company has been named as a defendant in Canada. These claims, and those of private entities generally, are not included in the settlement framework for U.S. governmental entities, or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. The Company has not concluded a loss is probable in any of these matters; nor is the amount of any possible loss reasonably estimable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, and the uncertainty of the scope of potential participation by governmental entities under the framework described above, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#8217;s financial position, cash flows or liquidity, or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">II. Other Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2013, the Company was served with a complaint filed in the United States District Court for the Northern District of California by True Health Chiropractic Inc., alleging that McKesson sent unsolicited marketing faxes in violation of the Telephone Consumer Protection Act of 1991 (&#8220;TCPA&#8221;), as amended by the Junk Fax Protection Act of 2005 or JFPA,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;No. CV-13-02219 (HG). Plaintiffs seek statutory damages from&#160;$<ix:nonFraction unitRef="usd" contextRef="i307db805735d4eed947d313935f69a7c_D20130517-20130517" decimals="INF" name="mck:LossContingencyDamagesSoughtPerViolationValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfOTg3Mw_cb758b5d-3a6c-441f-9205-229863bde59c">500</ix:nonFraction>&#160;to&#160;$<ix:nonFraction unitRef="usd" contextRef="i70c71945e9ab4abc8b1e9671bc5cf37f_D20130517-20130517" decimals="INF" format="ixt:numdotdecimal" name="mck:LossContingencyDamagesSoughtPerViolationValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfOTg3OQ_2b141489-b664-4e6c-9054-7c1c05e95ec4">1,500</ix:nonFraction>&#160;per violation plus injunctive relief. True Health Chiropractic later amended its complaint, adding McLaughlin Chiropractic Associates as an additional named plaintiff and McKesson Technologies Inc. as a defendant. Both plaintiffs alleged that defendants violated the TCPA by sending faxes that did not contain notices regarding how to opt out of receiving the faxes. On July 16, 2015, plaintiffs filed a motion for class certification. On August 22, 2016, the court denied plaintiffs&#8217; motion. On July 17, 2018, the United States Court of Appeals for the Ninth Circuit Court affirmed in part and reversed in part the district court&#8217;s denial of class certification and remanded the case to the district court for further proceedings. On August 13, 2019, the court granted plaintiffs&#8217; renewed motion for class certification. After class notice and the opt-out period, <ix:nonFraction unitRef="fax_number" contextRef="iea73c883add347f580abc569d92611ad_I20190813" decimals="INF" format="ixt:numdotdecimal" name="mck:LossContingencyClassActionNumberofFaxesRemainingintheClass" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMTA3NDc_3998dc24-2abb-4600-87d2-a250c2f65dc9">9,490</ix:nonFraction> fax numbers remain in the class, representing <ix:nonFraction unitRef="fax" contextRef="iea73c883add347f580abc569d92611ad_I20190813" decimals="INF" format="ixt:numdotdecimal" name="mck:LossContingencyClassActionNumberofFaxesReceived" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMTA3OTY_916b5f93-9c66-4e31-900c-fca0658a1821">48,769</ix:nonFraction> faxes received. On March 5, 2020, McKesson moved to decertify the class and moved for summary judgment on plaintiffs&#8217; claim for treble damages. Plaintiffs&#8217; moved for summary judgment on the same day. On December 24, 2020, the court declined to decertify the class but modified the class definition to distinguish between physical faxes (kept in the class) versus online or e-fax recipients (removed from the class). Because the court modified the class definition, the court deferred on ruling on the parties&#8217; cross-motions for summary judgment, and directed the parties to submit a statement agreeing or objecting to the court&#8217;s proposal for updated class notice. Due to the COVID-19 pandemic, the trial date for this case was taken off calendar to be re-scheduled during 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2017, <ix:nonFraction unitRef="investmentfund" contextRef="i4f79315064404a0d802db3a9c2d14fe6_I20171229" decimals="INF" format="ixt-sec:numwordsen" name="mck:NumberOfInvestmentFundsThatFiledClaims" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfOTM0NTg0ODg2OTgzMg_a3c52394-1138-444e-b599-4d8654a68f50">two</ix:nonFraction> investment funds holding shares in Celesio AG filed a complaint against McKesson Europe Holdings (formerly known as &#8220;Dragonfly GmbH &amp; Co KGaA&#8221;), a subsidiary of the Company, in a German court in Stuttgart, Germany, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 18 O 455/17. On December 30, 2017, <ix:nonFraction unitRef="investmentfund" contextRef="i4c90799af4454695aebcf7f2731092cd_I20171230" decimals="INF" format="ixt-sec:numwordsen" name="mck:NumberOfInvestmentFundsThatFiledClaims" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfOTM0NTg0ODg2OTg0Mw_08e1ab3c-2218-4453-ae85-f1f8780c8aa1">four</ix:nonFraction> investment funds, which had allegedly entered into swap transactions regarding shares in Celesio AG that would have enabled them to decide whether to accept McKesson Europe Holdings&#8217;s takeover offer in its acquisition of Celesio AG, filed a complaint, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson Kempner International (BVI) Ltd. et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No.16 O 475/17. The complaints allege that the public tender offer document published by McKesson Europe in its acquisition of Celesio AG incorrectly stated that McKesson Europe&#8217;s acquisition of convertible bonds would not be treated as a relevant acquisition of shares for the purposes of triggering minimum pricing considerations under Section 4 of the German Takeover Offer Ordinance. On May 11, 2018, the court in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dismissed the claims against McKesson Europe. Plaintiffs appealed this ruling and, on December 19, 2018, the Higher Regional Court (Oberlandesgericht) of Stuttgart confirmed the full dismissal of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> matter. Plaintiffs filed a complaint against denial of leave to appeal with the Federal Court of Justice (Bundesgerichtshof), which was rejected on November 17, 2020, making the dismissal final and binding. With no further right to appeal, Plaintiffs filed an objection against the decision of the Federal Court of Justice on November 27, 2020, claiming their right to be heard had been violated. On March 15, 2019, the lower court in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> similarly dismissed the case. Plaintiffs appealed this ruling and, on October 9, 2019, the Higher Regional Court (Oberlandesgericht) of Stuttgart confirmed the full dismissal of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> matter. On November 13, 2019, Plaintiffs filed a complaint against denial of leave to appeal with the Federal Court of Justice (Bundesgerichtshof).</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ic58b8ff6b5e04f72aed68ef7f2a106a5"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 25, 2018, Marion Diagnostic Center, LLC and Marion Healthcare, LLC filed a class action complaint in the United States District Court for the Eastern District of Pennsylvania alleging that the Company and its subsidiary, McKesson Medical-Surgical Inc., among others, violated the Sherman Act by restraining trade in the sale of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marion Diagnostic Center, LLC v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:18-cv-4137; MDL No. 16-MD-2724. On June 26, 2019, the court granted the Company&#8217;s motion to dismiss and authorized plaintiffs to seek leave to amend the claims against the Company. On December 30, 2019, a group of independent pharmacies and a hospital filed a class action complaint alleging that the Company and other distributors violated the Sherman Act by colluding with manufacturers to restrain trade in the sale of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reliable Pharmacy, et al. v. Actavis Holdco US, et al., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No. 2:19-cv-6044; MDL No. 16-MD-2724. The complaint seeks relief including treble damages, disgorgement, attorney fees, and costs in unspecified amounts. The court in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marion Diagnostic </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ordered dismissal of plaintiff&#8217;s complaint with prejudice on November 23, 2020 pursuant to a stipulation of the parties, but without waiving any rights Marion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostic Center, LLC and Marion Healthcare, LLC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">may have to participate in a settlement or judgment of any other action in the MDL as a class member.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">III.&#160;Government Subpoenas and Investigations</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 21, 2020, McKesson received correspondence from the U.S. Attorney&#8217;s Office for the Western District of Tennessee alleging reporting and documentation deficiencies in violation of the Controlled Substances Act at the Company&#8217;s former and no longer operational RxPak facility and at its Distribution Center in Memphis, Tennessee, and seeking civil penalties.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV.  State Opioid Statutes</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory or industry measures to address the misuse of prescription opioid medications could affect the Company&#8217;s business in ways that it may not be able to predict. For example, in April 2018, the State of New York adopted the Opioid Stewardship Act (the &#8220;OSA&#8221;) which required the creation of an aggregate $<ix:nonFraction unitRef="usd" contextRef="ic5f178fedc5b4cf6bdb61d18797a2680_I20180430" decimals="INF" format="ixt:numdotdecimal" name="mck:OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMTY4MDY_03d96da7-c7dc-4ef4-9f35-a637b87c1bf5">100</ix:nonFraction>&#160;million annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. The initial surcharge payment would have been due on January 1, 2019 for opioids sold or distributed during calendar year 2017. On July 6, 2018, the Healthcare Distribution Alliance filed a lawsuit challenging the constitutionality of the law and seeking an injunction against its enforcement. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State appealed that decision. On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#8217;s decision on procedural grounds. The Company has accrued a $<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMTc2MTI_2bb654a7-49a6-4aa9-a793-2876f8a78e93">50</ix:nonFraction>&#160;million pre-tax charge ($<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="mck:LossContingencyAccrualAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMTc2MzE_c25db658-9ffb-4c87-9d0a-7e36625c11e3">37</ix:nonFraction>&#160;million after-tax) as its estimated share of the OSA surcharge for calendar years 2017 and 2018. This OSA provision was recognized as Operating expenses in the accompanying condensed consolidated statement of operations for the nine months ended December 31, 2020 and as Other accrued liabilities in the condensed consolidated balance sheets as of December 31, 2020. The State of New York adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018. The Healthcare Distribution Alliance filed a petition for panel rehearing, or, in the alternative, for rehearing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">en banc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with the U.S. Court of Appeals for the Second Circuit; that petition was denied on December 18, 2020.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_94"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfNDU1Mw_2223c200-98ca-4147-a451-93ca1e8bf63a" continuedAt="ifc4fd48162b84c9aac431cbd6226d0bb" escape="true">Stockholders' Equity (Deficit) </ix:nonNumeric></span></div><ix:continuation id="ifc4fd48162b84c9aac431cbd6226d0bb" continuedAt="ica88b50affe44a30a69788b381b23856"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of the Company&#8217;s outstanding common stock is permitted <ix:nonFraction unitRef="vote" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="mck:CommonStockVotingRightsNumberofVotesPerCommonShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfNzk_283a6901-62bc-4e5c-87fe-f250c6117e8e">one</ix:nonFraction> vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2020, the Company raised its quarterly dividend from $<ix:nonFraction unitRef="usdPerShare" contextRef="i2b9d2822c0fe41fc86291a1793d818ec_D20200728-20200728" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzAy_91abbbb4-11de-4f7d-8336-b79b4c7d91e0">0.41</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="iee7001dbe701429a8640019b5e925c83_D20200729-20200729" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzA4_66012799-84b7-4027-8c46-848aff575d70">0.42</ix:nonFraction> per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time to time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2020, there were <ix:nonFraction unitRef="shares" contextRef="ie5c361bf141b4eb9891a9ae3f5e870b1_D20200401-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMTQwMA_dd8ca633-bf66-4c3c-9a24-9e8508924879">no</ix:nonFraction> share repurchases made under previously authorized share repurchase programs. During the three months ended September 30, 2020, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="ia83332fa877f4f95a2db6855471cfa83_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzg0ODI5MDcwMjU4OQ_e519b616-4994-4eb2-bccc-5f93f2d180ae">1.8</ix:nonFraction>&#160;million of the Company&#8217;s shares for $<ix:nonFraction unitRef="usd" contextRef="ia83332fa877f4f95a2db6855471cfa83_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMTU3MA_c9700104-b418-40d5-8895-00db6cd05695">269</ix:nonFraction> million through open market transactions at an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i85b5d437b88a43c3b57c3014d5ae8bf1_D20200701-20200930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMTYzOQ_8274a63d-a155-4072-9b3a-cbe56c9fba6e">151.23</ix:nonFraction>. During the three months ended December 31, 2020, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i85bcde357ef24cd5a6fe11d759211780_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMTMxOTQxMzk1Mzg4MDk_083105e6-851a-4e55-855e-d71b75d71230">1.5</ix:nonFraction>&#160;million of the Company&#8217;s shares for $<ix:nonFraction unitRef="usd" contextRef="i85bcde357ef24cd5a6fe11d759211780_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMTMxOTQxMzk1Mzg4NDE_d942db21-500f-41a8-9d73-6b5a239a3ea0">231</ix:nonFraction> million through open market transactions at an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i85bcde357ef24cd5a6fe11d759211780_D20201001-20201231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMTMxOTQxMzk1Mzg5MTE_c6c801ac-3965-4e90-8768-9d9b362467db">151.12</ix:nonFraction>. The total authorization outstanding for repurchases of the Company&#8217;s common stock was $<ix:nonFraction unitRef="usd" contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMTkwOQ_9034bffb-4093-4a9c-b775-eee9dbaccc85">1.0</ix:nonFraction> billion at December 31, 2020. In January 2021, the Board approved an increase of $<ix:nonFraction unitRef="usd" contextRef="i42de281c12634e1094f4341b8340f8c9_I20210131" decimals="INF" format="ixt:numdotdecimal" name="mck:StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMjc0ODc3OTA4NDk3Mw_12a7245a-1042-4c1e-bd1d-2d1619c37a19">2.0</ix:nonFraction> billion for the authorized share repurchase of McKesson&#8217;s common stock.</span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ica88b50affe44a30a69788b381b23856" continuedAt="if22bf4b72e1b4eff84cdf44265e8906a"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Comprehensive Income (Loss)</span></div><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfNDUyNg_5341b210-b35b-4319-92bc-d14ed2e2ce78" continuedAt="i59363f770e104484abf09b7f5a3262fb" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding Other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.261%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments arising during period, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMy0wLTEtMS0wL3RleHRyZWdpb246N2E4NDcxNjk4MzQwNDliY2FjNTYzZjc3ZDcwZmI0MDNfOTc_29e077d1-1fd8-4261-8b28-08da6bdcf2a8">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMy0wLTEtMS0wL3RleHRyZWdpb246N2E4NDcxNjk4MzQwNDliY2FjNTYzZjc3ZDcwZmI0MDNfMTAx_2c423133-9182-4ba4-ba3d-dc3032b9648c">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMy0wLTEtMS0wL3RleHRyZWdpb246N2E4NDcxNjk4MzQwNDliY2FjNTYzZjc3ZDcwZmI0MDNfMTA1_8923c70c-11eb-4f69-b0fe-e78ff0371009">nil</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMy0wLTEtMS0wL3RleHRyZWdpb246N2E4NDcxNjk4MzQwNDliY2FjNTYzZjc3ZDcwZmI0MDNfMTEz_c27b1af8-975d-447b-9be9-fdc62ed98a6f">nil</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) (3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMy0xLTEtMS0w_c404615c-29fb-4aa3-a4d0-c9e72bc94484">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245807132e61488c94b12390e4121f99_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMy0zLTEtMS0w_2fe2dd57-ce35-45f7-8173-f568da7cf9b6">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMy01LTEtMS0w_c2e3dc4e-64bc-4cb4-9fd7-853a60e7fc95">363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMy03LTEtMS0w_d1aac5db-4a3e-450a-8cc5-1e4750d98ada">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNC0wLTEtMS0wL3RleHRyZWdpb246N2MyYjRiZTA2YzE3NGQzMmJjM2E4MzFjNGMxYjc4MTBfNjc_2e88dce7-0136-4aec-86e3-147d4ff85939">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNC0wLTEtMS0wL3RleHRyZWdpb246N2MyYjRiZTA2YzE3NGQzMmJjM2E4MzFjNGMxYjc4MTBfNzE_c10e4fb1-10fc-49c2-8d1c-29fe6baaf5a1">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNC0wLTEtMS0wL3RleHRyZWdpb246N2MyYjRiZTA2YzE3NGQzMmJjM2E4MzFjNGMxYjc4MTBfNzU_9946274a-fa57-4485-afea-0ea6b060cf61">nil</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNC0wLTEtMS0wL3RleHRyZWdpb246N2MyYjRiZTA2YzE3NGQzMmJjM2E4MzFjNGMxYjc4MTBfODM_5f22ed0d-845e-4b0a-8393-d53bf7bcf891">nil</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNC0xLTEtMS0w_5ba3a758-f6ac-48f3-a9ed-eb58de1ce7c3">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245807132e61488c94b12390e4121f99_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNC0zLTEtMS0w_fdace17f-fb45-49f2-9338-95e92c1bd007">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNC01LTEtMS0w_8b97755f-9b85-4bd9-83d5-2bc63bb3bf24">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNC03LTEtMS0w_09ff6da0-32c3-468f-9974-bcb01aca6780">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNS0xLTEtMS0w_492e6be8-f368-49cf-b691-11155a030410">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245807132e61488c94b12390e4121f99_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNS0zLTEtMS0w_bd241194-3772-411d-a11d-46d900045189">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNS01LTEtMS0w_08354230-12cc-44b5-967c-9e277a75f1ad">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNS03LTEtMS0w_d29a7aa1-cc64-4961-88a9-35cef81403c8">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on net investment hedges arising during period, net of income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNy0wLTEtMS0wL3RleHRyZWdpb246YjJiZmYyOGQ2NzkwNDg2MTgzMWVlYzdkOTUxZDY2Y2NfMTE3_71efef6f-139d-4aac-a095-e46ec9e03940">33</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNy0wLTEtMS0wL3RleHRyZWdpb246YjJiZmYyOGQ2NzkwNDg2MTgzMWVlYzdkOTUxZDY2Y2NfMTIx_46f3fc26-cabd-49f1-80fb-cc042c1c7cf3">21</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNy0wLTEtMS0wL3RleHRyZWdpb246YjJiZmYyOGQ2NzkwNDg2MTgzMWVlYzdkOTUxZDY2Y2NfMTI1_74f872de-3f9d-4e33-ae1e-6b4502ca2199">80</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNy0wLTEtMS0wL3RleHRyZWdpb246YjJiZmYyOGQ2NzkwNDg2MTgzMWVlYzdkOTUxZDY2Y2NfMTMz_899517b2-9821-4dae-b997-cf890e62c6eb">1</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNy0xLTEtMS0w_2b929bcc-4b5e-4c1c-8a9e-f1db5bf91718">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNy0zLTEtMS0w_963541d4-b9fb-4b3a-81b9-f3af58f96fd2">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNy01LTEtMS0w_74861123-79e1-4790-8f75-34175d2772b3">229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNy03LTEtMS0w_6f6cce5f-98d5-4302-a929-514ab2f79c08">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOC0wLTEtMS0wL3RleHRyZWdpb246OTEwNGRkZjVhZDNkNGNkNDgxMzZmZWY3YWJiMjJjZTlfNjc_0d011b79-5ed1-49f0-8a81-51696f56db66">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOC0wLTEtMS0wL3RleHRyZWdpb246OTEwNGRkZjVhZDNkNGNkNDgxMzZmZWY3YWJiMjJjZTlfNzE_53b7211a-7859-43df-9ad5-74744bbddc6b">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOC0wLTEtMS0wL3RleHRyZWdpb246OTEwNGRkZjVhZDNkNGNkNDgxMzZmZWY3YWJiMjJjZTlfNzU_51ebd7aa-fa8c-4dd2-97aa-6da3c673458a">nil</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOC0wLTEtMS0wL3RleHRyZWdpb246OTEwNGRkZjVhZDNkNGNkNDgxMzZmZWY3YWJiMjJjZTlfODM_c7263a79-6e7c-4212-a5fd-c31e25432440">nil</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOC0xLTEtMS0w_bdcc6e21-f43e-49c0-a525-d1a86203dc8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOC0zLTEtMS0w_028227c3-02f6-4d35-9d29-36e9a3d2d12e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOC01LTEtMS0w_30b98531-9cdc-4b86-a13f-d7ce8a35faa7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOC03LTEtMS0w_edc1d21e-f7f1-494a-a51e-68b67d6faf80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOS0xLTEtMS0w_8d537d5d-c5d8-41cd-a768-c77053da79f4">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOS0zLTEtMS0w_6081a1e5-4827-44c5-bd66-816ef32cecb7">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOS01LTEtMS0w_2c4203fd-0c20-447d-bf13-05e734b8d554">229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOS03LTEtMS0w_3cfc9eb1-9fbd-4ad9-97ce-a60a6e750ae1">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges arising during period, net of income tax (expense) benefit of $<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjU4MzQzYzZlZTdjYTRkZjBhZWZkYjZlZDQ5YTVmODJhXzExMg_810ee6db-3ca8-458e-b64c-dafbee486a3c">2</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjU4MzQzYzZlZTdjYTRkZjBhZWZkYjZlZDQ5YTVmODJhXzExNg_00b5a114-7c2b-4905-a636-6f8dcff1fcea">3</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjU4MzQzYzZlZTdjYTRkZjBhZWZkYjZlZDQ5YTVmODJhXzEyMA_669c0e40-da4d-4004-b682-3dd5c5bcad10">6</ix:nonFraction>, and $(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjU4MzQzYzZlZTdjYTRkZjBhZWZkYjZlZDQ5YTVmODJhXzEyOA_d7d01fa0-66fb-4a2a-9610-0f6e4c30331c">7</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60ebfe67a3044298876108334986e57c_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTEtMS0xLTEtMA_6d0ef421-75d2-4719-abc2-3c6623188d2b">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTEtMy0xLTEtMA_6d0f7e93-67a7-4bc4-8390-b33afc2bd4bd">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTEtNS0xLTEtMA_045786b5-c15c-48d0-8893-1cfcd266447e">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTEtNy0xLTEtMA_3d6b7849-57cb-4bfa-8e87-34b73f59d842">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="i60ebfe67a3044298876108334986e57c_D20201001-20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTItMC0xLTEtMC90ZXh0cmVnaW9uOmRjODQ4ODNiZDg0NTQ1NGE5MWUxYzRhYjg4YzhkMGRhXzY3_fd3a1c2e-feed-4971-9479-798fd105c8fa">nil</ix:nonFraction>,  <ix:nonFraction unitRef="usd" contextRef="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTItMC0xLTEtMC90ZXh0cmVnaW9uOmRjODQ4ODNiZDg0NTQ1NGE5MWUxYzRhYjg4YzhkMGRhXzcy_2e868a45-5a41-43a7-bfaf-976054fb8927">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTItMC0xLTEtMC90ZXh0cmVnaW9uOmRjODQ4ODNiZDg0NTQ1NGE5MWUxYzRhYjg4YzhkMGRhXzc2_ab84f269-afa6-4746-8d46-bc3c10d8b3ff">nil</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTItMC0xLTEtMC90ZXh0cmVnaW9uOmRjODQ4ODNiZDg0NTQ1NGE5MWUxYzRhYjg4YzhkMGRhXzg0_d353656b-4037-427a-8ff0-b89282a9cf6f">nil</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60ebfe67a3044298876108334986e57c_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTItMS0xLTEtMA_09821dbb-b93c-4a1a-ba2e-2f65a3858e10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTItMy0xLTEtMA_640e7675-dc50-4306-a777-c034bfb45d35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTItNS0xLTEtMA_efeb9f89-df20-4628-b6e9-9161d74f28c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTItNy0xLTEtMA_e8f50c0f-12a3-4bc7-941e-2b4d2154ad85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60ebfe67a3044298876108334986e57c_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTMtMS0xLTEtMA_bfed6537-383e-4879-baec-5e3243350113">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTMtMy0xLTEtMA_7855bdb3-0a0d-44e2-aaff-96832918a43d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTMtNS0xLTEtMA_e364a151-844a-450a-ae66-cb5767a6ecad">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTMtNy0xLTEtMA_b65eff0f-7d63-4683-bb7f-5daa504bcc23">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss and prior service cost arising during the period, net of income tax benefit of <ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjUxYjNjMzE3MzM3MzQ1MTRhYWIzNDFjZDlmZDhhZTE5XzEwMg_b90893b9-e513-4f7d-92c8-c4bbe07597d0">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjUxYjNjMzE3MzM3MzQ1MTRhYWIzNDFjZDlmZDhhZTE5XzEwNg_410e4fe6-fdac-4367-9966-0fde1047775a">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjUxYjNjMzE3MzM3MzQ1MTRhYWIzNDFjZDlmZDhhZTE5XzExMA_b15c1cfc-c3d3-4755-b024-37069e65befe">nil</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjUxYjNjMzE3MzM3MzQ1MTRhYWIzNDFjZDlmZDhhZTE5XzExOA_7a627980-3cf4-450e-803f-22ac4a5d04bd">1</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b20d10786654fff938ed21b46d91890_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTUtMS0xLTEtMA_734192c1-3e62-401d-ab1f-4dfaceaa5396">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b48d9346ede475eaa9d050fcd5e2432_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTUtMy0xLTEtMA_c127f1d4-5b5e-4ccf-901b-9998eaa8669b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f8cdf78c925481bb9fb846b51a37d4c_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTUtNS0xLTEtMA_ba7a5dee-f8a0-41ed-a940-ed52bbbce8df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i171a7450485e4fa19bb98c562f3f0835_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTUtNy0xLTEtMA_5b7d2de9-e2d0-43bc-8a25-a72f5e710671">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss, prior service cost and transition obligation, net of income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOmQ3ZjE5NTIyMjliNDQ3Yjc5YzhiYTg1MzRkOWY2M2VmXzExMQ_73881e4f-0d2c-4866-8f1f-bb5f44dbd6f3">2</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOmQ3ZjE5NTIyMjliNDQ3Yjc5YzhiYTg1MzRkOWY2M2VmXzExNQ_dc16dced-1e51-4016-85da-125bf382e599">nil</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOmQ3ZjE5NTIyMjliNDQ3Yjc5YzhiYTg1MzRkOWY2M2VmXzExOQ_2d32dc45-6310-4798-80e6-2455434981d1">1</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOmQ3ZjE5NTIyMjliNDQ3Yjc5YzhiYTg1MzRkOWY2M2VmXzEyNw_494be4ed-cf7a-4878-acec-19de7c5eb767">nil</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad19a75609034338a9616075a375513e_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTYtMS0xLTEtMA_e1e2866a-c275-4918-8ae5-33e42d0a3306">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e441b29128c48aea910381165c7b723_D20191001-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTYtMy0xLTEtMA_396bebee-8913-4b65-b302-de86fef4a5cf">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad855b967ce4ddd8019fe6ca830c068_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTYtNS0xLTEtMA_17515d7c-0add-4ee1-8ff6-00c65a3433c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4b2c4b06218485da8544d4e41e7e4cc_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTYtNy0xLTEtMA_636c956f-0c0d-463d-a1e8-b660aa8c6a35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt-sec:numwordsen" name="mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjMxOWMzNDMzNzIwZDRiYWNhZWUxOGQxN2UwMzM1NDUxXzg1_ff49246d-ca4c-4ff3-b93b-0205e5fc7d04">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" format="ixt-sec:numwordsen" name="mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjMxOWMzNDMzNzIwZDRiYWNhZWUxOGQxN2UwMzM1NDUxXzg5_f8a92184-2947-4a25-93b4-ea4e0d1ba7e5">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt-sec:numwordsen" name="mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjMxOWMzNDMzNzIwZDRiYWNhZWUxOGQxN2UwMzM1NDUxXzkz_aa2cc8b2-3702-48d4-8d28-4db2d377550a">nil</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt-sec:numwordsen" name="mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjMxOWMzNDMzNzIwZDRiYWNhZWUxOGQxN2UwMzM1NDUxXzEwMQ_ff02aadc-d915-49de-87a4-d2190e0b09f2">nil</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i266fe3f418d84aa7b7249926cfc9d280_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTctMS0xLTEtMA_86a1f1d2-9533-4e02-9bfa-117390ba85c7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida514f8038f5465c9dc701830da2f003_D20191001-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTctMy0xLTEtMA_59d8f478-3f55-4f59-9796-829258f34c4c">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39719f584adb44c1b39699ef890bfe15_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTctNS0xLTEtMA_0bde280e-3764-4b28-abc7-1aedb4c2bd37">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b08f5f1f644db4945b8ba02324d11d_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTctNy0xLTEtMA_a5e7d543-e492-4c48-92bc-822b04be6caa">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of $<ix:nonFraction unitRef="usd" contextRef="icaec3dac337e46b3b24229e240ac2c53_D20201001-20201231" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmQ0NTg4MjRmMjdjYzQ5Y2E4MTk0NGNhMjFmZWYwMDI1XzY3_91615eab-65b5-4f4c-b27d-1ae1c6e37d1a">9</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i3048995a4a7944508cb95b392a4d29cd_D20191001-20191231" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmQ0NTg4MjRmMjdjYzQ5Y2E4MTk0NGNhMjFmZWYwMDI1Xzcx_482bf99a-fa68-413f-8445-8b28cd9166ad">3</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i4603c284d62e4e5c9442bdc1f75663f1_D20200401-20201231" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmQ0NTg4MjRmMjdjYzQ5Y2E4MTk0NGNhMjFmZWYwMDI1Xzc1_5d25c55e-f6a1-4c77-9091-76e983ece489">9</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i67aca6db78904dec90dc3b22e3800fd5_D20190401-20191231" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmQ0NTg4MjRmMjdjYzQ5Y2E4MTk0NGNhMjFmZWYwMDI1Xzgz_318235b8-b3ff-4de0-88dc-84227f293f6d">35</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaec3dac337e46b3b24229e240ac2c53_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTgtMS0xLTEtMA_35a99838-07f0-4f3b-9d86-c865e81b984a">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3048995a4a7944508cb95b392a4d29cd_D20191001-20191231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTgtMy0xLTEtMA_9f8fb740-be59-4b43-9a69-78200dadb31f">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4603c284d62e4e5c9442bdc1f75663f1_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTgtNS0xLTEtMA_2297bcc6-e22b-4bde-b308-bf58c475cbd0">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67aca6db78904dec90dc3b22e3800fd5_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTgtNy0xLTEtMA_97720a98-4554-456d-bc65-c759848d4c9d">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaec3dac337e46b3b24229e240ac2c53_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTktMS0xLTEtMA_c2e6f8ab-2f57-4ed0-8acd-084c7fe755ad">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3048995a4a7944508cb95b392a4d29cd_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTktMy0xLTEtMA_40f60079-2cb2-43be-9187-6f4add10fba4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4603c284d62e4e5c9442bdc1f75663f1_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTktNS0xLTEtMA_94f360d3-696f-4c2b-b033-18e8fb5bb8bd">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67aca6db78904dec90dc3b22e3800fd5_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTktNy0xLTEtMA_8d69e9e1-5356-4273-8c8b-9a77dcfb8589">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMjEtMS0xLTEtMA_a8c678e5-315d-4c24-8d1c-538533cc127d">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMjEtMy0xLTEtMA_d66d812a-8ee1-4ee2-9794-bf9dcf5615f6">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMjEtNS0xLTEtMA_ca78ed2a-409c-4eef-af17-f1383ab8ecc9">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMjEtNy0xLTEtMA_76fe5801-0f87-45ec-9c69-d19e2254eea5">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s foreign subsidiary, McKesson Europe, and its operations in Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">During the three and nine months ended December 31, 2020, net foreign currency translation adjustments were primarily due to the strengthening of the Canadian dollar and Euro against the U.S. dollar from April 1, 2020 to December 31, 2020. During the three and nine months ended December 31, 2019, the net foreign currency translation adjustments were primarily due to the strengthening of the Euro and Canadian dollar against the U.S. dollar, partially offset by weakening of the British pound sterling from April 1, 2019 to December 31, 2019.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and nine months ended December 31, 2020 includes net foreign currency translation adjustments of $<ix:nonFraction unitRef="usd" contextRef="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMjgyOA_9d5e4e67-657f-4061-9472-4de4441d99d7">20</ix:nonFraction> million and $(<ix:nonFraction unitRef="usd" contextRef="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231" decimals="-6" sign="-" name="mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMjgzNQ_4992a1ec-7bad-46ef-abb0-e4af90fe3798">41</ix:nonFraction>) million, respectively, and the three and nine months ended December 31, 2019 includes net foreign currency translation adjustments of $<ix:nonFraction unitRef="usd" contextRef="i245807132e61488c94b12390e4121f99_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMjkyMQ_73566e4e-8951-44d7-a184-49e5db82ec44">12</ix:nonFraction> million and $(<ix:nonFraction unitRef="usd" contextRef="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231" decimals="-6" sign="-" name="mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMjkyOA_27a079bc-1c8b-4dec-8b1d-e1b6b2bcc2e5">1</ix:nonFraction>) million, respectively, attributable to redeemable noncontrolling interests. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and nine months ended December 31, 2020 include adjustments for amounts related to the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 3, &#8220;Held for Sale.&#8221; These amounts were included in the current and prior periods calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Operating expenses in the Condensed Consolidated Statements of Operations.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="if22bf4b72e1b4eff84cdf44265e8906a" continuedAt="ifc5ffec66546475ba7a31bfc5e1f7479"><ix:continuation id="i59363f770e104484abf09b7f5a3262fb"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and nine months ended December 31, 2020 includes foreign currency losses of $<ix:nonFraction unitRef="usd" contextRef="ic3392a15e42349f38396d43edec58984_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzA0Mw_c5ba9968-07fa-4dfd-bde2-42bb1d6d4a83">84</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ieae8ce38c55c4a8183867cb63bfddafb_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzA1MA_74906e52-dbd8-4083-83c8-12d8716e7648">201</ix:nonFraction> million, respectively, on the net investment hedges from the &#8364;<ix:nonFraction unitRef="eur" contextRef="i0d9cf49bcf574771b799ca4645191cd5_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzEwNg_021d3b9c-6ae6-4e7f-80ba-ca0c2683cdb9"><ix:nonFraction unitRef="eur" contextRef="i2a0ca354dcd646dbb94a5e6bc0adc910_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzEwNg_36908ddb-0cde-4520-aa90-93836d21920d">1.7</ix:nonFraction></ix:nonFraction> billion&#160;Euro-denominated notes and &#163;<ix:nonFraction unitRef="gbp" contextRef="id38d110d6f9c4cf097c87208b255cff1_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzEzNg_dc5fe370-8c75-4d23-a5dc-c15904c855dd">450</ix:nonFraction> million&#160;British pound sterling-denominated notes, losses of $<ix:nonFraction unitRef="usd" contextRef="i36b3bcf8d524467bacd1c159707af361_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzE5MQ_c265c6c4-fd5c-467c-b20d-8276484e503a">45</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i09c294f2acd74c33bb8e9ada8e29bfef_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzE5OA_5a406b85-3edc-4fb4-9e38-8d9812c503b6">108</ix:nonFraction> million, respectively, on the net investment hedges from cross-currency swaps, and losses on net investment hedges of <ix:nonFraction unitRef="usd" contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzMxMQ_7d13e5f0-a990-4329-ab0b-09fbe6c5f6ec">nil</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMTMxOTQxMzk1NDE2Mjc_b8cd9cf5-37ff-4104-b65a-999678c06e2f">1</ix:nonFraction> million, respectively, attributable to redeemable noncontrolling interests. The three and nine months ended December 31, 2019 include foreign currency losses of $<ix:nonFraction unitRef="usd" contextRef="i8ac357c6d2694d3e854ab420c7c33a3e_D20191001-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzQwOA_0cf9bcaf-0217-4097-bdd6-8758c178ce93">59</ix:nonFraction> million and gains of $<ix:nonFraction unitRef="usd" contextRef="i6d10966d07b64ebba1b226a32e8e56fa_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzQxNQ_32364e8c-5518-494b-9bcf-03f7968c19c2">8</ix:nonFraction> million, respectively, on the net investment hedges from the &#8364;<ix:nonFraction unitRef="eur" contextRef="iaff277eea93447ab86287935d95d1f47_I20191231" decimals="-7" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzQ3MQ_3bc4b640-63bd-4c92-84dd-d7150ecd0d95">1.70</ix:nonFraction> billion Euro-denominated notes and&#160;&#163;<ix:nonFraction unitRef="gbp" contextRef="i1dd77d36d7ae4ca38af80569eac5764d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzUwMQ_a8386805-297d-47e9-8b3c-cc787c18eeaa">450</ix:nonFraction> million British pound sterling-denominated notes and losses of $<ix:nonFraction unitRef="usd" contextRef="if86aed3e96a64acfb7d6c3d4ba3f32e0_D20191001-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzU1OA_2bb5a721-22b1-40b1-97ee-0fe83616eacf">20</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i51b2cfed82a94bea9d5b40efccf351cc_D20190401-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzU2NQ_45bdb20e-77da-42e6-8dfa-c53808430199">11</ix:nonFraction> million, respectively, on the net investment hedges from cross-currency swaps. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and nine months ended December 31, 2020 include net actuarial gains of $<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzY3OQ_871c69f2-e4b2-433e-9848-3989e418c975">5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzY4Ng_9017ac59-f89a-4533-b38e-3093c2c2af95">3</ix:nonFraction> million, respectively, and the three and nine months ended December 31, 2019 include net actuarial losses of $<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzc0Ng_f0269db8-53ef-4b84-b176-dee714f025b1">2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzg0ODI5MDcwMjA4Nw_3f8858e7-05fb-4291-8723-d5a5fef66149">1</ix:nonFraction> million, respectively, which are attributable to redeemable noncontrolling interests.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Pre-tax amount was reclassified into Cost of sales and Operating expenses in the Condensed Consolidated Statements of Operations. The related tax expense was reclassified into Income tax benefit (expense) in the Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The nine months ended December 31, 2019 primarily reflects a reclassification of losses in the second quarter of 2020 upon a pension settlement charge from Accumulated other comprehensive loss to Other income (expense), net in the Condensed Consolidated Statement of Operations.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Income (Loss) </span></div><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfNDU0NQ_3ed250af-f74b-4852-b0ae-b1036cbeade1" continuedAt="i7dd213394b4b4b62a548a4771341503b" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss) by component for the three and nine months ended December 31, 2020 are as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Losses and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ab154724e0a4ea78f86170c48cb3e03_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMi0xLTEtMS0w_95cc592b-60ff-4128-aa6e-322857a9f2e5">1,512</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7016c62d475b44cf8995815c2ee6e6c2_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMi0zLTEtMS0w_bc4ef628-ebc9-465f-8bec-08d15b14fc9f">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53b88b03d43406caa082e97b8198de2_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMi01LTEtMS0w_081946ff-833b-4ce0-9135-de1acc04bed5">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i287fd1b1acc740579e26c343e6d1186f_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMi03LTEtMS0w_7d3266ac-eb6a-423f-b57f-e1c8664e3367">116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if702f6988b73408fb0203fbcf4cfff59_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMi05LTEtMS0w_f2c35a35-3982-4a1f-8982-c517f0c24814">1,597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMy0xLTEtMS0w_8f5991f4-129e-4b62-9901-aa8664f05c12">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMy0zLTEtMS0w_69467732-2bc8-4e5d-9fb3-2c7af9390221">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60ebfe67a3044298876108334986e57c_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMy01LTEtMS0w_7c688b7d-31c9-4671-acb2-ded098fe2197">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bafc11b2f6c48fe8846c0cbf49f1ca8_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMy03LTEtMS0w_f5a47133-7d79-45b3-8684-739396302f15">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMy05LTEtMS0w_60f5f66e-2740-45ef-ad8a-131b9eed67d7">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNC0xLTEtMS0w_80e293b9-1964-40e4-88bd-0ba4988b9be3">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNC0zLTEtMS0w_662930c3-6e8f-49b3-945b-59fbb57fe09d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60ebfe67a3044298876108334986e57c_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNC01LTEtMS0w_3475491f-1f56-4bcb-b9da-89e77d28ce29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bafc11b2f6c48fe8846c0cbf49f1ca8_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNC03LTEtMS0w_1feb2e5c-610f-4b75-b555-faafa61f17d2">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNC05LTEtMS0w_4a5358a4-2f51-4cdb-95d5-9e4c3aae4f2a">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNS0xLTEtMS0w_0de2ea5b-94b8-4328-b67a-62bf333b2eb3">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNS0zLTEtMS0w_4fda0725-a582-4d95-a427-ff5772fe5bd8">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60ebfe67a3044298876108334986e57c_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNS01LTEtMS0w_bdf93824-13de-40e5-9e6f-c9bd575c4cab">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bafc11b2f6c48fe8846c0cbf49f1ca8_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNS03LTEtMS0w_293e5dd7-f366-436b-9237-e202760f59f1">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNS05LTEtMS0w_585d5597-74e2-485e-8704-ee2f79ea4ff9">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNi0xLTEtMS0w_d98a6064-b713-4fcc-a89e-056fd05d6999">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNi0zLTEtMS0w_ee29c08b-b0df-4259-9f38-0ba3733134ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60ebfe67a3044298876108334986e57c_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNi01LTEtMS0w_2ba3a3ce-5eaa-4686-b7bb-bf660bf5e3f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bafc11b2f6c48fe8846c0cbf49f1ca8_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNi03LTEtMS0w_dc254d38-151f-4e49-bb3a-77bef4b61bc6">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNi05LTEtMS0w_2b322ebb-03db-4fcf-815a-b27ca2583e27">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNy0xLTEtMS0w_64e2a6e3-7716-4310-a248-457809518173">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNy0zLTEtMS0w_576c7bcb-e3dc-4e6e-a387-46f18ad3615a">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60ebfe67a3044298876108334986e57c_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNy01LTEtMS0w_bc7d8aeb-17d1-4db9-acee-ac1b51a572bc">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bafc11b2f6c48fe8846c0cbf49f1ca8_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNy03LTEtMS0w_c6b3f6e9-214e-418c-af52-9facc1966e81">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNy05LTEtMS0w_323f8f35-ae76-47cd-9a2c-d43a5778d75e">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8151b587ea184a12a863eb648c1d73b6_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfOC0xLTEtMS0w_9aea77a8-de9a-4ff6-a248-85675b5722ba">1,329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee018ab4a90c436e82e2d025bc7c4033_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfOC0zLTEtMS0w_13ce9bec-de4d-4c19-8563-22aafabd087e">90</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1029504ec8324cdc9d1a8a6f2a854090_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfOC01LTEtMS0w_c6053df0-69de-4de5-9bd5-e99b2cab3f5b">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28bde64152834b87bded353fb0352d95_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfOC03LTEtMS0w_772fe270-2cea-4eb3-b37f-3f7618f8c1dc">97</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6641e8af9e64c7aae662865d224c625_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfOC05LTEtMS0w_dfd8816e-3c51-4100-917f-5fe09d3727d2">1,503</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ifc5ffec66546475ba7a31bfc5e1f7479" continuedAt="i8075c677d88042e1bd7b21b40f64c51e"><ix:continuation id="i7dd213394b4b4b62a548a4771341503b" continuedAt="i5068712fccfb41fe9b9b34742618826c"><div style="margin-bottom:12pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71a3e94889974300a0f149383fe25f18_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMi0xLTEtMS0w_313833ab-1a9a-4b65-ad63-14ccd3eb1eda">1,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a62989bb2744f8a8d872418308d4ba_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMi0zLTEtMS0w_4e4126a2-2a27-4cf7-9af1-5ae1a445bb38">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513c2028d38b4884ac53975bfab5f078_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMi01LTEtMS0w_fda3bf84-3edc-4530-95ae-82d9f1538a1d">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12907ec702d147a3bd56ff8747ef063f_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMi03LTEtMS0w_946ecc15-a780-4c91-9907-ffcf4541eafa">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0374ed6096c4fc79915873d9944afab_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMi05LTEtMS0w_0ab92682-4715-4011-beae-15ae60e31a90">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMy0xLTEtMS0w_9d8c06e4-33f0-4151-84f6-644d428d5825">363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMy0zLTEtMS0w_4e068aa4-7b3b-4a2c-8459-8a5a8fd6e5a2">229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMy01LTEtMS0w_9b70c530-a676-496f-8f8b-a8603e0852ac">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a4dbe3271764ed783e43c160f22a5f7_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMy03LTEtMS0w_15c962ea-324e-4b5a-ab82-a052ef3f3484">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMy05LTEtMS0w_f6c61437-6472-4fdd-9468-52e84f349931">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNC0xLTEtMS0w_2a1b75fb-6773-474b-b0dc-85be9df23914">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNC0zLTEtMS0w_666b3eae-e334-4bc7-a2ca-d35d93be0d45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNC01LTEtMS0w_c0965ba4-e8bd-468b-a438-29ecf167e4b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a4dbe3271764ed783e43c160f22a5f7_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNC03LTEtMS0w_758f0c33-bf4b-4244-ae2d-308069764dcc">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNC05LTEtMS0w_4515edf2-4497-4bd9-b423-e85e50155aed">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNS0xLTEtMS0w_5e418452-7922-40f0-aba4-df5ea1d65454">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNS0zLTEtMS0w_2d087c7c-d14f-4d79-bb25-1faf3a5369be">229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNS01LTEtMS0w_3e9ffb77-4f1c-4082-b263-0c0ff134e546">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a4dbe3271764ed783e43c160f22a5f7_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNS03LTEtMS0w_f7ab517e-4642-4e00-abda-763995eea867">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNS05LTEtMS0w_edfc1fc4-16c8-4068-b865-6a3b7a400aa8">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNi0xLTEtMS0w_82aff7d5-2d26-49f7-b7fa-932d41c7a036">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNi0zLTEtMS0w_503ebcfe-eb22-4d92-8a6a-ad7be1a540e7">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNi01LTEtMS0w_0f54684b-714b-4b40-a3ca-67cab5bb1ae6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a4dbe3271764ed783e43c160f22a5f7_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNi03LTEtMS0w_bb32ee92-aa5a-471a-b4f6-f717ea436c52">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNi05LTEtMS0w_5273bf4a-ad90-4296-9293-cd7c6c52cb0e">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNy0xLTEtMS0w_02dc77d8-8d8e-4d5b-9afd-bcb6c111c1d3">451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNy0zLTEtMS0w_11f76d72-ca5f-4854-b569-0f1ecb4128e8">228</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNy01LTEtMS0w_ba3a16a1-b30c-4569-ac98-814ed3cd3d81">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a4dbe3271764ed783e43c160f22a5f7_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNy03LTEtMS0w_5cc3c33b-1457-4c7a-8cb0-c865eb0a3c77">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNy05LTEtMS0w_21ddbe1f-6d2f-4ca3-81a0-aba39f5ff0c3">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8151b587ea184a12a863eb648c1d73b6_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfOC0xLTEtMS0w_e626984d-bedd-4f11-8681-bdacd75bdadb">1,329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee018ab4a90c436e82e2d025bc7c4033_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfOC0zLTEtMS0w_89e3a419-e37d-4925-8612-1ebe6d65d247">90</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1029504ec8324cdc9d1a8a6f2a854090_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfOC01LTEtMS0w_11ecfed6-14a9-4def-b6f6-a1483238fb41">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28bde64152834b87bded353fb0352d95_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfOC03LTEtMS0w_aef9461e-c78f-4624-9aca-70c81e7db686">97</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6641e8af9e64c7aae662865d224c625_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfOC05LTEtMS0w_a9622f29-a231-4528-b11f-9af1e6410ed6">1,503</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss) by component for the three and nine months ended December 31, 2019 are as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.105%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ea78334a4a544dcba38daccc7916a10_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMi0xLTEtMS0w_3e0cc80c-f2ed-41a1-ad93-6ae445e529f3">1,659</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a906828b06245e58bece79897fe99fc_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMi0zLTEtMS0w_5dfdc950-dd3b-4b42-8c80-4a60e4224620">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icafc8c81f18e4ee2a2a6e3b81ae88a12_I20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMi01LTEtMS0w_c5acae59-f77a-49f9-9bae-77d362d345f9">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9c3b3edd0774f9db0813da0a381c7a0_I20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMi03LTEtMS0w_f440e741-d6eb-4341-a859-517074282acf">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e571302aec24a36936d3e24fb499981_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMi05LTEtMS0w_99fc99b0-21a8-4d1c-a6c6-87aa929e3221">1,704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245807132e61488c94b12390e4121f99_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMy0xLTEtMS0w_6fee2f67-dd9b-454b-a637-5fd179f8b6a0">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMy0zLTEtMS0w_9e25d183-b58f-46f1-b082-080f071dc376">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMy01LTEtMS0w_555ac192-5f57-4eb8-93be-ef29433bec88">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7ba00100ab34faa9bf1d5f5d42af04c_D20191001-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMy03LTEtMS0w_26c16da9-7873-4e65-a4f5-e1aadc69e5ef">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMy05LTEtMS0w_775117f1-2bbc-45fe-9655-b437c2792ca6">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245807132e61488c94b12390e4121f99_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNC0xLTEtMS0w_7030724e-b91f-4a20-a449-0336d28ff549">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNC0zLTEtMS0w_8d402c8c-109a-4fc2-a58a-f4615de31269">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNC01LTEtMS0w_b988fed0-884e-4057-bd9f-7429e73cf258">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7ba00100ab34faa9bf1d5f5d42af04c_D20191001-20191231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNC03LTEtMS0w_e784f1d3-4d5a-49a2-a78e-10af7e28fb6a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNC05LTEtMS0w_92bb9c19-a1fa-4dee-9275-081f02acca9e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245807132e61488c94b12390e4121f99_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNS0xLTEtMS0w_5dd7d040-5a88-4107-ab56-3054a90b3472">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNS0zLTEtMS0w_ed68ffc7-8edc-460a-9241-63073385b596">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNS01LTEtMS0w_1ada2357-605b-43d6-95ed-a2814efdb6d2">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7ba00100ab34faa9bf1d5f5d42af04c_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNS03LTEtMS0w_fbeb31da-0648-44ae-9035-ca7f19cfdd81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNS05LTEtMS0w_e8a9049c-d149-434c-8911-471b88a52e89">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245807132e61488c94b12390e4121f99_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNi0xLTEtMS0w_7525e56c-9442-449e-b39e-31e1a13ea1da">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNi0zLTEtMS0w_35623fc4-712e-484c-90e9-e89f85a817e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNi01LTEtMS0w_f701c4c0-feeb-418e-a1ff-cede43095ab3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7ba00100ab34faa9bf1d5f5d42af04c_D20191001-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNi03LTEtMS0w_1df9b99b-a7d6-4ba4-b1d9-d4019eb987ec">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNi05LTEtMS0w_dd95904c-5071-4e4d-90c6-1bf40edabe51">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245807132e61488c94b12390e4121f99_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNy0xLTEtMS0w_6c7268d7-2cb0-43a8-a933-0816327bbd2a">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNy0zLTEtMS0w_27ec9eb0-d18a-4cae-98ea-e50aadbf43f0">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNy01LTEtMS0w_0747ddca-e31d-4ca3-869a-1cc182051150">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7ba00100ab34faa9bf1d5f5d42af04c_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNy03LTEtMS0w_ad1b5024-c139-4baf-b6ab-6935986bcf6c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNy05LTEtMS0w_fc0b3f57-a253-49e6-8597-0137444ab3b3">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27e40da0240940a7926bf05b6174ccd4_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfOC0xLTEtMS0w_10384ee5-5334-4dc5-8b8d-546bee83d459">1,570</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3663290a78c548f4aa7609a2c7554daf_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfOC0zLTEtMS0w_2f903bde-fd0a-41c9-8629-9500ac695c48">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib213387c8afd446b96bae95715bec72d_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfOC01LTEtMS0w_e3b544ff-a3ee-4e93-a938-9d7fd36f9d54">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51ffaad82dab42a0ab9c8e587557236c_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfOC03LTEtMS0w_0086af43-0e72-4617-b654-88873d34e056">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd724fc113f1423fab76a0b7d9141942_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfOC05LTEtMS0w_baeea791-842f-476c-98b7-7c90679dd567">1,663</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:justify"><ix:continuation id="i8075c677d88042e1bd7b21b40f64c51e"><ix:continuation id="i5068712fccfb41fe9b9b34742618826c"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.105%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iade9d1af10904ff7acc439b8834a8395_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMi0xLTEtMS0w_8e1054db-0f47-4e7d-b881-09ea628bfc80">1,628</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab70a6f91f224f69a6be90a2c01a8355_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMi0zLTEtMS0w_1670e358-e9a9-4d10-848d-9b60000af2eb">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa5330bd233547c98905a08caa8ca3a3_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMi01LTEtMS0w_c2512342-0607-4115-b8ac-a7e2a6c223f4">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib822aec9103b458dbc079db87594cd6e_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMi03LTEtMS0w_e0197ec1-a166-4ae1-a3bd-f359eda2f0c6">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id686b4181792461ea0b02a307e3b6b16_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMi05LTEtMS0w_ff171746-d058-47c8-8484-c41794918430">1,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMy0xLTEtMS0w_df5f8dc5-59f6-47f8-94bd-9b352092e086">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMy0zLTEtMS0w_6e9f33c9-2d61-4e17-b200-5db7c1d8605d">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMy01LTEtMS0w_17ed954b-c0b3-4b01-abcd-fc731379722d">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3caf5544ee374eb3a48285ec3fd9279a_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMy03LTEtMS0w_f4ef63b7-0876-4249-9a7c-43ac2fb196b8">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMy05LTEtMS0w_e77fdd33-29e2-4ec2-a22e-c0a3d7078601">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNC0xLTEtMS0w_2e0cd72f-b23c-4b77-a254-19788f598ffd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNC0zLTEtMS0w_76699a94-1157-4002-97a5-409d3659b6c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNC01LTEtMS0w_1413b27f-3120-49d5-acf9-0d2cd0be89e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3caf5544ee374eb3a48285ec3fd9279a_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNC03LTEtMS0w_feac32d4-73a2-455c-a7b6-db1ae8b45a49">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNC05LTEtMS0w_e966d78e-434b-46d2-ada4-2ea702b8519f">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNS0xLTEtMS0w_b9359cca-89a1-4323-81a0-d747de095cec">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNS0zLTEtMS0w_f02bdb3f-00d2-488e-a56b-0415c7af5db5">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNS01LTEtMS0w_4b869105-aafd-432a-a1b9-f677d1f699cb">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3caf5544ee374eb3a48285ec3fd9279a_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNS03LTEtMS0w_84df0452-39fe-4b99-9c4f-7b19333193a6">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNS05LTEtMS0w_ac27fd54-8370-4dd6-80cf-7feb44339517">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNi0xLTEtMS0w_b02e0d8d-d570-4ff2-a6b2-4f0d2d1dac9d">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNi0zLTEtMS0w_b0c25ccc-97aa-4f2b-b3ad-03ad154ff3e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNi01LTEtMS0w_82e96d91-9452-4cf3-863a-f4ff1d7b4999">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3caf5544ee374eb3a48285ec3fd9279a_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNi03LTEtMS0w_1cd51645-ac81-4b46-a339-9d01dc43eebd">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNi05LTEtMS0w_1f957aac-e389-4cda-b8ba-fbe96c112c9f">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNy0xLTEtMS0w_391f44be-d1cc-425e-bab4-ba7933ed1f52">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNy0zLTEtMS0w_292bad85-8891-4999-b32d-5d4373bc2d9c">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNy01LTEtMS0w_d411a7d7-f085-4b9c-bf89-b123832f3b39">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3caf5544ee374eb3a48285ec3fd9279a_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNy03LTEtMS0w_3ff373a4-7e31-4796-aa11-34f383906dd0">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNy05LTEtMS0w_334eead4-a092-4764-9e18-fbd14cfdb7be">186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27e40da0240940a7926bf05b6174ccd4_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfOC0xLTEtMS0w_984884bd-989d-4da2-ad44-7c4b81ebe61d">1,570</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3663290a78c548f4aa7609a2c7554daf_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfOC0zLTEtMS0w_e3934d6b-c31d-461b-89fd-705f1cfca89d">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib213387c8afd446b96bae95715bec72d_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfOC01LTEtMS0w_22f9988c-c343-4d85-95d8-798f2fc6b227">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51ffaad82dab42a0ab9c8e587557236c_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfOC03LTEtMS0w_d2b6f14a-0a73-4a68-b69a-e89042e8b4b2">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd724fc113f1423fab76a0b7d9141942_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfOC05LTEtMS0w_937dadfc-f2a1-43e4-8f82-712b23b39d1e">1,663</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_97"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjg1MQ_a00aa14a-e358-43d2-b8d7-548e2061057e" continuedAt="if0bee3b4080f41428555ba2f947bdfe2" escape="true">Segments of Business</ix:nonNumeric></span></div><ix:continuation id="if0bee3b4080f41428555ba2f947bdfe2" continuedAt="i030bbe26ca424b68a2fbba88a1698fc3"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing with the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in <ix:nonFraction unitRef="segment" contextRef="i85b5d437b88a43c3b57c3014d5ae8bf1_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMTMw_a079cb11-ec42-4973-92f6-9097fc5925c9">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. Other, for retrospective periods presented, consists of the Company&#8217;s equity method investment in Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020. All prior segment information has been recast to reflect the Company&#8217;s new segment structure and current period presentation. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International segment includes the Company&#8217;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#8217;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in <ix:nonFraction unitRef="country" contextRef="id58d170d297c43bcace9dc7b5f556347_I20201231" decimals="INF" name="us-gaap:NumberOfCountriesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMjA2Nw_73cf175d-53a7-44cf-b349-35f6a0a4d931">13</ix:nonFraction> European countries where it owns, partners, or franchises with retail pharmacies and operates through <ix:nonFraction unitRef="business_operation" contextRef="id58d170d297c43bcace9dc7b5f556347_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="mck:NumberOfBusinessOperations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfOTM0NTg0ODg1MzY5OQ_a53f791d-6776-4a7e-8ec1-f2242a511020">two</ix:nonFraction> businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#8217;s Canada operations deliver vital medicines, supplies, and information technology services throughout Canada and includes Rexall Health retail pharmacies. McKesson Europe was previously reflected as the European Pharmaceutical Solutions reportable segment and McKesson Canada was previously included in Other.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than <ix:nonFraction unitRef="numberofproducts" contextRef="ia9435ea6faaa49bfa7de0a9fd3ee3563_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mck:NumberOfNationalBrandMedicalSurgicalProducts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMjg0Nw_7b7fc3d9-3d1b-456e-b849-b0f23ac2141a">275,000</ix:nonFraction> national brand medical-surgical products as well as McKesson&#8217;s own line of products through a network of distribution centers within the United States.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i030bbe26ca424b68a2fbba88a1698fc3" continuedAt="ic8aca22bafa343c581031dd5c4529b01"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RxTS segment brings together existing businesses, including CoverMyMeds, RelayHealth, RxCrossroads, and High Volume Solutions, to serve the Company&#8217;s biopharma and life sciences partners and patients, connecting pharmacies, providers, payers, and biopharma. RxCrossroads was previously included in the former U.S. Pharmaceutical and Specialty Solutions reportable segment and CoverMyMeds, RelayHealth, and High Volume Solutions were previously included in Other.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, for retrospective periods presented consists of the Company&#8217;s investment in the Change Healthcare JV, which was split-off from the Company in the fourth quarter of 2020.</span></div><ix:nonNumeric contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjgzNA_089f4d2c-7fd5-42c6-a5e0-95e526af12a2" continuedAt="i09b28d2306794a36bcb5aeb9017aa8d3" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic371359df42d46fc9cdaa20754eb2857_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMy0xLTEtMS0w_14f24bf6-7e1e-4729-a9ac-1ee35114b82b">49,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45c05b8f83b741d992b83ccc3df6b908_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMy0zLTEtMS0w_55059801-d0a1-4767-af98-635e99bf1733">46,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566978f4e878431094db0c99aa04c1ac_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMy01LTEtMS0w_03b78afb-f6a8-4b09-9627-d08b6011b2ab">142,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i294c2f089e43428d9f211ab6d5436a55_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMy03LTEtMS0w_a03fa08b-b109-434a-981e-d4030fa4f5fb">135,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e166dc2bc4e4407ac307367798e7a56_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNC0xLTEtMS0w_179f848c-790e-4567-ab0f-8c3f1287eb96">9,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08ed9c0c5f6d4a748a507235f5b297eb_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNC0zLTEtMS0w_714f890c-e8d2-4a0a-883e-8bd2702f2a0a">9,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNC01LTEtMS0w_556200e4-8af5-41f8-966f-0c9526e7cf67">27,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f352c2923e048e7bcd08e46042cbead_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNC03LTEtMS0w_8ecba241-7108-435c-b20a-082ad26e96b1">28,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4632c5240b01414e9082101b8768cac1_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNS0xLTEtMS0w_77b59c5e-804c-403a-a0d2-14a74b9a98b1">3,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifedf75934b37431f868f060ab5f6013a_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNS0zLTEtMS0w_8d82c592-03b2-416a-a4dc-30b476bf1f01">2,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i502121074c55491db6f36aeb28a2d5f2_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNS01LTEtMS0w_b638f8b9-6946-4bd9-b7f9-7a1ff0a4ea17">7,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f550bcedc934c8b80cc03ee44b800ab_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNS03LTEtMS0w_dfe7ab78-eaa5-4f72-9531-9d67ab896f7f">6,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b6999463f4433f9cc082295167d9ae_D20201001-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNi0xLTEtMS0w_be62de1c-44e1-4c56-8047-bda08be3d0bf">777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a67644704d4440bb71e3a2701c416c_D20191001-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNi0zLTEtMS0w_178f851e-d553-4ed6-8e22-420156738dd6">714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f55c7a43814e4181d18751f2048f0a_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNi01LTEtMS0w_2d1db3c4-1f8d-4bf9-b229-c50ca66b4b3d">2,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ae066f96784452da1de68ea4e97704b_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNi03LTEtMS0w_1f01e61f-4673-48e5-b785-2e6f1de896b4">1,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfOC0xLTEtMS0w_955fa9a2-2b7b-4305-91c0-7b79eb1f81f4">62,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfOC0zLTEtMS0w_0613cd70-1707-4ab2-843b-b4f62a838070">59,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfOC01LTEtMS0w_b7b596ca-fc00-4d37-89ba-f3b6b85c87a9">179,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfOC03LTEtMS0w_4eca435d-517a-4978-ac5e-e64226973878">172,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if54fe59c7ab4486da50c3e383e0514cb_D20201001-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTEtMS0xLTEtMA_fed8fdaa-c020-42d6-a778-fe657eea1b8e">635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic713f1d7bbaa46368d505facade21e5e_D20191001-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTEtMy0xLTEtMA_e2d29b63-cbf9-4c3c-8889-33a0885d7e67">677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTEtNS0xLTEtMA_4ed8a992-4d52-41b2-9390-87f38464e98e">1,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia76b1ab18790411e9e7fdeb98f2f4606_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTEtNy0xLTEtMA_83301dc3-604f-4f0b-9427-c708ad69cbbd">1,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc7a74b6b95d4a9e9c701380f77e3b51_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTItMS0xLTEtMA_e629f2e2-a72f-48aa-a850-6d5446a0878a">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib36209733adf465ab9a09ed10cfc40ba_D20191001-20191231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTItMy0xLTEtMA_3f257027-48a9-4ae0-8bee-0d0f35efce8a">290</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTItNS0xLTEtMA_693b5236-616b-4ff6-a725-304902791786">113</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55e8174fad24466896ea35fa3e18419c_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTItNy0xLTEtMA_8c1b2bc3-7ca7-4166-b1ff-c39145c21058">229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id80f00bff7b5467b812041c7200a62b2_D20201001-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTMtMS0xLTEtMA_8a110ce6-7ed5-4cf6-8d04-5ec36a020f9a">260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief6c871b558e47b38754e0ea56f455a3_D20191001-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTMtMy0xLTEtMA_97e38ad2-8757-405e-9772-dbc287daa22e">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTMtNS0xLTEtMA_b21710a2-6474-4e6e-9ad9-3f38b3ed8acd">536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifafa9479474c4281a1fb299fa0ed48b3_D20190401-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTMtNy0xLTEtMA_204e088c-a349-4d76-88f8-383b69c52113">378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee23f0fe86e64c7bae441a8ea5cc1c91_D20201001-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTQtMS0xLTEtMA_f78567fd-3514-49ff-8391-8322119ddfe8">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f91b4dd9d724e81a9d50e837b7e65d6_D20191001-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTQtMy0xLTEtMA_a769d9b9-efd8-49a4-942e-f57a781027de">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTQtNS0xLTEtMA_1d89c391-9492-42c3-baec-f878c7ccbc9f">270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33926b73aa0043d2989ae3b788c16046_D20190401-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTQtNy0xLTEtMA_345d178a-ca58-46e1-8ce7-fb4729a8376d">280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499179d5d599419b93690bc3104dd04a_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTUtMS0xLTEtMA_c3d6e869-a5a0-4707-aa9f-4c1ee6bbf6a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib74da540dfec4334b95c1028aad4aabb_D20191001-20191231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTUtMy0xLTEtMA_8a4c2d5c-990e-4243-9b9e-2dd14f0219fc">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTUtNS0xLTEtMA_fd5690a1-2a0a-4050-9769-918acaa896c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib06a1c55db15496e8c44849e29aea6c6_D20190401-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTUtNy0xLTEtMA_37c9dd1b-22c2-4a13-aada-3204ba9ff176">1,483</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79d5ebe53b9a4ebca65716989b93c5f8_D20201001-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTYtMS0xLTEtMA_c16abc4a-76a8-4daa-bc95-f675654d56a9">938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida0b040eb5e94d34b4dbc2a627b7da27_D20191001-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTYtMy0xLTEtMA_871f38e5-3612-4fe2-a1e8-989e77c50cab">560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if94267ba6de9458db3df283198381edf_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTYtNS0xLTEtMA_3b792441-4ae5-4fc2-9860-820be6338a64">2,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e8e81ee2fb849c29d5ea7c25273ee5e_D20190401-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTYtNy0xLTEtMA_2fc454f5-9d3f-4941-8659-082c0aa7df79">840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTctMS0xLTEtMA_f8a507b1-587d-428b-8889-a347c15fcc25">8,246</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTctMy0xLTEtMA_adc4f7dc-8b14-45bf-b4ee-d9a9f3579512">202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTctNS0xLTEtMA_b98726de-79be-476d-9897-bfd5e09ccde7">8,462</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTctNy0xLTEtMA_19e60296-8e6a-473b-a2a2-277b6cc50bb3">713</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTgtMS0xLTEtMA_8fc8729e-4c25-4964-b503-6f244045aeb5">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTgtMy0xLTEtMA_db7cf095-7dd2-40ad-b331-ed452140ad04">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTgtNS0xLTEtMA_857418ee-913d-47bd-b0c9-0b3cb27ce450">165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTgtNy0xLTEtMA_baa5c084-ed5c-463e-824f-13c256da90e3">184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTktMS0xLTEtMA_db6823a5-0630-4e9a-a3a3-0184f3e08552">7,363</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTktMy0xLTEtMA_84ba5057-558b-415c-9793-c6695b6b9171">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTktNS0xLTEtMA_9169fe83-9296-415e-8610-25b961f1aacb">6,063</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTktNy0xLTEtMA_089bf038-e92f-4342-854d-3892d0ea68fe">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than <ix:nonFraction unitRef="number" contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMzg2OQ_93e199c9-a8ea-4b45-b5a2-cb8f9dcdb97a"><ix:nonFraction unitRef="number" contextRef="ia76b1ab18790411e9e7fdeb98f2f4606_D20190401-20191231" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMzg2OQ_d9c5e2d3-fc82-43a4-bbf2-2a76d25fcfbd">1</ix:nonFraction></ix:nonFraction>% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than <ix:nonFraction unitRef="number" contextRef="i55e8174fad24466896ea35fa3e18419c_D20190401-20191231" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMzkzNQ_b03b3e13-d6a3-4fba-aed5-b55c48742338"><ix:nonFraction unitRef="number" contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMzkzNQ_f35d9d19-db1c-409d-ad28-860357163489">7</ix:nonFraction></ix:nonFraction>% of the International segment&#8217;s total revenues, less than <ix:nonFraction unitRef="number" contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMzk5NQ_2f6dc1cc-be15-464a-bb32-bb7776b39a2f"><ix:nonFraction unitRef="number" contextRef="ifafa9479474c4281a1fb299fa0ed48b3_D20190401-20191231" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMzk5NQ_39b9510d-092f-4416-8453-082740c1ac78">2</ix:nonFraction></ix:nonFraction>% of the Medical-Surgical Solutions segment&#8217;s total revenues, and approximately <ix:nonFraction unitRef="number" contextRef="i33926b73aa0043d2989ae3b788c16046_D20190401-20191231" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDA3Ng_02d63820-3166-4162-b46f-fa0ef0aa622c"><ix:nonFraction unitRef="number" contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDA3Ng_f29338cb-c0aa-4a48-84d5-1f6d44c25bee">38</ix:nonFraction></ix:nonFraction>% of the RxTS segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining <ix:nonFraction unitRef="segment" contextRef="i1de8191ab06245abb971e2b0ffe26491_D20200701-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDE5Nw_83484e51-22a4-4e92-9c27-20dfc48693e5">three</ix:nonFraction> reportable segments are domestic.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for the Company&#8217;s reportable segments. For retrospective periods presented, Operating loss for Other reflects equity earnings and charges from the Company&#8217;s equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for the three and nine months ended December 31, 2020 includes $<ix:nonFraction unitRef="usd" contextRef="ic371359df42d46fc9cdaa20754eb2857_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDczNg_4f90a79b-bdd5-4034-9e8e-21928d8b717d">11</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i566978f4e878431094db0c99aa04c1ac_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDc0Mw_9bed6aec-7b74-4732-84a4-82971691456a">115</ix:nonFraction> million, respectively, and for the three and nine months ended December 31, 2019 includes $<ix:nonFraction unitRef="usd" contextRef="i45c05b8f83b741d992b83ccc3df6b908_D20191001-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDgwOA_19ee1b37-7174-4bee-b760-71639ad57fdc">66</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i294c2f089e43428d9f211ab6d5436a55_D20190401-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDgxNQ_21ea48e6-d3e3-4444-b6d7-ac4aeb9393db">114</ix:nonFraction> million, respectively, of pre-tax credits related to the last-in, first-out (&#8220;LIFO&#8221;) method of accounting for inventories. The nine months ended December 31, 2020 also includes a charge of $<ix:nonFraction unitRef="usd" contextRef="i115a3e3004e949119c249e28526ae1d6_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyLossInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk4OQ_70e1a8c8-d554-4ca2-b6de-19ab1f6e3403">50</ix:nonFraction> million recorded in connection with the Company&#8217;s estimated liability under the State of New York&#8217;s OSA, as further discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONCLUDED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ic8aca22bafa343c581031dd5c4529b01"><ix:continuation id="i09b28d2306794a36bcb5aeb9017aa8d3"><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss for the three and nine months ended December 31, 2020 includes restructuring, impairment, and related charges of $<ix:nonFraction unitRef="usd" contextRef="i4e166dc2bc4e4407ac307367798e7a56_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjMzOTc5Ng_cc39d45e-37db-44fe-b5ef-c1403cb89c44">131</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjMzOTgxMA_1fd4637b-9fe1-4dae-8bb0-9f09474efae1">189</ix:nonFraction>&#160;million, respectively, driven largely by long-lived asset impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDMzMA_2eac6b27-072f-4a3e-9c14-3eca0f3ea5fc"><ix:nonFraction unitRef="usd" contextRef="i4e166dc2bc4e4407ac307367798e7a56_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDMzMA_81885a80-fb34-4c78-81cf-5e38bec59f5c">115</ix:nonFraction></ix:nonFraction> million primarily related to retail pharmacy businesses in Canada and Europe as well as costs associated with the closure of retail pharmacy stores within the U.K. business, as discussed in more detail in Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; and a second quarter goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i3d023e4934d548c9bc3bd440f7da7aa3_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNTQ1Ng_2bcc35bb-29be-41ee-a5fa-147a864624f5"><ix:nonFraction unitRef="usd" contextRef="i3d023e4934d548c9bc3bd440f7da7aa3_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNTQ1Ng_77d2d7c8-7a60-4ac6-a507-bd1574fda27f">69</ix:nonFraction></ix:nonFraction> million (pre-tax and after-tax) related to one of the Company&#8217;s reporting units in Europe, as discussed in more detail in Financial Note 8, &#8220;Goodwill and Intangible Assets, Net.&#8221; Restructuring, impairment, and related charges of $<ix:nonFraction unitRef="usd" contextRef="ic1ab6dd9883343f8a42baa07fb972b7a_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfODc5NjA5MzAzNjU0OA_e9014762-83ba-4543-a529-2bb7bddf57db">100</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic9ff51a496f742c5a3c83d3b38d4dbb1_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfODc5NjA5MzAzNjU1Ng_75ae8b70-4ff2-4e04-9336-def1a1850143">116</ix:nonFraction> million for the three and nine months ended December 31, 2019, respectively, reflects long-lived asset impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i8f352c2923e048e7bcd08e46042cbead_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDM0NA_5520f915-90ad-4a67-b0df-27d95f906a74"><ix:nonFraction unitRef="usd" contextRef="i08ed9c0c5f6d4a748a507235f5b297eb_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDM0NA_5720ffe0-1c23-487e-9b37-3b789233a625">94</ix:nonFraction></ix:nonFraction> million primarily related to retail pharmacy businesses in the U.K. and Canada. The segment&#8217;s operating loss also includes charges of $<ix:nonFraction unitRef="usd" contextRef="i938f21cb5003435093dd61e42f1e4b04_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDA4NA_606ed94e-b402-4a9f-8db5-9297a0ec658a"><ix:nonFraction unitRef="usd" contextRef="i938f21cb5003435093dd61e42f1e4b04_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:GainLossOnSaleOfBusinessNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDA4NA_dea21788-bca2-4401-9c70-831cbd82826e">47</ix:nonFraction></ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i568b05318ce7413fa9252c00b9a77597_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDEwMQ_40ba1865-c029-4e54-a5f7-23317a56a37e">57</ix:nonFraction>&#160;million for three and nine months ended December 31, 2020, respectively, to remeasure to fair value the assets and liabilities of the Company&#8217;s German pharmaceutical wholesale business which was contributed to a joint venture as further discussed in Note 3, &#8220;Held for Sale.&#8221; The Company recognized a fair value remeasurement charge related to the joint venture of $<ix:nonFraction unitRef="usd" contextRef="icd175625828b47dcab648e0b14392f10_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDA0NQ_62e2f44f-777c-488e-a9a2-e92a8e45659e"><ix:nonFraction unitRef="usd" contextRef="icd175625828b47dcab648e0b14392f10_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDA0NQ_6ae7b6a1-2644-4a56-8cab-1f1b116f0e73"><ix:nonFraction unitRef="usd" contextRef="i0736a2a757fc454b88a193a6988112ef_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDA0NQ_ca0bf28a-df2a-433b-b254-ca718669ab16"><ix:nonFraction unitRef="usd" contextRef="i0736a2a757fc454b88a193a6988112ef_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDA0NQ_dad717c7-9297-43f1-8161-63a54c923693">282</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million for the three and nine months ended December 31, 2019.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for the three and nine months ended December 31, 2020 includes charges totaling $<ix:nonFraction unitRef="usd" contextRef="i4632c5240b01414e9082101b8768cac1_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjMzNzMzMQ_45b18059-35b4-4efa-9789-9007c3cf4820">35</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i502121074c55491db6f36aeb28a2d5f2_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjMzNzM0NQ_49989e41-2a03-40de-92e1-ec3d6233269d">49</ix:nonFraction>&#160;million, respectively, on certain personal protective equipment and other related products due to inventory impairments and excess inventory.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for Other for the nine months ended December 31, 2019 includes a pre-tax impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i72904c34cf28486695441a05e83b4257_D20190701-20190930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNTY5Mg_3daeff53-6ccf-4d7f-beff-2bf2e918d6d8"><ix:nonFraction unitRef="usd" contextRef="i5b86094c4db947ae9f4ef0d8fd8d773a_D20190401-20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNTY5Mg_67077b77-7a3f-4458-89c4-9c928d588708">1.2</ix:nonFraction></ix:nonFraction> billion and a pre-tax dilution loss of $<ix:nonFraction unitRef="usd" contextRef="i5b86094c4db947ae9f4ef0d8fd8d773a_D20190401-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNTcyNg_2c450e52-ab9e-4c0d-816d-a6961db02af2"><ix:nonFraction unitRef="usd" contextRef="i72904c34cf28486695441a05e83b4257_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNTcyNg_f5906b50-0800-4327-9cc9-d5a1f8ba6891">246</ix:nonFraction></ix:nonFraction> million associated with the Company&#8217;s investment in Change Healthcare JV. Operating loss for Other also includes the Company&#8217;s proportionate share of loss from Change Healthcare JV of $<ix:nonFraction unitRef="usd" contextRef="i0946d2a17db14d63b64a7a7251e88c34_D20191001-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:ProportionateGainLossOnEquityMethodInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNTkwNQ_48078183-4582-42c2-8f3e-fff280b1665b">28</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5b86094c4db947ae9f4ef0d8fd8d773a_D20190401-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:ProportionateGainLossOnEquityMethodInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNTkxMg_2f77dafd-4f88-4d35-8550-f7fd68ffe028">75</ix:nonFraction> million for the three and nine months ended December 31, 2019, respectively.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net for the three and nine months ended December 31, 2020 includes a pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="i7ac4183cf22d4c829d4a7bc371cc268c_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMjE5OTAyMzI3MjM0Nw_dcac3458-4279-4dfe-9a7f-1fca14a1a501"><ix:nonFraction unitRef="usd" contextRef="i30c6a601291c426daef2c98a6924abf6_D20200401-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMjE5OTAyMzI3MjM0Nw_e9adc7c3-ed49-4c00-92cc-42ef2aa25053">8.1</ix:nonFraction></ix:nonFraction> billion ($<ix:nonFraction unitRef="usd" contextRef="i7ac4183cf22d4c829d4a7bc371cc268c_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="mck:LossContingencyAccrualProvisionNetOfTax" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMjE5OTAyMzI3MjM3NA_05bac1f2-f26a-4d94-bd1f-00678e229869"><ix:nonFraction unitRef="usd" contextRef="i30c6a601291c426daef2c98a6924abf6_D20200401-20201231" decimals="-5" format="ixt:numdotdecimal" name="mck:LossContingencyAccrualProvisionNetOfTax" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMjE5OTAyMzI3MjM3NA_4a2bd069-22f8-476e-96ad-73aeb42bae7e">6.7</ix:nonFraction></ix:nonFraction> billion after-tax) related to the estimated liability for opioid-related claims, as discussed in more detail in Financial </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, &#8220;Commitments and Contingent Liabilities." The nine months ended December 31, 2020 includes a net gain of $<ix:nonFraction unitRef="usd" contextRef="i115a3e3004e949119c249e28526ae1d6_D20200401-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjAyMg_efdddf12-30df-43a4-bca5-47486a8649b4">131</ix:nonFraction> million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program. Corporate expenses, net, for the three and nine months ended December 31, 2020 include net gains of $<ix:nonFraction unitRef="usd" contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjMxOA_ce08c030-ab1d-4e93-a740-480092bd0cab">30</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjMyNQ_1e009e7a-9832-4433-adb6-2217cdcaa7e2">89</ix:nonFraction> million, respectively, associated with certain of the Company&#8217;s equity investments and, for the nine months ended December 31, 2019, include settlement charges of $<ix:nonFraction unitRef="usd" contextRef="i69eab42c07a44d5aabd460e6391ea635_D20190401-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjQ4MA_0fddb45f-043a-457d-9746-356cf134381e">122</ix:nonFraction> million from the termination of the Company&#8217;s defined benefit pension plan and a settlement charge of $<ix:nonFraction unitRef="usd" contextRef="i797e794c99c4456e98cc170a98d8a85b_D20190401-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjU5Mg_cf4326b6-b2b0-46d2-acee-f2d115c51362">82</ix:nonFraction> million related to opioid claims. The three and nine months ended December 31, 2020 includes $<ix:nonFraction unitRef="usd" contextRef="ib6909fe531ae47989d16e4519df3b5f9_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjY2MA_1abf2417-6c99-456e-86f7-6250973c7f03">34</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i115a3e3004e949119c249e28526ae1d6_D20200401-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjY2Nw_33355363-996f-40bc-94cb-a77ce20a98ab">118</ix:nonFraction> million, respectively, and the three and nine months ended December 31, 2019 includes $<ix:nonFraction unitRef="usd" contextRef="i422fe30a34754885aa9558599f8972f8_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjcyOA_35050143-d047-42a4-b212-31f4020a10e9">36</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i797e794c99c4456e98cc170a98d8a85b_D20190401-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjczNQ_b031e05e-1275-425b-b52f-653415ed961e">108</ix:nonFraction> million, respectively, of pre-tax charges opioid-related costs, primarily litigation expenses.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_103"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_106"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of financial condition and results of operations, referred to as the &#8220;Financial Review,&#8221; is intended to assist the reader in the understanding and assessment of significant changes and trends related to the results of operations and financial position of McKesson Corporation together with its subsidiaries (collectively, the &#8220;Company,&#8221; &#8220;McKesson,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221; and other similar pronouns). This discussion and analysis should be read in conjunction with the condensed consolidated financial statements and accompanying financial notes in Item 1 of Part I of this Quarterly Report on Form 10-Q and in Item 8 of Part II of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020 previously filed with the Securities and Exchange Commission on May 22, 2020 (&#8220;2020 Annual Report&#8221;).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean our fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements in this report constitute forward-looking statements. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Cautionary Notice About Forward-Looking Statements&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Our Business:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. We partner with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We implemented a new segment reporting structure commencing with the second quarter of 2021, which resulted in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (&#8220;RxTS&#8221;). Other, for retrospective periods presented, consists of our equity method investment in Change Healthcare LLC (&#8220;Change Healthcare JV&#8221;), which was split-off from McKesson in the fourth quarter of 2020. All prior segment information has been recast to reflect our new segment structure and current period presentation. Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of individual business activities. We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes our four reportable segments and the changes made to our reporting structure commencing in the second quarter of 2021. Refer to Financial Note 15, &#8220;Segments of Business,&#8221; in the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for further information regarding our reportable segments. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">U.S. Pharmaceutical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, previously the U.S. Pharmaceutical and Specialty Solutions reportable segment, continues to distribute branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a new reportable segment that includes our operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. McKesson Europe was previously reflected as the European Pharmaceutical Solutions reportable segment and McKesson Canada was previously included in Other.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Medical-Surgical Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provides medical-surgical supply distribution, logistics, and other services to healthcare providers in the United States (&#8220;U.S.&#8221;) and was unaffected by the segment realignment.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">RxTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a new reportable segment that brings together existing businesses, including CoverMyMeds, RelayHealth, RxCrossroads, and High Volume Solutions to serve our biopharma and life sciences partners and patients. RxCrossroads was previously included in our former U.S. Pharmaceutical and Specialty Solutions reportable segment and CoverMyMeds, RelayHealth, and High Volume Solutions were previously included in Other.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Summary: </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary provides highlights and key factors that impacted our business, operating results, financial condition, and liquidity for the three and nine months ended December 31, 2020.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Coronavirus disease 2019 (&#8220;COVID-19&#8221;) impacted our results of operations for the three and nine months ended December 31, 2020. Following the onset of the pandemic, pharmaceutical distribution volumes decreased during the first quarter as a result of the weakened and uncertain global economic environment and COVID-19 restrictions, including government shutdowns and shelter-in-place orders. While pharmaceutical distribution volumes have improved across our businesses during the second and third quarters since the troughs we experienced during the first quarter, the recovery of the COVID-19 pandemic continues to be fluid. We also saw a continued increase in demand for COVID-19 tests;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We expanded our existing partnership with the Centers for Disease Control and Prevention (&#8220;CDC&#8221;) to support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines. We have also partnered with the Department of Health and Human Services (&#8220;HHS&#8221;) and Pfizer to manage the assembly and distribution of the ancillary supplies needed to administer COVID-19 vaccines; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On December 20, 2020, under the direction of the CDC, we began the distribution of Moderna&#8217;s COVID-19 vaccine. For a more in-depth discussion of how COVID-19 impacted our business, operations, and outlook, refer to the COVID-19 section of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Trends and Uncertainties"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included below;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Revenues of $62.6 billion for the three months ended December 31, 2020 increased 6% from the prior year, and revenues of $179.1 billion for the nine months ended December 31, 2020 increased 4% from the prior year. The increase in revenues is primarily driven by market growth in our U.S. Pharmaceutical segment. Revenues for the nine months ended December 31, 2020 also includes adverse impacts from COVID-19, primarily due to pharmaceutical distribution volume declines across our businesses largely during the first quarter of 2021;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Gross profit increased 4% and 2% for the three and nine months ended December 31, 2020, respectively, compared to the prior year primarily driven by sales of COVID-19 tests in our Medical-Surgical Solutions segment; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses for the three and nine months ended December 31, 2020 includes a charge of $8.1 billion related to our estimated liability for opioid-related claims. This charge is reflected within &#8220;Claims and litigation charges, net&#8221; in our Condensed Consolidated Statements of Operations and within &#8220;Long-term litigation liabilities&#8221; in our Condensed Consolidated Balance Sheets. Refer to the Opioid-Related Litigation and Claims section of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included below for further information;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses for the three and nine months ended December 31, 2020 includes charges of $115 million to impair certain long-lived assets within our International segment;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On November 1, 2020, we completed the contribution of our German pharmaceutical wholesale business to a newly formed joint venture with Walgreens Boots Alliance (&#8220;WBA&#8221;) in which we have a 30% ownership interest. In connection with the transaction, we recorded fair value remeasurement charges of $47&#160;million and $57&#160;million within total operating expenses for the three and nine months ended December 31, 2020, respectively; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses for the nine months ended December 31, 2020 also includes the following: a goodwill impairment charge of $69 million recorded in connection with our segment realignment that commenced in the second quarter of 2021; a charge of $50 million related to our estimated liability under the State of New York&#8217;s Opioid Stewardship Act (the &#8220;OSA&#8221;); and a net gain of $131 million recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Other income (expense), net for the three and nine months ended December 31, 2020 includes net gains of $30 million and $89 million, respectively, recognized from our equity investments;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Diluted loss per common share from continuing operations attributable to McKesson Corporation for the three and nine months ended December 31, 2020 of $39.03 and $32.28, respectively, reflects the aforementioned items, net of any respective tax impacts, and a lower share count compared to the prior year driven largely by the separation of our investment in Change Healthcare JV on March 10, 2020;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On December 3, 2020, we completed a public offering of 0.90% Notes due December 3, 2025 (the &#8220;2025 Notes&#8221;) in a principal amount of $500&#160;million and repaid $1.0 billion of long-term debt. Refer to Financial Note 9, &#8220;Debt and Financing Activities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">We returned $709 million of cash to shareholders through $500 million of common stock repurchases, excluding shares surrendered for tax withholding, and $209 million of dividend payments during the nine months ended December 31, 2020. On July 29, 2020, we raised our quarterly dividend from $0.41 to $0.42 per common share; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In January 2021, our Board of Directors (the &#8220;Board&#8221;) approved an increase of $2.0 billion for the authorized share repurchase of McKesson&#8217;s common stock. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trends and Uncertainties:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, a novel strain of coronavirus, which causes the infectious disease known as COVID-19, was reported in Wuhan, China. The World Health Organization declared COVID-19 a &#8220;Public Health Emergency of International Concern&#8221; on January 30, 2020 and a global pandemic on March 11, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to evaluate the nature and extent of the impacts COVID-19 has on our business and operations. The pandemic developed rapidly during our fourth quarter of 2020 and continues to evolve. Infection rates have increased to higher levels and significant numbers of new COVID-19 cases continued to be reported throughout the nine months ended December 31, 2020, particularly in the U.S. The full extent to which COVID-19 will impact us depends on many factors and future developments, which are described at the end of this COVID-19 section.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the COVID-19 pandemic, federal, state, and local government directives and policies have been put in place in the U.S. to enhance availability of medications and supplies to meet the increased demand, assist front-line healthcare providers, manage public health concerns by creating social distancing, and address the economic impacts, including sharply reduced business activity, increased unemployment, and overall uncertainty presented by this new healthcare emergency. Similar governmental actions have occurred in Canada and Europe, the timing of which has varied across geographies. On December 11, 2020, the U.S. Food and Drug Administration (&#8220;FDA&#8221;) issued the first Emergency Use Authorization (&#8220;EUA&#8221;) for the Pfizer-BioNTech COVID-19 vaccine manufactured by Pfizer, Inc. (&#8220;Pfizer Vaccine&#8221;) to be distributed in the U.S. On December 18, 2020, the FDA issued an EUA for the Moderna COVID-19 vaccine manufactured by ModernaTX, Inc. (&#8220;Moderna Vaccine&#8221;) to be distributed in the U.S. Similar COVID-19 vaccine authorizations have occurred in Canada and Europe. Government-coordinated administrative or allocation decisions at the federal, state, and local levels may cause variability in the timing and volume of COVID-19 vaccine distribution and administration activities. Our role in the distribution of COVID-19 vaccines as well as the assembly and distribution of related ancillary supply kits is discussed further below. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions, we are well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe. We have worked and continue to work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including personal protective equipment (&#8220;PPE&#8221;), and medicine reach our customers and patients. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Response to COVID-19 in the Workplace</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During this unprecedented time, we are committed in continuing to supply our customers and protect the safety of our employees. The various responses we put in place to mitigate the impact of COVID-19 on our business operations, including telecommuting and work-from-home policies, restricted travel, employee support programs, and enhanced safety measures, are intended to limit employee exposure to COVID-19. We expanded employee medical benefits covering COVID-19 related visits, treatments, and testing as well as expanded telehealth options to protect employee safety. We provided further support including additional emergency leave and an internal paid time off donation platform for employees impacted by COVID-19. For employees whose roles require presence at our facilities, we enhanced safety by promoting the practice of social distancing, providing reminders to wash or disinfect hands and avoid unnecessary face touching, making face masks available, placing hand sanitizers within our operating environments, and periodically cleaning and disinfecting our facilities. For employees whose roles do not require presence at our facilities, we added technology resources to support their working remotely. These responses were initially put in place during our fourth quarter of 2020. During the second quarter of 2021, we also implemented on-site workplace temperature screening as we continue to adapt our health and safety practices in response to the COVID-19 pandemic. When working in frozen vaccine storage environments, employees are provided with protective gear, including special clothing, gloves, and facial gear. These steps to protect employee safety have resulted in limited disruption from COVID-19 to our normal business operations, productivity trends, and have not materially impacted our operating expenses or operating margins.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have evaluated the impact of our telecommuting and work-from-home policies on our system of internal controls and we have concluded that these policies did not have a material effect on our internal control over financial reporting during the nine months ended December 31, 2020. We also took various actions to mitigate the impact of COVID-19 on our results from operations through cost-containment and payroll-related expenses.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trends in our Business</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter, we experienced growth in pharmaceutical distribution and specialty drug volumes at a lower rate in the U.S., while pharmaceutical distribution volumes decreased in Europe and Canada due to the COVID-19 pandemic, as compared to the same prior year period. Specialty drug volumes increased, but were negatively impacted by lower demand for elective specialty drugs, as compared to the same prior year period. We also experienced decreased demand for primary care medical-surgical supplies due to deferrals in elective procedures in hospitals and surgery centers as well as decreased traffic and closures of doctors&#8217; offices, which was partially offset by demand for COVID-19 tests and PPE. Additionally, the decreased traffic in doctors&#8217; offices and general shelter-in-place guidance by governmental authorities negatively impacted retail pharmacy foot traffic in both Europe and Canada. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second and third quarters, these trends improved compared to the first quarter as we experienced stabilization of prescription volumes across the enterprise and improved frequency of primary care patient visits. Additionally, we saw increased demand for COVID-19 tests and continued sales of PPE in our Medical-Surgical Solutions segment as well as improvements of retail pharmacy foot traffic in Europe and Canada.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Role in the Distribution of COVID-19 Vaccines and Ancillary Supply Kits</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 14, 2020, we expanded our partnership with the CDC through an amendment to our existing Vaccines for Children Program contract for the distribution of certain COVID-19 vaccines. The COVID-19 vaccine distribution agreement with the CDC was finalized during the third quarter of 2021. We support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines. In the centralized model, the U.S. government directs us on the distribution of the vaccines and related supplies to point-of-care sites across the country. We make no decisions on where products are to be distributed nor how the products are allocated between the various provider sites and ultimately administered to the individuals receiving a vaccine. We utilize our expertise and capabilities to support the CDC&#8217;s efforts to vaccinate everyone in the U.S. who wants to receive a COVID-19 vaccine. The CDC and McKesson collaborated similarly in response to the 2009 H1N1 pandemic. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2020, we began distributing the Moderna Vaccine in the U.S. We expect to distribute other future authorized COVID-19 vaccines that are refrigerated (2-8&#186;C) or frozen (-20&#186;C). Ancillary supply kits may be shipped either together with the Moderna Vaccine or in advance of the vaccines. The results of operations related to our vaccine distribution are reflected in our U.S. Pharmaceutical segment. The financial impact of vaccine distribution was not material for the three and nine months ended December 31, 2020 given the timing of authorization and subsequent distribution of the Moderna Vaccine late in our third quarter. The Pfizer Vaccine, which is ultra-frozen, is not being distributed by McKesson, although we are providing ancillary supplies needed for its administration. The results of operations for the kitting and distribution of ancillary supplies for the Pfizer Vaccine are reflected in our Medical-Surgical Solutions segment, as further discussed below.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 23, 2020, we announced our contract with the HHS under which our Medical-Surgical Solutions segment manages the assembly and distribution of ancillary supply kits and dry ice kits needed to administer COVID-19 vaccines, including sourcing some of those supplies. We also have an agreement with Pfizer to assemble and distribute ancillary supply kits needed to administer that particular COVID-19 vaccine. Ancillary supply kits include alcohol prep pads, face shields, surgical masks, needles and syringes, and other vaccine administration items. For the Pfizer Vaccine, ancillary supply kits also include the diluent needed to administer the ultra-frozen vaccine. We began assembling the ancillary supply kits in September 2020 and continued assembly throughout our third quarter, in preparation for vaccine authorization and subsequent distribution. Ancillary supply kits to administer the Pfizer Vaccine are shipped directly to point-of-care sites, and all other ancillary supply kits are shipped to our dedicated vaccine distribution centers. The future financial impact of the arrangements with the CDC and HHS depend on numerous uncertainties, which are described at the end of this COVID-19 section.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To manage the COVID-19 vaccine and ancillary supply kit distribution, we have set up special, dedicated vaccine distribution centers that include large-scale, custom freezers and refrigerators to safely store and process vaccines. We have also set up distribution centers for kitting and inventory management as part of our contract with the HHS. We are working with delivery partners to manage the delivery of vaccines and ancillary supply kits from our centralized vaccine distribution centers to point-of-care destinations as directed by the CDC. The capital expenditures we made during the second and third quarters of 2021 to prepare for vaccine and ancillary supply kit distribution were not material to our financial condition or liquidity.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact to our Results of Operations, Financial Condition, and Liquidity</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The demand for COVID-19 tests as well as the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines had a favorable impact in our Medical-Surgical Solutions segment on revenues and income (loss) from continuing operations before income taxes for the three and nine months ended December 31, 2020. Sales of PPE in this segment also had a favorable impact on revenues for the three and nine months ended December 31, 2020. However, during the first quarter, we had lower pharmaceutical volumes, specialty drug volumes, and patient care visits that negatively impacted our consolidated revenues and income (loss) from continuing operations before income taxes for the nine months ended December 31, 2020. During the three and nine months ended December 31, 2020, operating expenses decreased as a result of the pandemic, largely due to savings from restricted travel and decreased meetings. The favorable reduction in operating expenses was partially offset by increased costs of transport, costs for enhanced procedures to sanitize operating facilities, and costs of providing PPE and other related products for employee use. Additionally, increased costs for certain PPE compressed our margins. Certain PPE items held for resale were valued in our inventory at costs that were inflated by earlier COVID-19 pandemic demand levels. That inventory valuation, if not supported by market resale prices, may be written down to net realizable value. We may also write-off inventory due to decreased customer demand and excess inventory. During the three and nine months ended December 31, 2020, we recorded charges totaling $35&#160;million and $49&#160;million, respectively, on certain PPE and other related products due to inventory impairments and excess inventory in our Medical-Surgical Solutions segment. Although market price volatility and changes to anticipated customer demand may require additional write-downs in future periods, we are taking measures to mitigate such risk. Overall, these COVID-19 related items had a net favorable impact on consolidated income (loss) from continuing operations before income taxes for the three months ended December 31, 2020 and an immaterial impact for the nine months ended December 31, 2020 when compared to the same prior year periods. Impacts to future periods due to COVID-19 may differ based on future developments, which is described at the end of this COVID-19 section.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were able to maintain appropriate labor and overall vendor supply levels during the nine months ended December 31, 2020. Our inventory levels have fluctuated in response to supply availability and customer demand patterns for certain products, with varying inventory level impacts depending on the specific product within our portfolio of offerings. We collaborated closely with the federal government and other healthcare stakeholders to source more critical PPE to the U.S. This collaboration expedited the shipment of critical medical supplies to areas hit hardest by COVID-19, as identified by the Federal Emergency Management Agency. We are closely monitoring demand and usage of PPE and other related products. As our supply levels improve, and the federal government evolves guidance on the prioritization of providers or geographic markets, we will continue to adapt our distribution policies. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the U.S. government enacted the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) to address the economic impact of the COVID-19 pandemic. Among other things, the CARES Act provides certain changes to tax laws and includes provisions to provide relief for citizens, companies, healthcare providers and patients, and others. We have taken advantage of the provision to defer certain employer payroll taxes and continue to monitor the potential impact of other tax legislation changes as result of the CARES Act, including refundable payroll tax credits on certain qualified wages. We anticipate changes due to the CARES Act in the timing of certain cash flows, with no material impact to our financial results for the three and nine months ended December 31, 2020. On December 27, 2020, the U.S. government enacted the Consolidated Appropriations Act, 2021 (the &#8220;CA Act&#8221;), which enhances and expands certain provisions of the CARES Act. Currently, we do not expect the CA Act to have a material impact on our future financial condition, results of operations, or liquidity. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our condensed consolidated balance sheets and ability to maintain financial liquidity remains strong. We have experienced no material impacts to our liquidity or net working capital due to the COVID-19 pandemic. We are monitoring our customers closely for changes to their timing of payments or ability to pay amounts owed to us as a result of COVID-19 pandemic impacts to their businesses. We remain well-capitalized with access to liquidity from our revolving credit facility. Long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic. We believe we meet and have the ability to continue to meet the covenants of our credit agreements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact to our Supply Chain</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also continue to monitor the COVID-19 pandemic impacts on our supply chain. Although the availability of various products is dependent on our suppliers, their locations, and the extent to which they are impacted by the COVID-19 pandemic, we are proactively working with manufacturers, industry partners, and government agencies to meet the needs of our customers during the pandemic. We have assembled a Critical Care Drug Task Force, made up of our procurement specialists, clinical health systems pharmacists, and supply chain professionals, that is focused on securing additional product where available, sourcing back-up products, and protecting our operations across all locations and facilities. We are also working with manufacturers through several channels, including our ClarusONE and global sourcing teams in London, and our leaders are actively engaged in addressing potential shortages. We have a robust Business Continuity and Disaster Recovery Program (&#8220;BCRP&#8221;) and we have proactively enhanced our BCRP in response to the COVID-19 pandemic to protect the supply chain to minimize disruption in healthcare, protect our customers, ensure the safety and security of our employees and workplaces, and ensure the continuity of critical business processes. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks and Forward-Looking Information</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments, and assumptions used in our forecasts. We face numerous uncertainties in estimating the direct and indirect effects of COVID-19 on our future business operations, financial condition, results of operations, and liquidity. The full extent to which COVID-19 will impact us depends on many factors and future developments, including: the duration and spread of the virus; governmental actions to limit the spread of the virus; potential seasonality of viral outbreaks; potential new strains or variants of the original virus; the amount of COVID-19 vaccines authorized, manufactured, distributed, and administered; the amount of ancillary supply kits assembled and distributed; the effectiveness of COVID-19 vaccines and governmental measures in controlling the spread of the virus; and the effectiveness of treatments of infected individuals. Due to several rapidly changing variables related to the COVID-19 pandemic, estimations of future economic trends and the timing of when stability will return remains challenging. Additionally, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Key assumptions and estimates about future values in our impairment assessments can be affected by a variety of factors, including the impacts of the global pandemic on industry and economic trends as well as on our business strategy and internal forecasts. Material changes to key assumptions and estimates can decrease the projected cash flows or increase the discount rates and have resulted in impairment charges of certain long-lived assets as disclosed in Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q, and could potentially result in future impairment charges. Refer to Item 1A - Risk Factors in Part I of our 2020 Annual Report and Item 1A - Risk Factors in Part II of this Quarterly Report on Form 10-Q for a disclosure of risk factors related to COVID-19. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opioid-Related Litigation and Claims </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a defendant in over 3,200 legal proceedings asserting claims related to the distribution of controlled substances (opioids) in federal and state courts throughout the U.S., and in Puerto Rico and Canada. Those proceedings include approximately 2,900 federal cases and approximately 400 state court cases throughout the U.S., and cases in Puerto Rico and Canada. We continue to be involved in discussions with the objective of achieving broad resolution of opioid-related claims of states, their political subdivisions, and other government entities (&#8220;governmental entities&#8221;). We are in ongoing, advanced discussions with state attorneys general and plaintiffs&#8217; representatives regarding a framework under which the three largest U.S. pharmaceutical distributors would pay up to approximately $21.0 billion over a period of 18 years, with up to approximately $8.0 billion to be paid by us to resolve claims of governmental entities, with more than 90% of the total amount anticipated to be used to remediate the opioids crisis. Most of the remaining amount relates to plaintiffs&#8217; attorneys fees and costs, and would be payable over a shorter time period. In addition, the proposed framework would require the three distributors, including the Company, to adopt changes to anti-diversion programs. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have concluded that discussions under that framework have reached a stage at which a broad settlement of opioid claims by governmental entities is probable, and the loss related thereto can be reasonably estimated as of December 31, 2020. As a result of that conclusion, and our assessment of certain other opioid-related claims, we recorded a charge of $8.1 billion for the three and nine months ended December 31, 2020, related to our share of the settlement framework described above, as well as other opioid-related claims. Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, and the uncertainty of the scope of potential participation by plaintiffs, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss. In light of the uncertainty of the timing of amounts that would be paid with respect to the charge, the charge was recorded in &#8220;Long-term litigation liabilities&#8221; in our Condensed Consolidated Balance Sheet as of December 31, 2020. Moreover, in light of this uncertainty, the amount of any ultimate loss may differ materially from the amount accrued. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we continue to be involved in discussions regarding a potential broad settlement framework, we also continue to prepare for trial in these pending matters. We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on our financial position, cash flows or liquidity, or results of operations. Refer to Financial Note 13, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Opioid Statutes </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory, or industry measures to address the misuse of prescription opioid medications could affect our business in ways that we may not be able to predict. In April 2018, the State of New York adopted the OSA which required the imposition of an annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State of New York appealed to the U.S. Court of Appeals to the Second Circuit. The State of New York has subsequently adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA would apply only to opioid sales on or before December 31, 2018. The excise tax applies only to the first sale occurring in New York, and thus may not apply to sales from our distribution centers in New York to New York customers. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#8217;s decision on procedural grounds. The Healthcare Distribution Alliance filed a petition for panel rehearing, or, in the alternative, for rehearing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">en banc </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with the U.S. Court of Appeals for the Second Circuit; that petition was denied on December 18, 2020. Unless the appellate court&#8217;s decision is overturned, the OSA will be reinstated for calendar years 2017 and 2018 (but not beyond those years), and, subject to any further legal challenge, we will have to pay our ratable share of the annual surcharge for those two years. During the second quarter of 2021, we reflected an estimated liability of $50 million for the OSA surcharge in our accompanying condensed consolidated financial statements on the assumption that the appellate court&#8217;s decision will stand. Refer to Financial Note 13, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information.<br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Consolidated Results:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.977%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,516&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,033&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,851&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,687&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross profit margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,513)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,673)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,901)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,067)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total operating expenses as a percentage of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">16.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">8.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;NM  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity earnings and charges from investment in Change Healthcare Joint Venture</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,478)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,363)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;NM  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,063)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;NM  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;NM  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,174)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;NM  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,052)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;NM  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,174)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;NM  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,053)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;NM  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,226)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;NM  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,205)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;NM  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per common share attributable to McKesson Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;NM  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;NM  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.03&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;NM  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.66)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;NM  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average diluted common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NM - computation not meaningful</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues increased for the three and nine months ended December 31, 2020 compared to the same prior year periods primarily due to market growth in our U.S. Pharmaceutical segment. As a result of COVID-19, revenues were unfavorably impacted for the nine months ended December 31, 2020 due to reduced customer demand, which drove declines in pharmaceutical distribution volumes across our businesses largely during the first quarter of 2021. Market growth includes growing drug utilization, price increases, and newly launched products, partially offset by price deflation associated with branded to generic drug conversion. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit increased for the three months ended December 31, 2020 compared to the same prior year period primarily in our Medical-Surgical Solutions segment driven by increased demand for COVID-19 tests. Gross profit was also favorably impacted by growth in our RxTS segment and growth of specialty pharmaceuticals in our U.S. Pharmaceutical segment. Gross profit was unfavorably impacted by lower last-in, first-out (&#8220;LIFO&#8221;) credits in the third quarter of 2021 as further described below, as well as from the contribution of our German pharmaceutical wholesale business to a joint venture with WBA. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit increased for the nine months ended December 31, 2020 compared to the same prior year period primarily in our Medical-Surgical Solutions segment driven by the demand for COVID-19 tests and PPE. Gross profit was also favorably impacted by growth of specialty pharmaceuticals in our U.S. Pharmaceutical segment. These increases were partially offset by the adverse impacts from COVID-19 during the first quarter of 2021, including disruptions of doctors&#8217; office operations, deferred or cancelled elective procedures, lower demand for pharmaceuticals, and overall reduction of foot traffic in pharmacies. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFO inventory credits were $11 million and $66 million for the three months ended December 31, 2020 and 2019, respectively, and $115 million and $114 million for the nine months ended December 31, 2020 and 2019, respectively. LIFO credits are lower in the third quarter of 2021 compared to the same prior year period, which unfavorably impacted our gross profit margin, primarily due to delays of branded off-patent to generic drug launches as a result of COVID-19. Our U.S. Pharmaceutical business uses the LIFO method of accounting for the majority of its inventories, which results in cost of sales that more closely reflects replacement cost than under other accounting methods. The business&#8217; practice is to pass on to customers published price changes from suppliers. Manufacturers generally provide us with price protection, which limits price related inventory losses. A LIFO expense is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. Our quarterly LIFO credit is based on our estimates of the annual LIFO credit which is impacted by expected changes in year-end inventory quantities, product mix, and manufacturer pricing practices, which may be influenced by market and other external factors. Changes to any of the above factors could have a material impact to our annual LIFO credit. The actual valuation of inventory under the LIFO method is calculated at the end of the fiscal year. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Operating Expenses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the components of our total operating expenses for the three and nine months ended December 31, 2020 and 2019 is as follows: </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.266%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims and litigation charges, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;NM  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;NM  </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM    </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,067&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Percent of revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">16.79&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.52&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">8.32&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.10&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NM - computation not meaningful</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">&#8220;Claims and litigation charges, net&#8221; within total operating expenses includes adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates. Legal fees to defend claims, which are expensed as incurred, are included within &#8220;Operating expenses.&#8221; We have reclassified prior period amounts to conform to the current period presentation.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended December 31, 2020, total operating expenses and total operating expenses as a percentage of revenues increased compared to the same prior year periods. Total operating expenses were impacted by the following significant items:</span></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses for the three and nine months ended December 31, 2020 reflects charges of $47 million and $57&#160;million, respectively, to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA in which we have a 30% ownership interest within our International segment. Operating expenses for the three and nine months ended December 31, 2019 reflects a charge of $282 million to remeasure assets and liabilities held for sale to fair value less costs to sell related to the joint venture for those reporting periods;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Operating expenses for the three months ended December 31, 2020 and 2019 includes opioid-related expenses of $34 million and $36 million, respectively, and $118 million and $108 million for the nine months ended December 31, 2020 and 2019, respectively, primarily related to litigation expenses; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses for the three and nine months ended December 31, 2020 reflects cost savings of $23 million and $75 million, respectively, on travel and entertainment due to travel restrictions associated with COVID-19;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses for the nine months ended December 31, 2020 includes a charge of $50 million related to our estimated liability under the OSA as previously discussed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses for the three and nine months ended December 31, 2020 when compared to the same prior year periods include</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s higher corporate expenses and increased costs to support business growth, particularly in our Medical-Surgical Solutions segment, partially offset by lower operating expenses due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA and a divestiture in our Medical-Surgical Solutions segment that closed during the fourth quarter of 2020; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Claims and litigation charges, net for the three and nine months ended December 31, 2020 includes a charge of $8.1 billion related to our estimated liability for opioid-related claims as previously discussed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Claims and litigation charges, net for the nine months ended December 31, 2020 includes a net gain of $131 million reflecting insurance proceeds received, net of attorneys' fees and expenses awarded to plaintiffs' counsel, in connection with the previously reported $175 million settlement of the shareholder derivative action related to our controlled substances monitoring program;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Claims and litigation charges, net for the nine months ended December 31, 2019 includes a settlement charge of $82 million recorded in connection with an agreement to settle all opioid-related claims filed by two Ohio counties;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Goodwill impairment charges of $69 million for the nine months ended December 31, 2020 was recorded in connection with our segment realignment that commenced in the second quarter of 2021. Refer to the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Goodwill Impairment&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below for further details;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restructuring, impairment, and related charges for three and nine months ended December 31, 2020 and 2019 primarily includes charges related to our European and Canadian businesses in our International segment and Corporate expenses, net. In addition, certain charges related to restructuring initiatives are included under the caption &#8220;Cost of sales&#8221; in our Condensed Consolidated Statements of Operations and were not material for the three and nine months ended December 31, 2020 and 2019. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Restructuring Initiatives and Long-Lived Asset Impairments&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Operating Profit (Loss) and Corporate Expenses, Net&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sections below as well as Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information; and </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses were unfavorably impacted by foreign currency exchange fluctuations for the three and nine months ended December 31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Overview of Our Business&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section, our operating structure was realigned commencing in the second quarter of 2021 into four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. These reportable segments encompass all operating segments of the Company. The second quarter segment realignment resulted in changes in multiple reporting units across the Company. As a result, we were required to perform a goodwill impairment test for these reporting units and recorded a goodwill impairment charge in our Europe Retail Pharmacy reporting unit of $69 million during the second quarter of 2021. At December 31, 2020, the balance of goodwill for our reporting units in Europe was approximately nil and the remaining balance of goodwill in the International segment relates to one of our reporting units in Canada. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist. The annual impairment testing performed for 2021 did not indicate any impairment of goodwill. However, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment and certain reporting units within our RxTS segment, where the risk of a material goodwill impairment is higher than other reporting units. Refer to Financial Note 8, &#8220;Goodwill and Intangible Assets, Net&#8221; to the accompanying condensed financial statements appearing in this Quarterly Report on Form 10-Q for further information.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives and Long-Lived Asset Impairments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges within total operating expenses include charges for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted as well as long-lived asset impairments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, we committed to an initiative within the United Kingdom (&#8220;U.K.&#8221;), which forms part of the International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings. The initiative includes reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. The initiative is expected to be substantially completed by the end of 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we committed to certain programs to continue our operating model and cost optimization efforts. We continue to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency. The programs also include reorganization and consolidation of business operations, related headcount reductions, the further closures of retail pharmacy stores in Europe, and closures of other facilities. We anticipate these additional programs will be substantially completed in 2022.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we committed to certain actions in connection with the previously announced relocation of our corporate headquarters from San Francisco, California to Irving, Texas, which became effective April 1, 2019. The relocation was substantially complete in January 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the above initiatives, we expect to record total charges of approximately</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$515 million</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to $565 million, of which $442 million of charges were recorded to date, primarily representing employee severance, exit-related costs, asset impairment charges, and accelerated depreciation. Estimated remaining charges primarily consist of accelerated amortization of long-lived assets, facility, lease, and other exit costs, and employee-related costs. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges for the three and nine months ended December 31, 2020 also includes long-lived asset impairment charges of $115 million primarily related to our retail pharmacy businesses in Canada and Europe within our International segment. Restructuring, impairment, and related charges for the three and nine months ended December 31, 2019 includes long-lived asset impairment charges of $94 million primarily related to our retail pharmacy businesses in the U.K. and Canada within our International segment. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for further information on our restructuring initiatives and long-lived asset impairments.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in other income, net for the nine months ended December 31, 2020 compared to other expense, net for the same prior year period was primarily due to pension settlement charges of $122 million recognized during the nine months ended December 31, 2019 related to our previously approved termination of the frozen U.S. defined benefit pension plan. In connection with the pension plan termination, we purchased annuity contracts from an insurer that will pay and administer the future pension benefits of the remaining participants. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net for the three and nine months ended December 31, 2020 also includes net gains recognized from our equity investments of $30 million and $89 million, respectively. This primarily reflects mark-to-market gains on our investments in publicly traded securities as further described in Financial Note 12, &#8220;Fair Value Measurements,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q. In future periods, fair value adjustments recognized in our operating results for these types of investments may be adversely impacted by market volatility. Other expense, net for the nine months ended December 31, 2019 includes net settlement gains of $26 million from our derivative contracts. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Earnings and Charges from Investment in Change Healthcare Joint Venture</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the separation of our investment in Change Healthcare JV on March 10, 2020, we accounted for this investment using the equity method of accounting. Our proportionate share of loss from our investment in Change Healthcare JV was $28 million and $75 million for the three and nine months ended December 31, 2019, respectively, which primarily includes transaction and integration expenses incurred by the joint venture and basis differences between the joint venture and McKesson including amortization of fair value adjustments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2019, common stock and certain other securities of Change Healthcare, Inc. (&#8220;Change&#8221;) began trading on the NASDAQ (&#8220;IPO&#8221;). On July 1, 2019, upon the completion of its IPO, Change contributed net cash proceeds it received from its offering of common stock to Change Healthcare JV in exchange for additional membership interests of Change Healthcare JV at the equivalent of its offering price of $13 per share. The proceeds from the concurrent offering of other securities were also used by Change to acquire certain securities of Change Healthcare JV. As a result, McKesson&#8217;s equity interest in Change Healthcare JV was reduced from 70% to approximately 58.5%, which was used to recognize our proportionate share in net loss from Change Healthcare JV, commencing in the second quarter of 2020. As a result of the ownership dilution to 58.5% from 70%, we recognized a dilution loss of approximately $246 million in the second quarter of 2020. Additionally, our proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO and further diluted our ownership.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, we recorded an other-than-temporary-impairment (&#8220;OTTI&#8221;) charge of $1.2 billion to our investment in Change Healthcare JV, representing the difference between the carrying value of our investment and the fair value derived from the corresponding closing price of Change&#8217;s common stock at September 30, 2019. This charge was included within &#8220;Equity earnings and charges from investment in Change Healthcare Joint Venture&#8221; in our Condensed Consolidated Statement of Operations for the nine months ended December 31, 2019. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The March 10, 2020 split-off transaction eliminated our investment in the joint venture. During the fourth quarter of 2020 in conjunction with the split-off transaction, we recorded a reversal of the deferred tax liability related to our investment. Under the agreement with Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, there may be changes in future periods to the amount reversed. Any such change is not expected to be material.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the separation, Change Healthcare JV is required under the tax receivable agreement (&#8220;TRA&#8221;) to pay McKesson 85% of the net cash tax savings realized, or deemed to be realized, resulting from depreciation or amortization allocated to Change by McKesson. The receipt of any payments under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings, which creates uncertainty over the amount, timing, and probability of the gain recognized. As such, we accounted for the TRA as a gain contingency, with no receivable recognized as of December 31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense decreased for the three and nine months ended December 31, 2020 compared to the same prior year periods primarily due to a decrease in the issuance of commercial paper. Interest expense may also fluctuate based on timing, amounts, and interest rates of term debt repaid and new term debt issued, as well as amounts incurred associated with financing fees. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Benefit (Expense)</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2020 and 2019, we recorded an income tax benefit of $1.2 billion and income tax expense of $47 million, respectively. During the nine months ended December 31, 2020 and 2019, we recorded income tax benefits of $1.0 billion and $111 million, respectively. We reported an income tax benefit rate of 16.1% and an income tax expense rate of 16.0% for the three months ended December 31, 2020 and 2019, respectively. We reported income tax benefit rates of 16.7% and 194.7% for the nine months ended December 31, 2020 and 2019, respectively. The charge for opioid-related claims of $8.1 billion ($6.7 billion after-tax) unfavorably impacted our reported income tax benefit rates for the three and nine months ended December 31, 2020. During the three and nine months ended December 31, 2019, no tax benefit was recognized for the charge of $282 million to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture within our International segment. Fluctuations in our reported income tax rates are primarily due to changes within our business mix of income and discrete items recognized. Refer to Financial Note 5, &#8220;Income Taxes,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Attributable to Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to noncontrolling interests for the three and nine months ended December 31, 2020 and 2019 primarily represents ClarusONE Sourcing Services LLP, Vantage Oncology Holdings, LLC, and the accrual of the annual recurring compensation amount of &#8364;0.83 per McKesson Europe AG (&#8220;McKesson Europe&#8221;) share that McKesson is obligated to pay to the noncontrolling shareholders of McKesson Europe under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;). Noncontrolling interests with redemption features, such as put rights, that are not solely within our control are considered redeemable noncontrolling interests.&#160;Redeemable noncontrolling interests are presented outside of McKesson Corporation stockholders&#8217; equity (deficit) on our condensed consolidated balance sheets. Refer to Financial Note 6, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Attributable to McKesson Corporation</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to McKesson Corporation was $(6.2) billion and $186 million for the three months ended December 31, 2020 and 2019, respectively, and $(5.2) billion and $(121) million for the nine months ended December 31, 2020 and 2019, respectively. Diluted earnings (loss) per common share attributable to McKesson Corporation was $(39.03) and $1.03 for the three months ended December 31, 2020 and 2019, respectively, and $(32.29) and $(0.66) for the nine months ended December 31, 2020 and 2019, respectively. Net loss per diluted share for the three and nine months ended December 31, 2020 and for the nine months ended December 31, 2019 is calculated by excluding dilutive securities from the denominator due to their antidilutive effects. Additionally, our diluted earnings (loss) per share for the three and nine months ended December 31, 2020 and 2019 reflects the cumulative effects of share repurchases. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Weighted-Average Diluted Common Shares</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings (loss) per common share was calculated based on a weighted-average number of shares outstanding of</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159.5 million and 179.7 million for the three months ended December 31, 2020 and 2019, respectively, and 161.2 million and 183.1 million for the nine months ended December 31, 2020 and 2019, respectively. Weighted-average diluted shares for three and nine months ended December 31, 2020 decreased from the same prior year periods primarily due to the separation from our investment in Change Healthcare JV on March 10, 2020.</span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_109"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Segment Results:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Revenues:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,172&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,086&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,516&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Pharmaceutical</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended December 31, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Pharmaceutical revenues for the three months ended December 31, 2020 increased</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7% compared to the same prior year period primarily due to market growth, including branded pharmaceutical price increases, growth in specialty pharmaceuticals, and higher volumes from retail national account customers, partially offset by branded to generic drug conversions. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nine Months Ended December 31, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Pharmaceutical revenues for the nine months ended December 31, 2020 increased 5% compared to the same prior year period primarily due to market growth, including branded pharmaceutical price increases, growth in specialty pharmaceuticals, and higher volumes from retail national account customers, partially offset by branded to generic drug conversions. Revenues for this segment were unfavorably impacted by the loss of customers and reduced demand for pharmaceuticals in retail pharmacies and institutional healthcare providers due to COVID-19, particularly during the first quarter of 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended December 31, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenues for the three months ended December 31, 2020 decreased 6% compared to the same prior year period. Excluding the favorable effects of foreign currency exchange fluctuations, revenues for this segment decreased 10% largely due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA and to a lesser extent, the exit of unprofitable customers in our Canadian business. These decreases were partially offset by favorability due to additional sales days for the three months ended December 31, 2020 compared to the same prior year period in our European operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nine Months Ended December 31, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenues for the nine months ended December 31, 2020 decreased 4% compared to the same prior year period. Excluding the favorable effects of foreign currency exchange fluctuations, revenues for this segment decreased 6% primarily due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA, the exit of unprofitable customers in our Canadian business, and lower pharmaceutical distribution volumes resulting from the adverse impacts from COVID-19 largely during the first quarter of 2021. These decreases were partially offset by favorability due to additional sales days for the nine months ended December 31, 2020 compared to the same prior year period in our European operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical-Surgical Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended December 31, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical-Surgical Solutions revenues for the three months ended December 31, 2020 increased 43% compared to the same prior year period primarily due to sales of COVID-19 tests and PPE. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nine Months Ended December 31, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical-Surgical Solutions revenues for the nine months ended December 31, 2020 increased 21% compared to the same prior year period largely due to sales of COVID-19 tests. Revenues for this segment were also favorably impacted by sales of PPE, partially offset by lower demand due to customer closures in our primary care business primarily during the first quarter of 2021. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prescription Technology Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended December 31, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RxTS revenues for the three months ended December 31, 2020 increased 9% compared to the same prior year period primarily driven by increased volume with new and existing customers in our CoverMyMeds business. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nine Months Ended December 31, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RxTS revenues for the nine months ended December 31, 2020 increased 7% compared to the same prior year period primarily driven by increased volume with new and existing customers.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_112"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Operating Profit (Loss) and Corporate Expenses, Net:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.975%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,483)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,246)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,462)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(713)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,363)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM    </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,063)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM    </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.67&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.48&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.85&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.22&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NM - computation not meaningful</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for our reportable segments. For retrospective periods presented, operating loss for Other reflects equity earnings and charges from our equity method investment in Change Healthcare JV, which we split-off in the fourth quarter of 2020.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating profit for our U.S. Pharmaceutical segment includes a charge of $50 million for the nine months ended December 31, 2020 related to our estimated liability under the OSA.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for our International segment includes restructuring, impairment, and related charges of $131 million and $189 million for the three and nine months ended December 31, 2020, respectively, driven largely by long-lived asset impairment charges of $115 million primarily related to our retail pharmacy businesses in Canada and Europe as well as costs incurred in the closure of certain retail pharmacy stores within our U.K. business as part of our operating model and cost optimization efforts. Restructuring, impairment, and related charges of $100 million and $116 million for the three and nine months ended December 31, 2019, respectively, was driven largely by long-lived asset impairment charges of $94 million primarily related to our retail pharmacy businesses in the U.K. and Canada. Operating loss includes a goodwill impairment charge of $69 million for the nine months ended December 31, 2020 related to our European retail business as well as charges of $47 million and $57 million for three and nine months ended December 31, 2020, respectively, to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA. We recognized a fair value remeasurement charge related to the joint venture of $282 million for the three and nine months ended December 31, 2019. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for Other for the nine months ended December 31, 2019 includes an impairment charge of $1.2 billion and a dilution loss of $246 million related to our investment in Change Healthcare JV.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:6.34pt">Corporate expenses, net for the three and nine months ended December 31, 2020 includes a charge of $8.1 billion related to our estimated liability for opioid-related claims. Corporate expenses, net for the three and nine months ended December 31, 2020 also includes net gains from our equity investments of $30 million and $89 million, respectively, as well as a net gain of $131 million for nine months ended December 31, 2020 recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program. Corporate expenses, net for the nine months ended December 31, 2019 includes pension settlement charges of $122 million and a settlement charge of $82 million related to opioid claims.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Pharmaceutical</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended December 31, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit and operating profit margin decreased for this segment for the three months ended December 31, 2020 compared to the same prior year period primarily due to lower LIFO credits of $55 million and net cash proceeds of $22 million received in the prior year representing our share of antitrust legal settlements, partially offset by growth in specialty pharmaceuticals. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nine Months Ended December 31, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit and operating profit margin decreased for this segment for the nine months ended December 31, 2020 compared to the same prior year period primarily due to a charge of $50 million recorded during the second quarter of 2021 related to our estimated liability under the OSA, increased costs for strategic growth initiatives, and net cash proceeds of $22 million received in the prior year representing our share of antitrust legal settlements. This was partially offset by growth in specialty pharmaceuticals. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended December 31, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss and operating loss margin improved for this segment for the three months ended December 31, 2020 compared to the same prior year period primarily due to a decrease in the charges recorded to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA. The fair value remeasurement charges reflected for the three months ended December 31, 2020 and 2019 was $47 million and $282 million, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nine Months Ended December 31, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss and operating loss margin improved for this segment for the nine months ended December 31, 2020 compared to the same prior year period primarily due to a decrease in the fair value remeasurement charges discussed above, of which $57 million and $282 million was reflected for the nine months ended December 31, 2020 and 2019, respectively, and lower operating expenses across our European businesses. This was partially offset by higher restructuring charges in Europe and Canada and a goodwill impairment charge of $69 million recorded in the second quarter of 2021 related to our European retail pharmacy business.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical-Surgical Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended December 31, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit and operating profit margin for this segment increased for the three months ended December 31, 2020 compared to the same prior year period primarily due to COVID-19, including demand for COVID-19 tests and the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines, partially offset by inventory charges on certain PPE and other related products. Operating profit and operating profit margin for the three months ended December 31, 2019 also included a prior year remeasurement charge of assets and liabilities held for sale to fair value related to a divestiture that closed during the fourth quarter of 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nine Months Ended December 31, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit and operating profit margin for this segment increased for the nine months ended December 31, 2020 compared to the same prior year period primarily due to COVID-19, including demand for COVID-19 tests and PPE, as well as the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines. This was partially offset by customer closures in our primary care business largely during the first quarter of 2021 and inventory charges on certain PPE and other related products. Operating profit and operating profit margin for the nine months ended December 31, 2019 also included a prior year remeasurement charge of assets and liabilities held for sale to fair value related to a divestiture that closed during the fourth quarter of 2020.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prescription Technology Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended December 31, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit and operating profit margin for this segment increased for the three months ended December 31, 2020 compared to the same prior year period primarily driven by favorability in our CoverMyMeds business, including increased volumes with new and existing customers. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nine Months Ended December 31, 2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit and operating profit margin for this segment decreased for the nine months ended December 31, 2020 compared to the same prior year period primarily due to higher operating expenses to support business growth. Operating profit margin for this segment also decreased due to changes in our product mix.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss for Other for the nine months ended December 31, 2019 includes an impairment charge of $1.2 billion and a dilution loss of $246 million related to our investment in Change Healthcare JV. Operating loss for Other also includes our proportionate share of loss from Change Healthcare JV of $28 million and $75 million for the three and nine months ended December 31, 2019, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Expenses, Net</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate expenses, net increased for the three and nine months ended December 31, 2020 compared to the same prior year periods due to a charge of $8.1 billion related to our estimated liability for opioid-related claims.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate expenses, net also includes net gains recognized from our equity investments of $30 million and $89 million for the three and nine months ended December 31, 2020, respectively, as well as a net gain of $131 million recognized during the nine months ended December 31, 2020 in connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program. Corporate expenses, net, for the nine months ended December 31, 2019 includes pension settlement charges of $122 million, an opioid claim settlement charge of $82 million, and net settlement gains of $26 million recognized from our derivative contracts. </span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_118"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New accounting pronouncements that we have recently adopted as well as those that have been recently issued but not yet adopted by us are included in Financial Note 1, &#8220;Significant Accounting Policies,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.</span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_121"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL CONDITION, LIQUIDITY, AND CAPITAL RESOURCES </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our available cash generated from operations and our short-term investment portfolio, together with our existing sources of liquidity from our credit facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements. As described within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">section above, the COVID-19 pandemic developed rapidly. We continue to monitor its impact on demand within parts of our business, as well as trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us. We remain well-capitalized with access to liquidity from our revolving credit facility. Additionally, long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic. We have seen continued improvement in conditions in the debt markets and commercial paper markets as the Federal Reserve has taken steps to stabilize the markets. We believe we meet and have the ability to meet the covenants of our credit agreements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net change in cash, cash equivalents, and restricted cash for the periods shown: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(922)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(916)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities generated cash of $1.2 billion and used cash of $280 million during the nine months ended December 31, 2020 and 2019, respectively.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from operations can be significantly impacted by factors such as timing of receipts from customers, inventory receipts, and payments to vendors. Additionally, working capital is primarily a function of sales and purchase volumes, inventory requirements, and vendor payment terms. Operating activities for the nine months ended December 31, 2020 were affected by net income adjusted for non-cash items, a decrease in receivables of $1.5 billion and an increase in inventory of $2.0 billion, both primarily due to timing and higher sales recognized at year end, as well as a decrease in drafts and accounts payable of $1.2 billion from effective working capital management at year end. Operating activities for the nine months ended December 31, 2019 were affected by an increase in receivables of $1.0 billion due to revenue growth, as well as a decrease in drafts and accounts payable of $929 million and an increase in inventory of $689 million, both primarily associated with timing. Operating activities also includes non-cash fair value remeasurement charges of $57 million and $282 million related to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA for the nine months ended December 31, 2020 and 2019, respectively, and a non-cash pension settlement charge of $122 million for the nine months ended December 31, 2019. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities used cash of $210 million and $409 million during the nine months ended December 31, 2020 and 2019, respectively. Investing activities for the nine months ended December 31, 2020 and 2019 includes $427 million and $338 million, respectively, in capital expenditures for property, plant, and equipment, and capitalized software. Investing activities for the nine months ended December 31, 2020 also includes net cash proceeds of $297 million in exchange for the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities used cash of $1.2 billion and $254 million during the nine months ended December 31, 2020 and 2019, respectively. Financing activities for the nine months ended December 31, 2020 includes cash receipts of $5.5 billion and payments of $5.3 billion for short-term borrowings, primarily commercial paper. Financing activities for the nine months ended December 31, 2019 includes cash receipts of $15.9 billion and payments of $13.7 billion for short-term borrowings, primarily commercial paper. Financing activities for the nine months ended December 31, 2020 includes the issuance of the 2025 Notes in a principal amount of $500&#160;million, the retirement of our $700&#160;million total principal amount of notes due on November 30, 2020 at a fixed interest rate of 3.65% upon maturity, and the redemption of our 4.75% $323&#160;million total principal of notes due on March 1, 2021 prior to maturity. The notes were redeemed using cash on hand and the proceeds from the 2025 Notes. Financing activities for the nine months ended December 31, 2020 and 2019 includes $526 million and $2.0 billion, respectively, of cash paid for stock repurchases, including shares surrendered for tax withholding. Additionally, financing activities for the nine months ended December 31, 2020 and 2019 includes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$209 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $222 million of cash paid for dividends, respectively. Cash used for other financing activities generally includes payments to noncontrolling interests. Other financing activities for the nine months ended December 31, 2020 also includes restricted cash inflow related to funds temporarily held on behalf of unaffiliated medical practice groups and a payment of $49 million to purchase shares of McKesson Europe through exercises of a put right option by noncontrolling shareholders. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has authorized the repurchase of McKesson&#8217;s common stock from time to time in open market transactions, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations, and other market and economic conditions. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2019, we entered into an ASR program with a third-party financial institution to repurchase $600 million of the Company&#8217;s common stock. We repurchased a total of 4.7 million shares at an average price per share of $127.68 during the nine months ended December 31, 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2019, we repurchased 0.7 million of the Company&#8217;s shares for $84 million through open market transactions at an average price per share of $128.64. During the three months ended September 30, 2019, we repurchased 5.2 million of the Company&#8217;s shares for $750 million through open market transactions at an average price per share of $144.28. During the three months ended December 31, 2019, we repurchased 3.4 million of the Company&#8217;s shares for $500 million through open market transactions at an average price per share of $148.39.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2020, there were no share repurchases made under previously authorized share repurchase programs. During the three months ended September 30, 2020, we repurchased 1.8&#160;million of the Company&#8217;s shares for $269 million through open market transactions at an average price per share of $151.23. During the three months ended December 31, 2020, we repurchased 1.5&#160;million of the Company&#8217;s shares for $231 million through open market transactions at an average price per share of $151.12. The total authorization outstanding for repurchases of the Company&#8217;s common stock was $1.0 billion at December 31, 2020. In January 2021, the Board approved an increase of $2.0 billion for the authorized share repurchase of McKesson&#8217;s common stock.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our future operating cash flow, financial assets, and current access to capital and credit markets, including our existing credit facilities, will give us the ability to meet our financing needs for the foreseeable future. However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing. As described within the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above, the COVID-19 pandemic developed rapidly. We continue to monitor its impact on demand within parts of our business, as well as trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.</span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_124"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selected Measures of Liquidity and Capital Resources</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:55.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,732&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt to capital ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on McKesson stockholders&#8217; equity (deficit) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94.6)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Ratio is computed as total debt divided by the sum of total debt and McKesson stockholders&#8217; equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests and accumulated other comprehensive loss. This ratio of debt to capital differs from our total indebtedness to total capital ratio calculated under our credit agreement dated September 25, 2019, as amended.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Ratio is computed as net income (loss) attributable to McKesson Corporation for the last four quarters, divided by a five-quarter average of McKesson stockholders&#8217; equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds and overnight deposits with financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents balance as of December 31, 2020 and March 31, 2020 included approximately</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.1 billion and $1.7 billion of cash held by our subsidiaries outside of the U.S., respectively. Our primary intent is to utilize this cash for foreign operations for an indefinite period of time. Although the vast majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.&#160;Following enactment of the 2017 Tax Cuts and Jobs Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Working capital primarily includes cash and cash equivalents, receivables, and inventories, net of drafts and accounts payable, short-term borrowings, current portion of long-term debt, and other current liabilities. Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands. Inventory purchase activity is a function of sales activity and other requirements. The COVID-19 pandemic has potential to increase the variations in our working capital, which we will continue to monitor closely.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated working capital improved at December 31, 2020 compared to March 31, 2020 primarily due to an increase in inventory and a decrease in drafts and accounts payable, partially offset by decreases in receivables and cash and cash equivalents as well as an increase in other current liabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt to capital ratio increased for the nine months ended December 31, 2020 primarily due to a decrease in stockholders&#8217; equity driven by net loss for the year-to-date period and share repurchases. Our unfavorable return on McKesson&#8217;s stockholder&#8217;s equity (deficit) as of December 31, 2020 was also driven by net loss for the year-to-date period. Net loss for the nine months ended December 31, 2020 includes an after-tax charge of $6.7 billion related to our estimated liability for opioid-related claims.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2020, we raised our quarterly dividend from $0.41 to $0.42 per common share for dividends declared on or after such date by the Board. We anticipate that we will continue to pay quarterly cash dividends in the future. However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our redeemable noncontrolling interests primarily relate to our consolidated subsidiary, McKesson Europe. Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe have a right to put (&#8220;Put Right&#8221;) their shares at &#8364;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published semi-annually by the German Bundesbank, less any compensation amount or guaranteed dividend already paid by McKesson (&#8220;Put Amount&#8221;). The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests. During the nine months ended December 31, 2020, we paid $49 million to purchase 1.8&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. The ultimate amount and timing of any future cash payments related to the Put Amount are uncertain. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance of redeemable noncontrolling interests is reported at the greater of its carrying value or its maximum redemption value at each reporting date. The redemption value is the Put Amount adjusted for exchange rate fluctuations each period. The carrying value of redeemable noncontrolling interests is also adjusted each period for the portion of other comprehensive income attributable to the noncontrolling shareholders, which is primarily due to changes in foreign currency exchange rates. At December 31, 2020, the carrying value of redeemable noncontrolling interests related to McKesson Europe of $1.3 billion approximated the maximum redemption value, and at March 31, 2020, the carrying value of $1.4&#160;billion exceeded the maximum redemption value of $1.2 billion. In future periods, unfavorable foreign currency exchange rate fluctuations between the Euro and the U.S. dollar could adversely impact the carrying value of our redeemable noncontrolling interests and require an adjustment to increase the balance of our redeemable noncontrolling interests to its maximum redemption value. Such adjustments would be recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in our consolidated statements of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONCLUDED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we are obligated to pay an annual recurring compensation of &#8364;0.83 per McKesson Europe share (the &#8220;Compensation Amount&#8221;) to the noncontrolling shareholders of McKesson Europe under the Domination Agreement. The Compensation Amount is recognized ratably during the applicable annual period. The Domination Agreement does not expire, but it may be terminated at the end of any fiscal year by giving at least six month&#8217;s advance notice. The Put Amount, annual recurring compensation amount, and the guaranteed dividend are subject to ongoing appraisal proceedings as previously disclosed in Financial Note 9, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; in Item 8 of Part II of our 2020 Annual Report, the outcome of which is uncertain and could result in increased future payments to the noncontrolling shareholders of McKesson Europe.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 6, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information on redeemable noncontrolling interests. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Resources</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We fund our working capital requirements primarily with cash and cash equivalents as well as short-term borrowings from our credit facilities and commercial paper issuances. Funds necessary for future debt maturities and our other cash requirements are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions. Detailed information regarding our debt and financing activities is included in Financial Note 9, &#8220;Debt and Financing Activities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q. </span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_127"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTICE ABOUT FORWARD-LOOKING STATEMENTS </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q, including &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Item 2 of Part I of this report, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Some of these statements can be identified by the use of terminology such as &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;seeks,&#8221; &#8220;approximately,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;estimates,&#8221; or the negative of these words and other comparable terminology. The discussion of financial trends, strategy, plans, or intentions may also include forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date such statements were first made. We undertake no obligation to publicly release any updates or revisions to our forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, anticipated, or implied. Although it is not possible to predict or identify all such risks and uncertainties, they include factors described in the Risk Factors discussion in Item 1A of Part I of our most recent Annual Report on Form 10-K, as updated in Item 1A of Part II of our report on Form 10-Q for the quarter ended September 30, 2020. The reader should not consider that discussion to be a complete statement of all potential risks and uncertainties.</span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_130"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Quantitative and Qualitative Disclosures about Market Risk.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe there has been no material change in our exposure to risks associated with fluctuations in interest and foreign currency exchange rates as disclosed in our 2020 Annual Report. </span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_133"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Controls and Procedures. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Executive Officer and our Chief Financial Officer, with the participation of other members of the Company&#8217;s management, have evaluated the effectiveness of the Company&#8217;s &#8220;disclosure controls and procedures&#8221; (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;)) as of the end of the period covered by this quarterly report, and our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are effective based on their evaluation of these controls and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our &#8220;internal control over financial reporting&#8221; (as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that occurred during the three months ended December 31, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_136"></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II&#8212;OTHER INFORMATION</span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_139"></div><div><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Legal Proceedings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information set forth in Financial Note 13, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q, and in Financial Note 21, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2020, is incorporated herein by reference. Disclosure of an environmental proceeding with a governmental agency generally is included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.</span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_142"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.8pt">Risk Factors.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes during the period covered by this Quarterly Report on Form 10-Q to the risk factors disclosed in Part I, Item 1A, of our 2020 Annual Report, and as updated in Item 1A of Part II of our report on Form 10-Q for the quarter ended September 30, 2020.</span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_145"></div><div><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time to time in open market transactions, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2020, there were no share repurchases made under previously authorized share repurchase programs. During the three months ended September 30, 2020, the Company repurchased 1.8 million of the Company&#8217;s shares for $269 million through open market transactions at an average price per share of $151.23. During the three months ended December 31, 2020, the Company repurchased 1.5&#160;million of the Company&#8217;s shares for $231 million through open market transactions at an average price per share of $151.12. The total authorization outstanding for repurchases of the Company&#8217;s common stock was $1.0 billion at December 31, 2020. In January 2021, the Company&#8217;s Board of Directors approved an increase of $2.0 billion for the authorized share repurchase of McKesson&#8217;s common stock.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on the Company&#8217;s share repurchases during the three months ended December 31, 2020.</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.165%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.165%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.168%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number<br/>of Shares<br/>Purchased</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price<br/>Paid&#160;Per&#160;Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares Purchased<br/>As Part of Publicly<br/>Announced<br/>Program</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate<br/>Dollar&#160;Value&#160;of<br/>Shares&#160;that&#160;May<br/>Yet Be Purchased Under the Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1, 2020 &#8211; October 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,036</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1, 2020 &#8211; November 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,036</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1, 2020 &#8211; December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,036</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include shares tendered to satisfy the exercise price in connection with cashless exercises of employee stock options or shares tendered to satisfy tax withholding obligations in connection with employee equity awards. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_151"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Defaults Upon Senior Securities.</span></div><div style="margin-bottom:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_154"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Mine Safety Disclosures.</span></div><div style="margin-bottom:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_157"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Other Information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2021, the Company entered into Amendment No. 1 (the &#8220;Credit Agreement Amendment&#8221;) to the Credit Agreement, dated as of September 25, 2019, among the Company and certain of its subsidiaries, as borrowers, the lenders party thereto, the letter of credit issuers party thereto, Bank of America, N.A., as administrative agent, and Barclays Bank PLC, Citibank, N.A., Wells Fargo Bank, National Association, Goldman Sachs Bank USA, JPMorgan Chase Bank, N.A., and HSBC Securities (USA) Inc., as co-syndication agents (as amended, the &#8220;2020 Credit Facility&#8221;).  The Credit Agreement Amendment amended the financial covenant in Section 7.04 of the 2020 Credit Facility that obligates the Company to maintain a debt to capital ratio of no greater than 65%. The Amendment under that covenant excludes from the calculation of &#8220;Net Worth&#8221; as of December 31, 2020 any non-cash charge in respect of any claims or litigation in excess of $1.0 billion that the Company excludes from its &#8220;Adjusted Earnings (Non-GAAP)&#8221; for the fiscal quarter ended December 31, 2020, as reported in a current report on Form 8-K reporting operating results for such period. As of December 31, 2020, the Company was in compliance with the debt to capital ratio and all other covenants under the 2020 Credit Facility.</span></div><div style="margin-bottom:12pt;text-indent:24.75pt"><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_160"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:12pt;margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Exhibits. </span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits identified in parentheses below are on file with the SEC and are incorporated by reference as exhibits hereto. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000119312520309508/d17547dex41.htm">Officer&#8217;s Certificate, dated as of December 3, 2020, and related Form of 2025 Note (incorporated by reference to Exhibit 4.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 3, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit311x12312020.htm">Certification of the Chief Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit312x12312020.htm">Certification of the Chief Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#8224;&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit32x12312020.htm">Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the McKesson Corporation Quarterly Report on Form 10-Q for the quarter ended December 31, 2020, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Condensed Consolidated Statements of Operations, (ii) Condensed Consolidated Statements of Comprehensive Income (Loss), (iii) Condensed Consolidated Balance Sheets, (iv) Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit), (v) Condensed Consolidated Statements of Cash Flows, and (vi) related Financial Notes.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as iXBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#8224;&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="ib9c6f28fe5144278bb122fe3b38cf454_163"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib9c6f28fe5144278bb122fe3b38cf454_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.217%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESSON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ORPORATION</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Britt J. Vitalone</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.217%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESSON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ORPORATION</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Sundeep G. Reddy</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sundeep G. Reddy</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Controller</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>mck_exhibit311x12312020.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i3175e95d35c3497aa25427612f4f6496_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brian S. Tyler, certify that&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of McKesson Corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;Brian S. Tyler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>mck_exhibit312x12312020.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i9f4e1a9effb8412c980408bda4b7f358_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Britt J. Vitalone, certify that&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of McKesson Corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Britt J. Vitalone</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>mck_exhibit32x12312020.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i21c9d329b045472db518aaadfb143e17_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the quarterly report of McKesson Corporation (the &#8220;Company&#8221;) on Form 10-Q for the quarterly period ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned, in the capacities and on the dates indicated below, each hereby certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;margin-top:29pt;padding-left:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160; Brian S. Tyler</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:41pt;padding-left:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Britt J. Vitalone</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:27pt;text-indent:-9pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Report pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to McKesson Corporation and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>mck-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:734100a7-c7c1-4795-ad72-160dc37ce333,g:f6cbe616-07cc-4518-be11-bf83875971ba-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mck="http://mckesson123.com/20201231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://mckesson123.com/20201231">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://mckesson123.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://mckesson123.com/role/SignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNarrativeDetails" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2403401 - Disclosure - Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentinChangeHealthcareJointVenture" roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture">
        <link:definition>2104102 - Disclosure - Investment in Change Healthcare Joint Venture</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentinChangeHealthcareJointVentureDetails" roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails">
        <link:definition>2405402 - Disclosure - Investment in Change Healthcare Joint Venture (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSale" roleURI="http://mckesson123.com/role/HeldforSale">
        <link:definition>2106103 - Disclosure - Held for Sale</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleTables" roleURI="http://mckesson123.com/role/HeldforSaleTables">
        <link:definition>2307301 - Disclosure - Held for Sale (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleNarrativeDetails" roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails">
        <link:definition>2408403 - Disclosure - Held for Sale - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails">
        <link:definition>2409404 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedCharges" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges">
        <link:definition>2110104 - Disclosure - Restructuring, Impairment and Related Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesTables" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables">
        <link:definition>2311302 - Disclosure - Restructuring, Impairment and Related Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesNarrativeDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails">
        <link:definition>2412405 - Disclosure - Restructuring, Impairment and Related Charges - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails">
        <link:definition>2413406 - Disclosure - Restructuring, Impairment and Related Charges - Summary of Restructuring Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails">
        <link:definition>2414407 - Disclosure - Restructuring, Impairment and Related Charges - Summary of Restructuring Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://mckesson123.com/role/IncomeTaxes">
        <link:definition>2115105 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://mckesson123.com/role/IncomeTaxesDetails">
        <link:definition>2416408 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterests" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests">
        <link:definition>2117106 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables">
        <link:definition>2318303 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails">
        <link:definition>2419409 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails">
        <link:definition>2420410 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShare" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShare">
        <link:definition>2121107 - Disclosure - Earnings (Loss) Per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShareTables" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareTables">
        <link:definition>2322304 - Disclosure - Earnings (Loss) Per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShareDetails" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareDetails">
        <link:definition>2423411 - Disclosure - Earnings (Loss) Per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNet" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet">
        <link:definition>2124108 - Disclosure - Goodwill and Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetTables" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables">
        <link:definition>2325305 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails">
        <link:definition>2426412 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails">
        <link:definition>2427413 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails">
        <link:definition>2428414 - Disclosure - Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivities" roleURI="http://mckesson123.com/role/DebtandFinancingActivities">
        <link:definition>2129109 - Disclosure - Debt and Financing Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesTables" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables">
        <link:definition>2330306 - Disclosure - Debt and Financing Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesScheduleofLongTermDebtDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails">
        <link:definition>2431415 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1">
        <link:definition>2431415 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesLongTermDebtNarrativeDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails">
        <link:definition>2432416 - Disclosure - Debt and Financing Activities - Long-Term Debt Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails">
        <link:definition>2433417 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesCommercialPaperDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails">
        <link:definition>2434418 - Disclosure - Debt and Financing Activities - Commercial Paper (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StatementofIncomeIncludingGrossMarginStatement" roleURI="http://mckesson123.com/role/StatementofIncomeIncludingGrossMarginStatement">
        <link:definition>1008009 - Statement - Statement of Income (Including Gross Margin) (Statement)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefits" roleURI="http://mckesson123.com/role/PensionBenefits">
        <link:definition>2135110 - Disclosure - Pension Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsNarrativeDetails" roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails">
        <link:definition>2436419 - Disclosure - Pension Benefits - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivities" roleURI="http://mckesson123.com/role/HedgingActivities">
        <link:definition>2137111 - Disclosure - Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesTables" roleURI="http://mckesson123.com/role/HedgingActivitiesTables">
        <link:definition>2338307 - Disclosure - Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesNarrativeDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails">
        <link:definition>2439420 - Disclosure - Hedging Activities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesDerivativeInstrumentsFairValueDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails">
        <link:definition>2440421 - Disclosure - Hedging Activities - Derivative Instruments Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://mckesson123.com/role/FairValueMeasurements">
        <link:definition>2141112 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://mckesson123.com/role/FairValueMeasurementsDetails">
        <link:definition>2442422 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilities" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities">
        <link:definition>2143113 - Disclosure - Commitments and Contingent Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesNarrativeDetails" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails">
        <link:definition>2444423 - Disclosure - Commitments and Contingent Liabilities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficit" roleURI="http://mckesson123.com/role/StockholdersEquityDeficit">
        <link:definition>2145114 - Disclosure - Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitTables" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitTables">
        <link:definition>2346308 - Disclosure - Stockholders' Equity (Deficit) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitNarrativeDetails" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails">
        <link:definition>2447424 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails">
        <link:definition>2448425 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails">
        <link:definition>2449426 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusiness" roleURI="http://mckesson123.com/role/SegmentsofBusiness">
        <link:definition>2150115 - Disclosure - Segments of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessTables" roleURI="http://mckesson123.com/role/SegmentsofBusinessTables">
        <link:definition>2351309 - Disclosure - Segments of Business (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessDetails" roleURI="http://mckesson123.com/role/SegmentsofBusinessDetails">
        <link:definition>2452427 - Disclosure - Segments of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mck_CommonStockVotingRightsNumberofVotesPerCommonShare" abstract="false" name="CommonStockVotingRightsNumberofVotesPerCommonShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" abstract="false" name="RedeemableNoncontrollingInterestsMaximumRedemptionValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A285NotesDueMarch152023Member" abstract="true" name="A285NotesDueMarch152023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" abstract="true" name="SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_StrategicGrowthInitiativePlanOtherMember" abstract="true" name="StrategicGrowthInitiativePlanOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_CurrentAssetLiabilityMember" abstract="true" name="CurrentAssetLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation" abstract="false" name="LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_CorporateOperatingExpenseandOtherIncomeNet" abstract="false" name="CorporateOperatingExpenseandOtherIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencySettlementAgreementAwardPaymentPeriod" abstract="false" name="LossContingencySettlementAgreementAwardPaymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_GainLossOnSaleOfBusinessNetOfTax" abstract="false" name="GainLossOnSaleOfBusinessNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_WalgreensBootsAllianceJointVentureMember" abstract="true" name="WalgreensBootsAllianceJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" abstract="true" name="ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" abstract="false" name="OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_VantageandClarusOneSourcingServicesLLCMember" abstract="true" name="VantageandClarusOneSourcingServicesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A1625NotesDue2026Member" abstract="true" name="A1625NotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" abstract="false" name="AnnualRecurringCompensationPerSharetoNoncontrollingInterests" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" abstract="false" name="OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_IncreaseDecreaseInLitigationReserve" abstract="false" name="IncreaseDecreaseInLitigationReserve" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NumberOfNationalBrandMedicalSurgicalProducts" abstract="false" name="NumberOfNationalBrandMedicalSurgicalProducts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" abstract="false" name="LossContingencyClassActionNumberofFaxesRemainingintheClass" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member" abstract="true" name="PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" abstract="true" name="AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_TaxReceivableAgreementTRAMember" abstract="true" name="TaxReceivableAgreementTRAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" abstract="false" name="OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_MckessonEuropeSubsidiaryMember" abstract="true" name="MckessonEuropeSubsidiaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestsPutRightExercisePrice" abstract="false" name="NoncontrollingInterestsPutRightExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mck_EuroDenominatedNotesMember" abstract="true" name="EuroDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberofStates" abstract="false" name="LossContingencyNumberofStates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_LossContingencyAccrualAfterTax" abstract="false" name="LossContingencyAccrualAfterTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_BritishPoundSterlingDenominatedNotesMember" abstract="true" name="BritishPoundSterlingDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_November2018CrossCurrencySwapsMember" abstract="true" name="November2018CrossCurrencySwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_ChangeHealthcareInc.Member" abstract="true" name="ChangeHealthcareInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" abstract="true" name="StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_MedicalSurgicalSolutionsSegmentMember" abstract="true" name="MedicalSurgicalSolutionsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" abstract="false" name="OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A270NotesDueDecember152022Member" abstract="true" name="A270NotesDueDecember152022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A0625NotesDue2021Member" abstract="true" name="A0625NotesDue2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" abstract="true" name="TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_AcceleratedShareRepurchaseMember" abstract="true" name="AcceleratedShareRepurchaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DefinedBenefitPensionPlanLiabilitiesDerecognized" abstract="false" name="DefinedBenefitPensionPlanLiabilitiesDerecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A090NotesDueDecember32025Member" abstract="true" name="A090NotesDueDecember32025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" abstract="true" name="AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A2025NotesMember" abstract="true" name="A2025NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" abstract="false" name="LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" abstract="false" name="DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" abstract="false" name="AssetImpairmentChargesIncludingAcceleratedDepreciation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A765DebenturesDueMarch12027Member" abstract="true" name="A765DebenturesDueMarch12027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_RestructuringImpairmentandOtherRelatedCharges" abstract="false" name="RestructuringImpairmentandOtherRelatedCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_PutRightValueInterestRateSpread" abstract="false" name="PutRightValueInterestRateSpread" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" abstract="false" name="RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_A1500NotesDue2025Member" abstract="true" name="A1500NotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A395NotesDueFebruary162028Member" abstract="true" name="A395NotesDueFebruary162028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_GermanWholesaleBusinessMember" abstract="true" name="GermanWholesaleBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_GermanPharmaceuticalWholesaleJointVentureMember" abstract="true" name="GermanPharmaceuticalWholesaleJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" abstract="true" name="AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" abstract="false" name="DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_IncomeTaxExpenseBenefitDiscreteItems" abstract="false" name="IncomeTaxExpenseBenefitDiscreteItems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A150EuroNotesDueNovember172025Member" abstract="true" name="A150EuroNotesDueNovember172025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_ExecutiveBenefitRetirementPlanMember" abstract="true" name="ExecutiveBenefitRetirementPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencyAccrualProvisionNetOfTax" abstract="false" name="LossContingencyAccrualProvisionNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ReclassificationofTemporaryEquitytoLiability" abstract="false" name="ReclassificationofTemporaryEquitytoLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" abstract="true" name="ThreeLargestU.S.PharmaceuticalDistributorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices" abstract="false" name="EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_IncreaseDecreaseinOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseinOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_PrescriptionTechnologySolutionsSegmentMember" abstract="true" name="PrescriptionTechnologySolutionsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A163EuroNotesDueOctober302026Member" abstract="true" name="A163EuroNotesDueOctober302026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A488NotesDueMarch152044Member" abstract="true" name="A488NotesDueMarch152044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_RetailPharmacyReportingUnitMember" abstract="true" name="RetailPharmacyReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies" abstract="false" name="EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_NoncurrentAssetLiabilityMember" abstract="true" name="NoncurrentAssetLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A380NotesDueMarch152024Member" abstract="true" name="A380NotesDueMarch152024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased" abstract="false" name="StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NumberOfBusinessOperations" abstract="false" name="NumberOfBusinessOperations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_OperatingModelAndCostOptimizationProgramsMember" abstract="true" name="OperatingModelAndCostOptimizationProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_NumberOfInvestmentFundsThatFiledClaims" abstract="false" name="NumberOfInvestmentFundsThatFiledClaims" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" abstract="false" name="NoncontrollingInterestDecreaseForExerciseOfPutRight" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberofStateAttorneyGenerals" abstract="false" name="LossContingencyNumberofStateAttorneyGenerals" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_PharmacyLicensesMember" abstract="true" name="PharmacyLicensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember" abstract="true" name="EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencyDamagesSoughtPerViolationValue" abstract="false" name="LossContingencyDamagesSoughtPerViolationValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ProportionateGainLossOnEquityMethodInvestment" abstract="false" name="ProportionateGainLossOnEquityMethodInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberofCounties" abstract="false" name="LossContingencyNumberofCounties" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_StrategicGrowthInitiativePlanMember" abstract="true" name="StrategicGrowthInitiativePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" abstract="false" name="NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" abstract="false" name="EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NationalPrescriptionOpiateLitigationMember" abstract="true" name="NationalPrescriptionOpiateLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A063EuroNotesDueAugust172021Member" abstract="true" name="A063EuroNotesDueAugust172021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A3125NotesDue2029Member" abstract="true" name="A3125NotesDue2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_NumberOfCountyGovernments" abstract="false" name="NumberOfCountyGovernments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" abstract="true" name="SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue" abstract="false" name="IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" abstract="false" name="NoncontrollingInterestIncreaseDecreaseDuetoOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember" abstract="true" name="SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A475NotesDueMarch12021Member" abstract="true" name="A475NotesDueMarch12021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_ChangeHealthcareLLCChangeHealthcareMember" abstract="true" name="ChangeHealthcareLLCChangeHealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" abstract="false" name="TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_A475NotesDueMay302029Member" abstract="true" name="A475NotesDueMay302029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_RedeemableNoncontrollingInterestMember" abstract="true" name="RedeemableNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A365NotesDueNovember302020Member" abstract="true" name="A365NotesDueNovember302020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A313SterlingNotesDueFebruary172029Member" abstract="true" name="A313SterlingNotesDueFebruary172029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_InternationalSegmentMember" abstract="true" name="InternationalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" abstract="false" name="IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_USPharmaceuticalSegmentMember" abstract="true" name="USPharmaceuticalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A600NotesDueMarch12041Member" abstract="true" name="A600NotesDueMarch12041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" abstract="false" name="LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_LossContingencyClassActionNumberofFaxesReceived" abstract="false" name="LossContingencyClassActionNumberofFaxesReceived" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_RevenueDerivedFromServicesPercentage" abstract="false" name="RevenueDerivedFromServicesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember" abstract="true" name="EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember" abstract="true" name="PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DefinedBenefitPlanSettlementPlanParticipants" abstract="false" name="DefinedBenefitPlanSettlementPlanParticipants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_TransitionServicesAgreementsTSAMember" abstract="true" name="TransitionServicesAgreementsTSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_OpenMarketShareRepurchaseTransactionsMember" abstract="true" name="OpenMarketShareRepurchaseTransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>mck-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:734100a7-c7c1-4795-ad72-160dc37ce333,g:f6cbe616-07cc-4518-be11-bf83875971ba-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mckesson123.com/role/CoverPage" xlink:type="simple" xlink:href="mck-20201231.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_44f381eb-012a-4c51-82e3-5212613b05a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_95d3a711-c1ea-4ac7-8bd0-8422f1b32762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_44f381eb-012a-4c51-82e3-5212613b05a1" xlink:to="loc_us-gaap_OperatingIncomeLoss_95d3a711-c1ea-4ac7-8bd0-8422f1b32762" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_16ae2b8a-6459-428e-a596-addf83cd337f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_44f381eb-012a-4c51-82e3-5212613b05a1" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_16ae2b8a-6459-428e-a596-addf83cd337f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c1b9507f-711f-47a0-93b6-044f301f980b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_44f381eb-012a-4c51-82e3-5212613b05a1" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c1b9507f-711f-47a0-93b6-044f301f980b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_23b0abc3-412f-4b8b-8262-db44a24d8d7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_44f381eb-012a-4c51-82e3-5212613b05a1" xlink:to="loc_us-gaap_InterestAndDebtExpense_23b0abc3-412f-4b8b-8262-db44a24d8d7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d2e00ce2-d121-49aa-9b16-45e9f86eebe4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_beb31503-1bc1-45e0-af50-9fdd641b898a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_d2e00ce2-d121-49aa-9b16-45e9f86eebe4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_beb31503-1bc1-45e0-af50-9fdd641b898a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_dc3b4237-f5c7-4293-94c9-cffe2a981e51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_d2e00ce2-d121-49aa-9b16-45e9f86eebe4" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_dc3b4237-f5c7-4293-94c9-cffe2a981e51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_9c540920-8a7f-4cb1-bbeb-a996efa01c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e004bfa7-6cf1-4c4e-bf08-2b4e752a2c4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_9c540920-8a7f-4cb1-bbeb-a996efa01c7b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e004bfa7-6cf1-4c4e-bf08-2b4e752a2c4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_30ca3fb9-96e8-466f-b02c-901bb4c7c6db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_9c540920-8a7f-4cb1-bbeb-a996efa01c7b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_30ca3fb9-96e8-466f-b02c-901bb4c7c6db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_213e0c7d-5d82-40bc-8e3a-093f1d434e4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_98b66c3b-99fc-4900-88b3-09143821c1b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_213e0c7d-5d82-40bc-8e3a-093f1d434e4c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_98b66c3b-99fc-4900-88b3-09143821c1b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c4fa4c99-e8f8-4955-9aac-69daf7770895" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_213e0c7d-5d82-40bc-8e3a-093f1d434e4c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c4fa4c99-e8f8-4955-9aac-69daf7770895" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_75922d9e-f4d1-4743-872f-0feecf935a74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_54135826-143f-4bc9-a4c9-95219129ad27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_75922d9e-f4d1-4743-872f-0feecf935a74" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_54135826-143f-4bc9-a4c9-95219129ad27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_301f86cd-6d1e-43fd-808d-4b2e2487db9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalFees"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_75922d9e-f4d1-4743-872f-0feecf935a74" xlink:to="loc_us-gaap_LegalFees_301f86cd-6d1e-43fd-808d-4b2e2487db9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges_9bfca286-b248-4a84-b07d-66ba987b103d" xlink:href="mck-20201231.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_75922d9e-f4d1-4743-872f-0feecf935a74" xlink:to="loc_mck_RestructuringImpairmentandOtherRelatedCharges_9bfca286-b248-4a84-b07d-66ba987b103d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_113382f4-342f-41fe-93c9-b3cc455be76b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_75922d9e-f4d1-4743-872f-0feecf935a74" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_113382f4-342f-41fe-93c9-b3cc455be76b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_964d1e4f-8a35-4c88-b348-77d6ca21e2ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_f9d52cae-29d7-4b8c-a06d-86b18007af59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_964d1e4f-8a35-4c88-b348-77d6ca21e2ad" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_f9d52cae-29d7-4b8c-a06d-86b18007af59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_d68fc0b3-b25d-4de6-9ef9-6234f8ebd7e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_964d1e4f-8a35-4c88-b348-77d6ca21e2ad" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_d68fc0b3-b25d-4de6-9ef9-6234f8ebd7e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a0bbd4fd-ce83-49ac-825a-18e0a8cc277e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_ac1b91a2-130f-4085-9926-1efbf2da51f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a0bbd4fd-ce83-49ac-825a-18e0a8cc277e" xlink:to="loc_us-gaap_OperatingExpenses_ac1b91a2-130f-4085-9926-1efbf2da51f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d3e8aa8d-0531-44a3-85d8-6cc08d6694a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a0bbd4fd-ce83-49ac-825a-18e0a8cc277e" xlink:to="loc_us-gaap_GrossProfit_d3e8aa8d-0531-44a3-85d8-6cc08d6694a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c3271c2f-1927-43d7-a2a0-a0bc75474ab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1055af46-2309-4731-bcea-af9429965ab5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c3271c2f-1927-43d7-a2a0-a0bc75474ab2" xlink:to="loc_us-gaap_ProfitLoss_1055af46-2309-4731-bcea-af9429965ab5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f848ea22-3d11-4464-92e8-5122595f44df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c3271c2f-1927-43d7-a2a0-a0bc75474ab2" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f848ea22-3d11-4464-92e8-5122595f44df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_dbc9b46e-a8ce-4b80-9707-9ff6bb72acd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_023fb92a-bc31-470d-af3e-f5ef78419a08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_dbc9b46e-a8ce-4b80-9707-9ff6bb72acd9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_023fb92a-bc31-470d-af3e-f5ef78419a08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_0a81bb3e-731f-43f3-9ece-794c34b6d3bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_dbc9b46e-a8ce-4b80-9707-9ff6bb72acd9" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_0a81bb3e-731f-43f3-9ece-794c34b6d3bf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d1d2e97e-5baf-49a0-b591-f0d881ae3c87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_88d2f5c7-48b0-4229-9e29-e09749119754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d1d2e97e-5baf-49a0-b591-f0d881ae3c87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_88d2f5c7-48b0-4229-9e29-e09749119754" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3c6f3318-a079-4726-8d45-fa94ca709f2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d1d2e97e-5baf-49a0-b591-f0d881ae3c87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3c6f3318-a079-4726-8d45-fa94ca709f2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_413d12bc-68af-451b-a93d-1a54e62c4712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d1d2e97e-5baf-49a0-b591-f0d881ae3c87" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_413d12bc-68af-451b-a93d-1a54e62c4712" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d27886d3-9b0d-4eda-965c-8a35d5ff6727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9f2caa33-f530-4087-9821-5a82a3e4ee58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_d27886d3-9b0d-4eda-965c-8a35d5ff6727" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9f2caa33-f530-4087-9821-5a82a3e4ee58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_4db37764-f74b-4ffd-9fd6-cc2771f262d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_d27886d3-9b0d-4eda-965c-8a35d5ff6727" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_4db37764-f74b-4ffd-9fd6-cc2771f262d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6c04b6f4-b797-4560-aaa3-56be35188c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_013bbd32-ef14-4350-ae66-96be6077e335" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6c04b6f4-b797-4560-aaa3-56be35188c62" xlink:to="loc_us-gaap_ProfitLoss_013bbd32-ef14-4350-ae66-96be6077e335" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_157043fa-b2de-453d-9804-ef65fcbad3ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6c04b6f4-b797-4560-aaa3-56be35188c62" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_157043fa-b2de-453d-9804-ef65fcbad3ea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b37fdcef-a6a4-4729-b0f3-380efc16c989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_da7d44f1-07ae-4037-9f33-c9345372838c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b37fdcef-a6a4-4729-b0f3-380efc16c989" xlink:to="loc_us-gaap_AccountsPayableCurrent_da7d44f1-07ae-4037-9f33-c9345372838c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_850ba1c7-7188-4785-9e14-1ab47eb1455f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b37fdcef-a6a4-4729-b0f3-380efc16c989" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_850ba1c7-7188-4785-9e14-1ab47eb1455f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_c19cda9a-6a07-41a6-979b-42b04dbd97b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b37fdcef-a6a4-4729-b0f3-380efc16c989" xlink:to="loc_us-gaap_ShortTermBorrowings_c19cda9a-6a07-41a6-979b-42b04dbd97b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_da9e92a9-33b6-4a6e-b798-995148ea98a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b37fdcef-a6a4-4729-b0f3-380efc16c989" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_da9e92a9-33b6-4a6e-b798-995148ea98a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_0e850151-a35d-453c-a875-4f3b34e99df3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b37fdcef-a6a4-4729-b0f3-380efc16c989" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_0e850151-a35d-453c-a875-4f3b34e99df3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_5e210f31-39b0-4ced-ab1d-48b1104102c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b37fdcef-a6a4-4729-b0f3-380efc16c989" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_5e210f31-39b0-4ced-ab1d-48b1104102c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0d755644-3858-4806-be77-710f6587b65d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_13e73f34-22f7-466b-a2e9-d75bcd2bd7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0d755644-3858-4806-be77-710f6587b65d" xlink:to="loc_us-gaap_AssetsCurrent_13e73f34-22f7-466b-a2e9-d75bcd2bd7fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_de6efc68-f091-4ff8-b883-db0d4f33d4ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0d755644-3858-4806-be77-710f6587b65d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_de6efc68-f091-4ff8-b883-db0d4f33d4ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a6ab9257-6a8b-4615-a216-362eda2f5150" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0d755644-3858-4806-be77-710f6587b65d" xlink:to="loc_us-gaap_Goodwill_a6ab9257-6a8b-4615-a216-362eda2f5150" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bbbd43f3-7309-411f-82bc-c63a2baa2b7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0d755644-3858-4806-be77-710f6587b65d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bbbd43f3-7309-411f-82bc-c63a2baa2b7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1e493c50-255e-4f64-956c-fbe9b92c99c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0d755644-3858-4806-be77-710f6587b65d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1e493c50-255e-4f64-956c-fbe9b92c99c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7cc199ac-8e47-4ace-9d4e-1f2c711c26fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0d755644-3858-4806-be77-710f6587b65d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7cc199ac-8e47-4ace-9d4e-1f2c711c26fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_421587f0-448d-436f-a21b-2549a1916787" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1799b13e-68cd-41d7-9b17-968045ed6339" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_421587f0-448d-436f-a21b-2549a1916787" xlink:to="loc_us-gaap_StockholdersEquity_1799b13e-68cd-41d7-9b17-968045ed6339" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_95a86d32-9e9b-40ca-85eb-092690b1548d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_421587f0-448d-436f-a21b-2549a1916787" xlink:to="loc_us-gaap_MinorityInterest_95a86d32-9e9b-40ca-85eb-092690b1548d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_71744581-e69b-4502-beed-f5d01a4a555b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_94b65b29-4d1f-49ef-80b0-f424a2a3c06f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_71744581-e69b-4502-beed-f5d01a4a555b" xlink:to="loc_us-gaap_PreferredStockValue_94b65b29-4d1f-49ef-80b0-f424a2a3c06f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_458d0e50-8bb6-4db7-a957-390d1ced7224" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_71744581-e69b-4502-beed-f5d01a4a555b" xlink:to="loc_us-gaap_CommonStockValue_458d0e50-8bb6-4db7-a957-390d1ced7224" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_b28a8826-5f65-4d21-b51f-437a3400d7e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_71744581-e69b-4502-beed-f5d01a4a555b" xlink:to="loc_us-gaap_AdditionalPaidInCapital_b28a8826-5f65-4d21-b51f-437a3400d7e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2bf3bdb8-e66c-42a3-80c6-53e9adb0b4e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_71744581-e69b-4502-beed-f5d01a4a555b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2bf3bdb8-e66c-42a3-80c6-53e9adb0b4e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ba403105-391b-4803-8dad-9ee109e11d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_71744581-e69b-4502-beed-f5d01a4a555b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ba403105-391b-4803-8dad-9ee109e11d2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_cbb59ef4-1855-4011-b0f0-147b108547a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_71744581-e69b-4502-beed-f5d01a4a555b" xlink:to="loc_us-gaap_TreasuryStockValue_cbb59ef4-1855-4011-b0f0-147b108547a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_08e03c54-d6c1-4568-b05f-b70ef7871647" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f0786f4c-baa6-42ed-8870-ab84c3c553e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_08e03c54-d6c1-4568-b05f-b70ef7871647" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f0786f4c-baa6-42ed-8870-ab84c3c553e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_301cacea-c150-48a1-846a-2ac308c7cbe4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_08e03c54-d6c1-4568-b05f-b70ef7871647" xlink:to="loc_us-gaap_LiabilitiesCurrent_301cacea-c150-48a1-846a-2ac308c7cbe4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_0516251e-c64a-44aa-973f-35aec6ccea0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_08e03c54-d6c1-4568-b05f-b70ef7871647" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_0516251e-c64a-44aa-973f-35aec6ccea0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e3bdb76f-2bd8-40bd-b7af-e3baa64f78b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_08e03c54-d6c1-4568-b05f-b70ef7871647" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e3bdb76f-2bd8-40bd-b7af-e3baa64f78b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_53a53dfc-6c3e-4d12-8882-2386da3adbbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_08e03c54-d6c1-4568-b05f-b70ef7871647" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_53a53dfc-6c3e-4d12-8882-2386da3adbbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_eb6efe5e-e8c7-401f-9b73-546e07229fcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_08e03c54-d6c1-4568-b05f-b70ef7871647" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_eb6efe5e-e8c7-401f-9b73-546e07229fcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_62f00c49-5750-4232-990f-118c0d38d7da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_08e03c54-d6c1-4568-b05f-b70ef7871647" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_62f00c49-5750-4232-990f-118c0d38d7da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3fc085b4-b71b-4598-b9a2-fd4fbb92f963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_08e03c54-d6c1-4568-b05f-b70ef7871647" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3fc085b4-b71b-4598-b9a2-fd4fbb92f963" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6ffd5554-c614-4a0c-8285-1f5ac69f47ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_34e9ed1c-7b0b-4a79-b1a8-f44a2ae1fbe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6ffd5554-c614-4a0c-8285-1f5ac69f47ef" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_34e9ed1c-7b0b-4a79-b1a8-f44a2ae1fbe1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_d3fce1ff-f860-4751-85c3-ed0f8745fa6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6ffd5554-c614-4a0c-8285-1f5ac69f47ef" xlink:to="loc_us-gaap_ReceivablesNetCurrent_d3fce1ff-f860-4751-85c3-ed0f8745fa6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_978e6a2f-df73-4e45-a526-60724f9d5c34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6ffd5554-c614-4a0c-8285-1f5ac69f47ef" xlink:to="loc_us-gaap_InventoryNet_978e6a2f-df73-4e45-a526-60724f9d5c34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f724db3c-e99c-416d-966f-f15129c88bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6ffd5554-c614-4a0c-8285-1f5ac69f47ef" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f724db3c-e99c-416d-966f-f15129c88bca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_db3dd703-9606-4d81-aac9-9c0cd2ca7ffe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6ffd5554-c614-4a0c-8285-1f5ac69f47ef" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_db3dd703-9606-4d81-aac9-9c0cd2ca7ffe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eae87abb-26b5-48e7-96a6-6d989278168c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_d894817f-83ba-4ca2-b3f0-ca7e69550362" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eae87abb-26b5-48e7-96a6-6d989278168c" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_d894817f-83ba-4ca2-b3f0-ca7e69550362" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_7d7eadcb-aa10-4303-825d-2e6d304858a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eae87abb-26b5-48e7-96a6-6d989278168c" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_7d7eadcb-aa10-4303-825d-2e6d304858a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a7f7bcd1-42e8-417b-9bb2-d220361485af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eae87abb-26b5-48e7-96a6-6d989278168c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a7f7bcd1-42e8-417b-9bb2-d220361485af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_bcbc2388-1d91-440f-8eb8-63f1f18eafa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eae87abb-26b5-48e7-96a6-6d989278168c" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_bcbc2388-1d91-440f-8eb8-63f1f18eafa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_fc5b8575-49f5-470c-9a41-0b14281db185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eae87abb-26b5-48e7-96a6-6d989278168c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_fc5b8575-49f5-470c-9a41-0b14281db185" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ca755444-10d9-4ea0-9795-c8ea860ea016" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eae87abb-26b5-48e7-96a6-6d989278168c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ca755444-10d9-4ea0-9795-c8ea860ea016" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_2499c2b1-65f1-4a83-9e46-d0d422b73ed5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eae87abb-26b5-48e7-96a6-6d989278168c" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_2499c2b1-65f1-4a83-9e46-d0d422b73ed5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5bfee37d-0439-4461-9eab-205bb3ee5ff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eae87abb-26b5-48e7-96a6-6d989278168c" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5bfee37d-0439-4461-9eab-205bb3ee5ff5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_178712e9-81da-41c5-b05a-8dbb47654980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_1304a354-3b0e-4b3a-9eae-a0d6f4a27cde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_178712e9-81da-41c5-b05a-8dbb47654980" xlink:to="loc_us-gaap_RestrictedCashCurrent_1304a354-3b0e-4b3a-9eae-a0d6f4a27cde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6c22cc2c-276b-48b6-9815-84297b3817d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_178712e9-81da-41c5-b05a-8dbb47654980" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6c22cc2c-276b-48b6-9815-84297b3817d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2e649936-9e39-43f6-b90c-f8a711dc7c24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3db32021-4046-4d6a-be1e-1498432069d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2e649936-9e39-43f6-b90c-f8a711dc7c24" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3db32021-4046-4d6a-be1e-1498432069d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_b2b1d2de-5504-4cdf-8782-46ef123e454c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2e649936-9e39-43f6-b90c-f8a711dc7c24" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_b2b1d2de-5504-4cdf-8782-46ef123e454c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c3660f24-4467-4a0c-8a99-6b7ee2f57af3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2e649936-9e39-43f6-b90c-f8a711dc7c24" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c3660f24-4467-4a0c-8a99-6b7ee2f57af3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_30ab437b-f149-410c-a7ba-20de6a67d77d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2e649936-9e39-43f6-b90c-f8a711dc7c24" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_30ab437b-f149-410c-a7ba-20de6a67d77d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3936251e-6914-4593-9584-b215dee365fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2e649936-9e39-43f6-b90c-f8a711dc7c24" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3936251e-6914-4593-9584-b215dee365fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c54228d-bcc2-4f6a-a061-7be632a287af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e834469e-2f5f-4daa-b6d7-e6b204c46c02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c54228d-bcc2-4f6a-a061-7be632a287af" xlink:to="loc_us-gaap_ProfitLoss_e834469e-2f5f-4daa-b6d7-e6b204c46c02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1b667acc-e475-468d-9814-74f95be4194d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c54228d-bcc2-4f6a-a061-7be632a287af" xlink:to="loc_us-gaap_Depreciation_1b667acc-e475-468d-9814-74f95be4194d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_27a99fd3-a6fb-438f-9640-227863e70c24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c54228d-bcc2-4f6a-a061-7be632a287af" xlink:to="loc_us-gaap_AssetImpairmentCharges_27a99fd3-a6fb-438f-9640-227863e70c24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_472254fd-daf5-4825-85e0-6c98e39f0b06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c54228d-bcc2-4f6a-a061-7be632a287af" xlink:to="loc_us-gaap_AdjustmentForAmortization_472254fd-daf5-4825-85e0-6c98e39f0b06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_8de5fb07-0273-4fe8-9f93-2362de053229" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c54228d-bcc2-4f6a-a061-7be632a287af" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_8de5fb07-0273-4fe8-9f93-2362de053229" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_3a1b4aa2-16c6-49ca-8f96-e1ccce3d3855" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c54228d-bcc2-4f6a-a061-7be632a287af" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_3a1b4aa2-16c6-49ca-8f96-e1ccce3d3855" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_e0f51134-85cb-4f4f-b296-cf1018841910" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c54228d-bcc2-4f6a-a061-7be632a287af" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_e0f51134-85cb-4f4f-b296-cf1018841910" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_93706c95-f9df-4128-8aa6-d7e5128dd572" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c54228d-bcc2-4f6a-a061-7be632a287af" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_93706c95-f9df-4128-8aa6-d7e5128dd572" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_9e372963-7611-4b42-90b9-447091d5de49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c54228d-bcc2-4f6a-a061-7be632a287af" xlink:to="loc_us-gaap_OperatingLeaseExpense_9e372963-7611-4b42-90b9-447091d5de49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_67634988-65ff-4ada-8c64-d128eaf6d227" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c54228d-bcc2-4f6a-a061-7be632a287af" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_67634988-65ff-4ada-8c64-d128eaf6d227" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_3fec5e6d-4afb-45b3-8835-f3e3655f62c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c54228d-bcc2-4f6a-a061-7be632a287af" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_3fec5e6d-4afb-45b3-8835-f3e3655f62c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_5f0b4713-130f-422b-b038-a92a442d0bfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c54228d-bcc2-4f6a-a061-7be632a287af" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_5f0b4713-130f-422b-b038-a92a442d0bfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_dee874e9-fd65-475c-9f90-5bb43a32be3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c54228d-bcc2-4f6a-a061-7be632a287af" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_dee874e9-fd65-475c-9f90-5bb43a32be3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve_613b9f92-3e87-431d-8805-25767034a0f7" xlink:href="mck-20201231.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c54228d-bcc2-4f6a-a061-7be632a287af" xlink:to="loc_mck_IncreaseDecreaseInLitigationReserve_613b9f92-3e87-431d-8805-25767034a0f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_194a9979-eee8-49de-8df1-040c7ce6650b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c54228d-bcc2-4f6a-a061-7be632a287af" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_194a9979-eee8-49de-8df1-040c7ce6650b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseinOperatingLeaseLiabilities_b55b3f28-60a0-420f-9d4a-4f936278a0dd" xlink:href="mck-20201231.xsd#mck_IncreaseDecreaseinOperatingLeaseLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c54228d-bcc2-4f6a-a061-7be632a287af" xlink:to="loc_mck_IncreaseDecreaseinOperatingLeaseLiabilities_b55b3f28-60a0-420f-9d4a-4f936278a0dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_8a19c1ba-3f95-4d51-83d3-7c86b5c8a7a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c54228d-bcc2-4f6a-a061-7be632a287af" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_8a19c1ba-3f95-4d51-83d3-7c86b5c8a7a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8ee182f0-a5e4-4f65-8ce0-733c27017d1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_11245352-e171-407b-a1b4-d9c16552961e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8ee182f0-a5e4-4f65-8ce0-733c27017d1d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_11245352-e171-407b-a1b4-d9c16552961e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_81be33f2-271d-4e48-96e6-1dafaf479ab0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8ee182f0-a5e4-4f65-8ce0-733c27017d1d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_81be33f2-271d-4e48-96e6-1dafaf479ab0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cde8329e-c95c-4182-9496-07a0a9482fc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8ee182f0-a5e4-4f65-8ce0-733c27017d1d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cde8329e-c95c-4182-9496-07a0a9482fc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3069c213-fa44-4b5d-a606-8578abe86fda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8ee182f0-a5e4-4f65-8ce0-733c27017d1d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3069c213-fa44-4b5d-a606-8578abe86fda" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="mck-20201231.xsd#SignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mck-20201231.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture" xlink:type="simple" xlink:href="mck-20201231.xsd#InvestmentinChangeHealthcareJointVenture"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#InvestmentinChangeHealthcareJointVentureDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSale" xlink:type="simple" xlink:href="mck-20201231.xsd#HeldforSale"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HeldforSale" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleTables" xlink:type="simple" xlink:href="mck-20201231.xsd#HeldforSaleTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HeldforSaleTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#HeldforSaleNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_8cd2c427-6569-4649-b772-6ac6cb802812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_14123b78-ed09-4961-9209-f439732b5768" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_8cd2c427-6569-4649-b772-6ac6cb802812" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_14123b78-ed09-4961-9209-f439732b5768" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_5dd7f79f-8b8a-4815-b208-0069d3946275" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_8cd2c427-6569-4649-b772-6ac6cb802812" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_5dd7f79f-8b8a-4815-b208-0069d3946275" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_343c2346-0992-4dbf-b90a-ec7874c69612" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_8cd2c427-6569-4649-b772-6ac6cb802812" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_343c2346-0992-4dbf-b90a-ec7874c69612" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_7ad41184-8b06-45e9-a67e-29faf00f6c73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_7a37e4dc-e232-4eeb-8c85-aeda7d2260bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_7ad41184-8b06-45e9-a67e-29faf00f6c73" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_7a37e4dc-e232-4eeb-8c85-aeda7d2260bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_40ed6d90-ca2a-4675-b107-fe9709207381" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_7ad41184-8b06-45e9-a67e-29faf00f6c73" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_40ed6d90-ca2a-4675-b107-fe9709207381" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_4c318040-3b4c-4b79-a8a1-5247a270346d" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_7ad41184-8b06-45e9-a67e-29faf00f6c73" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_4c318040-3b4c-4b79-a8a1-5247a270346d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_6db5df6d-b138-4d97-86ed-63a3985b897b" xlink:href="mck-20201231.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_7ad41184-8b06-45e9-a67e-29faf00f6c73" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_6db5df6d-b138-4d97-86ed-63a3985b897b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="simple" xlink:href="mck-20201231.xsd#RestructuringImpairmentandRelatedCharges"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="simple" xlink:href="mck-20201231.xsd#RestructuringImpairmentandRelatedChargesTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#RestructuringImpairmentandRelatedChargesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_1a0465b8-7f54-4d15-8902-5c9d92501223" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_3c31f394-4758-49b0-b9c9-5544bafdad3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_1a0465b8-7f54-4d15-8902-5c9d92501223" xlink:to="loc_us-gaap_SeveranceCosts1_3c31f394-4758-49b0-b9c9-5544bafdad3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_2ef7c16d-f4cd-43b9-859e-da8fbc0a883d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_1a0465b8-7f54-4d15-8902-5c9d92501223" xlink:to="loc_us-gaap_BusinessExitCosts1_2ef7c16d-f4cd-43b9-859e-da8fbc0a883d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_19018a6e-4ec1-4e4a-bd3c-07138e4421d0" xlink:href="mck-20201231.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_1a0465b8-7f54-4d15-8902-5c9d92501223" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_19018a6e-4ec1-4e4a-bd3c-07138e4421d0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mck-20201231.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#IncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="simple" xlink:href="mck-20201231.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterests"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="simple" xlink:href="mck-20201231.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShare" xlink:type="simple" xlink:href="mck-20201231.xsd#EarningsLossPerCommonShare"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareTables" xlink:type="simple" xlink:href="mck-20201231.xsd#EarningsLossPerCommonShareTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#EarningsLossPerCommonShareDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_c701e81f-e930-4fc3-b4c1-041aa6e4b9c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_d0ca22a1-0505-4a05-828c-8fea8823c325" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_c701e81f-e930-4fc3-b4c1-041aa6e4b9c1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_d0ca22a1-0505-4a05-828c-8fea8823c325" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_786bae1e-affc-4543-b395-0e16681007f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_c701e81f-e930-4fc3-b4c1-041aa6e4b9c1" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_786bae1e-affc-4543-b395-0e16681007f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cab79464-5df5-41e2-bc7b-b1b05501852a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_912bb7f6-3b42-4781-bd13-dc98b3184bfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cab79464-5df5-41e2-bc7b-b1b05501852a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_912bb7f6-3b42-4781-bd13-dc98b3184bfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_98d30977-08ef-4118-a4b9-2bd6b0427de6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cab79464-5df5-41e2-bc7b-b1b05501852a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_98d30977-08ef-4118-a4b9-2bd6b0427de6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_59fd583e-4c3a-420d-ac77-8c62889c769b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_36c7a316-3e8d-4b80-af95-4612fab8c5ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_59fd583e-4c3a-420d-ac77-8c62889c769b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_36c7a316-3e8d-4b80-af95-4612fab8c5ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_6e6b61ef-acf8-4f8b-bfb3-6b055e66104c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_59fd583e-4c3a-420d-ac77-8c62889c769b" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_6e6b61ef-acf8-4f8b-bfb3-6b055e66104c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="mck-20201231.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="mck-20201231.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d818fc26-17ea-4b06-88d9-c86506b1de98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3c9cfd36-bae2-44b1-88a0-b83f80f927bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d818fc26-17ea-4b06-88d9-c86506b1de98" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3c9cfd36-bae2-44b1-88a0-b83f80f927bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_96dcde79-fc8f-47e5-9a51-d40612b9b64f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d818fc26-17ea-4b06-88d9-c86506b1de98" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_96dcde79-fc8f-47e5-9a51-d40612b9b64f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivities"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivitiesTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_6b350447-33c6-49f0-9827-a5b6d9cf21ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_2c517ba2-c19a-475d-b9f7-d4c15dc06bcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_6b350447-33c6-49f0-9827-a5b6d9cf21ed" xlink:to="loc_us-gaap_FinanceLeaseLiability_2c517ba2-c19a-475d-b9f7-d4c15dc06bcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_751c18fb-eead-486c-924b-02f935e29bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_6b350447-33c6-49f0-9827-a5b6d9cf21ed" xlink:to="loc_us-gaap_LongTermDebt_751c18fb-eead-486c-924b-02f935e29bc9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_3a9158a3-7a6d-47c2-a313-24899a59e95a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_4389ea24-d5d8-44dd-bd39-63cb799b43d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_3a9158a3-7a6d-47c2-a313-24899a59e95a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_4389ea24-d5d8-44dd-bd39-63cb799b43d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f492ca2c-c281-4355-a75e-62f5d5e6c143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_3a9158a3-7a6d-47c2-a313-24899a59e95a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f492ca2c-c281-4355-a75e-62f5d5e6c143" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivitiesLongTermDebtNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivitiesCommercialPaperDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StatementofIncomeIncludingGrossMarginStatement" xlink:type="simple" xlink:href="mck-20201231.xsd#StatementofIncomeIncludingGrossMarginStatement"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StatementofIncomeIncludingGrossMarginStatement" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefits" xlink:type="simple" xlink:href="mck-20201231.xsd#PensionBenefits"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefits" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#PensionBenefitsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivities" xlink:type="simple" xlink:href="mck-20201231.xsd#HedgingActivities"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HedgingActivities" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="simple" xlink:href="mck-20201231.xsd#HedgingActivitiesTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#HedgingActivitiesDerivativeInstrumentsFairValueDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mck-20201231.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#FairValueMeasurementsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="simple" xlink:href="mck-20201231.xsd#CommitmentsandContingentLiabilities"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#CommitmentsandContingentLiabilitiesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficit" xlink:type="simple" xlink:href="mck-20201231.xsd#StockholdersEquityDeficit"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficit" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitTables" xlink:type="simple" xlink:href="mck-20201231.xsd#StockholdersEquityDeficitTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#StockholdersEquityDeficitNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_64537694-8740-4c8b-8636-d89fe6696d6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_348032a0-4ede-4248-8525-f831569ff90f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_64537694-8740-4c8b-8636-d89fe6696d6b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_348032a0-4ede-4248-8525-f831569ff90f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_22d3a9fc-75b4-4aec-bcf6-f588c691c7fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_64537694-8740-4c8b-8636-d89fe6696d6b" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_22d3a9fc-75b4-4aec-bcf6-f588c691c7fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_41b802bd-2feb-43b9-9e6c-08fde55497f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_95ba52f3-a48d-40a7-a3dd-9eb3cb7c839e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_41b802bd-2feb-43b9-9e6c-08fde55497f2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_95ba52f3-a48d-40a7-a3dd-9eb3cb7c839e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_52ccdc23-9570-49ba-bcd3-6cb56b68d26e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_41b802bd-2feb-43b9-9e6c-08fde55497f2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_52ccdc23-9570-49ba-bcd3-6cb56b68d26e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="simple" xlink:href="mck-20201231.xsd#SegmentsofBusiness"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="simple" xlink:href="mck-20201231.xsd#SegmentsofBusinessTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#SegmentsofBusinessDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7ad06602-60cf-4653-bf0e-4ffa67962092" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8610e91e-8fac-4713-8a18-2332cc3ebaa6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7ad06602-60cf-4653-bf0e-4ffa67962092" xlink:to="loc_us-gaap_OperatingIncomeLoss_8610e91e-8fac-4713-8a18-2332cc3ebaa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_7cc1796d-56e3-4186-bfa1-732bbb46b65f" xlink:href="mck-20201231.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7ad06602-60cf-4653-bf0e-4ffa67962092" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_7cc1796d-56e3-4186-bfa1-732bbb46b65f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_40c9225f-4a25-4c93-be77-83ed1c3c5bbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7ad06602-60cf-4653-bf0e-4ffa67962092" xlink:to="loc_us-gaap_InterestAndDebtExpense_40c9225f-4a25-4c93-be77-83ed1c3c5bbe" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>mck-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:734100a7-c7c1-4795-ad72-160dc37ce333,g:f6cbe616-07cc-4518-be11-bf83875971ba-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CoverPage" xlink:type="simple" xlink:href="mck-20201231.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CoverPage" xlink:type="extended" id="ib4c9233793d4497ba13d861f36a2b407_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8f4fc86f-791b-4281-b673-da93918b564b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_DocumentType_8f4fc86f-791b-4281-b673-da93918b564b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_869e113a-c75d-41ab-9114-e2985c89fbbc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_DocumentQuarterlyReport_869e113a-c75d-41ab-9114-e2985c89fbbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_7628bb9e-9944-46a6-b1ba-4b026b4efc7e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_DocumentPeriodEndDate_7628bb9e-9944-46a6-b1ba-4b026b4efc7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_07a4ed66-299b-4a2a-9ced-a65dc6ec9159" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_DocumentTransitionReport_07a4ed66-299b-4a2a-9ced-a65dc6ec9159" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e6be84c4-a12a-4d29-93aa-89a93b75c88c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityFileNumber_e6be84c4-a12a-4d29-93aa-89a93b75c88c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_4084e12e-c709-430c-a66c-0acd99d785f5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityRegistrantName_4084e12e-c709-430c-a66c-0acd99d785f5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d62950dc-62da-4e5c-97ef-c2274b1775b5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d62950dc-62da-4e5c-97ef-c2274b1775b5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_04ce2894-3b90-4206-b18c-207fb1933e8b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityTaxIdentificationNumber_04ce2894-3b90-4206-b18c-207fb1933e8b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_710aa5ff-ebf3-46a8-9421-1de60b653a2e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityAddressAddressLine1_710aa5ff-ebf3-46a8-9421-1de60b653a2e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_8ff3902c-d662-4a7c-b2e6-ecdd46914742" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityAddressCityOrTown_8ff3902c-d662-4a7c-b2e6-ecdd46914742" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_057c5fa8-5512-4cd8-8330-2fef546aa916" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityAddressStateOrProvince_057c5fa8-5512-4cd8-8330-2fef546aa916" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_030fe5c2-3df9-495d-ab29-f0d9abc5afd9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityAddressPostalZipCode_030fe5c2-3df9-495d-ab29-f0d9abc5afd9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f3c315d7-d5c7-4845-9d0e-99bc0097a721" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_CityAreaCode_f3c315d7-d5c7-4845-9d0e-99bc0097a721" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_09a59829-29bc-4089-807c-055a1b9ecd41" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_LocalPhoneNumber_09a59829-29bc-4089-807c-055a1b9ecd41" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_55412bf6-9086-4941-b4bc-63220c768019" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_Security12bTitle_55412bf6-9086-4941-b4bc-63220c768019" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_a90e4218-050e-4b8a-8d7e-58069ccd7458" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_TradingSymbol_a90e4218-050e-4b8a-8d7e-58069ccd7458" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_5e8dd09e-e345-450f-aae3-4cb9ca43b445" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_SecurityExchangeName_5e8dd09e-e345-450f-aae3-4cb9ca43b445" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_2f452999-3692-41bb-a934-a9ff1884a4eb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityCurrentReportingStatus_2f452999-3692-41bb-a934-a9ff1884a4eb" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_6f4655d2-becf-445c-9600-0b84ff2bf2ba" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityInteractiveDataCurrent_6f4655d2-becf-445c-9600-0b84ff2bf2ba" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_10489906-bef0-4b57-a945-360508f5f81d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityFilerCategory_10489906-bef0-4b57-a945-360508f5f81d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_a2af2759-e6f1-4c9c-8c6c-eab918ab6589" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntitySmallBusiness_a2af2759-e6f1-4c9c-8c6c-eab918ab6589" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_70cb495b-f066-42e6-86ec-c3679c27972a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityEmergingGrowthCompany_70cb495b-f066-42e6-86ec-c3679c27972a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_8a035b35-6069-43c4-b346-f0da465f5b3e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityShellCompany_8a035b35-6069-43c4-b346-f0da465f5b3e" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_14276463-2ea4-4b98-9b73-bae04179ce77" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_14276463-2ea4-4b98-9b73-bae04179ce77" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_05c5cf8b-48ce-44d6-8807-c3f6d4cbeddc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityCentralIndexKey_05c5cf8b-48ce-44d6-8807-c3f6d4cbeddc" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_adc447f3-46c5-43a2-8bb1-4023d7e18529" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_DocumentFiscalYearFocus_adc447f3-46c5-43a2-8bb1-4023d7e18529" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_9262cfec-1397-4156-9a96-7a6d92764444" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_DocumentFiscalPeriodFocus_9262cfec-1397-4156-9a96-7a6d92764444" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ea651dab-3954-4257-b699-6e13f2194060" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_AmendmentFlag_ea651dab-3954-4257-b699-6e13f2194060" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_e7a40065-493f-47bd-bc5b-c65e6ac06651" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_CurrentFiscalYearEndDate_e7a40065-493f-47bd-bc5b-c65e6ac06651" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_4c85ed0d-21a4-4f6f-baf7-fcb7cc9b34ed" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntitiesTable_4c85ed0d-21a4-4f6f-baf7-fcb7cc9b34ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b530f9f0-9ca3-47e0-9f0f-517efb584580" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_4c85ed0d-21a4-4f6f-baf7-fcb7cc9b34ed" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b530f9f0-9ca3-47e0-9f0f-517efb584580" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b530f9f0-9ca3-47e0-9f0f-517efb584580_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b530f9f0-9ca3-47e0-9f0f-517efb584580" xlink:to="loc_us-gaap_ClassOfStockDomain_b530f9f0-9ca3-47e0-9f0f-517efb584580_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c248eecc-ea5e-4b6e-af03-722fb6ee7c45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b530f9f0-9ca3-47e0-9f0f-517efb584580" xlink:to="loc_us-gaap_ClassOfStockDomain_c248eecc-ea5e-4b6e-af03-722fb6ee7c45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ca5c08e0-91b4-4241-8683-78d7ddccfe9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c248eecc-ea5e-4b6e-af03-722fb6ee7c45" xlink:to="loc_us-gaap_CommonStockMember_ca5c08e0-91b4-4241-8683-78d7ddccfe9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A0625NotesDue2021Member_4ac17397-4145-4102-aed3-5050cb82e3ef" xlink:href="mck-20201231.xsd#mck_A0625NotesDue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c248eecc-ea5e-4b6e-af03-722fb6ee7c45" xlink:to="loc_mck_A0625NotesDue2021Member_4ac17397-4145-4102-aed3-5050cb82e3ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1500NotesDue2025Member_ab156aef-775e-480a-a8d7-8d4af20669dc" xlink:href="mck-20201231.xsd#mck_A1500NotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c248eecc-ea5e-4b6e-af03-722fb6ee7c45" xlink:to="loc_mck_A1500NotesDue2025Member_ab156aef-775e-480a-a8d7-8d4af20669dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1625NotesDue2026Member_33a3b90d-4683-48f5-a74f-38cb86514d77" xlink:href="mck-20201231.xsd#mck_A1625NotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c248eecc-ea5e-4b6e-af03-722fb6ee7c45" xlink:to="loc_mck_A1625NotesDue2026Member_33a3b90d-4683-48f5-a74f-38cb86514d77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3125NotesDue2029Member_1f314cc9-7f3c-4468-a29a-0339ecb516b7" xlink:href="mck-20201231.xsd#mck_A3125NotesDue2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c248eecc-ea5e-4b6e-af03-722fb6ee7c45" xlink:to="loc_mck_A3125NotesDue2029Member_1f314cc9-7f3c-4468-a29a-0339ecb516b7" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="i23ac2510ee944126b35ffc4d2eaa86ac_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended" id="i432f9c346a58485780dedb8fef9cd78d_CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended" id="i071655e4e80944c9add41f11399b0708_CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended" id="i766dc0c37dd04a28909703be641508a5_CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended" id="id207f0d567a54b048088fb763d060b37_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ecb969b4-c415-4ddb-a49c-acace24f8c72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ecb969b4-c415-4ddb-a49c-acace24f8c72" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_4d03d386-46f6-49f0-9b01-0767cbd26726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_SharesOutstanding_4d03d386-46f6-49f0-9b01-0767cbd26726" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_93f79231-eaaf-4fe4-8721-04d2bd585c34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_TreasuryStockShares_93f79231-eaaf-4fe4-8721-04d2bd585c34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4d749cbb-e684-40e3-80aa-5af5f24581cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4d749cbb-e684-40e3-80aa-5af5f24581cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_5f744614-0e37-49cb-a9dc-4a2c2639d67c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_5f744614-0e37-49cb-a9dc-4a2c2639d67c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_ee8c0df5-e764-4599-afd4-1b4d6c95f908" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_ee8c0df5-e764-4599-afd4-1b4d6c95f908" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d6f6fc9b-8872-48c2-bcb0-d0ae151d5701" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d6f6fc9b-8872-48c2-bcb0-d0ae151d5701" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e315bc1c-7fa9-4303-b39f-c3a9f48bfb37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e315bc1c-7fa9-4303-b39f-c3a9f48bfb37" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b616898f-395a-46cf-a73f-5b944627bf26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b616898f-395a-46cf-a73f-5b944627bf26" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_4e33fe26-cb51-4ce1-8253-78caece371a6" xlink:href="mck-20201231.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_4e33fe26-cb51-4ce1-8253-78caece371a6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_15d4fd07-a8e9-44e9-9d14-35b2e981a671" xlink:href="mck-20201231.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_15d4fd07-a8e9-44e9-9d14-35b2e981a671" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_79de7f50-f723-46c3-babd-852580a3d556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_79de7f50-f723-46c3-babd-852580a3d556" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_33b4b78f-8e34-4f38-abb6-f134a0fe9de6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_33b4b78f-8e34-4f38-abb6-f134a0fe9de6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_7075854a-2085-4e37-bd87-c96ad4d61aba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_DividendsCommonStockCash_7075854a-2085-4e37-bd87-c96ad4d61aba" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_b38828ee-ad37-44d8-842c-9d3dd9a81be4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_StockholdersEquityOther_b38828ee-ad37-44d8-842c-9d3dd9a81be4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_48fb2f66-cb11-44c2-b226-2cc18594ba65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_fbde4489-368e-4316-b3eb-bec5be67e725" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e9c356ce-7b57-4bea-a88a-9617801a6ed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_5b1501ac-2ba4-4d8f-ae81-6c249c301e0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ecb969b4-c415-4ddb-a49c-acace24f8c72" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_5b1501ac-2ba4-4d8f-ae81-6c249c301e0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ec81b323-2344-4609-9f1a-01effe726848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ecb969b4-c415-4ddb-a49c-acace24f8c72" xlink:to="loc_us-gaap_StatementTable_ec81b323-2344-4609-9f1a-01effe726848" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_fdcfa0d9-27e2-4653-8d31-8e0b48bdbdfa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ec81b323-2344-4609-9f1a-01effe726848" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_fdcfa0d9-27e2-4653-8d31-8e0b48bdbdfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_fdcfa0d9-27e2-4653-8d31-8e0b48bdbdfa_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_fdcfa0d9-27e2-4653-8d31-8e0b48bdbdfa" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_fdcfa0d9-27e2-4653-8d31-8e0b48bdbdfa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_62fa4775-ae7e-4dfa-a7e2-11eefd4a19bb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_fdcfa0d9-27e2-4653-8d31-8e0b48bdbdfa" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_62fa4775-ae7e-4dfa-a7e2-11eefd4a19bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_080ef9bb-c683-498e-a063-76d27d28be85" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_62fa4775-ae7e-4dfa-a7e2-11eefd4a19bb" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_080ef9bb-c683-498e-a063-76d27d28be85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_93552a1e-b476-41e3-89a1-5880b067c077" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_62fa4775-ae7e-4dfa-a7e2-11eefd4a19bb" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_93552a1e-b476-41e3-89a1-5880b067c077" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_edd6ad5e-e3fe-4f4e-9ab2-a4e9f7c351f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ec81b323-2344-4609-9f1a-01effe726848" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_edd6ad5e-e3fe-4f4e-9ab2-a4e9f7c351f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_edd6ad5e-e3fe-4f4e-9ab2-a4e9f7c351f8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_edd6ad5e-e3fe-4f4e-9ab2-a4e9f7c351f8" xlink:to="loc_us-gaap_EquityComponentDomain_edd6ad5e-e3fe-4f4e-9ab2-a4e9f7c351f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9f33b40f-21c7-4aa8-b063-3db38fab2197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_edd6ad5e-e3fe-4f4e-9ab2-a4e9f7c351f8" xlink:to="loc_us-gaap_EquityComponentDomain_9f33b40f-21c7-4aa8-b063-3db38fab2197" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_fbfa9431-81b3-452f-8c63-1dd14cad6dc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9f33b40f-21c7-4aa8-b063-3db38fab2197" xlink:to="loc_us-gaap_CommonStockMember_fbfa9431-81b3-452f-8c63-1dd14cad6dc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d03dc686-d673-47d5-99be-f09cbe317724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9f33b40f-21c7-4aa8-b063-3db38fab2197" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d03dc686-d673-47d5-99be-f09cbe317724" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAdditionalCapitalMember_65eda4bd-a9c6-4757-84fb-c0fc38f1413b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAdditionalCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9f33b40f-21c7-4aa8-b063-3db38fab2197" xlink:to="loc_us-gaap_OtherAdditionalCapitalMember_65eda4bd-a9c6-4757-84fb-c0fc38f1413b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8fa2c04e-6700-44be-9086-13b57bd49770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9f33b40f-21c7-4aa8-b063-3db38fab2197" xlink:to="loc_us-gaap_RetainedEarningsMember_8fa2c04e-6700-44be-9086-13b57bd49770" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1a4c7ff0-712a-4a3c-bbfd-48a9cbdf19b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9f33b40f-21c7-4aa8-b063-3db38fab2197" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1a4c7ff0-712a-4a3c-bbfd-48a9cbdf19b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_a51aa4ba-c25b-4f7f-a3ea-9e8772161e95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9f33b40f-21c7-4aa8-b063-3db38fab2197" xlink:to="loc_us-gaap_TreasuryStockMember_a51aa4ba-c25b-4f7f-a3ea-9e8772161e95" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_cec7fc1d-98b4-4976-843b-9e64aadf1b91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9f33b40f-21c7-4aa8-b063-3db38fab2197" xlink:to="loc_us-gaap_NoncontrollingInterestMember_cec7fc1d-98b4-4976-843b-9e64aadf1b91" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="extended" id="ieb753b6d0824438aa980f4ee9802ebfd_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="i47cdbe0a9c2149b29bf0e8e79c2f5b60_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="mck-20201231.xsd#SignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="extended" id="ida110a13ad8e4c5ba8e4147a0e85b6ff_SignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mck-20201231.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended" id="i046281b56ece4817a44f74a7f94d63df_SignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i9ed6270f72c444b29eb5f39d6fdc84d0_SignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_60652fa4-b5b2-4ca0-98c4-f9067a0e5363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_339107ea-3199-4444-ba3d-79527d52463a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_60652fa4-b5b2-4ca0-98c4-f9067a0e5363" xlink:to="loc_us-gaap_NumberOfReportableSegments_339107ea-3199-4444-ba3d-79527d52463a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_98ab90d0-ea1f-40b2-9169-a51c57c82cc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_60652fa4-b5b2-4ca0-98c4-f9067a0e5363" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_98ab90d0-ea1f-40b2-9169-a51c57c82cc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_cbcc7299-9340-43cd-9d7d-90e482642334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_60652fa4-b5b2-4ca0-98c4-f9067a0e5363" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_cbcc7299-9340-43cd-9d7d-90e482642334" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1763b0c4-e75c-4449-b853-15eb70fd8bf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_60652fa4-b5b2-4ca0-98c4-f9067a0e5363" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1763b0c4-e75c-4449-b853-15eb70fd8bf0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c72dde3d-ed84-433f-9b2f-043eb179f980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1763b0c4-e75c-4449-b853-15eb70fd8bf0" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c72dde3d-ed84-433f-9b2f-043eb179f980" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_c72dde3d-ed84-433f-9b2f-043eb179f980_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c72dde3d-ed84-433f-9b2f-043eb179f980" xlink:to="loc_us-gaap_TypeOfAdoptionMember_c72dde3d-ed84-433f-9b2f-043eb179f980_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_9fc781a6-4339-4508-8be5-8fd47d9b20eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c72dde3d-ed84-433f-9b2f-043eb179f980" xlink:to="loc_us-gaap_TypeOfAdoptionMember_9fc781a6-4339-4508-8be5-8fd47d9b20eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_eb68b927-c4eb-47b8-bf23-9eed39c61c91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_9fc781a6-4339-4508-8be5-8fd47d9b20eb" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_eb68b927-c4eb-47b8-bf23-9eed39c61c91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3a4d2e17-de4a-48b3-b5ee-6fb7be16722a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1763b0c4-e75c-4449-b853-15eb70fd8bf0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3a4d2e17-de4a-48b3-b5ee-6fb7be16722a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3a4d2e17-de4a-48b3-b5ee-6fb7be16722a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3a4d2e17-de4a-48b3-b5ee-6fb7be16722a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3a4d2e17-de4a-48b3-b5ee-6fb7be16722a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_764517e8-2b23-4a62-9f9f-a800e71bae9e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3a4d2e17-de4a-48b3-b5ee-6fb7be16722a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_764517e8-2b23-4a62-9f9f-a800e71bae9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a7041b5f-9290-4ae0-940b-09681094abed" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_764517e8-2b23-4a62-9f9f-a800e71bae9e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a7041b5f-9290-4ae0-940b-09681094abed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_115cdbd7-64e2-414c-909e-0f749b6e01f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1763b0c4-e75c-4449-b853-15eb70fd8bf0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_115cdbd7-64e2-414c-909e-0f749b6e01f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_115cdbd7-64e2-414c-909e-0f749b6e01f3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_115cdbd7-64e2-414c-909e-0f749b6e01f3" xlink:to="loc_us-gaap_EquityComponentDomain_115cdbd7-64e2-414c-909e-0f749b6e01f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5266d70e-c2b1-44d1-ad61-325fa0a8fbef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_115cdbd7-64e2-414c-909e-0f749b6e01f3" xlink:to="loc_us-gaap_EquityComponentDomain_5266d70e-c2b1-44d1-ad61-325fa0a8fbef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_07c502f7-cdc1-4027-9d59-2e90325ee272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5266d70e-c2b1-44d1-ad61-325fa0a8fbef" xlink:to="loc_us-gaap_RetainedEarningsMember_07c502f7-cdc1-4027-9d59-2e90325ee272" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture" xlink:type="simple" xlink:href="mck-20201231.xsd#InvestmentinChangeHealthcareJointVenture"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture" xlink:type="extended" id="i8d9198bd8b484f5ea19a0b22954e6af1_InvestmentinChangeHealthcareJointVenture"/>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#InvestmentinChangeHealthcareJointVentureDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails" xlink:type="extended" id="i7ef61230cf454bdda499513dcff9cf02_InvestmentinChangeHealthcareJointVentureDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90b862da-c485-4168-a320-453d3ffca20a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90b862da-c485-4168-a320-453d3ffca20a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_5b9f3e71-76d3-4b54-9a5d-e499986aba14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_5b9f3e71-76d3-4b54-9a5d-e499986aba14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_80e665b4-bea9-40bd-b4e9-fe04abe62a5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_80e665b4-bea9-40bd-b4e9-fe04abe62a5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_154df0ad-1a1a-452f-ac9b-a0850bddf052" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_154df0ad-1a1a-452f-ac9b-a0850bddf052" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_62f980c7-ae7c-4dd0-9114-4e71c2078b91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_62f980c7-ae7c-4dd0-9114-4e71c2078b91" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_dd79e954-6d6a-409a-a5e5-cd68927c194b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_dd79e954-6d6a-409a-a5e5-cd68927c194b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_cc0cfae7-531c-486f-90ec-cce083297d0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_cc0cfae7-531c-486f-90ec-cce083297d0e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_82e87207-7c1f-403d-bdd8-d706bad196f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_82e87207-7c1f-403d-bdd8-d706bad196f2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ProportionateGainLossOnEquityMethodInvestment_eadb4964-09ef-4a16-9ee2-c815e958e939" xlink:href="mck-20201231.xsd#mck_ProportionateGainLossOnEquityMethodInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_mck_ProportionateGainLossOnEquityMethodInvestment_eadb4964-09ef-4a16-9ee2-c815e958e939" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_93ac0e28-e2d0-4866-b8b7-c851b68da2c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_93ac0e28-e2d0-4866-b8b7-c851b68da2c1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_46d2c1fe-783e-4465-996e-981367b561a0" xlink:href="mck-20201231.xsd#mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_46d2c1fe-783e-4465-996e-981367b561a0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedParties_39be0ac8-adc4-4a5f-906e-e945670a1c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_DueFromRelatedParties_39be0ac8-adc4-4a5f-906e-e945670a1c5a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5fb3ac02-42dc-409b-9fe4-4a68ec9212b7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5fb3ac02-42dc-409b-9fe4-4a68ec9212b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_5fb3ac02-42dc-409b-9fe4-4a68ec9212b7_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5fb3ac02-42dc-409b-9fe4-4a68ec9212b7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_5fb3ac02-42dc-409b-9fe4-4a68ec9212b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1b20875b-522c-47b2-b012-f6962fe8a87f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5fb3ac02-42dc-409b-9fe4-4a68ec9212b7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1b20875b-522c-47b2-b012-f6962fe8a87f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ad3ab4f1-dd2c-47d0-ab68-a62e2f1aa092" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1b20875b-522c-47b2-b012-f6962fe8a87f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ad3ab4f1-dd2c-47d0-ab68-a62e2f1aa092" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1720b82b-19d5-4fce-88c6-d473e093ce47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1720b82b-19d5-4fce-88c6-d473e093ce47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_1720b82b-19d5-4fce-88c6-d473e093ce47_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1720b82b-19d5-4fce-88c6-d473e093ce47" xlink:to="loc_us-gaap_TypeOfAdoptionMember_1720b82b-19d5-4fce-88c6-d473e093ce47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_e0b1b519-900f-4f28-aebe-383bf59f1e43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1720b82b-19d5-4fce-88c6-d473e093ce47" xlink:to="loc_us-gaap_TypeOfAdoptionMember_e0b1b519-900f-4f28-aebe-383bf59f1e43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_1013052d-9e82-4193-9529-5189086ea76a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_e0b1b519-900f-4f28-aebe-383bf59f1e43" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_1013052d-9e82-4193-9529-5189086ea76a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f553d713-4754-4ada-a4c8-e79a45310ab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f553d713-4754-4ada-a4c8-e79a45310ab9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f553d713-4754-4ada-a4c8-e79a45310ab9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f553d713-4754-4ada-a4c8-e79a45310ab9" xlink:to="loc_us-gaap_EquityComponentDomain_f553d713-4754-4ada-a4c8-e79a45310ab9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b03ea7e8-d166-45ca-abef-df4d45f57015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f553d713-4754-4ada-a4c8-e79a45310ab9" xlink:to="loc_us-gaap_EquityComponentDomain_b03ea7e8-d166-45ca-abef-df4d45f57015" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d887ba0b-bebe-4674-bee1-dadca6c5cbec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b03ea7e8-d166-45ca-abef-df4d45f57015" xlink:to="loc_us-gaap_RetainedEarningsMember_d887ba0b-bebe-4674-bee1-dadca6c5cbec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a0c01716-8e96-4f1d-b36e-84b5cd48512e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a0c01716-8e96-4f1d-b36e-84b5cd48512e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a0c01716-8e96-4f1d-b36e-84b5cd48512e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a0c01716-8e96-4f1d-b36e-84b5cd48512e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a0c01716-8e96-4f1d-b36e-84b5cd48512e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_2a790b0f-6e00-428c-9d6f-21f3d6f8adc6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a0c01716-8e96-4f1d-b36e-84b5cd48512e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_2a790b0f-6e00-428c-9d6f-21f3d6f8adc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_a95dc9c2-841e-4a35-b94d-c4ff07637324" xlink:href="mck-20201231.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2a790b0f-6e00-428c-9d6f-21f3d6f8adc6" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_a95dc9c2-841e-4a35-b94d-c4ff07637324" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ca124dc5-db63-42a8-888c-dcdef7bea729" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ca124dc5-db63-42a8-888c-dcdef7bea729" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ca124dc5-db63-42a8-888c-dcdef7bea729_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ca124dc5-db63-42a8-888c-dcdef7bea729" xlink:to="loc_us-gaap_RelatedPartyDomain_ca124dc5-db63-42a8-888c-dcdef7bea729_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_42dfded6-ccac-4bfd-9dbb-26d7c5283b63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ca124dc5-db63-42a8-888c-dcdef7bea729" xlink:to="loc_us-gaap_RelatedPartyDomain_42dfded6-ccac-4bfd-9dbb-26d7c5283b63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_d605c579-3bef-4c6f-8780-9e955d893343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_42dfded6-ccac-4bfd-9dbb-26d7c5283b63" xlink:to="loc_us-gaap_CorporateJointVentureMember_d605c579-3bef-4c6f-8780-9e955d893343" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_eb402522-23d4-468d-8755-3a1a640fd6b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_eb402522-23d4-468d-8755-3a1a640fd6b3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_eb402522-23d4-468d-8755-3a1a640fd6b3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_eb402522-23d4-468d-8755-3a1a640fd6b3" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_eb402522-23d4-468d-8755-3a1a640fd6b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_4369aa06-69ec-4135-bf44-e00d99fd120a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_eb402522-23d4-468d-8755-3a1a640fd6b3" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_4369aa06-69ec-4135-bf44-e00d99fd120a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TransitionServicesAgreementsTSAMember_ca080a30-6eea-4837-ad7b-037309b8f5d9" xlink:href="mck-20201231.xsd#mck_TransitionServicesAgreementsTSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4369aa06-69ec-4135-bf44-e00d99fd120a" xlink:to="loc_mck_TransitionServicesAgreementsTSAMember_ca080a30-6eea-4837-ad7b-037309b8f5d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember_cb011bdf-7537-48d0-bbe6-91cefa85939c" xlink:href="mck-20201231.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4369aa06-69ec-4135-bf44-e00d99fd120a" xlink:to="loc_mck_TaxReceivableAgreementTRAMember_cb011bdf-7537-48d0-bbe6-91cefa85939c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f201a9d1-cd7d-4b54-a346-7cb92bbf4a80" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:to="loc_dei_LegalEntityAxis_f201a9d1-cd7d-4b54-a346-7cb92bbf4a80" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f201a9d1-cd7d-4b54-a346-7cb92bbf4a80_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_f201a9d1-cd7d-4b54-a346-7cb92bbf4a80" xlink:to="loc_dei_EntityDomain_f201a9d1-cd7d-4b54-a346-7cb92bbf4a80_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_65be2222-83da-4092-91f4-f8b0fd9919db" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_f201a9d1-cd7d-4b54-a346-7cb92bbf4a80" xlink:to="loc_dei_EntityDomain_65be2222-83da-4092-91f4-f8b0fd9919db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareInc.Member_bc11c624-2bd5-496e-8a8b-ef4d9205cd9c" xlink:href="mck-20201231.xsd#mck_ChangeHealthcareInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_65be2222-83da-4092-91f4-f8b0fd9919db" xlink:to="loc_mck_ChangeHealthcareInc.Member_bc11c624-2bd5-496e-8a8b-ef4d9205cd9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_e4b5c7d6-6994-4fe9-b2f5-57d6e4ecaba2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_e4b5c7d6-6994-4fe9-b2f5-57d6e4ecaba2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e4b5c7d6-6994-4fe9-b2f5-57d6e4ecaba2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e4b5c7d6-6994-4fe9-b2f5-57d6e4ecaba2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e4b5c7d6-6994-4fe9-b2f5-57d6e4ecaba2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6ac39634-17c3-41d4-aa38-d819f208d021" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e4b5c7d6-6994-4fe9-b2f5-57d6e4ecaba2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6ac39634-17c3-41d4-aa38-d819f208d021" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_747fc323-0340-4f68-85e3-709ccbac8b32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6ac39634-17c3-41d4-aa38-d819f208d021" xlink:to="loc_us-gaap_IPOMember_747fc323-0340-4f68-85e3-709ccbac8b32" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSale" xlink:type="simple" xlink:href="mck-20201231.xsd#HeldforSale"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSale" xlink:type="extended" id="i23556eb946c44f7085f450a040082224_HeldforSale"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleTables" xlink:type="simple" xlink:href="mck-20201231.xsd#HeldforSaleTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSaleTables" xlink:type="extended" id="i052ed63e1f734886967d1b077c50e980_HeldforSaleTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#HeldforSaleNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="extended" id="i365251841a96442990d2cd04d9ae772b_HeldforSaleNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_5b110c9b-3893-4d62-a9bd-148047870c16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_5b110c9b-3893-4d62-a9bd-148047870c16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_b8176c74-4e84-49b9-b382-3d1fa7d34aeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_b8176c74-4e84-49b9-b382-3d1fa7d34aeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b452fac2-aff7-4afd-91db-2c64be733184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b452fac2-aff7-4afd-91db-2c64be733184" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_74c274e9-c549-4a28-bd7e-908c697a39e5" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_74c274e9-c549-4a28-bd7e-908c697a39e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a60f2fa7-d11c-4982-86d3-2c24b9ace964" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a60f2fa7-d11c-4982-86d3-2c24b9ace964" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_e5e20958-9e6c-4791-a92a-9e600dc9242e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_e5e20958-9e6c-4791-a92a-9e600dc9242e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossOnSaleOfBusinessNetOfTax_41f81c59-60ed-4593-9bd1-42e113e27353" xlink:href="mck-20201231.xsd#mck_GainLossOnSaleOfBusinessNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_mck_GainLossOnSaleOfBusinessNetOfTax_41f81c59-60ed-4593-9bd1-42e113e27353" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_ca8488f9-9f3a-49d2-9679-41f0bef3cbd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_ca8488f9-9f3a-49d2-9679-41f0bef3cbd7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax_83686c74-c6ba-4316-b6bc-6520dab9efbb" xlink:href="mck-20201231.xsd#mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax_83686c74-c6ba-4316-b6bc-6520dab9efbb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_b135173c-b0e3-4332-86ee-be0eed9dc618" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_EquityMethodInvestments_b135173c-b0e3-4332-86ee-be0eed9dc618" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a51c14f9-6f98-4eab-9313-517fb1aca2a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a51c14f9-6f98-4eab-9313-517fb1aca2a1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_3b81306f-e85c-449a-8890-47e2bd0dfcc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_3b81306f-e85c-449a-8890-47e2bd0dfcc8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_76c735b6-cc84-4bae-aa3d-5eda8f2289b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_76c735b6-cc84-4bae-aa3d-5eda8f2289b8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd1a3861-e55c-41de-acc0-ef7922b5bd1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd1a3861-e55c-41de-acc0-ef7922b5bd1c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_99ce494f-bfa2-4dc0-b526-859dd16c8639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd1a3861-e55c-41de-acc0-ef7922b5bd1c" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_99ce494f-bfa2-4dc0-b526-859dd16c8639" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_99ce494f-bfa2-4dc0-b526-859dd16c8639_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_99ce494f-bfa2-4dc0-b526-859dd16c8639" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_99ce494f-bfa2-4dc0-b526-859dd16c8639_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_42e9a0cd-92d1-4a8a-9367-a5a1fb424f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_99ce494f-bfa2-4dc0-b526-859dd16c8639" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_42e9a0cd-92d1-4a8a-9367-a5a1fb424f5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2b20e2e1-828c-4c43-b705-6cc1ba5c3537" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_42e9a0cd-92d1-4a8a-9367-a5a1fb424f5c" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2b20e2e1-828c-4c43-b705-6cc1ba5c3537" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f5d62439-90a4-4b0e-ad64-6a41729f1637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_42e9a0cd-92d1-4a8a-9367-a5a1fb424f5c" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f5d62439-90a4-4b0e-ad64-6a41729f1637" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_969c391f-e24c-499f-916b-2eb8874583ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd1a3861-e55c-41de-acc0-ef7922b5bd1c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_969c391f-e24c-499f-916b-2eb8874583ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_969c391f-e24c-499f-916b-2eb8874583ab_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_969c391f-e24c-499f-916b-2eb8874583ab" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_969c391f-e24c-499f-916b-2eb8874583ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e2bce335-5e66-478d-8623-57f63df254dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_969c391f-e24c-499f-916b-2eb8874583ab" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e2bce335-5e66-478d-8623-57f63df254dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_1cfbd451-0557-44a1-b495-067d061f0c42" xlink:href="mck-20201231.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e2bce335-5e66-478d-8623-57f63df254dc" xlink:to="loc_mck_GermanWholesaleBusinessMember_1cfbd451-0557-44a1-b495-067d061f0c42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_896d0deb-c791-498a-9660-d4212863af28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd1a3861-e55c-41de-acc0-ef7922b5bd1c" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_896d0deb-c791-498a-9660-d4212863af28" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_896d0deb-c791-498a-9660-d4212863af28_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_896d0deb-c791-498a-9660-d4212863af28" xlink:to="loc_us-gaap_RelatedPartyDomain_896d0deb-c791-498a-9660-d4212863af28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_55bacfc2-16c3-468f-840a-170c3600d8a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_896d0deb-c791-498a-9660-d4212863af28" xlink:to="loc_us-gaap_RelatedPartyDomain_55bacfc2-16c3-468f-840a-170c3600d8a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_d6e79ec7-4541-4fd8-a393-52aadbe6e903" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_55bacfc2-16c3-468f-840a-170c3600d8a4" xlink:to="loc_us-gaap_CorporateJointVentureMember_d6e79ec7-4541-4fd8-a393-52aadbe6e903" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_229fbcc6-5eb1-4270-bc41-56bdcfbf956e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd1a3861-e55c-41de-acc0-ef7922b5bd1c" xlink:to="loc_srt_OwnershipAxis_229fbcc6-5eb1-4270-bc41-56bdcfbf956e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_229fbcc6-5eb1-4270-bc41-56bdcfbf956e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_229fbcc6-5eb1-4270-bc41-56bdcfbf956e" xlink:to="loc_srt_OwnershipDomain_229fbcc6-5eb1-4270-bc41-56bdcfbf956e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_aba6ee52-f972-4549-8169-ba19ac833937" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_229fbcc6-5eb1-4270-bc41-56bdcfbf956e" xlink:to="loc_srt_OwnershipDomain_aba6ee52-f972-4549-8169-ba19ac833937" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WalgreensBootsAllianceJointVentureMember_6f6956ac-adbb-4be8-96cb-ee938838e413" xlink:href="mck-20201231.xsd#mck_WalgreensBootsAllianceJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_aba6ee52-f972-4549-8169-ba19ac833937" xlink:to="loc_mck_WalgreensBootsAllianceJointVentureMember_6f6956ac-adbb-4be8-96cb-ee938838e413" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_45904a73-5f26-4953-8c52-9c2e8d9fe14c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd1a3861-e55c-41de-acc0-ef7922b5bd1c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_45904a73-5f26-4953-8c52-9c2e8d9fe14c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_45904a73-5f26-4953-8c52-9c2e8d9fe14c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_45904a73-5f26-4953-8c52-9c2e8d9fe14c" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_45904a73-5f26-4953-8c52-9c2e8d9fe14c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_56a3be9e-7170-41c2-a0c5-43b8375e389b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_45904a73-5f26-4953-8c52-9c2e8d9fe14c" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_56a3be9e-7170-41c2-a0c5-43b8375e389b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_7adc5686-ba6b-4f7d-b5cd-a7850db5684f" xlink:href="mck-20201231.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_56a3be9e-7170-41c2-a0c5-43b8375e389b" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_7adc5686-ba6b-4f7d-b5cd-a7850db5684f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended" id="if160581d19ab4b4e922c276dc727b086_HeldforSaleAssetsandLiabilitiesHeldforSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5393280c-8d26-40e8-9b96-9b4716a9ec02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_3c622d72-7488-4acb-919e-271ea3674977" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5393280c-8d26-40e8-9b96-9b4716a9ec02" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_3c622d72-7488-4acb-919e-271ea3674977" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_25e9dcef-a000-4775-8171-f08cadab07ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_3c622d72-7488-4acb-919e-271ea3674977" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_25e9dcef-a000-4775-8171-f08cadab07ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_a61969fc-e4f9-4b48-968a-ac27f711e04f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_3c622d72-7488-4acb-919e-271ea3674977" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_a61969fc-e4f9-4b48-968a-ac27f711e04f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_2d1ff4de-b2db-4aa6-b00b-9ab4581ae65e" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_3c622d72-7488-4acb-919e-271ea3674977" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_2d1ff4de-b2db-4aa6-b00b-9ab4581ae65e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_2a79524c-1018-4dcd-ada1-cf6c80b8e893" xlink:href="mck-20201231.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_3c622d72-7488-4acb-919e-271ea3674977" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_2a79524c-1018-4dcd-ada1-cf6c80b8e893" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_92f94bdb-5977-43c3-8ad6-03d5d08a8514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_3c622d72-7488-4acb-919e-271ea3674977" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_92f94bdb-5977-43c3-8ad6-03d5d08a8514" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_aec6fd28-a45b-4cee-9797-27b69db10b22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5393280c-8d26-40e8-9b96-9b4716a9ec02" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_aec6fd28-a45b-4cee-9797-27b69db10b22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_4d15bef0-b2f2-45ed-8727-f85f295c8b0a" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_aec6fd28-a45b-4cee-9797-27b69db10b22" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_4d15bef0-b2f2-45ed-8727-f85f295c8b0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_3f8ece2b-534f-44a4-b70d-71eaf5269fd3" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_aec6fd28-a45b-4cee-9797-27b69db10b22" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_3f8ece2b-534f-44a4-b70d-71eaf5269fd3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_e351ba90-1a71-462f-a81d-7ddbd5ca2491" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_aec6fd28-a45b-4cee-9797-27b69db10b22" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_e351ba90-1a71-462f-a81d-7ddbd5ca2491" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_9887db56-701f-4640-b84b-4febd5bfc70f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_aec6fd28-a45b-4cee-9797-27b69db10b22" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_9887db56-701f-4640-b84b-4febd5bfc70f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6849a781-b092-4964-9527-65ee8b4ecb61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5393280c-8d26-40e8-9b96-9b4716a9ec02" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6849a781-b092-4964-9527-65ee8b4ecb61" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e3fa2e0e-53e3-4192-9a4b-73101a46d367" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6849a781-b092-4964-9527-65ee8b4ecb61" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e3fa2e0e-53e3-4192-9a4b-73101a46d367" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e3fa2e0e-53e3-4192-9a4b-73101a46d367_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e3fa2e0e-53e3-4192-9a4b-73101a46d367" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e3fa2e0e-53e3-4192-9a4b-73101a46d367_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_96decc1e-41c0-4d60-9861-3f8b278f6d79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e3fa2e0e-53e3-4192-9a4b-73101a46d367" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_96decc1e-41c0-4d60-9861-3f8b278f6d79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_585d3783-d59b-4efe-83b1-2e050eae3c59" xlink:href="mck-20201231.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_96decc1e-41c0-4d60-9861-3f8b278f6d79" xlink:to="loc_mck_GermanWholesaleBusinessMember_585d3783-d59b-4efe-83b1-2e050eae3c59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_53ecde43-0f8c-4d4e-bc4e-92705fa28044" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6849a781-b092-4964-9527-65ee8b4ecb61" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_53ecde43-0f8c-4d4e-bc4e-92705fa28044" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_53ecde43-0f8c-4d4e-bc4e-92705fa28044_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_53ecde43-0f8c-4d4e-bc4e-92705fa28044" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_53ecde43-0f8c-4d4e-bc4e-92705fa28044_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_61e280c2-e52b-4f80-a53e-fba5170ea849" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_53ecde43-0f8c-4d4e-bc4e-92705fa28044" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_61e280c2-e52b-4f80-a53e-fba5170ea849" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7763c1eb-5bcb-4467-8770-5027a533f124" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_61e280c2-e52b-4f80-a53e-fba5170ea849" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7763c1eb-5bcb-4467-8770-5027a533f124" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="simple" xlink:href="mck-20201231.xsd#RestructuringImpairmentandRelatedCharges"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="extended" id="i65d72e1ab8d04d459dac08f96d334b82_RestructuringImpairmentandRelatedCharges"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="simple" xlink:href="mck-20201231.xsd#RestructuringImpairmentandRelatedChargesTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="extended" id="i0a4c985b2c7640f283c99d0e5f998263_RestructuringImpairmentandRelatedChargesTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#RestructuringImpairmentandRelatedChargesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="extended" id="i16bc7cdbb8f945de89221f7de8628118_RestructuringImpairmentandRelatedChargesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_17943d12-4aef-4804-8573-8d7fd62dbe35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_882b26c2-46ee-4d27-b50f-afe76b98dfb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_17943d12-4aef-4804-8573-8d7fd62dbe35" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_882b26c2-46ee-4d27-b50f-afe76b98dfb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_e68ab73f-79a3-424c-97ba-35d6269c8e93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_17943d12-4aef-4804-8573-8d7fd62dbe35" xlink:to="loc_us-gaap_RestructuringCharges_e68ab73f-79a3-424c-97ba-35d6269c8e93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_cfd97e8e-40a6-4ad2-b643-6552873a4114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_17943d12-4aef-4804-8573-8d7fd62dbe35" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_cfd97e8e-40a6-4ad2-b643-6552873a4114" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_2c6caab9-7d08-43f5-b451-e0173b4d78b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_17943d12-4aef-4804-8573-8d7fd62dbe35" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_2c6caab9-7d08-43f5-b451-e0173b4d78b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_380dfc79-fc48-4696-956c-a86ed43ee04d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_17943d12-4aef-4804-8573-8d7fd62dbe35" xlink:to="loc_us-gaap_RestructuringReserve_380dfc79-fc48-4696-956c-a86ed43ee04d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_5cfb7c9d-0058-4dc8-99e7-96c82e7250e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_17943d12-4aef-4804-8573-8d7fd62dbe35" xlink:to="loc_us-gaap_AssetImpairmentCharges_5cfb7c9d-0058-4dc8-99e7-96c82e7250e5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a9d8f495-cc21-4bb8-8e56-c847ac5754bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_17943d12-4aef-4804-8573-8d7fd62dbe35" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a9d8f495-cc21-4bb8-8e56-c847ac5754bc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_e863cb0c-8531-4c5f-8875-13d033b8b942" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a9d8f495-cc21-4bb8-8e56-c847ac5754bc" xlink:to="loc_us-gaap_RestructuringPlanAxis_e863cb0c-8531-4c5f-8875-13d033b8b942" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_e863cb0c-8531-4c5f-8875-13d033b8b942_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_e863cb0c-8531-4c5f-8875-13d033b8b942" xlink:to="loc_us-gaap_RestructuringPlanDomain_e863cb0c-8531-4c5f-8875-13d033b8b942_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_2e9d1fc0-0a81-4f19-a0e4-2081db6d8754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_e863cb0c-8531-4c5f-8875-13d033b8b942" xlink:to="loc_us-gaap_RestructuringPlanDomain_2e9d1fc0-0a81-4f19-a0e4-2081db6d8754" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_7473b5e5-ff31-4fc7-b4ef-fc51037a4c20" xlink:href="mck-20201231.xsd#mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_2e9d1fc0-0a81-4f19-a0e4-2081db6d8754" xlink:to="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_7473b5e5-ff31-4fc7-b4ef-fc51037a4c20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingModelAndCostOptimizationProgramsMember_602996a4-df70-4a82-9284-43f9ce34fd28" xlink:href="mck-20201231.xsd#mck_OperatingModelAndCostOptimizationProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_2e9d1fc0-0a81-4f19-a0e4-2081db6d8754" xlink:to="loc_mck_OperatingModelAndCostOptimizationProgramsMember_602996a4-df70-4a82-9284-43f9ce34fd28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanOtherMember_e6dac933-1a30-4d4b-b8fd-aa424b3513fb" xlink:href="mck-20201231.xsd#mck_StrategicGrowthInitiativePlanOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_2e9d1fc0-0a81-4f19-a0e4-2081db6d8754" xlink:to="loc_mck_StrategicGrowthInitiativePlanOtherMember_e6dac933-1a30-4d4b-b8fd-aa424b3513fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanMember_37f7df29-c199-499f-8ea6-a4dc3d4af115" xlink:href="mck-20201231.xsd#mck_StrategicGrowthInitiativePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_2e9d1fc0-0a81-4f19-a0e4-2081db6d8754" xlink:to="loc_mck_StrategicGrowthInitiativePlanMember_37f7df29-c199-499f-8ea6-a4dc3d4af115" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7c8003e3-6c9c-416d-acd8-6a8ef7d384c0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a9d8f495-cc21-4bb8-8e56-c847ac5754bc" xlink:to="loc_srt_RangeAxis_7c8003e3-6c9c-416d-acd8-6a8ef7d384c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7c8003e3-6c9c-416d-acd8-6a8ef7d384c0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7c8003e3-6c9c-416d-acd8-6a8ef7d384c0" xlink:to="loc_srt_RangeMember_7c8003e3-6c9c-416d-acd8-6a8ef7d384c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8cb99550-c976-419a-bc75-24ca73f82bb4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7c8003e3-6c9c-416d-acd8-6a8ef7d384c0" xlink:to="loc_srt_RangeMember_8cb99550-c976-419a-bc75-24ca73f82bb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e5ec6635-08f1-4696-bb3a-9d37dcadc04d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8cb99550-c976-419a-bc75-24ca73f82bb4" xlink:to="loc_srt_MinimumMember_e5ec6635-08f1-4696-bb3a-9d37dcadc04d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3c2a84a6-8534-4ca0-ac86-ac6cb439e618" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8cb99550-c976-419a-bc75-24ca73f82bb4" xlink:to="loc_srt_MaximumMember_3c2a84a6-8534-4ca0-ac86-ac6cb439e618" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e1d0af41-3fb4-48d9-b1d7-30ecb9558040" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a9d8f495-cc21-4bb8-8e56-c847ac5754bc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e1d0af41-3fb4-48d9-b1d7-30ecb9558040" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e1d0af41-3fb4-48d9-b1d7-30ecb9558040_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e1d0af41-3fb4-48d9-b1d7-30ecb9558040" xlink:to="loc_us-gaap_SegmentDomain_e1d0af41-3fb4-48d9-b1d7-30ecb9558040_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_55e5ee2d-20d5-44e0-afa1-2b57932ceb15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e1d0af41-3fb4-48d9-b1d7-30ecb9558040" xlink:to="loc_us-gaap_SegmentDomain_55e5ee2d-20d5-44e0-afa1-2b57932ceb15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_07025e9e-2294-4c83-a32e-8cb8a2b06a25" xlink:href="mck-20201231.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_55e5ee2d-20d5-44e0-afa1-2b57932ceb15" xlink:to="loc_mck_InternationalSegmentMember_07025e9e-2294-4c83-a32e-8cb8a2b06a25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_60a3ff0d-ac55-44ed-84a6-e9063511530f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a9d8f495-cc21-4bb8-8e56-c847ac5754bc" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_60a3ff0d-ac55-44ed-84a6-e9063511530f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_60a3ff0d-ac55-44ed-84a6-e9063511530f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_60a3ff0d-ac55-44ed-84a6-e9063511530f" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_60a3ff0d-ac55-44ed-84a6-e9063511530f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_fda24749-59a8-48fe-842f-9cacad14a365" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_60a3ff0d-ac55-44ed-84a6-e9063511530f" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_fda24749-59a8-48fe-842f-9cacad14a365" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember_ee8474f6-8ed6-414b-920c-86f667daff38" xlink:href="mck-20201231.xsd#mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_fda24749-59a8-48fe-842f-9cacad14a365" xlink:to="loc_mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember_ee8474f6-8ed6-414b-920c-86f667daff38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember_f1c74048-2a39-4334-8b90-959fb8b93055" xlink:href="mck-20201231.xsd#mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_fda24749-59a8-48fe-842f-9cacad14a365" xlink:to="loc_mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember_f1c74048-2a39-4334-8b90-959fb8b93055" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="extended" id="i1c95295c58c74c9aa1abc962cf7096e9_RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_ab3bafab-66f4-46a6-8966-779254a57acf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_19337d70-a36e-4e36-ac77-65dc601f2aad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ab3bafab-66f4-46a6-8966-779254a57acf" xlink:to="loc_us-gaap_SeveranceCosts1_19337d70-a36e-4e36-ac77-65dc601f2aad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_dc7e18fe-029a-406b-b8b1-92334c914fda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ab3bafab-66f4-46a6-8966-779254a57acf" xlink:to="loc_us-gaap_BusinessExitCosts1_dc7e18fe-029a-406b-b8b1-92334c914fda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_515356f8-f621-497d-bc11-c0215f737b1f" xlink:href="mck-20201231.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ab3bafab-66f4-46a6-8966-779254a57acf" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_515356f8-f621-497d-bc11-c0215f737b1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_5853061f-d4be-4a6d-a8ee-bacfcd795254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ab3bafab-66f4-46a6-8966-779254a57acf" xlink:to="loc_us-gaap_RestructuringCharges_5853061f-d4be-4a6d-a8ee-bacfcd795254" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6db4edd1-3266-4c0b-8682-9a7d660cde48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ab3bafab-66f4-46a6-8966-779254a57acf" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6db4edd1-3266-4c0b-8682-9a7d660cde48" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_48b805f9-dd2d-4999-b93b-5bce98b52fe8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6db4edd1-3266-4c0b-8682-9a7d660cde48" xlink:to="loc_srt_ConsolidationItemsAxis_48b805f9-dd2d-4999-b93b-5bce98b52fe8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_48b805f9-dd2d-4999-b93b-5bce98b52fe8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_48b805f9-dd2d-4999-b93b-5bce98b52fe8" xlink:to="loc_srt_ConsolidationItemsDomain_48b805f9-dd2d-4999-b93b-5bce98b52fe8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_fe97329b-071e-46c5-b5e3-bb1b5530318e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_48b805f9-dd2d-4999-b93b-5bce98b52fe8" xlink:to="loc_srt_ConsolidationItemsDomain_fe97329b-071e-46c5-b5e3-bb1b5530318e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_0e30959d-49d7-4caa-a285-2bbcddc3518c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_fe97329b-071e-46c5-b5e3-bb1b5530318e" xlink:to="loc_us-gaap_OperatingSegmentsMember_0e30959d-49d7-4caa-a285-2bbcddc3518c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_175a0007-9b33-4f21-89c7-174138d0255d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_fe97329b-071e-46c5-b5e3-bb1b5530318e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_175a0007-9b33-4f21-89c7-174138d0255d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0100522b-7a3e-4a60-9330-b025e53da3ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6db4edd1-3266-4c0b-8682-9a7d660cde48" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0100522b-7a3e-4a60-9330-b025e53da3ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0100522b-7a3e-4a60-9330-b025e53da3ad_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0100522b-7a3e-4a60-9330-b025e53da3ad" xlink:to="loc_us-gaap_SegmentDomain_0100522b-7a3e-4a60-9330-b025e53da3ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7f2b9baa-6a6a-48dd-a635-00ec8f169f41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0100522b-7a3e-4a60-9330-b025e53da3ad" xlink:to="loc_us-gaap_SegmentDomain_7f2b9baa-6a6a-48dd-a635-00ec8f169f41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_461f8da9-80a5-45b2-9677-6124ad94ab46" xlink:href="mck-20201231.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7f2b9baa-6a6a-48dd-a635-00ec8f169f41" xlink:to="loc_mck_USPharmaceuticalSegmentMember_461f8da9-80a5-45b2-9677-6124ad94ab46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_616c9613-3a30-49ff-83f2-d9f00252c3bf" xlink:href="mck-20201231.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7f2b9baa-6a6a-48dd-a635-00ec8f169f41" xlink:to="loc_mck_InternationalSegmentMember_616c9613-3a30-49ff-83f2-d9f00252c3bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_18cf685e-ee82-405a-a8d9-d47bfa474f87" xlink:href="mck-20201231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7f2b9baa-6a6a-48dd-a635-00ec8f169f41" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_18cf685e-ee82-405a-a8d9-d47bfa474f87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_159269fc-34bd-47f9-a4e6-1a174ec987f4" xlink:href="mck-20201231.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7f2b9baa-6a6a-48dd-a635-00ec8f169f41" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_159269fc-34bd-47f9-a4e6-1a174ec987f4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="extended" id="i48fe00592605419e840fe00fa02988a1_RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_ab796ec2-6e95-4f3c-93b2-1c5f3c459427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_cfb0a907-a8c7-4a06-8f72-c1d303322fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ab796ec2-6e95-4f3c-93b2-1c5f3c459427" xlink:to="loc_us-gaap_RestructuringReserveRollForward_cfb0a907-a8c7-4a06-8f72-c1d303322fd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_4577adf0-175b-4ae4-96e0-c34705da76cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb0a907-a8c7-4a06-8f72-c1d303322fd1" xlink:to="loc_us-gaap_RestructuringReserve_4577adf0-175b-4ae4-96e0-c34705da76cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_78dbc1ff-5b3b-4f86-8e39-856a98f053d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb0a907-a8c7-4a06-8f72-c1d303322fd1" xlink:to="loc_us-gaap_RestructuringCharges_78dbc1ff-5b3b-4f86-8e39-856a98f053d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_127299ae-c062-4c84-beb8-426a21ad0e51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb0a907-a8c7-4a06-8f72-c1d303322fd1" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_127299ae-c062-4c84-beb8-426a21ad0e51" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_dfb456eb-2e17-4737-8304-6cdff8ce35d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb0a907-a8c7-4a06-8f72-c1d303322fd1" xlink:to="loc_us-gaap_PaymentsForRestructuring_dfb456eb-2e17-4737-8304-6cdff8ce35d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_2ea640fb-056e-4ad8-80a4-9ec06b267b9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb0a907-a8c7-4a06-8f72-c1d303322fd1" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_2ea640fb-056e-4ad8-80a4-9ec06b267b9f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b9d03758-c195-4a37-a413-e1a4c3a7d5eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a3cc019a-60ec-4833-b12b-735608e8f564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ab796ec2-6e95-4f3c-93b2-1c5f3c459427" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a3cc019a-60ec-4833-b12b-735608e8f564" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8d541bbc-a650-405d-a9e5-4a835755a307" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a3cc019a-60ec-4833-b12b-735608e8f564" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8d541bbc-a650-405d-a9e5-4a835755a307" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8d541bbc-a650-405d-a9e5-4a835755a307_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8d541bbc-a650-405d-a9e5-4a835755a307" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8d541bbc-a650-405d-a9e5-4a835755a307_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_fd6e4388-be26-46f2-ad6e-bc228cfe2a80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8d541bbc-a650-405d-a9e5-4a835755a307" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_fd6e4388-be26-46f2-ad6e-bc228cfe2a80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_db130ef3-cacf-4f91-af7b-f71a7aeac28c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_fd6e4388-be26-46f2-ad6e-bc228cfe2a80" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_db130ef3-cacf-4f91-af7b-f71a7aeac28c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_71b7d974-db5d-44e6-8937-d55a399a1e84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_fd6e4388-be26-46f2-ad6e-bc228cfe2a80" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_71b7d974-db5d-44e6-8937-d55a399a1e84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_8b4791d9-b2cf-46a9-bb0b-14a2b3b91f5b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a3cc019a-60ec-4833-b12b-735608e8f564" xlink:to="loc_srt_ConsolidationItemsAxis_8b4791d9-b2cf-46a9-bb0b-14a2b3b91f5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8b4791d9-b2cf-46a9-bb0b-14a2b3b91f5b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_8b4791d9-b2cf-46a9-bb0b-14a2b3b91f5b" xlink:to="loc_srt_ConsolidationItemsDomain_8b4791d9-b2cf-46a9-bb0b-14a2b3b91f5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d3e828cf-a985-4464-ad0e-a729e45ed353" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_8b4791d9-b2cf-46a9-bb0b-14a2b3b91f5b" xlink:to="loc_srt_ConsolidationItemsDomain_d3e828cf-a985-4464-ad0e-a729e45ed353" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_86d08d7f-7069-4881-9959-5d44ca5c2858" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d3e828cf-a985-4464-ad0e-a729e45ed353" xlink:to="loc_us-gaap_OperatingSegmentsMember_86d08d7f-7069-4881-9959-5d44ca5c2858" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_60dc46d3-59b0-4377-a92b-ee25ea9ab49a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d3e828cf-a985-4464-ad0e-a729e45ed353" xlink:to="loc_us-gaap_CorporateNonSegmentMember_60dc46d3-59b0-4377-a92b-ee25ea9ab49a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_818bc06f-57df-4e96-a4b6-9370fba3d230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a3cc019a-60ec-4833-b12b-735608e8f564" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_818bc06f-57df-4e96-a4b6-9370fba3d230" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_818bc06f-57df-4e96-a4b6-9370fba3d230_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_818bc06f-57df-4e96-a4b6-9370fba3d230" xlink:to="loc_us-gaap_SegmentDomain_818bc06f-57df-4e96-a4b6-9370fba3d230_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6c17831d-027c-4651-b5d1-4be327457567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_818bc06f-57df-4e96-a4b6-9370fba3d230" xlink:to="loc_us-gaap_SegmentDomain_6c17831d-027c-4651-b5d1-4be327457567" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_62ebc18c-2f35-4745-866f-066cfc18c9ce" xlink:href="mck-20201231.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6c17831d-027c-4651-b5d1-4be327457567" xlink:to="loc_mck_USPharmaceuticalSegmentMember_62ebc18c-2f35-4745-866f-066cfc18c9ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_dba2b89b-0987-43cf-9c1a-8ec153610922" xlink:href="mck-20201231.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6c17831d-027c-4651-b5d1-4be327457567" xlink:to="loc_mck_InternationalSegmentMember_dba2b89b-0987-43cf-9c1a-8ec153610922" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_a32a56e0-f9d8-4b96-899e-170bc3e277c3" xlink:href="mck-20201231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6c17831d-027c-4651-b5d1-4be327457567" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_a32a56e0-f9d8-4b96-899e-170bc3e277c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_403168a2-66d8-42aa-a25b-7dd16c8e3f03" xlink:href="mck-20201231.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6c17831d-027c-4651-b5d1-4be327457567" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_403168a2-66d8-42aa-a25b-7dd16c8e3f03" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mck-20201231.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxes" xlink:type="extended" id="iac03edc434374fe9a83e25b507526674_IncomeTaxes"/>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="extended" id="i4ffb7b07ec6b4b9894660f680c9784a1_IncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d65b9236-c06b-4aa5-be0c-29f6013d71b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d65b9236-c06b-4aa5-be0c-29f6013d71b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ebe26805-db10-4314-be97-5f8321409b45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ebe26805-db10-4314-be97-5f8321409b45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_321a922c-799e-49c4-b077-648f2690992c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_321a922c-799e-49c4-b077-648f2690992c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualProvisionNetOfTax_2f7e4a6f-418c-4ce6-b5db-19def167964a" xlink:href="mck-20201231.xsd#mck_LossContingencyAccrualProvisionNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_mck_LossContingencyAccrualProvisionNetOfTax_2f7e4a6f-418c-4ce6-b5db-19def167964a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_ac365803-b856-4e48-a9bc-7ee68c2275ec" xlink:href="mck-20201231.xsd#mck_IncomeTaxExpenseBenefitDiscreteItems"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_ac365803-b856-4e48-a9bc-7ee68c2275ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCounties_9bf7586e-a05c-42f8-a1c3-f047ba839c81" xlink:href="mck-20201231.xsd#mck_LossContingencyNumberofCounties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_mck_LossContingencyNumberofCounties_9bf7586e-a05c-42f8-a1c3-f047ba839c81" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_66e1ffaa-c3d5-4cb7-90d1-68708699b403" xlink:href="mck-20201231.xsd#mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_66e1ffaa-c3d5-4cb7-90d1-68708699b403" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue_163d13ab-81a7-43ad-96f2-36ba7e5fafce" xlink:href="mck-20201231.xsd#mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue_163d13ab-81a7-43ad-96f2-36ba7e5fafce" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentChargeOnReclassifiedAssets_4075bef6-1886-4bc7-921b-77286d983850" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentChargeOnReclassifiedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_us-gaap_ImpairmentChargeOnReclassifiedAssets_4075bef6-1886-4bc7-921b-77286d983850" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_69dcaebf-63c7-44c4-8a67-db38967c919b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_69dcaebf-63c7-44c4-8a67-db38967c919b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0f7c126f-6039-4d00-b0ad-842f57aaebdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0f7c126f-6039-4d00-b0ad-842f57aaebdf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_63ad8b04-6bf1-417e-b2a2-5c59c005f184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_63ad8b04-6bf1-417e-b2a2-5c59c005f184" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_7ab5382f-f0c8-4a43-b68f-828886448cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_7ab5382f-f0c8-4a43-b68f-828886448cee" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_1f38e3a1-98c4-4db2-8c4c-b101928717d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_1f38e3a1-98c4-4db2-8c4c-b101928717d9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_a6a6ea9b-a2c1-4a68-81f3-9d4c7be86963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_1f38e3a1-98c4-4db2-8c4c-b101928717d9" xlink:to="loc_us-gaap_RestructuringPlanAxis_a6a6ea9b-a2c1-4a68-81f3-9d4c7be86963" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_a6a6ea9b-a2c1-4a68-81f3-9d4c7be86963_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_a6a6ea9b-a2c1-4a68-81f3-9d4c7be86963" xlink:to="loc_us-gaap_RestructuringPlanDomain_a6a6ea9b-a2c1-4a68-81f3-9d4c7be86963_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_cf18dda4-01f8-4f12-b635-dd7935352411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_a6a6ea9b-a2c1-4a68-81f3-9d4c7be86963" xlink:to="loc_us-gaap_RestructuringPlanDomain_cf18dda4-01f8-4f12-b635-dd7935352411" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember_394a8d63-ce7a-4303-904c-5ea7d7ed3829" xlink:href="mck-20201231.xsd#mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_cf18dda4-01f8-4f12-b635-dd7935352411" xlink:to="loc_mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember_394a8d63-ce7a-4303-904c-5ea7d7ed3829" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ecea0373-cc3a-480c-9fef-98f7a5d3f5a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_1f38e3a1-98c4-4db2-8c4c-b101928717d9" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ecea0373-cc3a-480c-9fef-98f7a5d3f5a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_ecea0373-cc3a-480c-9fef-98f7a5d3f5a3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ecea0373-cc3a-480c-9fef-98f7a5d3f5a3" xlink:to="loc_us-gaap_LossContingencyNatureDomain_ecea0373-cc3a-480c-9fef-98f7a5d3f5a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_01a70384-49cc-4272-8c00-41b662f23966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ecea0373-cc3a-480c-9fef-98f7a5d3f5a3" xlink:to="loc_us-gaap_LossContingencyNatureDomain_01a70384-49cc-4272-8c00-41b662f23966" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_5510b110-17da-4bc8-90c2-ba1e5e9d98c9" xlink:href="mck-20201231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_01a70384-49cc-4272-8c00-41b662f23966" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_5510b110-17da-4bc8-90c2-ba1e5e9d98c9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="simple" xlink:href="mck-20201231.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterests"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="extended" id="i8e3d8fcf980f40278718c68e750045c5_RedeemableNoncontrollingInterestsandNoncontrollingInterests"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="simple" xlink:href="mck-20201231.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="extended" id="i8ded6cc08e4b4e4a86f648d1319817dc_RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended" id="i744323b7cfdb4adb8cad3c69822f5bfb_RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_0d1bb8a8-bb3a-4bb5-b169-858f0fd41c09" xlink:href="mck-20201231.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_0d1bb8a8-bb3a-4bb5-b169-858f0fd41c09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_4942ab70-a88d-4c16-8bd3-2fc6251998b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_4942ab70-a88d-4c16-8bd3-2fc6251998b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice_7f1ff985-d566-480d-8a25-0ff9ae9b5789" xlink:href="mck-20201231.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePrice_7f1ff985-d566-480d-8a25-0ff9ae9b5789" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread_3de112e1-5dd6-412c-9af5-9162ad579162" xlink:href="mck-20201231.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_mck_PutRightValueInterestRateSpread_3de112e1-5dd6-412c-9af5-9162ad579162" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_f0dfbe2e-00e7-47fd-873d-8e2375df204d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_f0dfbe2e-00e7-47fd-873d-8e2375df204d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_ca548a52-780b-426e-91ad-9804cc8ca533" xlink:href="mck-20201231.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_ca548a52-780b-426e-91ad-9804cc8ca533" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_8443d7e9-1e74-42ca-935b-a16d9ce0ff2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_8443d7e9-1e74-42ca-935b-a16d9ce0ff2d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_dbd9919b-3ce4-4b05-b37b-987ca425d1e2" xlink:href="mck-20201231.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_dbd9919b-3ce4-4b05-b37b-987ca425d1e2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_89c72f33-0c02-4521-85df-8de28c31a82b" xlink:href="mck-20201231.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_89c72f33-0c02-4521-85df-8de28c31a82b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_18c70f10-9c66-4d31-b8fb-ed28f449f019" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_18c70f10-9c66-4d31-b8fb-ed28f449f019" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_969c079f-591b-45b8-b4ea-aba6685588ee" xlink:href="mck-20201231.xsd#mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_969c079f-591b-45b8-b4ea-aba6685588ee" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_dfd44ac7-d130-4878-8f9c-61d03042e39b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_dfd44ac7-d130-4878-8f9c-61d03042e39b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_479ddee5-786c-4c78-8338-7fd391d41de5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_us-gaap_MinorityInterest_479ddee5-786c-4c78-8338-7fd391d41de5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_139d6cec-17ec-425b-9381-14f6ee3c7951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_139d6cec-17ec-425b-9381-14f6ee3c7951" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_e337f27e-0657-4a9f-bbea-50788b17e510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_us-gaap_MinorityInterestTable_e337f27e-0657-4a9f-bbea-50788b17e510" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_8917569a-5223-4a3a-a487-b8b8981a62c1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_e337f27e-0657-4a9f-bbea-50788b17e510" xlink:to="loc_srt_OwnershipAxis_8917569a-5223-4a3a-a487-b8b8981a62c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_8917569a-5223-4a3a-a487-b8b8981a62c1_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_8917569a-5223-4a3a-a487-b8b8981a62c1" xlink:to="loc_srt_OwnershipDomain_8917569a-5223-4a3a-a487-b8b8981a62c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_9ccaed9b-a336-4889-a5c4-1795946a5158" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_8917569a-5223-4a3a-a487-b8b8981a62c1" xlink:to="loc_srt_OwnershipDomain_9ccaed9b-a336-4889-a5c4-1795946a5158" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_7822d4ef-50a4-461e-9a1d-91780dcdda7c" xlink:href="mck-20201231.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_9ccaed9b-a336-4889-a5c4-1795946a5158" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_7822d4ef-50a4-461e-9a1d-91780dcdda7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember_7d07c46b-22d7-408b-aabc-dd801d63d1d6" xlink:href="mck-20201231.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_9ccaed9b-a336-4889-a5c4-1795946a5158" xlink:to="loc_mck_VantageandClarusOneSourcingServicesLLCMember_7d07c46b-22d7-408b-aabc-dd801d63d1d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_bb8a0397-14d2-4699-8fdc-91ea0ef22797" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_e337f27e-0657-4a9f-bbea-50788b17e510" xlink:to="loc_dei_LegalEntityAxis_bb8a0397-14d2-4699-8fdc-91ea0ef22797" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bb8a0397-14d2-4699-8fdc-91ea0ef22797_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_bb8a0397-14d2-4699-8fdc-91ea0ef22797" xlink:to="loc_dei_EntityDomain_bb8a0397-14d2-4699-8fdc-91ea0ef22797_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_374df8c6-73e5-453d-a053-fbe46e1b5240" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_bb8a0397-14d2-4699-8fdc-91ea0ef22797" xlink:to="loc_dei_EntityDomain_374df8c6-73e5-453d-a053-fbe46e1b5240" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_e3389d05-1958-4fe3-a19a-5d1549de9a84" xlink:href="mck-20201231.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_374df8c6-73e5-453d-a053-fbe46e1b5240" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_e3389d05-1958-4fe3-a19a-5d1549de9a84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b515fec2-e27d-4166-91aa-d24552e7e99f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_e337f27e-0657-4a9f-bbea-50788b17e510" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b515fec2-e27d-4166-91aa-d24552e7e99f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b515fec2-e27d-4166-91aa-d24552e7e99f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b515fec2-e27d-4166-91aa-d24552e7e99f" xlink:to="loc_us-gaap_EquityComponentDomain_b515fec2-e27d-4166-91aa-d24552e7e99f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9cb4c0dc-9b3a-4a15-9926-152a82e17445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b515fec2-e27d-4166-91aa-d24552e7e99f" xlink:to="loc_us-gaap_EquityComponentDomain_9cb4c0dc-9b3a-4a15-9926-152a82e17445" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_427132ab-fd91-46aa-a71d-aae605f6e738" xlink:href="mck-20201231.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9cb4c0dc-9b3a-4a15-9926-152a82e17445" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_427132ab-fd91-46aa-a71d-aae605f6e738" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_72f8d7e7-5d12-4505-ac2e-f9287798eadd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9cb4c0dc-9b3a-4a15-9926-152a82e17445" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_72f8d7e7-5d12-4505-ac2e-f9287798eadd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="extended" id="id0adf43928f8452b8c76dd5c613517e3_RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_08c48f1a-96f6-458a-afa2-411110c9ab8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_26abef27-00e6-4ea2-88c1-9a5453113304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_08c48f1a-96f6-458a-afa2-411110c9ab8d" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_26abef27-00e6-4ea2-88c1-9a5453113304" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d453bb3a-ea83-481e-97b3-81c95dda27f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_26abef27-00e6-4ea2-88c1-9a5453113304" xlink:to="loc_us-gaap_MinorityInterest_d453bb3a-ea83-481e-97b3-81c95dda27f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7ad5b355-b54d-4af1-bfde-046c102f27f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_26abef27-00e6-4ea2-88c1-9a5453113304" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7ad5b355-b54d-4af1-bfde-046c102f27f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_6be89e08-1ae9-4d14-8656-213a95ecabc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_26abef27-00e6-4ea2-88c1-9a5453113304" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_6be89e08-1ae9-4d14-8656-213a95ecabc7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e9535d04-8986-4d7c-ab6c-dc4fc6936586" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_26abef27-00e6-4ea2-88c1-9a5453113304" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e9535d04-8986-4d7c-ab6c-dc4fc6936586" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_d517e25e-85f0-4604-be64-793b0a3ebb04" xlink:href="mck-20201231.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_26abef27-00e6-4ea2-88c1-9a5453113304" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_d517e25e-85f0-4604-be64-793b0a3ebb04" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_a85d1563-9d3f-4903-9c59-4ba39670a343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1818c129-de1f-4060-9489-9a172c14f7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_08c48f1a-96f6-458a-afa2-411110c9ab8d" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1818c129-de1f-4060-9489-9a172c14f7e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_68f86452-32b8-4e67-91f6-bd855331f7e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1818c129-de1f-4060-9489-9a172c14f7e7" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_68f86452-32b8-4e67-91f6-bd855331f7e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_272b7396-733b-4c4d-93f5-1b8fa22d00d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1818c129-de1f-4060-9489-9a172c14f7e7" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_272b7396-733b-4c4d-93f5-1b8fa22d00d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_38fe808d-e996-4ac9-81fa-6d3fd9248ba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_46930b98-48de-4729-bc7a-e9c78956cc31" xlink:href="mck-20201231.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1818c129-de1f-4060-9489-9a172c14f7e7" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_46930b98-48de-4729-bc7a-e9c78956cc31" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_7bf1aba0-9066-4e48-ad00-3ed8ebcfc15c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_1ca27f7c-1e97-401c-b4b5-22c03976e8f7" xlink:href="mck-20201231.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1818c129-de1f-4060-9489-9a172c14f7e7" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_1ca27f7c-1e97-401c-b4b5-22c03976e8f7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_ebd9b8f9-20f6-4792-a4a2-7451ae394343" xlink:href="mck-20201231.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_8c73eefc-24a8-4d29-a459-6fa06c8aefbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_94599f29-4502-4351-ba3a-b4c96c479cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_08c48f1a-96f6-458a-afa2-411110c9ab8d" xlink:to="loc_us-gaap_MinorityInterestTable_94599f29-4502-4351-ba3a-b4c96c479cb2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_68e42fe7-8a3e-4495-8813-df78f7146a3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_94599f29-4502-4351-ba3a-b4c96c479cb2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_68e42fe7-8a3e-4495-8813-df78f7146a3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_68e42fe7-8a3e-4495-8813-df78f7146a3a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_68e42fe7-8a3e-4495-8813-df78f7146a3a" xlink:to="loc_us-gaap_EquityComponentDomain_68e42fe7-8a3e-4495-8813-df78f7146a3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_aa2504fc-84dc-49a3-a98d-0f979383939e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_68e42fe7-8a3e-4495-8813-df78f7146a3a" xlink:to="loc_us-gaap_EquityComponentDomain_aa2504fc-84dc-49a3-a98d-0f979383939e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_fc5d1c26-007c-4529-9bd4-d68801de4b12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_aa2504fc-84dc-49a3-a98d-0f979383939e" xlink:to="loc_us-gaap_NoncontrollingInterestMember_fc5d1c26-007c-4529-9bd4-d68801de4b12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_1641d89f-c27f-48ea-b436-eb1bf3738329" xlink:href="mck-20201231.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_aa2504fc-84dc-49a3-a98d-0f979383939e" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_1641d89f-c27f-48ea-b436-eb1bf3738329" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShare" xlink:type="simple" xlink:href="mck-20201231.xsd#EarningsLossPerCommonShare"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShare" xlink:type="extended" id="i5ec17c31f22a44f197c08ddf1211fcda_EarningsLossPerCommonShare"/>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareTables" xlink:type="simple" xlink:href="mck-20201231.xsd#EarningsLossPerCommonShareTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareTables" xlink:type="extended" id="i5a9ab534fa5744df9e2047271809165d_EarningsLossPerCommonShareTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#EarningsLossPerCommonShareDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareDetails" xlink:type="extended" id="i9c165164121c4e2d973e15e92c53abd2_EarningsLossPerCommonShareDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="mck-20201231.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended" id="i0b581e73c2544c2eaae7ec2e71fe2f8e_GoodwillandIntangibleAssetsNet"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="mck-20201231.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended" id="i538130bf9f8a41be82725fe8b90c0fb0_GoodwillandIntangibleAssetsNetTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended" id="ic99bb6778e1246d689974427c8a2923e_GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_b93137be-fa80-4b0e-b563-369cd06fa7e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_1c53c6b0-d603-492c-984d-016ff49e4d39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_b93137be-fa80-4b0e-b563-369cd06fa7e6" xlink:to="loc_us-gaap_GoodwillRollForward_1c53c6b0-d603-492c-984d-016ff49e4d39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3a5b78cb-b96a-4819-8bb4-e0af8528b494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_1c53c6b0-d603-492c-984d-016ff49e4d39" xlink:to="loc_us-gaap_Goodwill_3a5b78cb-b96a-4819-8bb4-e0af8528b494" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_ee13e3db-823e-45d7-87f1-f77def6d39a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_1c53c6b0-d603-492c-984d-016ff49e4d39" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_ee13e3db-823e-45d7-87f1-f77def6d39a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_3e887b52-1a42-4e07-92ea-0322cbcb215a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_1c53c6b0-d603-492c-984d-016ff49e4d39" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_3e887b52-1a42-4e07-92ea-0322cbcb215a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_4688fe07-05a0-4efa-883b-6b24e0fbfa78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_1c53c6b0-d603-492c-984d-016ff49e4d39" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_4688fe07-05a0-4efa-883b-6b24e0fbfa78" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_b2697d88-3aa2-4501-9be3-860521ab1aa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_1c53c6b0-d603-492c-984d-016ff49e4d39" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_b2697d88-3aa2-4501-9be3-860521ab1aa0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_31f9f697-1c0e-4a38-9eab-a332358f9be5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_1c53c6b0-d603-492c-984d-016ff49e4d39" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_31f9f697-1c0e-4a38-9eab-a332358f9be5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c7ac49a1-a07c-4b03-8cf5-296fca450cf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_7e7fdb67-b98e-4d39-9391-2559ca6f6dec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_b93137be-fa80-4b0e-b563-369cd06fa7e6" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_7e7fdb67-b98e-4d39-9391-2559ca6f6dec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_81f880cd-643f-48c3-bfcd-451d1e3738a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7e7fdb67-b98e-4d39-9391-2559ca6f6dec" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_81f880cd-643f-48c3-bfcd-451d1e3738a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_81f880cd-643f-48c3-bfcd-451d1e3738a0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_81f880cd-643f-48c3-bfcd-451d1e3738a0" xlink:to="loc_us-gaap_SegmentDomain_81f880cd-643f-48c3-bfcd-451d1e3738a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_38b18cb0-cab5-46fd-8fc5-ee64bac672ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_81f880cd-643f-48c3-bfcd-451d1e3738a0" xlink:to="loc_us-gaap_SegmentDomain_38b18cb0-cab5-46fd-8fc5-ee64bac672ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_72742293-0fdf-4474-8aa2-6749c3022b51" xlink:href="mck-20201231.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_38b18cb0-cab5-46fd-8fc5-ee64bac672ed" xlink:to="loc_mck_USPharmaceuticalSegmentMember_72742293-0fdf-4474-8aa2-6749c3022b51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_454d547a-3aef-45b2-9b22-e275693b3c14" xlink:href="mck-20201231.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_38b18cb0-cab5-46fd-8fc5-ee64bac672ed" xlink:to="loc_mck_InternationalSegmentMember_454d547a-3aef-45b2-9b22-e275693b3c14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_a04b6fde-97bc-4927-b35c-2a2e02b36d08" xlink:href="mck-20201231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_38b18cb0-cab5-46fd-8fc5-ee64bac672ed" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_a04b6fde-97bc-4927-b35c-2a2e02b36d08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_b6c7a803-0096-4f8d-87d3-8e550be55755" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_38b18cb0-cab5-46fd-8fc5-ee64bac672ed" xlink:to="loc_us-gaap_AllOtherSegmentsMember_b6c7a803-0096-4f8d-87d3-8e550be55755" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended" id="ia8abf226da22435eb8cb4c83d9e93c20_GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c586ec5-3af5-4e9a-9d4f-f536d5cd88f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_9814f6fb-f001-4fb9-8e46-f7da14bca9e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c586ec5-3af5-4e9a-9d4f-f536d5cd88f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_9814f6fb-f001-4fb9-8e46-f7da14bca9e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d18b340e-0364-482d-8a8e-d186792f7740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c586ec5-3af5-4e9a-9d4f-f536d5cd88f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d18b340e-0364-482d-8a8e-d186792f7740" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e6f21841-6762-4e83-bb11-56fb2573d3e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c586ec5-3af5-4e9a-9d4f-f536d5cd88f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e6f21841-6762-4e83-bb11-56fb2573d3e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b5350914-6120-4451-ac5d-79bad6464d7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c586ec5-3af5-4e9a-9d4f-f536d5cd88f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b5350914-6120-4451-ac5d-79bad6464d7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_dcd4e65f-b00d-479b-ac71-97d4f5e213ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c586ec5-3af5-4e9a-9d4f-f536d5cd88f8" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_dcd4e65f-b00d-479b-ac71-97d4f5e213ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d6c0284-9196-4858-a8b2-254e82e7d81d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_dcd4e65f-b00d-479b-ac71-97d4f5e213ff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d6c0284-9196-4858-a8b2-254e82e7d81d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2d6c0284-9196-4858-a8b2-254e82e7d81d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d6c0284-9196-4858-a8b2-254e82e7d81d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2d6c0284-9196-4858-a8b2-254e82e7d81d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0fdd4d34-02ab-4958-a4f1-7e518eaeb3ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d6c0284-9196-4858-a8b2-254e82e7d81d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0fdd4d34-02ab-4958-a4f1-7e518eaeb3ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_b82e3618-bed6-4cb0-9698-e839362f5c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0fdd4d34-02ab-4958-a4f1-7e518eaeb3ca" xlink:to="loc_us-gaap_CustomerRelationshipsMember_b82e3618-bed6-4cb0-9698-e839362f5c6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_f1370227-be32-4934-97a4-cd81f6853e59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0fdd4d34-02ab-4958-a4f1-7e518eaeb3ca" xlink:to="loc_us-gaap_ServiceAgreementsMember_f1370227-be32-4934-97a4-cd81f6853e59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmacyLicensesMember_5beee388-8fd1-4f8d-85ef-dd750655f48a" xlink:href="mck-20201231.xsd#mck_PharmacyLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0fdd4d34-02ab-4958-a4f1-7e518eaeb3ca" xlink:to="loc_mck_PharmacyLicensesMember_5beee388-8fd1-4f8d-85ef-dd750655f48a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_80a7d9ff-a748-4a91-81b3-d7b3cdef36e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0fdd4d34-02ab-4958-a4f1-7e518eaeb3ca" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_80a7d9ff-a748-4a91-81b3-d7b3cdef36e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_fa79cf8e-a9ce-4bb3-8d99-36e68ce062d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0fdd4d34-02ab-4958-a4f1-7e518eaeb3ca" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_fa79cf8e-a9ce-4bb3-8d99-36e68ce062d8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_8b8fafa2-0cf7-4065-acd5-0e2102c42671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0fdd4d34-02ab-4958-a4f1-7e518eaeb3ca" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_8b8fafa2-0cf7-4065-acd5-0e2102c42671" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" xlink:type="extended" id="i393f74ab69e447799fb2f56ac113c9b7_GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1cbadabc-3033-4195-bc1e-1649f882c27c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_477041c7-7548-46f3-9de7-f5b66293b983" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1cbadabc-3033-4195-bc1e-1649f882c27c" xlink:to="loc_us-gaap_NumberOfReportableSegments_477041c7-7548-46f3-9de7-f5b66293b983" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_33c821a7-bfbe-4211-8463-bdcccfc7ab50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1cbadabc-3033-4195-bc1e-1649f882c27c" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_33c821a7-bfbe-4211-8463-bdcccfc7ab50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLossNetOfTax_f6f92709-0d40-4e64-bd00-23a03e8a870a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1cbadabc-3033-4195-bc1e-1649f882c27c" xlink:to="loc_us-gaap_GoodwillImpairmentLossNetOfTax_f6f92709-0d40-4e64-bd00-23a03e8a870a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fcdd18e8-93a9-45a4-aec1-d3d295dc6b64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1cbadabc-3033-4195-bc1e-1649f882c27c" xlink:to="loc_us-gaap_Goodwill_fcdd18e8-93a9-45a4-aec1-d3d295dc6b64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f716f3b0-6fac-45de-96ef-720552317511" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1cbadabc-3033-4195-bc1e-1649f882c27c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f716f3b0-6fac-45de-96ef-720552317511" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_71adbdf1-2c6b-46e2-b0e0-0883b74bca9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1cbadabc-3033-4195-bc1e-1649f882c27c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_71adbdf1-2c6b-46e2-b0e0-0883b74bca9e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_1245dbe3-166b-498b-8658-936511412270" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_71adbdf1-2c6b-46e2-b0e0-0883b74bca9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_1245dbe3-166b-498b-8658-936511412270" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_06c4d032-d19b-416a-b1a7-26793f9e541a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_71adbdf1-2c6b-46e2-b0e0-0883b74bca9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_06c4d032-d19b-416a-b1a7-26793f9e541a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_01cac9bf-4fb6-4779-bca4-d5e966d2feb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_71adbdf1-2c6b-46e2-b0e0-0883b74bca9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_01cac9bf-4fb6-4779-bca4-d5e966d2feb3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7b1bd9e1-5ccb-42b0-9ec9-66800040b96e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_71adbdf1-2c6b-46e2-b0e0-0883b74bca9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7b1bd9e1-5ccb-42b0-9ec9-66800040b96e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_20efbe3d-44e7-449b-873c-b09eeff83dd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_71adbdf1-2c6b-46e2-b0e0-0883b74bca9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_20efbe3d-44e7-449b-873c-b09eeff83dd9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_a69ba3d2-bcf3-4874-8d48-46bd936bbc45" xlink:href="mck-20201231.xsd#mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_71adbdf1-2c6b-46e2-b0e0-0883b74bca9e" xlink:to="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_a69ba3d2-bcf3-4874-8d48-46bd936bbc45" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_665a5cce-703a-43e1-9fe6-51e99f981197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1cbadabc-3033-4195-bc1e-1649f882c27c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_665a5cce-703a-43e1-9fe6-51e99f981197" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_f26e8e00-a97e-44bc-af9f-98d8854a811c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_665a5cce-703a-43e1-9fe6-51e99f981197" xlink:to="loc_us-gaap_ReportingUnitAxis_f26e8e00-a97e-44bc-af9f-98d8854a811c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_f26e8e00-a97e-44bc-af9f-98d8854a811c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_f26e8e00-a97e-44bc-af9f-98d8854a811c" xlink:to="loc_us-gaap_ReportingUnitDomain_f26e8e00-a97e-44bc-af9f-98d8854a811c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_153589db-fe4f-4356-a536-5464abd2b32f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_f26e8e00-a97e-44bc-af9f-98d8854a811c" xlink:to="loc_us-gaap_ReportingUnitDomain_153589db-fe4f-4356-a536-5464abd2b32f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_2e992f52-4fcc-4e38-8ba0-010f7b561a8d" xlink:href="mck-20201231.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_153589db-fe4f-4356-a536-5464abd2b32f" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_2e992f52-4fcc-4e38-8ba0-010f7b561a8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1d4038ba-5fc0-4fe1-82ea-76babc4dd6cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_665a5cce-703a-43e1-9fe6-51e99f981197" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1d4038ba-5fc0-4fe1-82ea-76babc4dd6cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1d4038ba-5fc0-4fe1-82ea-76babc4dd6cc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1d4038ba-5fc0-4fe1-82ea-76babc4dd6cc" xlink:to="loc_us-gaap_SegmentDomain_1d4038ba-5fc0-4fe1-82ea-76babc4dd6cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_96d0975b-d152-4f3e-9b3b-c77d183a8ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1d4038ba-5fc0-4fe1-82ea-76babc4dd6cc" xlink:to="loc_us-gaap_SegmentDomain_96d0975b-d152-4f3e-9b3b-c77d183a8ff0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_43adcb41-0f51-48e6-a8a3-be812e3910a2" xlink:href="mck-20201231.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_96d0975b-d152-4f3e-9b3b-c77d183a8ff0" xlink:to="loc_mck_InternationalSegmentMember_43adcb41-0f51-48e6-a8a3-be812e3910a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a8a4db0a-f635-4252-a7be-be5e05f475db" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_665a5cce-703a-43e1-9fe6-51e99f981197" xlink:to="loc_srt_StatementGeographicalAxis_a8a4db0a-f635-4252-a7be-be5e05f475db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a8a4db0a-f635-4252-a7be-be5e05f475db_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_a8a4db0a-f635-4252-a7be-be5e05f475db" xlink:to="loc_srt_SegmentGeographicalDomain_a8a4db0a-f635-4252-a7be-be5e05f475db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d74e1527-fbb5-4a4a-be08-a8e22a50851d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_a8a4db0a-f635-4252-a7be-be5e05f475db" xlink:to="loc_srt_SegmentGeographicalDomain_d74e1527-fbb5-4a4a-be08-a8e22a50851d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_605c5513-2453-4c8f-a7b5-ed1ddcc3443b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d74e1527-fbb5-4a4a-be08-a8e22a50851d" xlink:to="loc_srt_EuropeMember_605c5513-2453-4c8f-a7b5-ed1ddcc3443b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivities"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="extended" id="i915756234a2b4441a1e69f7d51696b05_DebtandFinancingActivities"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivitiesTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="extended" id="id8e77c38ade04b7caf35eecba78a5ec1_DebtandFinancingActivitiesTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended" id="i55b24dabb0844c59a24464572f46452b_DebtandFinancingActivitiesScheduleofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bc8124d4-e6c2-4168-bdf7-6231a1691852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_aa1f885e-1ae1-4f99-b6c7-bf65055dfd3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc8124d4-e6c2-4168-bdf7-6231a1691852" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_aa1f885e-1ae1-4f99-b6c7-bf65055dfd3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_689a4b05-b95e-46f2-9e29-13897bfeeea6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc8124d4-e6c2-4168-bdf7-6231a1691852" xlink:to="loc_us-gaap_LongTermDebt_689a4b05-b95e-46f2-9e29-13897bfeeea6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_bcbc3ca4-1f9f-4793-a492-f67f83918a39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc8124d4-e6c2-4168-bdf7-6231a1691852" xlink:to="loc_us-gaap_FinanceLeaseLiability_bcbc3ca4-1f9f-4793-a492-f67f83918a39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_2738b551-8d43-41d3-bc3a-c967733fc7f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc8124d4-e6c2-4168-bdf7-6231a1691852" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_2738b551-8d43-41d3-bc3a-c967733fc7f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a9b22a0f-27d1-4e77-943d-0efb2af49beb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc8124d4-e6c2-4168-bdf7-6231a1691852" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a9b22a0f-27d1-4e77-943d-0efb2af49beb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_cd525f3e-4f4d-4bf1-b72e-39f702799aee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc8124d4-e6c2-4168-bdf7-6231a1691852" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_cd525f3e-4f4d-4bf1-b72e-39f702799aee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b183d83f-fb07-496d-9819-4b626b051c69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc8124d4-e6c2-4168-bdf7-6231a1691852" xlink:to="loc_us-gaap_DebtInstrumentTable_b183d83f-fb07-496d-9819-4b626b051c69" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c799b287-e85c-4e8f-8a88-b60c8149a426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b183d83f-fb07-496d-9819-4b626b051c69" xlink:to="loc_us-gaap_DebtInstrumentAxis_c799b287-e85c-4e8f-8a88-b60c8149a426" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c799b287-e85c-4e8f-8a88-b60c8149a426_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c799b287-e85c-4e8f-8a88-b60c8149a426" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c799b287-e85c-4e8f-8a88-b60c8149a426_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c799b287-e85c-4e8f-8a88-b60c8149a426" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A365NotesDueNovember302020Member_fae0f5e9-a0f3-4a8e-a614-ac405c7f01da" xlink:href="mck-20201231.xsd#mck_A365NotesDueNovember302020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A365NotesDueNovember302020Member_fae0f5e9-a0f3-4a8e-a614-ac405c7f01da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMarch12021Member_f4d8f751-7728-4950-8129-0006dac8ab98" xlink:href="mck-20201231.xsd#mck_A475NotesDueMarch12021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A475NotesDueMarch12021Member_f4d8f751-7728-4950-8129-0006dac8ab98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member_a7f96246-4a53-4751-8d27-9496b99b1c24" xlink:href="mck-20201231.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A270NotesDueDecember152022Member_a7f96246-4a53-4751-8d27-9496b99b1c24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_a69f7611-e93e-4545-aa49-aaa075574d6a" xlink:href="mck-20201231.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A285NotesDueMarch152023Member_a69f7611-e93e-4545-aa49-aaa075574d6a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_8c84b556-2877-4fd1-8d0b-36b972c409b6" xlink:href="mck-20201231.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A380NotesDueMarch152024Member_8c84b556-2877-4fd1-8d0b-36b972c409b6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_b0f19c40-0ddc-4c70-9b69-dedf778c5feb" xlink:href="mck-20201231.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A090NotesDueDecember32025Member_b0f19c40-0ddc-4c70-9b69-dedf778c5feb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_ce09e67b-8425-4fe4-a98d-21da1a2d65d0" xlink:href="mck-20201231.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_ce09e67b-8425-4fe4-a98d-21da1a2d65d0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_018c85d2-05a9-42b0-b27b-412810486662" xlink:href="mck-20201231.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A395NotesDueFebruary162028Member_018c85d2-05a9-42b0-b27b-412810486662" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_99396759-0598-4054-a21b-9cbcd5ca3bef" xlink:href="mck-20201231.xsd#mck_A475NotesDueMay302029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A475NotesDueMay302029Member_99396759-0598-4054-a21b-9cbcd5ca3bef" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_5ba6cc9d-8a1b-417e-9f94-d53b4c34cc80" xlink:href="mck-20201231.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A600NotesDueMarch12041Member_5ba6cc9d-8a1b-417e-9f94-d53b4c34cc80" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_c5215cba-ac1c-43dd-bdbe-b309adc11dd2" xlink:href="mck-20201231.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A488NotesDueMarch152044Member_c5215cba-ac1c-43dd-bdbe-b309adc11dd2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member_330ef31c-5329-4d1c-9af7-a030fbdf4e5f" xlink:href="mck-20201231.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A063EuroNotesDueAugust172021Member_330ef31c-5329-4d1c-9af7-a030fbdf4e5f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member_d89d7323-01d0-4d13-8f96-cca3de86a5c3" xlink:href="mck-20201231.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A150EuroNotesDueNovember172025Member_d89d7323-01d0-4d13-8f96-cca3de86a5c3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member_16413b63-ebec-4155-8e72-5036deb0f49b" xlink:href="mck-20201231.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A163EuroNotesDueOctober302026Member_16413b63-ebec-4155-8e72-5036deb0f49b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member_26764edc-934e-413a-bf21-b3cec42d47c8" xlink:href="mck-20201231.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A313SterlingNotesDueFebruary172029Member_26764edc-934e-413a-bf21-b3cec42d47c8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e786c5b8-d630-4826-9e15-fe404df0e419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b183d83f-fb07-496d-9819-4b626b051c69" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e786c5b8-d630-4826-9e15-fe404df0e419" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e786c5b8-d630-4826-9e15-fe404df0e419_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e786c5b8-d630-4826-9e15-fe404df0e419" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e786c5b8-d630-4826-9e15-fe404df0e419_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_31229d46-f93a-4f71-8df6-00164344f006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e786c5b8-d630-4826-9e15-fe404df0e419" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_31229d46-f93a-4f71-8df6-00164344f006" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_e2870640-05f3-41f5-aeb8-2a81131e7e4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_31229d46-f93a-4f71-8df6-00164344f006" xlink:to="loc_us-gaap_LoansPayableMember_e2870640-05f3-41f5-aeb8-2a81131e7e4f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivitiesLongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="extended" id="id2020ab8a80a4a1aa7f1cb81dd520267_DebtandFinancingActivitiesLongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_14e0ea48-1f8f-41fd-8516-2f283aa46e1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_30c2a482-5440-4e8f-8433-dcbe7cc30011" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14e0ea48-1f8f-41fd-8516-2f283aa46e1b" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_30c2a482-5440-4e8f-8433-dcbe7cc30011" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_32f1f454-1139-43bb-a1b8-a88e04eefd74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14e0ea48-1f8f-41fd-8516-2f283aa46e1b" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_32f1f454-1139-43bb-a1b8-a88e04eefd74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_7bf10eff-2748-444c-95c2-a144d5e4c475" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14e0ea48-1f8f-41fd-8516-2f283aa46e1b" xlink:to="loc_us-gaap_DebtInstrumentTerm_7bf10eff-2748-444c-95c2-a144d5e4c475" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c9eb1b9d-ad8b-4517-a153-5b623392df7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14e0ea48-1f8f-41fd-8516-2f283aa46e1b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c9eb1b9d-ad8b-4517-a153-5b623392df7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_d06912a4-3f66-4f2f-aaac-0f188eaf43d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14e0ea48-1f8f-41fd-8516-2f283aa46e1b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_d06912a4-3f66-4f2f-aaac-0f188eaf43d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_5fedd45e-b8b5-4530-b3ec-18aeb1510f10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14e0ea48-1f8f-41fd-8516-2f283aa46e1b" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_5fedd45e-b8b5-4530-b3ec-18aeb1510f10" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_cf313d53-8783-442c-b1a2-63650daa6b61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14e0ea48-1f8f-41fd-8516-2f283aa46e1b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_cf313d53-8783-442c-b1a2-63650daa6b61" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6f616d66-e04b-40fb-af36-07051c095f83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14e0ea48-1f8f-41fd-8516-2f283aa46e1b" xlink:to="loc_us-gaap_DebtInstrumentTable_6f616d66-e04b-40fb-af36-07051c095f83" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ffc07d62-014b-4069-93fb-6f2de43cace8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6f616d66-e04b-40fb-af36-07051c095f83" xlink:to="loc_us-gaap_DebtInstrumentAxis_ffc07d62-014b-4069-93fb-6f2de43cace8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ffc07d62-014b-4069-93fb-6f2de43cace8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ffc07d62-014b-4069-93fb-6f2de43cace8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ffc07d62-014b-4069-93fb-6f2de43cace8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8fdc6166-7213-4794-b9f1-996d74f9773b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ffc07d62-014b-4069-93fb-6f2de43cace8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8fdc6166-7213-4794-b9f1-996d74f9773b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_ff13df0c-262a-49fc-9cb2-12820b9a68ea" xlink:href="mck-20201231.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8fdc6166-7213-4794-b9f1-996d74f9773b" xlink:to="loc_mck_A090NotesDueDecember32025Member_ff13df0c-262a-49fc-9cb2-12820b9a68ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A365NotesDueNovember302020Member_f4a0a63d-1eeb-4d80-947b-473297eb7f14" xlink:href="mck-20201231.xsd#mck_A365NotesDueNovember302020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8fdc6166-7213-4794-b9f1-996d74f9773b" xlink:to="loc_mck_A365NotesDueNovember302020Member_f4a0a63d-1eeb-4d80-947b-473297eb7f14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMarch12021Member_68a8208a-a701-4cfb-95e5-762b51b943c1" xlink:href="mck-20201231.xsd#mck_A475NotesDueMarch12021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8fdc6166-7213-4794-b9f1-996d74f9773b" xlink:to="loc_mck_A475NotesDueMarch12021Member_68a8208a-a701-4cfb-95e5-762b51b943c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d650b7d6-46c5-4aad-8a26-99f39e5c29f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6f616d66-e04b-40fb-af36-07051c095f83" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d650b7d6-46c5-4aad-8a26-99f39e5c29f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d650b7d6-46c5-4aad-8a26-99f39e5c29f8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d650b7d6-46c5-4aad-8a26-99f39e5c29f8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d650b7d6-46c5-4aad-8a26-99f39e5c29f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_06185953-db30-4e6f-bce3-e82b52c1886c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d650b7d6-46c5-4aad-8a26-99f39e5c29f8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_06185953-db30-4e6f-bce3-e82b52c1886c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_e5dac128-1d24-4250-8643-52f91485be6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_06185953-db30-4e6f-bce3-e82b52c1886c" xlink:to="loc_us-gaap_LoansPayableMember_e5dac128-1d24-4250-8643-52f91485be6c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="extended" id="ifdef8a7792bd460d871759de3f8e5c19_DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_c760b9d4-e12e-4f44-96dd-acce4b5956a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c11c3140-e76e-4d9b-a305-0ac89699bbf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c760b9d4-e12e-4f44-96dd-acce4b5956a8" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c11c3140-e76e-4d9b-a305-0ac89699bbf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_d9420622-2aef-4bfb-878e-23cd2c8b6646" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c760b9d4-e12e-4f44-96dd-acce4b5956a8" xlink:to="loc_us-gaap_DebtInstrumentTerm_d9420622-2aef-4bfb-878e-23cd2c8b6646" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_7b64f808-5000-4144-9e4c-a67eb42824e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c760b9d4-e12e-4f44-96dd-acce4b5956a8" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_7b64f808-5000-4144-9e4c-a67eb42824e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_93071afd-ae4a-43e0-a770-7c30e7e06553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c760b9d4-e12e-4f44-96dd-acce4b5956a8" xlink:to="loc_us-gaap_LineOfCredit_93071afd-ae4a-43e0-a770-7c30e7e06553" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_36b0d3db-cab7-414d-a87e-80e45ed7f187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c760b9d4-e12e-4f44-96dd-acce4b5956a8" xlink:to="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_36b0d3db-cab7-414d-a87e-80e45ed7f187" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_9897951b-b190-4d51-8e3c-652a09d93f0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c760b9d4-e12e-4f44-96dd-acce4b5956a8" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_9897951b-b190-4d51-8e3c-652a09d93f0f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_11fd98d5-69cc-4811-b0e5-23ee21ca9c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c760b9d4-e12e-4f44-96dd-acce4b5956a8" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_11fd98d5-69cc-4811-b0e5-23ee21ca9c7b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_34614e58-3b66-40ee-b841-cf73dbe0d832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_11fd98d5-69cc-4811-b0e5-23ee21ca9c7b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_34614e58-3b66-40ee-b841-cf73dbe0d832" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_34614e58-3b66-40ee-b841-cf73dbe0d832_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_34614e58-3b66-40ee-b841-cf73dbe0d832" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_34614e58-3b66-40ee-b841-cf73dbe0d832_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8ae9aa51-df75-41f4-88f9-fef2dd244d33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_34614e58-3b66-40ee-b841-cf73dbe0d832" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8ae9aa51-df75-41f4-88f9-fef2dd244d33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_5a39119f-0091-4e79-a57d-113b5fa50cc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8ae9aa51-df75-41f4-88f9-fef2dd244d33" xlink:to="loc_us-gaap_UnsecuredDebtMember_5a39119f-0091-4e79-a57d-113b5fa50cc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_47563849-22a7-426e-aba5-c3329de250a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_11fd98d5-69cc-4811-b0e5-23ee21ca9c7b" xlink:to="loc_us-gaap_CreditFacilityAxis_47563849-22a7-426e-aba5-c3329de250a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_47563849-22a7-426e-aba5-c3329de250a2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_47563849-22a7-426e-aba5-c3329de250a2" xlink:to="loc_us-gaap_CreditFacilityDomain_47563849-22a7-426e-aba5-c3329de250a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f572796c-a4ac-4783-a3b2-05b6463144ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_47563849-22a7-426e-aba5-c3329de250a2" xlink:to="loc_us-gaap_CreditFacilityDomain_f572796c-a4ac-4783-a3b2-05b6463144ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_2ccfbec0-9fc4-4eea-86d1-bd8add688648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f572796c-a4ac-4783-a3b2-05b6463144ce" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_2ccfbec0-9fc4-4eea-86d1-bd8add688648" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_aa0ca80f-8157-4bc1-9d83-a778d66ffe97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f572796c-a4ac-4783-a3b2-05b6463144ce" xlink:to="loc_us-gaap_LineOfCreditMember_aa0ca80f-8157-4bc1-9d83-a778d66ffe97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_650df279-adc2-4499-91fe-bdf2e8831c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_11fd98d5-69cc-4811-b0e5-23ee21ca9c7b" xlink:to="loc_us-gaap_DebtInstrumentAxis_650df279-adc2-4499-91fe-bdf2e8831c66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_650df279-adc2-4499-91fe-bdf2e8831c66_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_650df279-adc2-4499-91fe-bdf2e8831c66" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_650df279-adc2-4499-91fe-bdf2e8831c66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_da86f16f-6b41-49e2-9a9b-242f6293e3f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_650df279-adc2-4499-91fe-bdf2e8831c66" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_da86f16f-6b41-49e2-9a9b-242f6293e3f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_e2ed4b87-74d2-412a-90e1-ba8e0e7582bd" xlink:href="mck-20201231.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_da86f16f-6b41-49e2-9a9b-242f6293e3f3" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_e2ed4b87-74d2-412a-90e1-ba8e0e7582bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_acc5d8b4-ece5-4252-96fa-de76d8b8283e" xlink:href="mck-20201231.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_da86f16f-6b41-49e2-9a9b-242f6293e3f3" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_acc5d8b4-ece5-4252-96fa-de76d8b8283e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember_f236f55e-1da8-4595-8080-7c0de20aff91" xlink:href="mck-20201231.xsd#mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_da86f16f-6b41-49e2-9a9b-242f6293e3f3" xlink:to="loc_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember_f236f55e-1da8-4595-8080-7c0de20aff91" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivitiesCommercialPaperDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="extended" id="i9d6610802ac94137b99cc03071708459_DebtandFinancingActivitiesCommercialPaperDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c7649511-3275-411b-95f0-e1c400b335e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_96e540d6-49c2-4eb8-908c-aaec4f75e3c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c7649511-3275-411b-95f0-e1c400b335e2" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_96e540d6-49c2-4eb8-908c-aaec4f75e3c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_4c573b9f-2796-439c-ac2a-7d83e57933d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c7649511-3275-411b-95f0-e1c400b335e2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_4c573b9f-2796-439c-ac2a-7d83e57933d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_aae2e140-77ba-462f-898e-53207729bf6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c7649511-3275-411b-95f0-e1c400b335e2" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_aae2e140-77ba-462f-898e-53207729bf6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermCommercialPaperCurrent_a58a8201-0c22-44c2-9f74-c6eee8a64299" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermCommercialPaperCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c7649511-3275-411b-95f0-e1c400b335e2" xlink:to="loc_us-gaap_LongTermCommercialPaperCurrent_a58a8201-0c22-44c2-9f74-c6eee8a64299" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_7efe1059-7218-4bac-9d3a-27eb05ede1c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c7649511-3275-411b-95f0-e1c400b335e2" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_7efe1059-7218-4bac-9d3a-27eb05ede1c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4f56a43b-27a1-453e-8a28-2429370b9c75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c7649511-3275-411b-95f0-e1c400b335e2" xlink:to="loc_us-gaap_DebtInstrumentTable_4f56a43b-27a1-453e-8a28-2429370b9c75" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c0b26470-bf7f-4e09-9b71-78d8228d9949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4f56a43b-27a1-453e-8a28-2429370b9c75" xlink:to="loc_us-gaap_CreditFacilityAxis_c0b26470-bf7f-4e09-9b71-78d8228d9949" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c0b26470-bf7f-4e09-9b71-78d8228d9949_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_c0b26470-bf7f-4e09-9b71-78d8228d9949" xlink:to="loc_us-gaap_CreditFacilityDomain_c0b26470-bf7f-4e09-9b71-78d8228d9949_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8be77375-0217-4134-9c92-7bfc62c52c36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_c0b26470-bf7f-4e09-9b71-78d8228d9949" xlink:to="loc_us-gaap_CreditFacilityDomain_8be77375-0217-4134-9c92-7bfc62c52c36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_7cd7d1e6-9fc3-479c-9c53-e156b87bcbb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_8be77375-0217-4134-9c92-7bfc62c52c36" xlink:to="loc_us-gaap_CommercialPaperMember_7cd7d1e6-9fc3-479c-9c53-e156b87bcbb4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StatementofIncomeIncludingGrossMarginStatement" xlink:type="simple" xlink:href="mck-20201231.xsd#StatementofIncomeIncludingGrossMarginStatement"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StatementofIncomeIncludingGrossMarginStatement" xlink:type="extended" id="i40a560d4a0eb47b88b979f7021746102_StatementofIncomeIncludingGrossMarginStatement"/>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefits" xlink:type="simple" xlink:href="mck-20201231.xsd#PensionBenefits"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefits" xlink:type="extended" id="i12b6c53532a447c4bc6e6272566a1218_PensionBenefits"/>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#PensionBenefitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended" id="iab4cc9bcab994bd0823135f078ad3a5a_PensionBenefitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_29480089-ed63-4daf-b29a-1146278f2d22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_29480089-ed63-4daf-b29a-1146278f2d22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_01963b97-6cd4-4ed0-b38b-59497dd745e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_01963b97-6cd4-4ed0-b38b-59497dd745e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_9ca4b6f4-2360-4242-a1f3-bdd06a8e43b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_9ca4b6f4-2360-4242-a1f3-bdd06a8e43b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedPercentage_224794f6-87fa-4317-9257-1105ae5029a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedPercentage_224794f6-87fa-4317-9257-1105ae5029a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPensionPlanLiabilitiesDerecognized_cbaada5e-880c-4cbd-a65f-dc719c70b439" xlink:href="mck-20201231.xsd#mck_DefinedBenefitPensionPlanLiabilitiesDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_mck_DefinedBenefitPensionPlanLiabilitiesDerecognized_cbaada5e-880c-4cbd-a65f-dc719c70b439" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease_fc336ab9-da9d-4f1f-beb4-a73f867bc926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease_fc336ab9-da9d-4f1f-beb4-a73f867bc926" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanSettlementPlanParticipants_ea216ffd-a90c-4e50-b640-a20e7fe95553" xlink:href="mck-20201231.xsd#mck_DefinedBenefitPlanSettlementPlanParticipants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_mck_DefinedBenefitPlanSettlementPlanParticipants_ea216ffd-a90c-4e50-b640-a20e7fe95553" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_2bb2b150-6e72-4323-9e6b-02e72b7dab05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_2bb2b150-6e72-4323-9e6b-02e72b7dab05" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_7b66ad28-2df2-4a5b-a982-784ec170c6ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_7b66ad28-2df2-4a5b-a982-784ec170c6ce" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_8b7cb0e8-c759-4341-a691-7bb51976cbb7" xlink:href="mck-20201231.xsd#mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_8b7cb0e8-c759-4341-a691-7bb51976cbb7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_7ca00a84-9c2c-4101-b8a1-88b0bbd31e4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d87889c4-4436-4f17-b6e5-e5679c65516c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d87889c4-4436-4f17-b6e5-e5679c65516c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_ed7c1d01-1c89-4579-a3df-a09109289363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d87889c4-4436-4f17-b6e5-e5679c65516c" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_ed7c1d01-1c89-4579-a3df-a09109289363" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_ed7c1d01-1c89-4579-a3df-a09109289363_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ed7c1d01-1c89-4579-a3df-a09109289363" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_ed7c1d01-1c89-4579-a3df-a09109289363_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_988a45e9-9b06-4f74-9e2b-5871d313fc76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ed7c1d01-1c89-4579-a3df-a09109289363" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_988a45e9-9b06-4f74-9e2b-5871d313fc76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d3c1c8f9-a963-49a4-808a-927d32f6a92e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_988a45e9-9b06-4f74-9e2b-5871d313fc76" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d3c1c8f9-a963-49a4-808a-927d32f6a92e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_6b9342fe-7dcf-44d5-ab04-bd140a1a8d7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d87889c4-4436-4f17-b6e5-e5679c65516c" xlink:to="loc_us-gaap_RetirementPlanNameAxis_6b9342fe-7dcf-44d5-ab04-bd140a1a8d7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_6b9342fe-7dcf-44d5-ab04-bd140a1a8d7d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_6b9342fe-7dcf-44d5-ab04-bd140a1a8d7d" xlink:to="loc_us-gaap_RetirementPlanNameDomain_6b9342fe-7dcf-44d5-ab04-bd140a1a8d7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_5a5b7062-fc04-41ca-8088-bd9dee4011bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_6b9342fe-7dcf-44d5-ab04-bd140a1a8d7d" xlink:to="loc_us-gaap_RetirementPlanNameDomain_5a5b7062-fc04-41ca-8088-bd9dee4011bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExecutiveBenefitRetirementPlanMember_0c6f8038-e150-48ef-a330-543e3d7a6a8c" xlink:href="mck-20201231.xsd#mck_ExecutiveBenefitRetirementPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_5a5b7062-fc04-41ca-8088-bd9dee4011bb" xlink:to="loc_mck_ExecutiveBenefitRetirementPlanMember_0c6f8038-e150-48ef-a330-543e3d7a6a8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_88c3ebac-b61f-4724-ba00-cbd95b250cc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d87889c4-4436-4f17-b6e5-e5679c65516c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_88c3ebac-b61f-4724-ba00-cbd95b250cc9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_88c3ebac-b61f-4724-ba00-cbd95b250cc9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_88c3ebac-b61f-4724-ba00-cbd95b250cc9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_88c3ebac-b61f-4724-ba00-cbd95b250cc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_8bf87166-74d9-4fac-b3d1-8cc39189aace" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_88c3ebac-b61f-4724-ba00-cbd95b250cc9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_8bf87166-74d9-4fac-b3d1-8cc39189aace" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_aa1e7e4c-b10b-46fb-8382-5085cf000031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_8bf87166-74d9-4fac-b3d1-8cc39189aace" xlink:to="loc_us-gaap_DomesticPlanMember_aa1e7e4c-b10b-46fb-8382-5085cf000031" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_7ed51c36-44ae-469b-91dd-39b117ffa8ad" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_aa1e7e4c-b10b-46fb-8382-5085cf000031" xlink:to="loc_country_US_7ed51c36-44ae-469b-91dd-39b117ffa8ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_02dda6e8-219c-400f-adaf-dcdb2b27018d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d87889c4-4436-4f17-b6e5-e5679c65516c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_02dda6e8-219c-400f-adaf-dcdb2b27018d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_02dda6e8-219c-400f-adaf-dcdb2b27018d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_02dda6e8-219c-400f-adaf-dcdb2b27018d" xlink:to="loc_us-gaap_EquityComponentDomain_02dda6e8-219c-400f-adaf-dcdb2b27018d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d577afcb-85a3-4124-b64d-ebfd6a3ffab5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_02dda6e8-219c-400f-adaf-dcdb2b27018d" xlink:to="loc_us-gaap_EquityComponentDomain_d577afcb-85a3-4124-b64d-ebfd6a3ffab5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_c842a6fe-f377-4341-8e64-ad90e3d5300b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d577afcb-85a3-4124-b64d-ebfd6a3ffab5" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_c842a6fe-f377-4341-8e64-ad90e3d5300b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d0a5b98c-0abd-4868-ad49-8b579c4eb4f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d87889c4-4436-4f17-b6e5-e5679c65516c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d0a5b98c-0abd-4868-ad49-8b579c4eb4f0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d0a5b98c-0abd-4868-ad49-8b579c4eb4f0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d0a5b98c-0abd-4868-ad49-8b579c4eb4f0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d0a5b98c-0abd-4868-ad49-8b579c4eb4f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5090c88-1995-4d35-a0fe-0409d9e005f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d0a5b98c-0abd-4868-ad49-8b579c4eb4f0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5090c88-1995-4d35-a0fe-0409d9e005f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_deacd40e-ca08-4e4d-8586-3d0bb61db049" xlink:href="mck-20201231.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5090c88-1995-4d35-a0fe-0409d9e005f5" xlink:to="loc_mck_GermanWholesaleBusinessMember_deacd40e-ca08-4e4d-8586-3d0bb61db049" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_66e3c00e-fd82-42e9-a5c3-0467135c40e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d87889c4-4436-4f17-b6e5-e5679c65516c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_66e3c00e-fd82-42e9-a5c3-0467135c40e2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_66e3c00e-fd82-42e9-a5c3-0467135c40e2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_66e3c00e-fd82-42e9-a5c3-0467135c40e2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_66e3c00e-fd82-42e9-a5c3-0467135c40e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7f62b1cb-6a59-4c4c-96e1-8b0352b2e976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_66e3c00e-fd82-42e9-a5c3-0467135c40e2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7f62b1cb-6a59-4c4c-96e1-8b0352b2e976" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_228dd7eb-a865-438e-92df-52a665800763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7f62b1cb-6a59-4c4c-96e1-8b0352b2e976" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_228dd7eb-a865-438e-92df-52a665800763" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivities" xlink:type="simple" xlink:href="mck-20201231.xsd#HedgingActivities"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivities" xlink:type="extended" id="ia86044bf52424aeb866a1be66614eb40_HedgingActivities"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="simple" xlink:href="mck-20201231.xsd#HedgingActivitiesTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="extended" id="if52e39f812e1475b9d476f74b2c68ca7_HedgingActivitiesTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended" id="i2800cd8c409b4e278a603500a4818a48_HedgingActivitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d573e76c-bf34-422f-9053-e321840715be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_us-gaap_LongTermDebt_d573e76c-bf34-422f-9053-e321840715be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_bfe00421-45c6-43d4-8a6a-4cd6554e7c4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_bfe00421-45c6-43d4-8a6a-4cd6554e7c4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_fee89c05-2370-4cb2-80dc-8929eb702265" xlink:href="mck-20201231.xsd#mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_fee89c05-2370-4cb2-80dc-8929eb702265" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a6623425-7b2a-41c0-88b9-d25405205771" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a6623425-7b2a-41c0-88b9-d25405205771" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_f15ee9ea-2f30-44e7-a489-f73812e0e7d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_f15ee9ea-2f30-44e7-a489-f73812e0e7d9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_ea89c8ff-7ba2-4318-be03-7ec51c3b283c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_ea89c8ff-7ba2-4318-be03-7ec51c3b283c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_75abd86d-9a8a-442c-8732-03529a69d33b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_75abd86d-9a8a-442c-8732-03529a69d33b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_69fa08dd-3ef5-4eb3-8cbd-f7d854d30fed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_69fa08dd-3ef5-4eb3-8cbd-f7d854d30fed" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_c8db7c9d-deec-41e4-8b99-1d8fdce73937" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_us-gaap_DebtInstrumentTerm_c8db7c9d-deec-41e4-8b99-1d8fdce73937" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_63cc6335-9d9f-4d89-b9ff-e68f68f357e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_us-gaap_DerivativeTable_63cc6335-9d9f-4d89-b9ff-e68f68f357e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6dc54095-2ec6-4699-8086-fe1a8a1a3509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_63cc6335-9d9f-4d89-b9ff-e68f68f357e3" xlink:to="loc_us-gaap_DebtInstrumentAxis_6dc54095-2ec6-4699-8086-fe1a8a1a3509" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6dc54095-2ec6-4699-8086-fe1a8a1a3509_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6dc54095-2ec6-4699-8086-fe1a8a1a3509" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6dc54095-2ec6-4699-8086-fe1a8a1a3509_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_22d87eb3-ad2f-4cb7-8d45-24a49a0fe627" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6dc54095-2ec6-4699-8086-fe1a8a1a3509" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_22d87eb3-ad2f-4cb7-8d45-24a49a0fe627" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_a5b1277a-6718-44df-a599-c3bc959796cf" xlink:href="mck-20201231.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_22d87eb3-ad2f-4cb7-8d45-24a49a0fe627" xlink:to="loc_mck_EuroDenominatedNotesMember_a5b1277a-6718-44df-a599-c3bc959796cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_e04b9b86-e0b4-45d3-999f-a99f17390f9c" xlink:href="mck-20201231.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_22d87eb3-ad2f-4cb7-8d45-24a49a0fe627" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_e04b9b86-e0b4-45d3-999f-a99f17390f9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2025NotesMember_321dc822-ac93-4a3c-a5b1-213929c65d4f" xlink:href="mck-20201231.xsd#mck_A2025NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_22d87eb3-ad2f-4cb7-8d45-24a49a0fe627" xlink:to="loc_mck_A2025NotesMember_321dc822-ac93-4a3c-a5b1-213929c65d4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5e6f72f3-cf7b-4de5-971c-6d6f7173988c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_63cc6335-9d9f-4d89-b9ff-e68f68f357e3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5e6f72f3-cf7b-4de5-971c-6d6f7173988c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5e6f72f3-cf7b-4de5-971c-6d6f7173988c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5e6f72f3-cf7b-4de5-971c-6d6f7173988c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5e6f72f3-cf7b-4de5-971c-6d6f7173988c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_76f8b183-95a1-4fb2-a8ae-af7104a4dc97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5e6f72f3-cf7b-4de5-971c-6d6f7173988c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_76f8b183-95a1-4fb2-a8ae-af7104a4dc97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_b888547f-6784-42fb-b2f8-d1f51381593e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_76f8b183-95a1-4fb2-a8ae-af7104a4dc97" xlink:to="loc_us-gaap_LoansPayableMember_b888547f-6784-42fb-b2f8-d1f51381593e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_301b2c98-fd51-4f26-b36c-d2dffd8ea519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_63cc6335-9d9f-4d89-b9ff-e68f68f357e3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_301b2c98-fd51-4f26-b36c-d2dffd8ea519" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_301b2c98-fd51-4f26-b36c-d2dffd8ea519_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_301b2c98-fd51-4f26-b36c-d2dffd8ea519" xlink:to="loc_us-gaap_HedgingRelationshipDomain_301b2c98-fd51-4f26-b36c-d2dffd8ea519_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b0fe46bd-a079-4d2f-aec1-5c84f9e80699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_301b2c98-fd51-4f26-b36c-d2dffd8ea519" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b0fe46bd-a079-4d2f-aec1-5c84f9e80699" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_b0c58ce2-d64f-4fbd-bfa9-ef325217d97c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b0fe46bd-a079-4d2f-aec1-5c84f9e80699" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_b0c58ce2-d64f-4fbd-bfa9-ef325217d97c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_26017673-e91b-44bd-8689-9eb4f8c9ac01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b0fe46bd-a079-4d2f-aec1-5c84f9e80699" xlink:to="loc_us-gaap_CashFlowHedgingMember_26017673-e91b-44bd-8689-9eb4f8c9ac01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b9142a79-1a78-4d5e-9238-f6e2ef236ec0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_63cc6335-9d9f-4d89-b9ff-e68f68f357e3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b9142a79-1a78-4d5e-9238-f6e2ef236ec0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b9142a79-1a78-4d5e-9238-f6e2ef236ec0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b9142a79-1a78-4d5e-9238-f6e2ef236ec0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b9142a79-1a78-4d5e-9238-f6e2ef236ec0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8ccaf2ff-5f73-4f26-9e0b-7ff38398a52f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b9142a79-1a78-4d5e-9238-f6e2ef236ec0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8ccaf2ff-5f73-4f26-9e0b-7ff38398a52f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_November2018CrossCurrencySwapsMember_baa243cf-e726-4300-b207-0598b660f4c3" xlink:href="mck-20201231.xsd#mck_November2018CrossCurrencySwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8ccaf2ff-5f73-4f26-9e0b-7ff38398a52f" xlink:to="loc_mck_November2018CrossCurrencySwapsMember_baa243cf-e726-4300-b207-0598b660f4c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_193b2c60-9c49-4568-ad08-1dbd97af5ae0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8ccaf2ff-5f73-4f26-9e0b-7ff38398a52f" xlink:to="loc_us-gaap_CurrencySwapMember_193b2c60-9c49-4568-ad08-1dbd97af5ae0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e69ead89-c04f-4fe4-a7c2-2b4fee7f57a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8ccaf2ff-5f73-4f26-9e0b-7ff38398a52f" xlink:to="loc_us-gaap_InterestRateSwapMember_e69ead89-c04f-4fe4-a7c2-2b4fee7f57a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_6b9d4409-5dbf-42bc-9a43-188c9e11c849" xlink:href="mck-20201231.xsd#mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8ccaf2ff-5f73-4f26-9e0b-7ff38398a52f" xlink:to="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_6b9d4409-5dbf-42bc-9a43-188c9e11c849" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_fd19c4bd-60fb-4684-b15f-1ca90cc4e55f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_63cc6335-9d9f-4d89-b9ff-e68f68f357e3" xlink:to="loc_us-gaap_HedgingDesignationAxis_fd19c4bd-60fb-4684-b15f-1ca90cc4e55f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fd19c4bd-60fb-4684-b15f-1ca90cc4e55f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_fd19c4bd-60fb-4684-b15f-1ca90cc4e55f" xlink:to="loc_us-gaap_HedgingDesignationDomain_fd19c4bd-60fb-4684-b15f-1ca90cc4e55f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_bfcb8fb4-582e-48b2-bf0e-1f5e41f069b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_fd19c4bd-60fb-4684-b15f-1ca90cc4e55f" xlink:to="loc_us-gaap_HedgingDesignationDomain_bfcb8fb4-582e-48b2-bf0e-1f5e41f069b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2fb67a21-6939-4723-9754-87fd6d260401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_bfcb8fb4-582e-48b2-bf0e-1f5e41f069b0" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2fb67a21-6939-4723-9754-87fd6d260401" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_d3dfc605-f7de-4162-8d83-71e6b9a3fcef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_bfcb8fb4-582e-48b2-bf0e-1f5e41f069b0" xlink:to="loc_us-gaap_NondesignatedMember_d3dfc605-f7de-4162-8d83-71e6b9a3fcef" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#HedgingActivitiesDerivativeInstrumentsFairValueDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="extended" id="i78106c794fc14a52853ecb4ec7c27695_HedgingActivitiesDerivativeInstrumentsFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_1ac1a774-5d29-4e5f-bb5c-439186c0209b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a02235d4-f960-4c89-a4df-a6768e70106e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_1ac1a774-5d29-4e5f-bb5c-439186c0209b" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a02235d4-f960-4c89-a4df-a6768e70106e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_1aa70a61-8c22-4c4b-82d0-4ab1698e4228" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_1ac1a774-5d29-4e5f-bb5c-439186c0209b" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_1aa70a61-8c22-4c4b-82d0-4ab1698e4228" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_4c1fc621-43cc-43fd-83f0-788a2df728bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_1ac1a774-5d29-4e5f-bb5c-439186c0209b" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_4c1fc621-43cc-43fd-83f0-788a2df728bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_9ec2a2ba-be18-4259-82e0-e6517024899e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_1ac1a774-5d29-4e5f-bb5c-439186c0209b" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_9ec2a2ba-be18-4259-82e0-e6517024899e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8d4b740-ec88-4a15-bc77-c487a10ab456" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_1ac1a774-5d29-4e5f-bb5c-439186c0209b" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8d4b740-ec88-4a15-bc77-c487a10ab456" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0258da99-f936-4c70-a898-629bc8b60323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8d4b740-ec88-4a15-bc77-c487a10ab456" xlink:to="loc_us-gaap_HedgingDesignationAxis_0258da99-f936-4c70-a898-629bc8b60323" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0258da99-f936-4c70-a898-629bc8b60323_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_0258da99-f936-4c70-a898-629bc8b60323" xlink:to="loc_us-gaap_HedgingDesignationDomain_0258da99-f936-4c70-a898-629bc8b60323_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1c3f8f31-689d-4e2c-9ac3-d39e9246a8ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_0258da99-f936-4c70-a898-629bc8b60323" xlink:to="loc_us-gaap_HedgingDesignationDomain_1c3f8f31-689d-4e2c-9ac3-d39e9246a8ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3a205b69-1cd1-4b4d-ad1a-719f44b71cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_1c3f8f31-689d-4e2c-9ac3-d39e9246a8ea" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3a205b69-1cd1-4b4d-ad1a-719f44b71cb2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_bd5cb7d2-502a-4ee5-ae05-0e644c49cbd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_1c3f8f31-689d-4e2c-9ac3-d39e9246a8ea" xlink:to="loc_us-gaap_NondesignatedMember_bd5cb7d2-502a-4ee5-ae05-0e644c49cbd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a7cbfeac-23f7-4215-8e16-614a5f422937" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8d4b740-ec88-4a15-bc77-c487a10ab456" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a7cbfeac-23f7-4215-8e16-614a5f422937" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a7cbfeac-23f7-4215-8e16-614a5f422937_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a7cbfeac-23f7-4215-8e16-614a5f422937" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a7cbfeac-23f7-4215-8e16-614a5f422937_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1d2ebc89-769d-4ebe-b125-8bab484839dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a7cbfeac-23f7-4215-8e16-614a5f422937" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1d2ebc89-769d-4ebe-b125-8bab484839dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_af0cf686-c5f4-4aeb-afb7-91eb27ca143a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1d2ebc89-769d-4ebe-b125-8bab484839dd" xlink:to="loc_us-gaap_CurrencySwapMember_af0cf686-c5f4-4aeb-afb7-91eb27ca143a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b1bb7fd4-013c-4dda-b44f-9fd701d283a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1d2ebc89-769d-4ebe-b125-8bab484839dd" xlink:to="loc_us-gaap_InterestRateSwapMember_b1bb7fd4-013c-4dda-b44f-9fd701d283a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_66a2e185-534d-4293-865b-5c0b898695c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1d2ebc89-769d-4ebe-b125-8bab484839dd" xlink:to="loc_us-gaap_ForeignExchangeContractMember_66a2e185-534d-4293-865b-5c0b898695c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6af55a03-a04e-4376-9a28-2e81ce6f16f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8d4b740-ec88-4a15-bc77-c487a10ab456" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6af55a03-a04e-4376-9a28-2e81ce6f16f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6af55a03-a04e-4376-9a28-2e81ce6f16f5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6af55a03-a04e-4376-9a28-2e81ce6f16f5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6af55a03-a04e-4376-9a28-2e81ce6f16f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_51d17932-d0ee-4eb7-af11-d75d1981f06b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6af55a03-a04e-4376-9a28-2e81ce6f16f5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_51d17932-d0ee-4eb7-af11-d75d1981f06b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_89689689-c603-47c1-8361-583d1d5273be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_51d17932-d0ee-4eb7-af11-d75d1981f06b" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_89689689-c603-47c1-8361-583d1d5273be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_7250d2f0-5902-4ef6-8316-ab1964b5f5d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_51d17932-d0ee-4eb7-af11-d75d1981f06b" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_7250d2f0-5902-4ef6-8316-ab1964b5f5d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember_bd27a42e-51c4-4e5d-b5c0-f7fb440cfd6f" xlink:href="mck-20201231.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_51d17932-d0ee-4eb7-af11-d75d1981f06b" xlink:to="loc_mck_CurrentAssetLiabilityMember_bd27a42e-51c4-4e5d-b5c0-f7fb440cfd6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_2a744d29-da72-471b-b056-b91c5f6621d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_51d17932-d0ee-4eb7-af11-d75d1981f06b" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_2a744d29-da72-471b-b056-b91c5f6621d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_9613951f-6a90-4e0a-b6b1-9612777b9e75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_51d17932-d0ee-4eb7-af11-d75d1981f06b" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_9613951f-6a90-4e0a-b6b1-9612777b9e75" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncurrentAssetLiabilityMember_097938ff-72d0-45ad-a6e1-ac7cb2c4075b" xlink:href="mck-20201231.xsd#mck_NoncurrentAssetLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_51d17932-d0ee-4eb7-af11-d75d1981f06b" xlink:to="loc_mck_NoncurrentAssetLiabilityMember_097938ff-72d0-45ad-a6e1-ac7cb2c4075b" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mck-20201231.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FairValueMeasurements" xlink:type="extended" id="i209c50f4ff7d4fe8b617148fe9ef7617_FairValueMeasurements"/>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsDetails" xlink:type="extended" id="ia274427f7264475db9c7704a97a4fdfd_FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5ef769e0-b104-4800-9e33-2f6070de26e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:to="loc_us-gaap_LongTermDebt_5ef769e0-b104-4800-9e33-2f6070de26e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_92582c33-38be-4b00-9a9a-4f2836c62e83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:to="loc_us-gaap_DebtInstrumentFairValue_92582c33-38be-4b00-9a9a-4f2836c62e83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_783b23ba-b2a5-4955-b966-eab84174c526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_783b23ba-b2a5-4955-b966-eab84174c526" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_a377d1d8-60bb-4f9b-9549-c8ead959be33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_a377d1d8-60bb-4f9b-9549-c8ead959be33" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies_8ef9e647-d8dd-4ede-a2af-dd31afa866b8" xlink:href="mck-20201231.xsd#mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:to="loc_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies_8ef9e647-d8dd-4ede-a2af-dd31afa866b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices_9c31a91c-e3d8-45a0-ae29-42a14a75e303" xlink:href="mck-20201231.xsd#mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:to="loc_mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices_9c31a91c-e3d8-45a0-ae29-42a14a75e303" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_3ce5b043-0b98-4806-b0e3-32bf7c8deda3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_3ce5b043-0b98-4806-b0e3-32bf7c8deda3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_b25d330b-73b1-4cef-a638-b8775d3c88d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_b25d330b-73b1-4cef-a638-b8775d3c88d1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_83015e6a-79f4-4b13-9cf5-e84d1b366047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_83015e6a-79f4-4b13-9cf5-e84d1b366047" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fe903078-ca50-4e80-a524-dd814cda19f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_83015e6a-79f4-4b13-9cf5-e84d1b366047" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fe903078-ca50-4e80-a524-dd814cda19f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fe903078-ca50-4e80-a524-dd814cda19f1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fe903078-ca50-4e80-a524-dd814cda19f1" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fe903078-ca50-4e80-a524-dd814cda19f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_af83a1a1-da32-49a7-a4d0-54bd2a011222" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fe903078-ca50-4e80-a524-dd814cda19f1" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_af83a1a1-da32-49a7-a4d0-54bd2a011222" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4b8b0500-7855-4396-ac30-fb1f1003a7b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_af83a1a1-da32-49a7-a4d0-54bd2a011222" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4b8b0500-7855-4396-ac30-fb1f1003a7b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_e6e76272-c8e7-4e7e-9a7f-7722ac87cd1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_af83a1a1-da32-49a7-a4d0-54bd2a011222" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_e6e76272-c8e7-4e7e-9a7f-7722ac87cd1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fb1f281e-b7df-4dbc-bca3-bc20c56180ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_83015e6a-79f4-4b13-9cf5-e84d1b366047" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fb1f281e-b7df-4dbc-bca3-bc20c56180ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb1f281e-b7df-4dbc-bca3-bc20c56180ea_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fb1f281e-b7df-4dbc-bca3-bc20c56180ea" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb1f281e-b7df-4dbc-bca3-bc20c56180ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2ab2631f-ccb2-44ab-b61b-af4fa3e6cc2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fb1f281e-b7df-4dbc-bca3-bc20c56180ea" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2ab2631f-ccb2-44ab-b61b-af4fa3e6cc2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_bc2f39f6-35ce-4eeb-ba3b-2375f244b3ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2ab2631f-ccb2-44ab-b61b-af4fa3e6cc2f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_bc2f39f6-35ce-4eeb-ba3b-2375f244b3ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5fdbb1c0-c2cb-433d-b104-089d1be1f9e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2ab2631f-ccb2-44ab-b61b-af4fa3e6cc2f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5fdbb1c0-c2cb-433d-b104-089d1be1f9e1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="simple" xlink:href="mck-20201231.xsd#CommitmentsandContingentLiabilities"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="extended" id="i82faaeced57049e9b917d3cc65a2a319_CommitmentsandContingentLiabilities"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#CommitmentsandContingentLiabilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="extended" id="i4a9b022f22d249a197fbfc8baacabb69_CommitmentsandContingentLiabilitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_8b218ebe-3e4c-47f4-ac20-7ba8929ed326" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_8b218ebe-3e4c-47f4-ac20-7ba8929ed326" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCounties_68dc7a93-4ac2-4369-82db-882dd42c1fda" xlink:href="mck-20201231.xsd#mck_LossContingencyNumberofCounties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencyNumberofCounties_68dc7a93-4ac2-4369-82db-882dd42c1fda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_660d3a24-9aad-4d98-b4d8-6b433aadb26b" xlink:href="mck-20201231.xsd#mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_660d3a24-9aad-4d98-b4d8-6b433aadb26b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_9b5ac5ab-85a7-45e6-91e8-f1a88901285c" xlink:href="mck-20201231.xsd#mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_9b5ac5ab-85a7-45e6-91e8-f1a88901285c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates_c381937e-27e1-4033-93a7-55b8117a9aab" xlink:href="mck-20201231.xsd#mck_LossContingencyNumberofStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencyNumberofStates_c381937e-27e1-4033-93a7-55b8117a9aab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStateAttorneyGenerals_39c3e4b1-eb6b-483b-8c24-7f9e81fca93c" xlink:href="mck-20201231.xsd#mck_LossContingencyNumberofStateAttorneyGenerals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencyNumberofStateAttorneyGenerals_39c3e4b1-eb6b-483b-8c24-7f9e81fca93c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfCountyGovernments_1ba9833f-e782-4ba7-96fc-c4d11545d198" xlink:href="mck-20201231.xsd#mck_NumberOfCountyGovernments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_NumberOfCountyGovernments_1ba9833f-e782-4ba7-96fc-c4d11545d198" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_9172af24-1680-4e5b-a274-32d3925cc503" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_9172af24-1680-4e5b-a274-32d3925cc503" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_4c219297-ca78-4943-8f27-746b1dd62d06" xlink:href="mck-20201231.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_4c219297-ca78-4943-8f27-746b1dd62d06" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation_d0d16ad1-7bc6-4e65-acdc-1fa4557622c7" xlink:href="mck-20201231.xsd#mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation_d0d16ad1-7bc6-4e65-acdc-1fa4557622c7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_53a55d33-cbfd-469d-b34c-6ef279fcb89e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_53a55d33-cbfd-469d-b34c-6ef279fcb89e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualProvisionNetOfTax_05e03c2d-6fa4-499e-82e3-12fd47e0f398" xlink:href="mck-20201231.xsd#mck_LossContingencyAccrualProvisionNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencyAccrualProvisionNetOfTax_05e03c2d-6fa4-499e-82e3-12fd47e0f398" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyDamagesSoughtPerViolationValue_e162d1a6-dcce-442b-af3a-fccaab3ff16f" xlink:href="mck-20201231.xsd#mck_LossContingencyDamagesSoughtPerViolationValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencyDamagesSoughtPerViolationValue_e162d1a6-dcce-442b-af3a-fccaab3ff16f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_75671d29-188f-46a1-b779-7e0f7bbc2efa" xlink:href="mck-20201231.xsd#mck_LossContingencyClassActionNumberofFaxesRemainingintheClass"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_75671d29-188f-46a1-b779-7e0f7bbc2efa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesReceived_bd6ec089-2fd2-4b2c-ac37-fe66bd3ebaa7" xlink:href="mck-20201231.xsd#mck_LossContingencyClassActionNumberofFaxesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesReceived_bd6ec089-2fd2-4b2c-ac37-fe66bd3ebaa7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfInvestmentFundsThatFiledClaims_fd87c8c9-f56d-44f6-8af0-f6e76015b8f2" xlink:href="mck-20201231.xsd#mck_NumberOfInvestmentFundsThatFiledClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_NumberOfInvestmentFundsThatFiledClaims_fd87c8c9-f56d-44f6-8af0-f6e76015b8f2" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_076c1bd2-dc69-4102-b53b-33513e0f1225" xlink:href="mck-20201231.xsd#mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_076c1bd2-dc69-4102-b53b-33513e0f1225" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_803fb74c-12c2-4b4a-90e7-e85d9cea4acc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_803fb74c-12c2-4b4a-90e7-e85d9cea4acc" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualAfterTax_2022cedd-91cf-430f-bd15-6ad080e80a0f" xlink:href="mck-20201231.xsd#mck_LossContingencyAccrualAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencyAccrualAfterTax_2022cedd-91cf-430f-bd15-6ad080e80a0f" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_6af6df30-e7a8-4021-a39e-16e8cd8186f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_us-gaap_LossContingenciesTable_6af6df30-e7a8-4021-a39e-16e8cd8186f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_29d89cc8-2b88-49c5-a683-beccfd810652" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6af6df30-e7a8-4021-a39e-16e8cd8186f4" xlink:to="loc_us-gaap_LitigationStatusAxis_29d89cc8-2b88-49c5-a683-beccfd810652" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_29d89cc8-2b88-49c5-a683-beccfd810652_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_29d89cc8-2b88-49c5-a683-beccfd810652" xlink:to="loc_us-gaap_LitigationStatusDomain_29d89cc8-2b88-49c5-a683-beccfd810652_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_97b81571-bbaf-4fcc-b1d0-f1d2af66be34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_29d89cc8-2b88-49c5-a683-beccfd810652" xlink:to="loc_us-gaap_LitigationStatusDomain_97b81571-bbaf-4fcc-b1d0-f1d2af66be34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_d0ab1425-faa0-4a17-bf4a-00d939b1136e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_97b81571-bbaf-4fcc-b1d0-f1d2af66be34" xlink:to="loc_us-gaap_PendingLitigationMember_d0ab1425-faa0-4a17-bf4a-00d939b1136e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b04de950-6388-407d-81e9-3a8d1ee95e77" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6af6df30-e7a8-4021-a39e-16e8cd8186f4" xlink:to="loc_dei_LegalEntityAxis_b04de950-6388-407d-81e9-3a8d1ee95e77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b04de950-6388-407d-81e9-3a8d1ee95e77_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_b04de950-6388-407d-81e9-3a8d1ee95e77" xlink:to="loc_dei_EntityDomain_b04de950-6388-407d-81e9-3a8d1ee95e77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fc8af7ac-082d-452a-868f-fa99331ccbf8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_b04de950-6388-407d-81e9-3a8d1ee95e77" xlink:to="loc_dei_EntityDomain_fc8af7ac-082d-452a-868f-fa99331ccbf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_e2e8c8ac-bc3c-426e-8e88-50ba34458dfc" xlink:href="mck-20201231.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_fc8af7ac-082d-452a-868f-fa99331ccbf8" xlink:to="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_e2e8c8ac-bc3c-426e-8e88-50ba34458dfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_422f5ccb-08f7-417a-afca-58114b7901dc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6af6df30-e7a8-4021-a39e-16e8cd8186f4" xlink:to="loc_srt_StatementGeographicalAxis_422f5ccb-08f7-417a-afca-58114b7901dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_422f5ccb-08f7-417a-afca-58114b7901dc_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_422f5ccb-08f7-417a-afca-58114b7901dc" xlink:to="loc_srt_SegmentGeographicalDomain_422f5ccb-08f7-417a-afca-58114b7901dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8cd95211-a58b-43e5-81c4-76f70c72cd4d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_422f5ccb-08f7-417a-afca-58114b7901dc" xlink:to="loc_srt_SegmentGeographicalDomain_8cd95211-a58b-43e5-81c4-76f70c72cd4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_c3225357-6111-4a2e-8fa2-3cb1d5297a2f" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8cd95211-a58b-43e5-81c4-76f70c72cd4d" xlink:to="loc_country_CA_c3225357-6111-4a2e-8fa2-3cb1d5297a2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_bb8a1071-84be-4598-9bd0-51f2ef03695f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6af6df30-e7a8-4021-a39e-16e8cd8186f4" xlink:to="loc_srt_LitigationCaseAxis_bb8a1071-84be-4598-9bd0-51f2ef03695f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_bb8a1071-84be-4598-9bd0-51f2ef03695f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_bb8a1071-84be-4598-9bd0-51f2ef03695f" xlink:to="loc_srt_LitigationCaseTypeDomain_bb8a1071-84be-4598-9bd0-51f2ef03695f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b4322701-55d1-4608-b3ca-57c95882998a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_bb8a1071-84be-4598-9bd0-51f2ef03695f" xlink:to="loc_srt_LitigationCaseTypeDomain_b4322701-55d1-4608-b3ca-57c95882998a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_c2dcc0df-f469-4d67-b4bf-ceb138eb3cc3" xlink:href="mck-20201231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b4322701-55d1-4608-b3ca-57c95882998a" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_c2dcc0df-f469-4d67-b4bf-ceb138eb3cc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_7da3090e-8412-479e-b0ee-811f88266a7f" xlink:href="mck-20201231.xsd#mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b4322701-55d1-4608-b3ca-57c95882998a" xlink:to="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_7da3090e-8412-479e-b0ee-811f88266a7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member_6b10cf21-83aa-41eb-bc2f-fec15f9d844d" xlink:href="mck-20201231.xsd#mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b4322701-55d1-4608-b3ca-57c95882998a" xlink:to="loc_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member_6b10cf21-83aa-41eb-bc2f-fec15f9d844d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_598d2450-e4e2-46fc-aa3b-75dcfece40f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6af6df30-e7a8-4021-a39e-16e8cd8186f4" xlink:to="loc_srt_RangeAxis_598d2450-e4e2-46fc-aa3b-75dcfece40f8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_598d2450-e4e2-46fc-aa3b-75dcfece40f8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_598d2450-e4e2-46fc-aa3b-75dcfece40f8" xlink:to="loc_srt_RangeMember_598d2450-e4e2-46fc-aa3b-75dcfece40f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5faf996c-f1f7-4d27-b41b-f0d252cbca6e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_598d2450-e4e2-46fc-aa3b-75dcfece40f8" xlink:to="loc_srt_RangeMember_5faf996c-f1f7-4d27-b41b-f0d252cbca6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_123b37e6-3c10-48ff-851c-9bfdd851768a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5faf996c-f1f7-4d27-b41b-f0d252cbca6e" xlink:to="loc_srt_MinimumMember_123b37e6-3c10-48ff-851c-9bfdd851768a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_02d2224e-dd39-4622-9595-a15ec66ebb61" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5faf996c-f1f7-4d27-b41b-f0d252cbca6e" xlink:to="loc_srt_MaximumMember_02d2224e-dd39-4622-9595-a15ec66ebb61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3f341e72-b92f-4ec0-9435-c624470df638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6af6df30-e7a8-4021-a39e-16e8cd8186f4" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3f341e72-b92f-4ec0-9435-c624470df638" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_3f341e72-b92f-4ec0-9435-c624470df638_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3f341e72-b92f-4ec0-9435-c624470df638" xlink:to="loc_us-gaap_LossContingencyNatureDomain_3f341e72-b92f-4ec0-9435-c624470df638_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_f51fc8a4-f6d5-4e22-80e1-e91306f487ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3f341e72-b92f-4ec0-9435-c624470df638" xlink:to="loc_us-gaap_LossContingencyNatureDomain_f51fc8a4-f6d5-4e22-80e1-e91306f487ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_72a4f106-e1bf-4aa4-bbb5-77014b4b0828" xlink:href="mck-20201231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_f51fc8a4-f6d5-4e22-80e1-e91306f487ae" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_72a4f106-e1bf-4aa4-bbb5-77014b4b0828" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficit" xlink:type="simple" xlink:href="mck-20201231.xsd#StockholdersEquityDeficit"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficit" xlink:type="extended" id="i7d6d2680db3a428290881f6b3fd08834_StockholdersEquityDeficit"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitTables" xlink:type="simple" xlink:href="mck-20201231.xsd#StockholdersEquityDeficitTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitTables" xlink:type="extended" id="i76cfad0bdffe4d96bcd861ba878fa1eb_StockholdersEquityDeficitTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#StockholdersEquityDeficitNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="extended" id="i31689f68e5d649b38cb2688b358a81f9_StockholdersEquityDeficitNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_d96a2eb5-e50d-4cf5-8cab-4b31e8559b98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_a2547e83-b097-44e4-bd93-9b1860d5bf62" xlink:href="mck-20201231.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_d96a2eb5-e50d-4cf5-8cab-4b31e8559b98" xlink:to="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_a2547e83-b097-44e4-bd93-9b1860d5bf62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_1670ba55-1665-442a-9478-cb2a2b07af19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_d96a2eb5-e50d-4cf5-8cab-4b31e8559b98" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_1670ba55-1665-442a-9478-cb2a2b07af19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_3f353fbe-8fd5-4492-af32-a236bf4df303" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_d96a2eb5-e50d-4cf5-8cab-4b31e8559b98" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_3f353fbe-8fd5-4492-af32-a236bf4df303" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_251ac573-61be-43ff-b98f-6d12e63d24e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_d96a2eb5-e50d-4cf5-8cab-4b31e8559b98" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_251ac573-61be-43ff-b98f-6d12e63d24e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_51a53f0e-ca30-4d8e-bfcb-2d563a5ce536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_d96a2eb5-e50d-4cf5-8cab-4b31e8559b98" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_51a53f0e-ca30-4d8e-bfcb-2d563a5ce536" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9357a396-614a-4591-aec3-c90f09f3f6ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_d96a2eb5-e50d-4cf5-8cab-4b31e8559b98" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9357a396-614a-4591-aec3-c90f09f3f6ef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased_ecea85ca-ffa6-41dc-a86e-149a1e42ea70" xlink:href="mck-20201231.xsd#mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_d96a2eb5-e50d-4cf5-8cab-4b31e8559b98" xlink:to="loc_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased_ecea85ca-ffa6-41dc-a86e-149a1e42ea70" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_32accbea-f856-4487-9f7a-813614f5b9b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_d96a2eb5-e50d-4cf5-8cab-4b31e8559b98" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_32accbea-f856-4487-9f7a-813614f5b9b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_d81c86a0-dc76-4e32-b671-0fa082707ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_32accbea-f856-4487-9f7a-813614f5b9b4" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_d81c86a0-dc76-4e32-b671-0fa082707ff4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_d81c86a0-dc76-4e32-b671-0fa082707ff4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_d81c86a0-dc76-4e32-b671-0fa082707ff4" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_d81c86a0-dc76-4e32-b671-0fa082707ff4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_4aab3b0e-39a3-46f1-9078-1c3c2b9b52e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_d81c86a0-dc76-4e32-b671-0fa082707ff4" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_4aab3b0e-39a3-46f1-9078-1c3c2b9b52e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember_dccbaff6-d114-47dc-8cd1-8d9ad76a8a61" xlink:href="mck-20201231.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_4aab3b0e-39a3-46f1-9078-1c3c2b9b52e5" xlink:to="loc_mck_AcceleratedShareRepurchaseMember_dccbaff6-d114-47dc-8cd1-8d9ad76a8a61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketShareRepurchaseTransactionsMember_76ac2bef-2f92-44f1-99a4-de518ce9890f" xlink:href="mck-20201231.xsd#mck_OpenMarketShareRepurchaseTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_4aab3b0e-39a3-46f1-9078-1c3c2b9b52e5" xlink:to="loc_mck_OpenMarketShareRepurchaseTransactionsMember_76ac2bef-2f92-44f1-99a4-de518ce9890f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3bb0bf2a-9e20-4fd1-8ca5-f29aae0f2ec1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_32accbea-f856-4487-9f7a-813614f5b9b4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3bb0bf2a-9e20-4fd1-8ca5-f29aae0f2ec1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3bb0bf2a-9e20-4fd1-8ca5-f29aae0f2ec1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3bb0bf2a-9e20-4fd1-8ca5-f29aae0f2ec1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3bb0bf2a-9e20-4fd1-8ca5-f29aae0f2ec1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_889255c5-ea67-4201-a0af-815b0c7d4693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3bb0bf2a-9e20-4fd1-8ca5-f29aae0f2ec1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_889255c5-ea67-4201-a0af-815b0c7d4693" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_1ed6dab6-8166-4cfe-aa3b-b176f7ba114d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_889255c5-ea67-4201-a0af-815b0c7d4693" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_1ed6dab6-8166-4cfe-aa3b-b176f7ba114d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4bdd0a45-b8c4-4904-bfd9-258b1c12f27b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_32accbea-f856-4487-9f7a-813614f5b9b4" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4bdd0a45-b8c4-4904-bfd9-258b1c12f27b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4bdd0a45-b8c4-4904-bfd9-258b1c12f27b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4bdd0a45-b8c4-4904-bfd9-258b1c12f27b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4bdd0a45-b8c4-4904-bfd9-258b1c12f27b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_16279c6f-42dd-489f-9d7f-fb910913692e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4bdd0a45-b8c4-4904-bfd9-258b1c12f27b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_16279c6f-42dd-489f-9d7f-fb910913692e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6cc442ef-4f78-484d-aa7a-c7f0850d3920" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_16279c6f-42dd-489f-9d7f-fb910913692e" xlink:to="loc_us-gaap_SubsequentEventMember_6cc442ef-4f78-484d-aa7a-c7f0850d3920" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="extended" id="ie7dd326d24fa4a3aabb03bab3a473610_StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1cd8de49-b570-477f-b5ea-b246ee141b79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1cd8de49-b570-477f-b5ea-b246ee141b79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_131329a3-fded-49fe-a5fd-d764b3433f04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_131329a3-fded-49fe-a5fd-d764b3433f04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_544741e1-f695-4264-9458-f4ded30ea14e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_544741e1-f695-4264-9458-f4ded30ea14e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_02c56a9a-41f3-4fab-8f0a-56ff419a5062" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_02c56a9a-41f3-4fab-8f0a-56ff419a5062" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_baae6943-695b-42f4-84aa-06b55bcf98c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_baae6943-695b-42f4-84aa-06b55bcf98c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e1259460-78b3-4bbd-be45-97ac579e9436" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e1259460-78b3-4bbd-be45-97ac579e9436" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_7b55b79b-0a85-4501-9dcc-f147e73b906a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_7b55b79b-0a85-4501-9dcc-f147e73b906a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_631c5125-40d0-4409-90f5-2da202fb66cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_631c5125-40d0-4409-90f5-2da202fb66cb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_f00fc782-7565-40d4-8c5c-b0c9a41c7d46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_f00fc782-7565-40d4-8c5c-b0c9a41c7d46" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_6174479a-b390-40b9-a5af-13344e5dbb39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_6174479a-b390-40b9-a5af-13344e5dbb39" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_0197650c-b1aa-4bba-a294-0f6260200034" xlink:href="mck-20201231.xsd#mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_0197650c-b1aa-4bba-a294-0f6260200034" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_dfc2183e-5b65-4763-870f-98880526f587" xlink:href="mck-20201231.xsd#mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_dfc2183e-5b65-4763-870f-98880526f587" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_ceaae386-bffb-450c-a1b2-6840a9653a55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_ceaae386-bffb-450c-a1b2-6840a9653a55" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f5a4d7a1-0ef1-46b2-a4a8-4ec1896dc923" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_LongTermDebt_f5a4d7a1-0ef1-46b2-a4a8-4ec1896dc923" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_d6671392-7e0e-4228-b639-7bb33bc00dff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_d6671392-7e0e-4228-b639-7bb33bc00dff" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_31349b94-55d0-4c8f-bf42-f924f9f9a66e" xlink:href="mck-20201231.xsd#mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_31349b94-55d0-4c8f-bf42-f924f9f9a66e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f58645d2-6fd0-4324-940f-6d38f0124db5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f58645d2-6fd0-4324-940f-6d38f0124db5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7c1fea7c-4c86-46cd-b3aa-26edf803ccd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f58645d2-6fd0-4324-940f-6d38f0124db5" xlink:to="loc_us-gaap_HedgingDesignationAxis_7c1fea7c-4c86-46cd-b3aa-26edf803ccd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7c1fea7c-4c86-46cd-b3aa-26edf803ccd5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_7c1fea7c-4c86-46cd-b3aa-26edf803ccd5" xlink:to="loc_us-gaap_HedgingDesignationDomain_7c1fea7c-4c86-46cd-b3aa-26edf803ccd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_07d28cbb-e685-4312-aff6-6f8838550171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_7c1fea7c-4c86-46cd-b3aa-26edf803ccd5" xlink:to="loc_us-gaap_HedgingDesignationDomain_07d28cbb-e685-4312-aff6-6f8838550171" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_58dde556-cf0b-4f3f-babe-c2e9a58b6764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_07d28cbb-e685-4312-aff6-6f8838550171" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_58dde556-cf0b-4f3f-babe-c2e9a58b6764" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_008b1f12-71be-44c0-b66a-b1571402ec68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f58645d2-6fd0-4324-940f-6d38f0124db5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_008b1f12-71be-44c0-b66a-b1571402ec68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_008b1f12-71be-44c0-b66a-b1571402ec68_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_008b1f12-71be-44c0-b66a-b1571402ec68" xlink:to="loc_us-gaap_HedgingRelationshipDomain_008b1f12-71be-44c0-b66a-b1571402ec68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_aba83327-c261-42da-9685-a70c63b9913f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_008b1f12-71be-44c0-b66a-b1571402ec68" xlink:to="loc_us-gaap_HedgingRelationshipDomain_aba83327-c261-42da-9685-a70c63b9913f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_bf5fc528-3992-45a5-996a-50b5787b3293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_aba83327-c261-42da-9685-a70c63b9913f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_bf5fc528-3992-45a5-996a-50b5787b3293" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1e2f424c-8e80-43ad-900e-5c35f39c6da3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f58645d2-6fd0-4324-940f-6d38f0124db5" xlink:to="loc_us-gaap_DebtInstrumentAxis_1e2f424c-8e80-43ad-900e-5c35f39c6da3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1e2f424c-8e80-43ad-900e-5c35f39c6da3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1e2f424c-8e80-43ad-900e-5c35f39c6da3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1e2f424c-8e80-43ad-900e-5c35f39c6da3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7065d609-0389-47d9-bef8-5610f2f5a1d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1e2f424c-8e80-43ad-900e-5c35f39c6da3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7065d609-0389-47d9-bef8-5610f2f5a1d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_a5764a38-1354-40b2-9153-dee4254b50ec" xlink:href="mck-20201231.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7065d609-0389-47d9-bef8-5610f2f5a1d1" xlink:to="loc_mck_EuroDenominatedNotesMember_a5764a38-1354-40b2-9153-dee4254b50ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_2d26bd99-7bc3-4270-b3c9-7f65f967dbae" xlink:href="mck-20201231.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7065d609-0389-47d9-bef8-5610f2f5a1d1" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_2d26bd99-7bc3-4270-b3c9-7f65f967dbae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_25aa35fb-bbec-42a6-b104-082b2f5917a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f58645d2-6fd0-4324-940f-6d38f0124db5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_25aa35fb-bbec-42a6-b104-082b2f5917a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_25aa35fb-bbec-42a6-b104-082b2f5917a3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_25aa35fb-bbec-42a6-b104-082b2f5917a3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_25aa35fb-bbec-42a6-b104-082b2f5917a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6deb41a4-89a8-4b60-b780-80495ed58165" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_25aa35fb-bbec-42a6-b104-082b2f5917a3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6deb41a4-89a8-4b60-b780-80495ed58165" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_b08f2aad-c27e-433f-b63e-f58d506ee4c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6deb41a4-89a8-4b60-b780-80495ed58165" xlink:to="loc_us-gaap_LoansPayableMember_b08f2aad-c27e-433f-b63e-f58d506ee4c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a21d78f5-3747-4b64-8ef8-786498f98c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f58645d2-6fd0-4324-940f-6d38f0124db5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a21d78f5-3747-4b64-8ef8-786498f98c29" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a21d78f5-3747-4b64-8ef8-786498f98c29_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a21d78f5-3747-4b64-8ef8-786498f98c29" xlink:to="loc_us-gaap_EquityComponentDomain_a21d78f5-3747-4b64-8ef8-786498f98c29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_44aa06ff-3a50-4fac-b76f-fcabdc513d58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a21d78f5-3747-4b64-8ef8-786498f98c29" xlink:to="loc_us-gaap_EquityComponentDomain_44aa06ff-3a50-4fac-b76f-fcabdc513d58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_a6cea273-f3a6-4827-a2d8-8dc7aa164cae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_44aa06ff-3a50-4fac-b76f-fcabdc513d58" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_a6cea273-f3a6-4827-a2d8-8dc7aa164cae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_90fcdb7a-0232-4c5e-9805-9a0944a9d52e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_44aa06ff-3a50-4fac-b76f-fcabdc513d58" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_90fcdb7a-0232-4c5e-9805-9a0944a9d52e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_51dc8584-5100-4674-888a-df69a0af485a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_44aa06ff-3a50-4fac-b76f-fcabdc513d58" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_51dc8584-5100-4674-888a-df69a0af485a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_e73924dc-8244-4388-a603-d1695cc78a9b" xlink:href="mck-20201231.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_44aa06ff-3a50-4fac-b76f-fcabdc513d58" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_e73924dc-8244-4388-a603-d1695cc78a9b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_4b8e7f47-0fed-4249-ac7f-e686cd08c311" xlink:href="mck-20201231.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_44aa06ff-3a50-4fac-b76f-fcabdc513d58" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_4b8e7f47-0fed-4249-ac7f-e686cd08c311" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_53a8fb8b-dfa7-42f3-a834-dacca652b0aa" xlink:href="mck-20201231.xsd#mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_44aa06ff-3a50-4fac-b76f-fcabdc513d58" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_53a8fb8b-dfa7-42f3-a834-dacca652b0aa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_d98003b7-5f2d-433b-82f3-50d9c1e1cea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_44aa06ff-3a50-4fac-b76f-fcabdc513d58" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_d98003b7-5f2d-433b-82f3-50d9c1e1cea3" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="extended" id="i4f743cc484414f44851d43011934200e_StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_764c5fac-d701-4c86-ad42-5e494d42c8ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ed73b7c9-3d7a-4258-8ef2-83ca3940d017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_764c5fac-d701-4c86-ad42-5e494d42c8ac" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ed73b7c9-3d7a-4258-8ef2-83ca3940d017" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_23b58c45-6515-4e76-91f2-3940a3b1ebaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ed73b7c9-3d7a-4258-8ef2-83ca3940d017" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_23b58c45-6515-4e76-91f2-3940a3b1ebaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_28f93396-bbb8-4f2c-b469-d9bccbe2bf41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ed73b7c9-3d7a-4258-8ef2-83ca3940d017" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_28f93396-bbb8-4f2c-b469-d9bccbe2bf41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f6dd6e79-a656-42ed-9579-81204094a3d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ed73b7c9-3d7a-4258-8ef2-83ca3940d017" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f6dd6e79-a656-42ed-9579-81204094a3d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_faaecc82-a9fb-47e5-b686-b2437de3d34b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ed73b7c9-3d7a-4258-8ef2-83ca3940d017" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_faaecc82-a9fb-47e5-b686-b2437de3d34b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_9a756105-38bb-4703-8652-2bceace712d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ed73b7c9-3d7a-4258-8ef2-83ca3940d017" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_9a756105-38bb-4703-8652-2bceace712d1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_91157694-5cd3-4771-82df-8c9452d2f562" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ed73b7c9-3d7a-4258-8ef2-83ca3940d017" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_91157694-5cd3-4771-82df-8c9452d2f562" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b207a306-be91-4022-bd7a-f4de6b39508d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2809db73-88d8-4d40-8d1a-a77ec3ce1036" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_764c5fac-d701-4c86-ad42-5e494d42c8ac" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2809db73-88d8-4d40-8d1a-a77ec3ce1036" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_be500e6a-f641-4d3f-9bdd-d19a4e147585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2809db73-88d8-4d40-8d1a-a77ec3ce1036" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_be500e6a-f641-4d3f-9bdd-d19a4e147585" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_be500e6a-f641-4d3f-9bdd-d19a4e147585_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_be500e6a-f641-4d3f-9bdd-d19a4e147585" xlink:to="loc_us-gaap_EquityComponentDomain_be500e6a-f641-4d3f-9bdd-d19a4e147585_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_adea6b44-f327-412a-8373-4c84334e6f68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_be500e6a-f641-4d3f-9bdd-d19a4e147585" xlink:to="loc_us-gaap_EquityComponentDomain_adea6b44-f327-412a-8373-4c84334e6f68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_67a107e3-b394-495f-bfc0-e5db4839416d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_adea6b44-f327-412a-8373-4c84334e6f68" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_67a107e3-b394-495f-bfc0-e5db4839416d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_8e3c3904-4f2f-4c93-940b-f4eb661ec8a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_67a107e3-b394-495f-bfc0-e5db4839416d" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_8e3c3904-4f2f-4c93-940b-f4eb661ec8a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_da67098c-4b10-43af-8ae8-5462d11fd8d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_67a107e3-b394-495f-bfc0-e5db4839416d" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_da67098c-4b10-43af-8ae8-5462d11fd8d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_2bf4b034-902f-41cc-88bb-5673011bb324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_67a107e3-b394-495f-bfc0-e5db4839416d" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_2bf4b034-902f-41cc-88bb-5673011bb324" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_a90c026d-a9a6-465d-8f61-5769ee724497" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_67a107e3-b394-495f-bfc0-e5db4839416d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_a90c026d-a9a6-465d-8f61-5769ee724497" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="simple" xlink:href="mck-20201231.xsd#SegmentsofBusiness"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="extended" id="if16f77f536d14bc09badb977b22cef6b_SegmentsofBusiness"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="simple" xlink:href="mck-20201231.xsd#SegmentsofBusinessTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="extended" id="i3c6d647de1f54c858ca6565199082725_SegmentsofBusinessTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#SegmentsofBusinessDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessDetails" xlink:type="extended" id="i9004e6b391c446b486b9c98c4f4a205c_SegmentsofBusinessDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_5f897105-cbc4-44a6-90de-0bd870481b2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_NumberOfReportableSegments_5f897105-cbc4-44a6-90de-0bd870481b2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_894250c1-d89c-4f9e-92eb-3985f9da51e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_894250c1-d89c-4f9e-92eb-3985f9da51e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfBusinessOperations_ef18f8f5-fe2c-46f6-870e-49e2b6714a37" xlink:href="mck-20201231.xsd#mck_NumberOfBusinessOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_mck_NumberOfBusinessOperations_ef18f8f5-fe2c-46f6-870e-49e2b6714a37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_841cb678-0c54-4b99-9bac-93e6ace5f6a7" xlink:href="mck-20201231.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_841cb678-0c54-4b99-9bac-93e6ace5f6a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_dda0a238-ccf9-424c-9270-527da99d0238" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_dda0a238-ccf9-424c-9270-527da99d0238" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_c098eeeb-c2ed-4028-ac94-bdde92621dff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_dda0a238-ccf9-424c-9270-527da99d0238" xlink:to="loc_us-gaap_RevenuesAbstract_c098eeeb-c2ed-4028-ac94-bdde92621dff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f393134-9716-4801-8ef2-faeb36c8b737" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_c098eeeb-c2ed-4028-ac94-bdde92621dff" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f393134-9716-4801-8ef2-faeb36c8b737" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract_3c5a7ef0-ea86-4650-8ed3-126a05f973f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_dda0a238-ccf9-424c-9270-527da99d0238" xlink:to="loc_us-gaap_OperatingIncomeLossAbstract_3c5a7ef0-ea86-4650-8ed3-126a05f973f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_dafb231b-22e7-467e-8b57-9a5304852ecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_3c5a7ef0-ea86-4650-8ed3-126a05f973f0" xlink:to="loc_us-gaap_OperatingIncomeLoss_dafb231b-22e7-467e-8b57-9a5304852ecd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_ef2ebe92-44ef-48e4-8dd6-438eb9bdb756" xlink:href="mck-20201231.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_dda0a238-ccf9-424c-9270-527da99d0238" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_ef2ebe92-44ef-48e4-8dd6-438eb9bdb756" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_4a7e5c05-1039-446b-8455-0d26e03dd076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_dda0a238-ccf9-424c-9270-527da99d0238" xlink:to="loc_us-gaap_InterestAndDebtExpense_4a7e5c05-1039-446b-8455-0d26e03dd076" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d06f5bf-f2a3-4991-9d2d-f765c3f3d70f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_dda0a238-ccf9-424c-9270-527da99d0238" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d06f5bf-f2a3-4991-9d2d-f765c3f3d70f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage_f74714d0-462b-4552-89b6-f87cb3d0420a" xlink:href="mck-20201231.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_mck_RevenueDerivedFromServicesPercentage_f74714d0-462b-4552-89b6-f87cb3d0420a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_d14efc32-aee5-4e76-b1c0-7a596ce6aa13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_d14efc32-aee5-4e76-b1c0-7a596ce6aa13" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_f6e75bc9-9951-419d-ab25-d9d09e30f517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_f6e75bc9-9951-419d-ab25-d9d09e30f517" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a04f72d5-400d-4809-be6d-01b11c50b01f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_RestructuringCharges_a04f72d5-400d-4809-be6d-01b11c50b01f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_d3ae9c63-5d9b-43b5-aefb-e430383aefdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_AssetImpairmentCharges_d3ae9c63-5d9b-43b5-aefb-e430383aefdf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_e5fe67fc-c900-4210-8a78-80f8803ff118" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_e5fe67fc-c900-4210-8a78-80f8803ff118" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLossNetOfTax_38f430b9-80c0-4e48-b0e6-5d7a3d12dbf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_GoodwillImpairmentLossNetOfTax_38f430b9-80c0-4e48-b0e6-5d7a3d12dbf7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_9188ea7d-d3ed-4a95-9262-b813e667519a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_9188ea7d-d3ed-4a95-9262-b813e667519a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossOnSaleOfBusinessNetOfTax_8a494df2-56de-4972-a743-242fffd5fd2a" xlink:href="mck-20201231.xsd#mck_GainLossOnSaleOfBusinessNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_mck_GainLossOnSaleOfBusinessNetOfTax_8a494df2-56de-4972-a743-242fffd5fd2a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_f0f3166a-d999-4ea9-9565-fd697d01793f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_f0f3166a-d999-4ea9-9565-fd697d01793f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_0f38b259-e853-4b70-be8f-382f4b997f51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_InventoryWriteDown_0f38b259-e853-4b70-be8f-382f4b997f51" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_0766de10-31d1-4161-88ef-89deac65ee9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_0766de10-31d1-4161-88ef-89deac65ee9d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ProportionateGainLossOnEquityMethodInvestment_4f83f5e0-db0f-41d9-ac63-3e82b5994553" xlink:href="mck-20201231.xsd#mck_ProportionateGainLossOnEquityMethodInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_mck_ProportionateGainLossOnEquityMethodInvestment_4f83f5e0-db0f-41d9-ac63-3e82b5994553" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_1aaf33be-d786-433a-ac2a-c77b40d03ce4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_1aaf33be-d786-433a-ac2a-c77b40d03ce4" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualProvisionNetOfTax_e25c4f18-b25a-41fc-8560-f51b69e4ddd2" xlink:href="mck-20201231.xsd#mck_LossContingencyAccrualProvisionNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_mck_LossContingencyAccrualProvisionNetOfTax_e25c4f18-b25a-41fc-8560-f51b69e4ddd2" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment_4c2b7b65-fbdf-4b4b-9e26-c27faaad20f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment_4c2b7b65-fbdf-4b4b-9e26-c27faaad20f4" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_79282c34-66c8-4aaa-9007-c8ad18441265" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_79282c34-66c8-4aaa-9007-c8ad18441265" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_fd3a501a-af52-404d-8d6b-5eeb3547c3c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_fd3a501a-af52-404d-8d6b-5eeb3547c3c5" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_7d880d53-5c88-4cc6-9129-f46b2e741d70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_LitigationSettlementExpense_7d880d53-5c88-4cc6-9129-f46b2e741d70" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0b68243d-7693-41fe-b66e-fd25d39c519a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0b68243d-7693-41fe-b66e-fd25d39c519a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0b68243d-7693-41fe-b66e-fd25d39c519a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0b68243d-7693-41fe-b66e-fd25d39c519a" xlink:to="loc_us-gaap_SegmentDomain_0b68243d-7693-41fe-b66e-fd25d39c519a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e80deaf6-3fe9-481f-9763-a2534e1251d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0b68243d-7693-41fe-b66e-fd25d39c519a" xlink:to="loc_us-gaap_SegmentDomain_e80deaf6-3fe9-481f-9763-a2534e1251d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_f9beaa98-813e-4ad4-b2df-0b8ab25566c9" xlink:href="mck-20201231.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e80deaf6-3fe9-481f-9763-a2534e1251d3" xlink:to="loc_mck_USPharmaceuticalSegmentMember_f9beaa98-813e-4ad4-b2df-0b8ab25566c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_1427a1ea-425f-4518-b8d3-e90816c0dd5a" xlink:href="mck-20201231.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e80deaf6-3fe9-481f-9763-a2534e1251d3" xlink:to="loc_mck_InternationalSegmentMember_1427a1ea-425f-4518-b8d3-e90816c0dd5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_56242c1b-9914-4abb-9f94-4f8d1ae8a5d9" xlink:href="mck-20201231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e80deaf6-3fe9-481f-9763-a2534e1251d3" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_56242c1b-9914-4abb-9f94-4f8d1ae8a5d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_8144f4fb-1de7-4a04-9596-6c48258ebaae" xlink:href="mck-20201231.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e80deaf6-3fe9-481f-9763-a2534e1251d3" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_8144f4fb-1de7-4a04-9596-6c48258ebaae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_d5563daf-ca68-4af3-b92d-cf91730ee4fa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_srt_ConsolidationItemsAxis_d5563daf-ca68-4af3-b92d-cf91730ee4fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d5563daf-ca68-4af3-b92d-cf91730ee4fa_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_d5563daf-ca68-4af3-b92d-cf91730ee4fa" xlink:to="loc_srt_ConsolidationItemsDomain_d5563daf-ca68-4af3-b92d-cf91730ee4fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_22b5317a-237f-4001-96c1-9959a2ae497d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_d5563daf-ca68-4af3-b92d-cf91730ee4fa" xlink:to="loc_srt_ConsolidationItemsDomain_22b5317a-237f-4001-96c1-9959a2ae497d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9983a952-f6bb-4791-832f-0b349165f44c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_22b5317a-237f-4001-96c1-9959a2ae497d" xlink:to="loc_us-gaap_OperatingSegmentsMember_9983a952-f6bb-4791-832f-0b349165f44c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_0b01f591-22e7-4743-87c6-070670e38b79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_22b5317a-237f-4001-96c1-9959a2ae497d" xlink:to="loc_us-gaap_CorporateNonSegmentMember_0b01f591-22e7-4743-87c6-070670e38b79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_347704d8-1d4a-44ba-bd14-9da0a958659e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_srt_StatementGeographicalAxis_347704d8-1d4a-44ba-bd14-9da0a958659e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_347704d8-1d4a-44ba-bd14-9da0a958659e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_347704d8-1d4a-44ba-bd14-9da0a958659e" xlink:to="loc_srt_SegmentGeographicalDomain_347704d8-1d4a-44ba-bd14-9da0a958659e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5f03d81a-5a2d-472d-ab29-db9d63b8d315" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_347704d8-1d4a-44ba-bd14-9da0a958659e" xlink:to="loc_srt_SegmentGeographicalDomain_5f03d81a-5a2d-472d-ab29-db9d63b8d315" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_2dde090f-9285-44ae-b6e4-ca9372376808" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5f03d81a-5a2d-472d-ab29-db9d63b8d315" xlink:to="loc_country_US_2dde090f-9285-44ae-b6e4-ca9372376808" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_89bde78f-3c91-4b16-8603-2aea10a70932" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5f03d81a-5a2d-472d-ab29-db9d63b8d315" xlink:to="loc_srt_EuropeMember_89bde78f-3c91-4b16-8603-2aea10a70932" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_40477a18-4390-4a1e-8f51-cfff0730ed19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5f03d81a-5a2d-472d-ab29-db9d63b8d315" xlink:to="loc_us-gaap_NonUsMember_40477a18-4390-4a1e-8f51-cfff0730ed19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_27b2b2a6-5d32-47e8-92b5-eb8271b60e09" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_srt_LitigationCaseAxis_27b2b2a6-5d32-47e8-92b5-eb8271b60e09" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_27b2b2a6-5d32-47e8-92b5-eb8271b60e09_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_27b2b2a6-5d32-47e8-92b5-eb8271b60e09" xlink:to="loc_srt_LitigationCaseTypeDomain_27b2b2a6-5d32-47e8-92b5-eb8271b60e09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a0799ccd-10df-45f7-81dc-bd7ccdec4db7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_27b2b2a6-5d32-47e8-92b5-eb8271b60e09" xlink:to="loc_srt_LitigationCaseTypeDomain_a0799ccd-10df-45f7-81dc-bd7ccdec4db7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_839dd4f8-7669-47a5-b974-bb9a62f82fb2" xlink:href="mck-20201231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_a0799ccd-10df-45f7-81dc-bd7ccdec4db7" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_839dd4f8-7669-47a5-b974-bb9a62f82fb2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_1997ded8-2c00-42ba-8d28-994930055825" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_1997ded8-2c00-42ba-8d28-994930055825" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_1997ded8-2c00-42ba-8d28-994930055825_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_1997ded8-2c00-42ba-8d28-994930055825" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_1997ded8-2c00-42ba-8d28-994930055825_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_381b41e4-ce2f-4ffa-948b-9a2489026472" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_1997ded8-2c00-42ba-8d28-994930055825" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_381b41e4-ce2f-4ffa-948b-9a2489026472" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_8f088540-8271-4a14-8ad5-b776a7da249b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_381b41e4-ce2f-4ffa-948b-9a2489026472" xlink:to="loc_us-gaap_DomesticPlanMember_8f088540-8271-4a14-8ad5-b776a7da249b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_105f2826-5d94-46c4-ad08-d1ad2d006a51" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_8f088540-8271-4a14-8ad5-b776a7da249b" xlink:to="loc_country_US_105f2826-5d94-46c4-ad08-d1ad2d006a51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c76b0114-c180-48b4-9bd6-75d7b04fac46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c76b0114-c180-48b4-9bd6-75d7b04fac46" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_c76b0114-c180-48b4-9bd6-75d7b04fac46_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c76b0114-c180-48b4-9bd6-75d7b04fac46" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_c76b0114-c180-48b4-9bd6-75d7b04fac46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_cb9250ce-76ff-48af-8cdd-638312ef7295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c76b0114-c180-48b4-9bd6-75d7b04fac46" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_cb9250ce-76ff-48af-8cdd-638312ef7295" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_f4163485-f65e-475c-b95f-bb02c2564543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_cb9250ce-76ff-48af-8cdd-638312ef7295" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_f4163485-f65e-475c-b95f-bb02c2564543" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c41b64f9-6e8f-4716-aac8-4e0722ada504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c41b64f9-6e8f-4716-aac8-4e0722ada504" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c41b64f9-6e8f-4716-aac8-4e0722ada504_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c41b64f9-6e8f-4716-aac8-4e0722ada504" xlink:to="loc_us-gaap_RelatedPartyDomain_c41b64f9-6e8f-4716-aac8-4e0722ada504_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_70c8cc83-bf38-46e4-b3be-66aed30818eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c41b64f9-6e8f-4716-aac8-4e0722ada504" xlink:to="loc_us-gaap_RelatedPartyDomain_70c8cc83-bf38-46e4-b3be-66aed30818eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_61b81f41-5174-4f0a-9a1c-547841448b82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_70c8cc83-bf38-46e4-b3be-66aed30818eb" xlink:to="loc_us-gaap_CorporateJointVentureMember_61b81f41-5174-4f0a-9a1c-547841448b82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_da5efcc2-0461-499e-873f-1179e268fde3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_da5efcc2-0461-499e-873f-1179e268fde3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_da5efcc2-0461-499e-873f-1179e268fde3_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_da5efcc2-0461-499e-873f-1179e268fde3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_da5efcc2-0461-499e-873f-1179e268fde3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_be84a9f7-54ac-4004-9760-027ade6f5e1e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_da5efcc2-0461-499e-873f-1179e268fde3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_be84a9f7-54ac-4004-9760-027ade6f5e1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_7baec56c-4771-490c-92b6-93eeb0f4050c" xlink:href="mck-20201231.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_be84a9f7-54ac-4004-9760-027ade6f5e1e" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_7baec56c-4771-490c-92b6-93eeb0f4050c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_0e3dfd5b-4244-4616-a35b-874f942e4b0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_us-gaap_RestructuringPlanAxis_0e3dfd5b-4244-4616-a35b-874f942e4b0c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_0e3dfd5b-4244-4616-a35b-874f942e4b0c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_0e3dfd5b-4244-4616-a35b-874f942e4b0c" xlink:to="loc_us-gaap_RestructuringPlanDomain_0e3dfd5b-4244-4616-a35b-874f942e4b0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_7fe073a8-11da-45a9-a365-a81784427526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_0e3dfd5b-4244-4616-a35b-874f942e4b0c" xlink:to="loc_us-gaap_RestructuringPlanDomain_7fe073a8-11da-45a9-a365-a81784427526" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanMember_4d8bb826-4b41-49e3-b030-2c86e5d1d19e" xlink:href="mck-20201231.xsd#mck_StrategicGrowthInitiativePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_7fe073a8-11da-45a9-a365-a81784427526" xlink:to="loc_mck_StrategicGrowthInitiativePlanMember_4d8bb826-4b41-49e3-b030-2c86e5d1d19e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a650b846-cc76-414f-8bfa-bbdca91aefc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a650b846-cc76-414f-8bfa-bbdca91aefc5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_a650b846-cc76-414f-8bfa-bbdca91aefc5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a650b846-cc76-414f-8bfa-bbdca91aefc5" xlink:to="loc_us-gaap_LossContingencyNatureDomain_a650b846-cc76-414f-8bfa-bbdca91aefc5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_ef7026ad-a63a-472b-ba22-75263f87cfc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a650b846-cc76-414f-8bfa-bbdca91aefc5" xlink:to="loc_us-gaap_LossContingencyNatureDomain_ef7026ad-a63a-472b-ba22-75263f87cfc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_dfe08a47-5401-4239-ad3f-08d346edfe52" xlink:href="mck-20201231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_ef7026ad-a63a-472b-ba22-75263f87cfc5" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_dfe08a47-5401-4239-ad3f-08d346edfe52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fd5ee293-a984-4684-a908-576f8cb9a3a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fd5ee293-a984-4684-a908-576f8cb9a3a9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fd5ee293-a984-4684-a908-576f8cb9a3a9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fd5ee293-a984-4684-a908-576f8cb9a3a9" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fd5ee293-a984-4684-a908-576f8cb9a3a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e79cea6d-1529-4d02-9a33-2928a977718d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fd5ee293-a984-4684-a908-576f8cb9a3a9" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e79cea6d-1529-4d02-9a33-2928a977718d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_dbab3317-3bee-442a-90af-162996a8dc39" xlink:href="mck-20201231.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e79cea6d-1529-4d02-9a33-2928a977718d" xlink:to="loc_mck_GermanWholesaleBusinessMember_dbab3317-3bee-442a-90af-162996a8dc39" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>mck-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:734100a7-c7c1-4795-ad72-160dc37ce333,g:f6cbe616-07cc-4518-be11-bf83875971ba-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentType_0a0f3ca1-6dbf-4c90-9801-17eec4b25caf_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_8f6722b6-14f9-40c5-a636-d8fc13b8bbb4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_6a83c760-ea42-48e5-9504-4c8c1f211f60_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_29ad2977-3125-429a-8826-db14aab98770_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingent Liabilities</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_72ee6400-28d0-44e5-b5cc-38d2e46e25fa_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1173abaa-6967-4901-984f-e19a07f2cdf5_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_6c839e6f-f56a-490b-b281-b5c42276c8ec_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_63c1e5c6-e60c-4467-9cb0-ec14cf94214f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_label_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Debt Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDebtExpense" xlink:to="lab_us-gaap_InterestAndDebtExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_01f91472-377d-44ab-bc19-adb31b684680_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_6560cb21-b591-4e78-bf84-9e8960f6a772_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_8c09985f-f72b-4025-bb57-1811a45d4e05_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_91d91cba-f219-41f5-b8d7-26fcf0b364eb_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_3c6614e8-c5e5-4b86-9311-2013c84ea872_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_455c9a9c-5554-4e81-b2cb-88cca1288633_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding changes in accumulated other comprehensive income (loss), net of tax, by component</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_343c29ca-e011-4e5e-be78-c169b5475ea8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory impairments and excess inventory</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2f826183-8d58-4897-af7e-42080250dc14_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_c1bbe108-fd71-4985-90fb-ecb72c94bd7a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition accounting, transfers and other adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_b3fda17e-0817-4eb2-979d-348ebcaa15f5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_a0d70e9b-0a23-4a9f-ad7e-678165cf7f7b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payment for retirement plan</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncurrentAssetLiabilityMember_644b49d5-0fea-4914-8cad-bfc44c843f61_terseLabel_en-US" xlink:label="lab_mck_NoncurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Asset / Liability</link:label>
    <link:label id="lab_mck_NoncurrentAssetLiabilityMember_label_en-US" xlink:label="lab_mck_NoncurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Asset / Liability [Member]</link:label>
    <link:label id="lab_mck_NoncurrentAssetLiabilityMember_documentation_en-US" xlink:label="lab_mck_NoncurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Asset / Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncurrentAssetLiabilityMember" xlink:href="mck-20201231.xsd#mck_NoncurrentAssetLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncurrentAssetLiabilityMember" xlink:to="lab_mck_NoncurrentAssetLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TaxReceivableAgreementTRAMember_b0b672fd-0374-4fad-997b-f550be96a4ef_terseLabel_en-US" xlink:label="lab_mck_TaxReceivableAgreementTRAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement (&#8220;TRA&#8221;)</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementTRAMember_label_en-US" xlink:label="lab_mck_TaxReceivableAgreementTRAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement (&#8220;TRA&#8221;) [Member]</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementTRAMember_documentation_en-US" xlink:label="lab_mck_TaxReceivableAgreementTRAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement (&#8220;TRA&#8221;) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember" xlink:href="mck-20201231.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TaxReceivableAgreementTRAMember" xlink:to="lab_mck_TaxReceivableAgreementTRAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_f57127a9-bfab-40d3-ac32-4fcf1dd3b40a_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b3446035-850e-44dd-a99b-98744a2c87b4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND EQUITY (DEFICIT)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_42a47102-04e7-4b68-9f23-4ca8a98dac77_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_7e094dc2-584e-4823-9f65-de7b0ff5e0fb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_7320b052-625b-41ec-94e9-dd23527061d1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e278dde4-360d-4ff1-8a8b-390de7b53687_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in carrying value of non-controlling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_a5f979f8-2e8e-46f0-aca4-7d54bd26dc8f_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_129af95a-f2ef-42dc-a34f-758f856c7a2d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_96b5cbde-ab37-408c-b07e-0c95732c7737_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_49d67c68-ce43-4241-ac84-bb2011f7d4ee_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_f6e8ad38-84b4-45f9-9795-92597c133194_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and trade names</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_5c53c92e-af6f-4b4e-878d-bd20ac398ea3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuances of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_8124d6dd-77a7-4231-9047-a190f8c721a8_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_bf63bf88-f91f-4a50-be27-718100c8324c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating profit (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_689238a9-e09d-478d-b58c-d183d443f920_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_0571e599-f3ef-41e6-b5c9-223cd0b408a9_terseLabel_en-US" xlink:label="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate annual surcharge on licensed manufacturers and distributors of opioids</link:label>
    <link:label id="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_label_en-US" xlink:label="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Stewardship Act, Annual Surcharge on Licensed Manufacturers and Distributors of Opioids</link:label>
    <link:label id="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_documentation_en-US" xlink:label="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Stewardship Act, Annual Surcharge on Licensed Manufacturers and Distributors of Opioids</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" xlink:href="mck-20201231.xsd#mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" xlink:to="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_3d3812d3-4e42-4c1f-ad8e-262bce97ef25_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests and Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_601c0ec2-fb2a-4fd7-a330-c42f450443ab_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and employee-related costs, net</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_7bfb3b9e-e4c7-4a2b-ae42-2b4d1d91c57b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lump sum payments under settlement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_349e3015-29a4-4839-96e5-07849315cac5_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ChangeHealthcareInc.Member_73af2964-ddc0-4382-ab08-b1f49f5725c5_terseLabel_en-US" xlink:label="lab_mck_ChangeHealthcareInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, Inc.</link:label>
    <link:label id="lab_mck_ChangeHealthcareInc.Member_label_en-US" xlink:label="lab_mck_ChangeHealthcareInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, Inc. [Member]</link:label>
    <link:label id="lab_mck_ChangeHealthcareInc.Member_documentation_en-US" xlink:label="lab_mck_ChangeHealthcareInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareInc.Member" xlink:href="mck-20201231.xsd#mck_ChangeHealthcareInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ChangeHealthcareInc.Member" xlink:to="lab_mck_ChangeHealthcareInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_66a5f905-896d-47ca-82de-99b43c46bde8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases, including shares surrendered for tax withholding</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_687a484d-e377-4cc1-a473-608a44e40906_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6866b867-46ec-4829-a62f-d4bfaeec73bb_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_4ad31ca2-7086-4e30-8b64-925ae6482c6c_terseLabel_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased (shares)</link:label>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_label_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</link:label>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_documentation_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:href="mck-20201231.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:to="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_f6f9e60e-8983-4550-b1c9-da6dfd8852da_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofStateAttorneyGenerals_65cc6a4a-5054-4b2d-bcde-663fd587a77b_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of attorney generals that have filed claims</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStateAttorneyGenerals_label_en-US" xlink:label="lab_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of State Attorney Generals</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStateAttorneyGenerals_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of State Attorney Generals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:href="mck-20201231.xsd#mck_LossContingencyNumberofStateAttorneyGenerals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:to="lab_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease_1bf54177-b017-4981-a4b6-1509ba176e8e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss derecognized</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_58d9738f-5194-4ce7-8ea5-8d8ba33766c8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_131e4dba-8728-46e1-9ef0-93e0f6dd864c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c858c1d1-f670-479c-b518-08ee55595c8a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments, net</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberOfCountyGovernments_00cf992a-71d1-4302-b005-4c680440626a_terseLabel_en-US" xlink:label="lab_mck_NumberOfCountyGovernments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of county government plaintiffs</link:label>
    <link:label id="lab_mck_NumberOfCountyGovernments_label_en-US" xlink:label="lab_mck_NumberOfCountyGovernments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of County Governments</link:label>
    <link:label id="lab_mck_NumberOfCountyGovernments_documentation_en-US" xlink:label="lab_mck_NumberOfCountyGovernments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of County Governments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfCountyGovernments" xlink:href="mck-20201231.xsd#mck_NumberOfCountyGovernments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberOfCountyGovernments" xlink:to="lab_mck_NumberOfCountyGovernments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_b3ac3f93-8012-49f7-9b78-90ba7302f9fa_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveNoncurrent" xlink:to="lab_us-gaap_LitigationReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_7ff3421d-29ef-4169-9fc7-db976fced204_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_e508bcdc-6cbf-4f68-b969-41452fbb32e2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsSegmentMember_e4413d37-d622-4020-9e30-493176441c2a_terseLabel_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsSegmentMember_label_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions Segment [Member]</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsSegmentMember_documentation_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:href="mck-20201231.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:to="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_b8c5e2ea-a16a-4dfc-a844-79243e6da750_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_3b5dae4c-5bc8-4965-9ff6-6c638a398ae0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions made in exchange for additional membership interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_0c764a64-496a-448e-8d5a-32bfda6120e7_terseLabel_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes due March 15, 2024</link:label>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_label_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes Due March 15, 2024 [Member]</link:label>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_documentation_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes Due March 15, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member" xlink:href="mck-20201231.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A380NotesDueMarch152024Member" xlink:to="lab_mck_A380NotesDueMarch152024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_395620f1-0ee1-48e5-a0d9-839820ec6143_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment_8e9dbf17-025d-4912-bb09-9869a47194b5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gains associated with equity investments</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_6c987d7c-051a-46c9-badf-6c48b0e3b871_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Dollar, notional amount, liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_0b034ca8-3659-489c-a2f7-d46390d88cc4_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2b315229-f6c0-4618-8b02-5d123b25a0cc_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_7fb5ed2e-9579-4195-bec2-24ea6dfe83f9_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_00de6987-3178-4c05-9051-39f43c1112d4_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_4e62143d-88fe-435d-9b73-87efcceaa21c_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_3057dc5d-9ead-4cb4-a46e-58c19182ee07_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_2d3e138d-1a23-4707-a9c7-097e4f6bea6a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_7d9242c3-42c5-4f8f-9668-922ca9598114_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_62ceba05-87d3-4564-8064-7bd1021745cd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_b65aef09-7315-459d-af1a-e93362d05cad_terseLabel_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes per share of common stock permitted on proposals presented to stockholders (vote)</link:label>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_label_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number of Votes Per Common Share</link:label>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_documentation_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number of Votes Per Common Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:href="mck-20201231.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:to="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_087ad032-3bec-4969-9346-ae4f44ad1e12_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_a35d86cd-f136-4419-b4d9-825c9deacfa5_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_720ea319-5ccd-4635-9980-a29e07854770_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_bc4798dc-6ecc-4a86-b631-8264e0680ffa_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased_00e40fdc-a3cc-4ca9-a9bf-6b9797fb8e2b_terseLabel_en-US" xlink:label="lab_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approved increase to the authorized share repurchase amount</link:label>
    <link:label id="lab_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Amount Authorized to be Repurchased</link:label>
    <link:label id="lab_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased_documentation_en-US" xlink:label="lab_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Amount Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased" xlink:href="mck-20201231.xsd#mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased" xlink:to="lab_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_fbdc9b46-278f-4806-8e19-bb3c71a6659b_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_44693afa-b083-460b-81e4-4134c0befeb4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash charges</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_123597f8-9bb2-4b4b-b874-b95497fd2413_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_e4e3015a-534e-477f-843f-121f8d6460ea_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_976130fd-66e5-4f9e-a635-f987eb659e16_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_9f4fb607-0aeb-47fb-8995-a9ab824d0cb9_terseLabel_en-US" xlink:label="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward contracts to hedge Euro against British Pound cash flows</link:label>
    <link:label id="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_label_en-US" xlink:label="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]</link:label>
    <link:label id="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_documentation_en-US" xlink:label="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:href="mck-20201231.xsd#mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:to="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_f107d755-8cd9-4202-82a2-4be4bedccad8_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A475NotesDueMay302029Member_e579f303-f232-40e4-abc0-cb95bc927bb5_terseLabel_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes due May 30, 2029</link:label>
    <link:label id="lab_mck_A475NotesDueMay302029Member_label_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due May 30, 2029 [Member]</link:label>
    <link:label id="lab_mck_A475NotesDueMay302029Member_documentation_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due May 30, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member" xlink:href="mck-20201231.xsd#mck_A475NotesDueMay302029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A475NotesDueMay302029Member" xlink:to="lab_mck_A475NotesDueMay302029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_339d6ab0-0a8c-4642-a82f-e304a0b74eac_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8386f1cb-c3f1-4b7c-a914-4a268d59408d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_cefc84a0-e0ee-4326-97d7-adc08aae3cc0_verboseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fees earned from TSA</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Amounts of Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_9d35c262-7491-4728-a920-6d26a379dbf5_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted balance, April 1</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_9d16848e-88cf-4543-970d-234bf18ed83f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_732d9e5c-f545-4e80-913d-b99d95f5f670_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_aa356676-2727-4916-8851-711e86f8319e_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_848cb3f5-a1a4-4f32-9f89-b1e3bcabe4d1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_f0dc4b59-8f38-4d14-a219-bf4c25222f2e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_3d63aaf1-1ad8-4b0b-99b0-e11add8e370c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_dbeae3ce-daf8-417b-97f5-72997fbcbdb2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_ed1395ee-84e2-46a3-a672-aad3fb97ea36_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_5c45a844-4f05-42b5-bb2c-e51087774d8a_terseLabel_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual recurring dividend (in euro per share)</link:label>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_label_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Recurring Compensation Per Share to Noncontrolling Interests</link:label>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_documentation_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Recurring Compensation Per Share to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:href="mck-20201231.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:to="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_e8a78e53-3f0f-420d-bc79-01d40d10319a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax settlement expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_14f23f62-5eb7-4614-b22f-f62e2e2c798a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofCounties_e04bb8f2-ad64-434b-bc73-7c04e6278934_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofCounties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of counties that filed claims</link:label>
    <link:label id="lab_mck_LossContingencyNumberofCounties_label_en-US" xlink:label="lab_mck_LossContingencyNumberofCounties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Counties</link:label>
    <link:label id="lab_mck_LossContingencyNumberofCounties_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofCounties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Counties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCounties" xlink:href="mck-20201231.xsd#mck_LossContingencyNumberofCounties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofCounties" xlink:to="lab_mck_LossContingencyNumberofCounties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_bd89564d-1cdd-48aa-8829-f1e8f2b930dd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_050e328c-b4ba-4659-8e8c-537b5052b712_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_66885dbf-9682-4bd0-9277-413f3e2ad983_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_4ac0f119-0a4d-437e-be25-891a965bbc9d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per common share attributable to McKesson:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_2f12b5c3-80ac-45e9-b6ca-63cc2f7125f8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicated senior unsecured revolving credit facility term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_da5fbf75-147a-42e6-8990-7dcad8c6e22a_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_5d52daf6-9952-4657-820b-804d7d226a62_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_c2778892-e395-48b2-911d-aabc48f73a45_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_1af742d6-cf69-446d-a89d-7c432b1b2629_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalFees_1d403a71-3eb0-4bef-b272-3d7f9864247e_negatedLabel_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims and litigation charges, net</link:label>
    <link:label id="lab_us-gaap_LegalFees_label_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalFees" xlink:to="lab_us-gaap_LegalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_e05976f1-146f-41c9-8169-8135bf5fc0a1_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_3319e2d4-1e4a-426a-b701-34cb2171d4b7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair values of liabilities</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_c19328dc-64c2-43c5-b5ba-2d7a983465d2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_83e05eb9-ef70-4682-a819-7c4daff237c3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock transactions:</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_7bf08328-d94e-4ee2-aecc-b5af701c5e46_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_a898159e-97a4-49bd-a98e-fb2e584446ed_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_e23a93e5-5691-4a85-b445-86178890ef46_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameDomain" xlink:to="lab_us-gaap_RetirementPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_e332d631-0b36-4ad9-b742-53f97e43fc07_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_893161fd-acb7-44de-bc07-2c18264f40d5_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_862c16ad-fc63-443d-aacb-3f9ad1718800_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_d96a9e94-7bb8-4ff4-b83a-c9126fff31d5_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bcfbb602-c97f-4960-a13f-98c87a05def9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_dda04e0a-250e-40ac-a143-0105d46a2c7d_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Financing Activities</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_101199b4-dd6f-4625-8822-5572fa088165_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_495ef5df-dd0b-447b-8619-094950c59305_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_23684b92-cde2-4fe2-a316-1f0f533ad014_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_6bfbd8b6-ddd8-46ba-82e1-feafc9160267_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of computations for basic and diluted earnings per common share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_cb04a54b-1e48-4499-802f-436d5df52b32_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to income statement, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_340f6c4f-2968-45fe-a4d3-eb3a91ff5e8d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_203bd7e1-c8d1-4df6-883c-015eb50831ee_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_15b6ea3b-d35b-4b98-b7d5-03c38d7c9c07_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A365NotesDueNovember302020Member_c5f90418-940d-413d-9a44-7f380eb01d41_terseLabel_en-US" xlink:label="lab_mck_A365NotesDueNovember302020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.65% Notes due November 30, 2020</link:label>
    <link:label id="lab_mck_A365NotesDueNovember302020Member_label_en-US" xlink:label="lab_mck_A365NotesDueNovember302020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.65% Notes Due November 30, 2020 [Member]</link:label>
    <link:label id="lab_mck_A365NotesDueNovember302020Member_documentation_en-US" xlink:label="lab_mck_A365NotesDueNovember302020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.65% Notes Due November 30, 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A365NotesDueNovember302020Member" xlink:href="mck-20201231.xsd#mck_A365NotesDueNovember302020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A365NotesDueNovember302020Member" xlink:to="lab_mck_A365NotesDueNovember302020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLossNetOfTax_6c14ebe5-6e9e-4fd7-9af6-d5d930084c79_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLossNetOfTax" xlink:to="lab_us-gaap_GoodwillImpairmentLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_f7eb74a7-4303-4330-aac5-17e2a452fe0a_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ChangeHealthcareLLCChangeHealthcareMember_8cf8bc27-9285-46c1-8e56-a4654b4b131c_terseLabel_en-US" xlink:label="lab_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare JV</link:label>
    <link:label id="lab_mck_ChangeHealthcareLLCChangeHealthcareMember_label_en-US" xlink:label="lab_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, LLC (&#8220;Change Healthcare&#8221;) [Member]</link:label>
    <link:label id="lab_mck_ChangeHealthcareLLCChangeHealthcareMember_documentation_en-US" xlink:label="lab_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, LLC (&#8220;Change Healthcare&#8221;) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:href="mck-20201231.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:to="lab_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_9235da61-4453-40ee-ba47-67e884e969f2_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts outstanding under facility</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_5d666a79-30ac-4406-a647-d39e9f93f442_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_58abc69e-21d9-4e16-b683-15f2728ca363_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_7c9ded4f-012f-4db2-ac1c-ef00fb8e5566_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment and Related Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_89b0689b-85df-4b8b-84a1-d83a9aed4885_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_384c8f00-0b91-49b0-8176-7cb0d638c659_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax litigation expense</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_ba1b7acd-3343-4852-a37d-46f594584bbc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_55fef813-b60b-477f-ab25-2c0a80e69437_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_f1c48e19-a032-4c64-8013-d77e47e5cdd6_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Credit Facility</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:href="mck-20201231.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitDiscreteItems_178da4ca-08d2-4122-98cf-1b32714f6460_negatedTerseLabel_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discrete tax benefit</link:label>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitDiscreteItems_label_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit) Discrete Items</link:label>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitDiscreteItems_documentation_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit) Discrete Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:href="mck-20201231.xsd#mck_IncomeTaxExpenseBenefitDiscreteItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:to="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ProportionateGainLossOnEquityMethodInvestment_effb569d-9c37-4273-b60e-82bcec88508f_negatedTerseLabel_en-US" xlink:label="lab_mck_ProportionateGainLossOnEquityMethodInvestment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportionate loss from investment in Change Healthcare</link:label>
    <link:label id="lab_mck_ProportionateGainLossOnEquityMethodInvestment_label_en-US" xlink:label="lab_mck_ProportionateGainLossOnEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportionate Gain (Loss) on Equity Method Investment</link:label>
    <link:label id="lab_mck_ProportionateGainLossOnEquityMethodInvestment_documentation_en-US" xlink:label="lab_mck_ProportionateGainLossOnEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportionate Gain (Loss) on Equity Method Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ProportionateGainLossOnEquityMethodInvestment" xlink:href="mck-20201231.xsd#mck_ProportionateGainLossOnEquityMethodInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ProportionateGainLossOnEquityMethodInvestment" xlink:to="lab_mck_ProportionateGainLossOnEquityMethodInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_86c65e97-68c9-4832-97aa-1f82222a1a15_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, by Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_6a2a1a47-b235-4363-bb39-48d679cff9c8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Capacity Available for Specific Purpose Other than for Trade Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:to="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8f676a2c-e5db-4802-87e5-3cc5128f24bd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_a2c6a4ae-2d66-4edc-b36a-bf5cb98335cd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding the fair value of derivatives on a gross basis</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_6b4c85ab-f3a2-493b-8dd1-6d4877bc8ba7_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_fec29f76-b968-4d7d-8253-810b0dd765d5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_d358794c-20ed-4e22-81ec-ff5d38aa3837_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_c54058e3-fdf2-467d-b2f5-db5d7821baf4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueFromRelatedParties_250f98ca-bf1c-4187-aa4d-78ef262ec848_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable recognized</link:label>
    <link:label id="lab_us-gaap_DueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_DueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromRelatedParties" xlink:to="lab_us-gaap_DueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_089d653e-3e92-454e-8303-9d6565459975_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_01e990e6-a644-47fd-b7d0-a7ce5f857764_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to income statement, tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_0c713a60-f27a-4db1-9abf-5d1331abc521_terseLabel_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation gain (loss) attributable to redeemable noncontrolling interest</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" xlink:href="mck-20201231.xsd#mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_3b3e9070-9403-4e92-81e5-806e589b70b9_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_8100c9e1-492e-4e1c-8a85-576b0f4f0352_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_43a5cfba-d322-4006-8450-4bdc49b51a90_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_5b8f81b3-b1f2-408b-8c25-828b8658ee1e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt issuance</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanMember_63287937-05f0-48fe-8713-b529239abc23_terseLabel_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanMember_label_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan [Member]</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanMember_documentation_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanMember" xlink:href="mck-20201231.xsd#mck_StrategicGrowthInitiativePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StrategicGrowthInitiativePlanMember" xlink:to="lab_mck_StrategicGrowthInitiativePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_5fd1ae98-9fe5-4158-8086-5c3e3363cec7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f4986567-79f4-4c19-85b4-cacb58dab8ee_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_4dc3d1da-f05f-423a-b54e-0e6c10fdf9a6_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_c771f0b6-fd81-4f60-80e0-e9f253073124_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_30ef7050-34c6-4127-b255-b428db90ad3b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) on Cash Flow Hedges, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_edc236d3-41da-4ae1-b06d-8345298a9021_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price of shares repurchased (in usd per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_07562095-7b2e-46d1-849c-761f18a937d2_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_c2564a1a-719d-494a-b9ed-63fd9d864a17_verboseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_label_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) Due to Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) Due to Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:href="mck-20201231.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:to="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e451449e-4b65-4766-b9fb-b53d1993bb98_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_ccf8ad2c-ee83-4262-91ac-68701100d596_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional values of financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_aa4b2bd9-af7b-4037-aeef-96fe3942c0b3_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_773a3363-c700-4135-8544-e93e4fd20ab2_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_6434faa8-25be-4dde-a6fd-1267227eb55c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_5311ceeb-d3fc-4ffd-a3bb-5a7dd899665e_terseLabel_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary</link:label>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_label_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary [Member]</link:label>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_documentation_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember" xlink:href="mck-20201231.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MckessonEuropeSubsidiaryMember" xlink:to="lab_mck_MckessonEuropeSubsidiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_535b9b61-3200-4251-a99b-e113483e14a3_terseLabel_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments and other, net of income tax expense</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans, Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans, Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:href="mck-20201231.xsd#mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:to="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_d5e8be27-a4a4-473e-8e69-e129ceac4cfc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_e731a075-8a5a-438b-a728-f4dd07829b75_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Change Healthcare Joint Venture</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_85b8c16b-4471-4800-855b-695e89aa1ecd_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments of Business</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_8853451e-318a-40d8-8871-0370b558957a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in money market funds</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TransitionServicesAgreementsTSAMember_6a0f7e38-0f17-4411-8ce0-a16cd85b8ad3_terseLabel_en-US" xlink:label="lab_mck_TransitionServicesAgreementsTSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreements (&#8220;TSA&#8221;)</link:label>
    <link:label id="lab_mck_TransitionServicesAgreementsTSAMember_label_en-US" xlink:label="lab_mck_TransitionServicesAgreementsTSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreements (&#8220;TSA&#8221;) [Member]</link:label>
    <link:label id="lab_mck_TransitionServicesAgreementsTSAMember_documentation_en-US" xlink:label="lab_mck_TransitionServicesAgreementsTSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreements (&#8220;TSA&#8221;) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TransitionServicesAgreementsTSAMember" xlink:href="mck-20201231.xsd#mck_TransitionServicesAgreementsTSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TransitionServicesAgreementsTSAMember" xlink:to="lab_mck_TransitionServicesAgreementsTSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_499797cd-2738-44eb-a344-26f30db951a3_terseLabel_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes</link:label>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_label_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes [Member]</link:label>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_documentation_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember" xlink:href="mck-20201231.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_BritishPoundSterlingDenominatedNotesMember" xlink:to="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_6f42fac1-35f4-44a3-952b-6cc95c074687_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_474ebd2f-f00b-4a74-b047-311216b738cd_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_ed5b7314-daee-4869-8efc-7581083bfba9_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_7068b4ad-83df-4600-9232-ee081d835236_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax expenses related to estimated litigation liability</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualProvision" xlink:to="lab_us-gaap_LossContingencyAccrualProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_008df592-a668-4ad4-895f-6ee8b7330f3d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_cb06cae5-9a31-4679-8950-c886d49dfacc_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_5afd0bee-c96a-43a8-9b3e-8b003a57c95c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_87f77149-721f-4710-a851-815290d48dc9_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_1251b330-cb4d-4ec0-a7fd-2f8c8995a85f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_e5959663-47c9-4e03-a68d-3b3bfc71da2b_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_8d1913b2-0221-4f33-96a6-dec09116db53_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit and other-related costs</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_0dff7cf4-93df-488d-bff8-bbfe97fe760a_terseLabel_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes due December 3, 2025</link:label>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_label_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes Due December 3, 2025 [Member]</link:label>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_documentation_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes Due December 3, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member" xlink:href="mck-20201231.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A090NotesDueDecember32025Member" xlink:to="lab_mck_A090NotesDueDecember32025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_82d82802-78f9-40fc-8db5-fc6b6b5afcfe_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_7aadccb2-a396-4180-8830-9557b74b595f_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term assets</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Long-term Assets, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Long-term Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentChargeOnReclassifiedAssets_cd28c26b-9b5f-413f-ab3c-e8a23eb585fe_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentChargeOnReclassifiedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax impairment charge</link:label>
    <link:label id="lab_us-gaap_ImpairmentChargeOnReclassifiedAssets_label_en-US" xlink:label="lab_us-gaap_ImpairmentChargeOnReclassifiedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Charge on Reclassified Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentChargeOnReclassifiedAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentChargeOnReclassifiedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentChargeOnReclassifiedAssets" xlink:to="lab_us-gaap_ImpairmentChargeOnReclassifiedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_c5234a97-27d8-4bef-b447-7c76485422e4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_9eb1faa8-98e2-4452-a560-197f38d237a9_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest (percent)</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_92fb79fd-482a-4c56-83d6-900136bf8744_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on equity investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_7f6c8e25-f554-4c5b-8d29-8161ef7057e0_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_df303ac2-d3b4-4d41-b17a-31d9e429f895_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_a03b3029-9c3b-4d10-bfbb-e5247baac585_terseLabel_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum redemption value of redeemable noncontrolling interest</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_label_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests, Maximum Redemption Value</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_documentation_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests, Maximum Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:href="mck-20201231.xsd#mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:to="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_2bd2fd4c-ef44-4406-9302-ca685ba08eb1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_e6bf5785-4f45-434b-81da-00b35a767936_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_40a7d19d-d174-45ed-a2bc-3506cb9a7fd4_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_a556f814-fcf5-452c-86c7-04fb8cb1123c_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K and Canada</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_25d4dc40-a8ac-42da-84d0-2cd9121b397d_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_302d1d1a-e855-43e6-9cc8-1e8a21357fe7_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for purchase shares of Mckesson Europe</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A0625NotesDue2021Member_ea03bb00-c950-4c9b-8d54-fa0186b8e762_terseLabel_en-US" xlink:label="lab_mck_A0625NotesDue2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.625% notes Due 2021</link:label>
    <link:label id="lab_mck_A0625NotesDue2021Member_label_en-US" xlink:label="lab_mck_A0625NotesDue2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.625% notes Due 2021 [Member]</link:label>
    <link:label id="lab_mck_A0625NotesDue2021Member_documentation_en-US" xlink:label="lab_mck_A0625NotesDue2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.625% notes Due 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A0625NotesDue2021Member" xlink:href="mck-20201231.xsd#mck_A0625NotesDue2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A0625NotesDue2021Member" xlink:to="lab_mck_A0625NotesDue2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_aa53d429-e044-4e43-8a6f-f06731f8eb98_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_4793ba5a-d68f-42af-95e2-57a2923c144d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, inputs, level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_42912886-c9a2-418a-9995-8a6dfb08549a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_a96165b4-25b1-4c62-a322-34deedf65612_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in retirement-related benefit plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_52e5fa1a-ffc0-4893-a15c-2b84086682be_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_3e1583cb-edcd-44bc-8ab1-a9d27e9c77d2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c32850fc-8784-4ced-952e-237363cede7a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OperatingModelAndCostOptimizationProgramsMember_f7c5a694-27c7-44e7-be39-be02158aa196_terseLabel_en-US" xlink:label="lab_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Model and Cost Optimization Programs</link:label>
    <link:label id="lab_mck_OperatingModelAndCostOptimizationProgramsMember_label_en-US" xlink:label="lab_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Model and Cost Optimization Programs [Member]</link:label>
    <link:label id="lab_mck_OperatingModelAndCostOptimizationProgramsMember_documentation_en-US" xlink:label="lab_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Model and Cost Optimization Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:href="mck-20201231.xsd#mck_OperatingModelAndCostOptimizationProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:to="lab_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_0fffeb02-b6e9-4057-a140-fc8a1723ab3b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_defe3b7a-49bf-480b-8cf3-142d31ccacb1_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_21c11bd3-87b2-4619-b5c0-a7a83a3cf0d9_terseLabel_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_label_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase [Member]</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_documentation_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember" xlink:href="mck-20201231.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AcceleratedShareRepurchaseMember" xlink:to="lab_mck_AcceleratedShareRepurchaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_36978e01-8699-4059-8630-7fd37abcdf42_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_788f1de2-d7da-4165-af35-07116c132293_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_06201c77-173c-4654-aeda-c26a58e387d1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_10004da8-c131-4adb-94d0-8592a7421fdc_terseLabel_en-US" xlink:label="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) on non-derivative net investment hedge</link:label>
    <link:label id="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_label_en-US" xlink:label="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax</link:label>
    <link:label id="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_documentation_en-US" xlink:label="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:href="mck-20201231.xsd#mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:to="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d3eee9e8-6098-4da8-8b22-eb1fa473efcc_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_11f49e71-5cae-43e1-a5ea-95a0c6a5c7b4_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_a9010691-a873-4d58-9a70-85fe20bf05fa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_8a048bee-3feb-4f4a-95bf-7e4985f18e80_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_edfefe10-eea2-449f-b20b-f091bbd785d9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of interest in joint venture</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_220eb095-96f0-49e1-936c-fd86cec2d29c_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_c2c1261d-49bb-4846-ac58-5c52fe95a96a_terseLabel_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors</link:label>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_label_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors [Member]</link:label>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_documentation_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:href="mck-20201231.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:to="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_4051707a-a563-4e1b-8479-df2725dbab93_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_c38dbfc9-5e81-4d9a-b482-12842aafb654_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_1616fb05-1a6a-4278-9c02-0e4b9ba5e661_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_be750a6f-8324-4902-9ff4-72b2bf8195f7_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_28e6b053-4907-4df9-b85b-ae24c360315b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_6800369d-9386-4b04-b00a-ef923da2193c_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedPercentage_48b9f8c1-4d1c-47d7-a5ce-532774558190_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage threshold of greater of projected benefit obligation or market value of assets (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_1b03aad2-dc56-49df-a19c-98ff2fa87136_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_fff05737-545d-4c7f-8391-2df6be8a6f11_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberOfInvestmentFundsThatFiledClaims_f0ae1513-62ce-447a-91d1-6bd1afd7418f_terseLabel_en-US" xlink:label="lab_mck_NumberOfInvestmentFundsThatFiledClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of investment funds that filed claims</link:label>
    <link:label id="lab_mck_NumberOfInvestmentFundsThatFiledClaims_label_en-US" xlink:label="lab_mck_NumberOfInvestmentFundsThatFiledClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Investment Funds That Filed Claims</link:label>
    <link:label id="lab_mck_NumberOfInvestmentFundsThatFiledClaims_documentation_en-US" xlink:label="lab_mck_NumberOfInvestmentFundsThatFiledClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Investment Funds That Filed Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfInvestmentFundsThatFiledClaims" xlink:href="mck-20201231.xsd#mck_NumberOfInvestmentFundsThatFiledClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberOfInvestmentFundsThatFiledClaims" xlink:to="lab_mck_NumberOfInvestmentFundsThatFiledClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d6c9049d-b12c-4a97-a5ee-c2b19f6f6077_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_fb278d3d-daed-46c3-9a9f-32f086bee611_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1307a28f-215a-4134-a970-aaa91b46b368_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_a42b2946-9bff-4bfc-b347-006750e93dfe_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2bbf68ba-844b-498f-b8f1-bc52abd2d125_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a57949d3-c917-4b65-b146-6ae40df84405_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_3b8bb828-c684-4c6f-936e-b729ad0e53a8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of commercial paper</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_cba08ede-396f-4806-a1f6-06add76794d4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_1653d584-0b52-4fbc-9a59-32921bdcafd8_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annuity contracts purchased</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment For Annuity Contract</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment For Annuity Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:href="mck-20201231.xsd#mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:to="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_7252b4ac-37bf-4558-ab00-9109bc2bd72c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3fcff2e9-7f1c-49c8-ad31-8d303f71cafd_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1c92d301-3cb0-4717-bd38-da1b8f92976d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyAccrualProvisionNetOfTax_1fde038d-31a6-488c-9c6d-7c096ab32516_terseLabel_en-US" xlink:label="lab_mck_LossContingencyAccrualProvisionNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax expenses related to estimated litigation liability</link:label>
    <link:label id="lab_mck_LossContingencyAccrualProvisionNetOfTax_label_en-US" xlink:label="lab_mck_LossContingencyAccrualProvisionNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision, Net of Tax</link:label>
    <link:label id="lab_mck_LossContingencyAccrualProvisionNetOfTax_documentation_en-US" xlink:label="lab_mck_LossContingencyAccrualProvisionNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualProvisionNetOfTax" xlink:href="mck-20201231.xsd#mck_LossContingencyAccrualProvisionNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyAccrualProvisionNetOfTax" xlink:to="lab_mck_LossContingencyAccrualProvisionNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9cbd8fa6-a583-448b-89fc-7f4ad66b7150_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_871b946b-d1df-4b43-b418-19906265b13b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_97e5a0b8-cf9b-4564-b81a-39840d24fa8d_terseLabel_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss and prior servicecost arising during the period, net of income tax benefit</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service and Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service and Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:href="mck-20201231.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:to="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ffc9f64a-e28c-4d1a-a9d9-d13ecdaa2e15_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in retirement-related benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_0650e44f-389b-4c39-9f55-abc0a56f5ebc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of actuarial (gain) loss and prior service costs, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aa2e3878-bdec-416a-8db4-b80f9cb2350b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fcc16590-e4da-4b83-8c02-c757fe3c0b6e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_2b217bf6-dc43-4933-873d-499e0c5cf9e7_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_c1ccc4be-e3aa-4c8f-8974-3f0516020205_terseLabel_en-US" xlink:label="lab_mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset for the temporary difference arising from buyer's excess tax basis</link:label>
    <link:label id="lab_mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_label_en-US" xlink:label="lab_mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory</link:label>
    <link:label id="lab_mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_documentation_en-US" xlink:label="lab_mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:href="mck-20201231.xsd#mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:to="lab_mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_9cecfdfb-20e1-43fb-bcdd-6ccd65058dd8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_8a8bd5d2-e212-4e4a-97cf-e0b09fed8d44_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember_a4e21280-b816-438d-bc3f-f1efdb24f108_terseLabel_en-US" xlink:label="lab_mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retention Expenses, Severance, Accelerated Depreciation and Asset Impairments</link:label>
    <link:label id="lab_mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember_label_en-US" xlink:label="lab_mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retention Expenses, Severance, Accelerated Depreciation and Asset Impairments [Member]</link:label>
    <link:label id="lab_mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember_documentation_en-US" xlink:label="lab_mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retention Expenses, Asset Impairments and Accelerated Depreciation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember" xlink:href="mck-20201231.xsd#mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember" xlink:to="lab_mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_3ff7eb23-4e0d-4187-9233-13e3c7d511a9_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized amount available for future repurchases</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation_44bcb4f3-4f7d-4871-8aa7-1b2886888278_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement award anticipated to be used to remediate the opioid crisis (percent)</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation_label_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Percentage Anticipated To Be Used For Opioid Crisis Remediation</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Percentage Anticipated To Be Used For Opioid Crisis Remediation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation" xlink:href="mck-20201231.xsd#mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation" xlink:to="lab_mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_aa0c4d7c-b308-4ec8-8104-f025e72811ea_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_fab19cd3-b368-4097-ac71-c55189facc60_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss) attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_d4ab2aaa-5596-4fe9-9247-663447b672ec_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_75e27f4f-de49-4c07-9355-dec567e3f2fb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_17243f11-bb6b-488c-a496-f8152a9d93d7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_83e34ffb-6ab0-4bb1-9c2b-de17f2b74db0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from termination of derivative instruments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Derivative Instrument, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_e1dbe613-565b-4658-a5c1-1bb81e5819ae_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of countries in which entity segment operates</link:label>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Countries in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_d775ace1-9ec5-4430-b306-f24211d0e6b4_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_731343a5-d668-4c56-bb46-0ce9135d25cf_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_4432cc1a-ee3b-4949-b81c-197388c463cf_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_64759033-e9a6-469e-a88d-a8f96d00e414_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_7f659d3a-fc8c-4d59-aabe-286150afe248_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_78b928f2-a466-474c-b521-4291c513cdb7_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Par Value Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_35609170-95ce-4e95-aae8-ba4d59b819bd_terseLabel_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes due March 1, 2041</link:label>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_label_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes Due March 1, 2041 [Member]</link:label>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_documentation_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes Due March 1, 2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member" xlink:href="mck-20201231.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A600NotesDueMarch12041Member" xlink:to="lab_mck_A600NotesDueMarch12041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_9b4422ff-0c83-47db-9f27-e0a78c1e933f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_8ee700da-52e1-41e3-a283-d35c4ff4eca3_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_5a8542d9-6d82-4b9a-b370-dd941d76f60f_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_88a7818f-474d-40fd-88cd-041bb322071b_negatedTerseLabel_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of recurring compensation to other accrued liabilities</link:label>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_label_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Liability</link:label>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_documentation_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability" xlink:href="mck-20201231.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ReclassificationofTemporaryEquitytoLiability" xlink:to="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_236fb50a-91c9-4f9e-8fc6-7e4040201e36_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity earnings and charges from investment in Change Healthcare Joint Venture</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_b294629a-1009-4631-aaa7-bb11420d7605_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity earnings and charges from investment in Change Healthcare Joint Venture</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_fe8eab60-04be-4009-a868-1300d2c006df_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_c67c61ba-5ca1-47ea-981e-91198b8c94c9_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_4b6edf09-4ca1-499e-9289-a13ae343f6af_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_4f9a62ae-3262-42a0-839e-ef6056ada123_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to income statement, net of income tax expense</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_153ad35b-c416-48dc-8c56-a8d94a71707a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to earnings and other</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_8ce5a1cf-1fcb-4c8d-a11b-625ba46e917b_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLossAbstract_678d7020-c5b4-4001-931e-1b22170af6d4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating profit (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract" xlink:to="lab_us-gaap_OperatingIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_51125ef4-7093-4e92-9aa8-494d1e367dff_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_82fd9213-c4e5-4642-8053-eb6fb156ea77_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net and other current assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_c9a2a539-be89-4fbc-a356-20fe419a66aa_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on net investment hedges arising during period, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_42229189-784b-4cf7-ab1b-b34991a533dd_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_bab6c01b-07e4-4d26-9419-f08a1d5ea417_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_d9e136fc-ac77-41a1-909a-e146d69317a8_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_a87d22f6-7b23-45b4-bd3f-acbc719aaa79_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_fb9caf62-2a49-49e8-aebe-9061d5ec5a8f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_a17408c8-bdb4-4b76-8a8b-3122feebf60d_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated for hedge accounting</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_5a435b39-895e-4b27-9783-553bcaeda55f_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_b1c3c00e-1f9d-4528-ad60-9c726732166c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_fc3db077-9a87-479c-8e75-d2ed104dae59_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_6abf3f9d-c538-4e40-80ec-399b12633c84_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_753c7495-4449-4f15-acb5-e4a809269c6c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember_5ac46c8e-d7e1-4c49-83f1-06451a4c704c_terseLabel_en-US" xlink:label="lab_mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance, Accelerated Depreciation, and Project Consulting</link:label>
    <link:label id="lab_mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember_label_en-US" xlink:label="lab_mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance, Accelerated Depreciation, and Project Consulting [Member]</link:label>
    <link:label id="lab_mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember_documentation_en-US" xlink:label="lab_mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance, Accelerated Depreciation, and Project Consulting [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember" xlink:href="mck-20201231.xsd#mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember" xlink:to="lab_mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_5a80f7a4-d42b-488d-b3af-dfda7fd096d5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_c5e9abfe-d849-4342-a912-3c1b33fe0eda_verboseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_0de92438-999e-47d8-867d-afc574c8e9f8_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_adda130c-08e8-430d-b28f-832eca6b21a9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt outstanding</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_3ff2b465-4cc1-419f-8fa5-a2e9dfaf2c4c_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of liabilities</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_a4bdbdd8-5b28-46e9-9b66-9341b890d8c9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_a60fe86f-0490-4e94-8b0b-74c7b25096c7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_30e30856-ae35-4a42-8f8e-abc6776c03ba_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameAxis" xlink:to="lab_us-gaap_RetirementPlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_9d0de176-367f-4207-8067-733c9389c3d7_totalLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_0656ce24-2a5b-469f-8f11-e333fae99d25_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A1500NotesDue2025Member_fceb2e16-2182-408d-85e4-b20f9e72552c_terseLabel_en-US" xlink:label="lab_mck_A1500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025</link:label>
    <link:label id="lab_mck_A1500NotesDue2025Member_label_en-US" xlink:label="lab_mck_A1500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025 [Member]</link:label>
    <link:label id="lab_mck_A1500NotesDue2025Member_documentation_en-US" xlink:label="lab_mck_A1500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1500NotesDue2025Member" xlink:href="mck-20201231.xsd#mck_A1500NotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A1500NotesDue2025Member" xlink:to="lab_mck_A1500NotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_cfd2d00e-a79c-41f0-a003-d477aff92766_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Favorable (unfavorable) cumulative foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_ab209cb2-77eb-42e9-8292-e9c6b87a8a17_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases selected for possible remand to other federal courts</link:label>
    <link:label id="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_label_en-US" xlink:label="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts</link:label>
    <link:label id="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:href="mck-20201231.xsd#mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:to="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_1af14bdf-3a37-41a7-a741-28731ab97260_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_85785daa-fb7f-4b47-bd35-89def549555f_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_76393c22-1887-46e0-98fd-4a4f6ca5b80a_negatedLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities_013e434b-36ab-4e2d-9d73-035ec8494f14_terseLabel_en-US" xlink:label="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities_label_en-US" xlink:label="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liabilities</link:label>
    <link:label id="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseinOperatingLeaseLiabilities" xlink:href="mck-20201231.xsd#mck_IncreaseDecreaseinOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncreaseDecreaseinOperatingLeaseLiabilities" xlink:to="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_71b65a1e-cfe7-413a-bd5e-73983c6e00fe_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a6d038b2-057f-4a3e-8a72-f1528756f3cc_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_e6cb9054-0f32-4c29-83b9-9599d86821b8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) from cash flow hedges recorded within other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_43acca79-af82-467b-abd7-d823c81bbe46_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complaints filed against the entity</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_1fdf26f8-716f-4aba-8a03-4f12aa07f8dd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_27c3e2bf-56ab-426a-b884-0fe7b4916550_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_2106aa95-89b1-40e8-8665-9b4b730e3df8_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put right redemption price per share (in euros per share)</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_label_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:href="mck-20201231.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:to="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_c6d7da85-68a7-4dfd-b3ae-c7b87fab0efa_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_c80c01ef-b0fb-44cb-8f25-eb930e415132_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_0de58af0-af8d-4af9-aee6-d0cce392ec73_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_9e03a8dd-d16a-4ddf-b3ca-b3e44c94700d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_885e0c7f-582a-447e-8f6e-fda22d0226cb_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_555ba27c-8ee1-4d66-9447-1168d9835fe8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c2249e57-13cf-4362-9376-7f043ebb86e8_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e89f7986-a977-486e-a40f-a8ead6fc3027_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_049d4306-7ba7-47af-ab98-f8c9365558b2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_916a15a3-a4dc-4aad-9011-b51f4b0794c0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from sales of businesses and investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_0b64f840-8842-42cc-910a-20de646d754b_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d6310e41-1934-44f1-834e-f0ecdf9ba82b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_79e76f29-39e9-4740-8d00-8ebe0593c32c_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_0c312430-d659-4561-ba3d-31938d06a0d2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_1e1ecead-c94f-40e2-a639-905a97faf813_negatedTerseLabel_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate income (expenses), net</link:label>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_label_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expense and Other Income, Net</link:label>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_documentation_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expense and Other Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:href="mck-20201231.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:to="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_8604bd7a-cbb5-44af-b283-ed20e8b36a06_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ec685924-ce1f-4779-97cd-8f4c03267c36_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1f4d20b8-794e-4d37-ae8c-502495d307b3_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_58f8c3dc-6ed7-456e-bc4c-1940ffd3bc43_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Amortization Period (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_724c7087-af37-43b0-b256-ac7597a0ab4b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_679ab596-e068-4575-867a-49df52d4d48e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward starting interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_84014c23-f310-4421-901d-8005fe53877b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, remainder of 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_3d197293-10c3-4d3d-be62-142f9ce67fd1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_ab74db9a-a0b0-4ae0-a668-53bdea3f5dd1_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_655f7e89-52c0-4930-976a-ef53c3288a53_terseLabel_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions</link:label>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_label_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions Segment [Member]</link:label>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_documentation_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember" xlink:href="mck-20201231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MedicalSurgicalSolutionsSegmentMember" xlink:to="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_bda7df57-0ff2-4d12-9ab7-a5ba99b4df4a_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening retained earnings adjustment: adoption of new accounting standard</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiscalPeriod_8e0eb1c7-5455-4680-b86e-990f954ee5d8_terseLabel_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period</link:label>
    <link:label id="lab_us-gaap_FiscalPeriod_label_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiscalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiscalPeriod" xlink:to="lab_us-gaap_FiscalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_2322fbcb-2d70-4832-accf-22b61de384c7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Net Losses and Other Components of Benefit Plans, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices_896d3bab-cf4c-436b-829d-997575a597cc_terseLabel_en-US" xlink:label="lab_mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of investments that experienced transaction that resulted in change in observable price of those securities</link:label>
    <link:label id="lab_mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices_label_en-US" xlink:label="lab_mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, Equity Security Investments With Changes in Observable Prices</link:label>
    <link:label id="lab_mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices_documentation_en-US" xlink:label="lab_mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, Equity Security Investments With Changes in Observable Prices</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices" xlink:href="mck-20201231.xsd#mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices" xlink:to="lab_mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_b853f8d1-2b50-4843-b272-e64712201bca_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award payable under proposed framework</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_87a86f8b-45d3-4431-8ae9-1112704d9204_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_9799813f-b74c-4d44-b47c-c3dfa994df13_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_212945c0-93ad-47ee-af01-0c80d5314a6a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_3f7f4fb8-6261-4ff7-8a81-bf84ef738ae8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_4f403af9-2edb-4118-8988-3bd3c7cc682e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and other asset impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_78bebc05-3e39-47cb-af0f-817b1fb37379_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long-lived and intangible assets</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_WalgreensBootsAllianceJointVentureMember_44de2074-e70b-4e50-947f-a6f342aaead0_terseLabel_en-US" xlink:label="lab_mck_WalgreensBootsAllianceJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WBA Joint Venture</link:label>
    <link:label id="lab_mck_WalgreensBootsAllianceJointVentureMember_label_en-US" xlink:label="lab_mck_WalgreensBootsAllianceJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walgreens Boots Alliance Joint Venture [Member]</link:label>
    <link:label id="lab_mck_WalgreensBootsAllianceJointVentureMember_documentation_en-US" xlink:label="lab_mck_WalgreensBootsAllianceJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walgreens Boots Alliance Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WalgreensBootsAllianceJointVentureMember" xlink:href="mck-20201231.xsd#mck_WalgreensBootsAllianceJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_WalgreensBootsAllianceJointVentureMember" xlink:to="lab_mck_WalgreensBootsAllianceJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_57669b32-a0c8-4f22-92cb-b3e804472d81_terseLabel_en-US" xlink:label="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al</link:label>
    <link:label id="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_label_en-US" xlink:label="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]</link:label>
    <link:label id="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_documentation_en-US" xlink:label="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:href="mck-20201231.xsd#mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:to="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_cc60b204-759a-46aa-977b-354e3aedcb4f_terseLabel_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures due March 1, 2027</link:label>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_label_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures Due March 1, 2027 [Member]</link:label>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_documentation_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures Due March 1, 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member" xlink:href="mck-20201231.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A765DebenturesDueMarch12027Member" xlink:to="lab_mck_A765DebenturesDueMarch12027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_d62a1e2d-853f-4165-a93e-a8c4c28498f6_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in noncontrolling interest</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_5e7a71c6-9d24-4476-9034-67cd33ac3ebb_negatedTerseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercises of Put Right</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_label_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease for Exercise of Put Right</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease for Exercise of Put Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:href="mck-20201231.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:to="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofStates_6518bd4e-2e99-4437-9da4-96c06546987d_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which court cases are pending</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStates_label_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStates_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates" xlink:href="mck-20201231.xsd#mck_LossContingencyNumberofStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofStates" xlink:to="lab_mck_LossContingencyNumberofStates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_4de9ae90-1462-4514-b0d7-01035b1bb395_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_01808282-c78e-41ff-9fd5-96ffc41d4c7f_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_00c2d01d-5c0c-4e1c-8241-cc7bb0a1a7e2_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Possible decrease in unrecognized tax benefits during the next twelve months</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_547821f4-b5ff-4be6-9e86-c87700fe42e7_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Long-term Liabilities, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Long-term Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_75e5d17d-621d-465c-9a65-e720133432bf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_b532a07b-a583-4c55-8b8f-36f0d78286a4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_71369f31-1901-44fa-af9d-a144dc6558d5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_c302e99d-25e0-4ddf-9bed-320c0d942928_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ExecutiveBenefitRetirementPlanMember_052dc92e-d141-48d6-aedf-609c021dc5af_terseLabel_en-US" xlink:label="lab_mck_ExecutiveBenefitRetirementPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Benefit Retirement Plan</link:label>
    <link:label id="lab_mck_ExecutiveBenefitRetirementPlanMember_label_en-US" xlink:label="lab_mck_ExecutiveBenefitRetirementPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Benefit Retirement Plan [Member]</link:label>
    <link:label id="lab_mck_ExecutiveBenefitRetirementPlanMember_documentation_en-US" xlink:label="lab_mck_ExecutiveBenefitRetirementPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Benefit Retirement Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExecutiveBenefitRetirementPlanMember" xlink:href="mck-20201231.xsd#mck_ExecutiveBenefitRetirementPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ExecutiveBenefitRetirementPlanMember" xlink:to="lab_mck_ExecutiveBenefitRetirementPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_ed35dd23-94b4-40a2-8cc7-8003042e9d32_verboseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not Designated for Hedge Accounting</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_b39c2fb6-5177-4cec-96f3-5ad76820407d_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated for hedge accounting</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_91a87d1e-0b64-4cec-8c98-10a73fe6a297_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_d748263f-5f64-4e35-b309-c249083467a2_terseLabel_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments and other, tax</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_label_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Translation Impact On Pension Plans, Tax</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_documentation_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Translation Impact On Pension Plans, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:href="mck-20201231.xsd#mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:to="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_8c536e62-9604-4629-beab-5526f85c17e1_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-for-sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_cdb0c796-2bee-4b4f-be0d-b7d17c2df58b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_86bd0943-f5d6-49a5-9baf-12e24f878b78_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charge</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_95e948f5-5e41-4f6f-8e9a-0cead8233f78_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage (as a percent)</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_a4302251-9628-4da6-96c4-dcf3c04e9917_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAdditionalCapitalMember_14686fb3-d1b2-4d5a-9f1a-757539eb1107_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAdditionalCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Capital</link:label>
    <link:label id="lab_us-gaap_OtherAdditionalCapitalMember_label_en-US" xlink:label="lab_us-gaap_OtherAdditionalCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Additional Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAdditionalCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAdditionalCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAdditionalCapitalMember" xlink:to="lab_us-gaap_OtherAdditionalCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_20e430f7-cb22-4200-8602-303c224b5fe6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring liabilities</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_0e67f830-dafb-4666-af98-df470fea5d1b_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_ae12bcf1-f776-485b-9f85-60573f6de8c5_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4dba4345-d736-4f76-8078-e5bf6ddd75a6_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesReceived_63813557-85c5-4645-bb40-f912ca36a463_terseLabel_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of faxes received</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesReceived_label_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Received</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesReceived_documentation_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:href="mck-20201231.xsd#mck_LossContingencyClassActionNumberofFaxesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:to="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermCommercialPaperCurrent_45ce4ca9-871e-489c-9a60-ab9f52b8b4f0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermCommercialPaperCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_LongTermCommercialPaperCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermCommercialPaperCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Commercial Paper, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermCommercialPaperCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermCommercialPaperCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermCommercialPaperCurrent" xlink:to="lab_us-gaap_LongTermCommercialPaperCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_9d503856-f0cc-40a0-a1ad-446293b1069b_terseLabel_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">National Prescription Opioid Litigation</link:label>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_label_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">National Prescription Opiate Litigation [Member]</link:label>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_documentation_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In re: National Prescription Opiate Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember" xlink:href="mck-20201231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NationalPrescriptionOpiateLitigationMember" xlink:to="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_23abd368-5d89-4a07-b4e9-02a07e358edf_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_cfc1347d-fc96-44ce-ab17-0e13366da991_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_4e48bd50-702b-419f-b1d7-d17d7f6044bf_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Dollar, British Pound Sterling, and Euros Sublimit</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:href="mck-20201231.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_f646ffea-e980-4805-af9c-dfd143b1f52f_terseLabel_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of national brand medical-surgical products offered (more than)</link:label>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_label_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of National Brand Medical-Surgical Products</link:label>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_documentation_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of National Brand Medical-Surgical Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:href="mck-20201231.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:to="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PharmacyLicensesMember_fbf1c5e9-0ece-4e04-93f3-0fe89077c6cc_terseLabel_en-US" xlink:label="lab_mck_PharmacyLicensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy licenses</link:label>
    <link:label id="lab_mck_PharmacyLicensesMember_label_en-US" xlink:label="lab_mck_PharmacyLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Licenses [Member]</link:label>
    <link:label id="lab_mck_PharmacyLicensesMember_documentation_en-US" xlink:label="lab_mck_PharmacyLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy licenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmacyLicensesMember" xlink:href="mck-20201231.xsd#mck_PharmacyLicensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PharmacyLicensesMember" xlink:to="lab_mck_PharmacyLicensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_04bb42b6-9533-43e2-8236-7356f8e16764_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding other comprehensive income (loss) including noncontrolling and redeemable noncontrolling interests, net of tax, by component</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_af0da6e0-57b9-4042-b613-e51e365ca469_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_ea2df053-a149-41e4-b37a-0359fd7dbeed_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_bd27471d-ecc0-41d6-95a9-18825ef926f9_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8a022026-d275-4230-b795-98a200b0cf9c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposed of by sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_af96b23a-b2e2-487f-87da-fa24c1283296_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_822742ee-2154-4fdb-b4d3-da178fcc2e3f_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_ab25a0ee-7321-4ac8-a10a-a093867994c0_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_92c672b5-d15e-4539-b366-b7617fe98565_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c767df42-ca58-422a-81f2-c94fd2ab4c5f_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) attributable to McKesson</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_6712be3b-8f76-4241-8016-947addecf755_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_8029dcf8-3dec-440c-b3b6-2293b43e3690_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative, asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A3125NotesDue2029Member_61a370cb-7346-4b53-9e1d-c3db2a25f19e_terseLabel_en-US" xlink:label="lab_mck_A3125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029</link:label>
    <link:label id="lab_mck_A3125NotesDue2029Member_label_en-US" xlink:label="lab_mck_A3125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029 [Member]</link:label>
    <link:label id="lab_mck_A3125NotesDue2029Member_documentation_en-US" xlink:label="lab_mck_A3125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3125NotesDue2029Member" xlink:href="mck-20201231.xsd#mck_A3125NotesDue2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A3125NotesDue2029Member" xlink:to="lab_mck_A3125NotesDue2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_80dc90fe-72bb-4a10-bf35-0dbe79fcb811_terseLabel_en-US" xlink:label="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net cash tax savings realized or deemed realized under TRA (percent)</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_label_en-US" xlink:label="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_documentation_en-US" xlink:label="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:href="mck-20201231.xsd#mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:to="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_c2334773-c7f7-4df2-ae6d-abae82add366_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_97e6663e-8893-451b-9f68-1e44faeed303_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_4d326d6d-9db6-46ca-a520-d9bcf8924484_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, inputs, level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_a77284ba-98bc-47c7-b9a5-b77c48e450b1_negatedTerseLabel_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of assets of business held for sale to fair value less costs to sell</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_label_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_documentation_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:href="mck-20201231.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:to="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_33d7cc16-3dae-4579-b935-539877ff5f4f_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_e824c072-afcc-4189-86f8-66bca2373a95_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in the carrying amount of goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_b26ddb75-f8bd-4faa-b9f7-66610b5e148a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_a4b0e1e6-9e05-4c76-b855-3653f6a8c170_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_34efd6dc-69ad-4f68-abe5-3eaa6fece96c_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of largest pharmaceutical distributors to adopt anti-diversion programs under proposed framework</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_label_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Terms, Number of Companies to Adopt Anti-Diversion Programs Changes</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Terms, Number of Companies to Adopt Anti-Diversion Programs Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" xlink:href="mck-20201231.xsd#mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" xlink:to="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue_8d4c6340-194d-4a99-934a-6e867fd750a6_terseLabel_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit recognized for remeasurement of assets and liabilities held-for-sale to fair value</link:label>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue_label_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Remeasurement of Assets and Liabilities Held-for-Sale to Fair Value</link:label>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue_documentation_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Remeasurement of Assets and Liabilities Held-for-Sale to Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue" xlink:href="mck-20201231.xsd#mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue" xlink:to="lab_mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_924d2f20-37f9-4d57-8a2e-a87ab57fa81b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_5c3d1598-81b0-443c-82a5-7509a00ed3d6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Dollar notional amount, asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_f6babfc3-5bb4-4af4-ab6d-37d416f27f6f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_149b1e42-1d55-4065-825f-e934bd59f387_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_c65bff93-00a8-4488-8171-2553a65992c6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASU 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_49c82170-dd8c-40f5-a607-fb4219fad263_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member_7d999fad-89d9-4239-9538-b612050ef942_terseLabel_en-US" xlink:label="lab_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</link:label>
    <link:label id="lab_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member_label_en-US" xlink:label="lab_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA, No. 18 O 455/17 [Member]</link:label>
    <link:label id="lab_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member_documentation_en-US" xlink:label="lab_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA, No. 18 O 455/17</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member" xlink:href="mck-20201231.xsd#mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member" xlink:to="lab_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_960167c9-cc67-46e7-8929-352c44695337_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_ee4e1727-205f-4da2-8657-80438371505a_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_5708d153-2940-4aa5-84b2-1c641a0e2e1d_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_84505e3f-8e99-450c-8cb9-6edff14361f4_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_edd7c511-5cca-4064-b657-0fe2a44aa13a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_62553545-33e0-49ff-961b-8539381d8a2f_terseLabel_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC</link:label>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_label_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC [Member]</link:label>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_documentation_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:href="mck-20201231.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:to="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_56ffa47f-0fdb-4c04-85c0-e3a5cdf2cc26_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f3172d3a-9ad7-4d5c-a13a-a6f5b59fc919_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_ab25dca2-b32a-4a8c-ac7e-77c5c79f9eaa_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_9ce299a8-fb7e-4b17-bb07-35c0ebc21e7c_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_2085301b-ebdf-4713-ac75-61017c3cd1cd_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Translation and Other Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_fd864638-2c94-4a8e-bca1-539ac3cbb7be_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would reduce income tax expense and the effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_57040713-d63e-41bf-9db5-a09e521bc64a_terseLabel_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes due October 30, 2026</link:label>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_label_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes Due October 30, 2026 [Member]</link:label>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_documentation_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes Due October 30, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member" xlink:href="mck-20201231.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A163EuroNotesDueOctober302026Member" xlink:to="lab_mck_A163EuroNotesDueOctober302026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GainLossOnSaleOfBusinessNetOfTax_a2484537-d542-42f3-8a2c-e40b0b8d941f_negatedTerseLabel_en-US" xlink:label="lab_mck_GainLossOnSaleOfBusinessNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax loss on sale of business</link:label>
    <link:label id="lab_mck_GainLossOnSaleOfBusinessNetOfTax_label_en-US" xlink:label="lab_mck_GainLossOnSaleOfBusinessNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Business, Net of Tax</link:label>
    <link:label id="lab_mck_GainLossOnSaleOfBusinessNetOfTax_documentation_en-US" xlink:label="lab_mck_GainLossOnSaleOfBusinessNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Business, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossOnSaleOfBusinessNetOfTax" xlink:href="mck-20201231.xsd#mck_GainLossOnSaleOfBusinessNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GainLossOnSaleOfBusinessNetOfTax" xlink:to="lab_mck_GainLossOnSaleOfBusinessNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_eb25f583-4191-4742-9f32-2d1ff13da2df_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_07c724de-e4a6-4cfd-8198-7f2670ea3db3_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) from net investment hedges recorded within other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_21592713-ce3a-4e12-9ec8-5d98889d8999_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_28bf7128-ac41-414c-b6dd-6c631190bb3e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_eb88116c-e240-4823-80c6-d185c584288a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_8a58495a-689c-44cd-93b8-2027d332322a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3aa56cd4-0796-40b0-8736-7be104ea2576_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_59965ab7-3b93-4a59-bd3f-71e09049f109_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RetailPharmacyReportingUnitMember_4a624e09-95fc-4151-a0a3-c2916501f911_terseLabel_en-US" xlink:label="lab_mck_RetailPharmacyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Pharmacy Reporting Unit</link:label>
    <link:label id="lab_mck_RetailPharmacyReportingUnitMember_label_en-US" xlink:label="lab_mck_RetailPharmacyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Pharmacy Reporting Unit [Member]</link:label>
    <link:label id="lab_mck_RetailPharmacyReportingUnitMember_documentation_en-US" xlink:label="lab_mck_RetailPharmacyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Pharmacy Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember" xlink:href="mck-20201231.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RetailPharmacyReportingUnitMember" xlink:to="lab_mck_RetailPharmacyReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_9af91d82-0914-439a-b072-f2ba424748d1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Held for Sale</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_ed570a60-39fe-4819-a73a-76a0c2c5117a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_4c5d3607-6e3e-4c19-96f6-0e6f74965ffd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_f090f18e-64d9-4c81-8b30-cf97e400c9d2_terseLabel_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes due March 15, 2044</link:label>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_label_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes Due March 15, 2044 [Member]</link:label>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_documentation_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes Due March 15, 2044</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member" xlink:href="mck-20201231.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A488NotesDueMarch152044Member" xlink:to="lab_mck_A488NotesDueMarch152044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_be5fa300-bedd-4719-9344-dcc5100b634a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_527e3123-362a-49d0-b5b8-456f64f7d33a_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_c0e41a36-c1ef-47da-9e91-bf6425fe8bca_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_d7c3397b-f0fb-4877-bb8a-06068ff6a318_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_73f83a64-39ab-4204-a640-65ae84c7fee7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value, 800 shares authorized and 273 and 272 shares issued at December 31, 2020 and March 31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_e394b7a0-1e53-4306-b093-55ce22180a34_terseLabel_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes due February 16, 2028</link:label>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_label_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes Due February 16, 2028 [Member]</link:label>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_documentation_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes Due February 16, 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member" xlink:href="mck-20201231.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A395NotesDueFebruary162028Member" xlink:to="lab_mck_A395NotesDueFebruary162028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cc95ce1b-e04e-4d8d-ac16-f4465a5ef99e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_799f2190-cd9d-4a3b-8230-9ea390af436b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_9a3aa2e5-2a38-4410-a1d5-f4339e158dd7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_bcbd87bc-bf95-49ca-b1ff-db4b0a10735e_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6cee3ba2-bd91-4885-9cf7-7de0a29e93bd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_af3bd6ac-529f-4445-830b-cbd4b5733296_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_f8ee62bc-0983-42e8-b6e8-0552032720bb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Restricted cash at end of period included in Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_a7f49da4-fa0f-4deb-926f-25b909fa7a1a_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_bcc69c17-5930-484e-a1ab-8defa1f8c4e3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_3d21af12-e390-4402-b42b-8d09d5619a93_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyDamagesSoughtPerViolationValue_7fa9b49c-0804-4d29-9a00-4291d3e519a9_terseLabel_en-US" xlink:label="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory damages sought per violation</link:label>
    <link:label id="lab_mck_LossContingencyDamagesSoughtPerViolationValue_label_en-US" xlink:label="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought Per Violation, Value</link:label>
    <link:label id="lab_mck_LossContingencyDamagesSoughtPerViolationValue_documentation_en-US" xlink:label="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought Per Violation, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:href="mck-20201231.xsd#mck_LossContingencyDamagesSoughtPerViolationValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:to="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_2248d773-6609-408f-836b-76b1cb0a72cc_terseLabel_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of put right by noncontrolling shareholders of McKesson Europe</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_496c336b-9fb2-4e36-aca3-8f6ba365c7e7_verboseLabel_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associated increase in Company's ownership interest on its equity</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_label_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Exercise of Put Right</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_documentation_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Exercise of Put Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:href="mck-20201231.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:to="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_2c28697f-64d3-4466-a16b-3d66ad96f77e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected total pre-tax charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_4915a2f2-8c9c-4cb0-8727-07f749692822_terseLabel_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes due November 17, 2025</link:label>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_label_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes Due November 17, 2025 [Member]</link:label>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_documentation_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes Due November 17, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member" xlink:href="mck-20201231.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A150EuroNotesDueNovember172025Member" xlink:to="lab_mck_A150EuroNotesDueNovember172025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_54879c90-4a86-4470-bad9-eb5bc6411df8_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross currency swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_118220bf-406f-4336-9b53-b5ef2b80102b_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_af02f840-229b-41f0-be48-f59dfd8dfc22_terseLabel_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial gain (losses) attributable to redeemable noncontrolling interest</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Defined Benefit Plans Net Unamortized Gain Loss Attributable to Redeemable Noncontrolling Interest Arising During Period Net Of Tax</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_documentation_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Defined Benefit Plans Net Unamortized Gain Loss Attributable to Redeemable Noncontrolling Interest Arising During Period Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" xlink:href="mck-20201231.xsd#mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" xlink:to="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_eb99c45d-b636-44fb-a0df-c6713cc3b02d_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember_aa714021-3ef7-419c-b682-4e688df93fe0_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Facility</link:label>
    <link:label id="lab_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Revolving Credit Facility (Global Facility) [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Revolving Credit Facility (Global Facility) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember" xlink:href="mck-20201231.xsd#mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember" xlink:to="lab_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_594824e0-f491-4401-91c1-ee74768d3a32_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_575bd4c3-465d-43e6-9dc2-43dfd9e413f6_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_2676047b-a508-4f5a-b993-dceb7090884a_periodStartLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_6f904f0a-0944-4a3c-a27b-79936d7de419_periodEndLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_b222349a-9383-4d27-8cdb-21acc976d657_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_39d0a13c-0f9c-4e1e-80c0-91505c35371b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ad8a90c2-922f-4541-8601-c676f8c0c5eb_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_c18ed031-0867-4356-813a-34390edb870c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_ece830d9-f88a-4b93-b059-198024711f20_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a97f4aad-8577-4f59-9f9b-6d8feaa79b65_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_62906224-f941-46a3-9f77-d6c69172e3b0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_d4f51830-8a35-4902-a413-80ec7dc6f2c0_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireSoftware_c338c66c-0af4-4aa6-aa66-f341c874efb0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireSoftware" xlink:to="lab_us-gaap_PaymentsToAcquireSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_4f5a1e5d-2e7e-4078-8997-796de287e0bb_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_55e950b0-2eef-45ad-87fd-586255f1e958_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_52f2f5f4-327e-454b-9664-25e238ec51ce_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period over which award would be payable under proposed framework</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_label_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Award Payment Period</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Award Payment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:href="mck-20201231.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:to="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_ac76ba4d-db3e-4ef1-906d-ed956b0bbc22_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price as percentage of debt outstanding at which debt can be purchased</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_77735c91-9aa2-47a0-a896-84e624a64186_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_0caebbe6-60b8-452e-8e29-00c84162bdf0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_3231d456-8875-4c9e-bcae-b83389cc7e9d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total McKesson Corporation stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ea7e4191-6f24-41cc-b3e5-6e47ec4f65c4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_887e8cb7-03b4-4a2f-8076-451b5b40c833_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_e4770399-e7a3-43c8-b072-8c1a649cd97e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_de9aad14-d4cf-4628-86f2-f475ec28874e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, redeemable noncontrolling interests, and equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_37efbb6f-1a78-4eb8-845c-c9f6de95a175_terseLabel_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember" xlink:href="mck-20201231.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RedeemableNoncontrollingInterestMember" xlink:to="lab_mck_RedeemableNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanOtherMember_437eab27-80eb-4376-93c1-d8ec56623474_terseLabel_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Other</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanOtherMember_label_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Other [Member]</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanOtherMember_documentation_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanOtherMember" xlink:href="mck-20201231.xsd#mck_StrategicGrowthInitiativePlanOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StrategicGrowthInitiativePlanOtherMember" xlink:to="lab_mck_StrategicGrowthInitiativePlanOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_43676b0c-b187-468f-8977-98f47aaad399_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_2ebb6011-ecb4-4e90-a7f1-9e81eb908f85_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASU 2014-09</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_246fc0cf-e62e-4ad2-aca3-665c92996fcb_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_c81e0ac5-c4be-4d07-944e-0da7c09a29af_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (loss) on cash flow hedges arising during period, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_21fa7c3d-872b-4579-9c05-b32543527196_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a89ede00-85a4-47ca-a581-b5dafda79803_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A475NotesDueMarch12021Member_d38b9c25-a65c-421d-9794-c426f0e30f5f_terseLabel_en-US" xlink:label="lab_mck_A475NotesDueMarch12021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes due March 1, 2021</link:label>
    <link:label id="lab_mck_A475NotesDueMarch12021Member_label_en-US" xlink:label="lab_mck_A475NotesDueMarch12021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due March 1, 2021 [Member]</link:label>
    <link:label id="lab_mck_A475NotesDueMarch12021Member_documentation_en-US" xlink:label="lab_mck_A475NotesDueMarch12021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due March 1, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMarch12021Member" xlink:href="mck-20201231.xsd#mck_A475NotesDueMarch12021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A475NotesDueMarch12021Member" xlink:to="lab_mck_A475NotesDueMarch12021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_9d064b75-18bb-4240-aa70-68f57c331c0a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanSettlementPlanParticipants_96cbc87b-3eab-4593-9d30-977d936a84ae_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of participants elected to receive settlement</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanSettlementPlanParticipants_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Settlement, Plan Participants</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanSettlementPlanParticipants_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Settlement, Plan Participants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:href="mck-20201231.xsd#mck_DefinedBenefitPlanSettlementPlanParticipants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:to="lab_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GermanWholesaleBusinessMember_e2785296-9d16-4765-80d3-4e0b52bb19eb_terseLabel_en-US" xlink:label="lab_mck_GermanWholesaleBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Business</link:label>
    <link:label id="lab_mck_GermanWholesaleBusinessMember_label_en-US" xlink:label="lab_mck_GermanWholesaleBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Business [Member]</link:label>
    <link:label id="lab_mck_GermanWholesaleBusinessMember_documentation_en-US" xlink:label="lab_mck_GermanWholesaleBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember" xlink:href="mck-20201231.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GermanWholesaleBusinessMember" xlink:to="lab_mck_GermanWholesaleBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cf36d874-d758-4b7a-9299-e186d3be809f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_125a2956-8935-42e0-830f-d9557be0a871_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_51c01ed1-22c6-4957-93fa-7d68033a7715_terseLabel_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:href="mck-20201231.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:to="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_3b29bf79-102b-4ddb-8aad-1c54213baf9b_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_a9815268-aac8-480a-be9a-010c24fbddb3_verboseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_6d2c94c2-722c-46e5-b4d3-78ba7c5bda82_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_07fad8bc-a2f7-4677-ad8e-1c97f32149ab_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ef99f678-3d68-457d-bdca-40c633c44515_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive securities (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_e2b017aa-a55a-4150-8d22-3b3a8e2d12bd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss and prior service cost arising during the period, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_994e2745-0664-4b26-bc73-f1dcb29972b8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_0f283230-bfa9-47a9-bfff-5c2b77615734_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_a774211d-8249-40dc-9571-00f12e4be372_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_9d0b8a5d-e7ac-437f-a418-934b24ce5226_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service agreements</link:label>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_label_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceAgreementsMember" xlink:to="lab_us-gaap_ServiceAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_1ace03a9-f741-4094-9018-cd82014fd2c9_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_07ed5596-88a1-4733-809e-ef4e810a9a10_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:to="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_f1c39c54-3e8b-45ad-9f39-73401d95b017_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4568a34b-06f1-4eef-9ca8-f150148c83b1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_4b16cfda-95d9-4f06-a417-58a5d9046b39_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1c819bed-5271-4230-a66a-1d30fe252e67_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_5083e8bb-b70b-4d38-9c35-098218a89122_terseLabel_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairments and accelerated depreciation</link:label>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_label_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Accelerated Depreciation</link:label>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_documentation_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Accelerated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:href="mck-20201231.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:to="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_d5c9fc92-519c-4243-88a2-08d1ad36fc3d_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_3d47a6fa-bbdf-40fe-8338-c1d8f0fec480_terseLabel_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Amortization of Actuarial Loss, Prior Service Cost and Transition Obligation, Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Amortization of Actuarial Loss, Prior Service Cost and Transition Obligation, Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:href="mck-20201231.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:to="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_9ce7d4c6-a132-44a0-ab30-70f73fb0dfd7_terseLabel_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other/Other accrued liabilities</link:label>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_label_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Asset / Liability [Member]</link:label>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_documentation_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Asset / Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember" xlink:href="mck-20201231.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CurrentAssetLiabilityMember" xlink:to="lab_mck_CurrentAssetLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_0d17b8ef-251b-4af3-88d9-ca957f802c89_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities, net of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_e931166a-5514-49e5-87e7-ca4d15c75f3f_terseLabel_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue derived from services, percentage (less than)</link:label>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_label_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Derived From Services, Percentage</link:label>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_documentation_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Derived From Services, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage" xlink:href="mck-20201231.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RevenueDerivedFromServicesPercentage" xlink:to="lab_mck_RevenueDerivedFromServicesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_637531ba-43be-4f56-b261-6d56a10cbb74_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2abbc363-7564-4235-b417-d54d2e46e601_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_27aa97f5-9fab-40c7-92d2-4fff54a90a02_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_557d6bd2-3edc-423c-98b6-24a66b87f6c1_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_0c6758d0-0764-4321-a524-44ac37e5812e_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_efacfeb3-ad0f-4ac2-bfd5-bc57923b4c60_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b12866b0-a52a-46a7-932f-e968719de022_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_3855af37-5a00-4827-8f1f-8250a471c5d9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per common share attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_97a96c09-d6f2-4880-ab23-cbf5b2b0b809_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net restructuring, impairment and related charges recognized</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_df75ac61-9228-4714-a5c3-315fd17be73a_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_e0913c5e-a549-419a-9041-d62d54926ef3_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_669ff580-b91c-41c8-b278-5e690719b91e_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and other obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_21c10c67-9126-4d7d-9a5b-7e097382975e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax loss on sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b3c6b878-ed38-4899-9a96-edd4e37331d9_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A1625NotesDue2026Member_153960a5-85e0-4873-8f7e-643ecadc9df2_terseLabel_en-US" xlink:label="lab_mck_A1625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026</link:label>
    <link:label id="lab_mck_A1625NotesDue2026Member_label_en-US" xlink:label="lab_mck_A1625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026 [Member]</link:label>
    <link:label id="lab_mck_A1625NotesDue2026Member_documentation_en-US" xlink:label="lab_mck_A1625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1625NotesDue2026Member" xlink:href="mck-20201231.xsd#mck_A1625NotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A1625NotesDue2026Member" xlink:to="lab_mck_A1625NotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_5719a55b-cb2f-4020-94fd-8516e82c5f7f_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Corporation stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1f0cb007-2933-40db-9f95-9cd415e737bf_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_d6bba9a5-4f76-4dc4-9eda-a4c342fb5744_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_November2018CrossCurrencySwapsMember_72ab000e-87bd-4ef2-ba02-24f5c13621d1_terseLabel_en-US" xlink:label="lab_mck_November2018CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018 cross currency swaps</link:label>
    <link:label id="lab_mck_November2018CrossCurrencySwapsMember_label_en-US" xlink:label="lab_mck_November2018CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018 Cross Currency Swaps [Member]</link:label>
    <link:label id="lab_mck_November2018CrossCurrencySwapsMember_documentation_en-US" xlink:label="lab_mck_November2018CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018 Cross Currency Swaps [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_November2018CrossCurrencySwapsMember" xlink:href="mck-20201231.xsd#mck_November2018CrossCurrencySwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_November2018CrossCurrencySwapsMember" xlink:to="lab_mck_November2018CrossCurrencySwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_2473000d-5496-4d22-be0d-138c8584ee30_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid-related settlement charges</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OpenMarketShareRepurchaseTransactionsMember_f701ffde-3db3-4e35-9692-b22746b86d0a_terseLabel_en-US" xlink:label="lab_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Share Repurchase Transactions</link:label>
    <link:label id="lab_mck_OpenMarketShareRepurchaseTransactionsMember_label_en-US" xlink:label="lab_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Share Repurchase Transactions [Member]</link:label>
    <link:label id="lab_mck_OpenMarketShareRepurchaseTransactionsMember_documentation_en-US" xlink:label="lab_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Share Repurchase Transactions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:href="mck-20201231.xsd#mck_OpenMarketShareRepurchaseTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:to="lab_mck_OpenMarketShareRepurchaseTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_639278d1-dcde-4e40-8315-23a55d44d156_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_5e7e61da-6b0a-43e3-bf11-cac0f69cad91_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash contributions to the plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_2378214f-95d0-4bd4-833d-0cf02a301fdd_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration receivable</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration Receivable</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_bd922ed5-3996-40f7-9b3f-2a466dc45752_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax charges recorded to-date</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_14c187c6-ad41-407f-bac4-4295d1091b2b_negatedTerseLabel_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges</link:label>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_label_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment and Other Related Charges</link:label>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_documentation_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment and Other Related Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:href="mck-20201231.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:to="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9130866a-fd9e-445c-8579-73c31ccbf0bf_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee plans (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateJointVentureMember_5963e48f-f53c-40af-b69f-857c6b6d0bb6_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture</link:label>
    <link:label id="lab_us-gaap_CorporateJointVentureMember_label_en-US" xlink:label="lab_us-gaap_CorporateJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateJointVentureMember" xlink:to="lab_us-gaap_CorporateJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_ce618f5c-9b09-4521-acaa-918385d8f19a_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_0f92b017-69a7-4beb-81b4-2d42249b3483_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_c80c931b-1d80-4cce-bd1e-3780745a7856_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_40966abc-0de7-4db4-bd11-6fdab7c82c3c_terseLabel_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of faxes remaining in the class</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_label_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Remaining in the Class</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_documentation_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Remaining in the Class</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:href="mck-20201231.xsd#mck_LossContingencyClassActionNumberofFaxesRemainingintheClass"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:to="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_f4590274-f982-44a8-ad25-50a4f772f380_terseLabel_en-US" xlink:label="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, thereafter</link:label>
    <link:label id="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:label id="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="mck-20201231.xsd#mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_d66d46dd-1652-475d-852b-662267c4fe50_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_cb5b11bd-c19e-4d0d-80d6-fae50ef2a039_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyAccrualAfterTax_1557f473-2eb5-4c81-818e-cf8f31dc2e29_terseLabel_en-US" xlink:label="lab_mck_LossContingencyAccrualAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax accrual</link:label>
    <link:label id="lab_mck_LossContingencyAccrualAfterTax_label_en-US" xlink:label="lab_mck_LossContingencyAccrualAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, After Tax</link:label>
    <link:label id="lab_mck_LossContingencyAccrualAfterTax_documentation_en-US" xlink:label="lab_mck_LossContingencyAccrualAfterTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, After Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualAfterTax" xlink:href="mck-20201231.xsd#mck_LossContingencyAccrualAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyAccrualAfterTax" xlink:to="lab_mck_LossContingencyAccrualAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_33291cf7-d37c-4828-874d-7455855f7c6b_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_d3810eb6-4072-4761-b285-d0037fcd937c_verboseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in net investment hedge, gains (losses) gross</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:to="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_4bdf1a54-9ce1-4765-8497-ed085d9187d0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1d80c111-fe63-49a4-9dfd-6059fd0f14a5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_b2c91941-5830-4141-9ac4-55eb7109bae5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on debt instrument (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_abd0a919-c63a-4190-9d64-33b88a7d7909_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b4a5ff93-d5bd-4ac2-98bf-3be8c2e1d11c_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPensionPlanLiabilitiesDerecognized_1da46885-3fe1-4515-8c2a-00edb8ddad28_verboseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPensionPlanLiabilitiesDerecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension liabilities derecognized</link:label>
    <link:label id="lab_mck_DefinedBenefitPensionPlanLiabilitiesDerecognized_label_en-US" xlink:label="lab_mck_DefinedBenefitPensionPlanLiabilitiesDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Pension Plan, Liabilities Derecognized</link:label>
    <link:label id="lab_mck_DefinedBenefitPensionPlanLiabilitiesDerecognized_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPensionPlanLiabilitiesDerecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Pension Plan, Liabilities Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPensionPlanLiabilitiesDerecognized" xlink:href="mck-20201231.xsd#mck_DefinedBenefitPensionPlanLiabilitiesDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPensionPlanLiabilitiesDerecognized" xlink:to="lab_mck_DefinedBenefitPensionPlanLiabilitiesDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_55f696d6-a3c9-4f9b-9fb5-459efc6e3c14_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f694975-8cb4-4b60-a6a7-4b2f519bb586_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_ee6cac83-c701-4931-b9c1-9fa673912952_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_f45bc52e-f1cb-43f7-8510-6a7c8a98b922_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember_9a842ad5-5063-491a-840e-2dcd73ef4e51_terseLabel_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Pharmaceutical Wholesale Business</link:label>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember_label_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Pharmaceutical Wholesale Joint Venture [Member]</link:label>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember_documentation_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:href="mck-20201231.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:to="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cfacc230-ce16-4b12-af5e-abd654f27ed8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9c3523ab-c0e6-43c8-be5e-b13673ca917a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_35672b24-3a77-4b16-87e0-97cf3119d794_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InternationalSegmentMember_4cc04cda-6eef-4fae-b0bc-d3c02f53fc92_terseLabel_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_label_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_documentation_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember" xlink:href="mck-20201231.xsd#mck_InternationalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InternationalSegmentMember" xlink:to="lab_mck_InternationalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_7c57fb2a-4878-4915-b142-676203111e57_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_652e0721-b264-41bc-973e-fe5dbc8833ea_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_9cca6799-7328-4b67-a270-224e35cc50cc_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b3d27354-5adf-47c1-9e17-aa28f224fa9a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_4eb9a726-e103-4083-ac72-cedea8a24d56_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_68390bf1-cc2a-43c2-bfe3-0df4146f219c_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_b3154f92-f638-4f6b-a2cf-ae38c006be2d_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_fcfcc455-9016-4462-849c-e97644143086_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_b1ce1f60-a5ee-44ab-8f71-ac13815d3ec4_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_2ba84d5d-2717-4b85-a5c1-72d181083abc_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_a759c8e3-a2fa-4431-a459-e8e445b644ae_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest (percent)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_452f9625-37c5-4e49-b040-919eef239a76_terseLabel_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical</link:label>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_label_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical Segment [Member]</link:label>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_documentation_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember" xlink:href="mck-20201231.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_USPharmaceuticalSegmentMember" xlink:to="lab_mck_USPharmaceuticalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_0a2e9cff-898a-4e07-9c76-0d0de1a3b887_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax dilution loss</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:to="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberOfBusinessOperations_f4314850-1f59-42af-9301-0f54dc53454a_terseLabel_en-US" xlink:label="lab_mck_NumberOfBusinessOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business operations</link:label>
    <link:label id="lab_mck_NumberOfBusinessOperations_label_en-US" xlink:label="lab_mck_NumberOfBusinessOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Business Operations</link:label>
    <link:label id="lab_mck_NumberOfBusinessOperations_documentation_en-US" xlink:label="lab_mck_NumberOfBusinessOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Business Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfBusinessOperations" xlink:href="mck-20201231.xsd#mck_NumberOfBusinessOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberOfBusinessOperations" xlink:to="lab_mck_NumberOfBusinessOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ef5f0e19-11cd-457f-bf10-cc66039a00cf_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_db9a220c-4e82-4003-af3e-1042f850e25c_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_29e8309a-a54d-4b9e-ae7a-fcb4998e83e4_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_650ac2b1-c54b-46e8-90fc-59791fe16f13_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7784852a-3e6a-4a97-9385-d8416089eb84_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_ef204348-2983-42f3-bc82-5d688e7d1c70_terseLabel_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes due February 17, 2029</link:label>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_label_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes Due February 17, 2029 [Member]</link:label>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_documentation_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes Due February 17, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member" xlink:href="mck-20201231.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A313SterlingNotesDueFebruary172029Member" xlink:to="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_c6af2d1c-3978-4ae9-b7ae-4ca04737c9d5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_9a4a9510-1765-42af-89c2-5909c2d3a055_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_a223f7e8-81b5-4077-a7ee-2dbd5e96624b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_cf795536-6350-471b-84f9-f1468e63ce49_terseLabel_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_label_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters [Member]</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_documentation_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan Relocation of Corporate Headquarters [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:href="mck-20201231.xsd#mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:to="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_ba227cfb-9049-445c-a3ed-9f16e5cc39ac_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d35f3358-cbdb-4717-93ef-10f63e384511_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_60c41465-233b-414b-913d-ee863b504a9d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit) related to continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_a60e3273-df11-48a3-b52a-d061080adaa6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of German wholesale business</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_174dff9c-2a3f-4097-b563-a2bb142eb6f9_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0a22f204-17ed-4cdc-8eb5-d41c591baaa6_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c60114a5-5c4f-42ba-a642-268be14acaf8_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_d973bdb6-b2f1-46aa-b3b3-bbc4f6a42b98_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities measured at fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_faf07af7-54fd-4c3f-b97a-589037202c05_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_14a95980-7f43-4b62-9927-eff45b47fc2f_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A2025NotesMember_eb14506b-05c2-4b86-94f8-25c771da1ef2_terseLabel_en-US" xlink:label="lab_mck_A2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Notes</link:label>
    <link:label id="lab_mck_A2025NotesMember_label_en-US" xlink:label="lab_mck_A2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Notes [Member]</link:label>
    <link:label id="lab_mck_A2025NotesMember_documentation_en-US" xlink:label="lab_mck_A2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2025NotesMember" xlink:href="mck-20201231.xsd#mck_A2025NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A2025NotesMember" xlink:to="lab_mck_A2025NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_90ef2d41-a05c-47cc-b2e2-134cfc2e1e80_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7b0894e0-7ef8-4cf6-93ad-779d6d49453a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_8d3d4913-b0fc-44da-a9a6-13d9b9597dab_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_98048235-af2a-4285-95b8-01f2c9e62284_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_ab0f21a7-ac48-43b1-af3f-99fed58917e6_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember_8a0f63f0-91f8-456f-90db-342a9782253e_terseLabel_en-US" xlink:label="lab_mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Planned divestiture in Medical-Surgical Solutions business</link:label>
    <link:label id="lab_mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember_label_en-US" xlink:label="lab_mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Planned Divestiture in Medical Surgical Solutions Business [Member]</link:label>
    <link:label id="lab_mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember_documentation_en-US" xlink:label="lab_mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Planned Divestiture in Medical Surgical Solutions Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember" xlink:href="mck-20201231.xsd#mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember" xlink:to="lab_mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_86fc3801-51f5-48fb-8467-6b6182921685_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_0e5b725b-6b79-4dbe-ad61-5220e4794bf8_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_f8001eaa-9354-4e46-a495-023e9093dded_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_4b9eacfd-e20b-4eeb-af68-f666e2303c57_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_20c7b309-1c86-4fb7-95ed-170681e4a5a0_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_cb84ccf3-9ce6-4e10-8851-50d8a81b1d94_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative, liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_644f28c2-fcc8-40b3-852f-e441202ead1d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge in connection with State of New York's Opioid Stewardship Act</link:label>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_label_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Loss in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyLossInPeriod" xlink:to="lab_us-gaap_LossContingencyLossInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_7a6b43b3-6707-4235-ab40-db9d73481a9d_terseLabel_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes due December 15, 2022</link:label>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_label_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes Due December 15, 2022 [Member]</link:label>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_documentation_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes Due December 15, 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member" xlink:href="mck-20201231.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A270NotesDueDecember152022Member" xlink:to="lab_mck_A270NotesDueDecember152022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_54b44209-5d2d-451d-9bc8-6c5760395db3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicated senior unsecured revolving credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_65f321bb-7dca-4799-a732-d967522b6d47_netLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding notes (up to)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_79146b67-2629-41c4-abbe-4c86c326448e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_502c9467-f86a-4b9c-846d-d8af4b3333f5_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_43f5eabe-d517-4434-ae8b-80aa5700f231_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromOtherEquity_d91e0284-fdd4-4e3d-8f0c-987b35f93529_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromOtherEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from concurrent offering of other securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromOtherEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromOtherEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Other Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromOtherEquity" xlink:to="lab_us-gaap_ProceedsFromOtherEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_34ae51c6-0081-44ee-ad81-762b9addc26b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_03167842-556c-43dd-84e3-793a96016893_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_2673026f-8095-4568-bbdb-7cf00ee2d6b1_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_73fea388-4813-4908-a5eb-ea3f97bca27d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_944e8af2-b31c-496a-9c90-5616dff9efdf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_a71a299f-d1b9-4758-9564-2706cc8e3443_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_5029c4a5-6ddc-4c26-8824-c00297b3388e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposals</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_49744156-cc09-47e7-b9be-40c83cbaaee3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_39cf2fd5-b60f-440d-a213-a3f9b667ab98_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of commercial paper</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5f241c64-fb72-4282-96c9-2c1eb363a113_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9968165c-f710-4721-8379-36e763881d9d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported income tax expense (benefit) rates (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_ac513920-caa1-4023-9791-8d5d751edee7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_d9ff3796-e174-4399-9a26-0737e8616f78_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A063EuroNotesDueAugust172021Member_25f4ea5d-c7e7-4321-beb2-e98b16d4a66e_terseLabel_en-US" xlink:label="lab_mck_A063EuroNotesDueAugust172021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes due August 17, 2021</link:label>
    <link:label id="lab_mck_A063EuroNotesDueAugust172021Member_label_en-US" xlink:label="lab_mck_A063EuroNotesDueAugust172021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes Due August 17, 2021 [Member]</link:label>
    <link:label id="lab_mck_A063EuroNotesDueAugust172021Member_documentation_en-US" xlink:label="lab_mck_A063EuroNotesDueAugust172021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes Due August 17, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member" xlink:href="mck-20201231.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A063EuroNotesDueAugust172021Member" xlink:to="lab_mck_A063EuroNotesDueAugust172021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_485112d2-3380-4fa4-b134-44b1ecbc7984_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Asset Impairment Charges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_ce95e98c-544a-4764-81c5-f0c90e515185_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_167f10ab-b2aa-47ea-8146-a2a972a96ed7_terseLabel_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes due March 15, 2023</link:label>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_label_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes Due March 15, 2023 [Member]</link:label>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_documentation_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes Due March 15, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member" xlink:href="mck-20201231.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A285NotesDueMarch152023Member" xlink:to="lab_mck_A285NotesDueMarch152023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_e90c543d-0290-4cc0-a88e-5cee7f9d1cec_terseLabel_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation liabilities</link:label>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_label_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Litigation Reserve</link:label>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_documentation_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Litigation Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve" xlink:href="mck-20201231.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncreaseDecreaseInLitigationReserve" xlink:to="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cf55dd64-80ef-49ca-93a1-12a0aec5f1db_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_faf05b68-ff13-4d85-b0c0-af664639d652_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_9cf7216d-f792-43b1-ac90-8287afef3c57_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_6cdbff4b-7c31-4dda-9d6e-444307cce1a9_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_7400f7bc-b2c7-41fd-96e2-123b00b45432_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_e0b6cdea-fe4e-49f2-84e3-2e521adaa282_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment and related charges recognized</link:label>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_label_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Settlement and Impairment Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:to="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_5c719a9e-c397-4c36-9121-3a2bee31c5d6_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares, at cost, 114 and 110 shares at December 31, 2020 and March 31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_fbd87c66-43fb-459b-94d1-bb8dde4851a3_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_28b74b0d-8af0-47bb-935e-f6b10ac3a30d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Loss) Per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies_f85efc1e-7bbd-4bb9-9a48-0e0f24b2694e_terseLabel_en-US" xlink:label="lab_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of companies in which equity securities were converted into public common stock</link:label>
    <link:label id="lab_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies_label_en-US" xlink:label="lab_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, Equity Security Investments Converted Into Public Common Stock, Number of Companies</link:label>
    <link:label id="lab_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies_documentation_en-US" xlink:label="lab_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, Equity Security Investments Converted Into Public Common Stock, Number of Companies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies" xlink:href="mck-20201231.xsd#mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies" xlink:to="lab_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_c3a58637-292e-42ae-8e90-6d8e1b5c0512_terseLabel_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put right value, interest rate spread (as a percent)</link:label>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_label_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right Value, Interest Rate Spread</link:label>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_documentation_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right Value, Interest Rate Spread</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread" xlink:href="mck-20201231.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PutRightValueInterestRateSpread" xlink:to="lab_mck_PutRightValueInterestRateSpread" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_5b4ebafb-4b94-40c7-9783-b7cb2546b065_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_36b32225-aa47-414f-a93c-0429a72b6491_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_9e7c7082-70c6-49b4-816f-a6d1aabe1020_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_7c9a6d97-4b49-4510-9e91-9c37eacd2496_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_df9819c7-94ce-4c00-9844-28d3de228c0f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_e0a9fe9d-08a7-40ab-94e7-e26a8cb8e6c4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credits associated with last-in, first-out inventory method</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_cb41de65-19c2-4e60-832f-45f0737b445c_negatedLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax credits related to LIFO accounting</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve, Period Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:to="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EuroDenominatedNotesMember_7087c812-5264-445a-98d5-aa1b025630ce_terseLabel_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes</link:label>
    <link:label id="lab_mck_EuroDenominatedNotesMember_label_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes [Member]</link:label>
    <link:label id="lab_mck_EuroDenominatedNotesMember_documentation_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember" xlink:href="mck-20201231.xsd#mck_EuroDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EuroDenominatedNotesMember" xlink:to="lab_mck_EuroDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax_863e59c8-7e26-44bb-9fbc-27f6a216afec_terseLabel_en-US" xlink:label="lab_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, after tax</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax_label_en-US" xlink:label="lab_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment Other Than Temporary Impairment After Tax</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax_documentation_en-US" xlink:label="lab_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment Other Than Temporary Impairment After Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" xlink:href="mck-20201231.xsd#mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" xlink:to="lab_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_469c3422-b573-4dd9-b1d5-16f3811ec7f8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_d562ec66-793d-45d3-b852-63a87f281ba1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_e2a0b063-c244-4d30-9903-368b844b9c74_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_b252078b-c0a4-48e7-b484-2ee2f19491e8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of businesses and investments, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses and Interests in Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_7bce631e-d693-4db4-ab03-daa9d6c21b6c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_e407c9c6-797a-40f9-9a6c-ea876e5986f0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>mck-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:734100a7-c7c1-4795-ad72-160dc37ce333,g:f6cbe616-07cc-4518-be11-bf83875971ba-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mckesson123.com/role/CoverPage" xlink:type="simple" xlink:href="mck-20201231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_06be7e7f-e34b-4a6b-9cae-10dfc53767e3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_4c85ed0d-21a4-4f6f-baf7-fcb7cc9b34ed" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_06be7e7f-e34b-4a6b-9cae-10dfc53767e3" xlink:to="loc_dei_EntitiesTable_4c85ed0d-21a4-4f6f-baf7-fcb7cc9b34ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b530f9f0-9ca3-47e0-9f0f-517efb584580" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_4c85ed0d-21a4-4f6f-baf7-fcb7cc9b34ed" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b530f9f0-9ca3-47e0-9f0f-517efb584580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c248eecc-ea5e-4b6e-af03-722fb6ee7c45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b530f9f0-9ca3-47e0-9f0f-517efb584580" xlink:to="loc_us-gaap_ClassOfStockDomain_c248eecc-ea5e-4b6e-af03-722fb6ee7c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ca5c08e0-91b4-4241-8683-78d7ddccfe9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c248eecc-ea5e-4b6e-af03-722fb6ee7c45" xlink:to="loc_us-gaap_CommonStockMember_ca5c08e0-91b4-4241-8683-78d7ddccfe9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A0625NotesDue2021Member_4ac17397-4145-4102-aed3-5050cb82e3ef" xlink:href="mck-20201231.xsd#mck_A0625NotesDue2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c248eecc-ea5e-4b6e-af03-722fb6ee7c45" xlink:to="loc_mck_A0625NotesDue2021Member_4ac17397-4145-4102-aed3-5050cb82e3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1500NotesDue2025Member_ab156aef-775e-480a-a8d7-8d4af20669dc" xlink:href="mck-20201231.xsd#mck_A1500NotesDue2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c248eecc-ea5e-4b6e-af03-722fb6ee7c45" xlink:to="loc_mck_A1500NotesDue2025Member_ab156aef-775e-480a-a8d7-8d4af20669dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1625NotesDue2026Member_33a3b90d-4683-48f5-a74f-38cb86514d77" xlink:href="mck-20201231.xsd#mck_A1625NotesDue2026Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c248eecc-ea5e-4b6e-af03-722fb6ee7c45" xlink:to="loc_mck_A1625NotesDue2026Member_33a3b90d-4683-48f5-a74f-38cb86514d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3125NotesDue2029Member_1f314cc9-7f3c-4468-a29a-0339ecb516b7" xlink:href="mck-20201231.xsd#mck_A3125NotesDue2029Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c248eecc-ea5e-4b6e-af03-722fb6ee7c45" xlink:to="loc_mck_A3125NotesDue2029Member_1f314cc9-7f3c-4468-a29a-0339ecb516b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_4c85ed0d-21a4-4f6f-baf7-fcb7cc9b34ed" xlink:to="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8f4fc86f-791b-4281-b673-da93918b564b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_DocumentType_8f4fc86f-791b-4281-b673-da93918b564b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_869e113a-c75d-41ab-9114-e2985c89fbbc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_DocumentQuarterlyReport_869e113a-c75d-41ab-9114-e2985c89fbbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_7628bb9e-9944-46a6-b1ba-4b026b4efc7e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_DocumentPeriodEndDate_7628bb9e-9944-46a6-b1ba-4b026b4efc7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_07a4ed66-299b-4a2a-9ced-a65dc6ec9159" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_DocumentTransitionReport_07a4ed66-299b-4a2a-9ced-a65dc6ec9159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e6be84c4-a12a-4d29-93aa-89a93b75c88c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityFileNumber_e6be84c4-a12a-4d29-93aa-89a93b75c88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_4084e12e-c709-430c-a66c-0acd99d785f5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityRegistrantName_4084e12e-c709-430c-a66c-0acd99d785f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d62950dc-62da-4e5c-97ef-c2274b1775b5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d62950dc-62da-4e5c-97ef-c2274b1775b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_04ce2894-3b90-4206-b18c-207fb1933e8b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityTaxIdentificationNumber_04ce2894-3b90-4206-b18c-207fb1933e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_710aa5ff-ebf3-46a8-9421-1de60b653a2e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityAddressAddressLine1_710aa5ff-ebf3-46a8-9421-1de60b653a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_8ff3902c-d662-4a7c-b2e6-ecdd46914742" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityAddressCityOrTown_8ff3902c-d662-4a7c-b2e6-ecdd46914742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_057c5fa8-5512-4cd8-8330-2fef546aa916" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityAddressStateOrProvince_057c5fa8-5512-4cd8-8330-2fef546aa916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_030fe5c2-3df9-495d-ab29-f0d9abc5afd9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityAddressPostalZipCode_030fe5c2-3df9-495d-ab29-f0d9abc5afd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f3c315d7-d5c7-4845-9d0e-99bc0097a721" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_CityAreaCode_f3c315d7-d5c7-4845-9d0e-99bc0097a721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_09a59829-29bc-4089-807c-055a1b9ecd41" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_LocalPhoneNumber_09a59829-29bc-4089-807c-055a1b9ecd41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_55412bf6-9086-4941-b4bc-63220c768019" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_Security12bTitle_55412bf6-9086-4941-b4bc-63220c768019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_a90e4218-050e-4b8a-8d7e-58069ccd7458" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_TradingSymbol_a90e4218-050e-4b8a-8d7e-58069ccd7458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_5e8dd09e-e345-450f-aae3-4cb9ca43b445" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_SecurityExchangeName_5e8dd09e-e345-450f-aae3-4cb9ca43b445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_2f452999-3692-41bb-a934-a9ff1884a4eb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityCurrentReportingStatus_2f452999-3692-41bb-a934-a9ff1884a4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_6f4655d2-becf-445c-9600-0b84ff2bf2ba" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityInteractiveDataCurrent_6f4655d2-becf-445c-9600-0b84ff2bf2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_10489906-bef0-4b57-a945-360508f5f81d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityFilerCategory_10489906-bef0-4b57-a945-360508f5f81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_a2af2759-e6f1-4c9c-8c6c-eab918ab6589" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntitySmallBusiness_a2af2759-e6f1-4c9c-8c6c-eab918ab6589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_70cb495b-f066-42e6-86ec-c3679c27972a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityEmergingGrowthCompany_70cb495b-f066-42e6-86ec-c3679c27972a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_8a035b35-6069-43c4-b346-f0da465f5b3e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityShellCompany_8a035b35-6069-43c4-b346-f0da465f5b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_14276463-2ea4-4b98-9b73-bae04179ce77" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_14276463-2ea4-4b98-9b73-bae04179ce77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_05c5cf8b-48ce-44d6-8807-c3f6d4cbeddc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_EntityCentralIndexKey_05c5cf8b-48ce-44d6-8807-c3f6d4cbeddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_adc447f3-46c5-43a2-8bb1-4023d7e18529" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_DocumentFiscalYearFocus_adc447f3-46c5-43a2-8bb1-4023d7e18529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_9262cfec-1397-4156-9a96-7a6d92764444" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_DocumentFiscalPeriodFocus_9262cfec-1397-4156-9a96-7a6d92764444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ea651dab-3954-4257-b699-6e13f2194060" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_AmendmentFlag_ea651dab-3954-4257-b699-6e13f2194060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_e7a40065-493f-47bd-bc5b-c65e6ac06651" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c07462e3-8409-402d-ad4c-adfabde2a3e6" xlink:to="loc_dei_CurrentFiscalYearEndDate_e7a40065-493f-47bd-bc5b-c65e6ac06651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_db5db856-9445-48e6-93ac-f1535639b08e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_db5db856-9445-48e6-93ac-f1535639b08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_35c5fd06-97fe-43f5-b9cc-b2e9a10ebcaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_35c5fd06-97fe-43f5-b9cc-b2e9a10ebcaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d98ca331-2bf3-4bf1-9a53-fc0277e8cff9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_GrossProfit_d98ca331-2bf3-4bf1-9a53-fc0277e8cff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_0d60a226-b057-45e3-9c23-5c79fc5fb98b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_0d60a226-b057-45e3-9c23-5c79fc5fb98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_a889596e-7132-416b-8393-8a2d012ac864" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalFees"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_LegalFees_a889596e-7132-416b-8393-8a2d012ac864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_bad26821-a91c-4171-afda-737475cb40ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_bad26821-a91c-4171-afda-737475cb40ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges_bb845bc7-67ea-4a15-90f4-b439745a0c46" xlink:href="mck-20201231.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_mck_RestructuringImpairmentandOtherRelatedCharges_bb845bc7-67ea-4a15-90f4-b439745a0c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_12fff7c5-98da-4e2d-b356-dd6d658c6785" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_OperatingExpenses_12fff7c5-98da-4e2d-b356-dd6d658c6785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6306dc25-67d6-4b8c-b6f5-280613e5d83f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_OperatingIncomeLoss_6306dc25-67d6-4b8c-b6f5-280613e5d83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_49081bf6-2fcb-4fbd-ab71-c3f6c0d96a76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_49081bf6-2fcb-4fbd-ab71-c3f6c0d96a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a0ee2637-6180-4bc1-a48e-d8bbd3441110" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a0ee2637-6180-4bc1-a48e-d8bbd3441110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_89522a9b-9fe4-44ca-887c-c62630cc3c52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_InterestAndDebtExpense_89522a9b-9fe4-44ca-887c-c62630cc3c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_540a97bf-4129-4136-9de3-45eede4f4a81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_540a97bf-4129-4136-9de3-45eede4f4a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_41247f33-a504-441f-b657-e055ff548bf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_41247f33-a504-441f-b657-e055ff548bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_eb0f5a68-aef6-468a-be92-c61dd7d61378" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_eb0f5a68-aef6-468a-be92-c61dd7d61378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_53b36e2d-4e26-4e70-b49e-192ad5a2a7a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_53b36e2d-4e26-4e70-b49e-192ad5a2a7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bab90bf6-2ffd-4f79-be05-f2fe888b4f95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_ProfitLoss_bab90bf6-2ffd-4f79-be05-f2fe888b4f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b0c2ff4e-87e6-4245-9d88-d69d2773f5a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b0c2ff4e-87e6-4245-9d88-d69d2773f5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_149c6390-569c-406c-bf6d-58b3d3efe012" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_NetIncomeLoss_149c6390-569c-406c-bf6d-58b3d3efe012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_dde243ab-deec-4482-bc6d-edd4952e2df6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_EarningsPerShareAbstract_dde243ab-deec-4482-bc6d-edd4952e2df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_1beeba96-b0f8-4ca9-aed3-a5b20f40b59c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_dde243ab-deec-4482-bc6d-edd4952e2df6" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_1beeba96-b0f8-4ca9-aed3-a5b20f40b59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_45dc6923-906a-4548-a3f0-7154616bb51b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_1beeba96-b0f8-4ca9-aed3-a5b20f40b59c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_45dc6923-906a-4548-a3f0-7154616bb51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_3157af2c-c546-4687-9374-dbe417c12629" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_1beeba96-b0f8-4ca9-aed3-a5b20f40b59c" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_3157af2c-c546-4687-9374-dbe417c12629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a340527e-9fd6-4866-b16d-89576942e5dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_1beeba96-b0f8-4ca9-aed3-a5b20f40b59c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a340527e-9fd6-4866-b16d-89576942e5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_2f9e6a4b-94df-442c-a692-434ba7622f92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_dde243ab-deec-4482-bc6d-edd4952e2df6" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_2f9e6a4b-94df-442c-a692-434ba7622f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_311a9fb5-29bb-48d1-8795-787f3da22cce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_2f9e6a4b-94df-442c-a692-434ba7622f92" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_311a9fb5-29bb-48d1-8795-787f3da22cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_e28af122-5130-4cb9-8a38-3b914968324f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_2f9e6a4b-94df-442c-a692-434ba7622f92" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_e28af122-5130-4cb9-8a38-3b914968324f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e63eb29b-9c83-4ac1-a968-337febb87c6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_2f9e6a4b-94df-442c-a692-434ba7622f92" xlink:to="loc_us-gaap_EarningsPerShareBasic_e63eb29b-9c83-4ac1-a968-337febb87c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_dbddeb8c-0762-465b-8dee-0f74001be11d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_40cf7188-3cf0-4c84-bc7a-1813d36d0051" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_dbddeb8c-0762-465b-8dee-0f74001be11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cefe0f09-2b2a-4a81-ad77-d23f724272b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_dbddeb8c-0762-465b-8dee-0f74001be11d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cefe0f09-2b2a-4a81-ad77-d23f724272b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fa65f2c2-0f0e-4ee6-9ff7-9dfd113dcb90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_dbddeb8c-0762-465b-8dee-0f74001be11d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fa65f2c2-0f0e-4ee6-9ff7-9dfd113dcb90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_862a7fbb-59f4-4515-acae-7101c19ec85d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0848af8f-77b2-43f2-a9d4-fbd808c5bccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_862a7fbb-59f4-4515-acae-7101c19ec85d" xlink:to="loc_us-gaap_ProfitLoss_0848af8f-77b2-43f2-a9d4-fbd808c5bccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_0290eb2b-ebcf-4195-bec8-5fa74beb0157" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_862a7fbb-59f4-4515-acae-7101c19ec85d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_0290eb2b-ebcf-4195-bec8-5fa74beb0157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_844ff85a-f438-4d80-b8f5-e2da56ad4226" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_0290eb2b-ebcf-4195-bec8-5fa74beb0157" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_844ff85a-f438-4d80-b8f5-e2da56ad4226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_16bd385c-3aed-4913-b451-73f62aa2d7a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_0290eb2b-ebcf-4195-bec8-5fa74beb0157" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_16bd385c-3aed-4913-b451-73f62aa2d7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1d20be67-8cd0-4249-ab0c-f2d8e75c0ad1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_0290eb2b-ebcf-4195-bec8-5fa74beb0157" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1d20be67-8cd0-4249-ab0c-f2d8e75c0ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bddf9446-56d7-4f5c-b309-6d64ca515efb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_0290eb2b-ebcf-4195-bec8-5fa74beb0157" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bddf9446-56d7-4f5c-b309-6d64ca515efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b63b68a0-d16c-429c-b88f-4015397d0209" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_862a7fbb-59f4-4515-acae-7101c19ec85d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b63b68a0-d16c-429c-b88f-4015397d0209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_78c5f530-0397-491d-8eea-98556cccaafe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_862a7fbb-59f4-4515-acae-7101c19ec85d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_78c5f530-0397-491d-8eea-98556cccaafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d5188340-aded-497f-889d-b903496d5de4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_862a7fbb-59f4-4515-acae-7101c19ec85d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_d5188340-aded-497f-889d-b903496d5de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c9accda4-3672-4729-a656-cb67d152c3f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_3d6cdbad-e9d7-4873-b860-7f48182fa061" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c9accda4-3672-4729-a656-cb67d152c3f4" xlink:to="loc_us-gaap_AssetsAbstract_3d6cdbad-e9d7-4873-b860-7f48182fa061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_8fc17cc3-3a13-48b0-8c04-983fcdabdf35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3d6cdbad-e9d7-4873-b860-7f48182fa061" xlink:to="loc_us-gaap_AssetsCurrentAbstract_8fc17cc3-3a13-48b0-8c04-983fcdabdf35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1785b7c0-d4d3-4bf7-ad00-23cd8c1291a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8fc17cc3-3a13-48b0-8c04-983fcdabdf35" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1785b7c0-d4d3-4bf7-ad00-23cd8c1291a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_053b8ad1-b1fa-4488-8bf2-2cf26d60b17f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8fc17cc3-3a13-48b0-8c04-983fcdabdf35" xlink:to="loc_us-gaap_ReceivablesNetCurrent_053b8ad1-b1fa-4488-8bf2-2cf26d60b17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_0bba19ba-dc78-44b7-83f2-74f0ee2760f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8fc17cc3-3a13-48b0-8c04-983fcdabdf35" xlink:to="loc_us-gaap_InventoryNet_0bba19ba-dc78-44b7-83f2-74f0ee2760f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_3c0da2ab-9d41-4994-bce1-3595f848844f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8fc17cc3-3a13-48b0-8c04-983fcdabdf35" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_3c0da2ab-9d41-4994-bce1-3595f848844f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d7cf8448-1f97-4799-9e90-d9e8e96b5479" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8fc17cc3-3a13-48b0-8c04-983fcdabdf35" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d7cf8448-1f97-4799-9e90-d9e8e96b5479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_281c0838-ac37-4aef-96c3-6705b4384066" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8fc17cc3-3a13-48b0-8c04-983fcdabdf35" xlink:to="loc_us-gaap_AssetsCurrent_281c0838-ac37-4aef-96c3-6705b4384066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b2cc0a03-4c24-4305-bfde-723eb7fab17e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3d6cdbad-e9d7-4873-b860-7f48182fa061" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b2cc0a03-4c24-4305-bfde-723eb7fab17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b1b10d79-4a69-4df4-96b3-70456d68b72b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3d6cdbad-e9d7-4873-b860-7f48182fa061" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b1b10d79-4a69-4df4-96b3-70456d68b72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_142b99d9-e76b-420f-9060-1e0a8ba35b34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3d6cdbad-e9d7-4873-b860-7f48182fa061" xlink:to="loc_us-gaap_Goodwill_142b99d9-e76b-420f-9060-1e0a8ba35b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3951c162-e4dc-452c-8101-0d474ec5225a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3d6cdbad-e9d7-4873-b860-7f48182fa061" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3951c162-e4dc-452c-8101-0d474ec5225a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f54895c6-e5a7-40ab-9367-0477e87bca7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3d6cdbad-e9d7-4873-b860-7f48182fa061" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f54895c6-e5a7-40ab-9367-0477e87bca7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3d7238a0-4927-4ef5-b78a-1ebc48310143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3d6cdbad-e9d7-4873-b860-7f48182fa061" xlink:to="loc_us-gaap_Assets_3d7238a0-4927-4ef5-b78a-1ebc48310143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8903cf7e-0f7e-4d6b-b5df-97510ce1889f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c9accda4-3672-4729-a656-cb67d152c3f4" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8903cf7e-0f7e-4d6b-b5df-97510ce1889f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_57eeb7c7-f13d-464f-adff-929d32c9d029" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8903cf7e-0f7e-4d6b-b5df-97510ce1889f" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_57eeb7c7-f13d-464f-adff-929d32c9d029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f9d3b91b-f56a-4a45-b8ee-16f68990dccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_57eeb7c7-f13d-464f-adff-929d32c9d029" xlink:to="loc_us-gaap_AccountsPayableCurrent_f9d3b91b-f56a-4a45-b8ee-16f68990dccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_2068dcd5-628a-44cf-99cb-157fc3fcd813" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_57eeb7c7-f13d-464f-adff-929d32c9d029" xlink:to="loc_us-gaap_ShortTermBorrowings_2068dcd5-628a-44cf-99cb-157fc3fcd813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9f2f4950-5a20-4876-9bb0-90e366a193fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_57eeb7c7-f13d-464f-adff-929d32c9d029" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9f2f4950-5a20-4876-9bb0-90e366a193fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ef5a3f35-9981-46be-9ff4-4c257697e7fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_57eeb7c7-f13d-464f-adff-929d32c9d029" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ef5a3f35-9981-46be-9ff4-4c257697e7fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_e12d0362-4676-43ce-b495-ae46a74ebb46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_57eeb7c7-f13d-464f-adff-929d32c9d029" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_e12d0362-4676-43ce-b495-ae46a74ebb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_04e7edbd-bb36-4cb2-8bd8-fecde9161a2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_57eeb7c7-f13d-464f-adff-929d32c9d029" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_04e7edbd-bb36-4cb2-8bd8-fecde9161a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e13ce100-70bc-4374-835b-4ddbcaddf1c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_57eeb7c7-f13d-464f-adff-929d32c9d029" xlink:to="loc_us-gaap_LiabilitiesCurrent_e13ce100-70bc-4374-835b-4ddbcaddf1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_d2b3d42a-a60f-4dae-89cf-4426ff616ff2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8903cf7e-0f7e-4d6b-b5df-97510ce1889f" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_d2b3d42a-a60f-4dae-89cf-4426ff616ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_38f6d8f4-046f-4b5a-b5ca-f193be75a655" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8903cf7e-0f7e-4d6b-b5df-97510ce1889f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_38f6d8f4-046f-4b5a-b5ca-f193be75a655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_510e26f3-396d-4095-ac9c-a1494e03a346" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8903cf7e-0f7e-4d6b-b5df-97510ce1889f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_510e26f3-396d-4095-ac9c-a1494e03a346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_0da35ecf-21de-4140-8baf-208a75b8b28b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8903cf7e-0f7e-4d6b-b5df-97510ce1889f" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_0da35ecf-21de-4140-8baf-208a75b8b28b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_80ef5f95-7a87-4c54-a8a7-a01d926b8c87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8903cf7e-0f7e-4d6b-b5df-97510ce1889f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_80ef5f95-7a87-4c54-a8a7-a01d926b8c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_ee9abf60-1f0c-4539-83e7-3792bf1e42b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8903cf7e-0f7e-4d6b-b5df-97510ce1889f" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_ee9abf60-1f0c-4539-83e7-3792bf1e42b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_d66fccec-3433-405c-bdbc-1ab58a982658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8903cf7e-0f7e-4d6b-b5df-97510ce1889f" xlink:to="loc_us-gaap_StockholdersEquityAbstract_d66fccec-3433-405c-bdbc-1ab58a982658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_2e2d7302-311c-4cd2-9316-400e6eba6e33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d66fccec-3433-405c-bdbc-1ab58a982658" xlink:to="loc_us-gaap_PreferredStockValue_2e2d7302-311c-4cd2-9316-400e6eba6e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a498a924-fbb4-4bcc-a2c0-5469d3ddfb56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d66fccec-3433-405c-bdbc-1ab58a982658" xlink:to="loc_us-gaap_CommonStockValue_a498a924-fbb4-4bcc-a2c0-5469d3ddfb56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_a5ae7081-124d-4b2e-b295-5d6534ac83e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d66fccec-3433-405c-bdbc-1ab58a982658" xlink:to="loc_us-gaap_AdditionalPaidInCapital_a5ae7081-124d-4b2e-b295-5d6534ac83e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ee6ad04e-ddbc-44b8-85f7-12de93baf267" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d66fccec-3433-405c-bdbc-1ab58a982658" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ee6ad04e-ddbc-44b8-85f7-12de93baf267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e3ae9a99-106a-4bf7-9e39-ccc126de11e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d66fccec-3433-405c-bdbc-1ab58a982658" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e3ae9a99-106a-4bf7-9e39-ccc126de11e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_2edd5fa5-d3e2-4f3e-88a7-6d38866c10f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d66fccec-3433-405c-bdbc-1ab58a982658" xlink:to="loc_us-gaap_TreasuryStockValue_2edd5fa5-d3e2-4f3e-88a7-6d38866c10f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_751064a5-698a-4805-a3bc-fd800a2a3474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d66fccec-3433-405c-bdbc-1ab58a982658" xlink:to="loc_us-gaap_StockholdersEquity_751064a5-698a-4805-a3bc-fd800a2a3474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_5539c9ba-4518-426d-af23-808e72bd84a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d66fccec-3433-405c-bdbc-1ab58a982658" xlink:to="loc_us-gaap_MinorityInterest_5539c9ba-4518-426d-af23-808e72bd84a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f6348b96-2589-4084-b496-85fc012ff41b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d66fccec-3433-405c-bdbc-1ab58a982658" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f6348b96-2589-4084-b496-85fc012ff41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d3eb01f0-2b4b-4348-9d03-ccb013ec7281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8903cf7e-0f7e-4d6b-b5df-97510ce1889f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_d3eb01f0-2b4b-4348-9d03-ccb013ec7281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_04fafee0-d0ec-48e2-aa29-af3fc62c5823" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_22180bda-e250-4c08-b4bf-a19d12c41494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_04fafee0-d0ec-48e2-aa29-af3fc62c5823" xlink:to="loc_us-gaap_StockholdersEquityAbstract_22180bda-e250-4c08-b4bf-a19d12c41494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_c0fa29ba-e98d-4e0e-87de-a9d90753eb70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22180bda-e250-4c08-b4bf-a19d12c41494" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_c0fa29ba-e98d-4e0e-87de-a9d90753eb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_f8a41f20-864b-46e3-ae27-db9891521aa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22180bda-e250-4c08-b4bf-a19d12c41494" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_f8a41f20-864b-46e3-ae27-db9891521aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_4cdb2aa9-716e-41f6-8a53-e2ce4d8b051a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22180bda-e250-4c08-b4bf-a19d12c41494" xlink:to="loc_us-gaap_PreferredStockSharesIssued_4cdb2aa9-716e-41f6-8a53-e2ce4d8b051a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_47ce8ec6-4cf9-4ef4-a32e-2c6fa1866a56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22180bda-e250-4c08-b4bf-a19d12c41494" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_47ce8ec6-4cf9-4ef4-a32e-2c6fa1866a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_5a476a1f-a50b-455d-aab6-a84f6d2853f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22180bda-e250-4c08-b4bf-a19d12c41494" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_5a476a1f-a50b-455d-aab6-a84f6d2853f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_93f5c063-12f3-4e07-9046-41e0b3fac09c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22180bda-e250-4c08-b4bf-a19d12c41494" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_93f5c063-12f3-4e07-9046-41e0b3fac09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d5763e21-6d15-4128-bb8f-a3191cfe719a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22180bda-e250-4c08-b4bf-a19d12c41494" xlink:to="loc_us-gaap_CommonStockSharesIssued_d5763e21-6d15-4128-bb8f-a3191cfe719a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_6c2f061c-de97-4b85-9a65-77f3a7f7a430" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22180bda-e250-4c08-b4bf-a19d12c41494" xlink:to="loc_us-gaap_TreasuryStockShares_6c2f061c-de97-4b85-9a65-77f3a7f7a430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0d9defb5-412b-4588-ab05-1d2bf9adac84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ec81b323-2344-4609-9f1a-01effe726848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0d9defb5-412b-4588-ab05-1d2bf9adac84" xlink:to="loc_us-gaap_StatementTable_ec81b323-2344-4609-9f1a-01effe726848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_fdcfa0d9-27e2-4653-8d31-8e0b48bdbdfa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ec81b323-2344-4609-9f1a-01effe726848" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_fdcfa0d9-27e2-4653-8d31-8e0b48bdbdfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_62fa4775-ae7e-4dfa-a7e2-11eefd4a19bb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_fdcfa0d9-27e2-4653-8d31-8e0b48bdbdfa" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_62fa4775-ae7e-4dfa-a7e2-11eefd4a19bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_080ef9bb-c683-498e-a063-76d27d28be85" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_62fa4775-ae7e-4dfa-a7e2-11eefd4a19bb" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_080ef9bb-c683-498e-a063-76d27d28be85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_93552a1e-b476-41e3-89a1-5880b067c077" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_62fa4775-ae7e-4dfa-a7e2-11eefd4a19bb" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_93552a1e-b476-41e3-89a1-5880b067c077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_edd6ad5e-e3fe-4f4e-9ab2-a4e9f7c351f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ec81b323-2344-4609-9f1a-01effe726848" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_edd6ad5e-e3fe-4f4e-9ab2-a4e9f7c351f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9f33b40f-21c7-4aa8-b063-3db38fab2197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_edd6ad5e-e3fe-4f4e-9ab2-a4e9f7c351f8" xlink:to="loc_us-gaap_EquityComponentDomain_9f33b40f-21c7-4aa8-b063-3db38fab2197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_fbfa9431-81b3-452f-8c63-1dd14cad6dc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9f33b40f-21c7-4aa8-b063-3db38fab2197" xlink:to="loc_us-gaap_CommonStockMember_fbfa9431-81b3-452f-8c63-1dd14cad6dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d03dc686-d673-47d5-99be-f09cbe317724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9f33b40f-21c7-4aa8-b063-3db38fab2197" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d03dc686-d673-47d5-99be-f09cbe317724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAdditionalCapitalMember_65eda4bd-a9c6-4757-84fb-c0fc38f1413b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAdditionalCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9f33b40f-21c7-4aa8-b063-3db38fab2197" xlink:to="loc_us-gaap_OtherAdditionalCapitalMember_65eda4bd-a9c6-4757-84fb-c0fc38f1413b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8fa2c04e-6700-44be-9086-13b57bd49770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9f33b40f-21c7-4aa8-b063-3db38fab2197" xlink:to="loc_us-gaap_RetainedEarningsMember_8fa2c04e-6700-44be-9086-13b57bd49770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1a4c7ff0-712a-4a3c-bbfd-48a9cbdf19b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9f33b40f-21c7-4aa8-b063-3db38fab2197" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1a4c7ff0-712a-4a3c-bbfd-48a9cbdf19b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_a51aa4ba-c25b-4f7f-a3ea-9e8772161e95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9f33b40f-21c7-4aa8-b063-3db38fab2197" xlink:to="loc_us-gaap_TreasuryStockMember_a51aa4ba-c25b-4f7f-a3ea-9e8772161e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_cec7fc1d-98b4-4976-843b-9e64aadf1b91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9f33b40f-21c7-4aa8-b063-3db38fab2197" xlink:to="loc_us-gaap_NoncontrollingInterestMember_cec7fc1d-98b4-4976-843b-9e64aadf1b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ecb969b4-c415-4ddb-a49c-acace24f8c72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ec81b323-2344-4609-9f1a-01effe726848" xlink:to="loc_us-gaap_StatementLineItems_ecb969b4-c415-4ddb-a49c-acace24f8c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ecb969b4-c415-4ddb-a49c-acace24f8c72" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_4d03d386-46f6-49f0-9b01-0767cbd26726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_SharesOutstanding_4d03d386-46f6-49f0-9b01-0767cbd26726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_93f79231-eaaf-4fe4-8721-04d2bd585c34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_TreasuryStockShares_93f79231-eaaf-4fe4-8721-04d2bd585c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4d749cbb-e684-40e3-80aa-5af5f24581cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4d749cbb-e684-40e3-80aa-5af5f24581cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_5f744614-0e37-49cb-a9dc-4a2c2639d67c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_5f744614-0e37-49cb-a9dc-4a2c2639d67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_ee8c0df5-e764-4599-afd4-1b4d6c95f908" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_ee8c0df5-e764-4599-afd4-1b4d6c95f908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d6f6fc9b-8872-48c2-bcb0-d0ae151d5701" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d6f6fc9b-8872-48c2-bcb0-d0ae151d5701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e315bc1c-7fa9-4303-b39f-c3a9f48bfb37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e315bc1c-7fa9-4303-b39f-c3a9f48bfb37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b616898f-395a-46cf-a73f-5b944627bf26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b616898f-395a-46cf-a73f-5b944627bf26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_4e33fe26-cb51-4ce1-8253-78caece371a6" xlink:href="mck-20201231.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_4e33fe26-cb51-4ce1-8253-78caece371a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_15d4fd07-a8e9-44e9-9d14-35b2e981a671" xlink:href="mck-20201231.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_15d4fd07-a8e9-44e9-9d14-35b2e981a671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_79de7f50-f723-46c3-babd-852580a3d556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_79de7f50-f723-46c3-babd-852580a3d556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_33b4b78f-8e34-4f38-abb6-f134a0fe9de6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_33b4b78f-8e34-4f38-abb6-f134a0fe9de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_7075854a-2085-4e37-bd87-c96ad4d61aba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_DividendsCommonStockCash_7075854a-2085-4e37-bd87-c96ad4d61aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_b38828ee-ad37-44d8-842c-9d3dd9a81be4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_StockholdersEquityOther_b38828ee-ad37-44d8-842c-9d3dd9a81be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_48fb2f66-cb11-44c2-b226-2cc18594ba65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_SharesOutstanding_48fb2f66-cb11-44c2-b226-2cc18594ba65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_fbde4489-368e-4316-b3eb-bec5be67e725" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_TreasuryStockShares_fbde4489-368e-4316-b3eb-bec5be67e725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e9c356ce-7b57-4bea-a88a-9617801a6ed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_40841636-f1e0-440b-bfce-572a5e004e5d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e9c356ce-7b57-4bea-a88a-9617801a6ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_5b1501ac-2ba4-4d8f-ae81-6c249c301e0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ecb969b4-c415-4ddb-a49c-acace24f8c72" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_5b1501ac-2ba4-4d8f-ae81-6c249c301e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_450b7216-5b7f-4ba2-b0b5-df30e02ecf61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_e7bc4f81-374b-4f0a-8554-32407262e1f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_450b7216-5b7f-4ba2-b0b5-df30e02ecf61" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_e7bc4f81-374b-4f0a-8554-32407262e1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20201231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_966aac36-c5e7-4fad-b03b-3ec47ee3af13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2e9b17e3-df99-416e-996e-514e1106de2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_966aac36-c5e7-4fad-b03b-3ec47ee3af13" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2e9b17e3-df99-416e-996e-514e1106de2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8e71a2e5-c8b0-4960-be13-b81a77da250f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2e9b17e3-df99-416e-996e-514e1106de2d" xlink:to="loc_us-gaap_ProfitLoss_8e71a2e5-c8b0-4960-be13-b81a77da250f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2d4994e7-4409-42fa-94ab-e2e8bb87cb72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2e9b17e3-df99-416e-996e-514e1106de2d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2d4994e7-4409-42fa-94ab-e2e8bb87cb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_e999fafd-7cbd-448f-9595-b84961f8788e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2d4994e7-4409-42fa-94ab-e2e8bb87cb72" xlink:to="loc_us-gaap_Depreciation_e999fafd-7cbd-448f-9595-b84961f8788e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_b1a7a21f-63fa-4db5-8cd3-7445136ef10d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2d4994e7-4409-42fa-94ab-e2e8bb87cb72" xlink:to="loc_us-gaap_AdjustmentForAmortization_b1a7a21f-63fa-4db5-8cd3-7445136ef10d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_03646399-23af-4388-8944-3f2f4e25fba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2d4994e7-4409-42fa-94ab-e2e8bb87cb72" xlink:to="loc_us-gaap_AssetImpairmentCharges_03646399-23af-4388-8944-3f2f4e25fba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_169360ed-93d6-4dfd-babb-0319a9413a29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2d4994e7-4409-42fa-94ab-e2e8bb87cb72" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_169360ed-93d6-4dfd-babb-0319a9413a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_cbe1fc5d-8223-4f18-a8ef-d2ccafd2e670" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2d4994e7-4409-42fa-94ab-e2e8bb87cb72" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_cbe1fc5d-8223-4f18-a8ef-d2ccafd2e670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_45c7b387-df40-451a-ac2b-def9b03e4e70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2d4994e7-4409-42fa-94ab-e2e8bb87cb72" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_45c7b387-df40-451a-ac2b-def9b03e4e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_95e57f8a-e287-4301-88b7-946ada924088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2d4994e7-4409-42fa-94ab-e2e8bb87cb72" xlink:to="loc_us-gaap_OperatingLeaseExpense_95e57f8a-e287-4301-88b7-946ada924088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_ab51a015-fd99-4758-b89c-79f8516bc608" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2d4994e7-4409-42fa-94ab-e2e8bb87cb72" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_ab51a015-fd99-4758-b89c-79f8516bc608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_90c15884-a967-4671-b055-7e3c39023408" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2d4994e7-4409-42fa-94ab-e2e8bb87cb72" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_90c15884-a967-4671-b055-7e3c39023408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_ef586960-9c40-4431-83bb-8ca2775d61bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2d4994e7-4409-42fa-94ab-e2e8bb87cb72" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_ef586960-9c40-4431-83bb-8ca2775d61bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_dfb09b25-17a8-4d96-9222-eef938a109f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_ef586960-9c40-4431-83bb-8ca2775d61bf" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_dfb09b25-17a8-4d96-9222-eef938a109f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_027dd942-2297-44a9-be44-42fb80b4a10a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_ef586960-9c40-4431-83bb-8ca2775d61bf" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_027dd942-2297-44a9-be44-42fb80b4a10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_4634d41c-17d2-4b2d-b6d1-26842e0b8af5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_ef586960-9c40-4431-83bb-8ca2775d61bf" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_4634d41c-17d2-4b2d-b6d1-26842e0b8af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseinOperatingLeaseLiabilities_3f1dbbf3-e26c-4932-8c67-975eeb086c39" xlink:href="mck-20201231.xsd#mck_IncreaseDecreaseinOperatingLeaseLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_ef586960-9c40-4431-83bb-8ca2775d61bf" xlink:to="loc_mck_IncreaseDecreaseinOperatingLeaseLiabilities_3f1dbbf3-e26c-4932-8c67-975eeb086c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_b48dacf1-2cf4-473c-a438-11114989efd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_ef586960-9c40-4431-83bb-8ca2775d61bf" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_b48dacf1-2cf4-473c-a438-11114989efd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve_29cc0f71-641f-4304-8703-da144e8f24ef" xlink:href="mck-20201231.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_ef586960-9c40-4431-83bb-8ca2775d61bf" xlink:to="loc_mck_IncreaseDecreaseInLitigationReserve_29cc0f71-641f-4304-8703-da144e8f24ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_f1b8cf96-05d0-4106-ad1c-56a11d569b5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_ef586960-9c40-4431-83bb-8ca2775d61bf" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_f1b8cf96-05d0-4106-ad1c-56a11d569b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2719b9af-3991-4d6e-9502-4269dcf6bf00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2e9b17e3-df99-416e-996e-514e1106de2d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2719b9af-3991-4d6e-9502-4269dcf6bf00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_aaeb3b34-d858-4d79-813c-4fd231ab7add" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_966aac36-c5e7-4fad-b03b-3ec47ee3af13" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_aaeb3b34-d858-4d79-813c-4fd231ab7add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c5148d29-60b6-481b-8df6-d329876153f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_aaeb3b34-d858-4d79-813c-4fd231ab7add" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c5148d29-60b6-481b-8df6-d329876153f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_d31f25bd-c981-423b-889b-acb4975ae544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_aaeb3b34-d858-4d79-813c-4fd231ab7add" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_d31f25bd-c981-423b-889b-acb4975ae544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0aabb057-bab7-4d08-8f84-b85ddc822b8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_aaeb3b34-d858-4d79-813c-4fd231ab7add" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0aabb057-bab7-4d08-8f84-b85ddc822b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_9a56ef10-bd5d-441f-b4f0-47f4a74d6a5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_aaeb3b34-d858-4d79-813c-4fd231ab7add" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_9a56ef10-bd5d-441f-b4f0-47f4a74d6a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_64f18bac-5412-417b-8c7f-8e9be9a89a64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_aaeb3b34-d858-4d79-813c-4fd231ab7add" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_64f18bac-5412-417b-8c7f-8e9be9a89a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b0a4c645-d395-48e3-8bf5-9753b8a34fe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_aaeb3b34-d858-4d79-813c-4fd231ab7add" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b0a4c645-d395-48e3-8bf5-9753b8a34fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ceedb9c4-21cd-47ca-a0c0-1b6e1b3bd494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_966aac36-c5e7-4fad-b03b-3ec47ee3af13" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ceedb9c4-21cd-47ca-a0c0-1b6e1b3bd494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_b3c2fe00-74ad-461c-ac02-0c323834d2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ceedb9c4-21cd-47ca-a0c0-1b6e1b3bd494" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_b3c2fe00-74ad-461c-ac02-0c323834d2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_b84076bf-dbaf-4382-b410-79ec8dc8dd8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ceedb9c4-21cd-47ca-a0c0-1b6e1b3bd494" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_b84076bf-dbaf-4382-b410-79ec8dc8dd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_d98fb0d7-36e1-4c4a-a825-ad588b309678" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ceedb9c4-21cd-47ca-a0c0-1b6e1b3bd494" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_d98fb0d7-36e1-4c4a-a825-ad588b309678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_25b11d2b-4c6e-44a6-b9f4-5b01708df5e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ceedb9c4-21cd-47ca-a0c0-1b6e1b3bd494" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_25b11d2b-4c6e-44a6-b9f4-5b01708df5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_17ced76b-b721-4430-9356-d59ac786843d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ceedb9c4-21cd-47ca-a0c0-1b6e1b3bd494" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_17ced76b-b721-4430-9356-d59ac786843d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_b7b4fa1e-d858-4e76-9a9f-33a895bc352b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_17ced76b-b721-4430-9356-d59ac786843d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_b7b4fa1e-d858-4e76-9a9f-33a895bc352b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4ca0274d-247a-4ea6-b3fb-722f584687ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_17ced76b-b721-4430-9356-d59ac786843d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4ca0274d-247a-4ea6-b3fb-722f584687ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_134eb721-5df8-4914-a176-21cf72ae5428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ceedb9c4-21cd-47ca-a0c0-1b6e1b3bd494" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_134eb721-5df8-4914-a176-21cf72ae5428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7edf03c9-5086-45fc-b5a3-75a6d0e76edf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ceedb9c4-21cd-47ca-a0c0-1b6e1b3bd494" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7edf03c9-5086-45fc-b5a3-75a6d0e76edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8f90a65f-61ee-42af-bf6c-de4136089e39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ceedb9c4-21cd-47ca-a0c0-1b6e1b3bd494" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8f90a65f-61ee-42af-bf6c-de4136089e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ab51b269-5486-4875-a019-3c5977374786" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_966aac36-c5e7-4fad-b03b-3ec47ee3af13" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ab51b269-5486-4875-a019-3c5977374786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8c5c4a5a-7f40-486e-af2e-ee24eb456827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_966aac36-c5e7-4fad-b03b-3ec47ee3af13" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8c5c4a5a-7f40-486e-af2e-ee24eb456827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d59aa015-76b5-463b-85b9-38a866f3bcaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_966aac36-c5e7-4fad-b03b-3ec47ee3af13" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d59aa015-76b5-463b-85b9-38a866f3bcaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f6ce8d2e-6e47-4c5b-b51a-d497fb9dd7ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_966aac36-c5e7-4fad-b03b-3ec47ee3af13" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f6ce8d2e-6e47-4c5b-b51a-d497fb9dd7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_7179599e-67dc-4e85-bf2c-488d63dae22a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_966aac36-c5e7-4fad-b03b-3ec47ee3af13" xlink:to="loc_us-gaap_RestrictedCashCurrent_7179599e-67dc-4e85-bf2c-488d63dae22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_759011f5-3486-4841-a436-429ca88af21a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_966aac36-c5e7-4fad-b03b-3ec47ee3af13" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_759011f5-3486-4841-a436-429ca88af21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="mck-20201231.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0ccf41b4-f253-4c10-a218-c971c1d39cc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_71863b35-2572-40e1-b158-1c15bc1e72f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0ccf41b4-f253-4c10-a218-c971c1d39cc1" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_71863b35-2572-40e1-b158-1c15bc1e72f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mck-20201231.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2fd6d75e-728e-4011-8cf8-1e79da809981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_68e54de3-4961-4b8f-9fc5-e0fae9ab9dfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2fd6d75e-728e-4011-8cf8-1e79da809981" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_68e54de3-4961-4b8f-9fc5-e0fae9ab9dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_bf9acd02-b75b-4911-a08a-41ddc57fcd57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2fd6d75e-728e-4011-8cf8-1e79da809981" xlink:to="loc_us-gaap_UseOfEstimates_bf9acd02-b75b-4911-a08a-41ddc57fcd57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod_6ac49c94-6d41-4d61-80e9-d8f9ac3062c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiscalPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2fd6d75e-728e-4011-8cf8-1e79da809981" xlink:to="loc_us-gaap_FiscalPeriod_6ac49c94-6d41-4d61-80e9-d8f9ac3062c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_3d615e9a-b2a6-41de-944b-e554d133b00d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2fd6d75e-728e-4011-8cf8-1e79da809981" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_3d615e9a-b2a6-41de-944b-e554d133b00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_40a70b50-bd85-4b8b-b9da-df3239eb12cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2fd6d75e-728e-4011-8cf8-1e79da809981" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_40a70b50-bd85-4b8b-b9da-df3239eb12cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_8b097be9-45cb-408b-8151-668e468d8b1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2fd6d75e-728e-4011-8cf8-1e79da809981" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_8b097be9-45cb-408b-8151-668e468d8b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a9296bb4-5d7f-45ae-8423-a3e17c94dbdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1763b0c4-e75c-4449-b853-15eb70fd8bf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a9296bb4-5d7f-45ae-8423-a3e17c94dbdb" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1763b0c4-e75c-4449-b853-15eb70fd8bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c72dde3d-ed84-433f-9b2f-043eb179f980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1763b0c4-e75c-4449-b853-15eb70fd8bf0" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c72dde3d-ed84-433f-9b2f-043eb179f980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_9fc781a6-4339-4508-8be5-8fd47d9b20eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c72dde3d-ed84-433f-9b2f-043eb179f980" xlink:to="loc_us-gaap_TypeOfAdoptionMember_9fc781a6-4339-4508-8be5-8fd47d9b20eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_eb68b927-c4eb-47b8-bf23-9eed39c61c91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_9fc781a6-4339-4508-8be5-8fd47d9b20eb" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_eb68b927-c4eb-47b8-bf23-9eed39c61c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3a4d2e17-de4a-48b3-b5ee-6fb7be16722a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1763b0c4-e75c-4449-b853-15eb70fd8bf0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3a4d2e17-de4a-48b3-b5ee-6fb7be16722a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_764517e8-2b23-4a62-9f9f-a800e71bae9e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3a4d2e17-de4a-48b3-b5ee-6fb7be16722a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_764517e8-2b23-4a62-9f9f-a800e71bae9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a7041b5f-9290-4ae0-940b-09681094abed" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_764517e8-2b23-4a62-9f9f-a800e71bae9e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a7041b5f-9290-4ae0-940b-09681094abed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_115cdbd7-64e2-414c-909e-0f749b6e01f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1763b0c4-e75c-4449-b853-15eb70fd8bf0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_115cdbd7-64e2-414c-909e-0f749b6e01f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5266d70e-c2b1-44d1-ad61-325fa0a8fbef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_115cdbd7-64e2-414c-909e-0f749b6e01f3" xlink:to="loc_us-gaap_EquityComponentDomain_5266d70e-c2b1-44d1-ad61-325fa0a8fbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_07c502f7-cdc1-4027-9d59-2e90325ee272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5266d70e-c2b1-44d1-ad61-325fa0a8fbef" xlink:to="loc_us-gaap_RetainedEarningsMember_07c502f7-cdc1-4027-9d59-2e90325ee272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_60652fa4-b5b2-4ca0-98c4-f9067a0e5363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1763b0c4-e75c-4449-b853-15eb70fd8bf0" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_60652fa4-b5b2-4ca0-98c4-f9067a0e5363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_339107ea-3199-4444-ba3d-79527d52463a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_60652fa4-b5b2-4ca0-98c4-f9067a0e5363" xlink:to="loc_us-gaap_NumberOfReportableSegments_339107ea-3199-4444-ba3d-79527d52463a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_98ab90d0-ea1f-40b2-9169-a51c57c82cc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_60652fa4-b5b2-4ca0-98c4-f9067a0e5363" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_98ab90d0-ea1f-40b2-9169-a51c57c82cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_cbcc7299-9340-43cd-9d7d-90e482642334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_60652fa4-b5b2-4ca0-98c4-f9067a0e5363" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_cbcc7299-9340-43cd-9d7d-90e482642334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture" xlink:type="simple" xlink:href="mck-20201231.xsd#InvestmentinChangeHealthcareJointVenture"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_2c569169-261e-47b9-b1a4-ebe9aae4acd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_1df500a3-2a10-4d0a-a91a-3d9e5bb9ba56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_2c569169-261e-47b9-b1a4-ebe9aae4acd4" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_1df500a3-2a10-4d0a-a91a-3d9e5bb9ba56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#InvestmentinChangeHealthcareJointVentureDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_c189304d-a256-4027-a5e2-2fb2a38c74a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_c189304d-a256-4027-a5e2-2fb2a38c74a2" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5fb3ac02-42dc-409b-9fe4-4a68ec9212b7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5fb3ac02-42dc-409b-9fe4-4a68ec9212b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1b20875b-522c-47b2-b012-f6962fe8a87f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5fb3ac02-42dc-409b-9fe4-4a68ec9212b7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1b20875b-522c-47b2-b012-f6962fe8a87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ad3ab4f1-dd2c-47d0-ab68-a62e2f1aa092" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1b20875b-522c-47b2-b012-f6962fe8a87f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ad3ab4f1-dd2c-47d0-ab68-a62e2f1aa092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1720b82b-19d5-4fce-88c6-d473e093ce47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1720b82b-19d5-4fce-88c6-d473e093ce47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_e0b1b519-900f-4f28-aebe-383bf59f1e43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1720b82b-19d5-4fce-88c6-d473e093ce47" xlink:to="loc_us-gaap_TypeOfAdoptionMember_e0b1b519-900f-4f28-aebe-383bf59f1e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_1013052d-9e82-4193-9529-5189086ea76a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_e0b1b519-900f-4f28-aebe-383bf59f1e43" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_1013052d-9e82-4193-9529-5189086ea76a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f553d713-4754-4ada-a4c8-e79a45310ab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f553d713-4754-4ada-a4c8-e79a45310ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b03ea7e8-d166-45ca-abef-df4d45f57015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f553d713-4754-4ada-a4c8-e79a45310ab9" xlink:to="loc_us-gaap_EquityComponentDomain_b03ea7e8-d166-45ca-abef-df4d45f57015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d887ba0b-bebe-4674-bee1-dadca6c5cbec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b03ea7e8-d166-45ca-abef-df4d45f57015" xlink:to="loc_us-gaap_RetainedEarningsMember_d887ba0b-bebe-4674-bee1-dadca6c5cbec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a0c01716-8e96-4f1d-b36e-84b5cd48512e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a0c01716-8e96-4f1d-b36e-84b5cd48512e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_2a790b0f-6e00-428c-9d6f-21f3d6f8adc6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a0c01716-8e96-4f1d-b36e-84b5cd48512e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_2a790b0f-6e00-428c-9d6f-21f3d6f8adc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_a95dc9c2-841e-4a35-b94d-c4ff07637324" xlink:href="mck-20201231.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2a790b0f-6e00-428c-9d6f-21f3d6f8adc6" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_a95dc9c2-841e-4a35-b94d-c4ff07637324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ca124dc5-db63-42a8-888c-dcdef7bea729" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ca124dc5-db63-42a8-888c-dcdef7bea729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_42dfded6-ccac-4bfd-9dbb-26d7c5283b63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ca124dc5-db63-42a8-888c-dcdef7bea729" xlink:to="loc_us-gaap_RelatedPartyDomain_42dfded6-ccac-4bfd-9dbb-26d7c5283b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_d605c579-3bef-4c6f-8780-9e955d893343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_42dfded6-ccac-4bfd-9dbb-26d7c5283b63" xlink:to="loc_us-gaap_CorporateJointVentureMember_d605c579-3bef-4c6f-8780-9e955d893343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_eb402522-23d4-468d-8755-3a1a640fd6b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_eb402522-23d4-468d-8755-3a1a640fd6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_4369aa06-69ec-4135-bf44-e00d99fd120a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_eb402522-23d4-468d-8755-3a1a640fd6b3" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_4369aa06-69ec-4135-bf44-e00d99fd120a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TransitionServicesAgreementsTSAMember_ca080a30-6eea-4837-ad7b-037309b8f5d9" xlink:href="mck-20201231.xsd#mck_TransitionServicesAgreementsTSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4369aa06-69ec-4135-bf44-e00d99fd120a" xlink:to="loc_mck_TransitionServicesAgreementsTSAMember_ca080a30-6eea-4837-ad7b-037309b8f5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember_cb011bdf-7537-48d0-bbe6-91cefa85939c" xlink:href="mck-20201231.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4369aa06-69ec-4135-bf44-e00d99fd120a" xlink:to="loc_mck_TaxReceivableAgreementTRAMember_cb011bdf-7537-48d0-bbe6-91cefa85939c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f201a9d1-cd7d-4b54-a346-7cb92bbf4a80" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:to="loc_dei_LegalEntityAxis_f201a9d1-cd7d-4b54-a346-7cb92bbf4a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_65be2222-83da-4092-91f4-f8b0fd9919db" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_f201a9d1-cd7d-4b54-a346-7cb92bbf4a80" xlink:to="loc_dei_EntityDomain_65be2222-83da-4092-91f4-f8b0fd9919db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareInc.Member_bc11c624-2bd5-496e-8a8b-ef4d9205cd9c" xlink:href="mck-20201231.xsd#mck_ChangeHealthcareInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_65be2222-83da-4092-91f4-f8b0fd9919db" xlink:to="loc_mck_ChangeHealthcareInc.Member_bc11c624-2bd5-496e-8a8b-ef4d9205cd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_e4b5c7d6-6994-4fe9-b2f5-57d6e4ecaba2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_e4b5c7d6-6994-4fe9-b2f5-57d6e4ecaba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6ac39634-17c3-41d4-aa38-d819f208d021" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e4b5c7d6-6994-4fe9-b2f5-57d6e4ecaba2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6ac39634-17c3-41d4-aa38-d819f208d021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_747fc323-0340-4f68-85e3-709ccbac8b32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6ac39634-17c3-41d4-aa38-d819f208d021" xlink:to="loc_us-gaap_IPOMember_747fc323-0340-4f68-85e3-709ccbac8b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e96d0602-2962-4d13-a39f-b58c6aaed08d" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90b862da-c485-4168-a320-453d3ffca20a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90b862da-c485-4168-a320-453d3ffca20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_5b9f3e71-76d3-4b54-9a5d-e499986aba14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_5b9f3e71-76d3-4b54-9a5d-e499986aba14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_80e665b4-bea9-40bd-b4e9-fe04abe62a5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_80e665b4-bea9-40bd-b4e9-fe04abe62a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_154df0ad-1a1a-452f-ac9b-a0850bddf052" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_154df0ad-1a1a-452f-ac9b-a0850bddf052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_62f980c7-ae7c-4dd0-9114-4e71c2078b91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_62f980c7-ae7c-4dd0-9114-4e71c2078b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_dd79e954-6d6a-409a-a5e5-cd68927c194b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_dd79e954-6d6a-409a-a5e5-cd68927c194b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_cc0cfae7-531c-486f-90ec-cce083297d0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_cc0cfae7-531c-486f-90ec-cce083297d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_82e87207-7c1f-403d-bdd8-d706bad196f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_82e87207-7c1f-403d-bdd8-d706bad196f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ProportionateGainLossOnEquityMethodInvestment_eadb4964-09ef-4a16-9ee2-c815e958e939" xlink:href="mck-20201231.xsd#mck_ProportionateGainLossOnEquityMethodInvestment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_mck_ProportionateGainLossOnEquityMethodInvestment_eadb4964-09ef-4a16-9ee2-c815e958e939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_93ac0e28-e2d0-4866-b8b7-c851b68da2c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_93ac0e28-e2d0-4866-b8b7-c851b68da2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_46d2c1fe-783e-4465-996e-981367b561a0" xlink:href="mck-20201231.xsd#mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_46d2c1fe-783e-4465-996e-981367b561a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedParties_39be0ac8-adc4-4a5f-906e-e945670a1c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedParties"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7094f478-31f9-4368-a98f-8aee77230b80" xlink:to="loc_us-gaap_DueFromRelatedParties_39be0ac8-adc4-4a5f-906e-e945670a1c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSale" xlink:type="simple" xlink:href="mck-20201231.xsd#HeldforSale"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSale" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_1e540766-8adc-4dd8-84e5-abd82f8e685a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_3238aa54-9cd4-4a2b-a49b-e52ac74f685c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_1e540766-8adc-4dd8-84e5-abd82f8e685a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_3238aa54-9cd4-4a2b-a49b-e52ac74f685c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleTables" xlink:type="simple" xlink:href="mck-20201231.xsd#HeldforSaleTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6b4a9e8e-fa26-4e66-8293-09bc065ddab1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_96f0d392-2f1e-4179-b580-d7616f3fcb56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6b4a9e8e-fa26-4e66-8293-09bc065ddab1" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_96f0d392-2f1e-4179-b580-d7616f3fcb56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#HeldforSaleNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_80a45ad5-ce05-4baf-a513-9a7f1fd2288e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd1a3861-e55c-41de-acc0-ef7922b5bd1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_80a45ad5-ce05-4baf-a513-9a7f1fd2288e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd1a3861-e55c-41de-acc0-ef7922b5bd1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_99ce494f-bfa2-4dc0-b526-859dd16c8639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd1a3861-e55c-41de-acc0-ef7922b5bd1c" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_99ce494f-bfa2-4dc0-b526-859dd16c8639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_42e9a0cd-92d1-4a8a-9367-a5a1fb424f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_99ce494f-bfa2-4dc0-b526-859dd16c8639" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_42e9a0cd-92d1-4a8a-9367-a5a1fb424f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2b20e2e1-828c-4c43-b705-6cc1ba5c3537" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_42e9a0cd-92d1-4a8a-9367-a5a1fb424f5c" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2b20e2e1-828c-4c43-b705-6cc1ba5c3537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f5d62439-90a4-4b0e-ad64-6a41729f1637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_42e9a0cd-92d1-4a8a-9367-a5a1fb424f5c" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f5d62439-90a4-4b0e-ad64-6a41729f1637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_969c391f-e24c-499f-916b-2eb8874583ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd1a3861-e55c-41de-acc0-ef7922b5bd1c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_969c391f-e24c-499f-916b-2eb8874583ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e2bce335-5e66-478d-8623-57f63df254dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_969c391f-e24c-499f-916b-2eb8874583ab" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e2bce335-5e66-478d-8623-57f63df254dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_1cfbd451-0557-44a1-b495-067d061f0c42" xlink:href="mck-20201231.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e2bce335-5e66-478d-8623-57f63df254dc" xlink:to="loc_mck_GermanWholesaleBusinessMember_1cfbd451-0557-44a1-b495-067d061f0c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_896d0deb-c791-498a-9660-d4212863af28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd1a3861-e55c-41de-acc0-ef7922b5bd1c" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_896d0deb-c791-498a-9660-d4212863af28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_55bacfc2-16c3-468f-840a-170c3600d8a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_896d0deb-c791-498a-9660-d4212863af28" xlink:to="loc_us-gaap_RelatedPartyDomain_55bacfc2-16c3-468f-840a-170c3600d8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_d6e79ec7-4541-4fd8-a393-52aadbe6e903" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_55bacfc2-16c3-468f-840a-170c3600d8a4" xlink:to="loc_us-gaap_CorporateJointVentureMember_d6e79ec7-4541-4fd8-a393-52aadbe6e903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_229fbcc6-5eb1-4270-bc41-56bdcfbf956e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd1a3861-e55c-41de-acc0-ef7922b5bd1c" xlink:to="loc_srt_OwnershipAxis_229fbcc6-5eb1-4270-bc41-56bdcfbf956e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_aba6ee52-f972-4549-8169-ba19ac833937" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_229fbcc6-5eb1-4270-bc41-56bdcfbf956e" xlink:to="loc_srt_OwnershipDomain_aba6ee52-f972-4549-8169-ba19ac833937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WalgreensBootsAllianceJointVentureMember_6f6956ac-adbb-4be8-96cb-ee938838e413" xlink:href="mck-20201231.xsd#mck_WalgreensBootsAllianceJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_aba6ee52-f972-4549-8169-ba19ac833937" xlink:to="loc_mck_WalgreensBootsAllianceJointVentureMember_6f6956ac-adbb-4be8-96cb-ee938838e413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_45904a73-5f26-4953-8c52-9c2e8d9fe14c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd1a3861-e55c-41de-acc0-ef7922b5bd1c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_45904a73-5f26-4953-8c52-9c2e8d9fe14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_56a3be9e-7170-41c2-a0c5-43b8375e389b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_45904a73-5f26-4953-8c52-9c2e8d9fe14c" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_56a3be9e-7170-41c2-a0c5-43b8375e389b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_7adc5686-ba6b-4f7d-b5cd-a7850db5684f" xlink:href="mck-20201231.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_56a3be9e-7170-41c2-a0c5-43b8375e389b" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_7adc5686-ba6b-4f7d-b5cd-a7850db5684f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fd1a3861-e55c-41de-acc0-ef7922b5bd1c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_5b110c9b-3893-4d62-a9bd-148047870c16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_5b110c9b-3893-4d62-a9bd-148047870c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_b8176c74-4e84-49b9-b382-3d1fa7d34aeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_b8176c74-4e84-49b9-b382-3d1fa7d34aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b452fac2-aff7-4afd-91db-2c64be733184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b452fac2-aff7-4afd-91db-2c64be733184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_74c274e9-c549-4a28-bd7e-908c697a39e5" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_74c274e9-c549-4a28-bd7e-908c697a39e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a60f2fa7-d11c-4982-86d3-2c24b9ace964" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a60f2fa7-d11c-4982-86d3-2c24b9ace964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_e5e20958-9e6c-4791-a92a-9e600dc9242e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_e5e20958-9e6c-4791-a92a-9e600dc9242e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossOnSaleOfBusinessNetOfTax_41f81c59-60ed-4593-9bd1-42e113e27353" xlink:href="mck-20201231.xsd#mck_GainLossOnSaleOfBusinessNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_mck_GainLossOnSaleOfBusinessNetOfTax_41f81c59-60ed-4593-9bd1-42e113e27353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_ca8488f9-9f3a-49d2-9679-41f0bef3cbd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_ca8488f9-9f3a-49d2-9679-41f0bef3cbd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax_83686c74-c6ba-4316-b6bc-6520dab9efbb" xlink:href="mck-20201231.xsd#mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax_83686c74-c6ba-4316-b6bc-6520dab9efbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_b135173c-b0e3-4332-86ee-be0eed9dc618" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_EquityMethodInvestments_b135173c-b0e3-4332-86ee-be0eed9dc618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a51c14f9-6f98-4eab-9313-517fb1aca2a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a51c14f9-6f98-4eab-9313-517fb1aca2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_3b81306f-e85c-449a-8890-47e2bd0dfcc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_3b81306f-e85c-449a-8890-47e2bd0dfcc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_76c735b6-cc84-4bae-aa3d-5eda8f2289b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c54a5f83-6734-4e35-9b6f-cbedd60537f9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_76c735b6-cc84-4bae-aa3d-5eda8f2289b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_01618127-6765-4934-9c0c-166ad3594292" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6849a781-b092-4964-9527-65ee8b4ecb61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_01618127-6765-4934-9c0c-166ad3594292" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6849a781-b092-4964-9527-65ee8b4ecb61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e3fa2e0e-53e3-4192-9a4b-73101a46d367" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6849a781-b092-4964-9527-65ee8b4ecb61" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e3fa2e0e-53e3-4192-9a4b-73101a46d367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_96decc1e-41c0-4d60-9861-3f8b278f6d79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e3fa2e0e-53e3-4192-9a4b-73101a46d367" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_96decc1e-41c0-4d60-9861-3f8b278f6d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_585d3783-d59b-4efe-83b1-2e050eae3c59" xlink:href="mck-20201231.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_96decc1e-41c0-4d60-9861-3f8b278f6d79" xlink:to="loc_mck_GermanWholesaleBusinessMember_585d3783-d59b-4efe-83b1-2e050eae3c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_53ecde43-0f8c-4d4e-bc4e-92705fa28044" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6849a781-b092-4964-9527-65ee8b4ecb61" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_53ecde43-0f8c-4d4e-bc4e-92705fa28044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_61e280c2-e52b-4f80-a53e-fba5170ea849" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_53ecde43-0f8c-4d4e-bc4e-92705fa28044" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_61e280c2-e52b-4f80-a53e-fba5170ea849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7763c1eb-5bcb-4467-8770-5027a533f124" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_61e280c2-e52b-4f80-a53e-fba5170ea849" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7763c1eb-5bcb-4467-8770-5027a533f124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5393280c-8d26-40e8-9b96-9b4716a9ec02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6849a781-b092-4964-9527-65ee8b4ecb61" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5393280c-8d26-40e8-9b96-9b4716a9ec02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_3c622d72-7488-4acb-919e-271ea3674977" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5393280c-8d26-40e8-9b96-9b4716a9ec02" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_3c622d72-7488-4acb-919e-271ea3674977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_25e9dcef-a000-4775-8171-f08cadab07ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_3c622d72-7488-4acb-919e-271ea3674977" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_25e9dcef-a000-4775-8171-f08cadab07ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_a61969fc-e4f9-4b48-968a-ac27f711e04f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_3c622d72-7488-4acb-919e-271ea3674977" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_a61969fc-e4f9-4b48-968a-ac27f711e04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_2d1ff4de-b2db-4aa6-b00b-9ab4581ae65e" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_3c622d72-7488-4acb-919e-271ea3674977" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_2d1ff4de-b2db-4aa6-b00b-9ab4581ae65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_2a79524c-1018-4dcd-ada1-cf6c80b8e893" xlink:href="mck-20201231.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_3c622d72-7488-4acb-919e-271ea3674977" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_2a79524c-1018-4dcd-ada1-cf6c80b8e893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_92f94bdb-5977-43c3-8ad6-03d5d08a8514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_3c622d72-7488-4acb-919e-271ea3674977" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_92f94bdb-5977-43c3-8ad6-03d5d08a8514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_aec6fd28-a45b-4cee-9797-27b69db10b22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5393280c-8d26-40e8-9b96-9b4716a9ec02" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_aec6fd28-a45b-4cee-9797-27b69db10b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_4d15bef0-b2f2-45ed-8727-f85f295c8b0a" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_aec6fd28-a45b-4cee-9797-27b69db10b22" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_4d15bef0-b2f2-45ed-8727-f85f295c8b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_3f8ece2b-534f-44a4-b70d-71eaf5269fd3" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_aec6fd28-a45b-4cee-9797-27b69db10b22" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_3f8ece2b-534f-44a4-b70d-71eaf5269fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_e351ba90-1a71-462f-a81d-7ddbd5ca2491" xlink:href="mck-20201231.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_aec6fd28-a45b-4cee-9797-27b69db10b22" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_e351ba90-1a71-462f-a81d-7ddbd5ca2491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_9887db56-701f-4640-b84b-4febd5bfc70f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_aec6fd28-a45b-4cee-9797-27b69db10b22" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_9887db56-701f-4640-b84b-4febd5bfc70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="simple" xlink:href="mck-20201231.xsd#RestructuringImpairmentandRelatedCharges"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_fe51e3a6-b8d0-4d9c-a8e8-c766eb4aba97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_e80e6da0-d281-4078-b10f-de90a8433c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_fe51e3a6-b8d0-4d9c-a8e8-c766eb4aba97" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_e80e6da0-d281-4078-b10f-de90a8433c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="simple" xlink:href="mck-20201231.xsd#RestructuringImpairmentandRelatedChargesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f2f413c9-e02f-45c1-b972-f41a03dde53e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_05449994-b7e7-430c-9294-d07b3e01cadb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f2f413c9-e02f-45c1-b972-f41a03dde53e" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_05449994-b7e7-430c-9294-d07b3e01cadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_f54376d9-65d3-40ee-ae44-06fd7b40d672" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f2f413c9-e02f-45c1-b972-f41a03dde53e" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_f54376d9-65d3-40ee-ae44-06fd7b40d672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#RestructuringImpairmentandRelatedChargesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ef28ba69-fcff-481a-8c85-3d3a5c0bc788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a9d8f495-cc21-4bb8-8e56-c847ac5754bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ef28ba69-fcff-481a-8c85-3d3a5c0bc788" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a9d8f495-cc21-4bb8-8e56-c847ac5754bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_e863cb0c-8531-4c5f-8875-13d033b8b942" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a9d8f495-cc21-4bb8-8e56-c847ac5754bc" xlink:to="loc_us-gaap_RestructuringPlanAxis_e863cb0c-8531-4c5f-8875-13d033b8b942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_2e9d1fc0-0a81-4f19-a0e4-2081db6d8754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_e863cb0c-8531-4c5f-8875-13d033b8b942" xlink:to="loc_us-gaap_RestructuringPlanDomain_2e9d1fc0-0a81-4f19-a0e4-2081db6d8754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_7473b5e5-ff31-4fc7-b4ef-fc51037a4c20" xlink:href="mck-20201231.xsd#mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_2e9d1fc0-0a81-4f19-a0e4-2081db6d8754" xlink:to="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_7473b5e5-ff31-4fc7-b4ef-fc51037a4c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingModelAndCostOptimizationProgramsMember_602996a4-df70-4a82-9284-43f9ce34fd28" xlink:href="mck-20201231.xsd#mck_OperatingModelAndCostOptimizationProgramsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_2e9d1fc0-0a81-4f19-a0e4-2081db6d8754" xlink:to="loc_mck_OperatingModelAndCostOptimizationProgramsMember_602996a4-df70-4a82-9284-43f9ce34fd28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanOtherMember_e6dac933-1a30-4d4b-b8fd-aa424b3513fb" xlink:href="mck-20201231.xsd#mck_StrategicGrowthInitiativePlanOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_2e9d1fc0-0a81-4f19-a0e4-2081db6d8754" xlink:to="loc_mck_StrategicGrowthInitiativePlanOtherMember_e6dac933-1a30-4d4b-b8fd-aa424b3513fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanMember_37f7df29-c199-499f-8ea6-a4dc3d4af115" xlink:href="mck-20201231.xsd#mck_StrategicGrowthInitiativePlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_2e9d1fc0-0a81-4f19-a0e4-2081db6d8754" xlink:to="loc_mck_StrategicGrowthInitiativePlanMember_37f7df29-c199-499f-8ea6-a4dc3d4af115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7c8003e3-6c9c-416d-acd8-6a8ef7d384c0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a9d8f495-cc21-4bb8-8e56-c847ac5754bc" xlink:to="loc_srt_RangeAxis_7c8003e3-6c9c-416d-acd8-6a8ef7d384c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8cb99550-c976-419a-bc75-24ca73f82bb4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7c8003e3-6c9c-416d-acd8-6a8ef7d384c0" xlink:to="loc_srt_RangeMember_8cb99550-c976-419a-bc75-24ca73f82bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e5ec6635-08f1-4696-bb3a-9d37dcadc04d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8cb99550-c976-419a-bc75-24ca73f82bb4" xlink:to="loc_srt_MinimumMember_e5ec6635-08f1-4696-bb3a-9d37dcadc04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3c2a84a6-8534-4ca0-ac86-ac6cb439e618" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8cb99550-c976-419a-bc75-24ca73f82bb4" xlink:to="loc_srt_MaximumMember_3c2a84a6-8534-4ca0-ac86-ac6cb439e618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e1d0af41-3fb4-48d9-b1d7-30ecb9558040" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a9d8f495-cc21-4bb8-8e56-c847ac5754bc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e1d0af41-3fb4-48d9-b1d7-30ecb9558040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_55e5ee2d-20d5-44e0-afa1-2b57932ceb15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e1d0af41-3fb4-48d9-b1d7-30ecb9558040" xlink:to="loc_us-gaap_SegmentDomain_55e5ee2d-20d5-44e0-afa1-2b57932ceb15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_07025e9e-2294-4c83-a32e-8cb8a2b06a25" xlink:href="mck-20201231.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_55e5ee2d-20d5-44e0-afa1-2b57932ceb15" xlink:to="loc_mck_InternationalSegmentMember_07025e9e-2294-4c83-a32e-8cb8a2b06a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_60a3ff0d-ac55-44ed-84a6-e9063511530f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a9d8f495-cc21-4bb8-8e56-c847ac5754bc" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_60a3ff0d-ac55-44ed-84a6-e9063511530f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_fda24749-59a8-48fe-842f-9cacad14a365" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_60a3ff0d-ac55-44ed-84a6-e9063511530f" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_fda24749-59a8-48fe-842f-9cacad14a365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember_ee8474f6-8ed6-414b-920c-86f667daff38" xlink:href="mck-20201231.xsd#mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_fda24749-59a8-48fe-842f-9cacad14a365" xlink:to="loc_mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember_ee8474f6-8ed6-414b-920c-86f667daff38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember_f1c74048-2a39-4334-8b90-959fb8b93055" xlink:href="mck-20201231.xsd#mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_fda24749-59a8-48fe-842f-9cacad14a365" xlink:to="loc_mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember_f1c74048-2a39-4334-8b90-959fb8b93055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_17943d12-4aef-4804-8573-8d7fd62dbe35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a9d8f495-cc21-4bb8-8e56-c847ac5754bc" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_17943d12-4aef-4804-8573-8d7fd62dbe35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_882b26c2-46ee-4d27-b50f-afe76b98dfb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_17943d12-4aef-4804-8573-8d7fd62dbe35" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_882b26c2-46ee-4d27-b50f-afe76b98dfb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_e68ab73f-79a3-424c-97ba-35d6269c8e93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_17943d12-4aef-4804-8573-8d7fd62dbe35" xlink:to="loc_us-gaap_RestructuringCharges_e68ab73f-79a3-424c-97ba-35d6269c8e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_cfd97e8e-40a6-4ad2-b643-6552873a4114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_17943d12-4aef-4804-8573-8d7fd62dbe35" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_cfd97e8e-40a6-4ad2-b643-6552873a4114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_2c6caab9-7d08-43f5-b451-e0173b4d78b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_17943d12-4aef-4804-8573-8d7fd62dbe35" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_2c6caab9-7d08-43f5-b451-e0173b4d78b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_380dfc79-fc48-4696-956c-a86ed43ee04d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_17943d12-4aef-4804-8573-8d7fd62dbe35" xlink:to="loc_us-gaap_RestructuringReserve_380dfc79-fc48-4696-956c-a86ed43ee04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_5cfb7c9d-0058-4dc8-99e7-96c82e7250e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_17943d12-4aef-4804-8573-8d7fd62dbe35" xlink:to="loc_us-gaap_AssetImpairmentCharges_5cfb7c9d-0058-4dc8-99e7-96c82e7250e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ace69716-6656-4d39-8127-8278febc1140" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6db4edd1-3266-4c0b-8682-9a7d660cde48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ace69716-6656-4d39-8127-8278febc1140" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6db4edd1-3266-4c0b-8682-9a7d660cde48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_48b805f9-dd2d-4999-b93b-5bce98b52fe8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6db4edd1-3266-4c0b-8682-9a7d660cde48" xlink:to="loc_srt_ConsolidationItemsAxis_48b805f9-dd2d-4999-b93b-5bce98b52fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_fe97329b-071e-46c5-b5e3-bb1b5530318e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_48b805f9-dd2d-4999-b93b-5bce98b52fe8" xlink:to="loc_srt_ConsolidationItemsDomain_fe97329b-071e-46c5-b5e3-bb1b5530318e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_0e30959d-49d7-4caa-a285-2bbcddc3518c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_fe97329b-071e-46c5-b5e3-bb1b5530318e" xlink:to="loc_us-gaap_OperatingSegmentsMember_0e30959d-49d7-4caa-a285-2bbcddc3518c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_175a0007-9b33-4f21-89c7-174138d0255d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_fe97329b-071e-46c5-b5e3-bb1b5530318e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_175a0007-9b33-4f21-89c7-174138d0255d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0100522b-7a3e-4a60-9330-b025e53da3ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6db4edd1-3266-4c0b-8682-9a7d660cde48" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0100522b-7a3e-4a60-9330-b025e53da3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7f2b9baa-6a6a-48dd-a635-00ec8f169f41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0100522b-7a3e-4a60-9330-b025e53da3ad" xlink:to="loc_us-gaap_SegmentDomain_7f2b9baa-6a6a-48dd-a635-00ec8f169f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_461f8da9-80a5-45b2-9677-6124ad94ab46" xlink:href="mck-20201231.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7f2b9baa-6a6a-48dd-a635-00ec8f169f41" xlink:to="loc_mck_USPharmaceuticalSegmentMember_461f8da9-80a5-45b2-9677-6124ad94ab46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_616c9613-3a30-49ff-83f2-d9f00252c3bf" xlink:href="mck-20201231.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7f2b9baa-6a6a-48dd-a635-00ec8f169f41" xlink:to="loc_mck_InternationalSegmentMember_616c9613-3a30-49ff-83f2-d9f00252c3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_18cf685e-ee82-405a-a8d9-d47bfa474f87" xlink:href="mck-20201231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7f2b9baa-6a6a-48dd-a635-00ec8f169f41" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_18cf685e-ee82-405a-a8d9-d47bfa474f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_159269fc-34bd-47f9-a4e6-1a174ec987f4" xlink:href="mck-20201231.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7f2b9baa-6a6a-48dd-a635-00ec8f169f41" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_159269fc-34bd-47f9-a4e6-1a174ec987f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_ab3bafab-66f4-46a6-8966-779254a57acf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6db4edd1-3266-4c0b-8682-9a7d660cde48" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_ab3bafab-66f4-46a6-8966-779254a57acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_19337d70-a36e-4e36-ac77-65dc601f2aad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ab3bafab-66f4-46a6-8966-779254a57acf" xlink:to="loc_us-gaap_SeveranceCosts1_19337d70-a36e-4e36-ac77-65dc601f2aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_dc7e18fe-029a-406b-b8b1-92334c914fda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ab3bafab-66f4-46a6-8966-779254a57acf" xlink:to="loc_us-gaap_BusinessExitCosts1_dc7e18fe-029a-406b-b8b1-92334c914fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_515356f8-f621-497d-bc11-c0215f737b1f" xlink:href="mck-20201231.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ab3bafab-66f4-46a6-8966-779254a57acf" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_515356f8-f621-497d-bc11-c0215f737b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_5853061f-d4be-4a6d-a8ee-bacfcd795254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ab3bafab-66f4-46a6-8966-779254a57acf" xlink:to="loc_us-gaap_RestructuringCharges_5853061f-d4be-4a6d-a8ee-bacfcd795254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5fe5c369-f177-456d-a5b8-f397c28b3a85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a3cc019a-60ec-4833-b12b-735608e8f564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5fe5c369-f177-456d-a5b8-f397c28b3a85" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a3cc019a-60ec-4833-b12b-735608e8f564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8d541bbc-a650-405d-a9e5-4a835755a307" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a3cc019a-60ec-4833-b12b-735608e8f564" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8d541bbc-a650-405d-a9e5-4a835755a307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_fd6e4388-be26-46f2-ad6e-bc228cfe2a80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8d541bbc-a650-405d-a9e5-4a835755a307" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_fd6e4388-be26-46f2-ad6e-bc228cfe2a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_db130ef3-cacf-4f91-af7b-f71a7aeac28c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_fd6e4388-be26-46f2-ad6e-bc228cfe2a80" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_db130ef3-cacf-4f91-af7b-f71a7aeac28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_71b7d974-db5d-44e6-8937-d55a399a1e84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_fd6e4388-be26-46f2-ad6e-bc228cfe2a80" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_71b7d974-db5d-44e6-8937-d55a399a1e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_8b4791d9-b2cf-46a9-bb0b-14a2b3b91f5b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a3cc019a-60ec-4833-b12b-735608e8f564" xlink:to="loc_srt_ConsolidationItemsAxis_8b4791d9-b2cf-46a9-bb0b-14a2b3b91f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d3e828cf-a985-4464-ad0e-a729e45ed353" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_8b4791d9-b2cf-46a9-bb0b-14a2b3b91f5b" xlink:to="loc_srt_ConsolidationItemsDomain_d3e828cf-a985-4464-ad0e-a729e45ed353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_86d08d7f-7069-4881-9959-5d44ca5c2858" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d3e828cf-a985-4464-ad0e-a729e45ed353" xlink:to="loc_us-gaap_OperatingSegmentsMember_86d08d7f-7069-4881-9959-5d44ca5c2858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_60dc46d3-59b0-4377-a92b-ee25ea9ab49a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d3e828cf-a985-4464-ad0e-a729e45ed353" xlink:to="loc_us-gaap_CorporateNonSegmentMember_60dc46d3-59b0-4377-a92b-ee25ea9ab49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_818bc06f-57df-4e96-a4b6-9370fba3d230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a3cc019a-60ec-4833-b12b-735608e8f564" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_818bc06f-57df-4e96-a4b6-9370fba3d230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6c17831d-027c-4651-b5d1-4be327457567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_818bc06f-57df-4e96-a4b6-9370fba3d230" xlink:to="loc_us-gaap_SegmentDomain_6c17831d-027c-4651-b5d1-4be327457567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_62ebc18c-2f35-4745-866f-066cfc18c9ce" xlink:href="mck-20201231.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6c17831d-027c-4651-b5d1-4be327457567" xlink:to="loc_mck_USPharmaceuticalSegmentMember_62ebc18c-2f35-4745-866f-066cfc18c9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_dba2b89b-0987-43cf-9c1a-8ec153610922" xlink:href="mck-20201231.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6c17831d-027c-4651-b5d1-4be327457567" xlink:to="loc_mck_InternationalSegmentMember_dba2b89b-0987-43cf-9c1a-8ec153610922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_a32a56e0-f9d8-4b96-899e-170bc3e277c3" xlink:href="mck-20201231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6c17831d-027c-4651-b5d1-4be327457567" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_a32a56e0-f9d8-4b96-899e-170bc3e277c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_403168a2-66d8-42aa-a25b-7dd16c8e3f03" xlink:href="mck-20201231.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6c17831d-027c-4651-b5d1-4be327457567" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_403168a2-66d8-42aa-a25b-7dd16c8e3f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_ab796ec2-6e95-4f3c-93b2-1c5f3c459427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a3cc019a-60ec-4833-b12b-735608e8f564" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_ab796ec2-6e95-4f3c-93b2-1c5f3c459427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_cfb0a907-a8c7-4a06-8f72-c1d303322fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ab796ec2-6e95-4f3c-93b2-1c5f3c459427" xlink:to="loc_us-gaap_RestructuringReserveRollForward_cfb0a907-a8c7-4a06-8f72-c1d303322fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_4577adf0-175b-4ae4-96e0-c34705da76cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb0a907-a8c7-4a06-8f72-c1d303322fd1" xlink:to="loc_us-gaap_RestructuringReserve_4577adf0-175b-4ae4-96e0-c34705da76cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_78dbc1ff-5b3b-4f86-8e39-856a98f053d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb0a907-a8c7-4a06-8f72-c1d303322fd1" xlink:to="loc_us-gaap_RestructuringCharges_78dbc1ff-5b3b-4f86-8e39-856a98f053d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_127299ae-c062-4c84-beb8-426a21ad0e51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb0a907-a8c7-4a06-8f72-c1d303322fd1" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_127299ae-c062-4c84-beb8-426a21ad0e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_dfb456eb-2e17-4737-8304-6cdff8ce35d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb0a907-a8c7-4a06-8f72-c1d303322fd1" xlink:to="loc_us-gaap_PaymentsForRestructuring_dfb456eb-2e17-4737-8304-6cdff8ce35d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_2ea640fb-056e-4ad8-80a4-9ec06b267b9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb0a907-a8c7-4a06-8f72-c1d303322fd1" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_2ea640fb-056e-4ad8-80a4-9ec06b267b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b9d03758-c195-4a37-a413-e1a4c3a7d5eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_cfb0a907-a8c7-4a06-8f72-c1d303322fd1" xlink:to="loc_us-gaap_RestructuringReserve_b9d03758-c195-4a37-a413-e1a4c3a7d5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mck-20201231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d4461de8-3519-42f8-8788-a4783480a657" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_322980e3-a486-4426-84e2-444e38b9f8a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d4461de8-3519-42f8-8788-a4783480a657" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_322980e3-a486-4426-84e2-444e38b9f8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d69ca0c6-9a49-4d66-a07a-3b7733b4a12a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_1f38e3a1-98c4-4db2-8c4c-b101928717d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d69ca0c6-9a49-4d66-a07a-3b7733b4a12a" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_1f38e3a1-98c4-4db2-8c4c-b101928717d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_a6a6ea9b-a2c1-4a68-81f3-9d4c7be86963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_1f38e3a1-98c4-4db2-8c4c-b101928717d9" xlink:to="loc_us-gaap_RestructuringPlanAxis_a6a6ea9b-a2c1-4a68-81f3-9d4c7be86963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_cf18dda4-01f8-4f12-b635-dd7935352411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_a6a6ea9b-a2c1-4a68-81f3-9d4c7be86963" xlink:to="loc_us-gaap_RestructuringPlanDomain_cf18dda4-01f8-4f12-b635-dd7935352411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember_394a8d63-ce7a-4303-904c-5ea7d7ed3829" xlink:href="mck-20201231.xsd#mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_cf18dda4-01f8-4f12-b635-dd7935352411" xlink:to="loc_mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember_394a8d63-ce7a-4303-904c-5ea7d7ed3829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ecea0373-cc3a-480c-9fef-98f7a5d3f5a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_1f38e3a1-98c4-4db2-8c4c-b101928717d9" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ecea0373-cc3a-480c-9fef-98f7a5d3f5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_01a70384-49cc-4272-8c00-41b662f23966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ecea0373-cc3a-480c-9fef-98f7a5d3f5a3" xlink:to="loc_us-gaap_LossContingencyNatureDomain_01a70384-49cc-4272-8c00-41b662f23966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_5510b110-17da-4bc8-90c2-ba1e5e9d98c9" xlink:href="mck-20201231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_01a70384-49cc-4272-8c00-41b662f23966" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_5510b110-17da-4bc8-90c2-ba1e5e9d98c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_1f38e3a1-98c4-4db2-8c4c-b101928717d9" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d65b9236-c06b-4aa5-be0c-29f6013d71b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d65b9236-c06b-4aa5-be0c-29f6013d71b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ebe26805-db10-4314-be97-5f8321409b45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ebe26805-db10-4314-be97-5f8321409b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_321a922c-799e-49c4-b077-648f2690992c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_321a922c-799e-49c4-b077-648f2690992c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualProvisionNetOfTax_2f7e4a6f-418c-4ce6-b5db-19def167964a" xlink:href="mck-20201231.xsd#mck_LossContingencyAccrualProvisionNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_mck_LossContingencyAccrualProvisionNetOfTax_2f7e4a6f-418c-4ce6-b5db-19def167964a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_ac365803-b856-4e48-a9bc-7ee68c2275ec" xlink:href="mck-20201231.xsd#mck_IncomeTaxExpenseBenefitDiscreteItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_ac365803-b856-4e48-a9bc-7ee68c2275ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCounties_9bf7586e-a05c-42f8-a1c3-f047ba839c81" xlink:href="mck-20201231.xsd#mck_LossContingencyNumberofCounties"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_mck_LossContingencyNumberofCounties_9bf7586e-a05c-42f8-a1c3-f047ba839c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_66e1ffaa-c3d5-4cb7-90d1-68708699b403" xlink:href="mck-20201231.xsd#mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_66e1ffaa-c3d5-4cb7-90d1-68708699b403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue_163d13ab-81a7-43ad-96f2-36ba7e5fafce" xlink:href="mck-20201231.xsd#mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue_163d13ab-81a7-43ad-96f2-36ba7e5fafce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentChargeOnReclassifiedAssets_4075bef6-1886-4bc7-921b-77286d983850" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentChargeOnReclassifiedAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_us-gaap_ImpairmentChargeOnReclassifiedAssets_4075bef6-1886-4bc7-921b-77286d983850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_69dcaebf-63c7-44c4-8a67-db38967c919b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_69dcaebf-63c7-44c4-8a67-db38967c919b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0f7c126f-6039-4d00-b0ad-842f57aaebdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0f7c126f-6039-4d00-b0ad-842f57aaebdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_63ad8b04-6bf1-417e-b2a2-5c59c005f184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_63ad8b04-6bf1-417e-b2a2-5c59c005f184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_7ab5382f-f0c8-4a43-b68f-828886448cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44e53dc4-7d04-4c28-9575-d7d8bf91ddff" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_7ab5382f-f0c8-4a43-b68f-828886448cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="simple" xlink:href="mck-20201231.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterests"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_73869889-e8c2-42fa-b6ef-efd68fafeb25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_5a207a22-bce9-4a82-80ef-5d20f38c85a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_73869889-e8c2-42fa-b6ef-efd68fafeb25" xlink:to="loc_us-gaap_MinorityInterestDisclosureTextBlock_5a207a22-bce9-4a82-80ef-5d20f38c85a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="simple" xlink:href="mck-20201231.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_767d1f41-0d40-462a-bcba-9086db3f4238" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_b417a730-27bd-467c-ad46-0599666247a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_767d1f41-0d40-462a-bcba-9086db3f4238" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_b417a730-27bd-467c-ad46-0599666247a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_4bd70df0-bb40-47f2-b9cc-0d653fe0b802" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_e337f27e-0657-4a9f-bbea-50788b17e510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_4bd70df0-bb40-47f2-b9cc-0d653fe0b802" xlink:to="loc_us-gaap_MinorityInterestTable_e337f27e-0657-4a9f-bbea-50788b17e510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_8917569a-5223-4a3a-a487-b8b8981a62c1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_e337f27e-0657-4a9f-bbea-50788b17e510" xlink:to="loc_srt_OwnershipAxis_8917569a-5223-4a3a-a487-b8b8981a62c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_9ccaed9b-a336-4889-a5c4-1795946a5158" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_8917569a-5223-4a3a-a487-b8b8981a62c1" xlink:to="loc_srt_OwnershipDomain_9ccaed9b-a336-4889-a5c4-1795946a5158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_7822d4ef-50a4-461e-9a1d-91780dcdda7c" xlink:href="mck-20201231.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_9ccaed9b-a336-4889-a5c4-1795946a5158" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_7822d4ef-50a4-461e-9a1d-91780dcdda7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember_7d07c46b-22d7-408b-aabc-dd801d63d1d6" xlink:href="mck-20201231.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_9ccaed9b-a336-4889-a5c4-1795946a5158" xlink:to="loc_mck_VantageandClarusOneSourcingServicesLLCMember_7d07c46b-22d7-408b-aabc-dd801d63d1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_bb8a0397-14d2-4699-8fdc-91ea0ef22797" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_e337f27e-0657-4a9f-bbea-50788b17e510" xlink:to="loc_dei_LegalEntityAxis_bb8a0397-14d2-4699-8fdc-91ea0ef22797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_374df8c6-73e5-453d-a053-fbe46e1b5240" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_bb8a0397-14d2-4699-8fdc-91ea0ef22797" xlink:to="loc_dei_EntityDomain_374df8c6-73e5-453d-a053-fbe46e1b5240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_e3389d05-1958-4fe3-a19a-5d1549de9a84" xlink:href="mck-20201231.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_374df8c6-73e5-453d-a053-fbe46e1b5240" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_e3389d05-1958-4fe3-a19a-5d1549de9a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b515fec2-e27d-4166-91aa-d24552e7e99f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_e337f27e-0657-4a9f-bbea-50788b17e510" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b515fec2-e27d-4166-91aa-d24552e7e99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9cb4c0dc-9b3a-4a15-9926-152a82e17445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b515fec2-e27d-4166-91aa-d24552e7e99f" xlink:to="loc_us-gaap_EquityComponentDomain_9cb4c0dc-9b3a-4a15-9926-152a82e17445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_427132ab-fd91-46aa-a71d-aae605f6e738" xlink:href="mck-20201231.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9cb4c0dc-9b3a-4a15-9926-152a82e17445" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_427132ab-fd91-46aa-a71d-aae605f6e738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_72f8d7e7-5d12-4505-ac2e-f9287798eadd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9cb4c0dc-9b3a-4a15-9926-152a82e17445" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_72f8d7e7-5d12-4505-ac2e-f9287798eadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_e337f27e-0657-4a9f-bbea-50788b17e510" xlink:to="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_0d1bb8a8-bb3a-4bb5-b169-858f0fd41c09" xlink:href="mck-20201231.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_0d1bb8a8-bb3a-4bb5-b169-858f0fd41c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_4942ab70-a88d-4c16-8bd3-2fc6251998b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_4942ab70-a88d-4c16-8bd3-2fc6251998b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice_7f1ff985-d566-480d-8a25-0ff9ae9b5789" xlink:href="mck-20201231.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePrice_7f1ff985-d566-480d-8a25-0ff9ae9b5789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread_3de112e1-5dd6-412c-9af5-9162ad579162" xlink:href="mck-20201231.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_mck_PutRightValueInterestRateSpread_3de112e1-5dd6-412c-9af5-9162ad579162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_f0dfbe2e-00e7-47fd-873d-8e2375df204d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_f0dfbe2e-00e7-47fd-873d-8e2375df204d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_ca548a52-780b-426e-91ad-9804cc8ca533" xlink:href="mck-20201231.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_ca548a52-780b-426e-91ad-9804cc8ca533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_8443d7e9-1e74-42ca-935b-a16d9ce0ff2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_8443d7e9-1e74-42ca-935b-a16d9ce0ff2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_dbd9919b-3ce4-4b05-b37b-987ca425d1e2" xlink:href="mck-20201231.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_dbd9919b-3ce4-4b05-b37b-987ca425d1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_89c72f33-0c02-4521-85df-8de28c31a82b" xlink:href="mck-20201231.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_89c72f33-0c02-4521-85df-8de28c31a82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_18c70f10-9c66-4d31-b8fb-ed28f449f019" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_18c70f10-9c66-4d31-b8fb-ed28f449f019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_969c079f-591b-45b8-b4ea-aba6685588ee" xlink:href="mck-20201231.xsd#mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_969c079f-591b-45b8-b4ea-aba6685588ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_dfd44ac7-d130-4878-8f9c-61d03042e39b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_dfd44ac7-d130-4878-8f9c-61d03042e39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_479ddee5-786c-4c78-8338-7fd391d41de5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_us-gaap_MinorityInterest_479ddee5-786c-4c78-8338-7fd391d41de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_139d6cec-17ec-425b-9381-14f6ee3c7951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_87ecfbb4-8c1d-412f-97d5-b3ec6a60456b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_139d6cec-17ec-425b-9381-14f6ee3c7951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_2acac2b1-a6a0-459a-b212-0d5a2b7eaa87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_94599f29-4502-4351-ba3a-b4c96c479cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_2acac2b1-a6a0-459a-b212-0d5a2b7eaa87" xlink:to="loc_us-gaap_MinorityInterestTable_94599f29-4502-4351-ba3a-b4c96c479cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_68e42fe7-8a3e-4495-8813-df78f7146a3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_94599f29-4502-4351-ba3a-b4c96c479cb2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_68e42fe7-8a3e-4495-8813-df78f7146a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_aa2504fc-84dc-49a3-a98d-0f979383939e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_68e42fe7-8a3e-4495-8813-df78f7146a3a" xlink:to="loc_us-gaap_EquityComponentDomain_aa2504fc-84dc-49a3-a98d-0f979383939e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_fc5d1c26-007c-4529-9bd4-d68801de4b12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_aa2504fc-84dc-49a3-a98d-0f979383939e" xlink:to="loc_us-gaap_NoncontrollingInterestMember_fc5d1c26-007c-4529-9bd4-d68801de4b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_1641d89f-c27f-48ea-b436-eb1bf3738329" xlink:href="mck-20201231.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_aa2504fc-84dc-49a3-a98d-0f979383939e" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_1641d89f-c27f-48ea-b436-eb1bf3738329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_08c48f1a-96f6-458a-afa2-411110c9ab8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_94599f29-4502-4351-ba3a-b4c96c479cb2" xlink:to="loc_us-gaap_MinorityInterestLineItems_08c48f1a-96f6-458a-afa2-411110c9ab8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_26abef27-00e6-4ea2-88c1-9a5453113304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_08c48f1a-96f6-458a-afa2-411110c9ab8d" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_26abef27-00e6-4ea2-88c1-9a5453113304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d453bb3a-ea83-481e-97b3-81c95dda27f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_26abef27-00e6-4ea2-88c1-9a5453113304" xlink:to="loc_us-gaap_MinorityInterest_d453bb3a-ea83-481e-97b3-81c95dda27f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7ad5b355-b54d-4af1-bfde-046c102f27f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_26abef27-00e6-4ea2-88c1-9a5453113304" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7ad5b355-b54d-4af1-bfde-046c102f27f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_6be89e08-1ae9-4d14-8656-213a95ecabc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_26abef27-00e6-4ea2-88c1-9a5453113304" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_6be89e08-1ae9-4d14-8656-213a95ecabc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e9535d04-8986-4d7c-ab6c-dc4fc6936586" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_26abef27-00e6-4ea2-88c1-9a5453113304" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e9535d04-8986-4d7c-ab6c-dc4fc6936586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_d517e25e-85f0-4604-be64-793b0a3ebb04" xlink:href="mck-20201231.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_26abef27-00e6-4ea2-88c1-9a5453113304" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_d517e25e-85f0-4604-be64-793b0a3ebb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_a85d1563-9d3f-4903-9c59-4ba39670a343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_26abef27-00e6-4ea2-88c1-9a5453113304" xlink:to="loc_us-gaap_MinorityInterest_a85d1563-9d3f-4903-9c59-4ba39670a343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1818c129-de1f-4060-9489-9a172c14f7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_08c48f1a-96f6-458a-afa2-411110c9ab8d" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1818c129-de1f-4060-9489-9a172c14f7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_68f86452-32b8-4e67-91f6-bd855331f7e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1818c129-de1f-4060-9489-9a172c14f7e7" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_68f86452-32b8-4e67-91f6-bd855331f7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_272b7396-733b-4c4d-93f5-1b8fa22d00d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1818c129-de1f-4060-9489-9a172c14f7e7" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_272b7396-733b-4c4d-93f5-1b8fa22d00d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_38fe808d-e996-4ac9-81fa-6d3fd9248ba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1818c129-de1f-4060-9489-9a172c14f7e7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_38fe808d-e996-4ac9-81fa-6d3fd9248ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_46930b98-48de-4729-bc7a-e9c78956cc31" xlink:href="mck-20201231.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1818c129-de1f-4060-9489-9a172c14f7e7" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_46930b98-48de-4729-bc7a-e9c78956cc31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_7bf1aba0-9066-4e48-ad00-3ed8ebcfc15c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1818c129-de1f-4060-9489-9a172c14f7e7" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_7bf1aba0-9066-4e48-ad00-3ed8ebcfc15c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_1ca27f7c-1e97-401c-b4b5-22c03976e8f7" xlink:href="mck-20201231.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1818c129-de1f-4060-9489-9a172c14f7e7" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_1ca27f7c-1e97-401c-b4b5-22c03976e8f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_ebd9b8f9-20f6-4792-a4a2-7451ae394343" xlink:href="mck-20201231.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1818c129-de1f-4060-9489-9a172c14f7e7" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_ebd9b8f9-20f6-4792-a4a2-7451ae394343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_8c73eefc-24a8-4d29-a459-6fa06c8aefbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1818c129-de1f-4060-9489-9a172c14f7e7" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_8c73eefc-24a8-4d29-a459-6fa06c8aefbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShare" xlink:type="simple" xlink:href="mck-20201231.xsd#EarningsLossPerCommonShare"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a2cda741-9049-4224-862f-57f9bd1ba910" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_c22c84d1-fb2a-40c1-a19f-3124ef3def61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a2cda741-9049-4224-862f-57f9bd1ba910" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_c22c84d1-fb2a-40c1-a19f-3124ef3def61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareTables" xlink:type="simple" xlink:href="mck-20201231.xsd#EarningsLossPerCommonShareTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_614443dc-b76e-4abb-b51b-7b9ba449c587" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_944cb983-ec54-42f3-81cc-90367a1fe00f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_614443dc-b76e-4abb-b51b-7b9ba449c587" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_944cb983-ec54-42f3-81cc-90367a1fe00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#EarningsLossPerCommonShareDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f8a90482-22f8-425c-bb21-8f8b045395db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_7d60a688-6ed2-4c1b-9a79-a13e06b21dbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f8a90482-22f8-425c-bb21-8f8b045395db" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_7d60a688-6ed2-4c1b-9a79-a13e06b21dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2fc34d96-55dd-4a45-81ba-26acaa01c214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f8a90482-22f8-425c-bb21-8f8b045395db" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2fc34d96-55dd-4a45-81ba-26acaa01c214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_6f492e90-60e9-4697-b2c0-92bcebacf164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f8a90482-22f8-425c-bb21-8f8b045395db" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_6f492e90-60e9-4697-b2c0-92bcebacf164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_7c2a262e-ad16-42d6-824e-48760d3d0ce5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f8a90482-22f8-425c-bb21-8f8b045395db" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_7c2a262e-ad16-42d6-824e-48760d3d0ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_400df59a-8b86-44ce-8254-b92d06c2b107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f8a90482-22f8-425c-bb21-8f8b045395db" xlink:to="loc_us-gaap_NetIncomeLoss_400df59a-8b86-44ce-8254-b92d06c2b107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_719e7d97-ad8f-4652-a2cd-7d6d39bb0bb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f8a90482-22f8-425c-bb21-8f8b045395db" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_719e7d97-ad8f-4652-a2cd-7d6d39bb0bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f17ad604-e4c7-46ef-8f62-49614288ffc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_719e7d97-ad8f-4652-a2cd-7d6d39bb0bb6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f17ad604-e4c7-46ef-8f62-49614288ffc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_489f9e44-9140-403a-9868-f506c255f1d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_719e7d97-ad8f-4652-a2cd-7d6d39bb0bb6" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_489f9e44-9140-403a-9868-f506c255f1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7d5d3b4a-1303-4550-a632-77dc2d2b53e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_489f9e44-9140-403a-9868-f506c255f1d8" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7d5d3b4a-1303-4550-a632-77dc2d2b53e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b8ab9bf8-8e85-4c0f-b523-9b726cacd989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_719e7d97-ad8f-4652-a2cd-7d6d39bb0bb6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b8ab9bf8-8e85-4c0f-b523-9b726cacd989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_607498f9-8204-44f8-82c8-57e8ef4ca7dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f8a90482-22f8-425c-bb21-8f8b045395db" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_607498f9-8204-44f8-82c8-57e8ef4ca7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_8d8e96f0-d9d8-479b-a040-c2e1ff03d65a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_607498f9-8204-44f8-82c8-57e8ef4ca7dd" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_8d8e96f0-d9d8-479b-a040-c2e1ff03d65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_b5cfdef3-1235-4a42-a0ff-3dbe08907d69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_8d8e96f0-d9d8-479b-a040-c2e1ff03d65a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_b5cfdef3-1235-4a42-a0ff-3dbe08907d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_74fc5137-961c-4359-91c9-09a863c7d0e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_8d8e96f0-d9d8-479b-a040-c2e1ff03d65a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_74fc5137-961c-4359-91c9-09a863c7d0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_209c3c0a-be0b-40cd-ab61-986c57af1b72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_8d8e96f0-d9d8-479b-a040-c2e1ff03d65a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_209c3c0a-be0b-40cd-ab61-986c57af1b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_804694f1-87a8-4497-9b1e-d668670db15d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_607498f9-8204-44f8-82c8-57e8ef4ca7dd" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_804694f1-87a8-4497-9b1e-d668670db15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_f42f9979-7d27-4605-89d5-1a3175ff1247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_804694f1-87a8-4497-9b1e-d668670db15d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_f42f9979-7d27-4605-89d5-1a3175ff1247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_7f5ae386-bebf-4f2c-bd2f-3b02417ed2ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_804694f1-87a8-4497-9b1e-d668670db15d" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_7f5ae386-bebf-4f2c-bd2f-3b02417ed2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_486df09c-15be-4eda-865e-23b10ab6f5ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_804694f1-87a8-4497-9b1e-d668670db15d" xlink:to="loc_us-gaap_EarningsPerShareBasic_486df09c-15be-4eda-865e-23b10ab6f5ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_584ec5d2-b83a-417b-bc2b-6a8002602b37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f8a90482-22f8-425c-bb21-8f8b045395db" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_584ec5d2-b83a-417b-bc2b-6a8002602b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="mck-20201231.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d6d4fcb4-1e73-4fb9-9e44-af1d5e877726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_6f00fc6c-58fa-4835-8511-86a983b0dcce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d6d4fcb4-1e73-4fb9-9e44-af1d5e877726" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_6f00fc6c-58fa-4835-8511-86a983b0dcce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="mck-20201231.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2e264a31-7bcc-44c7-a433-53a0995d3ba3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_021a4641-4abe-4b3e-921b-4b6c0fd5acf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2e264a31-7bcc-44c7-a433-53a0995d3ba3" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_021a4641-4abe-4b3e-921b-4b6c0fd5acf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_76fc7957-ffec-45d3-875a-09950bc5dc82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2e264a31-7bcc-44c7-a433-53a0995d3ba3" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_76fc7957-ffec-45d3-875a-09950bc5dc82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_48e616ef-af4d-435f-b595-4141b1505fb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_7e7fdb67-b98e-4d39-9391-2559ca6f6dec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_48e616ef-af4d-435f-b595-4141b1505fb5" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_7e7fdb67-b98e-4d39-9391-2559ca6f6dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_81f880cd-643f-48c3-bfcd-451d1e3738a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7e7fdb67-b98e-4d39-9391-2559ca6f6dec" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_81f880cd-643f-48c3-bfcd-451d1e3738a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_38b18cb0-cab5-46fd-8fc5-ee64bac672ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_81f880cd-643f-48c3-bfcd-451d1e3738a0" xlink:to="loc_us-gaap_SegmentDomain_38b18cb0-cab5-46fd-8fc5-ee64bac672ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_72742293-0fdf-4474-8aa2-6749c3022b51" xlink:href="mck-20201231.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_38b18cb0-cab5-46fd-8fc5-ee64bac672ed" xlink:to="loc_mck_USPharmaceuticalSegmentMember_72742293-0fdf-4474-8aa2-6749c3022b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_454d547a-3aef-45b2-9b22-e275693b3c14" xlink:href="mck-20201231.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_38b18cb0-cab5-46fd-8fc5-ee64bac672ed" xlink:to="loc_mck_InternationalSegmentMember_454d547a-3aef-45b2-9b22-e275693b3c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_a04b6fde-97bc-4927-b35c-2a2e02b36d08" xlink:href="mck-20201231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_38b18cb0-cab5-46fd-8fc5-ee64bac672ed" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_a04b6fde-97bc-4927-b35c-2a2e02b36d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_b6c7a803-0096-4f8d-87d3-8e550be55755" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_38b18cb0-cab5-46fd-8fc5-ee64bac672ed" xlink:to="loc_us-gaap_AllOtherSegmentsMember_b6c7a803-0096-4f8d-87d3-8e550be55755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_b93137be-fa80-4b0e-b563-369cd06fa7e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7e7fdb67-b98e-4d39-9391-2559ca6f6dec" xlink:to="loc_us-gaap_GoodwillLineItems_b93137be-fa80-4b0e-b563-369cd06fa7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_1c53c6b0-d603-492c-984d-016ff49e4d39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_b93137be-fa80-4b0e-b563-369cd06fa7e6" xlink:to="loc_us-gaap_GoodwillRollForward_1c53c6b0-d603-492c-984d-016ff49e4d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3a5b78cb-b96a-4819-8bb4-e0af8528b494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1c53c6b0-d603-492c-984d-016ff49e4d39" xlink:to="loc_us-gaap_Goodwill_3a5b78cb-b96a-4819-8bb4-e0af8528b494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_ee13e3db-823e-45d7-87f1-f77def6d39a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1c53c6b0-d603-492c-984d-016ff49e4d39" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_ee13e3db-823e-45d7-87f1-f77def6d39a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_3e887b52-1a42-4e07-92ea-0322cbcb215a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1c53c6b0-d603-492c-984d-016ff49e4d39" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_3e887b52-1a42-4e07-92ea-0322cbcb215a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_4688fe07-05a0-4efa-883b-6b24e0fbfa78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1c53c6b0-d603-492c-984d-016ff49e4d39" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_4688fe07-05a0-4efa-883b-6b24e0fbfa78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_b2697d88-3aa2-4501-9be3-860521ab1aa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1c53c6b0-d603-492c-984d-016ff49e4d39" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_b2697d88-3aa2-4501-9be3-860521ab1aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_31f9f697-1c0e-4a38-9eab-a332358f9be5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1c53c6b0-d603-492c-984d-016ff49e4d39" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_31f9f697-1c0e-4a38-9eab-a332358f9be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c7ac49a1-a07c-4b03-8cf5-296fca450cf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1c53c6b0-d603-492c-984d-016ff49e4d39" xlink:to="loc_us-gaap_Goodwill_c7ac49a1-a07c-4b03-8cf5-296fca450cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a5383976-1c5b-494d-ab56-dbcbc926c46a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_dcd4e65f-b00d-479b-ac71-97d4f5e213ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a5383976-1c5b-494d-ab56-dbcbc926c46a" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_dcd4e65f-b00d-479b-ac71-97d4f5e213ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d6c0284-9196-4858-a8b2-254e82e7d81d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_dcd4e65f-b00d-479b-ac71-97d4f5e213ff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d6c0284-9196-4858-a8b2-254e82e7d81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0fdd4d34-02ab-4958-a4f1-7e518eaeb3ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2d6c0284-9196-4858-a8b2-254e82e7d81d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0fdd4d34-02ab-4958-a4f1-7e518eaeb3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_b82e3618-bed6-4cb0-9698-e839362f5c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0fdd4d34-02ab-4958-a4f1-7e518eaeb3ca" xlink:to="loc_us-gaap_CustomerRelationshipsMember_b82e3618-bed6-4cb0-9698-e839362f5c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_f1370227-be32-4934-97a4-cd81f6853e59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0fdd4d34-02ab-4958-a4f1-7e518eaeb3ca" xlink:to="loc_us-gaap_ServiceAgreementsMember_f1370227-be32-4934-97a4-cd81f6853e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmacyLicensesMember_5beee388-8fd1-4f8d-85ef-dd750655f48a" xlink:href="mck-20201231.xsd#mck_PharmacyLicensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0fdd4d34-02ab-4958-a4f1-7e518eaeb3ca" xlink:to="loc_mck_PharmacyLicensesMember_5beee388-8fd1-4f8d-85ef-dd750655f48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_80a7d9ff-a748-4a91-81b3-d7b3cdef36e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0fdd4d34-02ab-4958-a4f1-7e518eaeb3ca" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_80a7d9ff-a748-4a91-81b3-d7b3cdef36e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_fa79cf8e-a9ce-4bb3-8d99-36e68ce062d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0fdd4d34-02ab-4958-a4f1-7e518eaeb3ca" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_fa79cf8e-a9ce-4bb3-8d99-36e68ce062d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_8b8fafa2-0cf7-4065-acd5-0e2102c42671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0fdd4d34-02ab-4958-a4f1-7e518eaeb3ca" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_8b8fafa2-0cf7-4065-acd5-0e2102c42671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c586ec5-3af5-4e9a-9d4f-f536d5cd88f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_dcd4e65f-b00d-479b-ac71-97d4f5e213ff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c586ec5-3af5-4e9a-9d4f-f536d5cd88f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_9814f6fb-f001-4fb9-8e46-f7da14bca9e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c586ec5-3af5-4e9a-9d4f-f536d5cd88f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_9814f6fb-f001-4fb9-8e46-f7da14bca9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d18b340e-0364-482d-8a8e-d186792f7740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c586ec5-3af5-4e9a-9d4f-f536d5cd88f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d18b340e-0364-482d-8a8e-d186792f7740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e6f21841-6762-4e83-bb11-56fb2573d3e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c586ec5-3af5-4e9a-9d4f-f536d5cd88f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e6f21841-6762-4e83-bb11-56fb2573d3e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b5350914-6120-4451-ac5d-79bad6464d7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c586ec5-3af5-4e9a-9d4f-f536d5cd88f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b5350914-6120-4451-ac5d-79bad6464d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_51d4eae8-b70e-4610-97ca-3fbf452b471a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_665a5cce-703a-43e1-9fe6-51e99f981197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_51d4eae8-b70e-4610-97ca-3fbf452b471a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_665a5cce-703a-43e1-9fe6-51e99f981197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_f26e8e00-a97e-44bc-af9f-98d8854a811c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_665a5cce-703a-43e1-9fe6-51e99f981197" xlink:to="loc_us-gaap_ReportingUnitAxis_f26e8e00-a97e-44bc-af9f-98d8854a811c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_153589db-fe4f-4356-a536-5464abd2b32f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_f26e8e00-a97e-44bc-af9f-98d8854a811c" xlink:to="loc_us-gaap_ReportingUnitDomain_153589db-fe4f-4356-a536-5464abd2b32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_2e992f52-4fcc-4e38-8ba0-010f7b561a8d" xlink:href="mck-20201231.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_153589db-fe4f-4356-a536-5464abd2b32f" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_2e992f52-4fcc-4e38-8ba0-010f7b561a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1d4038ba-5fc0-4fe1-82ea-76babc4dd6cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_665a5cce-703a-43e1-9fe6-51e99f981197" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1d4038ba-5fc0-4fe1-82ea-76babc4dd6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_96d0975b-d152-4f3e-9b3b-c77d183a8ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1d4038ba-5fc0-4fe1-82ea-76babc4dd6cc" xlink:to="loc_us-gaap_SegmentDomain_96d0975b-d152-4f3e-9b3b-c77d183a8ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_43adcb41-0f51-48e6-a8a3-be812e3910a2" xlink:href="mck-20201231.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_96d0975b-d152-4f3e-9b3b-c77d183a8ff0" xlink:to="loc_mck_InternationalSegmentMember_43adcb41-0f51-48e6-a8a3-be812e3910a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a8a4db0a-f635-4252-a7be-be5e05f475db" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_665a5cce-703a-43e1-9fe6-51e99f981197" xlink:to="loc_srt_StatementGeographicalAxis_a8a4db0a-f635-4252-a7be-be5e05f475db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d74e1527-fbb5-4a4a-be08-a8e22a50851d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_a8a4db0a-f635-4252-a7be-be5e05f475db" xlink:to="loc_srt_SegmentGeographicalDomain_d74e1527-fbb5-4a4a-be08-a8e22a50851d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_605c5513-2453-4c8f-a7b5-ed1ddcc3443b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d74e1527-fbb5-4a4a-be08-a8e22a50851d" xlink:to="loc_srt_EuropeMember_605c5513-2453-4c8f-a7b5-ed1ddcc3443b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1cbadabc-3033-4195-bc1e-1649f882c27c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_665a5cce-703a-43e1-9fe6-51e99f981197" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1cbadabc-3033-4195-bc1e-1649f882c27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_477041c7-7548-46f3-9de7-f5b66293b983" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1cbadabc-3033-4195-bc1e-1649f882c27c" xlink:to="loc_us-gaap_NumberOfReportableSegments_477041c7-7548-46f3-9de7-f5b66293b983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_33c821a7-bfbe-4211-8463-bdcccfc7ab50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1cbadabc-3033-4195-bc1e-1649f882c27c" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_33c821a7-bfbe-4211-8463-bdcccfc7ab50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLossNetOfTax_f6f92709-0d40-4e64-bd00-23a03e8a870a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1cbadabc-3033-4195-bc1e-1649f882c27c" xlink:to="loc_us-gaap_GoodwillImpairmentLossNetOfTax_f6f92709-0d40-4e64-bd00-23a03e8a870a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fcdd18e8-93a9-45a4-aec1-d3d295dc6b64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1cbadabc-3033-4195-bc1e-1649f882c27c" xlink:to="loc_us-gaap_Goodwill_fcdd18e8-93a9-45a4-aec1-d3d295dc6b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f716f3b0-6fac-45de-96ef-720552317511" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1cbadabc-3033-4195-bc1e-1649f882c27c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f716f3b0-6fac-45de-96ef-720552317511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_71adbdf1-2c6b-46e2-b0e0-0883b74bca9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1cbadabc-3033-4195-bc1e-1649f882c27c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_71adbdf1-2c6b-46e2-b0e0-0883b74bca9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_1245dbe3-166b-498b-8658-936511412270" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_71adbdf1-2c6b-46e2-b0e0-0883b74bca9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_1245dbe3-166b-498b-8658-936511412270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_06c4d032-d19b-416a-b1a7-26793f9e541a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_71adbdf1-2c6b-46e2-b0e0-0883b74bca9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_06c4d032-d19b-416a-b1a7-26793f9e541a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_01cac9bf-4fb6-4779-bca4-d5e966d2feb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_71adbdf1-2c6b-46e2-b0e0-0883b74bca9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_01cac9bf-4fb6-4779-bca4-d5e966d2feb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7b1bd9e1-5ccb-42b0-9ec9-66800040b96e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_71adbdf1-2c6b-46e2-b0e0-0883b74bca9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7b1bd9e1-5ccb-42b0-9ec9-66800040b96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_20efbe3d-44e7-449b-873c-b09eeff83dd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_71adbdf1-2c6b-46e2-b0e0-0883b74bca9e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_20efbe3d-44e7-449b-873c-b09eeff83dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_a69ba3d2-bcf3-4874-8d48-46bd936bbc45" xlink:href="mck-20201231.xsd#mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_71adbdf1-2c6b-46e2-b0e0-0883b74bca9e" xlink:to="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_a69ba3d2-bcf3-4874-8d48-46bd936bbc45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_75585760-68a8-4eb2-b7a0-fd2d0b2ca73d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_7874c976-5295-4dc3-b202-a389a2e7ed76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_75585760-68a8-4eb2-b7a0-fd2d0b2ca73d" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_7874c976-5295-4dc3-b202-a389a2e7ed76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9abbfc92-34de-4119-903e-224c77ef0892" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_92a56054-1bf6-462b-9f65-19edeaed0ff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9abbfc92-34de-4119-903e-224c77ef0892" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_92a56054-1bf6-462b-9f65-19edeaed0ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_459b4026-09a0-41af-b614-2d302b3030c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b183d83f-fb07-496d-9819-4b626b051c69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_459b4026-09a0-41af-b614-2d302b3030c9" xlink:to="loc_us-gaap_DebtInstrumentTable_b183d83f-fb07-496d-9819-4b626b051c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c799b287-e85c-4e8f-8a88-b60c8149a426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b183d83f-fb07-496d-9819-4b626b051c69" xlink:to="loc_us-gaap_DebtInstrumentAxis_c799b287-e85c-4e8f-8a88-b60c8149a426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c799b287-e85c-4e8f-8a88-b60c8149a426" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A365NotesDueNovember302020Member_fae0f5e9-a0f3-4a8e-a614-ac405c7f01da" xlink:href="mck-20201231.xsd#mck_A365NotesDueNovember302020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A365NotesDueNovember302020Member_fae0f5e9-a0f3-4a8e-a614-ac405c7f01da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMarch12021Member_f4d8f751-7728-4950-8129-0006dac8ab98" xlink:href="mck-20201231.xsd#mck_A475NotesDueMarch12021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A475NotesDueMarch12021Member_f4d8f751-7728-4950-8129-0006dac8ab98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member_a7f96246-4a53-4751-8d27-9496b99b1c24" xlink:href="mck-20201231.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A270NotesDueDecember152022Member_a7f96246-4a53-4751-8d27-9496b99b1c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_a69f7611-e93e-4545-aa49-aaa075574d6a" xlink:href="mck-20201231.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A285NotesDueMarch152023Member_a69f7611-e93e-4545-aa49-aaa075574d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_8c84b556-2877-4fd1-8d0b-36b972c409b6" xlink:href="mck-20201231.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A380NotesDueMarch152024Member_8c84b556-2877-4fd1-8d0b-36b972c409b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_b0f19c40-0ddc-4c70-9b69-dedf778c5feb" xlink:href="mck-20201231.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A090NotesDueDecember32025Member_b0f19c40-0ddc-4c70-9b69-dedf778c5feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_ce09e67b-8425-4fe4-a98d-21da1a2d65d0" xlink:href="mck-20201231.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_ce09e67b-8425-4fe4-a98d-21da1a2d65d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_018c85d2-05a9-42b0-b27b-412810486662" xlink:href="mck-20201231.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A395NotesDueFebruary162028Member_018c85d2-05a9-42b0-b27b-412810486662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_99396759-0598-4054-a21b-9cbcd5ca3bef" xlink:href="mck-20201231.xsd#mck_A475NotesDueMay302029Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A475NotesDueMay302029Member_99396759-0598-4054-a21b-9cbcd5ca3bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_5ba6cc9d-8a1b-417e-9f94-d53b4c34cc80" xlink:href="mck-20201231.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A600NotesDueMarch12041Member_5ba6cc9d-8a1b-417e-9f94-d53b4c34cc80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_c5215cba-ac1c-43dd-bdbe-b309adc11dd2" xlink:href="mck-20201231.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A488NotesDueMarch152044Member_c5215cba-ac1c-43dd-bdbe-b309adc11dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member_330ef31c-5329-4d1c-9af7-a030fbdf4e5f" xlink:href="mck-20201231.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A063EuroNotesDueAugust172021Member_330ef31c-5329-4d1c-9af7-a030fbdf4e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member_d89d7323-01d0-4d13-8f96-cca3de86a5c3" xlink:href="mck-20201231.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A150EuroNotesDueNovember172025Member_d89d7323-01d0-4d13-8f96-cca3de86a5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member_16413b63-ebec-4155-8e72-5036deb0f49b" xlink:href="mck-20201231.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A163EuroNotesDueOctober302026Member_16413b63-ebec-4155-8e72-5036deb0f49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member_26764edc-934e-413a-bf21-b3cec42d47c8" xlink:href="mck-20201231.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c809e674-a576-4ac0-82e3-46eb636e1928" xlink:to="loc_mck_A313SterlingNotesDueFebruary172029Member_26764edc-934e-413a-bf21-b3cec42d47c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e786c5b8-d630-4826-9e15-fe404df0e419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b183d83f-fb07-496d-9819-4b626b051c69" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e786c5b8-d630-4826-9e15-fe404df0e419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_31229d46-f93a-4f71-8df6-00164344f006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e786c5b8-d630-4826-9e15-fe404df0e419" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_31229d46-f93a-4f71-8df6-00164344f006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_e2870640-05f3-41f5-aeb8-2a81131e7e4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_31229d46-f93a-4f71-8df6-00164344f006" xlink:to="loc_us-gaap_LoansPayableMember_e2870640-05f3-41f5-aeb8-2a81131e7e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bc8124d4-e6c2-4168-bdf7-6231a1691852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b183d83f-fb07-496d-9819-4b626b051c69" xlink:to="loc_us-gaap_DebtInstrumentLineItems_bc8124d4-e6c2-4168-bdf7-6231a1691852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_aa1f885e-1ae1-4f99-b6c7-bf65055dfd3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc8124d4-e6c2-4168-bdf7-6231a1691852" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_aa1f885e-1ae1-4f99-b6c7-bf65055dfd3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_689a4b05-b95e-46f2-9e29-13897bfeeea6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc8124d4-e6c2-4168-bdf7-6231a1691852" xlink:to="loc_us-gaap_LongTermDebt_689a4b05-b95e-46f2-9e29-13897bfeeea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_bcbc3ca4-1f9f-4793-a492-f67f83918a39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc8124d4-e6c2-4168-bdf7-6231a1691852" xlink:to="loc_us-gaap_FinanceLeaseLiability_bcbc3ca4-1f9f-4793-a492-f67f83918a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_2738b551-8d43-41d3-bc3a-c967733fc7f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc8124d4-e6c2-4168-bdf7-6231a1691852" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_2738b551-8d43-41d3-bc3a-c967733fc7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a9b22a0f-27d1-4e77-943d-0efb2af49beb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc8124d4-e6c2-4168-bdf7-6231a1691852" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a9b22a0f-27d1-4e77-943d-0efb2af49beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_cd525f3e-4f4d-4bf1-b72e-39f702799aee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc8124d4-e6c2-4168-bdf7-6231a1691852" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_cd525f3e-4f4d-4bf1-b72e-39f702799aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivitiesLongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3408ac37-96b5-449c-8adb-673e2699a41e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6f616d66-e04b-40fb-af36-07051c095f83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3408ac37-96b5-449c-8adb-673e2699a41e" xlink:to="loc_us-gaap_DebtInstrumentTable_6f616d66-e04b-40fb-af36-07051c095f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ffc07d62-014b-4069-93fb-6f2de43cace8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6f616d66-e04b-40fb-af36-07051c095f83" xlink:to="loc_us-gaap_DebtInstrumentAxis_ffc07d62-014b-4069-93fb-6f2de43cace8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8fdc6166-7213-4794-b9f1-996d74f9773b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ffc07d62-014b-4069-93fb-6f2de43cace8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8fdc6166-7213-4794-b9f1-996d74f9773b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_ff13df0c-262a-49fc-9cb2-12820b9a68ea" xlink:href="mck-20201231.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8fdc6166-7213-4794-b9f1-996d74f9773b" xlink:to="loc_mck_A090NotesDueDecember32025Member_ff13df0c-262a-49fc-9cb2-12820b9a68ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A365NotesDueNovember302020Member_f4a0a63d-1eeb-4d80-947b-473297eb7f14" xlink:href="mck-20201231.xsd#mck_A365NotesDueNovember302020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8fdc6166-7213-4794-b9f1-996d74f9773b" xlink:to="loc_mck_A365NotesDueNovember302020Member_f4a0a63d-1eeb-4d80-947b-473297eb7f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMarch12021Member_68a8208a-a701-4cfb-95e5-762b51b943c1" xlink:href="mck-20201231.xsd#mck_A475NotesDueMarch12021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8fdc6166-7213-4794-b9f1-996d74f9773b" xlink:to="loc_mck_A475NotesDueMarch12021Member_68a8208a-a701-4cfb-95e5-762b51b943c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d650b7d6-46c5-4aad-8a26-99f39e5c29f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6f616d66-e04b-40fb-af36-07051c095f83" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d650b7d6-46c5-4aad-8a26-99f39e5c29f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_06185953-db30-4e6f-bce3-e82b52c1886c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d650b7d6-46c5-4aad-8a26-99f39e5c29f8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_06185953-db30-4e6f-bce3-e82b52c1886c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_e5dac128-1d24-4250-8643-52f91485be6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_06185953-db30-4e6f-bce3-e82b52c1886c" xlink:to="loc_us-gaap_LoansPayableMember_e5dac128-1d24-4250-8643-52f91485be6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_14e0ea48-1f8f-41fd-8516-2f283aa46e1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6f616d66-e04b-40fb-af36-07051c095f83" xlink:to="loc_us-gaap_DebtInstrumentLineItems_14e0ea48-1f8f-41fd-8516-2f283aa46e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_30c2a482-5440-4e8f-8433-dcbe7cc30011" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14e0ea48-1f8f-41fd-8516-2f283aa46e1b" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_30c2a482-5440-4e8f-8433-dcbe7cc30011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_32f1f454-1139-43bb-a1b8-a88e04eefd74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14e0ea48-1f8f-41fd-8516-2f283aa46e1b" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_32f1f454-1139-43bb-a1b8-a88e04eefd74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_7bf10eff-2748-444c-95c2-a144d5e4c475" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14e0ea48-1f8f-41fd-8516-2f283aa46e1b" xlink:to="loc_us-gaap_DebtInstrumentTerm_7bf10eff-2748-444c-95c2-a144d5e4c475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c9eb1b9d-ad8b-4517-a153-5b623392df7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14e0ea48-1f8f-41fd-8516-2f283aa46e1b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c9eb1b9d-ad8b-4517-a153-5b623392df7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_d06912a4-3f66-4f2f-aaac-0f188eaf43d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14e0ea48-1f8f-41fd-8516-2f283aa46e1b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_d06912a4-3f66-4f2f-aaac-0f188eaf43d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_5fedd45e-b8b5-4530-b3ec-18aeb1510f10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14e0ea48-1f8f-41fd-8516-2f283aa46e1b" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_5fedd45e-b8b5-4530-b3ec-18aeb1510f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_cf313d53-8783-442c-b1a2-63650daa6b61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14e0ea48-1f8f-41fd-8516-2f283aa46e1b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_cf313d53-8783-442c-b1a2-63650daa6b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_69802b0e-efff-4f0c-bf88-9780e68cbcf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_11fd98d5-69cc-4811-b0e5-23ee21ca9c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_69802b0e-efff-4f0c-bf88-9780e68cbcf8" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_11fd98d5-69cc-4811-b0e5-23ee21ca9c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_34614e58-3b66-40ee-b841-cf73dbe0d832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_11fd98d5-69cc-4811-b0e5-23ee21ca9c7b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_34614e58-3b66-40ee-b841-cf73dbe0d832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8ae9aa51-df75-41f4-88f9-fef2dd244d33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_34614e58-3b66-40ee-b841-cf73dbe0d832" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8ae9aa51-df75-41f4-88f9-fef2dd244d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_5a39119f-0091-4e79-a57d-113b5fa50cc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8ae9aa51-df75-41f4-88f9-fef2dd244d33" xlink:to="loc_us-gaap_UnsecuredDebtMember_5a39119f-0091-4e79-a57d-113b5fa50cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_47563849-22a7-426e-aba5-c3329de250a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_11fd98d5-69cc-4811-b0e5-23ee21ca9c7b" xlink:to="loc_us-gaap_CreditFacilityAxis_47563849-22a7-426e-aba5-c3329de250a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f572796c-a4ac-4783-a3b2-05b6463144ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_47563849-22a7-426e-aba5-c3329de250a2" xlink:to="loc_us-gaap_CreditFacilityDomain_f572796c-a4ac-4783-a3b2-05b6463144ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_2ccfbec0-9fc4-4eea-86d1-bd8add688648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f572796c-a4ac-4783-a3b2-05b6463144ce" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_2ccfbec0-9fc4-4eea-86d1-bd8add688648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_aa0ca80f-8157-4bc1-9d83-a778d66ffe97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f572796c-a4ac-4783-a3b2-05b6463144ce" xlink:to="loc_us-gaap_LineOfCreditMember_aa0ca80f-8157-4bc1-9d83-a778d66ffe97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_650df279-adc2-4499-91fe-bdf2e8831c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_11fd98d5-69cc-4811-b0e5-23ee21ca9c7b" xlink:to="loc_us-gaap_DebtInstrumentAxis_650df279-adc2-4499-91fe-bdf2e8831c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_da86f16f-6b41-49e2-9a9b-242f6293e3f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_650df279-adc2-4499-91fe-bdf2e8831c66" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_da86f16f-6b41-49e2-9a9b-242f6293e3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_e2ed4b87-74d2-412a-90e1-ba8e0e7582bd" xlink:href="mck-20201231.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_da86f16f-6b41-49e2-9a9b-242f6293e3f3" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_e2ed4b87-74d2-412a-90e1-ba8e0e7582bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_acc5d8b4-ece5-4252-96fa-de76d8b8283e" xlink:href="mck-20201231.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_da86f16f-6b41-49e2-9a9b-242f6293e3f3" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_acc5d8b4-ece5-4252-96fa-de76d8b8283e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember_f236f55e-1da8-4595-8080-7c0de20aff91" xlink:href="mck-20201231.xsd#mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_da86f16f-6b41-49e2-9a9b-242f6293e3f3" xlink:to="loc_mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember_f236f55e-1da8-4595-8080-7c0de20aff91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_c760b9d4-e12e-4f44-96dd-acce4b5956a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_11fd98d5-69cc-4811-b0e5-23ee21ca9c7b" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_c760b9d4-e12e-4f44-96dd-acce4b5956a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c11c3140-e76e-4d9b-a305-0ac89699bbf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c760b9d4-e12e-4f44-96dd-acce4b5956a8" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c11c3140-e76e-4d9b-a305-0ac89699bbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_d9420622-2aef-4bfb-878e-23cd2c8b6646" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c760b9d4-e12e-4f44-96dd-acce4b5956a8" xlink:to="loc_us-gaap_DebtInstrumentTerm_d9420622-2aef-4bfb-878e-23cd2c8b6646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_7b64f808-5000-4144-9e4c-a67eb42824e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c760b9d4-e12e-4f44-96dd-acce4b5956a8" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_7b64f808-5000-4144-9e4c-a67eb42824e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_93071afd-ae4a-43e0-a770-7c30e7e06553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c760b9d4-e12e-4f44-96dd-acce4b5956a8" xlink:to="loc_us-gaap_LineOfCredit_93071afd-ae4a-43e0-a770-7c30e7e06553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_36b0d3db-cab7-414d-a87e-80e45ed7f187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c760b9d4-e12e-4f44-96dd-acce4b5956a8" xlink:to="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_36b0d3db-cab7-414d-a87e-80e45ed7f187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_9897951b-b190-4d51-8e3c-652a09d93f0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c760b9d4-e12e-4f44-96dd-acce4b5956a8" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_9897951b-b190-4d51-8e3c-652a09d93f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#DebtandFinancingActivitiesCommercialPaperDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_168dbad4-443b-4a27-818f-01272d9eef48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4f56a43b-27a1-453e-8a28-2429370b9c75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_168dbad4-443b-4a27-818f-01272d9eef48" xlink:to="loc_us-gaap_DebtInstrumentTable_4f56a43b-27a1-453e-8a28-2429370b9c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c0b26470-bf7f-4e09-9b71-78d8228d9949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4f56a43b-27a1-453e-8a28-2429370b9c75" xlink:to="loc_us-gaap_CreditFacilityAxis_c0b26470-bf7f-4e09-9b71-78d8228d9949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8be77375-0217-4134-9c92-7bfc62c52c36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_c0b26470-bf7f-4e09-9b71-78d8228d9949" xlink:to="loc_us-gaap_CreditFacilityDomain_8be77375-0217-4134-9c92-7bfc62c52c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_7cd7d1e6-9fc3-479c-9c53-e156b87bcbb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_8be77375-0217-4134-9c92-7bfc62c52c36" xlink:to="loc_us-gaap_CommercialPaperMember_7cd7d1e6-9fc3-479c-9c53-e156b87bcbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c7649511-3275-411b-95f0-e1c400b335e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4f56a43b-27a1-453e-8a28-2429370b9c75" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c7649511-3275-411b-95f0-e1c400b335e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_96e540d6-49c2-4eb8-908c-aaec4f75e3c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c7649511-3275-411b-95f0-e1c400b335e2" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_96e540d6-49c2-4eb8-908c-aaec4f75e3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_4c573b9f-2796-439c-ac2a-7d83e57933d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c7649511-3275-411b-95f0-e1c400b335e2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_4c573b9f-2796-439c-ac2a-7d83e57933d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_aae2e140-77ba-462f-898e-53207729bf6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c7649511-3275-411b-95f0-e1c400b335e2" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_aae2e140-77ba-462f-898e-53207729bf6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermCommercialPaperCurrent_a58a8201-0c22-44c2-9f74-c6eee8a64299" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermCommercialPaperCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c7649511-3275-411b-95f0-e1c400b335e2" xlink:to="loc_us-gaap_LongTermCommercialPaperCurrent_a58a8201-0c22-44c2-9f74-c6eee8a64299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_7efe1059-7218-4bac-9d3a-27eb05ede1c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c7649511-3275-411b-95f0-e1c400b335e2" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_7efe1059-7218-4bac-9d3a-27eb05ede1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StatementofIncomeIncludingGrossMarginStatement" xlink:type="simple" xlink:href="mck-20201231.xsd#StatementofIncomeIncludingGrossMarginStatement"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StatementofIncomeIncludingGrossMarginStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_9d190a31-b05c-4620-ac13-074d6e0073f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefits" xlink:type="simple" xlink:href="mck-20201231.xsd#PensionBenefits"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_daa6a0d9-8bcd-4b80-b463-a74f3a293d98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_3c61bae6-65fb-4bc5-9c59-296fe61d63f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_daa6a0d9-8bcd-4b80-b463-a74f3a293d98" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_3c61bae6-65fb-4bc5-9c59-296fe61d63f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#PensionBenefitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3e2ed899-1083-4949-adbb-c4488b8186df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d87889c4-4436-4f17-b6e5-e5679c65516c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3e2ed899-1083-4949-adbb-c4488b8186df" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d87889c4-4436-4f17-b6e5-e5679c65516c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_ed7c1d01-1c89-4579-a3df-a09109289363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d87889c4-4436-4f17-b6e5-e5679c65516c" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_ed7c1d01-1c89-4579-a3df-a09109289363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_988a45e9-9b06-4f74-9e2b-5871d313fc76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ed7c1d01-1c89-4579-a3df-a09109289363" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_988a45e9-9b06-4f74-9e2b-5871d313fc76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d3c1c8f9-a963-49a4-808a-927d32f6a92e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_988a45e9-9b06-4f74-9e2b-5871d313fc76" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d3c1c8f9-a963-49a4-808a-927d32f6a92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_6b9342fe-7dcf-44d5-ab04-bd140a1a8d7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d87889c4-4436-4f17-b6e5-e5679c65516c" xlink:to="loc_us-gaap_RetirementPlanNameAxis_6b9342fe-7dcf-44d5-ab04-bd140a1a8d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_5a5b7062-fc04-41ca-8088-bd9dee4011bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_6b9342fe-7dcf-44d5-ab04-bd140a1a8d7d" xlink:to="loc_us-gaap_RetirementPlanNameDomain_5a5b7062-fc04-41ca-8088-bd9dee4011bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExecutiveBenefitRetirementPlanMember_0c6f8038-e150-48ef-a330-543e3d7a6a8c" xlink:href="mck-20201231.xsd#mck_ExecutiveBenefitRetirementPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_5a5b7062-fc04-41ca-8088-bd9dee4011bb" xlink:to="loc_mck_ExecutiveBenefitRetirementPlanMember_0c6f8038-e150-48ef-a330-543e3d7a6a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_88c3ebac-b61f-4724-ba00-cbd95b250cc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d87889c4-4436-4f17-b6e5-e5679c65516c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_88c3ebac-b61f-4724-ba00-cbd95b250cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_8bf87166-74d9-4fac-b3d1-8cc39189aace" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_88c3ebac-b61f-4724-ba00-cbd95b250cc9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_8bf87166-74d9-4fac-b3d1-8cc39189aace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_aa1e7e4c-b10b-46fb-8382-5085cf000031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_8bf87166-74d9-4fac-b3d1-8cc39189aace" xlink:to="loc_us-gaap_DomesticPlanMember_aa1e7e4c-b10b-46fb-8382-5085cf000031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_7ed51c36-44ae-469b-91dd-39b117ffa8ad" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_aa1e7e4c-b10b-46fb-8382-5085cf000031" xlink:to="loc_country_US_7ed51c36-44ae-469b-91dd-39b117ffa8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_02dda6e8-219c-400f-adaf-dcdb2b27018d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d87889c4-4436-4f17-b6e5-e5679c65516c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_02dda6e8-219c-400f-adaf-dcdb2b27018d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d577afcb-85a3-4124-b64d-ebfd6a3ffab5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_02dda6e8-219c-400f-adaf-dcdb2b27018d" xlink:to="loc_us-gaap_EquityComponentDomain_d577afcb-85a3-4124-b64d-ebfd6a3ffab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_c842a6fe-f377-4341-8e64-ad90e3d5300b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d577afcb-85a3-4124-b64d-ebfd6a3ffab5" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_c842a6fe-f377-4341-8e64-ad90e3d5300b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d0a5b98c-0abd-4868-ad49-8b579c4eb4f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d87889c4-4436-4f17-b6e5-e5679c65516c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d0a5b98c-0abd-4868-ad49-8b579c4eb4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5090c88-1995-4d35-a0fe-0409d9e005f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d0a5b98c-0abd-4868-ad49-8b579c4eb4f0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5090c88-1995-4d35-a0fe-0409d9e005f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_deacd40e-ca08-4e4d-8586-3d0bb61db049" xlink:href="mck-20201231.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5090c88-1995-4d35-a0fe-0409d9e005f5" xlink:to="loc_mck_GermanWholesaleBusinessMember_deacd40e-ca08-4e4d-8586-3d0bb61db049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_66e3c00e-fd82-42e9-a5c3-0467135c40e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d87889c4-4436-4f17-b6e5-e5679c65516c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_66e3c00e-fd82-42e9-a5c3-0467135c40e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7f62b1cb-6a59-4c4c-96e1-8b0352b2e976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_66e3c00e-fd82-42e9-a5c3-0467135c40e2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7f62b1cb-6a59-4c4c-96e1-8b0352b2e976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_228dd7eb-a865-438e-92df-52a665800763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7f62b1cb-6a59-4c4c-96e1-8b0352b2e976" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_228dd7eb-a865-438e-92df-52a665800763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d87889c4-4436-4f17-b6e5-e5679c65516c" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_29480089-ed63-4daf-b29a-1146278f2d22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_29480089-ed63-4daf-b29a-1146278f2d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_01963b97-6cd4-4ed0-b38b-59497dd745e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_01963b97-6cd4-4ed0-b38b-59497dd745e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_9ca4b6f4-2360-4242-a1f3-bdd06a8e43b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_9ca4b6f4-2360-4242-a1f3-bdd06a8e43b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedPercentage_224794f6-87fa-4317-9257-1105ae5029a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedPercentage_224794f6-87fa-4317-9257-1105ae5029a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPensionPlanLiabilitiesDerecognized_cbaada5e-880c-4cbd-a65f-dc719c70b439" xlink:href="mck-20201231.xsd#mck_DefinedBenefitPensionPlanLiabilitiesDerecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_mck_DefinedBenefitPensionPlanLiabilitiesDerecognized_cbaada5e-880c-4cbd-a65f-dc719c70b439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease_fc336ab9-da9d-4f1f-beb4-a73f867bc926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease_fc336ab9-da9d-4f1f-beb4-a73f867bc926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanSettlementPlanParticipants_ea216ffd-a90c-4e50-b640-a20e7fe95553" xlink:href="mck-20201231.xsd#mck_DefinedBenefitPlanSettlementPlanParticipants"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_mck_DefinedBenefitPlanSettlementPlanParticipants_ea216ffd-a90c-4e50-b640-a20e7fe95553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_2bb2b150-6e72-4323-9e6b-02e72b7dab05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_2bb2b150-6e72-4323-9e6b-02e72b7dab05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_7b66ad28-2df2-4a5b-a982-784ec170c6ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_7b66ad28-2df2-4a5b-a982-784ec170c6ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_8b7cb0e8-c759-4341-a691-7bb51976cbb7" xlink:href="mck-20201231.xsd#mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_91e96afc-587f-4eb3-960c-834e058ce357" xlink:to="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_8b7cb0e8-c759-4341-a691-7bb51976cbb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_7ca00a84-9c2c-4101-b8a1-88b0bbd31e4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivities" xlink:type="simple" xlink:href="mck-20201231.xsd#HedgingActivities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_75c4b6fe-7326-46a4-ac3e-afc1607a3950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_713533a9-ea28-4635-8e86-545812357c78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_75c4b6fe-7326-46a4-ac3e-afc1607a3950" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_713533a9-ea28-4635-8e86-545812357c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="simple" xlink:href="mck-20201231.xsd#HedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_96de110e-e22c-4c53-8744-19f51422adc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_ad30eab2-dee2-4ab6-b6d7-3f59420949bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_96de110e-e22c-4c53-8744-19f51422adc4" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_ad30eab2-dee2-4ab6-b6d7-3f59420949bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_90cee0b0-a369-4434-a5c6-65d9e3ae0196" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_63cc6335-9d9f-4d89-b9ff-e68f68f357e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_90cee0b0-a369-4434-a5c6-65d9e3ae0196" xlink:to="loc_us-gaap_DerivativeTable_63cc6335-9d9f-4d89-b9ff-e68f68f357e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6dc54095-2ec6-4699-8086-fe1a8a1a3509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_63cc6335-9d9f-4d89-b9ff-e68f68f357e3" xlink:to="loc_us-gaap_DebtInstrumentAxis_6dc54095-2ec6-4699-8086-fe1a8a1a3509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_22d87eb3-ad2f-4cb7-8d45-24a49a0fe627" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6dc54095-2ec6-4699-8086-fe1a8a1a3509" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_22d87eb3-ad2f-4cb7-8d45-24a49a0fe627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_a5b1277a-6718-44df-a599-c3bc959796cf" xlink:href="mck-20201231.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_22d87eb3-ad2f-4cb7-8d45-24a49a0fe627" xlink:to="loc_mck_EuroDenominatedNotesMember_a5b1277a-6718-44df-a599-c3bc959796cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_e04b9b86-e0b4-45d3-999f-a99f17390f9c" xlink:href="mck-20201231.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_22d87eb3-ad2f-4cb7-8d45-24a49a0fe627" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_e04b9b86-e0b4-45d3-999f-a99f17390f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2025NotesMember_321dc822-ac93-4a3c-a5b1-213929c65d4f" xlink:href="mck-20201231.xsd#mck_A2025NotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_22d87eb3-ad2f-4cb7-8d45-24a49a0fe627" xlink:to="loc_mck_A2025NotesMember_321dc822-ac93-4a3c-a5b1-213929c65d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5e6f72f3-cf7b-4de5-971c-6d6f7173988c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_63cc6335-9d9f-4d89-b9ff-e68f68f357e3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5e6f72f3-cf7b-4de5-971c-6d6f7173988c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_76f8b183-95a1-4fb2-a8ae-af7104a4dc97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5e6f72f3-cf7b-4de5-971c-6d6f7173988c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_76f8b183-95a1-4fb2-a8ae-af7104a4dc97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_b888547f-6784-42fb-b2f8-d1f51381593e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_76f8b183-95a1-4fb2-a8ae-af7104a4dc97" xlink:to="loc_us-gaap_LoansPayableMember_b888547f-6784-42fb-b2f8-d1f51381593e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_301b2c98-fd51-4f26-b36c-d2dffd8ea519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_63cc6335-9d9f-4d89-b9ff-e68f68f357e3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_301b2c98-fd51-4f26-b36c-d2dffd8ea519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b0fe46bd-a079-4d2f-aec1-5c84f9e80699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_301b2c98-fd51-4f26-b36c-d2dffd8ea519" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b0fe46bd-a079-4d2f-aec1-5c84f9e80699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_b0c58ce2-d64f-4fbd-bfa9-ef325217d97c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b0fe46bd-a079-4d2f-aec1-5c84f9e80699" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_b0c58ce2-d64f-4fbd-bfa9-ef325217d97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_26017673-e91b-44bd-8689-9eb4f8c9ac01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b0fe46bd-a079-4d2f-aec1-5c84f9e80699" xlink:to="loc_us-gaap_CashFlowHedgingMember_26017673-e91b-44bd-8689-9eb4f8c9ac01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b9142a79-1a78-4d5e-9238-f6e2ef236ec0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_63cc6335-9d9f-4d89-b9ff-e68f68f357e3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b9142a79-1a78-4d5e-9238-f6e2ef236ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8ccaf2ff-5f73-4f26-9e0b-7ff38398a52f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b9142a79-1a78-4d5e-9238-f6e2ef236ec0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8ccaf2ff-5f73-4f26-9e0b-7ff38398a52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_November2018CrossCurrencySwapsMember_baa243cf-e726-4300-b207-0598b660f4c3" xlink:href="mck-20201231.xsd#mck_November2018CrossCurrencySwapsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8ccaf2ff-5f73-4f26-9e0b-7ff38398a52f" xlink:to="loc_mck_November2018CrossCurrencySwapsMember_baa243cf-e726-4300-b207-0598b660f4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_193b2c60-9c49-4568-ad08-1dbd97af5ae0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8ccaf2ff-5f73-4f26-9e0b-7ff38398a52f" xlink:to="loc_us-gaap_CurrencySwapMember_193b2c60-9c49-4568-ad08-1dbd97af5ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e69ead89-c04f-4fe4-a7c2-2b4fee7f57a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8ccaf2ff-5f73-4f26-9e0b-7ff38398a52f" xlink:to="loc_us-gaap_InterestRateSwapMember_e69ead89-c04f-4fe4-a7c2-2b4fee7f57a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_6b9d4409-5dbf-42bc-9a43-188c9e11c849" xlink:href="mck-20201231.xsd#mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8ccaf2ff-5f73-4f26-9e0b-7ff38398a52f" xlink:to="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_6b9d4409-5dbf-42bc-9a43-188c9e11c849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_fd19c4bd-60fb-4684-b15f-1ca90cc4e55f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_63cc6335-9d9f-4d89-b9ff-e68f68f357e3" xlink:to="loc_us-gaap_HedgingDesignationAxis_fd19c4bd-60fb-4684-b15f-1ca90cc4e55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_bfcb8fb4-582e-48b2-bf0e-1f5e41f069b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_fd19c4bd-60fb-4684-b15f-1ca90cc4e55f" xlink:to="loc_us-gaap_HedgingDesignationDomain_bfcb8fb4-582e-48b2-bf0e-1f5e41f069b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2fb67a21-6939-4723-9754-87fd6d260401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_bfcb8fb4-582e-48b2-bf0e-1f5e41f069b0" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2fb67a21-6939-4723-9754-87fd6d260401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_d3dfc605-f7de-4162-8d83-71e6b9a3fcef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_bfcb8fb4-582e-48b2-bf0e-1f5e41f069b0" xlink:to="loc_us-gaap_NondesignatedMember_d3dfc605-f7de-4162-8d83-71e6b9a3fcef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_63cc6335-9d9f-4d89-b9ff-e68f68f357e3" xlink:to="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d573e76c-bf34-422f-9053-e321840715be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_us-gaap_LongTermDebt_d573e76c-bf34-422f-9053-e321840715be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_bfe00421-45c6-43d4-8a6a-4cd6554e7c4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_bfe00421-45c6-43d4-8a6a-4cd6554e7c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_fee89c05-2370-4cb2-80dc-8929eb702265" xlink:href="mck-20201231.xsd#mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_fee89c05-2370-4cb2-80dc-8929eb702265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_a6623425-7b2a-41c0-88b9-d25405205771" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_us-gaap_DerivativeNotionalAmount_a6623425-7b2a-41c0-88b9-d25405205771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_f15ee9ea-2f30-44e7-a489-f73812e0e7d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_f15ee9ea-2f30-44e7-a489-f73812e0e7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_ea89c8ff-7ba2-4318-be03-7ec51c3b283c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_ea89c8ff-7ba2-4318-be03-7ec51c3b283c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_75abd86d-9a8a-442c-8732-03529a69d33b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_75abd86d-9a8a-442c-8732-03529a69d33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_69fa08dd-3ef5-4eb3-8cbd-f7d854d30fed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_69fa08dd-3ef5-4eb3-8cbd-f7d854d30fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_c8db7c9d-deec-41e4-8b99-1d8fdce73937" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_cec8bd6a-9427-4f8d-9a8d-5f779abd99a6" xlink:to="loc_us-gaap_DebtInstrumentTerm_c8db7c9d-deec-41e4-8b99-1d8fdce73937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#HedgingActivitiesDerivativeInstrumentsFairValueDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d9ec5302-33c8-4cc5-bdb6-4c804681cd0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8d4b740-ec88-4a15-bc77-c487a10ab456" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d9ec5302-33c8-4cc5-bdb6-4c804681cd0c" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8d4b740-ec88-4a15-bc77-c487a10ab456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0258da99-f936-4c70-a898-629bc8b60323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8d4b740-ec88-4a15-bc77-c487a10ab456" xlink:to="loc_us-gaap_HedgingDesignationAxis_0258da99-f936-4c70-a898-629bc8b60323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1c3f8f31-689d-4e2c-9ac3-d39e9246a8ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_0258da99-f936-4c70-a898-629bc8b60323" xlink:to="loc_us-gaap_HedgingDesignationDomain_1c3f8f31-689d-4e2c-9ac3-d39e9246a8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3a205b69-1cd1-4b4d-ad1a-719f44b71cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_1c3f8f31-689d-4e2c-9ac3-d39e9246a8ea" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3a205b69-1cd1-4b4d-ad1a-719f44b71cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_bd5cb7d2-502a-4ee5-ae05-0e644c49cbd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_1c3f8f31-689d-4e2c-9ac3-d39e9246a8ea" xlink:to="loc_us-gaap_NondesignatedMember_bd5cb7d2-502a-4ee5-ae05-0e644c49cbd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a7cbfeac-23f7-4215-8e16-614a5f422937" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8d4b740-ec88-4a15-bc77-c487a10ab456" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a7cbfeac-23f7-4215-8e16-614a5f422937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1d2ebc89-769d-4ebe-b125-8bab484839dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a7cbfeac-23f7-4215-8e16-614a5f422937" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1d2ebc89-769d-4ebe-b125-8bab484839dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_af0cf686-c5f4-4aeb-afb7-91eb27ca143a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1d2ebc89-769d-4ebe-b125-8bab484839dd" xlink:to="loc_us-gaap_CurrencySwapMember_af0cf686-c5f4-4aeb-afb7-91eb27ca143a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b1bb7fd4-013c-4dda-b44f-9fd701d283a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1d2ebc89-769d-4ebe-b125-8bab484839dd" xlink:to="loc_us-gaap_InterestRateSwapMember_b1bb7fd4-013c-4dda-b44f-9fd701d283a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_66a2e185-534d-4293-865b-5c0b898695c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1d2ebc89-769d-4ebe-b125-8bab484839dd" xlink:to="loc_us-gaap_ForeignExchangeContractMember_66a2e185-534d-4293-865b-5c0b898695c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6af55a03-a04e-4376-9a28-2e81ce6f16f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8d4b740-ec88-4a15-bc77-c487a10ab456" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6af55a03-a04e-4376-9a28-2e81ce6f16f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_51d17932-d0ee-4eb7-af11-d75d1981f06b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6af55a03-a04e-4376-9a28-2e81ce6f16f5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_51d17932-d0ee-4eb7-af11-d75d1981f06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_89689689-c603-47c1-8361-583d1d5273be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_51d17932-d0ee-4eb7-af11-d75d1981f06b" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_89689689-c603-47c1-8361-583d1d5273be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_7250d2f0-5902-4ef6-8316-ab1964b5f5d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_51d17932-d0ee-4eb7-af11-d75d1981f06b" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_7250d2f0-5902-4ef6-8316-ab1964b5f5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember_bd27a42e-51c4-4e5d-b5c0-f7fb440cfd6f" xlink:href="mck-20201231.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_51d17932-d0ee-4eb7-af11-d75d1981f06b" xlink:to="loc_mck_CurrentAssetLiabilityMember_bd27a42e-51c4-4e5d-b5c0-f7fb440cfd6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_2a744d29-da72-471b-b056-b91c5f6621d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_51d17932-d0ee-4eb7-af11-d75d1981f06b" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_2a744d29-da72-471b-b056-b91c5f6621d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_9613951f-6a90-4e0a-b6b1-9612777b9e75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_51d17932-d0ee-4eb7-af11-d75d1981f06b" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_9613951f-6a90-4e0a-b6b1-9612777b9e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncurrentAssetLiabilityMember_097938ff-72d0-45ad-a6e1-ac7cb2c4075b" xlink:href="mck-20201231.xsd#mck_NoncurrentAssetLiabilityMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_51d17932-d0ee-4eb7-af11-d75d1981f06b" xlink:to="loc_mck_NoncurrentAssetLiabilityMember_097938ff-72d0-45ad-a6e1-ac7cb2c4075b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_1ac1a774-5d29-4e5f-bb5c-439186c0209b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d8d4b740-ec88-4a15-bc77-c487a10ab456" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_1ac1a774-5d29-4e5f-bb5c-439186c0209b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a02235d4-f960-4c89-a4df-a6768e70106e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_1ac1a774-5d29-4e5f-bb5c-439186c0209b" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a02235d4-f960-4c89-a4df-a6768e70106e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_1aa70a61-8c22-4c4b-82d0-4ab1698e4228" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_1ac1a774-5d29-4e5f-bb5c-439186c0209b" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_1aa70a61-8c22-4c4b-82d0-4ab1698e4228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_4c1fc621-43cc-43fd-83f0-788a2df728bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_1ac1a774-5d29-4e5f-bb5c-439186c0209b" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_4c1fc621-43cc-43fd-83f0-788a2df728bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_9ec2a2ba-be18-4259-82e0-e6517024899e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_1ac1a774-5d29-4e5f-bb5c-439186c0209b" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_9ec2a2ba-be18-4259-82e0-e6517024899e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mck-20201231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7105cd12-8cfa-4133-bdb5-8fc58cb599f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_94d5bf85-6ec4-4c1e-8cee-b57b635d8db6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7105cd12-8cfa-4133-bdb5-8fc58cb599f1" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_94d5bf85-6ec4-4c1e-8cee-b57b635d8db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0450c9de-0cf6-4241-b5da-7e5e89b5ea9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_83015e6a-79f4-4b13-9cf5-e84d1b366047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0450c9de-0cf6-4241-b5da-7e5e89b5ea9b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_83015e6a-79f4-4b13-9cf5-e84d1b366047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fe903078-ca50-4e80-a524-dd814cda19f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_83015e6a-79f4-4b13-9cf5-e84d1b366047" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fe903078-ca50-4e80-a524-dd814cda19f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_af83a1a1-da32-49a7-a4d0-54bd2a011222" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fe903078-ca50-4e80-a524-dd814cda19f1" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_af83a1a1-da32-49a7-a4d0-54bd2a011222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4b8b0500-7855-4396-ac30-fb1f1003a7b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_af83a1a1-da32-49a7-a4d0-54bd2a011222" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4b8b0500-7855-4396-ac30-fb1f1003a7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_e6e76272-c8e7-4e7e-9a7f-7722ac87cd1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_af83a1a1-da32-49a7-a4d0-54bd2a011222" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_e6e76272-c8e7-4e7e-9a7f-7722ac87cd1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fb1f281e-b7df-4dbc-bca3-bc20c56180ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_83015e6a-79f4-4b13-9cf5-e84d1b366047" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fb1f281e-b7df-4dbc-bca3-bc20c56180ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2ab2631f-ccb2-44ab-b61b-af4fa3e6cc2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fb1f281e-b7df-4dbc-bca3-bc20c56180ea" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2ab2631f-ccb2-44ab-b61b-af4fa3e6cc2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_bc2f39f6-35ce-4eeb-ba3b-2375f244b3ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2ab2631f-ccb2-44ab-b61b-af4fa3e6cc2f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_bc2f39f6-35ce-4eeb-ba3b-2375f244b3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5fdbb1c0-c2cb-433d-b104-089d1be1f9e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2ab2631f-ccb2-44ab-b61b-af4fa3e6cc2f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5fdbb1c0-c2cb-433d-b104-089d1be1f9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_83015e6a-79f4-4b13-9cf5-e84d1b366047" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5ef769e0-b104-4800-9e33-2f6070de26e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:to="loc_us-gaap_LongTermDebt_5ef769e0-b104-4800-9e33-2f6070de26e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_92582c33-38be-4b00-9a9a-4f2836c62e83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:to="loc_us-gaap_DebtInstrumentFairValue_92582c33-38be-4b00-9a9a-4f2836c62e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_783b23ba-b2a5-4955-b966-eab84174c526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_783b23ba-b2a5-4955-b966-eab84174c526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_a377d1d8-60bb-4f9b-9549-c8ead959be33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_a377d1d8-60bb-4f9b-9549-c8ead959be33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies_8ef9e647-d8dd-4ede-a2af-dd31afa866b8" xlink:href="mck-20201231.xsd#mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:to="loc_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies_8ef9e647-d8dd-4ede-a2af-dd31afa866b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices_9c31a91c-e3d8-45a0-ae29-42a14a75e303" xlink:href="mck-20201231.xsd#mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:to="loc_mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices_9c31a91c-e3d8-45a0-ae29-42a14a75e303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_3ce5b043-0b98-4806-b0e3-32bf7c8deda3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_3ce5b043-0b98-4806-b0e3-32bf7c8deda3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_b25d330b-73b1-4cef-a638-b8775d3c88d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d73fffc-48f0-4bf3-a89d-b300ab7adaca" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_b25d330b-73b1-4cef-a638-b8775d3c88d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="simple" xlink:href="mck-20201231.xsd#CommitmentsandContingentLiabilities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f2726535-9560-40af-9814-ae7c980f3445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_12944951-2695-419b-b159-ced86498d8cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f2726535-9560-40af-9814-ae7c980f3445" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_12944951-2695-419b-b159-ced86498d8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#CommitmentsandContingentLiabilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_20ce0dcf-70bd-42f1-b832-b8ba7f285df5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_6af6df30-e7a8-4021-a39e-16e8cd8186f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_20ce0dcf-70bd-42f1-b832-b8ba7f285df5" xlink:to="loc_us-gaap_LossContingenciesTable_6af6df30-e7a8-4021-a39e-16e8cd8186f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_29d89cc8-2b88-49c5-a683-beccfd810652" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6af6df30-e7a8-4021-a39e-16e8cd8186f4" xlink:to="loc_us-gaap_LitigationStatusAxis_29d89cc8-2b88-49c5-a683-beccfd810652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_97b81571-bbaf-4fcc-b1d0-f1d2af66be34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_29d89cc8-2b88-49c5-a683-beccfd810652" xlink:to="loc_us-gaap_LitigationStatusDomain_97b81571-bbaf-4fcc-b1d0-f1d2af66be34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_d0ab1425-faa0-4a17-bf4a-00d939b1136e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_97b81571-bbaf-4fcc-b1d0-f1d2af66be34" xlink:to="loc_us-gaap_PendingLitigationMember_d0ab1425-faa0-4a17-bf4a-00d939b1136e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b04de950-6388-407d-81e9-3a8d1ee95e77" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6af6df30-e7a8-4021-a39e-16e8cd8186f4" xlink:to="loc_dei_LegalEntityAxis_b04de950-6388-407d-81e9-3a8d1ee95e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fc8af7ac-082d-452a-868f-fa99331ccbf8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_b04de950-6388-407d-81e9-3a8d1ee95e77" xlink:to="loc_dei_EntityDomain_fc8af7ac-082d-452a-868f-fa99331ccbf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_e2e8c8ac-bc3c-426e-8e88-50ba34458dfc" xlink:href="mck-20201231.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_fc8af7ac-082d-452a-868f-fa99331ccbf8" xlink:to="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_e2e8c8ac-bc3c-426e-8e88-50ba34458dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_422f5ccb-08f7-417a-afca-58114b7901dc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6af6df30-e7a8-4021-a39e-16e8cd8186f4" xlink:to="loc_srt_StatementGeographicalAxis_422f5ccb-08f7-417a-afca-58114b7901dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8cd95211-a58b-43e5-81c4-76f70c72cd4d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_422f5ccb-08f7-417a-afca-58114b7901dc" xlink:to="loc_srt_SegmentGeographicalDomain_8cd95211-a58b-43e5-81c4-76f70c72cd4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_c3225357-6111-4a2e-8fa2-3cb1d5297a2f" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8cd95211-a58b-43e5-81c4-76f70c72cd4d" xlink:to="loc_country_CA_c3225357-6111-4a2e-8fa2-3cb1d5297a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_bb8a1071-84be-4598-9bd0-51f2ef03695f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6af6df30-e7a8-4021-a39e-16e8cd8186f4" xlink:to="loc_srt_LitigationCaseAxis_bb8a1071-84be-4598-9bd0-51f2ef03695f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b4322701-55d1-4608-b3ca-57c95882998a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_bb8a1071-84be-4598-9bd0-51f2ef03695f" xlink:to="loc_srt_LitigationCaseTypeDomain_b4322701-55d1-4608-b3ca-57c95882998a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_c2dcc0df-f469-4d67-b4bf-ceb138eb3cc3" xlink:href="mck-20201231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b4322701-55d1-4608-b3ca-57c95882998a" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_c2dcc0df-f469-4d67-b4bf-ceb138eb3cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_7da3090e-8412-479e-b0ee-811f88266a7f" xlink:href="mck-20201231.xsd#mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b4322701-55d1-4608-b3ca-57c95882998a" xlink:to="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_7da3090e-8412-479e-b0ee-811f88266a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member_6b10cf21-83aa-41eb-bc2f-fec15f9d844d" xlink:href="mck-20201231.xsd#mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b4322701-55d1-4608-b3ca-57c95882998a" xlink:to="loc_mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member_6b10cf21-83aa-41eb-bc2f-fec15f9d844d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_598d2450-e4e2-46fc-aa3b-75dcfece40f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6af6df30-e7a8-4021-a39e-16e8cd8186f4" xlink:to="loc_srt_RangeAxis_598d2450-e4e2-46fc-aa3b-75dcfece40f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5faf996c-f1f7-4d27-b41b-f0d252cbca6e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_598d2450-e4e2-46fc-aa3b-75dcfece40f8" xlink:to="loc_srt_RangeMember_5faf996c-f1f7-4d27-b41b-f0d252cbca6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_123b37e6-3c10-48ff-851c-9bfdd851768a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5faf996c-f1f7-4d27-b41b-f0d252cbca6e" xlink:to="loc_srt_MinimumMember_123b37e6-3c10-48ff-851c-9bfdd851768a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_02d2224e-dd39-4622-9595-a15ec66ebb61" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5faf996c-f1f7-4d27-b41b-f0d252cbca6e" xlink:to="loc_srt_MaximumMember_02d2224e-dd39-4622-9595-a15ec66ebb61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3f341e72-b92f-4ec0-9435-c624470df638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6af6df30-e7a8-4021-a39e-16e8cd8186f4" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3f341e72-b92f-4ec0-9435-c624470df638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_f51fc8a4-f6d5-4e22-80e1-e91306f487ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3f341e72-b92f-4ec0-9435-c624470df638" xlink:to="loc_us-gaap_LossContingencyNatureDomain_f51fc8a4-f6d5-4e22-80e1-e91306f487ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_72a4f106-e1bf-4aa4-bbb5-77014b4b0828" xlink:href="mck-20201231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_f51fc8a4-f6d5-4e22-80e1-e91306f487ae" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_72a4f106-e1bf-4aa4-bbb5-77014b4b0828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6af6df30-e7a8-4021-a39e-16e8cd8186f4" xlink:to="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_8b218ebe-3e4c-47f4-ac20-7ba8929ed326" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_8b218ebe-3e4c-47f4-ac20-7ba8929ed326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCounties_68dc7a93-4ac2-4369-82db-882dd42c1fda" xlink:href="mck-20201231.xsd#mck_LossContingencyNumberofCounties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencyNumberofCounties_68dc7a93-4ac2-4369-82db-882dd42c1fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_660d3a24-9aad-4d98-b4d8-6b433aadb26b" xlink:href="mck-20201231.xsd#mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_660d3a24-9aad-4d98-b4d8-6b433aadb26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_9b5ac5ab-85a7-45e6-91e8-f1a88901285c" xlink:href="mck-20201231.xsd#mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_9b5ac5ab-85a7-45e6-91e8-f1a88901285c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates_c381937e-27e1-4033-93a7-55b8117a9aab" xlink:href="mck-20201231.xsd#mck_LossContingencyNumberofStates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencyNumberofStates_c381937e-27e1-4033-93a7-55b8117a9aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStateAttorneyGenerals_39c3e4b1-eb6b-483b-8c24-7f9e81fca93c" xlink:href="mck-20201231.xsd#mck_LossContingencyNumberofStateAttorneyGenerals"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencyNumberofStateAttorneyGenerals_39c3e4b1-eb6b-483b-8c24-7f9e81fca93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfCountyGovernments_1ba9833f-e782-4ba7-96fc-c4d11545d198" xlink:href="mck-20201231.xsd#mck_NumberOfCountyGovernments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_NumberOfCountyGovernments_1ba9833f-e782-4ba7-96fc-c4d11545d198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_9172af24-1680-4e5b-a274-32d3925cc503" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_9172af24-1680-4e5b-a274-32d3925cc503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_4c219297-ca78-4943-8f27-746b1dd62d06" xlink:href="mck-20201231.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_4c219297-ca78-4943-8f27-746b1dd62d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation_d0d16ad1-7bc6-4e65-acdc-1fa4557622c7" xlink:href="mck-20201231.xsd#mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation_d0d16ad1-7bc6-4e65-acdc-1fa4557622c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_53a55d33-cbfd-469d-b34c-6ef279fcb89e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_53a55d33-cbfd-469d-b34c-6ef279fcb89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualProvisionNetOfTax_05e03c2d-6fa4-499e-82e3-12fd47e0f398" xlink:href="mck-20201231.xsd#mck_LossContingencyAccrualProvisionNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencyAccrualProvisionNetOfTax_05e03c2d-6fa4-499e-82e3-12fd47e0f398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyDamagesSoughtPerViolationValue_e162d1a6-dcce-442b-af3a-fccaab3ff16f" xlink:href="mck-20201231.xsd#mck_LossContingencyDamagesSoughtPerViolationValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencyDamagesSoughtPerViolationValue_e162d1a6-dcce-442b-af3a-fccaab3ff16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_75671d29-188f-46a1-b779-7e0f7bbc2efa" xlink:href="mck-20201231.xsd#mck_LossContingencyClassActionNumberofFaxesRemainingintheClass"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_75671d29-188f-46a1-b779-7e0f7bbc2efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesReceived_bd6ec089-2fd2-4b2c-ac37-fe66bd3ebaa7" xlink:href="mck-20201231.xsd#mck_LossContingencyClassActionNumberofFaxesReceived"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesReceived_bd6ec089-2fd2-4b2c-ac37-fe66bd3ebaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfInvestmentFundsThatFiledClaims_fd87c8c9-f56d-44f6-8af0-f6e76015b8f2" xlink:href="mck-20201231.xsd#mck_NumberOfInvestmentFundsThatFiledClaims"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_NumberOfInvestmentFundsThatFiledClaims_fd87c8c9-f56d-44f6-8af0-f6e76015b8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_076c1bd2-dc69-4102-b53b-33513e0f1225" xlink:href="mck-20201231.xsd#mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_076c1bd2-dc69-4102-b53b-33513e0f1225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_803fb74c-12c2-4b4a-90e7-e85d9cea4acc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_803fb74c-12c2-4b4a-90e7-e85d9cea4acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualAfterTax_2022cedd-91cf-430f-bd15-6ad080e80a0f" xlink:href="mck-20201231.xsd#mck_LossContingencyAccrualAfterTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6fc3cd76-59ce-49c0-b97f-04752ce879d0" xlink:to="loc_mck_LossContingencyAccrualAfterTax_2022cedd-91cf-430f-bd15-6ad080e80a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficit" xlink:type="simple" xlink:href="mck-20201231.xsd#StockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2287bbbd-9c5c-44d3-9e6d-ad9633de1cc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8f06227c-8622-48fb-a9f7-feb1018a5b1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2287bbbd-9c5c-44d3-9e6d-ad9633de1cc1" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8f06227c-8622-48fb-a9f7-feb1018a5b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitTables" xlink:type="simple" xlink:href="mck-20201231.xsd#StockholdersEquityDeficitTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2c8b37dd-8b5c-4c7c-9dca-c6f8e6c12ecb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_9575b7e5-b4cf-4869-9e17-22fff10ee23e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2c8b37dd-8b5c-4c7c-9dca-c6f8e6c12ecb" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_9575b7e5-b4cf-4869-9e17-22fff10ee23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f8c719ed-3a5d-42f0-ad96-cedb28a134f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2c8b37dd-8b5c-4c7c-9dca-c6f8e6c12ecb" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f8c719ed-3a5d-42f0-ad96-cedb28a134f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#StockholdersEquityDeficitNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_91830272-f97d-401c-a844-822fc564af25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_32accbea-f856-4487-9f7a-813614f5b9b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_91830272-f97d-401c-a844-822fc564af25" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_32accbea-f856-4487-9f7a-813614f5b9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_d81c86a0-dc76-4e32-b671-0fa082707ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_32accbea-f856-4487-9f7a-813614f5b9b4" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_d81c86a0-dc76-4e32-b671-0fa082707ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_4aab3b0e-39a3-46f1-9078-1c3c2b9b52e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_d81c86a0-dc76-4e32-b671-0fa082707ff4" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_4aab3b0e-39a3-46f1-9078-1c3c2b9b52e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember_dccbaff6-d114-47dc-8cd1-8d9ad76a8a61" xlink:href="mck-20201231.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_4aab3b0e-39a3-46f1-9078-1c3c2b9b52e5" xlink:to="loc_mck_AcceleratedShareRepurchaseMember_dccbaff6-d114-47dc-8cd1-8d9ad76a8a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketShareRepurchaseTransactionsMember_76ac2bef-2f92-44f1-99a4-de518ce9890f" xlink:href="mck-20201231.xsd#mck_OpenMarketShareRepurchaseTransactionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_4aab3b0e-39a3-46f1-9078-1c3c2b9b52e5" xlink:to="loc_mck_OpenMarketShareRepurchaseTransactionsMember_76ac2bef-2f92-44f1-99a4-de518ce9890f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3bb0bf2a-9e20-4fd1-8ca5-f29aae0f2ec1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_32accbea-f856-4487-9f7a-813614f5b9b4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3bb0bf2a-9e20-4fd1-8ca5-f29aae0f2ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_889255c5-ea67-4201-a0af-815b0c7d4693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3bb0bf2a-9e20-4fd1-8ca5-f29aae0f2ec1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_889255c5-ea67-4201-a0af-815b0c7d4693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_1ed6dab6-8166-4cfe-aa3b-b176f7ba114d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_889255c5-ea67-4201-a0af-815b0c7d4693" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_1ed6dab6-8166-4cfe-aa3b-b176f7ba114d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4bdd0a45-b8c4-4904-bfd9-258b1c12f27b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_32accbea-f856-4487-9f7a-813614f5b9b4" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4bdd0a45-b8c4-4904-bfd9-258b1c12f27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_16279c6f-42dd-489f-9d7f-fb910913692e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4bdd0a45-b8c4-4904-bfd9-258b1c12f27b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_16279c6f-42dd-489f-9d7f-fb910913692e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6cc442ef-4f78-484d-aa7a-c7f0850d3920" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_16279c6f-42dd-489f-9d7f-fb910913692e" xlink:to="loc_us-gaap_SubsequentEventMember_6cc442ef-4f78-484d-aa7a-c7f0850d3920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_d96a2eb5-e50d-4cf5-8cab-4b31e8559b98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_32accbea-f856-4487-9f7a-813614f5b9b4" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesLineItems_d96a2eb5-e50d-4cf5-8cab-4b31e8559b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_a2547e83-b097-44e4-bd93-9b1860d5bf62" xlink:href="mck-20201231.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_d96a2eb5-e50d-4cf5-8cab-4b31e8559b98" xlink:to="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_a2547e83-b097-44e4-bd93-9b1860d5bf62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_1670ba55-1665-442a-9478-cb2a2b07af19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_d96a2eb5-e50d-4cf5-8cab-4b31e8559b98" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_1670ba55-1665-442a-9478-cb2a2b07af19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_3f353fbe-8fd5-4492-af32-a236bf4df303" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_d96a2eb5-e50d-4cf5-8cab-4b31e8559b98" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_3f353fbe-8fd5-4492-af32-a236bf4df303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_251ac573-61be-43ff-b98f-6d12e63d24e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_d96a2eb5-e50d-4cf5-8cab-4b31e8559b98" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_251ac573-61be-43ff-b98f-6d12e63d24e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_51a53f0e-ca30-4d8e-bfcb-2d563a5ce536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_d96a2eb5-e50d-4cf5-8cab-4b31e8559b98" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_51a53f0e-ca30-4d8e-bfcb-2d563a5ce536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9357a396-614a-4591-aec3-c90f09f3f6ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_d96a2eb5-e50d-4cf5-8cab-4b31e8559b98" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9357a396-614a-4591-aec3-c90f09f3f6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased_ecea85ca-ffa6-41dc-a86e-149a1e42ea70" xlink:href="mck-20201231.xsd#mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_d96a2eb5-e50d-4cf5-8cab-4b31e8559b98" xlink:to="loc_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased_ecea85ca-ffa6-41dc-a86e-149a1e42ea70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f5ea70ec-f7ee-4516-9d47-ff11b982a425" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f58645d2-6fd0-4324-940f-6d38f0124db5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f5ea70ec-f7ee-4516-9d47-ff11b982a425" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f58645d2-6fd0-4324-940f-6d38f0124db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7c1fea7c-4c86-46cd-b3aa-26edf803ccd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f58645d2-6fd0-4324-940f-6d38f0124db5" xlink:to="loc_us-gaap_HedgingDesignationAxis_7c1fea7c-4c86-46cd-b3aa-26edf803ccd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_07d28cbb-e685-4312-aff6-6f8838550171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_7c1fea7c-4c86-46cd-b3aa-26edf803ccd5" xlink:to="loc_us-gaap_HedgingDesignationDomain_07d28cbb-e685-4312-aff6-6f8838550171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_58dde556-cf0b-4f3f-babe-c2e9a58b6764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_07d28cbb-e685-4312-aff6-6f8838550171" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_58dde556-cf0b-4f3f-babe-c2e9a58b6764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_008b1f12-71be-44c0-b66a-b1571402ec68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f58645d2-6fd0-4324-940f-6d38f0124db5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_008b1f12-71be-44c0-b66a-b1571402ec68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_aba83327-c261-42da-9685-a70c63b9913f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_008b1f12-71be-44c0-b66a-b1571402ec68" xlink:to="loc_us-gaap_HedgingRelationshipDomain_aba83327-c261-42da-9685-a70c63b9913f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_bf5fc528-3992-45a5-996a-50b5787b3293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_aba83327-c261-42da-9685-a70c63b9913f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_bf5fc528-3992-45a5-996a-50b5787b3293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1e2f424c-8e80-43ad-900e-5c35f39c6da3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f58645d2-6fd0-4324-940f-6d38f0124db5" xlink:to="loc_us-gaap_DebtInstrumentAxis_1e2f424c-8e80-43ad-900e-5c35f39c6da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7065d609-0389-47d9-bef8-5610f2f5a1d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1e2f424c-8e80-43ad-900e-5c35f39c6da3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7065d609-0389-47d9-bef8-5610f2f5a1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_a5764a38-1354-40b2-9153-dee4254b50ec" xlink:href="mck-20201231.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7065d609-0389-47d9-bef8-5610f2f5a1d1" xlink:to="loc_mck_EuroDenominatedNotesMember_a5764a38-1354-40b2-9153-dee4254b50ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_2d26bd99-7bc3-4270-b3c9-7f65f967dbae" xlink:href="mck-20201231.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7065d609-0389-47d9-bef8-5610f2f5a1d1" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_2d26bd99-7bc3-4270-b3c9-7f65f967dbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_25aa35fb-bbec-42a6-b104-082b2f5917a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f58645d2-6fd0-4324-940f-6d38f0124db5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_25aa35fb-bbec-42a6-b104-082b2f5917a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6deb41a4-89a8-4b60-b780-80495ed58165" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_25aa35fb-bbec-42a6-b104-082b2f5917a3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6deb41a4-89a8-4b60-b780-80495ed58165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_b08f2aad-c27e-433f-b63e-f58d506ee4c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6deb41a4-89a8-4b60-b780-80495ed58165" xlink:to="loc_us-gaap_LoansPayableMember_b08f2aad-c27e-433f-b63e-f58d506ee4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a21d78f5-3747-4b64-8ef8-786498f98c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f58645d2-6fd0-4324-940f-6d38f0124db5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a21d78f5-3747-4b64-8ef8-786498f98c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_44aa06ff-3a50-4fac-b76f-fcabdc513d58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a21d78f5-3747-4b64-8ef8-786498f98c29" xlink:to="loc_us-gaap_EquityComponentDomain_44aa06ff-3a50-4fac-b76f-fcabdc513d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_a6cea273-f3a6-4827-a2d8-8dc7aa164cae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_44aa06ff-3a50-4fac-b76f-fcabdc513d58" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_a6cea273-f3a6-4827-a2d8-8dc7aa164cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_90fcdb7a-0232-4c5e-9805-9a0944a9d52e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_44aa06ff-3a50-4fac-b76f-fcabdc513d58" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_90fcdb7a-0232-4c5e-9805-9a0944a9d52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_51dc8584-5100-4674-888a-df69a0af485a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_44aa06ff-3a50-4fac-b76f-fcabdc513d58" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_51dc8584-5100-4674-888a-df69a0af485a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_e73924dc-8244-4388-a603-d1695cc78a9b" xlink:href="mck-20201231.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_44aa06ff-3a50-4fac-b76f-fcabdc513d58" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_e73924dc-8244-4388-a603-d1695cc78a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_4b8e7f47-0fed-4249-ac7f-e686cd08c311" xlink:href="mck-20201231.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_44aa06ff-3a50-4fac-b76f-fcabdc513d58" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_4b8e7f47-0fed-4249-ac7f-e686cd08c311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_53a8fb8b-dfa7-42f3-a834-dacca652b0aa" xlink:href="mck-20201231.xsd#mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_44aa06ff-3a50-4fac-b76f-fcabdc513d58" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_53a8fb8b-dfa7-42f3-a834-dacca652b0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_d98003b7-5f2d-433b-82f3-50d9c1e1cea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_44aa06ff-3a50-4fac-b76f-fcabdc513d58" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_d98003b7-5f2d-433b-82f3-50d9c1e1cea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f58645d2-6fd0-4324-940f-6d38f0124db5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1cd8de49-b570-477f-b5ea-b246ee141b79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1cd8de49-b570-477f-b5ea-b246ee141b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_131329a3-fded-49fe-a5fd-d764b3433f04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_131329a3-fded-49fe-a5fd-d764b3433f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_544741e1-f695-4264-9458-f4ded30ea14e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_544741e1-f695-4264-9458-f4ded30ea14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_02c56a9a-41f3-4fab-8f0a-56ff419a5062" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_02c56a9a-41f3-4fab-8f0a-56ff419a5062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_baae6943-695b-42f4-84aa-06b55bcf98c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_baae6943-695b-42f4-84aa-06b55bcf98c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e1259460-78b3-4bbd-be45-97ac579e9436" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e1259460-78b3-4bbd-be45-97ac579e9436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_7b55b79b-0a85-4501-9dcc-f147e73b906a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_7b55b79b-0a85-4501-9dcc-f147e73b906a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_631c5125-40d0-4409-90f5-2da202fb66cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_631c5125-40d0-4409-90f5-2da202fb66cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_f00fc782-7565-40d4-8c5c-b0c9a41c7d46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_f00fc782-7565-40d4-8c5c-b0c9a41c7d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_6174479a-b390-40b9-a5af-13344e5dbb39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_6174479a-b390-40b9-a5af-13344e5dbb39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_0197650c-b1aa-4bba-a294-0f6260200034" xlink:href="mck-20201231.xsd#mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_0197650c-b1aa-4bba-a294-0f6260200034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_dfc2183e-5b65-4763-870f-98880526f587" xlink:href="mck-20201231.xsd#mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_dfc2183e-5b65-4763-870f-98880526f587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_ceaae386-bffb-450c-a1b2-6840a9653a55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_ceaae386-bffb-450c-a1b2-6840a9653a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f5a4d7a1-0ef1-46b2-a4a8-4ec1896dc923" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_LongTermDebt_f5a4d7a1-0ef1-46b2-a4a8-4ec1896dc923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_d6671392-7e0e-4228-b639-7bb33bc00dff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_d6671392-7e0e-4228-b639-7bb33bc00dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_31349b94-55d0-4c8f-bf42-f924f9f9a66e" xlink:href="mck-20201231.xsd#mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_208096c3-d641-4122-97e1-625613fbf314" xlink:to="loc_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_31349b94-55d0-4c8f-bf42-f924f9f9a66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4e82f13b-b806-439d-b992-344bb60ec51c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2809db73-88d8-4d40-8d1a-a77ec3ce1036" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4e82f13b-b806-439d-b992-344bb60ec51c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2809db73-88d8-4d40-8d1a-a77ec3ce1036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_be500e6a-f641-4d3f-9bdd-d19a4e147585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2809db73-88d8-4d40-8d1a-a77ec3ce1036" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_be500e6a-f641-4d3f-9bdd-d19a4e147585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_adea6b44-f327-412a-8373-4c84334e6f68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_be500e6a-f641-4d3f-9bdd-d19a4e147585" xlink:to="loc_us-gaap_EquityComponentDomain_adea6b44-f327-412a-8373-4c84334e6f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_67a107e3-b394-495f-bfc0-e5db4839416d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_adea6b44-f327-412a-8373-4c84334e6f68" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_67a107e3-b394-495f-bfc0-e5db4839416d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_8e3c3904-4f2f-4c93-940b-f4eb661ec8a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_67a107e3-b394-495f-bfc0-e5db4839416d" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_8e3c3904-4f2f-4c93-940b-f4eb661ec8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_da67098c-4b10-43af-8ae8-5462d11fd8d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_67a107e3-b394-495f-bfc0-e5db4839416d" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_da67098c-4b10-43af-8ae8-5462d11fd8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_2bf4b034-902f-41cc-88bb-5673011bb324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_67a107e3-b394-495f-bfc0-e5db4839416d" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_2bf4b034-902f-41cc-88bb-5673011bb324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_a90c026d-a9a6-465d-8f61-5769ee724497" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_67a107e3-b394-495f-bfc0-e5db4839416d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_a90c026d-a9a6-465d-8f61-5769ee724497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_764c5fac-d701-4c86-ad42-5e494d42c8ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2809db73-88d8-4d40-8d1a-a77ec3ce1036" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_764c5fac-d701-4c86-ad42-5e494d42c8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ed73b7c9-3d7a-4258-8ef2-83ca3940d017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_764c5fac-d701-4c86-ad42-5e494d42c8ac" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ed73b7c9-3d7a-4258-8ef2-83ca3940d017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_23b58c45-6515-4e76-91f2-3940a3b1ebaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ed73b7c9-3d7a-4258-8ef2-83ca3940d017" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_23b58c45-6515-4e76-91f2-3940a3b1ebaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_28f93396-bbb8-4f2c-b469-d9bccbe2bf41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ed73b7c9-3d7a-4258-8ef2-83ca3940d017" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_28f93396-bbb8-4f2c-b469-d9bccbe2bf41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f6dd6e79-a656-42ed-9579-81204094a3d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ed73b7c9-3d7a-4258-8ef2-83ca3940d017" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f6dd6e79-a656-42ed-9579-81204094a3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_faaecc82-a9fb-47e5-b686-b2437de3d34b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ed73b7c9-3d7a-4258-8ef2-83ca3940d017" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_faaecc82-a9fb-47e5-b686-b2437de3d34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_9a756105-38bb-4703-8652-2bceace712d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ed73b7c9-3d7a-4258-8ef2-83ca3940d017" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_9a756105-38bb-4703-8652-2bceace712d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_91157694-5cd3-4771-82df-8c9452d2f562" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ed73b7c9-3d7a-4258-8ef2-83ca3940d017" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_91157694-5cd3-4771-82df-8c9452d2f562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b207a306-be91-4022-bd7a-f4de6b39508d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_ed73b7c9-3d7a-4258-8ef2-83ca3940d017" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b207a306-be91-4022-bd7a-f4de6b39508d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="simple" xlink:href="mck-20201231.xsd#SegmentsofBusiness"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3eb6b861-9b8a-4b3e-8065-9ebf8758cf73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_6d3c1cca-a74d-4bd6-b9ee-f37d871fcc48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3eb6b861-9b8a-4b3e-8065-9ebf8758cf73" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_6d3c1cca-a74d-4bd6-b9ee-f37d871fcc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="simple" xlink:href="mck-20201231.xsd#SegmentsofBusinessTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fe71d180-4344-4e84-a394-6d595c00f8cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_4a001032-898f-4f6c-a853-f561c7a4a056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fe71d180-4344-4e84-a394-6d595c00f8cb" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_4a001032-898f-4f6c-a853-f561c7a4a056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessDetails" xlink:type="simple" xlink:href="mck-20201231.xsd#SegmentsofBusinessDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_dccafe08-0593-41c7-8512-74496073fe87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_dccafe08-0593-41c7-8512-74496073fe87" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0b68243d-7693-41fe-b66e-fd25d39c519a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0b68243d-7693-41fe-b66e-fd25d39c519a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e80deaf6-3fe9-481f-9763-a2534e1251d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0b68243d-7693-41fe-b66e-fd25d39c519a" xlink:to="loc_us-gaap_SegmentDomain_e80deaf6-3fe9-481f-9763-a2534e1251d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_f9beaa98-813e-4ad4-b2df-0b8ab25566c9" xlink:href="mck-20201231.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e80deaf6-3fe9-481f-9763-a2534e1251d3" xlink:to="loc_mck_USPharmaceuticalSegmentMember_f9beaa98-813e-4ad4-b2df-0b8ab25566c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_1427a1ea-425f-4518-b8d3-e90816c0dd5a" xlink:href="mck-20201231.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e80deaf6-3fe9-481f-9763-a2534e1251d3" xlink:to="loc_mck_InternationalSegmentMember_1427a1ea-425f-4518-b8d3-e90816c0dd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_56242c1b-9914-4abb-9f94-4f8d1ae8a5d9" xlink:href="mck-20201231.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e80deaf6-3fe9-481f-9763-a2534e1251d3" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_56242c1b-9914-4abb-9f94-4f8d1ae8a5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_8144f4fb-1de7-4a04-9596-6c48258ebaae" xlink:href="mck-20201231.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e80deaf6-3fe9-481f-9763-a2534e1251d3" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_8144f4fb-1de7-4a04-9596-6c48258ebaae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_d5563daf-ca68-4af3-b92d-cf91730ee4fa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_srt_ConsolidationItemsAxis_d5563daf-ca68-4af3-b92d-cf91730ee4fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_22b5317a-237f-4001-96c1-9959a2ae497d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_d5563daf-ca68-4af3-b92d-cf91730ee4fa" xlink:to="loc_srt_ConsolidationItemsDomain_22b5317a-237f-4001-96c1-9959a2ae497d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9983a952-f6bb-4791-832f-0b349165f44c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_22b5317a-237f-4001-96c1-9959a2ae497d" xlink:to="loc_us-gaap_OperatingSegmentsMember_9983a952-f6bb-4791-832f-0b349165f44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_0b01f591-22e7-4743-87c6-070670e38b79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_22b5317a-237f-4001-96c1-9959a2ae497d" xlink:to="loc_us-gaap_CorporateNonSegmentMember_0b01f591-22e7-4743-87c6-070670e38b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_347704d8-1d4a-44ba-bd14-9da0a958659e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_srt_StatementGeographicalAxis_347704d8-1d4a-44ba-bd14-9da0a958659e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5f03d81a-5a2d-472d-ab29-db9d63b8d315" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_347704d8-1d4a-44ba-bd14-9da0a958659e" xlink:to="loc_srt_SegmentGeographicalDomain_5f03d81a-5a2d-472d-ab29-db9d63b8d315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_2dde090f-9285-44ae-b6e4-ca9372376808" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5f03d81a-5a2d-472d-ab29-db9d63b8d315" xlink:to="loc_country_US_2dde090f-9285-44ae-b6e4-ca9372376808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_89bde78f-3c91-4b16-8603-2aea10a70932" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5f03d81a-5a2d-472d-ab29-db9d63b8d315" xlink:to="loc_srt_EuropeMember_89bde78f-3c91-4b16-8603-2aea10a70932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_40477a18-4390-4a1e-8f51-cfff0730ed19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5f03d81a-5a2d-472d-ab29-db9d63b8d315" xlink:to="loc_us-gaap_NonUsMember_40477a18-4390-4a1e-8f51-cfff0730ed19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_27b2b2a6-5d32-47e8-92b5-eb8271b60e09" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_srt_LitigationCaseAxis_27b2b2a6-5d32-47e8-92b5-eb8271b60e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a0799ccd-10df-45f7-81dc-bd7ccdec4db7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_27b2b2a6-5d32-47e8-92b5-eb8271b60e09" xlink:to="loc_srt_LitigationCaseTypeDomain_a0799ccd-10df-45f7-81dc-bd7ccdec4db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_839dd4f8-7669-47a5-b974-bb9a62f82fb2" xlink:href="mck-20201231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_a0799ccd-10df-45f7-81dc-bd7ccdec4db7" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_839dd4f8-7669-47a5-b974-bb9a62f82fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_1997ded8-2c00-42ba-8d28-994930055825" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_1997ded8-2c00-42ba-8d28-994930055825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_381b41e4-ce2f-4ffa-948b-9a2489026472" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_1997ded8-2c00-42ba-8d28-994930055825" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_381b41e4-ce2f-4ffa-948b-9a2489026472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_8f088540-8271-4a14-8ad5-b776a7da249b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_381b41e4-ce2f-4ffa-948b-9a2489026472" xlink:to="loc_us-gaap_DomesticPlanMember_8f088540-8271-4a14-8ad5-b776a7da249b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_105f2826-5d94-46c4-ad08-d1ad2d006a51" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_8f088540-8271-4a14-8ad5-b776a7da249b" xlink:to="loc_country_US_105f2826-5d94-46c4-ad08-d1ad2d006a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c76b0114-c180-48b4-9bd6-75d7b04fac46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c76b0114-c180-48b4-9bd6-75d7b04fac46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_cb9250ce-76ff-48af-8cdd-638312ef7295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c76b0114-c180-48b4-9bd6-75d7b04fac46" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_cb9250ce-76ff-48af-8cdd-638312ef7295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_f4163485-f65e-475c-b95f-bb02c2564543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_cb9250ce-76ff-48af-8cdd-638312ef7295" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_f4163485-f65e-475c-b95f-bb02c2564543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c41b64f9-6e8f-4716-aac8-4e0722ada504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c41b64f9-6e8f-4716-aac8-4e0722ada504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_70c8cc83-bf38-46e4-b3be-66aed30818eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c41b64f9-6e8f-4716-aac8-4e0722ada504" xlink:to="loc_us-gaap_RelatedPartyDomain_70c8cc83-bf38-46e4-b3be-66aed30818eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_61b81f41-5174-4f0a-9a1c-547841448b82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_70c8cc83-bf38-46e4-b3be-66aed30818eb" xlink:to="loc_us-gaap_CorporateJointVentureMember_61b81f41-5174-4f0a-9a1c-547841448b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_da5efcc2-0461-499e-873f-1179e268fde3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_da5efcc2-0461-499e-873f-1179e268fde3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_be84a9f7-54ac-4004-9760-027ade6f5e1e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_da5efcc2-0461-499e-873f-1179e268fde3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_be84a9f7-54ac-4004-9760-027ade6f5e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_7baec56c-4771-490c-92b6-93eeb0f4050c" xlink:href="mck-20201231.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_be84a9f7-54ac-4004-9760-027ade6f5e1e" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_7baec56c-4771-490c-92b6-93eeb0f4050c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_0e3dfd5b-4244-4616-a35b-874f942e4b0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_us-gaap_RestructuringPlanAxis_0e3dfd5b-4244-4616-a35b-874f942e4b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_7fe073a8-11da-45a9-a365-a81784427526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_0e3dfd5b-4244-4616-a35b-874f942e4b0c" xlink:to="loc_us-gaap_RestructuringPlanDomain_7fe073a8-11da-45a9-a365-a81784427526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanMember_4d8bb826-4b41-49e3-b030-2c86e5d1d19e" xlink:href="mck-20201231.xsd#mck_StrategicGrowthInitiativePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_7fe073a8-11da-45a9-a365-a81784427526" xlink:to="loc_mck_StrategicGrowthInitiativePlanMember_4d8bb826-4b41-49e3-b030-2c86e5d1d19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a650b846-cc76-414f-8bfa-bbdca91aefc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a650b846-cc76-414f-8bfa-bbdca91aefc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_ef7026ad-a63a-472b-ba22-75263f87cfc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a650b846-cc76-414f-8bfa-bbdca91aefc5" xlink:to="loc_us-gaap_LossContingencyNatureDomain_ef7026ad-a63a-472b-ba22-75263f87cfc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_dfe08a47-5401-4239-ad3f-08d346edfe52" xlink:href="mck-20201231.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_ef7026ad-a63a-472b-ba22-75263f87cfc5" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_dfe08a47-5401-4239-ad3f-08d346edfe52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fd5ee293-a984-4684-a908-576f8cb9a3a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fd5ee293-a984-4684-a908-576f8cb9a3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e79cea6d-1529-4d02-9a33-2928a977718d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fd5ee293-a984-4684-a908-576f8cb9a3a9" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e79cea6d-1529-4d02-9a33-2928a977718d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_dbab3317-3bee-442a-90af-162996a8dc39" xlink:href="mck-20201231.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e79cea6d-1529-4d02-9a33-2928a977718d" xlink:to="loc_mck_GermanWholesaleBusinessMember_dbab3317-3bee-442a-90af-162996a8dc39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_78ba75f9-323c-4bec-80a9-879fb845799b" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_5f897105-cbc4-44a6-90de-0bd870481b2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_NumberOfReportableSegments_5f897105-cbc4-44a6-90de-0bd870481b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_894250c1-d89c-4f9e-92eb-3985f9da51e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_894250c1-d89c-4f9e-92eb-3985f9da51e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfBusinessOperations_ef18f8f5-fe2c-46f6-870e-49e2b6714a37" xlink:href="mck-20201231.xsd#mck_NumberOfBusinessOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_mck_NumberOfBusinessOperations_ef18f8f5-fe2c-46f6-870e-49e2b6714a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_841cb678-0c54-4b99-9bac-93e6ace5f6a7" xlink:href="mck-20201231.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_841cb678-0c54-4b99-9bac-93e6ace5f6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_dda0a238-ccf9-424c-9270-527da99d0238" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_dda0a238-ccf9-424c-9270-527da99d0238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_c098eeeb-c2ed-4028-ac94-bdde92621dff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_dda0a238-ccf9-424c-9270-527da99d0238" xlink:to="loc_us-gaap_RevenuesAbstract_c098eeeb-c2ed-4028-ac94-bdde92621dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f393134-9716-4801-8ef2-faeb36c8b737" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_c098eeeb-c2ed-4028-ac94-bdde92621dff" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f393134-9716-4801-8ef2-faeb36c8b737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract_3c5a7ef0-ea86-4650-8ed3-126a05f973f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_dda0a238-ccf9-424c-9270-527da99d0238" xlink:to="loc_us-gaap_OperatingIncomeLossAbstract_3c5a7ef0-ea86-4650-8ed3-126a05f973f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_dafb231b-22e7-467e-8b57-9a5304852ecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_3c5a7ef0-ea86-4650-8ed3-126a05f973f0" xlink:to="loc_us-gaap_OperatingIncomeLoss_dafb231b-22e7-467e-8b57-9a5304852ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_ef2ebe92-44ef-48e4-8dd6-438eb9bdb756" xlink:href="mck-20201231.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_dda0a238-ccf9-424c-9270-527da99d0238" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_ef2ebe92-44ef-48e4-8dd6-438eb9bdb756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_4a7e5c05-1039-446b-8455-0d26e03dd076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_dda0a238-ccf9-424c-9270-527da99d0238" xlink:to="loc_us-gaap_InterestAndDebtExpense_4a7e5c05-1039-446b-8455-0d26e03dd076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d06f5bf-f2a3-4991-9d2d-f765c3f3d70f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_dda0a238-ccf9-424c-9270-527da99d0238" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d06f5bf-f2a3-4991-9d2d-f765c3f3d70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage_f74714d0-462b-4552-89b6-f87cb3d0420a" xlink:href="mck-20201231.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_mck_RevenueDerivedFromServicesPercentage_f74714d0-462b-4552-89b6-f87cb3d0420a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_d14efc32-aee5-4e76-b1c0-7a596ce6aa13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_d14efc32-aee5-4e76-b1c0-7a596ce6aa13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_f6e75bc9-9951-419d-ab25-d9d09e30f517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_f6e75bc9-9951-419d-ab25-d9d09e30f517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a04f72d5-400d-4809-be6d-01b11c50b01f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_RestructuringCharges_a04f72d5-400d-4809-be6d-01b11c50b01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_d3ae9c63-5d9b-43b5-aefb-e430383aefdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_AssetImpairmentCharges_d3ae9c63-5d9b-43b5-aefb-e430383aefdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_e5fe67fc-c900-4210-8a78-80f8803ff118" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_e5fe67fc-c900-4210-8a78-80f8803ff118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLossNetOfTax_38f430b9-80c0-4e48-b0e6-5d7a3d12dbf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLossNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_GoodwillImpairmentLossNetOfTax_38f430b9-80c0-4e48-b0e6-5d7a3d12dbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_9188ea7d-d3ed-4a95-9262-b813e667519a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_9188ea7d-d3ed-4a95-9262-b813e667519a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossOnSaleOfBusinessNetOfTax_8a494df2-56de-4972-a743-242fffd5fd2a" xlink:href="mck-20201231.xsd#mck_GainLossOnSaleOfBusinessNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_mck_GainLossOnSaleOfBusinessNetOfTax_8a494df2-56de-4972-a743-242fffd5fd2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_f0f3166a-d999-4ea9-9565-fd697d01793f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_f0f3166a-d999-4ea9-9565-fd697d01793f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_0f38b259-e853-4b70-be8f-382f4b997f51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_InventoryWriteDown_0f38b259-e853-4b70-be8f-382f4b997f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_0766de10-31d1-4161-88ef-89deac65ee9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_0766de10-31d1-4161-88ef-89deac65ee9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ProportionateGainLossOnEquityMethodInvestment_4f83f5e0-db0f-41d9-ac63-3e82b5994553" xlink:href="mck-20201231.xsd#mck_ProportionateGainLossOnEquityMethodInvestment"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_mck_ProportionateGainLossOnEquityMethodInvestment_4f83f5e0-db0f-41d9-ac63-3e82b5994553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_1aaf33be-d786-433a-ac2a-c77b40d03ce4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_1aaf33be-d786-433a-ac2a-c77b40d03ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualProvisionNetOfTax_e25c4f18-b25a-41fc-8560-f51b69e4ddd2" xlink:href="mck-20201231.xsd#mck_LossContingencyAccrualProvisionNetOfTax"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_mck_LossContingencyAccrualProvisionNetOfTax_e25c4f18-b25a-41fc-8560-f51b69e4ddd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment_4c2b7b65-fbdf-4b4b-9e26-c27faaad20f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment_4c2b7b65-fbdf-4b4b-9e26-c27faaad20f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_79282c34-66c8-4aaa-9007-c8ad18441265" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_79282c34-66c8-4aaa-9007-c8ad18441265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_fd3a501a-af52-404d-8d6b-5eeb3547c3c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_fd3a501a-af52-404d-8d6b-5eeb3547c3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_7d880d53-5c88-4cc6-9129-f46b2e741d70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2bd7201e-960c-489e-aa43-f61d6b191ff3" xlink:to="loc_us-gaap_LitigationSettlementExpense_7d880d53-5c88-4cc6-9129-f46b2e741d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>mck-20201231_g1.jpg
<TEXT>
begin 644 mck-20201231_g1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ^ 9@# 2(  A$! Q$!_\0
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M?$#XA>(?$4S;FU&]DG'7A2QV@>V,5CE& CC:DO:?"C;/,RGE].*I?$S]#O\
MAY=\-O\ H$Z]_P!^(_\ XNO9?@-^T1X>_:#T[5;WP_:WUK'ITJ12B]15)+ D
M8PQXX-?C+7Z'_P#!+O\ Y%'QP?\ I]M__0&KU<SRG#X7#.K3O<\;*<ZQ6,Q4
M:-6UF?;]>6?%W]I;P!\%5\OQ'K2?VBR[ETVT'FW+#L=@^Z#ZL0#7._M>?'MO
M@3\,9+K3RI\0:DQM=/##(1B#ND(_V1^N*_)+5M8OM?U2YU'4KJ:^O[ES)-<3
MN6=V/4DG_/%>=EF4_7%[6H[1/4SC.OJ,O945>7Y'Z!:Q_P %0-"AN&73?!E_
M<P@\23W21D_\! /\ZDT7_@I]X=N)U35/!^HV<6?FEM[A)<#UVX&?SKY!^%O[
M,/Q'^,5JM[X<\/NVF%MO]H7DBP0'_=+'+?\  0:[;Q3^P+\8/#.GM=IH]GK2
M(-S1Z7=B20#V1@I8^R@FO;G@<JIOV<I:^I\]3S'.:B]I&+:]#])_A#\:_"_Q
MPT"75_"]S-/;0R>5,L\#1M$^ =IR,$X/\)-<O\>/VHO#'[/=]I5MX@L]0N9-
M1C>2+[#&K !2 <Y8>M:/[,WPJ'P=^#NA:#)%Y>H&(7-[QR9W^9@?ID+^%?)/
M_!4+_D9/!'_7K<?^A+7S6%PU'$8WV*^'4^LQF+Q&%R_V[^/0]8T__@I%\.=0
MOK:UCTK71)/(L2EH(P,DX!^_ZFOJ^&430I(O1E##Z&OPG\+C_BIM(_Z^XO\
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MD5^IL,R7$*2QL'C<!E93D$'H:^+QV"G@JG)+;H?H&6YC3S"ESQW6Z/&/CO\
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M6=^U=\!E^/OPRETJV=(=;L9/M>G3/]WS ""C'L&!(]N#VKP\'..$QL7/9/\
MX!]%CJ<L;E\E36LDG^I^/)]J_3W]AOXP?#MOA%H_ANTO;+1O$-HI2^M+EEBD
MGDW$F4$_?#9_#IVK\V_%W@W6O .NW&CZ_IT^F:C VUH;A"I//4'N#CJ*QU9D
M8.I*L#D$'!'N*_0<;A89A145+[C\PP.,GE==S<;O;4_>F.2.959&5E89#*<@
MUD>*/!>A>-M->PUW2;35;1Q@Q740<<^F>GX5^-?@OX^?$/X?R1G0_%VIVB(>
M(&G,D1QZHV01]17T]\)/^"E6M6%Q;V7Q!TF'4[1B%;5--7RYD]6:/[K?\!V]
M#P:^0KY)BJ'O4W?\S[K#\0X/$>Y6CR_D?>'@3P+HWPW\,VOA_0+3[%I=J7,4
M.XMMW,6/)]V-?GQ_P4TGN6^*WAR.0$6Z:83%Z9\P[C_*OT*\%^-M%^(?ARSU
MW0+^+4=,NEWQS1'\P1V([@UX1^VQ^SA=?'#P9;:EH2J_B;10SP0DX^TQ$9:+
M/9N 1[\=ZXLMKK#XQ3K'?FU!XG ..'/RFXSDC-?KK^R[\8OASXD^&>@Z7X<U
M"QTZZM+2.*?2Y&6*:.0* Q*G[V3D[AUS7Y*ZQHU_X?U&>PU.SFT^]@;;);W"
M%'4@]""*KPS26\JR1.T<BG*NA((]P:^ZQV"CF$$E*UC\YR[,)Y95;<+G[TAE
M;!&#7,>.OAAX7^)6EO8>)-$L]5@8;1YT8+K[JW4?A7Y$>"?VE_B;\/9$_L?Q
M?J"1)TM[F3SXOQ1P17U5\&?^"E#7%Y;Z;\1]*B@1R%&L:6"%7MF2(D\>ZG_@
M(KY"MDN+P_OTW>W;<^YP^?8+%6IU5:_?8^X_#?AVQ\)Z#8:-ID/V?3[&%8((
MLD[448 _*OAG_@IS\1)8Y/"W@BWE*QR(^IW<8/W@&V19'ID2'\!7W7H>N6/B
M/2[;4M-NH[VQN4$D,\+;E=2."#7Y;_\ !0[46OOVD;V%BQ%IIMK"N[I@AI./
M;+G]:RR:G[3&KGZ&V?5?9X!JGL[(^9_I7ZK_ +'/[,>D_"CP+IFO:M8Q7/C#
M4H%N9YI5#&T5AE8DST(!&XCJ<]J_,_X7Z3'KWQ*\*:=,H:&ZU6UBD5N 5,JA
MA^(S7[B0Q+#"B*,*J@ 5[7$&(G",*,79,^?X9PD*DIUYJ]MA)(8Y$:-T5D88
M*D<$5^>W[?W[,NE^%+.+XA^&+-+&WDF6'4[.!=L89N$E51TYX...17Z&UY7^
MU)HT.O?L\_$"WG7<L>CW%T!_M1(95/YH*^8R_$SP^(C*+TZGV&:82GB<+-26
MJ6A^,O\ .OUR_8C^(TWQ$^ >BO=R&6^TPMI\S,<L1'@(3]5Q^5?D;7Z+_P#!
M+^ZD?P#XP@+9C34T91Z$Q+G^0K[//J:GA>?JF? \-U94\;R=&CSO_@I]_P E
M%\(?]@Q__1K5\6JK.P5069C@*.2<\  5]H_\%/O^2B>$/^P8_P#Z--?(_@E0
MWC/0 >0=0MQ_Y%6NK*I<N @^R9Q9Q'FS&<>[,9D96*L"K*<%3P1Z@^]?H1_P
M3F^/@U'2;CX:ZS<YNK/-QI+R-R\)Y>(>ZGYA[,?05X9^W-\!3\)_B4-;TVW*
M>'/$!:>+:/E@N.LD9]CG</8D?PUX)X)\8ZE\/_%FE^(=(E,-_I\ZSQMG@X/*
MGV(R/QHKPIYKA+QW>WJ&&J5<GQMI=-_0_53]NK_DVWQ+]8?_ $8*_)"OT]_:
M+^)6G?%S]BF]\4Z8P,%]#"SQYR8I!(%>-O=6!'X#US7YA5QY#&4*$XRZ,[^(
MZD:N(A..S1^O'[#_ /R:[X(_ZY7'_I5+11^P_P#\FN^"/^N5Q_Z52T5\-BO]
MXJ>K_,_1L#_NM/T1C?\ !0+_ )-MUG_KZMO_ $8*_)^OU@_X*!?\FVZS_P!?
M5M_Z,%?D_7W&0?[J_4_.^)O]\7HC[_\ BU\/?^$R_P""??A'5(8M][X?M8;]
M"HR?*W%)1] K;O\ @ KX*TW4)M)U&UOK=MEQ;2K-&PX(92"/U K]>/@#X?M_
M%7[*/AK1KM!+:W^B&VD1NA5PRD?D:_)+Q7X>N/"7B?5=%NE*W&GW4EL^>"=C
M$9_$ ?G3RBMSRK4'T;(SK#NG&AB(]8K\"UX\\9ZA\0O%VJ>(M48-?ZA*9I=O
M0' &![ "ONC]@7X>_P!C_ KQSXNN(R+C64FMX&8?\L(8V&1]79_^^17Y_6EK
M)?7<%M"N^:9Q&B^K,0 /S(K]FO!O@>+X;_L]VWAV-0K6.B.DG&"9/*)<GW+$
MTLZK*C1A0CI=_@BL@H.O7G7GK9?BS\9+K_CZF_WV_F:_0O\ X)=_\BCXX_Z_
M;?\ ]%M7YZW7_'U/_P!=&_F:_0K_ ()=_P#(H^.?^OVW_P#1;5OG/^XOY'/D
M/_(RC\SZC^-?PCTCXV^ ;_PSJP,:S#?!=* 7MY1RKCZ']":_)#XP_ GQ;\$]
M>GL/$&FRBU$A6#4HD+6\ZY.TJW8D#[IYZU^T&IZM::+9O=7US%:6Z_>EF8*H
M^I-<MJGCKP)K5G)::CJVCWUK(-KPW$D<B,/0@Y&*^%PF>PRN7)4FK/HW8_0<
MPR'^U5SPB^9=4KGXG6&J7>E3":RNY[27KO@D9&XY'(J_K'C+7_$"!-3UK4+]
M%& MQ<O(/I@FOU+UKX'_ +-^O3/)=:'X<B=^3]CN3:C\!$ZX_"I=#^"_[.?A
M^9);30_#+NF-OVN87(^N)6;FO:?%N52U;5_5?YGS:X1S./NINWS_ ,AW[#_Q
M2G^)7P-TQ;PN^H:.W]G32,#\ZH!L;/?Y<#CTKYX_X*A?\C)X(_Z];C_T):^]
M?#,FCR:3#_87V0:<ORQBR"B,8[#;Q7P5_P %0O\ D9?!'_7M<?\ H2URY56A
MB,PC5I_"[GJ9Q1J8?*W2J.\E8^*=%M([[6;"UESY4UQ'&VW@[68 X/K@UZ)^
MT1\#-1^!/CIM*G#S:3=I]HTZ\8<31=P3_>4G!_ ]ZX'PO_R,ND?]?D/_ *&M
M?KW^T%\"M.^/7PK;1KA$CU6",3Z=>$?-#,%XY_NL/E(]#["OKL=COJ=>G?X7
MN?$Y=EWU[#U7'XE:Q^57P;^+VM_!/QQ9>(]$F.Z-@ES:L2$N82?FC;V/;T(!
MK]A/A/\ %#1?B_X)T_Q-H<_FVMROSQD_/#(,;HW'8@G^1[U^*GB/P[?^$]=O
M]&U6W:TU&QF:">%Q@JRG!'TKUW]E7]HZ_P#@#XV5IGDG\+Z@RQZC9@D[><"9
M1_>4?F,USYKE\<935:C\7YG5DV:2P%7V%;X7^!^P'\J^0?\ @I?_ ,D;T?\
M["B?^@-7U;H.NV/B;1K/5=,N8[RPNXEG@GB;<KHPR"#7RE_P4O\ ^2-Z/_V%
M$_\ 06KXW+4UC*:?<^\S:2E@*C78_,ZOOO\ 9U_8<^'?Q3^#/AKQ3K,NL+J6
MHPO),+:[5(\B1U&T;#CA1W]:^!*_2K]EO]J;X7^ _@/X3T+7?%EMI^JV=NZS
MV[0RDH3*[ 9"$=".AK[;.IXB%*/L+WOT/SW(88:=>7UFUK=3:_X=M_"C_GOK
M_P#X')_\;I/^';7PH_Y[Z_\ ^!R?_&Z[[_AM3X+_ /0]6G_@//\ _&Z/^&U/
M@O\ ]#U:?^ \_P#\;KX_VV9=Y?B?<_5\H[1/3/ /@G3_ (<>#M*\-:49FT[3
M(!! ;A]S[1_>.!D_A71=:XOX;_&#PA\7+6\N/"6M1:S#9NL<[11NH1F&0/F4
M=AVK!_:0^+S?!'X3ZKXGA2&:^A*16D,^=LDK,  0"#C&3QZ&O-5.I4J<C7O,
M]GVM*E1]HG[B1T?C_P"$_A#XI:?]C\4Z!9ZQ$!A6GC_>)[JX^9?P(KY>\??\
M$S?">JR23^$]?O\ 07;)%K=@74(/8!CAP/J6K<^%7_!13P)XMMXH/%<<OA34
MNCLZF6V)XR0PY'7N*][TWXX_#W6;<36GC;0)DV[L?VC$& ]2"V1^->C%X[ O
ME5U^1Y,EEN91YG9_F?FI\3?V#_B;\.[2>^M[2W\2:?"-S2:6Q,@'4GRR-W ]
M,U\Z,I5B&!!'!4\'Z8K]@?B-^V!\+?A_IL\DGB>SUFZ"DQV>E2K<M(>PRI*C
M\2*_)7QAKR^*/%NMZTEK'9)J5]-=K;1?=B$DC/L'L-V/PK[+*<5B<2G[>.G<
M^"SG!X3"2C]6G>_0^L_^";/Q*O\ 2_B-J?@R29I-+U&U:[CB;D1RQD D?53^
M@K])>*_,#_@F_P"%;O5OC=>:TBXL],TZ197Q_%(P"K^A-?9O[6'[0DO[/?@K
M3M4L;6"_U.\ODACM;@D*\8RTAR.AQ@=_O9P:^8S:C[7'^SHJ[9]ADF(]CEWM
M*S]U'9_$GX%^!OBW:M%XH\.6FHR8PMS@QSI_NR*0P_.OESQY_P $Q]#NO-F\
M'^*+O3G)RMKJB":/GL'4*P'U!->B_#'_ (* ?#7QM##%K-S)X4U%@ T5\I:+
M<>/ED7C'U KV>U^-?P_O;4W$/C;P_)"HW,_]IPX7Z_-Q^-<D:F/P,N571VSI
MY9F$>9\KO]Y^77Q:_8T^)/PCL;C4KS3H]8TB#)DO-,<R!%'\3*1N ]\5X6.3
MFOUB^-G[9GPS\%^%]3MK36;7Q/JDT#Q16.G,)D9F4@;G'R@<\\U^4-Q-]HN)
M9MBQ[W+[5Z#)S@#VS7V^5XK$8F#>(C:Q^>YQA,+A:B6&E?\ 0^__ /@F7\3+
MZ_L?$O@>\G:>VL0FH6"L<^4K,5E0>B[MAQZLWK7E'_!2+0Y--^/UK?%3Y&H:
M/!(K8XW*\B,,^N%4_P# A7=?\$P/"%Q)KGC+Q2T96TB@BTV.0YP[LPD=0?\
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M)?LB,Z_1F!(KNU4*-H  [ "N;$<0RE&U&%KG5A>%XQES8B=_)''?"/X6Z/\
M!WP-I_AG1(MEM:KEY6'SS2'EG;W)_D!VKJ[RTAU"TFMKB))[>9#')'(,JRD8
M(([@C-3B@U\C*4IRYF]6?;PIQA!4XK1'YI_M.?L(:[X/U:]\0?#^QFUOP],Q
ME?2[=2]S:9Y(5>KKGICD>_6OD*ZM9K&9X;B*2"9#M>.5"K @X((/?ZU^]-<K
MXJ^%?@_QM(9->\-:7JLV,>;<VJ.^/3=C/ZU]1@\^J48J%:/,OQ/CL;PW3K3=
M2A+E\NA^'5;'ACP?KGC75(=-T#2;S5[Z4X2&SA:1NO4X' 'J>!U-?L!#^RK\
M)K>19$\"Z2&7UC)_0FO0/#_A+1/"5N;?1=)LM*@[QV=ND0/UV@9KNJ<11M^Z
MAKYGGT^%ZG-^]J:>1\J?L@_L5GX7WEOXP\:QPW'B=5S:6*D/'99'+$]&DQD<
M<#MZC[#H/2CTKY#$8FIBJCJ5'=GW.$PE+!TE2I+0_.7_ (*>1NWQ$\(%59A_
M9C]!G_EJ:^2/!$$G_"::!^[;_D(V_P#"?^>JU^X.H:#INK,KWMA:WCJ,*UQ"
MKD>PR*JKX/T&-E9=%T]64Y#+:H"/<<5[N&SGZOAE0Y+^9\UB\@>)Q3Q'M+7>
MUC7C^XOTK&\9>$]/\<^%]3T'5(5GL-0@:"5",\,,9'N.H^E;GI17S2DXNZ/K
MW!2CRRV/Q&^,'PMU/X0_$;6?"U_%(SV<W[F;:<30L,QN#[J1]"#Z5QOD2?W'
M_P"^37[LW_A[2]5G$UYIUK=S8VAYX5=L ],D=.3^=5AX+T#_ * FG?\ @+'_
M (5]A3XA<8*,H7:\SX2KPNI3<H5+)^1Y)^P^I7]E_P $ @@^5<<'_KZEHKVZ
HTLX+"W2"UACMH%^['$H51WX Z45\G5G[6<I]V?:T:?L*4:6]E8__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>mck-20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mck="http://mckesson123.com/20201231"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mck-20201231.xsd" xlink:type="simple"/>
    <context id="id38061441e40423d8310f1dfcc2de952_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibe90ddd61815466e8647519b72b5ccc1_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id264d9c87dcc405e945fdd97ce807af7_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A0625NotesDue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if58e825fe2a34bef8acbd60f66bf6ca3_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1500NotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia0dab164e3ea46fe8045e94da8af3a96_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1625NotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i18b68afdbd2149a79f7d4fbccb76c182_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A3125NotesDue2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibf94a331dc864eada169fac303e5931b_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7a0bf71acb034de79df20792261b0fe2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8f75dc9fda5c41feb4e0a7addec435d0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i046c55cb833a40dea20cd595ea58722c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9738445b8a5e41869bba0cf8d810974d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i79239b1b57fc45128439b982e6e306d9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if702f6988b73408fb0203fbcf4cfff59_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i22f4cb39451147ea9fe68b8f991a70ff_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib03cda0901f74396a9d42a5e93e5f9eb_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icda41b88f4cc470eb74edf0bae68f725_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i76dbf276f41c433aa3233de59bace255_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i37974d926d4e49eeae69ab2a0f22c9e5_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i454504e100134adfada4c6b22b8a933a_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5f6abb61154c4e5580b369029cca081f_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7eb9f1e25c3d41efb703c958f350bf20_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia3e05b2e0a9d44ed8dea34e18361b913_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36774e6a606943108bbf2290e991ad35_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i67e7913b409c4c2188c465886e28af95_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib7265c70a233467086b5103a31edaceb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia6641e8af9e64c7aae662865d224c625_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia4ddbb098af84acd823dab9a811ce25e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i436786cf3fa44a21863b50c1e252c871_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1ab271cbf75f4a6992e0fb34901ba49d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib4bf4310d43a446aa281ebdc500f1c56_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ifa5fbe0fd0874aebab734ed30f8b57f0_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7a1d4b79fc7b43f7afae361190241425_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id0374ed6096c4fc79915873d9944afab_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i70252b6394004f7b954609f75985fb93_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie6cbf15310ca46869b7c2a9274df3ebf_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id344251a53d94ccf87e27d63b0bfe5c9_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i639bd12a270543c8ad6932bf9f601e45_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i846abdfeaa6544789a5e524558b9443a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if69ab677c8f149499b3a80ccbdfc1050_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i93b2ebdda56e4926b226f0d3df3470ab_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib4b3986493e54543ab88e63dc656f1a2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ibb7456909d2b497aa24862ae836a1a66_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5636635f7cb74ec7bf4beff8d593f7f3_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i935b818ca9a54205944e103ce26b3be1_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i16fd29d7481e4494b840a459e3299e08_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i28e45f80bb9349f5a5ec660f5376691c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8106bbb2dc0a4f59acc6299d4f71a45a_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2011d00a9d33400ab4105b02fddf648e_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2895dc4463844ffe85d8bea8b2472d44_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if6429e408d6643fe8ed7a32451d1973a_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idbfbb7ecfac64c7d996917034b9d6fbe_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i55fa8262a4e440d49790e9cf14b51dbd_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3bbd5766e5e1426fa1e48b9db23fb33a_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i6f3407c46f4b4be98e132df1cb8b89d7_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i45ef706885764ecd9440a440f9bd9396_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="id768d1b9bff84003a458da02ab6054de_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i9e571302aec24a36936d3e24fb499981_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="iaa37fcbfd262489885d497fe4920cf55_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i4fe05a45bd0447499ad4274ebee0e5de_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ic2706f6905b14cc3a97aaf70ac667df6_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i87686bf1372a401ab1608bbccf25c908_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2d696af4cf5445b28748e6c09ac7c601_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i308d835dd02042a8b515529815bd98ec_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7de52a5965ed47d1812e75a3c210ca1d_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i476906634a324f9287de597fd0120a9c_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i03968c2d88954a3f8b182452bc2bbaa5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1a823c07346941aca960d012bef9774a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i34964563458343118c3362841fc34697_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1510b0bae31c44278e232e7cafd63a4d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idd724fc113f1423fab76a0b7d9141942_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id25a265859cb4a5fab9c40c7cdf40f44_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id9025fe41f3c4206832a02f6067cccc8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia65b1cdade72453c9c9547d6ed17b3e9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i53dbe944eae1492aa687e479fc7a11b9_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="id0ed625dd55947b98750c596c6405402_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i48dad6b27bfc4bb98f4e86f70d71263b_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i3e42b52ae7334bbc8d4c95f67d0beb34_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="id686b4181792461ea0b02a307e3b6b16_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i81babc7a70954522b7b22ac34fdd8414_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i9dcbc3a9c5dd4e11aa4f98339c48f19c_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ic798201eb4fa4f7a804f2e801548f37c_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i7d03dd7c905342d1a2937caa74731528_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i46e5c95277ec49cb8ca34ae6e95c7f38_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i0170e2288b194e75bbcd4d3065c84185_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i9d01fe2b386243908ec14fc43582d826_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ic38570a58197439eb0c8a6f1f9b9fd62_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i3f0d013d62e64c1a9ff51d7df3d8f8fc_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i58124d80a4e44920b8506455c425e375_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="id6558f17c2334aff80dd0d663259b6c9_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="id8eca560196144a6ae00495db6084899_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ie8f0d7cc99df4d939573a16bbc9b0efb_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i36d180f203204936b0e8fc121ab9b7de_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i457a8c3bc27049ef85e109fd88303f2c_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9d7db3179e2e47f293b957b1ef8858cd_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i01c4d416ec1c40a593cf210126c97ef4_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic26a952d776148b6b791451cbf1e0f2c_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i956f7e118d784444a97416bdea861a56_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8fda1e3442374708947bef1923d2f19e_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1b34b0a4a2344072ae6737a15d1ec38a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2bf1ccbd66194ee193c7054b7fb9cad3_I20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-01</instant>
        </period>
    </context>
    <context id="ia2ee20a5c84e431a9dbe88126ea7debb_D20190701-20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="i24bafc5133144c1f9d0575855df32cdd_D20190701-20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="i651e12a9a9314eaead5f5def7b8cb902_I20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="i6b3a22eac44c42f8966d20ec62021a93_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i9bb3d5efc8c84f3896fe23c52b92310e_I20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="ieba62539ca00495ba37020bffe3d644f_I20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="i5b86094c4db947ae9f4ef0d8fd8d773a_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i72904c34cf28486695441a05e83b4257_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0946d2a17db14d63b64a7a7251e88c34_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9f856c9a81854c4287e9fd8fc2f4afdc_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TransitionServicesAgreementsTSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idaaf01c3e7a448f788de27496483bc0d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i715e9debe5f0419fa1ede68430828e3c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i54af79268ad141df9f90e22d7b9b6595_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic0ee8653fb6141acba5c088e3b9425bc_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:WalgreensBootsAllianceJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="icb1ee1c3366844f7af5c1f57a7d2a100_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="i06bcacee536741a5b8412ad11e052a04_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i938f21cb5003435093dd61e42f1e4b04_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1089a6502fe643b2af007927de94cff7_D20200401-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icd175625828b47dcab648e0b14392f10_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0736a2a757fc454b88a193a6988112ef_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia0497adf27fa406783b9193a572e5457_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="i5f9649ec563d482b84c3260463f09372_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id6d5fffd99d0450f8f071044f671a597_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i91c13ec8524c453f9fbf254e519c6157_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i616db767164b421690d7840423dc72a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icd12a38f8159497f9b8bc50d69f1a89a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i20a65cc8e8234e5eb9b8668ac6d80e35_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5777604ac50d42d29d8f706480015dbc_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i39bbef1ec8fc483a88d5b2eb2083b4a9_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaba638f6e46a48be9bcfd94e751a80d0_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if7e8ac65eea64557801e653b724c7e05_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i40a1d1ff2c634d9f894ff1faed74cab9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd41af04654b404a9739658b0498956b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7dcd5be0a9224164b3b9c477afe71a48_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if5111ebf6d6d4aa8b255575260d32886_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia582bee9ce874e8bb235617714cf6227_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icd022885b12e488c84b28eedee6a78ba_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4e8de5e2935b4c3496531d27f8e5fb9d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i60745e30425f4f529e698ec37e36d916_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0cf4b0b9a9c540999eb1517cab23e300_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic2223aea755c43138b22205b7dce1033_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if54fe59c7ab4486da50c3e383e0514cb_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifc7a74b6b95d4a9e9c701380f77e3b51_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id80f00bff7b5467b812041c7200a62b2_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iee23f0fe86e64c7bae441a8ea5cc1c91_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i499179d5d599419b93690bc3104dd04a_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia996899a77814c11b1495ca0445af186_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic713f1d7bbaa46368d505facade21e5e_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib36209733adf465ab9a09ed10cfc40ba_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ief6c871b558e47b38754e0ea56f455a3_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5f91b4dd9d724e81a9d50e837b7e65d6_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib74da540dfec4334b95c1028aad4aabb_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia76b1ab18790411e9e7fdeb98f2f4606_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i55e8174fad24466896ea35fa3e18419c_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifafa9479474c4281a1fb299fa0ed48b3_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i33926b73aa0043d2989ae3b788c16046_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib06a1c55db15496e8c44849e29aea6c6_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i23356c66de0b48bfa4370bb815d51010_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib632ae517264462ea49f0e14b37abe4d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic60a002dcc044ef2a73c71e490891614_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ifce4292925d84d7bb62d6111b21c8e27_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i877beefd260c4117b551163018536ff7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ifad220b5d8ba4d42a4c7b10bf33c3d2c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i65219f93663148a283a10dfe499597e9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3beceef97ffc465bb547b319a855c1fd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4bb04a8ba65947f39b3457cfdc48939a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4f647fda026d4fd8ab82de9ade2df506_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i001894ef5d384e6194e9a49a8e30453a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie1d41963e1e64af4a2db91749e48ba60_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9ae50b9f9854471da2e71204c4eedcb1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4ab08a4977fc44d4908e07229d064f40_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4e166dc2bc4e4407ac307367798e7a56_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8f352c2923e048e7bcd08e46042cbead_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i08ed9c0c5f6d4a748a507235f5b297eb_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7ac4183cf22d4c829d4a7bc371cc268c_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i30c6a601291c426daef2c98a6924abf6_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id2503fe9d11b43b3b558877f874ef3c7_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iea7615b447b24e05ba7119aa98301bad_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2c1af7ae051f4acd85bdcfaf6f8522c4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i626c1e0e782e474b92df366e001d6dd2_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9a434cdc734d4abf996142dfdc8544ec_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib5b1c59088c8425e8c672396cbc8f14f_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7442088aa6c644dab9cdca71fad61eba_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i96e8498baa5c4166b0360154493d4319_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia893650b8c174d97a0fff05ba6bde046_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib0a2cb17de16467787ff8f495afca17a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i10ab863a7218445ca985683b1005b32b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4f97e844a5a143218fd2d44d5b013a4e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i0e8778eb76054f0395746e9375d66efe_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if22a8f70dcc24adc95cac8f86540d584_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i849ff8d4511349eb9c3153967d1f7f12_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5a05c352bec44a6fae02dc63bfae55f7_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i31fd56c5e498439cbb9f159e3e0e2e0d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ied0e473ba615450b86643eccb05bd229_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie3a8cac6d54b4c2ca9b7378d13ef870b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4af1d24608d74947ab7497e23209ad59_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i0c62b22aacf74756b7dfff6157966085_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ie37cc4ec5c0e44558b2a32aba2c5fc0e_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i11866fb0993444bd8e695ef414d06b6a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic1e09321f5344cef88ba1a2c8931ec04_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i0ed9ea6e51234863bd501477e55a7136_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i85b5d437b88a43c3b57c3014d5ae8bf1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic4fae59f18a14a25b3bca73a248e3bc3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7dbd3be0a56f450cba497eb475a1c80b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie24dd23acc4f44e2a91794113bb10c51_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i02543cc7d8874da9b9dd772a66bad70c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib0fa20a992b84dd9a41f9cbb8b17ee14_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i566978f4e878431094db0c99aa04c1ac_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i502121074c55491db6f36aeb28a2d5f2_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i900790fc3b604ed6aeaa993f4b448b36_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic38f289eb4674ef2811a0175289d6579_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idb9d72428fbd4515ba2df2bc472b2522_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia9435ea6faaa49bfa7de0a9fd3ee3563_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9099621a5b034f1783335526d709c949_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i378dda10c10e4abda769223163b7e4e7_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8cd1df3bc0b547ba9f623f4ef73d5370_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i511bb16900684b6ea922b921c9d4dee0_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5cfa3015624b4bc5b6b7f68095b82e08_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6773d34279984d34b8e2570dbfeac99d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i658902b07b2b449f913e2bd8456c8fa2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i523fcde586d342cc8bd48e9569ed97f0_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i18fb0f7e2d57454c8ab3f9bf8d8d22cd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1b800361d6a84fc7b5a2446b3d1e7341_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i963a00ca4138498ca7ab4ca57f1a7f37_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i725fcea7818746d1a1609a91129d7859_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id285ee1563e043a08cf17e27f0adff21_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ibc05b27d7e0a4e78a4db26cb12058f85_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5769cd643a314785bc6bb343b9674112_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieafb5736403f465eb913bf612cdc985a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i659552bb536e4d988f20153df0383f90_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5a9556d9999d4dad8956e6c895b8d4ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1f42cc658d804c91ab0038c670ab193b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i0e3d82d95ff34d09ad54cbb7a9568eeb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A365NotesDueNovember302020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib62e3807a7114d0899925f4b51210868_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A365NotesDueNovember302020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i61243968789b45e78979a62d792f3bf2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMarch12021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic23cdb3eba794da3ab936c09bb3753eb_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMarch12021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic49f2f1769cd420c9df5352e8067b68d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iff33e00fbaee41eea7defea825d96e6c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5f896c781b42418fab54308abf10a3ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2024e246ff5243e1a182377483b428d9_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i83ba1dcc0fa0463e870a0c6af64a8894_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3929998884064e1fb42a501356c5aa3b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i45681222eb314cadaa16245b1eda2bb3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ida48ca8acd984f98badfab324817c495_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i13860847712f4090af128c3ef55aac24_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iccb710e426964f068ee01c91061447f5_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i722ba8780dd64ef3998e85ae30f7b8e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9c3b5bf1138e4193b4ed05d0221ddb16_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iee65e5a7c91d480fa442a25bf99a4310_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa304a69e98947ed8c2ebd69d84693fe_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i543d6ee25e6648e9bfddfd675bdc4e0f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icac37f0bb50c47a88452230ae579cc0e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i59f7fd483700447b913388bbe402cb2a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ice7a4f35e6e047a59039a07c27481e3c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if338ee6ce8f3482a80ee390eacdd1b93_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaf0ef65f413640089349522b6d1f61fb_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if9e2e544a5d24e309b0b1d476df167c4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5859abcac6664cec9fd998af2d0f2d14_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i57d99627daf846ff9841f02dd67e8763_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if427cce4e6654f628a7f645a93e796d1_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i54d06a347a4e4e5e91c4f62ec54e8cc2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i06786762035a45b180efa3c21821bf20_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1b3e1030e25049dcab5e8f463f79cc7e_I20201203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-03</instant>
        </period>
    </context>
    <context id="i5a3ede9e6e5140df88d6504a6002bf36_D20201203-20201203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-03</startDate>
            <endDate>2020-12-03</endDate>
        </period>
    </context>
    <context id="i6dcb7ea25a61456ea8011e544254a46e_I20201201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMarch12021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-01</instant>
        </period>
    </context>
    <context id="ie8b3fd2d698249cdb62866fb761a1437_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="icbedee4fddac4d1e918ff2e43b85f5b3_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ide009e05a6744804a59fcd84efd0b7a3_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i5b8012a1221f40588f7488916fd1b3b0_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia75a14b05a5c4c2ba266322f4ed4794b_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9d587484c8314278aa228f8a047c449e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3673260c4a0e4c6789566685bcdc80f9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia561add5441945f9b6e6f005c32de046_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i3df3eaf8483344e189aadb44a6e73dfc_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5cf6891e4f624ba4b2c8f2b8b8ad994a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifc76a63f576047c49638f41ac0d91ae3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if13ed91051e047c597b44d113a7413be_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i451d84e1d8a944789fa6835d4573fb2a_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1c39c0200ce7449fb14e39cf375472fa_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9572515afb1f475086d3833719ce1ee7_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i89e2b4abb66f4b8490bd136400166514_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia909bddd810745a78d740e262952804d_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5720a12c6a9847d3959ececda0b47b78_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie862f63e9e384a2384d0f8f2895b4fef_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:ExecutiveBenefitRetirementPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5a58762e511c405da243fad3b79d9702_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:ExecutiveBenefitRetirementPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib9ce75f89ad84830aa465d0823e6683b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i87abebafd2444aea947519a813b73651_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie662489344214deea919f1b5ac9b8617_D20190601-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i27e1b65706fe43c8b7b96d04e78a9a4b_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if044bd6776b7450a96d800457d558593_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i77fd18e4162c441aa58436014d857d12_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0d9cf49bcf574771b799ca4645191cd5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2a0ca354dcd646dbb94a5e6bc0adc910_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ide3c05407d4f405faeeb775e3cadb1ad_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic3392a15e42349f38396d43edec58984_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ieae8ce38c55c4a8183867cb63bfddafb_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8ac357c6d2694d3e854ab420c7c33a3e_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6d10966d07b64ebba1b226a32e8e56fa_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iae697c5a606444c8a0bf468944693083_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4c3d87e0bc6d4b3788054a9adf38efdf_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib05778dd9f2047e7ab989296e4f1f027_I20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="i4ffae78da5324045885fd5c5f9e72fe7_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i3a1e7fab3c5a46bc80683fd7a9936356_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i36b3bcf8d524467bacd1c159707af361_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i09c294f2acd74c33bb8e9ada8e29bfef_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if86aed3e96a64acfb7d6c3d4ba3f32e0_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i51b2cfed82a94bea9d5b40efccf351cc_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i132f49f70d8e4b459e1dfdc3b23932f9_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i5bed0108d30a4edbadaa59d784d7e6f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia6fd83f4ec5346a89c43a4d4970b587b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7e172a5b89714b5f980c0d1515d155bb_I20200427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-27</instant>
        </period>
    </context>
    <context id="idae826ee5fc34b5a8ac7443ee5012249_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A2025NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4108ab99008d4e68a3dd3eae636c4e61_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iacfcda1e22f341b0934dd329fa019e54_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if2a0e643e93146bc9920807b4ff5583b_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i906ea84070b64689a6d04852f20df452_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i35d99ea68d0b48eab76bb746417d8dd8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0eeec9e2862e4c51b6d12a38ac428a0e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic99175677b954f009bf7dd3ff1f205b9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie84b0678aefd46f39446455df3d55df3_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3ba05cbb6a39421ca690fc9912bd454c_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i57bde6e22b1b418fb5cb8d67718f73cc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0b4553eec3884a74b9c29ba57c8f46fc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i041bb96bdf7c4fd18af85821acc08bdb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if8c751112cf84239a9ea0b86ba0c4dce_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i70cef476be954ba5826ef9cb90ed5bb0_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i941389e63f2541a1a376a9b746120d0e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2ec64489b9604c8d8f972120fbda6056_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idbfc5ce51aac4403bc97157e950c8b20_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i149087f716324b259895a04a05c5bb9c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6b7780a8f9e948f093b5fd1cce4b2871_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i89165375051c4a2399f00117e4669f3f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i85e18c845f544dc5b2de3609dccc18d1_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i0e01229209e24fcbbaac835c6868ce3e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i46eff3e723494b9b8db10c46e8d5141e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie1a73cb404974bc2b79ec51446e9c1ae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9417de73a5c549f0be8c082c4db84e40_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i69cadcfb856d4a7a9004d7cc9933b9d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieb9595c53e61414fa6ad030992206402_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i20f0b972582444239e16f4edffd19f90_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d9d75c3418b485e94de80a639f2a0fa_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib047b820d28e468fb76500c99500cb2c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieaf792582ac14ec9877670dd6af11a65_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7840da1cacf0419993b0a527d8920e10_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4c9db4a4610b4829b8b00be2a529a9cc_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i701d2f10e13b41148f385570a86bf3b1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iadffe49dd7104768a9a656790d004b41_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia32a43bf4c32481bb6ea7a38d845082c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0f2700a332404782bc605abd43a2168b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9a5ab16c64ae4891a9ee3b4e317ce1eb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i11feebab2b6a424dbf4daff39a96c1b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieb5a21abc8d848b6956e3feaf80201be_I20200114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-14</instant>
        </period>
    </context>
    <context id="i1814ff2457bd41d6804ef58f25e4d38e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icbc6c502b0884c4985e06716f2758c89_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if621de71312448b2a9e258676fa2ca7f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i466b8e02cb9445f399b466a5da7612c9_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i296306fefeb14dec9e27a205cd23548a_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i810be42fbf2d4974a731649985916aec_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i9b59d9c3f0e146b8a720c89acae06997_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i0f96022346a941118bddf4181736007f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i307db805735d4eed947d313935f69a7c_D20130517-20130517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-05-17</startDate>
            <endDate>2013-05-17</endDate>
        </period>
    </context>
    <context id="i70c71945e9ab4abc8b1e9671bc5cf37f_D20130517-20130517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-05-17</startDate>
            <endDate>2013-05-17</endDate>
        </period>
    </context>
    <context id="iea73c883add347f580abc569d92611ad_I20190813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-13</instant>
        </period>
    </context>
    <context id="i4f79315064404a0d802db3a9c2d14fe6_I20171229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-29</instant>
        </period>
    </context>
    <context id="i4c90799af4454695aebcf7f2731092cd_I20171230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-30</instant>
        </period>
    </context>
    <context id="ic5f178fedc5b4cf6bdb61d18797a2680_I20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2018-04-30</instant>
        </period>
    </context>
    <context id="i2b9d2822c0fe41fc86291a1793d818ec_D20200728-20200728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-07-28</startDate>
            <endDate>2020-07-28</endDate>
        </period>
    </context>
    <context id="iee7001dbe701429a8640019b5e925c83_D20200729-20200729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-07-29</startDate>
            <endDate>2020-07-29</endDate>
        </period>
    </context>
    <context id="ie5c361bf141b4eb9891a9ae3f5e870b1_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia83332fa877f4f95a2db6855471cfa83_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i85bcde357ef24cd5a6fe11d759211780_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketShareRepurchaseTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i42de281c12634e1094f4341b8340f8c9_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i245807132e61488c94b12390e4121f99_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i30850816b81c420cb3a11454129cb099_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4565d58c6438432884a322271cdcb467_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i60ebfe67a3044298876108334986e57c_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9b20d10786654fff938ed21b46d91890_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3b48d9346ede475eaa9d050fcd5e2432_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2f8cdf78c925481bb9fb846b51a37d4c_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i171a7450485e4fa19bb98c562f3f0835_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iad19a75609034338a9616075a375513e_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4e441b29128c48aea910381165c7b723_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7ad855b967ce4ddd8019fe6ca830c068_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia4b2c4b06218485da8544d4e41e7e4cc_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i266fe3f418d84aa7b7249926cfc9d280_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ida514f8038f5465c9dc701830da2f003_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i39719f584adb44c1b39699ef890bfe15_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i58b08f5f1f644db4945b8ba02324d11d_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icaec3dac337e46b3b24229e240ac2c53_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3048995a4a7944508cb95b392a4d29cd_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4603c284d62e4e5c9442bdc1f75663f1_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i67aca6db78904dec90dc3b22e3800fd5_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id38d110d6f9c4cf097c87208b255cff1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaff277eea93447ab86287935d95d1f47_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1dd77d36d7ae4ca38af80569eac5764d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0ab154724e0a4ea78f86170c48cb3e03_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7016c62d475b44cf8995815c2ee6e6c2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic53b88b03d43406caa082e97b8198de2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i287fd1b1acc740579e26c343e6d1186f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3bafc11b2f6c48fe8846c0cbf49f1ca8_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8151b587ea184a12a863eb648c1d73b6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee018ab4a90c436e82e2d025bc7c4033_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1029504ec8324cdc9d1a8a6f2a854090_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i28bde64152834b87bded353fb0352d95_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i71a3e94889974300a0f149383fe25f18_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i06a62989bb2744f8a8d872418308d4ba_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i513c2028d38b4884ac53975bfab5f078_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i12907ec702d147a3bd56ff8747ef063f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8a4dbe3271764ed783e43c160f22a5f7_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7ea78334a4a544dcba38daccc7916a10_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i4a906828b06245e58bece79897fe99fc_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="icafc8c81f18e4ee2a2a6e3b81ae88a12_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="if9c3b3edd0774f9db0813da0a381c7a0_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ib7ba00100ab34faa9bf1d5f5d42af04c_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i27e40da0240940a7926bf05b6174ccd4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3663290a78c548f4aa7609a2c7554daf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib213387c8afd446b96bae95715bec72d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i51ffaad82dab42a0ab9c8e587557236c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iade9d1af10904ff7acc439b8834a8395_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="iab70a6f91f224f69a6be90a2c01a8355_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ifa5330bd233547c98905a08caa8ca3a3_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ib822aec9103b458dbc079db87594cd6e_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i3caf5544ee374eb3a48285ec3fd9279a_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id58d170d297c43bcace9dc7b5f556347_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic371359df42d46fc9cdaa20754eb2857_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i45c05b8f83b741d992b83ccc3df6b908_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i294c2f089e43428d9f211ab6d5436a55_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4632c5240b01414e9082101b8768cac1_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifedf75934b37431f868f060ab5f6013a_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5f550bcedc934c8b80cc03ee44b800ab_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i08b6999463f4433f9cc082295167d9ae_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i03a67644704d4440bb71e3a2701c416c_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i52f55c7a43814e4181d18751f2048f0a_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0ae066f96784452da1de68ea4e97704b_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i79d5ebe53b9a4ebca65716989b93c5f8_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ida0b040eb5e94d34b4dbc2a627b7da27_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if94267ba6de9458db3df283198381edf_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9e8e81ee2fb849c29d5ea7c25273ee5e_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1de8191ab06245abb971e2b0ffe26491_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i115a3e3004e949119c249e28526ae1d6_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3d023e4934d548c9bc3bd440f7da7aa3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic1ab6dd9883343f8a42baa07fb972b7a_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic9ff51a496f742c5a3c83d3b38d4dbb1_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i568b05318ce7413fa9252c00b9a77597_D20200401-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i69eab42c07a44d5aabd460e6391ea635_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i797e794c99c4456e98cc170a98d8a85b_D20190401-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib6909fe531ae47989d16e4519df3b5f9_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i422fe30a34754885aa9558599f8972f8_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>mck:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="county">
        <measure>mck:county</measure>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="participant">
        <measure>mck:participant</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="company">
        <measure>mck:company</measure>
    </unit>
    <unit id="investmentsecurity">
        <measure>mck:investmentSecurity</measure>
    </unit>
    <unit id="case">
        <measure>mck:case</measure>
    </unit>
    <unit id="state">
        <measure>mck:state</measure>
    </unit>
    <unit id="stateattorney">
        <measure>mck:stateAttorney</measure>
    </unit>
    <unit id="fax_number">
        <measure>mck:fax_number</measure>
    </unit>
    <unit id="fax">
        <measure>mck:fax</measure>
    </unit>
    <unit id="investmentfund">
        <measure>mck:investmentFund</measure>
    </unit>
    <unit id="vote">
        <measure>mck:vote</measure>
    </unit>
    <unit id="country">
        <measure>mck:country</measure>
    </unit>
    <unit id="business_operation">
        <measure>mck:business_operation</measure>
    </unit>
    <unit id="numberofproducts">
        <measure>mck:numberOfProducts</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80L2ZyYWc6MTU5OTdmZWM3NzNjNDY0ZmFlMTZiYTc2Nzk0YTA0NmQvdGFibGU6MTk1YzI1NGYyZWIxNDU0MjlkNTc4YmNiNzhkMDFhMmUvdGFibGVyYW5nZToxOTVjMjU0ZjJlYjE0NTQyOWQ1NzhiY2I3OGQwMWEyZV8zLTItMS0xLTA_576b9a88-aeff-4b10-8f96-0f6f5d9c9287">0000927653</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80L2ZyYWc6MTU5OTdmZWM3NzNjNDY0ZmFlMTZiYTc2Nzk0YTA0NmQvdGFibGU6MTk1YzI1NGYyZWIxNDU0MjlkNTc4YmNiNzhkMDFhMmUvdGFibGVyYW5nZToxOTVjMjU0ZjJlYjE0NTQyOWQ1NzhiY2I3OGQwMWEyZV80LTQtMS0xLTA_95fba560-ace9-45ee-a330-846e28a79ab8">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80L2ZyYWc6MTU5OTdmZWM3NzNjNDY0ZmFlMTZiYTc2Nzk0YTA0NmQvdGFibGU6MTk1YzI1NGYyZWIxNDU0MjlkNTc4YmNiNzhkMDFhMmUvdGFibGVyYW5nZToxOTVjMjU0ZjJlYjE0NTQyOWQ1NzhiY2I3OGQwMWEyZV8xMS0yLTEtMS0w_55c28bf5-46f5-4e46-9b50-21544f2b5d7d">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80L2ZyYWc6MTU5OTdmZWM3NzNjNDY0ZmFlMTZiYTc2Nzk0YTA0NmQvdGFibGU6MTk1YzI1NGYyZWIxNDU0MjlkNTc4YmNiNzhkMDFhMmUvdGFibGVyYW5nZToxOTVjMjU0ZjJlYjE0NTQyOWQ1NzhiY2I3OGQwMWEyZV8xMi0yLTEtMS0w_54133081-b974-4cf1-b7de-c4076a82813d">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80L2ZyYWc6MTU5OTdmZWM3NzNjNDY0ZmFlMTZiYTc2Nzk0YTA0NmQvdGFibGU6MTk1YzI1NGYyZWIxNDU0MjlkNTc4YmNiNzhkMDFhMmUvdGFibGVyYW5nZToxOTVjMjU0ZjJlYjE0NTQyOWQ1NzhiY2I3OGQwMWEyZV8xMy0yLTEtMS0w_9675a51a-b29e-4bf5-be60-136b19c26ab6">false</dei:AmendmentFlag>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="id344251a53d94ccf87e27d63b0bfe5c9_D20190401-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNC0wLTEtMS0w_e059b575-1bdb-42b0-8a48-ed92a77e999c">us-gaap:AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <dei:DocumentType
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTUz_69faf067-f085-4548-8861-c83b0157bdf8">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MWVjYzczNjcwNzNiNGFkODg1YWNlYjI5MjFhNzY1YjEvdGFibGVyYW5nZToxZWNjNzM2NzA3M2I0YWQ4ODVhY2ViMjkyMWE3NjViMV8wLTAtMS0xLTA_6418e029-c3a6-4adf-95a3-61420a31f265">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8xMjQ_646c2896-ca6a-4056-b87f-78a0ba3c0688">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6ZGYzOWQzYzFhNDNiNDEzMDk4ZDMxODc5YWY2NzZlNDkvdGFibGVyYW5nZTpkZjM5ZDNjMWE0M2I0MTMwOThkMzE4NzlhZjY3NmU0OV8wLTAtMS0xLTA_59551cc1-9211-4675-b5c4-a4771f6841ae">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTQ2_238a4f3f-27e2-4afe-bb9e-4bf0e1c0f675">1-13252</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTU0_1dc22c18-ee5e-41ec-b879-ee06a927c6b0">McKESSON CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6ZDIxMWQzNjBmNjRiNDIyM2EzZGJiY2NhNWJkZDU4ZjIvdGFibGVyYW5nZTpkMjExZDM2MGY2NGI0MjIzYTNkYmJjY2E1YmRkNThmMl8wLTAtMS0xLTA_ba384fbe-3564-48b5-bbe6-662e329f35bd">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6ZDIxMWQzNjBmNjRiNDIyM2EzZGJiY2NhNWJkZDU4ZjIvdGFibGVyYW5nZTpkMjExZDM2MGY2NGI0MjIzYTNkYmJjY2E1YmRkNThmMl8wLTItMS0xLTA_cca22bfb-1f8d-4caf-8990-a32d8be3817a">94-3207296</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTQ4_c173ba11-3877-45ec-a8c7-c89ce16f6a51">6555 State Hwy 161</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTU3_1006e0b0-1e67-4cfd-bfbb-6ccbbcdc9337">Irving</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTU1_2b70c50a-4491-4d4a-b18f-cdae349fd683">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTQ5_7aa2a0ec-2bb4-474e-ade9-db5345e26b8a">75039</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTUw_80c302e6-0db2-464f-a116-25a9e7689661">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTU4_8e8419f4-158f-4eab-8949-1143ae830069">446-4800</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ibe90ddd61815466e8647519b72b5ccc1_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl8xLTAtMS0xLTA_61ac50c0-6315-4505-b4df-b6fedbd7a13d">Common stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ibe90ddd61815466e8647519b72b5ccc1_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl8xLTEtMS0xLTA_a06509ff-937d-4f17-a68d-cd29c097f5be">MCK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ibe90ddd61815466e8647519b72b5ccc1_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl8xLTItMS0xLTA_4a4e960d-13d7-4a70-b0b1-b41141a012f9">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="id264d9c87dcc405e945fdd97ce807af7_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl8yLTAtMS0xLTA_d7c5d5c9-dbf9-4e5a-af28-9b4a42d8af8e">0.625% Notes due 2021</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="id264d9c87dcc405e945fdd97ce807af7_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl8yLTEtMS0xLTA_15c53130-e3a6-469e-bd6c-4fab2dfc4f3c">MCK21A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="id264d9c87dcc405e945fdd97ce807af7_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl8yLTItMS0xLTA_8c859c90-756c-45a4-bba5-5bc6888f2d9f">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="if58e825fe2a34bef8acbd60f66bf6ca3_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl8zLTAtMS0xLTA_0679891a-fcff-4da8-a0ad-f27da2cdad08">1.500% Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if58e825fe2a34bef8acbd60f66bf6ca3_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl8zLTEtMS0xLTA_9dea067d-55ee-4eba-9b4d-1f80e8d018ff">MCK25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if58e825fe2a34bef8acbd60f66bf6ca3_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl8zLTItMS0xLTA_6bae8fb3-fb02-43af-8ee7-ef5032cd0833">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ia0dab164e3ea46fe8045e94da8af3a96_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl80LTAtMS0xLTA_b5190e81-07bc-4095-a6dc-97186deb6e21">1.625% Notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia0dab164e3ea46fe8045e94da8af3a96_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl80LTEtMS0xLTA_e745d746-2d3d-4723-9381-86d19af0ca3a">MCK26</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia0dab164e3ea46fe8045e94da8af3a96_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl80LTItMS0xLTA_f7e4545f-d7cc-4944-9e67-186fe77e0ea2">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i18b68afdbd2149a79f7d4fbccb76c182_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl81LTAtMS0xLTA_3e6de1a3-5066-41b6-b46b-7200c8151afb">3.125% Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i18b68afdbd2149a79f7d4fbccb76c182_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl81LTEtMS0xLTA_1cbfcaec-a913-437b-806c-8377347e3022">MCK29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i18b68afdbd2149a79f7d4fbccb76c182_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6MDc3NjkyYmY0YzFhNDliZGI3MTNlMTgwN2VkYWRiOWYvdGFibGVyYW5nZTowNzc2OTJiZjRjMWE0OWJkYjcxM2UxODA3ZWRhZGI5Zl81LTItMS0xLTA_954e424c-7be6-41df-9f99-2fd6c6288080">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTQ3_cecacc0a-bbf4-4fdd-8401-60dae61d223e">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTUx_db19779f-dba6-4f21-aa45-07b0aa03e44f">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6YTgxZDA0ZTY3NTYwNDMwNWIxODM3MGRmZTFhNmJjY2YvdGFibGVyYW5nZTphODFkMDRlNjc1NjA0MzA1YjE4MzcwZGZlMWE2YmNjZl8wLTAtMS0xLTA_24396a5a-de37-4380-a59a-e51847c01294">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6YTgxZDA0ZTY3NTYwNDMwNWIxODM3MGRmZTFhNmJjY2YvdGFibGVyYW5nZTphODFkMDRlNjc1NjA0MzA1YjE4MzcwZGZlMWE2YmNjZl8xLTYtMS0xLTA_0b73d386-92ff-4df1-8b06-8eb2c5b279de">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGFibGU6YTgxZDA0ZTY3NTYwNDMwNWIxODM3MGRmZTFhNmJjY2YvdGFibGVyYW5nZTphODFkMDRlNjc1NjA0MzA1YjE4MzcwZGZlMWE2YmNjZl8yLTYtMS0xLTA_7ab563de-0adf-4397-b160-33a1ef431307">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMTUy_efbf747d-4216-4e05-bf03-2ed3089e1eb7">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xL2ZyYWc6OTMxMTJhN2I4ZWQ5NGVmZjg3ZmViYWY3YjAxYjMxNTQvdGV4dHJlZ2lvbjo5MzExMmE3YjhlZDk0ZWZmODdmZWJhZjdiMDFiMzE1NF8yMDc5_d0a944c8-f25e-4fa2-9c74-de3f25694fcd"
      unitRef="shares">159167434</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMi0xLTEtMS0w_9cfd0c92-26aa-4ca2-a492-76d59a5bc9b4"
      unitRef="usd">62599000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMi0zLTEtMS0w_04e0e2be-ab98-4c5a-8d00-db0e9042b8aa"
      unitRef="usd">59172000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMi01LTEtMS0w_4a58c509-2704-4330-8db0-5b8959329e40"
      unitRef="usd">179086000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMi03LTEtMS0w_720ea66a-89ba-46b0-9c98-c2b5dc637d9a"
      unitRef="usd">172516000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMy0xLTEtMS0w_97c59048-6fac-4327-a5a6-b712eed73e99"
      unitRef="usd">59448000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMy0zLTEtMS0w_08b141f7-03c8-4195-912f-00f8309651f4"
      unitRef="usd">56139000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMy01LTEtMS0w_b3930a6b-9777-4967-b9ac-4f0455756cb1"
      unitRef="usd">170235000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMy03LTEtMS0w_32bfb0a0-24f2-43b2-a877-92f9ccd8869c"
      unitRef="usd">163829000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNC0xLTEtMS0w_7148c174-f1de-482d-a4a5-c59145d7aad0"
      unitRef="usd">3151000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNC0zLTEtMS0w_4b69d88b-9fbc-4926-bdef-bbfbabd178b9"
      unitRef="usd">3033000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNC01LTEtMS0w_4ac6d36b-2445-4489-9869-7ba99dacd0bc"
      unitRef="usd">8851000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNC03LTEtMS0w_427619ba-a04c-4019-831a-fc9ef1ffc3b7"
      unitRef="usd">8687000000</us-gaap:GrossProfit>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNS0xLTEtMS0w_a412aeae-f5bc-4bc3-a16c-309c8d4acdb9"
      unitRef="usd">2291000000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNS0zLTEtMS0w_0a861e3d-d18e-4eeb-aeef-b71d20f76dda"
      unitRef="usd">2535000000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNS01LTEtMS0w_e5c696dd-c246-4827-976d-f36175cc6755"
      unitRef="usd">6625000000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNS03LTEtMS0w_60a37aaf-df8d-4164-9c1f-52eb50ee5d62"
      unitRef="usd">6779000000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:LegalFees
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNi0xLTEtMS05MTEw_6fb61f4c-6697-499c-a65c-14a48ed33076"
      unitRef="usd">8067000000</us-gaap:LegalFees>
    <us-gaap:LegalFees
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNi0zLTEtMS05MTE1_2571c192-e5ef-4048-9398-cf0c27d3c3da"
      unitRef="usd">0</us-gaap:LegalFees>
    <us-gaap:LegalFees
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNi01LTEtMS05MTE5_d33bc0c4-50df-45e4-90a9-23c2b860d2b4"
      unitRef="usd">7936000000</us-gaap:LegalFees>
    <us-gaap:LegalFees
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNi03LTEtMS05MTIz_8d6abc16-5819-4969-b900-576fdac2061d"
      unitRef="usd">82000000</us-gaap:LegalFees>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNi0xLTEtMS0w_94a6f080-9fb9-4e17-bfaf-d6caf638d6ee"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNi0zLTEtMS0w_f5d23a7a-df84-4c25-8d2a-b778efdcb5ce"
      unitRef="usd">2000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNi01LTEtMS0w_19b3b7e3-b01a-4ee5-ba62-911dc87ba09d"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNi03LTEtMS0w_d463aba3-fe27-4cd7-b51f-4e31436d341c"
      unitRef="usd">2000000</us-gaap:GoodwillImpairmentLoss>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNy0xLTEtMS0w_1ccd0277-913e-4d76-b87e-1c3aa3fa31f2"
      unitRef="usd">155000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNy0zLTEtMS0w_8c53aa32-8142-4a80-a55e-1373e9659d16"
      unitRef="usd">136000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNy01LTEtMS0w_768bc297-e084-4f69-b09e-713022ede34d"
      unitRef="usd">271000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfNy03LTEtMS0w_3861f252-beb0-4681-beb8-0ec39fcfc17b"
      unitRef="usd">204000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <us-gaap:OperatingExpenses
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfOS0xLTEtMS0w_04540a09-d6fb-4739-bd2d-3dba144b9e9c"
      unitRef="usd">10513000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfOS0zLTEtMS0w_782e86c7-f930-4b20-8d50-4c6bd6959749"
      unitRef="usd">2673000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfOS01LTEtMS0w_9290b6f8-e653-454c-91ba-7906bd1f456b"
      unitRef="usd">14901000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfOS03LTEtMS0w_36d5107d-cbf5-461b-8a1f-84c1b4da84c5"
      unitRef="usd">7067000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTAtMS0xLTEtMA_ea87d2c4-2a3d-4794-90ed-895f46f7bbba"
      unitRef="usd">-7362000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTAtMy0xLTEtMA_645babee-da86-4218-b93e-614ec6fa766f"
      unitRef="usd">360000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTAtNS0xLTEtMA_a5b198e7-af93-45ae-b664-c90dbca70d94"
      unitRef="usd">-6050000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTAtNy0xLTEtMA_bd483183-71e3-4f80-aa03-8741a31f9372"
      unitRef="usd">1620000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTEtMS0xLTEtMA_7a7b8fa6-e615-4c7b-a1c0-192ed6abb94f"
      unitRef="usd">54000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTEtMy0xLTEtMA_78a8202d-ad38-4f74-9b8e-e1de36aacb27"
      unitRef="usd">26000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTEtNS0xLTEtMA_34ae9270-0b47-41d8-aa36-7ab1b8a57c11"
      unitRef="usd">152000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTEtNy0xLTEtMA_579dd05f-1e8c-4881-a3af-e4d1d96d1a58"
      unitRef="usd">-15000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTItMS0xLTEtMA_afcfa422-ae95-4011-a951-ab177c621e65"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTItMy0xLTEtMA_feb0b3be-d9df-4daf-bee8-dcfd07bcb532"
      unitRef="usd">-28000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTItNS0xLTEtMA_3ff0cea5-a177-40dc-9e2a-1db5d4bceb27"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTItNy0xLTEtMA_c8eadb3b-b9e0-490f-8dc7-bc74e2cfd301"
      unitRef="usd">-1478000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InterestAndDebtExpense
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTMtMS0xLTEtMA_9d962c3b-2f1f-4a42-a178-d9cf326c34e4"
      unitRef="usd">55000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTMtMy0xLTEtMA_18936180-0a64-4abd-bdfe-a104de2f044e"
      unitRef="usd">64000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTMtNS0xLTEtMA_b6ee5fa2-3f9b-49f8-9224-ee6583c90156"
      unitRef="usd">165000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTMtNy0xLTEtMA_89b3b0d3-9f08-4113-b417-bdd50425cc65"
      unitRef="usd">184000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTQtMS0xLTEtMA_025cd720-b901-4dd5-bb0b-e52be64515f4"
      unitRef="usd">-7363000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTQtMy0xLTEtMA_ed9c1ed0-c115-4acb-9068-ff14aaa30fb8"
      unitRef="usd">294000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTQtNS0xLTEtMA_10884d1c-ecad-4b67-b796-d466cb2d6e1d"
      unitRef="usd">-6063000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTQtNy0xLTEtMA_d857a982-7afd-4980-b425-d2df3a8375d2"
      unitRef="usd">-57000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTUtMS0xLTEtMA_7bfe2f06-43e2-4102-8eb0-2792fcd28a33"
      unitRef="usd">-1189000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTUtMy0xLTEtMA_627ff4ae-19f5-4cd9-ab0d-ec9241415758"
      unitRef="usd">47000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTUtNS0xLTEtMA_6736f3ab-0929-4f56-a676-d2fd67a44d57"
      unitRef="usd">-1011000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTUtNy0xLTEtMA_5e5d1c20-42c4-45d4-bf90-1cb24a4ba0ea"
      unitRef="usd">-111000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTYtMS0xLTEtMA_d557c4c4-786d-4e45-8bc6-0470da424b70"
      unitRef="usd">-6174000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTYtMy0xLTEtMA_e9f5dad7-6a53-4fed-a5d5-d0672fe4a590"
      unitRef="usd">247000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTYtNS0xLTEtMA_7223f6e3-5761-4722-83d9-c134d250c489"
      unitRef="usd">-5052000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTYtNy0xLTEtMA_5de437a6-43ba-4cb0-ac5c-de857ae55039"
      unitRef="usd">54000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTctMS0xLTEtMA_e79a75e4-1484-43b7-8e69-6a652ee7c1e1"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTctMy0xLTEtMA_7aef10ce-20d9-4635-a645-f886085daaf4"
      unitRef="usd">-5000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTctNS0xLTEtMA_c8e427bb-e670-42a8-8c7a-1a5b3c4d52a3"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTctNy0xLTEtMA_13abd7d6-bbb5-4998-8425-896c5a604fcb"
      unitRef="usd">-12000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTgtMS0xLTEtMA_bbaca1a9-f543-4578-8483-144d55e82a05"
      unitRef="usd">-6174000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTgtMy0xLTEtMA_6f5a221b-09c8-460b-9443-ddd1a670e5cf"
      unitRef="usd">242000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTgtNS0xLTEtMA_bc338b22-34c8-4c98-b338-9e3e5d8db7b3"
      unitRef="usd">-5053000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTgtNy0xLTEtMA_4c5ec2a4-f8a4-4579-9695-4069349473bb"
      unitRef="usd">42000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTktMS0xLTEtMA_c4750c3f-6138-4933-996a-10e9f32b18a6"
      unitRef="usd">52000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTktMy0xLTEtMA_23b88cd6-58b3-43ec-a246-ef482c9f8469"
      unitRef="usd">56000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTktNS0xLTEtMA_a9465ed1-4769-40f1-ba61-df29f3e2ff55"
      unitRef="usd">152000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMTktNy0xLTEtMA_8d239508-a043-41ab-acf9-f92fae0c01ed"
      unitRef="usd">163000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjAtMS0xLTEtMA_90be2734-1597-48a4-8831-e6dacfa8f058"
      unitRef="usd">-6226000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjAtMy0xLTEtMA_64a6d9f2-237b-4650-b67d-e1f789f97dd6"
      unitRef="usd">186000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjAtNS0xLTEtMA_669f2bd7-392a-4353-be7a-7a8218c52618"
      unitRef="usd">-5205000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjAtNy0xLTEtMA_11c42248-cf4f-4e73-b2c4-176be3f7e9ae"
      unitRef="usd">-121000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjQtMS0xLTEtMA_c1d499f7-d489-483f-8417-07efbe9447d3"
      unitRef="usdPerShare">-39.03</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjQtMy0xLTEtMA_5624a897-033e-475e-aa0b-5c384de6cdaf"
      unitRef="usdPerShare">1.06</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjQtNS0xLTEtMA_d20782f2-c749-4f82-94f0-839356704341"
      unitRef="usdPerShare">-32.28</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjQtNy0xLTEtMA_3d8620a1-a630-4072-bbbf-dcac28113986"
      unitRef="usdPerShare">-0.60</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjUtMS0xLTEtMA_7811f332-03b3-4776-9b95-3bfe59a32a77"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjUtMy0xLTEtMA_691e7955-1b15-49eb-8db5-7f7e9104dcb6"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjUtNS0xLTEtMA_cee9a770-0880-4cf3-bc50-e71b01509e3e"
      unitRef="usdPerShare">-0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjUtNy0xLTEtMA_c0da256f-20c2-42d8-a3d9-7b1ff63442ff"
      unitRef="usdPerShare">-0.06</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjYtMS0xLTEtMA_863b8a47-7d29-4a23-9cd0-72baa2d301a4"
      unitRef="usdPerShare">-39.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjYtMy0xLTEtMA_7695407c-5618-468c-a651-e008430d5655"
      unitRef="usdPerShare">1.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjYtNS0xLTEtMA_0a170516-09e4-460b-8577-62315c60a495"
      unitRef="usdPerShare">-32.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjYtNy0xLTEtMA_202b57d9-f5c1-45a6-a14f-2735b5247818"
      unitRef="usdPerShare">-0.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjgtMS0xLTEtMA_8a2adeb0-15a7-4726-9c17-95e0d4db63c5"
      unitRef="usdPerShare">-39.03</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjgtMy0xLTEtMA_125c5ec6-5691-41a2-9aad-d4bf813f5062"
      unitRef="usdPerShare">1.06</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjgtNS0xLTEtMA_6c2f9bd5-78a6-405d-bd1b-508061f88a2c"
      unitRef="usdPerShare">-32.28</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjgtNy0xLTEtMA_aaa3f2c2-e1c6-489f-8abe-9929edcf99f0"
      unitRef="usdPerShare">-0.60</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjktMS0xLTEtMA_d0e4166b-34c3-416f-aac4-fe9adc1168eb"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjktMy0xLTEtMA_4a8dd4f3-e7a0-4e7b-b71d-5c65480bf42e"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjktNS0xLTEtMA_7674386c-8208-4d9d-b45f-df20979d455d"
      unitRef="usdPerShare">-0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMjktNy0xLTEtMA_b4ba164d-b49e-4755-ab49-d19b3e7dc16c"
      unitRef="usdPerShare">-0.06</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzAtMS0xLTEtMA_1b8037ad-9c24-4800-936a-345cd9386aaf"
      unitRef="usdPerShare">-39.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzAtMy0xLTEtMA_0a6eef13-0991-4c4e-8161-a58104161924"
      unitRef="usdPerShare">1.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzAtNS0xLTEtMA_f8f48523-c256-41c1-b2e2-36a61be13839"
      unitRef="usdPerShare">-32.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzAtNy0xLTEtMA_183bb1fd-8efe-4c6b-b2c0-38697d666cc2"
      unitRef="usdPerShare">-0.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzMtMS0xLTEtMA_7bd76a5b-08e4-4542-a811-336989bd3eb8"
      unitRef="shares">159500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzMtMy0xLTEtMA_e15a305f-1a4c-46df-be36-859ddf8eefa2"
      unitRef="shares">179700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzMtNS0xLTEtMA_c9f217a6-11be-4fe4-a93d-19d9aa000d3d"
      unitRef="shares">161200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzMtNy0xLTEtMA_8539dc93-b672-4f4d-92db-eaacece505fd"
      unitRef="shares">183100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzQtMS0xLTEtMA_5ec88204-e80f-4be7-8aa5-4ab92a0f341d"
      unitRef="shares">159500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzQtMy0xLTEtMA_f5e38d10-6ee8-477d-8bc4-fe8fe3995667"
      unitRef="shares">178700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzQtNS0xLTEtMA_c3be9645-e9fd-43e8-8318-61330e00d3fa"
      unitRef="shares">161200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xMy9mcmFnOmYwMDZhOWVmMmYwODQxZWE4MGJhZGQwNmJiMjQyMTlkL3RhYmxlOmY2OTBhYTFjYjQxMjQ0Mjk4ODEzZDE3NjRkMzNhYzQ5L3RhYmxlcmFuZ2U6ZjY5MGFhMWNiNDEyNDQyOTg4MTNkMTc2NGQzM2FjNDlfMzQtNy0xLTEtMA_c8dd6b6a-0f71-43ba-af1b-a79bbfcd366d"
      unitRef="shares">183100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ProfitLoss
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMi0xLTEtMS0w_f36efcc3-dfe8-479c-bfca-b3aef005d93d"
      unitRef="usd">-6174000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMi0zLTEtMS0w_98ce5f8b-db22-49c4-840c-69ce1935aadc"
      unitRef="usd">242000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMi01LTEtMS0w_c9a0922a-d28d-42ed-a43b-77423b9376e3"
      unitRef="usd">-5053000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMi03LTEtMS0w_2a5fd172-fb86-42ba-9375-0dae5b0a0c1d"
      unitRef="usd">42000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNS0xLTEtMS0w_36147f49-79da-4639-9aa1-9ed2caf81841"
      unitRef="usd">107000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNS0zLTEtMS0w_eebdbebc-98be-4a67-8477-790ed96dde7e"
      unitRef="usd">43000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNS01LTEtMS0w_4846c016-0869-4809-b56f-5e3fe0ba5124"
      unitRef="usd">181000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNS03LTEtMS0w_1c1afd5d-c173-4935-b2a1-bff6b68697f8"
      unitRef="usd">55000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNi0xLTEtMS0w_8587366c-40da-44ae-a75a-aaf4aa598360"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNi0zLTEtMS0w_f3f8a8c3-25c8-434e-8a25-fd261c0c989e"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNi01LTEtMS0w_a536251d-5e55-4a1e-b52c-2c8ad0d73260"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNi03LTEtMS0w_fa12ce50-1e79-4c47-b44f-2b6693c3d87f"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNy0xLTEtMS0w_f912cc71-b51d-4202-ab18-512ac74b806b"
      unitRef="usd">-24000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNy0zLTEtMS0w_d8b64dc4-1613-4baf-991b-8b5314165587"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNy01LTEtMS0w_27ec72c5-43da-489d-be03-f3e3f97d7e31"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfNy03LTEtMS0w_051e4e87-bb0f-4b6b-90ae-abc2856c7d65"
      unitRef="usd">-96000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfOC0xLTEtMS0w_2fe515ab-e180-41d5-a8e2-54887c2284d3"
      unitRef="usd">119000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfOC0zLTEtMS0w_9205f941-b4c4-4509-a932-3de717e5e69c"
      unitRef="usd">51000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfOC01LTEtMS0w_8bfbfd51-3dca-44bc-8560-9ed6e3dfb018"
      unitRef="usd">161000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfOC03LTEtMS0w_b12776be-0017-4656-920d-ee14195ab95a"
      unitRef="usd">184000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTAtMS0xLTEtMA_3d1a3490-abc2-4a44-b5e4-357493757ba4"
      unitRef="usd">-6055000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTAtMy0xLTEtMA_2f904aae-a067-47fb-b774-8b5d72d34223"
      unitRef="usd">293000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTAtNS0xLTEtMA_2c00ad67-e5ad-4400-85cf-59700ab32d49"
      unitRef="usd">-4892000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTAtNy0xLTEtMA_caf88b90-6ccb-4009-9c41-e5c8dbd4a3d2"
      unitRef="usd">226000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTEtMS0xLTEtMA_e5654083-23db-40ae-a1cc-67ae49015e4d"
      unitRef="usd">77000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTEtMy0xLTEtMA_2ba0514a-9be1-44aa-b979-b543acee6ebe"
      unitRef="usd">66000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTEtNS0xLTEtMA_d8471ad3-9e48-41cc-a8af-ab0dfda687ea"
      unitRef="usd">113000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTEtNy0xLTEtMA_a6bacac7-4c3a-4cdb-af4f-32c25a6f3294"
      unitRef="usd">161000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTItMS0xLTEtMA_2d2e8af5-4c3e-4e38-8042-d0695032a0ac"
      unitRef="usd">-6132000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTItMy0xLTEtMA_cb0d9080-32e7-43f3-a268-17cfbb06385b"
      unitRef="usd">227000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTItNS0xLTEtMA_4d564aed-e1af-4bbf-8cd0-07a259990838"
      unitRef="usd">-5005000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xNi9mcmFnOjc4ZjcwMzEyOTk0MzQ0YTFiMjRkOTQ2ZjFlNzM2OWZiL3RhYmxlOjJjODg1NzUzZjQ1OTRjYjdiYTNmNzg0MDVkNWI1ZTYxL3RhYmxlcmFuZ2U6MmM4ODU3NTNmNDU5NGNiN2JhM2Y3ODQwNWQ1YjVlNjFfMTItNy0xLTEtMA_c7de2cf6-2259-4597-bd10-51c59dca1921"
      unitRef="usd">65000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMy0xLTEtMS0w_01330c39-4e99-41cb-98b6-5c365309c216"
      unitRef="usd">3577000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMy0zLTEtMS0w_83123532-c282-436a-9ac2-d90d09e6aedf"
      unitRef="usd">4015000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNC0xLTEtMS0w_6e10c948-5267-40d7-a782-3edc25c56262"
      unitRef="usd">18877000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNC0zLTEtMS0w_def8965c-f989-4143-9eab-cc29f6b3be6a"
      unitRef="usd">19950000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNS0xLTEtMS0w_19c9a059-8ace-4084-bcbb-09489e1b64ef"
      unitRef="usd">19211000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNS0zLTEtMS0w_efe1d79e-7983-4f8b-bf14-e442d0d16214"
      unitRef="usd">16734000000</us-gaap:InventoryNet>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNi0xLTEtMS0w_c89d11cf-6d0b-4300-b3ab-fda2f57ce921"
      unitRef="usd">15000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNi0zLTEtMS0w_071bf1ea-d871-4020-9aa2-1eb0b2d41e75"
      unitRef="usd">906000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNy0xLTEtMS0w_401e68a2-188a-4e76-9bb3-306b4d40d831"
      unitRef="usd">688000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNy0zLTEtMS0w_4aab5848-2c4e-45ca-a670-3470c762423a"
      unitRef="usd">617000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfOC0xLTEtMS0w_6933e80a-67c7-4921-9984-4913eca5b23c"
      unitRef="usd">42368000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfOC0zLTEtMS0w_9fe5ebc2-684e-447b-aff6-c434f5719378"
      unitRef="usd">42222000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfOS0xLTEtMS0w_e7389535-57be-48b2-a5cc-a951a21a19cd"
      unitRef="usd">2518000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfOS0zLTEtMS0w_9412a11f-48c5-4e95-b310-28ee6cbd8725"
      unitRef="usd">2365000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTAtMS0xLTEtMA_6169cf53-c72e-4101-b336-f5c19064d3e6"
      unitRef="usd">1955000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTAtMy0xLTEtMA_acb6f8f8-293f-422a-92de-3f0705231041"
      unitRef="usd">1886000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTEtMS0xLTEtMA_d50ca2a5-4acf-4973-bb4a-a7a8e7654778"
      unitRef="usd">9511000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTEtMy0xLTEtMA_5e330ce2-c570-47e2-95d3-43d276f344f0"
      unitRef="usd">9360000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTItMS0xLTEtMA_c7679771-250e-4bfb-83e1-06e367dba6df"
      unitRef="usd">2980000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTItMy0xLTEtMA_8eabd7d4-deda-46d7-8659-e9a98201f471"
      unitRef="usd">3156000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTQtMS0xLTEtMA_7058ed73-cdfc-4794-bbab-2a6e158e5fb9"
      unitRef="usd">2513000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTQtMy0xLTEtMA_9912a4e9-2000-489a-bd2a-eb6b1ebe0cc0"
      unitRef="usd">2258000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTUtMS0xLTEtMA_b2c7f03a-0c6f-4ca6-acde-673d8dbb9896"
      unitRef="usd">61845000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTUtMy0xLTEtMA_a6ea614c-d644-46a9-ae51-a4d8449125de"
      unitRef="usd">61247000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTktMS0xLTEtMA_bf250d77-f546-423d-a460-5c3df4acb599"
      unitRef="usd">36509000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMTktMy0xLTEtMA_38244ec6-448f-4a51-aff8-795ae0a94775"
      unitRef="usd">37195000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:ShortTermBorrowings
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjAtMS0xLTEtMA_d222728c-444b-457a-aedc-a5f50e7bf787"
      unitRef="usd">152000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjAtMy0xLTEtMA_74280825-1da1-40bc-81b7-182e2ec63de6"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjEtMS0xLTEtMA_5093443d-cf97-4ade-8d98-26f0f1e39199"
      unitRef="usd">777000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjEtMy0xLTEtMA_2e6b51c7-4e3a-4c8e-b10e-4972ca3bc7cd"
      unitRef="usd">1052000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjItMS0xLTEtMA_9afb4d56-80d9-44e0-ac56-448dc559089c"
      unitRef="usd">384000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjItMy0xLTEtMA_df2483aa-20c2-472f-800e-cd713a7b92fd"
      unitRef="usd">354000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjMtMS0xLTEtMA_ed04638f-32a4-47c4-b25e-1710b6782462"
      unitRef="usd">14000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjMtMy0xLTEtMA_2ddac7a0-db6e-4707-9edc-64addb8ada67"
      unitRef="usd">683000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjQtMS0xLTEtMA_4347b0db-5f6e-4ea2-b02b-9858d602d4ac"
      unitRef="usd">4094000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjQtMy0xLTEtMA_d45998d4-7b55-40b0-9688-ea198a6d6b8b"
      unitRef="usd">3340000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjUtMS0xLTEtMA_1546eb8d-2cb4-4cde-9498-d613f3059be6"
      unitRef="usd">41930000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjUtMy0xLTEtMA_8f4e625e-6cfe-4f82-b7ad-251958f6762e"
      unitRef="usd">42624000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjYtMS0xLTEtMA_7f87af7c-ec20-4713-b600-ae3daa3b9c5c"
      unitRef="usd">6467000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjYtMy0xLTEtMA_c94b99b1-2b93-4198-b7fc-6fbbf633b80b"
      unitRef="usd">6335000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjctMS0xLTEtMA_5295c878-8c9a-4624-acf5-2a4e4be08868"
      unitRef="usd">773000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjctMy0xLTEtMA_00e6adfc-f857-4e64-bad0-f7653c54176e"
      unitRef="usd">2255000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjgtMS0xLTEtMA_1d8cf1d4-f219-4ef9-aea9-2b08ab24d34e"
      unitRef="usd">1747000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjgtMy0xLTEtMA_a8dd5c2e-cc18-4d01-8d8a-344a0d86afe8"
      unitRef="usd">1660000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjktMS0xLTEtOTEzNw_53a07912-e8a0-455b-99fc-5afc70045045"
      unitRef="usd">8067000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjktMy0xLTEtOTE0MQ_d55c320b-2230-492c-9cb0-08f9361c9d2d"
      unitRef="usd">0</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjktMS0xLTEtMA_10a233b5-9626-4840-b71f-4e15388aae04"
      unitRef="usd">1846000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMjktMy0xLTEtMA_d2bdfa68-d892-4c79-b9f5-283746539820"
      unitRef="usd">1662000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzAtMS0xLTEtMA_b060a2b2-ca8b-4219-9a9d-6305999d7a7d"
      unitRef="usd">1292000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzAtMy0xLTEtMA_3ca2a79b-1081-4d5f-adcd-75c01db69567"
      unitRef="usd">1402000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmE0ZmFlZDcxYjhmNTQwOThiZWIzNGNmZDM4OWFjODY1XzIx_3fe9e2be-26de-4056-b017-795573aec4cc"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmE0ZmFlZDcxYjhmNTQwOThiZWIzNGNmZDM4OWFjODY1XzIx_6f467565-6738-438d-b4f5-5d464a812492"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmE0ZmFlZDcxYjhmNTQwOThiZWIzNGNmZDM4OWFjODY1XzM1_86b3902c-67e9-42f7-a39f-02e954f8de3e"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmE0ZmFlZDcxYjhmNTQwOThiZWIzNGNmZDM4OWFjODY1XzM1_a875dc21-f80d-463f-8ea0-111b63a41f87"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmE0ZmFlZDcxYjhmNTQwOThiZWIzNGNmZDM4OWFjODY1XzU3_4ac1a8c6-3df0-49a2-898a-f6b730b3e3d2"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmE0ZmFlZDcxYjhmNTQwOThiZWIzNGNmZDM4OWFjODY1XzU3_b021712f-d960-4e73-89af-8c0fb66e7640"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmE0ZmFlZDcxYjhmNTQwOThiZWIzNGNmZDM4OWFjODY1XzU3_b17732ee-c5d6-4dd2-b57f-3872ad73b79e"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmE0ZmFlZDcxYjhmNTQwOThiZWIzNGNmZDM4OWFjODY1XzU3_d752486e-9981-4894-86c2-075e213c26a9"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMS0xLTEtMA_83645076-2e04-4456-bd59-72efcf8b03b8"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzItMy0xLTEtMA_1dfefa8b-f593-4b91-94e7-0f07f2059452"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmFjY2NmZWZhMTFjMDQxNGM4YTY3NzMzZDY2NGJhMDRhXzE4_227ed880-b9bb-442f-b86d-f66189914553"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmFjY2NmZWZhMTFjMDQxNGM4YTY3NzMzZDY2NGJhMDRhXzE4_afff7ec1-fda5-49f8-bbff-c50a5fd16f6a"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmFjY2NmZWZhMTFjMDQxNGM4YTY3NzMzZDY2NGJhMDRhXzMy_0d7951a7-3c2d-43ad-af48-759b6df3ecf4"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmFjY2NmZWZhMTFjMDQxNGM4YTY3NzMzZDY2NGJhMDRhXzMy_b414934d-366f-42de-80cb-91eb6ac5615b"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmFjY2NmZWZhMTFjMDQxNGM4YTY3NzMzZDY2NGJhMDRhXzU3_80aa1230-9d97-4ab3-8199-bc9566793aed"
      unitRef="shares">273000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmFjY2NmZWZhMTFjMDQxNGM4YTY3NzMzZDY2NGJhMDRhXzY0_f0f6b23e-f9ca-4d2e-9e81-45a6fc06214c"
      unitRef="shares">272000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzMtMS0xLTEtMA_77d114e3-8336-403c-8376-f72bbe0a60bb"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzMtMy0xLTEtMA_9c4d7451-c0ee-4c05-8341-c1802eace13e"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzQtMS0xLTEtMA_b50c46e8-02a9-4cd7-90c1-6e36a2141563"
      unitRef="usd">6847000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzQtMy0xLTEtMA_a70c4d91-6147-4dab-9415-2922a24aff0d"
      unitRef="usd">6663000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzUtMS0xLTEtMA_9bc2b261-1810-4e9e-b991-fc58ced0f09a"
      unitRef="usd">7595000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzUtMy0xLTEtMA_7bf012d3-b6e5-4a15-89dd-ffc9f404d07f"
      unitRef="usd">13022000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzYtMS0xLTEtMA_f8c59633-226b-495f-b795-247f5a4d6251"
      unitRef="usd">-1503000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzYtMy0xLTEtMA_99c474e8-e7da-42d7-be40-f54bb7ef965d"
      unitRef="usd">-1703000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjhmZmFiMTA1OTgyMzRjZWQ4ZjU2MjIwYjg2MjQyZmY4XzMw_e8244370-e136-454e-aa6d-073f39480b3c"
      unitRef="shares">114000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjhmZmFiMTA1OTgyMzRjZWQ4ZjU2MjIwYjg2MjQyZmY4XzM3_06dcda9c-79c9-4b94-8ab1-12ec831aaeeb"
      unitRef="shares">110000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzgtMS0xLTEtMA_18330d79-c361-4abb-9108-262668f46695"
      unitRef="usd">13418000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzgtMy0xLTEtMA_5f3db5e7-f5c4-4180-99ed-c980f25d18f5"
      unitRef="usd">12892000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzktMS0xLTEtMA_c469b38c-91ab-49fe-ae10-fc31b876df53"
      unitRef="usd">-477000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfMzktMy0xLTEtMA_88c125f5-f5e0-4607-a2bc-8a84330d4846"
      unitRef="usd">5092000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNDAtMS0xLTEtMA_803854ba-1536-4fbc-8009-74280b8c751e"
      unitRef="usd">200000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNDAtMy0xLTEtMA_40917d5b-c401-4ce1-bc45-41574c3cf4c3"
      unitRef="usd">217000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNDEtMS0xLTEtMA_f099bbba-29d4-4fb9-a58e-0f662f79eff0"
      unitRef="usd">-277000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNDEtMy0xLTEtMA_a959a278-d153-466c-ad50-935bf6fdd473"
      unitRef="usd">5309000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNDItMS0xLTEtMA_73d863f7-eb8b-4c0d-8341-ddca010998db"
      unitRef="usd">61845000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8xOS9mcmFnOmIyNTgzYjk0NDJlYTQzYzhiMWI5ZTg1YWNmZjc0MTE1L3RhYmxlOjdiMTcxZmI1YmZiNTQyZTY4ODU4MWY3N2QzNWZjNDkyL3RhYmxlcmFuZ2U6N2IxNzFmYjViZmI1NDJlNjg4NTgxZjc3ZDM1ZmM0OTJfNDItMy0xLTEtMA_190d1595-9223-4025-8265-34f0ee18a3a2"
      unitRef="usd">61247000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i8f75dc9fda5c41feb4e0a7addec435d0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy0xLTEtMS0w_6345d238-d026-43a2-8cec-25924159d19e"
      unitRef="shares">273000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8f75dc9fda5c41feb4e0a7addec435d0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy0zLTEtMS0w_ff0d76c5-b225-4f58-b093-f5b9c5f9975d"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i046c55cb833a40dea20cd595ea58722c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy01LTEtMS0w_1b070b21-2c29-4a9c-89fc-bfdde8109f5a"
      unitRef="usd">6780000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9738445b8a5e41869bba0cf8d810974d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy03LTEtMS0w_54afc0a7-b3c3-45bc-9554-24699623fa0f"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i79239b1b57fc45128439b982e6e306d9_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy05LTEtMS0w_51dbc168-6f55-4c32-bcf5-159d55aac455"
      unitRef="usd">13890000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if702f6988b73408fb0203fbcf4cfff59_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy0xMS0xLTEtMA_285dce36-044a-4e54-b56b-f18658865278"
      unitRef="usd">-1597000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i22f4cb39451147ea9fe68b8f991a70ff_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy0xMy0xLTEtMA_cb455fec-98c0-49f1-8bbc-5c7d9b6d6481"
      unitRef="shares">112000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i22f4cb39451147ea9fe68b8f991a70ff_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy0xNS0xLTEtMA_1bbd6441-44ed-4216-94bb-08da1b393407"
      unitRef="usd">-13185000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib03cda0901f74396a9d42a5e93e5f9eb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy0xNy0xLTEtMA_8643847d-558c-4ed5-932b-ac8aaa4e920a"
      unitRef="usd">200000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icda41b88f4cc470eb74edf0bae68f725_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMy0xOS0xLTEtMA_1fa02627-4c73-4453-8809-2ecb51a20ec3"
      unitRef="usd">6090000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i76dbf276f41c433aa3233de59bace255_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfNC01LTEtMS0w_afc5b65d-b543-4342-adf1-1f0185eaddf7"
      unitRef="usd">16000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i37974d926d4e49eeae69ab2a0f22c9e5_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfNC0xNS0xLTEtMA_1e255789-bce0-4607-9da7-7ec99922538a"
      unitRef="usd">-2000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfNC0xOS0xLTEtMA_11bf9911-f195-4141-9034-b250d2d08600"
      unitRef="usd">14000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i76dbf276f41c433aa3233de59bace255_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfNS01LTEtMS0w_73420101-43b5-4d4a-a492-af19df4f4e9f"
      unitRef="usd">51000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfNS0xOS0xLTEtMA_07042638-64fb-43d8-b1e2-cccc5366c284"
      unitRef="usd">51000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i454504e100134adfada4c6b22b8a933a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfNi0xNy0xLTEtMA_a567cfc7-bdc8-4f1f-bd50-cf78eb16a052"
      unitRef="usd">41000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfNi0xOS0xLTEtMA_232cc3cd-3313-42b2-afed-d4d5daf6bed2"
      unitRef="usd">41000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5f6abb61154c4e5580b369029cca081f_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfNy0xMS0xLTEtMA_8b9f8900-6d69-4578-b6ca-d1fd1a8ed371"
      unitRef="usd">94000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfNy0xOS0xLTEtMA_4eeb4d18-c286-409b-8b99-49d612cfaa14"
      unitRef="usd">94000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i7eb9f1e25c3d41efb703c958f350bf20_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfOC05LTEtMS0w_18074c1b-6eca-49f3-86ee-665961fddfa3"
      unitRef="usd">-6226000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i454504e100134adfada4c6b22b8a933a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfOC0xNy0xLTEtMA_95c3abc5-85b2-4e1e-9925-cec3ab21b282"
      unitRef="usd">41000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfOC0xOS0xLTEtMA_c24bcdd6-beb4-4e3f-b92f-69baa840f309"
      unitRef="usd">-6185000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i37974d926d4e49eeae69ab2a0f22c9e5_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfOS0xMy0xLTEtMA_eadc64ca-c5a6-4bce-a0b4-5affeeda7eda"
      unitRef="shares">2000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i37974d926d4e49eeae69ab2a0f22c9e5_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfOS0xNS0xLTEtMA_87007e1d-8ab7-4cd8-9892-05c0e28affd8"
      unitRef="usd">231000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfOS0xOS0xLTEtMA_e124d0f3-fb2f-47dc-9130-8abc8d142ff0"
      unitRef="usd">231000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjllMmQ5NDk2N2M4ZjRkMzE5MTFiY2RhYjczMmMwNTIyXzI5_6e5a7202-0483-4f7b-b7de-0c05ac392a27"
      unitRef="usdPerShare">0.42</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i7eb9f1e25c3d41efb703c958f350bf20_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTEtOS0xLTEtMA_74447c45-3df5-4781-9b0c-e9dfa4430e02"
      unitRef="usd">67000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTEtMTktMS0xLTA_ac312f48-c6bb-4e6e-86c6-fee2fb40f007"
      unitRef="usd">67000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i7eb9f1e25c3d41efb703c958f350bf20_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTItOS0xLTEtMA_e068d79f-bf51-486e-8850-23407b940c79"
      unitRef="usd">2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTItMTktMS0xLTA_41160d5a-4b28-4132-b355-cca663f461f7"
      unitRef="usd">2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="ia3e05b2e0a9d44ed8dea34e18361b913_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtMS0xLTEtMA_09bcc949-1636-4dc4-a1df-7c2830209068"
      unitRef="shares">273000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia3e05b2e0a9d44ed8dea34e18361b913_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtMy0xLTEtMA_9784ad11-a502-4258-95fd-51bf45e3f48f"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36774e6a606943108bbf2290e991ad35_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtNS0xLTEtMA_f772c1b5-8f2d-4f21-9a75-f5f51e2bd73b"
      unitRef="usd">6847000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i67e7913b409c4c2188c465886e28af95_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtNy0xLTEtMA_9315e81e-d499-4bbb-b560-62bffb350567"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib7265c70a233467086b5103a31edaceb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtOS0xLTEtMA_eb483862-e126-4331-a8b9-923106ebb6e2"
      unitRef="usd">7595000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6641e8af9e64c7aae662865d224c625_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtMTEtMS0xLTA_e56ea226-de44-43cd-b355-fa44947ac085"
      unitRef="usd">-1503000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="ia4ddbb098af84acd823dab9a811ce25e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtMTMtMS0xLTA_7cb0ae83-2ab4-4e38-8f47-0cc09140c2f9"
      unitRef="shares">114000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia4ddbb098af84acd823dab9a811ce25e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtMTUtMS0xLTA_2a9b3d26-1392-47be-bdb9-5f829e53ecc8"
      unitRef="usd">-13418000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i436786cf3fa44a21863b50c1e252c871_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtMTctMS0xLTA_5cc8a09c-cdcc-4b79-be63-d25a85fcb0f2"
      unitRef="usd">200000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjkxNTFmMmUwYTZlMjQyMzQ4YjQ1NGU3NjcwZTFlODMwL3RhYmxlcmFuZ2U6OTE1MWYyZTBhNmUyNDIzNDhiNDU0ZTc2NzBlMWU4MzBfMTMtMTktMS0xLTA_ad61256f-60b6-4750-9e7b-57a62e46fb9d"
      unitRef="usd">-277000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i1ab271cbf75f4a6992e0fb34901ba49d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy0xLTEtMS0w_bc52030a-34a8-4823-ba0b-e80af923b63e"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1ab271cbf75f4a6992e0fb34901ba49d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy0zLTEtMS0w_66b06f44-e347-422e-9125-b93175efab31"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib4bf4310d43a446aa281ebdc500f1c56_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy01LTEtMS0w_a9a1083e-a59b-4054-82a3-2a33cd6ae40a"
      unitRef="usd">6663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifa5fbe0fd0874aebab734ed30f8b57f0_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy03LTEtMS0w_df84968d-7fde-4315-9fdb-7cbba3f828ad"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7a1d4b79fc7b43f7afae361190241425_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy05LTEtMS0w_5b4084f0-7395-4aeb-81e3-17047cdb11cf"
      unitRef="usd">13022000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id0374ed6096c4fc79915873d9944afab_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy0xMS0xLTEtMA_77b068fb-579b-426c-90c5-939cc64c6e82"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i70252b6394004f7b954609f75985fb93_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy0xMy0xLTEtMA_7a2f002e-eac1-443b-9e04-eb6c2506406f"
      unitRef="shares">110000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i70252b6394004f7b954609f75985fb93_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy0xNS0xLTEtMA_1fe8ebf8-23de-4f81-ac22-1f777a918cae"
      unitRef="usd">-12892000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie6cbf15310ca46869b7c2a9274df3ebf_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy0xNy0xLTEtMA_680e6789-0bd4-422f-903e-3c0803c6e908"
      unitRef="usd">217000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMy0xOS0xLTEtMA_91a25646-e879-43f2-a445-154ce97a26d5"
      unitRef="usd">5309000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i639bd12a270543c8ad6932bf9f601e45_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNC05LTEtMS0w_9af07a0b-826a-4e32-9bdd-da9b36bf81b6"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i846abdfeaa6544789a5e524558b9443a_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNC0xOS0xLTEtMA_a9c13e6c-7637-4d18-b6f0-dfdb244d597c"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="if69ab677c8f149499b3a80ccbdfc1050_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS0xLTEtMS0w_73fd2a71-eb29-4a46-8325-1ed8391b9dc1"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if69ab677c8f149499b3a80ccbdfc1050_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS0zLTEtMS0w_f4d86166-3d4f-4e86-9945-65547d3302f3"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i93b2ebdda56e4926b226f0d3df3470ab_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS01LTEtMS0w_950ef0d1-9db0-4ac1-8310-b4c9102afec0"
      unitRef="usd">6663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib4b3986493e54543ab88e63dc656f1a2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS03LTEtMS0w_14012112-dd4b-47b2-8302-9411430fb828"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb7456909d2b497aa24862ae836a1a66_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS05LTEtMS0w_06d46c25-fb3f-4bf6-ba34-e9daf351ec97"
      unitRef="usd">13009000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5636635f7cb74ec7bf4beff8d593f7f3_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS0xMS0xLTEtMA_8d3d09b2-269a-4fa2-87c6-04744a4a7d98"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i935b818ca9a54205944e103ce26b3be1_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS0xMy0xLTEtMA_bda781aa-aa46-41a6-9a9f-01f6b79e7e97"
      unitRef="shares">110000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i935b818ca9a54205944e103ce26b3be1_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS0xNS0xLTEtMA_d3760df4-2277-488b-a2b1-35f5d9234179"
      unitRef="usd">-12892000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i16fd29d7481e4494b840a459e3299e08_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS0xNy0xLTEtMA_90db6ef3-9d22-4d7a-8b77-d18553dd7a32"
      unitRef="usd">217000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28e45f80bb9349f5a5ec660f5376691c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNS0xOS0xLTEtMA_a12a9d48-f5ca-470c-8e1e-0df6911d5170"
      unitRef="usd">5296000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i8106bbb2dc0a4f59acc6299d4f71a45a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNi0xLTEtMS0w_e552c61a-9f4e-48b7-965a-6b616fb2c32c"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i2011d00a9d33400ab4105b02fddf648e_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNi01LTEtMS0w_8ad5699e-6c4b-4652-9aea-acf69565d91e"
      unitRef="usd">55000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i2895dc4463844ffe85d8bea8b2472d44_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNi0xNS0xLTEtMA_08fee3e7-b7ba-4343-8d32-06830c843285"
      unitRef="usd">-26000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNi0xOS0xLTEtMA_39bba303-060b-46aa-b1d2-1f4dcd0eefa8"
      unitRef="usd">29000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2011d00a9d33400ab4105b02fddf648e_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNy01LTEtMS0w_c66de18c-22e4-4cd3-b89a-1ec0898cc7c0"
      unitRef="usd">110000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfNy0xOS0xLTEtMA_4005afb2-fb74-416a-a2d6-e0bd17af7be7"
      unitRef="usd">110000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="if6429e408d6643fe8ed7a32451d1973a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfOC0xNy0xLTEtMA_01e2ef85-e1a1-4755-a4c5-404430383156"
      unitRef="usd">134000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfOC0xOS0xLTEtMA_05d0270d-3e0c-4924-811b-b225a1f06e98"
      unitRef="usd">134000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="idbfbb7ecfac64c7d996917034b9d6fbe_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfOS0xMS0xLTEtMA_8368b42a-6497-400f-9081-e2c7633dc93f"
      unitRef="usd">200000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfOS0xOS0xLTEtMA_f9b2f044-34e2-45f2-8493-9b79e546e94f"
      unitRef="usd">200000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i55fa8262a4e440d49790e9cf14b51dbd_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTAtOS0xLTEtMA_1e2a1f67-9454-482c-8fbd-1fd598a4ade9"
      unitRef="usd">-5205000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="if6429e408d6643fe8ed7a32451d1973a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTAtMTctMS0xLTA_2e4c1bac-178b-4d41-a07a-3dacb4b2705d"
      unitRef="usd">120000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTAtMTktMS0xLTA_53b516bb-59b8-4aaa-8ddf-7073b5d69b24"
      unitRef="usd">-5085000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i2011d00a9d33400ab4105b02fddf648e_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTEtNS0xLTEtMA_df1ab7d3-d8e9-4449-a4fa-825f49428494"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTEtMTktMS0xLTA_a629d382-56f8-43b9-9497-3c78635a2ebe"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i2895dc4463844ffe85d8bea8b2472d44_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTItMTMtMS0xLTA_fdc286b2-fccf-4db7-98bb-73cd4f84d33e"
      unitRef="shares">4000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i2895dc4463844ffe85d8bea8b2472d44_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTItMTUtMS0xLTA_df6ad40c-46cb-4742-a49a-236adca24f71"
      unitRef="usd">500000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTItMTktMS0xLTA_158c37b8-689e-493f-9267-3c5e28546d52"
      unitRef="usd">500000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjNiNDAwOTE1N2U5YTQxNDA5OTQxYjViMjI0MjcyOThkXzI5_53c44595-d486-4960-9557-f1d6fbff076d"
      unitRef="usdPerShare">1.25</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i55fa8262a4e440d49790e9cf14b51dbd_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTMtOS0xLTEtMA_2d66b728-ed40-4447-ab64-2a740db01460"
      unitRef="usd">203000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTMtMTktMS0xLTA_259d8b3e-f87d-431f-9fd1-9d5ac531c854"
      unitRef="usd">203000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i2011d00a9d33400ab4105b02fddf648e_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTQtNS0xLTEtMA_aeb57684-097b-49e6-895e-6e7ddaa5de3e"
      unitRef="usd">-16000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i55fa8262a4e440d49790e9cf14b51dbd_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTQtOS0xLTEtMA_211369b4-1dcc-4cfb-b2b0-74de89569af0"
      unitRef="usd">6000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="if6429e408d6643fe8ed7a32451d1973a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTQtMTctMS0xLTA_f7f680ba-faf5-483d-a017-dd8e30ab75c9"
      unitRef="usd">3000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTQtMTktMS0xLTA_bd8c98b3-6015-4753-a843-7896d05ce9c8"
      unitRef="usd">-7000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="ia3e05b2e0a9d44ed8dea34e18361b913_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtMS0xLTEtMA_ca9f7f5a-2b96-407b-bf4b-436330669a4d"
      unitRef="shares">273000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia3e05b2e0a9d44ed8dea34e18361b913_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtMy0xLTEtMA_9b9330a8-36e9-4ed4-baf5-075bb565f061"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36774e6a606943108bbf2290e991ad35_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtNS0xLTEtMA_a054dc5f-fa2f-46dd-8024-05d6c75ff9de"
      unitRef="usd">6847000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i67e7913b409c4c2188c465886e28af95_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtNy0xLTEtMA_ddf221b2-5e12-436c-8e7f-c95413bf7042"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib7265c70a233467086b5103a31edaceb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtOS0xLTEtMA_4837afb0-4dd8-4031-9d61-8d7079c070b0"
      unitRef="usd">7595000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6641e8af9e64c7aae662865d224c625_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtMTEtMS0xLTA_5f36c289-9765-43ff-8be4-085ad5a16ea8"
      unitRef="usd">-1503000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="ia4ddbb098af84acd823dab9a811ce25e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtMTMtMS0xLTA_0f15c38e-be5c-4a9b-81b2-538a94e5d447"
      unitRef="shares">114000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia4ddbb098af84acd823dab9a811ce25e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtMTUtMS0xLTA_232392fc-54eb-4ae3-9cf9-fe82b3d64433"
      unitRef="usd">-13418000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i436786cf3fa44a21863b50c1e252c871_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtMTctMS0xLTA_5304d2ca-79ba-44dd-9c75-7f26df8bc65e"
      unitRef="usd">200000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmUxMTc2NWI5MzQzYzRjMTA4ODkyY2EyYjgyZDQ5M2JmL3RhYmxlcmFuZ2U6ZTExNzY1YjkzNDNjNGMxMDg4OTJjYTJiODJkNDkzYmZfMTUtMTktMS0xLTA_b007e6ad-c61e-4d59-ad54-73a47793e7e3"
      unitRef="usd">-277000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i3bbd5766e5e1426fa1e48b9db23fb33a_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy0xLTEtMS0w_234d7993-be89-4c89-a351-839ee7ed9350"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3bbd5766e5e1426fa1e48b9db23fb33a_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy0zLTEtMS0w_5801b2c9-db7e-49e3-801e-d659f639b1dc"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6f3407c46f4b4be98e132df1cb8b89d7_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy01LTEtMS0w_eb8ef151-9118-43be-bae7-0b92758d36df"
      unitRef="usd">6573000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i45ef706885764ecd9440a440f9bd9396_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy03LTEtMS0w_bc987ca2-101c-4581-9c69-85d3d0ba3946"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id768d1b9bff84003a458da02ab6054de_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy05LTEtMS0w_9b7f7b26-7508-43f6-b8d4-59df2bf432af"
      unitRef="usd">11965000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e571302aec24a36936d3e24fb499981_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy0xMS0xLTEtMA_7e815890-f460-44f8-adf0-5120614b68a2"
      unitRef="usd">-1704000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="iaa37fcbfd262489885d497fe4920cf55_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy0xMy0xLTEtMA_eb1f2b2e-b102-4844-b36f-a8e99bfe9fab"
      unitRef="shares">92000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa37fcbfd262489885d497fe4920cf55_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy0xNS0xLTEtMA_9cacca82-84a2-42c8-92da-7dd115a22901"
      unitRef="usd">-10353000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4fe05a45bd0447499ad4274ebee0e5de_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy0xNy0xLTEtMA_2da0f569-8110-4483-ad32-2659413d9ca9"
      unitRef="usd">210000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic2706f6905b14cc3a97aaf70ac667df6_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMy0xOS0xLTEtMA_9dd5cfaa-f6f3-4f28-bcba-221ed4fa1810"
      unitRef="usd">6692000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i87686bf1372a401ab1608bbccf25c908_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfNC01LTEtMS0w_9628d7c1-ba1b-4333-932a-a13147d3498f"
      unitRef="usd">11000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfNC0xOS0xLTEtMA_05469a60-50b9-4a5b-b763-5338ad1064fb"
      unitRef="usd">11000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i87686bf1372a401ab1608bbccf25c908_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfNS01LTEtMS0w_bcb538b8-29ef-47fc-bdd8-77d4e0ad9b76"
      unitRef="usd">30000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfNS0xOS0xLTEtMA_4888f223-478c-4a06-83d7-9dc117149ecb"
      unitRef="usd">30000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i2d696af4cf5445b28748e6c09ac7c601_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfNi0xNy0xLTEtMA_9ee0b5a8-0872-47f3-bbad-e95b78252e16"
      unitRef="usd">39000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfNi0xOS0xLTEtMA_3e91e13e-f650-4350-bbf5-3d36e5c4f73c"
      unitRef="usd">39000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i308d835dd02042a8b515529815bd98ec_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfNy0xMS0xLTEtMA_c24705a3-4e66-4409-b9d4-8a17637dfd1c"
      unitRef="usd">41000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfNy0xOS0xLTEtMA_2e01db98-0ea2-4df4-bafa-d7d2ac7150df"
      unitRef="usd">41000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i7de52a5965ed47d1812e75a3c210ca1d_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfOC05LTEtMS0w_26c4c2be-28f3-40b2-8b6a-37068973cc3f"
      unitRef="usd">186000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i2d696af4cf5445b28748e6c09ac7c601_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfOC0xNy0xLTEtMA_96255b74-9645-478c-b46f-87cb845c36df"
      unitRef="usd">45000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfOC0xOS0xLTEtMA_2b70629a-153b-48f3-bfde-781190f0b8d3"
      unitRef="usd">231000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i476906634a324f9287de597fd0120a9c_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfOS0xMy0xLTEtMA_1beedf6b-8b9f-4712-8fcb-bf97c9f756b0"
      unitRef="shares">3000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i476906634a324f9287de597fd0120a9c_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfOS0xNS0xLTEtMA_d6c39f69-fdbe-4a00-be8a-d466badb7731"
      unitRef="usd">500000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfOS0xOS0xLTEtMA_0b710c3e-376c-4c32-bb1f-59c89702c039"
      unitRef="usd">500000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjhhYTQyMDNhYmYwZDRlMWQ5ZWU1ZmNjODYwMWY4OTQzXzI5_80c6f8f9-a71b-41e4-ad80-5392995cef5d"
      unitRef="usdPerShare">0.41</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i7de52a5965ed47d1812e75a3c210ca1d_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTEtOS0xLTEtMA_d7593f67-8290-4838-bacb-b305744f7ece"
      unitRef="usd">73000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTEtMTktMS0xLTA_d4902c31-0acd-4b72-ac5c-0e65b9cc3396"
      unitRef="usd">73000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i7de52a5965ed47d1812e75a3c210ca1d_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTItOS0xLTEtMA_360e3655-5fa0-41d4-9e54-83c83e491d0f"
      unitRef="usd">3000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i2d696af4cf5445b28748e6c09ac7c601_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTItMTctMS0xLTA_0cc96a20-08d0-4e48-a4c3-e9153e4b808e"
      unitRef="usd">5000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTItMTktMS0xLTA_29aac2dd-e118-4c8d-880f-5d05f991b0a2"
      unitRef="usd">8000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i03968c2d88954a3f8b182452bc2bbaa5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtMS0xLTEtMA_0952d5f5-82f5-4453-b7f6-4057a1fbdcbf"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03968c2d88954a3f8b182452bc2bbaa5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtMy0xLTEtMA_f500d4f3-52bc-4fec-a4ee-3e92b9efa0df"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1a823c07346941aca960d012bef9774a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtNS0xLTEtMA_1e66d456-b345-4523-a528-dddfbc7bcf73"
      unitRef="usd">6614000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i34964563458343118c3362841fc34697_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtNy0xLTEtMA_48fc012e-126e-480e-bf9b-589f3db53375"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1510b0bae31c44278e232e7cafd63a4d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtOS0xLTEtMA_c1953dc4-c992-4bee-80d8-059ca691eaf0"
      unitRef="usd">12075000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idd724fc113f1423fab76a0b7d9141942_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtMTEtMS0xLTA_f789c116-8cc0-427a-98a9-bbee1328b551"
      unitRef="usd">-1663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="id25a265859cb4a5fab9c40c7cdf40f44_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtMTMtMS0xLTA_56dcd076-fc63-4f21-b841-9fb3c8832fb2"
      unitRef="shares">95000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id25a265859cb4a5fab9c40c7cdf40f44_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtMTUtMS0xLTA_c73b4105-23ca-4a9d-a16d-d0bb4f610eca"
      unitRef="usd">-10853000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id9025fe41f3c4206832a02f6067cccc8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtMTctMS0xLTA_e72d1843-14f6-40c0-942f-d0a81e507fc8"
      unitRef="usd">211000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia65b1cdade72453c9c9547d6ed17b3e9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOjBmODkwZGZlZTU3ZjQ4OTlhM2RkYjA2Yzg0YjcxNjEyL3RhYmxlcmFuZ2U6MGY4OTBkZmVlNTdmNDg5OWEzZGRiMDZjODRiNzE2MTJfMTMtMTktMS0xLTA_af716d83-6494-4521-8f79-61a55f4d40e6"
      unitRef="usd">6385000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i53dbe944eae1492aa687e479fc7a11b9_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy0xLTEtMS0w_fd8693ba-7df1-41fb-b2fb-db4b40c27128"
      unitRef="shares">271000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53dbe944eae1492aa687e479fc7a11b9_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy0zLTEtMS0w_27956f88-5690-454c-a10d-de1d0ab09409"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id0ed625dd55947b98750c596c6405402_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy01LTEtMS0w_a067cd2b-a897-4e8e-9e4d-b6f25b06a57b"
      unitRef="usd">6435000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i48dad6b27bfc4bb98f4e86f70d71263b_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy03LTEtMS0w_cdbf7d95-2de8-42c5-96ec-c1f1e24c2d0c"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3e42b52ae7334bbc8d4c95f67d0beb34_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy05LTEtMS0w_09bebc05-9127-4a6e-a4cf-6f68402fdf5a"
      unitRef="usd">12409000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id686b4181792461ea0b02a307e3b6b16_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy0xMS0xLTEtMA_69decfb6-19b7-46b2-bdc6-8ab8142dd1a4"
      unitRef="usd">-1849000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i81babc7a70954522b7b22ac34fdd8414_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy0xMy0xLTEtMA_080b7a4c-3df5-4535-b599-1ccd0612f242"
      unitRef="shares">81000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i81babc7a70954522b7b22ac34fdd8414_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy0xNS0xLTEtMA_35879ad5-7ece-4a58-9c1e-8af6d73ebcb0"
      unitRef="usd">-8902000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9dcbc3a9c5dd4e11aa4f98339c48f19c_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy0xNy0xLTEtMA_6f6f3cf1-8bdd-4392-9995-c80d2824fdec"
      unitRef="usd">193000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic798201eb4fa4f7a804f2e801548f37c_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMy0xOS0xLTEtMA_67a55ebe-7a3d-4060-b250-097bab860225"
      unitRef="usd">8287000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d03dd7c905342d1a2937caa74731528_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNC05LTEtMS0w_0751bbf9-8bf5-46a6-aaf4-3e4ac4801973"
      unitRef="usd">11000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i46e5c95277ec49cb8ca34ae6e95c7f38_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNC0xOS0xLTEtMA_51be2d57-b30e-44a6-9bf4-048de5dc07ba"
      unitRef="usd">11000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i0170e2288b194e75bbcd4d3065c84185_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS0xLTEtMS0w_9f3520d0-23e6-4c5f-b415-29a5c889b65c"
      unitRef="shares">271000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0170e2288b194e75bbcd4d3065c84185_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS0zLTEtMS0w_d34687d9-756b-4571-8b29-246406a02893"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9d01fe2b386243908ec14fc43582d826_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS01LTEtMS0w_a4619b00-9903-4173-a104-0d5f3a9c371b"
      unitRef="usd">6435000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic38570a58197439eb0c8a6f1f9b9fd62_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS03LTEtMS0w_074f6c53-c7c1-4cf2-95df-5cfa59159eb7"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3f0d013d62e64c1a9ff51d7df3d8f8fc_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS05LTEtMS0w_a32510e1-900c-454d-82b4-a129023e85b3"
      unitRef="usd">12420000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i58124d80a4e44920b8506455c425e375_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS0xMS0xLTEtMA_9352c3ef-4dfa-407a-8795-058ad7a190d3"
      unitRef="usd">-1849000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="id6558f17c2334aff80dd0d663259b6c9_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS0xMy0xLTEtMA_a53f19f6-9804-4744-a4d7-27275e32a952"
      unitRef="shares">81000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id6558f17c2334aff80dd0d663259b6c9_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS0xNS0xLTEtMA_4e689e17-722f-4d99-b4c5-d8097017f9d3"
      unitRef="usd">-8902000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id8eca560196144a6ae00495db6084899_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS0xNy0xLTEtMA_551a0fcd-7afd-4a56-9ee8-a2ce16db93c5"
      unitRef="usd">193000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie8f0d7cc99df4d939573a16bbc9b0efb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNS0xOS0xLTEtMA_202be8a3-d8f2-4ffa-a2b1-fd5f17b1f604"
      unitRef="usd">8298000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i36d180f203204936b0e8fc121ab9b7de_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNi0xLTEtMS0w_bddd1bc4-4b4d-4d17-8c7a-fd65dc16dabf"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i457a8c3bc27049ef85e109fd88303f2c_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNi01LTEtMS0w_7d9077bc-6030-4e0d-8e5b-c0ce13efb918"
      unitRef="usd">89000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i9d7db3179e2e47f293b957b1ef8858cd_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNi0xNS0xLTEtMA_ad853ecd-1973-47c1-9a96-4ecf5b0ad2cb"
      unitRef="usd">-17000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNi0xOS0xLTEtMA_f7736bf1-b4e0-40fd-b6dd-227686a3e610"
      unitRef="usd">72000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i457a8c3bc27049ef85e109fd88303f2c_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNy01LTEtMS0w_1a4e6fb3-43bb-45fd-8040-5082d0752f06"
      unitRef="usd">90000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfNy0xOS0xLTEtMA_a4273781-5e79-46f5-aceb-bb24050c5184"
      unitRef="usd">90000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i01c4d416ec1c40a593cf210126c97ef4_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfOC0xNy0xLTEtMA_42aee07c-a9da-4459-847a-3140afa7fba7"
      unitRef="usd">115000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfOC0xOS0xLTEtMA_3245b18d-2b69-41b3-b899-ae65187d22ef"
      unitRef="usd">115000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic26a952d776148b6b791451cbf1e0f2c_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfOS0xMS0xLTEtMA_aa7e5523-d01e-4e01-aade-1fd4cec565ee"
      unitRef="usd">186000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfOS0xOS0xLTEtMA_628368fd-5adf-4761-9b92-217f05db66e6"
      unitRef="usd">186000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i956f7e118d784444a97416bdea861a56_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTAtOS0xLTEtMA_017557f7-9cab-4499-9900-a60bb2d3abb1"
      unitRef="usd">-121000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i01c4d416ec1c40a593cf210126c97ef4_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTAtMTctMS0xLTA_87987629-f0a8-4242-a76e-dc7052363fd0"
      unitRef="usd">130000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTAtMTktMS0xLTA_665fe426-db92-45b1-bae2-a95eb895dc4a"
      unitRef="usd">9000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i9d7db3179e2e47f293b957b1ef8858cd_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTEtMTMtMS0xLTA_ba615539-f158-42fb-a388-48f85bcaf26d"
      unitRef="shares">14000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i9d7db3179e2e47f293b957b1ef8858cd_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTEtMTUtMS0xLTA_bcfd79b8-d19f-43ef-8f6a-623bb2ae0813"
      unitRef="usd">1934000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTEtMTktMS0xLTA_3516f936-5834-42af-a821-7244a1fa1cd4"
      unitRef="usd">1934000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOmVjMzM3NDdhMjUyMDRkMjk4NmE1ODY0MGZkNmIwMjU4XzI5_2eef1799-3121-48ee-a062-4fc972653a58"
      unitRef="usdPerShare">1.21</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i956f7e118d784444a97416bdea861a56_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTMtOS0xLTEtMA_d8d493e2-9740-4b81-8117-49347807c37a"
      unitRef="usd">221000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTMtMTktMS0xLTA_c595e89b-2dc3-436c-9772-cb3ab05a7c0e"
      unitRef="usd">221000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i956f7e118d784444a97416bdea861a56_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTQtOS0xLTEtMA_27ee8667-f88a-4f83-916b-b8b521c7bb43"
      unitRef="usd">3000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i01c4d416ec1c40a593cf210126c97ef4_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTQtMTctMS0xLTA_031446d2-211c-4e95-9b83-2e21871321df"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTQtMTktMS0xLTA_6f8baf1f-51aa-4d9e-b64c-ad8d7c819e10"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i03968c2d88954a3f8b182452bc2bbaa5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtMS0xLTEtMA_3e93348f-8de4-43af-9f48-9ad65a7d3ed7"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03968c2d88954a3f8b182452bc2bbaa5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtMy0xLTEtMA_f6e32402-cccf-45ed-81c2-433278e3d66a"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1a823c07346941aca960d012bef9774a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtNS0xLTEtMA_5f7ed4be-bf9c-40be-9ab3-500d5d780630"
      unitRef="usd">6614000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i34964563458343118c3362841fc34697_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtNy0xLTEtMA_74937f04-2899-4f82-8500-4c4a8dba9136"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1510b0bae31c44278e232e7cafd63a4d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtOS0xLTEtMA_c92ef7ea-4da3-4cd4-b219-7e2118d10b23"
      unitRef="usd">12075000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idd724fc113f1423fab76a0b7d9141942_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtMTEtMS0xLTA_e9951693-d610-4129-b43f-711257ff6d38"
      unitRef="usd">-1663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="id25a265859cb4a5fab9c40c7cdf40f44_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtMTMtMS0xLTA_b3be4bf3-7912-4b61-bda7-d7c58e74d746"
      unitRef="shares">95000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id25a265859cb4a5fab9c40c7cdf40f44_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtMTUtMS0xLTA_ea025fea-9db6-4f66-9317-66998a553849"
      unitRef="usd">-10853000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id9025fe41f3c4206832a02f6067cccc8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtMTctMS0xLTA_f4f7b707-f0da-4eaa-ad1b-8b52eaf732df"
      unitRef="usd">211000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia65b1cdade72453c9c9547d6ed17b3e9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yMi9mcmFnOmY5ZmMxZTY0NWI4ZjQwZGI4OGYzNWQ2ZTJiZjc0ODk4L3RhYmxlOmNhYzc1YmM4NjM3YTQ5MzVhOWY1Mjc0ZTk1OTVjMTNkL3RhYmxlcmFuZ2U6Y2FjNzViYzg2MzdhNDkzNWE5ZjUyNzRlOTU5NWMxM2RfMTUtMTktMS0xLTA_c709b98c-f242-43eb-94e0-35ea29fa4c12"
      unitRef="usd">6385000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMy0xLTEtMS0w_bfe94764-7a6c-4801-b48c-5bdc5a696013"
      unitRef="usd">-5053000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMy0zLTEtMS0w_46158649-55e0-43b8-8c0f-687c22e119cc"
      unitRef="usd">42000000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNS0xLTEtMS0w_06b12535-f2cd-4636-8377-46b693abc9c8"
      unitRef="usd">237000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNS0zLTEtMS0w_096f952c-cf2d-4ad1-b95a-f87a0b9dd6a3"
      unitRef="usd">239000000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNi0xLTEtMS0w_a800f90e-151a-472d-ad37-3c017ab0d66a"
      unitRef="usd">429000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNi0zLTEtMS0w_3fc6e6f6-30b2-4d53-b6b4-6fbe2d697a98"
      unitRef="usd">452000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AssetImpairmentCharges
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNy0xLTEtMS0w_9331ab45-d684-4b4c-b34b-979d050b327f"
      unitRef="usd">236000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNy0zLTEtMS0w_ba441c0b-70f5-464e-a6a2-5ce69b101a27"
      unitRef="usd">113000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfOC0xLTEtMS0w_d7b4d545-0db5-456f-96ba-aa2e89dca5e0"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfOC0zLTEtMS0w_12316356-b05c-44d4-b0b6-ece80f1f6054"
      unitRef="usd">-1478000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfOS0xLTEtMS0w_680f0915-34c7-4a63-9aab-547e9ee8d9b5"
      unitRef="usd">1520000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfOS0zLTEtMS0w_2a4d20e0-f4dd-4c3f-aaea-6484707b1ff5"
      unitRef="usd">387000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTAtMS0xLTEtMA_5e2d58cc-c8a3-440e-a0c9-686c1d76c2ee"
      unitRef="usd">-115000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTAtMy0xLTEtMA_fa42d7ef-54ea-485a-8675-12baf8571e31"
      unitRef="usd">-114000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:OperatingLeaseExpense
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTEtMS0xLTEtMA_a94ef5fa-88f1-4dc2-8241-1780d7401f13"
      unitRef="usd">264000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTEtMy0xLTEtMA_2b6a94d4-da31-4f09-af93-93f601ca3638"
      unitRef="usd">276000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTItMS0xLTEtMA_002cfacd-3fdf-4eef-a535-be45c22893f8"
      unitRef="usd">-50000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTItMy0xLTEtMA_dc310a4c-fff2-4bed-adc8-a60993489e6c"
      unitRef="usd">-8000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTMtMS0xLTEtMA_b209b2f6-212f-446b-b47d-475284d335ad"
      unitRef="usd">-67000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTMtMy0xLTEtMA_dcfe5aa7-4e15-4752-96d9-27a17c947886"
      unitRef="usd">-534000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTUtMS0xLTEtMA_c4d5d0ae-7478-48da-b019-c4ae98619cbe"
      unitRef="usd">-1500000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTUtMy0xLTEtMA_465e98d2-3031-4ec9-a9c2-5180a4d1363d"
      unitRef="usd">1044000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTYtMS0xLTEtMA_103b7866-6361-43f7-9c96-b0e02a70bfe8"
      unitRef="usd">2046000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTYtMy0xLTEtMA_e3f66c92-837e-457d-965d-5ba84d313ac6"
      unitRef="usd">689000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTctMS0xLTEtMA_f568f4cf-e790-47ec-93ae-37f8539e13f3"
      unitRef="usd">-1240000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTctMy0xLTEtMA_a142db73-0756-4805-895b-8ed8d612a8d6"
      unitRef="usd">-929000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <mck:IncreaseDecreaseinOperatingLeaseLiabilities
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTgtMS0xLTEtMA_c456394d-63e4-45c9-a671-85c665266378"
      unitRef="usd">-291000000</mck:IncreaseDecreaseinOperatingLeaseLiabilities>
    <mck:IncreaseDecreaseinOperatingLeaseLiabilities
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTgtMy0xLTEtMA_a0d10a9c-771c-42a7-9777-63b98650c55a"
      unitRef="usd">-287000000</mck:IncreaseDecreaseinOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTktMS0xLTEtMA_a3ca3d6d-77dd-4c71-8cf1-33ffbce40d7a"
      unitRef="usd">184000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMTktMy0xLTEtMA_5815376c-e611-4bb3-b0d5-bb849f6d2877"
      unitRef="usd">11000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjAtMS0xLTEtOTE0OQ_b6c8c5f8-56be-4da0-8a76-714b61dd122f"
      unitRef="usd">8067000000</mck:IncreaseDecreaseInLitigationReserve>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjAtMy0xLTEtOTE1Mw_87dc55fd-6609-4807-b06a-31b557e3f007"
      unitRef="usd">0</mck:IncreaseDecreaseInLitigationReserve>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjAtMS0xLTEtMA_509d8d9f-16db-4b38-98f0-becbeb08fa77"
      unitRef="usd">-403000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjAtMy0xLTEtMA_cf5aa750-ffdf-44ca-b61f-5bc4a9edf9cf"
      unitRef="usd">-17000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjEtMS0xLTEtMA_da6ef98e-480f-4f66-8b33-5783391d4551"
      unitRef="usd">1172000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjEtMy0xLTEtMA_25e04b02-3771-4353-a941-faa86769ddc2"
      unitRef="usd">-280000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjQtMS0xLTEtMA_99dd2f97-a7c7-4d6b-a9b8-d68da14d4bf3"
      unitRef="usd">293000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjQtMy0xLTEtMA_0a2adb30-d38b-47b4-a2d3-4640abb07942"
      unitRef="usd">242000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjUtMS0xLTEtMA_93433fa6-3241-4cf4-ba4f-5e7d74ac9205"
      unitRef="usd">134000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjUtMy0xLTEtMA_bb12c521-f30f-47d2-9baf-bb3438de5a3a"
      unitRef="usd">96000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjYtMS0xLTEtMA_5049ba3a-d183-4d79-8155-744d9343d8f5"
      unitRef="usd">33000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjYtMy0xLTEtMA_b8e30ea1-b083-4a8a-ab50-af9213af0ada"
      unitRef="usd">97000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjctMS0xLTEtMA_8424b149-cb09-4f82-ad44-6c040c6e94e7"
      unitRef="usd">325000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjctMy0xLTEtMA_f7c4c1f5-694c-4e8a-baa9-5f2dcc3fa0f9"
      unitRef="usd">6000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjgtMS0xLTEtMA_e4b70f5a-d609-4358-b107-29a6e6785ea6"
      unitRef="usd">75000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjgtMy0xLTEtMA_a6ac0e31-00d8-4033-84ae-71e117db0349"
      unitRef="usd">-20000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjktMS0xLTEtMA_4c8bbf11-f123-44db-b45a-58d359eecdb7"
      unitRef="usd">-210000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMjktMy0xLTEtMA_9ecc116c-4bdf-48e4-8957-542d867feac4"
      unitRef="usd">-409000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzItMS0xLTEtMA_1b38bd52-e33b-4114-b72e-75bcdced3d1a"
      unitRef="usd">5455000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzItMy0xLTEtMA_91d45bea-3c7b-4947-bac7-168fac641e89"
      unitRef="usd">15852000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzMtMS0xLTEtMA_e9c4ae41-9a19-4c1a-b3ab-dfa16330d419"
      unitRef="usd">5303000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzMtMy0xLTEtMA_05b0a0f5-2777-4857-b6b7-7d1cb9c7c075"
      unitRef="usd">13743000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzQtMS0xLTEtMA_6329f7eb-9234-46c0-be96-71f309468443"
      unitRef="usd">500000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzQtMy0xLTEtMA_da176e79-1e86-493c-b914-cb25a03908cd"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzUtMS0xLTEtMA_466df291-6d7a-48b4-82f3-f7761ea675c7"
      unitRef="usd">1030000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzUtMy0xLTEtMA_d1da35c2-8d65-4b6c-81f2-0f3db2c82682"
      unitRef="usd">8000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzctMS0xLTEtMA_62162324-1463-4b93-9893-2bbba8f9ea53"
      unitRef="usd">55000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzctMy0xLTEtMA_a5a1c04c-be7f-431c-8dde-6dca5f9f635c"
      unitRef="usd">89000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzgtMS0xLTEtMA_68967c61-8c3f-4b60-a67b-e20e280df5c7"
      unitRef="usd">526000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzgtMy0xLTEtMA_cf0200f0-4085-4b7c-a86a-e7df984d36bc"
      unitRef="usd">1951000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzktMS0xLTEtMA_cc1b772b-47e9-4c71-8861-9775a04cfdc2"
      unitRef="usd">209000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfMzktMy0xLTEtMA_002845b2-3de6-4c75-a467-cbc45f147269"
      unitRef="usd">222000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDAtMS0xLTEtMA_d53595c5-dd6c-42c1-bc38-1376371a2eeb"
      unitRef="usd">-118000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDAtMy0xLTEtMA_aa8f92d5-127e-41a8-ba4e-07530fbc195f"
      unitRef="usd">-271000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDEtMS0xLTEtMA_9160e7ac-dc47-4cba-b3fc-453df41fa607"
      unitRef="usd">-1176000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDEtMy0xLTEtMA_31b8548a-4406-44b1-8151-2f254af3d783"
      unitRef="usd">-254000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDItMS0xLTEtMA_fead058d-81f8-4a23-97d1-2d6bc970a45d"
      unitRef="usd">-77000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDItMy0xLTEtMA_1e5c20e0-5cdb-4a63-9dc6-883a63f41187"
      unitRef="usd">27000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDMtMS0xLTEtMA_f6d48e75-076d-42cd-9fd4-26cf45c85366"
      unitRef="usd">-291000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDMtMy0xLTEtMA_c767f1bf-bf46-4fd3-9a88-6b4d3ea8b48a"
      unitRef="usd">-916000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDQtMS0xLTEtMA_e70afbcd-b1df-4051-bd5d-843d837e2e03"
      unitRef="usd">4023000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic798201eb4fa4f7a804f2e801548f37c_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDQtMy0xLTEtMA_d801ccf5-b767-48f0-894f-63efb4bd5423"
      unitRef="usd">2981000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDUtMS0xLTEtMA_488baa5d-9d83-4477-81a7-e37d1242164d"
      unitRef="usd">3732000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia65b1cdade72453c9c9547d6ed17b3e9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDUtMy0xLTEtMA_72df9064-e4b2-4b53-a362-a2b1b2013b7e"
      unitRef="usd">2065000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RestrictedCashCurrent
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDYtMS0xLTEtMA_1debfa1e-08d2-4437-81a0-32d8de058338"
      unitRef="usd">155000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="ia65b1cdade72453c9c9547d6ed17b3e9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDYtMy0xLTEtMA_f213dd9d-de34-44dd-b499-d9935c5a907c"
      unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDgtMS0xLTEtMA_1393b58c-9507-4320-91ba-23ffc6cab701"
      unitRef="usd">3577000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia65b1cdade72453c9c9547d6ed17b3e9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8yNS9mcmFnOmVmMzQ1NTZiZDJkYzQ1YzlhMmZkZDllMDYyMDIyZjIyL3RhYmxlOmFhMDgxNTZkMTM0MDRiYjdhMmFiMjA1Mzk0MTJmMjZlL3RhYmxlcmFuZ2U6YWEwODE1NmQxMzQwNGJiN2EyYWIyMDUzOTQxMmYyNmVfNDgtMy0xLTEtMA_c634a34d-6557-4d99-9b75-1a19e43b8eea"
      unitRef="usd">2065000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zMS9mcmFnOjdkZTVmMDI0N2U0ZjRhYWZiNjFjNGFmNmNjOGQyNjcwL3RleHRyZWdpb246N2RlNWYwMjQ3ZTRmNGFhZmI2MWM0YWY2Y2M4ZDI2NzBfMTA2ODE_0dea23ac-fc7f-4700-814d-b37e0bca4b3f">Significant Accounting Policies&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nature of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: McKesson Corporation (&#x201c;McKesson,&#x201d; or the &#x201c;Company,&#x201d;) is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. Commencing with the second quarter of 2021, the Company reports its financial results in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (&#x201c;RxTS&#x201d;). The Company&#x2019;s equity method investment in Change Healthcare LLC (&#x201c;Change Healthcare JV&#x201d;), which was split-off from McKesson in the fourth quarter of 2020, has been included in Other for retrospective periods presented. All prior segment information has been recast to reflect the Company&#x2019;s new segment structure and current period presentation. Refer to Financial Note 15, &#x201c;Segments of Business,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and controlled companies. For those consolidated subsidiaries where the Company&#x2019;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers itself to control an entity if it has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#x201c;VIE&#x201d;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;U.S.&#x201d;) of America (&#x201c;GAAP&#x201d;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The severity, magnitude, and duration, as well as the economic consequences of the coronavirus disease 2019 (&#x201c;COVID-19&#x201d;) pandemic, are uncertain, rapidly changing and difficult to predict. Therefore, the Company&#x2019;s accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;) was enacted on March 27, 2020 in the U.S., and includes several provisions related to employment and income taxes, including provisions for the deferral of the employer portion of social security taxes through December 31, 2020. On December 27, 2020, the U.S. government enacted the Consolidated Appropriations Act, 2021, which enhances and expands certain provisions of the CARES Act. These legislative acts are not expected to have a material impact on the Company&#x2019;s consolidated financial results. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for the three and nine months ended December 31, 2020 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended March 31, 2020 previously filed with the SEC on May 22, 2020 (&#x201c;2020 Annual Report&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company prospectively adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs in a cloud computing arrangement that has a software license. As a result, the Company began capitalizing eligible implementation costs for such contracts and recognizing the expense over the service period. The adoption of this amended guidance did not have a material impact on the Company&#x2019;s condensed consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company retrospectively adopted ASU 2018-14, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Retirement Benefits - Defined Benefit Plans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires the Company to disclose the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates, and an explanation of reasons for significant gains and losses related to changes in the benefit obligation for the period. The amended guidance also requires the Company to remove disclosures on the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit costs over the next fiscal year. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#x2019;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company adopted ASU 2018-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to remove, modify and add disclosure requirements on fair value measurements. Certain requirements were applied prospectively while other changes were applied retrospectively on the effective date. The amended guidance removes disclosure requirements for transfers between Level 1 and Level 2 measurements and valuation processes for Level 3 measurements, but adds new disclosure requirements including changes in unrealized gains or losses in other comprehensive income related to recurring Level 3 measurements and requirements to disclose the range, and weighted-average used to develop significant unobservable inputs for Level 3 fair value measurements. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#x2019;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company adopted ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2016-13&#x201d;), which changed the impairment model for most financial assets from one based on current losses to a forward-looking model based on expected losses. The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses. The amended guidance requires financial assets that are measured at amortized cost be presented at the net amount expected to be collected. An allowance for credit losses is established as a valuation account that is deducted from the amortized cost basis of financial assets. The guidance also requires enhanced disclosures. This guidance was adopted on a modified retrospective basis and did not have a material impact on the Company&#x2019;s condensed consolidated financial statements or disclosures. Upon adoption of the amended guidance in the first quarter of 2021, the Company recorded a cumulative-effect adjustment of $13 million to the opening balance of retained earnings, primarily as a result of adjustments to allowances for trade accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for Credit Losses: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the adoption of ASU 2016-13 in the first quarter of 2021, the Company began using the Current Expected Credit Losses ("CECL") methodology to determine an allowance for credit losses related to financial assets measured at amortized cost. The Company considers historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop its allowance for credit losses. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $221 million was included in Receivables, net on the Condensed Consolidated Balance Sheet as of December 31, 2020. Changes in the allowance were not material for the three and nine months ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In December 2019, ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, was issued with the intent to simplify various aspects related to accounting for income taxes.&#160;The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The guidance is effective for the Company in the first quarter of 2022 and&#160;early adoption is permitted.&#160;The Company is currently evaluating the impact of this amended guidance on its condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i8fda1e3442374708947bef1923d2f19e_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zMS9mcmFnOjdkZTVmMDI0N2U0ZjRhYWZiNjFjNGFmNmNjOGQyNjcwL3RleHRyZWdpb246N2RlNWYwMjQ3ZTRmNGFhZmI2MWM0YWY2Y2M4ZDI2NzBfNjIw_4fdce319-6d18-4e0c-8a31-f6cc08f903d8"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zMS9mcmFnOjdkZTVmMDI0N2U0ZjRhYWZiNjFjNGFmNmNjOGQyNjcwL3RleHRyZWdpb246N2RlNWYwMjQ3ZTRmNGFhZmI2MWM0YWY2Y2M4ZDI2NzBfMTA3MDc_b5948665-274f-4d7b-8c68-475d596ed0e0">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and controlled companies. For those consolidated subsidiaries where the Company&#x2019;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers itself to control an entity if it has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#x201c;VIE&#x201d;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;U.S.&#x201d;) of America (&#x201c;GAAP&#x201d;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The severity, magnitude, and duration, as well as the economic consequences of the coronavirus disease 2019 (&#x201c;COVID-19&#x201d;) pandemic, are uncertain, rapidly changing and difficult to predict. Therefore, the Company&#x2019;s accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.&lt;/span&gt;&lt;/div&gt;The Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;) was enacted on March 27, 2020 in the U.S., and includes several provisions related to employment and income taxes, including provisions for the deferral of the employer portion of social security taxes through December 31, 2020. On December 27, 2020, the U.S. government enacted the Consolidated Appropriations Act, 2021, which enhances and expands certain provisions of the CARES Act. These legislative acts are not expected to have a material impact on the Company&#x2019;s consolidated financial results.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zMS9mcmFnOjdkZTVmMDI0N2U0ZjRhYWZiNjFjNGFmNmNjOGQyNjcwL3RleHRyZWdpb246N2RlNWYwMjQ3ZTRmNGFhZmI2MWM0YWY2Y2M4ZDI2NzBfMTA2NzA_73211cd9-ea06-4501-893a-d09d186f97f2">The results of operations for the three and nine months ended December 31, 2020 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended March 31, 2020 previously filed with the SEC on May 22, 2020 (&#x201c;2020 Annual Report&#x201d;).</us-gaap:UseOfEstimates>
    <us-gaap:FiscalPeriod
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zMS9mcmFnOjdkZTVmMDI0N2U0ZjRhYWZiNjFjNGFmNmNjOGQyNjcwL3RleHRyZWdpb246N2RlNWYwMjQ3ZTRmNGFhZmI2MWM0YWY2Y2M4ZDI2NzBfMTA2NzI_779d8fd1-894a-476c-adcd-78c41908e4e6">The Company&#x2019;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.</us-gaap:FiscalPeriod>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zMS9mcmFnOjdkZTVmMDI0N2U0ZjRhYWZiNjFjNGFmNmNjOGQyNjcwL3RleHRyZWdpb246N2RlNWYwMjQ3ZTRmNGFhZmI2MWM0YWY2Y2M4ZDI2NzBfMTA3MDk_3a6d610a-5f1f-42b5-8b6c-ca1c1da7443a">Certain prior year amounts have been reclassified to conform to the current year presentation.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zMS9mcmFnOjdkZTVmMDI0N2U0ZjRhYWZiNjFjNGFmNmNjOGQyNjcwL3RleHRyZWdpb246N2RlNWYwMjQ3ZTRmNGFhZmI2MWM0YWY2Y2M4ZDI2NzBfMTA2OTE_47c07d96-a9ef-484c-8d61-491651fec44c">&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company prospectively adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs in a cloud computing arrangement that has a software license. As a result, the Company began capitalizing eligible implementation costs for such contracts and recognizing the expense over the service period. The adoption of this amended guidance did not have a material impact on the Company&#x2019;s condensed consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company retrospectively adopted ASU 2018-14, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Retirement Benefits - Defined Benefit Plans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires the Company to disclose the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates, and an explanation of reasons for significant gains and losses related to changes in the benefit obligation for the period. The amended guidance also requires the Company to remove disclosures on the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit costs over the next fiscal year. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#x2019;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company adopted ASU 2018-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to remove, modify and add disclosure requirements on fair value measurements. Certain requirements were applied prospectively while other changes were applied retrospectively on the effective date. The amended guidance removes disclosure requirements for transfers between Level 1 and Level 2 measurements and valuation processes for Level 3 measurements, but adds new disclosure requirements including changes in unrealized gains or losses in other comprehensive income related to recurring Level 3 measurements and requirements to disclose the range, and weighted-average used to develop significant unobservable inputs for Level 3 fair value measurements. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#x2019;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company adopted ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2016-13&#x201d;), which changed the impairment model for most financial assets from one based on current losses to a forward-looking model based on expected losses. The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses. The amended guidance requires financial assets that are measured at amortized cost be presented at the net amount expected to be collected. An allowance for credit losses is established as a valuation account that is deducted from the amortized cost basis of financial assets. The guidance also requires enhanced disclosures. This guidance was adopted on a modified retrospective basis and did not have a material impact on the Company&#x2019;s condensed consolidated financial statements or disclosures. Upon adoption of the amended guidance in the first quarter of 2021, the Company recorded a cumulative-effect adjustment of $13 million to the opening balance of retained earnings, primarily as a result of adjustments to allowances for trade accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for Credit Losses: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the adoption of ASU 2016-13 in the first quarter of 2021, the Company began using the Current Expected Credit Losses ("CECL") methodology to determine an allowance for credit losses related to financial assets measured at amortized cost. The Company considers historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop its allowance for credit losses. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $221 million was included in Receivables, net on the Condensed Consolidated Balance Sheet as of December 31, 2020. Changes in the allowance were not material for the three and nine months ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In December 2019, ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, was issued with the intent to simplify various aspects related to accounting for income taxes.&#160;The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The guidance is effective for the Company in the first quarter of 2022 and&#160;early adoption is permitted.&#160;The Company is currently evaluating the impact of this amended guidance on its condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1b34b0a4a2344072ae6737a15d1ec38a_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zMS9mcmFnOjdkZTVmMDI0N2U0ZjRhYWZiNjFjNGFmNmNjOGQyNjcwL3RleHRyZWdpb246N2RlNWYwMjQ3ZTRmNGFhZmI2MWM0YWY2Y2M4ZDI2NzBfODg3NA_d76e450d-de57-4828-97bd-79dae34483d8"
      unitRef="usd">13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zMS9mcmFnOjdkZTVmMDI0N2U0ZjRhYWZiNjFjNGFmNmNjOGQyNjcwL3RleHRyZWdpb246N2RlNWYwMjQ3ZTRmNGFhZmI2MWM0YWY2Y2M4ZDI2NzBfOTcxMw_63ccdfe3-7a49-45c7-8b54-71c9ae55e1a8"
      unitRef="usd">221000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfNTkwNQ_aeee6395-5de6-48e6-821c-952b3509b363">Investment in Change Healthcare Joint Venture&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Until the separation of its interest in the Change Healthcare JV on March 10, 2020, the Company accounted for its interest in the joint venture using the equity method of accounting with a one-month reporting lag, with disclosure made for any intervening events of the joint venture in the lag period that could materially affect its condensed consolidated financial statements. Effective April 1, 2019, the Change Healthcare JV adopted the amended revenue recognition guidance. In the first quarter of 2020, the Company recorded its proportionate share of the joint venture&#x2019;s adoption impact of the amended revenue recognition guidance of approximately $80 million, net of tax, to the Company&#x2019;s opening retained earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 27, 2019, common stock and certain other securities of Change Healthcare Inc. (&#x201c;Change&#x201d;) began trading on the NASDAQ (&#x201c;IPO&#x201d;). Change was a holding company and did not own any material assets or have any operations other than its interest in the Change Healthcare JV. On July 1, 2019, upon the completion of its IPO, Change received net cash proceeds of approximately $888 million. Change contributed the proceeds of $609 million from its offering of common stock to the Change Healthcare&#160;JV in exchange for additional membership interests of the Change Healthcare JV (&#x201c;LLC Units&#x201d;) at the equivalent of its offering price of $13 per share. The proceeds of $279 million from the concurrent offering of other securities were used by Change to acquire certain securities of the Change Healthcare JV that substantially mirrored the terms of other securities included in the offering by Change. As a result, McKesson&#x2019;s equity interest in the Change Healthcare JV was diluted from approximately 70% to approximately 58.5% while Change owned approximately 41.5% of the outstanding LLC Units. Accordingly, in the second quarter of 2020, the Company recognized a pre-tax dilution loss of $246 million primarily representing the difference between its proportionate share of the IPO proceeds and the dilution effect on the investment&#x2019;s carrying value. These items were included in Equity earnings and charges from investment in Change Healthcare Joint Venture in the Company&#x2019;s Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2019. The Company&#x2019;s proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2020, the Company recorded a pre-tax other-than-temporary&#160;impairment (&#x201c;OTTI&#x201d;) charge of $1.2 billion to its investment in the Change Healthcare JV, representing the difference between the carrying value of the Company&#x2019;s investment and the fair value derived from the corresponding closing price of Change&#x2019;s common stock at September 30, 2019. This charge was included in Equity earnings and charges from investment in Change Healthcare Joint Venture in the Company&#x2019;s Condensed Consolidated Statements of Operations for the nine months ended December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded its proportionate share of loss from its investment in Change Healthcare JV of $28 million and $75 million, respectively, for the three and nine months ended December 31, 2019. The Company&#x2019;s proportionate share of income or loss from this investment included integration expenses incurred by Change Healthcare JV and basis differences between the joint venture and McKesson, including amortization of fair value adjustments primarily representing incremental intangible assets. These amounts were included within Equity earnings and charges from investment in Change Healthcare Joint Venture in the Company&#x2019;s Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 10, 2020, the Company completed the previously announced separation of its interest in the Change Healthcare JV which eliminated the Company&#x2019;s investment in the joint venture. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While a party to the joint venture, the Company had various ancillary agreements related to the Change Healthcare JV, including transition services agreements (&#x201c;TSA&#x201d;), a transaction and advisory fee agreement (&#x201c;Advisory Agreement&#x201d;), a tax receivable agreement (&#x201c;TRA&#x201d;), and certain other agreements. Revenues recognized and expenses incurred under these agreements with the Change Healthcare JV were not material during the three and nine months ended December 31, 2020 and the three months ended December 31, 2019. Fees earned from the TSA were $18 million for the nine months ended December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the agreement executed in 2019 between the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson. McKesson exercised its right under the agreement and allocated certain depreciation and amortization deductions to Change for the tax years ended March 31, 2019 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After McKesson&#x2019;s separation of its interest in the Change Healthcare JV, the aforementioned TRA agreement requires the Change Healthcare JV to pay McKesson 85% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the depreciation or amortization allocated to Change by McKesson. The receipt of any payments from the Change Healthcare JV under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings. This creates uncertainty over the amount, timing, and probability of the gain recognized. As such, the Company accounts for the TRA as a gain contingency, with no receivable recognized as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2020 in conjunction with the separation transaction, the Company recorded a reversal of the deferred tax liability related to its investment. Under the agreement with the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, there may be changes in future periods to the amount reversed as the relevant periods are audited by tax authorities. Any such change is not expected to have a material impact on the Company&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2bf1ccbd66194ee193c7054b7fb9cad3_I20190401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfNjY3_3e280b1c-66a7-4d54-8dfe-3f5239038f08"
      unitRef="usd">80000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="ia2ee20a5c84e431a9dbe88126ea7debb_D20190701-20190701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMTEwMg_f12e98b5-8bac-4eee-8d35-021d0fe7e8d8"
      unitRef="usd">888000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="i24bafc5133144c1f9d0575855df32cdd_D20190701-20190701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMTE0MQ_8c81baa0-6d28-422a-98ef-be94a5ef408c"
      unitRef="usd">609000000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i651e12a9a9314eaead5f5def7b8cb902_I20190701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMTMzOQ_6cde08a5-6e61-4cc1-ae57-f2bf9e229680"
      unitRef="usdPerShare">13</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="ia2ee20a5c84e431a9dbe88126ea7debb_D20190701-20190701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMTM2OQ_ea3be112-7cb1-498c-93fb-9b7c566daab1"
      unitRef="usd">279000000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i6b3a22eac44c42f8966d20ec62021a93_I20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMTY5Mg_a48a2ef8-74a1-4194-9e46-c40d153be751"
      unitRef="number">0.70</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i9bb3d5efc8c84f3896fe23c52b92310e_I20190701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMTcxMg_100f0637-f1dc-42c4-9186-72ad879ce1f8"
      unitRef="number">0.585</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ieba62539ca00495ba37020bffe3d644f_I20190701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMTc0OA_9b5c766d-035f-4efb-917a-d124ff3a4d48"
      unitRef="number">0.415</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="i5b86094c4db947ae9f4ef0d8fd8d773a_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMTg3NQ_2c450e52-ab9e-4c0d-816d-a6961db02af2"
      unitRef="usd">-246000000</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="i72904c34cf28486695441a05e83b4257_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMTg3NQ_f5906b50-0800-4327-9cc9-d5a1f8ba6891"
      unitRef="usd">-246000000</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i72904c34cf28486695441a05e83b4257_D20190701-20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMjQyNQ_3daeff53-6ccf-4d7f-beff-2bf2e918d6d8"
      unitRef="usd">1200000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i5b86094c4db947ae9f4ef0d8fd8d773a_D20190401-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMjQyNQ_67077b77-7a3f-4458-89c4-9c928d588708"
      unitRef="usd">1200000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <mck:ProportionateGainLossOnEquityMethodInvestment
      contextRef="i0946d2a17db14d63b64a7a7251e88c34_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMjg3OA_48078183-4582-42c2-8f3e-fff280b1665b"
      unitRef="usd">-28000000</mck:ProportionateGainLossOnEquityMethodInvestment>
    <mck:ProportionateGainLossOnEquityMethodInvestment
      contextRef="i5b86094c4db947ae9f4ef0d8fd8d773a_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMjg4NQ_2f77dafd-4f88-4d35-8550-f7fd68ffe028"
      unitRef="usd">-75000000</mck:ProportionateGainLossOnEquityMethodInvestment>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="i9f856c9a81854c4287e9fd8fc2f4afdc_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfMzg0ODI5MDcwMzMzMA_99b7cc4f-9e41-45ac-bd36-a90c99a9fa04"
      unitRef="usd">18000000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <mck:TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized
      contextRef="idaaf01c3e7a448f788de27496483bc0d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfNDg5OQ_1d51ed06-5f25-4f56-9818-6f6053a9b169"
      unitRef="number">0.85</mck:TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized>
    <us-gaap:DueFromRelatedParties
      contextRef="idaaf01c3e7a448f788de27496483bc0d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF8zNC9mcmFnOjYxNjA1MGMxODdlYzRhYmJhODgyOTEwMmNjOWQ0ZmFlL3RleHRyZWdpb246NjE2MDUwYzE4N2VjNGFiYmE4ODI5MTAyY2M5ZDRmYWVfNTM5NA_e9fa13e4-12ab-445a-8b06-776eae11234d"
      unitRef="usd">0</us-gaap:DueFromRelatedParties>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMzM2OQ_1fc6fe4b-ca4e-44a7-accb-c87a8ff72236">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities to be disposed of by sale (&#x201c;disposal groups&#x201d;) are reclassified into &#x201c;held for sale&#x201d; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The reclassification occurs when the disposal group is available for immediate sale and the sale is highly probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell and are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less cost to sell is reported as an adjustment to the carrying value of the disposal group. Assets and liabilities that have met the classification of held for sale were $15 million and $14 million, respectively, at December 31, 2020 and $906&#160;million and $683&#160;million, respectively, at March 31, 2020. These amounts at March 31, 2020 primarily consisted of the majority of the Company&#x2019;s German pharmaceutical wholesale business described below. This disposal group had been recorded as assets and liabilities held for sale since the third quarter of 2020 through its contribution to a joint venture in the third quarter of 2021. Based on its analysis, the Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations and are not considered to be significant disposals based on its quantitative and qualitative evaluation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;German Pharmaceutical Wholesale Joint Venture&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2020, the Company completed its previously announced transaction with Walgreens Boots Alliance (&#x201c;WBA&#x201d;) whereby the majority of its German pharmaceutical wholesale business was contributed to a newly formed joint venture in which McKesson has a 30% noncontrolling interest. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consideration received included a receivable amount of $43&#160;million, primarily related to working capital and net debt adjustments from WBA, and the 30% interest in the newly formed joint venture. At the transaction date, the carrying value of the equity investment in the joint venture was recorded at its fair value, which was measured using inputs that fell within Level 3 of the fair value hierarchy. The carrying value of the investment in the joint venture was nil as of December 31, 2020. The joint venture also assumed a note payable to the Company in the amount of approximately $291&#160;million as of the transaction date, which was paid to the Company in the third quarter of 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the contribution, the Company recorded a loss of $47&#160;million (pre-tax and after-tax) in operating expenses in the three months ended December 31, 2020. In addition to this amount, the Company recorded charges of $10&#160;million (pre-tax and after-tax) in the three and six months ended September 30, 2020 and $282&#160;million (pre-tax and after-tax) in the three and nine months ended December 31, 2019 to remeasure the assets and liabilities held for sale to fair value less costs to sell. These charges were included within operating expenses in the condensed consolidated statements of operations. The Company&#x2019;s measurement of the fair value of the disposal group was based on estimates of total consideration to be received by the Company as outlined in the contribution agreement between the Company and WBA. As a result of finalization of working capital amounts contributed and other adjustments, the Company may record additional gains or losses in future periods; however, these adjustments are not expected to have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its interest in the joint venture as an equity method investment within the International segment. The Company does not provide for losses on the investment as the Company has no guaranteed obligations for the joint venture to fund losses and is not otherwise committed to providing further financial support for the investee. If the joint venture subsequently generates income, the Company will only recognize its share of such income to the extent it exceeds its share of the previously unrecognized losses. As such, the Company has not recognized its proportionate share of earnings for the intervening period from the transaction date to December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the completion of the transaction on November 1, 2020, there were no assets or liabilities of the German pharmaceutical wholesale joint venture classified as held for sale on the Company&#x2019;s consolidated balance sheet. Total assets and liabilities of the German pharmaceutical wholesale joint venture that were classified as held for sale on the Company&#x2019;s consolidated balance sheet as of March 31, 2020, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of business held for sale to fair value less costs to sell&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes the effect of approximately $3 million of favorable cumulative foreign currency translation adjustment as of March 31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i715e9debe5f0419fa1ede68430828e3c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI2MTE0Ng_72389648-3b27-4c36-9f5f-60cead645247"
      unitRef="usd">15000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i715e9debe5f0419fa1ede68430828e3c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI2MTE1Ng_c8446eff-017f-450b-b22c-62f60d33374d"
      unitRef="usd">14000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i54af79268ad141df9f90e22d7b9b6595_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMzg0ODI5MDcyODU0Mg_902d5f9c-7f6d-4077-a32c-804876b3ad0c"
      unitRef="usd">906000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i54af79268ad141df9f90e22d7b9b6595_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMzg0ODI5MDcyODU0NQ_06868b5a-e8f2-4ca9-9ddd-e01db858bb71"
      unitRef="usd">683000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="ic0ee8653fb6141acba5c088e3b9425bc_I20201101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfOTM0NTg0ODg2Mzc5MQ_c855f2d2-0a60-4e2d-9452-d46f031d2966"
      unitRef="number">0.30</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable
      contextRef="icb1ee1c3366844f7af5c1f57a7d2a100_I20201101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI4MzQ0Mg_c5f99519-278d-4cb6-96cf-40e52b9097ba"
      unitRef="usd">43000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="ic0ee8653fb6141acba5c088e3b9425bc_I20201101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfOTM0NTg0ODg2NzQxOA_c855f2d2-0a60-4e2d-9452-d46f031d2966"
      unitRef="number">0.30</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:EquityMethodInvestments
      contextRef="i06bcacee536741a5b8412ad11e052a04_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI5MjM2Mg_08252936-efd5-4176-af94-f2ceefb8c668"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i938f21cb5003435093dd61e42f1e4b04_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjc0ODc3OTA5Nzg5MA_8f1fddd0-01a4-4557-a5f6-e2c7938bf145"
      unitRef="usd">291000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i938f21cb5003435093dd61e42f1e4b04_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI3NDEzMA_606ed94e-b402-4a9f-8db5-9297a0ec658a"
      unitRef="usd">-47000000</us-gaap:GainLossOnSaleOfBusiness>
    <mck:GainLossOnSaleOfBusinessNetOfTax
      contextRef="i938f21cb5003435093dd61e42f1e4b04_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI3NDEzMA_dea21788-bca2-4401-9c70-831cbd82826e"
      unitRef="usd">-47000000</mck:GainLossOnSaleOfBusinessNetOfTax>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i1089a6502fe643b2af007927de94cff7_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI5MDI1Mg_1da3716d-1156-476a-afc9-d5015faef904"
      unitRef="usd">10000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax
      contextRef="i1089a6502fe643b2af007927de94cff7_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI5MDI1Mg_2335f551-1510-4f6e-bfd6-8a78a78479ca"
      unitRef="usd">10000000</mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i1089a6502fe643b2af007927de94cff7_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI5MDI1Mg_44964288-5537-466f-9181-d994d2abee99"
      unitRef="usd">10000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax
      contextRef="i1089a6502fe643b2af007927de94cff7_D20200401-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI5MDI1Mg_5dc00723-21ed-499d-80a8-32d231b446d0"
      unitRef="usd">10000000</mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="icd175625828b47dcab648e0b14392f10_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI5MDMzNw_62e2f44f-777c-488e-a9a2-e92a8e45659e"
      unitRef="usd">282000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax
      contextRef="icd175625828b47dcab648e0b14392f10_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI5MDMzNw_6ae7b6a1-2644-4a56-8cab-1f1b116f0e73"
      unitRef="usd">282000000</mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax>
    <mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax
      contextRef="i0736a2a757fc454b88a193a6988112ef_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI5MDMzNw_ca0bf28a-df2a-433b-b254-ca718669ab16"
      unitRef="usd">282000000</mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i0736a2a757fc454b88a193a6988112ef_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI5MDMzNw_dad717c7-9297-43f1-8161-63a54c923693"
      unitRef="usd">282000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="ia0497adf27fa406783b9193a572e5457_I20201101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfOTM0NTg0ODg2Mzc5OA_94889de2-c246-4661-9c16-962863c8385c"
      unitRef="usd">0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="ia0497adf27fa406783b9193a572e5457_I20201101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfOTM0NTg0ODg2Mzc5OA_a613b756-53c3-460b-b53c-5453c131dd7f"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMzM2Ng_4d55e88b-a388-4eb8-acf7-4d1b97ccf63a">Total assets and liabilities of the German pharmaceutical wholesale joint venture that were classified as held for sale on the Company&#x2019;s consolidated balance sheet as of March 31, 2020, were as follows:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of business held for sale to fair value less costs to sell&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes the effect of approximately $3 million of favorable cumulative foreign currency translation adjustment as of March 31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i5f9649ec563d482b84c3260463f09372_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RhYmxlOmI4OGVkNDIyMTYyYjRjZDJiMzlkMmMyZTgwMTAxZjFmL3RhYmxlcmFuZ2U6Yjg4ZWQ0MjIxNjJiNGNkMmIzOWQyYzJlODAxMDFmMWZfMy0zLTEtMS0w_869fd75c-208e-46dd-ab6a-c0f80e40dbfe"
      unitRef="usd">548000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="i5f9649ec563d482b84c3260463f09372_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RhYmxlOmI4OGVkNDIyMTYyYjRjZDJiMzlkMmMyZTgwMTAxZjFmL3RhYmxlcmFuZ2U6Yjg4ZWQ0MjIxNjJiNGNkMmIzOWQyYzJlODAxMDFmMWZfNC0zLTEtMS0w_5b0aaa30-dd95-4860-9a23-def2ff6687ef"
      unitRef="usd">478000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent
      contextRef="i5f9649ec563d482b84c3260463f09372_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RhYmxlOmI4OGVkNDIyMTYyYjRjZDJiMzlkMmMyZTgwMTAxZjFmL3RhYmxlcmFuZ2U6Yjg4ZWQ0MjIxNjJiNGNkMmIzOWQyYzJlODAxMDFmMWZfNi0zLTEtMS0w_ff5faa33-2b66-4f7b-a3b8-5d6b30356fd4"
      unitRef="usd">88000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent>
    <mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1
      contextRef="i5f9649ec563d482b84c3260463f09372_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RhYmxlOmI4OGVkNDIyMTYyYjRjZDJiMzlkMmMyZTgwMTAxZjFmL3RhYmxlcmFuZ2U6Yjg4ZWQ0MjIxNjJiNGNkMmIzOWQyYzJlODAxMDFmMWZfNy0zLTEtMS0w_18c12685-1fb0-416a-a7c5-f42c626aaff8"
      unitRef="usd">272000000</mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i5f9649ec563d482b84c3260463f09372_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RhYmxlOmI4OGVkNDIyMTYyYjRjZDJiMzlkMmMyZTgwMTAxZjFmL3RhYmxlcmFuZ2U6Yjg4ZWQ0MjIxNjJiNGNkMmIzOWQyYzJlODAxMDFmMWZfOC0zLTEtMS0w_48c5c6a6-e3a7-45f8-9f2b-4eccb456cdde"
      unitRef="usd">842000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent
      contextRef="i5f9649ec563d482b84c3260463f09372_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RhYmxlOmI4OGVkNDIyMTYyYjRjZDJiMzlkMmMyZTgwMTAxZjFmL3RhYmxlcmFuZ2U6Yjg4ZWQ0MjIxNjJiNGNkMmIzOWQyYzJlODAxMDFmMWZfMTItMy0xLTEtMA_5579c5b7-9d6d-4bd9-a042-7c66487b3196"
      unitRef="usd">450000000</mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent
      contextRef="i5f9649ec563d482b84c3260463f09372_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RhYmxlOmI4OGVkNDIyMTYyYjRjZDJiMzlkMmMyZTgwMTAxZjFmL3RhYmxlcmFuZ2U6Yjg4ZWQ0MjIxNjJiNGNkMmIzOWQyYzJlODAxMDFmMWZfMTMtMy0xLTEtMA_22416a31-0241-45dc-b913-36373a64ebde"
      unitRef="usd">40000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent
      contextRef="i5f9649ec563d482b84c3260463f09372_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RhYmxlOmI4OGVkNDIyMTYyYjRjZDJiMzlkMmMyZTgwMTAxZjFmL3RhYmxlcmFuZ2U6Yjg4ZWQ0MjIxNjJiNGNkMmIzOWQyYzJlODAxMDFmMWZfMTQtMy0xLTEtMA_1c1d4d53-4e91-436b-be98-a78284603f92"
      unitRef="usd">166000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i5f9649ec563d482b84c3260463f09372_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RhYmxlOmI4OGVkNDIyMTYyYjRjZDJiMzlkMmMyZTgwMTAxZjFmL3RhYmxlcmFuZ2U6Yjg4ZWQ0MjIxNjJiNGNkMmIzOWQyYzJlODAxMDFmMWZfMTUtMy0xLTEtMA_28afb2dd-bc90-4201-8088-4f0229903985"
      unitRef="usd">656000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses
      contextRef="id6d5fffd99d0450f8f071044f671a597_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80My9mcmFnOjk2NGQ4YWNkYTFiMjQ2M2E5MGFlNGE2YjVhY2I0ZGVlL3RleHRyZWdpb246OTY0ZDhhY2RhMWIyNDYzYTkwYWU0YTZiNWFjYjRkZWVfMjE5OTAyMzI2NDk3MQ_668f2109-cb43-4744-ad5e-0caa5f89aab7"
      unitRef="usd">3000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfNTg1Mw_6f5a7297-e56a-4862-8d6b-0f5009d87006">Restructuring, Impairment, and Related Charges&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded restructuring, impairment, and related charges of $155 million and $271 million during the three and nine months ended December 31, 2020, respectively, and $136 million and $204 million during the three and nine months ended December 31, 2019, respectively. These charges are included under the caption, &#x201c;Restructuring, impairment, and related charges&#x201d; in Operating expenses in the Condensed Consolidated Statements of Operations. In addition, charges related to restructuring initiatives are included under the caption &#x201c;Cost of sales&#x201d; in its Condensed Consolidated Statements of Operations and were not material for the three and nine months ended December 31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring Initiatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously announced on November 30, 2018, the Company relocated its corporate headquarters, effective April 1, 2019, from San Francisco, California to Irving, Texas to improve efficiency, collaboration, and cost competitiveness. The Company expects to record total charges of approximately $105 million to $125 million, of which $104 million of charges were recorded to date. The Company recorded charges of $14 million and $27&#160;million, respectively, during the three and nine months ended December 31, 2020 and $14 million and $34 million, respectively, during the three and nine months ended December 31, 2019, consisting primarily of employee retention expenses, severance, accelerated depreciation, and long-lived asset impairments. The relocation was substantially complete in January 2021 and the estimated remaining charges primarily relate to lease costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2019, the Company committed to certain programs to continue its operating model and cost optimization efforts. The Company continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency. The programs also include reorganization and consolidation of business operations, related headcount reductions, the further closures of retail pharmacy stores in Europe, and closures of other facilities. The Company expects to incur total charges of approximately $310 million to $320 million for these programs, of which $288 million of charges were recorded to date. The Company recorded charges of $17 million and $53 million, respectively, during the three and nine months ended December 31, 2020 and $20 million and $59 million, respectively, during the three and nine months ended December 31, 2019, consisting primarily of employee severance, accelerated depreciation expense, and project consulting fees. The Company anticipates these additional programs will be substantially completed in 2022. The estimated remaining charges primarily consist of facility and other exit costs and employee-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; During the first quarter of 2021, the Company committed to an initiative within the United Kingdom (&#x201c;U.K.&#x201d;), which is included in the Company&#x2019;s International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings. The initiative includes reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. The Company expects to incur total charges of approximately $100 million to $120 million. The Company recorded charges of $9 million and $50 million, respectively, in the three and nine months ended December 31, 2020, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. The initiative is expected to be substantially complete by the end of 2021 and estimated remaining charges primarily consist of accelerated amortization of long-lived assets, facility and other exit costs, and employee-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges during the three and nine months ended December 31, 2020 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#x2019;s corporate headquarters described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily consist of project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#x2019;s corporate headquarters described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily consist of project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges during the three and nine months ended December 31, 2019 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.193%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents exit costs associated with a disposition and costs related to the relocation of the Company&#x2019;s corporate headquarters described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts described above. Additionally, includes costs associated with a growth initiative, substantially completed in the year ended March 31, 2020, which included a reduction in workforce and facility consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.193%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents exit costs associated with a disposition and costs related to the relocation of the Company&#x2019;s corporate headquarters described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#x2019;s corporate headquarters described above. Additionally, includes costs associated with a growth initiative, substantially completed in the year ended March 31, 2020, which included a reduction in workforce and facility consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the restructuring liabilities associated with the Company&#x2019;s restructuring initiatives for the nine months ended December 31, 2020: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of March 31, 2020, the total reserve balance was $157 million, of which $118 million was recorded in Other accrued liabilities and $39 million was recorded in Other non-current liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of December 31, 2020, the total reserve balance was $132 million, of which $101 million was recorded in Other accrued liabilities and $31 million was recorded in Other non-current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Lived Asset Impairments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, the Company recognized charges of $115 million to impair certain long-lived assets within the Company&#x2019;s International segment. These charges primarily related to long-lived assets associated with the Company&#x2019;s retail pharmacy businesses in Canada and Europe and were due to declines in estimated future cash flows partially driven by a revised outlook regarding the impacts of COVID-19. The Company used both an income approach (a discounted cash flow (&#x201c;DCF&#x201d;) method) and a market approach to estimate the fair value of the long-lived assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2020, the Company recognized charges of $94 million to impair certain long-lived assets within the Company&#x2019;s International segment. These charges primarily related to long-lived assets associated with the Company&#x2019;s retail pharmacy businesses in the U.K. and Canada due to declines in estimated future cash flows driven by government reimbursement reductions and lower than expected growth in both prescription volume and sales of non-prescription goods, respectively. The Company used both income (DCF) and market approaches to estimate the fair value of the long-lived assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the long-lived assets is considered a Level 3 fair value measurement due to the significance of unobservable inputs developed using company specific information. Refer to Financial Note 12, &#x201c;Fair Value Measurements,&#x201d; for more information on nonrecurring fair value measurements.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfODM_2ae30b5a-3fea-431f-8e1a-3149191e6301"
      unitRef="usd">155000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfOTA_9bfb9ce0-59d0-4e46-b050-531f31f70db1"
      unitRef="usd">271000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMTI2_3721e1e1-ae3d-4828-bc16-1e43c87a66e3"
      unitRef="usd">136000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMTMz_cd079e56-d37b-405e-9637-95fa6a27e73a"
      unitRef="usd">204000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i91c13ec8524c453f9fbf254e519c6157_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfODMx_86555117-cf72-40ce-9787-4239d0a88718"
      unitRef="usd">105000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i616db767164b421690d7840423dc72a9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfODM3_e8285521-5ddd-469c-903f-f9844b57f7f7"
      unitRef="usd">125000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="icd12a38f8159497f9b8bc50d69f1a89a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfODUw_e622af82-aed7-48ee-ab37-23e9e476bc55"
      unitRef="usd">104000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringCharges
      contextRef="i20a65cc8e8234e5eb9b8668ac6d80e35_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDcyMzgzMQ_9de31508-f725-46f4-8500-4e3bec6e8a15"
      unitRef="usd">14000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5777604ac50d42d29d8f706480015dbc_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDcyNDA2OA_7b0f7c33-6665-461b-aff6-ce2a5e73439a"
      unitRef="usd">27000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i39bbef1ec8fc483a88d5b2eb2083b4a9_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDczMTk1OA_f3ac1787-d353-4d59-9d16-6e6901c79d30"
      unitRef="usd">14000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iaba638f6e46a48be9bcfd94e751a80d0_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDczMTk2Nw_9d3da84d-93f1-491f-b793-26e2af7cb4d1"
      unitRef="usd">34000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="if7e8ac65eea64557801e653b724c7e05_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDcwMzEwMQ_73d58968-64a6-4269-8ff7-f6c4bf7c36fd"
      unitRef="usd">310000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i40a1d1ff2c634d9f894ff1faed74cab9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDcwMzEwNQ_58b146ca-375f-46f6-bd02-65492693f785"
      unitRef="usd">320000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="ibd41af04654b404a9739658b0498956b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDcwMzEwOQ_ae5a0318-faf0-4025-b0fc-3f7aebaf7786"
      unitRef="usd">288000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringCharges
      contextRef="i7dcd5be0a9224164b3b9c477afe71a48_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDcyNDIxNQ_b26dbe73-b89e-46d6-b419-3d131aa402c0"
      unitRef="usd">17000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if5111ebf6d6d4aa8b255575260d32886_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDcyNDIyNA_d48122df-6e4a-4628-b2c3-3b1461d83582"
      unitRef="usd">53000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia582bee9ce874e8bb235617714cf6227_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDczMjIzOQ_9b4edd3f-cf4f-4e06-9e76-783fb96f9d87"
      unitRef="usd">20000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="icd022885b12e488c84b28eedee6a78ba_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDczMjI0OA_36991e99-0df9-4fc3-93fe-82e63f161406"
      unitRef="usd">59000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i4e8de5e2935b4c3496531d27f8e5fb9d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDcwMzIwMQ_2716b3ae-ace3-4803-acbe-6f438f659f26"
      unitRef="usd">100000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i60745e30425f4f529e698ec37e36d916_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMzg0ODI5MDcwMzIwNQ_60ddbef6-84de-4465-bbcc-4ba9eb0b9d3c"
      unitRef="usd">120000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringCharges
      contextRef="i0cf4b0b9a9c540999eb1517cab23e300_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMjc2MQ_caf62305-de50-4b57-ad20-fb37bdc409af"
      unitRef="usd">9000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic2223aea755c43138b22205b7dce1033_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMjc2OA_135aa197-7f45-4472-9350-ab471659089a"
      unitRef="usd">50000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfNTgzNw_d99e6391-26f6-4d13-9ac5-3e256d909ca0">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges during the three and nine months ended December 31, 2020 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#x2019;s corporate headquarters described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily consist of project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#x2019;s corporate headquarters described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily consist of project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges during the three and nine months ended December 31, 2019 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.193%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents exit costs associated with a disposition and costs related to the relocation of the Company&#x2019;s corporate headquarters described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts described above. Additionally, includes costs associated with a growth initiative, substantially completed in the year ended March 31, 2020, which included a reduction in workforce and facility consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.193%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents exit costs associated with a disposition and costs related to the relocation of the Company&#x2019;s corporate headquarters described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#x2019;s corporate headquarters described above. Additionally, includes costs associated with a growth initiative, substantially completed in the year ended March 31, 2020, which included a reduction in workforce and facility consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="if54fe59c7ab4486da50c3e383e0514cb_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMi0xLTEtMS0w_d6954091-fb6a-47f3-b770-81986645096d"
      unitRef="usd">3000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ifc7a74b6b95d4a9e9c701380f77e3b51_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMi0zLTEtMS0w_2aaa0cf1-1287-4f2b-9f7e-e35637944abf"
      unitRef="usd">2000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="id80f00bff7b5467b812041c7200a62b2_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMi01LTEtMS0w_fa7579f9-8d30-4525-aa57-e8db6d7e50f3"
      unitRef="usd">-3000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="iee23f0fe86e64c7bae441a8ea5cc1c91_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMi03LTEtMS0w_e32212c7-57a7-440c-a2cb-8ee7d2ea8584"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i499179d5d599419b93690bc3104dd04a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMi05LTEtMS0w_7f03d915-97b7-43b3-aa44-c6007f89b84e"
      unitRef="usd">7000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMi0xMS0xLTEtMA_6284ecf9-1805-4f8d-9ea0-f62be0af43ca"
      unitRef="usd">9000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="if54fe59c7ab4486da50c3e383e0514cb_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMy0xLTEtMS0w_76e9bc8b-cb9c-45a7-9ba8-fb132245c6a4"
      unitRef="usd">3000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ifc7a74b6b95d4a9e9c701380f77e3b51_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMy0zLTEtMS0w_402d5a34-53e4-4423-924b-b1f83ed27fb6"
      unitRef="usd">5000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="id80f00bff7b5467b812041c7200a62b2_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMy01LTEtMS0w_c2869d61-b0ff-413b-b1fb-069aa21a8be1"
      unitRef="usd">1000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="iee23f0fe86e64c7bae441a8ea5cc1c91_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMy03LTEtMS0w_fd204cb9-8bb9-45cc-b58d-d6cf10e05bb5"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i499179d5d599419b93690bc3104dd04a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMy05LTEtMS0w_9c168fba-1b0e-40a9-84b0-d3bc4c0be43f"
      unitRef="usd">6000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfMy0xMS0xLTEtMA_5de76d56-5e28-45df-931e-8abefda0f38d"
      unitRef="usd">15000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="if54fe59c7ab4486da50c3e383e0514cb_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNC0xLTEtMS0w_fb53b5e5-7c9c-4abc-abe5-2b038fd9a18c"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ifc7a74b6b95d4a9e9c701380f77e3b51_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNC0zLTEtMS0w_677989f5-2983-4a3d-8b00-c92ae48f2dc8"
      unitRef="usd">9000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="id80f00bff7b5467b812041c7200a62b2_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNC01LTEtMS0w_b9f7a427-80da-4dda-88d4-589fe018b8e8"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="iee23f0fe86e64c7bae441a8ea5cc1c91_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNC03LTEtMS0w_cd1924e9-4914-43e5-adec-0347f493fdf5"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i499179d5d599419b93690bc3104dd04a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNC05LTEtMS0w_fce9b152-8fee-4062-a7a6-18d4ed675a4f"
      unitRef="usd">7000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNC0xMS0xLTEtMA_a07e077b-52ef-43c5-abd7-f08b54c60f4a"
      unitRef="usd">16000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="if54fe59c7ab4486da50c3e383e0514cb_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNS0xLTEtMS0w_d41ab884-f810-4bce-b1d4-f3d45e3021f4"
      unitRef="usd">6000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ifc7a74b6b95d4a9e9c701380f77e3b51_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNS0zLTEtMS0w_805f2239-8c33-4a10-978c-2a23ad8633f7"
      unitRef="usd">16000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id80f00bff7b5467b812041c7200a62b2_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNS01LTEtMS0w_09da208c-6869-419c-acfc-4bb22db8bb99"
      unitRef="usd">-2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iee23f0fe86e64c7bae441a8ea5cc1c91_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNS03LTEtMS0w_670db83f-071f-4965-b235-f12f8a0f1dc2"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i499179d5d599419b93690bc3104dd04a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNS05LTEtMS0w_94069cd3-676d-4131-bf17-ee907e791e59"
      unitRef="usd">20000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjJkODhlMGY3MjAwNzQ4Mzk5OWQyN2EzODQzOGI1Yjk1L3RhYmxlcmFuZ2U6MmQ4OGUwZjcyMDA3NDgzOTk5ZDI3YTM4NDM4YjViOTVfNS0xMS0xLTEtMA_4b18eeb9-8a76-4dcf-b342-282125f418e8"
      unitRef="usd">40000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMi0xLTEtMS0w_a240db9a-1c99-4815-b45f-73164ebffe3f"
      unitRef="usd">10000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMi0zLTEtMS0w_d722d895-ad99-449e-b96a-c17fe6a8dd49"
      unitRef="usd">22000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMi01LTEtMS0w_4004b8ba-ad65-479e-ac36-1a6f2d24bd6f"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMi03LTEtMS0w_f3b1e3a6-0954-4997-9298-cc9166445abc"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMi05LTEtMS0w_3e7bc6f6-5c85-42fc-921a-9e930451d1ab"
      unitRef="usd">31000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMi0xMS0xLTEtMA_53edab48-9f87-4c88-86ff-9ce4c267804a"
      unitRef="usd">63000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMy0xLTEtMS0w_b1a3e6d0-5806-4185-8201-77d2f95e7027"
      unitRef="usd">8000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMy0zLTEtMS0w_ba52ad24-ecfa-4a57-a73b-df84d9766f7a"
      unitRef="usd">12000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMy01LTEtMS0w_35e23a73-4b23-4ab6-8d3c-27220c20d5d7"
      unitRef="usd">3000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMy03LTEtMS0w_b4290713-6ed0-41f0-8c42-15b18dc68f05"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMy05LTEtMS0w_2e95b740-d7c1-47ed-b31d-cc8959354b43"
      unitRef="usd">20000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfMy0xMS0xLTEtMA_27150825-1407-4a0d-bb50-cd59605be990"
      unitRef="usd">43000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNC0xLTEtMS0w_45cd54f0-08a6-43f8-ba41-178ab24b8d36"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNC0zLTEtMS0w_a088d70a-5bcf-4fc8-8ba0-528f76dd279d"
      unitRef="usd">40000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNC01LTEtMS0w_b7e58ce2-1cf8-48fb-95e8-c2589a25f9f7"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNC03LTEtMS0w_a0aa29da-1cce-40d8-a2d4-d5f91444310d"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNC05LTEtMS0w_5800ed4d-f31c-4e5d-931f-0e7c9379ff17"
      unitRef="usd">9000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNC0xMS0xLTEtMA_331ce0ab-b3a3-470d-a635-00af20d6a478"
      unitRef="usd">50000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNS0xLTEtMS0w_9b81aae9-d2f4-4281-a094-87d8f8ea1999"
      unitRef="usd">18000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNS0zLTEtMS0w_de52ded8-f968-4dc5-a1cf-230d53aa8e06"
      unitRef="usd">74000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNS01LTEtMS0w_11f195e9-d86f-42e5-b5cd-78b27cee20ef"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNS03LTEtMS0w_9eaabd19-bc46-4c0d-ae1f-c989f0dced56"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNS05LTEtMS0w_44893fd6-cdcb-4d14-9ec5-17d4b9bd6bb5"
      unitRef="usd">60000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjY0NzYwNGJkNzkxNzQ5ZmNiYjcyYjI0MzA3ZmIyNzg0L3RhYmxlcmFuZ2U6NjQ3NjA0YmQ3OTE3NDlmY2JiNzJiMjQzMDdmYjI3ODRfNS0xMS0xLTEtMA_1df32a61-dab9-4b83-ac20-5a0c4af777aa"
      unitRef="usd">156000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="ic713f1d7bbaa46368d505facade21e5e_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMi0xLTEtMS0w_9fb31436-7b2f-4e03-884d-c6b5ff66c7a3"
      unitRef="usd">7000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ib36209733adf465ab9a09ed10cfc40ba_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMi0zLTEtMS0w_58f92d6a-f562-4cce-9663-9f092a4c7565"
      unitRef="usd">1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ief6c871b558e47b38754e0ea56f455a3_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMi01LTEtMS0w_ab86178c-0bb7-47e2-be0c-16046b381014"
      unitRef="usd">1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i5f91b4dd9d724e81a9d50e837b7e65d6_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMi03LTEtMS0w_ea1b94ab-38c3-4944-ab2a-2bace3c25f94"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ib74da540dfec4334b95c1028aad4aabb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMi05LTEtMS0w_105dd2e6-c283-4cfb-b86b-0ff5cf373289"
      unitRef="usd">7000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMi0xMS0xLTEtMA_2f8abc9c-64c6-4a2a-bcdf-35fbe39af20e"
      unitRef="usd">16000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ic713f1d7bbaa46368d505facade21e5e_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMy0xLTEtMS0w_d1da2860-e2d8-496a-8a0e-b60f9c636dc9"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ib36209733adf465ab9a09ed10cfc40ba_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMy0zLTEtMS0w_d5667697-3e84-4a05-8768-084dca68570f"
      unitRef="usd">3000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ief6c871b558e47b38754e0ea56f455a3_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMy01LTEtMS0w_6a828c06-d4ac-4117-84da-2c4d3ce47bff"
      unitRef="usd">5000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i5f91b4dd9d724e81a9d50e837b7e65d6_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMy03LTEtMS0w_1467e9be-799b-4b93-8d4c-2ad8643093ac"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ib74da540dfec4334b95c1028aad4aabb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMy05LTEtMS0w_39e75418-6c8e-4aaf-8a3c-a5e5f9710c3b"
      unitRef="usd">13000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfMy0xMS0xLTEtMA_fdc1ba42-d600-402d-b5c7-c90ea8ba0a18"
      unitRef="usd">21000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ic713f1d7bbaa46368d505facade21e5e_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNC0xLTEtMS0w_b9d07a90-be1d-45cf-9c66-935c935f8e91"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ib36209733adf465ab9a09ed10cfc40ba_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNC0zLTEtMS0w_e045ade9-2137-4f44-bcce-129b7714b889"
      unitRef="usd">2000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ief6c871b558e47b38754e0ea56f455a3_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNC01LTEtMS0w_4ea5979e-3548-4c44-a343-41df26068489"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i5f91b4dd9d724e81a9d50e837b7e65d6_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNC03LTEtMS0w_e1acf4ba-f7ea-4592-9314-68cda5ae1b38"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ib74da540dfec4334b95c1028aad4aabb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNC05LTEtMS0w_c2a4c5c6-842e-4178-9a0d-da914665bf0d"
      unitRef="usd">3000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNC0xMS0xLTEtMA_5750a0a1-a146-4d62-a660-0ab8a20ed6c3"
      unitRef="usd">5000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="ic713f1d7bbaa46368d505facade21e5e_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNS0xLTEtMS0w_b4d3e7d7-cfaa-4f73-a3a8-cdbb5487d0ec"
      unitRef="usd">7000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib36209733adf465ab9a09ed10cfc40ba_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNS0zLTEtMS0w_27140b1c-e2e1-4203-a4b9-351414c5d2e8"
      unitRef="usd">6000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ief6c871b558e47b38754e0ea56f455a3_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNS01LTEtMS0w_5c0b57b7-b89f-47b1-8213-4baf3dc9caf2"
      unitRef="usd">6000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5f91b4dd9d724e81a9d50e837b7e65d6_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNS03LTEtMS0w_83880986-f407-424e-80b6-50f3238a6b6b"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib74da540dfec4334b95c1028aad4aabb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNS05LTEtMS0w_05b5bf81-79f4-40c7-8cce-48d92e73c312"
      unitRef="usd">23000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOmZjNzEzZGQzN2YyYTQ5ODU5MGNiN2UwYmRmNGYyZjRhL3RhYmxlcmFuZ2U6ZmM3MTNkZDM3ZjJhNDk4NTkwY2I3ZTBiZGY0ZjJmNGFfNS0xMS0xLTEtMA_7854908a-d95b-416b-80a9-4537d648f03d"
      unitRef="usd">42000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="ia76b1ab18790411e9e7fdeb98f2f4606_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMi0xLTEtMS0w_34f7c404-94e2-4746-bd8a-d55f19c358fb"
      unitRef="usd">9000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i55e8174fad24466896ea35fa3e18419c_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMi0zLTEtMS0w_ee4988da-6e36-45ae-97b5-59aa6710a3b5"
      unitRef="usd">5000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ifafa9479474c4281a1fb299fa0ed48b3_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMi01LTEtMS0w_f6bba208-1b7b-49fd-9048-2ec8140faa9d"
      unitRef="usd">2000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i33926b73aa0043d2989ae3b788c16046_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMi03LTEtMS0w_3cad037a-6697-4e09-a04a-8bc0c5e325df"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ib06a1c55db15496e8c44849e29aea6c6_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMi05LTEtMS0w_83d2ed0f-f2f7-4469-a464-d5c0b65fe6db"
      unitRef="usd">23000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMi0xMS0xLTEtMA_4f40f04c-5a4e-41b0-93fd-49179e81787e"
      unitRef="usd">39000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ia76b1ab18790411e9e7fdeb98f2f4606_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMy0xLTEtMS0w_d61f3cfa-ffc6-4f21-96af-2bf749553b60"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i55e8174fad24466896ea35fa3e18419c_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMy0zLTEtMS0w_5659f28e-a876-4b87-974b-26d3dbc9c88d"
      unitRef="usd">9000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ifafa9479474c4281a1fb299fa0ed48b3_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMy01LTEtMS0w_1d54d8ea-67d5-41c7-8ed1-bf8e6464577d"
      unitRef="usd">9000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i33926b73aa0043d2989ae3b788c16046_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMy03LTEtMS0w_131a31ca-8134-4cea-9e0e-9839d061dc20"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ib06a1c55db15496e8c44849e29aea6c6_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMy05LTEtMS0w_159f118a-e0f5-4c62-8476-d34ebe8f5459"
      unitRef="usd">36000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfMy0xMS0xLTEtMA_f4e7ee60-caf3-4b58-b708-11ee1baa803f"
      unitRef="usd">54000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ia76b1ab18790411e9e7fdeb98f2f4606_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNC0xLTEtMS0w_0d3d482f-50e7-414e-abfc-3f607819f8d1"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i55e8174fad24466896ea35fa3e18419c_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNC0zLTEtMS0w_217b9c48-3856-46a1-ad22-d5be2caa8cd2"
      unitRef="usd">8000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ifafa9479474c4281a1fb299fa0ed48b3_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNC01LTEtMS0w_ac291fd1-8040-4988-b9e9-9fd763d4bc30"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i33926b73aa0043d2989ae3b788c16046_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNC03LTEtMS0w_eafafca9-0a46-4fcd-aabe-e398793555b5"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ib06a1c55db15496e8c44849e29aea6c6_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNC05LTEtMS0w_551dc3b7-f4ae-4bf2-84b4-17378c9d08ad"
      unitRef="usd">8000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNC0xMS0xLTEtMA_899212b8-416f-4ad9-be28-679fb5297510"
      unitRef="usd">17000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="ia76b1ab18790411e9e7fdeb98f2f4606_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNS0xLTEtMS0w_bc854a4e-052b-4483-a7a0-2ed05c8467c1"
      unitRef="usd">9000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i55e8174fad24466896ea35fa3e18419c_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNS0zLTEtMS0w_60886531-404c-4e7b-a8c8-c48521eabd8b"
      unitRef="usd">22000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ifafa9479474c4281a1fb299fa0ed48b3_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNS01LTEtMS0w_89c09da3-3806-4912-8b33-c754b42ae02b"
      unitRef="usd">12000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i33926b73aa0043d2989ae3b788c16046_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNS03LTEtMS0w_d4e0cd29-d779-4504-818e-239e51a25865"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib06a1c55db15496e8c44849e29aea6c6_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNS05LTEtMS0w_1a8fce6a-cd31-4095-9a7a-ab9225a97f49"
      unitRef="usd">67000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjA4MDRlMTZhOWI3MjRiOGU4OGVkZmRmNzAwNjA4OTg5L3RhYmxlcmFuZ2U6MDgwNGUxNmE5YjcyNGI4ZTg4ZWRmZGY3MDA2MDg5ODlfNS0xMS0xLTEtMA_6e545b20-9fac-401c-8b01-66f3ac656fea"
      unitRef="usd">110000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfNTg0Ng_5556c572-3904-4512-8216-44b39b3343b5">&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the restructuring liabilities associated with the Company&#x2019;s restructuring initiatives for the nine months ended December 31, 2020: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of March 31, 2020, the total reserve balance was $157 million, of which $118 million was recorded in Other accrued liabilities and $39 million was recorded in Other non-current liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of December 31, 2020, the total reserve balance was $132 million, of which $101 million was recorded in Other accrued liabilities and $31 million was recorded in Other non-current liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i23356c66de0b48bfa4370bb815d51010_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMS0xLTEtMS0w_03ee3093-b359-4a0f-989c-4b8a7024ec63"
      unitRef="usd">29000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ib632ae517264462ea49f0e14b37abe4d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMS0zLTEtMS0w_f7c739e2-3dab-4961-9c62-746d3b67ebc4"
      unitRef="usd">66000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ic60a002dcc044ef2a73c71e490891614_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMS01LTEtMS0w_0a2f7ac7-208c-450b-a8ac-c154520c3c42"
      unitRef="usd">22000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ifce4292925d84d7bb62d6111b21c8e27_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMS03LTEtMS0w_702ffca0-4a87-4ad2-9684-f6952e22e399"
      unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i877beefd260c4117b551163018536ff7_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMS05LTEtMS0w_55676d78-a804-427e-98e7-74a0c039ebcb"
      unitRef="usd">39000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMS0xMS0xLTEtMA_5a3574ba-98cf-4823-a178-10e96bb4a4ea"
      unitRef="usd">157000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMi0xLTEtMS0w_9dc6ab05-7d19-4aaf-ae93-c5b0fb896e29"
      unitRef="usd">18000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMi0zLTEtMS0w_f75e94e5-1747-45ac-9ffb-6f45ad4a55c9"
      unitRef="usd">74000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMi01LTEtMS0w_7aa764ca-ccfe-4e74-afe2-1d381c4dc98b"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMi03LTEtMS0w_0dc6cce0-be12-47cd-8719-232ae2c39108"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMi05LTEtMS0w_60188f71-906a-4a5c-9303-84182a882179"
      unitRef="usd">60000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMi0xMS0xLTEtMA_b3bb591d-78cb-4f89-84a5-03da7fbd2fe4"
      unitRef="usd">156000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMy0xLTEtMS0w_36629507-9fe6-499d-97ea-3f4d70e3ccd7"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMy0zLTEtMS0w_a3f3ab21-1f2c-4e5b-89c7-3c68aa9b504f"
      unitRef="usd">40000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMy01LTEtMS0w_94a4991d-b210-49c2-8c84-ea5f636d8c72"
      unitRef="usd">1000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMy03LTEtMS0w_2597b158-17b9-463c-87c8-21de16de5160"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMy05LTEtMS0w_9e3816bb-5d97-4f82-9291-c06f9f627a8e"
      unitRef="usd">9000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfMy0xMS0xLTEtMA_e715f54f-9837-448f-b565-e7bf0fb8f4df"
      unitRef="usd">50000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring
      contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNC0xLTEtMS0w_ec587641-0ce9-46e4-b03f-b4ea42902bbe"
      unitRef="usd">24000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNC0zLTEtMS0w_0466ee6e-991c-4721-9e02-a2101e717bc2"
      unitRef="usd">24000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNC01LTEtMS0w_43975ec9-3852-49f3-9f71-e6b7e1e1ee25"
      unitRef="usd">19000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNC03LTEtMS0w_d37ebcc7-090e-4f8b-afd3-98d7796004c3"
      unitRef="usd">1000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNC05LTEtMS0w_2d9ad094-07db-4a1c-af4b-613ebdf9d05a"
      unitRef="usd">64000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNC0xMS0xLTEtMA_82db6cf7-d6ac-4a0e-bbe2-4b06cbb73fda"
      unitRef="usd">132000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNS0xLTEtMS0w_52cce12d-3ad7-40bf-8df8-f9d061ac7a70"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNS0zLTEtMS0w_92c276fa-12d2-417c-8b1b-82a2e6d25f4c"
      unitRef="usd">-1000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNS01LTEtMS0w_874a6509-2605-47d1-ab97-d21078a38682"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNS03LTEtMS0w_db58a4ed-80a2-4ef3-bbdc-ddece297c6b4"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNS05LTEtMS0w_acb67465-bdef-4200-ab95-312f2b94e6a5"
      unitRef="usd">2000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNS0xMS0xLTEtMA_527d97b0-085b-457b-b0f6-90f179f457af"
      unitRef="usd">1000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="ifad220b5d8ba4d42a4c7b10bf33c3d2c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNi0xLTEtMS0w_dad90133-fdd4-4376-b5f4-2b9ac7790851"
      unitRef="usd">23000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i65219f93663148a283a10dfe499597e9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNi0zLTEtMS0w_fab0552b-ef87-4613-a83a-4271f344748e"
      unitRef="usd">75000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i3beceef97ffc465bb547b319a855c1fd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNi01LTEtMS0w_1c1c2d43-e7f0-41a5-a6dc-6ace2bf26ecb"
      unitRef="usd">6000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i4bb04a8ba65947f39b3457cfdc48939a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNi03LTEtMS0w_9d493835-aee0-47ec-8c46-3a8c0964979f"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i4f647fda026d4fd8ab82de9ade2df506_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNi05LTEtMS0w_50ed2902-a430-4b65-9e54-ba3853d38011"
      unitRef="usd">28000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RhYmxlOjI2NmNmNzcyNjU3MzRkZmI4YmIwMzBjYWU4NjQyMGRhL3RhYmxlcmFuZ2U6MjY2Y2Y3NzI2NTczNGRmYjhiYjAzMGNhZTg2NDIwZGFfNi0xMS0xLTEtMA_289881b8-d612-421c-8033-94fa0a9ce3e5"
      unitRef="usd">132000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfNTY1OA_297654f8-95b8-4380-9e8d-bb3cc74591c3"
      unitRef="usd">157000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i001894ef5d384e6194e9a49a8e30453a_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfNTY3MQ_b1349ff3-8b47-4a37-80ff-8b45e3b19eae"
      unitRef="usd">118000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ie1d41963e1e64af4a2db91749e48ba60_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfNTY5Nw_e36dccfc-ffdf-4ed6-9fc1-4d076160851a"
      unitRef="usd">39000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfNTc3Nw_6b7277a6-8f4e-43ce-ab4d-acecfe34fe40"
      unitRef="usd">132000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9ae50b9f9854471da2e71204c4eedcb1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfNTc5MA_f2cfd90d-c49e-4509-aa3d-9f24e9a747ee"
      unitRef="usd">101000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i4ab08a4977fc44d4908e07229d064f40_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfNTgxNg_25871e6e-dfcb-451f-9c2d-3900c615df6c"
      unitRef="usd">31000000</us-gaap:RestructuringReserve>
    <us-gaap:AssetImpairmentCharges
      contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMjE5OTAyMzI4MTkzNg_2eac6b27-072f-4a3e-9c14-3eca0f3ea5fc"
      unitRef="usd">115000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i4e166dc2bc4e4407ac307367798e7a56_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMjE5OTAyMzI4MTkzNg_81885a80-fb34-4c78-81cf-5e38bec59f5c"
      unitRef="usd">115000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i8f352c2923e048e7bcd08e46042cbead_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMjc0ODc3OTA5ODA3Mw_5520f915-90ad-4a67-b0df-27d95f906a74"
      unitRef="usd">94000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i08ed9c0c5f6d4a748a507235f5b297eb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF80OS9mcmFnOjBmN2JiZWRiNjk5YzRmYTc5MzlkYmNjMjQyNWUwZDdhL3RleHRyZWdpb246MGY3YmJlZGI2OTljNGZhNzkzOWRiY2MyNDI1ZTBkN2FfMjc0ODc3OTA5ODA3Mw_5720ffe0-1c23-487e-9b37-3b789233a625"
      unitRef="usd">94000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjczMA_855fb525-86b5-42d5-972d-0f4366ae8798">Income Taxes During the three months ended December 31, 2020 and 2019, the Company recorded an income tax benefit of $1.2 billion and income tax expense of $47 million, respectively. During the nine months ended December 31, 2020 and 2019, the Company recorded an income tax benefit of $1.0 billion and $111 million, respectively. The Company reported an income tax benefit rate of 16.1% and an income tax expense rate of 16.0% for the three months ended December 31, 2020 and 2019, respectively, and income tax benefit rates of 16.7% and 194.7% for the nine months ended December 31, 2020 and 2019, respectively. Fluctuations in the Company&#x2019;s reported income tax rates are primarily due to changes within the mix of earnings between various taxing jurisdictions, discrete items recognized in the quarters, including the impact of an intercompany sale of intellectual property during the nine months ended December 31, 2020, and impairment to the Company&#x2019;s investment in the Change Healthcare JV, decreasing pre-tax income, for the nine months ended December 31, 2019. The charge for opioid-related claims of $8.1 billion ($6.7 billion after-tax), as described further in Financial Note 13, &#x201c;Commitments and Contingent Liabilities,&#x201d; unfavorably impacted the Company&#x2019;s reported income tax benefit rates for the three and nine months ended December 31, 2020. Income tax benefit (expense) for the three and nine months ended December 31, 2019 included a discrete tax benefit of $24 million recognized in connection with a planned divestiture in the Medical-Surgical Solutions segment and $21 million recognized in connection with an agreement executed in December 2019 to settle all opioid-related claims filed by two Ohio counties.&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2021, the Company sold intellectual property between wholly-owned legal entities within McKesson that are based in different tax jurisdictions. The transferor entity recognized a gain on the sale of assets which was not subject to income tax in its local jurisdiction; such gain was eliminated upon consolidation. The acquiring entity of the intellectual property is entitled to amortize the purchase price of the assets for tax purposes. In accordance with ASU 2016-16, &#x201c;Intra-Entity Transfers of Assets Other Than Inventory,&#x201d; a discrete tax benefit of $105 million was recognized for the nine months ended December 31, 2020 with a corresponding increase to a deferred tax asset for the temporary difference arising from the buyer&#x2019;s excess tax basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended December 31, 2019, no tax benefit was recognized for the pre-tax impairment charge of $282 million for the remeasurement of assets and liabilities held for sale to fair value related to the formation of a new German pharmaceutical wholesale joint venture within the Company&#x2019;s International segment. Refer to Financial Note 3, &#x201c;Held for Sale,&#x201d; for more information on this transaction which closed on November 1, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, the Company had $1.5 billion of unrecognized tax benefits, of which $1.4 billion would reduce income tax expense and the effective tax rate if recognized. The increase of $497 million during the three months ended December 31, 2020 in unrecognized tax benefit is mainly due to uncertainty in connection with the deductibility of Opioid related litigation and claims. Because many of the uncertainties associated with any potential settlement arrangements or other resolution of opioid claims, including provisions related to deductibility, have not been finalized, the actual amount of the tax benefit related to uncertain tax positions may differ from these estimates. Refer to Financial Note 13, &#x201c;Commitments and Contingent Liabilities,&#x201d; for more information. During the next twelve months, it is reasonably possible that the Company&#x2019;s unrecognized tax benefits may decrease by as much as $93 million due to settlements of tax examinations and statute of limitations expirations in the U.S. federal and state jurisdictions and in foreign jurisdictions. However, this amount may change as the Company continues to have ongoing negotiations with various taxing authorities throughout the year. The unrecognized tax benefit may also increase or decrease due to future developments in the Opioid related litigation and claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#x201c;IRS&#x201d;) is currently examining the Company&#x2019;s U.S. corporation income tax returns for 2016 through 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2013 through the current fiscal year.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfOTc_c20c1adb-1946-4208-b89b-7f067683d096"
      unitRef="usd">-1200000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMTI5_87222a8b-5b50-4d08-b616-1795909b2350"
      unitRef="usd">47000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjYy_f443e21c-9b06-4f19-ac07-d09ce3adc437"
      unitRef="usd">-1000000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjk0_ab73f726-bd87-418c-b73f-7ba312d42726"
      unitRef="usd">-111000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfNDAy_4b03b6c3-1595-400b-845b-fb626ea1981b"
      unitRef="number">-0.161</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfNDIw_82d212de-b23d-4fa0-afc7-2f6aab19b93f"
      unitRef="number">0.160</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfNDg5_156586ea-c08f-42ed-b151-dd198b46b4e4"
      unitRef="number">-0.167</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfNTA3_0bad5666-a576-4339-8b1a-d3a25f567a0b"
      unitRef="number">-1.947</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i7ac4183cf22d4c829d4a7bc371cc268c_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfODI0NjMzNzIxODE3Mw_dcac3458-4279-4dfe-9a7f-1fca14a1a501"
      unitRef="usd">8100000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i30c6a601291c426daef2c98a6924abf6_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfODI0NjMzNzIxODE3Mw_e9adc7c3-ed49-4c00-92cc-42ef2aa25053"
      unitRef="usd">8100000000</us-gaap:LossContingencyAccrualProvision>
    <mck:LossContingencyAccrualProvisionNetOfTax
      contextRef="i7ac4183cf22d4c829d4a7bc371cc268c_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfODI0NjMzNzIxODE3OA_05bac1f2-f26a-4d94-bd1f-00678e229869"
      unitRef="usd">6700000000</mck:LossContingencyAccrualProvisionNetOfTax>
    <mck:LossContingencyAccrualProvisionNetOfTax
      contextRef="i30c6a601291c426daef2c98a6924abf6_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfODI0NjMzNzIxODE3OA_4a2bd069-22f8-476e-96ad-73aeb42bae7e"
      unitRef="usd">6700000000</mck:LossContingencyAccrualProvisionNetOfTax>
    <mck:IncomeTaxExpenseBenefitDiscreteItems
      contextRef="id2503fe9d11b43b3b558877f874ef3c7_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjE5OTAyMzI2MDAyNA_971470c0-70cd-4992-9bfd-8e7b1fc6c593"
      unitRef="usd">-24000000</mck:IncomeTaxExpenseBenefitDiscreteItems>
    <mck:IncomeTaxExpenseBenefitDiscreteItems
      contextRef="iea7615b447b24e05ba7119aa98301bad_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjE5OTAyMzI2MDAyNA_d02a0a9f-61ba-46db-88aa-962e02399e8c"
      unitRef="usd">-24000000</mck:IncomeTaxExpenseBenefitDiscreteItems>
    <mck:IncomeTaxExpenseBenefitDiscreteItems
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjE5OTAyMzI2MDA0Nw_08b06498-c31b-480e-a754-3d59e32f7e52"
      unitRef="usd">-21000000</mck:IncomeTaxExpenseBenefitDiscreteItems>
    <mck:IncomeTaxExpenseBenefitDiscreteItems
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjE5OTAyMzI2MDA0Nw_4ec1fb6d-f118-426b-bf9e-9150193325d0"
      unitRef="usd">-21000000</mck:IncomeTaxExpenseBenefitDiscreteItems>
    <mck:LossContingencyNumberofCounties
      contextRef="ia65b1cdade72453c9c9547d6ed17b3e9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfOTM0NTg0ODg0MDYwMQ_0f1fe092-4718-4c21-bfe4-d919228495a4"
      unitRef="county">2</mck:LossContingencyNumberofCounties>
    <mck:IncomeTaxExpenseBenefitDiscreteItems
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMTQ0OQ_7d6d29df-ceb2-42fc-9ca2-9393dc4bf7ba"
      unitRef="usd">-105000000</mck:IncomeTaxExpenseBenefitDiscreteItems>
    <mck:IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMTQ0OQ_b2315211-d338-4834-8f5b-6edf818472e9"
      unitRef="usd">105000000</mck:IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory>
    <mck:IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfOTM0NTg0ODgzOTYwNA_51071a41-95ed-40fb-a57d-5cdd62c146f5"
      unitRef="usd">0</mck:IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue>
    <mck:IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfOTM0NTg0ODgzOTYwNA_686e33ef-3098-4603-9e69-119c9cfd1fc0"
      unitRef="usd">0</mck:IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue>
    <us-gaap:ImpairmentChargeOnReclassifiedAssets
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMzg0ODI5MDcwMDIyOQ_2933554b-8702-49c7-a9a3-033ce9e3d122"
      unitRef="usd">282000000</us-gaap:ImpairmentChargeOnReclassifiedAssets>
    <us-gaap:ImpairmentChargeOnReclassifiedAssets
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMzg0ODI5MDcwMDIyOQ_a528c512-4b2c-4d14-8df9-de891cbedace"
      unitRef="usd">282000000</us-gaap:ImpairmentChargeOnReclassifiedAssets>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjc0ODc3OTA3NzYzMw_8a905995-6055-4a9f-b535-f2ab2203b468"
      unitRef="usd">1500000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjc0ODc3OTA3NzY1MQ_8bcb306c-5c05-42fc-9dfc-b705c43329d7"
      unitRef="usd">1400000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjc0ODc3OTA3NzY1OQ_50955440-4ec1-43d3-87ef-c94df2f871f8"
      unitRef="usd">497000000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81Mi9mcmFnOjUyNzkxMjljY2QxNTQ3OTk5ZGM0NjkwZGU1YmYyYTNlL3RleHRyZWdpb246NTI3OTEyOWNjZDE1NDc5OTlkYzQ2OTBkZTViZjJhM2VfMjc0ODc3OTA3NzczOQ_a23489f5-80ca-4031-a2cc-bde8a0dde33b"
      unitRef="usd">93000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMzM3Ng_f89fb045-6a07-4f57-b4e6-c2c3c7e90fe4">Redeemable Noncontrolling Interests and Noncontrolling Interests&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s redeemable noncontrolling interests primarily relate to its consolidated subsidiary, McKesson Europe AG (&#x201c;McKesson Europe&#x201d;). Under the December 2014 domination and profit and loss transfer agreement (the &#x201c;Domination Agreement&#x201d;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#x20ac;0.83 per share. As a result, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $11 million and $32 million during the three and nine months ended December 31, 2020, respectively, and $11 million and $33 million during the three and nine months ended December 31, 2019, respectively. All amounts were recorded in Net income attributable to noncontrolling interests in the Company&#x2019;s Condensed Consolidated Statements of Operations and the corresponding liability balance was recorded in Other accrued liabilities in the Company&#x2019;s Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe have a right to put (&#x201c;Put Right&#x201d;) their noncontrolling shares at &#x20ac;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#x201c;Put Amount&#x201d;). The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests. During the nine months ended December 31, 2020, the Company paid $49 million to purchase 1.8&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $49 million, and the associated effect of the increase in the Company&#x2019;s ownership interest on its equity of $3 million was recorded as a net increase to McKesson&#x2019;s stockholders paid-in capital during 2021. During the three months ended December 31, 2020, and the three and nine months ended December 31, 2019, there were no material exercises of the Put Right. The balance of the associated liability for Redeemable noncontrolling interests is reported as the greater of its carrying value or its maximum redemption value at each reporting date. The redemption value is the Put Amount adjusted for exchange rate fluctuations each period. The Redeemable noncontrolling interest is also adjusted each period for the proportion of other comprehensive income, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders. At December 31, 2020, the carrying value of redeemable noncontrolling interests of $1.3&#160;billion approximated the maximum redemption value of $1.3 billion, and at March 31, 2020, the carrying value of $1.4&#160;billion exceeded the maximum redemption value of $1.2 billion. At December 31, 2020 and March 31, 2020, the Company owned approximately 78% and 77%, respectively, of McKesson Europe&#x2019;s outstanding common shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent third-party equity interests in the Company&#x2019;s consolidated entities primarily related to ClarusONE Sourcing Services LLP, Vantage Oncology Holdings, LLC, and McKesson Europe, which were $200 million and $217 million at December 31, 2020 and March 31, 2020, respectively, in the Company&#x2019;s Condensed Consolidated Balance Sheets. The Company allocated a total of $41 million and $120 million of net income to noncontrolling interests during the three and nine months ended December 31, 2020, respectively, and $45 million and $130 million during the three and nine months ended December 31, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMzM4Mw_5ddcd829-16ff-4d3c-9936-aeb6d62c536a">Redeemable Noncontrolling Interests and Noncontrolling Interests&lt;div style="margin-bottom:6pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s redeemable noncontrolling interests primarily relate to its consolidated subsidiary, McKesson Europe AG (&#x201c;McKesson Europe&#x201d;). Under the December 2014 domination and profit and loss transfer agreement (the &#x201c;Domination Agreement&#x201d;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#x20ac;0.83 per share. As a result, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $11 million and $32 million during the three and nine months ended December 31, 2020, respectively, and $11 million and $33 million during the three and nine months ended December 31, 2019, respectively. All amounts were recorded in Net income attributable to noncontrolling interests in the Company&#x2019;s Condensed Consolidated Statements of Operations and the corresponding liability balance was recorded in Other accrued liabilities in the Company&#x2019;s Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe have a right to put (&#x201c;Put Right&#x201d;) their noncontrolling shares at &#x20ac;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#x201c;Put Amount&#x201d;). The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests. During the nine months ended December 31, 2020, the Company paid $49 million to purchase 1.8&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $49 million, and the associated effect of the increase in the Company&#x2019;s ownership interest on its equity of $3 million was recorded as a net increase to McKesson&#x2019;s stockholders paid-in capital during 2021. During the three months ended December 31, 2020, and the three and nine months ended December 31, 2019, there were no material exercises of the Put Right. The balance of the associated liability for Redeemable noncontrolling interests is reported as the greater of its carrying value or its maximum redemption value at each reporting date. The redemption value is the Put Amount adjusted for exchange rate fluctuations each period. The Redeemable noncontrolling interest is also adjusted each period for the proportion of other comprehensive income, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders. At December 31, 2020, the carrying value of redeemable noncontrolling interests of $1.3&#160;billion approximated the maximum redemption value of $1.3 billion, and at March 31, 2020, the carrying value of $1.4&#160;billion exceeded the maximum redemption value of $1.2 billion. At December 31, 2020 and March 31, 2020, the Company owned approximately 78% and 77%, respectively, of McKesson Europe&#x2019;s outstanding common shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent third-party equity interests in the Company&#x2019;s consolidated entities primarily related to ClarusONE Sourcing Services LLP, Vantage Oncology Holdings, LLC, and McKesson Europe, which were $200 million and $217 million at December 31, 2020 and March 31, 2020, respectively, in the Company&#x2019;s Condensed Consolidated Balance Sheets. The Company allocated a total of $41 million and $120 million of net income to noncontrolling interests during the three and nine months ended December 31, 2020, respectively, and $45 million and $130 million during the three and nine months ended December 31, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
    <mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests
      contextRef="i2c1af7ae051f4acd85bdcfaf6f8522c4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfNDEw_e2a57c79-8ce3-4c38-a3d2-cbef92e29472"
      unitRef="eurPerShare">0.83</mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i626c1e0e782e474b92df366e001d6dd2_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfNTQ5_7471724f-0e86-4aa9-af30-4e2ed51c52e8"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i9a434cdc734d4abf996142dfdc8544ec_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfNTU2_6a1a5dfc-7d8f-404f-bf6c-3c61afd5e4ce"
      unitRef="usd">32000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ib5b1c59088c8425e8c672396cbc8f14f_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfNTky_29b694bd-f50c-45c8-abd3-fa786ef668f3"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i7442088aa6c644dab9cdca71fad61eba_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfNTk5_b5c1c592-1241-45c4-ba02-c57af4a2aca5"
      unitRef="usd">33000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfOTkx_3c191e21-caa5-4f30-859d-3d82ccba1607"
      unitRef="eurPerShare">22.99</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:PutRightValueInterestRateSpread
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMTA1NA_6d8d64db-d1cc-4692-bf90-d8864cb304a2"
      unitRef="number">0.05</mck:PutRightValueInterestRateSpread>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i9a434cdc734d4abf996142dfdc8544ec_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMTQxOQ_34504549-d512-4b6a-8210-d48460bea525"
      unitRef="usd">49000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased
      contextRef="i9a434cdc734d4abf996142dfdc8544ec_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMTQzNA_a9ad44f8-69ff-4b31-b381-c1386e5a2d4e"
      unitRef="shares">1800000</mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="i96e8498baa5c4166b0360154493d4319_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMTYwMw_fef3b712-4f81-489f-8486-8b44ea287f5c"
      unitRef="usd">49000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i2011d00a9d33400ab4105b02fddf648e_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMTcwMg_df1ab7d3-d8e9-4449-a4fa-825f49428494"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="ia893650b8c174d97a0fff05ba6bde046_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMjE5OTAyMzI1OTIzMw_a18d3925-9dfe-4fe4-b748-e0f5b17e74e1"
      unitRef="usd">1300000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue
      contextRef="ia893650b8c174d97a0fff05ba6bde046_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMjE5OTAyMzI1OTM3Mg_d8f8450b-2f06-421d-9ba0-64f1b58fbd47"
      unitRef="usd">1300000000</mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="ib0a2cb17de16467787ff8f495afca17a_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMjQ2OQ_084bf1bf-3daa-42d0-b74e-7005137c5dbc"
      unitRef="usd">1400000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue
      contextRef="ib0a2cb17de16467787ff8f495afca17a_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMjE5OTAyMzI1OTM2Ng_66f19403-ba61-4dd5-ab76-7345df64db60"
      unitRef="usd">1200000000</mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="ia893650b8c174d97a0fff05ba6bde046_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMjU3OA_a2a84dd7-500b-42c5-86a1-4854407d56c5"
      unitRef="number">0.78</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="ib0a2cb17de16467787ff8f495afca17a_I20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMjU4NQ_9e4db841-1dc2-40d2-a48f-aa1225d3d172"
      unitRef="number">0.77</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterest
      contextRef="i10ab863a7218445ca985683b1005b32b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMjg5Nw_a7c8d33d-641d-4d93-8c31-7d865200cbc7"
      unitRef="usd">200000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i4f97e844a5a143218fd2d44d5b013a4e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMjkwNA_4b249df4-35f6-4a51-a48c-f667484cd013"
      unitRef="usd">217000000</us-gaap:MinorityInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0e8778eb76054f0395746e9375d66efe_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMzAyNA_145d3335-5bcb-48ac-bbfc-9d6e42c204d8"
      unitRef="usd">41000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if22a8f70dcc24adc95cac8f86540d584_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMzAzMQ_0dbf4b62-f1f1-4316-aa40-aec0e6f3773f"
      unitRef="usd">120000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i849ff8d4511349eb9c3153967d1f7f12_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMzEwOQ_b91624e7-7b0b-4fb9-9493-08c177afed03"
      unitRef="usd">45000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5a05c352bec44a6fae02dc63bfae55f7_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMzExNg_d263924a-f4fd-41c8-9aa8-ee9351bd7652"
      unitRef="usd">130000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RleHRyZWdpb246MTg2ZmE2MDVlZTY4NGQzOGI2NDJlYTRhOGFhM2E0Y2FfMzM3OA_ee2bc009-80db-4470-a9a9-2b16cf46ce4c">&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock>
    <us-gaap:MinorityInterest
      contextRef="ib03cda0901f74396a9d42a5e93e5f9eb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfMS0yLTEtMS0w_1d825a28-4f89-40ab-bcff-d695f19d9931"
      unitRef="usd">200000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i31fd56c5e498439cbb9f159e3e0e2e0d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfMS00LTEtMS0w_20b631ae-1d3a-47f3-b8bb-868003b1e61c"
      unitRef="usd">1265000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i454504e100134adfada4c6b22b8a933a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfMi0yLTEtMS0w_d47f881f-c624-4797-8d76-a08c1af52ef7"
      unitRef="usd">41000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ied0e473ba615450b86643eccb05bd229_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfMi00LTEtMS0w_9cd23287-0e2c-4589-a87d-5aa6acafa057"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i454504e100134adfada4c6b22b8a933a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfMy0yLTEtMS0w_af96aa51-1a3e-453a-a6e1-476e32e47f1c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ied0e473ba615450b86643eccb05bd229_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfMy00LTEtMS0w_e3f427c1-76e0-4f23-a003-2d5332d12e2f"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="ied0e473ba615450b86643eccb05bd229_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfNC00LTEtMS0w_d1266f8a-d7d2-4c22-9d37-126bf36769e6"
      unitRef="usd">11000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i454504e100134adfada4c6b22b8a933a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfNS0yLTEtMS0w_a3b6e3b2-097c-4e7a-b47b-53b1db85f824"
      unitRef="usd">41000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ied0e473ba615450b86643eccb05bd229_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfNS00LTEtMS0w_4c15b3a4-1916-4f01-a0f9-81a8cd5d6f32"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i454504e100134adfada4c6b22b8a933a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfNy0yLTEtMS0w_ddf44a6c-9a17-48d4-8e61-a863c8ea5784"
      unitRef="usd">0</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="ied0e473ba615450b86643eccb05bd229_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfNy00LTEtMS0w_7f8a2334-ef29-4d0d-ab68-34d4a3fe1cb3"
      unitRef="usd">2000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="i436786cf3fa44a21863b50c1e252c871_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfOC0yLTEtMS0w_ce10be1b-773a-4e9c-8e35-a82cff97b357"
      unitRef="usd">200000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="ie3a8cac6d54b4c2ca9b7378d13ef870b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOmNlNGQ3YjA0YWY2YjQ3OGQ4OGQxNmU5ZGIxMzExNjE1L3RhYmxlcmFuZ2U6Y2U0ZDdiMDRhZjZiNDc4ZDg4ZDE2ZTlkYjEzMTE2MTVfOC00LTEtMS0w_5971cb7d-029e-423d-afe9-00a5a3925a03"
      unitRef="usd">1292000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:MinorityInterest
      contextRef="ie6cbf15310ca46869b7c2a9274df3ebf_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfMS0yLTEtMS0w_ce914db1-ba89-4bf9-838d-e202344251cf"
      unitRef="usd">217000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i4af1d24608d74947ab7497e23209ad59_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfMS00LTEtMS0w_f54d0e8a-7c99-45fd-addc-7c77e2f8cb7c"
      unitRef="usd">1402000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if6429e408d6643fe8ed7a32451d1973a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfMi0yLTEtMS0w_295a768b-8241-4f91-b700-ddadaa79173c"
      unitRef="usd">120000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i96e8498baa5c4166b0360154493d4319_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfMi00LTEtMS0w_296e23af-13f0-4659-9a3f-0623ac326ac7"
      unitRef="usd">32000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="if6429e408d6643fe8ed7a32451d1973a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfMy0yLTEtMS0w_09b8a6f2-6939-4d88-a18a-9ef4483433f2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i96e8498baa5c4166b0360154493d4319_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfMy00LTEtMS0w_efe7f365-b216-4980-a3fc-5b5093239eab"
      unitRef="usd">-65000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i96e8498baa5c4166b0360154493d4319_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfNC00LTEtMS0w_682b074a-1f14-4c2e-a2bd-beb687e5a501"
      unitRef="usd">32000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="if6429e408d6643fe8ed7a32451d1973a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfNS0yLTEtMS0w_1a792eb8-929a-4520-a193-4eea41278427"
      unitRef="usd">134000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i96e8498baa5c4166b0360154493d4319_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfNS00LTEtMS0w_087e8df4-9c8f-437d-b69b-8c6f92af8317"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="i96e8498baa5c4166b0360154493d4319_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfNi00LTEtMS0w_fef3b712-4f81-489f-8486-8b44ea287f5c"
      unitRef="usd">49000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="if6429e408d6643fe8ed7a32451d1973a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfNy0yLTEtMS0w_e92ada89-8e79-44a7-88d9-92270b5ab827"
      unitRef="usd">-3000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i96e8498baa5c4166b0360154493d4319_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfNy00LTEtMS0w_d863b56c-38d2-447d-bc59-5bc8827fe2be"
      unitRef="usd">4000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="i436786cf3fa44a21863b50c1e252c871_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfOC0yLTEtMS0w_1561544f-9a3d-4537-8b1b-23e0ee43ebdd"
      unitRef="usd">200000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="ie3a8cac6d54b4c2ca9b7378d13ef870b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjdmYTI4ZWM5ZDQ3NTQ5NDc4MTdkZWUxM2Q5M2UyYTEyL3RhYmxlcmFuZ2U6N2ZhMjhlYzlkNDc1NDk0NzgxN2RlZTEzZDkzZTJhMTJfOC00LTEtMS0w_9704bae5-ccea-45c5-92db-70c168689490"
      unitRef="usd">1292000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:MinorityInterest
      contextRef="i4fe05a45bd0447499ad4274ebee0e5de_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfMS0yLTEtMS0w_47217942-340b-4d83-b133-9f0655ee7751"
      unitRef="usd">210000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i0c62b22aacf74756b7dfff6157966085_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfMS00LTEtMS0w_d0e78aed-c1e3-4086-a7bf-0bad22fb94bf"
      unitRef="usd">1384000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i2d696af4cf5445b28748e6c09ac7c601_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfMi0yLTEtMS0w_a44e837c-e346-46ab-a6eb-8db125428a94"
      unitRef="usd">45000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ie37cc4ec5c0e44558b2a32aba2c5fc0e_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfMi00LTEtMS0w_eee1fee2-930e-4096-a0f3-981a49313010"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i2d696af4cf5445b28748e6c09ac7c601_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfMy0yLTEtMS0w_21f1e207-f100-4bc7-ab62-d7d8b9cb3e0a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie37cc4ec5c0e44558b2a32aba2c5fc0e_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfMy00LTEtMS0w_2e82be07-72b1-42bd-af0b-d9b0812a74bd"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="ie37cc4ec5c0e44558b2a32aba2c5fc0e_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfNC00LTEtMS0w_976820dc-9221-4567-83a3-7e819e8a8606"
      unitRef="usd">11000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i2d696af4cf5445b28748e6c09ac7c601_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfNS0yLTEtMS0w_2c06013f-5abe-4bae-b336-4f5202018ea7"
      unitRef="usd">39000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ie37cc4ec5c0e44558b2a32aba2c5fc0e_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfNS00LTEtMS0w_d5387634-46df-4d13-aad3-1a7c3bbde508"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i2d696af4cf5445b28748e6c09ac7c601_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfNi0yLTEtMS0w_d2b50cfc-2318-49e0-b809-e031f08f5c8b"
      unitRef="usd">-5000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="ie37cc4ec5c0e44558b2a32aba2c5fc0e_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfNi00LTEtMS0w_546d2a77-db2c-413f-ba3c-70db6aa4dda8"
      unitRef="usd">3000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="id9025fe41f3c4206832a02f6067cccc8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfNy0yLTEtMS0w_baf9a8a4-dd7a-486d-83ef-afd1c37d6672"
      unitRef="usd">211000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i11866fb0993444bd8e695ef414d06b6a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjE5ZGU1Yzk5NmNkODRlNDQ5ZDM5MTk3YzQ3OGM5MTYzL3RhYmxlcmFuZ2U6MTlkZTVjOTk2Y2Q4NGU0NDlkMzkxOTdjNDc4YzkxNjNfNy00LTEtMS0w_9979300e-5fe4-4905-9f18-a81406e87b01"
      unitRef="usd">1397000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:MinorityInterest
      contextRef="i9dcbc3a9c5dd4e11aa4f98339c48f19c_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfMS0yLTEtMS0w_38de8691-83e2-4bd6-aa9a-411d05978a74"
      unitRef="usd">193000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="ic1e09321f5344cef88ba1a2c8931ec04_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfMS00LTEtMS0w_65b0f103-f379-40cd-8b35-2f6d8020c9a2"
      unitRef="usd">1393000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i01c4d416ec1c40a593cf210126c97ef4_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfMi0yLTEtMS0w_93fc0124-f5ce-4479-83ba-803614c2aee1"
      unitRef="usd">130000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i0ed9ea6e51234863bd501477e55a7136_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfMi00LTEtMS0w_86be89c4-1162-4e88-9fc1-2b0722d9eb7e"
      unitRef="usd">33000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i01c4d416ec1c40a593cf210126c97ef4_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfMy0yLTEtMS0w_513596f4-903e-4e80-aa74-82596420e84d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i0ed9ea6e51234863bd501477e55a7136_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfMy00LTEtMS0w_24252f57-c600-4223-9fa6-180a2dfface0"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i0ed9ea6e51234863bd501477e55a7136_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfNC00LTEtMS0w_6621bbf9-30e0-46dc-8c74-4b448a564ced"
      unitRef="usd">33000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i01c4d416ec1c40a593cf210126c97ef4_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfNS0yLTEtMS0w_31655cac-adc5-4b8e-85ba-01546e16083f"
      unitRef="usd">115000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i0ed9ea6e51234863bd501477e55a7136_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfNS00LTEtMS0w_e3abef4d-edbd-48b3-a089-885b2dd0dfcd"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i01c4d416ec1c40a593cf210126c97ef4_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfNi0yLTEtMS0w_bec2f353-10a9-4081-9309-644ab4e728e1"
      unitRef="usd">3000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i0ed9ea6e51234863bd501477e55a7136_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfNi00LTEtMS0w_96e1e1dc-67cc-49ae-a6fe-66a8d28f7d93"
      unitRef="usd">6000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="id9025fe41f3c4206832a02f6067cccc8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfNy0yLTEtMS0w_ba233d64-bba0-4db5-95e6-3a14eaa391a6"
      unitRef="usd">211000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i11866fb0993444bd8e695ef414d06b6a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF81OC9mcmFnOjE4NmZhNjA1ZWU2ODRkMzhiNjQyZWE0YThhYTNhNGNhL3RhYmxlOjY1MGM1OWM0MTJhNTQ4N2U4MmQ0Njc0MDA5ZDRmOTc1L3RhYmxlcmFuZ2U6NjUwYzU5YzQxMmE1NDg3ZTgyZDQ2NzQwMDlkNGY5NzVfNy00LTEtMS0w_017f8471-f8ea-42c7-97cb-0359062aa065"
      unitRef="usd">1397000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RleHRyZWdpb246OTJmMDY3YzBmNTA0NGQwOTliYWQ2MjUwYzBlMjE4MWZfMTEzOA_d7700a09-65ec-4b01-a812-f043a41a03fd">Earnings (Loss) Per Common ShareBasic earnings (loss) per common share are computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings (loss) per common share is similar to that of basic earnings (loss) per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Diluted loss per common share for the three and nine months ended December 31, 2020, and nine months ended December 31, 2019 was calculated by excluding potentially dilutive securities from the denominator of the share computation due to their anti-dilutive effects.&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computations for basic and diluted earnings or loss per common share are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.967%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,052)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable to McKesson: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.06)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.06)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt; Certain computations may reflect rounding adjustments.&lt;/span&gt;&lt;/div&gt;Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Approximately 2&#160;million of potentially dilutive securities for the three months ended December 31, 2019 were excluded from the computation of diluted net earnings per common share as they were anti-dilutive.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RleHRyZWdpb246OTJmMDY3YzBmNTA0NGQwOTliYWQ2MjUwYzBlMjE4MWZfMTE0NQ_df65d3a2-574e-421a-8486-32dca09e9125">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computations for basic and diluted earnings or loss per common share are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.967%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,052)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable to McKesson: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.06)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.06)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt; Certain computations may reflect rounding adjustments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMi0xLTEtMS0w_8fe5a1ac-55d1-48f9-8dbd-273ce8352ce7"
      unitRef="usd">-6174000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMi0zLTEtMS0w_54f20ed4-3382-4098-841d-5b747f26d83a"
      unitRef="usd">247000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMi01LTEtMS0w_51b74202-d553-4aab-a843-14e36b8e3be7"
      unitRef="usd">-5052000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMi03LTEtMS0w_428c5dba-3d24-462b-9f6a-bd6f375f9c06"
      unitRef="usd">54000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMy0xLTEtMS0w_c4750c3f-6138-4933-996a-10e9f32b18a6"
      unitRef="usd">52000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMy0zLTEtMS0w_23b88cd6-58b3-43ec-a246-ef482c9f8469"
      unitRef="usd">56000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMy01LTEtMS0w_a9465ed1-4769-40f1-ba61-df29f3e2ff55"
      unitRef="usd">152000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMy03LTEtMS0w_8d239508-a043-41ab-acf9-f92fae0c01ed"
      unitRef="usd">163000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNC0xLTEtMS0w_6d6df432-723f-41ad-aa84-ec26d05de516"
      unitRef="usd">-6226000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNC0zLTEtMS0w_30fdd225-4e95-44b4-9691-9ffe04887884"
      unitRef="usd">191000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNC01LTEtMS0w_84c2630c-8914-45b1-b572-4375cb8c2fc3"
      unitRef="usd">-5204000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNC03LTEtMS0w_f3280f94-09e2-4ad0-a640-e6fae09d81dc"
      unitRef="usd">-109000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNS0xLTEtMS0w_11e5afbd-fbe3-4713-9fdd-469c738cf88b"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNS0zLTEtMS0w_5869a3c8-e355-46e7-9a31-e0d7f4247f05"
      unitRef="usd">-5000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNS01LTEtMS0w_613a1ce9-873b-431c-ad3b-137780d2c43e"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNS03LTEtMS0w_73630e47-2e5c-4bf7-abef-934781d225fc"
      unitRef="usd">-12000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNi0xLTEtMS0w_a2d16288-ee24-417c-89af-0a60c06c1a87"
      unitRef="usd">-6226000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNi0zLTEtMS0w_ac3692c4-a0eb-48ed-b565-d03e95cdf48b"
      unitRef="usd">186000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNi01LTEtMS0w_31119bd6-9a93-42a8-8f54-a91fdaf2e336"
      unitRef="usd">-5205000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfNi03LTEtMS0w_ec34254e-a6ae-46a5-b4ba-8195e65d11d8"
      unitRef="usd">-121000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfOS0xLTEtMS0w_5ec88204-e80f-4be7-8aa5-4ab92a0f341d"
      unitRef="shares">159500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfOS0zLTEtMS0w_f5e38d10-6ee8-477d-8bc4-fe8fe3995667"
      unitRef="shares">178700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfOS01LTEtMS0w_c3be9645-e9fd-43e8-8318-61330e00d3fa"
      unitRef="shares">161200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfOS03LTEtMS0w_c8dd6b6a-0f71-43ba-af1b-a79bbfcd366d"
      unitRef="shares">183100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTEtMS0xLTEtMA_82e0fe20-287a-472b-8617-126331d27469"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTEtMy0xLTEtMA_f80ebe62-5e36-4759-bb70-7bbab1076f02"
      unitRef="shares">1000000.0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTEtNS0xLTEtMA_526b1e6a-99cd-4a1d-ab1d-e6e108b44359"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTEtNy0xLTEtMA_ae7457e4-8c28-4fee-92d4-c4ed76fdd7b6"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTItMS0xLTEtMA_9b34f811-f2f9-40c3-bd26-3055ea47ead1"
      unitRef="shares">159500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTItMy0xLTEtMA_9c99725f-2504-4874-8921-6c862a38f323"
      unitRef="shares">179700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTItNS0xLTEtMA_2e042990-042d-40f7-87cb-1e6fd3a25c57"
      unitRef="shares">161200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTItNy0xLTEtMA_a1b1fa1f-ffb9-476d-a5d6-ef252e11bed2"
      unitRef="shares">183100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTYtMS0xLTEtMA_c1d499f7-d489-483f-8417-07efbe9447d3"
      unitRef="usdPerShare">-39.03</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTYtMy0xLTEtMA_5624a897-033e-475e-aa0b-5c384de6cdaf"
      unitRef="usdPerShare">1.06</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTYtNS0xLTEtMA_d20782f2-c749-4f82-94f0-839356704341"
      unitRef="usdPerShare">-32.28</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTYtNy0xLTEtMA_3d8620a1-a630-4072-bbbf-dcac28113986"
      unitRef="usdPerShare">-0.60</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTctMS0xLTEtMA_7811f332-03b3-4776-9b95-3bfe59a32a77"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTctMy0xLTEtMA_691e7955-1b15-49eb-8db5-7f7e9104dcb6"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTctNS0xLTEtMA_cee9a770-0880-4cf3-bc50-e71b01509e3e"
      unitRef="usdPerShare">-0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTctNy0xLTEtMA_c0da256f-20c2-42d8-a3d9-7b1ff63442ff"
      unitRef="usdPerShare">-0.06</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTgtMS0xLTEtMA_b5228bb6-3252-4351-bf4e-58998af8f656"
      unitRef="usdPerShare">-39.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTgtMy0xLTEtMA_2f7c4981-5d40-48d8-bde4-401a69cbbadf"
      unitRef="usdPerShare">1.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTgtNS0xLTEtMA_43d949a6-e37b-4a67-a275-cd2505fd1284"
      unitRef="usdPerShare">-32.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMTgtNy0xLTEtMA_8f1ddd0a-424b-4358-b030-a20b17d0d75a"
      unitRef="usdPerShare">-0.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjAtMS0xLTEtMA_8a2adeb0-15a7-4726-9c17-95e0d4db63c5"
      unitRef="usdPerShare">-39.03</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjAtMy0xLTEtMA_125c5ec6-5691-41a2-9aad-d4bf813f5062"
      unitRef="usdPerShare">1.06</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjAtNS0xLTEtMA_6c2f9bd5-78a6-405d-bd1b-508061f88a2c"
      unitRef="usdPerShare">-32.28</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjAtNy0xLTEtMA_aaa3f2c2-e1c6-489f-8abe-9929edcf99f0"
      unitRef="usdPerShare">-0.60</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjEtMS0xLTEtMA_d0e4166b-34c3-416f-aac4-fe9adc1168eb"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjEtMy0xLTEtMA_4a8dd4f3-e7a0-4e7b-b71d-5c65480bf42e"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjEtNS0xLTEtMA_7674386c-8208-4d9d-b45f-df20979d455d"
      unitRef="usdPerShare">-0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjEtNy0xLTEtMA_b4ba164d-b49e-4755-ab49-d19b3e7dc16c"
      unitRef="usdPerShare">-0.06</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjItMS0xLTEtMA_322211a7-165c-4c9e-9f8e-e49ca7154d1a"
      unitRef="usdPerShare">-39.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjItMy0xLTEtMA_13ce185f-5c2f-493f-8ebb-19f4b78764cd"
      unitRef="usdPerShare">1.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjItNS0xLTEtMA_a893edcc-26f9-4819-b823-3ebb9ae9f073"
      unitRef="usdPerShare">-32.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RhYmxlOmU5MTg5OWJmOWRlNzQwYzY5NTFhN2NiNzNkYjM1OTE2L3RhYmxlcmFuZ2U6ZTkxODk5YmY5ZGU3NDBjNjk1MWE3Y2I3M2RiMzU5MTZfMjItNy0xLTEtMA_142ae44b-cd0a-4ce2-8012-8f09fbd80e7b"
      unitRef="usdPerShare">-0.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82NC9mcmFnOjkyZjA2N2MwZjUwNDRkMDk5YmFkNjI1MGMwZTIxODFmL3RleHRyZWdpb246OTJmMDY3YzBmNTA0NGQwOTliYWQ2MjUwYzBlMjE4MWZfOTM0NTg0ODgzODgzNw_fa5d130a-02b6-4f14-9872-59deeefdd29b"
      unitRef="shares">2000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTgxNA_3c6b37df-af1f-4989-9fce-224d8d1c2f83">Goodwill and Intangible Assets, Net &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. These reportable segments encompass all operating segments of the Company. This segment change prompted changes in multiple reporting units across the Company. As a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach and assessed for impairment both before and after the reallocation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a goodwill impairment charge of $69 million (pre-tax and after-tax) in the nine months ended December 31, 2020 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment. This impairment charge is included under the caption, &#x201c;Goodwill impairment charges&#x201d; in the Condensed Consolidated Statements of Operations. At December 31, 2020, the balance of goodwill for the reporting units in Europe was approximately nil and the remaining balance of goodwill in the International segment primarily relates to one of its reporting units in Canada. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist. The annual impairment testing performed for 2021 did not indicate any impairment of goodwill. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 12, &#x201c;Fair Value Measurements,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.092%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.942%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition accounting, transfers and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding intangible assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Amortization&lt;br/&gt;Period&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,318)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,680)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Amortization expense of intangible assets was $108 million and $320 million during the three and nine months ended December 31, 2020, respectively, and $113 million and $343 million during the three and nine months ended December 31, 2019, respectively. Estimated amortization expense of these assets is as follows: $96 million, $371 million, $272 million, $254 million, and $251 million for the remainder of 2021 and each of the succeeding years through 2025 and $1.7 billion thereafter. All intangible assets were subject to amortization as of December 31, 2020 and March 31, 2020.</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i85b5d437b88a43c3b57c3014d5ae8bf1_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTIw_a079cb11-ec42-4973-92f6-9097fc5925c9"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:GoodwillImpairmentLossNetOfTax
      contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfNjEy_1799222b-3c6d-4ea4-a0db-0d1fcb46757b"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLossNetOfTax>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfNjEy_ddf155c1-4a61-4282-8503-f91b9e9814c1"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="ic4fae59f18a14a25b3bca73a248e3bc3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTEyMg_5e1e910d-a2e9-4fac-ac11-e710ce3bc1af"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTgyNQ_4cbf3242-b956-4d79-ae6d-23a93135fe88">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.092%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.942%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition accounting, transfers and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i7dbd3be0a56f450cba497eb475a1c80b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMS0xLTEtMS0w_c909658b-0dbb-4f9f-a4f8-fb00ba20ba8f"
      unitRef="usd">3924000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie24dd23acc4f44e2a91794113bb10c51_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMS0zLTEtMS0w_eab34dfb-e5d6-4cb8-a826-980eca7eeb97"
      unitRef="usd">1443000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i02543cc7d8874da9b9dd772a66bad70c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMS01LTEtMS0w_202e8c2a-3c7b-4570-9be7-a264e97618e5"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib0fa20a992b84dd9a41f9cbb8b17ee14_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMS03LTEtMS0w_e9867538-8f6a-4807-8e29-ad4ba61e4397"
      unitRef="usd">1540000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMS05LTEtMS0w_372cb643-4c02-44bf-b016-5188a40c20a8"
      unitRef="usd">9360000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i566978f4e878431094db0c99aa04c1ac_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMi0xLTEtMS0w_f9816502-bb3b-4189-8888-e2b71013809d"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMi0zLTEtMS0w_f00692c2-5873-47cc-99db-21fe2d8cfaa0"
      unitRef="usd">4000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i502121074c55491db6f36aeb28a2d5f2_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMi01LTEtMS0w_c0365e6a-86a3-4bb8-9399-f72bf0597865"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i900790fc3b604ed6aeaa993f4b448b36_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMi03LTEtMS0w_eaecf279-0979-4500-b0a5-bfc7d3749750"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfMi05LTEtMS0w_1cbb7073-475a-45d8-ac0f-c4fed356884d"
      unitRef="usd">4000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i566978f4e878431094db0c99aa04c1ac_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNC0xLTEtMS0w_715373fd-d5d5-4d94-ac93-f0c4f4d5f6bf"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNC0zLTEtMS0w_7ce56f16-27d7-4fc1-b0c2-1fc600b81f34"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i502121074c55491db6f36aeb28a2d5f2_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNC01LTEtMS0w_bf4be2f7-be45-4b5b-9a41-c88362048fe9"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i900790fc3b604ed6aeaa993f4b448b36_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNC03LTEtMS0w_74464673-7171-404d-9ee3-9ed1e7cbf615"
      unitRef="usd">2000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNC05LTEtMS0w_db4f3466-9b83-4bba-ad28-da2a9d19dd84"
      unitRef="usd">2000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i566978f4e878431094db0c99aa04c1ac_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNS0xLTEtMS0w_e7ce519b-24fd-4d36-8d25-3c623e135f65"
      unitRef="usd">1000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNS0zLTEtMS0w_e64431fb-708d-4010-830b-f97e19a16308"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i502121074c55491db6f36aeb28a2d5f2_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNS01LTEtMS0w_d53ce7c0-918c-49bd-8c4a-3c37527f69e4"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i900790fc3b604ed6aeaa993f4b448b36_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNS03LTEtMS0w_e4628454-828a-4c8f-ab9b-0c0ecd19c056"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNS05LTEtMS0w_bbf680c5-99da-49d1-8bd3-b9a4958c8a7b"
      unitRef="usd">1000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i566978f4e878431094db0c99aa04c1ac_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNi0xLTEtMS0w_34b07aa7-9739-44ba-98d6-5d75d4fb64e0"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLossNetOfTax
      contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNi0zLTEtMS0w_1799222b-3c6d-4ea4-a0db-0d1fcb46757b"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLossNetOfTax>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNi0zLTEtMS0w_ddf155c1-4a61-4282-8503-f91b9e9814c1"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i502121074c55491db6f36aeb28a2d5f2_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNi01LTEtMS0w_acdae681-43a3-47eb-81ee-13fde1a58223"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i900790fc3b604ed6aeaa993f4b448b36_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNi03LTEtMS0w_c61479f1-5cde-4fce-89fd-760723c88e12"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNi05LTEtMS0w_6b3438ab-0f8b-40bb-821b-a0621acc1897"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i566978f4e878431094db0c99aa04c1ac_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNy0xLTEtMS0w_469342f3-d38a-4dbc-8d7f-23eaf1048ed8"
      unitRef="usd">67000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNy0zLTEtMS0w_74c27ff0-11c2-4096-9fc7-25bb060644d8"
      unitRef="usd">148000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i502121074c55491db6f36aeb28a2d5f2_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNy01LTEtMS0w_79cd9f25-1b6c-429e-b7bd-60f9f25a3eed"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i900790fc3b604ed6aeaa993f4b448b36_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNy03LTEtMS0w_fd7c53c8-5446-4408-83b4-9f0af065665f"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfNy05LTEtMS0w_ff9c8547-c4fd-41b7-9952-9e49aad40e05"
      unitRef="usd">215000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ic38f289eb4674ef2811a0175289d6579_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfOC0xLTEtMS0w_fe86e305-6ffa-43d7-a316-3114d0feb0a5"
      unitRef="usd">3990000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="idb9d72428fbd4515ba2df2bc472b2522_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfOC0zLTEtMS0w_8982b889-ef62-410b-8671-c954aac92cba"
      unitRef="usd">1526000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia9435ea6faaa49bfa7de0a9fd3ee3563_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfOC01LTEtMS0w_a0a051f1-8e67-4411-8cf9-4142c973bcc1"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9099621a5b034f1783335526d709c949_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfOC03LTEtMS0w_0bf4ff4b-9fd3-47ab-ac90-b7863b154e3d"
      unitRef="usd">1542000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjBhZjgyYjQ4NTMyZTQyMDZiYWYxMTI2Y2ZkMGMzNWJjL3RhYmxlcmFuZ2U6MGFmODJiNDg1MzJlNDIwNmJhZjExMjZjZmQwYzM1YmNfOC05LTEtMS0w_e980d20b-d269-47a5-a3f2-f92f6b803209"
      unitRef="usd">9511000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTgxOQ_8fd3e2f0-5ae5-45c1-94ed-36b7ac47c0e9">&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding intangible assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Amortization&lt;br/&gt;Period&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,318)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,680)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i378dda10c10e4abda769223163b7e4e7_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMi0xLTEtMS0w_8665a917-7b7f-4093-9540-b9eb2cc30edb">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8cd1df3bc0b547ba9f623f4ef73d5370_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMi0zLTEtMS0w_a3a1d710-8f35-4036-bdb3-54cd607b721b"
      unitRef="usd">3972000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8cd1df3bc0b547ba9f623f4ef73d5370_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMi01LTEtMS0w_e16cf310-1e4e-4636-8ecc-849e82132abd"
      unitRef="usd">2318000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8cd1df3bc0b547ba9f623f4ef73d5370_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMi03LTEtMS0w_eb03e5bd-3e1d-4f46-91ee-06976cb4e5f4"
      unitRef="usd">1654000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i511bb16900684b6ea922b921c9d4dee0_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMi05LTEtMS0w_8884c9fd-db1c-41c1-bd85-329e884e20fe"
      unitRef="usd">3650000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i511bb16900684b6ea922b921c9d4dee0_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMi0xMS0xLTEtMA_84bd4b53-7cef-4104-9f45-e2d2795fbe69"
      unitRef="usd">1950000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i511bb16900684b6ea922b921c9d4dee0_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMi0xMy0xLTEtMA_8f6bd5ce-3bda-4ecc-b41d-7815862f33b2"
      unitRef="usd">1700000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i5cfa3015624b4bc5b6b7f68095b82e08_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMy0xLTEtMS0w_1eb28007-2748-4bec-a126-88c2bb6969b0">P10Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6773d34279984d34b8e2570dbfeac99d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMy0zLTEtMS0w_fdc85ec7-310d-4d72-b4c1-e8877306b33d"
      unitRef="usd">859000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6773d34279984d34b8e2570dbfeac99d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMy01LTEtMS0w_a54989ab-a482-46ff-b7d4-43b2962e488c"
      unitRef="usd">402000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6773d34279984d34b8e2570dbfeac99d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMy03LTEtMS0w_2f19b141-0505-4e6d-8494-45c2ce26487f"
      unitRef="usd">457000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i658902b07b2b449f913e2bd8456c8fa2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMy05LTEtMS0w_e7cf506f-4210-4ad3-9291-44c9460f97dd"
      unitRef="usd">994000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i658902b07b2b449f913e2bd8456c8fa2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMy0xMS0xLTEtMA_25da2455-8656-45cf-b3df-711b6e3226e5"
      unitRef="usd">480000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i658902b07b2b449f913e2bd8456c8fa2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfMy0xMy0xLTEtMA_a578154f-aa82-477c-8720-4a7a0cdb4265"
      unitRef="usd">514000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i523fcde586d342cc8bd48e9569ed97f0_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNC0xLTEtMS0w_3b520e7d-0310-4638-9fb1-688ada8526ad">P26Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i18fb0f7e2d57454c8ab3f9bf8d8d22cd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNC0zLTEtMS0w_c60ac607-d125-4849-aad8-2736ab59ed7a"
      unitRef="usd">503000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i18fb0f7e2d57454c8ab3f9bf8d8d22cd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNC01LTEtMS0w_f9b5f2f8-5fd3-4111-b1ee-fed45344e1e4"
      unitRef="usd">240000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i18fb0f7e2d57454c8ab3f9bf8d8d22cd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNC03LTEtMS0w_cc28112e-e947-499e-918a-7bb842d42063"
      unitRef="usd">263000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1b800361d6a84fc7b5a2446b3d1e7341_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNC05LTEtMS0w_3f0682de-13e5-483c-ac3d-a9bd178ee494"
      unitRef="usd">492000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1b800361d6a84fc7b5a2446b3d1e7341_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNC0xMS0xLTEtMA_b68b42d7-244f-46ec-91ef-3282fab5a698"
      unitRef="usd">232000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1b800361d6a84fc7b5a2446b3d1e7341_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNC0xMy0xLTEtMA_b07481ac-d095-4518-9e60-b6cf675c3970"
      unitRef="usd">260000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i963a00ca4138498ca7ab4ca57f1a7f37_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNS0xLTEtMS0w_f8d9a4d1-b97c-4fe4-9a35-9c46279465ad">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i725fcea7818746d1a1609a91129d7859_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNS0zLTEtMS0w_9ab62bea-a408-4ef8-9777-1c212d4699bc"
      unitRef="usd">922000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i725fcea7818746d1a1609a91129d7859_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNS01LTEtMS0w_25f3bc9e-9b03-44a3-b8d1-d8e562eca255"
      unitRef="usd">379000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i725fcea7818746d1a1609a91129d7859_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNS03LTEtMS0w_ddcda345-ab96-42b6-845f-d3cef84cafae"
      unitRef="usd">543000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id285ee1563e043a08cf17e27f0adff21_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNS05LTEtMS0w_32d4a428-c5fd-4849-8ed2-3b002270fe75"
      unitRef="usd">808000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id285ee1563e043a08cf17e27f0adff21_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNS0xMS0xLTEtMA_89e51750-aaa4-4c24-bb51-a668905e1e3b"
      unitRef="usd">242000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id285ee1563e043a08cf17e27f0adff21_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNS0xMy0xLTEtMA_4558b8d2-463e-4f6e-9f46-4f2a9151c3f3"
      unitRef="usd">566000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="ibc05b27d7e0a4e78a4db26cb12058f85_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNi0xLTEtMS0w_4f71b347-e166-4ec1-8e8c-96ef559c371f">P5Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5769cd643a314785bc6bb343b9674112_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNi0zLTEtMS0w_09e0dffc-d663-4a50-bb01-3c7bfe7bb4d0"
      unitRef="usd">149000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5769cd643a314785bc6bb343b9674112_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNi01LTEtMS0w_04817886-79cd-4c0f-9337-37d1d2d0dbea"
      unitRef="usd">118000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5769cd643a314785bc6bb343b9674112_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNi03LTEtMS0w_432daa6e-ae13-4c20-a394-b515271517c9"
      unitRef="usd">31000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ieafb5736403f465eb913bf612cdc985a_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNi05LTEtMS0w_1533ec40-98df-45d1-9425-cbb1f3489c51"
      unitRef="usd">175000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ieafb5736403f465eb913bf612cdc985a_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNi0xMS0xLTEtMA_ad814117-2ccd-40f8-81e9-f511b10632ca"
      unitRef="usd">111000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ieafb5736403f465eb913bf612cdc985a_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNi0xMy0xLTEtMA_de8b27be-26f2-4b43-8c2f-8a3b3e126e3c"
      unitRef="usd">64000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i659552bb536e4d988f20153df0383f90_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNy0xLTEtMS0w_4fd8e46b-4c0e-4980-a61c-84ba61c6281e">P5Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5a9556d9999d4dad8956e6c895b8d4ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNy0zLTEtMS0w_11c3d281-635e-4609-8437-e46ca101095b"
      unitRef="usd">255000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5a9556d9999d4dad8956e6c895b8d4ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNy01LTEtMS0w_ec39ddfd-4523-41c8-9574-d33c30683ffa"
      unitRef="usd">223000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5a9556d9999d4dad8956e6c895b8d4ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNy03LTEtMS0w_a78435fd-1c0d-49e9-8b37-33294eaae10f"
      unitRef="usd">32000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1f42cc658d804c91ab0038c670ab193b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNy05LTEtMS0w_7cb58aa1-3f43-43f5-8dde-b76fb87d8efd"
      unitRef="usd">273000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1f42cc658d804c91ab0038c670ab193b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNy0xMS0xLTEtMA_d382154a-aafc-4045-ab74-55fd3658270a"
      unitRef="usd">221000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1f42cc658d804c91ab0038c670ab193b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfNy0xMy0xLTEtMA_87ce633e-c29b-4e41-b842-7b28789da4ab"
      unitRef="usd">52000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfOC0zLTEtMS0w_906e4a09-2345-40f5-a8d7-12c046c8e7cc"
      unitRef="usd">6660000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfOC01LTEtMS0w_c27b0146-ea9b-4c53-979f-f252a2d9dfe0"
      unitRef="usd">3680000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfOC03LTEtMS0w_ce3c9d2b-de52-4ba2-b777-21837cba5943"
      unitRef="usd">2980000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfOC05LTEtMS0w_8ef33103-8810-494f-8fd1-e6dde14609cf"
      unitRef="usd">6392000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfOC0xMS0xLTEtMA_a7f1cfcf-8e56-4659-9649-4991eae13809"
      unitRef="usd">3236000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RhYmxlOjllNDQyNzcwYjMxNjRkNWJhYzc3MDBkZWMwYjQzM2RkL3RhYmxlcmFuZ2U6OWU0NDI3NzBiMzE2NGQ1YmFjNzcwMGRlYzBiNDMzZGRfOC0xMy0xLTEtMA_3ac6b007-a843-4f4b-8fd3-bbd65571e1e8"
      unitRef="usd">3156000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTQ5MA_8f3b0dc9-b133-457b-8ee0-43a03ab01549"
      unitRef="usd">108000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTQ5Nw_a8b3d5a3-2f67-4251-8544-d5464b01ea17"
      unitRef="usd">320000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTUzMw_2a7cf7a9-1404-48b4-9e2a-c26197c87523"
      unitRef="usd">113000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTU0MA_0ef74c10-632f-4e06-948c-5b9ce89d13de"
      unitRef="usd">343000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTYzNA_3e3657d5-e882-4086-9c1c-cc6dcbeb0351"
      unitRef="usd">96000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTYzOA_2b2a0e4c-278c-49e9-bf89-88c60f5b62c4"
      unitRef="usd">371000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTY0Mg_58b3e439-64d1-4527-87b6-f5c1bfb66e2f"
      unitRef="usd">272000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTY0Ng_bf10959a-9224-427f-848b-d2d5ebd683ad"
      unitRef="usd">254000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTY1NA_d1943b31-2d25-4644-b298-f66144f8f23d"
      unitRef="usd">251000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <mck:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF82Ny9mcmFnOjRiNDRlZWRhOWU2ODQxN2JhNGU1OWI4ZDMyNmNkOTgyL3RleHRyZWdpb246NGI0NGVlZGE5ZTY4NDE3YmE0ZTU5YjhkMzI2Y2Q5ODJfMTcyOQ_1a4c5d9e-0c82-4e4c-a0bb-9e69dae5e2c8"
      unitRef="usd">1700000000</mck:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjg1Nw_efd9fc75-4a98-4489-8e86-39e234c8415b">Debt and Financing Activities&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S. Dollar notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.65% Notes due November 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due March 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85% Notes due March 15, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% Notes due March 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90% Notes due December 3, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65% Debentures due March 1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95% Notes due February 16, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due May 30, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00% Notes due March 1, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88% Notes due March 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;Foreign currency notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.63% Euro Notes due August 17, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50% Euro Notes due November 17, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63% Euro Notes due October 30, 2026 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13% Sterling Notes due February 17, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and other obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These notes are unsecured and unsubordinated obligations of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these notes is payable semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these foreign currency notes is payable annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. Debt outstanding totaled $7.2 billion and $7.4 billion at December 31, 2020 and March 31, 2020, respectively, of which $777 million and $1.1 billion, respectively, was included under the caption &#x201c;Current portion of long-term debt&#x201d; within the Company&#x2019;s Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 3, 2020, the Company completed a public offering of 0.90% Notes due December 3, 2025 (the &#x201c;2025 Notes&#x201d;) in a principal amount of $500&#160;million. Interest on the 2025 Notes is payable semi-annually on June 3rd and December 3rd of each year, commencing on June 3, 2021. Proceeds received from this note issuance, net of discounts and offering expenses, were $496&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2025 Notes, which constitutes a &#x201c;Series,&#x201d; are an unsecured and unsubordinated obligation of the Company and rank equally with all of the Company&#x2019;s existing, and from time-to-time, future unsecured and unsubordinated indebtedness outstanding. The 2025 Notes are governed&#160;by materially similar indentures and officers&#x2019; certificates as those of other Series issued by the Company. Upon required notice to holders of notes with fixed interest rates, the Company may redeem those notes at any time prior to maturity, in whole or in part, for cash at redemption prices. In the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of a Series below an investment grade rating by each of Fitch Inc., Moody&#x2019;s Investors Service, Inc. and Standard &amp;amp; Poor&#x2019;s Ratings Services within a specified period, an offer must be made to purchase the 2025 Notes from the holders at a price equal to&#160;101%&#160;of the then outstanding principal amount of the 2025 Notes, plus accrued and unpaid interest to, but not including, the date of repurchase. The indenture and the related officers&#x2019; certificate for the 2025 Note, subject to the exceptions and in compliance with the conditions as applicable, specify that the Company may not consolidate, merge or sell all or substantially all of its assets, incur liens, or enter into sale-leaseback transactions exceeding specific terms, without lenders&#x2019; consent. The indentures also contain customary events of default provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended December 31, 2020, the Company retired its $700&#160;million total principal amount of notes due on November 30, 2020 at a fixed interest rate of 3.65% upon maturity. On December 1, 2020, the Company redeemed its 4.75% $323&#160;million total principal of notes due on March 1, 2021 prior to maturity. These notes were redeemed using cash on hand and the proceeds of the notes offering discussed above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;McKesson maintains a syndicated $4 billion five-year senior unsecured credit facility, dated as of September 25, 2019, as amended (the &#x201c;2020 Credit Facility&#x201d;), which has a $3.6 billion aggregate sublimit of availability in Canadian dollars, British pound sterling and Euro. The 2020 Credit Facility matures in September 2024 and had no&#160;borrowings during the three and nine months ended December 31, 2020 and no amounts outstanding as of December 31, 2020 and March 31, 2020. The remaining terms and conditions of the 2020 Credit Facility are substantially similar to those previously in place under the&#160;$3.5 billion five-year senior unsecured revolving credit facility (the &#x201c;Global Facility&#x201d;), which was scheduled to mature in October 2020. The Global Facility was terminated in connection with the execution of the 2020 Credit Facility in September 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility contains financial covenants which obligate the Company to maintain a maximum debt to capital ratio, as defined in the 2020 Credit Facility, along with other customary investment grade covenants. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. As of December 31, 2020, the Company was in compliance with all covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also maintains bilateral credit facilities primarily denominated in Euro with a committed amount of $8 million and an uncommitted amount of $183 million as of December 31, 2020. Borrowings and repayments were not material during the three and nine months ended December 31, 2020 and 2019, and amounts outstanding under these credit lines were not material as of December 31, 2020 and March 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $4.0 billion in outstanding commercial paper notes. During the nine months ended December 31, 2020 and 2019, the Company borrowed $5.5 billion and $15.9 billion, respectively, and repaid $5.3 billion and $13.7 billion, respectively, under the program. At December 31, 2020 there were $152 million of commercial paper notes outstanding with a weighted average interest rate of 0.21%. At March 31, 2020, there were no commercial paper notes outstanding.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjg2Ng_02b20c29-578f-4608-a94a-b7e85c1ef2ae">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S. Dollar notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.65% Notes due November 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due March 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85% Notes due March 15, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% Notes due March 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90% Notes due December 3, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65% Debentures due March 1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95% Notes due February 16, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due May 30, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00% Notes due March 1, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88% Notes due March 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;Foreign currency notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.63% Euro Notes due August 17, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50% Euro Notes due November 17, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63% Euro Notes due October 30, 2026 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13% Sterling Notes due February 17, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and other obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These notes are unsecured and unsubordinated obligations of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these notes is payable semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these foreign currency notes is payable annually.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0e3d82d95ff34d09ad54cbb7a9568eeb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMi0wLTEtMS0wL3RleHRyZWdpb246YzZmOGQ3YTI1Zjg4NDBiZTlkNmNjOWE5MzNiMzlmYTFfNA_c0083833-55ef-4826-a7e8-f652dc59d4d5"
      unitRef="number">0.0365</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i0e3d82d95ff34d09ad54cbb7a9568eeb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMi0xLTEtMS0w_1436ab57-9578-4153-b7c4-77b39186ffdc"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ib62e3807a7114d0899925f4b51210868_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMi0zLTEtMS0w_e898cc15-e7f7-4850-b39e-4cd5c9f2002d"
      unitRef="usd">700000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i61243968789b45e78979a62d792f3bf2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMy0wLTEtMS0wL3RleHRyZWdpb246NDI5OTRjMzM5Y2NhNGVhNTg5ZWMzNDE5NzA5NjFmZWZfNA_ab24e655-d00d-4b56-9e78-afabf9f90176"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i61243968789b45e78979a62d792f3bf2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMy0xLTEtMS0w_001f08d6-9db6-4b7f-a52c-e92a347a1c53"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ic23cdb3eba794da3ab936c09bb3753eb_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMy0zLTEtMS0w_5f0c3936-019a-43fe-b713-3ce033b35da0"
      unitRef="usd">323000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic49f2f1769cd420c9df5352e8067b68d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNC0wLTEtMS0wL3RleHRyZWdpb246YTc0N2Y1NzkxZmIyNDY4YWJmMTI5YWM3ZjY3ZTdhMmNfNA_8778e7e8-be87-4f05-a6c6-54467057fff5"
      unitRef="number">0.0270</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ic49f2f1769cd420c9df5352e8067b68d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNC0xLTEtMS0w_b84fae37-c1c8-4ad1-97e0-cc27a6b24606"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iff33e00fbaee41eea7defea825d96e6c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNC0zLTEtMS0w_3def5078-2888-4ea2-84ee-c3bebb724ea0"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5f896c781b42418fab54308abf10a3ab_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNS0wLTEtMS0wL3RleHRyZWdpb246MmZhMDFlYWM0MmIzNGNjYjk5ODljOGFlODg0YTA5Y2NfNA_f5108284-b30c-4cab-b53a-9da0f6050973"
      unitRef="number">0.0285</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i5f896c781b42418fab54308abf10a3ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNS0xLTEtMS0w_aa6090e8-5447-452c-99ae-86aeaed79ba1"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2024e246ff5243e1a182377483b428d9_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNS0zLTEtMS0w_bc048ab1-9b87-48f3-a9e5-a947d34a4c77"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i83ba1dcc0fa0463e870a0c6af64a8894_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNi0wLTEtMS0wL3RleHRyZWdpb246MmQxNDc2OTIxZDBkNGE5OTk4MTJlYzg4Y2NjYjM4YWFfNA_0ed52caa-1c85-46c6-bd6a-f668f810ec36"
      unitRef="number">0.0380</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i83ba1dcc0fa0463e870a0c6af64a8894_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNi0xLTEtMS0w_bb110fc4-7902-4d90-a667-21c47c20b89d"
      unitRef="usd">1100000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3929998884064e1fb42a501356c5aa3b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNi0zLTEtMS0w_82c44b42-fb1e-439b-94d9-042a4bbe024e"
      unitRef="usd">1100000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i45681222eb314cadaa16245b1eda2bb3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNy0wLTEtMS0yMTc4L3RleHRyZWdpb246YWM3MTkzZmYxZDkwNDdhNjkwODA4Yzk5MmIyMTNiNzlfMTA5OTUxMTYyNzgxNw_76190811-12c2-42ff-a82c-6a97d617f5f2"
      unitRef="number">0.0090</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i45681222eb314cadaa16245b1eda2bb3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNy0xLTEtMS0yMTgx_12d53baa-4a10-4f15-b1da-000a928667f8"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ida48ca8acd984f98badfab324817c495_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNy0zLTEtMS0yMTgx_a4030ee5-51b7-4e40-87a0-9162ffc9e79c"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i13860847712f4090af128c3ef55aac24_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNy0wLTEtMS0wL3RleHRyZWdpb246MWZmZTU2MTlhODZhNDg2ZmJjZTkwNmMwM2RlMWY4NGVfNA_59314a12-3435-4307-8d7e-c5efac78b2c7"
      unitRef="number">0.0765</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i13860847712f4090af128c3ef55aac24_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNy0xLTEtMS0w_b032a572-0180-476f-8857-f2ff0bf42e72"
      unitRef="usd">167000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iccb710e426964f068ee01c91061447f5_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfNy0zLTEtMS0w_e8c90e52-3b30-4626-b0fa-10d204ced3f1"
      unitRef="usd">167000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i722ba8780dd64ef3998e85ae30f7b8e5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfOC0wLTEtMS0wL3RleHRyZWdpb246ZTFjZWRlZDg1MjBkNGJlZTlhMjJmNTcxNzU0MzA0ZDZfNA_06b2d41f-d41f-4e9f-b8a8-01cfd4514402"
      unitRef="number">0.0395</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i722ba8780dd64ef3998e85ae30f7b8e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfOC0xLTEtMS0w_7f7a822c-7b10-484f-b15d-82d04dd79682"
      unitRef="usd">600000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9c3b5bf1138e4193b4ed05d0221ddb16_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfOC0zLTEtMS0w_d72f1290-8752-4cd5-bbb7-72426a1d0089"
      unitRef="usd">600000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iee65e5a7c91d480fa442a25bf99a4310_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfOS0wLTEtMS0wL3RleHRyZWdpb246OTY3YWI1ODM4ZGJlNGMzY2JiZTIxY2YzMmRjYTQ0NjZfNA_7f64990c-c3a5-417d-9365-1e533ad57f9c"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="iee65e5a7c91d480fa442a25bf99a4310_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfOS0xLTEtMS0w_f7f944c3-6179-4535-925b-19f5de6dda64"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ifa304a69e98947ed8c2ebd69d84693fe_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfOS0zLTEtMS0w_ca2f5c72-8357-4f86-9408-18c94f715ce3"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i543d6ee25e6648e9bfddfd675bdc4e0f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjFmN2Q1NGEwNTY3NzQ5N2FiMmU1NzIyMjVlOGZlYjYzXzQ_d8eca8b1-1bc2-4a36-afe6-7ce3ceda0726"
      unitRef="number">0.0600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i543d6ee25e6648e9bfddfd675bdc4e0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTAtMS0xLTEtMA_4e30b8da-c44d-44ed-8e30-6410e1564cab"
      unitRef="usd">282000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="icac37f0bb50c47a88452230ae579cc0e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTAtMy0xLTEtMA_9febebee-2948-436b-97ab-1db5307fe6bb"
      unitRef="usd">282000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i59f7fd483700447b913388bbe402cb2a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjNkYzEwZTUzYjY0MzQ2OTViNzA0MzE3YWE4Mzg2NmU3XzQ_312a246c-15a7-4345-a37a-948b5363cb6b"
      unitRef="number">0.0488</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i59f7fd483700447b913388bbe402cb2a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTEtMS0xLTEtMA_3837f395-4944-4fc1-8fba-6f05594d4fb3"
      unitRef="usd">411000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ice7a4f35e6e047a59039a07c27481e3c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTEtMy0xLTEtMA_70f72eb3-b529-4d40-b372-67be69544d1e"
      unitRef="usd">411000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if338ee6ce8f3482a80ee390eacdd1b93_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjlkYjdkMDg5YjY5NTQwNmU5MjgzNDBmYjhlZGZiZDk5XzQ_23edd7b0-e461-48d5-ab63-77d4c852c549"
      unitRef="number">0.0063</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="if338ee6ce8f3482a80ee390eacdd1b93_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTMtMS0xLTEtMA_29557055-383b-4c80-99dd-bfc62264fc28"
      unitRef="usd">733000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iaf0ef65f413640089349522b6d1f61fb_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTMtMy0xLTEtMA_e09a5e9a-a3a6-47eb-83d9-5756054ce014"
      unitRef="usd">662000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if9e2e544a5d24e309b0b1d476df167c4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOmYzZWZmM2EzYjQ2ZDQ0MmJiNDE1YWJiMTljZDgyZjA2XzQ_dc57e325-2eea-481d-85e4-769c6d8b9aae"
      unitRef="number">0.0150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="if9e2e544a5d24e309b0b1d476df167c4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTQtMS0xLTEtMA_c9dbe91b-4192-42b2-a72b-34952951a9ba"
      unitRef="usd">729000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5859abcac6664cec9fd998af2d0f2d14_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTQtMy0xLTEtMA_f8f699f6-e505-4ce2-804f-7eb8983cdcdb"
      unitRef="usd">659000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i57d99627daf846ff9841f02dd67e8763_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjBkNDViMzBjMjdlNzQxM2Y5NDIxYzMxMzZlZGZhOGQ5XzQ_2e68b1e3-abf1-4fd6-913b-99436b1c8bf1"
      unitRef="number">0.0163</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i57d99627daf846ff9841f02dd67e8763_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTUtMS0xLTEtMA_4310cc24-bf51-4d37-aad4-07862aad6f39"
      unitRef="usd">611000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if427cce4e6654f628a7f645a93e796d1_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTUtMy0xLTEtMA_9c470eb3-7175-461b-8257-f0c271254cd4"
      unitRef="usd">552000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i54d06a347a4e4e5e91c4f62ec54e8cc2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjE1Y2Q0NThmNDhlNDQxYmI5YjFmNmQ5OTgwZWQ2ZTE3XzQ_2f7566b5-75f9-4053-9f3c-65ab5ffc0936"
      unitRef="number">0.0313</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i54d06a347a4e4e5e91c4f62ec54e8cc2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTYtMS0xLTEtMA_5bce1ad5-d79c-4301-8bd3-ebf300fadcd0"
      unitRef="usd">639000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i06786762035a45b180efa3c21821bf20_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTYtMy0xLTEtMA_7fbd6715-a742-4a92-84dd-5f816ae5ca0a"
      unitRef="usd">557000000</us-gaap:LongTermDebt>
    <us-gaap:FinanceLeaseLiability
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTgtMS0xLTEtMA_1136daed-120e-4d65-899f-17b0d10eda99"
      unitRef="usd">272000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTgtMy0xLTEtMA_7f39cbad-942a-436a-8ad7-a2b710e17ac3"
      unitRef="usd">174000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTktMS0xLTEtMA_02519961-2e5d-4ba9-9d18-19a9bca09ab8"
      unitRef="usd">7244000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMTktMy0xLTEtMA_c0f7b402-127a-47f7-b7ed-0e257825703d"
      unitRef="usd">7387000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMjAtMS0xLTEtMA_7378860e-75fe-4ca4-bbab-67dd05b82f8a"
      unitRef="usd">777000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMjAtMy0xLTEtMA_64948903-13bf-42ab-9c2c-0f41a884b186"
      unitRef="usd">1052000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMjEtMS0xLTEtMA_bf802b38-e05b-4c90-8abb-8b21fa42ac6b"
      unitRef="usd">6467000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RhYmxlOjliYjVjYWEzMTZlZTQ2ZjZiMzliMDc2OGM5N2MzYjUzL3RhYmxlcmFuZ2U6OWJiNWNhYTMxNmVlNDZmNmIzOWIwNzY4Yzk3YzNiNTNfMjEtMy0xLTEtMA_cf229cea-9815-488d-b4a6-313ad2afacdf"
      unitRef="usd">6335000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMzg0_3f28a9cb-a33f-4609-830c-002aea138994"
      unitRef="usd">7200000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMzkx_e6cec240-c399-4936-8896-f9f31dc13114"
      unitRef="usd">7400000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfNDMx_bf51c6d2-8f89-491d-9a6c-c5b4738612fa"
      unitRef="usd">777000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfNDM4_d6774732-7bb2-4de7-875f-c13dab3701d6"
      unitRef="usd">1100000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1b3e1030e25049dcab5e8f463f79cc7e_I20201203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMTA5OTUxMTY0NzIwOQ_fd625e7f-36f6-4824-92bf-f8301e5aefa7"
      unitRef="number">0.0090</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1b3e1030e25049dcab5e8f463f79cc7e_I20201203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMTA5OTUxMTY0NzI1NQ_05fbcd20-1fca-450d-a5a5-909013b67805"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i5a3ede9e6e5140df88d6504a6002bf36_D20201203-20201203"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjE5OTAyMzI3NTIxNg_65399be8-6a72-4904-834f-43e154b76b65"
      unitRef="usd">496000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
      contextRef="i5a3ede9e6e5140df88d6504a6002bf36_D20201203-20201203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfOTM0NTg0ODg1NTcxOA_a05135f2-056b-4a8c-9aa4-0e8be247f22c"
      unitRef="number">1.01</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0e3d82d95ff34d09ad54cbb7a9568eeb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMTA5OTUxMTY0NzE1Nw_46f52404-b079-4eb4-b82e-1cc7744af7d9"
      unitRef="usd">700000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0e3d82d95ff34d09ad54cbb7a9568eeb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMTA5OTUxMTY0NzE2OA_e1f40325-8ca0-4b4f-a5da-f2d04bb0a7ce"
      unitRef="number">0.0365</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6dcb7ea25a61456ea8011e544254a46e_I20201201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMTA5OTUxMTY0NzE3Ng_2ac92dd0-848c-43f1-b30f-f50207db4982"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6dcb7ea25a61456ea8011e544254a46e_I20201201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMTA5OTUxMTY0NzE5MQ_8f8475a1-04e6-4f53-9a12-04d3a9af79c6"
      unitRef="usd">323000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ie8b3fd2d698249cdb62866fb761a1437_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfNjUw_0e6fd3cb-19b8-44ec-a6ad-55c06bd04942"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="icbedee4fddac4d1e918ff2e43b85f5b3_D20190701-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjg2OA_a494cca0-7d8f-4082-b779-f9111cdfeddb">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ide009e05a6744804a59fcd84efd0b7a3_I20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfNzM2_ab43fde8-080c-43a9-a950-59be6d8c7ec8"
      unitRef="usd">3600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i5b8012a1221f40588f7488916fd1b3b0_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfODg3_00d51bc5-fe85-421f-b0bf-acd1e234cf1f"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ia75a14b05a5c4c2ba266322f4ed4794b_D20201001-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfODg3_ce47ccaa-ea11-4c0a-940c-e87781c91a84"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i9d587484c8314278aa228f8a047c449e_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfOTQ1_6986e7a3-1c9b-4b9d-9560-a4adf3153364"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i3673260c4a0e4c6789566685bcdc80f9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfOTQ1_a4b75796-c12f-45d3-bd4a-0af4e818e043"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia561add5441945f9b6e6f005c32de046_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMTExMw_ae2279d3-4179-4d5a-9a5d-b7dc1553fa8d"
      unitRef="usd">3500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i3df3eaf8483344e189aadb44a6e73dfc_D20190901-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjg3MA_e45033ec-cc9f-4d86-a892-6da86b4b9441">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases
      contextRef="i5cf6891e4f624ba4b2c8f2b8b8ad994a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjE5Mw_7db7af00-43a6-46be-9063-95b10cbbbc95"
      unitRef="usd">8000000</us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i5cf6891e4f624ba4b2c8f2b8b8ad994a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjIyNQ_15bc9105-18c7-401d-b82f-202691b8adf5"
      unitRef="usd">183000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ifc76a63f576047c49638f41ac0d91ae3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjYxNA_4edc2938-88fb-40da-a190-4b81e3649a07"
      unitRef="usd">4000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="if13ed91051e047c597b44d113a7413be_D20200401-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjcxNQ_ffe7db09-9692-4037-8407-25681ea1f589"
      unitRef="usd">5500000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="i451d84e1d8a944789fa6835d4573fb2a_D20190401-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjcyMg_6edc5439-1623-4265-9db8-8ec3ea4fea37"
      unitRef="usd">15900000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="if13ed91051e047c597b44d113a7413be_D20200401-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjc1MQ_f711933f-544c-431c-93fa-83f739181ff8"
      unitRef="usd">5300000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="i451d84e1d8a944789fa6835d4573fb2a_D20190401-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjc1OA_241b646e-da7f-41b8-b943-69b7abcd8855"
      unitRef="usd">13700000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:LongTermCommercialPaperCurrent
      contextRef="ifc76a63f576047c49638f41ac0d91ae3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMTA5OTUxMTY0ODQ1Mg_a54c0c7a-63c8-4813-965f-861b5f94bf91"
      unitRef="usd">152000000</us-gaap:LongTermCommercialPaperCurrent>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="ifc76a63f576047c49638f41ac0d91ae3_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMTA5OTUxMTY0ODU2Ng_a7c70888-aab5-4539-893a-da8259726de4"
      unitRef="number">0.0021</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:LongTermCommercialPaperCurrent
      contextRef="i1c39c0200ce7449fb14e39cf375472fa_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83MC9mcmFnOjIyODE2ZTFjNGUyMTQ0YTJhNjBkZTEyNTc5OTU3ZmM4L3RleHRyZWdpb246MjI4MTZlMWM0ZTIxNDRhMmE2MGRlMTI1Nzk5NTdmYzhfMjgyMA_c6f9c4e0-2d9d-45fd-8d4d-69a392f870a8"
      unitRef="usd">0</us-gaap:LongTermCommercialPaperCurrent>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMjAyMA_c12e5b9f-da22-4e02-b18f-3749b7606da1">Pension Benefits&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net periodic expense for defined benefit pension plans was $4 million and $17 million for the three and nine months ended December 31, 2020, respectively, and $16 million and $151 million for the three and nine months ended December 31, 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash contributions to these plans were $8 million and $19 million for the three and nine months ended December 31, 2020, respectively, and $120 million and $132 million for the three and nine months ended December 31, 2019, respectively. The three and nine months ended December 31, 2019 included a cash payment of $114&#160;million from the executive benefit retirement plan. The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#x2019; service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized on a straight-line basis over the average remaining future service periods and expected life expectancy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended December 31, 2020, the Company derecognized $187&#160;million of pension liabilities included in liabilities held for sale and $24&#160;million of accumulated other comprehensive loss, net of tax, related to its German pharmaceutical wholesale business contributed to a joint venture, as discussed in more detail in Financial Note 3, &#x201c;Held for Sale.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 23, 2018, the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;) approved the termination of its frozen U.S. defined benefit pension plan (&#x201c;Plan&#x201d;). During the first quarter of 2020, the Company offered the option of receiving a lump sum payment to certain participants with vested qualified Plan benefits in lieu of receiving monthly annuity payments. Approximately 1,300 participants elected to receive the settlement, and lump sum payments of approximately $49 million were made from Plan assets to these participants in June 2019. The benefit obligation settled approximated payments to Plan participants and a pre-tax settlement charge of $17 million was recorded during the first quarter of 2020. During the second quarter of 2020, the Company transferred the remainder of the Plan&#x2019;s pension obligation to a third-party insurance provider by purchasing annuity contracts for approximately $280 million which was fully funded directly by Plan assets. The third-party insurance provider assumed the obligation to pay future benefits and provide administrative services on November 1, 2019 and a pre-tax settlement charge of $105&#160;million was recorded during the second quarter of 2020. Settlement charges were included within Other income (expense), net in the condensed consolidated statement of operations for the nine months ended December 31, 2019 as a result of the termination of the Plan.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i9572515afb1f475086d3833719ce1ee7_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfNzU_672c13cb-698d-43b8-812e-238225b3f5cb"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i89e2b4abb66f4b8490bd136400166514_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfODI_59d95cfe-3051-4a22-9d3d-ec429b475c88"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ia909bddd810745a78d740e262952804d_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMTE1_f5529e79-b266-4865-9d1c-ecd5fde93238"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i5720a12c6a9847d3959ececda0b47b78_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMTIy_ba196d31-1169-4239-a5f3-4244436c2b9e"
      unitRef="usd">151000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i9572515afb1f475086d3833719ce1ee7_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMTkw_6a220ae3-4c7b-4635-aff1-df93f4a2c15d"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i89e2b4abb66f4b8490bd136400166514_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMTk3_a3d6e2cb-59ca-400b-8872-feb6addece80"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ia909bddd810745a78d740e262952804d_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMjMw_c310b72b-634a-4f79-8c1a-9a971eb17543"
      unitRef="usd">120000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i5720a12c6a9847d3959ececda0b47b78_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMjM3_d63185d0-7223-4582-8cba-b791413d59ab"
      unitRef="usd">132000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="ie862f63e9e384a2384d0f8f2895b4fef_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMjE5OTAyMzI1OTM3Ng_21911d0c-1b42-462c-bbe7-432ba5dab447"
      unitRef="usd">114000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i5a58762e511c405da243fad3b79d9702_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMjE5OTAyMzI1OTM3Ng_b28dc718-68af-432b-8040-21ba2471300f"
      unitRef="usd">114000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanFundedPercentage
      contextRef="ib9ce75f89ad84830aa465d0823e6683b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfNDQ5_02ed5624-0054-4280-a2ee-db54a08475a4"
      unitRef="number">0.10</us-gaap:DefinedBenefitPlanFundedPercentage>
    <mck:DefinedBenefitPensionPlanLiabilitiesDerecognized
      contextRef="i938f21cb5003435093dd61e42f1e4b04_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMjE5OTAyMzI2MzIyMg_1aeb2f84-4970-4bc9-98af-2754a64031d5"
      unitRef="usd">187000000</mck:DefinedBenefitPensionPlanLiabilitiesDerecognized>
    <us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease
      contextRef="i87abebafd2444aea947519a813b73651_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMjE5OTAyMzI2NTMzOA_c21c1207-7351-44d2-8060-3a59245577e8"
      unitRef="usd">-24000000</us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease>
    <mck:DefinedBenefitPlanSettlementPlanParticipants
      contextRef="ie662489344214deea919f1b5ac9b8617_D20190601-20190630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMTAwMw_275b31fa-52b2-41f7-8ece-b93c8ad40502"
      unitRef="participant">1300</mck:DefinedBenefitPlanSettlementPlanParticipants>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="ie662489344214deea919f1b5ac9b8617_D20190601-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMTA5Mw_df66aa0c-e124-4259-86ef-583f2a5e8b28"
      unitRef="usd">49000000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i27e1b65706fe43c8b7b96d04e78a9a4b_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMTI2OA_662cde7f-0da0-4bd0-a836-22f55b18c847"
      unitRef="usd">-17000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <mck:DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract
      contextRef="if044bd6776b7450a96d800457d558593_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMTUxMA_3257658e-7342-4d53-b2d1-c5330dc8ba43"
      unitRef="usd">280000000</mck:DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i77fd18e4162c441aa58436014d857d12_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83Ni9mcmFnOmJkMTU1MGM4Nzg1NTRmNWQ5ZjJlNzIxNThjMzIyYTIyL3RleHRyZWdpb246YmQxNTUwYzg3ODU1NGY1ZDlmMmU3MjE1OGMzMjJhMjJfMjc0ODc3OTA3ODY5OA_6eab9474-e521-4068-a2b6-d6145713e674"
      unitRef="usd">-105000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMTAyODY_2c972310-5da0-4620-abf0-751a5dfe77af">Hedging Activities &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives such as cross-currency swaps, foreign currency forward contracts, and interest rate swaps. In accordance with the Company&#x2019;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:2.25pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Exchange Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#x2019;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-Derivative Instruments Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020 and March 31, 2020, the Company had &#x20ac;1.7 billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#x2019;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded in foreign currency translation adjustments within Accumulated other comprehensive loss in the Condensed Consolidated Statements of Stockholders&#x2019; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#x2019;s net investments.&#160;To the extent foreign currency denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. In December 2019, the Company prospectively de-designated from net investment hedges &#x20ac;250 million of its Euro-denominated notes which matured in February 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains or losses from net investment hedges recorded within Other comprehensive income were losses of $84 million and $201 million during the three and nine months ended December 31, 2020, respectively, and losses of $59 million and gains of $8 million during the three and nine months ended December 31, 2019, respectively. There was no ineffectiveness in non-derivative net investment hedges during the three and nine months ended December 31, 2020. Ineffectiveness on the Company&#x2019;s non-derivative net investment hedges during the three and nine months ended December 31, 2019 resulted in losses of $3 million and gains of $26&#160;million, respectively, which were recorded in earnings in Other income (expense), net in the Condensed Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020 and March 31, 2020, the Company had cross-currency swaps designated as net investment hedges with a total gross notional amount of $999 million and $1.5 billion Canadian dollars, respectively. Under the terms of the cross-currency swap contracts, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These swaps are utilized to hedge portions of the Company&#x2019;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in Accumulated other comprehensive loss in the Condensed Consolidated Statements of Stockholders&#x2019; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#x2019;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in the Company&#x2019;s net investment hedges for the three and nine months ended December 31, 2020 and 2019. In November 2020, cross currency swaps with an aggregate gross notional amount of $500&#160;million Canadian dollars matured and the remaining cross-currency swaps will mature between March 2021 and November 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2020, the Company terminated cross-currency swaps with a total gross notional amount of &#xa3;932 million British pound sterling due to ineffectiveness in its British pound sterling hedging program that arose due to 2019 impairments of goodwill and certain long-lived assets in the U.K. businesses. Proceeds from the termination of these swaps totaled $84 million and resulted in a settlement gain of $34 million for the nine months ended December 31, 2019. This gain was recorded in earnings in Other income (expense), net, net in the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains or losses from the Company&#x2019;s cross-currency swaps designated as net investment hedges recorded in Other comprehensive income were losses of $45 million and $108 million during the three and nine months ended December 31, 2020, respectively, and losses of $20 million and $11 million during the three and nine months ended December 31, 2019, respectively. There was no ineffectiveness in the Company&#x2019;s cross-currency swap hedges for the three and nine months ended December 31, 2020 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2019, the Company entered into a number of cross-currency swaps designated as fair value hedges with total notional amounts of &#xa3;450 million British pound sterling. Under the terms of the cross-currency swap contracts, the Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. These swaps are utilized to hedge the changes in the fair value of the underlying &#xa3;450 million British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives, which are designated as fair value hedges, and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from these fair value hedges recorded in earnings for the three and nine months December 31, 2020 and 2019 were largely offset by the losses recorded in earnings related to these notes. The swaps will mature in February 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company also enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies. For cross-currency swap transactions, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These cross-currency swaps are designed to reduce the income statement effects arising from fluctuations in foreign exchange rates and have been designated as cash flow hedges. At December 31, 2020 and March 31, 2020, the Company had cross-currency swaps with total gross notional amounts of approximately $2.6 billion and $2.9 billion, respectively, which are designated as cash flow hedges. These swaps will mature between February 2021 and January 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For forward contracts and cross-currency swaps that are designated as cash flow hedges, the effective portion of changes in the fair value&#160;of the hedges is recorded in Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 27, 2020, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with combined notional amounts of $500 million and &#x20ac;600 million, to hedge the variability of future benchmark interest rates on planned bond issuances. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $500 million swaps for floating interest payments in U.S. dollars based on three-month LIBOR and to pay fixed interest payments for floating interest payments in Euros based on six-month Euro Interbank Offered Rate (&#x201c;EURIBOR&#x201d;) for the &#x20ac;600 million swaps. The $500 million swaps were terminated upon the issuance of the 2025 Notes in November 2020. The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes. Refer to Financial Note 9, &#x201c;Debt and Financing Activities,&#x201d; for more information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Gains or losses from cash flow hedges recorded in Other comprehensive income were losses of $14 million and $42 million during the three and nine months ended December 31, 2020, respectively, and were gains of $5 million and $40 million during the three and nine months ended December 31, 2019, respectively. Gains or losses reclassified from Accumulated other comprehensive income and recorded in Operating expenses in the Condensed Consolidated Statements of Operations were not material in the three and nine months ended December 31, 2020 and 2019. There was no ineffectiveness in the Company&#x2019;s cash flow hedges for the three and nine months ended December 31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives Not Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in fair value included in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a number of forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. At December 31, 2020 and March 31, 2020, the total gross notional amounts of these contracts were $13 million and $29 million, respectively. These contracts will predominantly mature between January 2021 and October 2021 and none of these contracts were designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in Operating expenses. Changes in the fair values were not material in the three and nine months ended December 31, 2020 and 2019. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended December 31, 2019, the Company also entered into a number of forward contracts and swaps to offset a portion of the earnings impacts from the ineffectiveness of the net investment hedges discussed above. These contracts matured through January 2020 and none of these contracts were designated for hedge accounting. In December 2019, the Company entered into a series of forward contracts with a total notional amount of &#x20ac;250 million to offset the earnings impact from its Euro-denominated notes. These contracts and the notes against which they offset matured in February 2020 and were not designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly in earnings. During the three and nine months ended December 31, 2019, gains of $3 million and losses of $36 million, respectively, were recorded in earnings within Other income (expense), net in the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the fair value of derivatives on a gross basis is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.481%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet &lt;br/&gt;Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Refer to Financial Note 12, "Fair Value Measurements," for more information on these recurring fair value measurements.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i0d9cf49bcf574771b799ca4645191cd5_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMTUwMg_021d3b9c-6ae6-4e7f-80ba-ca0c2683cdb9"
      unitRef="eur">1700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2a0ca354dcd646dbb94a5e6bc0adc910_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMTUwMg_36908ddb-0cde-4520-aa90-93836d21920d"
      unitRef="eur">1700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ide3c05407d4f405faeeb775e3cadb1ad_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMzg0ODI5MDcwNzYxMw_1eb2fa98-4cbe-459e-90d1-b726bc467efc"
      unitRef="eur">250000000</us-gaap:LongTermDebt>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ic3392a15e42349f38396d43edec58984_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMjU1MQ_c5ba9968-07fa-4dfd-bde2-42bb1d6d4a83"
      unitRef="usd">-84000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ieae8ce38c55c4a8183867cb63bfddafb_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMjU1OA_74906e52-dbd8-4083-83c8-12d8716e7648"
      unitRef="usd">-201000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i8ac357c6d2694d3e854ab420c7c33a3e_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMjYwMw_0cf9bcaf-0217-4097-bdd6-8758c178ce93"
      unitRef="usd">-59000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6d10966d07b64ebba1b226a32e8e56fa_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMjYxMA_32364e8c-5518-494b-9bcf-03f7968c19c2"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMjgzMQ_c105f2c6-ef97-47a5-8818-94c59cb3c378"
      unitRef="usd">-3000000</mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax>
    <mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMjgzOA_04a399ef-c153-436f-a65a-0b3ca99d7ffa"
      unitRef="usd">26000000</mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iae697c5a606444c8a0bf468944693083_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMzEzNA_2928e209-b2ec-4922-b1c9-56cb1e1cee31"
      unitRef="cad">999000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4c3d87e0bc6d4b3788054a9adf38efdf_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMzg0ODI5MDcwNzc3MA_2da95d14-eac2-4187-bad9-124376739a71"
      unitRef="cad">1500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib05778dd9f2047e7ab989296e4f1f027_I20201130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfOTM0NTg0ODg1MDk1Nw_dff3c3c7-bf2b-4629-be56-c9ee9bb88756"
      unitRef="cad">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4ffae78da5324045885fd5c5f9e72fe7_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNDUxNg_54e795c7-8566-4fa2-8e39-be606831e5ee"
      unitRef="gbp">932000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="i3a1e7fab3c5a46bc80683fd7a9936356_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNDc2NQ_9b6eb1e0-0c39-40da-83bd-86249ca91b09"
      unitRef="usd">84000000</us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i3a1e7fab3c5a46bc80683fd7a9936356_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNDgwNQ_e082606d-4848-4e0b-a187-257097b48fa5"
      unitRef="usd">34000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i36b3bcf8d524467bacd1c159707af361_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNTA4NA_c265c6c4-fd5c-467c-b20d-8276484e503a"
      unitRef="usd">-45000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i09c294f2acd74c33bb8e9ada8e29bfef_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNTA5MQ_5a406b85-3edc-4fb4-9e38-8d9812c503b6"
      unitRef="usd">-108000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="if86aed3e96a64acfb7d6c3d4ba3f32e0_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNTEzNg_2bb5a721-22b1-40b1-97ee-0fe83616eacf"
      unitRef="usd">-20000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i51b2cfed82a94bea9d5b40efccf351cc_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNTE0Mw_45bdb20e-77da-42e6-8dfa-c53808430199"
      unitRef="usd">-11000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:LongTermDebt
      contextRef="i132f49f70d8e4b459e1dfdc3b23932f9_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNTUxNw_f843b2be-4d8f-481d-8510-602cba550667"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i132f49f70d8e4b459e1dfdc3b23932f9_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNTg2OQ_f843b2be-4d8f-481d-8510-602cba550667"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5bed0108d30a4edbadaa59d784d7e6f2_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNzEzMQ_cfc6d829-ed8e-49ae-b1ec-e66b006e318d"
      unitRef="usd">2600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia6fd83f4ec5346a89c43a4d4970b587b_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfNzEzOA_0344d20b-d9ad-40f5-93aa-08564f3198e7"
      unitRef="usd">2900000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7e172a5b89714b5f980c0d1515d155bb_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMzg0ODI5MDcwODI1MA_4902c8bd-6378-46b3-843c-fbdfcde1d946"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7e172a5b89714b5f980c0d1515d155bb_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMzg0ODI5MDcwODMwNw_12a3dcbf-6234-453f-85dd-3f2065ee9284"
      unitRef="eur">600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7e172a5b89714b5f980c0d1515d155bb_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMzg0ODI5MDcwODI3OQ_4902c8bd-6378-46b3-843c-fbdfcde1d946"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7e172a5b89714b5f980c0d1515d155bb_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMzg0ODI5MDcwODMzNg_12a3dcbf-6234-453f-85dd-3f2065ee9284"
      unitRef="eur">600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7e172a5b89714b5f980c0d1515d155bb_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMzg0ODI5MDcwODc3OQ_4902c8bd-6378-46b3-843c-fbdfcde1d946"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DebtInstrumentTerm
      contextRef="idae826ee5fc34b5a8ac7443ee5012249_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfOTM0NTg0ODg1MTA0MA_fab6e01f-bd20-46ce-8d2c-b34ac8e99ea4">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i4108ab99008d4e68a3dd3eae636c4e61_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfODM0MQ_fd734b77-9f1e-4fa5-906d-e51dab07060f"
      unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="iacfcda1e22f341b0934dd329fa019e54_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfODM0OA_7e7f07da-99be-4721-a213-d4a47c70b034"
      unitRef="usd">-42000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="if2a0e643e93146bc9920807b4ff5583b_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfODM5OA_0dd4c7b5-e3cb-4c9f-90e5-e4a7f53ee311"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i906ea84070b64689a6d04852f20df452_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfODQwNQ_0e11c3f7-8a69-4530-934c-a5fcd3a6546a"
      unitRef="usd">40000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i35d99ea68d0b48eab76bb746417d8dd8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfOTEwNg_65c1f275-f38e-482f-93d6-2d754556e0fe"
      unitRef="usd">13000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0eeec9e2862e4c51b6d12a38ac428a0e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfOTExMw_d76ab664-6490-4a0c-81af-143ea3a07d29"
      unitRef="usd">29000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic99175677b954f009bf7dd3ff1f205b9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMzg0ODI5MDcwODUzOQ_831ffe8a-94af-4df8-8279-3244528d28d9"
      unitRef="usd">250000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ie84b0678aefd46f39446455df3d55df3_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfOTk3NQ_04a2bb21-9b44-40b8-bb99-146cae670408"
      unitRef="usd">3000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i3ba05cbb6a39421ca690fc9912bd454c_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfOTk4Mg_03dba129-017e-441c-a19a-09a8aa7b72cd"
      unitRef="usd">-36000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RleHRyZWdpb246MzAzYmZhNmVhMmNkNDMxNjg0ZjI2MjQ4OGVlNzNjOGVfMTAyODg_f37cf93f-ac34-4feb-9b50-08b675518475">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the fair value of derivatives on a gross basis is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.481%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet &lt;br/&gt;Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i57bde6e22b1b418fb5cb8d67718f73cc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNS0yLTEtMS0w_b98d4ba0-1b52-4d8b-a257-eab5f24f0f31"
      unitRef="usd">7000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i0b4553eec3884a74b9c29ba57c8f46fc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNS00LTEtMS0w_07443f66-289e-425d-994f-776d19358a15"
      unitRef="usd">74000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i041bb96bdf7c4fd18af85821acc08bdb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNS01LTEtMS0w_ae47ffb4-58fd-4663-9b8a-5059e50917c6"
      unitRef="usd">1084000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if8c751112cf84239a9ea0b86ba0c4dce_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNS03LTEtMS0w_c910e85e-a2ae-488a-bed7-31a99ce36e68"
      unitRef="usd">112000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i70cef476be954ba5826ef9cb90ed5bb0_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNS05LTEtMS0w_67908c75-395f-40cd-b5c9-2e1298d4e78d"
      unitRef="usd">19000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i941389e63f2541a1a376a9b746120d0e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNS0xMC0xLTEtMA_1e644a77-1d85-4fe8-9874-542317463696"
      unitRef="usd">1279000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i2ec64489b9604c8d8f972120fbda6056_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNi0yLTEtMS0w_aedb25b3-5b2e-462a-ab7f-33a36fadc49d"
      unitRef="usd">85000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="idbfc5ce51aac4403bc97157e950c8b20_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNi00LTEtMS0w_b2fe77a7-c8e0-4dbc-9a95-2debceedeb4d"
      unitRef="usd">104000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i149087f716324b259895a04a05c5bb9c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNi01LTEtMS0w_6f95755f-b017-450f-a6eb-1f9aba36ce34"
      unitRef="usd">2776000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6b7780a8f9e948f093b5fd1cce4b2871_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNi03LTEtMS0w_508e9a4c-8f1e-442f-9703-ffb7eaa7b789"
      unitRef="usd">182000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i89165375051c4a2399f00117e4669f3f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNi05LTEtMS0w_770134a3-447a-4552-9acc-b3985f3336ec"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i85e18c845f544dc5b2de3609dccc18d1_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNi0xMC0xLTEtMA_dffc2093-3654-4241-aafb-ffdf2984d16c"
      unitRef="usd">3313000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i0e01229209e24fcbbaac835c6868ce3e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNy0yLTEtMS0w_9493cc9b-8b8e-4e69-b2a7-a92d5f4b05a0"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i0e01229209e24fcbbaac835c6868ce3e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNy00LTEtMS0w_a7657ba4-973a-49ee-b459-cca944192073"
      unitRef="usd">9000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i0e01229209e24fcbbaac835c6868ce3e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNy01LTEtMS0w_e85ba2db-513d-4f16-8360-bca7ff88a70c"
      unitRef="usd">733000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i46eff3e723494b9b8db10c46e8d5141e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNy03LTEtMS0w_fea3ee2e-6801-467c-b480-d06875662bd9"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i46eff3e723494b9b8db10c46e8d5141e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNy05LTEtMS0w_bb8b7710-5ad5-4725-8359-1cde833337e2"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i46eff3e723494b9b8db10c46e8d5141e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfNy0xMC0xLTEtMA_b3faf721-4ad6-4d02-aa8a-a1f4bab5304c"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie1a73cb404974bc2b79ec51446e9c1ae_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfOS0yLTEtMS0w_c7c401b8-9651-44dc-8536-e3864e75dbb6"
      unitRef="usd">92000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie1a73cb404974bc2b79ec51446e9c1ae_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfOS00LTEtMS0w_cbb0a159-a18f-44cb-bb8c-86216339213d"
      unitRef="usd">187000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9417de73a5c549f0be8c082c4db84e40_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfOS03LTEtMS0w_23808b49-a335-496f-8289-36b70cf6b83b"
      unitRef="usd">294000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9417de73a5c549f0be8c082c4db84e40_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfOS05LTEtMS0w_65bf58fe-3a69-4928-946d-0ddc8a60276c"
      unitRef="usd">19000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i69cadcfb856d4a7a9004d7cc9933b9d9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTEtMi0xLTEtMA_daf80920-94a4-4a12-889e-1d61146a17ed"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i69cadcfb856d4a7a9004d7cc9933b9d9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTEtNC0xLTEtMA_aad864fb-f6fa-4028-9e7e-d124a0561f66"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i69cadcfb856d4a7a9004d7cc9933b9d9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTEtNS0xLTEtMA_99df6695-ec63-4bf4-a621-0a1e6a3cc05c"
      unitRef="usd">1000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ieb9595c53e61414fa6ad030992206402_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTEtNy0xLTEtMA_428336ed-da2a-477d-baca-bb50bed1fecc"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ieb9595c53e61414fa6ad030992206402_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTEtOS0xLTEtMA_ebddd893-8ab3-40ad-85fe-102b6c8f88aa"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ieb9595c53e61414fa6ad030992206402_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTEtMTAtMS0xLTA_ead9f842-50b9-472b-98a4-65e531cbd98d"
      unitRef="usd">24000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i20f0b972582444239e16f4edffd19f90_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTItMi0xLTEtMA_05bc247a-65df-41b8-92b7-4a62dc74d5ff"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i20f0b972582444239e16f4edffd19f90_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTItNC0xLTEtMA_105f808b-88ae-4399-918a-e05642371996"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i20f0b972582444239e16f4edffd19f90_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTItNS0xLTEtMA_82467b9e-83c4-4f43-b883-1c7bb710a9a3"
      unitRef="usd">12000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4d9d75c3418b485e94de80a639f2a0fa_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTItNy0xLTEtMA_cc1c9cac-77a7-455a-9dea-5d8fc40810da"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i4d9d75c3418b485e94de80a639f2a0fa_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTItOS0xLTEtMA_dfeaeead-dbe7-49ec-938c-8ec815a3db96"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i4d9d75c3418b485e94de80a639f2a0fa_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTItMTAtMS0xLTA_019e059e-760a-499f-869e-00cd76834150"
      unitRef="usd">5000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib047b820d28e468fb76500c99500cb2c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTMtMi0xLTEtMA_ea1d70d1-c86d-417a-86bc-5009b55dc079"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib047b820d28e468fb76500c99500cb2c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTMtNC0xLTEtMA_c6ed28dd-abe4-47db-aa45-362f4273c7ef"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ieaf792582ac14ec9877670dd6af11a65_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTMtNy0xLTEtMA_81595513-7ba5-4fd0-b4ed-26796e69681d"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ieaf792582ac14ec9877670dd6af11a65_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF83OS9mcmFnOjMwM2JmYTZlYTJjZDQzMTY4NGYyNjI0ODhlZTczYzhlL3RhYmxlOjk5YTIxNjExNmYyMTRiMzA5MmExYjU2NzUwM2Q0ZDg5L3RhYmxlcmFuZ2U6OTlhMjE2MTE2ZjIxNGIzMDkyYTFiNTY3NTAzZDRkODlfMTMtOS0xLTEtMA_356e74c7-6278-46e3-a39c-230a475ee6b1"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfNjcwOA_528000a3-a4e4-4df8-abef-1f1b4c92043f">Fair Value Measurements&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020 and March 31, 2020, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt is carried at amortized cost. The carrying amounts and estimated fair values of these liabilities were $7.2 billion and $8.0 billion at December 31, 2020, respectively, and $7.4 billion and $7.8 billion at March 31, 2020, respectively. The estimated fair value of the Company&#x2019;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents at December 31, 2020 and March 31, 2020 included investments in money market funds of $123 million and $2.0 billion, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level&#160;1 inputs. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair values of the Company&#x2019;s foreign currency forward contracts were determined using observable inputs from available market information. Fair values of the Company&#x2019;s cross-currency swaps were determined using quoted foreign currency exchange rates and other observable inputs from available market information. Fair values of the Company&#x2019;s interest rate swaps were determined using observable inputs from available market information. These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 11, &#x201c;Hedging Activities,&#x201d; for fair value and other information on the Company&#x2019;s foreign currency derivatives including forward foreign currency contracts and cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry and which have carrying values of $267 million and $170 million at December 31, 2020 and March 31, 2020, respectively. These investments primarily consist of equity securities without readily determinable fair values and are included within Other non-current assets in the Condensed Consolidated Balance Sheets. In the second quarter of 2021, three of the companies in which McKesson holds investments in equity securities were converted into shares of public common stock through initial public offerings and an acquisition and are adjusted to fair value at each reporting period. In the third quarter of 2021, two of the Company&#x2019;s investments in equity securities without readily determinable fair values experienced transactions which resulted in changes in the observable price of those securities. As a result, net gains related to the Company&#x2019;s investments in equity securities, primarily representing unrealized gains on the securities discussed above, were $28 million and $87 million for the three and nine months ended December 31, 2020, respectively. These gains were recorded under the caption, &#x201c;Other income (expense), net,&#x201d; in the Condensed Consolidated Income Statements. There were no other material changes in the carrying value of these investments during the three and nine months ended December 31, 2020. The carrying value of publicly traded investments was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets measured at fair value on a nonrecurring basis as of December 31, 2020 included long-lived assets in the Company&#x2019;s International segment and goodwill of the Company&#x2019;s Europe Retail Pharmacy reporting unit within the International segment. At March 31, 2020, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#x2019;s European and Rexall Health businesses within the International segment. Refer to Financial Note 4, &#x201c;Restructuring, Impairment, and Related Charges,&#x201d; and Financial Note 8, &#x201c;Goodwill and Intangible Assets, Net,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aforementioned investments in equity securities includes the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no liabilities measured at fair value on a nonrecurring basis at December 31, 2020 and March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash, included within Prepaid expenses and other on the Company&#x2019;s Condensed Consolidated Balance Sheet as of December 31, 2020, primarily consists of funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. The amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds have been recorded by the Company within Other accrued liabilities on the Company&#x2019;s Condensed Consolidated Balance Sheet as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of its reporting units. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.&lt;/span&gt;&lt;/div&gt;The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i7840da1cacf0419993b0a527d8920e10_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfNjE0_a8b04a56-b991-4dfb-8735-d8f1bbd098fc"
      unitRef="usd">7200000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i7840da1cacf0419993b0a527d8920e10_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfNjIx_e2747597-5017-4424-b689-650ceec6d59a"
      unitRef="usd">8000000000.0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebt
      contextRef="i4c9db4a4610b4829b8b00be2a529a9cc_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfNjQ5_f1e7fd6e-6188-48cb-8088-5780766b55db"
      unitRef="usd">7400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i4c9db4a4610b4829b8b00be2a529a9cc_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfNjU2_9129330d-7584-4c9a-b131-31ab64e9d2b1"
      unitRef="usd">7800000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i701d2f10e13b41148f385570a86bf3b1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfMTE3OA_397d9093-ae2b-43ed-a86d-de89210b0164"
      unitRef="usd">123000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iadffe49dd7104768a9a656790d004b41_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfMTE4NQ_b1fa2561-86d1-416f-83c9-6af2ce40eef5"
      unitRef="usd">2000000000.0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfNjA0NzMxMzk2MDk1Mg_7fed0def-9a4a-4f4e-a06f-ecf66c76d33b"
      unitRef="usd">267000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i7a0bf71acb034de79df20792261b0fe2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfNjA0NzMxMzk2MDk2MA_2f896b8a-5043-40d8-b258-0899798e1cb2"
      unitRef="usd">170000000</us-gaap:EquitySecuritiesFvNi>
    <mck:EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies
      contextRef="i85b5d437b88a43c3b57c3014d5ae8bf1_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfMjg0Mg_b814b168-f0b7-4bb6-8268-a6a551b123c1"
      unitRef="company">3</mck:EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies>
    <mck:EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfOTM0NTg0ODg0NDQ3MQ_ee92e97d-5ed6-4a76-bcf0-80321d26b345"
      unitRef="investmentsecurity">2</mck:EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfMjE5OTAyMzI2Mzk1Nw_e4e06af2-c971-4ea9-a1f9-649cadffe2ec"
      unitRef="usd">28000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfMjE5OTAyMzI2Mzk2NA_19cff5a0-cd58-4533-a4ef-20275f8c7101"
      unitRef="usd">87000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia32a43bf4c32481bb6ea7a38d845082c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfNDc3NA_ba217e50-dc8a-4b7b-8e8a-5790b6dc1b73"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0f2700a332404782bc605abd43a2168b_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84NS9mcmFnOjBhZjQ4NDhjYzg0YTRlODQ5ODAwMmUyZjE4NGNhOTQxL3RleHRyZWdpb246MGFmNDg0OGNjODRhNGU4NDk4MDAyZTJmMTg0Y2E5NDFfNDc3NA_e693014f-15d7-4608-b95b-255b2e10f776"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMTgxNTY_19fcbe3b-8a18-4277-9355-9802d1727ea1">Commitments and Contingent Liabilities&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/927653/000092765320000033/mck10k3312020.htm#sFDC7F65C03045D74BF3631026AD9426B" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Note 21 to the Company&#x2019;s 2020 Annual Report&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Note 13 to the Company&#x2019;s 10-Q filing for the quarterly period ended June 30, 2020&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Note 13 to the Company&lt;/a&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&#x2019;&lt;/a&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;s 10-Q fil&lt;/a&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;ing for the quarterly period ended &lt;/a&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;September 30, 2020&lt;/a&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;,&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, it is not reasonably possible for the Company to determine that a loss is probable for a claim, or to reasonably estimate the amount of loss or a range of loss, because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to be resolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the loss probability has changed and whether it can make a reasonable estimate of the possible loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability in the amount of its estimate for the ultimate loss. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;I. Litigation and Claims Involving Distribution of Controlled Substances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and its affiliates are defendants in many cases asserting claims related to distribution of controlled substances. They are named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions include state attorneys general, county and municipal governments, hospitals, Indian tribes, pension funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico, and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#x201c;RICO&#x201d;), state and federal controlled substances laws, and other statutes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since December 5, 2017, nearly all such cases pending in federal district courts have been transferred for consolidated pre-trial proceedings to a multi-district litigation (&#x201c;MDL&#x201d;) in the United States District Court for the Northern District of Ohio captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re: National Prescription Opiate Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Case No. 17-md-2804. At present, there are approximately 2,900 cases under the jurisdiction of the MDL court. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Three cases involving McKesson that were previously part of the federal MDL have been remanded to other federal courts for discovery and trial. On January 14, 2020, the Judicial Panel on Multidistrict Litigation finalized its Conditional Remand Order, ordering that the cases against the three largest distributors brought by Cabell County, West Virginia and the City of Huntington, West Virginia be remanded to the U.S. District Court for the Southern District of West Virginia. Trial in that case is scheduled to begin on May 3, 2021. On February 5, 2020, the case brought by the City and County of San Francisco was remanded to the U.S. District Court for the Northern District of California; trial has been set for December 6, 2021. Also on February 5, 2020, the case brought by the Cherokee Nation was remanded by the MDL court to the U.S. District Court for the Eastern District of Oklahoma.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also named in approximately 400 similar state court cases pending in 38 states plus Puerto Rico, along with 3 cases in Canada. These include actions filed by 26 state attorneys general, and some by or on behalf of individuals, including wrongful death lawsuits, and putative class action lawsuits brought on behalf of children with neonatal abstinence syndrome due to alleged exposure to opioids in utero. Trial dates have been set in several of these state court cases. For example, trial was previously set to begin in March 2020 in the Supreme Court of New York, Suffolk County for a case brought by the New York attorney general and two New York county governments, but the trial was postponed in light of the COVID-19 pandemic. The case brought by the Alabama attorney general is scheduled to go to trial in May 2021, as is the case brought by the Washington attorney general.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continues to be involved in discussions with the objective of achieving broad resolution of opioid-related claims of states, their political subdivisions, and other government entities (&#x201c;governmental entities&#x201d;). The Company is in ongoing, advanced discussions with state attorneys general and plaintiffs&#x2019; representatives regarding a framework under which the three largest U.S. pharmaceutical distributors would pay up to approximately $21.0 billion over a period of 18 years, with up to approximately $8.0 billion to be paid by the Company to resolve claims of governmental entities, with more than 90% of the total amount anticipated to be used to remediate the opioids crisis. Most of the remaining amount relates to plaintiffs&#x2019; attorneys fees and costs, and would be payable over a shorter time period. In addition, the proposed framework would require the three distributors, including the Company, to adopt changes to anti-diversion programs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the framework, before the distributors determine whether to enter into any final settlement, they would assess the sufficiency of the scope of settlement, based in part on the number and identities of the governmental entities that would participate in any such settlement. The framework contemplates that if certain governmental entities did not agree to a settlement under the framework, but the distributors nonetheless concluded that there was sufficient participation to warrant going forward with the settlement, there would be a corresponding reduction in the amount due from the Company to account for the governmental entities that did not agree. Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has concluded that discussions under that framework have reached a stage at which a broad settlement of opioid claims by governmental entities is probable, and the loss related thereto can be reasonably estimated as of December 31, 2020. As a result of that conclusion, and its assessment of certain other opioid-related claims, the Company has recorded a charge of $8.1 billion ($6.7 billion after-tax) within Claims and litigation charges, net in the Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2020, related to its share of the settlement framework described above, as well as those certain other opioid-related claims. In light of the uncertainty, as described below, of the timing of amounts that would be paid with respect to the charge, the charge was recorded in Long-term litigation liabilities in the Company&#x2019;s Condensed Consolidated Balance Sheet as of December 31, 2020. Moreover, in light of the uncertainties described below, the amount of loss that the Company ultimately might incur may differ materially from the amount accrued.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discussions with attorneys general and other parties continue. If the negotiating parties agree on terms under the framework for a broad resolution of claims of governmental entities, then those potential terms would need to be agreed to by numerous other state and local governments before an agreement could be accepted by the Company and finalized. In some cases, discovery has been paused during the parties&#x2019; discussions. While the Company continues to be involved in discussions regarding a potential broad settlement framework, the Company also continues to prepare for trial in these pending matters. The Company believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the vast majority of opioid claims have been brought by U.S. governmental entities, the Company is also a defendant in cases brought by private plaintiffs, such as hospitals, pension funds, third-party payors, and individuals, as well as 3 cases in which the Company has been named as a defendant in Canada. These claims, and those of private entities generally, are not included in the settlement framework for U.S. governmental entities, or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. The Company has not concluded a loss is probable in any of these matters; nor is the amount of any possible loss reasonably estimable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, and the uncertainty of the scope of potential participation by governmental entities under the framework described above, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#x2019;s financial position, cash flows or liquidity, or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;II. Other Litigation and Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 17, 2013, the Company was served with a complaint filed in the United States District Court for the Northern District of California by True Health Chiropractic Inc., alleging that McKesson sent unsolicited marketing faxes in violation of the Telephone Consumer Protection Act of 1991 (&#x201c;TCPA&#x201d;), as amended by the Junk Fax Protection Act of 2005 or JFPA,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;True Health Chiropractic Inc., et al. v. McKesson Corporation, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#160;No. CV-13-02219 (HG). Plaintiffs seek statutory damages from&#160;$500&#160;to&#160;$1,500&#160;per violation plus injunctive relief. True Health Chiropractic later amended its complaint, adding McLaughlin Chiropractic Associates as an additional named plaintiff and McKesson Technologies Inc. as a defendant. Both plaintiffs alleged that defendants violated the TCPA by sending faxes that did not contain notices regarding how to opt out of receiving the faxes. On July 16, 2015, plaintiffs filed a motion for class certification. On August 22, 2016, the court denied plaintiffs&#x2019; motion. On July 17, 2018, the United States Court of Appeals for the Ninth Circuit Court affirmed in part and reversed in part the district court&#x2019;s denial of class certification and remanded the case to the district court for further proceedings. On August 13, 2019, the court granted plaintiffs&#x2019; renewed motion for class certification. After class notice and the opt-out period, 9,490 fax numbers remain in the class, representing 48,769 faxes received. On March 5, 2020, McKesson moved to decertify the class and moved for summary judgment on plaintiffs&#x2019; claim for treble damages. Plaintiffs&#x2019; moved for summary judgment on the same day. On December 24, 2020, the court declined to decertify the class but modified the class definition to distinguish between physical faxes (kept in the class) versus online or e-fax recipients (removed from the class). Because the court modified the class definition, the court deferred on ruling on the parties&#x2019; cross-motions for summary judgment, and directed the parties to submit a statement agreeing or objecting to the court&#x2019;s proposal for updated class notice. Due to the COVID-19 pandemic, the trial date for this case was taken off calendar to be re-scheduled during 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 29, 2017, two investment funds holding shares in Celesio AG filed a complaint against McKesson Europe Holdings (formerly known as &#x201c;Dragonfly GmbH &amp;amp; Co KGaA&#x201d;), a subsidiary of the Company, in a German court in Stuttgart, Germany, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp;amp; Co. KGaA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 18 O 455/17. On December 30, 2017, four investment funds, which had allegedly entered into swap transactions regarding shares in Celesio AG that would have enabled them to decide whether to accept McKesson Europe Holdings&#x2019;s takeover offer in its acquisition of Celesio AG, filed a complaint, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Davidson Kempner International (BVI) Ltd. et al. v. McKesson Europe Holdings GmbH &amp;amp; Co. KGaA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No.16 O 475/17. The complaints allege that the public tender offer document published by McKesson Europe in its acquisition of Celesio AG incorrectly stated that McKesson Europe&#x2019;s acquisition of convertible bonds would not be treated as a relevant acquisition of shares for the purposes of triggering minimum pricing considerations under Section 4 of the German Takeover Offer Ordinance. On May 11, 2018, the court in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Polygon&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; dismissed the claims against McKesson Europe. Plaintiffs appealed this ruling and, on December 19, 2018, the Higher Regional Court (Oberlandesgericht) of Stuttgart confirmed the full dismissal of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Polygon&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; matter. Plaintiffs filed a complaint against denial of leave to appeal with the Federal Court of Justice (Bundesgerichtshof), which was rejected on November 17, 2020, making the dismissal final and binding. With no further right to appeal, Plaintiffs filed an objection against the decision of the Federal Court of Justice on November 27, 2020, claiming their right to be heard had been violated. On March 15, 2019, the lower court in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Davidson&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; similarly dismissed the case. Plaintiffs appealed this ruling and, on October 9, 2019, the Higher Regional Court (Oberlandesgericht) of Stuttgart confirmed the full dismissal of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Davidson&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; matter. On November 13, 2019, Plaintiffs filed a complaint against denial of leave to appeal with the Federal Court of Justice (Bundesgerichtshof).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 25, 2018, Marion Diagnostic Center, LLC and Marion Healthcare, LLC filed a class action complaint in the United States District Court for the Eastern District of Pennsylvania alleging that the Company and its subsidiary, McKesson Medical-Surgical Inc., among others, violated the Sherman Act by restraining trade in the sale of generic drugs. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Marion Diagnostic Center, LLC v. McKesson Corporation, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 2:18-cv-4137; MDL No. 16-MD-2724. On June 26, 2019, the court granted the Company&#x2019;s motion to dismiss and authorized plaintiffs to seek leave to amend the claims against the Company. On December 30, 2019, a group of independent pharmacies and a hospital filed a class action complaint alleging that the Company and other distributors violated the Sherman Act by colluding with manufacturers to restrain trade in the sale of generic drugs. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reliable Pharmacy, et al. v. Actavis Holdco US, et al., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No. 2:19-cv-6044; MDL No. 16-MD-2724. The complaint seeks relief including treble damages, disgorgement, attorney fees, and costs in unspecified amounts. The court in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Marion Diagnostic &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ordered dismissal of plaintiff&#x2019;s complaint with prejudice on November 23, 2020 pursuant to a stipulation of the parties, but without waiving any rights Marion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diagnostic Center, LLC and Marion Healthcare, LLC&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;may have to participate in a settlement or judgment of any other action in the MDL as a class member.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;III.&#160;Government Subpoenas and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 21, 2020, McKesson received correspondence from the U.S. Attorney&#x2019;s Office for the Western District of Tennessee alleging reporting and documentation deficiencies in violation of the Controlled Substances Act at the Company&#x2019;s former and no longer operational RxPak facility and at its Distribution Center in Memphis, Tennessee, and seeking civil penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IV.  State Opioid Statutes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legislative, regulatory or industry measures to address the misuse of prescription opioid medications could affect the Company&#x2019;s business in ways that it may not be able to predict. For example, in April 2018, the State of New York adopted the Opioid Stewardship Act (the &#x201c;OSA&#x201d;) which required the creation of an aggregate $100&#160;million annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. The initial surcharge payment would have been due on January 1, 2019 for opioids sold or distributed during calendar year 2017. On July 6, 2018, the Healthcare Distribution Alliance filed a lawsuit challenging the constitutionality of the law and seeking an injunction against its enforcement. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State appealed that decision. On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#x2019;s decision on procedural grounds. The Company has accrued a $50&#160;million pre-tax charge ($37&#160;million after-tax) as its estimated share of the OSA surcharge for calendar years 2017 and 2018. This OSA provision was recognized as Operating expenses in the accompanying condensed consolidated statement of operations for the nine months ended December 31, 2020 and as Other accrued liabilities in the condensed consolidated balance sheets as of December 31, 2020. The State of New York adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018. The Healthcare Distribution Alliance filed a petition for panel rehearing, or, in the alternative, for rehearing &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;en banc&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; with the U.S. Court of Appeals for the Second Circuit; that petition was denied on December 18, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMTgxNjg_c3135543-6ccc-4ba1-b6a6-b8493fc739b2">&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/Archives/edgar/data/927653/000092765320000033/mck10k3312020.htm#sFDC7F65C03045D74BF3631026AD9426B" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Note 21 to the Company&#x2019;s 2020 Annual Report&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Note 13 to the Company&#x2019;s 10-Q filing for the quarterly period ended June 30, 2020&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Note 13 to the Company&lt;/a&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&#x2019;&lt;/a&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;s 10-Q fil&lt;/a&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;ing for the quarterly period ended &lt;/a&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;September 30, 2020&lt;/a&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;,&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.&lt;/span&gt;Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, it is not reasonably possible for the Company to determine that a loss is probable for a claim, or to reasonably estimate the amount of loss or a range of loss, because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to be resolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the loss probability has changed and whether it can make a reasonable estimate of the possible loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability in the amount of its estimate for the ultimate loss. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i9a5ab16c64ae4891a9ee3b4e317ce1eb_I20201231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMzcxMg_d7d2a64d-95f2-4fec-b779-d45cd49777d0"
      unitRef="case">2900</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts
      contextRef="i11feebab2b6a424dbf4daff39a96c1b9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNDM5OA_5a076b3f-a12e-4644-abb0-8326224cacda"
      unitRef="case">3</mck:LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts>
    <mck:LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges
      contextRef="ieb5a21abc8d848b6956e3feaf80201be_I20200114"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNDY4Mw_3845396f-aabf-48de-8de4-6ff650a89600"
      unitRef="company">3</mck:LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i1814ff2457bd41d6804ef58f25e4d38e_I20201231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNTMwNA_944420a9-e589-4fdf-8309-489494aeae69"
      unitRef="case">400</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyNumberofStates
      contextRef="i1814ff2457bd41d6804ef58f25e4d38e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNTM0NA_35bd083a-920d-43c0-98f7-156f917c9238"
      unitRef="state">38</mck:LossContingencyNumberofStates>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="icbc6c502b0884c4985e06716f2758c89_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNTM4Mw_ff22acd3-2157-407e-ac19-d617dc92d644"
      unitRef="case">3</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyNumberofStateAttorneyGenerals
      contextRef="i1814ff2457bd41d6804ef58f25e4d38e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNTQzNA_0f79ef79-e244-44a3-a765-ac3279ce49ca"
      unitRef="stateattorney">26</mck:LossContingencyNumberofStateAttorneyGenerals>
    <mck:NumberOfCountyGovernments
      contextRef="if621de71312448b2a9e258676fa2ca7f_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNTkwNw_3c22623e-5b4b-4766-a213-760b2bfffb1c"
      unitRef="county">2</mck:NumberOfCountyGovernments>
    <mck:LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges
      contextRef="i466b8e02cb9445f399b466a5da7612c9_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNjQ5OQ_20f3e42a-554e-4fdb-9aef-873391c547c5"
      unitRef="company">3</mck:LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i296306fefeb14dec9e27a205cd23548a_D20201001-20201031"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNjU5Nw_71e80eef-41e5-4dc7-b14a-b73416f8aba0"
      unitRef="usd">21000000000.0</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementAgreementAwardPaymentPeriod
      contextRef="i296306fefeb14dec9e27a205cd23548a_D20201001-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNjYwNQ_e1aeed9e-5ed5-4daf-a514-3a7d43076e78">P18Y</mck:LossContingencySettlementAgreementAwardPaymentPeriod>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i810be42fbf2d4974a731649985916aec_D20201001-20201031"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfNjYzNA_e6508f07-ae97-4e3a-8e07-5c90bca3ec1d"
      unitRef="usd">8000000000.0</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation
      contextRef="i9b59d9c3f0e146b8a720c89acae06997_I20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMjE5OTAyMzMyNzQ3Mg_7521db71-5c06-43b6-ae9a-6faf14ae2459"
      unitRef="number">0.90</mck:LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i7ac4183cf22d4c829d4a7bc371cc268c_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMjE5OTAyMzI5MzA3MQ_dcac3458-4279-4dfe-9a7f-1fca14a1a501"
      unitRef="usd">8100000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i30c6a601291c426daef2c98a6924abf6_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMjE5OTAyMzI5MzA3MQ_e9adc7c3-ed49-4c00-92cc-42ef2aa25053"
      unitRef="usd">8100000000</us-gaap:LossContingencyAccrualProvision>
    <mck:LossContingencyAccrualProvisionNetOfTax
      contextRef="i7ac4183cf22d4c829d4a7bc371cc268c_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMjE5OTAyMzI5MzA4OQ_05bac1f2-f26a-4d94-bd1f-00678e229869"
      unitRef="usd">6700000000</mck:LossContingencyAccrualProvisionNetOfTax>
    <mck:LossContingencyAccrualProvisionNetOfTax
      contextRef="i30c6a601291c426daef2c98a6924abf6_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMjE5OTAyMzI5MzA4OQ_4a2bd069-22f8-476e-96ad-73aeb42bae7e"
      unitRef="usd">6700000000</mck:LossContingencyAccrualProvisionNetOfTax>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i0f96022346a941118bddf4181736007f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMjE5OTAyMzMyNzc2Mw_dd589bf4-e774-44b3-8a2a-ade814a09670"
      unitRef="case">3</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyDamagesSoughtPerViolationValue
      contextRef="i307db805735d4eed947d313935f69a7c_D20130517-20130517"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfOTg3Mw_cb758b5d-3a6c-441f-9205-229863bde59c"
      unitRef="usd">500</mck:LossContingencyDamagesSoughtPerViolationValue>
    <mck:LossContingencyDamagesSoughtPerViolationValue
      contextRef="i70c71945e9ab4abc8b1e9671bc5cf37f_D20130517-20130517"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfOTg3OQ_2b141489-b664-4e6c-9054-7c1c05e95ec4"
      unitRef="usd">1500</mck:LossContingencyDamagesSoughtPerViolationValue>
    <mck:LossContingencyClassActionNumberofFaxesRemainingintheClass
      contextRef="iea73c883add347f580abc569d92611ad_I20190813"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMTA3NDc_3998dc24-2abb-4600-87d2-a250c2f65dc9"
      unitRef="fax_number">9490</mck:LossContingencyClassActionNumberofFaxesRemainingintheClass>
    <mck:LossContingencyClassActionNumberofFaxesReceived
      contextRef="iea73c883add347f580abc569d92611ad_I20190813"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMTA3OTY_916b5f93-9c66-4e31-900c-fca0658a1821"
      unitRef="fax">48769</mck:LossContingencyClassActionNumberofFaxesReceived>
    <mck:NumberOfInvestmentFundsThatFiledClaims
      contextRef="i4f79315064404a0d802db3a9c2d14fe6_I20171229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfOTM0NTg0ODg2OTgzMg_a3c52394-1138-444e-b599-4d8654a68f50"
      unitRef="investmentfund">2</mck:NumberOfInvestmentFundsThatFiledClaims>
    <mck:NumberOfInvestmentFundsThatFiledClaims
      contextRef="i4c90799af4454695aebcf7f2731092cd_I20171230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfOTM0NTg0ODg2OTg0Mw_08e1ab3c-2218-4453-ae85-f1f8780c8aa1"
      unitRef="investmentfund">4</mck:NumberOfInvestmentFundsThatFiledClaims>
    <mck:OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids
      contextRef="ic5f178fedc5b4cf6bdb61d18797a2680_I20180430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMTY4MDY_03d96da7-c7dc-4ef4-9f35-a637b87c1bf5"
      unitRef="usd">100000000</mck:OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMTc2MTI_2bb654a7-49a6-4aa9-a793-2876f8a78e93"
      unitRef="usd">50000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <mck:LossContingencyAccrualAfterTax
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF84OC9mcmFnOmE0NTJhNjZiYzc5MTQ1NDRiOTU5NzQ1MjgwZmQ1YmQwL3RleHRyZWdpb246YTQ1MmE2NmJjNzkxNDU0NGI5NTk3NDUyODBmZDViZDBfMTc2MzE_c25db658-9ffb-4c87-9d0a-7e36625c11e3"
      unitRef="usd">37000000</mck:LossContingencyAccrualAfterTax>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfNDU1Mw_2223c200-98ca-4147-a451-93ca1e8bf63a">Stockholders' Equity (Deficit) &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of the Company&#x2019;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 29, 2020, the Company raised its quarterly dividend from $0.41 to $0.42 per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements, and other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Plans &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock repurchases may be made from time to time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#x201c;ASR&#x201d;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#x2019;s stock price, corporate and regulatory requirements, restrictions under the Company&#x2019;s debt obligations, and other market and economic conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June 30, 2020, there were no share repurchases made under previously authorized share repurchase programs. During the three months ended September 30, 2020, the Company repurchased 1.8&#160;million of the Company&#x2019;s shares for $269 million through open market transactions at an average price per share of $151.23. During the three months ended December 31, 2020, the Company repurchased 1.5&#160;million of the Company&#x2019;s shares for $231 million through open market transactions at an average price per share of $151.12. The total authorization outstanding for repurchases of the Company&#x2019;s common stock was $1.0 billion at December 31, 2020. In January 2021, the Board approved an increase of $2.0 billion for the authorized share repurchase of McKesson&#x2019;s common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding Other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments arising during period, net of income tax expense of nil, nil, nil, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil, nil, nil, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized losses on net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized losses on net investment hedges arising during period, net of income tax benefit of $33, $21, $80, and $1 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil, nil, nil, and nil&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on cash flow hedges arising during period, net of income tax (expense) benefit of $2, $3, $6, and $(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil,  nil, nil, and nil&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in retirement-related benefit plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss and prior service cost arising during the period, net of income tax benefit of nil, nil, nil, and $1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial loss, prior service cost and transition obligation, net of income tax benefit of $2, nil, $1, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments and other, net of income tax expense of nil, nil, nil, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24.75pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of $9, $3, $9, and $35 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(8)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income, net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s foreign subsidiary, McKesson Europe, and its operations in Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;During the three and nine months ended December 31, 2020, net foreign currency translation adjustments were primarily due to the strengthening of the Canadian dollar and Euro against the U.S. dollar from April 1, 2020 to December 31, 2020. During the three and nine months ended December 31, 2019, the net foreign currency translation adjustments were primarily due to the strengthening of the Euro and Canadian dollar against the U.S. dollar, partially offset by weakening of the British pound sterling from April 1, 2019 to December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three and nine months ended December 31, 2020 includes net foreign currency translation adjustments of $20 million and $(41) million, respectively, and the three and nine months ended December 31, 2019 includes net foreign currency translation adjustments of $12 million and $(1) million, respectively, attributable to redeemable noncontrolling interests. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three and nine months ended December 31, 2020 include adjustments for amounts related to the contribution of the Company&#x2019;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 3, &#x201c;Held for Sale.&#x201d; These amounts were included in the current and prior periods calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Operating expenses in the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three and nine months ended December 31, 2020 includes foreign currency losses of $84 million and $201 million, respectively, on the net investment hedges from the &#x20ac;1.7 billion&#160;Euro-denominated notes and &#xa3;450 million&#160;British pound sterling-denominated notes, losses of $45 million and $108 million, respectively, on the net investment hedges from cross-currency swaps, and losses on net investment hedges of nil and $1 million, respectively, attributable to redeemable noncontrolling interests. The three and nine months ended December 31, 2019 include foreign currency losses of $59 million and gains of $8 million, respectively, on the net investment hedges from the &#x20ac;1.70 billion Euro-denominated notes and&#160;&#xa3;450 million British pound sterling-denominated notes and losses of $20 million and $11 million, respectively, on the net investment hedges from cross-currency swaps. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three and nine months ended December 31, 2020 include net actuarial gains of $5 million and $3 million, respectively, and the three and nine months ended December 31, 2019 include net actuarial losses of $2 million and $1 million, respectively, which are attributable to redeemable noncontrolling interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Pre-tax amount was reclassified into Cost of sales and Operating expenses in the Condensed Consolidated Statements of Operations. The related tax expense was reclassified into Income tax benefit (expense) in the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(8)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The nine months ended December 31, 2019 primarily reflects a reclassification of losses in the second quarter of 2020 upon a pension settlement charge from Accumulated other comprehensive loss to Other income (expense), net in the Condensed Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Income (Loss) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s Accumulated other comprehensive income (loss) by component for the three and nine months ended December 31, 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Losses and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s Accumulated other comprehensive income (loss) by component for the three and nine months ended December 31, 2019 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,570)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,570)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <mck:CommonStockVotingRightsNumberofVotesPerCommonShare
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfNzk_283a6901-62bc-4e5c-87fe-f250c6117e8e"
      unitRef="vote">1</mck:CommonStockVotingRightsNumberofVotesPerCommonShare>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i2b9d2822c0fe41fc86291a1793d818ec_D20200728-20200728"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzAy_91abbbb4-11de-4f7d-8336-b79b4c7d91e0"
      unitRef="usdPerShare">0.41</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iee7001dbe701429a8640019b5e925c83_D20200729-20200729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzA4_66012799-84b7-4027-8c46-848aff575d70"
      unitRef="usdPerShare">0.42</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ie5c361bf141b4eb9891a9ae3f5e870b1_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMTQwMA_dd8ca633-bf66-4c3c-9a24-9e8508924879"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ia83332fa877f4f95a2db6855471cfa83_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzg0ODI5MDcwMjU4OQ_e519b616-4994-4eb2-bccc-5f93f2d180ae"
      unitRef="shares">1800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ia83332fa877f4f95a2db6855471cfa83_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMTU3MA_c9700104-b418-40d5-8895-00db6cd05695"
      unitRef="usd">269000000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i85b5d437b88a43c3b57c3014d5ae8bf1_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMTYzOQ_8274a63d-a155-4072-9b3a-cbe56c9fba6e"
      unitRef="usdPerShare">151.23</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i85bcde357ef24cd5a6fe11d759211780_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMTMxOTQxMzk1Mzg4MDk_083105e6-851a-4e55-855e-d71b75d71230"
      unitRef="shares">1500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i85bcde357ef24cd5a6fe11d759211780_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMTMxOTQxMzk1Mzg4NDE_d942db21-500f-41a8-9d73-6b5a239a3ea0"
      unitRef="usd">231000000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i85bcde357ef24cd5a6fe11d759211780_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMTMxOTQxMzk1Mzg5MTE_c6c801ac-3965-4e90-8768-9d9b362467db"
      unitRef="usdPerShare">151.12</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMTkwOQ_9034bffb-4093-4a9c-b775-eee9dbaccc85"
      unitRef="usd">1000000000.0</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <mck:StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased
      contextRef="i42de281c12634e1094f4341b8340f8c9_I20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMjc0ODc3OTA4NDk3Mw_12a7245a-1042-4c1e-bd1d-2d1619c37a19"
      unitRef="usd">2000000000.0</mck:StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfNDUyNg_5341b210-b35b-4319-92bc-d14ed2e2ce78">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding Other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments arising during period, net of income tax expense of nil, nil, nil, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil, nil, nil, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized losses on net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized losses on net investment hedges arising during period, net of income tax benefit of $33, $21, $80, and $1 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil, nil, nil, and nil&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on cash flow hedges arising during period, net of income tax (expense) benefit of $2, $3, $6, and $(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil,  nil, nil, and nil&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in retirement-related benefit plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss and prior service cost arising during the period, net of income tax benefit of nil, nil, nil, and $1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial loss, prior service cost and transition obligation, net of income tax benefit of $2, nil, $1, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments and other, net of income tax expense of nil, nil, nil, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24.75pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of $9, $3, $9, and $35 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(8)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income, net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s foreign subsidiary, McKesson Europe, and its operations in Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;During the three and nine months ended December 31, 2020, net foreign currency translation adjustments were primarily due to the strengthening of the Canadian dollar and Euro against the U.S. dollar from April 1, 2020 to December 31, 2020. During the three and nine months ended December 31, 2019, the net foreign currency translation adjustments were primarily due to the strengthening of the Euro and Canadian dollar against the U.S. dollar, partially offset by weakening of the British pound sterling from April 1, 2019 to December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three and nine months ended December 31, 2020 includes net foreign currency translation adjustments of $20 million and $(41) million, respectively, and the three and nine months ended December 31, 2019 includes net foreign currency translation adjustments of $12 million and $(1) million, respectively, attributable to redeemable noncontrolling interests. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three and nine months ended December 31, 2020 include adjustments for amounts related to the contribution of the Company&#x2019;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 3, &#x201c;Held for Sale.&#x201d; These amounts were included in the current and prior periods calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Operating expenses in the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three and nine months ended December 31, 2020 includes foreign currency losses of $84 million and $201 million, respectively, on the net investment hedges from the &#x20ac;1.7 billion&#160;Euro-denominated notes and &#xa3;450 million&#160;British pound sterling-denominated notes, losses of $45 million and $108 million, respectively, on the net investment hedges from cross-currency swaps, and losses on net investment hedges of nil and $1 million, respectively, attributable to redeemable noncontrolling interests. The three and nine months ended December 31, 2019 include foreign currency losses of $59 million and gains of $8 million, respectively, on the net investment hedges from the &#x20ac;1.70 billion Euro-denominated notes and&#160;&#xa3;450 million British pound sterling-denominated notes and losses of $20 million and $11 million, respectively, on the net investment hedges from cross-currency swaps. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three and nine months ended December 31, 2020 include net actuarial gains of $5 million and $3 million, respectively, and the three and nine months ended December 31, 2019 include net actuarial losses of $2 million and $1 million, respectively, which are attributable to redeemable noncontrolling interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Pre-tax amount was reclassified into Cost of sales and Operating expenses in the Condensed Consolidated Statements of Operations. The related tax expense was reclassified into Income tax benefit (expense) in the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(8)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The nine months ended December 31, 2019 primarily reflects a reclassification of losses in the second quarter of 2020 upon a pension settlement charge from Accumulated other comprehensive loss to Other income (expense), net in the Condensed Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMy0wLTEtMS0wL3RleHRyZWdpb246N2E4NDcxNjk4MzQwNDliY2FjNTYzZjc3ZDcwZmI0MDNfOTc_29e077d1-1fd8-4261-8b28-08da6bdcf2a8"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMy0wLTEtMS0wL3RleHRyZWdpb246N2E4NDcxNjk4MzQwNDliY2FjNTYzZjc3ZDcwZmI0MDNfMTAx_2c423133-9182-4ba4-ba3d-dc3032b9648c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMy0wLTEtMS0wL3RleHRyZWdpb246N2E4NDcxNjk4MzQwNDliY2FjNTYzZjc3ZDcwZmI0MDNfMTA1_8923c70c-11eb-4f69-b0fe-e78ff0371009"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMy0wLTEtMS0wL3RleHRyZWdpb246N2E4NDcxNjk4MzQwNDliY2FjNTYzZjc3ZDcwZmI0MDNfMTEz_c27b1af8-975d-447b-9be9-fdc62ed98a6f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMy0xLTEtMS0w_c404615c-29fb-4aa3-a4d0-c9e72bc94484"
      unitRef="usd">156000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i245807132e61488c94b12390e4121f99_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMy0zLTEtMS0w_2fe2dd57-ce35-45f7-8173-f568da7cf9b6"
      unitRef="usd">101000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMy01LTEtMS0w_c2e3dc4e-64bc-4cb4-9fd7-853a60e7fc95"
      unitRef="usd">363000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMy03LTEtMS0w_d1aac5db-4a3e-450a-8cc5-1e4750d98ada"
      unitRef="usd">57000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNC0wLTEtMS0wL3RleHRyZWdpb246N2MyYjRiZTA2YzE3NGQzMmJjM2E4MzFjNGMxYjc4MTBfNjc_2e88dce7-0136-4aec-86e3-147d4ff85939"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNC0wLTEtMS0wL3RleHRyZWdpb246N2MyYjRiZTA2YzE3NGQzMmJjM2E4MzFjNGMxYjc4MTBfNzE_c10e4fb1-10fc-49c2-8d1c-29fe6baaf5a1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNC0wLTEtMS0wL3RleHRyZWdpb246N2MyYjRiZTA2YzE3NGQzMmJjM2E4MzFjNGMxYjc4MTBfNzU_9946274a-fa57-4485-afea-0ea6b060cf61"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNC0wLTEtMS0wL3RleHRyZWdpb246N2MyYjRiZTA2YzE3NGQzMmJjM2E4MzFjNGMxYjc4MTBfODM_5f22ed0d-845e-4b0a-8393-d53bf7bcf891"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNC0xLTEtMS0w_5ba3a758-f6ac-48f3-a9ed-eb58de1ce7c3"
      unitRef="usd">-47000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i245807132e61488c94b12390e4121f99_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNC0zLTEtMS0w_fdace17f-fb45-49f2-9338-95e92c1bd007"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNC01LTEtMS0w_8b97755f-9b85-4bd9-83d5-2bc63bb3bf24"
      unitRef="usd">-47000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNC03LTEtMS0w_09ff6da0-32c3-468f-9974-bcb01aca6780"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNS0xLTEtMS0w_492e6be8-f368-49cf-b691-11155a030410"
      unitRef="usd">203000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i245807132e61488c94b12390e4121f99_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNS0zLTEtMS0w_bd241194-3772-411d-a11d-46d900045189"
      unitRef="usd">101000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNS01LTEtMS0w_08354230-12cc-44b5-967c-9e277a75f1ad"
      unitRef="usd">410000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNS03LTEtMS0w_d29a7aa1-cc64-4961-88a9-35cef81403c8"
      unitRef="usd">57000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNy0wLTEtMS0wL3RleHRyZWdpb246YjJiZmYyOGQ2NzkwNDg2MTgzMWVlYzdkOTUxZDY2Y2NfMTE3_71efef6f-139d-4aac-a095-e46ec9e03940"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNy0wLTEtMS0wL3RleHRyZWdpb246YjJiZmYyOGQ2NzkwNDg2MTgzMWVlYzdkOTUxZDY2Y2NfMTIx_46f3fc26-cabd-49f1-80fb-cc042c1c7cf3"
      unitRef="usd">21000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNy0wLTEtMS0wL3RleHRyZWdpb246YjJiZmYyOGQ2NzkwNDg2MTgzMWVlYzdkOTUxZDY2Y2NfMTI1_74f872de-3f9d-4e33-ae1e-6b4502ca2199"
      unitRef="usd">80000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNy0wLTEtMS0wL3RleHRyZWdpb246YjJiZmYyOGQ2NzkwNDg2MTgzMWVlYzdkOTUxZDY2Y2NfMTMz_899517b2-9821-4dae-b997-cf890e62c6eb"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNy0xLTEtMS0w_2b929bcc-4b5e-4c1c-8a9e-f1db5bf91718"
      unitRef="usd">-96000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNy0zLTEtMS0w_963541d4-b9fb-4b3a-81b9-f3af58f96fd2"
      unitRef="usd">-58000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNy01LTEtMS0w_74861123-79e1-4790-8f75-34175d2772b3"
      unitRef="usd">-229000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfNy03LTEtMS0w_6f6cce5f-98d5-4302-a929-514ab2f79c08"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOC0wLTEtMS0wL3RleHRyZWdpb246OTEwNGRkZjVhZDNkNGNkNDgxMzZmZWY3YWJiMjJjZTlfNjc_0d011b79-5ed1-49f0-8a81-51696f56db66"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOC0wLTEtMS0wL3RleHRyZWdpb246OTEwNGRkZjVhZDNkNGNkNDgxMzZmZWY3YWJiMjJjZTlfNzE_53b7211a-7859-43df-9ad5-74744bbddc6b"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOC0wLTEtMS0wL3RleHRyZWdpb246OTEwNGRkZjVhZDNkNGNkNDgxMzZmZWY3YWJiMjJjZTlfNzU_51ebd7aa-fa8c-4dd2-97aa-6da3c673458a"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOC0wLTEtMS0wL3RleHRyZWdpb246OTEwNGRkZjVhZDNkNGNkNDgxMzZmZWY3YWJiMjJjZTlfODM_c7263a79-6e7c-4212-a5fd-c31e25432440"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOC0xLTEtMS0w_bdcc6e21-f43e-49c0-a525-d1a86203dc8a"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOC0zLTEtMS0w_028227c3-02f6-4d35-9d29-36e9a3d2d12e"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOC01LTEtMS0w_30b98531-9cdc-4b86-a13f-d7ce8a35faa7"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOC03LTEtMS0w_edc1d21e-f7f1-494a-a51e-68b67d6faf80"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOS0xLTEtMS0w_8d537d5d-c5d8-41cd-a768-c77053da79f4"
      unitRef="usd">-96000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOS0zLTEtMS0w_6081a1e5-4827-44c5-bd66-816ef32cecb7"
      unitRef="usd">-58000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOS01LTEtMS0w_2c4203fd-0c20-447d-bf13-05e734b8d554"
      unitRef="usd">-229000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfOS03LTEtMS0w_3cfc9eb1-9fbd-4ad9-97ce-a60a6e750ae1"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjU4MzQzYzZlZTdjYTRkZjBhZWZkYjZlZDQ5YTVmODJhXzExMg_810ee6db-3ca8-458e-b64c-dafbee486a3c"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjU4MzQzYzZlZTdjYTRkZjBhZWZkYjZlZDQ5YTVmODJhXzExNg_00b5a114-7c2b-4905-a636-6f8dcff1fcea"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjU4MzQzYzZlZTdjYTRkZjBhZWZkYjZlZDQ5YTVmODJhXzEyMA_669c0e40-da4d-4004-b682-3dd5c5bcad10"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjU4MzQzYzZlZTdjYTRkZjBhZWZkYjZlZDQ5YTVmODJhXzEyOA_d7d01fa0-66fb-4a2a-9610-0f6e4c30331c"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i60ebfe67a3044298876108334986e57c_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTEtMS0xLTEtMA_6d0ef421-75d2-4719-abc2-3c6623188d2b"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTEtMy0xLTEtMA_6d0f7e93-67a7-4bc4-8390-b33afc2bd4bd"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTEtNS0xLTEtMA_045786b5-c15c-48d0-8893-1cfcd266447e"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTEtNy0xLTEtMA_3d6b7849-57cb-4bfa-8e87-34b73f59d842"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i60ebfe67a3044298876108334986e57c_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTItMC0xLTEtMC90ZXh0cmVnaW9uOmRjODQ4ODNiZDg0NTQ1NGE5MWUxYzRhYjg4YzhkMGRhXzY3_fd3a1c2e-feed-4971-9479-798fd105c8fa"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTItMC0xLTEtMC90ZXh0cmVnaW9uOmRjODQ4ODNiZDg0NTQ1NGE5MWUxYzRhYjg4YzhkMGRhXzcy_2e868a45-5a41-43a7-bfaf-976054fb8927"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTItMC0xLTEtMC90ZXh0cmVnaW9uOmRjODQ4ODNiZDg0NTQ1NGE5MWUxYzRhYjg4YzhkMGRhXzc2_ab84f269-afa6-4746-8d46-bc3c10d8b3ff"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTItMC0xLTEtMC90ZXh0cmVnaW9uOmRjODQ4ODNiZDg0NTQ1NGE5MWUxYzRhYjg4YzhkMGRhXzg0_d353656b-4037-427a-8ff0-b89282a9cf6f"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i60ebfe67a3044298876108334986e57c_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTItMS0xLTEtMA_09821dbb-b93c-4a1a-ba2e-2f65a3858e10"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTItMy0xLTEtMA_640e7675-dc50-4306-a777-c034bfb45d35"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTItNS0xLTEtMA_efeb9f89-df20-4628-b6e9-9161d74f28c5"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTItNy0xLTEtMA_e8f50c0f-12a3-4bc7-941e-2b4d2154ad85"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i60ebfe67a3044298876108334986e57c_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTMtMS0xLTEtMA_bfed6537-383e-4879-baec-5e3243350113"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTMtMy0xLTEtMA_7855bdb3-0a0d-44e2-aaff-96832918a43d"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTMtNS0xLTEtMA_e364a151-844a-450a-ae66-cb5767a6ecad"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTMtNy0xLTEtMA_b65eff0f-7d63-4683-bb7f-5daa504bcc23"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjUxYjNjMzE3MzM3MzQ1MTRhYWIzNDFjZDlmZDhhZTE5XzEwMg_b90893b9-e513-4f7d-92c8-c4bbe07597d0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjUxYjNjMzE3MzM3MzQ1MTRhYWIzNDFjZDlmZDhhZTE5XzEwNg_410e4fe6-fdac-4367-9966-0fde1047775a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjUxYjNjMzE3MzM3MzQ1MTRhYWIzNDFjZDlmZDhhZTE5XzExMA_b15c1cfc-c3d3-4755-b024-37069e65befe"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjUxYjNjMzE3MzM3MzQ1MTRhYWIzNDFjZDlmZDhhZTE5XzExOA_7a627980-3cf4-450e-803f-22ac4a5d04bd"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9b20d10786654fff938ed21b46d91890_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTUtMS0xLTEtMA_734192c1-3e62-401d-ab1f-4dfaceaa5396"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3b48d9346ede475eaa9d050fcd5e2432_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTUtMy0xLTEtMA_c127f1d4-5b5e-4ccf-901b-9998eaa8669b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2f8cdf78c925481bb9fb846b51a37d4c_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTUtNS0xLTEtMA_ba7a5dee-f8a0-41ed-a940-ed52bbbce8df"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i171a7450485e4fa19bb98c562f3f0835_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTUtNy0xLTEtMA_5b7d2de9-e2d0-43bc-8a25-a72f5e710671"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOmQ3ZjE5NTIyMjliNDQ3Yjc5YzhiYTg1MzRkOWY2M2VmXzExMQ_73881e4f-0d2c-4866-8f1f-bb5f44dbd6f3"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOmQ3ZjE5NTIyMjliNDQ3Yjc5YzhiYTg1MzRkOWY2M2VmXzExNQ_dc16dced-1e51-4016-85da-125bf382e599"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOmQ3ZjE5NTIyMjliNDQ3Yjc5YzhiYTg1MzRkOWY2M2VmXzExOQ_2d32dc45-6310-4798-80e6-2455434981d1"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOmQ3ZjE5NTIyMjliNDQ3Yjc5YzhiYTg1MzRkOWY2M2VmXzEyNw_494be4ed-cf7a-4878-acec-19de7c5eb767"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iad19a75609034338a9616075a375513e_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTYtMS0xLTEtMA_e1e2866a-c275-4918-8ae5-33e42d0a3306"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4e441b29128c48aea910381165c7b723_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTYtMy0xLTEtMA_396bebee-8913-4b65-b302-de86fef4a5cf"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7ad855b967ce4ddd8019fe6ca830c068_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTYtNS0xLTEtMA_17515d7c-0add-4ee1-8ff6-00c65a3433c3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia4b2c4b06218485da8544d4e41e7e4cc_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTYtNy0xLTEtMA_636c956f-0c0d-463d-a1e8-b660aa8c6a35"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjMxOWMzNDMzNzIwZDRiYWNhZWUxOGQxN2UwMzM1NDUxXzg1_ff49246d-ca4c-4ff3-b93b-0205e5fc7d04"
      unitRef="usd">0</mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax>
    <mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjMxOWMzNDMzNzIwZDRiYWNhZWUxOGQxN2UwMzM1NDUxXzg5_f8a92184-2947-4a25-93b4-ea4e0d1ba7e5"
      unitRef="usd">0</mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax>
    <mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjMxOWMzNDMzNzIwZDRiYWNhZWUxOGQxN2UwMzM1NDUxXzkz_aa2cc8b2-3702-48d4-8d28-4db2d377550a"
      unitRef="usd">0</mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax>
    <mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjMxOWMzNDMzNzIwZDRiYWNhZWUxOGQxN2UwMzM1NDUxXzEwMQ_ff02aadc-d915-49de-87a4-d2190e0b09f2"
      unitRef="usd">0</mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i266fe3f418d84aa7b7249926cfc9d280_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTctMS0xLTEtMA_86a1f1d2-9533-4e02-9bfa-117390ba85c7"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ida514f8038f5465c9dc701830da2f003_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTctMy0xLTEtMA_59d8f478-3f55-4f59-9796-829258f34c4c"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i39719f584adb44c1b39699ef890bfe15_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTctNS0xLTEtMA_0bde280e-3764-4b28-abc7-1aedb4c2bd37"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i58b08f5f1f644db4945b8ba02324d11d_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTctNy0xLTEtMA_a5e7d543-e492-4c48-92bc-822b04be6caa"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="icaec3dac337e46b3b24229e240ac2c53_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmQ0NTg4MjRmMjdjYzQ5Y2E4MTk0NGNhMjFmZWYwMDI1XzY3_91615eab-65b5-4f4c-b27d-1ae1c6e37d1a"
      unitRef="usd">9000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i3048995a4a7944508cb95b392a4d29cd_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmQ0NTg4MjRmMjdjYzQ5Y2E4MTk0NGNhMjFmZWYwMDI1Xzcx_482bf99a-fa68-413f-8445-8b28cd9166ad"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i4603c284d62e4e5c9442bdc1f75663f1_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmQ0NTg4MjRmMjdjYzQ5Y2E4MTk0NGNhMjFmZWYwMDI1Xzc1_5d25c55e-f6a1-4c77-9091-76e983ece489"
      unitRef="usd">9000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i67aca6db78904dec90dc3b22e3800fd5_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmQ0NTg4MjRmMjdjYzQ5Y2E4MTk0NGNhMjFmZWYwMDI1Xzgz_318235b8-b3ff-4de0-88dc-84227f293f6d"
      unitRef="usd">35000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="icaec3dac337e46b3b24229e240ac2c53_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTgtMS0xLTEtMA_35a99838-07f0-4f3b-9d86-c865e81b984a"
      unitRef="usd">-24000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3048995a4a7944508cb95b392a4d29cd_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTgtMy0xLTEtMA_9f8fb740-be59-4b43-9a69-78200dadb31f"
      unitRef="usd">-8000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4603c284d62e4e5c9442bdc1f75663f1_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTgtNS0xLTEtMA_2297bcc6-e22b-4bde-b308-bf58c475cbd0"
      unitRef="usd">-24000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i67aca6db78904dec90dc3b22e3800fd5_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTgtNy0xLTEtMA_97720a98-4554-456d-bc65-c759848d4c9d"
      unitRef="usd">-98000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icaec3dac337e46b3b24229e240ac2c53_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTktMS0xLTEtMA_c2e6f8ab-2f57-4ed0-8acd-084c7fe755ad"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3048995a4a7944508cb95b392a4d29cd_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTktMy0xLTEtMA_40f60079-2cb2-43be-9187-6f4add10fba4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4603c284d62e4e5c9442bdc1f75663f1_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTktNS0xLTEtMA_94f360d3-696f-4c2b-b033-18e8fb5bb8bd"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i67aca6db78904dec90dc3b22e3800fd5_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMTktNy0xLTEtMA_8d69e9e1-5356-4273-8c8b-9a77dcfb8589"
      unitRef="usd">96000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMjEtMS0xLTEtMA_a8c678e5-315d-4c24-8d1c-538533cc127d"
      unitRef="usd">119000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMjEtMy0xLTEtMA_d66d812a-8ee1-4ee2-9794-bf9dcf5615f6"
      unitRef="usd">51000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMjEtNS0xLTEtMA_ca78ed2a-409c-4eef-af17-f1383ab8ecc9"
      unitRef="usd">161000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmI2MTc2MjUzZGY1ODRlY2JhYWFiNDcxZDkzYjU2ZjJkL3RhYmxlcmFuZ2U6YjYxNzYyNTNkZjU4NGVjYmFhYWI0NzFkOTNiNTZmMmRfMjEtNy0xLTEtMA_76fe5801-0f87-45ec-9c69-d19e2254eea5"
      unitRef="usd">184000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest
      contextRef="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMjgyOA_9d5e4e67-657f-4061-9472-4de4441d99d7"
      unitRef="usd">20000000</mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest>
    <mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest
      contextRef="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMjgzNQ_4992a1ec-7bad-46ef-abb0-e4af90fe3798"
      unitRef="usd">-41000000</mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest>
    <mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest
      contextRef="i245807132e61488c94b12390e4121f99_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMjkyMQ_73566e4e-8951-44d7-a184-49e5db82ec44"
      unitRef="usd">12000000</mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest>
    <mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest
      contextRef="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMjkyOA_27a079bc-1c8b-4dec-8b1d-e1b6b2bcc2e5"
      unitRef="usd">-1000000</mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ic3392a15e42349f38396d43edec58984_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzA0Mw_c5ba9968-07fa-4dfd-bde2-42bb1d6d4a83"
      unitRef="usd">-84000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ieae8ce38c55c4a8183867cb63bfddafb_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzA1MA_74906e52-dbd8-4083-83c8-12d8716e7648"
      unitRef="usd">-201000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:LongTermDebt
      contextRef="i0d9cf49bcf574771b799ca4645191cd5_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzEwNg_021d3b9c-6ae6-4e7f-80ba-ca0c2683cdb9"
      unitRef="eur">1700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2a0ca354dcd646dbb94a5e6bc0adc910_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzEwNg_36908ddb-0cde-4520-aa90-93836d21920d"
      unitRef="eur">1700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="id38d110d6f9c4cf097c87208b255cff1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzEzNg_dc5fe370-8c75-4d23-a5dc-c15904c855dd"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i36b3bcf8d524467bacd1c159707af361_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzE5MQ_c265c6c4-fd5c-467c-b20d-8276484e503a"
      unitRef="usd">-45000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i09c294f2acd74c33bb8e9ada8e29bfef_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzE5OA_5a406b85-3edc-4fb4-9e38-8d9812c503b6"
      unitRef="usd">-108000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzMxMQ_7d13e5f0-a990-4329-ab0b-09fbe6c5f6ec"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMTMxOTQxMzk1NDE2Mjc_b8cd9cf5-37ff-4104-b65a-999678c06e2f"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i8ac357c6d2694d3e854ab420c7c33a3e_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzQwOA_0cf9bcaf-0217-4097-bdd6-8758c178ce93"
      unitRef="usd">-59000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6d10966d07b64ebba1b226a32e8e56fa_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzQxNQ_32364e8c-5518-494b-9bcf-03f7968c19c2"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:LongTermDebt
      contextRef="iaff277eea93447ab86287935d95d1f47_I20191231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzQ3MQ_3bc4b640-63bd-4c92-84dd-d7150ecd0d95"
      unitRef="eur">1700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1dd77d36d7ae4ca38af80569eac5764d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzUwMQ_a8386805-297d-47e9-8b3c-cc787c18eeaa"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="if86aed3e96a64acfb7d6c3d4ba3f32e0_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzU1OA_2bb5a721-22b1-40b1-97ee-0fe83616eacf"
      unitRef="usd">-20000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i51b2cfed82a94bea9d5b40efccf351cc_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzU2NQ_45bdb20e-77da-42e6-8dfa-c53808430199"
      unitRef="usd">-11000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzY3OQ_871c69f2-e4b2-433e-9848-3989e418c975"
      unitRef="usd">5000000</mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax>
    <mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzY4Ng_9017ac59-f89a-4533-b38e-3093c2c2af95"
      unitRef="usd">3000000</mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax>
    <mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzc0Ng_f0269db8-53ef-4b84-b176-dee714f025b1"
      unitRef="usd">-2000000</mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax>
    <mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfMzg0ODI5MDcwMjA4Nw_3f8858e7-05fb-4291-8723-d5a5fef66149"
      unitRef="usd">-1000000</mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RleHRyZWdpb246NTg3ODQzYWIxZWJhNGNlMTk3ODY1MTliOTdkYzVjY2RfNDU0NQ_3ed250af-f74b-4852-b0ae-b1036cbeade1">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s Accumulated other comprehensive income (loss) by component for the three and nine months ended December 31, 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Losses and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s Accumulated other comprehensive income (loss) by component for the three and nine months ended December 31, 2019 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,570)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,570)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ab154724e0a4ea78f86170c48cb3e03_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMi0xLTEtMS0w_95cc592b-60ff-4128-aa6e-322857a9f2e5"
      unitRef="usd">-1512000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7016c62d475b44cf8995815c2ee6e6c2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMi0zLTEtMS0w_bc4ef628-ebc9-465f-8bec-08d15b14fc9f"
      unitRef="usd">6000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic53b88b03d43406caa082e97b8198de2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMi01LTEtMS0w_081946ff-833b-4ce0-9135-de1acc04bed5"
      unitRef="usd">25000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i287fd1b1acc740579e26c343e6d1186f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMi03LTEtMS0w_7d3266ac-eb6a-423f-b57f-e1c8664e3367"
      unitRef="usd">-116000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if702f6988b73408fb0203fbcf4cfff59_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMi05LTEtMS0w_f2c35a35-3982-4a1f-8982-c517f0c24814"
      unitRef="usd">-1597000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMy0xLTEtMS0w_8f5991f4-129e-4b62-9901-aa8664f05c12"
      unitRef="usd">156000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMy0zLTEtMS0w_69467732-2bc8-4e5d-9fb3-2c7af9390221"
      unitRef="usd">-96000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i60ebfe67a3044298876108334986e57c_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMy01LTEtMS0w_7c688b7d-31c9-4671-acb2-ded098fe2197"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3bafc11b2f6c48fe8846c0cbf49f1ca8_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMy03LTEtMS0w_f5a47133-7d79-45b3-8684-739396302f15"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfMy05LTEtMS0w_60f5f66e-2740-45ef-ad8a-131b9eed67d7"
      unitRef="usd">50000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNC0xLTEtMS0w_80e293b9-1964-40e4-88bd-0ba4988b9be3"
      unitRef="usd">-47000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNC0zLTEtMS0w_662930c3-6e8f-49b3-945b-59fbb57fe09d"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i60ebfe67a3044298876108334986e57c_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNC01LTEtMS0w_3475491f-1f56-4bcb-b9da-89e77d28ce29"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3bafc11b2f6c48fe8846c0cbf49f1ca8_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNC03LTEtMS0w_1feb2e5c-610f-4b75-b555-faafa61f17d2"
      unitRef="usd">-22000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNC05LTEtMS0w_4a5358a4-2f51-4cdb-95d5-9e4c3aae4f2a"
      unitRef="usd">-69000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNS0xLTEtMS0w_0de2ea5b-94b8-4328-b67a-62bf333b2eb3"
      unitRef="usd">203000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNS0zLTEtMS0w_4fda0725-a582-4d95-a427-ff5772fe5bd8"
      unitRef="usd">-96000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i60ebfe67a3044298876108334986e57c_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNS01LTEtMS0w_bdf93824-13de-40e5-9e6f-c9bd575c4cab"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3bafc11b2f6c48fe8846c0cbf49f1ca8_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNS03LTEtMS0w_293e5dd7-f366-436b-9237-e202760f59f1"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNS05LTEtMS0w_585d5597-74e2-485e-8704-ee2f79ea4ff9"
      unitRef="usd">119000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNi0xLTEtMS0w_d98a6064-b713-4fcc-a89e-056fd05d6999"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNi0zLTEtMS0w_ee29c08b-b0df-4259-9f38-0ba3733134ca"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i60ebfe67a3044298876108334986e57c_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNi01LTEtMS0w_2ba3a3ce-5eaa-4686-b7bb-bf660bf5e3f5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i3bafc11b2f6c48fe8846c0cbf49f1ca8_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNi03LTEtMS0w_dc254d38-151f-4e49-bb3a-77bef4b61bc6"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNi05LTEtMS0w_2b322ebb-03db-4fcf-815a-b27ca2583e27"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id0b5ee426c95417ba3646ce1e23abea0_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNy0xLTEtMS0w_64e2a6e3-7716-4310-a248-457809518173"
      unitRef="usd">183000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i41fe14e5160d47f6a8666aa942628e57_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNy0zLTEtMS0w_576c7bcb-e3dc-4e6e-a387-46f18ad3615a"
      unitRef="usd">-96000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i60ebfe67a3044298876108334986e57c_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNy01LTEtMS0w_bc7d8aeb-17d1-4db9-acee-ac1b51a572bc"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3bafc11b2f6c48fe8846c0cbf49f1ca8_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNy03LTEtMS0w_c6b3f6e9-214e-418c-af52-9facc1966e81"
      unitRef="usd">19000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfNy05LTEtMS0w_323f8f35-ae76-47cd-9a2c-d43a5778d75e"
      unitRef="usd">94000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8151b587ea184a12a863eb648c1d73b6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfOC0xLTEtMS0w_9aea77a8-de9a-4ff6-a248-85675b5722ba"
      unitRef="usd">-1329000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iee018ab4a90c436e82e2d025bc7c4033_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfOC0zLTEtMS0w_13ce9bec-de4d-4c19-8563-22aafabd087e"
      unitRef="usd">-90000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1029504ec8324cdc9d1a8a6f2a854090_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfOC01LTEtMS0w_c6053df0-69de-4de5-9bd5-e99b2cab3f5b"
      unitRef="usd">13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28bde64152834b87bded353fb0352d95_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfOC03LTEtMS0w_772fe270-2cea-4eb3-b37f-3f7618f8c1dc"
      unitRef="usd">-97000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6641e8af9e64c7aae662865d224c625_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjUwZTFlMWFkNjE2ZTQ0ZjY4YWMwNjdiNzAxMzk3YjRlL3RhYmxlcmFuZ2U6NTBlMWUxYWQ2MTZlNDRmNjhhYzA2N2I3MDEzOTdiNGVfOC05LTEtMS0w_dfd8816e-3c51-4100-917f-5fe09d3727d2"
      unitRef="usd">-1503000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i71a3e94889974300a0f149383fe25f18_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMi0xLTEtMS0w_313833ab-1a9a-4b65-ad63-14ccd3eb1eda"
      unitRef="usd">-1780000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i06a62989bb2744f8a8d872418308d4ba_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMi0zLTEtMS0w_4e4126a2-2a27-4cf7-9af1-5ae1a445bb38"
      unitRef="usd">138000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i513c2028d38b4884ac53975bfab5f078_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMi01LTEtMS0w_fda3bf84-3edc-4530-95ae-82d9f1538a1d"
      unitRef="usd">49000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i12907ec702d147a3bd56ff8747ef063f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMi03LTEtMS0w_946ecc15-a780-4c91-9907-ffcf4541eafa"
      unitRef="usd">-110000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id0374ed6096c4fc79915873d9944afab_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMi05LTEtMS0w_0ab92682-4715-4011-beae-15ae60e31a90"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMy0xLTEtMS0w_9d8c06e4-33f0-4151-84f6-644d428d5825"
      unitRef="usd">363000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMy0zLTEtMS0w_4e068aa4-7b3b-4a2c-8459-8a5a8fd6e5a2"
      unitRef="usd">-229000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMy01LTEtMS0w_9b70c530-a676-496f-8f8b-a8603e0852ac"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8a4dbe3271764ed783e43c160f22a5f7_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMy03LTEtMS0w_15c962ea-324e-4b5a-ab82-a052ef3f3484"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfMy05LTEtMS0w_f6c61437-6472-4fdd-9468-52e84f349931"
      unitRef="usd">90000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNC0xLTEtMS0w_2a1b75fb-6773-474b-b0dc-85be9df23914"
      unitRef="usd">-47000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNC0zLTEtMS0w_666b3eae-e334-4bc7-a2ca-d35d93be0d45"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNC01LTEtMS0w_c0965ba4-e8bd-468b-a438-29ecf167e4b9"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8a4dbe3271764ed783e43c160f22a5f7_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNC03LTEtMS0w_758f0c33-bf4b-4244-ae2d-308069764dcc"
      unitRef="usd">-24000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNC05LTEtMS0w_4515edf2-4497-4bd9-b423-e85e50155aed"
      unitRef="usd">-71000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNS0xLTEtMS0w_5e418452-7922-40f0-aba4-df5ea1d65454"
      unitRef="usd">410000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNS0zLTEtMS0w_2d087c7c-d14f-4d79-bb25-1faf3a5369be"
      unitRef="usd">-229000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNS01LTEtMS0w_3e9ffb77-4f1c-4082-b263-0c0ff134e546"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8a4dbe3271764ed783e43c160f22a5f7_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNS03LTEtMS0w_f7ab517e-4642-4e00-abda-763995eea867"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNS05LTEtMS0w_edfc1fc4-16c8-4068-b865-6a3b7a400aa8"
      unitRef="usd">161000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNi0xLTEtMS0w_82aff7d5-2d26-49f7-b7fa-932d41c7a036"
      unitRef="usd">-41000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNi0zLTEtMS0w_503ebcfe-eb22-4d92-8a6a-ad7be1a540e7"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNi01LTEtMS0w_0f54684b-714b-4b40-a3ca-67cab5bb1ae6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i8a4dbe3271764ed783e43c160f22a5f7_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNi03LTEtMS0w_bb32ee92-aa5a-471a-b4f6-f717ea436c52"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNi05LTEtMS0w_5273bf4a-ad90-4296-9293-cd7c6c52cb0e"
      unitRef="usd">-39000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i47cc52e2bf06420496b36792fc2f1e05_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNy0xLTEtMS0w_02dc77d8-8d8e-4d5b-9afd-bcb6c111c1d3"
      unitRef="usd">451000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i04d9bf8dac4a4a3daf9fabfe51a9bf3c_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNy0zLTEtMS0w_11f76d72-ca5f-4854-b569-0f1ecb4128e8"
      unitRef="usd">-228000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7b2623bc885f416e9254d7d6f2359648_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNy01LTEtMS0w_ba3a16a1-b30c-4569-ac98-814ed3cd3d81"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8a4dbe3271764ed783e43c160f22a5f7_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNy03LTEtMS0w_5cc3c33b-1457-4c7a-8cb0-c865eb0a3c77"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfNy05LTEtMS0w_21ddbe1f-6d2f-4ca3-81a0-aba39f5ff0c3"
      unitRef="usd">200000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8151b587ea184a12a863eb648c1d73b6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfOC0xLTEtMS0w_e626984d-bedd-4f11-8681-bdacd75bdadb"
      unitRef="usd">-1329000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iee018ab4a90c436e82e2d025bc7c4033_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfOC0zLTEtMS0w_89e3a419-e37d-4925-8612-1ebe6d65d247"
      unitRef="usd">-90000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1029504ec8324cdc9d1a8a6f2a854090_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfOC01LTEtMS0w_11ecfed6-14a9-4def-b6f6-a1483238fb41"
      unitRef="usd">13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28bde64152834b87bded353fb0352d95_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfOC03LTEtMS0w_aef9461e-c78f-4624-9aca-70c81e7db686"
      unitRef="usd">-97000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6641e8af9e64c7aae662865d224c625_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOjAxYjY1Mzc4M2Y1OTQ2ODliODAzZDY4YzNlZTlhNmVjL3RhYmxlcmFuZ2U6MDFiNjUzNzgzZjU5NDY4OWI4MDNkNjhjM2VlOWE2ZWNfOC05LTEtMS0w_a9622f29-a231-4528-b11f-9af1e6410ed6"
      unitRef="usd">-1503000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ea78334a4a544dcba38daccc7916a10_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMi0xLTEtMS0w_3e0cc80c-f2ed-41a1-ad93-6ae445e529f3"
      unitRef="usd">-1659000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a906828b06245e58bece79897fe99fc_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMi0zLTEtMS0w_5dfdc950-dd3b-4b42-8c80-4a60e4224620"
      unitRef="usd">109000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icafc8c81f18e4ee2a2a6e3b81ae88a12_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMi01LTEtMS0w_c5acae59-f77a-49f9-9bae-77d362d345f9"
      unitRef="usd">-12000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if9c3b3edd0774f9db0813da0a381c7a0_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMi03LTEtMS0w_f440e741-d6eb-4341-a859-517074282acf"
      unitRef="usd">-142000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e571302aec24a36936d3e24fb499981_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMi05LTEtMS0w_99fc99b0-21a8-4d1c-a6c6-87aa929e3221"
      unitRef="usd">-1704000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i245807132e61488c94b12390e4121f99_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMy0xLTEtMS0w_6fee2f67-dd9b-454b-a637-5fd179f8b6a0"
      unitRef="usd">101000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMy0zLTEtMS0w_9e25d183-b58f-46f1-b082-080f071dc376"
      unitRef="usd">-58000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMy01LTEtMS0w_555ac192-5f57-4eb8-93be-ef29433bec88"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib7ba00100ab34faa9bf1d5f5d42af04c_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMy03LTEtMS0w_26c16da9-7873-4e65-a4f5-e1aadc69e5ef"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfMy05LTEtMS0w_775117f1-2bbc-45fe-9655-b437c2792ca6"
      unitRef="usd">45000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i245807132e61488c94b12390e4121f99_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNC0xLTEtMS0w_7030724e-b91f-4a20-a449-0336d28ff549"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNC0zLTEtMS0w_8d402c8c-109a-4fc2-a58a-f4615de31269"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNC01LTEtMS0w_b988fed0-884e-4057-bd9f-7429e73cf258"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib7ba00100ab34faa9bf1d5f5d42af04c_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNC03LTEtMS0w_e784f1d3-4d5a-49a2-a78e-10af7e28fb6a"
      unitRef="usd">-6000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNC05LTEtMS0w_92bb9c19-a1fa-4dee-9275-081f02acca9e"
      unitRef="usd">-6000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i245807132e61488c94b12390e4121f99_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNS0xLTEtMS0w_5dd7d040-5a88-4107-ab56-3054a90b3472"
      unitRef="usd">101000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNS0zLTEtMS0w_ed68ffc7-8edc-460a-9241-63073385b596"
      unitRef="usd">-58000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNS01LTEtMS0w_1ada2357-605b-43d6-95ed-a2814efdb6d2"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib7ba00100ab34faa9bf1d5f5d42af04c_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNS03LTEtMS0w_fbeb31da-0648-44ae-9035-ca7f19cfdd81"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNS05LTEtMS0w_e8a9049c-d149-434c-8911-471b88a52e89"
      unitRef="usd">51000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i245807132e61488c94b12390e4121f99_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNi0xLTEtMS0w_7525e56c-9442-449e-b39e-31e1a13ea1da"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNi0zLTEtMS0w_35623fc4-712e-484c-90e9-e89f85a817e0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNi01LTEtMS0w_f701c4c0-feeb-418e-a1ff-cede43095ab3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ib7ba00100ab34faa9bf1d5f5d42af04c_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNi03LTEtMS0w_1df9b99b-a7d6-4ba4-b1d9-d4019eb987ec"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNi05LTEtMS0w_dd95904c-5071-4e4d-90c6-1bf40edabe51"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i245807132e61488c94b12390e4121f99_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNy0xLTEtMS0w_6c7268d7-2cb0-43a8-a933-0816327bbd2a"
      unitRef="usd">89000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i30850816b81c420cb3a11454129cb099_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNy0zLTEtMS0w_27ec9eb0-d18a-4cae-98ea-e50aadbf43f0"
      unitRef="usd">-58000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6116163f6a7e4b57826a15bf08101fbb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNy01LTEtMS0w_0747ddca-e31d-4ca3-869a-1cc182051150"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib7ba00100ab34faa9bf1d5f5d42af04c_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNy03LTEtMS0w_ad1b5024-c139-4baf-b6ab-6935986bcf6c"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfNy05LTEtMS0w_fc0b3f57-a253-49e6-8597-0137444ab3b3"
      unitRef="usd">41000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i27e40da0240940a7926bf05b6174ccd4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfOC0xLTEtMS0w_10384ee5-5334-4dc5-8b8d-546bee83d459"
      unitRef="usd">-1570000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3663290a78c548f4aa7609a2c7554daf_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfOC0zLTEtMS0w_2f903bde-fd0a-41c9-8629-9500ac695c48"
      unitRef="usd">51000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib213387c8afd446b96bae95715bec72d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfOC01LTEtMS0w_e3b544ff-a3ee-4e93-a938-9d7fd36f9d54"
      unitRef="usd">-4000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i51ffaad82dab42a0ab9c8e587557236c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfOC03LTEtMS0w_0086af43-0e72-4617-b654-88873d34e056"
      unitRef="usd">-140000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idd724fc113f1423fab76a0b7d9141942_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmMyMGU4ZGM1OTVhMDQwNzFiZTAwMGZlMmYxYjUzMDRmL3RhYmxlcmFuZ2U6YzIwZThkYzU5NWEwNDA3MWJlMDAwZmUyZjFiNTMwNGZfOC05LTEtMS0w_baeea791-842f-476c-98b7-7c90679dd567"
      unitRef="usd">-1663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iade9d1af10904ff7acc439b8834a8395_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMi0xLTEtMS0w_8e1054db-0f47-4e7d-b881-09ea628bfc80"
      unitRef="usd">-1628000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iab70a6f91f224f69a6be90a2c01a8355_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMi0zLTEtMS0w_1670e358-e9a9-4d10-848d-9b60000af2eb"
      unitRef="usd">53000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifa5330bd233547c98905a08caa8ca3a3_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMi01LTEtMS0w_c2512342-0607-4115-b8ac-a7e2a6c223f4"
      unitRef="usd">-37000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib822aec9103b458dbc079db87594cd6e_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMi03LTEtMS0w_e0197ec1-a166-4ae1-a3bd-f359eda2f0c6"
      unitRef="usd">-237000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id686b4181792461ea0b02a307e3b6b16_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMi05LTEtMS0w_ff171746-d058-47c8-8484-c41794918430"
      unitRef="usd">-1849000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMy0xLTEtMS0w_df5f8dc5-59f6-47f8-94bd-9b352092e086"
      unitRef="usd">57000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMy0zLTEtMS0w_6e9f33c9-2d61-4e17-b200-5db7c1d8605d"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMy01LTEtMS0w_17ed954b-c0b3-4b01-abcd-fc731379722d"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3caf5544ee374eb3a48285ec3fd9279a_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMy03LTEtMS0w_f4ef63b7-0876-4249-9a7c-43ac2fb196b8"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfMy05LTEtMS0w_e77fdd33-29e2-4ec2-a22e-c0a3d7078601"
      unitRef="usd">86000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNC0xLTEtMS0w_2e0cd72f-b23c-4b77-a254-19788f598ffd"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNC0zLTEtMS0w_76699a94-1157-4002-97a5-409d3659b6c4"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNC01LTEtMS0w_1413b27f-3120-49d5-acf9-0d2cd0be89e9"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3caf5544ee374eb3a48285ec3fd9279a_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNC03LTEtMS0w_feac32d4-73a2-455c-a7b6-db1ae8b45a49"
      unitRef="usd">-98000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNC05LTEtMS0w_e966d78e-434b-46d2-ada4-2ea702b8519f"
      unitRef="usd">-98000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNS0xLTEtMS0w_b9359cca-89a1-4323-81a0-d747de095cec"
      unitRef="usd">57000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNS0zLTEtMS0w_f02bdb3f-00d2-488e-a56b-0415c7af5db5"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNS01LTEtMS0w_4b869105-aafd-432a-a1b9-f677d1f699cb"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3caf5544ee374eb3a48285ec3fd9279a_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNS03LTEtMS0w_84df0452-39fe-4b99-9c4f-7b19333193a6"
      unitRef="usd">96000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNS05LTEtMS0w_ac27fd54-8370-4dd6-80cf-7feb44339517"
      unitRef="usd">184000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNi0xLTEtMS0w_b02e0d8d-d570-4ff2-a6b2-4f0d2d1dac9d"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNi0zLTEtMS0w_b0c25ccc-97aa-4f2b-b3ad-03ad154ff3e8"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNi01LTEtMS0w_82e96d91-9452-4cf3-863a-f4ff1d7b4999"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i3caf5544ee374eb3a48285ec3fd9279a_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNi03LTEtMS0w_1cd51645-ac81-4b46-a339-9d01dc43eebd"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNi05LTEtMS0w_1f957aac-e389-4cda-b8ba-fbe96c112c9f"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib5e952e9bd8d49a8a9dd0dd5bd60800d_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNy0xLTEtMS0w_391f44be-d1cc-425e-bab4-ba7933ed1f52"
      unitRef="usd">58000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4565d58c6438432884a322271cdcb467_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNy0zLTEtMS0w_292bad85-8891-4999-b32d-5d4373bc2d9c"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if12acea9988f4ed9b77a5ffa11ac41fb_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNy01LTEtMS0w_d411a7d7-f085-4b9c-bf89-b123832f3b39"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3caf5544ee374eb3a48285ec3fd9279a_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNy03LTEtMS0w_3ff373a4-7e31-4796-aa11-34f383906dd0"
      unitRef="usd">97000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfNy05LTEtMS0w_334eead4-a092-4764-9e18-fbd14cfdb7be"
      unitRef="usd">186000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i27e40da0240940a7926bf05b6174ccd4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfOC0xLTEtMS0w_984884bd-989d-4da2-ad44-7c4b81ebe61d"
      unitRef="usd">-1570000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3663290a78c548f4aa7609a2c7554daf_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfOC0zLTEtMS0w_e3934d6b-c31d-461b-89fd-705f1cfca89d"
      unitRef="usd">51000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib213387c8afd446b96bae95715bec72d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfOC01LTEtMS0w_22f9988c-c343-4d85-95d8-798f2fc6b227"
      unitRef="usd">-4000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i51ffaad82dab42a0ab9c8e587557236c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfOC03LTEtMS0w_d2b6f14a-0a73-4a68-b69a-e89042e8b4b2"
      unitRef="usd">-140000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idd724fc113f1423fab76a0b7d9141942_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85NC9mcmFnOjU4Nzg0M2FiMWViYTRjZTE5Nzg2NTE5Yjk3ZGM1Y2NkL3RhYmxlOmYxYmQ1ZGIyMjdhYTQzNzA5NTI2NmJhOWQ4NDE2NGFjL3RhYmxlcmFuZ2U6ZjFiZDVkYjIyN2FhNDM3MDk1MjY2YmE5ZDg0MTY0YWNfOC05LTEtMS0w_937dadfc-f2a1-43e4-8f82-712b23b39d1e"
      unitRef="usd">-1663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjg1MQ_a00aa14a-e358-43d2-b8d7-548e2061057e">Segments of Business&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commencing with the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. Other, for retrospective periods presented, consists of the Company&#x2019;s equity method investment in Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020. All prior segment information has been recast to reflect the Company&#x2019;s new segment structure and current period presentation. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The International segment includes the Company&#x2019;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#x2019;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in 13 European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#x2019;s Canada operations deliver vital medicines, supplies, and information technology services throughout Canada and includes Rexall Health retail pharmacies. McKesson Europe was previously reflected as the European Pharmaceutical Solutions reportable segment and McKesson Canada was previously included in Other.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than 275,000 national brand medical-surgical products as well as McKesson&#x2019;s own line of products through a network of distribution centers within the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The RxTS segment brings together existing businesses, including CoverMyMeds, RelayHealth, RxCrossroads, and High Volume Solutions, to serve the Company&#x2019;s biopharma and life sciences partners and patients, connecting pharmacies, providers, payers, and biopharma. RxCrossroads was previously included in the former U.S. Pharmaceutical and Specialty Solutions reportable segment and CoverMyMeds, RelayHealth, and High Volume Solutions were previously included in Other.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other, for retrospective periods presented consists of the Company&#x2019;s investment in the Change Healthcare JV, which was split-off from the Company in the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information relating to the Company&#x2019;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating profit (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,063)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#x2019;s total revenues, less than 7% of the International segment&#x2019;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#x2019;s total revenues, and approximately 38% of the RxTS segment&#x2019;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for the Company&#x2019;s reportable segments. For retrospective periods presented, Operating loss for Other reflects equity earnings and charges from the Company&#x2019;s equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s U.S. Pharmaceutical segment&#x2019;s operating profit for the three and nine months ended December 31, 2020 includes $11 million and $115 million, respectively, and for the three and nine months ended December 31, 2019 includes $66 million and $114 million, respectively, of pre-tax credits related to the last-in, first-out (&#x201c;LIFO&#x201d;) method of accounting for inventories. The nine months ended December 31, 2020 also includes a charge of $50 million recorded in connection with the Company&#x2019;s estimated liability under the State of New York&#x2019;s OSA, as further discussed in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Note 13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, &#x201c;Commitments and Contingent Liabilities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s International segment&#x2019;s operating loss for the three and nine months ended December 31, 2020 includes restructuring, impairment, and related charges of $131&#160;million and $189&#160;million, respectively, driven largely by long-lived asset impairment charges of $115 million primarily related to retail pharmacy businesses in Canada and Europe as well as costs associated with the closure of retail pharmacy stores within the U.K. business, as discussed in more detail in Financial Note 4, &#x201c;Restructuring, Impairment, and Related Charges,&#x201d; and a second quarter goodwill impairment charge of $69 million (pre-tax and after-tax) related to one of the Company&#x2019;s reporting units in Europe, as discussed in more detail in Financial Note 8, &#x201c;Goodwill and Intangible Assets, Net.&#x201d; Restructuring, impairment, and related charges of $100 million and $116 million for the three and nine months ended December 31, 2019, respectively, reflects long-lived asset impairment charges of $94 million primarily related to retail pharmacy businesses in the U.K. and Canada. The segment&#x2019;s operating loss also includes charges of $47 million and $57&#160;million for three and nine months ended December 31, 2020, respectively, to remeasure to fair value the assets and liabilities of the Company&#x2019;s German pharmaceutical wholesale business which was contributed to a joint venture as further discussed in Note 3, &#x201c;Held for Sale.&#x201d; The Company recognized a fair value remeasurement charge related to the joint venture of $282 million for the three and nine months ended December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s Medical-Surgical Solutions segment&#x2019;s operating profit for the three and nine months ended December 31, 2020 includes charges totaling $35&#160;million and $49&#160;million, respectively, on certain personal protective equipment and other related products due to inventory impairments and excess inventory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Operating loss for Other for the nine months ended December 31, 2019 includes a pre-tax impairment charge of $1.2 billion and a pre-tax dilution loss of $246 million associated with the Company&#x2019;s investment in Change Healthcare JV. Operating loss for Other also includes the Company&#x2019;s proportionate share of loss from Change Healthcare JV of $28 million and $75 million for the three and nine months ended December 31, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Corporate expenses, net for the three and nine months ended December 31, 2020 includes a pre-tax charge of $8.1 billion ($6.7 billion after-tax) related to the estimated liability for opioid-related claims, as discussed in more detail in Financial &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Note 13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, &#x201c;Commitments and Contingent Liabilities." The nine months ended December 31, 2020 includes a net gain of $131 million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#x2019;s controlled substances monitoring program. Corporate expenses, net, for the three and nine months ended December 31, 2020 include net gains of $30 million and $89 million, respectively, associated with certain of the Company&#x2019;s equity investments and, for the nine months ended December 31, 2019, include settlement charges of $122 million from the termination of the Company&#x2019;s defined benefit pension plan and a settlement charge of $82 million related to opioid claims. The three and nine months ended December 31, 2020 includes $34 million and $118 million, respectively, and the three and nine months ended December 31, 2019 includes $36 million and $108 million, respectively, of pre-tax charges opioid-related costs, primarily litigation expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i85b5d437b88a43c3b57c3014d5ae8bf1_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMTMw_a079cb11-ec42-4973-92f6-9097fc5925c9"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfCountriesInWhichEntityOperates
      contextRef="id58d170d297c43bcace9dc7b5f556347_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMjA2Nw_73cf175d-53a7-44cf-b349-35f6a0a4d931"
      unitRef="country">13</us-gaap:NumberOfCountriesInWhichEntityOperates>
    <mck:NumberOfBusinessOperations
      contextRef="id58d170d297c43bcace9dc7b5f556347_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfOTM0NTg0ODg1MzY5OQ_a53f791d-6776-4a7e-8ec1-f2242a511020"
      unitRef="business_operation">2</mck:NumberOfBusinessOperations>
    <mck:NumberOfNationalBrandMedicalSurgicalProducts
      contextRef="ia9435ea6faaa49bfa7de0a9fd3ee3563_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMjg0Nw_7b7fc3d9-3d1b-456e-b849-b0f23ac2141a"
      unitRef="numberofproducts">275000</mck:NumberOfNationalBrandMedicalSurgicalProducts>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjgzNA_089f4d2c-7fd5-42c6-a5e0-95e526af12a2">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information relating to the Company&#x2019;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating profit (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,063)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#x2019;s total revenues, less than 7% of the International segment&#x2019;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#x2019;s total revenues, and approximately 38% of the RxTS segment&#x2019;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for the Company&#x2019;s reportable segments. For retrospective periods presented, Operating loss for Other reflects equity earnings and charges from the Company&#x2019;s equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s U.S. Pharmaceutical segment&#x2019;s operating profit for the three and nine months ended December 31, 2020 includes $11 million and $115 million, respectively, and for the three and nine months ended December 31, 2019 includes $66 million and $114 million, respectively, of pre-tax credits related to the last-in, first-out (&#x201c;LIFO&#x201d;) method of accounting for inventories. The nine months ended December 31, 2020 also includes a charge of $50 million recorded in connection with the Company&#x2019;s estimated liability under the State of New York&#x2019;s OSA, as further discussed in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Note 13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, &#x201c;Commitments and Contingent Liabilities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s International segment&#x2019;s operating loss for the three and nine months ended December 31, 2020 includes restructuring, impairment, and related charges of $131&#160;million and $189&#160;million, respectively, driven largely by long-lived asset impairment charges of $115 million primarily related to retail pharmacy businesses in Canada and Europe as well as costs associated with the closure of retail pharmacy stores within the U.K. business, as discussed in more detail in Financial Note 4, &#x201c;Restructuring, Impairment, and Related Charges,&#x201d; and a second quarter goodwill impairment charge of $69 million (pre-tax and after-tax) related to one of the Company&#x2019;s reporting units in Europe, as discussed in more detail in Financial Note 8, &#x201c;Goodwill and Intangible Assets, Net.&#x201d; Restructuring, impairment, and related charges of $100 million and $116 million for the three and nine months ended December 31, 2019, respectively, reflects long-lived asset impairment charges of $94 million primarily related to retail pharmacy businesses in the U.K. and Canada. The segment&#x2019;s operating loss also includes charges of $47 million and $57&#160;million for three and nine months ended December 31, 2020, respectively, to remeasure to fair value the assets and liabilities of the Company&#x2019;s German pharmaceutical wholesale business which was contributed to a joint venture as further discussed in Note 3, &#x201c;Held for Sale.&#x201d; The Company recognized a fair value remeasurement charge related to the joint venture of $282 million for the three and nine months ended December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s Medical-Surgical Solutions segment&#x2019;s operating profit for the three and nine months ended December 31, 2020 includes charges totaling $35&#160;million and $49&#160;million, respectively, on certain personal protective equipment and other related products due to inventory impairments and excess inventory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Operating loss for Other for the nine months ended December 31, 2019 includes a pre-tax impairment charge of $1.2 billion and a pre-tax dilution loss of $246 million associated with the Company&#x2019;s investment in Change Healthcare JV. Operating loss for Other also includes the Company&#x2019;s proportionate share of loss from Change Healthcare JV of $28 million and $75 million for the three and nine months ended December 31, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Corporate expenses, net for the three and nine months ended December 31, 2020 includes a pre-tax charge of $8.1 billion ($6.7 billion after-tax) related to the estimated liability for opioid-related claims, as discussed in more detail in Financial &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Note 13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, &#x201c;Commitments and Contingent Liabilities." The nine months ended December 31, 2020 includes a net gain of $131 million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#x2019;s controlled substances monitoring program. Corporate expenses, net, for the three and nine months ended December 31, 2020 include net gains of $30 million and $89 million, respectively, associated with certain of the Company&#x2019;s equity investments and, for the nine months ended December 31, 2019, include settlement charges of $122 million from the termination of the Company&#x2019;s defined benefit pension plan and a settlement charge of $82 million related to opioid claims. The three and nine months ended December 31, 2020 includes $34 million and $118 million, respectively, and the three and nine months ended December 31, 2019 includes $36 million and $108 million, respectively, of pre-tax charges opioid-related costs, primarily litigation expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic371359df42d46fc9cdaa20754eb2857_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMy0xLTEtMS0w_14f24bf6-7e1e-4729-a9ac-1ee35114b82b"
      unitRef="usd">49495000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45c05b8f83b741d992b83ccc3df6b908_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMy0zLTEtMS0w_55059801-d0a1-4767-af98-635e99bf1733"
      unitRef="usd">46453000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i566978f4e878431094db0c99aa04c1ac_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMy01LTEtMS0w_03b78afb-f6a8-4b09-9627-d08b6011b2ab"
      unitRef="usd">142232000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i294c2f089e43428d9f211ab6d5436a55_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMy03LTEtMS0w_a03fa08b-b109-434a-981e-d4030fa4f5fb"
      unitRef="usd">135855000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e166dc2bc4e4407ac307367798e7a56_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNC0xLTEtMS0w_179f848c-790e-4567-ab0f-8c3f1287eb96"
      unitRef="usd">9273000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08ed9c0c5f6d4a748a507235f5b297eb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNC0zLTEtMS0w_714f890c-e8d2-4a0a-883e-8bd2702f2a0a"
      unitRef="usd">9864000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNC01LTEtMS0w_556200e4-8af5-41f8-966f-0c9526e7cf67"
      unitRef="usd">27365000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f352c2923e048e7bcd08e46042cbead_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNC03LTEtMS0w_8ecba241-7108-435c-b20a-082ad26e96b1"
      unitRef="usd">28592000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4632c5240b01414e9082101b8768cac1_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNS0xLTEtMS0w_77b59c5e-804c-403a-a0d2-14a74b9a98b1"
      unitRef="usd">3054000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifedf75934b37431f868f060ab5f6013a_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNS0zLTEtMS0w_8d82c592-03b2-416a-a4dc-30b476bf1f01"
      unitRef="usd">2141000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i502121074c55491db6f36aeb28a2d5f2_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNS01LTEtMS0w_b638f8b9-6946-4bd9-b7f9-7a1ff0a4ea17"
      unitRef="usd">7388000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f550bcedc934c8b80cc03ee44b800ab_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNS03LTEtMS0w_dfe7ab78-eaa5-4f72-9531-9d67ab896f7f"
      unitRef="usd">6100000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08b6999463f4433f9cc082295167d9ae_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNi0xLTEtMS0w_be62de1c-44e1-4c56-8047-bda08be3d0bf"
      unitRef="usd">777000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03a67644704d4440bb71e3a2701c416c_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNi0zLTEtMS0w_178f851e-d553-4ed6-8e22-420156738dd6"
      unitRef="usd">714000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52f55c7a43814e4181d18751f2048f0a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNi01LTEtMS0w_2d1db3c4-1f8d-4bf9-b229-c50ca66b4b3d"
      unitRef="usd">2101000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ae066f96784452da1de68ea4e97704b_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfNi03LTEtMS0w_1f01e61f-4673-48e5-b785-2e6f1de896b4"
      unitRef="usd">1969000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfOC0xLTEtMS0w_955fa9a2-2b7b-4305-91c0-7b79eb1f81f4"
      unitRef="usd">62599000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfOC0zLTEtMS0w_0613cd70-1707-4ab2-843b-b4f62a838070"
      unitRef="usd">59172000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfOC01LTEtMS0w_b7b596ca-fc00-4d37-89ba-f3b6b85c87a9"
      unitRef="usd">179086000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfOC03LTEtMS0w_4eca435d-517a-4978-ac5e-e64226973878"
      unitRef="usd">172516000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="if54fe59c7ab4486da50c3e383e0514cb_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTEtMS0xLTEtMA_fed8fdaa-c020-42d6-a778-fe657eea1b8e"
      unitRef="usd">635000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic713f1d7bbaa46368d505facade21e5e_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTEtMy0xLTEtMA_e2d29b63-cbf9-4c3c-8889-33a0885d7e67"
      unitRef="usd">677000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTEtNS0xLTEtMA_4ed8a992-4d52-41b2-9390-87f38464e98e"
      unitRef="usd">1871000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia76b1ab18790411e9e7fdeb98f2f4606_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTEtNy0xLTEtMA_83301dc3-604f-4f0b-9427-c708ad69cbbd"
      unitRef="usd">1894000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifc7a74b6b95d4a9e9c701380f77e3b51_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTItMS0xLTEtMA_e629f2e2-a72f-48aa-a850-6d5446a0878a"
      unitRef="usd">-71000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib36209733adf465ab9a09ed10cfc40ba_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTItMy0xLTEtMA_3f257027-48a9-4ae0-8bee-0d0f35efce8a"
      unitRef="usd">-290000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTItNS0xLTEtMA_693b5236-616b-4ff6-a725-304902791786"
      unitRef="usd">-113000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i55e8174fad24466896ea35fa3e18419c_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTItNy0xLTEtMA_8c1b2bc3-7ca7-4166-b1ff-c39145c21058"
      unitRef="usd">-229000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id80f00bff7b5467b812041c7200a62b2_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTMtMS0xLTEtMA_8a110ce6-7ed5-4cf6-8d04-5ec36a020f9a"
      unitRef="usd">260000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ief6c871b558e47b38754e0ea56f455a3_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTMtMy0xLTEtMA_97e38ad2-8757-405e-9772-dbc287daa22e"
      unitRef="usd">124000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTMtNS0xLTEtMA_b21710a2-6474-4e6e-9ad9-3f38b3ed8acd"
      unitRef="usd">536000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifafa9479474c4281a1fb299fa0ed48b3_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTMtNy0xLTEtMA_204e088c-a349-4d76-88f8-383b69c52113"
      unitRef="usd">378000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iee23f0fe86e64c7bae441a8ea5cc1c91_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTQtMS0xLTEtMA_f78567fd-3514-49ff-8391-8322119ddfe8"
      unitRef="usd">114000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5f91b4dd9d724e81a9d50e837b7e65d6_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTQtMy0xLTEtMA_a769d9b9-efd8-49a4-942e-f57a781027de"
      unitRef="usd">82000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTQtNS0xLTEtMA_1d89c391-9492-42c3-baec-f878c7ccbc9f"
      unitRef="usd">270000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i33926b73aa0043d2989ae3b788c16046_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTQtNy0xLTEtMA_345d178a-ca58-46e1-8ce7-fb4729a8376d"
      unitRef="usd">280000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i499179d5d599419b93690bc3104dd04a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTUtMS0xLTEtMA_c3d6e869-a5a0-4707-aa9f-4c1ee6bbf6a6"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib74da540dfec4334b95c1028aad4aabb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTUtMy0xLTEtMA_8a4c2d5c-990e-4243-9b9e-2dd14f0219fc"
      unitRef="usd">-33000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i99739bb45fd0447c89efe136d2b8fa9a_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTUtNS0xLTEtMA_fd5690a1-2a0a-4050-9769-918acaa896c2"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib06a1c55db15496e8c44849e29aea6c6_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTUtNy0xLTEtMA_37c9dd1b-22c2-4a13-aada-3204ba9ff176"
      unitRef="usd">-1483000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i79d5ebe53b9a4ebca65716989b93c5f8_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTYtMS0xLTEtMA_c16abc4a-76a8-4daa-bc95-f675654d56a9"
      unitRef="usd">938000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ida0b040eb5e94d34b4dbc2a627b7da27_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTYtMy0xLTEtMA_871f38e5-3612-4fe2-a1e8-989e77c50cab"
      unitRef="usd">560000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if94267ba6de9458db3df283198381edf_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTYtNS0xLTEtMA_3b792441-4ae5-4fc2-9860-820be6338a64"
      unitRef="usd">2564000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9e8e81ee2fb849c29d5ea7c25273ee5e_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTYtNy0xLTEtMA_2fc454f5-9d3f-4941-8659-082c0aa7df79"
      unitRef="usd">840000000</us-gaap:OperatingIncomeLoss>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTctMS0xLTEtMA_f8a507b1-587d-428b-8889-a347c15fcc25"
      unitRef="usd">8246000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTctMy0xLTEtMA_adc4f7dc-8b14-45bf-b4ee-d9a9f3579512"
      unitRef="usd">202000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTctNS0xLTEtMA_b98726de-79be-476d-9897-bfd5e09ccde7"
      unitRef="usd">8462000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTctNy0xLTEtMA_19e60296-8e6a-473b-a2a2-277b6cc50bb3"
      unitRef="usd">713000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <us-gaap:InterestAndDebtExpense
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTgtMS0xLTEtMA_8fc8729e-4c25-4964-b503-6f244045aeb5"
      unitRef="usd">55000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTgtMy0xLTEtMA_db7cf095-7dd2-40ad-b331-ed452140ad04"
      unitRef="usd">64000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTgtNS0xLTEtMA_857418ee-913d-47bd-b0c9-0b3cb27ce450"
      unitRef="usd">165000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTgtNy0xLTEtMA_baa5c084-ed5c-463e-824f-13c256da90e3"
      unitRef="usd">184000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTktMS0xLTEtMA_db6823a5-0630-4e9a-a3a3-0184f3e08552"
      unitRef="usd">-7363000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTktMy0xLTEtMA_84ba5057-558b-415c-9793-c6695b6b9171"
      unitRef="usd">294000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTktNS0xLTEtMA_9169fe83-9296-415e-8610-25b961f1aacb"
      unitRef="usd">-6063000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7da94f298edc48b3ba2407faa6bb3257_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RhYmxlOjU5YmY2Y2IzNDgzMTQyOGQ5YjIyMmZlN2ViODMzZWMxL3RhYmxlcmFuZ2U6NTliZjZjYjM0ODMxNDI4ZDliMjIyZmU3ZWI4MzNlYzFfMTktNy0xLTEtMA_089bf038-e92f-4342-854d-3892d0ea68fe"
      unitRef="usd">-57000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="id933ef12d3a24d5fade86060a23e0a6a_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMzg2OQ_93e199c9-a8ea-4b45-b5a2-cb8f9dcdb97a"
      unitRef="number">0.01</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ia76b1ab18790411e9e7fdeb98f2f4606_D20190401-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMzg2OQ_d9c5e2d3-fc82-43a4-bbf2-2a76d25fcfbd"
      unitRef="number">0.01</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i55e8174fad24466896ea35fa3e18419c_D20190401-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMzkzNQ_b03b3e13-d6a3-4fba-aed5-b55c48742338"
      unitRef="number">0.07</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ic84712afb97a4dbb87b53fe4b09363cf_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMzkzNQ_f35d9d19-db1c-409d-ad28-860357163489"
      unitRef="number">0.07</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ia996899a77814c11b1495ca0445af186_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMzk5NQ_2f6dc1cc-be15-464a-bb32-bb7776b39a2f"
      unitRef="number">0.02</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ifafa9479474c4281a1fb299fa0ed48b3_D20190401-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMzk5NQ_39b9510d-092f-4416-8453-082740c1ac78"
      unitRef="number">0.02</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i33926b73aa0043d2989ae3b788c16046_D20190401-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDA3Ng_02d63820-3166-4162-b46f-fa0ef0aa622c"
      unitRef="number">0.38</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i9c607836fc804e60b2b8bc6cf260cc1b_D20200401-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDA3Ng_f29338cb-c0aa-4a48-84d5-1f6d44c25bee"
      unitRef="number">0.38</mck:RevenueDerivedFromServicesPercentage>
    <us-gaap:NumberOfReportableSegments
      contextRef="i1de8191ab06245abb971e2b0ffe26491_D20200701-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDE5Nw_83484e51-22a4-4e92-9c27-20dfc48693e5"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="ic371359df42d46fc9cdaa20754eb2857_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDczNg_4f90a79b-bdd5-4034-9e8e-21928d8b717d"
      unitRef="usd">-11000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i566978f4e878431094db0c99aa04c1ac_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDc0Mw_9bed6aec-7b74-4732-84a4-82971691456a"
      unitRef="usd">-115000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i45c05b8f83b741d992b83ccc3df6b908_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDgwOA_19ee1b37-7174-4bee-b760-71639ad57fdc"
      unitRef="usd">-66000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i294c2f089e43428d9f211ab6d5436a55_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDgxNQ_21ea48e6-d3e3-4444-b6d7-ac4aeb9393db"
      unitRef="usd">-114000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="i115a3e3004e949119c249e28526ae1d6_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk4OQ_70e1a8c8-d554-4ca2-b6de-19ab1f6e3403"
      unitRef="usd">50000000</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:RestructuringCharges
      contextRef="i4e166dc2bc4e4407ac307367798e7a56_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjMzOTc5Ng_cc39d45e-37db-44fe-b5ef-c1403cb89c44"
      unitRef="usd">131000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjMzOTgxMA_1fd4637b-9fe1-4dae-8bb0-9f09474efae1"
      unitRef="usd">189000000</us-gaap:RestructuringCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i3c50feca7ee54358a769c9e227ade88b_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDMzMA_2eac6b27-072f-4a3e-9c14-3eca0f3ea5fc"
      unitRef="usd">115000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i4e166dc2bc4e4407ac307367798e7a56_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDMzMA_81885a80-fb34-4c78-81cf-5e38bec59f5c"
      unitRef="usd">115000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GoodwillImpairmentLossNetOfTax
      contextRef="i3d023e4934d548c9bc3bd440f7da7aa3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNTQ1Ng_2bcc35bb-29be-41ee-a5fa-147a864624f5"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLossNetOfTax>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3d023e4934d548c9bc3bd440f7da7aa3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNTQ1Ng_77d2d7c8-7a60-4ac6-a507-bd1574fda27f"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:RestructuringCharges
      contextRef="ic1ab6dd9883343f8a42baa07fb972b7a_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfODc5NjA5MzAzNjU0OA_e9014762-83ba-4543-a529-2bb7bddf57db"
      unitRef="usd">100000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic9ff51a496f742c5a3c83d3b38d4dbb1_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfODc5NjA5MzAzNjU1Ng_75ae8b70-4ff2-4e04-9336-def1a1850143"
      unitRef="usd">116000000</us-gaap:RestructuringCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i8f352c2923e048e7bcd08e46042cbead_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDM0NA_5520f915-90ad-4a67-b0df-27d95f906a74"
      unitRef="usd">94000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i08ed9c0c5f6d4a748a507235f5b297eb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDM0NA_5720ffe0-1c23-487e-9b37-3b789233a625"
      unitRef="usd">94000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i938f21cb5003435093dd61e42f1e4b04_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDA4NA_606ed94e-b402-4a9f-8db5-9297a0ec658a"
      unitRef="usd">-47000000</us-gaap:GainLossOnSaleOfBusiness>
    <mck:GainLossOnSaleOfBusinessNetOfTax
      contextRef="i938f21cb5003435093dd61e42f1e4b04_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDA4NA_dea21788-bca2-4401-9c70-831cbd82826e"
      unitRef="usd">-47000000</mck:GainLossOnSaleOfBusinessNetOfTax>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i568b05318ce7413fa9252c00b9a77597_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDEwMQ_40ba1865-c029-4e54-a5f7-23317a56a37e"
      unitRef="usd">-57000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="icd175625828b47dcab648e0b14392f10_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDA0NQ_62e2f44f-777c-488e-a9a2-e92a8e45659e"
      unitRef="usd">282000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax
      contextRef="icd175625828b47dcab648e0b14392f10_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDA0NQ_6ae7b6a1-2644-4a56-8cab-1f1b116f0e73"
      unitRef="usd">282000000</mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax>
    <mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax
      contextRef="i0736a2a757fc454b88a193a6988112ef_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDA0NQ_ca0bf28a-df2a-433b-b254-ca718669ab16"
      unitRef="usd">282000000</mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i0736a2a757fc454b88a193a6988112ef_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjM0MDA0NQ_dad717c7-9297-43f1-8161-63a54c923693"
      unitRef="usd">282000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:InventoryWriteDown
      contextRef="i4632c5240b01414e9082101b8768cac1_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjMzNzMzMQ_45b18059-35b4-4efa-9789-9007c3cf4820"
      unitRef="usd">35000000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i502121074c55491db6f36aeb28a2d5f2_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNDk0NzgwMjMzNzM0NQ_49989e41-2a03-40de-92e1-ec3d6233269d"
      unitRef="usd">49000000</us-gaap:InventoryWriteDown>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i72904c34cf28486695441a05e83b4257_D20190701-20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNTY5Mg_3daeff53-6ccf-4d7f-beff-2bf2e918d6d8"
      unitRef="usd">1200000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i5b86094c4db947ae9f4ef0d8fd8d773a_D20190401-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNTY5Mg_67077b77-7a3f-4458-89c4-9c928d588708"
      unitRef="usd">1200000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="i5b86094c4db947ae9f4ef0d8fd8d773a_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNTcyNg_2c450e52-ab9e-4c0d-816d-a6961db02af2"
      unitRef="usd">-246000000</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="i72904c34cf28486695441a05e83b4257_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNTcyNg_f5906b50-0800-4327-9cc9-d5a1f8ba6891"
      unitRef="usd">-246000000</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <mck:ProportionateGainLossOnEquityMethodInvestment
      contextRef="i0946d2a17db14d63b64a7a7251e88c34_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNTkwNQ_48078183-4582-42c2-8f3e-fff280b1665b"
      unitRef="usd">-28000000</mck:ProportionateGainLossOnEquityMethodInvestment>
    <mck:ProportionateGainLossOnEquityMethodInvestment
      contextRef="i5b86094c4db947ae9f4ef0d8fd8d773a_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNTkxMg_2f77dafd-4f88-4d35-8550-f7fd68ffe028"
      unitRef="usd">-75000000</mck:ProportionateGainLossOnEquityMethodInvestment>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i7ac4183cf22d4c829d4a7bc371cc268c_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMjE5OTAyMzI3MjM0Nw_dcac3458-4279-4dfe-9a7f-1fca14a1a501"
      unitRef="usd">8100000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i30c6a601291c426daef2c98a6924abf6_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMjE5OTAyMzI3MjM0Nw_e9adc7c3-ed49-4c00-92cc-42ef2aa25053"
      unitRef="usd">8100000000</us-gaap:LossContingencyAccrualProvision>
    <mck:LossContingencyAccrualProvisionNetOfTax
      contextRef="i7ac4183cf22d4c829d4a7bc371cc268c_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMjE5OTAyMzI3MjM3NA_05bac1f2-f26a-4d94-bd1f-00678e229869"
      unitRef="usd">6700000000</mck:LossContingencyAccrualProvisionNetOfTax>
    <mck:LossContingencyAccrualProvisionNetOfTax
      contextRef="i30c6a601291c426daef2c98a6924abf6_D20200401-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfMjE5OTAyMzI3MjM3NA_4a2bd069-22f8-476e-96ad-73aeb42bae7e"
      unitRef="usd">6700000000</mck:LossContingencyAccrualProvisionNetOfTax>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="i115a3e3004e949119c249e28526ae1d6_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjAyMg_efdddf12-30df-43a4-bca5-47486a8649b4"
      unitRef="usd">-131000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment
      contextRef="ibf94a331dc864eada169fac303e5931b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjMxOA_ce08c030-ab1d-4e93-a740-480092bd0cab"
      unitRef="usd">30000000</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment
      contextRef="id38061441e40423d8310f1dfcc2de952_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjMyNQ_1e009e7a-9832-4433-adb6-2217cdcaa7e2"
      unitRef="usd">89000000</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i69eab42c07a44d5aabd460e6391ea635_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjQ4MA_0fddb45f-043a-457d-9746-356cf134381e"
      unitRef="usd">-122000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i797e794c99c4456e98cc170a98d8a85b_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjU5Mg_cf4326b6-b2b0-46d2-acee-f2d115c51362"
      unitRef="usd">-82000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:LitigationSettlementExpense
      contextRef="ib6909fe531ae47989d16e4519df3b5f9_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjY2MA_1abf2417-6c99-456e-86f7-6250973c7f03"
      unitRef="usd">34000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i115a3e3004e949119c249e28526ae1d6_D20200401-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjY2Nw_33355363-996f-40bc-94cb-a77ce20a98ab"
      unitRef="usd">118000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i422fe30a34754885aa9558599f8972f8_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjcyOA_35050143-d047-42a4-b212-31f4020a10e9"
      unitRef="usd">36000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i797e794c99c4456e98cc170a98d8a85b_D20190401-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI5YzZmMjhmZTUxNDQyNzhiYjEyMmZlM2IzOGNmNDU0L3NlYzpiOWM2ZjI4ZmU1MTQ0Mjc4YmIxMjJmZTNiMzhjZjQ1NF85Ny9mcmFnOjI0MDJkZGRhNjMzNzQxYThiMWVkMzQ2ZDQ0YTQyYjA2L3RleHRyZWdpb246MjQwMmRkZGE2MzM3NDFhOGIxZWQzNDZkNDRhNDJiMDZfNjczNQ_b031e05e-1275-425b-b52f-653415ed961e"
      unitRef="usd">108000000</us-gaap:LitigationSettlementExpense>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588226216776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-13252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">McKESSON CORPORATION<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3207296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6555 State Hwy 161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irving<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75039<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">446-4800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">159,167,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000927653<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A0625NotesDue2021Member', window );">0.625% notes Due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.625% Notes due 2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK21A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A1500NotesDue2025Member', window );">1.500% Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.500% Notes due 2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A1625NotesDue2026Member', window );">1.625% Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.625% Notes due 2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A3125NotesDue2029Member', window );">3.125% Notes Due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.125% Notes due 2029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A0625NotesDue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A0625NotesDue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A1500NotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A1500NotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A1625NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A1625NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A3125NotesDue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A3125NotesDue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588226172008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 62,599<span></span>
</td>
<td class="nump">$ 59,172<span></span>
</td>
<td class="nump">$ 179,086<span></span>
</td>
<td class="nump">$ 172,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(59,448)<span></span>
</td>
<td class="num">(56,139)<span></span>
</td>
<td class="num">(170,235)<span></span>
</td>
<td class="num">(163,829)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">3,151<span></span>
</td>
<td class="nump">3,033<span></span>
</td>
<td class="nump">8,851<span></span>
</td>
<td class="nump">8,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Operating expenses</a></td>
<td class="num">(2,291)<span></span>
</td>
<td class="num">(2,535)<span></span>
</td>
<td class="num">(6,625)<span></span>
</td>
<td class="num">(6,779)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Claims and litigation charges, net</a></td>
<td class="num">(8,067)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7,936)<span></span>
</td>
<td class="num">(82)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RestructuringImpairmentandOtherRelatedCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="num">(155)<span></span>
</td>
<td class="num">(136)<span></span>
</td>
<td class="num">(271)<span></span>
</td>
<td class="num">(204)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="num">(10,513)<span></span>
</td>
<td class="num">(2,673)<span></span>
</td>
<td class="num">(14,901)<span></span>
</td>
<td class="num">(7,067)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(7,362)<span></span>
</td>
<td class="nump">360<span></span>
</td>
<td class="num">(6,050)<span></span>
</td>
<td class="nump">1,620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity earnings and charges from investment in Change Healthcare Joint Venture</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,478)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Interest expense</a></td>
<td class="num">(55)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
<td class="num">(165)<span></span>
</td>
<td class="num">(184)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="num">(7,363)<span></span>
</td>
<td class="nump">294<span></span>
</td>
<td class="num">(6,063)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="nump">1,189<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="num">(6,174)<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="num">(5,052)<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(6,174)<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="num">(5,053)<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(52)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="num">(152)<span></span>
</td>
<td class="num">(163)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to McKesson Corporation</a></td>
<td class="num">$ (6,226)<span></span>
</td>
<td class="nump">$ 186<span></span>
</td>
<td class="num">$ (5,205)<span></span>
</td>
<td class="num">$ (121)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="num">$ (39.03)<span></span>
</td>
<td class="nump">$ 1.06<span></span>
</td>
<td class="num">$ (32.28)<span></span>
</td>
<td class="num">$ (0.60)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
<td class="num">(0.06)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="num">(39.03)<span></span>
</td>
<td class="nump">1.03<span></span>
</td>
<td class="num">(32.29)<span></span>
</td>
<td class="num">(0.66)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="num">(39.03)<span></span>
</td>
<td class="nump">1.06<span></span>
</td>
<td class="num">(32.28)<span></span>
</td>
<td class="num">(0.60)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
<td class="num">(0.06)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="num">$ (39.03)<span></span>
</td>
<td class="nump">$ 1.04<span></span>
</td>
<td class="num">$ (32.29)<span></span>
</td>
<td class="num">$ (0.66)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">159.5<span></span>
</td>
<td class="nump">179.7<span></span>
</td>
<td class="nump">161.2<span></span>
</td>
<td class="nump">183.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">159.5<span></span>
</td>
<td class="nump">178.7<span></span>
</td>
<td class="nump">161.2<span></span>
</td>
<td class="nump">183.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RestructuringImpairmentandOtherRelatedCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring, Impairment and Other Related Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RestructuringImpairmentandOtherRelatedCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588229704920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (6,174)<span></span>
</td>
<td class="nump">$ 242<span></span>
</td>
<td class="num">$ (5,053)<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Other comprehensive income, net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Unrealized gains (losses) on cash flow hedges</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Changes in retirement-related benefit plans</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="num">(6,055)<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="num">(4,892)<span></span>
</td>
<td class="nump">226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(77)<span></span>
</td>
<td class="num">(66)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
<td class="num">(161)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss) attributable to McKesson Corporation</a></td>
<td class="num">$ (6,132)<span></span>
</td>
<td class="nump">$ 227<span></span>
</td>
<td class="num">$ (5,005)<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588229798360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 3,577<span></span>
</td>
<td class="nump">$ 4,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net</a></td>
<td class="nump">18,877<span></span>
</td>
<td class="nump">19,950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">19,211<span></span>
</td>
<td class="nump">16,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">688<span></span>
</td>
<td class="nump">617<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">42,368<span></span>
</td>
<td class="nump">42,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">2,518<span></span>
</td>
<td class="nump">2,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,955<span></span>
</td>
<td class="nump">1,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,511<span></span>
</td>
<td class="nump">9,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">2,980<span></span>
</td>
<td class="nump">3,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">2,513<span></span>
</td>
<td class="nump">2,258<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">61,845<span></span>
</td>
<td class="nump">61,247<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="nump">36,509<span></span>
</td>
<td class="nump">37,195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">777<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">384<span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">683<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">4,094<span></span>
</td>
<td class="nump">3,340<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">41,930<span></span>
</td>
<td class="nump">42,624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="nump">6,467<span></span>
</td>
<td class="nump">6,335<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liabilities</a></td>
<td class="nump">773<span></span>
</td>
<td class="nump">2,255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">1,747<span></span>
</td>
<td class="nump">1,660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveNoncurrent', window );">Long-term litigation liabilities</a></td>
<td class="nump">8,067<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">1,846<span></span>
</td>
<td class="nump">1,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">1,292<span></span>
</td>
<td class="nump">1,402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>McKesson Corporation stockholders&#8217; equity (deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value, 800 shares authorized and 273 and 272 shares issued at December 31, 2020 and March 31, 2020, respectively</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">6,847<span></span>
</td>
<td class="nump">6,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">7,595<span></span>
</td>
<td class="nump">13,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,503)<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury shares, at cost, 114 and 110 shares at December 31, 2020 and March 31, 2020, respectively</a></td>
<td class="num">(13,418)<span></span>
</td>
<td class="num">(12,892)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total McKesson Corporation stockholders&#8217; equity (deficit)</a></td>
<td class="num">(477)<span></span>
</td>
<td class="nump">5,092<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity (deficit)</a></td>
<td class="num">(277)<span></span>
</td>
<td class="nump">5,309<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable noncontrolling interests, and equity (deficit)</a></td>
<td class="nump">$ 61,845<span></span>
</td>
<td class="nump">$ 61,247<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588230993800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>McKesson Corporation stockholders&#8217; equity (deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">800,000,000<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">273,000,000<span></span>
</td>
<td class="nump">272,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">114,000,000<span></span>
</td>
<td class="nump">110,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588221594888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Other Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
<th class="th"><div>Opening retained earnings adjustment: adoption of new accounting standard</div></th>
<th class="th">
<div>Opening retained earnings adjustment: adoption of new accounting standard </div>
<div>Retained Earnings</div>
</th>
<th class="th"><div>Adjusted balance, April 1</div></th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Common Stock</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Additional Paid-in Capital</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Other Capital</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Retained Earnings</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Accumulated Other Comprehensive Loss</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Treasury</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Noncontrolling Interests</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2019</a></td>
<td class="nump">$ 8,287<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 6,435<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="nump">$ 12,409<span></span>
</td>
<td class="num">$ (1,849)<span></span>
</td>
<td class="num">$ (8,902)<span></span>
</td>
<td class="nump">$ 193<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 8,298<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 6,435<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="nump">$ 12,420<span></span>
</td>
<td class="num">$ (1,849)<span></span>
</td>
<td class="num">$ (8,902)<span></span>
</td>
<td class="nump">$ 193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of shares under employee plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans</a></td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(121)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(1,934)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,934)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(221)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(221)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="nump">6,385<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">6,614<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">12,075<span></span>
</td>
<td class="num">(1,663)<span></span>
</td>
<td class="num">$ (10,853)<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2019</a></td>
<td class="nump">$ 8,287<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">6,435<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">12,409<span></span>
</td>
<td class="num">(1,849)<span></span>
</td>
<td class="num">$ (8,902)<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">8,298<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">6,435<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">12,420<span></span>
</td>
<td class="num">(1,849)<span></span>
</td>
<td class="num">$ (8,902)<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares) at Mar. 31, 2020</a></td>
<td class="num">(110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="nump">$ 5,309<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,663<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,022<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
<td class="num">$ (12,892)<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="nump">5,296<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,663<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,009<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
<td class="num">$ (12,892)<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(92)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Sep. 30, 2019</a></td>
<td class="nump">$ 6,692<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">6,573<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">11,965<span></span>
</td>
<td class="num">(1,704)<span></span>
</td>
<td class="num">$ (10,353)<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="nump">231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(73)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="nump">$ 6,385<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">6,614<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">12,075<span></span>
</td>
<td class="num">(1,663)<span></span>
</td>
<td class="num">$ (10,853)<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares) at Mar. 31, 2020</a></td>
<td class="num">(110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="nump">$ 5,309<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,663<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,022<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
<td class="num">$ (12,892)<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="nump">$ 5,296<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 6,663<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 13,009<span></span>
</td>
<td class="num">$ (1,703)<span></span>
</td>
<td class="num">$ (12,892)<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of shares under employee plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="num">(5,085)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(203)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(203)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares) at Dec. 31, 2020</a></td>
<td class="num">(114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="num">$ (277)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,847<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,595<span></span>
</td>
<td class="num">(1,503)<span></span>
</td>
<td class="num">$ (13,418)<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Sep. 30, 2020</a></td>
<td class="nump">6,090<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,780<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,890<span></span>
</td>
<td class="num">(1,597)<span></span>
</td>
<td class="num">$ (13,185)<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="num">(6,185)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,226)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(231)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (231)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(67)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">$ (2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares) at Dec. 31, 2020</a></td>
<td class="num">(114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="num">$ (277)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 6,847<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 7,595<span></span>
</td>
<td class="num">$ (1,503)<span></span>
</td>
<td class="num">$ (13,418)<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588230861768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 29, 2020</div></th>
<th class="th"><div>Jul. 28, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588229665752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (5,053)<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">429<span></span>
</td>
<td class="nump">452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill and other asset impairment charges</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity earnings and charges from investment in Change Healthcare Joint Venture</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred taxes</a></td>
<td class="num">(1,520)<span></span>
</td>
<td class="num">(387)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Credits associated with last-in, first-out inventory method</a></td>
<td class="num">(115)<span></span>
</td>
<td class="num">(114)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Non-cash operating lease expense</a></td>
<td class="nump">264<span></span>
</td>
<td class="nump">276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Loss from sales of businesses and investments</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>Changes in assets and liabilities, net of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="num">(1,044)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(2,046)<span></span>
</td>
<td class="num">(689)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Drafts and accounts payable</a></td>
<td class="num">(1,240)<span></span>
</td>
<td class="num">(929)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncreaseDecreaseinOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(291)<span></span>
</td>
<td class="num">(287)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable', window );">Taxes</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncreaseDecreaseInLitigationReserve', window );">Litigation liabilities</a></td>
<td class="nump">8,067<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="nump">403<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">1,172<span></span>
</td>
<td class="num">(280)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Payments for property, plant, and equipment</a></td>
<td class="num">(293)<span></span>
</td>
<td class="num">(242)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireSoftware', window );">Capitalized software expenditures</a></td>
<td class="num">(134)<span></span>
</td>
<td class="num">(96)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</a></td>
<td class="num">(33)<span></span>
</td>
<td class="num">(97)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates', window );">Proceeds from sales of businesses and investments, net</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="num">(75)<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(210)<span></span>
</td>
<td class="num">(409)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings</a></td>
<td class="nump">5,455<span></span>
</td>
<td class="nump">15,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayments of short-term borrowings</a></td>
<td class="num">(5,303)<span></span>
</td>
<td class="num">(13,743)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuances of long-term debt</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(1,030)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract', window );"><strong>Common stock transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Issuances</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Share repurchases, including shares surrendered for tax withholding</a></td>
<td class="num">(526)<span></span>
</td>
<td class="num">(1,951)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(209)<span></span>
</td>
<td class="num">(222)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(118)<span></span>
</td>
<td class="num">(271)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(1,176)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="num">(77)<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(291)<span></span>
</td>
<td class="num">(916)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at beginning of period</a></td>
<td class="nump">4,023<span></span>
</td>
<td class="nump">2,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at end of period</a></td>
<td class="nump">3,732<span></span>
</td>
<td class="nump">2,065<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Less: Restricted cash at end of period included in Prepaid expenses and other</a></td>
<td class="num">(155)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 3,577<span></span>
</td>
<td class="nump">$ 2,065<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncreaseDecreaseInLitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Litigation Reserve</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncreaseDecreaseInLitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncreaseDecreaseinOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncreaseDecreaseinOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588225881096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: McKesson Corporation (&#8220;McKesson,&#8221; or the &#8220;Company,&#8221;) is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. Commencing with the second quarter of 2021, the Company reports its financial results in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (&#8220;RxTS&#8221;). The Company&#8217;s equity method investment in Change Healthcare LLC (&#8220;Change Healthcare JV&#8221;), which was split-off from McKesson in the fourth quarter of 2020, has been included in Other for retrospective periods presented. All prior segment information has been recast to reflect the Company&#8217;s new segment structure and current period presentation. Refer to Financial Note 15, &#8220;Segments of Business,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers itself to control an entity if it has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S.&#8221;) of America (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The severity, magnitude, and duration, as well as the economic consequences of the coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic, are uncertain, rapidly changing and difficult to predict. Therefore, the Company&#8217;s accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) was enacted on March 27, 2020 in the U.S., and includes several provisions related to employment and income taxes, including provisions for the deferral of the employer portion of social security taxes through December 31, 2020. On December 27, 2020, the U.S. government enacted the Consolidated Appropriations Act, 2021, which enhances and expands certain provisions of the CARES Act. These legislative acts are not expected to have a material impact on the Company&#8217;s consolidated financial results. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three and nine months ended December 31, 2020 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2020 previously filed with the SEC on May 22, 2020 (&#8220;2020 Annual Report&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current year presentation.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company prospectively adopted Accounting Standards Update (&#8220;ASU&#8221;) 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs in a cloud computing arrangement that has a software license. As a result, the Company began capitalizing eligible implementation costs for such contracts and recognizing the expense over the service period. The adoption of this amended guidance did not have a material impact on the Company&#8217;s condensed consolidated financial statements or disclosures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company retrospectively adopted ASU 2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Retirement Benefits - Defined Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires the Company to disclose the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates, and an explanation of reasons for significant gains and losses related to changes in the benefit obligation for the period. The amended guidance also requires the Company to remove disclosures on the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit costs over the next fiscal year. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#8217;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company adopted ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to remove, modify and add disclosure requirements on fair value measurements. Certain requirements were applied prospectively while other changes were applied retrospectively on the effective date. The amended guidance removes disclosure requirements for transfers between Level 1 and Level 2 measurements and valuation processes for Level 3 measurements, but adds new disclosure requirements including changes in unrealized gains or losses in other comprehensive income related to recurring Level 3 measurements and requirements to disclose the range, and weighted-average used to develop significant unobservable inputs for Level 3 fair value measurements. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#8217;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company adopted ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2016-13&#8221;), which changed the impairment model for most financial assets from one based on current losses to a forward-looking model based on expected losses. The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses. The amended guidance requires financial assets that are measured at amortized cost be presented at the net amount expected to be collected. An allowance for credit losses is established as a valuation account that is deducted from the amortized cost basis of financial assets. The guidance also requires enhanced disclosures. This guidance was adopted on a modified retrospective basis and did not have a material impact on the Company&#8217;s condensed consolidated financial statements or disclosures. Upon adoption of the amended guidance in the first quarter of 2021, the Company recorded a cumulative-effect adjustment of $13 million to the opening balance of retained earnings, primarily as a result of adjustments to allowances for trade accounts receivable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for Credit Losses: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the adoption of ASU 2016-13 in the first quarter of 2021, the Company began using the Current Expected Credit Losses ("CECL") methodology to determine an allowance for credit losses related to financial assets measured at amortized cost. The Company considers historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop its allowance for credit losses. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $221 million was included in Receivables, net on the Condensed Consolidated Balance Sheet as of December 31, 2020. Changes in the allowance were not material for the three and nine months ended December 31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In December 2019, ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was issued with the intent to simplify various aspects related to accounting for income taxes.&#160;The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The guidance is effective for the Company in the first quarter of 2022 and&#160;early adoption is permitted.&#160;The Company is currently evaluating the impact of this amended guidance on its condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588224158760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in Change Healthcare Joint Venture<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Investment in Change Healthcare Joint Venture</a></td>
<td class="text">Investment in Change Healthcare Joint Venture<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the separation of its interest in the Change Healthcare JV on March 10, 2020, the Company accounted for its interest in the joint venture using the equity method of accounting with a one-month reporting lag, with disclosure made for any intervening events of the joint venture in the lag period that could materially affect its condensed consolidated financial statements. Effective April 1, 2019, the Change Healthcare JV adopted the amended revenue recognition guidance. In the first quarter of 2020, the Company recorded its proportionate share of the joint venture&#8217;s adoption impact of the amended revenue recognition guidance of approximately $80 million, net of tax, to the Company&#8217;s opening retained earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2019, common stock and certain other securities of Change Healthcare Inc. (&#8220;Change&#8221;) began trading on the NASDAQ (&#8220;IPO&#8221;). Change was a holding company and did not own any material assets or have any operations other than its interest in the Change Healthcare JV. On July 1, 2019, upon the completion of its IPO, Change received net cash proceeds of approximately $888 million. Change contributed the proceeds of $609 million from its offering of common stock to the Change Healthcare&#160;JV in exchange for additional membership interests of the Change Healthcare JV (&#8220;LLC Units&#8221;) at the equivalent of its offering price of $13 per share. The proceeds of $279 million from the concurrent offering of other securities were used by Change to acquire certain securities of the Change Healthcare JV that substantially mirrored the terms of other securities included in the offering by Change. As a result, McKesson&#8217;s equity interest in the Change Healthcare JV was diluted from approximately 70% to approximately 58.5% while Change owned approximately 41.5% of the outstanding LLC Units. Accordingly, in the second quarter of 2020, the Company recognized a pre-tax dilution loss of $246 million primarily representing the difference between its proportionate share of the IPO proceeds and the dilution effect on the investment&#8217;s carrying value. These items were included in Equity earnings and charges from investment in Change Healthcare Joint Venture in the Company&#8217;s Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2019. The Company&#8217;s proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, the Company recorded a pre-tax other-than-temporary&#160;impairment (&#8220;OTTI&#8221;) charge of $1.2 billion to its investment in the Change Healthcare JV, representing the difference between the carrying value of the Company&#8217;s investment and the fair value derived from the corresponding closing price of Change&#8217;s common stock at September 30, 2019. This charge was included in Equity earnings and charges from investment in Change Healthcare Joint Venture in the Company&#8217;s Condensed Consolidated Statements of Operations for the nine months ended December 31, 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded its proportionate share of loss from its investment in Change Healthcare JV of $28 million and $75 million, respectively, for the three and nine months ended December 31, 2019. The Company&#8217;s proportionate share of income or loss from this investment included integration expenses incurred by Change Healthcare JV and basis differences between the joint venture and McKesson, including amortization of fair value adjustments primarily representing incremental intangible assets. These amounts were included within Equity earnings and charges from investment in Change Healthcare Joint Venture in the Company&#8217;s Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2020, the Company completed the previously announced separation of its interest in the Change Healthcare JV which eliminated the Company&#8217;s investment in the joint venture. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While a party to the joint venture, the Company had various ancillary agreements related to the Change Healthcare JV, including transition services agreements (&#8220;TSA&#8221;), a transaction and advisory fee agreement (&#8220;Advisory Agreement&#8221;), a tax receivable agreement (&#8220;TRA&#8221;), and certain other agreements. Revenues recognized and expenses incurred under these agreements with the Change Healthcare JV were not material during the three and nine months ended December 31, 2020 and the three months ended December 31, 2019. Fees earned from the TSA were $18 million for the nine months ended December 31, 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the agreement executed in 2019 between the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson. McKesson exercised its right under the agreement and allocated certain depreciation and amortization deductions to Change for the tax years ended March 31, 2019 and 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After McKesson&#8217;s separation of its interest in the Change Healthcare JV, the aforementioned TRA agreement requires the Change Healthcare JV to pay McKesson 85% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the depreciation or amortization allocated to Change by McKesson. The receipt of any payments from the Change Healthcare JV under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings. This creates uncertainty over the amount, timing, and probability of the gain recognized. As such, the Company accounts for the TRA as a gain contingency, with no receivable recognized as of December 31, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020 in conjunction with the separation transaction, the Company recorded a reversal of the deferred tax liability related to its investment. Under the agreement with the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, there may be changes in future periods to the amount reversed as the relevant periods are audited by tax authorities. Any such change is not expected to have a material impact on the Company&#8217;s condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588225900792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Held for Sale</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are reclassified into &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The reclassification occurs when the disposal group is available for immediate sale and the sale is highly probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell and are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less cost to sell is reported as an adjustment to the carrying value of the disposal group. Assets and liabilities that have met the classification of held for sale were $15 million and $14 million, respectively, at December 31, 2020 and $906&#160;million and $683&#160;million, respectively, at March 31, 2020. These amounts at March 31, 2020 primarily consisted of the majority of the Company&#8217;s German pharmaceutical wholesale business described below. This disposal group had been recorded as assets and liabilities held for sale since the third quarter of 2020 through its contribution to a joint venture in the third quarter of 2021. Based on its analysis, the Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations and are not considered to be significant disposals based on its quantitative and qualitative evaluation. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">German Pharmaceutical Wholesale Joint Venture</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2020, the Company completed its previously announced transaction with Walgreens Boots Alliance (&#8220;WBA&#8221;) whereby the majority of its German pharmaceutical wholesale business was contributed to a newly formed joint venture in which McKesson has a 30% noncontrolling interest. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration received included a receivable amount of $43&#160;million, primarily related to working capital and net debt adjustments from WBA, and the 30% interest in the newly formed joint venture. At the transaction date, the carrying value of the equity investment in the joint venture was recorded at its fair value, which was measured using inputs that fell within Level 3 of the fair value hierarchy. The carrying value of the investment in the joint venture was nil as of December 31, 2020. The joint venture also assumed a note payable to the Company in the amount of approximately $291&#160;million as of the transaction date, which was paid to the Company in the third quarter of 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the contribution, the Company recorded a loss of $47&#160;million (pre-tax and after-tax) in operating expenses in the three months ended December 31, 2020. In addition to this amount, the Company recorded charges of $10&#160;million (pre-tax and after-tax) in the three and six months ended September 30, 2020 and $282&#160;million (pre-tax and after-tax) in the three and nine months ended December 31, 2019 to remeasure the assets and liabilities held for sale to fair value less costs to sell. These charges were included within operating expenses in the condensed consolidated statements of operations. The Company&#8217;s measurement of the fair value of the disposal group was based on estimates of total consideration to be received by the Company as outlined in the contribution agreement between the Company and WBA. As a result of finalization of working capital amounts contributed and other adjustments, the Company may record additional gains or losses in future periods; however, these adjustments are not expected to have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its interest in the joint venture as an equity method investment within the International segment. The Company does not provide for losses on the investment as the Company has no guaranteed obligations for the joint venture to fund losses and is not otherwise committed to providing further financial support for the investee. If the joint venture subsequently generates income, the Company will only recognize its share of such income to the extent it exceeds its share of the previously unrecognized losses. As such, the Company has not recognized its proportionate share of earnings for the intervening period from the transaction date to December 31, 2020.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the completion of the transaction on November 1, 2020, there were no assets or liabilities of the German pharmaceutical wholesale joint venture classified as held for sale on the Company&#8217;s consolidated balance sheet. Total assets and liabilities of the German pharmaceutical wholesale joint venture that were classified as held for sale on the Company&#8217;s consolidated balance sheet as of March 31, 2020, were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of business held for sale to fair value less costs to sell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes the effect of approximately $3 million of favorable cumulative foreign currency translation adjustment as of March 31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588224164120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment and Related Charges<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring, Impairment and Related Charges</a></td>
<td class="text">Restructuring, Impairment, and Related Charges<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded restructuring, impairment, and related charges of $155 million and $271 million during the three and nine months ended December 31, 2020, respectively, and $136 million and $204 million during the three and nine months ended December 31, 2019, respectively. These charges are included under the caption, &#8220;Restructuring, impairment, and related charges&#8221; in Operating expenses in the Condensed Consolidated Statements of Operations. In addition, charges related to restructuring initiatives are included under the caption &#8220;Cost of sales&#8221; in its Condensed Consolidated Statements of Operations and were not material for the three and nine months ended December 31, 2020 and 2019.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously announced on November 30, 2018, the Company relocated its corporate headquarters, effective April 1, 2019, from San Francisco, California to Irving, Texas to improve efficiency, collaboration, and cost competitiveness. The Company expects to record total charges of approximately $105 million to $125 million, of which $104 million of charges were recorded to date. The Company recorded charges of $14 million and $27&#160;million, respectively, during the three and nine months ended December 31, 2020 and $14 million and $34 million, respectively, during the three and nine months ended December 31, 2019, consisting primarily of employee retention expenses, severance, accelerated depreciation, and long-lived asset impairments. The relocation was substantially complete in January 2021 and the estimated remaining charges primarily relate to lease costs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, the Company committed to certain programs to continue its operating model and cost optimization efforts. The Company continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency. The programs also include reorganization and consolidation of business operations, related headcount reductions, the further closures of retail pharmacy stores in Europe, and closures of other facilities. The Company expects to incur total charges of approximately $310 million to $320 million for these programs, of which $288 million of charges were recorded to date. The Company recorded charges of $17 million and $53 million, respectively, during the three and nine months ended December 31, 2020 and $20 million and $59 million, respectively, during the three and nine months ended December 31, 2019, consisting primarily of employee severance, accelerated depreciation expense, and project consulting fees. The Company anticipates these additional programs will be substantially completed in 2022. The estimated remaining charges primarily consist of facility and other exit costs and employee-related costs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the first quarter of 2021, the Company committed to an initiative within the United Kingdom (&#8220;U.K.&#8221;), which is included in the Company&#8217;s International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings. The initiative includes reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. The Company expects to incur total charges of approximately $100 million to $120 million. The Company recorded charges of $9 million and $50 million, respectively, in the three and nine months ended December 31, 2020, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. The initiative is expected to be substantially complete by the end of 2021 and estimated remaining charges primarily consist of accelerated amortization of long-lived assets, facility and other exit costs, and employee-related costs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three and nine months ended December 31, 2020 consisted of the following: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of project consulting fees.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of project consulting fees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three and nine months ended December 31, 2019 consisted of the following: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.193%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents exit costs associated with a disposition and costs related to the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts described above. Additionally, includes costs associated with a growth initiative, substantially completed in the year ended March 31, 2020, which included a reduction in workforce and facility consolidation.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.193%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents exit costs associated with a disposition and costs related to the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above. Additionally, includes costs associated with a growth initiative, substantially completed in the year ended March 31, 2020, which included a reduction in workforce and facility consolidation.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the nine months ended December 31, 2020: </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March 31, 2020, the total reserve balance was $157 million, of which $118 million was recorded in Other accrued liabilities and $39 million was recorded in Other non-current liabilities. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of December 31, 2020, the total reserve balance was $132 million, of which $101 million was recorded in Other accrued liabilities and $31 million was recorded in Other non-current liabilities.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Long-Lived Asset Impairments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company recognized charges of $115 million to impair certain long-lived assets within the Company&#8217;s International segment. These charges primarily related to long-lived assets associated with the Company&#8217;s retail pharmacy businesses in Canada and Europe and were due to declines in estimated future cash flows partially driven by a revised outlook regarding the impacts of COVID-19. The Company used both an income approach (a discounted cash flow (&#8220;DCF&#8221;) method) and a market approach to estimate the fair value of the long-lived assets. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2020, the Company recognized charges of $94 million to impair certain long-lived assets within the Company&#8217;s International segment. These charges primarily related to long-lived assets associated with the Company&#8217;s retail pharmacy businesses in the U.K. and Canada due to declines in estimated future cash flows driven by government reimbursement reductions and lower than expected growth in both prescription volume and sales of non-prescription goods, respectively. The Company used both income (DCF) and market approaches to estimate the fair value of the long-lived assets. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the long-lived assets is considered a Level 3 fair value measurement due to the significance of unobservable inputs developed using company specific information. Refer to Financial Note 12, &#8220;Fair Value Measurements,&#8221; for more information on nonrecurring fair value measurements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588225840792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes During the three months ended December 31, 2020 and 2019, the Company recorded an income tax benefit of $1.2 billion and income tax expense of $47 million, respectively. During the nine months ended December 31, 2020 and 2019, the Company recorded an income tax benefit of $1.0 billion and $111 million, respectively. The Company reported an income tax benefit rate of 16.1% and an income tax expense rate of 16.0% for the three months ended December 31, 2020 and 2019, respectively, and income tax benefit rates of 16.7% and 194.7% for the nine months ended December 31, 2020 and 2019, respectively. Fluctuations in the Company&#8217;s reported income tax rates are primarily due to changes within the mix of earnings between various taxing jurisdictions, discrete items recognized in the quarters, including the impact of an intercompany sale of intellectual property during the nine months ended December 31, 2020, and impairment to the Company&#8217;s investment in the Change Healthcare JV, decreasing pre-tax income, for the nine months ended December 31, 2019. The charge for opioid-related claims of $8.1 billion ($6.7 billion after-tax), as described further in Financial Note 13, &#8220;Commitments and Contingent Liabilities,&#8221; unfavorably impacted the Company&#8217;s reported income tax benefit rates for the three and nine months ended December 31, 2020. Income tax benefit (expense) for the three and nine months ended December 31, 2019 included a discrete tax benefit of $24 million recognized in connection with a planned divestiture in the Medical-Surgical Solutions segment and $21 million recognized in connection with an agreement executed in December 2019 to settle all opioid-related claims filed by two Ohio counties.<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company sold intellectual property between wholly-owned legal entities within McKesson that are based in different tax jurisdictions. The transferor entity recognized a gain on the sale of assets which was not subject to income tax in its local jurisdiction; such gain was eliminated upon consolidation. The acquiring entity of the intellectual property is entitled to amortize the purchase price of the assets for tax purposes. In accordance with ASU 2016-16, &#8220;Intra-Entity Transfers of Assets Other Than Inventory,&#8221; a discrete tax benefit of $105 million was recognized for the nine months ended December 31, 2020 with a corresponding increase to a deferred tax asset for the temporary difference arising from the buyer&#8217;s excess tax basis. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended December 31, 2019, no tax benefit was recognized for the pre-tax impairment charge of $282 million for the remeasurement of assets and liabilities held for sale to fair value related to the formation of a new German pharmaceutical wholesale joint venture within the Company&#8217;s International segment. Refer to Financial Note 3, &#8220;Held for Sale,&#8221; for more information on this transaction which closed on November 1, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company had $1.5 billion of unrecognized tax benefits, of which $1.4 billion would reduce income tax expense and the effective tax rate if recognized. The increase of $497 million during the three months ended December 31, 2020 in unrecognized tax benefit is mainly due to uncertainty in connection with the deductibility of Opioid related litigation and claims. Because many of the uncertainties associated with any potential settlement arrangements or other resolution of opioid claims, including provisions related to deductibility, have not been finalized, the actual amount of the tax benefit related to uncertain tax positions may differ from these estimates. Refer to Financial Note 13, &#8220;Commitments and Contingent Liabilities,&#8221; for more information. During the next twelve months, it is reasonably possible that the Company&#8217;s unrecognized tax benefits may decrease by as much as $93 million due to settlements of tax examinations and statute of limitations expirations in the U.S. federal and state jurisdictions and in foreign jurisdictions. However, this amount may change as the Company continues to have ongoing negotiations with various taxing authorities throughout the year. The unrecognized tax benefit may also increase or decrease due to future developments in the Opioid related litigation and claims.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#8220;IRS&#8221;) is currently examining the Company&#8217;s U.S. corporation income tax returns for 2016 through 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2013 through the current fiscal year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588225895768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Redeemable Noncontrolling Interests and Noncontrolling Interests</a></td>
<td class="text">Redeemable Noncontrolling Interests and Noncontrolling Interests<div style="margin-bottom:6pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s redeemable noncontrolling interests primarily relate to its consolidated subsidiary, McKesson Europe AG (&#8220;McKesson Europe&#8221;). Under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#8364;0.83 per share. As a result, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $11 million and $32 million during the three and nine months ended December 31, 2020, respectively, and $11 million and $33 million during the three and nine months ended December 31, 2019, respectively. All amounts were recorded in Net income attributable to noncontrolling interests in the Company&#8217;s Condensed Consolidated Statements of Operations and the corresponding liability balance was recorded in Other accrued liabilities in the Company&#8217;s Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe have a right to put (&#8220;Put Right&#8221;) their noncontrolling shares at &#8364;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#8220;Put Amount&#8221;). The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests. During the nine months ended December 31, 2020, the Company paid $49 million to purchase 1.8&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $49 million, and the associated effect of the increase in the Company&#8217;s ownership interest on its equity of $3 million was recorded as a net increase to McKesson&#8217;s stockholders paid-in capital during 2021. During the three months ended December 31, 2020, and the three and nine months ended December 31, 2019, there were no material exercises of the Put Right. The balance of the associated liability for Redeemable noncontrolling interests is reported as the greater of its carrying value or its maximum redemption value at each reporting date. The redemption value is the Put Amount adjusted for exchange rate fluctuations each period. The Redeemable noncontrolling interest is also adjusted each period for the proportion of other comprehensive income, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders. At December 31, 2020, the carrying value of redeemable noncontrolling interests of $1.3&#160;billion approximated the maximum redemption value of $1.3 billion, and at March 31, 2020, the carrying value of $1.4&#160;billion exceeded the maximum redemption value of $1.2 billion. At December 31, 2020 and March 31, 2020, the Company owned approximately 78% and 77%, respectively, of McKesson Europe&#8217;s outstanding common shares.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity interests in the Company&#8217;s consolidated entities primarily related to ClarusONE Sourcing Services LLP, Vantage Oncology Holdings, LLC, and McKesson Europe, which were $200 million and $217 million at December 31, 2020 and March 31, 2020, respectively, in the Company&#8217;s Condensed Consolidated Balance Sheets. The Company allocated a total of $41 million and $120 million of net income to noncontrolling interests during the three and nine months ended December 31, 2020, respectively, and $45 million and $130 million during the three and nine months ended December 31, 2019, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2020 were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2019 were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.031%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.543%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588225753320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (Loss) Per Common Share</a></td>
<td class="text">Earnings (Loss) Per Common ShareBasic earnings (loss) per common share are computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings (loss) per common share is similar to that of basic earnings (loss) per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Diluted loss per common share for the three and nine months ended December 31, 2020, and nine months ended December 31, 2019 was calculated by excluding potentially dilutive securities from the denominator of the share computation due to their anti-dilutive effects.<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:52.439%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.967%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,174)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,052)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,226)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,204)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,226)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,205)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.03&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.29)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.66)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.29)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.66)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"> Certain computations may reflect rounding adjustments.</span></div>Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Approximately 2&#160;million of potentially dilutive securities for the three months ended December 31, 2019 were excluded from the computation of diluted net earnings per common share as they were anti-dilutive.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588225702920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets, Net</a></td>
<td class="text">Goodwill and Intangible Assets, Net <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. These reportable segments encompass all operating segments of the Company. This segment change prompted changes in multiple reporting units across the Company. As a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach and assessed for impairment both before and after the reallocation. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a goodwill impairment charge of $69 million (pre-tax and after-tax) in the nine months ended December 31, 2020 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment. This impairment charge is included under the caption, &#8220;Goodwill impairment charges&#8221; in the Condensed Consolidated Statements of Operations. At December 31, 2020, the balance of goodwill for the reporting units in Europe was approximately nil and the remaining balance of goodwill in the International segment primarily relates to one of its reporting units in Canada. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist. The annual impairment testing performed for 2021 did not indicate any impairment of goodwill. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 12, &#8220;Fair Value Measurements,&#8221; for more information.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.092%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.942%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March&#160;31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting, transfers and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,990&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,526&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,511&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,318)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,654&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,950)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(480)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,660&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,680)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,980&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,392&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,236)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,156&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Amortization expense of intangible assets was $108 million and $320 million during the three and nine months ended December 31, 2020, respectively, and $113 million and $343 million during the three and nine months ended December 31, 2019, respectively. Estimated amortization expense of these assets is as follows: $96 million, $371 million, $272 million, $254 million, and $251 million for the remainder of 2021 and each of the succeeding years through 2025 and $1.7 billion thereafter. All intangible assets were subject to amortization as of December 31, 2020 and March 31, 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588225830472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt and Financing Activities</a></td>
<td class="text">Debt and Financing Activities<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.65% Notes due November 30, 2020</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due March 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% Notes due December 15, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63% Euro Notes due August 17, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63% Euro Notes due October 30, 2026 </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,244&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,387&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,467&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,335&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. Debt outstanding totaled $7.2 billion and $7.4 billion at December 31, 2020 and March 31, 2020, respectively, of which $777 million and $1.1 billion, respectively, was included under the caption &#8220;Current portion of long-term debt&#8221; within the Company&#8217;s Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 3, 2020, the Company completed a public offering of 0.90% Notes due December 3, 2025 (the &#8220;2025 Notes&#8221;) in a principal amount of $500&#160;million. Interest on the 2025 Notes is payable semi-annually on June 3rd and December 3rd of each year, commencing on June 3, 2021. Proceeds received from this note issuance, net of discounts and offering expenses, were $496&#160;million.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 Notes, which constitutes a &#8220;Series,&#8221; are an unsecured and unsubordinated obligation of the Company and rank equally with all of the Company&#8217;s existing, and from time-to-time, future unsecured and unsubordinated indebtedness outstanding. The 2025 Notes are governed&#160;by materially similar indentures and officers&#8217; certificates as those of other Series issued by the Company. Upon required notice to holders of notes with fixed interest rates, the Company may redeem those notes at any time prior to maturity, in whole or in part, for cash at redemption prices. In the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of a Series below an investment grade rating by each of Fitch Inc., Moody&#8217;s Investors Service, Inc. and Standard &amp; Poor&#8217;s Ratings Services within a specified period, an offer must be made to purchase the 2025 Notes from the holders at a price equal to&#160;101%&#160;of the then outstanding principal amount of the 2025 Notes, plus accrued and unpaid interest to, but not including, the date of repurchase. The indenture and the related officers&#8217; certificate for the 2025 Note, subject to the exceptions and in compliance with the conditions as applicable, specify that the Company may not consolidate, merge or sell all or substantially all of its assets, incur liens, or enter into sale-leaseback transactions exceeding specific terms, without lenders&#8217; consent. The indentures also contain customary events of default provisions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended December 31, 2020, the Company retired its $700&#160;million total principal amount of notes due on November 30, 2020 at a fixed interest rate of 3.65% upon maturity. On December 1, 2020, the Company redeemed its 4.75% $323&#160;million total principal of notes due on March 1, 2021 prior to maturity. These notes were redeemed using cash on hand and the proceeds of the notes offering discussed above.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson maintains a syndicated $4 billion five-year senior unsecured credit facility, dated as of September 25, 2019, as amended (the &#8220;2020 Credit Facility&#8221;), which has a $3.6 billion aggregate sublimit of availability in Canadian dollars, British pound sterling and Euro. The 2020 Credit Facility matures in September 2024 and had no&#160;borrowings during the three and nine months ended December 31, 2020 and no amounts outstanding as of December 31, 2020 and March 31, 2020. The remaining terms and conditions of the 2020 Credit Facility are substantially similar to those previously in place under the&#160;$3.5 billion five-year senior unsecured revolving credit facility (the &#8220;Global Facility&#8221;), which was scheduled to mature in October 2020. The Global Facility was terminated in connection with the execution of the 2020 Credit Facility in September 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#8220;LIBOR&#8221;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility contains financial covenants which obligate the Company to maintain a maximum debt to capital ratio, as defined in the 2020 Credit Facility, along with other customary investment grade covenants. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. As of December 31, 2020, the Company was in compliance with all covenants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains bilateral credit facilities primarily denominated in Euro with a committed amount of $8 million and an uncommitted amount of $183 million as of December 31, 2020. Borrowings and repayments were not material during the three and nine months ended December 31, 2020 and 2019, and amounts outstanding under these credit lines were not material as of December 31, 2020 and March 31, 2020. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $4.0 billion in outstanding commercial paper notes. During the nine months ended December 31, 2020 and 2019, the Company borrowed $5.5 billion and $15.9 billion, respectively, and repaid $5.3 billion and $13.7 billion, respectively, under the program. At December 31, 2020 there were $152 million of commercial paper notes outstanding with a weighted average interest rate of 0.21%. At March 31, 2020, there were no commercial paper notes outstanding.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588225823672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension Benefits</a></td>
<td class="text">Pension Benefits<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic expense for defined benefit pension plans was $4 million and $17 million for the three and nine months ended December 31, 2020, respectively, and $16 million and $151 million for the three and nine months ended December 31, 2019, respectively. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash contributions to these plans were $8 million and $19 million for the three and nine months ended December 31, 2020, respectively, and $120 million and $132 million for the three and nine months ended December 31, 2019, respectively. The three and nine months ended December 31, 2019 included a cash payment of $114&#160;million from the executive benefit retirement plan. The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized on a straight-line basis over the average remaining future service periods and expected life expectancy.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2020, the Company derecognized $187&#160;million of pension liabilities included in liabilities held for sale and $24&#160;million of accumulated other comprehensive loss, net of tax, related to its German pharmaceutical wholesale business contributed to a joint venture, as discussed in more detail in Financial Note 3, &#8220;Held for Sale.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 23, 2018, the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) approved the termination of its frozen U.S. defined benefit pension plan (&#8220;Plan&#8221;). During the first quarter of 2020, the Company offered the option of receiving a lump sum payment to certain participants with vested qualified Plan benefits in lieu of receiving monthly annuity payments. Approximately 1,300 participants elected to receive the settlement, and lump sum payments of approximately $49 million were made from Plan assets to these participants in June 2019. The benefit obligation settled approximated payments to Plan participants and a pre-tax settlement charge of $17 million was recorded during the first quarter of 2020. During the second quarter of 2020, the Company transferred the remainder of the Plan&#8217;s pension obligation to a third-party insurance provider by purchasing annuity contracts for approximately $280 million which was fully funded directly by Plan assets. The third-party insurance provider assumed the obligation to pay future benefits and provide administrative services on November 1, 2019 and a pre-tax settlement charge of $105&#160;million was recorded during the second quarter of 2020. Settlement charges were included within Other income (expense), net in the condensed consolidated statement of operations for the nine months ended December 31, 2019 as a result of the termination of the Plan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588224471608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Hedging Activities</a></td>
<td class="text">Hedging Activities <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives such as cross-currency swaps, foreign currency forward contracts, and interest rate swaps. In accordance with the Company&#8217;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. </span></div><div style="margin-bottom:6pt;padding-left:2.25pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#8217;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Derivative Instruments Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020 and March 31, 2020, the Company had &#8364;1.7 billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#8217;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded in foreign currency translation adjustments within Accumulated other comprehensive loss in the Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments.&#160;To the extent foreign currency denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. In December 2019, the Company prospectively de-designated from net investment hedges &#8364;250 million of its Euro-denominated notes which matured in February 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from net investment hedges recorded within Other comprehensive income were losses of $84 million and $201 million during the three and nine months ended December 31, 2020, respectively, and losses of $59 million and gains of $8 million during the three and nine months ended December 31, 2019, respectively. There was no ineffectiveness in non-derivative net investment hedges during the three and nine months ended December 31, 2020. Ineffectiveness on the Company&#8217;s non-derivative net investment hedges during the three and nine months ended December 31, 2019 resulted in losses of $3 million and gains of $26&#160;million, respectively, which were recorded in earnings in Other income (expense), net in the Condensed Consolidated Statements of Operations. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020 and March 31, 2020, the Company had cross-currency swaps designated as net investment hedges with a total gross notional amount of $999 million and $1.5 billion Canadian dollars, respectively. Under the terms of the cross-currency swap contracts, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These swaps are utilized to hedge portions of the Company&#8217;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in Accumulated other comprehensive loss in the Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in the Company&#8217;s net investment hedges for the three and nine months ended December 31, 2020 and 2019. In November 2020, cross currency swaps with an aggregate gross notional amount of $500&#160;million Canadian dollars matured and the remaining cross-currency swaps will mature between March 2021 and November 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2020, the Company terminated cross-currency swaps with a total gross notional amount of &#163;932 million British pound sterling due to ineffectiveness in its British pound sterling hedging program that arose due to 2019 impairments of goodwill and certain long-lived assets in the U.K. businesses. Proceeds from the termination of these swaps totaled $84 million and resulted in a settlement gain of $34 million for the nine months ended December 31, 2019. This gain was recorded in earnings in Other income (expense), net, net in the Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from the Company&#8217;s cross-currency swaps designated as net investment hedges recorded in Other comprehensive income were losses of $45 million and $108 million during the three and nine months ended December 31, 2020, respectively, and losses of $20 million and $11 million during the three and nine months ended December 31, 2019, respectively. There was no ineffectiveness in the Company&#8217;s cross-currency swap hedges for the three and nine months ended December 31, 2020 and 2019. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2019, the Company entered into a number of cross-currency swaps designated as fair value hedges with total notional amounts of &#163;450 million British pound sterling. Under the terms of the cross-currency swap contracts, the Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. These swaps are utilized to hedge the changes in the fair value of the underlying &#163;450 million British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives, which are designated as fair value hedges, and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from these fair value hedges recorded in earnings for the three and nine months December 31, 2020 and 2019 were largely offset by the losses recorded in earnings related to these notes. The swaps will mature in February 2023.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company also enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies. For cross-currency swap transactions, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These cross-currency swaps are designed to reduce the income statement effects arising from fluctuations in foreign exchange rates and have been designated as cash flow hedges. At December 31, 2020 and March 31, 2020, the Company had cross-currency swaps with total gross notional amounts of approximately $2.6 billion and $2.9 billion, respectively, which are designated as cash flow hedges. These swaps will mature between February 2021 and January 2024. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For forward contracts and cross-currency swaps that are designated as cash flow hedges, the effective portion of changes in the fair value&#160;of the hedges is recorded in Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 27, 2020, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with combined notional amounts of $500 million and &#8364;600 million, to hedge the variability of future benchmark interest rates on planned bond issuances. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $500 million swaps for floating interest payments in U.S. dollars based on three-month LIBOR and to pay fixed interest payments for floating interest payments in Euros based on six-month Euro Interbank Offered Rate (&#8220;EURIBOR&#8221;) for the &#8364;600 million swaps. The $500 million swaps were terminated upon the issuance of the 2025 Notes in November 2020. The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes. Refer to Financial Note 9, &#8220;Debt and Financing Activities,&#8221; for more information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Gains or losses from cash flow hedges recorded in Other comprehensive income were losses of $14 million and $42 million during the three and nine months ended December 31, 2020, respectively, and were gains of $5 million and $40 million during the three and nine months ended December 31, 2019, respectively. Gains or losses reclassified from Accumulated other comprehensive income and recorded in Operating expenses in the Condensed Consolidated Statements of Operations were not material in the three and nine months ended December 31, 2020 and 2019. There was no ineffectiveness in the Company&#8217;s cash flow hedges for the three and nine months ended December 31, 2020 and 2019.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in fair value included in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a number of forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. At December 31, 2020 and March 31, 2020, the total gross notional amounts of these contracts were $13 million and $29 million, respectively. These contracts will predominantly mature between January 2021 and October 2021 and none of these contracts were designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in Operating expenses. Changes in the fair values were not material in the three and nine months ended December 31, 2020 and 2019. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended December 31, 2019, the Company also entered into a number of forward contracts and swaps to offset a portion of the earnings impacts from the ineffectiveness of the net investment hedges discussed above. These contracts matured through January 2020 and none of these contracts were designated for hedge accounting. In December 2019, the Company entered into a series of forward contracts with a total notional amount of &#8364;250 million to offset the earnings impact from its Euro-denominated notes. These contracts and the notes against which they offset matured in February 2020 and were not designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly in earnings. During the three and nine months ended December 31, 2019, gains of $3 million and losses of $36 million, respectively, were recorded in earnings within Other income (expense), net in the Condensed Consolidated Statements of Operations.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.481%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.033%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.672%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.817%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.206%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated for hedge accounting</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div>Refer to Financial Note 12, "Fair Value Measurements," for more information on these recurring fair value measurements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588225914392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020 and March 31, 2020, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is carried at amortized cost. The carrying amounts and estimated fair values of these liabilities were $7.2 billion and $8.0 billion at December 31, 2020, respectively, and $7.4 billion and $7.8 billion at March 31, 2020, respectively. The estimated fair value of the Company&#8217;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at December 31, 2020 and March 31, 2020 included investments in money market funds of $123 million and $2.0 billion, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level&#160;1 inputs. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of the Company&#8217;s foreign currency forward contracts were determined using observable inputs from available market information. Fair values of the Company&#8217;s cross-currency swaps were determined using quoted foreign currency exchange rates and other observable inputs from available market information. Fair values of the Company&#8217;s interest rate swaps were determined using observable inputs from available market information. These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 11, &#8220;Hedging Activities,&#8221; for fair value and other information on the Company&#8217;s foreign currency derivatives including forward foreign currency contracts and cross-currency swaps.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry and which have carrying values of $267 million and $170 million at December 31, 2020 and March 31, 2020, respectively. These investments primarily consist of equity securities without readily determinable fair values and are included within Other non-current assets in the Condensed Consolidated Balance Sheets. In the second quarter of 2021, three of the companies in which McKesson holds investments in equity securities were converted into shares of public common stock through initial public offerings and an acquisition and are adjusted to fair value at each reporting period. In the third quarter of 2021, two of the Company&#8217;s investments in equity securities without readily determinable fair values experienced transactions which resulted in changes in the observable price of those securities. As a result, net gains related to the Company&#8217;s investments in equity securities, primarily representing unrealized gains on the securities discussed above, were $28 million and $87 million for the three and nine months ended December 31, 2020, respectively. These gains were recorded under the caption, &#8220;Other income (expense), net,&#8221; in the Condensed Consolidated Income Statements. There were no other material changes in the carrying value of these investments during the three and nine months ended December 31, 2020. The carrying value of publicly traded investments was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets measured at fair value on a nonrecurring basis as of December 31, 2020 included long-lived assets in the Company&#8217;s International segment and goodwill of the Company&#8217;s Europe Retail Pharmacy reporting unit within the International segment. At March 31, 2020, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#8217;s European and Rexall Health businesses within the International segment. Refer to Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; and Financial Note 8, &#8220;Goodwill and Intangible Assets, Net,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aforementioned investments in equity securities includes the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no liabilities measured at fair value on a nonrecurring basis at December 31, 2020 and March 31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash, included within Prepaid expenses and other on the Company&#8217;s Condensed Consolidated Balance Sheet as of December 31, 2020, primarily consists of funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. The amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds have been recorded by the Company within Other accrued liabilities on the Company&#8217;s Condensed Consolidated Balance Sheet as of December 31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of its reporting units. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.</span></div>The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588225859176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingent Liabilities</a></td>
<td class="text">Commitments and Contingent Liabilities<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/927653/000092765320000033/mck10k3312020.htm#sFDC7F65C03045D74BF3631026AD9426B" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Note 21 to the Company&#8217;s 2020 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Note 13 to the Company&#8217;s 10-Q filing for the quarterly period ended June 30, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Note 13 to the Company</a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#8217;</a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">s 10-Q fil</a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ing for the quarterly period ended </a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">September 30, 2020</a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">,</a></span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, it is not reasonably possible for the Company to determine that a loss is probable for a claim, or to reasonably estimate the amount of loss or a range of loss, because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to be resolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the loss probability has changed and whether it can make a reasonable estimate of the possible loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability in the amount of its estimate for the ultimate loss. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">I. Litigation and Claims Involving Distribution of Controlled Substances</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates are defendants in many cases asserting claims related to distribution of controlled substances. They are named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions include state attorneys general, county and municipal governments, hospitals, Indian tribes, pension funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico, and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), state and federal controlled substances laws, and other statutes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since December 5, 2017, nearly all such cases pending in federal district courts have been transferred for consolidated pre-trial proceedings to a multi-district litigation (&#8220;MDL&#8221;) in the United States District Court for the Northern District of Ohio captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: National Prescription Opiate Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 17-md-2804. At present, there are approximately 2,900 cases under the jurisdiction of the MDL court. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three cases involving McKesson that were previously part of the federal MDL have been remanded to other federal courts for discovery and trial. On January 14, 2020, the Judicial Panel on Multidistrict Litigation finalized its Conditional Remand Order, ordering that the cases against the three largest distributors brought by Cabell County, West Virginia and the City of Huntington, West Virginia be remanded to the U.S. District Court for the Southern District of West Virginia. Trial in that case is scheduled to begin on May 3, 2021. On February 5, 2020, the case brought by the City and County of San Francisco was remanded to the U.S. District Court for the Northern District of California; trial has been set for December 6, 2021. Also on February 5, 2020, the case brought by the Cherokee Nation was remanded by the MDL court to the U.S. District Court for the Eastern District of Oklahoma.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also named in approximately 400 similar state court cases pending in 38 states plus Puerto Rico, along with 3 cases in Canada. These include actions filed by 26 state attorneys general, and some by or on behalf of individuals, including wrongful death lawsuits, and putative class action lawsuits brought on behalf of children with neonatal abstinence syndrome due to alleged exposure to opioids in utero. Trial dates have been set in several of these state court cases. For example, trial was previously set to begin in March 2020 in the Supreme Court of New York, Suffolk County for a case brought by the New York attorney general and two New York county governments, but the trial was postponed in light of the COVID-19 pandemic. The case brought by the Alabama attorney general is scheduled to go to trial in May 2021, as is the case brought by the Washington attorney general.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to be involved in discussions with the objective of achieving broad resolution of opioid-related claims of states, their political subdivisions, and other government entities (&#8220;governmental entities&#8221;). The Company is in ongoing, advanced discussions with state attorneys general and plaintiffs&#8217; representatives regarding a framework under which the three largest U.S. pharmaceutical distributors would pay up to approximately $21.0 billion over a period of 18 years, with up to approximately $8.0 billion to be paid by the Company to resolve claims of governmental entities, with more than 90% of the total amount anticipated to be used to remediate the opioids crisis. Most of the remaining amount relates to plaintiffs&#8217; attorneys fees and costs, and would be payable over a shorter time period. In addition, the proposed framework would require the three distributors, including the Company, to adopt changes to anti-diversion programs. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the framework, before the distributors determine whether to enter into any final settlement, they would assess the sufficiency of the scope of settlement, based in part on the number and identities of the governmental entities that would participate in any such settlement. The framework contemplates that if certain governmental entities did not agree to a settlement under the framework, but the distributors nonetheless concluded that there was sufficient participation to warrant going forward with the settlement, there would be a corresponding reduction in the amount due from the Company to account for the governmental entities that did not agree. Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has concluded that discussions under that framework have reached a stage at which a broad settlement of opioid claims by governmental entities is probable, and the loss related thereto can be reasonably estimated as of December 31, 2020. As a result of that conclusion, and its assessment of certain other opioid-related claims, the Company has recorded a charge of $8.1 billion ($6.7 billion after-tax) within Claims and litigation charges, net in the Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2020, related to its share of the settlement framework described above, as well as those certain other opioid-related claims. In light of the uncertainty, as described below, of the timing of amounts that would be paid with respect to the charge, the charge was recorded in Long-term litigation liabilities in the Company&#8217;s Condensed Consolidated Balance Sheet as of December 31, 2020. Moreover, in light of the uncertainties described below, the amount of loss that the Company ultimately might incur may differ materially from the amount accrued.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discussions with attorneys general and other parties continue. If the negotiating parties agree on terms under the framework for a broad resolution of claims of governmental entities, then those potential terms would need to be agreed to by numerous other state and local governments before an agreement could be accepted by the Company and finalized. In some cases, discovery has been paused during the parties&#8217; discussions. While the Company continues to be involved in discussions regarding a potential broad settlement framework, the Company also continues to prepare for trial in these pending matters. The Company believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the vast majority of opioid claims have been brought by U.S. governmental entities, the Company is also a defendant in cases brought by private plaintiffs, such as hospitals, pension funds, third-party payors, and individuals, as well as 3 cases in which the Company has been named as a defendant in Canada. These claims, and those of private entities generally, are not included in the settlement framework for U.S. governmental entities, or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. The Company has not concluded a loss is probable in any of these matters; nor is the amount of any possible loss reasonably estimable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, and the uncertainty of the scope of potential participation by governmental entities under the framework described above, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#8217;s financial position, cash flows or liquidity, or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">II. Other Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2013, the Company was served with a complaint filed in the United States District Court for the Northern District of California by True Health Chiropractic Inc., alleging that McKesson sent unsolicited marketing faxes in violation of the Telephone Consumer Protection Act of 1991 (&#8220;TCPA&#8221;), as amended by the Junk Fax Protection Act of 2005 or JFPA,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;No. CV-13-02219 (HG). Plaintiffs seek statutory damages from&#160;$500&#160;to&#160;$1,500&#160;per violation plus injunctive relief. True Health Chiropractic later amended its complaint, adding McLaughlin Chiropractic Associates as an additional named plaintiff and McKesson Technologies Inc. as a defendant. Both plaintiffs alleged that defendants violated the TCPA by sending faxes that did not contain notices regarding how to opt out of receiving the faxes. On July 16, 2015, plaintiffs filed a motion for class certification. On August 22, 2016, the court denied plaintiffs&#8217; motion. On July 17, 2018, the United States Court of Appeals for the Ninth Circuit Court affirmed in part and reversed in part the district court&#8217;s denial of class certification and remanded the case to the district court for further proceedings. On August 13, 2019, the court granted plaintiffs&#8217; renewed motion for class certification. After class notice and the opt-out period, 9,490 fax numbers remain in the class, representing 48,769 faxes received. On March 5, 2020, McKesson moved to decertify the class and moved for summary judgment on plaintiffs&#8217; claim for treble damages. Plaintiffs&#8217; moved for summary judgment on the same day. On December 24, 2020, the court declined to decertify the class but modified the class definition to distinguish between physical faxes (kept in the class) versus online or e-fax recipients (removed from the class). Because the court modified the class definition, the court deferred on ruling on the parties&#8217; cross-motions for summary judgment, and directed the parties to submit a statement agreeing or objecting to the court&#8217;s proposal for updated class notice. Due to the COVID-19 pandemic, the trial date for this case was taken off calendar to be re-scheduled during 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2017, two investment funds holding shares in Celesio AG filed a complaint against McKesson Europe Holdings (formerly known as &#8220;Dragonfly GmbH &amp; Co KGaA&#8221;), a subsidiary of the Company, in a German court in Stuttgart, Germany, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 18 O 455/17. On December 30, 2017, four investment funds, which had allegedly entered into swap transactions regarding shares in Celesio AG that would have enabled them to decide whether to accept McKesson Europe Holdings&#8217;s takeover offer in its acquisition of Celesio AG, filed a complaint, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson Kempner International (BVI) Ltd. et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No.16 O 475/17. The complaints allege that the public tender offer document published by McKesson Europe in its acquisition of Celesio AG incorrectly stated that McKesson Europe&#8217;s acquisition of convertible bonds would not be treated as a relevant acquisition of shares for the purposes of triggering minimum pricing considerations under Section 4 of the German Takeover Offer Ordinance. On May 11, 2018, the court in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dismissed the claims against McKesson Europe. Plaintiffs appealed this ruling and, on December 19, 2018, the Higher Regional Court (Oberlandesgericht) of Stuttgart confirmed the full dismissal of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> matter. Plaintiffs filed a complaint against denial of leave to appeal with the Federal Court of Justice (Bundesgerichtshof), which was rejected on November 17, 2020, making the dismissal final and binding. With no further right to appeal, Plaintiffs filed an objection against the decision of the Federal Court of Justice on November 27, 2020, claiming their right to be heard had been violated. On March 15, 2019, the lower court in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> similarly dismissed the case. Plaintiffs appealed this ruling and, on October 9, 2019, the Higher Regional Court (Oberlandesgericht) of Stuttgart confirmed the full dismissal of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> matter. On November 13, 2019, Plaintiffs filed a complaint against denial of leave to appeal with the Federal Court of Justice (Bundesgerichtshof).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 25, 2018, Marion Diagnostic Center, LLC and Marion Healthcare, LLC filed a class action complaint in the United States District Court for the Eastern District of Pennsylvania alleging that the Company and its subsidiary, McKesson Medical-Surgical Inc., among others, violated the Sherman Act by restraining trade in the sale of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marion Diagnostic Center, LLC v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:18-cv-4137; MDL No. 16-MD-2724. On June 26, 2019, the court granted the Company&#8217;s motion to dismiss and authorized plaintiffs to seek leave to amend the claims against the Company. On December 30, 2019, a group of independent pharmacies and a hospital filed a class action complaint alleging that the Company and other distributors violated the Sherman Act by colluding with manufacturers to restrain trade in the sale of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reliable Pharmacy, et al. v. Actavis Holdco US, et al., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No. 2:19-cv-6044; MDL No. 16-MD-2724. The complaint seeks relief including treble damages, disgorgement, attorney fees, and costs in unspecified amounts. The court in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marion Diagnostic </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ordered dismissal of plaintiff&#8217;s complaint with prejudice on November 23, 2020 pursuant to a stipulation of the parties, but without waiving any rights Marion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostic Center, LLC and Marion Healthcare, LLC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">may have to participate in a settlement or judgment of any other action in the MDL as a class member.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">III.&#160;Government Subpoenas and Investigations</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 21, 2020, McKesson received correspondence from the U.S. Attorney&#8217;s Office for the Western District of Tennessee alleging reporting and documentation deficiencies in violation of the Controlled Substances Act at the Company&#8217;s former and no longer operational RxPak facility and at its Distribution Center in Memphis, Tennessee, and seeking civil penalties.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV.  State Opioid Statutes</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory or industry measures to address the misuse of prescription opioid medications could affect the Company&#8217;s business in ways that it may not be able to predict. For example, in April 2018, the State of New York adopted the Opioid Stewardship Act (the &#8220;OSA&#8221;) which required the creation of an aggregate $100&#160;million annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. The initial surcharge payment would have been due on January 1, 2019 for opioids sold or distributed during calendar year 2017. On July 6, 2018, the Healthcare Distribution Alliance filed a lawsuit challenging the constitutionality of the law and seeking an injunction against its enforcement. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State appealed that decision. On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#8217;s decision on procedural grounds. The Company has accrued a $50&#160;million pre-tax charge ($37&#160;million after-tax) as its estimated share of the OSA surcharge for calendar years 2017 and 2018. This OSA provision was recognized as Operating expenses in the accompanying condensed consolidated statement of operations for the nine months ended December 31, 2020 and as Other accrued liabilities in the condensed consolidated balance sheets as of December 31, 2020. The State of New York adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018. The Healthcare Distribution Alliance filed a petition for panel rehearing, or, in the alternative, for rehearing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">en banc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with the U.S. Court of Appeals for the Second Circuit; that petition was denied on December 18, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588224486312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity (Deficit)</a></td>
<td class="text">Stockholders' Equity (Deficit) <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of the Company&#8217;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2020, the Company raised its quarterly dividend from $0.41 to $0.42 per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time to time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2020, there were no share repurchases made under previously authorized share repurchase programs. During the three months ended September 30, 2020, the Company repurchased 1.8&#160;million of the Company&#8217;s shares for $269 million through open market transactions at an average price per share of $151.23. During the three months ended December 31, 2020, the Company repurchased 1.5&#160;million of the Company&#8217;s shares for $231 million through open market transactions at an average price per share of $151.12. The total authorization outstanding for repurchases of the Company&#8217;s common stock was $1.0 billion at December 31, 2020. In January 2021, the Board approved an increase of $2.0 billion for the authorized share repurchase of McKesson&#8217;s common stock.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Comprehensive Income (Loss)</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding Other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.261%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments arising during period, net of income tax expense of nil, nil, nil, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) (3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil, nil, nil, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on net investment hedges arising during period, net of income tax benefit of $33, $21, $80, and $1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil, nil, nil, and nil</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges arising during period, net of income tax (expense) benefit of $2, $3, $6, and $(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil,  nil, nil, and nil</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss and prior service cost arising during the period, net of income tax benefit of nil, nil, nil, and $1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss, prior service cost and transition obligation, net of income tax benefit of $2, nil, $1, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other, net of income tax expense of nil, nil, nil, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of $9, $3, $9, and $35 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s foreign subsidiary, McKesson Europe, and its operations in Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">During the three and nine months ended December 31, 2020, net foreign currency translation adjustments were primarily due to the strengthening of the Canadian dollar and Euro against the U.S. dollar from April 1, 2020 to December 31, 2020. During the three and nine months ended December 31, 2019, the net foreign currency translation adjustments were primarily due to the strengthening of the Euro and Canadian dollar against the U.S. dollar, partially offset by weakening of the British pound sterling from April 1, 2019 to December 31, 2019.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and nine months ended December 31, 2020 includes net foreign currency translation adjustments of $20 million and $(41) million, respectively, and the three and nine months ended December 31, 2019 includes net foreign currency translation adjustments of $12 million and $(1) million, respectively, attributable to redeemable noncontrolling interests. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and nine months ended December 31, 2020 include adjustments for amounts related to the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 3, &#8220;Held for Sale.&#8221; These amounts were included in the current and prior periods calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Operating expenses in the Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and nine months ended December 31, 2020 includes foreign currency losses of $84 million and $201 million, respectively, on the net investment hedges from the &#8364;1.7 billion&#160;Euro-denominated notes and &#163;450 million&#160;British pound sterling-denominated notes, losses of $45 million and $108 million, respectively, on the net investment hedges from cross-currency swaps, and losses on net investment hedges of nil and $1 million, respectively, attributable to redeemable noncontrolling interests. The three and nine months ended December 31, 2019 include foreign currency losses of $59 million and gains of $8 million, respectively, on the net investment hedges from the &#8364;1.70 billion Euro-denominated notes and&#160;&#163;450 million British pound sterling-denominated notes and losses of $20 million and $11 million, respectively, on the net investment hedges from cross-currency swaps. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and nine months ended December 31, 2020 include net actuarial gains of $5 million and $3 million, respectively, and the three and nine months ended December 31, 2019 include net actuarial losses of $2 million and $1 million, respectively, which are attributable to redeemable noncontrolling interests.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Pre-tax amount was reclassified into Cost of sales and Operating expenses in the Condensed Consolidated Statements of Operations. The related tax expense was reclassified into Income tax benefit (expense) in the Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The nine months ended December 31, 2019 primarily reflects a reclassification of losses in the second quarter of 2020 upon a pension settlement charge from Accumulated other comprehensive loss to Other income (expense), net in the Condensed Consolidated Statement of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Income (Loss) </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss) by component for the three and nine months ended December 31, 2020 are as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Losses and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,512)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,597)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,329)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,503)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,780)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,329)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,503)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss) by component for the three and nine months ended December 31, 2019 are as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.105%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,659)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,704)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,570)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,663)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.105%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,628)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,570)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,663)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588226307112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments of Business</a></td>
<td class="text">Segments of Business<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing with the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. Other, for retrospective periods presented, consists of the Company&#8217;s equity method investment in Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020. All prior segment information has been recast to reflect the Company&#8217;s new segment structure and current period presentation. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International segment includes the Company&#8217;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#8217;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in 13 European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#8217;s Canada operations deliver vital medicines, supplies, and information technology services throughout Canada and includes Rexall Health retail pharmacies. McKesson Europe was previously reflected as the European Pharmaceutical Solutions reportable segment and McKesson Canada was previously included in Other.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than 275,000 national brand medical-surgical products as well as McKesson&#8217;s own line of products through a network of distribution centers within the United States.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RxTS segment brings together existing businesses, including CoverMyMeds, RelayHealth, RxCrossroads, and High Volume Solutions, to serve the Company&#8217;s biopharma and life sciences partners and patients, connecting pharmacies, providers, payers, and biopharma. RxCrossroads was previously included in the former U.S. Pharmaceutical and Specialty Solutions reportable segment and CoverMyMeds, RelayHealth, and High Volume Solutions were previously included in Other.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, for retrospective periods presented consists of the Company&#8217;s investment in the Change Healthcare JV, which was split-off from the Company in the fourth quarter of 2020.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.260%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,599&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,172&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,086&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,516&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,564&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,246)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,462)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(713)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,363)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,063)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than 7% of the International segment&#8217;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#8217;s total revenues, and approximately 38% of the RxTS segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for the Company&#8217;s reportable segments. For retrospective periods presented, Operating loss for Other reflects equity earnings and charges from the Company&#8217;s equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for the three and nine months ended December 31, 2020 includes $11 million and $115 million, respectively, and for the three and nine months ended December 31, 2019 includes $66 million and $114 million, respectively, of pre-tax credits related to the last-in, first-out (&#8220;LIFO&#8221;) method of accounting for inventories. The nine months ended December 31, 2020 also includes a charge of $50 million recorded in connection with the Company&#8217;s estimated liability under the State of New York&#8217;s OSA, as further discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss for the three and nine months ended December 31, 2020 includes restructuring, impairment, and related charges of $131&#160;million and $189&#160;million, respectively, driven largely by long-lived asset impairment charges of $115 million primarily related to retail pharmacy businesses in Canada and Europe as well as costs associated with the closure of retail pharmacy stores within the U.K. business, as discussed in more detail in Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; and a second quarter goodwill impairment charge of $69 million (pre-tax and after-tax) related to one of the Company&#8217;s reporting units in Europe, as discussed in more detail in Financial Note 8, &#8220;Goodwill and Intangible Assets, Net.&#8221; Restructuring, impairment, and related charges of $100 million and $116 million for the three and nine months ended December 31, 2019, respectively, reflects long-lived asset impairment charges of $94 million primarily related to retail pharmacy businesses in the U.K. and Canada. The segment&#8217;s operating loss also includes charges of $47 million and $57&#160;million for three and nine months ended December 31, 2020, respectively, to remeasure to fair value the assets and liabilities of the Company&#8217;s German pharmaceutical wholesale business which was contributed to a joint venture as further discussed in Note 3, &#8220;Held for Sale.&#8221; The Company recognized a fair value remeasurement charge related to the joint venture of $282 million for the three and nine months ended December 31, 2019.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for the three and nine months ended December 31, 2020 includes charges totaling $35&#160;million and $49&#160;million, respectively, on certain personal protective equipment and other related products due to inventory impairments and excess inventory.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for Other for the nine months ended December 31, 2019 includes a pre-tax impairment charge of $1.2 billion and a pre-tax dilution loss of $246 million associated with the Company&#8217;s investment in Change Healthcare JV. Operating loss for Other also includes the Company&#8217;s proportionate share of loss from Change Healthcare JV of $28 million and $75 million for the three and nine months ended December 31, 2019, respectively.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net for the three and nine months ended December 31, 2020 includes a pre-tax charge of $8.1 billion ($6.7 billion after-tax) related to the estimated liability for opioid-related claims, as discussed in more detail in Financial </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, &#8220;Commitments and Contingent Liabilities." The nine months ended December 31, 2020 includes a net gain of $131 million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program. Corporate expenses, net, for the three and nine months ended December 31, 2020 include net gains of $30 million and $89 million, respectively, associated with certain of the Company&#8217;s equity investments and, for the nine months ended December 31, 2019, include settlement charges of $122 million from the termination of the Company&#8217;s defined benefit pension plan and a settlement charge of $82 million related to opioid claims. The three and nine months ended December 31, 2020 includes $34 million and $118 million, respectively, and the three and nine months ended December 31, 2019 includes $36 million and $108 million, respectively, of pre-tax charges opioid-related costs, primarily litigation expenses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588230860248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers itself to control an entity if it has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S.&#8221;) of America (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The severity, magnitude, and duration, as well as the economic consequences of the coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic, are uncertain, rapidly changing and difficult to predict. Therefore, the Company&#8217;s accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.</span></div>The Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) was enacted on March 27, 2020 in the U.S., and includes several provisions related to employment and income taxes, including provisions for the deferral of the employer portion of social security taxes through December 31, 2020. On December 27, 2020, the U.S. government enacted the Consolidated Appropriations Act, 2021, which enhances and expands certain provisions of the CARES Act. These legislative acts are not expected to have a material impact on the Company&#8217;s consolidated financial results.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">The results of operations for the three and nine months ended December 31, 2020 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2020 previously filed with the SEC on May 22, 2020 (&#8220;2020 Annual Report&#8221;).<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Fiscal Period</a></td>
<td class="text">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text">Certain prior year amounts have been reclassified to conform to the current year presentation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company prospectively adopted Accounting Standards Update (&#8220;ASU&#8221;) 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs in a cloud computing arrangement that has a software license. As a result, the Company began capitalizing eligible implementation costs for such contracts and recognizing the expense over the service period. The adoption of this amended guidance did not have a material impact on the Company&#8217;s condensed consolidated financial statements or disclosures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company retrospectively adopted ASU 2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Retirement Benefits - Defined Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires the Company to disclose the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates, and an explanation of reasons for significant gains and losses related to changes in the benefit obligation for the period. The amended guidance also requires the Company to remove disclosures on the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit costs over the next fiscal year. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#8217;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company adopted ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to remove, modify and add disclosure requirements on fair value measurements. Certain requirements were applied prospectively while other changes were applied retrospectively on the effective date. The amended guidance removes disclosure requirements for transfers between Level 1 and Level 2 measurements and valuation processes for Level 3 measurements, but adds new disclosure requirements including changes in unrealized gains or losses in other comprehensive income related to recurring Level 3 measurements and requirements to disclose the range, and weighted-average used to develop significant unobservable inputs for Level 3 fair value measurements. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#8217;s Condensed Consolidated Statements of Operations, Comprehensive Income, Balance Sheets, or Cash Flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company adopted ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2016-13&#8221;), which changed the impairment model for most financial assets from one based on current losses to a forward-looking model based on expected losses. The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses. The amended guidance requires financial assets that are measured at amortized cost be presented at the net amount expected to be collected. An allowance for credit losses is established as a valuation account that is deducted from the amortized cost basis of financial assets. The guidance also requires enhanced disclosures. This guidance was adopted on a modified retrospective basis and did not have a material impact on the Company&#8217;s condensed consolidated financial statements or disclosures. Upon adoption of the amended guidance in the first quarter of 2021, the Company recorded a cumulative-effect adjustment of $13 million to the opening balance of retained earnings, primarily as a result of adjustments to allowances for trade accounts receivable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for Credit Losses: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the adoption of ASU 2016-13 in the first quarter of 2021, the Company began using the Current Expected Credit Losses ("CECL") methodology to determine an allowance for credit losses related to financial assets measured at amortized cost. The Company considers historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop its allowance for credit losses. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $221 million was included in Receivables, net on the Condensed Consolidated Balance Sheet as of December 31, 2020. Changes in the allowance were not material for the three and nine months ended December 31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In December 2019, ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was issued with the intent to simplify various aspects related to accounting for income taxes.&#160;The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The guidance is effective for the Company in the first quarter of 2022 and&#160;early adoption is permitted.&#160;The Company is currently evaluating the impact of this amended guidance on its condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/927653/000092765320000033/mck10k3312020.htm#sFDC7F65C03045D74BF3631026AD9426B" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Note 21 to the Company&#8217;s 2020 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000061/mck-20200630.htm#i7a3258d8f8b843148ac6a8d7049bbcb3_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Note 13 to the Company&#8217;s 10-Q filing for the quarterly period ended June 30, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Note 13 to the Company</a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#8217;</a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">s 10-Q fil</a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ing for the quarterly period ended </a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">September 30, 2020</a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765320000093/mck-20200930.htm#iecfa0e5b7669406c886f8e2dcd87b845_88" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">,</a></span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span>Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, it is not reasonably possible for the Company to determine that a loss is probable for a claim, or to reasonably estimate the amount of loss or a range of loss, because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to be resolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the loss probability has changed and whether it can make a reasonable estimate of the possible loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability in the amount of its estimate for the ultimate loss. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6052-115624<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=d3e5291-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588226431256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Assets and Liabilities Held for Sale</a></td>
<td class="text">Total assets and liabilities of the German pharmaceutical wholesale joint venture that were classified as held for sale on the Company&#8217;s consolidated balance sheet as of March 31, 2020, were as follows:<div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of business held for sale to fair value less costs to sell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes the effect of approximately $3 million of favorable cumulative foreign currency translation adjustment as of March 31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588225730328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment and Related Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring, Impairment and Related Costs</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three and nine months ended December 31, 2020 consisted of the following: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of project consulting fees.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of project consulting fees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three and nine months ended December 31, 2019 consisted of the following: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.193%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents exit costs associated with a disposition and costs related to the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts described above. Additionally, includes costs associated with a growth initiative, substantially completed in the year ended March 31, 2020, which included a reduction in workforce and facility consolidation.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.193%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents exit costs associated with a disposition and costs related to the relocation of the Company&#8217;s corporate headquarters described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with a growth initiative which included a reduction in workforce, facility consolidation, and store closures. These initiatives were substantially completed in the year ended March 31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above. Additionally, includes costs associated with a growth initiative, substantially completed in the year ended March 31, 2020, which included a reduction in workforce and facility consolidation.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring and Asset Impairment Charges</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the nine months ended December 31, 2020: </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March 31, 2020, the total reserve balance was $157 million, of which $118 million was recorded in Other accrued liabilities and $39 million was recorded in Other non-current liabilities. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of December 31, 2020, the total reserve balance was $132 million, of which $101 million was recorded in Other accrued liabilities and $31 million was recorded in Other non-current liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588224222936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock', window );">Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2020 were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three and nine months ended December 31, 2019 were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:69.031%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.543%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588225670584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of computations for basic and diluted earnings per common share</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:52.439%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.967%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,174)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,052)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,226)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,204)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,226)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,205)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.03&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.29)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.66)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.29)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.66)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"> Certain computations may reflect rounding adjustments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588225912184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of changes in the carrying amount of goodwill</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.092%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.942%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March&#160;31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting, transfers and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,990&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,526&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,511&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of information regarding intangible assets</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,318)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,654&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,950)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(480)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,660&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,680)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,980&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,392&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,236)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,156&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588224166600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Long-Term Debt</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.65% Notes due November 30, 2020</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due March 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% Notes due December 15, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63% Euro Notes due August 17, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63% Euro Notes due October 30, 2026 </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,244&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,387&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,467&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,335&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588226441368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of information regarding the fair value of derivatives on a gross basis</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.481%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.033%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.672%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.817%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.206%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated for hedge accounting</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588224346088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of information regarding other comprehensive income (loss) including noncontrolling and redeemable noncontrolling interests, net of tax, by component</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding Other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.261%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments arising during period, net of income tax expense of nil, nil, nil, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) (3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil, nil, nil, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on net investment hedges arising during period, net of income tax benefit of $33, $21, $80, and $1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil, nil, nil, and nil</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges arising during period, net of income tax (expense) benefit of $2, $3, $6, and $(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil,  nil, nil, and nil</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss and prior service cost arising during the period, net of income tax benefit of nil, nil, nil, and $1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss, prior service cost and transition obligation, net of income tax benefit of $2, nil, $1, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other, net of income tax expense of nil, nil, nil, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of $9, $3, $9, and $35 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s foreign subsidiary, McKesson Europe, and its operations in Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">During the three and nine months ended December 31, 2020, net foreign currency translation adjustments were primarily due to the strengthening of the Canadian dollar and Euro against the U.S. dollar from April 1, 2020 to December 31, 2020. During the three and nine months ended December 31, 2019, the net foreign currency translation adjustments were primarily due to the strengthening of the Euro and Canadian dollar against the U.S. dollar, partially offset by weakening of the British pound sterling from April 1, 2019 to December 31, 2019.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and nine months ended December 31, 2020 includes net foreign currency translation adjustments of $20 million and $(41) million, respectively, and the three and nine months ended December 31, 2019 includes net foreign currency translation adjustments of $12 million and $(1) million, respectively, attributable to redeemable noncontrolling interests. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and nine months ended December 31, 2020 include adjustments for amounts related to the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 3, &#8220;Held for Sale.&#8221; These amounts were included in the current and prior periods calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Operating expenses in the Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and nine months ended December 31, 2020 includes foreign currency losses of $84 million and $201 million, respectively, on the net investment hedges from the &#8364;1.7 billion&#160;Euro-denominated notes and &#163;450 million&#160;British pound sterling-denominated notes, losses of $45 million and $108 million, respectively, on the net investment hedges from cross-currency swaps, and losses on net investment hedges of nil and $1 million, respectively, attributable to redeemable noncontrolling interests. The three and nine months ended December 31, 2019 include foreign currency losses of $59 million and gains of $8 million, respectively, on the net investment hedges from the &#8364;1.70 billion Euro-denominated notes and&#160;&#163;450 million British pound sterling-denominated notes and losses of $20 million and $11 million, respectively, on the net investment hedges from cross-currency swaps. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three and nine months ended December 31, 2020 include net actuarial gains of $5 million and $3 million, respectively, and the three and nine months ended December 31, 2019 include net actuarial losses of $2 million and $1 million, respectively, which are attributable to redeemable noncontrolling interests.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Pre-tax amount was reclassified into Cost of sales and Operating expenses in the Condensed Consolidated Statements of Operations. The related tax expense was reclassified into Income tax benefit (expense) in the Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The nine months ended December 31, 2019 primarily reflects a reclassification of losses in the second quarter of 2020 upon a pension settlement charge from Accumulated other comprehensive loss to Other income (expense), net in the Condensed Consolidated Statement of Operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of information regarding changes in accumulated other comprehensive income (loss), net of tax, by component</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss) by component for the three and nine months ended December 31, 2020 are as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Losses and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,512)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,597)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,329)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,503)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,780)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,329)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,503)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss) by component for the three and nine months ended December 31, 2019 are as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.105%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,659)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,704)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,570)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,663)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.105%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,628)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,570)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,663)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588225783880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.260%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,599&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,172&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,086&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,516&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,564&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,246)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,462)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(713)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,363)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,063)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than 7% of the International segment&#8217;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#8217;s total revenues, and approximately 38% of the RxTS segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for the Company&#8217;s reportable segments. For retrospective periods presented, Operating loss for Other reflects equity earnings and charges from the Company&#8217;s equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for the three and nine months ended December 31, 2020 includes $11 million and $115 million, respectively, and for the three and nine months ended December 31, 2019 includes $66 million and $114 million, respectively, of pre-tax credits related to the last-in, first-out (&#8220;LIFO&#8221;) method of accounting for inventories. The nine months ended December 31, 2020 also includes a charge of $50 million recorded in connection with the Company&#8217;s estimated liability under the State of New York&#8217;s OSA, as further discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss for the three and nine months ended December 31, 2020 includes restructuring, impairment, and related charges of $131&#160;million and $189&#160;million, respectively, driven largely by long-lived asset impairment charges of $115 million primarily related to retail pharmacy businesses in Canada and Europe as well as costs associated with the closure of retail pharmacy stores within the U.K. business, as discussed in more detail in Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; and a second quarter goodwill impairment charge of $69 million (pre-tax and after-tax) related to one of the Company&#8217;s reporting units in Europe, as discussed in more detail in Financial Note 8, &#8220;Goodwill and Intangible Assets, Net.&#8221; Restructuring, impairment, and related charges of $100 million and $116 million for the three and nine months ended December 31, 2019, respectively, reflects long-lived asset impairment charges of $94 million primarily related to retail pharmacy businesses in the U.K. and Canada. The segment&#8217;s operating loss also includes charges of $47 million and $57&#160;million for three and nine months ended December 31, 2020, respectively, to remeasure to fair value the assets and liabilities of the Company&#8217;s German pharmaceutical wholesale business which was contributed to a joint venture as further discussed in Note 3, &#8220;Held for Sale.&#8221; The Company recognized a fair value remeasurement charge related to the joint venture of $282 million for the three and nine months ended December 31, 2019.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for the three and nine months ended December 31, 2020 includes charges totaling $35&#160;million and $49&#160;million, respectively, on certain personal protective equipment and other related products due to inventory impairments and excess inventory.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for Other for the nine months ended December 31, 2019 includes a pre-tax impairment charge of $1.2 billion and a pre-tax dilution loss of $246 million associated with the Company&#8217;s investment in Change Healthcare JV. Operating loss for Other also includes the Company&#8217;s proportionate share of loss from Change Healthcare JV of $28 million and $75 million for the three and nine months ended December 31, 2019, respectively.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net for the three and nine months ended December 31, 2020 includes a pre-tax charge of $8.1 billion ($6.7 billion after-tax) related to the estimated liability for opioid-related claims, as discussed in more detail in Financial </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, &#8220;Commitments and Contingent Liabilities." The nine months ended December 31, 2020 includes a net gain of $131 million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program. Corporate expenses, net, for the three and nine months ended December 31, 2020 include net gains of $30 million and $89 million, respectively, associated with certain of the Company&#8217;s equity investments and, for the nine months ended December 31, 2019, include settlement charges of $122 million from the termination of the Company&#8217;s defined benefit pension plan and a settlement charge of $82 million related to opioid claims. The three and nine months ended December 31, 2020 includes $34 million and $118 million, respectively, and the three and nine months ended December 31, 2019 includes $36 million and $108 million, respectively, of pre-tax charges opioid-related costs, primarily litigation expenses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588308058712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Shareholders' equity</a></td>
<td class="nump">$ 6,090<span></span>
</td>
<td class="num">$ (277)<span></span>
</td>
<td class="nump">$ 5,309<span></span>
</td>
<td class="nump">$ 6,385<span></span>
</td>
<td class="nump">$ 6,692<span></span>
</td>
<td class="nump">$ 8,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Shareholders' equity</a></td>
<td class="nump">$ 13,890<span></span>
</td>
<td class="nump">$ 7,595<span></span>
</td>
<td class="nump">13,022<span></span>
</td>
<td class="nump">$ 12,075<span></span>
</td>
<td class="nump">$ 11,965<span></span>
</td>
<td class="nump">12,409<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Opening retained earnings adjustment: adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Shareholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Opening retained earnings adjustment: adoption of new accounting standard | Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Shareholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member', window );">ASU 2016-13 | Opening retained earnings adjustment: adoption of new accounting standard | Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Shareholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588228569928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in Change Healthcare Joint Venture (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Apr. 01, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Shareholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,385,000,000<span></span>
</td>
<td class="nump">$ 6,692,000,000<span></span>
</td>
<td class="nump">$ 6,385,000,000<span></span>
</td>
<td class="num">$ (277,000,000)<span></span>
</td>
<td class="nump">$ 6,090,000,000<span></span>
</td>
<td class="nump">$ 5,309,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,287,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ChangeHealthcareInc.Member', window );">Change Healthcare, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from Issuance Initial Public Offering</a></td>
<td class="nump">$ 888,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Proceeds from concurrent offering of other securities</a></td>
<td class="nump">$ 279,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ChangeHealthcareInc.Member', window );">Change Healthcare, Inc. | IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Offering price (in usd per share)</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=mck_TransitionServicesAgreementsTSAMember', window );">Transition Services Agreements (&#8220;TSA&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Fees earned from TSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=mck_TaxReceivableAgreementTRAMember', window );">Tax Receivable Agreement (&#8220;TRA&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized', window );">Percentage of net cash tax savings realized or deemed realized under TRA (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Receivable recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember', window );">Change Healthcare JV | Change Healthcare, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Contributions made in exchange for additional membership interests</a></td>
<td class="nump">$ 609,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest (percent)</a></td>
<td class="nump">41.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember', window );">Change Healthcare JV | Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest (percent)</a></td>
<td class="nump">58.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Pre-tax dilution loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246,000,000<span></span>
</td>
<td class="nump">246,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000,000<span></span>
</td>
<td class="nump">1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ProportionateGainLossOnEquityMethodInvestment', window );">Proportionate loss from investment in Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Shareholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,075,000,000<span></span>
</td>
<td class="nump">$ 11,965,000,000<span></span>
</td>
<td class="nump">$ 12,075,000,000<span></span>
</td>
<td class="nump">$ 7,595,000,000<span></span>
</td>
<td class="nump">$ 13,890,000,000<span></span>
</td>
<td class="nump">13,022,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,409,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Opening retained earnings adjustment: adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Shareholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Opening retained earnings adjustment: adoption of new accounting standard | Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Shareholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Opening retained earnings adjustment: adoption of new accounting standard | ASU 2014-09 | Retained Earnings | Change Healthcare JV | Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Shareholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ProportionateGainLossOnEquityMethodInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proportionate Gain (Loss) on Equity Method Investment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ProportionateGainLossOnEquityMethodInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=121548190&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_ChangeHealthcareInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_ChangeHealthcareInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mck_TransitionServicesAgreementsTSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mck_TransitionServicesAgreementsTSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mck_TaxReceivableAgreementTRAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mck_TaxReceivableAgreementTRAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588228473160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Nov. 01, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mck_WalgreensBootsAllianceJointVentureMember', window );">WBA Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling interest (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Joint Venture | German Pharmaceutical Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Carrying value of interest in joint venture</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable', window );">Consideration receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of German wholesale business</a></td>
<td class="nump">291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Pre-tax loss on sale of business</a></td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GainLossOnSaleOfBusinessNetOfTax', window );">After-tax loss on sale of business</a></td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses', window );">Favorable (unfavorable) cumulative foreign currency translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposed of by sale | German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 282<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax', window );">Impairment, after tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 282<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment Other Than Temporary Impairment After Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GainLossOnSaleOfBusinessNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Sale of Business, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GainLossOnSaleOfBusinessNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) in the disposal group, including discontinued operation, recognized in the statement of income as a result of the sale or complete or substantially complete liquidation of an investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=121548190&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_WalgreensBootsAllianceJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_WalgreensBootsAllianceJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588226037512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Held for Sale - Assets and Liabilities Held for Sale (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total assets held for sale</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total liabilities held for sale</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">683<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total assets held for sale</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total liabilities held for sale</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">683<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Receivables, net and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Inventories, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent', window );">Long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1', window );">Remeasurement of assets of business held for sale to fair value less costs to sell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(272)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent', window );">Long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 656<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Reclassified Long-term Assets, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Reclassified Long-term Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588235640840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment and Related Charges - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Restructuring, impairment and related charges recognized</a></td>
<td class="nump">$ 155<span></span>
</td>
<td class="nump">$ 136<span></span>
</td>
<td class="nump">$ 271<span></span>
</td>
<td class="nump">$ 204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Net restructuring, impairment and related charges recognized</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring liabilities</a></td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment of long-lived and intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Net restructuring, impairment and related charges recognized</a></td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment of long-lived and intangible assets</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember', window );">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Pre-tax charges recorded to-date</a></td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember', window );">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters | Employee Retention Expenses, Severance, Accelerated Depreciation and Asset Impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Net restructuring, impairment and related charges recognized</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember', window );">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember', window );">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_OperatingModelAndCostOptimizationProgramsMember', window );">Operating Model and Cost Optimization Programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Pre-tax charges recorded to-date</a></td>
<td class="nump">288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_OperatingModelAndCostOptimizationProgramsMember', window );">Operating Model and Cost Optimization Programs | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_OperatingModelAndCostOptimizationProgramsMember', window );">Operating Model and Cost Optimization Programs | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanOtherMember', window );">Strategic Growth Initiative Plan - Other | Employee Severance, Accelerated Depreciation, and Project Consulting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Net restructuring, impairment and related charges recognized</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanMember', window );">Strategic Growth Initiative Plan | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Net restructuring, impairment and related charges recognized</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanMember', window );">Strategic Growth Initiative Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanMember', window );">Strategic Growth Initiative Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">$ 120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringSettlementAndImpairmentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of restructuring charges, remediation cost, and asset impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringSettlementAndImpairmentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_OperatingModelAndCostOptimizationProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_OperatingModelAndCostOptimizationProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588231334504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment and Related Charges - Summary of Restructuring Charges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment Charges, Including Accelerated Depreciation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AssetImpairmentChargesIncludingAcceleratedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588228329256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment and Related Charges - Summary of Restructuring Activity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(132)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAndOtherAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588228413432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>county</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>county</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit) related to continuing operations</a></td>
<td class="num">$ (1,189,000,000)<span></span>
</td>
<td class="nump">$ 47,000,000<span></span>
</td>
<td class="num">$ (1,011,000,000)<span></span>
</td>
<td class="num">$ (111,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Reported income tax expense (benefit) rates (percent)</a></td>
<td class="num">(16.10%)<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="num">(16.70%)<span></span>
</td>
<td class="num">(194.70%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncomeTaxExpenseBenefitDiscreteItems', window );">Discrete tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000,000<span></span>
</td>
<td class="nump">$ 105,000,000<span></span>
</td>
<td class="nump">$ 21,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofCounties', window );">Number of counties that filed claims | county</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory', window );">Deferred tax asset for the temporary difference arising from buyer's excess tax basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue', window );">Tax benefit recognized for remeasurement of assets and liabilities held-for-sale to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentChargeOnReclassifiedAssets', window );">Pre-tax impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 282,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">282,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would reduce income tax expense and the effective tax rate</a></td>
<td class="nump">1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Increase in unrecognized tax benefits</a></td>
<td class="nump">497,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Possible decrease in unrecognized tax benefits during the next twelve months</a></td>
<td class="nump">93,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Pre-tax expenses related to estimated litigation liability</a></td>
<td class="nump">8,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyAccrualProvisionNetOfTax', window );">After-tax expenses related to estimated litigation liability</a></td>
<td class="nump">$ 6,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember', window );">Planned divestiture in Medical-Surgical Solutions business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncomeTaxExpenseBenefitDiscreteItems', window );">Discrete tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncomeTaxExpenseBenefitDiscreteItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Expense (Benefit) Discrete Items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncomeTaxExpenseBenefitDiscreteItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Expense (Benefit), Remeasurement of Assets and Liabilities Held-for-Sale to Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyAccrualProvisionNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Accrual, Provision, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyAccrualProvisionNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofCounties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Counties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofCounties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentChargeOnReclassifiedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the asset that is reclassified back to held and used from held-for-sale, the amount of impairment charge that is recognized on the reclassification date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 44<br> -URI http://asc.fasb.org/extlink&amp;oid=29634951&amp;loc=d3e1756-110224<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2459-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentChargeOnReclassifiedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588228958712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestsPutRightExercisePrice', window );">Put right redemption price per share (in euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_PutRightValueInterestRateSpread', window );">Put right value, interest rate spread (as a percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Decrease in carrying value of non-controlling interest</a></td>
<td class="nump">$ 41,000,000<span></span>
</td>
<td class="nump">$ 39,000,000<span></span>
</td>
<td class="nump">$ 134,000,000<span></span>
</td>
<td class="nump">$ 115,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Associated increase in Company's ownership interest on its equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Carrying value of redeemable noncontrolling interests</a></td>
<td class="nump">1,292,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,292,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,402,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">52,000,000<span></span>
</td>
<td class="nump">56,000,000<span></span>
</td>
<td class="nump">152,000,000<span></span>
</td>
<td class="nump">163,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">11,000,000<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="nump">32,000,000<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Decrease in carrying value of non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Decrease in noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Carrying value of redeemable noncontrolling interests</a></td>
<td class="nump">1,292,000,000<span></span>
</td>
<td class="nump">1,397,000,000<span></span>
</td>
<td class="nump">1,292,000,000<span></span>
</td>
<td class="nump">1,397,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,265,000,000<span></span>
</td>
<td class="nump">1,402,000,000<span></span>
</td>
<td class="nump">$ 1,384,000,000<span></span>
</td>
<td class="nump">$ 1,393,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Associated increase in Company's ownership interest on its equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember', window );">Mckesson Europe Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests', window );">Annual recurring dividend (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember', window );">Mckesson Europe Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">11,000,000<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="nump">32,000,000<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Payments for purchase shares of Mckesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased', window );">Shares purchased (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Carrying value of redeemable noncontrolling interests</a></td>
<td class="nump">1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue', window );">Maximum redemption value of redeemable noncontrolling interest</a></td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage (as a percent)</a></td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember', window );">Vantage and ClarusOne Sourcing Services LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 217,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">$ 41,000,000<span></span>
</td>
<td class="nump">$ 45,000,000<span></span>
</td>
<td class="nump">$ 120,000,000<span></span>
</td>
<td class="nump">$ 130,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual Recurring Compensation Per Share to Noncontrolling Interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease for Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseForExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestsPutRightExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interests, Put Right, Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestsPutRightExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_PutRightValueInterestRateSpread">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Put Right Value, Interest Rate Spread</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_PutRightValueInterestRateSpread</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Noncontrolling Interests, Maximum Redemption Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588308067096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="nump">$ 163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
<td class="num">(115)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
<td class="num">(115)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Ending balance</a></td>
<td class="nump">1,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
<td class="num">(115)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
<td class="num">(115)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Beginning balance</a></td>
<td class="nump">1,265<span></span>
</td>
<td class="nump">1,384<span></span>
</td>
<td class="nump">1,402<span></span>
</td>
<td class="nump">1,393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationofTemporaryEquitytoLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Exercises of Put Right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Ending balance</a></td>
<td class="nump">$ 1,292<span></span>
</td>
<td class="nump">$ 1,397<span></span>
</td>
<td class="nump">$ 1,292<span></span>
</td>
<td class="nump">$ 1,397<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease for Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseForExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase (Decrease) Due to Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestIncreaseDecreaseDuetoOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationofTemporaryEquitytoLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationofTemporaryEquitytoLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInMinorityInterestRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInMinorityInterestRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588227900504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="num">$ (6,174)<span></span>
</td>
<td class="nump">$ 247<span></span>
</td>
<td class="num">$ (5,052)<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(52)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="num">(152)<span></span>
</td>
<td class="num">(163)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income (loss) from continuing operations attributable to McKesson Corporation</a></td>
<td class="num">(6,226)<span></span>
</td>
<td class="nump">191<span></span>
</td>
<td class="num">(5,204)<span></span>
</td>
<td class="num">(109)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to McKesson Corporation</a></td>
<td class="num">$ (6,226)<span></span>
</td>
<td class="nump">$ 186<span></span>
</td>
<td class="num">$ (5,205)<span></span>
</td>
<td class="num">$ (121)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">159.5<span></span>
</td>
<td class="nump">178.7<span></span>
</td>
<td class="nump">161.2<span></span>
</td>
<td class="nump">183.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Restricted stock units (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">159.5<span></span>
</td>
<td class="nump">179.7<span></span>
</td>
<td class="nump">161.2<span></span>
</td>
<td class="nump">183.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="num">$ (39.03)<span></span>
</td>
<td class="nump">$ 1.06<span></span>
</td>
<td class="num">$ (32.28)<span></span>
</td>
<td class="num">$ (0.60)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
<td class="num">(0.06)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="num">(39.03)<span></span>
</td>
<td class="nump">1.03<span></span>
</td>
<td class="num">(32.29)<span></span>
</td>
<td class="num">(0.66)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="num">(39.03)<span></span>
</td>
<td class="nump">1.06<span></span>
</td>
<td class="num">(32.28)<span></span>
</td>
<td class="num">(0.60)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
<td class="num">(0.06)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="num">$ (39.03)<span></span>
</td>
<td class="nump">$ 1.04<span></span>
</td>
<td class="num">$ (32.29)<span></span>
</td>
<td class="num">$ (0.66)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588235533528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers and other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">9,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers and other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">3,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers and other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">1,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers and other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">2,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers and other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 1,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588228912744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 6,660<span></span>
</td>
<td class="nump">$ 6,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(3,680)<span></span>
</td>
<td class="num">(3,236)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 2,980<span></span>
</td>
<td class="nump">3,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 3,972<span></span>
</td>
<td class="nump">3,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,318)<span></span>
</td>
<td class="num">(1,950)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 1,654<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember', window );">Service agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 859<span></span>
</td>
<td class="nump">994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(402)<span></span>
</td>
<td class="num">(480)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 457<span></span>
</td>
<td class="nump">514<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mck_PharmacyLicensesMember', window );">Pharmacy licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">26 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 503<span></span>
</td>
<td class="nump">492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(240)<span></span>
</td>
<td class="num">(232)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 263<span></span>
</td>
<td class="nump">260<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 922<span></span>
</td>
<td class="nump">808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(379)<span></span>
</td>
<td class="num">(242)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 543<span></span>
</td>
<td class="nump">566<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 149<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(118)<span></span>
</td>
<td class="num">(111)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 255<span></span>
</td>
<td class="nump">273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(223)<span></span>
</td>
<td class="num">(221)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mck_PharmacyLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mck_PharmacyLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588231408712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,000,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,511,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,511,000,000<span></span>
</td>
<td class="nump">9,511,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,360,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense of intangible assets</a></td>
<td class="nump">108,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320,000,000<span></span>
</td>
<td class="nump">$ 343,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract', window );"><strong>Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Estimated annual amortization expense, remainder of 2021</a></td>
<td class="nump">96,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,000,000<span></span>
</td>
<td class="nump">96,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated annual amortization expense, 2022</a></td>
<td class="nump">371,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">371,000,000<span></span>
</td>
<td class="nump">371,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated annual amortization expense, 2023</a></td>
<td class="nump">272,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272,000,000<span></span>
</td>
<td class="nump">272,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated annual amortization expense, 2024</a></td>
<td class="nump">254,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254,000,000<span></span>
</td>
<td class="nump">254,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated annual amortization expense, 2025</a></td>
<td class="nump">251,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,000,000<span></span>
</td>
<td class="nump">251,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Estimated annual amortization expense, thereafter</a></td>
<td class="nump">1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000,000<span></span>
</td>
<td class="nump">1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLossNetOfTax', window );">After-tax goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,526,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,526,000,000<span></span>
</td>
<td class="nump">1,526,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,443,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember', window );">Retail Pharmacy Reporting Unit | International | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of loss recognized that results from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588234600408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt and Financing Activities - Schedule of Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 03, 2020</div></th>
<th class="th"><div>Dec. 01, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Lease and other obligations</a></td>
<td class="nump">$ 272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Total debt</a></td>
<td class="nump">7,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less: Current portion</a></td>
<td class="nump">777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="nump">$ 6,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,335<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A365NotesDueNovember302020Member', window );">3.65% Notes due November 30, 2020 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMarch12021Member', window );">4.75% Notes due March 1, 2021 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">323<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member', window );">2.70% Notes due December 15, 2022 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member', window );">2.85% Notes due March 15, 2023 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member', window );">3.80% Notes due March 15, 2024 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member', window );">0.90% Notes due December 3, 2025 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member', window );">7.65% Debentures due March 1, 2027 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member', window );">3.95% Notes due February 16, 2028 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member', window );">4.75% Notes due May 30, 2029 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member', window );">6.00% Notes due March 1, 2041 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member', window );">4.88% Notes due March 15, 2044 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member', window );">0.63% Euro Notes due August 17, 2021 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">0.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member', window );">1.50% Euro Notes due November 17, 2025 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">659<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member', window );">1.63% Euro Notes due October 30, 2026 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">1.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member', window );">3.13% Sterling Notes due February 17, 2029 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 557<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A365NotesDueNovember302020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A365NotesDueNovember302020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMarch12021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMarch12021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588229683512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt and Financing Activities - Long-Term Debt Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 03, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 01, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,244,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,387,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 777,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,052,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member', window );">0.90% Notes due December 3, 2025 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt principal amount</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt issuance</a></td>
<td class="nump">$ 496,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Price as percentage of debt outstanding at which debt can be purchased</a></td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A365NotesDueNovember302020Member', window );">3.65% Notes due November 30, 2020 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMarch12021Member', window );">4.75% Notes due March 1, 2021 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 323,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount of debt redeemed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A365NotesDueNovember302020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A365NotesDueNovember302020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMarch12021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMarch12021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588318577624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Revolving Credit Facilities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Global Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Syndicated senior unsecured revolving credit facility</a></td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Syndicated senior unsecured revolving credit facility term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases', window );">Committed balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Uncommitted balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Revolving Credit Facility | The 2020 Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Syndicated senior unsecured revolving credit facility</a></td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Syndicated senior unsecured revolving credit facility term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings under facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Amounts outstanding under facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Revolving Credit Facility | Canadian Dollar, British Pound Sterling, and Euros Sublimit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Syndicated senior unsecured revolving credit facility</a></td>
<td class="nump">$ 3,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum amount of borrowing capacity under a line of credit that is available as of the balance sheet date for a specific purpose other than for financing goods acquired for inventory or imminent delivery to a customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588224454920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Commercial Paper (Details) - Commercial Paper - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Outstanding notes (up to)</a></td>
<td class="nump">$ 4,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper', window );">Proceeds from issuance of commercial paper</a></td>
<td class="nump">5,500,000,000<span></span>
</td>
<td class="nump">$ 15,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfCommercialPaper', window );">Repayments of commercial paper</a></td>
<td class="nump">5,300,000,000<span></span>
</td>
<td class="nump">$ 13,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermCommercialPaperCurrent', window );">Commercial paper</a></td>
<td class="nump">$ 152,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="nump">0.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermCommercialPaperCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the current portion of long-term unsecured obligations issued by corporations and other borrowers to investors (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermCommercialPaperCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowing by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow due to repaying amounts borrowed by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588310232712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($) </div>
<div>participant</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPensionPlanLiabilitiesDerecognized', window );">Pension liabilities derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Changes in retirement-related benefit plans | German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease', window );">Accumulated other comprehensive loss derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Cash contributions to the plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedPercentage', window );">Percentage threshold of greater of projected benefit obligation or market value of assets (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanSettlementPlanParticipants', window );">Number of participants elected to receive settlement | participant</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Lump sum payments under settlement</a></td>
<td class="nump">$ 49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Pre-tax settlement expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract', window );">Annuity contracts purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | United States | Other income (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Pre-tax settlement expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Executive Benefit Retirement Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Cash payment for retirement plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 114<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPensionPlanLiabilitiesDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Pension Plan, Liabilities Derecognized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPensionPlanLiabilitiesDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Payment For Annuity Contract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanSettlementPlanParticipants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Settlement, Plan Participants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanSettlementPlanParticipants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of plan assets to benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=mck_ExecutiveBenefitRetirementPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=mck_ExecutiveBenefitRetirementPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588227302312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities - Narrative (Details)<br> &#163; in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="3"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="3"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Apr. 27, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 27, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>GBP (&#163;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax', window );">Gains (losses) on non-derivative net investment hedge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Gains (losses) from cash flow hedges recorded within other comprehensive income</a></td>
<td class="num">$ (12,000,000)<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="num">$ (36,000,000)<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) from net investment hedges recorded within other comprehensive income</a></td>
<td class="num">(84,000,000)<span></span>
</td>
<td class="num">(59,000,000)<span></span>
</td>
<td class="num">(201,000,000)<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember', window );">Forward contracts to hedge Euro against British Pound cash flows | Derivatives not Designated for Hedge Accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional values of financial instruments</a></td>
<td class="nump">13,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Gain (loss) on financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax', window );">Derivatives used in net investment hedge, gains (losses) gross</a></td>
<td class="num">(45,000,000)<span></span>
</td>
<td class="num">(20,000,000)<span></span>
</td>
<td class="num">(108,000,000)<span></span>
</td>
<td class="num">(11,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | November 2018 cross currency swaps | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional values of financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 999,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities', window );">Proceeds from termination of derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Gain (loss) on financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Gains (losses) from cash flow hedges recorded within other comprehensive income</a></td>
<td class="num">(14,000,000)<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="num">(42,000,000)<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Cross currency swap | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional values of financial instruments</a></td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Forward starting interest rate swaps | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional values of financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">&#8364; 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember', window );">Euro Denominated Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember', window );">Euro Denominated Notes | Term Loan | Derivatives not Designated for Hedge Accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember', window );">Euro Denominated Notes | Term Loan | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember', window );">British Pound Sterling Denominated Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A2025NotesMember', window );">2025 Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow provided by derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_November2018CrossCurrencySwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_November2018CrossCurrencySwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A2025NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A2025NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588227765352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Hedging Activities - Derivative Instruments Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">$ 92<span></span>
</td>
<td class="nump">$ 294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">187<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Prepaid expenses and other/Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">1,084<span></span>
</td>
<td class="nump">1,279<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Other noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Non-current Asset / Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">2,776<span></span>
</td>
<td class="nump">3,313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Forward starting interest rate swaps | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">733<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated for hedge accounting | Foreign Exchange Contract | Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated for hedge accounting | Foreign Exchange Contract | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">U.S. Dollar, notional amount, liability</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_CurrentAssetLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_CurrentAssetLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_NoncurrentAssetLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_NoncurrentAssetLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588230482408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>investmentSecurity</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>company</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">$ 267,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 267,000,000<span></span>
</td>
<td class="nump">$ 170,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies', window );">Number of companies in which equity securities were converted into public common stock | company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices', window );">Number of investments that experienced transaction that resulted in change in observable price of those securities | investmentSecurity</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Unrealized gain (loss) on equity investments</a></td>
<td class="nump">$ 28,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Fair value, inputs, level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying amount of liabilities</a></td>
<td class="nump">7,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200,000,000<span></span>
</td>
<td class="nump">7,400,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of liabilities</a></td>
<td class="nump">8,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000,000,000.0<span></span>
</td>
<td class="nump">7,800,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Fair value, inputs, level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Investments in money market funds</a></td>
<td class="nump">123,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123,000,000<span></span>
</td>
<td class="nump">2,000,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities measured at fair value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, Equity Security Investments Converted Into Public Common Stock, Number of Companies</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, Equity Security Investments With Changes in Observable Prices</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588221367624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 17, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($) </div>
<div>company</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>stateAttorney </div>
<div>case </div>
<div>state</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>stateAttorney </div>
<div>case </div>
<div>state</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>county</div>
</th>
<th class="th">
<div>Jan. 14, 2020 </div>
<div>company</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>county</div>
</th>
<th class="th">
<div>Aug. 13, 2019 </div>
<div>fax_number </div>
<div>fax</div>
</th>
<th class="th">
<div>Apr. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 30, 2017 </div>
<div>investmentFund</div>
</th>
<th class="th">
<div>Dec. 29, 2017 </div>
<div>investmentFund</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofCounties', window );">Number of counties that filed claims | county</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids', window );">Aggregate annual surcharge on licensed manufacturers and distributors of opioids</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Pre-tax accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyAccrualAfterTax', window );">After-tax accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,000,000<span></span>
</td>
<td class="nump">37,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Pre-tax expenses related to estimated litigation liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,100,000,000<span></span>
</td>
<td class="nump">8,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyAccrualProvisionNetOfTax', window );">After-tax expenses related to estimated litigation liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,700,000,000<span></span>
</td>
<td class="nump">$ 6,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass', window );">Number of faxes remaining in the class | fax_number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyClassActionNumberofFaxesReceived', window );">Number of faxes received | fax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyDamagesSoughtPerViolationValue', window );">Statutory damages sought per violation</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyDamagesSoughtPerViolationValue', window );">Statutory damages sought per violation</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member', window );">Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberOfInvestmentFundsThatFiledClaims', window );">Number of investment funds that filed claims | investmentFund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStates', window );">Number of states in which court cases are pending | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStateAttorneyGenerals', window );">Number of attorney generals that have filed claims | stateAttorney</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberOfCountyGovernments', window );">Number of county government plaintiffs | county</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending | National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts', window );">Number of cases selected for possible remand to other federal courts | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation', window );">Settlement award anticipated to be used to remediate the opioid crisis (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending | Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending | Three Largest U.S. Pharmaceutical Distributors | National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges', window );">Number of largest pharmaceutical distributors to adopt anti-diversion programs under proposed framework | company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod', window );">Period over which award would be payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyAccrualAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Accrual, After Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyAccrualAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyAccrualProvisionNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Accrual, Provision, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyAccrualProvisionNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyClassActionNumberofFaxesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action, Number of Faxes Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyClassActionNumberofFaxesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action, Number of Faxes Remaining in the Class</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyClassActionNumberofFaxesRemainingintheClass</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyDamagesSoughtPerViolationValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Damages Sought Per Violation, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyDamagesSoughtPerViolationValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofCounties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Counties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofCounties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofStateAttorneyGenerals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of State Attorney Generals</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofStateAttorneyGenerals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement Agreement, Award Payment Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementAgreementAwardPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement Agreement, Percentage Anticipated To Be Used For Opioid Crisis Remediation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement Agreement, Terms, Number of Companies to Adopt Anti-Diversion Programs Changes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberOfCountyGovernments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of County Governments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberOfCountyGovernments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberOfInvestmentFundsThatFiledClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Investment Funds That Filed Claims</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberOfInvestmentFundsThatFiledClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Opioid Stewardship Act, Annual Surcharge on Licensed Manufacturers and Distributors of Opioids</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_ThreeLargestU.S.PharmaceuticalDistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_ThreeLargestU.S.PharmaceuticalDistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588229142024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 29, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 28, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CommonStockVotingRightsNumberofVotesPerCommonShare', window );">Number of votes per share of common stock permitted on proposals presented to stockholders (vote) | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price of shares repurchased (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 151.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Authorized amount available for future repurchases | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased', window );">Approved increase to the authorized share repurchase amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember', window );">Accelerated Share Repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketShareRepurchaseTransactionsMember', window );">Open Market Share Repurchase Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Shares repurchased | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 231,000,000<span></span>
</td>
<td class="nump">$ 269,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price of shares repurchased (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 151.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CommonStockVotingRightsNumberofVotesPerCommonShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Voting Rights, Number of Votes Per Common Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CommonStockVotingRightsNumberofVotesPerCommonShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Additional Amount Authorized to be Repurchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredParValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredParValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketShareRepurchaseTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketShareRepurchaseTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588227429704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)<br> &#8364; in Millions, &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>GBP (&#163;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax', window );">Foreign currency translation adjustments, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax', window );">Reclassified to income statement, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Unrealized gains (loss) on cash flow hedges arising during period, tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect', window );">Net actuarial loss and prior service cost arising during the period, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax', window );">Amortization of actuarial (gain) loss and prior service costs, tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax', window );">Foreign currency translation adjustments and other, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax', window );">Net actuarial gain (losses) attributable to redeemable noncontrolling interest</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">363<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">410<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest', window );">Translation gain (loss) attributable to redeemable noncontrolling interest</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(96)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="num">(229)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(96)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="num">(229)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Unrealized gains (losses) on net investment hedges arising during period, tax</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassified to income statement, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) from net investment hedges recorded within other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember', window );">Unrealized Gains (Losses) on Cash Flow Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassified to income statement, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember', window );">Net actuarial loss and prior servicecost arising during the period, net of income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember', window );">Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember', window );">Foreign currency translation adjustments and other, net of income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Changes in retirement-related benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassified to income statement, tax</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember', window );">Euro Denominated Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember', window );">British Pound Sterling Denominated Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Euro Denominated Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) from net investment hedges recorded within other comprehensive income</a></td>
<td class="num">(84)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="num">(201)<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax', window );">Derivatives used in net investment hedge, gains (losses) gross</a></td>
<td class="num">$ (45)<span></span>
</td>
<td class="num">$ (20)<span></span>
</td>
<td class="num">$ (108)<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss) Defined Benefit Plans Net Unamortized Gain Loss Attributable to Redeemable Noncontrolling Interest Arising During Period Net Of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss) Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income Translation Impact On Pension Plans, Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30755-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30755-110894<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588227098424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 6,090<span></span>
</td>
<td class="nump">$ 6,692<span></span>
</td>
<td class="nump">$ 5,309<span></span>
</td>
<td class="nump">$ 8,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(277)<span></span>
</td>
<td class="nump">6,385<span></span>
</td>
<td class="num">(277)<span></span>
</td>
<td class="nump">6,385<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,597)<span></span>
</td>
<td class="num">(1,704)<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
<td class="num">(1,849)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,503)<span></span>
</td>
<td class="num">(1,663)<span></span>
</td>
<td class="num">(1,503)<span></span>
</td>
<td class="num">(1,663)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,512)<span></span>
</td>
<td class="num">(1,659)<span></span>
</td>
<td class="num">(1,780)<span></span>
</td>
<td class="num">(1,628)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">363<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">410<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">183<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">451<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,329)<span></span>
</td>
<td class="num">(1,570)<span></span>
</td>
<td class="num">(1,329)<span></span>
</td>
<td class="num">(1,570)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(96)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="num">(229)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(96)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="num">(229)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="num">(96)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="num">(228)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(90)<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="num">(90)<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember', window );">Unrealized Gains (Losses) on Cash Flow Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">25<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">13<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Net Losses and Other Components of Benefit Plans, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(116)<span></span>
</td>
<td class="num">(142)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="num">(237)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">$ (97)<span></span>
</td>
<td class="num">$ (140)<span></span>
</td>
<td class="num">$ (97)<span></span>
</td>
<td class="num">$ (140)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140588220810680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business (Details)<br> numberOfProducts in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>business_operation </div>
<div>country </div>
<div>numberOfProducts</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>segment </div>
<div>business_operation </div>
<div>country </div>
<div>numberOfProducts</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>business_operation </div>
<div>country </div>
<div>numberOfProducts</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 62,599.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,172.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 179,086.0<span></span>
</td>
<td class="nump">$ 172,516.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="num">(7,362.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,050.0)<span></span>
</td>
<td class="nump">1,620.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CorporateOperatingExpenseandOtherIncomeNet', window );">Corporate income (expenses), net</a></td>
<td class="num">(8,246.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(202.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,462.0)<span></span>
</td>
<td class="num">(713.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Interest expense</a></td>
<td class="num">(55.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(165.0)<span></span>
</td>
<td class="num">(184.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="num">(7,363.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,063.0)<span></span>
</td>
<td class="num">(57.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Pre-tax credits related to LIFO accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115.0<span></span>
</td>
<td class="nump">114.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">40.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156.0<span></span>
</td>
<td class="nump">110.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill and other asset impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236.0<span></span>
</td>
<td class="nump">113.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment', window );">Net gains associated with equity investments</a></td>
<td class="nump">30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Pre-tax loss on sale of business</a></td>
<td class="nump">47.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GainLossOnSaleOfBusinessNetOfTax', window );">After-tax loss on sale of business</a></td>
<td class="nump">47.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Pre-tax expenses related to estimated litigation liability</a></td>
<td class="nump">8,100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyAccrualProvisionNetOfTax', window );">After-tax expenses related to estimated litigation liability</a></td>
<td class="nump">6,700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Joint Venture | Change Healthcare JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Pre-tax dilution loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 246.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ProportionateGainLossOnEquityMethodInvestment', window );">Proportionate loss from investment in Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States | Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Pre-tax settlement expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CorporateOperatingExpenseandOtherIncomeNet', window );">Corporate income (expenses), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyLossInPeriod', window );">Charge in connection with State of New York's Opioid Stewardship Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Opioid-related settlement charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Pre-tax litigation expense</a></td>
<td class="nump">34.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118.0<span></span>
</td>
<td class="nump">108.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">U.K and Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">938.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">560.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,564.0<span></span>
</td>
<td class="nump">840.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1,483.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.0<span></span>
</td>
<td class="nump">67.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">49,495.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,453.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,232.0<span></span>
</td>
<td class="nump">135,855.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Pre-tax credits related to LIFO accounting</a></td>
<td class="nump">11.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115.0<span></span>
</td>
<td class="nump">114.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">635.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">677.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,871.0<span></span>
</td>
<td class="nump">$ 1,894.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.0<span></span>
</td>
<td class="nump">$ 9.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">9,273.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,864.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,365.0<span></span>
</td>
<td class="nump">28,592.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">131.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Goodwill and other asset impairment charges</a></td>
<td class="nump">115.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115.0<span></span>
</td>
<td class="nump">94.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLossNetOfTax', window );">After-tax goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Strategic Growth Initiative Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">$ 9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfCountriesInWhichEntityOperates', window );">Number of countries in which entity segment operates | country</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberOfBusinessOperations', window );">Number of business operations | business_operation</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="num">$ (71.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(290.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (113.0)<span></span>
</td>
<td class="num">$ (229.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">$ 16.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74.0<span></span>
</td>
<td class="nump">$ 22.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberOfNationalBrandMedicalSurgicalProducts', window );">Number of national brand medical-surgical products offered (more than) | numberOfProducts</a></td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 3,054.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,141.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,388.0<span></span>
</td>
<td class="nump">6,100.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory impairments and excess inventory</a></td>
<td class="nump">35.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">260.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 536.0<span></span>
</td>
<td class="nump">$ 378.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="num">(2.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="nump">$ 12.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember', window );">Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">777.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">714.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,101.0<span></span>
</td>
<td class="nump">1,969.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember', window );">Prescription Technology Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit (loss)</a></td>
<td class="nump">114.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 270.0<span></span>
</td>
<td class="nump">$ 280.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CorporateOperatingExpenseandOtherIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate Operating Expense and Other Income, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CorporateOperatingExpenseandOtherIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GainLossOnSaleOfBusinessNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Sale of Business, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GainLossOnSaleOfBusinessNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyAccrualProvisionNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Accrual, Provision, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyAccrualProvisionNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberOfBusinessOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Business Operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberOfBusinessOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberOfNationalBrandMedicalSurgicalProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of National Brand Medical-Surgical Products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberOfNationalBrandMedicalSurgicalProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ProportionateGainLossOnEquityMethodInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proportionate Gain (Loss) on Equity Method Investment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ProportionateGainLossOnEquityMethodInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RevenueDerivedFromServicesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue Derived From Services, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RevenueDerivedFromServicesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in earnings from investment in debt and equity securities measured at fair value with change in fair value recognized in net income, and recognized from transfer of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and investment in debt security measured at amortized cost (held-to-maturity) to investment in debt security measured at fair value with change in fair value recognized in net income (trading). Excludes other-than-temporary impairment (OTTI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=121548190&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of loss recognized that results from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyLossInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyLossInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfCountriesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of countries in which the entity operates as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfCountriesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>72
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M-:2?;^GGX_1SC^@WZ8=]A_(M_?R7HI]OZ><_&_T:E+Z(0]@B#I9^_H_2KT'
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MM2&VIKR-<'3A;<@P- L?-L*'G<)/KZN.<C)LCU25SB.];4R@S>'(0!/J\]R
M&?AFR8[]MI/;W5_[]^36;$=S,K0/UENEV !SA_K:-G'Y@Z&V3F(3EWOB4SL'
M)QCG]W5C*7FVW$F\S F2#%$&_51R!L<3N@&4))P(<\&K\QVIZ>L5SP0*0]T7
M \AQ]'W%B#J8,\>^N&^^N'\Z'UKVS),O1 @HB5/&MXR7^X+1&M>TYWIZ033
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M^@]8-T(IT?272\X@WK4!_+X00CW=Z&]BVV^@Q_\#4$L#!!0    ( )> 0E)
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M\V*<OEQ%58?\LKYI.L_7/YV7"NN>.--57J2+JK!@L(B3S>_P>S40>P4\;BA
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ML\-9YEB2(6??::;R@75JH8PL\(JI.[ZY(LUY>EHOY4R:7[1I?!T+I2NI>-'
MD$%!RWK$3\UWV '<[@' :P"O+> W@-\6Z#9 MRW0:X!>6^"D 4[: OT&Z)O+
MJK^NN9H(*QP&@F^0T-Z@IB?F?@T--T)+78F)$K!+@5/A<'(;Q;=)'"&8)9/K
M<70Q R.9P7 3W\X2-!F!-1E^N9I<1_%=\A[%7^_'LQ_H*(I'X^%X=HR.IEB0
M4N5$T12S8_01O4,VDCFLRL!6D*6.9:=-1I_JC+P#&7U>L0[RSCX@S_&</?BP
M#7YZ$(_>QB.2=I#O'L3CUKA[M@<?_5_TRW^.;D-=;(O#VQ:'9_3\ WJ)PHI
MVU&(+U"B>/J0<Y81(:$('E=4/:.?%W.I!/237V^$\[?A?!.N>RA]NJ89*3,)
MO21E4#T9JHA *2\*:%JFGM 1+5'&&>Q*LVE6C_=561VK;V+I?KP.G4[7"^SU
M;BWM=7)?.T5ME.(V2J._G=R.UWOM=+G7Z8]2_6GMG;^\?C)NL%C24B)&%H Y
MG3XT(E&WX=I0O#)=8,X5]!0SS>'E(D([P/Z"<_5BZ,:R?0O#WU!+ P04
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MKO24R9>!=J5H?D+0W"B^K=_"+[A2O*PO-Y1HNAL!_?V*<_5V8QYP^"''U?\
M4$L#!!0    ( )> 0E*,Y$]HK1   % P   8    >&PO=V]R:W-H965T<R]S
M:&5E=#DN>&UL[5MM<QLWDOXK*.U;4D51$N4DMF.[2J;M7>W:B<JT?75UM1_
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MM3PMU?J-;8AJ*VB+4;I69Z>G?Y*8I!@CCT)#^EH;<C26)P92E<,$*.X*#L-
M&S71JJA*H6\I^@![3TM(T$(_ "2XZ*=!I.ZZUB[[+DH[)"DZ,&!\GMPRSTVP
M&-EW2%("7I^E-Q9<!/9!KM',VF1SI.?:ZT+"?J,1"PQK4UE41;P*=!@,;Y.S
M25_2;20Z-V8NF-EQ'U48\G#&*[P4YPLB1U.MR$K!1-!78;,DPZ[PF(/PVG'2
MCD,HK0 :H X9.1:N*^_@&&_HGS2GV[2N7V^@&#0.B8A!$F1S/A!KE0:;W5*0
M!8):AI!+BGD!56NI%H<M:P,76/H< '8-Q++[H[/CU,B+GRY?[Z7<'/Y>813#
MOB9#8-6D64FZ=^'7W]$%0J9('I&S.?6,=T3!A1]ELWD**QV>U*X3S$13 MKL
M%1JIE[:B?<&!Y@80L8C@,29754_E@SC-"7QA;S+T0")-*,>0NH@RI4XC3D)X
MDJJ"PA&VIE_-90/P0< H= 3VM%A;4JP(@/50),*H$-* 4-0:=FW!$;?TW#0A
M9$BICZC!8I@..94R>*K_X(B++:B_T.GY7R\NKM)SVB4#Q6Y'E0('6K 5URQ]
M%0*Z->N^"E53<#/7# N#5",.I6&O;PK)OU3#6._S(G;Q>IX4" L@N5$>*1W[
M/-(]47J>%3E$K"] F\AOA \\(<OD.9BQ4=<]]O&[CH$G773)X>0B#$5J$ ;8
M563$25XO;W'FP_?/@(I':<<>(77!!OVV"44F!8[F D^,FKA\2WZ7+ ;J"&10
M68$XFS09FS83/OL#^M+DF!#PT=PTA%/$,!P4\#QX6 H#4#IJ!HB)JFPU8M"N
MJ#[@LDB6BWM+*DLH>(,(@VW((@C #JZ02A KLN<FM($=SO J!"\5L6YK"W81
M@DO*_+!%1 4*S6O;]I[<;7!Z1]%U]F0H[7[^=/GJ^.Q)0A$HHS00)T'<0Q@*
M6XME6]W84LXW]3H"FO9E"]3"Q!WP/JK9CC<B*)SL3?19<![V,%DMX)Y)AXI\
M@@_ VM!&:<&H/$_.)I!$4+? 6:UZ+N%"X4@LREJYQM8A 0[@$X7[6B-K=L)'
M7\Q,>:A).%')B:*1C57^TD?JK@T\Y(G<B3.T6FG;CLK)Z+V<6KT5[\>C!X:X
M5$:$4X_V&[6JW&Y<\:W"P3:2TYX*6G+7 )4+6TY0TE;6K$3TZPBRP$VW!/(!
M1!?O7R_HEX0B.@V8&C4%C 45WND626GV@[0P$NF"["8QQ,AT7N OY\)KZQD(
MK:G8YI2<MDWE;IDDLL#L] WEG*'6R2;'O9=4GI/@8%F1!%AE99!WXM&X0Y:;
M2HY7<-IVB1FQ$3-5/]?#KW%ODX'&AX-S,D6H$ <@7310%ADJ9 &8<!(.H9+'
M3;T9"D"P#_Z@&I*0S/<9MI4<P2Y%D%1F;3WEF&M*R$1HK>&\0$Q6!+-R2M4I
M:I1%N,*[KMX;O0<"(>!2L+07I,D9,*D1/JU1O^#8P]TR0]VR^V9.&L>HL1S5
M=&SF786=QQ4Y,1 5+,VPQ[@PU4F0=FMT&PUT/V-G$>TWKJ]*$D7=WI"\?@$G
M,F12'R&DR,@9^T1-1A7)4">-ZB?LTOA["?BN_2]DM?><=LA)U)O%*>GX'VF?
M*R1V#*%]!K-* ":;(O2OK>L]3+FR=(A+>T%!(0%[JV:S,#J&.7\9+?]PPR%7
M8PD@$DYK0!XN5&>":()SXH?SLRD*,3[Y<6F_HSJ4C (R(E)M*8@EO0&UFMM<
ME'P@GM?P&QI%9X.]ALO4F:IYBB'J&_#TF*^'"A/T72$GH0R60 FE2SQ<QH8
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M.+%K GM'6FPUUU?GL=,,8:UO7> DRG2MG8$A"\IJW-[L/H^OS^.KGC"TO'#
MD8SQ.]NO/W25WSE.MN92I/D0['KC'G;<K?\*6&,L.M5UF&\U]L.!*HT.B\V<
MD%8VMLI'8'HV:1IBV/6M OA!P7:JY6Z_1%*"14^F+4<_JH%\C$'H1!W33<+#
M/0),JWK<MQM.+?^%]_TLT;2E4PW0WG\":N4PRMDJC#$ZU$4@37Y:H*QA-D2'
M\HR*4F+01-=5;OL4G-*8%VJ.U.%\91(N%*Q" FN#NFP^:NV)$U_HKI8NHUL
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M_I@I"030 KQ?&./C%U+0_.I[]C]02P,$%     @ EX!"4K(BC)Z)"0  0QH
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M] G:_R<G[SV993!&3T\)1F Z)(%VU@J;20\.5"!*?[=1=+?9%^Q;6A%2':>
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;,59:V_;.!;]*X0WLT@
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M@Q;@_5PI6]^0@>8SW>7_ %!+ P04    " "7@$)2QWFAK[@$   _#   &0
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M-WQNR #?+S5V_'I"&[3_,\S^ 5!+ P04    " "7@$)2_E^GDJ &  !\#P
M&0   'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6RM5UEO&[<6_BL':G!A XHU
MJRPEM@';:=(\I#5BMWVXN _T#*5A.S-42$YD_?M^AQR-)&]HBPL+'BYG_<Y"
M\FRMS9^VDM+10U.W]GQ4.;=Z-YG8HI*-L"=Z)5OL++1IA,/4+"=V9:0H/5-3
M3Y(HFDX:H=K1Q9E?NS$79[ISM6KEC2';-8TPFRM9Z_7Y*!YM%[ZJ9>5X87)Q
MMA)+>2O=KZL;@]EDD%*J1K96Z9:,7)R/+N-W5QG3>X+?E%S;O3&Q)_=:_\F3
MS^7Y*&*#9"T+QQ($/M_EM:QK%@0SOO4R1X-*9MP?;Z5_]+[#EWMAY;6N?U>E
MJ\Y'LQ&5<B&ZVGW5ZY]D[T_.\@I=6_^?UH$V3T=4=-;IIF>&!8UJPU<\]#CL
M,<RB%QB2GB'Q=@=%WLH/PHF+,Z/79)@:TGC@7?7<,$ZU')1;9["KP.<N/FE=
MKE5=DVA+^MPZT2[5?2WITEKI[)A^ENYLXJ"(R2=%+_0J"$U>$#JG+[IUE:4?
MVU*6A_P3&#A8F6RMO$I>%?A!%B>4QF-*HB1Z15XZ>)UZ>>F_\IH^*%O4VG9&
MTG\O[ZTSR)W_O:(V&]1F7FWV_P7[5:%<M>_L2A3R?(2RM-)\EZ._HPG+Y"I)
M5A8:1-\Z89PTI!<,,J#FO6O=K$2[(=6L:HE2=+(D02UJS<HESU&7*VV<:I<$
MF+K",6;K2A45=BPJ PRJI87N3$\JV(R>V[ZC7T]N3^BF$BBP0G9.%:(>L\'2
MM(++EJ=?9,GK;V\[L^0!W>JZXTTXPOY]?;B#D+L*SC^GA&1;L!_6D@ BZ&=&
M!(NW!/!YSUL6I>S@85$!/$DK@UUV)\PMN]7 005D]E#H6@6!HC :Z@Z$7F*Y
M!V5,RVU\5%O471E0 LI(-(P?BUL+BS48KPO!^YWE/996"VYJM!#*T'=1=Y+$
M"I8*X,_(P&>)7XD &"]>&>_3O785W4NLRD"WX-"SN8,:P.LQ'7+ ($],Z1-@
M9_U.)& Q@ E0OIG.T:GJFION$5+RK1,/.RT\.V9O65N+7*8F] K)O8)0Z;*Y
MAS';:H</GE1:IQKO_9ZS?>!^[ RB2E^E$ZK>9M/F$8P>19Q!WE$!M)T'U5JU
M;#FLPI@-TP;)W.E+@@=[X695G$G:*G^B_#/MRE6]C(/TWN99GW5/$>7%;9)T
MP"C$J1 KYA_3?WZ8)4GT_M.+(;&>(GZ_]> :U8Y#%=(PLKI6I4?UUN$SE,,O
MH4A @,1U3Z,2VL.]J$5;^# ,*<&9%A+I,(>AO0>*X^"S],$'M-X@#4*C"GQ\
ME6"^YZ2_AB!*% *-JC>A,! TIQ%"+R%$^XE)UZ(5I3A,=,D9X-D/G-H#EF\3
M_&L[:$>F($0BP%8XS3#%H3$)QW2*C54-,<YC4K"EY7[FM/$\*^T@4XF#T,D'
M95TPJU>SM^FX%N %8L2WLKZ\N6M3J4IJM=NJ8.[-@>4[+$^0L0O.)DT?50ND
MV82?80S%R9!6'[G6?O,5\06U@N[N4V2\S2E6W' 746VX(/JV<?VH9K:E)1K=
M'1I!*$?)X"TTVLX:!\(1CJ6^>]CCYXZ'1\%_^7"@&W3;PBA?*'0GBZK5M5YN
M]BCNM /'54@T'#3"H'$.G><-I>-YDN$;C[,LQ3<99WGJYWG&^_-Q.HUH=]@6
MWSIE$ ^&)T[>4S:,=BN73-1W$%$4C BP04$9T5H$Q/K408-&;$3Y!ZZ H2H?
M2]I^$_SAPH*N)&I+1_'QBY2\]_E)>]AM3^=/>?TB[K^XW:(7=L;@,-T$6VL1
M?-C9.,;5P-'TE.)L]M3..-\A_;3->[#G40 WF3X"._%@YW&,Z ^)AH)>"E-R
M9JG=%4>$.URHR2&MGBI\%.RC#R 5)ISK0_[][F_ULGQ+G_R)?ED4'4Y]WS'Y
M#O7\ZK6_MTO3']"05*F515T%+T_Y>Y2,TWAV[/V;YIG?F>;L_U$\GN=1V#F-
M(KK%E4ZA#XJED7V'CB.:Y7,ZRJ+DF++\E.;S#+,9N/(XVYU!-?C0ZBT!T#Q*
MH30#23)-*9LGF*4)SR*Z,Z)$W\5#,/1AGE(K&NF-GB>@34^1"#FJ8!;-6 XX
M\^ETOZQRA!TVQ>Q5&E-\FO,$.3?-Z!>?SCDE.1:3) 4%\O:4+4I D2=]*;ZA
MZ7@Z]2@ CIE'(1G/9Y'?2>=)V$G2Z;%'+,ZG]-S%?++W(D(@EO[=9\E76W@<
M#:O#T_(RO*AVY.%=BCQ9*O2*6B[ &IV<YB,RX:T7)DZO_/L*ERI$W0\K/(^E
M80+L+S2::C]A!<.#^^(O4$L#!!0    ( )> 0E*"3#>X90L  (4>   9
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M&PP59S2'(,0-6=*VSC3(W02Y: 5AB).LX@VR,& \Y25M<CGB5"M"F P&K_%
MR8?]"+:?-7;$"S<DRW8TWFZ=VI*G/4U^A>9HD;<2C7?-0BC[KZ61&;(_#NU(
MEBLX00/@$@&6";]?P0AGVMZ:+O](I^!!ZL>F:Q[MW<2\D]2$.T,_XN%_2YE
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M0&R=)CO8#AK_4?0$K.C&_9 6OZ=S7-.5@^-T^R2QG?2<U1T:TI:P9$*,*4B
M@F+6UR7=$7$HTVNL,-K$S L1%1"+%VDQJ;;*!-=;!W9*;&P.);H-8N9K$Z[Q
MG,%U$"UYM"RC9I(&I_-DW#0@W5]\'FG. U5OSOU]+NHJ$H8 FJ06G188[M\6
MR>6Q"[A])&EFG T89\GJ&&,]Q 69>NCFD !6\89GLI@V8<[+]2$\>I#%Y+KC
MMX*4,ZCT<JL>S]WC9#IYPBH,KRD["AC[ V<FA]Y@G7=>#?(&1B] O>!KK?"6
ML/FV><?Z)KQ:;,G#"]H/H0-A<]J =8QA_T2X\-(S?*ALR2\:U[9"J>?'G4*!
M=T2 OV\L5(X?Z(#FS?/K_P)02P,$%     @ EX!"4O;J0SH!!@  :0\  !D
M  !X;"]W;W)K<VAE971S+W-H965T,3@N>&ULM5=;<Q,W%/XK&C?MP$SP-8$
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MKW\?5_]V;BVYT')^X_=O4+&=6TE<2U.@0J6*#?KH+<4B;4Y.D0A7@SGB@$
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MDZ*;^!2OE[J49:)E+G0) VOVYD3\C"U7IJADN4$JDXZ(@V-)W2'L-E,4RK*
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MZ(24I05XOS3HY^(7.J#]#PSG_P902P,$%     @ EX!"4K=1,MK&'   V5$
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MM*$94_J<%SGOES0&<7+"RSSW&1>;';(DH_>5EV79A :Q_9>3/:8<&R7G\*5
M(X,Q8U'H@'%Y;X*AT\20JY)ZG S9L+<;/AQJ6&%$(?H\(EFZ0'O.ZU<+'=#0
MI_# =+PBD[GHG>1(Z9CNP+,9-VIG9RG/EE0+V\LT!QRT)M?R!9F<4Q7"?R7:
M$6,F=.*(=$)*O9/L;')Z=DP*X0N6K:\Z1V!$BTR&;@"IT.G+R8OG9UXE1;,(
M#E^%9E=LS48CJ>R=G\720NIF6%PFE/@!.I"_?Y,$O'H/)V183W(,30$S#CY>
M[U&U^]9FU*"HD:@V?(:8L)^,!A>"/N=TN>'@6:@^6EDDVB:H!W\,*S=UO-A
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M$YJ0;_WD8P2COP"_$;)Z]+I/*&Y7=O$X.!1I-_PIT0XT_0H!"3=>!&A1J=N
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M/8#OZ5>PPC]H@_AKCC_^#U!+ P04    " "7@$)2[%^A4]8,   5,0  &0
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MJN5S*3X??0O# P/;HUF79;^0,/83;%>?T70?H?'T * 79)A#<-@<_]Z%;I8
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M';F[[J]W0-EX3%5N64QW:[WKY+*@2M.-S)U<B[(SSG7WV?>K. QLOPT!A\J
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M]/CA@;S3S!^B6_$S];F+P"3^<VE0<7I:@-_))?,'.J#\?PLO_P=02P,$%
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MH>)%I4E2,=$:9?4X7>IT1BDITK?POM-J(G71;:GT0%(.ZU>F*10%@R3,XU_
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MW+K%5"YRNTZ)F_EYOY:'3X_GH4*Y.S=,@HAA0\Q0,_.278VT$ M&QV R8CP
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M1X*G0M, /!\J9<L+6J#Z[/+T/U!+ P04    " "7@$)2WAO$W9D)  !I'0
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M+_!]]EF+,M%R9;US*Y)EH3*U>.CL'(_';!S8O7[  F\ZFK);@G5SNA,V"F'
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MF)IE_7K)J=WMM78?*1&-W0.&;@H_&-BP$K8G8] L54H667Z)U&.?6FO(=JO
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M9).J1[[]".6"AH8OYJDL_J)M:>M8*-Y(Q;,2K"/(*-O]DF]E(FH -^P N"7
M/1?@E0#O%( [ (,2,#@7,"P!PW,!?@GPSP4$)2 HQ-IEMY!F1A29C 3?(F&L
M-9L9%/H6:*T(9:84%TKHMU3CU&1!5XPN:4R80M=QS#=,4;9"#SRE,06)+M!G
M(@0Q]8+>ST 1FLH/Z!VB#-W3--75)$>VTH$8.CLNG=[LG+H=3CUTSYE:2S1G
M"20M^&D_WN_!VSH!51;<?19NW%["!>27R'-^1J[C.D^+&7K_[H.$E?[D5%MT
M_60SB#49/I-LUD]V3T2#K(5E?G9(..IFN3T[2WTL=V>OJ(/E2$*O*F2OH/4Z
M:#_K7:]>P((S/8[!I%TB+M!T3=@*3.$>F5$6TSP%],<OFA!]4I#)/WO"&53A
M#(IP!EWA;+)G$(@O]7Z=<Z'(L_915H%$?Z/N@KC9$0\+8M-)7B:#D?U2K[\^
MBZ-HAU6TP]YH%VLB8,W3!(3\"<'7#57?VT+;L?@UQ[X3.2?1-8TNW" X-IHU
MC8:>$QT;S5O<>>'PV.BVQ<B/W&.CNZ91Z(9!>]+\*FE^;]*N4]W'B2XQI$\$
M*!:04(52+B6T;8E3OR&:Z^+V"((J@J W@D>S'S-(T)P(ILM9]A1N6'&&;^$[
MBJIPHE>IS*@A,/;"1FDVK8)A=%)0LZ@A%/8<]Z2BYBT.72<X+<X6*QSY)U9W
M+1[=0>UK.,H<=@ZMW>G-W:_ZO&K$$?LR@;),$$G^TD<+(^F5'O.\.!7JO8II
M\<E!5:D(2XCHZ["X=M# ;Z&PL'L(R'V-TIJ5-'5Y+K!W(F&+$>[XNO&AI6'O
MOQ%0-YQ_LU?@0Y?#@S<AZJ&1X5?I9+.2Y@>B-MM&IZB'KH%_T#863^;HXVMW
M6I;_3>)#C\'!FY#XT*!P^#H2ART]X40]NW9SRD"LBDNQ1,4R=I>HZFEU\;XN
MKIOVP7QW:]?GVA5E$J6PU%#G,M#%(W87X=U$\;RXASUSI6]UQ7 -1*_"&.CW
M2\[5?F(<5/^.F/P#4$L#!!0    ( )> 0E(P_;DO/P8  .(>   9    >&PO
M=V]R:W-H965T<R]S:&5E=#,U+GAM;+U9;5/;.!#^*YK<&YTIQ):=Q&F!&<I+
M"5RG#+2]#S?W0=B;Q%?;<F69T)O[\;=R3)3$BF)Z3/A _++/:K6[>G8E'\ZX
M^%I, 21Y3).L..I,I<S?=+M%.(64%0<\APS?C+E(F<1;,>D6N0 65: TZ5+'
MZ7=3%F>=X\/JV8TX/N2E3.(,;@0IRC1EXOL[2/CLJ.-VGA[<QI.I5 ^ZQX<Y
MF\ =R,_YC<"[[D)+%*>0%3'/B(#Q4>?$?7/M4P6H)+[$,"N6KHF:RCWG7]7-
M*#KJ.,HB2""42@7#GP<XA211FM".;[72SF),!5R^?M)^44T>)W//"CCER1]Q
M)*='G:!#(ABS,I&W?'8)]81Z2E_(DZ+Z3V:UK-,A85E(GM9@M""-L_DO>ZP=
ML01P_0T 6@/H.J"_ >#5 *\MP*\!?EM KP;TU@&]#8!^#>BW'6%0 P9M1PAJ
M0-#6K<,:,&P+<)VGR#EMC7(7P9XGW3Q+JA0[8Y(='PH^(T+)HSYU4>5IA<?,
MBC.UI.ZDP+<QXN3Q*'N 0N(:D23.R.F491,@E\ 2.0V9 '+%8WSU!=^7>+=W
M!I+%2?&*[)//=V=D[^=7AUV)9BAEW; >\MU\2+IAR*LR.2".^YI0QQT:X*=V
M^!F$!\3;##^SP^\@1[BS$7[^_T:_: VGC@'^OK7Q1OBE'?Z!">OHHVV!RZRN
MN[+#3W)AC?MU:^/7X5U,^D7FTT7FTTJ?M\F76)VB,@'"Q^3\6QG+[^0#R"F/
MB%X3!?GS=X21D82T^,LRJ+<8U*L&]3<-.L5%->5)!*+XC4 UK&D)S+7T*RVJ
M*CX<][V@YU1_A]V'Y70WB/:'U"1ZWE[K15-TGPX&)M'W!JW.T#&)7C9%>]Z3
M[*KH=5,TH,&Z 2LQ\!<Q\*TQ:)#<:XQX>&");F^AN;>[E.HO!NU;IW,C> @0
M%60L>$I&15&R+$3]62QCEI";\CZ)0_)Q/ 819Q,37?>;K@X"FZ<'"],&SS M
MY%E8"J%*#:^M48[B<@K8XP&^0XNA,%DX:%A(!^MILV)AL+ P^)%<(/^2T<U'
M2W"&"_W#W66$Z^BB[EBG]11MDHL8<V$/2WM91"17CE8,9*[:3L/+KF=VK[O4
M7KA62SX)ANUWU3W?@7A :PIR,A$ \YGO_?I30*GS]M/=277EOGUE<X#F=G>'
MY.YJ=G?M]'X!.#U@(H-HGO,X+V./,5?36W:U=<6YFMQ<.[M]8H_D%D*(']@]
MSG_A:^WJVU:NUISG[I#T7,UZ[A;: Q&B9MSVJ8$SW'R&K)@2B=,OV /F?H$[
M/I;$_V HN,!=%GHATH_*#$LP05^0O7RNR;0F+K88$?0.'.<7VWPT5;IVKER*
MF8"03S)EIM&D)AEN2AK-@JZ=!E>Z?-MT-.^Y.R0^JHF/;B&^68:=U33.<3<C
M0>! UOB.MJ@;.%OB2S414CL1&K967[#,/+\9H4L-[@Y)D&H2I'82/.69%/%]
MJ4B_P,UJ!&IK"8_A?*IC7(TLBJJ:@/U)"NG]6LB,+0"UM)GF]*>:,ZF=,Y^9
M->^VJ//=@YX]:S2YTMZ/9$W;]4HUG=+^#G-%LQZUL]ZS/6]7UPNV>5Y3(K53
MXHV ?55,HCBI,IDDO# EYEFM9[F64[]OW'^U$EVU5Q,N'5KM':4YBX4*D]'(
M8;/AJ/>(32M;R:YN?S5!>W9&Q2U!SD6U]B54/ITW2K']',JX1W::WEQOHNI]
M;U-RL+[M79V/IG7/3NNWZD!,M7OGV/6IKL-V2*"9V]OEV<32X<0+G4XTN1@S
MI.'2^GS"(.P.^T;A\^=HOC (#WI#H^Q[DV(OV'1,86C//8<:#U6N3<+4MY<F
M3Y<F;TMIRD&E%?:$=9Y!G6=80_\NYYGP!J]Y7I%4U0K/" M#7F92 0O)LHB)
MR)8@NAQY.^SU/5V</'N;W3(O+VLURZ'8Q\ 9H]84=5UKR'1-\[;4M)<*&1;Z
M9]&+KFU>L,,PZA+EV4M4ZS .FX>/F\+8%+6'T=>5RM^RE7C!,)[<?5;'UOZ^
M,S0%U;0/>%ZCY^N"Y;N[B[VO*YI/7R+V5[6:E<-(<^O17?KHI;[^?F!B$N.&
M(X$Q0IV# :YM,?^@.K^1/*^^@]US*7E:74X!=R="">#[,>?RZ49]6EM\UC[^
M#U!+ P04    " "7@$)2E>>5 &4%  "R&0  &0   'AL+W=O<FMS:&5E=',O
M<VAE970S-BYX;6S56=]OXC@0_E<LM">U4EL2AY\512K00D_;O6JKW7TXW8-)
M#'@WB3G;@:UT?_R-DQ #25RJW9>^ #'SS7SC&<],DL&6BQ]R1:E"/Z,PEC>-
ME5+KZV93^BL:$7G%US2&?Q9<1$3!I5@VY5I0$J2@*&QBQ^DT(\+BQG"0KCV)
MX8 G*F0Q?1)()E%$Q,N(AGQ[TW ;NX7/;+E2>J$Y'*S)DCY3]67])."J66@)
M6$1CR7B,!%W<-&[=ZYF'-2"5^,KH5N[]1MJ5.><_],5#<--P-",:4E]I%02^
M-G1,PU!K A[_YDH;A4T-W/^]TWZ?.@_.S(FD8QY^8X%:W31Z#130!4E"]9EO
M9S1WJ*WU^3R4Z2?:YK). _F)5#S*P< @8G'V37[F&[$' #W5 )P#\#&@50/P
M<H!WJH56#FB="FCG@/:IE#HYH',,Z-0 NCF@>ZJ%7@[HI='-PI'&<D(4&0X$
MWR*AI4&;_I$F1(J&$+)8Y^ZS$O O YP:SF@8(#@"Z)F$%%VB3T0(HM,)G4VH
M(BR4Y[#ZY7F"SCZ<HP^(Q>B1A2&DG1PT%1#0:II^;FR4&<,UQCSTR&.UDN@N
M#FA0@9_8\9W7\'=V?/\U_-2.=[%%01-VOMA^O-O^$;9JG%#_"GGN!<(.=BH(
MC4^&N_VJ_;3#G^D:X$ZM];M?(W__:^2G=O@C$5;K,SO\$]]<(:<2?A!)KSA(
M7JK/J]'W$/L\HNA9$46AMJL+-"(AB7U82GL0B0-T&P1,5VP2H@F3?LAE(JA$
M\Q=]N>82UJ>")VMY@4!=F 0L7J:2D'0L3FB _EI3?3SA]*&_/P(#] #6Y#\6
M_JV"?ROEWZKA?RLE51*M=O4 R-"J$YYIZ:1:=&/<#-WVH+G9SYK71:9ED;[3
M*60.'&@7#K2M#GQD9,Y"V%]Z@A>9JO8^Q=:1%Z^+3,LBG9Y7[46G\*)C]>+;
MZ!;]R5FLT%=((D@/2VB[A<[NNTS-7L&_9]V33SS69@2'O@-687,H<%/H#"SZ
MX,]YU>FWJ_2<*\?YP\*M7W#K6Q4=Q K]AZ84!JH8/:T(?/LT4<R'K?NVXB'5
MN8A&B00-4EI,NX[IW<Z[#*R[-WVXUNT;P[CQHBUN2)A0Q!<FNC!I?$\W=U-U
M$/)QPRV=0.?H&%M%#EECPQI;6>=!?EM432-QWV<G<4TK<>V]9 Q:69#KASL<
MG[(-F5=6XIE;;@6MFAKJFE;@VGO!D^ ^I8%$"\&CM GHU,K#MBW"-J\,6YY:
MY>*.^VX-,5/=77MY?Q+T4I&?" (F$>S-CIJ52:?$I-4]SO*R3+M;0]:T#;=K
M'PD6<!3?3K=KHWM(Q70 UUZO]6W*)33TRW)#/]1HZK;;?Y>G#)OJCYW?,K'E
M:MJVD>T$F6F%3.W0ADT'P/8.\*:Q+=?5L<UM)\A,<;DIU$YNV+0%;&\+!TEJ
M9H$WM0ELV@1^GVT"FS:!?\LMQS17LQ^M7@O71,OT"/S[[A>FN&+4;]?EOND&
MV-X-3MR &2Y7]YH9!IOBCNW%_2WNSW)=G1,(F)*.[27]GFRXT%,!.DOBQ>[B
M'/E)E(39(RB@1-DRAB4A:.R_("5(+,-LK"#!]T0JG?F5 >N5&->=;],RL'W6
MS\X,' K= 5_0+YQRSQ1Y[WV.^)XI\)Z]P#]$:\)$39S&7KE:XQX^+->3"B'W
M:,Z_?T71(7E3TCU[23?D+Q#1XQ""<:C2#WR*'V6ALA]V19D?S;T'OA$5R_3A
MOT0^3V*5/;(J5HL7#+?I8_6C]9%[/78KUN_<Z_OL]8%1G[W->"1BR2!/0KH
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M31LOZS:BGC9B<$T+L>4@*M9D;8D/W?$+1_Q8]E?;:>BITRZ1,V%(DE. X4>
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MS^P1-#E;@F%<Z+>SP*!L2Q'$E9SK4DYT1$Z??)"YV6ARDR>0>/B7W?S3#OX
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MVCWHGKM5513Z<'4$;7CF;D0-KFZVOJEW3=M#;4*/%<E)M$U8^U%(NV?AN]2
M^I; )JV>-QH? W82;1/8?D+2[A%Y)UB>H^$)]BM$87 BVE+[  F/F3B_+]3:
M7I![*0JWZN-DQRF/,[WK<W _W*+P.Z9EM!](4?= .G6EC-JS*!IXQ^<IE*6Q
MP<%!0 8XN.T)C"YWO?(KL'Y:G_*\<V<;+YY?T\L%]3Q?TLN;\@QG+[X\4OJ
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M$P"(=H@$UO*%W?IU7@FU]<J*@%Y(T ]9.2%MQEH7\?1CJN?TE.H)@.SJ"8"
MZ@FANJHGT7I-W'I=3CC$C]@:;4XJ +DT8QG"4(,:@.E(::+7 L2]%NA7!0((
MOU6Y(!#&)L<3+*UZ++5I:NTGY .7=42++'&+[%EU@=B*:OFW%Q+T0U9.2)NQ
MUFWBUNUSZT)MUET7()!5%R"071= 5&==T"L+XMZV=]<%>P]M3:H-L>L"@+'J
M@HWIJ@MZ44/<BYK^A''EBUY1D,E[+\R(%FGR 2)-@$VEN<\!,-8R#<!<CD?F
MS &@CI4TT4I-/D:IB:V<5L3V0H)^R,H):9\':GVF9^HSM473/! #($:*!0#$
M+#  9-S!2JLSQ1\H6U3+(W5OC4_:PE![7XJ)&=)+"$6OAJ8_ =3QR4;M4LA6
MUS:&'AT>NT7ZG;8Q%-@(FP)V B8 ,-3R!(#I\H.6;NJ6[K/J([5UU*J/ ,:J
MCP#&KH\0J*,^4BW9U"W9]RQ*0B'B;1R%Y2M(OD4YBPYY7DQYX0[EB^J)B@A>
M.BF,HOS -BB)PW6<Q#)F<$@ :FW'Q F@  +940&!NL)"2S]U2_^Y^D'M,P=3
M/_HA03]DY82T2>N%"'4?;:Q>6![%@HDB&NX.$I4OPJ%#60H=OD\[^M=K%7K"
M6@7T*K >,;UJ0RS]LB&6?MF0+OW22Q'J7HKT[RYK ZW72-:9XQ)"T>G$)'F*
MK56?K8JJ=_2B/&7YKOQ"0:CJ<,AD]9ZRN=M\!?&U?/=OW%_@ZR4&[@?X>E5]
MXZ#-5Y]<W(:Y4F.!$K957?E?)FI*\NHKANI"\L?R-?V:2\G3\N>>A1N6%P#U
M?,NY?+TH.FB^)9G_!E!+ P04    " "7@$)2  BMTAT%   &%@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970T-"YX;6RU6-MNXS80_17"V(<$V%@BY9L"QT!B
MN^BB31%LNMV'H@^,1-O$2J)+TDGV[SN4%,FF*"9[Z4LL4F>&,T=S"^=/0GY1
M.\8T>LZS0ET-=EKO+X- )3N64S44>U; FXV0.=6PE-M [26C:2F49P$)PTF0
M4UX,%O-R[TXNYN*@,UZP.XG4(<^I_'K#,O%T-<"#EXV/?+O39B-8S/=TR^Z9
M_K2_D[ *&BTISUFAN"B09)NKP36^7!-B!$K$7YP]J:-G9%QY$.*+67Q(KP:A
ML8AE+-%&!86?1[9D668T@1W_UDH'S9E&\/CY1?LOI?/@S -5;"FRSSS5NZO!
M;(!2MJ&'3'\43[^RVJ&QT9>(3)5_T5.-#0<H.2@M\EH8+,AY4?W2YYJ((P'0
MXQ8@M0"Q!48] E$M$+WUA%$M,'KK">-:H'0]J'POB5M131=S*9Z0-&C09AY*
M]DMIX(L7)E#NM82W'.3T8DUEP8NM0F>_"Z7.T1V3:"GR'+[A_8Y*ALY63%.>
MP:L+].E^A<[>G:-W*$#*O%6(%^A3P;5Z?[1QR[,,@@#VWATOYX$&@\VQ05(;
M=U,91WJ,B]"M*/1.H761LM0AO_++QQ[Y (AJV"(O;-T0K\(52X8HPN\1"4GH
ML&?Y9G$<N]SYL=/7WWWZ"1E1$SI1J2]Z+71,S%3!\O?U@](2DO\?C_Y1HW]4
MZA_UZ/]0)"*' ,S*P-Q(D:,$/B<O#G J@E(IJ>Z+JTKSI-1L:N7CXF*"IZ-Y
M\'C\M;HH,IJ>8E8.3>-P3$Y1ZRYJW!YVXOVX\7[L]?X/:!*\8H!J+?G#0=.'
MC"$M4"$*0X04D%? !"\T@\S33B*J0\8GYEO&+UV8B46# X,[++A D\C-PZ3A
M8?)3HJ##TFWR&U,*ZMA2R+VH4"Z&)EVC)X18_B^[*!QCBR.'IC$)K:!;.U X
MC-TD31N2IEZ23.VNN$FYJNEAZ1$[[U$!\20V2--G%PG3CE&A14 7<3&V_'=
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M+%)%"*K_O; ;EJ9%)(WCWRKHH,Y9..Y>OT7_7 Y>#^:92G;#T^])K)97@W
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ME@+![Z\F;^&;]XR5 7K$GQ%_S!O;H#R5599]+W=N-U<3KZR(QWPMRQ2A^O?
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MS*;@:NN!)RNE0^P=KB#P7_7M/GP*5S%W2#ZHCQF,<47-Z_1SYRG=IJK5/)=
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MIT$\1>>2/P(1T 0=H0>?<U_R"?K0I\(/PN17]/X=;KJ?4!"C^R ,@7*2D[J
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M7EEV3NWAN$OJD%-M%'8AIEG4T[HKEUV-45C/'G+BC_SB?P[V_A3\_9&X:[M
M00"^UL_V%&6A#T>=TN?D&>$.5#,+6B0&#8>#,GU5*XPA;F#0"3WR"_VO,6A^
M]^Z)7 *EB4P?,:ZII$H#:=Q21E7+U@8YH4?]3NETBHW\77D+(<TBUA=91J3/
MY!2IDWS45O+]NE&5]'$9;=6D":W3?.37_)9E4M/I8UR&6S5J@NO4'[V^V3=P
M?^>WO-L(<*?M.W8*CMNV[XU$X&I;7E[C-28-G0)V*H[]C7O+-9Y%]:+UF9RB
M+9S&^+>"7UPT!VVEQ@3\\;38$&[>S@37DBQTV]_VV&T"..ITM3GIQFT/99I7
M6_6TI<)?U:1IM3GMQVVUW[_:7M9_K\DI6J?_V*__[105UW3T9;!5$]1P,(>=
M_N/7]_R_7QMMF@WLQ!]WVOI'3O&CMJU_\\&JKZ//#E9?W?1';LN(.CGQB5[>
M-KPFIVC=MA'YMXU":5Q4:\./&%6.I6'EY+IJTR]!#@K?5NR'K1LBUXPK$-.5
M\0DOAV:^\O"MZ'"CQ3;]W/(@M!9)>KFAQ"3:&ICW*R'T\<9^P<F_V$W_!U!+
M P04    " "7@$)2OH/^1S $  #'#P  &0   'AL+W=O<FMS:&5E=',O<VAE
M970U-2YX;6S-5UM/ZS@0_BM6M0\@(7)I:0MJ*]'+T2(=CA"(LP^K?7#3:6.1
MV#FVT\**'[]C)TU2DH8>:1_@@=K.S.?Y9L8>SV@GY(L* 31YC2.NQIU0Z^3&
M<5000DS5I4B XY>UD#'5.)4;1R42Z,HJQ9'CNV[?B2GCG<G(KCW(R4BD.F(<
M'B11:1Q3^3:%2.S&':^S7WADFU";!6<R2N@&GD _)P\29TZ!LF(Q<,4$)Q+6
MX\ZM=[/P!D;!2OQDL%.5,3%4ED*\F,G=:MQQC4400: -!,6?+<P@B@P2VO$K
M!^T4>QK%ZGB/_LV21S)+JF FHK_82H?CSK!#5K"F::0?Q>Y/R E=&;Q 1,K^
M)[M<UNV0(%5:Q+DR6A SGOW2U]P1%87N]1$%/U?P/RCXWA&%;J[0/56AEROT
M3E6XRA4L=2?C;ATWIYI.1E+LB#32B&8&UOM6&_W%N$F4)RWQ*T,]/?E&F20_
M:90"N0>J4@F8!5J1LSEHRB)U/G(T;F.$G2"'G&:0_A'(+KD77(>*+/@*5@WZ
M\W;]ZQ9]!^D5'/T]QZG?"CB'X))TO0OBN[[[_#0G9W^<,[X%I0W7)PA2R?1;
M@Z&S=MPG2!#7S7 #$2>4-Z',?]^Z!I1%.\H]E9^@'+BN6Z1'U\)V/TV/"W*K
M%&!F4+XBWQE=LHAI!FJ?-BN"Q_[1^%(ROK%2/P27Q<*4*J;(W]]Q W*G(5;_
MM)C7*\SK6?-Z1\R[*Z*H".,$?J482**RB*)Q3<F;(?8MHKE&MQ._/W#MW\C9
M5N-VLN2B+NGE@J7D <&K@N!5*\$?:;P$2<2:9/EE'(Y$=R$+PCI=L@,)*(E>
MD1HCPK@6)$F7$0N,?HP1P@LE>"'OY'BZSC*+KBIDNLTD^@6)_HDD6"5>.J2:
MP&L"D@$/T%HM*5<TJQ_VHP2%U[WE08*0\@V8D5@JD%NZC( DD@5@<'4H%%0=
M\4Y..N#3?HVKW\QU4' =M')]QI2G$?L7K=Y@F29GD5#JW)R-/%H5%S09-*CG
MW+ Q.0<URX<?<_. P+ @,&PE4![A=V)/_S8[_8PGJ587)((M1,1O.;S7Q4[7
M7_%N\=RR-+JMKIA1*=_LAK%(N3:)%I7&-19&MQ:5@>]^O GR(GBZ[*))ME>3
M/:19>0%XK3072C-\<:&7UT6\U2EDO7H*NL?(GBZ[:) =##\AZY=D_?\AO;VV
M_"EKI_<EBZ=75D_OM\HGU@=XP\>E?,$&99WR57/8>[7P>'ZW.>HGBRX:1/UZ
M@ASR+(NH]TD5K?BRS7%E0?/Z7S*R917RVLM0U9)X;PF6U/*$-X:V7GUJ(?U4
M9-$JDO%Q*@U+#')C.T6%CQ*\9K-W?;%:=*.WM@?[L#[U;F993UG"9"TN/H@W
MC"L\T&N$="\'F"(RZQJSB1:);8N60F.398<A=MH@C0!^7PNA]Q.S0=&[3_X#
M4$L#!!0    ( )> 0E)(V?97C0<  ,8B   9    >&PO=V]R:W-H965T<R]S
M:&5E=#4V+GAM;+5:;6_;-A#^*X2Q#1W0VGKS6Y<$2)WFI4U:HVFW#\,PT!)M
M$Y5$E:3B!-B/WY%23,N2:*&M^Z&A;-[Q.=[=<T?*)QO&OXHU(1(])G$J3GMK
M*;/7@X$(UR3!HL\RDL(W2\83+.&1KP8BXP1'6BB)!Y[CC 8)IFGO[$1_-N=G
M)RR7,4W)G".1)PGF3V](S#:G/;?W_,$GNEI+]<'@["3#*W)/Y)=LSN%IL-42
MT82D@K(4<;(\[9V[KV^#B1+0,_ZD9"-VQDB9LF#LJWJXB4Y[CD)$8A)*I0+#
MGP<R(W&L- &.;Z72WG9-);@[?M9^J8T'8Q98D!F+_Z*17)_V)CT4D27.8_F)
M;:Y):=!0Z0M9+/3_:%/.=7HHS(5D22D,"!*:%G_Q8[D1.P)>FX!7"GC[ I,6
M ;\4\/<$ K]%("@%@JX"PU)@V-6&42DPVA=P6P3&I<"XZPJ34F"R+S!N$9B6
M M.ND%SGV7-.5T^X6V?7O-TJ\NQN5_M[4 26CLH++/'9"6<;Q-5\T*<&.K2U
M/ 0C3546WDL.WU*0DV<SEB140EI)@7 :H1E+)4U7\(QN*5[0F$I*!'J%/F#.
ML<H8].*"2$QC\?O)0 ("I6<0EJN]*5;S6E:[PT_(';]$GN/Z7^XOT(M?FI3,
M[$H^AK*/?%=I\9Q22\B2#*=/#<HN[,HN2%A3)B26Y%Q*QE/R%$**ZP\:=+\]
MHN[+0SO)C>Z0Y:EL,O[*KN0=3OO(#9Z5M&WA=6<SW6DKE!N[DO-\!5#\0LD2
M/_Z;YLF"<!@UZ'IW0%>F]L;1NB;M8?:^BUF%EC%-'\!3*DTN\S1J4';;09DW
M/:QL /F[36)OF\2>UNZW:+]E0IC,#57"_GT+<]"-)(GXQ[*"OUW!URL$+2M\
MT-Y ;(FT@]4*<HTE6M*81"B,,4T$^@^U>O^Z4#_4ZE5G\'#FG0P>&A %6T2!
M%='Y:L7)"G(':"O-<0Q]! _7F*\(@N(>TQ Z!8"6X#1?0JG/.>$%PT542$X7
M.:2@4 :QC#(:B:8P*Q",=D"[3OFO&?QP"WYH!3_GY)7$C]"#A!RP-]'6L+;V
M<'_I@H,Z3*Q@'&TQCNP;O)2$'T(YJKG5'S>B[#"Q@G*\13FV!R96S1RX'[94
MA)QFNK?[J'T*%4S2E9Y@28')=J7)D9)LNEUAVBDJR&.F@E= EQM#@$=(,@2$
M01/]$&^-@F%1H1OKWK2VXY-Z]!;.Z32U8I+KF/["Z1A&/\>L<KG=>!^-6^SJ
M-K=JV$[CY!XY\ES#[^ZQ"-XU#._:*1XZP0QX7#6"!:OC%3P)"41/$-0J\(=B
M>&A9&MW20/#3ND,.S*I"-Z7 M=>"SSPGZ)K@6*[1;$TYR[@ZW87H)@W[+Q&<
M97'<1P]]=!>^)T* FV:,9XQK!Y7?V_;0T+H[/):?#"V[=EXVI1B:(YU-ZK -
M"R*::E]!-1:J&)LNJK$=JS/R-)BVN<+0L7N CVOH0@*'AJC TPAD7 ,23,:C
M:0L20]?NY.A! :CO8&^3/+&YSO"[.SU2>'B&;ST[W][#>4+U-D\HP@E>P1*"
MY:NU1!FXY8&RN(&5BJ.;5V?+85MN>H8F/3M-_BPWX,<#;O!VNN5CL:EGV-2S
ML^D/N,&O=YWM?C <Z=DY<L[BIQ7L[ML<7$ P#+[EBM(_9K#9,D_5^ X+*-9(
MG4J:'%.(HFL61[!S ETEBVOT&TZR/V W^^C]%3ZW[9UA4>]8+.H9%O6ZLJ@Y
MC:$E&-Y\L#EX_GOOU?DTJ%:_VX8I+8<@S_"M9^?;&4YQA&U;8@C3.U:#ZQD&
M].PM[H\U&5Z]4?7W.@SKE.K1UU"J;Z?4.4E5P-N.T88.??=81W7#;[YWQ$TN
ME5<"N=;('9A4!;YSR=#UED'?B@G5T6S6-%RKBP4N-60XQ',"+*I= F:TW9]=
M^/5>TY_LFV&=4[7",*UO9UIC!2[O^1"XFG <E]RRQ@]DGV J]X*-Y@1U\ACM
MFV.=4S7'L+%OOZO8N_H!8]@#X:DFS"+,Z')IO?RY+%?H0'R^(7#?3N#S;03\
M^$',-W3KCX^5OH:'?7OCNK/A.MZ+5U80+$O&408 Z"(FNNU/]1F:05ISM"21
M"K$B4X0MOR<'2=0ZI6J587[?SOSG&\PCE.$GK-!#$07,&?033-W2+3E.B'I=
MU_0VH%2\VQ!-'/LI/C#<'AQHEXF4,='!C#5"#+X-:?9\0;$ K*(8PHZ3B*H;
M1\6CQ;4A@G@35* 7T-:%H*3Q=<8!"%.G[SB_6D(G,-4EL#?;)BD.]@6!*2?!
ML=KEP#!_<,S+AZ"!QO="VCJE"GKG!OI 2[W=[<]K3@BZ5;?/@/E+_[Z/YFO,
M$QR2',()TO)B]];Y9W!68 @\.%8['1@V#KJVTW&Y"5G5_LJM.R03CE@F=;*]
MBBC4$_U6'_A@!4P@6NE!5YFVUU2SH.&2N1H&5]8I5=M-30CL+?CW,UNI>)?9
M//<0M9DZ$MCKR)QPRB*DJG79114,MV%Y'"EB^R[(]C7="7HBF(NFH!KLO*56
MO_"X@TB!'$<Q68(NIS\&K_#B1Q/%@V29?G&]8- 7)7JX)ABPJ@GP_9(Q^?R@
MWH5O?[IR]C]02P,$%     @ EX!"4A7D=1)9!   !!$  !D   !X;"]W;W)K
M<VAE971S+W-H965T-3<N>&ULO5AM;]LV$/XKA%%@";!9HFSYI; -)+';).BZ
M(%ZW#\,^T!(=$9%$A:3L=MB/WU&2)5F6& ]=Y@^V2-WSW OOCJ1G>RZ>94"I
M0E^C,);S7J!4\MZRI!?0B,@^3V@,;[9<1$3!4#Q9,A&4^!DH"BW'MD=61%C<
M6\RRN0>QF/%4A2RF#P+)-(J(^'9-0[Z?]W#O,/'(G@*E)ZS%+"%/=$W5E^1!
MP,@J67P6T5@R'B-!M_/>%7Y_C\<:D$G\QNA>UIZ1=F7#^;,>W/GSGJTMHB'U
ME*8@\+.C-S0,-1/8\5*0]DJ=&EA_/K!_R)P'9S9$TAL>_LY\%<Q[DQ[RZ9:D
MH7KD^UM:..1J/H^',OM&^T+6[B$OE8I'!1@LB%B<_Y*O12!J &?8 7 *@',N
M8%  !@W $'< A@5@V  ,QAT MP"X39.ZG!X5@-&Y/HP+P+AIDML!F!2 R;D:
MI@5@V@1T10G;AY6SLPS*ESS+ER519#$3?(^$E@<^_9 E78:'-&&QKH^U$O"6
M 4XMUHI[SP$/?2KD#VCUDC+U#5TLZ99Y3%VBG]!G(@31.:QG%6&AO)Q9"C1K
MO.456JYS+4Z'EOLT["-G^B-R;,=^ARPD R*H;"&Z.8=H<@;1TDRTI%X?#7!.
M]&6]1!?O+G=<T8JSDWEE9E[3!)CM(^8S6#^\YGA<L7:2?#S;:3PU1N_V>Z/7
MPGGW7QEW_TJH2%P:APOCCEDL*)*R4IRR4IR,=M!!>^5YT-6A%JB/UMHT]$B3
M5'@!=&>)_O@$XNA.T4C^:5 V*)4-,F7##F6?TVA#!>);I,,J40*#+!YZRN-1
M!%N+U*6KWT1,::-@*A$\X9*$ (#0T5A/*YY+%D6.+C3C)?H[8VXKG-PR-[-,
M;Z^[!9Y9NWIRF"2.W!V6[@Z-[B[9CODT]B5L;5X(;OJ9QP=',\<O6(Q\'L+;
M6CBT'\9<N<X5CVNVVOVA<^S03:M0P^OE.4P?SV&Z/17"?<<]%KIK%>J(LUO&
MV37&^6H'"?Q$(3N8EZ52'C<XZ!PRV<_BG$K_7\1XY9Z:ZH*Q@W9C1Z6Q([.Q
MJ0JX8'^!323B::P0V<'^0S8A17 P1-M4I9 7HE:%8&A;1N=Z1G7[[,.GL31G
MB1ZY,R[=&1O=6:<;25]2*$JTVL&WH4M,2LK)V[>D::EL:EZ.!+K+#C2QV(.3
MN*2ZLZB (E*M4UZIU8H<%JY]7>ZG)\%V7@DVMJMSC6TVUQ ;0S1P[>"$WS[X
MN-I]L&/TYZ;>])OUFI>F+E3#^<(YZ=I=0:YV*6S>IGZ!:QKZF8AGN,@U8X!^
M%226)+L&25,(JDT"#_^'B%>]$IN;Y?=&?%GP'^V3;DO36;4)3DQ54+50;.ZA
MZ]/^WM$C\6GG<P:XK4>NVD1'4V/95DT2F[ODV^Q0RT)K<XO"3L->JW:3TO\/
M0&X_L5BBD&X!:/?'L$8BOW+G \63['*UX0HN:]EC0 D<M+0 O-]R.&45 WU?
M*__X6/P#4$L#!!0    ( )> 0E)AH@S!: D  )HX   9    >&PO=V]R:W-H
M965T<R]S:&5E=#4X+GAM;,5;;5/C.!+^*ZK<UMY012:Q_)*$ ZH@-@PSS!XU
MS.Q]N+H/)E82W_@E:RLPL[4__EJVB1Q)E@+DX LDSM,M=;O5_;0L'S_DQ?=R
M20A%/](D*T]Z2TI71X-!.5N2-"S?YRN2P2_SO$A#"E^+Q:!<%22,*J$T&>#A
MT!ND89SU3H^K:S?%Z7&^IDF<D9L"E>LT#8N?YR3)'TYZ5N_QPI=XL:3LPN#T
M>!4NR"VAWU8W!7P;;+1$<4JR,LXS5)#Y2>_,.OKD8290(7Z/R4/9^HR8*7=Y
M_IU]N8I.>D,V(Y*0&64J0OAW3Z8D29@FF,<?C=+>9DPFV/[\J/VB,AZ,N0M+
M,LV3?\4179[TQCT4D7FX3NB7_.$#:0QRF;Y9GI357_308(<]-%N7-$\;89A!
M&F?U__!'XXB6 +8Z!' C@'<5L!L!>U<!IQ%P=A5P&P%W5P&O$?!V%1@U J-=
M!<:-P'A7@4DC,-E5P!H^WKGASB*;FUT'71TE58CY(0U/CXO\ 14,#_K8ARI.
M*WF(K#AC2^J6%O!K#'+T]);FL^_+/(E(4?X=!7^L8_H3O?/)/)[%] #UT2TL
MXFB=$)3/T3_IDA1HFJ>P>I=L6=T3=)7-\I2@=]=Y61X<HM\@"P#R:_B#::%A
MG)0'Z->_C6W/^0>*,_0Y3A)82N4A7+0\6[CV2_OK\8""@6R:@UECS'EM#.XP
MQD:?\XPN2Q1D$8D4\KY>?J*1'X!C-][%C]X]QUJ%/IF]1[9UB/ 0#[_=^NC=
M+P>*:4UWUF)-NK7X>YE+L)>Y7#QA+L&W+^A=$R(J79=/T'5Y?L-TL<A2J?J@
M5_4Y+':?UM43'&72]?$)N@PF?M*KNB4K4#4TJ=J*=GN32^Q*M]VA^VPV6Z?K
M)*0D,J<*].]K$$=7E*3E?S2#.YO!G6IPIV/P>L#9UH!Q,V!2#7A'@($0X &S
M)"S+&#)<2+OR3#V65XW%6,G]J3L\'MRWUZP,<=QMB"]#)H*60(:,O0UDRQ'N
MQA&NUA%?-O;!;:#YHQ-*"O<%N! ]1%F=HYL?**1J\@,H6DE4GJ@'<UL3]":"
M)Q00P1$R8F0)CI AD[':$=[&$=[+(D)EKB=-P[)$>V6,*UCC*]1XHL4*S-A1
MFSS:F#S2F@PL$SAD!M2A*$@V^XEH$69E$M;L-?HO, H6 E!IX:ZKS!])<Q+#
MWHCPC8A A]BR>[RQ>_S"F.^P=VRTUXCPC8A A]BR=[*Q=Z*U]UL&[5,2_PG6
M+J!M*A]3'-SE65@NT1PZ)02\;4%*%!9Q&6<+%*T+]F]%BCB/.ATRD::*!8?(
M"%MPB(P0\D$@(_HCM4>L(2>R0ZU/&/.$!FT-]H8)8OY 81:A%9@++20I[N,9
M@6Q04M$CD"9,7FF&UL6)&>*;(8$"8G4XIL7P+:UCSM*\H/&?=1* O,^=](X%
MSX'.5]V9HAE4%RD*B.02&2*F2:V6;9=@[A*\ESQ9>25G=:3;#]@<&D:(;X8$
M6LBV'SAAL^PGK!D6#74F(9!+0DJ+^&Y-PSMH_B"G%B0B)*V^93GDUXP6.31J
ML(#BC)*"E%3I'ELNEJ)[9$@?B_Z1,;;H'X6:KK7#2:6E9Y6/@3)]#)2OK4 Y
M:Q=4WOAJR*S%29SEOCZ7MCAULE[(G9[$IBT%U7$],0P4H*'(JQ0@VY,B04'0
MNLH+9U:6GEKMF59;,@=R1J)'S%QK!S6!5LVV-SC?LO2$ZUG<VI)Y$![:HM$R
M2!$&,LBQI(0I@SK#@!,O2\^\VNN?Y\N]94L%_9*JB8RQI'2I(%B.5%@5H(Z$
MB3D+PWH6UF*FES4SO6[J"3B,Y<BK[)[421-]J CJCJD3<[Z#K==/G9AS"ZSG
M%OM-G5BN^OV)F#I5('<LQ(0*A+'0VP9*5$=0<)J!]31CS[D3RY5>7"1FB&^&
M!%K(MB\XH\ OW*=26NSL$@4*D!P%"I B"E2H#LLYI<'ZC2EUT]JD!A8 ,4\-
MS^I=L;R'9(OE18'!8G518,92:,B8KMS)21?6DZYG[V)@F?!("\((\<V00 O9
MMIH3*ZPG5I>M*CHO\K0C%"!;YD4$CGF(Z1(D\LYUI/20F4HI()WED/,DK.=)
MVG(X95LU%VRKYFF5D),5/'G]2FAS+F#KN<!^*Z$M;XWT1>(S58#$#*C28XL;
M5 I0*Y5L^X,3$UN_$;/G,F@;MU>F9HAOA@1:R+8O.$NR7\B2E!8KR(D< C)(
M"@&%'CD$9%!G"+2>D+V4"76D>-O,><P0WPP)M)!MJSGGL?6<9Y>M6=/.K+PT
M[DA&YC'5I2K.3>PWV&ZQ>>6W7W.[Q3;3 3/$-T,"!:3?M40X'[#U?*![NYIY
MXE"YH0_!5.W@QK7071(O*OF=,^KV7'EYM\=O$#:\OMOZS8@]AXUB/T!*KF:,
MK\!(@:.#;#_^YVS#T;.-Y^SI/R<Z'%[OG3?8B'!XB75><R/"D<NA&!P*2%\\
M":#"".4Y4& ZB+C#"Z^C+[S399BQ-B)F!T%I7%35ME^0^NXTI02MDE"T?GN\
MUFD4YPWN/:]GSJL> G$47;,CWGU%URS>?+.:0('I.@CB\/KJ_!^.@CAR=9.-
M-M=1!<02N:8",^DX!N3P0NJ\](E%!]=TY$Y8/ *C@(BG ,Q: I46M\-L7I,=
M?<L=K(L<^23+TSBKEM]O.86%_Q?Z2HH47>=AIEMAO/8Z;]!;N[S:N?IJ=YUG
MBSYE%D7D#E;RFL)]S2+&FO]Z/&^K.K38J+5P.QQ'PX[JZ_):Y^I[V_,"N%>Y
M1#?Y&LKK+<RL>MCQW/O@\BKGXC>X#[RNN/JZ8K@/[&BEZDAKH]6RVD^PQ".&
M'W="?3*AMBWC%<PU-VW"PYK:JA<M,+=UC/$-6C*7EPQ77S*>N< N&K7="ZR"
M?3#"MJ?-D[ZK3_H^M,OW(7M-I82)ET"(*P<"SZLW4J&=FL$2I6"'SDT\V[IO
MT &Y/ N[^@[H53:/7473,Q:9@ KD"@7/5X&P^'0[4*"ZCL+R>N'IZ\43X@+B
M6[WV-7?,XX7">X.FR./EPM,W16T_K$N80ZQ^]G0H/J-:%/!!>6*X'K!]A+LO
MG@2?JD#BDWU?!;*&8G>D1(G]T:#U1E!*BD7UTEJ)JEM\4ATEWUS=O!AW5KT.
M)EP_MXZFEN*Z;QT%JNL7UM&EZOJ5=?2Q?F.)3Z=^:^]S6"R8IQ,RAZD-WX\@
M[HOZ1;CZ"\U7U?M+=SFE>5I]7)(P(@4#P._S'.I/\X4-L'D=\?1_4$L#!!0
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MBY8+7\E5DF5)MC)K21IG"XEEULY$6)DHE]6'BW T-5%[.)PN1!1.65,TAZ*
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M?'<2?_=&J_OJJ/FMTEIMJI=K&2]E7@K,]W=*Z1]OR@OL_S_$Q?\ 4$L#!!0
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M@>=/<KZ7ZF<D5\1.W0N!%PO>M<0$6D!71@R#%:(^O$:4+"4Q63%BA*XM/#9
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MR]T.O:@Z1D2>Q]5LOBKF,^*^%8_+Q6RR<1O%QGU\GZ\\R 2 3'J$_"OQ(%,
M,NT%\FZRG*RF<^)!9@!DUB-D$,D<@,S[?-RI!SD"($=]0F8>Y$< \F.?D+D'
M^0F _(0+6?"]Y.Y8*BV9E*5JI'6S,UDKP4O.C ?Y&8#\C NYD*_,V/8@PB69
M'JC<,_+ J+"'DNI@,A]"L_D0%_.!B8JX7Y*"B@ *5 RR8YY<Y'13VD:[Y_J>
M+.HCY;H+)945>?(Q(<G$R)99R%+5C&SHCZ#3Q9!38F2I/+&*N9.XBY*5<GS2
MMBE1.SP6TJ4S/B9DE1A9*W.JI8,RY&:IC'E'UB['F:JZ5I(4!QI@0EZ)D<7R
M3:GJC0O1]3L70#>(6P(R,<:E?>]]3,@L,;):9FQ[&AKW7%)9MD][TN:SW(;3
M80R9)496RYI)X]K('9-LQVW !<DD1K;) ZOVOX\89) 862'W;M8CSU0TC'QG
MU#2:M3_P\1)('0FR.MKQRCO#F:[S357GX7::7G*Z]3$AF23(,BFL*E\.2E1,
MFS_(_._&+3/)S<SUP9+;=SXEN&!!=DG!]J=(JAVY:PR7S 0/&G)*@NP4,-\*
MU@ )Y)0$V2E!*D-N-JT$3?" (94DR"H!<YHPB)!*$F25@/E#B G))$&6"9@_
MA)B06Q)DMX#Y0X@)B29!%@V8/Y ;OUP""2=%7ZM<FOK:*$\AV:2]RL:OZ:20
M;=(>;',UEF!YK%?M^%6=%-).BJP=<*$?UAHA_Z3(_@GM^(&LJ-:TK7FWW=-2
M'Q/R3XKLGTO,TTJKFYPNDLH4\D^*[!_8YD'?A/R3(OL'QO1KCBGDGQ39/S"F
M7W7,(/]DR/[QZSVG4<-%,%UFD'HR]*(9E+GY73*#U),AJP?&]+MD!LDG0Y8/
MG& &T03_G4&6#YQ@!IB0?+(^ZVCA0X?DDR'+!\8,YB%(/AFR?.!T_8./"<DG
M0Y8/B!DD1ADDGZS/Q4\PA')(/CFR?&!,?PCED(5R9 M=5GDO,DT?$[)0CFRA
M*TM)']3'A"R4(UOH*N:,:?[:<?J8D(5R9 O]IE!]SI%\3/ M >S7!*""=?@N
M V2A'-E"8 TAQ(0LE"-;",8,YDW(0CGVRP(@9C!O0A;*D2UTO2)S98TQ@B0T
MZB0T.+^55KF[E*Q:N2L8UUY24:XU:3]._YUG>?O_UJX18NK:'N52T>K\DMOY
M!;VO_P!02P,$%     @ EX!"4I@;6I[[ 0  RR,  !H   !X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<\W:2VZC0!2%X:U8+"#E^R))*\ZH)YE&V0!RR@_%
M-HBBE63W;3D#YZ >]"2J,T(%XO*//A#P\)P/W;3O3V6W'\KBXW@XE56SFZ;A
M5TIEO<O'KMST0SZ=CVSZ\=A-Y^6X34.W?NNV.>ERV:;Q^XSF\>'[S,7+YY#_
M9V*_V>S7^7>__G/,I^D?@]-[/[Z57<Y3LWCIQFV>5DWZ.%QWEW39R,UY<K-X
M>ETUX].K-*EVD$*0U@\R"++Z00Y!7C\H("CJ![40U-8/NH6@V_I!=Q!T5S_H
M'H+NZP?)$F5<$B3-L";06I!K(?!:$&PA$%N0;"$P6Q!M(5!;D&TA<%L0;B&0
M6Y!N(;!;$&\AT%M1;R706U%O)=!;9P_;!'HKZJT$>BOJK01Z*^JM!'HKZJT$
M>BOJK01Z*^JM!'HKZJT$>AOJ;01Z&^IM!'H;ZFT$>MOL90F!WH9Z&X'>AGH;
M@=Z&>AN!WH9Z&X'>AGH;@=Z&>AN!WHYZ.X'>CGH[@=Z.>CN!WHYZ.X'>/GO9
M3:"WH]Y.H+>CWDZ@MZ/>3J"WH]Y.H+>CWDZ@=Z#>0:!WH-Y!H'>@WD&@=Z#>
M0:!WH-Y!H'?,/E82Z!VH=Q#H':AW$.@=J'<0Z!VH=Q#HW:+>[4_J7:;/0R[7
MGJ\U7O\GJ9[.Y^;KY2_+KYUXOV@O."?X=^?Q+U!+ P04    " "7@$)2=-+&
M8MX!  !:(P  $P   %M#;VYT96YT7U1Y<&5S72YX;6S-VEU/PC 4!N"_0G9K
M6.D7?@2X46_5"_] W0ZPL*U-6Q#^O=T $XT2#2:^-UNVMN<]:Y/G:I/GG:,P
MV#9U&Z;9,D9WPU@HEM28D%M';1J96]^8F![]@CE3K,R"F!B-QJRP;:0V#F-7
M(YM-[FANUG4<W&_3ZU#9=IIYJD,VN-U/[+*FF7&NK@H3TSC;M.6GE.$A(4\K
M^SEA6;EPD29D[,N$;N3[@,.ZQPUY7Y4T>#(^/I@FS6+;FH6XJRGDITM\T:.=
MSZN"2ENLF[0D#\Z3*<.2*#9UOB]Z<3HYIAVF_96?G=^7.1689CYYZT(Z,4^_
MCSL>2;=ZZ%(A\K$Z_8GOB:GTV=]'W6F75/XP.VWOJ_6K_CP"ZV_G[_'',WZO
M_\L^!$@?$J0/!=*'!NEC#-+')4@?5R!]7(/TP4<HC:"(RE%(Y2BF<A14.8JJ
M'(55CN(J1X&5H\@J4&05*+(*%%D%BJP"15:!(JM D56@R"I09!4HLDH4626*
MK!)%5HDBJT215:+(*E%DE2BR2A19)8JL"D56A2*K0I%5H<BJ4&15*+(J%%D5
MBJP*15:%(JM&D56CR*I19-4HLFH4636*K!I%5HTBJT:15:/(.OY/65^L7?WU
MWQ[=/6],U1[S6?]+S>P-4$L! A0#%     @ EX!"4@=!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "7
M@$)21FTQ?>X    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " "7@$)2F5R<(Q &  "<)P  $P
M@ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( )> 0E)T6!B9
M*P8  * ?   8              " @0T(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " "7@$)2IM!>FT,'  " (0  &
M@(%N#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ EX!"
M4A9D:N8F!   +PX  !@              ("!YQ4  'AL+W=O<FMS:&5E=',O
M<VAE970S+GAM;%!+ 0(4 Q0    ( )> 0E(T)/":W@8   \=   8
M      " @4,:  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M" "7@$)20-O&F.\"  #."0  &               @(%7(0  >&PO=V]R:W-H
M965T<R]S:&5E=#4N>&UL4$L! A0#%     @ EX!"4LG%AHY4#   ]$P  !@
M             ("!?"0  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4
M Q0    ( )> 0E)$.WFCEP(  !<'   8              " @08Q  !X;"]W
M;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "7@$)2'!1U714(  #4
M(0  &               @('3,P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL
M4$L! A0#%     @ EX!"4HSD3VBM$   4#   !@              ("!'CP
M 'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( )> 0E*\++.T
ML@D   $>   9              " @0%-  !X;"]W;W)K<VAE971S+W-H965T
M,3 N>&UL4$L! A0#%     @ EX!"4K(BC)Z)"0  0QH  !D
M ("!ZE8  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " "7
M@$)2!UF'H> +  #]+P  &0              @(&J8   >&PO=V]R:W-H965T
M<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( )> 0E+Q$LS>B0@  #@7   9
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M970Q-RYX;6Q02P$"% ,4    " "7@$)2]NI#.@$&  !I#P  &0
M    @('TE   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (
M )> 0E(Q)ORI0@X  /0X   9              " @2R;  !X;"]W;W)K<VAE
M971S+W-H965T,3DN>&UL4$L! A0#%     @ EX!"4I%F/&EE"@  S"   !D
M             ("!I:D  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"
M% ,4    " "7@$)2MU$RVL8<  #940  &0              @(%!M   >&PO
M=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( )> 0E+L7Z%3U@P
M !4Q   9              " @3[1  !X;"]W;W)K<VAE971S+W-H965T,C(N
M>&UL4$L! A0#%     @ EX!"4D-$(O &#@  ;RL  !D              ("!
M2]X  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "7@$)2
MW=53C2T0  ##,   &0              @(&([   >&PO=V]R:W-H965T<R]S
M:&5E=#(T+GAM;%!+ 0(4 Q0    ( )> 0E*G?\VI= ,  '0'   9
M      " @>S\  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%
M  @ EX!"4LG+%,!'!@  V1H  !D              ("!EP ! 'AL+W=O<FMS
M:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " "7@$)2%.*$O7P#  !7#
M&0              @($5!P$ >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+
M 0(4 Q0    ( )> 0E(L/]+4X@,  &X)   9              " @<@* 0!X
M;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ EX!"4MU$2QU6
M!   UPD  !D              ("!X0X! 'AL+W=O<FMS:&5E=',O<VAE970R
M.2YX;6Q02P$"% ,4    " "7@$)2="5NA]P#  "["   &0
M@(%N$P$ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( )>
M0E+Z=R=:=P,  '@(   9              " @8$7 0!X;"]W;W)K<VAE971S
M+W-H965T,S$N>&UL4$L! A0#%     @ EX!"4OI'^IOA"0  @BD  !D
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M=#,V+GAM;%!+ 0(4 Q0    ( )> 0E)33&DOE@,  '\-   9
M  " @6(_ 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @
MEX!"4J/+CP'3!0  H1\  !D              ("!+T,! 'AL+W=O<FMS:&5E
M=',O<VAE970S."YX;6Q02P$"% ,4    " "7@$)2O?8L(/0%  #Q(0  &0
M            @($Y20$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4
M Q0    ( )> 0E)7)("%208  -<C   9              " @61/ 0!X;"]W
M;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ EX!"4BF'4?82!0
M-Q,  !D              ("!Y%4! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX
M;6Q02P$"% ,4    " "7@$)2&O'J^4H&   %(   &0              @($M
M6P$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( )> 0E+X
M')BH^P4  %<B   9              " @:YA 0!X;"]W;W)K<VAE971S+W-H
M965T-#,N>&UL4$L! A0#%     @ EX!"4@ (K=(=!0  !A8  !D
M     ("!X&<! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )> 0E+?&6D>J0,  ,,-   9              "
M@2B$ 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ EX!"
M4DO*) /@ P  +A   !D              ("!"(@! 'AL+W=O<FMS:&5E=',O
M<VAE970U,"YX;6Q02P$"% ,4    " "7@$)24B?>AN0"   ["   &0
M        @($?C $ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0
M   ( )> 0E(8R7$+"@4  .<3   9              " @3J/ 0!X;"]W;W)K
M<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ EX!"4@6SSN\G!P  *B8
M !D              ("!>Y0! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q0
M2P$"% ,4    " "7@$)2) =+\^($  "]&P  &0              @('9FP$
M>&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( )> 0E*^@_Y'
M, 0  ,</   9              " @?*@ 0!X;"]W;W)K<VAE971S+W-H965T
M-34N>&UL4$L! A0#%     @ EX!"4DC9]E>-!P  QB(  !D
M ("!6:4! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " "7
M@$)2%>1U$ED$   $$0  &0              @($=K0$ >&PO=V]R:W-H965T
M<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( )> 0E)AH@S!: D  )HX   9
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M 0!X;"]S='EL97,N>&UL4$L! A0#%     @ EX!"4I>*NQS     $P(   L
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64$L%!@    !$ $0 DQ(  "'= 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>464</ContextCount>
  <ElementCount>426</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>124</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>23</UnitCount>
  <MyReports>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104102 - Disclosure - Investment in Change Healthcare Joint Venture</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture</Role>
      <ShortName>Investment in Change Healthcare Joint Venture</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2106103 - Disclosure - Held for Sale</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSale</Role>
      <ShortName>Held for Sale</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2110104 - Disclosure - Restructuring, Impairment and Related Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges</Role>
      <ShortName>Restructuring, Impairment and Related Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2115105 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2117106 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2121107 - Disclosure - Earnings (Loss) Per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShare</Role>
      <ShortName>Earnings (Loss) Per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2124108 - Disclosure - Goodwill and Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNet</Role>
      <ShortName>Goodwill and Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2129109 - Disclosure - Debt and Financing Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivities</Role>
      <ShortName>Debt and Financing Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2135110 - Disclosure - Pension Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefits</Role>
      <ShortName>Pension Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2137111 - Disclosure - Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivities</Role>
      <ShortName>Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2141112 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2143113 - Disclosure - Commitments and Contingent Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilities</Role>
      <ShortName>Commitments and Contingent Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2145114 - Disclosure - Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficit</Role>
      <ShortName>Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2150115 - Disclosure - Segments of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusiness</Role>
      <ShortName>Segments of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - Held for Sale (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleTables</Role>
      <ShortName>Held for Sale (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/HeldforSale</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - Restructuring, Impairment and Related Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables</Role>
      <ShortName>Restructuring, Impairment and Related Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2318303 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2322304 - Disclosure - Earnings (Loss) Per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShareTables</Role>
      <ShortName>Earnings (Loss) Per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/EarningsLossPerCommonShare</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2325305 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables</Role>
      <ShortName>Goodwill and Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/GoodwillandIntangibleAssetsNet</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2330306 - Disclosure - Debt and Financing Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesTables</Role>
      <ShortName>Debt and Financing Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/DebtandFinancingActivities</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2338307 - Disclosure - Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesTables</Role>
      <ShortName>Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/HedgingActivities</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2346308 - Disclosure - Stockholders' Equity (Deficit) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitTables</Role>
      <ShortName>Stockholders' Equity (Deficit) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficit</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2351309 - Disclosure - Segments of Business (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessTables</Role>
      <ShortName>Segments of Business (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SegmentsofBusiness</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2403401 - Disclosure - Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Investment in Change Healthcare Joint Venture (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails</Role>
      <ShortName>Investment in Change Healthcare Joint Venture (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Held for Sale - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleNarrativeDetails</Role>
      <ShortName>Held for Sale - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails</Role>
      <ShortName>Held for Sale - Assets and Liabilities Held for Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Restructuring, Impairment and Related Charges - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails</Role>
      <ShortName>Restructuring, Impairment and Related Charges - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - Restructuring, Impairment and Related Charges - Summary of Restructuring Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails</Role>
      <ShortName>Restructuring, Impairment and Related Charges - Summary of Restructuring Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2414407 - Disclosure - Restructuring, Impairment and Related Charges - Summary of Restructuring Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails</Role>
      <ShortName>Restructuring, Impairment and Related Charges - Summary of Restructuring Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/IncomeTaxes</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2419409 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2420410 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2423411 - Disclosure - Earnings (Loss) Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShareDetails</Role>
      <ShortName>Earnings (Loss) Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/EarningsLossPerCommonShareTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2426412 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2427413 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2428414 - Disclosure - Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2431415 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails</Role>
      <ShortName>Debt and Financing Activities - Schedule of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2432416 - Disclosure - Debt and Financing Activities - Long-Term Debt Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails</Role>
      <ShortName>Debt and Financing Activities - Long-Term Debt Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2433417 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails</Role>
      <ShortName>Debt and Financing Activities - Revolving Credit Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2434418 - Disclosure - Debt and Financing Activities - Commercial Paper (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails</Role>
      <ShortName>Debt and Financing Activities - Commercial Paper (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2436419 - Disclosure - Pension Benefits - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsNarrativeDetails</Role>
      <ShortName>Pension Benefits - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2439420 - Disclosure - Hedging Activities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesNarrativeDetails</Role>
      <ShortName>Hedging Activities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2440421 - Disclosure - Hedging Activities - Derivative Instruments Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails</Role>
      <ShortName>Hedging Activities - Derivative Instruments Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2442422 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/FairValueMeasurements</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2444423 - Disclosure - Commitments and Contingent Liabilities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails</Role>
      <ShortName>Commitments and Contingent Liabilities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2447424 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficitTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2448425 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficitTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2449426 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficitTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="mck-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2452427 - Disclosure - Segments of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessDetails</Role>
      <ShortName>Segments of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SegmentsofBusinessTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="mck-20201231.htm">mck-20201231.htm</File>
    <File>mck-20201231.xsd</File>
    <File>mck-20201231_cal.xml</File>
    <File>mck-20201231_def.xml</File>
    <File>mck-20201231_lab.xml</File>
    <File>mck-20201231_pre.xml</File>
    <File>mck_exhibit311x12312020.htm</File>
    <File>mck_exhibit312x12312020.htm</File>
    <File>mck_exhibit32x12312020.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mck-20201231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>77
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mck-20201231.htm": {
   "axisCustom": 0,
   "axisStandard": 38,
   "contextCount": 464,
   "dts": {
    "calculationLink": {
     "local": [
      "mck-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mck-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "mck-20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mck-20201231_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mck-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "mck-20201231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 648,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 1,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 6
   },
   "keyCustom": 58,
   "keyStandard": 368,
   "memberCustom": 62,
   "memberStandard": 58,
   "nsprefix": "mck",
   "nsuri": "http://mckesson123.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://mckesson123.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104102 - Disclosure - Investment in Change Healthcare Joint Venture",
     "role": "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture",
     "shortName": "Investment in Change Healthcare Joint Venture",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106103 - Disclosure - Held for Sale",
     "role": "http://mckesson123.com/role/HeldforSale",
     "shortName": "Held for Sale",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110104 - Disclosure - Restructuring, Impairment and Related Charges",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges",
     "shortName": "Restructuring, Impairment and Related Charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115105 - Disclosure - Income Taxes",
     "role": "http://mckesson123.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117106 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121107 - Disclosure - Earnings (Loss) Per Common Share",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShare",
     "shortName": "Earnings (Loss) Per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124108 - Disclosure - Goodwill and Intangible Assets, Net",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNet",
     "shortName": "Goodwill and Intangible Assets, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129109 - Disclosure - Debt and Financing Activities",
     "role": "http://mckesson123.com/role/DebtandFinancingActivities",
     "shortName": "Debt and Financing Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135110 - Disclosure - Pension Benefits",
     "role": "http://mckesson123.com/role/PensionBenefits",
     "shortName": "Pension Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137111 - Disclosure - Hedging Activities",
     "role": "http://mckesson123.com/role/HedgingActivities",
     "shortName": "Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ibf94a331dc864eada169fac303e5931b_D20201001-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ibf94a331dc864eada169fac303e5931b_D20201001-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141112 - Disclosure - Fair Value Measurements",
     "role": "http://mckesson123.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143113 - Disclosure - Commitments and Contingent Liabilities",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilities",
     "shortName": "Commitments and Contingent Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2145114 - Disclosure - Stockholders' Equity (Deficit)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficit",
     "shortName": "Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150115 - Disclosure - Segments of Business",
     "role": "http://mckesson123.com/role/SegmentsofBusiness",
     "shortName": "Segments of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307301 - Disclosure - Held for Sale (Tables)",
     "role": "http://mckesson123.com/role/HeldforSaleTables",
     "shortName": "Held for Sale (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - Restructuring, Impairment and Related Charges (Tables)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables",
     "shortName": "Restructuring, Impairment and Related Charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318303 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322304 - Disclosure - Earnings (Loss) Per Common Share (Tables)",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShareTables",
     "shortName": "Earnings (Loss) Per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325305 - Disclosure - Goodwill and Intangible Assets, Net (Tables)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables",
     "shortName": "Goodwill and Intangible Assets, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ibf94a331dc864eada169fac303e5931b_D20201001-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ibf94a331dc864eada169fac303e5931b_D20201001-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330306 - Disclosure - Debt and Financing Activities (Tables)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesTables",
     "shortName": "Debt and Financing Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338307 - Disclosure - Hedging Activities (Tables)",
     "role": "http://mckesson123.com/role/HedgingActivitiesTables",
     "shortName": "Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2346308 - Disclosure - Stockholders' Equity (Deficit) (Tables)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitTables",
     "shortName": "Stockholders' Equity (Deficit) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2351309 - Disclosure - Segments of Business (Tables)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessTables",
     "shortName": "Segments of Business (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i85b5d437b88a43c3b57c3014d5ae8bf1_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403401 - Disclosure - Significant Accounting Policies - Narrative (Details)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ia65b1cdade72453c9c9547d6ed17b3e9_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Investment in Change Healthcare Joint Venture (Details)",
     "role": "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
     "shortName": "Investment in Change Healthcare Joint Venture (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ia2ee20a5c84e431a9dbe88126ea7debb_D20190701-20190701",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Held for Sale - Narrative (Details)",
     "role": "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
     "shortName": "Held for Sale - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ic0ee8653fb6141acba5c088e3b9425bc_I20201101",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (Details)",
     "role": "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
     "shortName": "Held for Sale - Assets and Liabilities Held for Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i5f9649ec563d482b84c3260463f09372_I20200331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ibf94a331dc864eada169fac303e5931b_D20201001-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringSettlementAndImpairmentProvisions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - Restructuring, Impairment and Related Charges - Narrative (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
     "shortName": "Restructuring, Impairment and Related Charges - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ibf94a331dc864eada169fac303e5931b_D20201001-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringSettlementAndImpairmentProvisions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ibf94a331dc864eada169fac303e5931b_D20201001-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - Restructuring, Impairment and Related Charges - Summary of Restructuring Charges (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
     "shortName": "Restructuring, Impairment and Related Charges - Summary of Restructuring Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ibf94a331dc864eada169fac303e5931b_D20201001-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i7a0bf71acb034de79df20792261b0fe2_I20200331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i7a0bf71acb034de79df20792261b0fe2_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414407 - Disclosure - Restructuring, Impairment and Related Charges - Summary of Restructuring Activity (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
     "shortName": "Restructuring, Impairment and Related Charges - Summary of Restructuring Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserveSettledWithoutCash2",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ibf94a331dc864eada169fac303e5931b_D20201001-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - Income Taxes (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ibf94a331dc864eada169fac303e5931b_D20201001-20201231",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:NoncontrollingInterestsPutRightExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419409 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:NoncontrollingInterestsPutRightExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i7a0bf71acb034de79df20792261b0fe2_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420410 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ib03cda0901f74396a9d42a5e93e5f9eb_I20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ibf94a331dc864eada169fac303e5931b_D20201001-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423411 - Disclosure - Earnings (Loss) Per Common Share (Details)",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShareDetails",
     "shortName": "Earnings (Loss) Per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ibf94a331dc864eada169fac303e5931b_D20201001-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i7a0bf71acb034de79df20792261b0fe2_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426412 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427413 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i85b5d437b88a43c3b57c3014d5ae8bf1_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428414 - Disclosure - Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ibf94a331dc864eada169fac303e5931b_D20201001-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431415 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
     "shortName": "Debt and Financing Activities - Schedule of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432416 - Disclosure - Debt and Financing Activities - Long-Term Debt Narrative (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
     "shortName": "Debt and Financing Activities - Long-Term Debt Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i1b3e1030e25049dcab5e8f463f79cc7e_I20201203",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ia561add5441945f9b6e6f005c32de046_I20190930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433417 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
     "shortName": "Debt and Financing Activities - Revolving Credit Facilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i3df3eaf8483344e189aadb44a6e73dfc_D20190901-20190930",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ifc76a63f576047c49638f41ac0d91ae3_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434418 - Disclosure - Debt and Financing Activities - Commercial Paper (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
     "shortName": "Debt and Financing Activities - Commercial Paper (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ifc76a63f576047c49638f41ac0d91ae3_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i938f21cb5003435093dd61e42f1e4b04_D20201001-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:DefinedBenefitPensionPlanLiabilitiesDerecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436419 - Disclosure - Pension Benefits - Narrative (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
     "shortName": "Pension Benefits - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i938f21cb5003435093dd61e42f1e4b04_D20201001-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:DefinedBenefitPensionPlanLiabilitiesDerecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439420 - Disclosure - Hedging Activities - Narrative (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
     "shortName": "Hedging Activities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i3d08c0edcce54610b8dd1656b39357cb_D20191001-20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ie1a73cb404974bc2b79ec51446e9c1ae_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440421 - Disclosure - Hedging Activities - Derivative Instruments Fair Value (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
     "shortName": "Hedging Activities - Derivative Instruments Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ie1a73cb404974bc2b79ec51446e9c1ae_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442422 - Disclosure - Fair Value Measurements (Details)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i7a0bf71acb034de79df20792261b0fe2_I20200331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ia65b1cdade72453c9c9547d6ed17b3e9_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:LossContingencyNumberofCounties",
      "reportCount": 1,
      "unitRef": "county",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444423 - Disclosure - Commitments and Contingent Liabilities - Narrative (Details)",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
     "shortName": "Commitments and Contingent Liabilities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ic5f178fedc5b4cf6bdb61d18797a2680_I20180430",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mck:OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i5e18039fed9d4c7b8c71724ab62c8fc6_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:CommonStockVotingRightsNumberofVotesPerCommonShare",
      "reportCount": 1,
      "unitRef": "vote",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447424 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails",
     "shortName": "Stockholders' Equity (Deficit) - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i85b5d437b88a43c3b57c3014d5ae8bf1_D20200701-20200930",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockAcquiredAverageCostPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ibf94a331dc864eada169fac303e5931b_D20201001-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448425 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails",
     "shortName": "Stockholders' Equity (Deficit) - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ibf94a331dc864eada169fac303e5931b_D20201001-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "icda41b88f4cc470eb74edf0bae68f725_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449426 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
     "shortName": "Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i0ab154724e0a4ea78f86170c48cb3e03_I20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i53dbe944eae1492aa687e479fc7a11b9_I20190331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i36d180f203204936b0e8fc121ab9b7de_D20190401-20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "i85b5d437b88a43c3b57c3014d5ae8bf1_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452427 - Disclosure - Segments of Business (Details)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessDetails",
     "shortName": "Segments of Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "ibf94a331dc864eada169fac303e5931b_D20201001-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:CorporateOperatingExpenseandOtherIncomeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "iee7001dbe701429a8640019b5e925c83_D20200729-20200729",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Significant Accounting Policies",
     "role": "http://mckesson123.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20201231.htm",
      "contextRef": "id38061441e40423d8310f1dfcc2de952_D20200401-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 124,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mck_A0625NotesDue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.625% notes Due 2021",
        "label": "0.625% notes Due 2021 [Member]",
        "terseLabel": "0.625% notes Due 2021"
       }
      }
     },
     "localname": "A0625NotesDue2021Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A063EuroNotesDueAugust172021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.63% Euro Notes Due August 17, 2021",
        "label": "0.63% Euro Notes Due August 17, 2021 [Member]",
        "terseLabel": "0.63% Euro Notes due August 17, 2021"
       }
      }
     },
     "localname": "A063EuroNotesDueAugust172021Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A090NotesDueDecember32025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.90% Notes Due December 3, 2025",
        "label": "0.90% Notes Due December 3, 2025 [Member]",
        "terseLabel": "0.90% Notes due December 3, 2025"
       }
      }
     },
     "localname": "A090NotesDueDecember32025Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A1500NotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.500% Notes Due 2025",
        "label": "1.500% Notes Due 2025 [Member]",
        "terseLabel": "1.500% Notes Due 2025"
       }
      }
     },
     "localname": "A1500NotesDue2025Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A150EuroNotesDueNovember172025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.50% Euro Notes Due November 17, 2025",
        "label": "1.50% Euro Notes Due November 17, 2025 [Member]",
        "terseLabel": "1.50% Euro Notes due November 17, 2025"
       }
      }
     },
     "localname": "A150EuroNotesDueNovember172025Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A1625NotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.625% Notes Due 2026",
        "label": "1.625% Notes Due 2026 [Member]",
        "terseLabel": "1.625% Notes Due 2026"
       }
      }
     },
     "localname": "A1625NotesDue2026Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A163EuroNotesDueOctober302026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.63% Euro Notes Due October 30, 2026",
        "label": "1.63% Euro Notes Due October 30, 2026 [Member]",
        "terseLabel": "1.63% Euro Notes due October 30, 2026"
       }
      }
     },
     "localname": "A163EuroNotesDueOctober302026Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A2025NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2025 Notes",
        "label": "2025 Notes [Member]",
        "terseLabel": "2025 Notes"
       }
      }
     },
     "localname": "A2025NotesMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A270NotesDueDecember152022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.70% Notes Due December 15, 2022",
        "label": "2.70% Notes Due December 15, 2022 [Member]",
        "terseLabel": "2.70% Notes due December 15, 2022"
       }
      }
     },
     "localname": "A270NotesDueDecember152022Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A285NotesDueMarch152023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.85% Notes Due March 15, 2023",
        "label": "2.85% Notes Due March 15, 2023 [Member]",
        "terseLabel": "2.85% Notes due March 15, 2023"
       }
      }
     },
     "localname": "A285NotesDueMarch152023Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A3125NotesDue2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.125% Notes Due 2029",
        "label": "3.125% Notes Due 2029 [Member]",
        "terseLabel": "3.125% Notes Due 2029"
       }
      }
     },
     "localname": "A3125NotesDue2029Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A313SterlingNotesDueFebruary172029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.13% Sterling Notes Due February 17, 2029",
        "label": "3.13% Sterling Notes Due February 17, 2029 [Member]",
        "terseLabel": "3.13% Sterling Notes due February 17, 2029"
       }
      }
     },
     "localname": "A313SterlingNotesDueFebruary172029Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A365NotesDueNovember302020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.65% Notes Due November 30, 2020",
        "label": "3.65% Notes Due November 30, 2020 [Member]",
        "terseLabel": "3.65% Notes due November 30, 2020"
       }
      }
     },
     "localname": "A365NotesDueNovember302020Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A380NotesDueMarch152024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.80% Notes Due March 15, 2024",
        "label": "3.80% Notes Due March 15, 2024 [Member]",
        "terseLabel": "3.80% Notes due March 15, 2024"
       }
      }
     },
     "localname": "A380NotesDueMarch152024Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A395NotesDueFebruary162028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.95% Notes Due February 16, 2028",
        "label": "3.95% Notes Due February 16, 2028 [Member]",
        "terseLabel": "3.95% Notes due February 16, 2028"
       }
      }
     },
     "localname": "A395NotesDueFebruary162028Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A475NotesDueMarch12021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.75% Notes Due March 1, 2021",
        "label": "4.75% Notes Due March 1, 2021 [Member]",
        "terseLabel": "4.75% Notes due March 1, 2021"
       }
      }
     },
     "localname": "A475NotesDueMarch12021Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A475NotesDueMay302029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.75% Notes Due May 30, 2029",
        "label": "4.75% Notes Due May 30, 2029 [Member]",
        "terseLabel": "4.75% Notes due May 30, 2029"
       }
      }
     },
     "localname": "A475NotesDueMay302029Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A488NotesDueMarch152044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.88% Notes Due March 15, 2044",
        "label": "4.88% Notes Due March 15, 2044 [Member]",
        "terseLabel": "4.88% Notes due March 15, 2044"
       }
      }
     },
     "localname": "A488NotesDueMarch152044Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A600NotesDueMarch12041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "6.00% Notes Due March 1, 2041",
        "label": "6.00% Notes Due March 1, 2041 [Member]",
        "terseLabel": "6.00% Notes due March 1, 2041"
       }
      }
     },
     "localname": "A600NotesDueMarch12041Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A765DebenturesDueMarch12027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "7.65% Debentures Due March 1, 2027",
        "label": "7.65% Debentures Due March 1, 2027 [Member]",
        "terseLabel": "7.65% Debentures due March 1, 2027"
       }
      }
     },
     "localname": "A765DebenturesDueMarch12027Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AcceleratedShareRepurchaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase [Member]",
        "label": "Accelerated Share Repurchase [Member]",
        "terseLabel": "Accelerated Share Repurchase"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Defined Benefit Plans Adjustment, Amortization of Actuarial Loss, Prior Service Cost and Transition Obligation, Including Portion Attributable to Noncontrolling Interest [Member]",
        "label": "Accumulated Defined Benefit Plans Adjustment, Amortization of Actuarial Loss, Prior Service Cost and Transition Obligation, Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service and Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service and Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Net actuarial loss and prior servicecost arising during the period, net of income tax benefit"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Defined Benefit Plans, Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "label": "Accumulated Defined Benefit Plans, Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign currency translation adjustments and other, net of income tax expense"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Exercise of Put Right",
        "label": "Adjustments to Additional Paid in Capital, Exercise of Put Right",
        "terseLabel": "Exercise of put right by noncontrolling shareholders of McKesson Europe",
        "verboseLabel": "Associated increase in Company's ownership interest on its equity"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual Recurring Compensation Per Share to Noncontrolling Interests",
        "label": "Annual Recurring Compensation Per Share to Noncontrolling Interests",
        "terseLabel": "Annual recurring dividend (in euro per share)"
       }
      }
     },
     "localname": "AnnualRecurringCompensationPerSharetoNoncontrollingInterests",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_AssetImpairmentChargesIncludingAcceleratedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Impairment Charges, Including Accelerated Depreciation",
        "label": "Asset Impairment Charges, Including Accelerated Depreciation",
        "terseLabel": "Asset impairments and accelerated depreciation"
       }
      }
     },
     "localname": "AssetImpairmentChargesIncludingAcceleratedDepreciation",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_BritishPoundSterlingDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "British Pound Sterling Denominated Notes [Member]",
        "label": "British Pound Sterling Denominated Notes [Member]",
        "terseLabel": "British Pound Sterling Denominated Notes"
       }
      }
     },
     "localname": "BritishPoundSterlingDenominatedNotesMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ChangeHealthcareInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change Healthcare, Inc. [Member]",
        "label": "Change Healthcare, Inc. [Member]",
        "terseLabel": "Change Healthcare, Inc."
       }
      }
     },
     "localname": "ChangeHealthcareInc.Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ChangeHealthcareLLCChangeHealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change Healthcare, LLC (\u201cChange Healthcare\u201d) [Member]",
        "label": "Change Healthcare, LLC (\u201cChange Healthcare\u201d) [Member]",
        "terseLabel": "Change Healthcare JV"
       }
      }
     },
     "localname": "ChangeHealthcareLLCChangeHealthcareMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CommonStockVotingRightsNumberofVotesPerCommonShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Voting Rights, Number of Votes Per Common Share",
        "label": "Common Stock, Voting Rights, Number of Votes Per Common Share",
        "terseLabel": "Number of votes per share of common stock permitted on proposals presented to stockholders (vote)"
       }
      }
     },
     "localname": "CommonStockVotingRightsNumberofVotesPerCommonShare",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_CorporateOperatingExpenseandOtherIncomeNet": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/SegmentsofBusinessDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Operating Expense and Other Income, Net",
        "label": "Corporate Operating Expense and Other Income, Net",
        "negatedTerseLabel": "Corporate income (expenses), net"
       }
      }
     },
     "localname": "CorporateOperatingExpenseandOtherIncomeNet",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_CurrentAssetLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Asset / Liability [Member]",
        "label": "Current Asset / Liability [Member]",
        "terseLabel": "Prepaid expenses and other/Other accrued liabilities"
       }
      }
     },
     "localname": "CurrentAssetLiabilityMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DefinedBenefitPensionPlanLiabilitiesDerecognized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Pension Plan, Liabilities Derecognized",
        "label": "Defined Benefit Pension Plan, Liabilities Derecognized",
        "verboseLabel": "Pension liabilities derecognized"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlanLiabilitiesDerecognized",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets, Payment For Annuity Contract",
        "label": "Defined Benefit Plan, Plan Assets, Payment For Annuity Contract",
        "terseLabel": "Annuity contracts purchased"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanSettlementPlanParticipants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Settlement, Plan Participants",
        "label": "Defined Benefit Plan, Settlement, Plan Participants",
        "terseLabel": "Number of participants elected to receive settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementPlanParticipants",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration Receivable",
        "label": "Disposal Group, Including Discontinued Operation, Consideration Receivable",
        "terseLabel": "Consideration receivable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current",
        "label": "Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Reclassified Long-term Assets, Current",
        "label": "Disposal Group, Including Discontinued Operation, Reclassified Long-term Assets, Current",
        "terseLabel": "Long-term assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Reclassified Long-term Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Reclassified Long-term Liabilities, Current",
        "terseLabel": "Long-term liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1",
        "negatedTerseLabel": "Remeasurement of assets of business held for sale to fair value less costs to sell"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainonWritedown1",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Retention Expenses, Asset Impairments and Accelerated Depreciation [Member]",
        "label": "Employee Retention Expenses, Severance, Accelerated Depreciation and Asset Impairments [Member]",
        "terseLabel": "Employee Retention Expenses, Severance, Accelerated Depreciation and Asset Impairments"
       }
      }
     },
     "localname": "EmployeeRetentionExpensesSeveranceAcceleratedDepreciationAndAssetImpairmentsMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Severance, Accelerated Depreciation, and Project Consulting [Member]",
        "label": "Employee Severance, Accelerated Depreciation, and Project Consulting [Member]",
        "terseLabel": "Employee Severance, Accelerated Depreciation, and Project Consulting"
       }
      }
     },
     "localname": "EmployeeSeveranceAcceleratedDepreciationAndProjectConsultingMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment Other Than Temporary Impairment After Tax",
        "label": "Equity Method Investment Other Than Temporary Impairment After Tax",
        "terseLabel": "Impairment, after tax"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, Equity Security Investments Converted Into Public Common Stock, Number of Companies",
        "label": "Equity Securities, Equity Security Investments Converted Into Public Common Stock, Number of Companies",
        "terseLabel": "Number of companies in which equity securities were converted into public common stock"
       }
      }
     },
     "localname": "EquitySecuritiesEquitySecurityInvestmentsConvertedIntoPublicCommonStockNumberOfCompanies",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, Equity Security Investments With Changes in Observable Prices",
        "label": "Equity Securities, Equity Security Investments With Changes in Observable Prices",
        "terseLabel": "Number of investments that experienced transaction that resulted in change in observable price of those securities"
       }
      }
     },
     "localname": "EquitySecuritiesEquitySecurityInvestmentsWithChangesInObservablePrices",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_EuroDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Denominated Notes [Member]",
        "label": "Euro Denominated Notes [Member]",
        "terseLabel": "Euro Denominated Notes"
       }
      }
     },
     "localname": "EuroDenominatedNotesMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ExecutiveBenefitRetirementPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Executive Benefit Retirement Plan",
        "label": "Executive Benefit Retirement Plan [Member]",
        "terseLabel": "Executive Benefit Retirement Plan"
       }
      }
     },
     "localname": "ExecutiveBenefitRetirementPlanMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "terseLabel": "Estimated annual amortization expense, thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]",
        "label": "Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]",
        "terseLabel": "Forward contracts to hedge Euro against British Pound cash flows"
       }
      }
     },
     "localname": "ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GainLossOnSaleOfBusinessNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Sale of Business, Net of Tax",
        "label": "Gain (Loss) on Sale of Business, Net of Tax",
        "negatedTerseLabel": "After-tax loss on sale of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusinessNetOfTax",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GermanPharmaceuticalWholesaleJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "German Wholesale Joint Venture [Member]",
        "label": "German Pharmaceutical Wholesale Joint Venture [Member]",
        "terseLabel": "German Pharmaceutical Wholesale Business"
       }
      }
     },
     "localname": "GermanPharmaceuticalWholesaleJointVentureMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GermanWholesaleBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "German Wholesale Business [Member]",
        "label": "German Wholesale Business [Member]",
        "terseLabel": "German Wholesale Business"
       }
      }
     },
     "localname": "GermanWholesaleBusinessMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_IncomeTaxExpenseBenefitDiscreteItems": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Expense (Benefit) Discrete Items",
        "label": "Income Tax Expense (Benefit) Discrete Items",
        "negatedTerseLabel": "Discrete tax benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitDiscreteItems",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Expense (Benefit), Remeasurement of Assets and Liabilities Held-for-Sale to Fair Value",
        "label": "Income Tax Expense (Benefit), Remeasurement of Assets and Liabilities Held-for-Sale to Fair Value",
        "terseLabel": "Tax benefit recognized for remeasurement of assets and liabilities held-for-sale to fair value"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitRemeasurementOfAssetsAndLiabilitiesHeldForSaleToFairValue",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory",
        "label": "Increase (Decrease) in Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory",
        "terseLabel": "Deferred tax asset for the temporary difference arising from buyer's excess tax basis"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredTaxAssetIntraEntityTransferAssetOtherThanInventory",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IncreaseDecreaseInLitigationReserve": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Litigation Reserve",
        "label": "Increase (Decrease) in Litigation Reserve",
        "terseLabel": "Litigation liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInLitigationReserve",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IncreaseDecreaseinOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Operating Lease Liabilities",
        "label": "Increase (Decrease) in Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseinOperatingLeaseLiabilities",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_InternationalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Segment [Member]",
        "label": "International Segment [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalSegmentMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_LossContingencyAccrualAfterTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Accrual, After Tax",
        "label": "Loss Contingency Accrual, After Tax",
        "terseLabel": "After-tax accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAfterTax",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LossContingencyAccrualProvisionNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Accrual, Provision, Net of Tax",
        "label": "Loss Contingency Accrual, Provision, Net of Tax",
        "terseLabel": "After-tax expenses related to estimated litigation liability"
       }
      }
     },
     "localname": "LossContingencyAccrualProvisionNetOfTax",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LossContingencyClassActionNumberofFaxesReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Class Action, Number of Faxes Received",
        "label": "Loss Contingency, Class Action, Number of Faxes Received",
        "terseLabel": "Number of faxes received"
       }
      }
     },
     "localname": "LossContingencyClassActionNumberofFaxesReceived",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyClassActionNumberofFaxesRemainingintheClass": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Class Action, Number of Faxes Remaining in the Class",
        "label": "Loss Contingency, Class Action, Number of Faxes Remaining in the Class",
        "terseLabel": "Number of faxes remaining in the class"
       }
      }
     },
     "localname": "LossContingencyClassActionNumberofFaxesRemainingintheClass",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyDamagesSoughtPerViolationValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Damages Sought Per Violation, Value",
        "label": "Loss Contingency, Damages Sought Per Violation, Value",
        "terseLabel": "Statutory damages sought per violation"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtPerViolationValue",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts",
        "label": "Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts",
        "terseLabel": "Number of cases selected for possible remand to other federal courts"
       }
      }
     },
     "localname": "LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofCounties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Counties",
        "label": "Loss Contingency, Number of Counties",
        "terseLabel": "Number of counties that filed claims"
       }
      }
     },
     "localname": "LossContingencyNumberofCounties",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofStateAttorneyGenerals": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of State Attorney Generals",
        "label": "Loss Contingency, Number of State Attorney Generals",
        "terseLabel": "Number of attorney generals that have filed claims"
       }
      }
     },
     "localname": "LossContingencyNumberofStateAttorneyGenerals",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States",
        "label": "Loss Contingency, Number of States",
        "terseLabel": "Number of states in which court cases are pending"
       }
      }
     },
     "localname": "LossContingencyNumberofStates",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencySettlementAgreementAwardPaymentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Settlement Agreement, Award Payment Period",
        "label": "Loss Contingency, Settlement Agreement, Award Payment Period",
        "terseLabel": "Period over which award would be payable under proposed framework"
       }
      }
     },
     "localname": "LossContingencySettlementAgreementAwardPaymentPeriod",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Settlement Agreement, Percentage Anticipated To Be Used For Opioid Crisis Remediation",
        "label": "Loss Contingency, Settlement Agreement, Percentage Anticipated To Be Used For Opioid Crisis Remediation",
        "terseLabel": "Settlement award anticipated to be used to remediate the opioid crisis (percent)"
       }
      }
     },
     "localname": "LossContingencySettlementAgreementPercentageAnticipatedToBeUsedForOpioidCrisisRemediation",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Settlement Agreement, Terms, Number of Companies to Adopt Anti-Diversion Programs Changes",
        "label": "Loss Contingency, Settlement Agreement, Terms, Number of Companies to Adopt Anti-Diversion Programs Changes",
        "terseLabel": "Number of largest pharmaceutical distributors to adopt anti-diversion programs under proposed framework"
       }
      }
     },
     "localname": "LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_MckessonEuropeSubsidiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mckesson Europe Subsidiary [Member]",
        "label": "Mckesson Europe Subsidiary [Member]",
        "terseLabel": "Mckesson Europe Subsidiary"
       }
      }
     },
     "localname": "MckessonEuropeSubsidiaryMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_MedicalSurgicalSolutionsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical-Surgical Solutions Segment [Member]",
        "label": "Medical-Surgical Solutions Segment [Member]",
        "terseLabel": "Medical-Surgical Solutions"
       }
      }
     },
     "localname": "MedicalSurgicalSolutionsSegmentMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NationalPrescriptionOpiateLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In re: National Prescription Opiate Litigation [Member]",
        "label": "National Prescription Opiate Litigation [Member]",
        "terseLabel": "National Prescription Opioid Litigation"
       }
      }
     },
     "localname": "NationalPrescriptionOpiateLitigationMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax",
        "label": "Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax",
        "terseLabel": "Gains (losses) on non-derivative net investment hedge"
       }
      }
     },
     "localname": "NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestDecreaseForExerciseOfPutRight": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Decrease for Exercise of Put Right",
        "label": "Noncontrolling Interest, Decrease for Exercise of Put Right",
        "negatedTerseLabel": "Exercises of Put Right",
        "terseLabel": "Decrease in noncontrolling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseForExerciseOfPutRight",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestIncreaseDecreaseDuetoOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Increase (Decrease) Due to Other",
        "label": "Noncontrolling Interest, Increase (Decrease) Due to Other",
        "terseLabel": "Other",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseDecreaseDuetoOther",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestsPutRightExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interests, Put Right, Exercise Price",
        "label": "Noncontrolling Interests, Put Right, Exercise Price",
        "terseLabel": "Put right redemption price per share (in euros per share)"
       }
      }
     },
     "localname": "NoncontrollingInterestsPutRightExercisePrice",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_NoncurrentAssetLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-current Asset / Liability [Member]",
        "label": "Non-current Asset / Liability [Member]",
        "terseLabel": "Non-current Asset / Liability"
       }
      }
     },
     "localname": "NoncurrentAssetLiabilityMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_November2018CrossCurrencySwapsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 2018 Cross Currency Swaps [Member]",
        "label": "November 2018 Cross Currency Swaps [Member]",
        "terseLabel": "November 2018 cross currency swaps"
       }
      }
     },
     "localname": "November2018CrossCurrencySwapsMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NumberOfBusinessOperations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Business Operations",
        "label": "Number of Business Operations",
        "terseLabel": "Number of business operations"
       }
      }
     },
     "localname": "NumberOfBusinessOperations",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_NumberOfCountyGovernments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of County Governments",
        "label": "Number of County Governments",
        "terseLabel": "Number of county government plaintiffs"
       }
      }
     },
     "localname": "NumberOfCountyGovernments",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_NumberOfInvestmentFundsThatFiledClaims": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Investment Funds That Filed Claims",
        "label": "Number of Investment Funds That Filed Claims",
        "terseLabel": "Number of investment funds that filed claims"
       }
      }
     },
     "localname": "NumberOfInvestmentFundsThatFiledClaims",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_NumberOfNationalBrandMedicalSurgicalProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of National Brand Medical-Surgical Products",
        "label": "Number of National Brand Medical-Surgical Products",
        "terseLabel": "Number of national brand medical-surgical products offered (more than)"
       }
      }
     },
     "localname": "NumberOfNationalBrandMedicalSurgicalProducts",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_OpenMarketShareRepurchaseTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Open Market Share Repurchase Transactions [Member]",
        "label": "Open Market Share Repurchase Transactions [Member]",
        "terseLabel": "Open Market Share Repurchase Transactions"
       }
      }
     },
     "localname": "OpenMarketShareRepurchaseTransactionsMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OperatingModelAndCostOptimizationProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Model and Cost Optimization Programs",
        "label": "Operating Model and Cost Optimization Programs [Member]",
        "terseLabel": "Operating Model and Cost Optimization Programs"
       }
      }
     },
     "localname": "OperatingModelAndCostOptimizationProgramsMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opioid Stewardship Act, Annual Surcharge on Licensed Manufacturers and Distributors of Opioids",
        "label": "Opioid Stewardship Act, Annual Surcharge on Licensed Manufacturers and Distributors of Opioids",
        "terseLabel": "Aggregate annual surcharge on licensed manufacturers and distributors of opioids"
       }
      }
     },
     "localname": "OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss) Defined Benefit Plans Net Unamortized Gain Loss Attributable to Redeemable Noncontrolling Interest Arising During Period Net Of Tax",
        "label": "Other Comprehensive Income (Loss) Defined Benefit Plans Net Unamortized Gain Loss Attributable to Redeemable Noncontrolling Interest Arising During Period Net Of Tax",
        "terseLabel": "Net actuarial gain (losses) attributable to redeemable noncontrolling interest"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss) Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest",
        "label": "Other Comprehensive Income (Loss) Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest",
        "terseLabel": "Translation gain (loss) attributable to redeemable noncontrolling interest"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income Translation Impact On Pension Plans, Tax",
        "label": "Other Comprehensive Income Translation Impact On Pension Plans, Tax",
        "terseLabel": "Foreign currency translation adjustments and other, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_PharmacyLicensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy licenses [Member]",
        "label": "Pharmacy Licenses [Member]",
        "terseLabel": "Pharmacy licenses"
       }
      }
     },
     "localname": "PharmacyLicensesMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Planned Divestiture in Medical Surgical Solutions Business [Member]",
        "label": "Planned Divestiture in Medical Surgical Solutions Business [Member]",
        "terseLabel": "Planned divestiture in Medical-Surgical Solutions business"
       }
      }
     },
     "localname": "PlannedDivestitureinMedicalSurgicalSolutionsBusinessMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA, No. 18 O 455/17",
        "label": "Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA, No. 18 O 455/17 [Member]",
        "terseLabel": "Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA"
       }
      }
     },
     "localname": "PolygonEuropeanEquityOpportunityMasterFundEtAlVMcKessonEuropeHoldingsGmbHCoKGaANo18O45517Member",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PrescriptionTechnologySolutionsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prescription Technology Solutions Segment",
        "label": "Prescription Technology Solutions Segment [Member]",
        "terseLabel": "Prescription Technology Solutions"
       }
      }
     },
     "localname": "PrescriptionTechnologySolutionsSegmentMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ProportionateGainLossOnEquityMethodInvestment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proportionate Gain (Loss) on Equity Method Investment",
        "label": "Proportionate Gain (Loss) on Equity Method Investment",
        "negatedTerseLabel": "Proportionate loss from investment in Change Healthcare"
       }
      }
     },
     "localname": "ProportionateGainLossOnEquityMethodInvestment",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_PutRightValueInterestRateSpread": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Put Right Value, Interest Rate Spread",
        "label": "Put Right Value, Interest Rate Spread",
        "terseLabel": "Put right value, interest rate spread (as a percent)"
       }
      }
     },
     "localname": "PutRightValueInterestRateSpread",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_ReclassificationofTemporaryEquitytoLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of Temporary Equity to Liability",
        "label": "Reclassification of Temporary Equity to Liability",
        "negatedTerseLabel": "Reclassification of recurring compensation to other accrued liabilities"
       }
      }
     },
     "localname": "ReclassificationofTemporaryEquitytoLiability",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RedeemableNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest [Member]",
        "label": "Redeemable Noncontrolling Interest [Member]",
        "terseLabel": "Redeemable Noncontrolling Interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interests, Maximum Redemption Value",
        "label": "Redeemable Noncontrolling Interests, Maximum Redemption Value",
        "terseLabel": "Maximum redemption value of redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestsMaximumRedemptionValue",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased",
        "label": "Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased",
        "terseLabel": "Shares purchased (shares)"
       }
      }
     },
     "localname": "RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_RestructuringImpairmentandOtherRelatedCharges": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring, Impairment and Other Related Charges",
        "label": "Restructuring, Impairment and Other Related Charges",
        "negatedTerseLabel": "Restructuring, impairment, and related charges"
       }
      }
     },
     "localname": "RestructuringImpairmentandOtherRelatedCharges",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RetailPharmacyReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retail Pharmacy Reporting Unit [Member]",
        "label": "Retail Pharmacy Reporting Unit [Member]",
        "terseLabel": "Retail Pharmacy Reporting Unit"
       }
      }
     },
     "localname": "RetailPharmacyReportingUnitMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RevenueDerivedFromServicesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Derived From Services, Percentage",
        "label": "Revenue Derived From Services, Percentage",
        "terseLabel": "Revenue derived from services, percentage (less than)"
       }
      }
     },
     "localname": "RevenueDerivedFromServicesPercentage",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "label": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "terseLabel": "Canadian Dollar, British Pound Sterling, and Euros Sublimit"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]",
        "label": "Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]",
        "terseLabel": "The 2020 Credit Facility"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Revolving Credit Facility (Global Facility) [Member]",
        "label": "Senior Unsecured Revolving Credit Facility (Global Facility) [Member]",
        "terseLabel": "Global Facility"
       }
      }
     },
     "localname": "SeniorUnsecuredRevolvingCreditFacilityGlobalFacilityMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program, Additional Amount Authorized to be Repurchased",
        "label": "Stock Repurchase Program, Additional Amount Authorized to be Repurchased",
        "terseLabel": "Approved increase to the authorized share repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_StrategicGrowthInitiativePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Growth Initiative Plan [Member]",
        "label": "Strategic Growth Initiative Plan [Member]",
        "terseLabel": "Strategic Growth Initiative Plan"
       }
      }
     },
     "localname": "StrategicGrowthInitiativePlanMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StrategicGrowthInitiativePlanOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Growth Initiative Plan - Other [Member]",
        "label": "Strategic Growth Initiative Plan - Other [Member]",
        "terseLabel": "Strategic Growth Initiative Plan - Other"
       }
      }
     },
     "localname": "StrategicGrowthInitiativePlanOtherMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Growth Initiative Plan Relocation of Corporate Headquarters [Member]",
        "label": "Strategic Growth Initiative Plan - Relocation of Corporate Headquarters [Member]",
        "terseLabel": "Strategic Growth Initiative Plan - Relocation of Corporate Headquarters"
       }
      }
     },
     "localname": "StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized",
        "label": "Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized",
        "terseLabel": "Percentage of net cash tax savings realized or deemed realized under TRA (percent)"
       }
      }
     },
     "localname": "TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_TaxReceivableAgreementTRAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Receivable Agreement (\u201cTRA\u201d) [Member]",
        "label": "Tax Receivable Agreement (\u201cTRA\u201d) [Member]",
        "terseLabel": "Tax Receivable Agreement (\u201cTRA\u201d)"
       }
      }
     },
     "localname": "TaxReceivableAgreementTRAMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ThreeLargestU.S.PharmaceuticalDistributorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Largest U.S. Pharmaceutical Distributors [Member]",
        "label": "Three Largest U.S. Pharmaceutical Distributors [Member]",
        "terseLabel": "Three Largest U.S. Pharmaceutical Distributors"
       }
      }
     },
     "localname": "ThreeLargestU.S.PharmaceuticalDistributorsMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TransitionServicesAgreementsTSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transition Services Agreements (\u201cTSA\u201d) [Member]",
        "label": "Transition Services Agreements (\u201cTSA\u201d) [Member]",
        "terseLabel": "Transition Services Agreements (\u201cTSA\u201d)"
       }
      }
     },
     "localname": "TransitionServicesAgreementsTSAMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]",
        "label": "True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]",
        "terseLabel": "True Health Chiropractic Inc., et al. v. McKesson Corporation, et al"
       }
      }
     },
     "localname": "TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_USPharmaceuticalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Pharmaceutical Segment [Member]",
        "label": "U.S. Pharmaceutical Segment [Member]",
        "terseLabel": "U.S. Pharmaceutical"
       }
      }
     },
     "localname": "USPharmaceuticalSegmentMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_VantageandClarusOneSourcingServicesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vantage and ClarusOne Sourcing Services LLC [Member]",
        "label": "Vantage and ClarusOne Sourcing Services LLC [Member]",
        "terseLabel": "Vantage and ClarusOne Sourcing Services LLC"
       }
      }
     },
     "localname": "VantageandClarusOneSourcingServicesLLCMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_WalgreensBootsAllianceJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Walgreens Boots Alliance Joint Venture",
        "label": "Walgreens Boots Alliance Joint Venture [Member]",
        "terseLabel": "WBA Joint Venture"
       }
      }
     },
     "localname": "WalgreensBootsAllianceJointVentureMember",
     "nsuri": "http://mckesson123.com/20201231",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r194",
      "r207",
      "r208",
      "r209",
      "r210",
      "r212",
      "r214",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r194",
      "r207",
      "r208",
      "r209",
      "r210",
      "r212",
      "r214",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": {
     "auth_ref": [
      "r146",
      "r154",
      "r240",
      "r441",
      "r442",
      "r443",
      "r464",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]",
        "terseLabel": "Adjusted balance, April 1"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r146",
      "r154",
      "r240",
      "r441",
      "r442",
      "r443",
      "r464",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Opening retained earnings adjustment: adoption of new accounting standard"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r146",
      "r154",
      "r240",
      "r441",
      "r442",
      "r443",
      "r464",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r146",
      "r154",
      "r240",
      "r441",
      "r442",
      "r443",
      "r464",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r422",
      "r432",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r582",
      "r649",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r422",
      "r432",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r582",
      "r649",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r359",
      "r422",
      "r432",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r582",
      "r649",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r359",
      "r422",
      "r432",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r582",
      "r649",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r222",
      "r223",
      "r331",
      "r332",
      "r650",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r222",
      "r223",
      "r331",
      "r332",
      "r650",
      "r665",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accelerated Share Repurchases [Line Items]",
        "terseLabel": "Accelerated Share Repurchases [Line Items]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTable": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table reflecting activity in an accelerated share repurchase (ASR) program.",
        "label": "Accelerated Share Repurchases [Table]",
        "terseLabel": "Accelerated Share Repurchases [Table]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update 2014-09 [Member]",
        "terseLabel": "ASU 2014-09"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "terseLabel": "ASU 2016-13"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r150",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r464",
      "r465",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible List]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r78",
      "r84",
      "r86",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Changes in retirement-related benefit plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r77",
      "r84",
      "r86",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Net Losses and Other Components of Benefit Plans, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r72",
      "r84",
      "r86",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": {
     "auth_ref": [
      "r84",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.",
        "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gains (Losses) on Cash Flow Hedges, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r74",
      "r75",
      "r76",
      "r84",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]",
        "verboseLabel": "Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r40",
      "r81",
      "r83",
      "r84",
      "r627",
      "r659",
      "r663"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r80",
      "r84",
      "r86",
      "r143",
      "r144",
      "r145",
      "r493",
      "r654",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Total Accumulated Other Comprehensive Loss",
        "verboseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r38",
      "r444"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r441",
      "r442",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r129",
      "r263"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r150",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r462",
      "r463",
      "r464",
      "r465",
      "r585",
      "r586",
      "r587",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r434",
      "r435",
      "r445",
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r189",
      "r207",
      "r208",
      "r209",
      "r210",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "Prescription Technology Solutions"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r44",
      "r227",
      "r243"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r129",
      "r258",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive securities (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accumulated other comprehensive income.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Period Increase (Decrease)",
        "negatedTerseLabel": "Accumulated other comprehensive loss derecognized"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r129",
      "r269"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Goodwill and other asset impairment charges",
        "verboseLabel": "Impairment of long-lived and intangible assets"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r136",
      "r202",
      "r209",
      "r216",
      "r234",
      "r486",
      "r497",
      "r546",
      "r603",
      "r624"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r25",
      "r26",
      "r67",
      "r136",
      "r234",
      "r486",
      "r497",
      "r546"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r1",
      "r2",
      "r15",
      "r17",
      "r21",
      "r276"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r15",
      "r17",
      "r21",
      "r272",
      "r276"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held for sale",
        "totalLabel": "Total assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r514",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r129",
      "r281",
      "r287",
      "r293"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "terseLabel": "Exit and other-related costs"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r23",
      "r48",
      "r131"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents at end of period"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Investments in money market funds"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r126",
      "r131",
      "r132"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r126",
      "r550"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r134",
      "r136",
      "r162",
      "r166",
      "r167",
      "r169",
      "r171",
      "r179",
      "r180",
      "r181",
      "r234",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r296",
      "r297",
      "r298",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingent Liabilities"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r133",
      "r310",
      "r666",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per common share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r143",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value, 800 shares authorized and 273 and 272 shares issued at December 31, 2020 and March 31, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r89",
      "r91",
      "r92",
      "r102",
      "r619",
      "r642"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss) attributable to McKesson Corporation"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income, net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r89",
      "r91",
      "r101",
      "r484",
      "r485",
      "r501",
      "r618",
      "r641"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r89",
      "r91",
      "r100",
      "r483",
      "r501",
      "r617",
      "r640"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock": {
     "auth_ref": [
      "r494",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]",
        "terseLabel": "Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r133",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporation owned and operated by a small group of ventures to accomplish a mutually beneficial venture or project.",
        "label": "Corporate Joint Venture [Member]",
        "terseLabel": "Joint Venture"
       }
      }
     },
     "localname": "CorporateJointVentureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r207",
      "r208",
      "r209",
      "r210",
      "r212",
      "r218",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r109",
      "r583"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Cross currency swap"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r609",
      "r633"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) recognized in earnings from investment in debt and equity securities measured at fair value with change in fair value recognized in net income, and recognized from transfer of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and investment in debt security measured at amortized cost (held-to-maturity) to investment in debt security measured at fair value with change in fair value recognized in net income (trading). Excludes other-than-temporary impairment (OTTI).",
        "label": "Debt and Equity Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment",
        "terseLabel": "Net gains associated with equity investments"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Debt and Financing Activities"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r31",
      "r32",
      "r33",
      "r604",
      "r605",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r562",
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Estimated fair values of liabilities"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate on debt instrument (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of principal amount of debt redeemed.",
        "label": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed",
        "terseLabel": "Price as percentage of debt outstanding at which debt can be purchased"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r57",
      "r138",
      "r321",
      "r322",
      "r323",
      "r324",
      "r561",
      "r562",
      "r563",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Syndicated senior unsecured revolving credit facility term",
        "verboseLabel": "Debt instrument term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Debt, Weighted Average Interest Rate",
        "terseLabel": "Weighted average interest rate (percent)"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r453"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Possible decrease in unrecognized tax benefits during the next twelve months"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r448",
      "r449"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Long-term deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r352",
      "r360",
      "r362",
      "r406",
      "r408",
      "r409"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Cash contributions to the plans"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of plan assets to benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Funded Percentage",
        "terseLabel": "Percentage threshold of greater of projected benefit obligation or market value of assets (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r371",
      "r398",
      "r408",
      "r409"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "terseLabel": "Net periodic pension expense"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r354",
      "r412"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "terseLabel": "Cash payment for retirement plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r337",
      "r378",
      "r405"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "negatedTerseLabel": "Pre-tax settlement expense"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "terseLabel": "Lump sum payments under settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r129",
      "r273"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r506",
      "r507",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "U.S. Dollar notional amount, asset"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative, Name [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r68",
      "r69",
      "r516",
      "r581"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Fair value of derivative, asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r68",
      "r69",
      "r516",
      "r581"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Fair value of derivative, liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r515",
      "r517",
      "r521",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative, by Nature [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r512",
      "r515",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r520",
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Gain (loss) on financial instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r506",
      "r507",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "terseLabel": "U.S. Dollar, notional amount, liability"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r507",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional values of financial instruments"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r505",
      "r508",
      "r509",
      "r512",
      "r513",
      "r519",
      "r521",
      "r528",
      "r529",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives designated for hedge accounting"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r270",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposed of by sale"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r17",
      "r268",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Held-for-sale"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r1",
      "r2",
      "r15",
      "r276"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Receivables, net and other current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses": {
     "auth_ref": [
      "r555"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) in the disposal group, including discontinued operation, recognized in the statement of income as a result of the sale or complete or substantially complete liquidation of an investment in a foreign entity.",
        "label": "Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)",
        "terseLabel": "Favorable (unfavorable) cumulative foreign currency translation adjustment"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r15",
      "r272",
      "r276"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r22",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Held for Sale"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSale"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r415",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r325"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r414",
      "r418",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueFromRelatedParties": {
     "auth_ref": [
      "r140",
      "r569",
      "r608",
      "r634"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.",
        "label": "Due from Related Parties",
        "terseLabel": "Receivable recognized"
       }
      }
     },
     "localname": "DueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings (loss) per common share attributable to McKesson Corporation"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r103",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r160",
      "r162",
      "r169",
      "r170",
      "r171",
      "r175",
      "r176",
      "r620",
      "r643"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Total (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings (loss) per common share attributable to McKesson:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r103",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r162",
      "r169",
      "r170",
      "r171",
      "r175",
      "r176",
      "r620",
      "r643"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Total (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r172",
      "r173",
      "r174",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings (Loss) Per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r550"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Reported income tax expense (benefit) rates (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r148",
      "r157",
      "r159",
      "r178",
      "r240",
      "r320",
      "r325",
      "r441",
      "r442",
      "r443",
      "r464",
      "r465",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r558",
      "r654",
      "r655",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r230"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Impairment"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership interest (percent)"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r49",
      "r203",
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Carrying value of interest in joint venture"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Investment in Change Healthcare Joint Venture"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r543"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Investments in equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r229",
      "r645"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized gain (loss) on equity investments"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r533",
      "r534",
      "r535",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r533",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of information regarding the fair value of derivatives on a gross basis"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r360",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r408",
      "r534",
      "r572",
      "r573",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r533",
      "r534",
      "r537",
      "r538",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r360",
      "r362",
      "r367",
      "r408",
      "r534",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair value, inputs, level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r360",
      "r362",
      "r367",
      "r408",
      "r534",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair value, inputs, level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r360",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r408",
      "r572",
      "r573",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r533",
      "r534",
      "r537",
      "r538",
      "r539",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r540",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r514",
      "r519",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r565",
      "r567"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "verboseLabel": "Lease and other obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r262"
     ],
     "calculation": {
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Estimated annual amortization expense, 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Estimated annual amortization expense, remainder of 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated annual amortization expense, 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated annual amortization expense, 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated annual amortization expense, 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r259",
      "r260",
      "r262",
      "r265",
      "r584",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r262",
      "r588"
     ],
     "calculation": {
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r259",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r262",
      "r584"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted- Average Remaining Amortization Period (Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiscalPeriod": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.",
        "label": "Fiscal Period, Policy [Policy Text Block]",
        "terseLabel": "Fiscal Period"
       }
      }
     },
     "localname": "FiscalPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r360",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "verboseLabel": "Foreign Exchange Contract"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r129",
      "r496"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Pre-tax loss on sale of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfOtherAssets": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of other assets.",
        "label": "Gain (Loss) on Disposition of Other Assets",
        "negatedTerseLabel": "Loss from sales of businesses and investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee": {
     "auth_ref": [
      "r104",
      "r105",
      "r129",
      "r612",
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee",
        "negatedTerseLabel": "Pre-tax dilution loss"
       }
      }
     },
     "localname": "GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedTerseLabel": "Opioid-related settlement charges"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r246",
      "r248",
      "r602"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Net"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation adjustments, net"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r129",
      "r247",
      "r251",
      "r256"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Goodwill impairment charges",
        "terseLabel": "Goodwill impairment charge"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLossNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of loss recognized that results from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss, Net of Tax",
        "terseLabel": "After-tax goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r253",
      "r474"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Acquisition accounting, transfers and other adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r250"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedTerseLabel": "Disposals"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r106",
      "r136",
      "r202",
      "r208",
      "r212",
      "r215",
      "r218",
      "r234",
      "r546"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r512",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentChargeOnReclassifiedAssets": {
     "auth_ref": [
      "r267",
      "r271"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the asset that is reclassified back to held and used from held-for-sale, the amount of impairment charge that is recognized on the reclassification date.",
        "label": "Impairment Charge on Reclassified Assets",
        "terseLabel": "Pre-tax impairment charge"
       }
      }
     },
     "localname": "ImpairmentChargeOnReclassifiedAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r107",
      "r130",
      "r152",
      "r153",
      "r154",
      "r155",
      "r168",
      "r171",
      "r482"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Income (loss) from continuing operations attributable to McKesson Corporation"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r95",
      "r202",
      "r208",
      "r212",
      "r215",
      "r218",
      "r601",
      "r613",
      "r621",
      "r646"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/SegmentsofBusinessDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r136",
      "r147",
      "r202",
      "r208",
      "r212",
      "r215",
      "r218",
      "r234",
      "r483",
      "r546"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Income (loss) from continuing operations",
        "totalLabel": "Income (loss) from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r94",
      "r103",
      "r147",
      "r152",
      "r153",
      "r154",
      "r155",
      "r162",
      "r169",
      "r170",
      "r610",
      "r614",
      "r620",
      "r636"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Continuing operations (in dollars per share)",
        "verboseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r94",
      "r103",
      "r147",
      "r152",
      "r153",
      "r154",
      "r155",
      "r162",
      "r169",
      "r170",
      "r171",
      "r620",
      "r636",
      "r639",
      "r643"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Continuing operations (in dollars per share)",
        "verboseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r18",
      "r21",
      "r470",
      "r637"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Loss from discontinued operations, net of tax",
        "verboseLabel": "Loss from discontinued operations, net of tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r97",
      "r103",
      "r166",
      "r169",
      "r170",
      "r620",
      "r637",
      "r639",
      "r643"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Discontinued operations (in dollars per share)",
        "verboseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r166",
      "r169",
      "r170",
      "r503"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Discontinued operations (in dollars per share)",
        "verboseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r96",
      "r129",
      "r199",
      "r231",
      "r611",
      "r635"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Equity earnings and charges from investment in Change Healthcare Joint Venture",
        "terseLabel": "Equity earnings and charges from investment in Change Healthcare Joint Venture"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r415",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r2",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r16",
      "r19",
      "r20",
      "r21",
      "r278",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r454",
      "r457",
      "r459",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r452",
      "r458",
      "r460",
      "r466",
      "r468",
      "r471",
      "r472",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r137",
      "r158",
      "r159",
      "r200",
      "r450",
      "r467",
      "r469",
      "r647"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit (expense)",
        "terseLabel": "Income tax expense (benefit) related to continuing operations"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.",
        "label": "Increase (Decrease) in Accrued Taxes Payable",
        "terseLabel": "Taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Assets [Abstract]",
        "terseLabel": "Changes in assets and liabilities, net of acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r171"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Restricted stock units (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InterestAndDebtExpense": {
     "auth_ref": [
      "r560"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      },
      "http://mckesson123.com/role/SegmentsofBusinessDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.",
        "label": "Interest and Debt Expense",
        "negatedLabel": "Interest expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestAndDebtExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Forward starting interest rate swaps"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryLIFOReservePeriodCharge": {
     "auth_ref": [
      "r64",
      "r65",
      "r66",
      "r245"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.",
        "label": "Inventory, LIFO Reserve, Period Charge",
        "negatedLabel": "Pre-tax credits related to LIFO accounting",
        "terseLabel": "Credits associated with last-in, first-out inventory method"
       }
      }
     },
     "localname": "InventoryLIFOReservePeriodCharge",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r24",
      "r63"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory impairments and excess inventory"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LegalFees": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.",
        "label": "Legal Fees",
        "negatedLabel": "Claims and litigation charges, net"
       }
      }
     },
     "localname": "LegalFees",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r43",
      "r136",
      "r234",
      "r546",
      "r607",
      "r630"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable noncontrolling interests, and equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND EQUITY (DEFICIT)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r55",
      "r136",
      "r234",
      "r487",
      "r497",
      "r498",
      "r546"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r533"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Liabilities measured at fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r1",
      "r2",
      "r15",
      "r17",
      "r21",
      "r276"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r15",
      "r17",
      "r21",
      "r272",
      "r276"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Liabilities held for sale",
        "totalLabel": "Total liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r33",
      "r605",
      "r623"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Amounts outstanding under facility"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum amount of borrowing capacity under a line of credit that is available as of the balance sheet date for a specific purpose other than for financing goods acquired for inventory or imminent delivery to a customer.",
        "label": "Line of Credit Facility, Capacity Available for Specific Purpose Other than for Trade Purchases",
        "terseLabel": "Committed balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Uncommitted balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "netLabel": "Outstanding notes (up to)",
        "terseLabel": "Syndicated senior unsecured revolving credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r52",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserveNoncurrent": {
     "auth_ref": [
      "r59",
      "r299"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.",
        "label": "Estimated Litigation Liability, Noncurrent",
        "terseLabel": "Long-term litigation liabilities"
       }
      }
     },
     "localname": "LitigationReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Award payable under proposed framework"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Pre-tax litigation expense"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Term Loan",
        "verboseLabel": "Notes payable"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermCommercialPaperCurrent": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the current portion of long-term unsecured obligations issued by corporations and other borrowers to investors (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Long-term Commercial Paper, Current",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "LongTermCommercialPaperCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r33",
      "r314",
      "r605",
      "r626"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt outstanding",
        "verboseLabel": "Carrying amount of liabilities"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/FairValueMeasurementsDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "terseLabel": "Less: Current portion",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r57",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Pre-tax accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualProvision": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.",
        "label": "Loss Contingency Accrual, Provision",
        "terseLabel": "Pre-tax expenses related to estimated litigation liability"
       }
      }
     },
     "localname": "LossContingencyAccrualProvision",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyLossInPeriod": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.",
        "label": "Loss Contingency, Loss in Period",
        "terseLabel": "Charge in connection with State of New York's Opioid Stewardship Act"
       }
      }
     },
     "localname": "LossContingencyLossInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Complaints filed against the entity"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r62",
      "r136",
      "r234",
      "r546",
      "r606",
      "r629"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r325"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Payments to noncontrolling interests",
        "negatedTerseLabel": "Payments to noncontrolling interests",
        "terseLabel": "Decrease in carrying value of non-controlling interest"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "terseLabel": "Redeemable Noncontrolling Interests and Noncontrolling Interests"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Noncontrolling interest (percent)"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Ownership percentage (as a percent)"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r62",
      "r108",
      "r481",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MovementInMinorityInterestRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "MovementInMinorityInterestRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r126",
      "r127",
      "r130"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r21",
      "r87",
      "r90",
      "r98",
      "r130",
      "r136",
      "r147",
      "r152",
      "r153",
      "r154",
      "r155",
      "r158",
      "r159",
      "r168",
      "r202",
      "r208",
      "r212",
      "r215",
      "r218",
      "r234",
      "r546",
      "r615",
      "r638"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income (loss) attributable to McKesson Corporation"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r87",
      "r90",
      "r158",
      "r159",
      "r490",
      "r500"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net income attributable to noncontrolling interests",
        "negatedTerseLabel": "Net income attributable to noncontrolling interests",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "verboseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r154",
      "r175",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r462",
      "r463",
      "r464",
      "r465",
      "r585",
      "r586",
      "r587",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "U.K and Canada"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]",
        "terseLabel": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r325",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives not designated for hedge accounting",
        "verboseLabel": "Derivatives not Designated for Hedge Accounting"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfCountriesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of countries in which the entity operates as of balance sheet date.",
        "label": "Number of Countries in which Entity Operates",
        "terseLabel": "Number of countries in which entity segment operates"
       }
      }
     },
     "localname": "NumberOfCountriesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "negatedTerseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "negatedTotalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r202",
      "r208",
      "r212",
      "r215",
      "r218"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/SegmentsofBusinessDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Total operating profit (loss)",
        "totalLabel": "Operating income (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss) [Abstract]",
        "terseLabel": "Segment operating profit (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r566"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Non-cash operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r207",
      "r208",
      "r209",
      "r210",
      "r212",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAdditionalCapitalMember": {
     "auth_ref": [
      "r112",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents a category to capture additional Paid-in Capital other than attributable to capital contributed by shareholders in excess of the par or stated value of the common or preferred stock issued by an entity. Certain entities report two components of additional Paid-in Capital consisting of (i) capital in excess of par or stated value and (ii) other additional capital. This member is only to be used if the entity distinguishes between additional Paid-in Capital and other additional capital in its financial statements. If using this element, the preparer would be expected to elevate the Other Additional Capital [Member] to the same level as the Additional Paid-in Capital [Member].",
        "label": "Other Additional Capital [Member]",
        "terseLabel": "Other Capital"
       }
      }
     },
     "localname": "OtherAdditionalCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r71",
      "r82",
      "r547",
      "r549",
      "r557"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax",
        "terseLabel": "Foreign currency translation adjustments, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax",
        "negatedTerseLabel": "Amortization of actuarial (gain) loss and prior service costs, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r84",
      "r93",
      "r551",
      "r553",
      "r558"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "verboseLabel": "Unrealized gains (losses) on net investment hedges arising during period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r73",
      "r81"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Gains (losses) from cash flow hedges recorded within other comprehensive income",
        "verboseLabel": "Unrealized gains (losses) on cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Unrealized gains (loss) on cash flow hedges arising during period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax": {
     "auth_ref": [
      "r82",
      "r549",
      "r557"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Tax",
        "terseLabel": "Reclassified to income statement, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "verboseLabel": "Gain (loss) from net investment hedges recorded within other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r88",
      "r91",
      "r93",
      "r99",
      "r320",
      "r551",
      "r556",
      "r558",
      "r616",
      "r639"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r88",
      "r91",
      "r483",
      "r484",
      "r492"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Less: amounts attributable to noncontrolling and redeemable noncontrolling interests",
        "verboseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r88",
      "r91",
      "r483",
      "r484",
      "r492"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income",
        "totalLabel": "Other comprehensive income (loss) attributable to McKesson"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r79",
      "r81"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Changes in retirement-related benefit plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect": {
     "auth_ref": [
      "r82",
      "r483"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax (expense) benefit for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Tax",
        "terseLabel": "Net actuarial loss and prior service cost arising during the period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other noncurrent assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "verboseLabel": "Other noncurrent liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other income (expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r114",
      "r117",
      "r141"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Share repurchases, including shares surrendered for tax withholding"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.",
        "label": "Payments for Repurchase of Redeemable Noncontrolling Interest",
        "terseLabel": "Payments for purchase shares of Mckesson Europe"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r124",
      "r283"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash, cash equivalents, and restricted cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInJointVenture": {
     "auth_ref": [
      "r115"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.",
        "label": "Payments to Acquire Interest in Joint Venture",
        "terseLabel": "Contributions made in exchange for additional membership interests"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInJointVenture",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Payments for property, plant, and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireSoftware": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments to Acquire Software",
        "negatedLabel": "Capitalized software expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireSoftware",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r359",
      "r361",
      "r367",
      "r385",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r408",
      "r410",
      "r411",
      "r413",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Pension Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r334",
      "r336",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r383",
      "r384",
      "r386",
      "r389",
      "r393",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r413",
      "r414",
      "r428",
      "r429",
      "r430",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r25",
      "r46",
      "r47"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassification"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r119"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from debt issuance"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow provided by derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.",
        "label": "Proceeds from Derivative Instrument, Investing Activities",
        "terseLabel": "Proceeds from termination of derivative instruments"
       }
      }
     },
     "localname": "ProceedsFromDerivativeInstrumentInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from sale of German wholesale business"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).",
        "label": "Proceeds from Divestiture of Businesses and Interests in Affiliates",
        "terseLabel": "Proceeds from sales of businesses and investments, net"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r118"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from Issuance Initial Public Offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommercialPaper": {
     "auth_ref": [
      "r119"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from borrowing by issuing commercial paper.",
        "label": "Proceeds from Issuance of Commercial Paper",
        "terseLabel": "Proceeds from issuance of commercial paper"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from issuances of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r118",
      "r436"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Issuances"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised [Abstract]",
        "terseLabel": "Common stock transactions:"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r119",
      "r139"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Borrowings under facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "auth_ref": [
      "r118"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the issuance of equity classified as other.",
        "label": "Proceeds from Other Equity",
        "terseLabel": "Proceeds from concurrent offering of other securities"
       }
      }
     },
     "localname": "ProceedsFromOtherEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r120",
      "r123",
      "r141"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-term Debt",
        "terseLabel": "Proceeds from short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r21",
      "r87",
      "r90",
      "r125",
      "r136",
      "r147",
      "r158",
      "r159",
      "r202",
      "r208",
      "r212",
      "r215",
      "r218",
      "r234",
      "r483",
      "r489",
      "r491",
      "r500",
      "r501",
      "r546",
      "r621"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r28",
      "r29",
      "r274",
      "r632"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r37",
      "r45",
      "r631",
      "r664"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Receivables, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r84",
      "r86",
      "r93",
      "r551",
      "r555",
      "r558"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedLabel": "Reclassified to income statement, net of income tax expense",
        "negatedTerseLabel": "Amounts reclassified to earnings and other"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r82",
      "r85"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "terseLabel": "Reclassified to income statement, tax"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount": {
     "auth_ref": [
      "r316",
      "r317",
      "r318",
      "r319"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.",
        "label": "Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Redeemable noncontrolling interests",
        "verboseLabel": "Carrying value of redeemable noncontrolling interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCommonCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r386",
      "r568",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "auth_ref": [
      "r568",
      "r570"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transactions with related party during the financial reporting period.",
        "label": "Related Party Transaction, Amounts of Transaction",
        "verboseLabel": "Fees earned from TSA"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r386",
      "r568",
      "r569",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r386",
      "r568",
      "r570",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow due to repaying amounts borrowed by issuing commercial paper.",
        "label": "Repayments of Commercial Paper",
        "terseLabel": "Repayments of commercial paper"
       }
      }
     },
     "localname": "RepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-term Debt",
        "negatedLabel": "Repayments of short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r255",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r23",
      "r27",
      "r132"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "negatedTerseLabel": "Less: Restricted cash at end of period included in Prepaid expenses and other"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring, Impairment and Related Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r282",
      "r284",
      "r291",
      "r294"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Pre-tax charges recorded to-date"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r282",
      "r284",
      "r291",
      "r294"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Expected total pre-tax charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r129",
      "r281",
      "r287",
      "r293"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring, impairment, and related charges",
        "totalLabel": "Total",
        "verboseLabel": "Net restructuring, impairment and related charges recognized"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r283",
      "r289"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Restructuring liabilities"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r281",
      "r288"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "negatedTerseLabel": "Non-cash charges"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveTranslationAndOtherAdjustment": {
     "auth_ref": [
      "r283",
      "r288"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).",
        "label": "Restructuring Reserve, Translation and Other Adjustment",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAndOtherAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringSettlementAndImpairmentProvisions": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of restructuring charges, remediation cost, and asset impairment loss.",
        "label": "Restructuring, Settlement and Impairment Provisions",
        "terseLabel": "Restructuring, impairment and related charges recognized"
       }
      }
     },
     "localname": "RestructuringSettlementAndImpairmentProvisions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r39",
      "r325",
      "r444",
      "r628",
      "r658",
      "r663"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r148",
      "r157",
      "r159",
      "r240",
      "r441",
      "r442",
      "r443",
      "r464",
      "r465",
      "r654",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanNameAxis": {
     "auth_ref": [
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r386",
      "r389",
      "r393",
      "r394",
      "r395",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Axis]",
        "terseLabel": "Retirement Plan Name [Axis]"
       }
      }
     },
     "localname": "RetirementPlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanNameDomain": {
     "auth_ref": [
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r386",
      "r389",
      "r393",
      "r394",
      "r395",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Domain]",
        "terseLabel": "Retirement Plan Name [Domain]"
       }
      }
     },
     "localname": "RetirementPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r386",
      "r389",
      "r394",
      "r395",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r414",
      "r418",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r386",
      "r389",
      "r394",
      "r395",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r414",
      "r418",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r334",
      "r335",
      "r336",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r383",
      "r384",
      "r386",
      "r389",
      "r393",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r428",
      "r429",
      "r430",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r334",
      "r335",
      "r336",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r383",
      "r384",
      "r386",
      "r389",
      "r393",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r428",
      "r429",
      "r430",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r193",
      "r194",
      "r207",
      "r213",
      "r214",
      "r221",
      "r222",
      "r225",
      "r330",
      "r331",
      "r583"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenues",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Segment revenues"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Offering price (in usd per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r84",
      "r556",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of information regarding changes in accumulated other comprehensive income (loss), net of tax, by component"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of information regarding other comprehensive income (loss) including noncontrolling and redeemable noncontrolling interests, net of tax, by component"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r392",
      "r393",
      "r396",
      "r397",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r2",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r16",
      "r19",
      "r20",
      "r21",
      "r278",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Assets and Liabilities Held for Sale"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of computations for basic and diluted earnings per common share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r21",
      "r136",
      "r233",
      "r234",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r259",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of information regarding intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r254",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r254",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of changes in the carrying amount of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r285",
      "r286",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r285",
      "r286",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring, Impairment and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r283",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring and Asset Impairment Charges"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r202",
      "r205",
      "r211",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r202",
      "r205",
      "r211",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r189",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r207",
      "r208",
      "r209",
      "r210",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r218",
      "r225",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r189",
      "r191",
      "r192",
      "r202",
      "r206",
      "r212",
      "r216",
      "r217",
      "r218",
      "r219",
      "r221",
      "r224",
      "r225",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segments of Business"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]",
        "terseLabel": "Segment Reporting Information, Profit (Loss) [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ServiceAgreementsMember": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Limited duration contract between, for example, an electricity transmission customer and an electricity transmission provider for service.",
        "label": "Service Agreements [Member]",
        "terseLabel": "Service agreements"
       }
      }
     },
     "localname": "ServiceAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r129",
      "r281",
      "r287",
      "r293"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance and employee-related costs, net"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (shares)",
        "periodStartLabel": "Beginning balance (shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r30",
      "r604",
      "r625"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "terseLabel": "Short-term borrowings"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r8",
      "r189",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r207",
      "r208",
      "r209",
      "r210",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r218",
      "r225",
      "r254",
      "r277",
      "r284",
      "r294",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Business Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r34",
      "r35",
      "r36",
      "r134",
      "r136",
      "r162",
      "r166",
      "r167",
      "r169",
      "r171",
      "r179",
      "r180",
      "r181",
      "r234",
      "r320",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r61",
      "r143",
      "r144",
      "r145",
      "r148",
      "r157",
      "r159",
      "r178",
      "r240",
      "r320",
      "r325",
      "r441",
      "r442",
      "r443",
      "r464",
      "r465",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r558",
      "r654",
      "r655",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r178",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r35",
      "r36",
      "r320",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of shares under employee plans (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r35",
      "r36",
      "r320",
      "r325"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of shares under employee plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Authorized amount available for future repurchases"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r35",
      "r36",
      "r320",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Repurchase of common stock (shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r35",
      "r36",
      "r320",
      "r325"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r36",
      "r41",
      "r42",
      "r136",
      "r228",
      "r234",
      "r546"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total McKesson Corporation stockholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "McKesson Corporation stockholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r136",
      "r143",
      "r144",
      "r145",
      "r148",
      "r157",
      "r234",
      "r240",
      "r325",
      "r441",
      "r442",
      "r443",
      "r464",
      "r465",
      "r480",
      "r481",
      "r499",
      "r546",
      "r551",
      "r552",
      "r558",
      "r655",
      "r656"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Shareholders' equity",
        "totalLabel": "Total equity (deficit)",
        "verboseLabel": "Shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r135",
      "r325",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity (Deficit)"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r559",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r559",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r559",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and trade names"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax": {
     "auth_ref": [
      "r548",
      "r553"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.",
        "label": "Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax",
        "verboseLabel": "Derivatives used in net investment hedge, gains (losses) gross"
       }
      }
     },
     "localname": "TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Average price of shares repurchased (in usd per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r60",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r60",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Ending balance (shares)",
        "negatedPeriodStartLabel": "Beginning balance (shares)",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r36",
      "r320",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Common stock repurchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r60",
      "r327",
      "r328"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury shares, at cost, 114 and 110 shares at December 31, 2020 and March 31, 2020, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredParValueMethod": {
     "auth_ref": [
      "r320",
      "r325",
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.",
        "label": "Treasury Stock, Value, Acquired, Par Value Method",
        "terseLabel": "Shares repurchased"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredParValueMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r150",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r462",
      "r463",
      "r464",
      "r465",
      "r585",
      "r586",
      "r587",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r447",
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "verboseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.",
        "label": "Unrecognized Tax Benefits, Period Increase (Decrease)",
        "terseLabel": "Increase in unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r456"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "verboseLabel": "Unrecognized tax benefits that would reduce income tax expense and the effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured Debt"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r161",
      "r171"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average common shares outstanding",
        "verboseLabel": "Weighted-average common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r160",
      "r171"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 23
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.T)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868742-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117546-209714"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=121548190&loc=d3e32787-111569"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL82887624-210437"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.L)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e99989-122729"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "44",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=29634951&loc=d3e1756-110224"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2599-110228"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2459-110228"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2473-110228"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4815-112606"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=d3e5291-111683"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613673-111683"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30304-110892"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30755-110894"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10(3))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(g))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6052-115624"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r677": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r678": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r679": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r680": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r681": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r682": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e526-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868656-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>78
<FILENAME>0000927653-21-000013-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000927653-21-000013-xbrl.zip
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M?][/\4Z6Y,9HI?=?] F2R3V;5YHMSK/3?\ZK;:9K+,+X@3CT,H?IVLL<6O)
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M9\J^]5[!?MACF<Y/Q\Z\700>_R'(_SE62&4QEB7":"-34F,6@<#96$PO$V#
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M[W*.NQI2V)-P0&$"#-F12*F2$T@F<CY$FY*%VJ)S:5?#!'L2#LCUKVQZ4]M
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MSZH9DG78J"0$)LHJ:WSKY8[42OC:]FP:IS+>QO)J*3&7@BEE]="M)0LE5#0
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M!2@C2'O=LWDH;+Z2@+>/R;MH*J 1J#'UDKXQ]NKI7+-I(VA)L2?H( FZL63
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M4V)DDRB"$*$EYR)Z)UE";&-*UATVMM>3:W#A?:N<^U/O^];-VQ_L?:/$DFK
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M 7/;9SXRAB)$F5H-58)%K #&4RW)AJ03O:F9G-E!>NYG]Y%QU$(Q.;5DHW=
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M:HW.=26YD!U 3\H2&QL(M\:VM+([2V%7)Z$',5*&Q,V-N7=<.(7JP6:"'*0
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MXWX1Q3G'%GE:8B=6AQ@E4>^)H-X03266S%L27)20TJ_W)''EY#^30\6G[>9
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MZ=;[;N?T9%PAF-X3'U.S?>K=]JA2:8*DW_ONL6Y_.>RT?/RP'['Y(EK?-$[
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M\J4_^N[F:TJN*'CWRW %7;[V1WGM[N@-0S6)][E4?BZN/3VM_UDB2]=N;_B
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M7S[1[8U_#O?P/\W:T;?SVI=-4C^*/_\C?WQHK/=KN_ L_O<KITAZB!6P1'-
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M_ V.MQ87S9,B;97?G7>JBJ7Y[1DADJS+>M?K5PF*SS^^2F@)Q)X#Z P&E-,
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MS$2-J;W]3U;0ARKH]4*#9+9NUAB,J'=S:-3FMA#KI75XO.U*TV  #AV(-"L
MU0(" PV*'!R#4J2C.$(,29.:['6ZWXK=1,#%Z'DOP![L-(H(,*=.62F<M12F
M%NXL.*>$]1(*'6YMMI?]AR<H\/FD_^"$98[9E/,-"E#/-- !2Z!,5&WLI XR
MLF(,4S'[[Z+>Z4>=<*<^G1J[L4/WJFCYB5J;_8:'JNS8;T#,,H((!+X\I\R5
M!\9Q&ST(;; +E@9B2[\!H_6LHP_5T>PZ/*L:CUT':2535D$@6%)>IBDP1C/
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MJVVZ_UFZSQ&VI=&'#KMC0!YX8+I>?P,ZQ!M<U:T?^KRW],>5YW#<;(\61/%
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MO$:#Q$%IH7?Q"3#*$332.<09-T01)FQ)@T@-:3#^D&FPTC1X<4F#D'KHL?%
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M:+_8Z/1UJ^A,M;/!HC5MJ>JIA\L#6_F@UB/LR?9DNP-(&84:*N!X,( *$IU
MAQT@SNCHSQOERWZR<)FAFPW:'IQBKDRGIBGN#[UFT,^D4T(&_>- /T[7"(F]
MY%: H$AT(@U.0_98_,ERX[AB2M"RQPD7&?,9\U7HK9 Q_SC,C[,]"BMH>)#
M<T9 M/H6*&0T$ I&T*- (VM'0T^7%9Q"8Z,,^L4"_4S:,630/P[T$]DB[AB"
M(FJR"0Q$#\T J5$ DEIDJ-/QORP=M7K:N>;98O[5#Y(8=V=LMFWGV!>_M3J]
MW@WQ/23Q_9JI;@J)C%Z\X?C38SAOJQ1AKIA[Z(R<QGIBO$%>8_VKUU(X;"G
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M90/+9KMX>ZC;![[XR^M6_]#JKB_^[C3C2__$UT^[_E4VP:A>A\MQ@O-=%.%
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M9Z,71Z=5KY'Y*_-7E6[\(1[:4^O2LH?VHB2'+DG.*@T5QAHX+!V@.'4+H<0
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M2-T1*='1K'-OHIGD]^]/D $X%V%[!N L 3@1@CM)!=*. .6I!#09/RUU -I
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MDM#0!(&T-9!0YX5R 4.A,.;(P.#Q@)<@R;Q4+5X:-V66)%H-1C"P6&) "==
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M1$9I<- I#O"@_[7< :9YW'M1T6;:=\NL_WHVZ<@TTS#-YPLG8R/G7',3"M.
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M0N(RW79K:'>0W/!H\+WA%*Q!?T=BV#HC!AT\=<D(PMVX;9HA)H,F- 1J&=#
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M,[+#?;0G5Z*H29EU*#R1@O89?)D/$Z4566<\];KP/#%9TL,4=Y':(A^XLHY
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MY9X^RZDL@.H *H,'GZQ)3/"86?#&&QOU]2R'91M:38#LC "3-RFSHNPL8X:
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MX-8F!=QFH]]>]X?#[33:R;ONVY7EX=ZX0>IA.;BIO)F+30T"!TVE$P224@2
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M\:)6RY9<$">Y(3'&[(/V(6NQM*J6%0/D*N2J]H9ZH)9[5V41&P&",1.$4-P
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M(ZXX$  >%****@!Q:HUX8@TH.I6^9/>IJ^IS9_P?"$RTNC+P*+6)1"%%:68
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M0/6:$L^EX!>^C)^3"U_[T64)?LZYN=)E?_R:INS&%VN>"W6Y1_"39@=KT=/
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MM.V-5/9'F[GMTCB^K27S-LME<QA>-T+I;/M*MOWW-KDW8+UI,@I9E:<D!NG
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M2\C4;[(]W$RI/^C;:9>OL")(+;22TYQR1[A!WN52CJ0ILH%S)#W(SLMH>%1
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M1Q1WIA;QY$7OC^?OG_?>5EH33TK(8Z.WG3GIL*A%_G6GVO/H_0G ?-[\[^?
MD#=MI@]^W"\CV7K[T1\.*T"8O6T&7>^^[;]O<.EY;W^^7<N1K_KWI)SB 7H<
MQ>EA25[Z$B?3 D:P8U]5K97^>ZYLO_WV:G;M\Z_^Y\_FNS9Z7P_[_K#WU4X
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MX\F;N^WSO.C=)]W+,)CM>4[)S R@V>)YA-],3R>PTCC3S!9H%3"JD.N"-UM
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M9 (62F@A0F+4AW"C^\26=GR3_=&F+]E0C:W:'A:&71/LI[Q+\,[O'[77!#P
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MJ[SE@H7!;;Z:US<4G .4S_,[)DL&DX-H\L66-$-[J-MQLQS-GTM(OIKO7C$
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M2/, #BZ7 CGG/>+.FN@P:"CS.65LMB#4&_S 8"3GQUKC!<?&0".((,I;\&!
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M/2W>3; G,4<BLQ)A(SCBQBADJ-'(>T.DS*N4J[V,>L&[@G<O!N^,8L;E$$\
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MJPX.NHW!4<R_=GV50-3HINJ=M]UCZ.=YY46I7_KPM4MZQZ-HPW]/;6\0>WV
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M_LM1\^+'Q0'<ZS/=/P<@(5\.?_W1I  FAY_) 8"(45+PI)$1@"0<S"XPPW1
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M-?XGVO;@R.=!_/W?FUFS>M%6@?^37D1YE(<#OCG_3%]F4@SWU*KO=4]:W59
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M#P1,RY ,"E$;XET,UL?<Q>EJI?)LTW*$%KU)@)]P_BL.F0EVVD- ^>JB*D@
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M7*PO&24,GC6<;=?%=%-[G=O,O18O)AC.-[ _A_?_=!CC+7J#38]Q%QJ ^6@
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M44%(+];>J*NQMKMT6+\;>I3UO>/Z\N:';R:"P&M.$ F>(HX#19;KA*PEE(K
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MCYQ%%\)"F+D6)PY+BB]=.]*YRV$+3A:<+&Q<+Q)L)SH4*\R=C0*!Q9N/A;T
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MB5G7B1AL<L$R'1GW@9H$0,:CYA&T(6-X;=:^&<_T\(2'Z,<XX:DF^NVA[1S
M[5J=1F_,J#8K7[)A.V'VAV"U-0:'$?[KQ5A_%9[7 --K<-AO1'C7<#F:0TSC
M%*YNV'QUN]T][;^^[W8MQ)=7N20+\64AOKQQ6E:0Y+$07ZX@\>63/4GX%(\'
M0^6#:^7S"/R7SST0-O?[/YMP%T\1"\N%"YASQ8VQ ?PD'EV,.(H0<[B+&&S
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MO1X8*+7E!3(XZ()$5G>HA??*#GMK.S;8RY;4PX6<W_S3]7Y_,]-N&]I%7.1
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MT=^!D'YCUY[!0@VQB":?5$'\UUV#P<O;GU]&<ZK,+!6NY.22C";8:)CA$AN
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MIR:[U]26%\&LD8N8@LC!&R>3%SXXH2-U(0BC1+[UU):&+>_/EE.4J0J- @Z
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MV4'_ %8!#T;/!BQ@>(+"_E7K,%>4FKK#B)0PK"LPQQ(P?S]"33$$]03O<C?
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M7;5EA3UGB4;"@N0 >G@D(61#I. !^_@&*<V=VHHHKZS1/"O&HJ1P!RY%\4D
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M33AY>S[<6R6@^^Y@+MQ[H;#AZ@CA<!(BO"J!',\V=<OH%(:MD(]/<QY=-"I
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MK2J<JDG"5>A6EDHB'[#'83!;"=(KU8E5;L_**=7$'2^ @EJ-A^^-T(QJ8Q$
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M#Z_%P>LCEH7<<Z:)$-RC16R(TA[,XC+/%;6"EU9<ZC",;J&%=,,Y)^)9K-C
M*I'I,.HB<[Z2ZS0T8ZK(LR+XX WE0$QP$I>:9<(ZE@LN]6*#NP6B(_(Z^2J-
M.[Y%<3&I> =;I7MWF&(XKS YL2$D]>@("9YW=E12+S,/E,.I%X0[6Q+8(4U,
MF7.P<R4<C)BZ0K=7^%9,U<TL9N[KNN(0A/%%.#0WHH1%>>.F(RP2N)ZPB;O_
M2I_CSZ_B6!_=EK\_VW]]Y*GVWBF/S4-QRW4@6E!.<ETZGF=EX4OYY"F5BP55
MJ2YC*YUG7RL0),T,"+!@ L,,*:[+G!9<*2D4+;2W&X%P!]3Q);:_$)D,64FT
M5R7A/M<$E(22"*LR8W7N+75/GLJ+Y$%2^V(G@P6 ^EBF%>M]6JK;2G6K(K/8
M[6H"9_YZY:9?N<_FTR*-4$[9/&2><FS77K+,2J6M]EFA5+E:MV'7$R@@1#!U
M11][5%4P6WZ"M/2[?S>.&0,'45E]-@+M<_S&8^N 2(0-A6$HX%&1V*R7YA[,
MXW6^=WQ4"K#134F!OK*"\-P42'B:@(T>X!SRC OUY*E:IK;_I[;S)H/H04E5
M0WJV$1491C352'=I U()7>U!L7%SMCM[@W%C.&(XK=MO@4LF:R.:,\NJ^DRE
M#[XJ),#&7Y6QD32HR WG*6,MG97CDT'LXST!(ZS=Z;M&V4H!0!"N8-]BNGBC
M\Z<'5D6\K1:9\S4D\]"U%?=M18F-FG73<@P_Z,?D\DK-QE=&/?NAY/._F[4S
MJ]<0ZSW#H%J].7UW1='@H!.3TU)7>!1A,<.CJK8^K=.XSZM]28"X"?-Z&@*0
M(HJ.IA>;Q5:+:*RV[D[U)6!$IM26Y$E+,BT5M+C&/JT>LU)>5NDRE<(^JKD@
M1CC[YZEF8?;:"GJXH:HH.T^'%9E'\-?0H,RN?I\#Z8Z5G1JE82I4F#V_W46N
MM>R5]V9NS?M8BG/B>U4WF*HA3IT6@U6'>CQ;S$EK<M51 T?X".ONHPF.2@&>
MZ3/GPL).X0-KGM3PPG9#EH@OF_+UYFHHT1,;ZS,7CC)MHX^J":5?L#%SJX6K
M/XAEMGW2F@Z,8/43F@''3RI7U' Z&D]]Y>^H 0I:V4/MLKCD\IC5ICU IU,L
MY)TGG[8/IJ9'!$1NJ#XZRD<>\;L1F3K60&,Y<86(7SF@6E3=.*#J!3?G:[:L
M5<&[U>38Q&K6ILH0:1$!%'2_ZF^X6+WNUK;<Z>R,8U4RHB$DJ1!;*>+LQ_'P
M:&HAYP"Z:X:N.DJM<J7-PP2<Z%:UK:Y1F>%)U]'T2VTYE;D-##1]*YERH.P;
MFY?46E;()4U_,5]"W+Q490=;(.G>J[H-U*/5[5M-S,7>EYU\[_61L]KF7$3D
M70568/!$Z3(0&JP&Q8MJ@4W,K['/>68+7<#^*6HY*YSV@5DE=:$8UR84E_6L
MW^SS-]EG4*:=+6U./-C9A-LL(XHA.BV#_=&:B4SD:,_1*_0SK V\G^X;_Z^P
MUQ9I8M]/#L*A_KRAC40;_.#U42:,MC0P$EBA008H3HRC@61944K/F)*85W7/
M9,!FKV^TUUPSX[)"$<:"Q) LR/M".U+FVAO.C/:E?_*TV"ZO(0=B'1R9Z,\_
MUZT'G[60FF=9\;9JB![[#C4M[%?V'(S),$U/HX,&Y:E1LI.YBR_HHZ%V"E1P
M,JY@[E:TN&R!.J!"-#[!<MO:'IMI=C.EL 638T"UFRO$K]# +E>CHBT_%XV>
M]JO;)JFV?P$K::OQ9B BSW$,A%;]+UN&7>U5B\8-&BX51E>,.\<UWFK]7.4&
M5^H;##@V]$$+M[TW[?:0W6_0'K*S!Z8VZLA;2Q'ZV9I$@W)Q15: -S75$DT#
MGPK&!M3FT_CHB#@3X6=<-X0$S!V!QN"*QH:KG46I0^8#L89V%T/.JX/-%19)
M!4%>Q^H;#+J^/QY,NLD:K2]*)CY:VQBN767;5PD]JR+VE_IY)PDA*6+J-9!:
MZ4V)ZON^<>;%D:1?SM%)XA&_KX5$D01#;V#G<4MJAP_VH:F=MQ4<'3[46L2!
M7')61S",NIXG<G3,'HL)4UNM$J(FSW^HH[/13>L^L_4*UK["ED6*R%#=GI][
MX543)]K9 +,E6[)66YZ7N6EA^OO<JX;8=GA484/-2C(P4ZQ.DEX);V\0(>53
MXS&:Q)7X!.OEDJ]A/,.XKZB@0=^O'!7=26VKQIY6L>_P8!F8L;E^!K^1GM<-
MU>Y%WVIK[HE^(C0/>EUB3@ENXJ9Z_O:KY^FF>OX>C&53/;^IGK]WU?,KZ^ O
MK6M?J(.W0AH90F&$SW@HF?:ND#Z4@6F:%5K\P'7P.SU0?*;'*5+Q"4$L3_6'
MP:BJQ9SW-<_2NEO9I3&%:[UBM53VIF=1 #SD4^U$ZWG#4?<3JE&S..<,I;2%
M_79]L+<Y.^HZ)3A94$7&6,X+K3BE5!KG J>2EGF19742]Z8$Y_;B\I;MG1TY
M)Z0R@1-?EEA_87(B-=-$.R\IUYDJRNSB<IQ97FH[G! )N(%+7"#'^0J>.B*1
MPB>#A,];$V@3::EL&^Q.6JM[W3H,5-FS*^U\5'8OXAZ$V>ZWK.F6*3UO)VPM
MN@S6*,ES^G'J^=1HR8V^W<"$IW:>M49<V:N-9ES?.?\J?#S.?Q8'6X&<7 6$
M%R'"?X,[1W4.>[MSY_D"Q.TJ+-H'8D'_/@\#';%"YWT4>CP>V&[T?B03.RY/
M;8&UZ"S&I(^KJ.&HLE O3&6?N61F <.6TV@IAV#VVOF(^-J0Y"JS?<G9M7!F
M1./I$ICPZ7"(;K 1D,<9_!!)MLZDJ;&0&[3A.5K:[NST&_SW#U-W7"]7[83P
M<\Z$-91[95SY5:ZM99SYK78K9IQ5]S_3KNNBV^YR!/H'@S5,!8(MOMSNQ,3(
MU9###X/I#U(9#V)\@AJ1S[- S#WQHT\-O\>V]%$WFH'4?AW<Y@PW EGW<#3U
MG7]Y#7IAYQEH58-A/%AMYV7?(L)MC00;/2X-5,XXI=R@:];&<:3VY#$?1G].
MYTN#'5LSYZ'O^>')H!]=\6/TI75>C4"H))5L)XV.*D6;NIC#9Z]V9HBQ>'R?
M^C;NQ)_3_L?."_UYQ7-8E@GDGS]?O-K9^B[]?Z\)+'K)PJ.#N[?=^;0]6_1G
M5?.1*#/2]W>*-YI6%?%&G_U-:$Y :::J\].__OAYN_-JA@H=\8\3:N^@!8",
MOO'TA.O$=O.L=$9FHLR%XYA4SDN7TUSE(A1*ES&V2_-,T)+4/UR]/GHW#>UM
M-$Y>^='?-07_C0V]'ZVR?G!XG(.";DT)=K%P)->%!06=!H1+$"1&;7/CO%#V
MR5.Q A,C;?-D</WM+C-;4L6%5]IP1)HRU(,A0(T5-N1@BUUANV\2W]U0PEI*
MP%HP0SGE4A%3%&"J>2 'E0E.2DMM!GLEO.5/GM*M];2 "MSL?(CH&77;GY@A
MAT#HV^O/)E1@1\UA@&'6YI3<BAG-$=;M+PV[UT,KKWWO3JU1C^.!,LN !I4L
MF8F-*R*J'HWX/?3VI ^R]1AU6Q32"_;D=N=WT+K;>/AU)7U*#IP!]:>9IY2\
M#IYQ>)Z-JTA%.C_G<CB1)3#^"S]W[5QQ)G9!BN7Y<.9-)PE$WOKNISH<%!^6
M@.:FH$;3B -%Q59[E$FM $5VD #E4K\43([%;@788PH_CP_9F1XCECQC\3%%
M%?N-*@=H55V_JK(T/;8UAJ3WR*T5:DQ3Q[\#*CYP\$R1@8<"#71'=MJME1QL
MNS Z;:4RITX%40F??3A+_ZT1TAM5'(><0 I6S+=Z6HW15==95]&E^2?&88;I
M* 4ZVVVZ9FM&(Y085>TU.\8TXI6+-O)]?X9JU25[LH.1C>JK1!V-*0<T09 F
M4J[_UGH7&-#(T<J2%J_+W$J9 X/DO Q"9B"!1:&<8@6EVJ$CC*I,TOQ69.XS
MG,5.'%Q=H/L"R?=-71V!-.#C58]6 .\=[L!G]BA72CK+.&':&,*++".R=(Q@
M=IUEH1#.8A'+%E]1QX)"H<KW'U>E)XWC"1=W:U8,CF+D(KJYKP2#(M"[1TTE
M!X?OCQ0MC @J)\H6!5;643BG,TN"U5DAI*8@;)X\Y7*K+-1*,DD^R+B8498E
M!)8&,K Y&D\'GZHV-CX)J/,9.:7F+O$"%&-@]YTB[N#,^])?(?]25ZJ4'N#1
M>]-T^'JUXH"YZ-G1A:41W4:?QSDT"4-L#G*U/L4L&CIKYX(%):<#!Q*X/A3B
MQW"V@X2JZT/P<  2G7;')QWC)V<Q4^/D?!S+W=.J_O31#R=S7/=S!P\NS"WI
MXPC0=/4$.14VH#OLQJ22GX!;TV3KO*)T*V@>E2-Q-I,+1SD_Y:I#" Q^-(T-
MNZME6\@EL2-@/Y).I/'*]4Y^1-<=103C]C-BO\BI.>U.4MG#I'):8FY,?..H
MQN1 Q64P&UYS6*?*-%Q N'8Z='7N6W/P;7=VI\WYO 3%LM5"<7&SMF3=<3K6
MT>TRT1\]^BJPUTX/5;51TS".S#!9JER;B*;Y8/Q1,YY0=?N9M6*_V__DQQ/<
M/HS%+2)\A%+E%,'%><9UYF3&G,FULLQ1'GP13X"2@LGXE0!(+YM1O,"(X"&H
MRR]0CTV.PD<K^0\0S_#P.#O8/69@K'W9.S[2N14L5YQ0FDLPV[DG1B@LP)"%
MX+J0061KD)%F6YWBKF!N]*+9$9-:$P0>UM%U!YV=/QH[8N:PK).HFG/B^72$
MP81_I<> 0,--CPT4/_8'9WTTJ"K/W^Y('P_Z ;[YX]3\J_/_ZM/A;Z#W=_[W
M#]WV",9&45W712DTF.MI&Y,_=></#U35KT0=?/)V,IU,P'H"696^@@OOEU_P
MU:!W?MRL%8SH^7^F&)X_& X'HPFRX3F<PPBAVT'27^4H7%SFN27<CFMXMXV*
M8H\BV3GH<"%^H>7\N9PZ8W^%#+(J*Y72@7/!"R6T-Q9S-\J<9HI95\N@/-O(
MH.\@@[*]LZ-,>JI-;@GP+<H@D1/MI2"!!EG*S$JM01$-P*27"Z&ZN?.)=K6#
M!0.$F)(4S7[4-,[T,#4_J[$X9QZ3E:*KE?$>HWH^MEZ-&LQII0IVW5R-=DH"
M7<MRC=J"2D6LP!_$W/!N:C:M+?!TW64ZM$:RM2Q%[YM\VM6?N@ZG_+_^=-B/
M?0 1SKONC_;3[W^__+GSUP0,AA]4,M$"!5.9!--A5$2KK:@]>K.J@*K;(J9-
M-'OL!G8:R35^.3Y)X:K%);B,$E*S>=2D>^=51^V%&%QZ4$-I"T\"D?@)S1<T
MGLP #^\JMWTP09T6S*JZX!?K>GO^DX[U"7//J'BE=L(-IR,$ATC!]E'W^#@U
ME#@%H^)T>HJ),C8V-P6&Z[JFC"9E ;RMHG.\/J:K@_FPYH^#N'8'R*18XU&9
MF^<=2MONPN8<OU\\49W9=TFZ:'6>=L?CF<77KL]?()JY^)R.OM9X'W9*3B8@
MF$U;: <VIS)5[7WX%[P9/GSCCQ/7)X_L3P=P90\MKC'2ACV9_!Q[']0Z%Y)&
MY;.-SNEIKU</NP&+W>SLTLZFM).Y/5NO:\^<VCV/1UG"S/((7EH#5%2MA&;>
M]C_1(+4>9/>TM7?CDT'XN3YM4V77AV38 UWL ],FNBAK+\JI_EB''6:;FL!+
MT"U@NC&^L=WY=P0B'C0.\U$LHVK&N;5BGOW:.X!^^1;D1-WJOJ:=M3-KCY@U
M(XY,4HVYVQH(R,<3CY@>J&/$_,$Z8M/R@E'1=NBG5*1[*I[J(_M.J;CJBX E
M-O.22H^O(8\.[&2 FZC:B_]HI-&]V,A:'!VTI4 3W;H+(;6]*;*Z_2(KMBFR
MN@=CV119;8JL?HPBJP=<- 4GW5LLV$[JHZ@-(= #<?:[77W<'^#A!.8[;MI6
MYZ^_GJ7<H71%2F&R8$RGKYJ#L=W&8W9*7B?#=U4SM5>^WQ^?]\"BQW9[<PF\
MB]7F$:&B<:&W(KI[WF&XDKR=PCYAW+)*!S[%KD:QN&"\-9_']/8D6?28?VO.
M,6]],JI0+>$'YYO:&)UD5"RC@35SH^EQ"_SQ?BA:%V_M?4[*C;YU!MQ"["?"
M:5[^%KOS18][0?9V"2L9K[*Q^K[#BO5I2:O*%ZJ$I!3E1E4YDI&>3DX&H]B%
MM)58AIY8S/V=Z7B8L+?*/=%ZT\I8@,)0S_%H,!U6K7,\UO5''UL"D^]60*BZ
MJ1F\C,DNYHL*O[ -&WD1L</NUOU[(H:P[D\#O'$ZPA2;!$$<F>$'Y(0W'O%:
M8*"OTDJ?MU/38?I@D8RC/]<..N_>UE]^<Z?UA6.N6$ A"Q09YZM98,ZU&REU
M7&6>MM%LY])/(@C'\6!T7,%[-KU5$(EW:P;%&_LD]1$M)^5@5,@Z]3OOI9-@
M6>3=Y1;&=L6IK<G,(&]D2R..9OL7&6\X\A^P=?*"PR=U<<T2@BGZN1-X[*0[
MG,Y7J%39*@DX%I^("91G.N73HFR(+J)Q=:[?K_V[T^VZM@ZT6;OFY0@==5*=
MD(M RG-8L*-68ELJE$W'E)Z#$$91%Z,ZZ> [C3SPPQ0,WNDV79-J7KY\N9W*
M&6:-V#IOIV8X\'V=])&4(E!5,CZ0^L47,?D08>0QV0[^G:]@K!)&HUU1K40L
M8_W/U./)&&*9>TJTB*GM^+1/*".FXW:/+(TIOEV_  #5U-YW*A3M*K,0L<;G
M%KYY7^0B.ZAJ9U/%\2#"3Z1,>1@_0KGI?A]]F@D'(#T;(YV(OS6)B]< X./$
M\4X?8!*IZ  1E2ML9(2XJ..?J#@D=<#XU/?73F.FY7PY_S;0S/KQX[-!@6[:
MA"/ \F@1ZFQ4:>^GI]C1L4%?AG.KAU_:$88YX Q-( "M"H5+ +R3\&BJJT]2
M*0X*<53"@2Q'Y_-PA8.6P!JW1KA2T3^<HYK9=DZJ39CM8*QGB*'AT7G4GU+-
MO)F.@3K'#Z9U0%TBP^A2AG6=AMT"D(_-.YM,X(@L4?=T;?2C T2Q]XVWX-]^
MV5MPZ/NXA@AQ69M$(X^I9E78I<EG2/R*2<2QR4!W394O^AY'8 ^AZV)JQA.,
MYH^CH31O9\TJXF,.8 +8''2P;7($N:P2"(!>WWQ^I3]VP*!"U,A$GA']K7:*
MF%2M_ZSNF]#9\Z?#DRZH<<W<JEZLH./'#(7(&&!" CFCB/E1#L?KGD]_;W>2
M^ZB3&L/$7Z83_T .HK^ 6L>]2JJ/_#$J\UAA'$^8))U @FGL89L:CS@WJIME
M@%$QK?%=(B3%,-%P6J?3Z/U*^2L)[$&'$*%/5]!O+84B!(T^GX$3HF)7I=O4
MD!;P,GCR9*'[+=RX,QP!2<X2+-*VM3K:ICXJE?NAV4Z/K2?&)]UA9+"?\+LJ
M@?;@;9,G6X7PJQ.L<L!@_D_%M1&D\AA3Y."5UZG.M2+04@;OK##<AL(X4U!'
M9:E*S0J9Q4Q+F?&+,RW7U_ND:;9F"9/<Z?>GNO=V.DH@.0?]OT# (53L7MOI
MLM-WNRWGS4%(CYHE91:/+"ES[_ ]W]M]?Y3E3A5.E\26SA+N R<JY(+H(B^-
M+"TU03QY2M<6[I[60,QQ&T!I&=4]&OH1*W/>]97*05I.M%ZU64E3Z$7MI+G
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M5>5K5V#[M@VV/ZO2G(,>:Z3H%9HA)%-M7$%ZU3)Q!?[_FB&8"N]_C'C_X_6
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M) ['#@/DTY^6';#)!6+'2>Q$NS7!B>WWU2OU\_1%K6X@N[T6Q*$U8THG+$X
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M'C.2387D!AI@$,D##+6QAPA(*YQD)%_PO*K>#<]+B^<9X*Q=Y*29BRBF'K
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MM(?YPSYNETOT&J_#&QVSW*$A_+9_F-[=,^.BCK/NCF*6FH?"B@4R*)R6+/*
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M9*X@E&>Q7CAD'XO+(4& H'(HGFR6>F@BT-]5N@26YRB/W4"]4%!/1_ZY<2$
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M_D(?_/)L4_=[^V%XU"N?3P"]\8\X^&7CZXR,KCWUO1,P0JT9\_YPV*L7?CC
M?;K#W_CKQUX^VOL2"9SZULE,\<E70J19^7!T\5>F!IBPPN-RX[OH:S?(4[(^
MBK+?#G'ZY][@RVC>AS?(X@##.Q8*#?9AV/\8/@_7?OGFF0YZ_2\7MR1L9Z;L
MPB<LY7JV=.D)QP)+9'@X& G70T()#NJG:$QA:<;2V1M45?!_/3*Y39&NH!8
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M7&8^FBILH4B,:QOZ[/[UE?+H&QTV.EQ^.IS%@"Q!*\5CEDIIL,D[SW7@+H5
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MU30GA8RX-0G.2S41&#(Q_!ICM9>QX$ C_!*_G 96XPT::SJFHPGN]^1B)"]
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M)L0*GH(E$L<2&^LS7GR6"O!!$EQ*&R_.#WY]2V,)UFV>12H&7X>:C&((IXA
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M\(Q![M2NUAODSCQ@H2!"R9ES<)%PJH!YXGU<N$PO,.^E%RX T#1C7O3R7CX
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MK7 300KK4B$]C/V/'AS%H9ZLO5N-A!2D>G>',WB&MQ_FO4_G<,;C42ULF_'
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MW4"T;0T8_ATX<>HEMW^=GIPV"$@LYJ%['3;.'0,6#2]7_2!O25?NTW(6T'Y
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M;XJ%;[TX-3,WWAU7O9RH!,<,:'/:XC)W<H+$383?15)"$T?;C=!%.&[8=_3
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M-]VF8]XHF))M_  -\/<F '_X1@1G_6&6'2D/D_TC77D;%*E@C@:S<V!;ZNG
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M5^FMU(VOV5_\)S[[I^H<P^WC2R9/.H6C0V'&2K%)2 Z/MY2OC/N-6SX3[#/
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M$U\=GOBCCT-OMK./SLJJU%%#9C_[@MY&OS^?B/*T?B)IM":BYU+<4RV\T>@
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M,R^N-6_@^<<\Q!/ SS0<$U@%VQ_:S$3;'X$&N@+0.-S*&5>!=PHN_ QV,2<
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M<=#/GKCCFOF!%V+' UA?0]%C>4,$V8<CK=0>DVM4[VTXM:>,INV!HJCV#Y4
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M#6Q51>84Q3S0N>CQT!$Y">?&$U>,)O RT&Q$TGH4Q.8?%*N,$G]B%8DW%;&
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M!Y&;$47-!3SF-,N8Q^;I-"@ H,ZHV>J\$:"!'[<)DTZ[V1Z)=Y^TFOW^FZV
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MM,'@W@@HG2QI:#\O[[:J0N:8M;/MR)A=JFC%10QP=2*=8'<B9XT>!7HB$ ,
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M_%BA29PN^LON#7N*, H=8SJU;&Z-S_AL<A!/N$*3? ;A7+@$(G\3'@7=V(K
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MSY,WN),,C1BB5#Z4+^454E@_[\OQ%2NXN:G=T$##Z)N^]DA['#.:A>=->/Z
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M1K5[N4VU2+BS<]=,G!Z@U1U'RZRAR*ZJ*3)_LDJW[&>>OR^ZGU!+ P04
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MWK(ID@PF@HX^G('>K<2Z]@^'#,^A(_$3*?ZK2P5_O@ 2ZCPD XEI46H^G'F
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M[ 4[L4BM#7I-]>1JR<H>ERJ0O>."LK$;YN:MN8242$77C  .G;!$1N* = /
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MTS .%SR</ZF_=KO7TDWE^EK)_"Q^G S)5UY[U@1\E=]^^G]02P,$%     @
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M]D]77__ZX/M?Q/S;S#GW<O[;FZ].A\N^B(]E+__SUW<G\0S./1F.IS,_CF6
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M8!\G6V,"*[@#$ITJ_=,M)TXZ3:CQU#N)&HJ[Y.B&)P=VE:#Z\3FZ+0?V<>Y
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MAJ?HR3;"<I/N6R4S[GC\D^6P+Y'U^,JN( G#^35(YA(21'+Y 0MSKD[1<V!
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M01OK.(ADVG2=W8;FY!2F/]DWZ6)]W^0O>QT$F[GEDLE@)=-9* 8J%!:-3Q8
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M3T+ON8#_SFCT+IC^=.E9>Q'5)4OG$"D/E9Z5%?JZQ)&1Y&L--:M9/>)FX&1
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M9+.%8KE0N5[<-9WL33S#K[']Z<*F@].'R!L<B+XL!6MF)%[A>T\NWL7LSTD
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MU(*]07G!A"X642473)/DAKV1GHK.M*5HBU(=?5Z]*8>+J&Q4RA7ID'%K'--
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MC''3Y-\C#7GWN*>D/\WE/D 9A1'X>OEI:X\$59@.M51],K3$1E#!.H*DFQ2
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M6D]$&A5;@G0\,)YU[49@-0'CG$D%7*$'[WC3IB+;8?W-K%8Z;-B]9E12SN1
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M6^$1*]QH8>B\X#:YH$L2FH(-;Q2FJ#%10.EL, ];&'9[9E^'SG>?_,=M%:F
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MFW0XR_J$>([\>S(5]ESYL..U^KB !0%+RHN@'#+I4##-E6)!$41CHA>"##/
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M)19%IFA+9$GOA(VHVFP@ S+AD:K-H8APB*A;S)5<)=W?@;NIZ\H<HM#2L +
MZ]A=QV(A%Y;S'%2(0BC;9HCD=CQ/X$SVH*[-:9$]R+K'(H>,X]$?^!FN?J6-
M;['J#12YSA@,9U95@G.7F1<8F *?!=+?H-O2S'"^EO<<TS\^3[_]'_KHE<KI
MBTU-;WGL&6S[IPJSQU3T"F6%XH:S77#LWM\/5N[]9P^[B9^LA&F/$NS16#_
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M\D,R@[LL?8J1H:TY"TK4;NG%TCOAO?+&<.&:M*49EA&/5( .28A#!-Z "&M
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M$&>7;/? N5[>=(FD-47XWL:0R''318/D)FV19S\9ZC>?^P&_5B-5#5&9SK[
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M_+T7.4%_U!1JZEK(>"<;_>?W6])[BQ]_^&[][?+%NT7ZX;O_ U!+ P04
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MBC8L3H-#4GMM:$BK8&C1+<%CD9WA1,'V_<4MR0!86EUG,G*.;!C&9=[GHW_
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M0[PY#MZ$:/ZFP9Q [^XE4A^4_?@&I>+N%:NFHB-GL;;ND"R'"5FX#6U)]*E
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MNR:J/PK=FME&SQUJ'//0XFIC<GJKOA9G?D"8WX@K*-;4X<>T(KEGIH4^WK?
M%V8'I;I^S"M.SFC,+OO)*F/-2)P-< *G%M:M]>+DJG1[L-(ARB:83=4=+9Z)
M,\%PE9%FT:-T*F @2,C*G)F"9B 2INYT!(JF>(Q9Z]ET7J-!3'38C>]4X'(5
M%<":4@1!-"_^[6Z/2;MB0Y7M+W*ZW+S<RX$G3OK>]5N(L",?<MO1K1M^7=TS
MJ9B!?M"H8N8(_S\?%$"VZGQ"]L=@R<<P/(860)\'W*)$0GE A0$J4+).@2.@
M>!X=\ALZ6,S8Y4AHF (E!B:';+DI$T10B+Q8>%'%5YN3"IS K4@V-MB6L<XF
MW[ORW5I$\([EP-ZF_8N9VW><!8F?YN7@[L/26-_ON ,][9N(0^GJ+T="P19$
MV,3D[^5@*!?\/"<:G[8*E:$"75-ZJ,,Q[!,:R8!_IUCB38IY@(EZ(N#R\\/J
M;-2+:U_=CVR_.Y_3$MQZ8(_"3<%4BD+&S6UW1I6Z#_65_J8O1*][AX,I_!I^
M_U-@&&NKUZ-6M$8[Q]"-X/N0[(A5V%O*#?1N+U8&UJAF^,UP\'ON:"Q[ZHOP
MY/O(5N'W@93V82Q>"(HOZ>$.5%91==/:#=)2YX;$JE571=?ZU1X-$KD1(U8D
MC=%9/#1^2R3$^=C1?LKL\.$GUX&<[^UDNDM;WE,TC,TW<0,U\P286D9Y20U4
M@,%N!(N/61$/(,<5(&<5D3'.#4,/*Y6>Q&X-<7RVRTCQ:/O<)4&OE!*RHFOM
M?S,F9>VIS^W9_.@O5JL;1$@4Y1_:A*G =KI1JNJA..5(@YCWK^]1@166 MI@
MM/X@^!@027D6BJ30%X!V]90R*C",;3_:WK>%[1[BH1P-\=!E6L*:D4=)6QS]
MH0*'/S"_(: !"4HS(#W:B>X6Z33-HE1I47"/89@*X 6AK5G'[=CEF7G(6A%V
M>7L6[O^OB6>U4K2FBK"KI:XRD)W>0MKPD5$D33""H-[F+%&!STF^6/;Q=J_*
M[[V+)9]<Y0?*4J4>-S,H<*3O/L$4[FU*M5VWNR.N$Z81D,G[SV>VP^;"-][+
M^2G(.\<CKAC7U;E,S.<B@:5=*$N@#X_5@*ILQ>@%8K'VFGI<[)90/.Y7(8#4
MSN] K(-1K6*0A/>\Z]IZ*87"]QNJC"]3@::(CD?!R&^XUK#5GO(08>.SR'KN
MP2-ZIG!9K00NQ$Y.0;?U7&@\9:U@&J$6>)+;>QC!1^E#Z("#GSN$HCXXGLWI
MC=<P_=P35):T$YRZRT<>_8$9_<US$ )ZSXT+F?(PKI1^+U#L]_C&M\7!X!S!
MR3?9FMHAUB4&?$VH 9X /":=U;S5XI8QC69XDJJG@G,^F4>#C*8PKLP )!ZA
MN$_\ 4_/G)B!G6MS-$WBWV"YK&/WDZ;FF^@8)!_E))AN/'(!RN/DK2\VK,)*
M6Q/RQ@=;OU>OXOI"&#)8(F#!EETW[/IN=EKGP=9Y[)^B;9[_7+5K"[<)*]N!
M,FTK^SZ9C(O<FO"V7]!QOI1WNMOHYA5)+S%R/T&8QG(+C QW!I[\MF, IAT^
M?@SGH+_FSX_HQK*5R*I!(YZD=1'+>*$GO==RVZTG#E?7X('F0E_16VM*D*0U
MCHLL"@/L!ZA(Z#<_E+Z&%Z]>598^ZOT)SKH.DJ%6]S):5?<[\K=(_RW8%V=)
MD(^6I<J-SF;,;HJ-W5^2(TJK8P9?G5"JMV&_^ S8 $H>&O%V6U:*."S;"L<L
MB ;<4T#*^L^P4H16_N8XK@+0_9]$M\JO2TMW=WM/+;UK_$&Y'%12LC,D:3#D
M[?T\+>SIBR[9QYR%9T1.ILPFC<Q'P63.F#S^XV<;WG"FD]=ZOL+H#WKS$I'5
MNXEG% ._@J=T^OBU#9_/V*L/5 WPS+ENL[:>\VHQ;!_SHJ3X0=GKN9J$Z_)7
M*Q<RV$M/SD;R((L1>SBE>4P,@H=0$6L6UN;@7'CQ_)^IB;PF/4U7:'&X(8_^
M%T-%P;P>+/]"68.F><5ODQ-+.RL(2=NN6%U(20C..LYLX,*;7N?C6]&Q?4*I
M=?M:$G1K(9)FB.:K1$62?'7J?0OZU5-98VI( ^\!7>B<"G^K[9^9:T,/*S[K
M=+G[IC+L3S![UQ7P&<[4Q3:YHRUBU@(0!Y]RC+K1WW@V;!'"TW? MLZR-O_Y
M0,>)VU]X)#.-E"T,TT4E'NF$HDI7]$[O85ZTW_.Z]U4[0W+\4.N&G+*DG$G:
M &GI[Y]:##<)_*U,-J^0#Z!7T$=>WHLHQBL*)/ELEJU)BL%%*M"*7/Z*V^+.
M?;]:5ZXT_<MA6CM)R=&@Q*CT^]?"63+S15LG80O;6R]^>CU#^7>$U3Q<7@/=
MKJ91W'OO[;#$=^@:551.CVDL$!/WBOQ$0RPL"/TQ^WHLUC'NI2,G/>0,U-LX
M[X>EY*W>R7EIUWM&JSYO?4H@[Z<*JMTO"<(1"(V&\E6B.6 =,GIO9VK?>+8/
ME/;X\M2E[IT\MA-?-"9WT1S;#+$Q X:9CKKS.WN.50>X>CR=LWO(,"S[9)$2
M>#M$E>;[[^5I-/*,%O1BPF/T3_E')N4&-?1'%[:NW7H<8ZJP^%1A0S\?Z48+
M8/2L^C9=+)2F_ ^-=4-]'!Q/(L=$-M_#ZB5,!(T0P.HU^#M[HGUW^/A!A2>1
MW3*_,0-%'?\?4$L#!!0    ( )> 0E(,G\XX.ST! !3;#  4    ;6-K+3(P
M,C Q,C,Q7VQA8BYX;6SDO7MSX[B2+_C__138,SNSW1%&-Q\@"<S<F1LN5U4?
MSU27O57N,W>C8T.!I\US9-&'I-SE^?0+\"')ED0!%,GBQ,ZCVK9(9.8/P@\)
M()'Y/__7M\<E>)9YD6:K?_V3_Y/W)R!7/!/IZOY?__3;W4>(__2__NU__(__
M^7] ^+_???D$WF=\_2A7);C*)2VE '^DY0/X3R&+OP&59X_@/[/\;^DSA?#?
MJI>NLJ>7/+U_*$'@!?[;3_-_3D+D>QY-($^X#U%"(DA%$D _]@0/$R[#,+RX
M_V<5<R9C/X9>PCE$D8\AD[X/F<(A3B*2^*QN=)FN_O;/YA]&"PFT<:NB^O5?
M__10ED___///?_SQQT_?6+[\*<OO?PX\+_RY??I/S>/?]I[_(ZR>]@DA/U>?
M;AXMTD,/ZF;]G__WKY^^\@?Y2&&Z*DJZXD9 D?YS4?WQ4\9I66%^4B]P] GS
M&VP?@^9/T ]@Z/_TK1!_^K?_ 4 -1YXMY1>I@/GO;U^NCXHD/YLG?E[)>].S
MMS)/,_&UI'GYB3*YU-I7K94O3_)?_U2DCT]+V?[M(9?J<+/+/'_5JM&2&"W]
MV&CY#\>$_7R&^@/I6^[K.H!RE;F?A]*Q"]//@ZE[I_E!CJ_PCIBS5:Z_4!]6
M8JKO[D;4V:J/K_%07XNLI,L)OA9;,3LJ+\T?/NF?&C&FH0XRK>0TU+VCJOQ6
MRI60-5N^:AJDXE__I']:")DNVEGO3K^T\*BG0DY]& NF(.+$@P1[/O03*3EB
M0<2I6I2;[_)"KN!O7UNQ5=N'&_Z3@R7ED1&9RR);YWP[ESTN#TU0>FXRLQG^
M>44?9?%$FQ>T=F;:KQ7^M\U4;Y3[GS]OU7? :CD: LLY&)_Q5PHLS:2>Y6\M
MS?A12[>#H]!*5F86DO]TGSW_K%_1Y@:>^0&:'Z#^CM5S^S_L-??S7I]<YJUN
M-.<G &V>^)EGVDMY*N$K;(U7UVU$F75W9PV.%O(GD.5"YMK//*#PYDNT+N ]
MI4^+F_)!YI^S5?8D<^TKK>ZOM6/Z*#]\>Y*K0BZPBI,@8#'TD2(0>5Q[CG$8
M0X$5]T.&&6/(9AC:B9O;X*RT!6FE(OA!UDK^> &TCV(W5"U1[A[ PV,W\K"N
M8=O5%%PW&#;*_GC^8'=#Y=7\6"&B:,$JDYJ&:AJ0R[)H__*6#RPE3L(2;M:W
MW.'X5C]&N<H>GW+YH%M*GV7=L':2;]0=_7;)BC*GO%S$%(<\B3TH*0H@PC*"
M)/*0GN<Q]U7@^RKV7&C%0N8\N87O*MXP3<4O(%.@I-_<:,8&>CNN&1C0D0GG
ME;8;KOF4%84FZ\\UF%KS"W!9EGG*UB5E2PG*#-S2W+@?O[<V_;_#\9(#@D.2
MDXW821G* 8>W-.7R:F^N>DQ+XTH5ERMQE:T,&<H53V7Q/BWX,BO6N;S3ZY=W
MVJ2_+0)"14"21(,>1!#I7R'&@?:&F(\H900GB2MM.8B?&X/M: _H2H"-_B7X
ME%*6+M-2&^+,8"X=8DUF(\$\/J\=1MBH#K:Z@]^-]J!2?U@*ZX';P&SFHL'4
MQ-8#G0,<UZ>5?G3W13YEN1'PVRHM+[^EQ2()I(R1Y\$ "P\BI!TQ%G$.0RP"
MB6(91(JZ,-J>A+F1UD9!8#34,[_6\?B0L431CH;.PF9DIG&#Q9E)CIH^)%GL
M"YF4#X[:^';('W^P[ZA>5COD-"]?[G*Z*K1?E&:KXMW+[B?5%]7WDY R2F%,
MX@0BHD$D&"DH?4*]1 5<J,AMN-N*GA\/5/J!2L&>-& -NRT_C 'FZ,3A@&,/
MWG"%9%A"L98^,=.XHK)/0<XM]..FZY4>S+(HM6_S7K*RW?",.0Z)C!5444P-
M#S'( NP;WP,%0:(_EGRQ>XYV<O <%F0U4$X># XY7EH]0;.;[,8YQ^ ,N2\C
M'D,9>UQ[<9K;"6<>E-Q'7!$4^$@M]LY_I\/TV-'V[(&U(^XS<)J&I#?8F$6D
M41%\. &2,U-W8S D*Q^1-"D#=UO[EFU//-V/6>]R2?7:\.5KJ=>%O\I')O.%
MYROBHR2 89((S0-4TRKW":2"A3Z+,8JQT_[4 1ES\^-:%=V&^R'P[,;ZF9",
M/-!;[4"E'OB]5G! AZS#_"''^"$QDP[P#CO?CNZN1_L-[5_359:GY4O+&W?F
MN&(11WIR9X%QDH@/D4RP"<Q$D$A,8D_%-$D"E\%]4,K<AO=GW5W9JM3REO4Q
M<C.1_5YIZ[AB.XRKW;@_&ZV11WY?H)P9H!.((3G@L*!)6:#3UK<\T/UP/R;X
M6FKWV6P.OUL7Z4H6Q5=Y7^\5FVT%S#W]M8CT*BH)&$1>$$'&H@3ZV/<IB@22
MGM-N3J>TN3%#JUNOO9MN7(DOB,\9A2K0SA/RE<85BP0&L>+*8V&,)%L\RYQE
MDR.[*W4\;%LMP8@@V]'N8,"-3+^V0#G3K14 0])NM\!)Z=?*]K<T;/=2/SJ^
M-:$(V4JOXZKHG=NL*'-9IGDM3ZZD2LN#Y]0ACV,?20QY)".(&(XA"7U?]X$?
M<HPDQ6Z^6U]%YD;BC1V@5=F-8'IWAQWW3 'RZ+OSK;X;B$>*%3@7K"$IK+<N
MD[+;N8B]);ZSV^OIHO('*=9+>:,N.5\_KJOC@TJ# ^%;)B2O\HNW8Q%%$2>4
M<!A%$=++6G,*$' &,>:<^@'&<1@Z.;'GZ3,WAFS-,2&,Z4IE^6-UHQ'D\I[F
MY@(IX _Z>5GH3P'=6@RRH_&EX(=E'1FY#3.] .RE>C9;Z2^+HYMWYA? TA&<
MKEO'=A5W>G3'%E '!'>$LC9K>3 *?P^$[Z">Z)DJ3>NK#H/?GC<[4+-]3V^?
M-1UD^<M_YFDIWV=_K!8A"GE .(72\\TN9"0A,UN1W(\)BU 2:5_6A:[W1<R-
M@3<:@O3QB:;Y-AQ3?N-FD9RV#[@>.>Z!:WO<> YDHQ\UMFA5VD&AU1ORE/&8
MZ<.>,.Y)F?AT\9B5^R>+1Y\\UYO[(K7_N.;E.M=.AG8JF\"0*^U6UB2S"!0.
M8A^'$(L(0X1) JE*)$2!A[T@\@3WG>X&.LB>&T?LSNFOE*]XHHV1JO3O=W3A
MTB^N#M6@:$_H/)T+]!D^DC5DX_A#I\5_)]_'&I?C?HY]$_T8[I<L$W^DR^6M
M_DH^T$)JORI;5U'WE^*OZZ(.Q5]PGS'I>Q@JD6@WA^ ($D\Q*#E+ DX0$XE3
M7+R5U+FQVB7_^SHMTFJ]23<*7X#21 PJK4 UZ.J%)MV:X<9L=OUAQVF#HSPR
MF[7Z7H!68[!5&5Q:0.K,84X0#<E>=H(GY2TG+-XREMO+?8]_]1KNBWQJ1(CW
M%2DV:9P>J/XJ+EBH!/6UU^5A/]'K,19 DA !0X0EXY3ZD8IZA'Z>EFPUC*8/
M ]WJ;%P$O2I^U.155-%0/Q25XL=S#_3M ]NCS$$@G<C/JA#;T1;4ZH):WPM0
M:SSD.:<M.L,>=IZ4.O&)IRT*^\>>UF_VXZ+W4J4K*9J#A%O];3'_?UD4LBS:
MTX5;FHH%]43B2<*@1X,0(DJ4238H89Q@/XZX2E3"7%PG6\%S\YZN:/$ GNA+
M=?JFLAQL3V/ DW[2C8:LX;<CHS% '9F2&I7;@TQ@%+ZH_@6UWA?;,TZC^G#<
MY K6D QE+7M2GG)%Y"U;.;_OQEF/_&\+$Q"YSDUZCZK9-B/!2Q/M'2/$$!$1
M])0T-Y!\!#&G C+%$>(8A2KV;5CJM*BY\9+6%C;JU@,'_+S)UV"YA6V!;S<-
M#8O:R,33"=CI&'M7Y$23W*TZYYT(P5<R9XND-7';@U-3M7Z^XE\_:-C7HH%)
M^-;>D)9A'=YPY]0[^NV+Y#)]-OMPE_>YK+R9NR^7S5>7>2Q. B6@%R8((J7Y
ME)"$015%'I,DIDA:)>VTD#4W5M7J@JV^8*,P^.&?_@$'@?<O6O/J)_]?+!>@
M-H"?9MD!81R99ET0[,&ZIZ"TI]T!(9V(=X>%UHF&+<'JX.%3+4Q&Q):F[#*Q
M[2MN5%SDY>*+"?IJOKHJ2OP@H40[K]3< Q$AI#P,- %SY0L1,N19'5:\:7=N
M%&LBN].B3#E=@E^K.W?UE_CW]]DC35>67/ 6O&X*/0.2T7?H>J)A/7R/V-ZQ
MNM5O[*QL]6]O5[5OFYQD[!ZQHQVGQS[NMTVVD_GN<B6J7;F';*G?+S[\?:U]
ML$T>3A8B%'MA!''D28B0$) 2PB#!"4(TX#AQRZQL*WANH_K3]>6[ZT_7=]<?
MOEZ +Q_>?_CPZ^6[3Q_ YYO/5S>?[[[<?/IT_?D7</WY[L.7#U_O]$.7G]^#
M#__W;]=W_P_XX?V'C]=7UW>.>_K6G62WF38&]".SQX[*U2%NK>@HB5!=T1ER
M]\Q:]J2[9ZZ(O-T]<WZ_+Y6MY(VZRJ5(RV:R1 %%B>\%T$,R@8C%&!)E=ODY
MQ91@07F2N)'66Q&SHR>MH3E)K'5TI9D] &T)Y1Q81J>.741&R#%QW/IAJ6%/
MRL0D<,S*_>%^],F^"0-W0JQ,8%459E7(_%D:6=>E?"P6B?0($CR $4;:/\%Z
ME!,51U#(A'E*1=)33L=X-D+G-OA?1Q@:I9LPPTIM\'LU%"K-G7,'6O2 '5<,
MC>O([#$$I#W2"-IC-&P"00NY$Z<.M$=B/VF@P[O#9+YY+[G)KB,_:D/>Z]5N
ME;S?)"J\RUXG/&E?^'/M!RV2,/"8%P4P#B(&D2\Y)$@2*$001D'BQ;[P>X1%
M#:6?U8"</GCJMHY6*$QIA-7KA#)I8X!C=.=@'2J#! LA$0QC3T"DE \QQ0R&
MQ#,S4A3&V,GSG+0GIZPGUMAAKH-RFN<OIO.>Z7)=^6PK<P!WH%>_4Z?22)&$
M* P#B;6/$2L/4DX13$2$F ABP;%R2P/Z'0?H_W_'IIVC\CU&W,C.S)&D6Q=@
M,PJK:KVOK#/]=RQ95V/A>,FZSL5\S/Q>O77[KBG!SD7T5!:QL]OO'>TI<[WB
MK"\6W]%O.WM.GV6Y\ -"%8E,BBRI( H$AS1$"B815CB*>4(#X1CDV25O;K/L
MIVQU#[6@1R :Q4T6!;#L6_;F%-QV##L@B",39ZMIF^# '%#O*%L5[1HT?M,&
MEX'#-CM%3AVM:6/_@2!-J]?Z,DR>/M.R2EY@UI5M"9P_2W%O+M%P_5$EZE "
M)Q*SB#,A(65A I&'.62>N03#2:27?CQ)0J?5P#G*S(V;&IW!5FE7+CJC8VR)
M:AJX1V>QU@RP8T>UG[7?">.7ZQH"U6$Y\ Q])B;(\Y';9\\!VG2C5E,:^JOD
M:^,_?OA6YX7ZK+^_"T1$G/ 80RY1J+TUY.MU-D:0L<#S?94()*5M,?5# N9&
M@:V.H%42&"WMJZL?!+&;VH: 9F2Z<D3%J>QZE^EGE%\_V.QD9=B[C-HMQ][Y
M7-_J#E3(1YK_S5!&]8MIM&@#_F*)J0@QQ(@AB")%S*7?")(@(@GWP] G3K%#
MG=+F-KBWRE8S;6E^!=4+KC4@NB"V<V0& V[DH?\&L^K7:O07H]2(L !EV&H1
M70(GKAMA8?M^!0F;EWJF+,XS+J4HS/[1=5&LJ3;C1IG]BSN9/YIR-(N(1R$G
M@5Y,J5A!S2@2X@0+R$3@41X2+*E3!L[3(N=&*:W&]79MVNA<F!.3Y<Y.#W,\
M)[' WHYFAD5T9*YY#6:KKL%RNVOVO@M+]]S#UO ,FF7XM-1I\PE;H["7.=C^
MS7XD=/,D<UI6F]1MGLH%]@,D8B%@DM!$KTE"'Q(/)9#ZQ%.8)X%O$DEF)5W:
ML<X!&4XTLY$TWLC8J/@Z$:\;J1S"DJDX9 ICJ(BO&9Q&'F0R2&#B8]_S. X#
MQ%T8_%PLI_ "37^!;(/H4YZ9I !#(6K'RV?B-#(1;[]NK]((#\>['>8/2;2'
MQ$S*K!UVOJ72KD?/OE!R55_J7<28!"&F!$J/"(@J7RW"' H?AP*A4)' <Z'.
M?1%S8\YZM+=7QWL?LQW TFZ@GX?0R./\U<%9H]XHUS?>F#[218U6RO>ZDO'&
MRH[+%V^?=+]0?_.49JGX6LH_:"Z*A_3IDI>7J]6:+K]6B9SR>WFS^I1R4R]4
M_$I7:T5-_*6>7TTMT38<(,N+&U4W52R\*/%E1 A4H3F9]V5LJBH3& 0A%QY#
MGB8.VSOXPZLW-S?B\OX^K\*W *WL D5K&,A6FFAJT\#CKFW5%HK8L<ZL;;+:
M/OO[Z"-T?3>7??\.'=W?,1J!'>O,\=L%J T$7W=[MK41_+K7L^_?].S-#'K6
M/CG!]^WAB?(9?*>>=DI\,%Y'=.1*&$'H9.D5Q@-L-R/#B%(&NO)PJ'R<"+$?
MB! BB0*(N&]2*F()@SA@7))$JL"IT*>%S+E-U%^DD/*Q2E]R)'JV'M/'/CPS
M-+IWJ,O 4(\\A1X+3!X]=L4!IE%CD+]W)(H##B<CAX<O]2:?96XVAZMD_/XB
M]GSN21Y Q0(*D1()I&'H08X"A2(/H9 Z71%]T_[<*&BC7EW\Y_%IF;U("?.F
MZ 0W2E=%U1P33+]!U8Y7SL!J9 [9PE2I-F"*Z,,F#YH/^HV(:9,_'[9O+]/S
MD<>&2NO\59;ELLHE5&R3LBX2IEC(B(02\00B&C!(C3,2,"2J<MG1N5F=#\J=
M&P=\6C\^@6+]V"9V+L!ZI<$&Q4;Y<],Z'X;?CA1& '5DLK!(ZGR[DT+[ZVF8
M!\CNW G:N,F=#XO^SKF=._$XG=JY^_6^82WRB:;BP[<GLU!K:][63;=;^R$B
M,O3\" :$(HAP2"")902]!",2^A&GW&G59"%S;G35J QDK?-.P1[72);3<-M1
MU, @CDQ/+7Z-NA5\=9W6EIT&/V]Q &C8:);38B<.9['&83^>Q?Y5]S.;JRK&
M]\^2+LL'3G-3>_6G)F@T":D*2(R@$-R#*,0!I,S#D/D*$14E063'.-UBYD8R
MM:9@J^J%"3CXR7[#O /1TT<:P^ T,H\<@:A'&N,.K.P/"8;!;*+-_M[8.6W7
MGX:D8]N]X^7)ML]/&["[#6[Q=$_'K%D7?<SR;36B&W55%>*J4A4NXMCD_? B
MB$ELPE<XA3@0$A+"4,A1S(3$;ED_3@NU^EY/FL^C*LH$\HVZVI=(5WRY%F;C
MM:Y49@ZC]62EP=<K)+/\,7?,_TC+!Y/M43_FZ,.=[AE+%VX8M"?RX-IUNL'O
M=7&X6F%0:3R@_V:-SJ#NVVFITWIOUBCL.6_V;_9CJ-H/W*3XC7%"$48"RC!)
M(.+<AQ0E(8P]3!&2R"->[+)*?-W\W'RURZ]?/]Q]=2..-X#9D41_&$8FA%JQ
M43(='[9YR&'^1L*D0_JP=6^'[Y&GW L<;"M"UTF-?Y7E0R9,P?NZMNK^7V5U
M;>KR6UKH01W'#,=Z/,>2F^2E!-(X4% @IJB4/ F9U6[UN8K,;?AOM;ZHKO_I
M8:"U=*B<<%:O=#/'E%B/S#&N,#N59!@"HW-K.)REPV1%'X9 :K=*Q"#MN6\X
M[;I!VS"8P]F_ZE*O.W5@%XB*T.<T@(F'8XADZ$',8F3NBE,9:VKDL=7=H+,U
MF1L7U@J";85CM_K0Y_?,Z;VMR? >F0]?K[M.AW*UY:5W"U!/U2OVNVB3]<Y$
M&VVC]I+39MP@R';LUYW7_F1;>H/ L+OK-TR#/9?=G&?KE;D:=YLM4VYJE[0K
M2A4K(F-/0DQP"%%DKJ_ZG$!!8Z$$QE$@K.J7G18UMSEHJREH5;59F;H";+ED
M'P2VL9?O_1!S7\N?!&/0=?UQ:=.N\4]:O;?>/_V&N\=KKLU>956K<L5?/J_-
MP42F3,D[>5GJCEO)EU_D2N9TJ=?Z$><Q111&7H0@8H& C L)XSA4(L()3>PB
MTUP%SXU+:F7-U$T;3<%]HRHH'V@)'NBS!"I=FEC5)4T?':XT.77(:;]V+)A'
MYAZC-MC16R_N-YA7NH-6>=!J/Q+$]D[J6%!/Y),.";F3"]H'MPZ/TZFYR1S,
M/D;N^I.]WN_I/F8\O6[/1V^SW'SMM(CJ-I9Q8H^E0[^5>6IV8^HLZFTV]87/
M5(3\)(',\Q.("#:G/BR&?N011OTDEECVJ \SK)8]#JVGJ!*CI_SUX[J^]%#%
M$@*>/3[E\D&N"I,+UZ1@ >;0FF?WJ_2_;)?N(_6TI>\[?<=-Y"_?7%V#C66@
M,0WLVM91D>("U :"UD+P0VOC@'EDQ@%_4/]\6 VG]>E'07=O'3".%/<$R!_T
M=%2^7 JA6R^JF>@FO\VSYU2#M8BP($F(%8Q\HM<*7"802QI!+#"C89C$,<>V
MB9"[!,UM;5#K"AIE+QK7*<M!J[!];N1.?+O)=DC41J;-_H YI4VV0>.,],F=
MS4^61MG&R-UTRE;/G[4)6=S2%T-*[=4%/_0E$HQ"G 38Q SXD$CE01)*3\5"
MX-@M?]YA,7,CA?<Y5<VM>=HH;*ZU&8U[[3R^1=5IU_$,K*;9<2Q H^$(=SZZ
M,1AAH_&MI.^QR7C$VB,;C,>>[L<#OV29^"-=+C]FN4SO5W6C_.4NIZMB66UI
M_$+3594)DN,(<U_X4,6)!U%".&21CZ&'I8RBB$0<.QU.V(N>&U\T&C=I^/B+
M2;W>Z@RH^.NZCH+H<P?>H3_L6&4<E$=FFE;I"]!"W>H-=A0'1O/!<WFZ S8D
M+3E(GY2JW%%Y2U\]6G _+ZDWWDR0M&;*EU^R9YFOJJ&X\#RN" DH3 R%H= +
M(/.\2"]]8NPAY,5!;,5>G5+F1E3;+>)JZG@!]QM=P=-2PUVF2CELS1^']_11
MQR"@C<P[6[QJ+<&.FD.@9']:,0A:$QU-]$+-Z0SB)!H=!P['WYWL=.&D^KM'
M":<?[IL^N4SOJV_"E[I4O=F&:A8H+*0\5"2$6&,'$5$))"S!D'B,)IHJ%5%.
MKEV'K+E1Y+84PW*C]#EYE8^#;.>O#03=V+M"19D^5N<>6WTW=4O-V>1&Z2'S
M+Y]$9MA$S,?%39R1^:3=^ZF93[_2CT6^R)*:K"8?:+Y*5_?%SA&8R7?"TW*1
M*!6BP!<P(%7>Y9A HG@"!2-)K+@4@>=4D^NTR+EQ2JLQD(W*;B1B@;$=EPR+
MW,B4L@&MU1;\L'N^VB@\X$+/'ITA:<5"ZJ3L8H_"6Y)Q>//,8CF?S$G8E_3^
MH;Q1OQ6RNEFWD)&'&1<<QIQIFE$QAHQHKD$^B@+%6!C(H%>IET/2YL8PVXHF
MR^HP.C?JPDS!M<G-4]T\[%GZY2#6=G0S&((C,\T6O$K1"_"E14\K6^<S&J$T
M3!<HHQ2).2CP^Y2+Z;+]:.&8SI?<MX9N]5>(Y^F3\8KN)']89<OL_N5KMER;
MOQ1?Y;U993499"1"?BA"[;3$@5X0&:1-"C5HTJ4EL?Z0!]:[12Z"Y\8SN[J#
MK?)@H[W]KH@3_J>WD\9"=63N.0DH:#3OD1')"6'[K:BQD)YH=\H:\6&VJOJ@
MU;%[Y=3<9!M:?8S<W>/J]7[?^M%Z&EGG+U7"E/HJUR7_^SK-I5@PS",92 JI
M'U.(A.*08H1@0@(4REC0)/+<JD<?E34W8F]2_A1&TYW<2P+\D*Z T_5?&Z#M
M_,>!X!N9P5LMZW1)[=7/"]"J.F3YZ)-X#%L\^KBXB4M'G[1[OW#TZ5?.2^-V
MES4-MO&:UZM_S])5^1?]X3J7BY!%@DK$8<0XUGYB'$&B5*Q7IW&(:4@PE4Y<
M8BEW?KRRJD-=JYGUT517UX0BO_$Z=Z')/4:%2,W'= D>*X:ORA:E_>J3V':/
M'0.- /K8_F2;U:W,6@;:%BO1R%=J@T;OX7.[60(U1H*W4Z*_2Y8W2SR.I7JS
M?=U]]7L98N]S5LKB_5K^JM]\\".-+VH6 Q[7BUH:(\-;VA%"6$(L(@K#@"E!
M8S_P9&*[W.V4-#>Z"G_"WC^"2ET@UA)4"@,_N@!&9_NE5S>\IU>S@X$V,MWL
MXO5^#Z\>:]9NX.P7J8,!.-&JM!O(89:B5IATK#V[WY]LL6EEQN[JTNZ%GE$4
MV>K^3N:/[R4K+U?BBCZEINBSV:J\8<OFT+58A"2* T_YT)/2AYI/(T@]02#6
MCJ F4Q[[*'0*J+ 2.S=VK8M5+S<1%D)K[QA/80>WG7<W/(@CL^TV-L6H7-U/
MJ+0%6W4'#*]P0F?02 L[R=,&73BAL1=_X?9VWX)55>-UKKVODJ_S*F#IMY5>
M"R_-;>,VGO;#M^8V8E7]X4ZOQ.[DXU.6T_SE^O&)IKF9[Q98$L&4GT OB(1V
M!/T ,N812'!,*$I\@IA3D9AAU9L;M7V6);C7!A3FM#7C:16C8#*2 UD9K-=>
M;3)$QQ7MP-UJ1XW?K[-&IM -<=:F@:UM%V!KW>Y-@@NPL;&N< -+;:6FX<9,
ML+5SR-);8^ _;(6N036<N)#7&.CNU_L:14K?R2%/G_4T\RPW49G:):YVW2X?
M363Q(N8$)R+AT(M\O>;7OT)&A8(Q1YAY,F0X\=WX_H3$N5'X;S]]_0F\SY9+
MFE^ 5:,JH)6N%YL0X!=7]CZ%NRTA#XCFZ!S;ZOHZ!+A!M-9W2*ZTA&98^CLE
M=&)&L\1@GZ1L7^S'.Y_E'SN)\/)LI7_D=<G#F[RNM7.]VGTB7?'T::FU6<EK
M/<<6"X]Y(>(4PS".B%XZ$PYIH!(H4!P23V#,N5/X\-D:S8VWM$%@-_GC*Y-,
M9H:F3I3V:%X]UM@%?C>6@<HTQ\2:YW>N'?E-VF4CD^,DO>7,H8,A/"3'GJ_4
MI!P\&(9O.7JXAGOF!KFYNGZ=L>B6FJLC>LU[H^[HMR]9=8OW#YJ+1<!"/PH"
M E5L"CW&/H;:>PQ@)/P@9$%$/>Z6,,1>]MQXN4HP]C:=6*V]]H9D:2Y(:@O
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MEGG*UJ5QO>\RDT3 ,&2V7%9%HC4)R*)<A"(.*54^]*G05,4\!@EA'I2^_H/
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MSTIXRV--=]-I>9PPY21->/APQ?P,/X9PA>4HAQ97"_<Z1QRN,#U[(.)L /O
MNJTK]O><*S3U(6^Y_OJ\SIZR?U611W=%_E"0IS;*7B8L(G&*8)"P1-F.(H%4
MA*GZ/R]05B4A?FJ4DCQ@[+EQ\>X H9*_"7]0ID]7!=#J8!Y]9CLE_6P[,M"3
M'=*88#P@U,\6;/,0P!%!GR@TT-$+;A4S.!"UGEA"VR=.%F,X4-5N[.'01[AR
M2MXREF]6Z_*.O%2&GR>E%-0+((V%[F4:)9#XR(.28>(G04AH2"T+X/2/.+<U
MX7U!9!,)1QI)P7,MZK6.RD.LASHKKT#P=1R6K<#@[@*0#KR69\ 9UW-Y..@K
M>R_/8'#9@WGN1E=L4Z7F;2GO'7G.UF3Y1:P77$@1TH1 E%+=G-ZC$#,90A\%
M//09(XSZUYZ'G!M\?H<C PIF6V ]E':NPN]5^:?.R-T90TUQ'<WQG?W:#5#*
MC$E-EP <EZ/.CO[*9'4)E<NL=?$) [+5&!-+_4#!O^N\U%V27%L'P&>^3WD(
M<4(#B&)?;: CYD&2$!R2D$F/&_5M,AEL;B921UY0"=S)([5(T;H$\>5=L4O@
M1F:F/LR&Y+== L\BT<TAB!-M:Z\#TRX#SA"=OE2X2X^8+B?.4)F]Y#C3>X:?
M=']:E>NB>F^J>EUAG"98J"4-QVFU!4W5OT(/)I*'":&,2V1]N+T_Q-P(54L(
M=B(.*GYV DCS ^OA\$QP1FV!S*!3Z=/*NSZ(/AAE\K/GTUJ>.FX^<^7 H&[.
M,[T8D.4=R?BG56.=M8V1,)8^%P'D"5=[/S^.()%A!+W$]V/FAT&0AE;QV'VC
MS>VKWPD+M+10;50:>2TCIWLA-B,!9\"-;4:=Q6R,&&,34)R&!_<..&UDKXGN
M1T&Y1C==F2%V4#3,BY6YQ9($^DG(U$8L0I (128LB$F$18@3;E6Q_<PX<R./
MG3.CE7-@7MB@&FP.0)KLV''$0FP78!@E0>PU2[%=T/=LDIB38FQZ,_(E7[T7
M1?9#/?6'*/\H!<]67\3ZT[:[Z7\*K@/D]CU$OQ5Y6>;RGOQ<^)[G(4XP5,:%
M#Q'A%*:Z?"..TH D*/ E-RJQZD*8N5&*;H19UJUC1=T\=I6O(-^J"%9BW6DD
M"QZU>N8NBZOG[K(_:,H9&9F_=!9P1Q>@E=&N;*4.V.D#*H5N3O5FNP&57KJN
MF])LPFDR]SQ-.5T3>::FFC8K'Y8KG'M\7%</,9D/S!4871^9LV<.W6.WV6[E
M??Y-:!"RI:@$T%U/='/C^_P=*1_OBOQ'Q@5_^Z)E_+3:+M"W3$E>'8)MBQ[Q
M4 B1"@QC+\6P6C,Q#0(HJ"\)2D(AF54Q\C&$G-L*VM%19\,6K9;Z![UX5F4=
MGAO] 'T!;S8U/_S2*?9 MFK^S=8/,,)K8.H^>-W)'=WKL#>O6P4;6J\:/]4-
MX/6?M9[@KCO+?[2SW#F"WNH[2EVM,2?$K<=C!#DG=I2,A_2Q?V7$L:YIIZ='
M_JB@J>N+;=1 S8CY2K>8U7'NK#H]6OB^1*E(?!@Q(G1);!^22!"81L1C,8E8
M0M&BVY;>L$&<L00VM-*58SQVV8G<K@*YWH<IJY'GRR4I2J!^6Y?'MLQHM)T<
MDGJ^%Z=J2G 2JC4_PC EB=X=2Q%X5'J1M$KB&G%JIBE#.9>),5N%1X1[Y 5V
M?PW5) LZX._DKYJ1@TJ%^N#?=4M%:_#<-UDT%^$5VBY:XW.Z$:/]8^Q6I[)8
M+SZK9>ZA>J1:$>M.8)AX"%,A8"@%U2T9];I#)4P$2A7'^5A@SX3?3C]^;O2U
MDU";I'8MU<X V,]#U\,R,LU8(F+,(?V*]U"$NK%##^JG0VHX\^1)OOQ^K=H/
M^\)5PZS*#_^SR=8OOXOU8\YW7I1R(;@44O@>%$(7A$2IA%09)E!ZJ4\I3W!D
M%G5Y89RY?<GO2%&\Z)6PJB*K?8/;@A?*&/EGKGX"NO3(IF=!M,+9S-YP@-[(
M'WPM(:A%[#A@'=;-N0""2_O@W%"3V@$7]#U<[R]=;L</7&2+#\ID6+]\6LF\
M>*HXY_.N>WO@">JE$4QCZ4&US_1A&L8,2HYC)EC @]3(9]D_S-S8H984=$0=
MT++] K+]A. .K['Y8"!4QJQ@AL2.%,J6%4K!?GW(?_R'>D!-".H?ASQPX>&3
MT("9@BT+&%YM'PAPKR!4WU7QH CECU^__WJG-@M/:LXWZXR1Y?NLK*O\Y44;
MU\("Y@>QSW6"F3+],8HA81&&$8L"*=*(I+&1:V/(X',CC$I^T"@ M 9@7P70
MU<'\Z-AZ4BZ?Z(\)]<A<8X?R@!P0:[C-3^;'A'VBDWC7\%N=N _%K^>$W?J1
MDYVH#U6V>X(^^!G7G%K<DY\GNOT@+_(3+R&01'$(D? IQ"A)(9=!$D2<$FH7
MD]XSUMP6AL8-JV1UT62I#V0;A_;5T$WCO+9';:"/NA</]_[HT\.]@N^Y5^_3
M?N;^6X9QQS?Q(U_^T(G&A>#9^B-A.G_\I;4S0\RI9"F,!/8AXBF!%.$ ^@%&
M 2&2QA&R88_>T>;&'UMA02TM:,6U(XY^A,VHPQEN(Y/'6<A&"%<WPL0E@?0/
M."F%&.E^2")F-PVCD>_L4?#-4GR5O^4Y_RM;+NO*FW[LQY)Z$?1)3" *$@Q3
MY@70$XBFE$0BCJWR6<Z,,S?J:,74SNU6T&%%4,\!:\8;#N :F3$&(67-%1=P
M<,D2YX::E!\NZ'O(#)<N'RN8ZJV0>2&VQHTH/_Q4-HT:(UN1XJ7RJIWI;T]%
M$GFZHRP. P11JB@EE1+!)* !E=A/(YDLUOF:+&VV-:/(:L5-6XG'CTY9[J)3
MV,G0(%II#++Z^K76V75<T/ 7P&;+]>K3.LV6[6*\43NCNRU>52;J=)>C*6.1
MKIZ$:>.6AHL[LQBGJW&WCX>Z?LAABY&6::]?\-N7+T2'&'R5NU^_5&%! 1:Q
M,EE#O:PD:M,K4TAQ1"$1 6)A[(5^9%4TU'SHN9FQ6O).!^T74,L]J**+Q028
M<?LXL(Y,U0,1M>9<>W!<4JC%Z),RHCTJAP0WX D#C>>[KXV'*,9*TSCE, UQ
M#!'U$*2>1Z"0:1!R$OAI:)6ZMGWRW-A&"69I7VXQ,K0&AV@^MNUV]W4$W]B1
MIDX-I.W#IS5G#G4Z,CZ.+AA:Q.VP ^/'S8H+?E?WX2(/8H$P325FVB7N,X@2
MGD 2,0&C,$@2%$5J VH4>FT^Y-P^UIUD8*U>KO(Q7W+MPWDH!%'CZW\^%_D_
M!>LVTLWILHU8S@OP1(K_%NM=%"BIZ]@.[G=V<=;,6,+M7(Q,'Z>ZW-Z 6F"P
MD]AEB3E3=-R6G+LXZL0EZ$Q1."Y)9WSG0$_\AI;B?S;J61]T$'6S0/K4"PGA
M >0L4D9$RB4D?LI@BJ4,),&)'QJUR>D=96X<M1,25%):>MY/ FGH=[\6GK&]
M[@?(C&""]$+@U.%^<J!IW>U]NAXYVWLO'O;1WQ597B@*R7+^3;"E6DDSF;%J
MI=UE6;\7)2NRYRI<3DKI14F8P A%'"*6:$]ZZL. RY@*3&+I6YW+V0HP-ZHX
M%-J.*JSA-V.1,4$=/1!@7]X;\"Y_>B9%W9[@!>SD!W_>Y<N,O8![\7,-WJK/
MZK\=LM!0"%T2E+4,DW+74(0.:6WP<P;4S=MHROPJ=QDXVH8J[Q_)^F.V%/S=
MDF1/Y4)Z1/B1'\(X4%LSA!("4Y_[,*;<)Y(GR,?2N#J>T9!S8[5:ZCK#;ENM
M2VK!U::-J']JT0&K9+>HJ68&?S_'C0/JR*RVP[-3_:R2&6BA024U>#<.GA:5
MZ)SC.E6].1?XVA63LX*JKV2<V8.F*PQGI=A>^3>[.P<:K.2E*?QSR_YGDQ7B
M[:94^V)=J_.+6'^5NNQ/\Q>^X#%+/;5GA=0/&$0DU=XV(2 +J)_*6,9>DMBU
MT[(9WN@[F;2A5B59F34U1'0I-O7%Z&IL-W5--K6[R'Z0I5;PIFH+I<]/BZQR
MQ547D$8U2RO79LX,+5S7\S#-.M"*K>NC->*!G>15YRT])57IM-M+6-O;M -
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M!E:S.@N#^TI4QT.]0A6IL_J>K@!U_O*!/<&96K$V2[W%_*IVGX5.)BO$H]J
M9C^:8E)-?FXHF92!2&$B=66&E"F.X*$/,0^]4":^-CKMCL:,QY[?L5A'=%#)
M#O:$![J:C657;N.)\%D:*,S52\VH!U'B)Y#R$$-.?(IE&J1)S*TZKH\Q#9/T
M)]$N$?":4V'&[Z, /#+CWWY]]^DH]NN.%..DM%LCY+2WN/'@TS8,M\7DJ NX
M]0/LW1?[5;M>U)#%ABRKMN*EV@)5<?WWY.?"EUQX(>8*>Q)#A#&#*8LY3)B7
MQH2&0>0;5<FP&'-N;'4KU2AP37X"\?-9.WC+VE]<^7:!*-?94_7#<M=\=)DU
M6=WF6VC3";GLM1@!YM&/] ]* #8RJ]UP*_4V@TA)[AY4<T_$".!.Y'MP!;*5
MK\$2KA[O@NF3)O,G6*K6]2#8WCILA_"U/;VJ@B@^MY2D:\DV@4(IHQQ+Q>LD
MPB%$"%.(4\G41@$1'L<T\2.KFFT71YP;M>]BB79'?<LJF*AE\,RVPO=EU,UL
M3Z=8CLS?6UGK2*P;L!6WKJ7M.AC+&!N7UN;E02>U,HTQ.+0NS6\<1CL?LU6V
M5L_](?@GM:BM'C*U":F]H[=/^DSN7]5"]Z&VI?ZO(,5']2(N<.+3%,44<I_K
M0'\40HI\#-7+Y\5!'%$_M"HQ/4R,N1'4AZUU258KM48 TI&]M4=O@'IE(SN:
M&CA+9MPU/O8C$UJM *PT #L5ZD.:&Z %KQ+?NMK< *T(T)JX8[KKD'1)?P,E
MF903KT/KD"BO?)K]GKRS[S\^8RIW):.4?5B5EOHNBA\9$V3%U6]^(]E*VY6?
M5FRYX3H1HPXT[[J"UOGI1@*-4RQ-1$0\BB&3*84HBA&DV"<P3#'R>( DP4;^
MR1GH,C<>U_LJPM8;4NC0,]UGIHHD>]:J@[+6G>6ENJA06P!E2/$ZH4G'E3U7
M%<2V54UVS6?:(L+F^^'7?L,N.R_^%[TW8SMR.^[Q4W$#9:=B8+UQKP !#2+5
M^Z5_JT%I&^%L@0$-,D>>XC.M;P9TKW[M=\W<I_._Z)V;R%?TO^S=LW))S62V
M>UQ=KRWA9"ZTUU;TA&MN+B(-=/F=.2[20MWI7RA95O6ATIVR-@JQSNJT_[-*
MUOYQ*5DJ8T2@"##3'1X()"E/U5X]%(P3$@@_:LO-W5OX"\<1UXA0]\O3W4]1
MQ.E1%TLHE0$'=IK ]BBI;0CQK'6R=#F.-.N&CLI7G,2)W)LG@A/>U$K^4D4I
MW)Q<)&\ T2>'X+#V[][:65_BY+QEH@EQZE,=2=1I/;'CXGWDOQUY./<K3]=;
MLAM8)]#I8!5CF3_FQ<&J^TY=6W?NUG3EQ9$G$)(PQ-I]P<(4IC**(*',(U$L
M(T&9XT5J&LUFNIYUE:^:%6W]&V\>E"'TRQDW!]!^#D69:].#_/E,A(,5<49O
MS,P7S_T=I58/O*D5_.6F;TVMLZHUFC?3K:O33NM42_!$6LUFM9YV%FT6]HDE
MFR1M7>^&%WKO&.($0\J%VEGZ,8&84WWPX,F4T2",/*MCWP$RS.VLX)KD9LOT
MER$S9K8&CCP/(R]:XTS!V$GE71!?,:&\$F/.R>1=G*Y,)-][E)/4OK=DJ4N*
M?'\40M=!NN6\ZFI EN^SDBF+>E/H#LOJA^>\),O?BGSSO/,WZFOJ#O."[QK,
MU]^M9,R/H]2# G$"$<4AQ,P+($NB1(J0>32VJJ0YD=QS8^=6 U"K<-,YU^AJ
M 79J#*/FJ5X+,SJ?X62/O 2,,,_7)E:.C?J(B9JCB?Z:B9]CS\>%1-+1AQ^V
MGOU1JL6SC5LL%P$-_(3*&'*&0HC24"T[2<C5OU+AL8C)5"0VR\[^X^>V.BCI
MM,VXE<^.\P^@,Z/FX8",S*"'6-R IJWEJ.TM3\/ADMH.1IB4@4YK=T@49ZZR
MCTBLRL*34KP7]7\_K=X+*8I"\'ORLPJ%_*3+6WQ01+)^N2_(JE1_K7Y?.2+N
M'\E*]TQ;J2E[63"?,8:H@"(DR@!E6$*<)@B&THO\V--H&Q4%=BW8W#BDU:0*
M\2-:9J!V'E4HH")^M1LAQ0O@F517"5TWL@T9K/R>=/,BBG\O@?C)1%G648*D
MS"QZ+SJ=\\L!?Z\UDR.37ZL6>-,J]HL^^-_.K5*NC2:O](.B4A"T&M[4?VT2
MX]=*2[!5\Y7FTCR@[K7F=*+HN%>96ZL8MS$FH"=@S>EPDT6?C0%2-Y1LE.</
M+!9392TTQ;.W18Y2)ICDDJH)%3Y$H?H799S#F#$>1UZ$N5DQPMY1YK:ZMG7X
MJX75MK[(21C-S/2KP1EYP6KKS[7XC%$HJA<#IY5!3@XT;160/EV/*G[T7CSP
MF]\=$^9%]_QP@0FF/.(!%($?0"00@6G")!0>]5(I..;(JDSTV9'F]NUW9;/\
M\L^":?CUNX!H; 8P0<?^F[^DN=/O_NQ@TW[[EW0^^OXOWF"_=__P]+S,7X3X
M)M;:_MPF*I;?Q0]1:,_A+6-BJ5U_.M;]N1"L+FBN?8F5=?+T3+)""U4V*34$
M:<; GDX+C)7!@+DR&$()I2\DIP&2OF=<O=B]>'-CFU9#L%41M#K>@*V6-Z"C
M)^@J6H7.U3N%CJ[FF[\17H#+V_G7G=:1&7*<&1V06S?"U)KO[E]WBB?:X_=.
M]?$45A-[;M;=YJ^-!W_/#G^$02?;YX\'6'>W/^(H Z/Q=%/F;Z(MIW]7Y \%
M>?HF=&O&;/6P:[:]NT99'IO5VE^$4B:"!J':&W@<(A\G, W"$/JA"%G"(]\G
MJ550WF!1YK:F[T35E5@VVH_P@V3+*H-5.^GE9KTIA.XAT^AAV_AE^*29;42F
MF8J1U^%*";"3$#1JZ+CP1A'0F:G.A;4N#B/TKH;3::#><&FFC=>[&K6CL+WK
MGWAU#=7O8KU>UB6^'PI1_>-.J#=>V2H/XE9=QK+G*C<G?RO^* 576[VOSUF>
M\7?Z *]4P@I>+PD+A"BC2"H"EHDB8)SX$!.20)\&&,<8XR QWFB-)N7<N'FG
M&2!_D4*7S-IJH\L+4 $V9?W/HM%"5*>J>:4?8)6"X,US#<<O@\N,.GP1+F^X
M9C&](_/]8>E2O=G:SO56SQNPTQ1T5 7W.7@K@-:VZJI2ZPMJA4%'XSE,^.!*
MM*\S\:]4NW;J%^":FK?N)\:\2J[#L5^KKJY[^'HJ\8XPV+#-V[MM!TGU+-U
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M@QX66!&BIXS, $N(PT P$M/ )U9'U]V'S^TSWF6M<R4=R#?K<JUV>]8AKGL
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ME 5%,4Q2)"#B80*)P Q&7H#2B(=>0D.[G@K&8]M\F-,T3.B*_N^@B8M[HX\
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MR4Z 2?EJ$#:'1#;L(5=WKGFG*X_=,FW8MVT</I*?HOPFF,A^"+Z(0^R'491
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M$HJ1Y?=-\:#_>U?D?,/6Y4+&*)92$"A2[$&$O4B'\3+()?=12'T9!<86CLW
M<[-1=F?3J];C2+7XX*F6'Y:- N"YT4!=*X5FJC=/>2' ^I&L#/-/K2?)P)T^
M$O1C.]2WJ&_]O)7DH!$=MK*#5OB1$+9PJH^$]$3KK$/$[3SJ V#K\ZG;/&XZ
MK_H )??\ZD/NMU\@[AY)\438R^>,";64M;66))4^B[0/73 !D? 03$,90D\*
MG'I)PF+&3)>"TT/,C?1;*<&R$=.<7<Y@>)FIKT=F9$[>@M)*.&!_=08=<Y:]
M'J6)^/3H%?I_W+U;<]PXEB[Z5Q"Q3\^X(H0:$@ OV/,DWZI]QF7Y6*KNF*B'
M#%REW)W.U"13KE+_^@/PDIG*"Q,@08J]'ZILR22QU@?RP\+"N@3>4+0#T<*0
M9VX<C0O;!=]GO0M7]FU-?*+PH U^*SN*WJD_-V\7MD%E1#@GB*>0)AA#@A6"
M.<(IS'"2ZES%:9:2;CV*G<:?&C/N]]2=+_7*3%!YS+Y6]VQ=)FJ5%6J!>%&L
M<UX5ZWRS,/K]9'^JFYHO7^;O6W/#&,Y*?2\[QQW\Z[Q.'R^NP%*5W?\V[,\K
M6W;$#K9:MH5X!7D5'$]!AYO@@0G^9('5-Y_+.:NZ) ,K-BCE'J1ALA=BPW1.
M=A/AE5HH>^%SOI>RWV,"Y%J_6Q6;ZZ6L4^;*D *F(\E2%<$DXQ22B"#(TQA#
ME<0*IXE@)*6=TZZ/QYL:C[[,W[PSS^\4LG$)93?*"HC=P!3E#UN_U-?S8 R6
M!7MBR-=+B#VO?VMN;,MMW=CD(YNO_\863^JZ*-2F,,_^O"M:\*MBA?6ZWBR_
M6?>K%<!<\&6U7#<_OF7%O+#WE\;*G1(/R_G_/*F*\6:*(:FC!-OVRH:*8D4@
MQQF#$4ZHEIGD2GFU31I2V*GQF-45E,J"6K.R$.6GY>-3W;%@JPG8J5*;$YYD
M-^A+X,:44YG:@6EVH%GUYN(QX Y)Y(/*.^HJ, ;RATO(*&-V6W^^LN<F6_K%
M0C?C$F4DBR540D1F[9#64< HC/,<)4I3E&K:E,%V6SW.#>5$#R]K8 \>OE,\
M@,=:7#\J/XNG&PWWPF@D;VDM8EF:XH60X>CQ$@PAJ>WL6*/2TB6-#RGEXO4!
M^H=4/QAFTF_+B.:+3418A S(*334D4""< 1Y1A-(<V8@X9'0U.DX)80P4S,G
M&_&M=X\_@Y[]1'QGQHU\QL)[8((Z["QR /WM:_<7Z8CL8$U&?.5YO4XC'9%K
M;3?2]9G]>H[,F*8I1YA!CA2"),\TS#/)H&:(B!CE&%&O@E?-@Z?&>XU<W3I<
MS')DK%"D%$1Q0B#1DD-.)(:2Q5FNA4 *:_^:BUW ^I>IL[A[Q3A*6&2PRS"*
M(6$BARR.&&01Q7F:44I$Y%M;L3MRTZZGN 7-;:7L L/ J][%#ZUSEY0A%J#M
MLU^E$\JYA>'HWWO4[SYS%/5%;6[T'?OSZVIM5Y7KS68]YT^;\H!JU71 02+-
M$$^@C!,%28(IY#A-C3&=QIE6-$_2Q+O$=W=YIK:DW)P]A^]0$KS'-(DLS:0F
M" J6Y&:[@QC,8VU^I&:=0HP3D>C99K5AB^E-TU:JUYBF)ER"[6D!-BOPJ_@O
M512N!3I"3:,;XX\X.0,O%"T]9ZN0"+,YJJ)0[FP42JT4N#Z8K- =<0(!'+S<
M? ^1QJ](WQ^_DT7K SS6/_/]?1W.6/;,+6OF?U./9J19FL6(*\QA;LL$$T1B
MF$=Q"BG)F)1*Z"QQ6A[;!IG:FM?("7:"@DI2]X3WLX"V,V HF(;V^O@CY)7G
M?@F"'EGN9Q\]6H[[)>7V,]PO7MO1\VQVB3_8QA#,]K3L1N]^69Z<S?((42ET
M#K'YSB$AD3"6,4\ALE7."%8XI5YE$UT&G1H5E$?8/\HC;+-&RZVP5X!9<3V]
MRBZH.WJ/ V,Y-%]L)0.E:%=@%QMP95W'MHQK*Z#^7F /A()Z>UW&'=>KZX'$
MD??6YU[_5*%K'*/DRVJCBO=/-KN5UD<H:<QP%@D.,TR,U<$3#*F*)118<L10
MHF.J7'.%SHPQ-:;!/QLQ_P)*08&1U":C4_>4F'-(MM-)('P&9H^3T'1(&SJ'
MD7O>4 "L1DH<\GN=O'*&+H#0DC1T[L[1LH8NB+Z?-G3I4G^R,YNWJMZUW;-=
MWZ]5&0Y7-TJ]T6:#9T-AS%6W[,=\>5]\4VPQ_Z>2QA"3@D9:P0QQ#@F+(\@U
M3F DN<JH%CR/G6J/]1%B:G2YUS'8)M6K#1 VCFC#_@1%)3E8UZ*;"0(V&TC)
MW:^>EF;.P-VW:_#&K[ESKXF\3,9C3,_ ;&V$ SL=P%:)JZ;+<YD=;B:L#/RR
M5]>Z@$:9$6;"G?+'F)&1UH0!9\9K >D+:<L*T_G1HRU!?97?7Z-Z/ZN;]\ 6
M7U\MRX*;[^<_YE(M96$&O7U@:_5>B87Y0\X$PIAD&88BTQDD4B/(5"HAXTSE
MB$F)4Z^8"Y=!I[9(;04UZT\E(7BLCFF,*J"PHH,W\R609?6>HOS'\K>.BY'7
MA+@Y%D+#//!B4XE;U>&UP6>UQ"6C@5)H\]M:['"^!1^00OH6G,8=U;?@@\2A
M;\'KWJY^3K[YM+01NY88/YIWZ/J[[5 VHYE*TQ0KF.<40Y+$MA5JFL-8$:*9
M4A)'3BW"+@TT.48R<H+']7PIYH]L 5@II*\7\PRFKI[+_D@-[JWD-DNID=$Z
M*X4QE]JQZN"@; <BK%/RS%@C.R+;-3YV/EZXOF<6:)6(]EG]4 O45.25&*72
MF"E4\A225##($@.II%SHG")"<J\Z'2UC38T:=D<=5V!>2GL%%E9>@#HF6)[
MUXTC J$V,$WL'V%\J@'[7 $V0%2[ R:#Y"">&.YU4@C/ZWTV [#E%G_WW8M
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M"Z60].4V\*A4Y87%(2WYW1R8@C[\N;%5[?E"?9X7FQFA(D=Q%D$I<V$L/YU
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M;@.ITSR7FF*M(E<_17<QIN93J&0$C9#N>Z\>,W%Y S\.O@,3=:4$V&H!MFJ
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MQ?:#-CWO[-!;<6-,4'4_%\9,_6/S\&EI%@;S7OU0MNA0V5JX?N&)86W&;9>
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MYA4+*M74C,ROJXW99L_98O$,&N5 L=4.O"FL[*Z^L+ 3Z,:_HT_+T$<!>_J
MG4*@T0C83Q_LZ63MS48KV\<<E'I=!:?EH$ 'K8021+!QZZ.$Q/*H:DK0AX>O
MI?+5_J+L\5M>]755;-9J,U^7H7Q[\7W%WM\_F2>M?I17W+$_/VBM;&\]Q*,X
M8S:E-C&\'B<1S"5"$'/,<H5DC+@,568EE-!36P"L"Y2)S1-;SVUO#EMHTB9&
M/!K+?FT6@O6/N5! &&T/ZZ\8%(:IP1+L]7!;/Z8VZ0,O+Z<JM[RI-/X)6)VO
MP.DXZ*_E&W%;OQ'O[!OQYMU:R?GFIQ'+MH2>D;$JN@23>S+%7D+/A$\=F.!C
M=VWXM%0WNOH(/C)AF[H\?][6'Z:4*)21!$9I2B#A*(5<9!CJ6 J.*,T0S_VZ
M'K:,-K5EQ0I6-AXMQ06-O'TJ/;>"[<;UP2 <F*1[H=>AE9,#*F'[.+4-.'(3
M)P?=CSLXN=S4PW"V_A96/%2$]^'/1T-W:A9IE&.$(\@UHY!DYG]<:PT3@7B6
MI7&283);JGM;+='#WCTUEM.G0*M/87_$H<V6Y6H)R[J <XMT!Y/S)+ >=F)G
ML,8T[FHAMY$-M9SG?3C=++0V+(*;52<'&]\6:M/YI '3>D,WAMBZ71]72V/,
M5-&A,Y9E!,6QA#DBAATB*2!-LAA&D8Z1(ESA#/E8&R='F9J540D)ME)VC"L^
MC:@;+?3&:6!*\(?(FPU:(0C)!*<'&I4%6G4]9(#VB[M]_?4&_/I^K<J]3),+
M2&7$<Y9(V[U;V/9@&C(2YY!BL_,@0B4(>56D/#/.U!B@\4>PK9Q^G_XY.-T^
M_@ @#?SY-_CL1!R@O<,%&$)2P+FA1B6!"_H>TL"ER[L1P2]KZPA9K_1\,XO-
MY$?8; AT1F*S^%,":60^?B%SVQA"VP@@G\;2>\_V^N!'Z"%=B@8>2]G\/O5]
MP-P^[XXP#/Q)5PA\;4? ^QL^H6O([W;_\:-^JR?T.OP^3UW2[9O\M78P?EK^
M.E^NUF;Q;V(EOJT6BX^K]1]L+6=1IF22T!3F.3-?:X8QS".JH-)$Y7'$*(LC
MGZ7::=2I+=QGPHP\EV\WP-V^]N P#KVT[W4.__<Z.LLU60'\;G4"M5(!30$O
M$$,2C-O HU*/%Q:'I.1W<S>Z,ISWJ-:;9WL\LKE>2OL./=I!OZC-3,<"4Y$0
MB%5NBYTQ":G&%&:81+&DB3UZ]V&IML&F1DZ-K%?@T4I[51Z)JT;@*[!4GK9'
M*])N]!0*OX%9:0==*6B)W(<=<E]:D/,F&Q=(0G),ZWBC4HN+YH>,XG1/Q]JN
M\^5\HS[/?RAI6,J\#G.S_%P7A=H4U]]MNM(_RUBCVO_YWXJM[\R\J!E)TIQA
MPF&4:F,)*:4A%2R'.D[,MB47.>9>M1 ZRC$U^OE0;.;?R_9F;+E\8@O ]H0'
MJI*^K'5,/*O =IPG-X8: ?V!R:O2 )8J@)T.H%3")G@^5A4N]]6Y E834*H2
ML(AL/RR#5I7M*,JX96;[X754=[;GXSK&O9<#W.CW\^)Q5;"%V9@^/6[S/FW#
MDK+E\).2-X;)J]QNPN-4:,D@322%1$>I]?MF,+'.8!J1E&.O/N(=9)@:?58J
M@ >UD$#;*$:V\$P:ZC(1;APY,+P#\V,C-2C%WD^6WY<<;$6_JI@S0)G4 /@%
M#3GO(,:X >;=<3H*)^_QJ*Z-E.[8GY^D34QI^KE5):=GL<ACRI6$ML4:)#8:
MAJ4I@['$D58H02IUVI1>'&EJG%:W#+(-Q5Z*"RIY?1LKG0.XG<6"PC;TP7=7
MQ#HT6KJ 1N]V2^>>/W+3I0MJ'K=>NG1#AP9,EHP^?7]D\[7=NKY[8.M[M:N-
M<2V$6E@24O*]>EPK,:\6YR3*K1N+0YY%MLH$SLU&$R<PHCF*<Y;3&#E%QW07
M86J$4FH!YELUJK0/MA,>R#WI/?H1=9N@=MX9!_:!":E"?*<!J%78-Z/VM #O
MQ\3?HU/4X/,P4O&G0>;#K\54+RC;FD]U>_!X;:EZ*?ZB856_)W7;I[^HRS23
MB:!:4 23F-JV?P3;@UT$HUS&3.)4"RQ]@B]>/'UJX1='11(!.SAQ_%7\ERH*
M8V:]6ZT?5VL/^CH-K]N^NC-H Y/^486YHQ/:KVS=UA['>X=\$HF0>]^7 XRZ
MJSVIV^%^]?1%'4Q-89:AIT7%'8>]1XIK^7^>BHWEG'V'X$I?-[FT99Z:S9FL
MP[]LQJ0QL>[6YN9YF7G-%_/[\JXNI=WJ.$4L2<92S2#G4D-B-L$PQ\:Z%;',
MM?E)D-PIEN1?1>')F='[)S,K?9!*?74RC]K8V9LM*&"U1:4\5[8/J0EV8[:N
M]6&/A_WW+S")+M;^OX :$UIF]N ZF;Y=@!UD5^#PI=W"5B> GTCUMB_M#CUP
ML_?2=JZ8VJ7;[;_ :^&SE_H74&>*.[?_.]]VO[WCO]"KT[93_5=08[Q]\;\"
M&J=VX?]*<OOO!-X]K>T>K?0U?)XS7B9\-WE70F62B!2R&"-("(L@XSB"6:0S
MK'DDM70ZD;HPSM3LWJ]K]<CFLK%/*^_QRF:\_D>5A,R$6-NSX$6MQUQYM IL
M _RR[1@(QH%-MEK*ZH0<_ ?82MK!+&K#R]T:"83;2$9 #_R\%EH'5%K6M[:[
M1UM6'%389W.7R[LY3@U[KQ4KU'M5_?EI68<,+._KX"I>F*VQV,PB&6<\5QJB
M).:0,&V=JI)"P6B2Z3Q"(O<*:W(>>6I$^^[!_&3X=;X$K(IKLDR[QZI;KP$3
M__,TK];+XG_[>5S=Y\7-&SL(V@/S<2,S>--(_9,%?2MX'<H$?F]D#Y@UXXU7
M2'^N^^"C^GJ],3GT _L_P-\R_*9^J.63*KL+5J4U:Q/65M,4=A&\5S-%<1S;
M**4DB0DD5"4PSU1FN(S(.!%9HK%39U/7 :=&8;7,0%9"5P5L:Y>H=9%N!0=O
M%K;%[\90GD?S+:<YN&PUAD9V8+IJ0*WE!5;@QHEAG1I;F0,#Z6Y.A@9T)+NR
M/[!>YJ4/2BUVIM-C1C,X?93:MSR][O-CZV*]J>NQ_*HV#ROY:?E#%1NEOIA7
MH2[XD^(LP3%GD&"N(-%)"CE*8YC*)&5Q)#C/B M/7QYJ:@Q=25AGZ)GK/.LH
M.6#;SK]A$1O<4/0%RYD0W'%H,0#-0_:,/_/3H>'G,,HH3.&N;<,1'G>$+UO^
M16UN]!W[<X88YP*G&&:)+>R*L&VH%&=0)D0B15*51K%/P(_+H%.+ ZJ<?.)%
M&>D.S5.]<'?;>X9&<V V.56/^Z EY9=J?S]:C>U#E,:JD;T==S(UK@^1\*E1
M?71OQQK3J^6],0&^OU=\8SM4V[;T,Y0Q1C.=0*H9MPUM,DB11,9FT3HAC$8L
M\BKV>&J0J=DH5D9HA016RBM0]I3_W4KJ6TCZ%*)NW-(7IX&YI M$_M6B6S (
M6B3ZU#CCUH9NT?2H)'3;M7VR@6MG_"Q),IER\XUC)6V4,1:0YCR%B+ TY7FF
M4^%E=+QX^M2LBSL[!A#U"0]KSR%U ,_MZ^X,R<"?=277%:@E"YU,>Z!P^#39
M9H!72( ]T.UT:NOA1?Y)J_43/LX+P1:V&L"'I7S/-FH6B31+<FFPR>Q6 :,8
ML@01&R<@<*:2/$;*-5_UW"!36ZB;@]E*T*HZAA$56%G=TU3/0MK^+8<":N!/
MNA-&7HFIET#HD9-Z]M&CI:->4FX_$_7BM5U;GC?]9FR,T^WC:EFLUI]759IK
M[?12F@FM.(9,1AJ:3QY!KF4"N4@RBC G(O4J].@PYM3(8"=R&9D):J%!(W7'
MBNTNZ+LM^H$Q'?S4IR^<';KQ.@,4MNWNY6%'[J_KC,-Q(UWW6[NQT0D?1.-_
MV(^0O#L3(3GC,<K--B*RU@F#)&49I!AIJ&B:9S&5*D*HZ2USYTY8/<5R^O!>
MMJ&Y&\/ .>7U/$R#7+Z, I]WJV_;=U[=.'",:1K)KG+SHUZY!NV'H]% &(>D
MV+XBC4J_@? [I.90C^W8RN>P]6X39H?S)&$:9S!A401)CC*8ZUC#'"41(UDL
M$ND5_GANH*F9B]L^UG5R^6-UR/3=6#9E(_(!LLW/SH$;=X9 =F!2/&X./D@0
MXR4D@G8".C?6N,V +FA\U _HTO5=MZ+F,4]B4_9EKBM@S&C&:"HB"F6JD6&0
MW.:E( P%UPE'/.)Y1&<_U)JOW'>?Q\/XO.7[@PWWLMM%?KTOZ=5>D:,R=GJM
MJLQ!4:E@?A:K^^7\GTKZ[D%/P"YUEC"1QI BE$/#U,28U *;]S?1-J1=99CY
MN.G[@CZ:MSX =BJB,1:),HC9%G8Q99!&)#9O,)+F-RA5&ONY2WIB-XI_Y,RK
M>G7J70T LJM7I!]T@[M!]L1KZC:%='F<USZLC^/$.",[-<YK>NS%:+FV<]UX
M9N3\;,/SMYE&LS2E6B=FP>(T%H8'1 XYRG*8J)1&64S-KY7?TG5RG.FM7:5\
MNTS*O=(@GE_^:5S=/OW>6 W\[=?R@5+ JUW:7]#:Z^<1"%Q9_<1 8]=-/Z_K
MB:KH+1=W;&/'YDOKG[E9WK*%NM%OGXKYTFSI9B@6L3T^A31&*20RDY"RA,/,
MF D9SA'-$M7!)7ENO(GZ&K^N%;1U@.QV&-A=L!':.K%X+;9G"[QS8+M10R_L
M1FJ.9T1L*JT9N*J:U?.F],?;2ZCYM\V[ $G0'GKGQAJWH=X%C8^ZZUVZOAMO
MO*A&OBOX>+(<>;&7B,"QL.%2.52V"##)*36T0E/SHR0*9QC'?IZUCG),;1_R
MLK)_ER20OA/C1D$CP#TP0W5"VIN7>N(4DK:ZBC(JJ_7$ZY#T^CZN0[7*.$7)
ME]5&%>^?E)F)M"[_$2>8IA%+8)XH>Y*089CK3,&48"68%%1J]\KGI\>8&I?%
M/QLQ_P)*08&1U#;*2CUJS)U!LIV@ N$S,/F<A*9+';XS&'F4ONN/U4@)P7ZO
MDU\1MW80VNJFG;ESO%)E[:*_J YVX=)N!N!^^]LJ)W![<I=DL=DJFKVBX,@6
MQ37+$B5:&@J,4Y4CD>C,J>#"Y:&F1GVGCD-!L2?^O_VO',79?Y;-3#?/X(U4
M>B[F&\]TO1;LW<RX,(@.3)9.#9:K\MV#'*A>!BFDF=8RVJB6V&6M#XTMASLZ
M9N#LRAJV9?I]-OO93QOUO9C%.A(\BC*(*,:&>"2'5-,$4B%)G*@,9]R+>'P%
MF!H=[1=JO9CH"GZW>H!2$<\]I_=$N;'4D/ /S%T#(.^?7M01OJ 92+XRC)ND
MU!&AHSRFKL_Q3W5Z7QO=53[%5[6>K^1'\[MB)E/.F;&[(-&9==@+ JF2##(B
M,$&:)QEQ*I_2.LK4&*X1M,GDJ40%I:SNR4[G06TGJF!0#>WSZH*25[K3111Z
MY#N=?_9H"4\7U=O/>+I\L;][Z<OJ1[EI,]O0_-W:<$F55B6>;_]@CT6]^\\0
M,]9/I&"><0F)T@AR%B&(B$Y$C%,42Z=V[JX#3HT,&IF!%1H(*W6=Q"R>06'E
M=O>P. %^V245&L:!B>(E@J7 H)$8E")W<%8Y0>GNN0H-Z4ANK!#0>CFW?'!J
M\70Y/68TMY>/4OL^,*_[^D52?*MB!N]6G^>;.GSH5FTVBS(!;89(A@U'2Y@0
M:JTT9#A:F1]CG(L\R8E2..H15M$Z^$1C+&X>YZNYA$VL9;&5MUO8I=L\N.U
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MJ!2Y KL9*94!WPYGY-UH,^)^ICG.S(QTP#GP#'F=>?8'MN4 M,?#1SL-[0_
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M<S5;+5RE)(ZC!"91'$"<(@8SK A4"">93"(N,;'=1O1AT-((>.\3J)T"!Z^
M<0M </#,9/CL?0-=Y^PWR;S,ZO#>Y-QS-?GACY=I&K&IZ66^[#<\YYZWF39#
M!^?/S^PY;9CZA+IG,]7+,+-MM/H$I;L)Z_6^8U/_]%W-=_WF@99EDXI=-1=C
M>I&2<L4@"3"!&,<<TD@*2!1*9,QY1*A5V?_@2$M[^U7V=51P'%JT#:-JFZ?@
M :N)WSYN,(U((!B P&].P+G!9C[F'_#Y^.1^Z(+1\M[K1WE'?S0!_'M92)5O
M5R**513%&>1,,!,XFZ0HJ2 *5!+)*,,Q0FU1F1TKG!G)ZGO^LEYL8E9HY/]-
MM1BK;03OFJT(Q^3=<^ F 3<:P#$,HTB#B["F7A0)*&661"P.,"5.XHV70#MK
MN[T]L V>X%V#\$]@(VM5V.T:\$KC9F>.C5TK58:0MR-E#WA.3,D-E-I$\+&%
MLK'R_'=TC,YY'PZ>)<U/#C6W>GF?OR>$RGL_?OE!^H?<U,/EIJ'[H1A$EBN:
M!#(*TP@*A1#$&8T@,QFL(DA0D 544.JD_&@QYM+(Y.7A;MG(&?Y#;A[U<NK[
MO3:C^EU;\S;^]/S<'+B?FWM =M83\XZ]W>(NGXW"'."9ZI#\W+!O=CP^@$/?
MP?C0I>,5J,W_3,;H-_U0%=OR#SW,)C>' N8?K@OQ\A>=3ZY0BH52A,.01@KB
M@*2:JQ*C5L5,9TW)$D7<2X\NLLGEB9NOXL@8>06X$7*6!UNOJA93F[TK]0?H
M5L>F;8&2?C9K*]WEL,=/:T##T.3H0I1* 3$7'&:2Q5!@Q&."&#6O(,?*I)DG
M=?J"),<IE?K7;S*9=N^RV:9GZOV,:E8JQ?2/W5DYV%[_HYFEU[_K7.!76/UB
M8'T+L(\W:':A]HNQ.R7H?OE-Q[UM?Y??KSE?[RJ=5_UR+_2/O-KZ*3]O;N[U
M%UE^*KJ?R N>/SW(6FJ8)P%"F,8PYEB_;4-&(4UP",,D8U+_ Z<J<UD97&3-
MTM8,VAEPL!6\=,>HT=0.F>2M%Q]K?!JG"7W9?-HQ\VRS-#$S=U#7$5<AZ$:O
M1?Y\$N8HS+#QA?/C3,Q></5)S)<9-"LQ>\'N-3'[N>E(Q?R<LORA:D_U"\TW
M_T,?=O)#7O*'=:G76RM!TH@)ED 6*@1Q0BED$8L@8YJ)$ZJIF#@Q;_]P2Z/6
MCK7@L>IT;9+ZMD!IT\$W8[NCDGX_V':TZ _"B7GOE[R@^HMJ$B UR_V^+M3^
M%QT?KH#Q E1N@(,?'L7WK?#R*L+?/^*\8OQ6WA^)\MM=-;H_Y68G16>,N@'P
M=J6H"E*J4AAC99;?D8*,I!3&&0DB4]7% [=RA',C+8UHZH;=M#87/!SL=6[Z
M> 99.VKQ@M?TT50%T@L*:<STVB"Q'PG/_0W/##9W>\)^GT]T%QRX8&27 +HQ
M6X#EK=Q4 AT?C+RI%"MDBI5(%L!4X0ABEH20D#"%4BD<,YPJ'CH)=)T9QXD<
M9E/<>J?7!V+]\$ WI=E+ Z6QV+4#P!E@[=C! UP3<T-KH9'P!Y6-5Z"QTJ.4
M?S\,7H7[SPPUKTQ_O[]'HOP#'Q\AKZ'1B:LB[U9&@R$<!PF#0<Q#T]$G@02K
M#(8Q3U,D*)(JM);1>'7SI44&QKQ:9\!!L^$U8/W/]Z4P3/Q0'Q 8(U_Q&@H'
MF8H+()DI ]OBR^$F-W'&Y3Y9B=>7S"<?<<;8%S(1YS[CQD)"YJM?-7(/M_?K
M0M8ZIBL2:)H1&$&J:0CBE'/(0AE"%&&N(Q&)9&8EYG/JYDMCH<H^4!D(:@OM
M'L&3P/6ST:5P3,Q&#DA8/WI]+A_"B;*-)TK)?_ZZ_O9_]&5U**%_>!U!G+SE
M+(]FGS/MH]G[F7%KA@]RDW^KB@\^%>5V4[%O>5V(IGOQ-=?_5"U1#ML8UTQ_
MD/+M*F5!1K#4ZPJIHPC]].IX(J("IBD1B< $QY&5A+H'6Y;VX!]< 1U?J@V]
MMB7WP9W.]AWXJ_7(\6#IDGFT6\;,-#L3\]"4$^.\)/( J<]ETR7FS+JT\H#;
MZ^67CUNZ]UR]V3WN'JI1/RHE^?:V2O;YK*[%^JG3<CP3D:93%$%FU(,Q%A12
M0A,=,@G"2$Q20:UT(^R'7!J?'JP&M=E7H#;<I$BUIH_HWFHY ?T,.0VL$Q.A
M)T2=^L"Z@71I>UC+T6;K&NOF?;>9K..5(TM"^;T4.].7YX-DV^J,_$[^V+[7
MYO]K1;( 9V$40ZI""G&8Q9#$+-.(JY 3F82AHRQVSV!+XY[65O-@_+HNOL([
MN7D$QF['ZM ^@.UB,%^P3<PM7<2,H4TN#C"V@LI8GQ6C%IAX+1KM&V_>NE$+
MSX]*1VVN&4<@O^7%>E.I2-?*T+_FA?RTE8_EBNJX)40TA91CO5",&#(-1Q0D
M1$D19P2ETJE"Z>Q(2Z..,WKKX"]C,:A,=ESGG0?9CD&\0#<Q?5R$FC-_#"+B
MDSS.#S8K<PSZ_)HVAB]P/Y\R:A>%%)TRI;SX38JJD^IN\[7Z<UTWZ"S;\J7F
M-"*CIO)<F8;19N<I3C27!(+!"(>4I%D8QI%5E_O+S%@:VS2> -$IU<L+T#@#
M6V_ WAW'@L@+)VWX-&V>J9B8O=I9^'!R%L")6=@WRG,_I[M@.NQ/].:9EIG.
M_J:<'J=#P\M1[3E>O.#FLQU$7@Y ]\C2P]TN/4$YQ&)9HGB4Z==_C%0,<::,
MTF"2PH0E* M)B)+,*2'SQ!A+>_ET-M;'1[>GL'0]G5AB1.L*S@4G"9.&KZ>&
M>:.=_\&0M>^C8Y_TIXWD>?W"#&3,TC!F^IE."<2"24A%HI_X, PD3@EF;K5U
MW9LO[]D^V.;Z0'<@LWV2QP$Q^2-L@<&(Y_;86;\/;.?^,S^IQYX=/Z(G/N.>
M8O2QT"_\YVLA]'R7S1_FF4<KE04!DI1"$L488HD32#&)81!&D@0D$D)::6OU
MCK*TI[4V%#0F7K4_@.K%TR?1[0!L_Z/L#:Z)G^G12#FE* TB<4&NTOE[SY:T
M-.A>-WMI^,/C7LU_U()QMW2S?;[;T**DO'-\:UHE4ZX$E&' - U(!JE*,JB2
M))%A%$0\3EW>U;VC+8T.&F-!92WHF.MX7&X'M=T[WAN $Q/$!=@YAP)6F/B,
M#?H'G#58L/+]=?1@=]'8<.+CH]R8S)]:H_EF_?A$B^=5&/"410&!B&<)Q(JE
MD,120)0&288DIC&U3E[N&6=I'-*\*%M;6^'RQEK7@.(TM+8AQ<6 S1-4N&(U
M(J3H1>+BH.+TW6<.*WI=/ XL^C]^Z?[>OJ3;')X?-A?J*L[G%6<9YEQ%D'"I
MN4&B &99C& <B(QFB"%!G')D; =>&EG\LE=Y,/D?8F_PU;Y V[%7O/4,N&X5
M^L-UOOW#O7E= 8@KPS+5PF4(X MV%NW0FF:[<6#L-]J#M$/D_,:DY?4C%6KT
M%^*F$L_^*@O^;/[ZJ:@S!U<)QBK,> @5YQG$ 8M@%H<*2HR1G@M)!7+2'.\9
M:VGL='-/-[5JE)[N0M;1_/=<OZ$K57U#6489[)_KS;_^7H+/3_DZ%Z9S]7<C
M/W6?/YGR $?UFIZ)L&,L3_!.3%+&+- Q\PI4O]%(W_9K6+I+TPSCX567IF>X
M>45IAOT^4J2QN&1,:7D:M.W#/TA>':.BV'1F;)(+4IHP; 2ODC1((:XRAQD.
MH&!$I!'.D&53 YO!EL8PX<]I\+>F\EH8<:;&9H!BE^Z55CCW\X=O]"8FD"YP
M'TX!-ZJ0?0!!E\)V?TC.5>@^A*BO^G<[9'KKX0=N,6-]O)TS+^OE+:\9*S98
MZ!#Q9B-%OOV%\BHZ_(W^R!]WC^_7&[W6U>Q^0_5WP"R"8LPP#@,"8Q$*B&,D
M(&$ZRDMXG"9!1&+!(C?I0?O!ET;%7YX+DP%DMG!+6>3K#=@5I>25'N%&?EL_
M?#,[-+SR#:C&.5=M0H>Y26(5A8@QF I.(4X)@32-0BA(DL9AR!*!TU4A+67O
MO<_,OK/2U.KVGW?;TDBZ&O2+BIW>[9[ =NVHR^2$O66H/=&W?>K8VYQ8FF:1
M]5>YM?P*-+:#O?&@M=ZG4J0[9GYU(QW&GUE%TAV98TW)$?<8VVU(/M%<-!V,
M3/ES);#8J-/5?9[; )\@G+ DA6$2$H@1QSK 9Q)BGB4\"A.,,ZL,?/>AE_:.
M:2QONYC56@)K8[QKFR%K\.VH;!I()R:R%LV/731KF<_&\+H1O<]L[/& ^6U#
M9#WZS-V(7%$Y;DKD?(=Q_-77GI[SNHA:BFZG^E4<A)R8U&R5)3HB8X2;3&T!
M14859I'^CXK=6ENZ&^$6F\W1];)C*.A:ZL9H(Z;#CMDF@G@V>6]M/*RL!P?S
M&UJ[ L[8._/<>/A\\MT(*V;EO?$HO>:_"^[D+BG3A(9-I( U?4G]&2ABE$*,
M(QVFR8S!+* T3H- A1&R58YY<>>E16&-<?;*+R]QZN>=B[R?F$[:!9Z_<.BL
MMY<*LKR\Z6RZ*R=]Z<JKG/[ Y0U;JRC'](+:/J\$03((,PR5$"83/1(P4P&'
M)$M9%"L2Q2$9VZ2U,\[2'LN7/43-9#5!_%HIN6GZ%5:+)5#MRXT0[S^'N.TB
MZ6(<)U\1=2&LET*UD=-T7CV!PE3=5KM#O5F'U1/^]G55/?7Q<53QN6YG7GR]
M69>5UER[0%I%F,H8\00&08;T6UN:VC+]4YJ$C% A>)BP=E%R9\\99P<<L0"Y
MFX$\]O;N]U;<F.$\P';<<!E>\[## :/*R&J[Y.,06L[\,(B$3X8X/]BL'#'H
M\VN6&+Y@]*ZL?E=NI/BR7?-_5<T!RNO=]GZ]R?\CQ2J(4))F.(1QG'"((Z$C
M"QU?P)1$E"0!2C+B=-[7/]SR HS&6E :<Z_J_A[Z.=A;7'4 J7_K>+PT +SU
M+JPG.*??>6V0_%(C6=L*#L9ZW6FU ,7S[FK?B'/OJ%IX?V(7U>:JD>*/\JM)
M1_E#/IE-B.+KIT*M-X_57H0.?E2^-8EC>\'H,$FC($P4S (2&_FE##(F&$RY
M"@(I0Y$PJUV%4:,OC8$:X\'>>M Q_PK4#H!WQH6?1LM[N\V/'3--AOK$1.4;
M<'?%R3' >96@=#)@7DW*,=@<B52.NLG(#MLOQ 9;?;OVE#M2DD99!G&&(HA)
MD$$:2P;U+Q5)&:=AZI0GWS?8TGCMC JCXQJL%UX[GO(%VL2T=%:UTOLYM0T@
M7OM,]XTW;QMI"\^/ND3;7#.R-##_E@M9B/)F_?BX+JK [(:6]RN"L<RH"B&+
MD%Z3D81"PDD XP0E0BDBE5 C-G#.C;?0_1MCFA&CK&T&0O('';2>7T:X86Q'
M'A=!-E-Q7VOB%:B-;!=@QDZ/A7P#2'@MW#LWUKR%>@,>'Q7F#7U^K#;)EN:%
M%&V'Q^;E1U-$0T(4%(@1B-,X@R1., S3(.$\DQ'&3OLVIX=96E316@E:,UW%
M1TYB:<<%ER,T,1,<@3-!\- /@E]]D9,CS2PLTN?ML:)([Z?'/?[_6*_%]_SA
MX?]M\NU6%I^5:H1+[M9?J!'B;]5(_RSRK<E'(QS3&"9"Z,B!APG,LA!#'NA_
M2%FD%R-R1.3@9,1"PXD/>?FT+NF#(V6XX6_')/[AG(=@6KNO0&.Y.8<'K<K1
M=@V,]>9(?J]Y;!SP1SZC<//)26X&S$I5H[!YS6#C;N+O7*I3V+/"),48Q0GD
M/# !CDPA(Z9$(.!9Q!FE4EY\,-49;VF1SKF3J76G]LGKT507^_%G4R,1?:/#
MJ8ZUTYY.G8!EZN.I[I!O?CYUPG^; ZI3EXU=13W1YZHKXV=EUF=RPW/Z<$N?
M=/@?$:Y")6+(DD!!C ,!:8@B:'9I69*DE!$G+>:>L9;&,@=3S6N;[XT%3\9:
MU\75>8AM5UA>@)M\F=7%[& GN.W%;,12:Q -O^NM\\/-O.@:]/MXY35\R<B:
MH%9CJ4FX+T0KL)2;[O;4='(5GXL_3/:I24C5'_A]76S:O[ZG95XIU-;-"&(5
M8L03#!5+0],',80DX02&'$D6)1%%R"FF\6K=TKBIJT_6%.V9]+2.AZ!U$:P+
ML'>R^E3735#Y>4%?";]? CLN?+.IG9@]WV16W6N<ID#?:_F35P/GK8R: MNC
MHJE)!AGW#JF[[E:]P76$)>_HCS_TFKJ6U=KIP9K,SW51K@A),I3$'*H4!7K1
M&R*812F!42+3),HR).R$K]R'7AK[U]D;F@3RRG*PI3_:/&[PCLE"JGS[$]#&
M&_4/[077;W_'5;##O-AQ]C1H3TS(>Z-!;3709@-CM^%>_43K9Z9-C:I1]L>R
M[GCYI%"'T6?E1W=47I/?B#N,S'Z26W/">;M9FZ-/\?[YS](4J7XJJBYJFE6-
M%17EKBB/443T1'!*$<1!&$&2$DUO(A9IC*20,EUMUUOZ8,=L]D,[,=O>@ DS
M?>06<)/;L"LK>M/_;6P&=&^T8YJ4_3S8,=DTZ$[,9 ;8*FFD-1NP9_#NSQKE
MG\#>>' ]#+-[5I4S8EYSK.Q'GS?CRAF5H_PK]SN,/(^0U3[CK_I>7RMR;!4>
MB5(Z!$N@1"F&."($$AHF,$BC5&8)2E3JM#MX9IREQ5^-F8[G"F<PM#Q/N!R9
MJ<\1:@O!P<0I=(3Z8?!Z;G!FJ'G/"_K]/3HG&/CX"#GB((D^[C;K5H+S>O=U
M5VY1JD%#S1<XC!66-!:0FW-('.EU&9,LA))D#"4"TR2Q[A@^/-S2N"#X.8G^
M!HS-'5WBVFR TDH*%CEHZ@[#W<\7_D&<F#:.\/MPC-\8<>)A(!WDB;T".I-
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M)+'8TX$-Q,-LZAFXB3FUM1:\:^W]R1RU=J!L;/8+HSVW>H9S)H:]'%8GLG4
MJ8=R;>XR&_$ZN-2E7Y?+QNV\=;3$Z_X*Z\>GC;R71;E/)#&Z.=56Q8JK.!;"
M+"X#J2 FG$(240112 ,J>:R08"Y;;BZ#+XV>NXK[3:N1KO5M6E6K*%7YX)B
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M,!SCR&G5-JFU2V.EUL$+&FKYGU$[+EO,/$U,B:V?5Z#UTN24U7XV(D>0&<_
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M[O"%V3N\@-FV+\98PJS/5,'QQK/O5/XQ];3TU(Q,-O1LA293@]>M3IE\+/>
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MF%&>2_23G A$]6V1AM))A=-BT*4]VHW-8&\TZ%A]00,RJPFPBP1\PSHQ.7A
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M2$?M*%%1AI#DJ7)K/W]NI*6]8=ZO-YOU]ZKJ<V=DHX"BW&RR.4IKG$?6;@/
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MBN0S184E61P0([<>/DZXT1@AAXNW$WR\6X39<EJ%<HEQ9@/MH<: \+X>"8@
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M:3S?8+KF+";2:YZX$8 J)U!:)'"<U,FRL@J3%D(W&3;_,%D].,2#H&9 Z7>
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M>SK_^'$^N[KU^N1C/5.;(/H02RUH+*S6I$E/80]:D-:+6#@J$9L$"(>3W$U
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M7')!(A"IMA<PEK':7H V>$8KA(C7-F;E;9LBX^WDC%M.-3R !A!Z!]#9H4_
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M1M9F8O"^A(X\,[,-TIIJJP,T_H:_WY#<8CZC;],Z ;-Q1[_>W;<5"Y9%79N
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MV?QCF,XFUBC-+3H0D1:0"D8 F?T"P3&&EL> ?I?ZVT&@MR%I'(O6!@)[X.L
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MK?:1YZ(9"Q)$X*S._ P0/"?O)WO4,?H8=)NF;3N3V$,XWP9AVU-$@ZOMD1O
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M%X5UQ63;OC_U_^U,=CCT!NI,M@\.NK@M=U^G+.UTEI:"LJQ]I*"L(#@9.9!
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M#U)$CVBZO%LHT&=>$JD\U&"_< ^!H2(8.)ZCR<12D\JI>^CIR&8=IND?8><
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M6K",H-)E4_EV8'%>Y#R_ZM,3YOF/Q:OP?7X>SK8AFB@N6[3U_"4'3]/!'))
M*+4WB_4.0\XM+,^C5$T;!HT'JO%5T &>[A[P;Z\3"YW%5&)4X!*OQED4\#9K
MB!*3"88I;9H43CQ(T;35^^-[0N.(?N)3[,5B<1'./F*Z6%V.5/Q62]TV6OF
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M&]Q.#^!&&N[ /=QD3U0&PMF-J]X[T?[VSA[SU>C(%ZM5[7^\&1<TLUEG&54
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MI9)LB+JW-F3/[6)M'"2.H+]N4?@.S]^7S^&O63'%"\L\L*QJAS^CB!'&0,C
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M[%?+]?EZI@OFK#1"=#4+05.<'"4FX"[0;M&<.&,MP/0T:7UF]1T#JY'5T0'
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M1#> %S9+44SPHDEOMZ<(ZPU1AZA_MZ\_CBXZP-9M(=5*\\LV,=%+)0J"S:E
MG2<$(3(%,7/% @\NV]S>-FW)F?;Y<*H#[R!E= FIJWVG@XZ6&0$E$?6*IU"W
MAB,^?$94C//8I#?[0P3U9)X.4_:3^#E \A,W#?GM+TP7-1:_VF6W>;HRLBR9
MXIAT-=>,@7)(#H&4#+22*+,-)K@[X>#.]B!#UNH-)(=H=-E0O-T9G$_?EXOU
M<O6V_EC54MU4SB6)]1$J&DZ;R@K:3X$Q2"0N'47M^=SD7?!)RJ9-89CJ9#M6
M1;UC[CKEMI!':4SM54:Q2ZG,R<S!I20]=SZ$-BV7!]#6DU4[&@W[8.T U72
M-J(:U^?S=,-&A\#1UEX!D;,(RM0V%+).,&9.I\+H/[+-P*][I'2,I4.T?3?3
MX3C13PB>5*>*K7[._O%I9C%KGJK55@&)8A_!\YQ!^LBY+26XL".<6V_1LL;T
M?[XL?_S'U2=>@N7J+W=Q\FO5B7.,C]3;\B@A=F SKE,:?ON?BUKEO/Q&>Z.F
M%FX,+!,Y!X,.!/<)%&/DXN50(*<<1126<=<DP'^4JFG3[T[G#8VGF@YP=H>'
M;:-";6THB7:8#K+V::4#W*@,&$LV0=)NB4U*A'=2,_&#R7C:7HXM^@[P\R*E
MBV\79W7&](Y]]R+_]\7Z_'(D]56JVH?E:J.Z\_/5/%Z<U]WX>?ENN4A+LM3+
M,UKGRS87\<KP)Z=$, 6A2&M!254;.1A%@O8,ZZA-QII</+5G;5IDCX"_9==@
MZ&![W,E/?!G.:JG)IZ^(YR\6^47.\\I_.+MQ0+W\27_YOER'L]]7RXOOZVMA
MU7]#<IDO+C"__XZK#5 NS5!F04?O$K 0,RAG' E$U70H3<>9PJA*D_*AT[ W
M;0+VZ1R+#L'2P1;:B\$;=ZQ),\^2<\"]UZ"RU! 8&0ZF:O<?9$R7-FU.#J-W
MVK.@1^C=#>5/@(.)7T]^Q]6WL/CG5_I$8A1?7JQKO\GU]FT:0\J*(:3 '"A4
M=:RY,R SB]'P'-G=+BP[GTT>763BJ/\4*EZVD'<'=O+.%KYU(6L,RL2(E9*=
M "6P3LU,D@1D+)<Z$9=-NB0\0M.T/>HF.]0/5DN_"+O:A+88$3D%#B9H#RJI
M!-X@N>>124VQ,/HV"7&/4M75J7JX[H=AZ@!%=("J3=4%Q7S+2\M>([[*W6]_
MU7QHW(Y0%"YGBQ&",V3AI4/P(A?0% P:[1BS;5)XAQ#7)<8.P<*RL6(Z -M]
M:__+V+^]KJWU'+T))=6<PMJC*TJ2&DO@I$*F74*IFQ1J#:)N$-SL\S\XQU=5
ME_A[A^<?<#5?YGFZ^NJKY?I\)KRBS>,\8*Z)J/5..0H?@'-EA'5%9-&HK]4P
M J=N030Z-IY$WPB*ZA* K^I=:[U]K4'5RY^_??M^MOQ9T\BX-S)Z"R;57JB8
M&43I(FBOO"6;KW2; 1.#*9RZ+='I(3B&JKK$8/W_B_4:S]?;HLX/89YG/@45
M35$@I&'D(RL!@1<),6=F@D-%3)\&@KL)G+J%T>D1.(*BN@3@FXM:(TSV/54-
M?D'R:Y7UJA@@J=6Q'>2Y>*$MF76F VI&)KY1D^RG2)NZR]'I07>4<B:^TKW#
MS:_ZH[?S$&N;PSFN7^,*T_++8OZ_F&<IAI"#1G".!*92S!",KAD%EOMD651R
MR"WOONM.W>2H%:J:Z^!@?/W 55R.E86Q3/-#'M4O'5KZR16&-;[&R]]G)4EI
M0O20@\\U;".?%J."8&5QQL;D19.KO''9F/:&N;VAG%#I1W15_5*S0SZWL*TU
M@1C/S\^NTXD_!)))FG\/B_/U#(/@IM0Y7+[N:3HE:EX+@R 8VH)>WQMX-L2N
M/KKFM#<U)[6IX\F^2_?P%V_K7Q[P3,0H8JVQ,F@%N2&"9(<F A/T]VASB.Q$
M/N).^@;!SST_^+544Y?H^WCMF;S#\]_#?/%VN5Z_OB #?X-A7L=1FI!K:_=<
MB,^@(^TW)\ ZA8E;EDR;@J5#"1Z$3_]WPF<#1?9Z$O_:?Q\N>R*_6:Y>+!:7
M&:>+RSY&+MH4&3I(MCY.U5S.8#P'&Z/FWIH4HSWH2!ZP^+#[:_;\T'<:=3QK
M.YD"8\'5"2J"O!%.%BVZP"G8BRS&+#FJ#NWDN(W__A/SEUN#]VXK=E"KO_N?
M,49SOR<H&VWXWVK^8],T\%=OY?6+1;ZW^H[V:U:G>MF)8*4PH$R@&"E)!-JH
MW# ;I-=-DJV/H/GXO;;WTK_Z9-9T%BF#!ZQS9Y21&APZ UII1ZK7-ME&$Q4/
M)WKJY\W3H/.^QW(B-7?:#O4>GYLLAE%LX]4G-;&0NZCLP$YZDY%SAH"BGK-U
MN)BS2@'W17,E1,BIT0/R9';R39BO_BN<7>#+GS=3Z#?YS/,ZRF&[64*6#$,4
MD!&KBQ\-1),MR**]$LPK'YL4\ XE\/G:OWU0=]?^-5'?<[%U(S1_?OHSF]B_
MDS2 /@J3+"&RR"!(XVLNG*JYOK5Q>/8H ];\C;^9)?RU]&4FH)$I&4D^@<^>
M0MGL/$1?"J!QA?Y'[@$V2>"]0\<SMFM[8.AAOVY_9701Z=\<@7.9/9^35LQK
M$)BJE^M];:!FH" /%,L'J5FS44&W2>D%40=H]M%IGWN+N3N@W"@0$R([6Z_/
M0A:E/NA;<%D16RHH7TO%C&B4T+V;H*E!<YRB'\7-@5*?NF_EQ6KY&A?+;_-%
MO15_MSS';1E@T)$+:P,86X=AJ=J^6I-\DHS):V^]2>4)O^CQ%7H"PZ':6XXN
MRHD!\7)%!_'ZZX?EQ2)_HH\\JW6HN[E"IJ*/M%GH>%:@=);@/5G?0+]P*STK
M?D@[T^$K3IWX/#)@&HEZ8@"]( 7KF[1+P7-R0D!(7E+,*!/4_0""2R]J,4Q6
M0^S(W<^=.@=Y9# <);8.7) ZL9,^[5L5S/48!(VF6%$DI&(C>65(_IGE"4RF
MKU?<NKL-C\=Q/W81,[7Q&,]?/5K4'<)E6[9IBHO<D773@8,JD>#O0KW$MYS1
M#LK)-_%7=Y,SK8-RO)J?P,T!,N\".6%1'_/K-KHRE=$YIY4MY%XY.AU%B1!%
M<9!YT5PZKKUL\K!]GY2^$'.(@N]AYBAI=X"7G7=/VYR#ES^OKJ ^XMEE=Y6O
M\^^;C289CR)Y!R7K*C1A($J3((M<2G88-&]TT7((N5,[0V->QC175P>@W,'&
MU6:-Y"(J4PLOF/4D.W(B R8..CE5/#IFVDR8?Y"BJ:/T]G!8MM!-!R![AQ2B
M_,#+UI-77&UM.$LUC4Y -JK4(R%#+#6%H4BA!;?9VR:.^<,D30NSD72^;**
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MU[/5_/UMN)G&5_//G^>SCZMY_.?;VQ+RO<MEU(Z?E3%\%C"^T]*05";F2$A
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M8,M/UW[UZ_0&TCI=9)*3-=%&1[+2Z"#*K(GUF9*LP6C*5,#8^H#CU^>?U@]
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MW49L>T^^?_2<%D%RC#;GE40[^D4RS'[WBW_":H>53PL_6_HNRV([EP@I1[E
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M;,RF2K'N4P2=;.1VOO?GZ3+>S)>W"_B$HGR)'_WG1"<168SE.D8FY#DAP!T
MR>A]6\-RC+)*X-^#MI$SB(= R2-;-+!&6BTF>[20NZO 84S-YJOJ&)Q]=-8V
M.QD]_<1L2< J\T;!2E(V-:*3<BI2FFV=7I;5S,ZFWNU=WGW"ZUF>+SYW>GKY
M;?/'>^!+3RFC G=U9S.164?BK1($74<6C<<_JRI%6$?2VZAY.@1-C\S3&31W
M,2;KA)K5)[^KCM&J61OZ),X2;E$9J"54.5&RZPRQBG%BI'2:&I%AM]'57\IJ
M=:DMQ@9O5,:PA(N21 L170'OB#4N!RN5<;NSPT>Q6.-7CPZ"HA.MU<$::^#(
M[:Z,;;O4MXN_*V.C05LN12)&=\++0(+6Z"DFKI)P43%7*</B&:I&!EIM3#Q5
M57JR@EI VYKV31$;6)K 9TUP$3HB+<O$E49TGBLARQ@$EFI&PTU5D9ZNW?V!
MX!&B'KG7YA\?WU][7$<1;E?3Z&\VC&S2@[,+X+VSQ#(,BZ5/DH1R"DPQ5 Y<
M*:VC^X'S],.'-+&3':.X>0TIC@R'[GATUDE_EPLFN?$,NN-:# H4LR38) @X
M:IF.-"759_K\TT\8-Z-I&" ,)+^14? [I [%MXNK[M_YS6V76O4]0TISR2,+
MQ#F&D:D/^%LN]0ZYY(.#]2KU,0Z]'C9N+M PV!A>JB/#Y#VJ(2ZF7[IQ'A"O
M9_.;^=6W)_BR3,HL<R L@4&^J"1..4UTE)8K6U)*^_1G.^29XZ;E# .::C(>
M$3O+Q6KR"HF?WVS&QW7I^YT/EG W%,EG$KVVR$$6)#B>2,R.&4$!9.X3 N$3
M'CBH^&K7.7V:A)%WH3/%.P.IH#D0;58;YT$)9CSAPN!>2\L<+1WQ!RX'SSU(
M9_K<XQ\)HS%#G:$4^RQ.CI!R ^'PNR^P\&4I;:.^C=5TS@KO%"=9=VE;CA$K
M>''/A71,JRQEE1K!)^AI"3?'*'HW$6D J3< GE?S!1IBORK=1+_?=&F@+"LD
MG_.RZ1I9>OM'3:BAVE 0-I@J(X6>I&B<':P:@(:1_,@[U=W)TV\POUKX+]<E
M NBLLI#&4)DL^FP28T,9/ D)/7^7/&[BRFKE8*BMZDDJ1@ZOSNCT#*.(L=&T
MEL1#%C8+364JDF6>*(\[NS3XPP?N2 HN:5'.&UB?CI3]T/04%>/M8 -I=SZT
MJ$?$2YS?SE:+;Y,_/DYX2D!=&3O#RW19Z<L!-TCT!YTP:)FUI7MRPY9;="PA
M_G0U__K?FV]< V3S8A<?]T\=$0S#J&Y^DAQ'MA2_W"[F7[9M2:P+"8S-1,22
M\AJ8)E9307 #]HQZ0YWHD[#?RS@\?/!X#LFP$#A)H WXL.A _;%UOR5%@^B9
M+;V>*0:##(C-BF$PF#,MT6!B5;S6!S2,XW0,#XM3Q3NRB7@S74VO.K&_\DOH
M-DMN @_<:Z*2X*6(SZ*I"XI L-RPT@^<]@%'+T/Q^/$C']N>T1D]4?1- ><3
M_H]MNUR*#,>8"*.IW'1E0RQ+L=17X+L090I]4LF.@,\]$>.Y':<J]4E\'"GA
MD2^)WFXN0Q]>9+S[,D4__9Z[[78J7$HR6V*T=B@FKTAP1I(0G-<\6Y[#CG^R
M]XJH_Q-; <FQFIU7%W,#7LN'N_G+I0/>QR_EC&GQ9KX9*EB6%W/.),#8CD>*
MFRW'V,XFCFO,22<H5<KR*F,8?DC9N&74Y\Z=&U91K2-OLUZ%94&R$OQ!:4J:
MLR=.VD"<Y](ZRC7ZD&?'7@NY=@.CX1"L':&:!M"&5,-R-8V%H:VESM1:51HL
MHIM0H@A)K$]HKHW1WB3DHTX^^F-2&L;2,=J>#RKZ-D[W&%696UZ<S)(NI*,D
M/E%+$O.))TJU5WM:CUSDZ=Y0>GM\M'>($!NP&=\OC.)&=I8U&ATH0]9C5SAF
M@RSS<#0Q*IE 9?915JF\VT_.N TWQO6"CE))D\#:F-D8'%<T @8/&<VL+2,&
M8DI$"RL8AVRX.X.O/7:</Z2R?XB?(R3? (+>EZXS\UG7M?S[1N;;K'C)M)!6
MD:P58!BJ,,CM.J4'RB-76BI9I1[E1X2UAJACU#^OJ(L&L/4!NMZ([_UB]:T;
MO.UCEPW[\MO#OZR7HF1!2S3E&DHILV&:>!_+S'AJ./?)*UIE-DA_$L?MVG/^
M[;&*ZAH#Y6;-&AIMC%:0D 727>Z(@PA M/:0!+7,0I7X[3$I8QNU.DI_!EM'
M:* !#-WENOWO^72V^CN*]G9Q-U2$!<O04!/%3"D'H1C@>A:)DL9*)M'+L%5.
MFIZAJ1U4':/NI_(,3Y3]V+EA=P9]W1SM=UA=S]/]F+''[P*\]9_7CBLN+\@Q
M<D*EQNC9.4"C+C)AS#C@VN8$?7RR?NEC)Q#:"WCVTO?,LZIS[$2E)_C8+.P
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M8T;'PIPKN)X'D'A"9J'JI((@TQ23E5*PIF^BC$4+/>*"%A- 1?[$@1UL"$<
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M+Y@HW1L"&]'Z]P+[-&-W/<(&":,Q$@XD'XJ=41C',0NWZ^A[3?<!#00^ARW
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M,#(P,3(S,5]D968N>&UL4$L! A0#%     @ EX!"4C#=/6SQ*@  ="P  !,
M             ( !,G8$ &UC:RTR,#(P,3(S,5]G,2YJ<&=02P$"% ,4
M" "7@$)2#)_..#L] 0 4VPP %               @ %4H00 ;6-K+3(P,C Q
M,C,Q7VQA8BYX;6Q02P$"% ,4    " "7@$)2 #^]T5#/  !;5PD %
M        @ '!W@4 ;6-K+3(P,C Q,C,Q7W!R92YX;6Q02P$"% ,4    " "7
M@$)27PEPBE,(  "H*0  &P              @ %#K@8 ;6-K7V5X:&EB:70S
M,3%X,3(S,3(P,C N:'1M4$L! A0#%     @ EX!"4D1>215H"   H"D  !L
M             ( !S[8& &UC:U]E>&AI8FET,S$R>#$R,S$R,#(P+FAT;5!+
M 0(4 Q0    ( )> 0E)\7[I8, 8  -@D   :              "  7"_!@!M
M8VM?97AH:6)I=#,R>#$R,S$R,#(P+FAT;5!+!08     "@ * )\"  #8Q08
"   !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
